Psyllid ID: psy10954

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560--
Protein Sequence
KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPNNKLKRIKPKIEEWPSSQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV
Secondary Structure (PSIPRED)
ccEEEEEcccccccccccHHHHHHHHHHHcccccccEEEEEEEEEccEEEEEEEccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEccccccccccccccccccccccccccccEEEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEcccccccccccccccccccEEEcccccccccccccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHcccccHHHHHHHHHcccccccccccHHHHHcccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccHHHHccccccccccccccHHHHHHHHHHHccccccccccccccccccccEEEccccccccccccccccccEEEEccccccccccEEEcHHHHHHHHHHcccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHcccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cEEEEHHHEcEccccEccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccEEHHHHHHHcHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHcccccccccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHHcHHHHHccccccccccccccccccccccccHHHHHHHcHHHHHHHcHHHHHHHHHccccccccccccccccccccccccHHHcccccccccccccccccccccEEEEEEcccccccccEEEEEccccccccccEEEEHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHcccccccccccccccHHHccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
kvsdesrprsrvqvegvpstALREISVLkelkhpnvirlhdvipvDFKLFLVFEFLRQDLKDflqttpvpvppaLAKSYLYQLLEALRYCHSRriihrdlkpqnilinksgalkladfglsraftipmnrythevvtlwyrppeillgakVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRriihrdlkpqnilinksgalkladfglsraftipmnrythevvtlwyrppeillgakVYSTTVDIWSAGcifsemitkktlfagdsEIDQLFRIFRTlgtphedvwpgvsklpiyktdfpewrpkkfseilnlpdplavdvfskimaldpkqrvSAKTILQheyfnqvemvkptlavfpelgyggngckdFKPWIAKLIKTQWqrswddipnnklkrikpkieewpssqrstrmEEVVLTRLRIghtrlthkylftrepqpvcqcgetlsiqhilvcpthahirsslpsppslsddavsiDVVTYHEsitkktlfagdsEIDQLFRIFRTlgtphedvwpgvsklpiyktdfpewrpkkfseilnlpdplavdvfsrv
Flexible Loop (DISEMBL)
kvsdesrprsrvqvegvpstalreISVLkelkhpnvirlHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHrdlkpqniLINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHrdlkpqniLINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLgtphedvwpgvskLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTqwqrswddipnnklkrikpkieewpssqrstrmeeVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESITkktlfagdseiDQLFRIFRTLgtphedvwpgvskLPIYKTDFPEWRPKKFseilnlpdplavdvfsrv
Low Complexity Region (SEG)
KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPNNKLKRIKPKIEEWPSSQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRsslpsppslsDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV
Disordered region (IsUnstruct)
********************ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPNNKLK*******************EVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHI*************AVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV****
Disordered Region (DISOPRED)
KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKP**************************************************************EVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV
Disordered Region (DISEMBL)
*****************PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPNNKLKRIKPKIEEW********MEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV
Disordered Region (DISPRO)
KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPNNKLKRIKPKIEEWPSSQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPNNKLKRIKPKIEEWPSSQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	562	2.2.26 [Sep-21-2011]
P97377	346	Cyclin-dependent kinase 2	yes	N/A	0.544	0.884	0.468	8e-80
Q00526	305	Cyclin-dependent kinase 3	yes	N/A	0.327	0.603	0.632	2e-68
P43450	298	Cyclin-dependent kinase 2	N/A	N/A	0.330	0.624	0.607	2e-66
P29618	294	Cyclin-dependent kinase A	yes	N/A	0.334	0.639	0.592	3e-66
P24941	298	Cyclin-dependent kinase 2	no	N/A	0.330	0.624	0.607	5e-66
O55076	298	Cyclin-dependent kinase 2	no	N/A	0.338	0.637	0.602	1e-65
Q63699	298	Cyclin-dependent kinase 2	yes	N/A	0.330	0.624	0.602	1e-65
P48963	298	Cyclin-dependent kinase 2	N/A	N/A	0.338	0.637	0.602	1e-65
Q5E9Y0	298	Cyclin-dependent kinase 2	yes	N/A	0.330	0.624	0.602	1e-65
P93101	294	Cell division control pro	N/A	N/A	0.330	0.632	0.582	3e-65

>sp|P97377|CDK2_MOUSE Cyclin-dependent kinase 2 OS=Mus musculus GN=Cdk2 PE=1 SV=2

 Score =  298 bits (763), Expect = 8e-80,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 210/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM  +     A      RR
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMHLVCTQHHAKCCGEHRR 213

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                L P    +  +     +  G   A + P     H V                   
Sbjct: 214 NGRHSLCPLCSYLEVAA----SQGGGMTAVSAP-----HPV------------------- 245

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                          T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 246 ---------------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2

>sp|Q00526|CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1

 Score =  260 bits (665), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 117/185 (63%), Positives = 145/185 (78%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG+K Y+T VDIWS GCIF+EM+T+K LF GDSEIDQLFRIFR LGTP ED
Sbjct: 166 LWYRAPEILLGSKFYTTAVDIWSIGCIFAEMVTRKALFPGDSEIDQLFRIFRMLGTPSED 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WPGV++LP YK  FP+W  K   EI+   +P   D+  +++  DP QR++AKT L H Y
Sbjct: 226 TWPGVTQLPDYKGSFPKWTRKGLEEIVPNLEPEGRDLLMQLLQYDPSQRITAKTALAHPY 285

Query: 349 FNQVE 353
           F+  E
Sbjct: 286 FSSPE 290

Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0-G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-independent manner.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P43450|CDK2_CARAU Cyclin-dependent kinase 2 OS=Carassius auratus GN=cdk2 PE=2 SV=1

 Score =  254 bits (648), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 143/191 (74%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  G +KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAQGEIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EMIT+K LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMITRKALFPGDSEIDQLFRIFRTLGTPDES 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           +WPGV+ +P YK  FP+W  +  S+++   D    D+  +++  DP +R+SAK  L H +
Sbjct: 226 IWPGVTSMPDYKPSFPKWARQDLSKVVPPLDEDGRDLLGQMLIYDPNKRISAKNALVHRF 285

Query: 349 FNQVEMVKPTL 359
           F  V M  P L
Sbjct: 286 FRDVTMPVPPL 296

Involved in the control of the cell cycle. Interacts with cyclins A, B1, B3, D, or E. Activity of CDK2 is maximal during S phase and G2.

Carassius auratus (taxid: 7957)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1

 Score =  253 bits (645), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 112/189 (59%), Positives = 150/189 (79%), Gaps = 1/189 (0%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV 227
           SYLYQ+L  + YCHS R++HRDLKPQN+LI++ + ALKLADFGL+RAF IP+  +THEVV
Sbjct: 106 SYLYQILRGVAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TLWYR PEILLG++ YST VD+WS GCIF+EM+ +K LF GDSEID+LF+IFR LGTP+E
Sbjct: 166 TLWYRAPEILLGSRQYSTPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRVLGTPNE 225

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
             WPGVS LP YK+ FP+W+ +  + I+   DP  +D+ SK++  +P +R++A+  L+HE
Sbjct: 226 QSWPGVSSLPDYKSAFPKWQAQDLATIVPTLDPAGLDLLSKMLRYEPNKRITARQALEHE 285

Query: 348 YFNQVEMVK 356
           YF  +EMV+
Sbjct: 286 YFKDLEMVQ 294

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P24941|CDK2_HUMAN Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2

 Score =  252 bits (644), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|O55076|CDK2_CRIGR Cyclin-dependent kinase 2 OS=Cricetulus griseus GN=CDK2 PE=2 SV=1

 Score =  251 bits (641), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 144/191 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Cricetulus griseus (taxid: 10029)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q63699|CDK2_RAT Cyclin-dependent kinase 2 OS=Rattus norvegicus GN=Cdk2 PE=1 SV=1

 Score =  251 bits (641), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 144/191 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P48963|CDK2_MESAU Cyclin-dependent kinase 2 OS=Mesocricetus auratus GN=CDK2 PE=2 SV=1

 Score =  251 bits (641), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 144/191 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Mesocricetus auratus (taxid: 10036)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q5E9Y0|CDK2_BOVIN Cyclin-dependent kinase 2 OS=Bos taurus GN=CDK2 PE=2 SV=1

 Score =  251 bits (641), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 144/191 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINADGSIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P93101|CDC2_CHERU Cell division control protein 2 homolog OS=Chenopodium rubrum GN=CDC2 PE=2 SV=1

 Score =  249 bits (637), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 109/187 (58%), Positives = 148/187 (79%), Gaps = 1/187 (0%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +LYQ+L  + YCHS R++HRDLKPQN+LI++ + ALKLADFGL+RAF IP+  +THEVVT
Sbjct: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRQTNALKLADFGLARAFGIPVRTFTHEVVT 166

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG++ YST VD+WS GCIF+EM+ +K LF GDSEID+LF+IFRTLGTP+E+
Sbjct: 167 LWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRTLGTPNEE 226

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WPGV+ LP +K+ FP+W  K  S ++   DP  +D+ +K++ LDP +R++A+  L+HEY
Sbjct: 227 TWPGVTSLPDFKSSFPKWISKDLSAVVPNLDPAGIDLLNKMLCLDPSKRITARNALEHEY 286

Query: 349 FNQVEMV 355
           F  +  V
Sbjct: 287 FKDIGFV 293

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Chenopodium rubrum (taxid: 3560)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	562
410046531	346	PREDICTED: cyclin-dependent kinase 2 [Pa	0.544	0.884	0.474	4e-79
348580968	346	PREDICTED: cyclin-dependent kinase 2 iso	0.544	0.884	0.474	4e-79
355677364	346	cyclin-dependent kinase 2 [Mustela putor	0.544	0.884	0.474	8e-79
395835170	346	PREDICTED: cyclin-dependent kinase 2 iso	0.544	0.884	0.471	2e-78
345842359	346	cyclin-dependent kinase 2 [Cricetulus gr	0.548	0.890	0.468	3e-78
291389407	346	PREDICTED: cyclin-dependent kinase 2 iso	0.544	0.884	0.468	4e-78
74196133	346	unnamed protein product [Mus musculus]	0.544	0.884	0.468	5e-78
34556205	346	cyclin-dependent kinase 2 isoform 1 [Mus	0.544	0.884	0.468	5e-78
431914001	346	Cell division protein kinase 2 [Pteropus	0.544	0.884	0.468	6e-78
2117786	346	protein kinase (EC 2.7.1.37) cdk2, beta	0.544	0.884	0.468	1e-77

>gi|410046531|ref|XP_003952210.1| PREDICTED: cyclin-dependent kinase 2 [Pan troglodytes] gi|119617265|gb|EAW96859.1| cyclin-dependent kinase 2, isoform CRA_c [Homo sapiens]

 Score =  302 bits (773), Expect = 4e-79,   Method: Compositional matrix adjust.
 Identities = 168/354 (47%), Positives = 213/354 (60%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM +L       R C   R
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-HLVGTQHHARCCGEHR 212

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                         ++G          R    P+  Y     +  +       G    ST
Sbjct: 213 --------------RNG----------RQSLCPLCSYLEVAASQGW-------GMTAVST 241

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                         +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 242 PYP-----------VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Pan troglodytes

Species: Pan troglodytes

Genus: Pan

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|348580968|ref|XP_003476250.1| PREDICTED: cyclin-dependent kinase 2 isoform 2 [Cavia porcellus]

 Score =  302 bits (773), Expect = 4e-79,   Method: Compositional matrix adjust.
 Identities = 168/354 (47%), Positives = 212/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T VP+P  L K+YL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF 
Sbjct: 96  LTGVPLP--LIKNYLFQLLQGLAFCHSHRVLHRDLKPQNLLINADGAIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM YL       + C   R
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-YLVCTQHHAKCCGEHR 212

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                         ++G          R    P+  Y     +          G    ST
Sbjct: 213 --------------RNG----------RHSLCPLCSYLEVAASQGG-------GMTAVST 241

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                         +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 242 -----------PHPVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKTVPHL 344

Source: Cavia porcellus

Species: Cavia porcellus

Genus: Cavia

Family: Caviidae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|355677364|gb|AER95973.1| cyclin-dependent kinase 2 [Mustela putorius furo]

 Score =  301 bits (770), Expect = 8e-79,   Method: Compositional matrix adjust.
 Identities = 168/354 (47%), Positives = 212/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGAIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM +L       R C   R
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-HLVCTQHHARCCGEHR 212

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                         ++G          R    P+  Y            E+        T
Sbjct: 213 --------------RNG----------RHSLCPLCSYL-----------EVAASQGGGMT 237

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
            V            +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 238 AVST-------PHPVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Mustela putorius furo

Species: Mustela putorius

Genus: Mustela

Family: Mustelidae

Order: Carnivora

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|395835170|ref|XP_003790555.1| PREDICTED: cyclin-dependent kinase 2 isoform 2 [Otolemur garnettii]

 Score =  299 bits (766), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 167/354 (47%), Positives = 212/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM +L       R C   R
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-HLVCTQHHARCCGEHR 212

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                         ++G          R    P+  Y     +          G    ST
Sbjct: 213 --------------RNG----------RHSLCPLCSYLEVAASQGG-------GMTAVST 241

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                         +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 242 -----------PHPVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALTHPFFQDVTKPVPHL 344

Source: Otolemur garnettii

Species: Otolemur garnettii

Genus: Otolemur

Family: Galagidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|345842359|ref|NP_001230956.1| cyclin-dependent kinase 2 [Cricetulus griseus] gi|3059091|emb|CAA11682.1| cyclin-dependent kinase 2 (CDK2L) [Cricetulus griseus]

 Score =  299 bits (765), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 165/352 (46%), Positives = 211/352 (59%), Gaps = 44/352 (12%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + 
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 69  VP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
           V  +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P
Sbjct: 96  VTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVP 155

Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRII 187
           +  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM +L       + C   R  
Sbjct: 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-HLVCTQHHAKCCGEHR-- 212

Query: 188 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV 247
                       ++G          R    P+  Y     +          G    ST  
Sbjct: 213 ------------RNG----------RHSLCPLCSYLEVAASQGG-------GMTAVSTPY 243

Query: 248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR 307
            +           T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W 
Sbjct: 244 PV-----------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 292

Query: 308 PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
            + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 293 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Cricetulus griseus

Species: Cricetulus griseus

Genus: Cricetulus

Family: Cricetidae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|291389407|ref|XP_002711108.1| PREDICTED: cyclin-dependent kinase 2 isoform 2 [Oryctolagus cuniculus]

 Score =  298 bits (764), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 210/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM  +     A      RR
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMHLVCAQHHAGCCGEHRR 213

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                L P    +  +     +  G   A + P     H V                   
Sbjct: 214 NGRHSLCPLCSYLEVAA----SQGGGMTAVSTP-----HPV------------------- 245

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                          T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 246 ---------------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Oryctolagus cuniculus

Species: Oryctolagus cuniculus

Genus: Oryctolagus

Family: Leporidae

Order: Lagomorpha

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|74196133|dbj|BAE32983.1| unnamed protein product [Mus musculus]

 Score =  298 bits (763), Expect = 5e-78,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 210/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM  +     A      RR
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMHLVCTQHHAKCCGEHRR 213

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                L P    +  +     +  G   A + P     H V                   
Sbjct: 214 NGRHSLCPLCSYLEVAA----SQGGGMTAVSAP-----HPV------------------- 245

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                          T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 246 ---------------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Mus musculus

Species: Mus musculus

Genus: Mus

Family: Muridae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|34556205|ref|NP_904326.1| cyclin-dependent kinase 2 isoform 1 [Mus musculus] gi|8039782|sp|P97377.2|CDK2_MOUSE RecName: Full=Cyclin-dependent kinase 2; AltName: Full=Cell division protein kinase 2 gi|2832437|emb|CAA11533.1| cyclin dependent kinase [Mus musculus] gi|13542925|gb|AAH05654.1| Cyclin-dependent kinase 2 [Mus musculus] gi|74147117|dbj|BAE27476.1| unnamed protein product [Mus musculus] gi|74150533|dbj|BAE32294.1| unnamed protein product [Mus musculus] gi|74195090|dbj|BAE28290.1| unnamed protein product [Mus musculus] gi|74207324|dbj|BAE30846.1| unnamed protein product [Mus musculus] gi|117616298|gb|ABK42167.1| Cdk2 [synthetic construct]

 Score =  298 bits (763), Expect = 5e-78,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 210/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM  +     A      RR
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMHLVCTQHHAKCCGEHRR 213

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                L P    +  +     +  G   A + P     H V                   
Sbjct: 214 NGRHSLCPLCSYLEVAA----SQGGGMTAVSAP-----HPV------------------- 245

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                          T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 246 ---------------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Mus musculus

Species: Mus musculus

Genus: Mus

Family: Muridae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|431914001|gb|ELK15263.1| Cell division protein kinase 2 [Pteropus alecto]

 Score =  298 bits (762), Expect = 6e-78,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 210/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGIPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM  +     A      RR
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMHLVCTQHHAKCCGEHRR 213

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                L P    +  +     +  G   A + P     H V                   
Sbjct: 214 NGRHSLCPLCSYLEVAA----SQGGGMTAVSTP-----HPV------------------- 245

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
                          T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 246 ---------------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALTHPFFQDVTKPVPHL 344

Source: Pteropus alecto

Species: Pteropus alecto

Genus: Pteropus

Family: Pteropodidae

Order: Chiroptera

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|2117786|pir||I78840 protein kinase (EC 2.7.1.37) cdk2, beta splice form - rat gi|710027|dbj|BAA05948.1| cyclin dependent kinase 2-beta [Rattus rattus]

 Score =  297 bits (760), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 166/354 (46%), Positives = 212/354 (59%), Gaps = 48/354 (13%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-- 66
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+    
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF 
Sbjct: 96  LTGLPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFG 153

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
           +P+  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM +L       + C   R
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-HLVCTQHHAKCCGEHR 212

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
                         ++G          R    P+  Y     +          G    ST
Sbjct: 213 --------------RNG----------RHSLCPLCSYLEVAASQGG-------GMTAVST 241

Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
              +           T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+
Sbjct: 242 PYPV-----------TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 290

Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTL 359
           W  + FS+++   D     + S+++  DP +R+SAK  L H +F  V    P L
Sbjct: 291 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 344

Source: Rattus rattus

Species: Rattus rattus

Genus: Rattus

Family: Muridae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	562
UNIPROTKB|G3V5T9	346	CDK2 "Cyclin-dependent kinase	0.313	0.508	0.617	5.1e-81
MGI|MGI:104772	346	Cdk2 "cyclin-dependent kinase	0.284	0.462	0.652	2.2e-80
UNIPROTKB|Q00526	305	CDK3 "Cyclin-dependent kinase	0.329	0.606	0.632	4.7e-64
UNIPROTKB|F1RW06	305	CDK3 "Uncharacterized protein"	0.329	0.606	0.616	3.3e-63
UNIPROTKB|F1NA68	327	CDK3 "Uncharacterized protein"	0.322	0.553	0.646	1.1e-66
UNIPROTKB|K7EJ83	213	CDK3 "Cyclin-dependent kinase	0.261	0.690	0.700	1.6e-56
UNIPROTKB|P43450	298	cdk2 "Cyclin-dependent kinase	0.339	0.640	0.607	5.4e-63
UNIPROTKB|E2RPT8	304	CDK3 "Uncharacterized protein"	0.329	0.608	0.627	9.7e-64
UNIPROTKB|E2QW70	298	CDK2 "Uncharacterized protein"	0.339	0.640	0.607	1.8e-62
UNIPROTKB|P24941	298	CDK2 "Cyclin-dependent kinase	0.339	0.640	0.607	1.8e-62

UNIPROTKB|G3V5T9 CDK2 "Cyclin-dependent kinase 2, isoform CRA_c" [Homo sapiens (taxid:9606)]

 Score = 574 (207.1 bits), Expect = 5.1e-81, Sum P(2) = 5.1e-81
 Identities = 110/178 (61%), Positives = 134/178 (75%)

Query:     9 RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
             R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + 
Sbjct:    36 RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query:    69 VP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
             +  +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P
Sbjct:    96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query:   128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
             +  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM +L       R C   R
Sbjct:   156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-HLVGTQHHARCCGEHR 212

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:104772 Cdk2 "cyclin-dependent kinase 2" [Mus musculus (taxid:10090)]

 Score = 568 (205.0 bits), Expect = 2.2e-80, Sum P(2) = 2.2e-80
 Identities = 105/161 (65%), Positives = 129/161 (80%)

Query:     9 RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
             R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + 
Sbjct:    36 RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query:    69 VP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
             +  +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P
Sbjct:    96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVP 155

Query:   128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM
Sbjct:   156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISO;IPI

GO:0000781 "chromosome, telomeric region" evidence=IDA

GO:0000793 "condensed chromosome" evidence=IDA

GO:0000805 "X chromosome" evidence=IDA

GO:0000806 "Y chromosome" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005667 "transcription factor complex" evidence=IDA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005768 "endosome" evidence=ISO

GO:0005829 "cytosol" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0006813 "potassium ion transport" evidence=IGI

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007049 "cell cycle" evidence=IDA

GO:0007067 "mitosis" evidence=IEA

GO:0007126 "meiosis" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0015030 "Cajal body" evidence=ISO

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016572 "histone phosphorylation" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030332 "cyclin binding" evidence=ISO;IPI

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IGI

GO:0032403 "protein complex binding" evidence=ISO

GO:0032869 "cellular response to insulin stimulus" evidence=ISO

GO:0043231 "intracellular membrane-bounded organelle" evidence=ISO

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IGI

GO:0046872 "metal ion binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0051591 "response to cAMP" evidence=ISO

GO:0051602 "response to electrical stimulus" evidence=ISO

GO:0060968 "regulation of gene silencing" evidence=ISO

UNIPROTKB|Q00526 CDK3 "Cyclin-dependent kinase 3" [Homo sapiens (taxid:9606)]

 Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
 Identities = 117/185 (63%), Positives = 145/185 (78%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:   106 SYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYTHEVVT 165

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG+K Y+T VDIWS GCIF+EM+T+K LF GDSEIDQLFRIFR LGTP ED
Sbjct:   166 LWYRAPEILLGSKFYTTAVDIWSIGCIFAEMVTRKALFPGDSEIDQLFRIFRMLGTPSED 225

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
              WPGV++LP YK  FP+W  K   EI+   +P   D+  +++  DP QR++AKT L H Y
Sbjct:   226 TWPGVTQLPDYKGSFPKWTRKGLEEIVPNLEPEGRDLLMQLLQYDPSQRITAKTALAHPY 285

Query:   349 FNQVE 353
             F+  E
Sbjct:   286 FSSPE 290

GO:0005524 "ATP binding" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0045023 "G0 to G1 transition" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

UNIPROTKB|F1RW06 CDK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 645 (232.1 bits), Expect = 3.3e-63, P = 3.3e-63
 Identities = 114/185 (61%), Positives = 145/185 (78%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ + +CHS R+IHRDLKPQN+LI++ GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:   106 SYLFQLLQGVNFCHSHRVIHRDLKPQNLLISELGAIKLADFGLARAFGVPLRTYTHEVVT 165

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG K YST VD+WS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct:   166 LWYRAPEILLGCKFYSTAVDVWSIGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPSEA 225

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +WPGV++LP YK  FP+W  K   EI+   +P   D+ ++++  DP +R+SAK  L H Y
Sbjct:   226 MWPGVTQLPDYKGSFPKWTRKGLEEIVPSLEPEGRDLLTQLLQYDPSRRISAKAALAHPY 285

Query:   349 FNQVE 353
             F+  E
Sbjct:   286 FSSTE 290

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1NA68 CDK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 656 (236.0 bits), Expect = 1.1e-66, Sum P(2) = 1.1e-66
 Identities = 117/181 (64%), Positives = 145/181 (80%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             +YL+QLL+ + +CHS R+IHRDLKPQN+LIN++GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:   128 NYLFQLLQGVSFCHSHRVIHRDLKPQNLLINEAGAIKLADFGLARAFGVPLRTYTHEVVT 187

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG K YST VDIWS GCIF+EM+T+K LF GDSEIDQLFRIFRTLGTP E 
Sbjct:   188 LWYRAPEILLGCKYYSTAVDIWSIGCIFAEMVTRKALFQGDSEIDQLFRIFRTLGTPTEA 247

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
              WPGVS+LP YK DFP+W  K+  EI+   D    D+ ++++  DP +R+SAK  L H+Y
Sbjct:   248 TWPGVSQLPDYKGDFPQWARKEMKEIVPNLDRHGRDLLAQLLLYDPSKRISAKAALSHQY 307

Query:   349 F 349
             F
Sbjct:   308 F 308

GO:0005524 "ATP binding" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

UNIPROTKB|K7EJ83 CDK3 "Cyclin-dependent kinase 3" [Homo sapiens (taxid:9606)]

 Score = 582 (209.9 bits), Expect = 1.6e-56, P = 1.6e-56
 Identities = 103/147 (70%), Positives = 123/147 (83%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:    66 SYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYTHEVVT 125

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG+K Y+T VDIWS GCIF+EM+T+K LF GDSEIDQLFRIFR LGTP ED
Sbjct:   126 LWYRAPEILLGSKFYTTAVDIWSIGCIFAEMVTRKALFPGDSEIDQLFRIFRMLGTPSED 185

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEIL 315
              WPGV++LP YK  FP+W  K   EI+
Sbjct:   186 TWPGVTQLPDYKGSFPKWTRKGLEEIV 212

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P43450 cdk2 "Cyclin-dependent kinase 2" [Carassius auratus (taxid:7957)]

 Score = 643 (231.4 bits), Expect = 5.4e-63, P = 5.4e-63
 Identities = 116/191 (60%), Positives = 143/191 (74%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ L +CHS R++HRDLKPQN+LIN  G +KLADFGL+RAF +P+  YTHEVVT
Sbjct:   106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAQGEIKLADFGLARAFGVPVRTYTHEVVT 165

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG K YST VDIWS GCIF+EMIT+K LF GDSEIDQLFRIFRTLGTP E 
Sbjct:   166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMITRKALFPGDSEIDQLFRIFRTLGTPDES 225

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +WPGV+ +P YK  FP+W  +  S+++   D    D+  +++  DP +R+SAK  L H +
Sbjct:   226 IWPGVTSMPDYKPSFPKWARQDLSKVVPPLDEDGRDLLGQMLIYDPNKRISAKNALVHRF 285

Query:   349 FNQVEMVKPTL 359
             F  V M  P L
Sbjct:   286 FRDVTMPVPPL 296

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|E2RPT8 CDK3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 650 (233.9 bits), Expect = 9.7e-64, P = 9.7e-64
 Identities = 116/185 (62%), Positives = 143/185 (77%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:   105 SYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYTHEVVT 164

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG K YST VD+WS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct:   165 LWYRAPEILLGTKFYSTAVDVWSIGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPSEA 224

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
              WPGV++LP YK  FP+W  K   EI+   +P   D+  +++  DP QR+SAK  L H Y
Sbjct:   225 TWPGVTQLPDYKGSFPKWTRKGLEEIVPSLEPEGKDLLMQLLQYDPSQRISAKAALVHPY 284

Query:   349 FNQVE 353
             F+  E
Sbjct:   285 FSSAE 289

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2QW70 CDK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 638 (229.6 bits), Expect = 1.8e-62, P = 1.8e-62
 Identities = 116/191 (60%), Positives = 144/191 (75%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:   106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGAIKLADFGLARAFGVPVRTYTHEVVT 165

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct:   166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct:   226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query:   349 FNQVEMVKPTL 359
             F  V    P L
Sbjct:   286 FQDVTKPVPHL 296

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0015030 "Cajal body" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P24941 CDK2 "Cyclin-dependent kinase 2" [Homo sapiens (taxid:9606)]

 Score = 638 (229.6 bits), Expect = 1.8e-62, P = 1.8e-62
 Identities = 116/191 (60%), Positives = 144/191 (75%)

Query:   169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct:   106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165

Query:   229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct:   166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query:   289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct:   226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

Query:   349 FNQVEMVKPTL 359
             F  V    P L
Sbjct:   286 FQDVTKPVPHL 296

GO:0005524 "ATP binding" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0035173 "histone kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0007126 "meiosis" evidence=TAS

GO:0051298 "centrosome duplication" evidence=TAS

GO:0006260 "DNA replication" evidence=TAS

GO:0060968 "regulation of gene silencing" evidence=IDA

GO:0031571 "mitotic G1 DNA damage checkpoint" evidence=TAS

GO:0071732 "cellular response to nitric oxide" evidence=TAS

GO:0005813 "centrosome" evidence=TAS

GO:0015030 "Cajal body" evidence=IDA

GO:0005768 "endosome" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=NAS

GO:0030332 "cyclin binding" evidence=IDA

GO:0000075 "cell cycle checkpoint" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000085 "G2 phase of mitotic cell cycle" evidence=TAS

GO:0000216 "M/G1 transition of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0031145 "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process" evidence=TAS

GO:0051439 "regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=IEP

GO:0016572 "histone phosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q63699	CDK2_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.6020	0.3309	0.6241	yes	N/A
Q00526	CDK3_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.6324	0.3274	0.6032	yes	N/A
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.5706	0.3274	0.6174	yes	N/A
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.5628	0.3256	0.6354	yes	N/A
P23573	CDC2C_DROME	2, ., 7, ., 1, 1, ., 2, 3	0.5763	0.3416	0.6114	yes	N/A
P24100	CDKA1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.5945	0.3274	0.6258	yes	N/A
P29618	CDKA1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.5925	0.3345	0.6394	yes	N/A
P34112	CDK1_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.5891	0.3274	0.6216	yes	N/A
P00546	CDK1_YEAST	2, ., 7, ., 1, 1, ., 2, 2	0.5659	0.3185	0.6006	yes	N/A
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.5611	0.3060	0.5791	yes	N/A
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.5706	0.3274	0.6174	yes	N/A
Q5E9Y0	CDK2_BOVIN	2, ., 7, ., 1, 1, ., 2, 2	0.6020	0.3309	0.6241	yes	N/A
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.5683	0.3256	0.6354	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	562
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-110
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-105
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-99
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-97
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-92
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-90
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-90
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-82
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-79
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-79
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-79
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-79
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-79
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-77
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-77
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-76
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-76
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-76
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-75
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-72
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-71
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-70
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-69
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-67
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-66
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-65
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-65
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-64
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-62
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-61
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-60
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-60
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-60
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-60
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-60
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-60
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-60
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-59
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-59
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-59
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-58
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-57
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-56
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-56
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-55
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-55
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-55
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-55
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-54
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-54
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-54
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-53
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-53
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-52
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-52
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-52
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-52
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-51
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-50
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-50
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-49
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-49
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-48
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-47
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-47
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-47
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-47
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-46
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-46
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-44
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-44
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-44
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-44
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-43
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-43
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-43
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-43
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-43
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-43
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-42
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-42
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-41
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-41
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-40
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-40
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-40
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-39
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-38
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-37
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-37
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-36
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-36
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-36
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-35
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-35
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-35
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-34
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-34
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-33
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-33
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-33
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-33
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-33
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-33
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-32
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-31
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-31
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-29
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-28
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-27
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-26
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-26
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-25
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-23
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-22
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-21
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-21
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-21
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-20
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-20
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-16
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-16
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-15
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-15
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-15
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-14
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-14
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-13
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-06
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	5e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.001
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	0.001
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.003
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	0.003
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  331 bits (851), Expect = e-110
 Identities = 119/181 (65%), Positives = 142/181 (78%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S +YQLL  L YCHS RI+HRDLKPQNILIN+ G LKLADFGL+RAF IP+  YTHEVVT
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT 161

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG+K YST VDIWS GCIF+EMIT K LF GDSEIDQLF+IF+ LGTP E+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WPGV+KLP YK  FP++ PK   ++L   DP  +D+ SK++  +P +R+SAK  L+H Y
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Query: 349 F 349
           F
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  316 bits (812), Expect = e-105
 Identities = 117/181 (64%), Positives = 145/181 (80%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYLYQLL+ + YCHS R++HRDLKPQN+LI++ GALKLADFGL+RAF +P+  YTHEVVT
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG++ YST VDIWS GCIF+EM+ ++ LF GDSEIDQLFRIFRTLGTP ED
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED 222

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ LP YK  FP+W  +  S+++   D   +D+ SK++  DP +R+SAK  LQH Y
Sbjct: 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Query: 349 F 349
           F
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  302 bits (776), Expect = 2e-99
 Identities = 108/154 (70%), Positives = 125/154 (81%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG+PSTALREIS+LKELKHPN+++L DVI  + KL+LVFE+   DLK +L   P P+ P 
Sbjct: 39  EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPN 98

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L KS +YQLL  L YCHS RI+HRDLKPQNILIN+ G LKLADFGL+RAF IP+  YTHE
Sbjct: 99  LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYR PEILLG+K YST VDIWS GCIF+EM
Sbjct: 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEM 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  296 bits (759), Expect = 5e-97
 Identities = 115/181 (63%), Positives = 142/181 (78%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 163

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ LP YK  FP+W  + FS+++   D    D+ S+++  DP +R+SAK  L H +
Sbjct: 224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Query: 349 F 349
           F
Sbjct: 284 F 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  284 bits (728), Expect = 2e-92
 Identities = 112/181 (61%), Positives = 136/181 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYLYQ+L+ + +CHSRR++HRDLKPQN+LI+  G +KLADFGL+RAF IP+  YTHEVVT
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PE+LLG+  YST VDIWS G IF+EM TKK LF GDSEIDQLFRIFR LGTP ED
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ LP YK  FP+W+       +   D   +D+  K++  DP +R+SAK  L H Y
Sbjct: 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Query: 349 F 349
           F
Sbjct: 285 F 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  279 bits (716), Expect = 2e-90
 Identities = 111/188 (59%), Positives = 147/188 (78%), Gaps = 1/188 (0%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVV 227
           +YLYQ+L  + YCHS R++HRDLKPQN+LI++   ALKLADFGL+RAF IP+  +THEVV
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TLWYR PEILLG++ YST VDIWS GCIF+EM+ +K LF GDSEID+LF+IFR LGTP+E
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE 225

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           + WPGV+ LP YK+ FP+W PK  + ++   +P  VD+ SK++ LDP +R++A+  L+HE
Sbjct: 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285

Query: 348 YFNQVEMV 355
           YF  +   
Sbjct: 286 YFKDLGDA 293

Length = 294

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  278 bits (713), Expect = 4e-90
 Identities = 104/155 (67%), Positives = 130/155 (83%), Gaps = 1/155 (0%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV-PVPP 73
           EGVPSTA+REIS+LKEL HPN++RL DV+  + KL+LVFEFL  DLK ++ ++P+  + P
Sbjct: 39  EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP 98

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
            L KSYLYQLL+ + YCHS R++HRDLKPQN+LI++ GALKLADFGL+RAF +P+  YTH
Sbjct: 99  PLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           EVVTLWYR PEILLG++ YST VDIWS GCIF+EM
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEM 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  258 bits (661), Expect = 2e-82
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 1/161 (0%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  +P
Sbjct: 34  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASP 93

Query: 69  VP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
           +  +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P
Sbjct: 94  LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153

Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM
Sbjct: 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  251 bits (643), Expect = 1e-79
 Identities = 92/184 (50%), Positives = 125/184 (67%), Gaps = 3/184 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVV 227
            Y+ QLLE L+Y HS  I+HRD+K  NILIN  G LKLADFGL+R +T   +  YT+ V+
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TLWYRPPE+LLGA  Y   VD+WS GCI +E+   K +F G +E++QL +IF   G+P +
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 288 DVWPGVSKLPIYKT-DFPEWRPKKFSEIL-NLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           + WPGVSKLP ++     +   ++  E   +L DP A+D+  K++ LDPK+R+SA   LQ
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283

Query: 346 HEYF 349
           HEYF
Sbjct: 284 HEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  251 bits (643), Expect = 1e-79
 Identities = 100/183 (54%), Positives = 133/183 (72%), Gaps = 2/183 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVV 227
           S++YQLL+ + +CH   ++HRDLKPQN+L++K  G LK+AD GL RAF+IP+  YTHE+V
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TLWYR PE+LLG+  YST VDIWS GCIF+EM  K+ LF GDSE+ QL  IF+ LGTP E
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
            VWPGVSKL  +  +FP+W+P+  S  +    P  +D+  K++  DP +R+SAK  L H 
Sbjct: 234 QVWPGVSKLRDWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292

Query: 348 YFN 350
           YF+
Sbjct: 293 YFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  250 bits (641), Expect = 2e-79
 Identities = 98/162 (60%), Positives = 126/162 (77%), Gaps = 2/162 (1%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
           R   + EGVPSTA+REIS+LKEL+HPN++ L DV+  + +L+L+FEFL  DLK +L + P
Sbjct: 34  RLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLP 93

Query: 69  VP--VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               +   L KSYLYQ+L+ + +CHSRR++HRDLKPQN+LI+  G +KLADFGL+RAF I
Sbjct: 94  KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           P+  YTHEVVTLWYR PE+LLG+  YST VDIWS G IF+EM
Sbjct: 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  251 bits (642), Expect = 2e-79
 Identities = 98/181 (54%), Positives = 136/181 (75%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+ YQLL+ + +CH  R++HRDLKPQN+LINK G LKLADFGL+RAF IP+N +++EVVT
Sbjct: 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++LLG++ YST++DIWS GCI +EMIT + LF G +  DQL +IFR +GTP E 
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WPG+S+LP YK  FP + P+   ++    DPL +D+  +++ L+P+ R+SA   LQH +
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Query: 349 F 349
           F
Sbjct: 284 F 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  250 bits (640), Expect = 3e-79
 Identities = 95/155 (61%), Positives = 127/155 (81%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVPS+ALREI +LKELKH N++RL+DV+  D KL LVFE+  QDLK +  +    + P 
Sbjct: 40  EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPE 99

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           + KS+++QLL+ L +CHS  ++HRDLKPQN+LINK+G LKLADFGL+RAF IP+  Y+ E
Sbjct: 100 IVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E++
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  246 bits (630), Expect = 1e-77
 Identities = 86/181 (47%), Positives = 118/181 (65%), Gaps = 1/181 (0%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SY+   L  L Y HS  I+HRDLKP N+LI   G LKLADFGL+R+F  P  + TH+VVT
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PE+L GA+ Y   VD+WS GCIF+E++ +     GDS+IDQL +IF  LGTP E+
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WPGV+ LP Y  +F  + P    +I       A+D+  +++ L+P +R++A+  L+H Y
Sbjct: 226 NWPGVTSLPDY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Query: 349 F 349
           F
Sbjct: 285 F 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  244 bits (625), Expect = 8e-77
 Identities = 91/183 (49%), Positives = 124/183 (67%), Gaps = 5/183 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           + QLL  + + H   I+HRDLK  N+L+N  G LK+ DFGL+R +  P+  YT  VVTLW
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW 171

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LLGAK YST +D+WS GCIF+E++TKK LF G SEIDQL +IF+ LGTP E +W
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 291 PGVSKLPIYK----TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           PG S+LP  K    T +P  + +K    L+L D    D+ ++++  DP +R+SA+  L+H
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSD-NGFDLLNRLLTYDPAKRISAEDALKH 290

Query: 347 EYF 349
            YF
Sbjct: 291 PYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  243 bits (623), Expect = 1e-76
 Identities = 100/183 (54%), Positives = 130/183 (71%), Gaps = 1/183 (0%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            SYLYQLL+ L +CHS  I+HRDLKP+N+LIN  G LKLADFGL+R+F  P+  YTH VV
Sbjct: 101 KSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T WYR PE+LLG K YST VDIWS GCIF+E+++++ LF G SEIDQLF+IFRTLGTP  
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP 220

Query: 288 DVWPGVSKLPI-YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           +VWP  + L   YK  FP+       ++     P A+D+ S+++  DP +R++A+  L H
Sbjct: 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280

Query: 347 EYF 349
            YF
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  242 bits (618), Expect = 5e-76
 Identities = 93/156 (59%), Positives = 124/156 (79%), Gaps = 2/156 (1%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT--TPVPVP 72
           EG PSTA+REIS++KELKH N++RLHDVI  + KL LVFE++ +DLK ++ T      + 
Sbjct: 39  EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD 98

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
           P   KS+ YQLL+ + +CH  R++HRDLKPQN+LINK G LKLADFGL+RAF IP+N ++
Sbjct: 99  PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +EVVTLWYR P++LLG++ YST++DIWS GCI +EM
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEM 194

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  241 bits (618), Expect = 6e-76
 Identities = 98/183 (53%), Positives = 132/183 (72%), Gaps = 3/183 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+++QLL+ L +CHS  ++HRDLKPQN+LINK+G LKLADFGL+RAF IP+  Y+ EVVT
Sbjct: 103 SFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVT 162

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHE 287
           LWYRPP++L GAK+YST++D+WSAGCIF+E+    + LF G+   DQL RIFR LGTP E
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222

Query: 288 DVWPGVSKLPIYKTDFPEWRP-KKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           + WPGVSKLP YK  +P +        ++   +    D+   ++  +P QR+SA+  LQH
Sbjct: 223 ESWPGVSKLPDYK-PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281

Query: 347 EYF 349
            YF
Sbjct: 282 PYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  241 bits (616), Expect = 2e-75
 Identities = 92/184 (50%), Positives = 127/184 (69%), Gaps = 4/184 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +L+QLL  L YCH RR++HRDLKPQN+LI++ G LKLADFGL+RA ++P   Y++EVVTL
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHED 288
           WYRPP++LLG+  YST++D+W  GCIF EM T + LF G +++ DQL +IFR LGTP E+
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227

Query: 289 VWPGVSKLPIYKT-DFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            WPGVS  P +K   FP + P+            P   ++  K +  +PK+R+SA   ++
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287

Query: 346 HEYF 349
           H YF
Sbjct: 288 HPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  232 bits (594), Expect = 3e-72
 Identities = 87/184 (47%), Positives = 123/184 (66%), Gaps = 2/184 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVV 227
           SY+  LL+ + Y H+  I+HRDLKP N+LI+  G LK+ADFGL+R F+    R Y+H+V 
Sbjct: 103 SYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T WYR PE+L GA+ Y   VD+W+ GCIF+E++    LF G+++I+QL  +FRTLGTP+E
Sbjct: 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE 222

Query: 288 DVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           + WPG++ LP Y K  FPE +P    EI     P A+D+   ++  DP +R+SA   L+H
Sbjct: 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282

Query: 347 EYFN 350
            YF 
Sbjct: 283 PYFT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  231 bits (590), Expect = 1e-71
 Identities = 97/156 (62%), Positives = 125/156 (80%), Gaps = 2/156 (1%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPP 73
           EGVPSTA+REIS+LKE++H N++RL DV+  + +L+LVFE+L  DLK  + ++P     P
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP 101

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYT 132
            L K+YLYQ+L  + YCHS R++HRDLKPQN+LI++   ALKLADFGL+RAF IP+  +T
Sbjct: 102 RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           HEVVTLWYR PEILLG++ YST VDIWS GCIF+EM
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197

Length = 294

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  226 bits (578), Expect = 5e-70
 Identities = 94/158 (59%), Positives = 116/158 (73%)

Query: 11  RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP 70
           R + EG+P TALREI +LKEL HPN+I+L DV      L+LVFEF+  DL   ++     
Sbjct: 35  RFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG 94

Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
           +P +L KSYLYQLL+ L +CHS  I+HRDLKP+N+LIN  G LKLADFGL+R+F  P+  
Sbjct: 95  LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           YTH VVT WYR PE+LLG K YST VDIWS GCIF+E+
Sbjct: 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAEL 192

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  223 bits (571), Expect = 6e-69
 Identities = 84/154 (54%), Positives = 113/154 (73%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE S+LK+LKH N++ LHD+I     L LVFE+L  DLK ++      +   
Sbjct: 44  EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH 103

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             + +L+QLL  L YCH RR++HRDLKPQN+LI++ G LKLADFGL+RA ++P   Y++E
Sbjct: 104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYRPP++LLG+  YST++D+W  GCIF EM
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  219 bits (560), Expect = 4e-67
 Identities = 80/153 (52%), Positives = 103/153 (67%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           +G+  TALREI +L+ELKHPN+I L DV      + LVFEF+  DL+  ++   + + PA
Sbjct: 43  DGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPA 102

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             KSY+   L  L Y HS  I+HRDLKP N+LI   G LKLADFGL+R+F  P  + TH+
Sbjct: 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
           VVT WYR PE+L GA+ Y   VD+WS GCIF+E
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  216 bits (552), Expect = 4e-66
 Identities = 78/157 (49%), Positives = 108/157 (68%), Gaps = 3/157 (1%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTPVPVP 72
           EG P TA+REI +L++L+HPN++RL +++    K  +++VFE++  DL   L +  V   
Sbjct: 39  EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFT 98

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RY 131
            +  K Y+ QLLE L+Y HS  I+HRD+K  NILIN  G LKLADFGL+R +T   +  Y
Sbjct: 99  ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T+ V+TLWYRPPE+LLGA  Y   VD+WS GCI +E+
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  214 bits (547), Expect = 2e-65
 Identities = 91/172 (52%), Positives = 120/172 (69%), Gaps = 11/172 (6%)

Query: 9   RSRVQVEGVPSTALREISVLKELKH-PNVIRLHDVIPVDFK-----LFLVFEFLRQDLKD 62
           R  +  EG+P TALREIS+L+ L     ++RL DV  V+ K     L+LVFE+L  DLK 
Sbjct: 35  RLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK 94

Query: 63  FLQTT----PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLAD 117
           F+ +       P+P    KS++YQLL+ + +CH   ++HRDLKPQN+L++K  G LK+AD
Sbjct: 95  FMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIAD 154

Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            GL RAF+IP+  YTHE+VTLWYR PE+LLG+  YST VDIWS GCIF+EMS
Sbjct: 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  214 bits (547), Expect = 2e-65
 Identities = 81/179 (45%), Positives = 114/179 (63%), Gaps = 4/179 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           + QLL  + + HS RI+HRDLKPQNIL+   G +K+ADFGL+R ++  M   T  VVTLW
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLW 171

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+E+  ++ LF G SE DQL +IF  +G P E+ W
Sbjct: 172 YRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
           P    LP  ++ FP + P+ F   +       +D+  K++  +P +R+SA   LQH YF
Sbjct: 231 PRNVSLP--RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  212 bits (542), Expect = 4e-64
 Identities = 89/195 (45%), Positives = 116/195 (59%), Gaps = 15/195 (7%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM----------- 219
           L Q+L  L   H    +HRDL P NI IN  G  K+ADFGL+R +  P            
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 220 ---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
                 T +VVTLWYR PE+L+GA+ Y   VD+WS GCIF+E++T K LF G++EIDQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           RIF  LGTP+ED WP   KLP+Y T+F   +PK    I       A+D+   ++ L+P +
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303

Query: 337 RVSAKTILQHEYFNQ 351
           R+SAK  L+HEYF  
Sbjct: 304 RISAKEALKHEYFKS 318

Length = 335

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  207 bits (530), Expect = 2e-62
 Identities = 80/187 (42%), Positives = 109/187 (58%), Gaps = 5/187 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVV 227
           LYQ+L  L+Y HS  +IHRDLKP NIL+N +  LK+ DFGL+R      +     T  VV
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T WYR PE+LL +  Y+  +DIWS GCIF+E++T+K LF G   IDQL  I   LGTP E
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228

Query: 288 DV--WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +   +    K   Y    P+   K  S++     P A+D+  K++  DPK+R++A   L 
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288

Query: 346 HEYFNQV 352
           H Y  Q+
Sbjct: 289 HPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  203 bits (519), Expect = 3e-61
 Identities = 73/155 (47%), Positives = 102/155 (65%), Gaps = 1/155 (0%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
            G+P+ ALREI  L+  +HP V++L DV P      LV E++  DL + L+    P+P A
Sbjct: 40  GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEA 99

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTH 133
             KSY+  LL+ + Y H+  I+HRDLKP N+LI+  G LK+ADFGL+R F+    R Y+H
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +V T WYR PE+L GA+ Y   VD+W+ GCIF+E+
Sbjct: 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  201 bits (513), Expect = 2e-60
 Identities = 88/184 (47%), Positives = 127/184 (69%), Gaps = 1/184 (0%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +L+QLL  L YCH R+++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y++EVVTL
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL 168

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYRPP+ILLG+  YST +D+W  GCIF EM T + LF G +  +QL  IFR LGTP E+ 
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228

Query: 290 WPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           WPG+     +K+ ++P++R           D    ++ SK++  + ++R+SA+  ++H Y
Sbjct: 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Query: 349 FNQV 352
           F+ +
Sbjct: 289 FHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  200 bits (510), Expect = 4e-60
 Identities = 95/189 (50%), Positives = 127/189 (67%), Gaps = 10/189 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
             +++QLL  L Y H + I+HRDLKPQN+LI+  G LKLADFGL+RA +IP   Y+ EVV
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPH 286
           TLWYRPP++LLGA  YS+ +DIW AGCIF EM+  +  F G S++ +QL +I+  LG P 
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225

Query: 287 EDVWPGVSKLPIYKTDFPEW----RPKKFSEILNLPD--PLAVDVFSKIMALDPKQRVSA 340
           ED WPGVSKLP YK   PEW    +P++   +       P A D+ S+++ + PK R+SA
Sbjct: 226 EDTWPGVSKLPNYK---PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282

Query: 341 KTILQHEYF 349
           +  L H YF
Sbjct: 283 QDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  200 bits (510), Expect = 4e-60
 Identities = 85/181 (46%), Positives = 124/181 (68%), Gaps = 1/181 (0%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +++QLL  L YCH R+I+HRDLKPQN+LIN+ G LKLADFGL+RA ++P   Y++EVVTL
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL 167

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYRPP++LLG+  YST +D+W  GCI  EM T + +F G +  ++L  IFR LGTP E+ 
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227

Query: 290 WPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           WPG++    +++  FP++R +         D   +D+ S ++  + K R+SA+  L+H Y
Sbjct: 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Query: 349 F 349
           F
Sbjct: 288 F 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  201 bits (513), Expect = 4e-60
 Identities = 85/196 (43%), Positives = 121/196 (61%), Gaps = 20/196 (10%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMN------- 220
           Y+ QLLE + Y H   I+HRD+K  NILI+  G LK+ADFGL+R +    P         
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 221 --RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             +YT+ VVT WYRPPE+LLG + Y+T VDIW  GC+F+EM T++ +  G S+IDQL  I
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239

Query: 279 FRTLGTPHEDVWPGVSKLP-----IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
           F+  GTP E+ WPG   LP        T++P    ++F ++     P  +D+ SK+++LD
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG----PEGLDLLSKLLSLD 295

Query: 334 PKQRVSAKTILQHEYF 349
           P +R++A   L+H YF
Sbjct: 296 PYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  200 bits (511), Expect = 5e-60
 Identities = 73/157 (46%), Positives = 107/157 (68%), Gaps = 4/157 (2%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQDLKDFLQTTPVPV 71
           EG P T+LREI++L +L+HPN++ + +V+    +D K+++V E++  DLK  ++T   P 
Sbjct: 45  EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPF 103

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
             +  K  + QLL  + + H   I+HRDLK  N+L+N  G LK+ DFGL+R +  P+  Y
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T  VVTLWYR PE+LLGAK YST +D+WS GCIF+E+
Sbjct: 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  200 bits (510), Expect = 6e-60
 Identities = 81/163 (49%), Positives = 109/163 (66%), Gaps = 11/163 (6%)

Query: 15  EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 66
           EG+P + LREI++LK+L+   HPN++RL DV        + KL LVFE + QDL  +L  
Sbjct: 39  EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK 98

Query: 67  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            P P +PP   K  + QLL  + + HS RI+HRDLKPQNIL+   G +K+ADFGL+R ++
Sbjct: 99  CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+E+
Sbjct: 159 FEM-ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  200 bits (510), Expect = 8e-60
 Identities = 89/196 (45%), Positives = 131/196 (66%), Gaps = 4/196 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +LYQ+L  L YCH R+++HRDLKPQN+LIN+ G LKLADFGL+RA ++P   Y++EVVTL
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYRPP++LLG+  YST +D+W  GCIF EM + + LF G +  D+L  IFR LGTP E+ 
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228

Query: 290 WPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           WPG+S    +K  +FP+++P+         D   +++ +K +  + K+R+SA+  ++H Y
Sbjct: 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288

Query: 349 FNQVEMVKPTLAVFPE 364
           F     +   +   PE
Sbjct: 289 FRS---LGTRIHSLPE 301

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  197 bits (504), Expect = 2e-59
 Identities = 72/160 (45%), Positives = 99/160 (61%), Gaps = 4/160 (2%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
            + +++      LREI +LK+LKHPN++RL+DV   + KL+LV E+    DL D L+   
Sbjct: 33  KKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG 92

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 128
             +    A+ YL Q+L AL Y HS+ I+HRDLKP+NIL+++ G +KLADFGL+R      
Sbjct: 93  -RLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151

Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            + T  V T  Y  PE+LLG K Y   VDIWS G I  E+
Sbjct: 152 -KLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYEL 189

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  198 bits (504), Expect = 4e-59
 Identities = 89/155 (57%), Positives = 116/155 (74%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE+S+LK+LKH N++ LHD+I  +  L LVFE+L +DLK +L      +   
Sbjct: 45  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH 104

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K +L+QLL  L YCH R+++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y++E
Sbjct: 105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP+ILLG+  YST +D+W  GCIF EMS
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  198 bits (505), Expect = 5e-59
 Identities = 86/184 (46%), Positives = 120/184 (65%), Gaps = 7/184 (3%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVT 228
            LL  L Y H  +I+HRD+K  NILI K G LKLADFGL+RAF++      NRYT+ VVT
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I +  G+   +
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246

Query: 289 VWPGVSKLPIYKT-DFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           VWPGV KL ++K  + P+ + +K  E L   + DP A+D+  K++ LDP +R+ A T L 
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306

Query: 346 HEYF 349
           H++F
Sbjct: 307 HDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  195 bits (497), Expect = 4e-58
 Identities = 85/155 (54%), Positives = 113/155 (72%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE+S+LK LKH N++ LHD+I  +  L LVFE+L  DLK +L      +   
Sbjct: 44  EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH 103

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K +++QLL  L YCH R+I+HRDLKPQN+LIN+ G LKLADFGL+RA ++P   Y++E
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP++LLG+  YST +D+W  GCI  EM+
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA 198

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  194 bits (495), Expect = 1e-57
 Identities = 85/155 (54%), Positives = 116/155 (74%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE+S+LK+LKH N++ LHD++  D  L LVFE+L +DLK ++      +   
Sbjct: 45  EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH 104

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K +LYQ+L  L YCH R+++HRDLKPQN+LIN+ G LKLADFGL+RA ++P   Y++E
Sbjct: 105 NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP++LLG+  YST +D+W  GCIF EM+
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA 199

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  191 bits (485), Expect = 3e-56
 Identities = 97/187 (51%), Positives = 128/187 (68%), Gaps = 4/187 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +L+QLL  L Y H R I+HRDLKPQN+LI+ +G LKLADFGL+RA ++P + Y++EVVTL
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL 167

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHED 288
           WYRPP++LLG+  YST +D+W  GCIF EMI     F G  +I DQL RIF  LGTP+ED
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227

Query: 289 VWPGVSKLPIYKTD-FPEWRPKKFSEILNLPDPL--AVDVFSKIMALDPKQRVSAKTILQ 345
            WPGV  LP +K + F  + PK   +  N    +  A D+ SK++   PK R+SA+  L 
Sbjct: 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287

Query: 346 HEYFNQV 352
           HEYF+ +
Sbjct: 288 HEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  189 bits (481), Expect = 4e-56
 Identities = 74/196 (37%), Positives = 101/196 (51%), Gaps = 25/196 (12%)

Query: 157 DIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
           D  S G   SE        Q+L  L Y HS  IIHRDLKP+NIL++++G +K+ADFGL++
Sbjct: 87  DYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAK 146

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID 273
                 +  T  V T WY  PE+LLG   Y   VD+WS G I  E++T K  F+G++ +D
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206

Query: 274 QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
           QL  I R LG P              + D P+W               A D+  K +  D
Sbjct: 207 QLQLIRRILGPP-------------LEFDEPKWSSG---------SEEAKDLIKKCLNKD 244

Query: 334 PKQRVSAKTILQHEYF 349
           P +R +A+ ILQH +F
Sbjct: 245 PSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  190 bits (485), Expect = 6e-56
 Identities = 79/205 (38%), Positives = 115/205 (56%), Gaps = 24/205 (11%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTH 224
           S L+Q+L  + Y HS  ++HRDLKP NIL+     + G +K+ D GL+R F  P+     
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 225 E---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE---------I 272
               VVT+WYR PE+LLGA+ Y+  +DIW+ GCIF+E++T + +F G             
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS--------EILNLPDPLAVD 324
           DQL RIF  LGTP E  WP + K+P Y T   +++ K +         E    PD    D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 325 VFSKIMALDPKQRVSAKTILQHEYF 349
           +  K++  DP +R++A+  L+H YF
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  189 bits (481), Expect = 1e-55
 Identities = 80/186 (43%), Positives = 109/186 (58%), Gaps = 17/186 (9%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           QLL  L+Y H   IIHRDLK  N+L+   G LK+ADFGL+R + +P    T +VVTLWYR
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+LLG   Y+T +D+W+ GCI +E++  K L  G SEI+QL  I + LGTP+E +WPG
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235

Query: 293 VSKLPIYKTDFPEWRP-----KKFSEI----LNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            S LP+        +P      KF  +    L L + L        +  DPK+R +A+  
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL--------LMYDPKKRATAEEA 287

Query: 344 LQHEYF 349
           L+  YF
Sbjct: 288 LESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  187 bits (477), Expect = 3e-55
 Identities = 71/156 (45%), Positives = 104/156 (66%), Gaps = 1/156 (0%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E V  TALRE+ VL++L+H N++ L +      +L+LVFE++ + L + L+ +P  +PP 
Sbjct: 41  EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPD 100

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTH 133
             +SY++QLL+A+ YCHS  IIHRD+KP+NIL+++SG LKL DFG +RA         T 
Sbjct: 101 AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            V T WYR PE+L+G   Y   VD+W+ GCI +E+ 
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  186 bits (474), Expect = 5e-55
 Identities = 67/159 (42%), Positives = 91/159 (57%), Gaps = 2/159 (1%)

Query: 11  RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV 69
           R +      TA REI +L+ L HPN++RL D       L+LV E+    DL D+L +   
Sbjct: 35  RSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGG 93

Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
           P+    AK    Q+L  L Y HS  IIHRDLKP+NIL++++G +K+ADFGL++      +
Sbjct: 94  PLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS 153

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  V T WY  PE+LLG   Y   VD+WS G I  E+
Sbjct: 154 SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192

Length = 260

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  187 bits (475), Expect = 6e-55
 Identities = 84/154 (54%), Positives = 109/154 (70%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVP TA+RE S+LK LKH N++ LHD+I     L  VFE++  DL  ++   P  + P 
Sbjct: 44  EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY 103

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             + +++QLL  L Y H + I+HRDLKPQN+LI+  G LKLADFGL+RA +IP   Y+ E
Sbjct: 104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYRPP++LLGA  YS+ +DIW AGCIF EM
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  186 bits (474), Expect = 2e-54
 Identities = 70/156 (44%), Positives = 100/156 (64%), Gaps = 2/156 (1%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQDLKDFLQTTPVPVP 72
           +G+P ++LREI++L  L+HPN++ L +V+       +FLV E+  QDL   L   P P  
Sbjct: 47  DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS 106

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
            +  K  + QLL  L+Y H   IIHRDLK  N+L+   G LK+ADFGL+R + +P    T
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +VVTLWYR PE+LLG   Y+T +D+W+ GCI +E+
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  186 bits (473), Expect = 2e-54
 Identities = 83/193 (43%), Positives = 116/193 (60%), Gaps = 13/193 (6%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           FSE    S++ QLLE L YCH +  +HRD+K  NIL+N  G +KLADFGL+R +    +R
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 222 -YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            YT++V+TLWYRPPE+LLG + Y   +D+WS GCI  E+ TKK +F  + E+ QL  I R
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPEWRPKK-----FSEILNLPDPLAVDVFSKIMALDPK 335
             G+P   VWP V KLP + T     +PKK       E  +     A+D+   ++ LDP 
Sbjct: 233 LCGSPCPAVWPDVIKLPYFNT----MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPS 288

Query: 336 QRVSAKTILQHEY 348
           +R +A+  L   +
Sbjct: 289 KRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  182 bits (465), Expect = 8e-54
 Identities = 71/181 (39%), Positives = 97/181 (53%), Gaps = 27/181 (14%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            YL Q+L AL Y HS+ I+HRDLKP+NIL+++ G +KLADFGL+R       + T  V T
Sbjct: 101 FYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGT 159

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+LLG K Y   VDIWS G I  E++T K  F GD ++ +LF+           
Sbjct: 160 PEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK------- 211

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                   P      PEW     S       P A D+  K++  DP++R++A+  LQH +
Sbjct: 212 --------PKPPFPPPEW---DIS-------PEAKDLIRKLLVKDPEKRLTAEEALQHPF 253

Query: 349 F 349
           F
Sbjct: 254 F 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  183 bits (467), Expect = 2e-53
 Identities = 80/166 (48%), Positives = 101/166 (60%), Gaps = 12/166 (7%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPV------DFK--LFLVFEFLRQDLKDFLQT 66
           EG P TALREI +L+ LKH NV+ L ++          +K   +LVFEF   DL   L  
Sbjct: 52  EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN 111

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             V    +  K  +  LL  L Y H  +I+HRD+K  NILI K G LKLADFGL+RAF++
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 127 PM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 NRYT+ VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  182 bits (465), Expect = 2e-53
 Identities = 76/191 (39%), Positives = 108/191 (56%), Gaps = 16/191 (8%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVV 227
           SY++QLL+A+ YCHS  IIHRD+KP+NIL+++SG LKL DFG +RA         T  V 
Sbjct: 104 SYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG--TP 285
           T WYR PE+L+G   Y   VD+W+ GCI +E++  + LF GDS+IDQL+ I + LG   P
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 286 -------HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                      + GV+     + +  E R              A+D     + +DPK+R+
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRY------PGKVSSPALDFLKACLRMDPKERL 277

Query: 339 SAKTILQHEYF 349
           +   +LQH YF
Sbjct: 278 TCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  180 bits (458), Expect = 3e-53
 Identities = 70/169 (41%), Positives = 94/169 (55%), Gaps = 3/169 (1%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
            LREI +LK+L HPN+++L+ V   +  L+LV E+     LKD L+     +        
Sbjct: 38  LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRI 97

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           L Q+LE L Y HS  IIHRDLKP+NIL++  +G +KLADFGLS+  T   +     V T 
Sbjct: 98  LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA-LRYCHSRRI 186
            Y  PE+LLG   YS   DIWS G I  E+  L  L+   L+    +R 
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRP 206

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  180 bits (459), Expect = 1e-52
 Identities = 79/185 (42%), Positives = 110/185 (59%), Gaps = 8/185 (4%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S +YQ+L+ L + H     HRDLKP+N+L++    +K+ADFGL+R        YT  V T
Sbjct: 103 SIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE-IRSRPPYTDYVST 161

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PEILL +  YS+ VDIW+ GCI +E+ T + LF G SEIDQL++I   LGTP + 
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221

Query: 289 VWPG----VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
            WP      SKL      FP++ P    +++    P A+D+   ++  DPK+R +A   L
Sbjct: 222 DWPEGYKLASKLGF---RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278

Query: 345 QHEYF 349
           QH YF
Sbjct: 279 QHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  182 bits (464), Expect = 1e-52
 Identities = 82/183 (44%), Positives = 110/183 (60%), Gaps = 5/183 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP NI +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 124 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---VATRW 180

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T KTLF G   IDQL RI   +GTP E++ 
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240

Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y    P+   K F E+ +  +PLA+D+  K++ LDP +R++A   L H Y
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 349 FNQ 351
             +
Sbjct: 301 LAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  180 bits (460), Expect = 3e-52
 Identities = 71/172 (41%), Positives = 106/172 (61%), Gaps = 13/172 (7%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDL----KDF 63
            + Q  G+  +A REI++L+ELKH NV+ L +V     D  ++L+F++   DL    K  
Sbjct: 38  DKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFH 97

Query: 64  LQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFG 119
            Q   V +PP++ KS L+Q+L  + Y HS  ++HRDLKP NIL+     + G +K+ D G
Sbjct: 98  RQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157

Query: 120 LSRAFTIPMNRYTHE---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L+R F  P+         VVT+WYR PE+LLGA+ Y+  +DIW+ GCIF+E+
Sbjct: 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  179 bits (455), Expect = 5e-52
 Identities = 84/154 (54%), Positives = 111/154 (72%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE S+LK LKH N++ LHD+I     L LVFE++  DL  ++   P  + P 
Sbjct: 44  EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE 103

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K +L+QLL  L Y H R I+HRDLKPQN+LI+ +G LKLADFGL+RA ++P + Y++E
Sbjct: 104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYRPP++LLG+  YST +D+W  GCIF EM
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  177 bits (451), Expect = 4e-51
 Identities = 75/173 (43%), Positives = 103/173 (59%), Gaps = 19/173 (10%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--------LFLVFEFLRQDLKDFLQT 66
           +G P TALREI +LK+LKHPNV+ L D+              +++V  ++  DL   L+ 
Sbjct: 48  DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN 107

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT- 125
             V +  +  K Y+ QLLE + Y H   I+HRD+K  NILI+  G LK+ADFGL+R +  
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 126 -IPMN---------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             P           +YT+ VVT WYRPPE+LLG + Y+T VDIW  GC+F+EM
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  175 bits (447), Expect = 3e-50
 Identities = 77/195 (39%), Positives = 107/195 (54%), Gaps = 21/195 (10%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-----IPMNRYTHE 225
           +YQLL+AL+Y HS  +IHRDLKP NIL+N    +KLADFGL+R+ +           T  
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PEILLG+  Y+  VD+WS GCI  EM+  K LF G S ++QL +I   +G P
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232

Query: 286 -HEDV--------WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
             ED+           +  LP           K   E+L      A+D+  K++  +P +
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRP-------RKPLDELLPKASDDALDLLKKLLVFNPNK 285

Query: 337 RVSAKTILQHEYFNQ 351
           R++A+  L+H Y  Q
Sbjct: 286 RLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  174 bits (442), Expect = 6e-50
 Identities = 74/165 (44%), Positives = 107/165 (64%), Gaps = 11/165 (6%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVI-----PVDFK-----LFLVFEFLRQDLKDFL 64
           EG P TA+REI +L++L H N++ L +++      +DFK      +LVFE++  DL   L
Sbjct: 47  EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL 106

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
           ++  V       KS++ QLLE L YCH +  +HRD+K  NIL+N  G +KLADFGL+R +
Sbjct: 107 ESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166

Query: 125 TIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               +R YT++V+TLWYRPPE+LLG + Y   +D+WS GCI  E+
Sbjct: 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  173 bits (442), Expect = 1e-49
 Identities = 70/172 (40%), Positives = 101/172 (58%), Gaps = 19/172 (11%)

Query: 21  ALREISVLKELKHPNVIRLHDVI----PVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 75
            LREI +L+ L+H N+I L D++    P DF  +++V E +  DL   +++ P P+    
Sbjct: 46  ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDH 104

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---T 132
            + +LYQ+L  L+Y HS  +IHRDLKP NIL+N +  LK+ DFGL+R      +     T
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
             VVT WYR PE+LL +  Y+  +DIWS GCIF+E+           Y+ QL
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  174 bits (442), Expect = 1e-49
 Identities = 76/191 (39%), Positives = 110/191 (57%), Gaps = 12/191 (6%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-------MNR 221
           S++YQ+L  L+Y HS  ++HRDLKP N+L+N    LK+ DFGL+R F+         M  
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168

Query: 222 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
           Y   V T WYR PEI+L  + Y+  +D+WS GCI +E++ +K +F G   +DQL +I + 
Sbjct: 169 Y---VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 282 LGTPHEDVWP--GVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
           LGTP E+     G  K   Y    P    K F  I    +PLA+D+  K++A DP +R+S
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285

Query: 340 AKTILQHEYFN 350
            +  L+H Y  
Sbjct: 286 VEEALEHPYLA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  170 bits (432), Expect = 4e-48
 Identities = 73/188 (38%), Positives = 113/188 (60%), Gaps = 6/188 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRY-THE 225
           +LYQLL  L+Y HS  +IHRDLKP N+L+N+   L++ DFG++R           + T  
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PE+LL    Y+T +D+WS GCIF+EM+ ++ LF G + + QL  I   LG+P
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231

Query: 286 HEDVWP--GVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            E+V    G  ++  Y  + P  +P  +S+I     P A+D+ S+++  DP++R++ +  
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291

Query: 344 LQHEYFNQ 351
           LQH +  Q
Sbjct: 292 LQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  167 bits (424), Expect = 2e-47
 Identities = 75/189 (39%), Positives = 114/189 (60%), Gaps = 16/189 (8%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL+Q+L  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   YT  V T 
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR 164

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT---PH 286
           WYR PE+L+G   Y   VDIW+ GC+ +EM+T + LF GDS+IDQL+ I + LG     H
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224

Query: 287 EDVWPGVSKLPIY------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA 340
           ++++    K P++      +    E   K+F ++      L +D+  + + +DP  R S+
Sbjct: 225 QEIF---QKNPLFAGMRLPEVKEIEPLEKRFPKL----SGLVLDLAKQCLRIDPDDRPSS 277

Query: 341 KTILQHEYF 349
             +L HE+F
Sbjct: 278 SQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  167 bits (424), Expect = 2e-47
 Identities = 70/148 (47%), Positives = 96/148 (64%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
           ALREI +LK+LKHPN++ L +V     KL LVFE+    + + L+  P  VP  L K  +
Sbjct: 47  ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKII 106

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           +Q L+A+ +CH    IHRD+KP+NILI K G +KL DFG +R  T P + YT  V T WY
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           R PE+L+G   Y   VD+W+ GC+F+E+
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  167 bits (425), Expect = 4e-47
 Identities = 81/186 (43%), Positives = 110/186 (59%), Gaps = 11/186 (5%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L+ L+Y H+  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   VVT W
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY---VVTRW 180

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE++L    Y+ TVDIWS GCI +EM+T K LF G   +DQL  I +  GTP ++  
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF- 239

Query: 291 PGVSKLPI-----YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
             V KL       Y    P +R K F  +L   +PLAV+V  K++ LD + R++A   L 
Sbjct: 240 --VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297

Query: 346 HEYFNQ 351
           H YF +
Sbjct: 298 HPYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  165 bits (419), Expect = 6e-47
 Identities = 77/177 (43%), Positives = 108/177 (61%), Gaps = 4/177 (2%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  M   T  VVTLWYR
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYR 174

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+LL +  Y+T VD+WS GCIF+EM  +K LF G+SE DQL +IF  +G P ED WP 
Sbjct: 175 APEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
              LP  +  F    P+    ++   +     +  +++  +P +R+SA   LQH +F
Sbjct: 234 DVTLP--RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  165 bits (418), Expect = 1e-46
 Identities = 88/171 (51%), Positives = 114/171 (66%), Gaps = 13/171 (7%)

Query: 9   RSRVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQ 58
           R RVQ   EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + Q
Sbjct: 34  RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ 93

Query: 59  DLKDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL  +L   P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLAD
Sbjct: 94  DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153

Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM
Sbjct: 154 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  163 bits (416), Expect = 2e-46
 Identities = 75/190 (39%), Positives = 105/190 (55%), Gaps = 9/190 (4%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPM 219
             E    SY+YQLL++L + H   I HRD+KP+NILI K   LKLADFG  R      P 
Sbjct: 97  LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPP- 154

Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
             YT  + T WYR PE LL    Y   +DIW+ GC+F E+++   LF G +E+DQ+ +I 
Sbjct: 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212

Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
             LGTP  +V     K      +FP  +     ++L       +D+  K++A DP +R++
Sbjct: 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272

Query: 340 AKTILQHEYF 349
           AK  L+H YF
Sbjct: 273 AKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  159 bits (403), Expect = 2e-44
 Identities = 71/188 (37%), Positives = 106/188 (56%), Gaps = 10/188 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
              ++Q L+A+ +CH    IHRD+KP+NILI K G +KL DFG +R  T P + YT  V 
Sbjct: 103 KKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT--- 284
           T WYR PE+L+G   Y   VD+W+ GC+F+E++T + L+ G S++DQL+ I +TLG    
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222

Query: 285 PHEDVWPGVSKLPIYKTDFPEWR---PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
            H+ ++             PE R     KF  I       A+      + +DP +R+S +
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNI----SSPALSFLKGCLQMDPTERLSCE 278

Query: 342 TILQHEYF 349
            +L+H YF
Sbjct: 279 ELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 3e-44
 Identities = 59/151 (39%), Positives = 93/151 (61%), Gaps = 3/151 (1%)

Query: 20  TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAK 77
             LRE+  L++L  HPN+++L +V   + +L+ VFE++  +L   ++     P   ++ +
Sbjct: 43  MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR 102

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
           S +YQ+L+ L + H     HRDLKP+N+L++    +K+ADFGL+R        YT  V T
Sbjct: 103 SIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE-IRSRPPYTDYVST 161

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            WYR PEILL +  YS+ VDIW+ GCI +E+
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  158 bits (400), Expect = 3e-44
 Identities = 81/179 (45%), Positives = 112/179 (62%), Gaps = 4/179 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++  M   T  VVTLW
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLW 174

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G S++DQL +I   +G P E+ W
Sbjct: 175 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
           P    LP  +  F     +   + +   D L  D+  K +  +P +R+SA + L H YF
Sbjct: 234 PRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 3e-44
 Identities = 69/188 (36%), Positives = 107/188 (56%), Gaps = 7/188 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----THE 225
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +    T  
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLTEY 169

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PEI+L +K Y+  +DIWS GCI +EM++ + LF G   + QL  I   LGTP
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229

Query: 286 HEDVWPGV--SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            ++    +   +   Y    P      ++++    DP A+D+  K++  +P +R++ +  
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289

Query: 344 LQHEYFNQ 351
           L H Y  Q
Sbjct: 290 LAHPYLEQ 297

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  158 bits (401), Expect = 1e-43
 Identities = 72/160 (45%), Positives = 96/160 (60%), Gaps = 22/160 (13%)

Query: 23  REISVLKELK-HPNVIRLHDVIPV--DFKLFLVFEFLRQDL-----KDFLQTTPVPVPPA 74
           REI  L+EL  HPN+++L +VI    D  ++LVFE++  DL      + L+         
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------- 106

Query: 75  LAKSY-LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-----IPM 128
           + K Y +YQLL+AL+Y HS  +IHRDLKP NIL+N    +KLADFGL+R+ +        
Sbjct: 107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166

Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              T  V T WYR PEILLG+  Y+  VD+WS GCI  EM
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  158 bits (402), Expect = 1e-43
 Identities = 72/184 (39%), Positives = 106/184 (57%), Gaps = 6/184 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THEVVT 228
           +LYQ+L  L+Y HS  I+HRD+KP N+L+N +  LK+ DFGL+R      +++ T EVVT
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH-E 287
            +YR PEIL+G++ Y++ VDIWS GCIF+E++ ++ LF   S I QL  I   LGTP  E
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL---AVDVFSKIMALDPKQRVSAKTIL 344
            +         +    P  +P     +  L       AV +  +++  DP +R+SA   L
Sbjct: 228 AMRSACEGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 345 QHEY 348
            H Y
Sbjct: 287 AHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  157 bits (399), Expect = 2e-43
 Identities = 79/183 (43%), Positives = 106/183 (57%), Gaps = 5/183 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y   V T W
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRW 180

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++  K LF G+  IDQL RI   +GTP  +V 
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240

Query: 291 PGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y    P    +   +I    +PLA+D+  K++ LD  +R+SA   L H Y
Sbjct: 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Query: 349 FNQ 351
           F+Q
Sbjct: 301 FSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  156 bits (397), Expect = 2e-43
 Identities = 79/181 (43%), Positives = 107/181 (59%), Gaps = 5/181 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +LYQ+L  L+Y HS  ++HRDLKP NILIN++  LK+ DFGL+R   I   + T  V T 
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTR 169

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           +YR PEI+L  + Y   VDIWSAGCIF+EM+  K LF G   ++Q   I   LGTP +DV
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229

Query: 290 WPGVSKLPIYK--TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
              +      +     P+  P  FSE     DP A+D+  K++  DP++R+SA   L H 
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289

Query: 348 Y 348
           Y
Sbjct: 290 Y 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  156 bits (396), Expect = 5e-43
 Identities = 85/198 (42%), Positives = 113/198 (57%), Gaps = 14/198 (7%)

Query: 162 GCIFSE--MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G   SE  + YL YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     
Sbjct: 111 GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+T KTLF G   +DQL +I
Sbjct: 171 MTGY---VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227

Query: 279 FRTLGTPHEDVWPGVSKL-----PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
            +  G P  +    V KL       Y    P++  K FS +     P AVD+  K++ LD
Sbjct: 228 LKVTGVPGPEF---VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD 284

Query: 334 PKQRVSAKTILQHEYFNQ 351
             +R++A   L+H YF+ 
Sbjct: 285 VDKRLTATEALEHPYFDS 302

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  154 bits (392), Expect = 6e-43
 Identities = 67/152 (44%), Positives = 98/152 (64%)

Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           V   A+REI +LK+L+H N++ L +V     +L+LVFEF+   + D L+  P  +  +  
Sbjct: 43  VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV 102

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           + YL+Q+L  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   YT  V 
Sbjct: 103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA 162

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T WYR PE+L+G   Y   VDIW+ GC+ +EM
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  155 bits (393), Expect = 2e-42
 Identities = 72/183 (39%), Positives = 107/183 (58%), Gaps = 2/183 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +LYQLL  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R  +   +  T  VVT 
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PE+LL    Y+T +D+WS GCIF+E++ +K LF G   + QL  I   LG+P E+ 
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232

Query: 290 WPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
              +   K   Y    P    + F+ +    +PLA+D+  K++  DP +R++ +  L H 
Sbjct: 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292

Query: 348 YFN 350
           Y  
Sbjct: 293 YLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  153 bits (387), Expect = 9e-42
 Identities = 78/186 (41%), Positives = 107/186 (57%), Gaps = 11/186 (5%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 182

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL- 241

Query: 291 PGVSKLP-----IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
             + K+       Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L 
Sbjct: 242 --LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299

Query: 346 HEYFNQ 351
           H YF Q
Sbjct: 300 HAYFAQ 305

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  151 bits (382), Expect = 1e-41
 Identities = 78/169 (46%), Positives = 109/169 (64%), Gaps = 13/169 (7%)

Query: 11  RVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 60
           RVQ   +G+P + +RE+++LK L+   HPN++RL DV        + K+ LVFE + QDL
Sbjct: 34  RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDL 93

Query: 61  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           + +L   P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFG
Sbjct: 94  RTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153

Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM
Sbjct: 154 LARIYSCQM-ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  151 bits (382), Expect = 8e-41
 Identities = 84/208 (40%), Positives = 112/208 (53%), Gaps = 35/208 (16%)

Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR----AFTIPMNRY 222
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +F +     
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----- 174

Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
           T  VVT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  +I   L
Sbjct: 175 TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK----FSEILNLPDPL---------------AV 323
           GTP ++    +S+L     ++ E RPK     F E+   PD L               A 
Sbjct: 234 GTPSDEF---MSRLQPTVRNYVENRPKYAGYSFEEL--FPDVLFPPDSESHNKLKASQAR 288

Query: 324 DVFSKIMALDPKQRVSAKTILQHEYFNQ 351
           D+ SK++ +DP++R+S    LQH Y N 
Sbjct: 289 DLLSKMLVIDPEKRISVDDALQHPYINV 316

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  149 bits (377), Expect = 2e-40
 Identities = 70/182 (38%), Positives = 105/182 (57%), Gaps = 12/182 (6%)

Query: 17  VPSTA---LREISVLKELKHPNVIRLHDVI--PV-DFK-LFLVFEFLRQDLKDFLQTTPV 69
           VP+ A   LRE+ +L+  KH N+I + D++  P  DFK +++V + +  DL   + +   
Sbjct: 44  VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ- 102

Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTI 126
           P+     + +LYQLL  L+Y HS  +IHRDLKP N+L+N+   L++ DFG++R       
Sbjct: 103 PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162

Query: 127 PMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
               + T  V T WYR PE+LL    Y+T +D+WS GCIF+EM    QL     Y H  +
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222

Query: 186 II 187
           +I
Sbjct: 223 LI 224

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  147 bits (372), Expect = 3e-40
 Identities = 70/156 (44%), Positives = 101/156 (64%), Gaps = 2/156 (1%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E V  T LRE+ +L+ LK  N++ L +      KL+LVFE++ +++ + L+  P  VPP 
Sbjct: 41  EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE 100

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTH 133
             +SY+YQL++A+ +CH   I+HRD+KP+N+LI+ +  LKL DFG +R  +   N  YT 
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            V T WYR PE+LLGA  Y   VD+WS GCI  E+S
Sbjct: 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELS 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  148 bits (374), Expect = 6e-40
 Identities = 69/189 (36%), Positives = 107/189 (56%), Gaps = 13/189 (6%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHE--- 225
           ++YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+R   I    Y+H+   
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYL 175

Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
              +VT WYR P +LL    Y+  +D+W+AGCIF+EM+T K LFAG  E++Q+  I  ++
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Query: 283 GTPHE-DVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSA 340
               E D    ++ +P          P++   ++L   +P A+D   +I+  +P  R++A
Sbjct: 236 PVVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294

Query: 341 KTILQHEYF 349
           +  L H Y 
Sbjct: 295 EEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  146 bits (371), Expect = 2e-39
 Identities = 69/181 (38%), Positives = 100/181 (55%), Gaps = 17/181 (9%)

Query: 3   SDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQDLK 61
           +D ++ R  V + G+  T LRE+ ++ E+KH N++ L DV +  DF + LV + +  DLK
Sbjct: 49  NDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLK 107

Query: 62  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 121
             +    + +  +  K  L Q+L  L   H    +HRDL P NI IN  G  K+ADFGL+
Sbjct: 108 KVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166

Query: 122 RAFTIPM--------------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
           R +  P                  T +VVTLWYR PE+L+GA+ Y   VD+WS GCIF+E
Sbjct: 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226

Query: 168 M 168
           +
Sbjct: 227 L 227

Length = 335

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  143 bits (363), Expect = 2e-38
 Identities = 78/188 (41%), Positives = 106/188 (56%), Gaps = 8/188 (4%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF---TIPMNRYTHEV 226
           +LYQLL AL+Y H+  + HRDLKP+NIL N    LK+ DFGL+R     T     +T  V
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 227 VTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            T WYR PE L G+    Y+  +DIWS GCIF+E++T K LF G + + QL  I   LGT
Sbjct: 168 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226

Query: 285 PHEDVWPGV--SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
           P  +    V   K   Y +   + +P  FS+     DPLA+ +  +++A DPK R +A+ 
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Query: 343 ILQHEYFN 350
            L   YF 
Sbjct: 287 ALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  139 bits (354), Expect = 8e-38
 Identities = 55/156 (35%), Positives = 78/156 (50%), Gaps = 15/156 (9%)

Query: 22  LREISVLKELKHPNVIR-LHDVIPVDFKLFLVF-EF-----LRQDLKDFLQTTPVPVPPA 74
            REI +L  L+HPN++R        +     +F E+     L   LK F       +P  
Sbjct: 47  EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----KLPEP 101

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTH 133
           + + Y  Q+LE L Y HS  I+HRD+K  NIL++  G +KLADFG ++    I     T 
Sbjct: 102 VIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161

Query: 134 EVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            V  T ++  PE++ G + Y    DIWS GC   EM
Sbjct: 162 SVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEM 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  142 bits (360), Expect = 1e-37
 Identities = 63/154 (40%), Positives = 99/154 (64%), Gaps = 7/154 (4%)

Query: 21  ALREISVLKELKHPNVIRLHDVIP---VDF--KLFLVFEFLRQDLKDFLQTTPVPVPPAL 75
             RE+ +L   KH NV+   D++    +D   ++++V E ++ DL   +  +P P+    
Sbjct: 46  VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKII-VSPQPLSSDH 104

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THE 134
            K +LYQ+L  L+Y HS  I+HRD+KP N+L+N +  LK+ DFGL+R      +++ T E
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT +YR PEIL+G++ Y++ VDIWS GCIF+E+
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  139 bits (352), Expect = 2e-37
 Identities = 69/160 (43%), Positives = 93/160 (58%), Gaps = 9/160 (5%)

Query: 20  TALREISVLKELK-HPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 76
             LREI  L+ L  HPN++RL +V+      +L LVFE +  +L + ++    P+P    
Sbjct: 43  NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRV 102

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 134
           KSY+YQLL++L + H   I HRD+KP+NILI K   LKLADFG  R      P   YT  
Sbjct: 103 KSYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPP---YTEY 158

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
           + T WYR PE LL    Y   +DIW+ GC+F E+  L+ L
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL 198

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  137 bits (345), Expect = 2e-36
 Identities = 74/188 (39%), Positives = 107/188 (56%), Gaps = 11/188 (5%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVV 227
           SY+YQL++A+ +CH   I+HRD+KP+N+LI+ +  LKL DFG +R  +   N  YT  V 
Sbjct: 104 SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT-PH 286
           T WYR PE+LLGA  Y   VD+WS GCI  E+   + LF G+SEIDQLF I + LG  P 
Sbjct: 164 TRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222

Query: 287 EDVW-----PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
           E +      P    L     + P+   +++  IL+    + +D+   ++ L+P  R   +
Sbjct: 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILS---GVLLDLMKNLLKLNPTDRYLTE 279

Query: 342 TILQHEYF 349
             L H  F
Sbjct: 280 QCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  137 bits (347), Expect = 3e-36
 Identities = 63/152 (41%), Positives = 94/152 (61%), Gaps = 6/152 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           LREI +L+ L H NVI + D++P      F  +++V+E +  DL   +  +   +     
Sbjct: 52  LREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQII-RSSQTLSDDHC 110

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           + +LYQLL  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R  +   +  T  VV
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV 170

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T WYR PE+LL    Y+T +D+WS GCIF+E+
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  136 bits (344), Expect = 5e-36
 Identities = 72/182 (39%), Positives = 108/182 (59%), Gaps = 17/182 (9%)

Query: 4   DESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLK 61
           D      +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL 
Sbjct: 28  DRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLW 87

Query: 62  DFLQ--------TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NK 109
             ++          PV +P  + KS LYQ+L+ + Y H+  ++HRDLKP NIL+     +
Sbjct: 88  HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 147

Query: 110 SGALKLADFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS 166
            G +K+AD G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+
Sbjct: 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207

Query: 167 EM 168
           E+
Sbjct: 208 EL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  136 bits (343), Expect = 1e-35
 Identities = 66/147 (44%), Positives = 91/147 (61%), Gaps = 6/147 (4%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           RE+ +LK L+H N+I L D+     + ++ V E L  DL   L + P+       + +LY
Sbjct: 58  RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLE--KQFIQYFLY 115

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           Q+L  L+Y HS  ++HRDLKP NILIN++  LK+ DFGL+R   I   + T  V T +YR
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYR 172

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PEI+L  + Y   VDIWSAGCIF+EM
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 2e-35
 Identities = 67/174 (38%), Positives = 98/174 (56%), Gaps = 22/174 (12%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVD----FK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 75
            LREI +L+  KH N+I + D+I       F  +++V E +  DL   ++T  +      
Sbjct: 50  TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLS--NDH 107

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 131
            + +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +    
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFL 166

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQLL 175
           T  V T WYR PEI+L +K Y+  +DIWS GCI +EM           YL+QL 
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  133 bits (335), Expect = 8e-35
 Identities = 71/206 (34%), Positives = 113/206 (54%), Gaps = 25/206 (12%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTH 224
           S LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+AD G +R F  P+     
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI--------- 272
               VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++T + +F    E          
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL---------PDPLAV 323
           DQL RIF  +G P +  W  + K+P + T   ++R   ++    +         PD  A 
Sbjct: 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291

Query: 324 DVFSKIMALDPKQRVSAKTILQHEYF 349
            +  K++ +DP +R++++  +Q  YF
Sbjct: 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  132 bits (334), Expect = 1e-34
 Identities = 70/175 (40%), Positives = 108/175 (61%), Gaps = 17/175 (9%)

Query: 11  RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQ--- 65
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   ++   
Sbjct: 35  QIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHR 94

Query: 66  -----TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLA 116
                  P+ +P ++ KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 95  ASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154

Query: 117 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E+
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  131 bits (331), Expect = 1e-34
 Identities = 59/155 (38%), Positives = 88/155 (56%), Gaps = 11/155 (7%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQT-TPVPVPPA 74
           AL E+ +LK+L HPN+I+ ++      KL +V E+     L Q +K   +   P P    
Sbjct: 46  ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L   +  QL  AL+Y HSR+I+HRD+KPQNI +  +G +KL DFG+S+  +  ++     
Sbjct: 106 L--DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKT 162

Query: 135 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VV T +Y  PE+    K Y+   DIWS GC+  E+
Sbjct: 163 VVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYEL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  130 bits (330), Expect = 9e-34
 Identities = 64/156 (41%), Positives = 85/156 (54%), Gaps = 19/156 (12%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALA 76
           RE+ +LK + H NVI L DV      L      +LV   +  DL + ++         L+
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK------LS 116

Query: 77  KSY----LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
             +    +YQ+L  L+Y HS  IIHRDLKP NI +N+   LK+ DFGL+R     M  Y 
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY- 175

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             V T WYR PEI+L    Y+ TVDIWS GCI +E+
Sbjct: 176 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  130 bits (327), Expect = 1e-33
 Identities = 73/206 (35%), Positives = 113/206 (54%), Gaps = 25/206 (12%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTH 224
           S LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+AD G +R F  P+     
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI--------- 272
               VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++T + +F    E          
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKF--SEILNL-------PDPLAV 323
           DQL RIF  +G P +  W  + K+P Y T   ++R   +  S ++         PD    
Sbjct: 232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF 291

Query: 324 DVFSKIMALDPKQRVSAKTILQHEYF 349
            +  K++ +DP +R++++  LQ  YF
Sbjct: 292 LLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  130 bits (329), Expect = 1e-33
 Identities = 75/199 (37%), Positives = 104/199 (52%), Gaps = 24/199 (12%)

Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYV 183

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  E++    +F G   IDQ  ++   LGTP 
Sbjct: 184 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242

Query: 286 ----------------HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI 329
                           +   +PG+S    ++  FP+W     SE   L    A D+ SK+
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGIS----FEELFPDWIFPSESERDKLKTSQARDLLSKM 298

Query: 330 MALDPKQRVSAKTILQHEY 348
           + +DP +R+S    L+H Y
Sbjct: 299 LVIDPDKRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (323), Expect = 2e-33
 Identities = 57/184 (30%), Positives = 83/184 (45%), Gaps = 31/184 (16%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV 227
            Y  Q+LE L Y HS  I+HRD+K  NIL++  G +KLADFG ++    I     T  V 
Sbjct: 105 KYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFRTLGTP 285
            T ++  PE++ G + Y    DIWS GC   EM T K  ++   + +  L++I  +   P
Sbjct: 165 GTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP 223

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                           + PE                A D   K +  DPK+R +A  +LQ
Sbjct: 224 ----------------EIPEHLS-----------EEAKDFLRKCLRRDPKKRPTADELLQ 256

Query: 346 HEYF 349
           H + 
Sbjct: 257 HPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  132 bits (332), Expect = 2e-33
 Identities = 73/187 (39%), Positives = 110/187 (58%), Gaps = 8/187 (4%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y YQL  AL Y HS+ I HRDLKPQN+LI+  +  LKL DFG ++   +   R    + +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICS 233

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++LGA  Y+T +D+WS GCI +EMI    +F+G S +DQL RI + LGTP ED
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293

Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEIL--NLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
               ++  P Y    FP+ +PK   ++     PD  A++  S+ +  +P +R++    L 
Sbjct: 294 QLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDD-AINFISQFLKYEPLKRLNPIEALA 350

Query: 346 HEYFNQV 352
             +F+ +
Sbjct: 351 DPFFDDL 357

Length = 440

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  129 bits (325), Expect = 4e-33
 Identities = 66/192 (34%), Positives = 106/192 (55%), Gaps = 33/192 (17%)

Query: 5   ESRPRSRVQVEGVPST-------ALREISVLKELKHPNVIRLHDVI-------------P 44
           +S    RV V+ +  T       ALREI +++ L H N++++++V+              
Sbjct: 26  DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85

Query: 45  VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQ 103
            +   +++V E++  DL + L+  P+      A+ ++YQLL  L+Y HS  ++HRDLKP 
Sbjct: 86  TELNSVYIVQEYMETDLANVLEQGPLS--EEHARLFMYQLLRGLKYIHSANVLHRDLKPA 143

Query: 104 NILINKSG-ALKLADFGLSRAFTIPMNRYTHE------VVTLWYRPPEILLGAKVYSTTV 156
           N+ IN     LK+ DFGL+R   I    Y+H+      +VT WYR P +LL    Y+  +
Sbjct: 144 NVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200

Query: 157 DIWSAGCIFSEM 168
           D+W+AGCIF+EM
Sbjct: 201 DMWAAGCIFAEM 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  125 bits (315), Expect = 6e-33
 Identities = 46/93 (49%), Positives = 57/93 (61%), Gaps = 1/93 (1%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEV 226
           +  L Q+LE L Y HS  IIHRDLKP+NIL++  +G +KLADFGLS+  T   +     V
Sbjct: 95  LRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            T  Y  PE+LLG   YS   DIWS G I  E+
Sbjct: 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  128 bits (323), Expect = 6e-33
 Identities = 65/185 (35%), Positives = 102/185 (55%), Gaps = 25/185 (13%)

Query: 5   ESRPRSRVQVEGVPST---------ALREISVLKELK-HPNVIRLHD---VIPVDFK-LF 50
           E+     V ++ + +          ALRE+ +L+  + H N+  L+D   V P +F  L+
Sbjct: 23  ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82

Query: 51  LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS 110
           L  E +  DL   +++   P+  A  +S++YQ+L  L+Y HS  ++HRDLKP N+L+N  
Sbjct: 83  LYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD 141

Query: 111 GALKLADFGLSRAFTIP-------MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC 163
             LK+ DFGL+R F+         M  Y   V T WYR PEI+L  + Y+  +D+WS GC
Sbjct: 142 CELKICDFGLARGFSENPGENAGFMTEY---VATRWYRAPEIMLSFQSYTKAIDVWSVGC 198

Query: 164 IFSEM 168
           I +E+
Sbjct: 199 ILAEL 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  125 bits (315), Expect = 9e-32
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)

Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 179

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 286 -------HEDVWPGVSKLPIYK-TDFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 299 PAKRISVDEALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  125 bits (314), Expect = 1e-31
 Identities = 76/190 (40%), Positives = 104/190 (54%), Gaps = 25/190 (13%)

Query: 6   SRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-----IPVDFKLF-LVFEFLRQD 59
           SRP    Q E     A RE+++LK ++H NVI L DV        +F+ F LV  +++ D
Sbjct: 49  SRP---FQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD 105

Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           L+  +     P+     +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFG
Sbjct: 106 LQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG 162

Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------S 169
           L+R     M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM           
Sbjct: 163 LARHADAEMTGY---VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219

Query: 170 YLYQLLEALR 179
           YL QL + L+
Sbjct: 220 YLDQLTQILK 229

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  124 bits (313), Expect = 2e-31
 Identities = 79/200 (39%), Positives = 103/200 (51%), Gaps = 22/200 (11%)

Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 186

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKK--------FSEIL--------NLPDPLAVDVFSKIM 330
            +    + KL      + E RPK         F ++L         L    A D+ SK++
Sbjct: 246 PEF---MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

Query: 331 ALDPKQRVSAKTILQHEYFN 350
            +D  +R+S    LQH Y N
Sbjct: 303 VIDASKRISVDEALQHPYIN 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  123 bits (309), Expect = 6e-31
 Identities = 68/162 (41%), Positives = 91/162 (56%), Gaps = 11/162 (6%)

Query: 13  QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQT 66
           Q E     A RE+ +LK +KH NVI L DV   D  L      +LV  F+  DL   ++ 
Sbjct: 53  QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH 112

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             +       +  +YQ+L+ L+Y H+  IIHRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 113 EKLS--EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM
Sbjct: 171 EMTGY---VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (303), Expect = 7e-31
 Identities = 54/148 (36%), Positives = 79/148 (53%), Gaps = 3/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           + EI +LK+ KHPN+++ +       +L++V EF     LKD L++T   +  +      
Sbjct: 45  INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            +LL+ L Y HS  IIHRD+K  NIL+   G +KL DFGLS   +    R    V T ++
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGTPYW 163

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++ G K Y    DIWS G    E+
Sbjct: 164 MAPEVING-KPYDYKADIWSLGITAIEL 190

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (300), Expect = 2e-30
 Identities = 60/185 (32%), Positives = 93/185 (50%), Gaps = 34/185 (18%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           F E   + +  QL  AL+Y HSR+I+HRD+KPQNI +  +G +KL DFG+S+  +  ++ 
Sbjct: 100 FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158

Query: 222 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
               VV T +Y  PE+    K Y+   DIWS GC+  E+ T K  F G++ ++   +I +
Sbjct: 159 LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA 340
             G             PI         P ++S  L        ++ S ++  DP++R S 
Sbjct: 218 --GQY----------PPI---------PSQYSSELR-------NLVSSLLQKDPEERPSI 249

Query: 341 KTILQ 345
             ILQ
Sbjct: 250 AQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  119 bits (301), Expect = 2e-30
 Identities = 59/169 (34%), Positives = 88/169 (52%), Gaps = 11/169 (6%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT 66
            ++ +  +      L E  +L + + P V++L+        L+LV E+L   DL   L+ 
Sbjct: 27  KKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN 86

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA--- 123
               +   +A+ Y+ +++ AL Y HS  IIHRDLKP NILI+ +G LKL DFGLS+    
Sbjct: 87  VGS-LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145

Query: 124 ----FTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
                     +    +V T  Y  PE++LG + +S TVD WS GCI  E
Sbjct: 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 3e-30
 Identities = 55/151 (36%), Positives = 79/151 (52%), Gaps = 5/151 (3%)

Query: 20  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
             L E ++L  + HP +++LH     + KL+LV E+    +L   L           A+ 
Sbjct: 39  HTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARF 97

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 137
           Y  +++ AL Y HS  II+RDLKP+NIL++  G +KL DFGL++         T+    T
Sbjct: 98  YAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGT 156

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  PE+LLG K Y   VD WS G +  EM
Sbjct: 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEM 186

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  116 bits (293), Expect = 2e-29
 Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 39/194 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-------FTIPMNRY 222
           Y+ +++ AL Y HS  IIHRDLKP NILI+ +G LKL DFGLS+              + 
Sbjct: 98  YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157

Query: 223 THEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
              +V T  Y  PE++LG + +S TVD WS GCI  E +     F G++  +++F     
Sbjct: 158 DKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIF----- 210

Query: 282 LGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV--- 338
                         +   K ++P        E + + D  A+D+ SK++  DP++R+   
Sbjct: 211 ------------QNILNGKIEWP--------EDVEVSDE-AIDLISKLLVPDPEKRLGAK 249

Query: 339 SAKTILQHEYFNQV 352
           S + I  H +F  +
Sbjct: 250 SIEEIKNHPFFKGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 60/168 (35%), Positives = 93/168 (55%), Gaps = 17/168 (10%)

Query: 11  RVQVEGVPSTAL----REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLK 61
           ++ +E +   AL    +EI +LK LKHPN+++    I     L+++ E+     LRQ +K
Sbjct: 32  QISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK 91

Query: 62  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 121
            F      P P +L   Y+YQ+L+ L Y H + +IHRD+K  NIL  K G +KLADFG++
Sbjct: 92  KF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146

Query: 122 RAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 +++    VV T ++  PE++  +   ST  DIWS GC   E+
Sbjct: 147 TKLND-VSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (298), Expect = 2e-29
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 22/226 (9%)

Query: 20  TALREISVLKELKHP-NVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP--VPVPPAL 75
             LREI +L  L HP N+++L+D    +  L+LV E++    L+D L+      P+  + 
Sbjct: 43  RFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT------IPM 128
           A   L Q+L AL Y HS+ IIHRD+KP+NIL+++ G  +KL DFGL++            
Sbjct: 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162

Query: 129 NRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMSYLY--------QLLEAL 178
              +  V T  Y  PE+LLG  +   S++ DIWS G    E+                + 
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222

Query: 179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYT 223
                  +    L       N     K A   L +     P NR +
Sbjct: 223 TLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268

Length = 384

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  118 bits (297), Expect = 3e-29
 Identities = 63/157 (40%), Positives = 94/157 (59%), Gaps = 12/157 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVI----PVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           LREI +L+ L+HP+++ +  ++      +FK +++VFE +  DL   ++     + P   
Sbjct: 47  LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHH 105

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF---TIPMNRYTH 133
           + +LYQLL AL+Y H+  + HRDLKP+NIL N    LK+ DFGL+R     T     +T 
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 134 EVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEM 168
            V T WYR PE L G+    Y+  +DIWS GCIF+E+
Sbjct: 166 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEV 201

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  115 bits (291), Expect = 4e-29
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 19/173 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           LRE  ++++L HPNV++L  V   +  L++V E++   DL  +L+     +  +   S+ 
Sbjct: 49  LREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA 108

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            Q+   + Y  S+  IHRDL  +N L+ ++  +K++DFGLSR   +  + Y  +      
Sbjct: 109 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYRKRGGKLP 166

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGC----IFS--EMSY----LYQLLEALR 179
             W   PE L     +++  D+WS G     IF+  E  Y      ++LE L+
Sbjct: 167 IRWM-APESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 5e-29
 Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 33/279 (11%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT------IPMNR 221
             L Q+L AL Y HS+ IIHRD+KP+NIL+++ G  +KL DFGL++              
Sbjct: 105 FILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164

Query: 222 YTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMITKKTLF---AGDSEIDQLF 276
            +  V T  Y  PE+LLG  +   S++ DIWS G    E++T    F      S   Q  
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224

Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           +I   L TP                  PE   K  S++L            K++A DPK 
Sbjct: 225 KIILELPTPS--------LASPLSPSNPELISKAASDLLK-----------KLLAKDPKN 265

Query: 337 RVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWDDIPN 396
           R+S+ + L H+    +++ +  L+   +            P +  LI +    S     +
Sbjct: 266 RLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISS--LNSLAISGS 323

Query: 397 NKLKRIKPKIEEWPSSQRSTRMEEVVLTRLRIGHTRLTH 435
           +         +E   +  S+         L    ++ + 
Sbjct: 324 DLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSS 362

Length = 384

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (288), Expect = 8e-29
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 18/173 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++K+L HPN++RL  V      L++V E++   DL DFL+     +         
Sbjct: 49  LEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMA 108

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            Q+ + + Y  S+  +HRDL  +N L+ ++  +K++DFGLSR      + Y         
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGGKLP 167

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGC----IFS--EMSY----LYQLLEALR 179
             W   PE L     +++  D+WS G     IF+  E  Y      ++LE L 
Sbjct: 168 IKWM-APESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (286), Expect = 2e-28
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 16/172 (9%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 79
           LRE  ++++L HPN+++L  V   +  L +V E++   DL D+L+   P  +  +   S+
Sbjct: 49  LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTIPMNRYTHEVVTL 138
             Q+   + Y  S+  IHRDL  +N L+ ++  +K++DFGLSR  +     +     + +
Sbjct: 109 ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI 168

Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGC----IFS--EMSY----LYQLLEALR 179
            W   PE L     +++  D+WS G     IF+  E  Y      ++LE L+
Sbjct: 169 RWM-APESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (285), Expect = 4e-28
 Identities = 51/148 (34%), Positives = 83/148 (56%), Gaps = 2/148 (1%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           + EI ++K+ KHPN++  +D   V  +L++V E++    L D +    V +         
Sbjct: 63  INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            ++L+ L Y HS+ +IHRD+K  NIL++K G++KLADFG +   T   ++    V T ++
Sbjct: 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYW 182

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++   K Y   VDIWS G +  EM
Sbjct: 183 MAPEVIKR-KDYGPKVDIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (283), Expect = 5e-28
 Identities = 59/156 (37%), Positives = 83/156 (53%), Gaps = 9/156 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFL-QTTPVPVPPAL 75
           L+EI +LK+L HPNVI+       + +L +V E      L + +K F  Q   +P    +
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTI 108

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
            K Y  QL  AL + HS+RI+HRD+KP N+ I  +G +KL D GL R F+         V
Sbjct: 109 WK-YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
            T +Y  PE +     Y+   DIWS GC+  EM+ L
Sbjct: 168 GTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAAL 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  114 bits (286), Expect = 9e-28
 Identities = 63/162 (38%), Positives = 86/162 (53%), Gaps = 27/162 (16%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ ++K + H N+I L +V      L      +LV E +  +L   +Q         
Sbjct: 62  AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD------- 114

Query: 75  LAK---SYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR----AFTI 126
           L     SYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +F +
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                T  VVT +YR PE++LG   Y   VDIWS GCI  EM
Sbjct: 175 -----TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 3e-27
 Identities = 60/184 (32%), Positives = 85/184 (46%), Gaps = 35/184 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  +++ AL Y HS  II+RDLKP+NIL++  G +KL DFGL++         T+    T
Sbjct: 98  YAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGT 156

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+LLG K Y   VD WS G +  EM+T K  F  +        I+         
Sbjct: 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEK------- 204

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR---VSAKTILQ 345
               + K P+    FPE+             P A D+ S ++  DP +R     A+ I  
Sbjct: 205 ----ILKDPLR---FPEFL-----------SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246

Query: 346 HEYF 349
           H +F
Sbjct: 247 HPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (277), Expect = 3e-27
 Identities = 60/185 (32%), Positives = 82/185 (44%), Gaps = 31/185 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHE 225
           Y  QLLE L Y HS  I+HRD+KP NI ++ +G +KL DFG    L    T         
Sbjct: 104 YTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163

Query: 226 VVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
             T  Y  PE++ G K   +    DIWS GC+  EM T K  +   SE+D  F+I   +G
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVG 220

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
             H+   P   +L                       P   D   + +  DPK+R +A  +
Sbjct: 221 AGHKPPIPDSLQL----------------------SPEGKDFLDRCLESDPKKRPTASEL 258

Query: 344 LQHEY 348
           LQH +
Sbjct: 259 LQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  111 bits (279), Expect = 6e-27
 Identities = 64/152 (42%), Positives = 89/152 (58%), Gaps = 11/152 (7%)

Query: 23  REISVLKELKHPNVIRLHDVI-PV----DF-KLFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           RE+ +LK +KH NVI L DV  P     +F +++LV   +  DL + ++   +       
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS--DEHV 120

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           +  +YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y   V 
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VA 177

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T WYR PEI+L    Y+ TVDIWS GCI +E+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (273), Expect = 1e-26
 Identities = 60/186 (32%), Positives = 90/186 (48%), Gaps = 21/186 (11%)

Query: 24  EISVLKELKHPNVIRLHD--VIPVDFKLFLVFEFL-RQDLKDFLQ---TTPVPVPPALAK 77
           E+++L+ELKHPN++R +D  +   +  L++V E+    DL   +Q        +      
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 78  SYLYQLLEALRYCHSR-----RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
             L QLL AL  CH+R      ++HRDLKP NI ++ +  +KL DFGL++      +   
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY---------QLLEALRYCHS 183
             V T +Y  PE L     Y    DIWS GC+  E+  L          QL   ++    
Sbjct: 169 TYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF 227

Query: 184 RRIIHR 189
           RRI +R
Sbjct: 228 RRIPYR 233

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (271), Expect = 2e-26
 Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 8/153 (5%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
            E+ VL+ LKHPN+++ + V     K+++  E+     L++ L+   + +   + + Y  
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTL 106

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEVVT 137
           QLLE L Y HS  I+HRD+KP NI ++ +G +KL DFG    L    T           T
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Query: 138 LWYRPPEILLGAKV--YSTTVDIWSAGCIFSEM 168
             Y  PE++ G K   +    DIWS GC+  EM
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEM 199

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  109 bits (274), Expect = 3e-26
 Identities = 63/152 (41%), Positives = 85/152 (55%), Gaps = 11/152 (7%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALA 76
           RE+ +LK +KH NVI L DV      L      +LV   +  DL + ++   +       
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 122

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 179

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T WYR PEI+L    Y+ TVDIWS GCI +E+
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 39/71 (54%), Positives = 51/71 (71%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E + ++ LF GDSEIDQLFRIFRTLGTP EDVWPGV+ LP YK  FP+W  +  S+++  
Sbjct: 192 EMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN 251

Query: 551 PDPLAVDVFSR 561
            D   +D+ S+
Sbjct: 252 LDEDGLDLLSK 262

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (264), Expect = 2e-25
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 28/187 (14%)

Query: 166 SEMSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 224
            +++Y+  ++L+ L Y HS+ +IHRD+K  NIL++K G++KLADFG +   T   ++   
Sbjct: 116 PQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            V T ++  PE++   K Y   VDIWS G +  EM   +  +  +  +  LF I  T G 
Sbjct: 176 VVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI-TTKGI 233

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           P                      P+K+S           D  +K +  DP++R SA+ +L
Sbjct: 234 P----------------PLKN--PEKWSPEFK-------DFLNKCLVKDPEKRPSAEELL 268

Query: 345 QHEYFNQ 351
           QH +  +
Sbjct: 269 QHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 2e-25
 Identities = 52/147 (35%), Positives = 78/147 (53%), Gaps = 6/147 (4%)

Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
              LRE+  L+  + P V++ +     + ++ +V E++    L D L+       P LA 
Sbjct: 44  KQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY 103

Query: 78  SYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEV 135
               Q+L+ L Y H+ R IIHRD+KP N+LIN  G +K+ADFG+S+     +    T  V
Sbjct: 104 -IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-V 161

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAG 162
            T+ Y  PE + G + YS   DIWS G
Sbjct: 162 GTVTYMSPERIQG-ESYSYAADIWSLG 187

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 20/162 (12%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP--------VP 72
           L+E  V+K+L HPNV+RL  V   +  L+LV E++   DL D+L+ +           + 
Sbjct: 44  LKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS 103

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
                S+  Q+ + + Y  S++ +HRDL  +N L+ +   +K++DFGLSR      + Y 
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYR 162

Query: 133 HEVVTL----WYRPPEILLGAKVYSTTVDIWSAGC----IFS 166
            +        W   PE L    ++++  D+WS G     IF+
Sbjct: 163 KKTGGKLPIRWM-APESLKD-GIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  104 bits (261), Expect = 6e-25
 Identities = 40/72 (55%), Positives = 52/72 (72%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ LP YK  FP+W  + FS+++  
Sbjct: 193 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPP 252

Query: 551 PDPLAVDVFSRV 562
            D    D+ S++
Sbjct: 253 LDEDGRDLLSQM 264

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  106 bits (265), Expect = 1e-24
 Identities = 65/170 (38%), Positives = 94/170 (55%), Gaps = 13/170 (7%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVD-FK-------LFLVFEFLRQDLKDFLQ---T 66
           P    RE+ ++K L H N+I L D    + FK       L +V EF+ Q +  +++    
Sbjct: 103 PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR 162

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFT 125
               +P  L K Y YQL  AL Y HS+ I HRDLKPQN+LI+  +  LKL DFG ++   
Sbjct: 163 NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL- 221

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           +   R    + + +YR PE++LGA  Y+T +D+WS GCI +EM   Y + 
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271

Length = 440

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (257), Expect = 1e-24
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 13/152 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-----LKDFLQTTPVPVPPALAK 77
           +EI++L +L+HPN+++       +  L++  E +        LK +        P  + +
Sbjct: 51  QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-----GSFPEPVIR 105

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
            Y  Q+L  L Y H R  +HRD+K  NIL++ +G +KLADFG+++   +    +      
Sbjct: 106 LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKG 163

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + ++  PE++     Y    DIWS GC   EM
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 55/187 (29%), Positives = 80/187 (42%), Gaps = 44/187 (23%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              +LL+ L Y HS  IIHRD+K  NIL+   G +KL DFGLS   +    R    V T 
Sbjct: 103 VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGTP 161

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           ++  PE++ G K Y    DIWS G    E+   K                     P+   
Sbjct: 162 YWMAPEVING-KPYDYKADIWSLGITAIELAEGK--------------------PPY--- 197

Query: 290 WPGVSKLPIYKT-------DFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
               S+LP  K          P  R P+K+S+          D   K +  +P++R +A+
Sbjct: 198 ----SELPPMKALFKIATNGPPGLRNPEKWSDEF-------KDFLKKCLQKNPEKRPTAE 246

Query: 342 TILQHEY 348
            +L+H +
Sbjct: 247 QLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/204 (28%), Positives = 84/204 (41%), Gaps = 54/204 (26%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-------------- 215
           Y  ++L AL Y HS+ IIHRDLKP+NIL++K   +K+ DFG ++                
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 216 ----TIPMNRYTHE--VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
                I  NR      V T  Y  PE+L        + D+W+ GCI  +M+T K  F G 
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGS 225

Query: 270 SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI 329
           +E    +  F+            + KL      FP               P A D+  K+
Sbjct: 226 NE----YLTFQK-----------ILKLEY---SFPP-----------NFPPDAKDLIEKL 256

Query: 330 MALDPKQR----VSAKTILQHEYF 349
           + LDP+ R         +  H +F
Sbjct: 257 LVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (253), Expect = 6e-24
 Identities = 55/181 (30%), Positives = 79/181 (43%), Gaps = 34/181 (18%)

Query: 171 LYQLLEALRYCHSR-----RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 225
           L QLL AL  CH+R      ++HRDLKP NI ++ +  +KL DFGL++      +     
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T +Y  PE L     Y    DIWS GC+  E+      F   ++  QL          
Sbjct: 171 VGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQL---------- 218

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   SK  I +  F    P ++S  LN        V   ++ +DP +R S + +LQ
Sbjct: 219 -------ASK--IKEGKFRRI-PYRYSSELNE-------VIKSMLNVDPDKRPSTEELLQ 261

Query: 346 H 346
            
Sbjct: 262 L 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 57/189 (30%), Positives = 87/189 (46%), Gaps = 34/189 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           F E     Y+YQ+L+ L Y H + +IHRD+K  NIL  K G +KLADFG++      +++
Sbjct: 96  FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSK 154

Query: 222 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
               VV T ++  PE++  +   ST  DIWS GC   E++T    +   + +  LFRI  
Sbjct: 155 DDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-- 211

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA 340
            +   H          P+         P+  S  L        D   +    DP  R +A
Sbjct: 212 -VQDDH---------PPL---------PEGISPELK-------DFLMQCFQKDPNLRPTA 245

Query: 341 KTILQHEYF 349
           K +L+H + 
Sbjct: 246 KQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.9 bits (250), Expect = 2e-23
 Identities = 40/71 (56%), Positives = 51/71 (71%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E IT K LF GDSEIDQLF+IF+ LGTP E+ WPGV+KLP YK  FP++ PK   ++L  
Sbjct: 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR 250

Query: 551 PDPLAVDVFSR 561
            DP  +D+ S+
Sbjct: 251 LDPEGIDLLSK 261

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  100 bits (249), Expect = 2e-23
 Identities = 58/155 (37%), Positives = 83/155 (53%), Gaps = 7/155 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALA 76
           ++EI +LK+L HPNVI+  D    D +L +V E      L Q +K F +   + +P    
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTV 108

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
             Y  QL  A+ + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V 
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
           T +Y  PE  +    Y+   DIWS GC+  EM+ L
Sbjct: 169 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAAL 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 99.7 bits (248), Expect = 2e-23
 Identities = 57/155 (36%), Positives = 83/155 (53%), Gaps = 7/155 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALA 76
           ++EI +LK+L HPNVI+ +     D +L +V E      L + +K F +   + +P    
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTV 108

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
             Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V 
Sbjct: 109 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
           T +Y  PE  +    Y+   DIWS GC+  EM+ L
Sbjct: 169 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAAL 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y+ ++ EA+   H    IHRDLKP+N LI+ SG +KL DFGLS+        Y + VV +
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV----TYANSVVGS 161

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+L G   Y  TVD WS GC+  E +     F+G +  +    +          
Sbjct: 162 PDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY-------- 212

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-SAKTILQHE 347
            W    + P+Y         + +  I  L +             DP +R  S + I  H 
Sbjct: 213 -WKETLQRPVYDDPRFNLSDEAWDLITKLIN-------------DPSRRFGSLEDIKNHP 258

Query: 348 YFNQV 352
           +F +V
Sbjct: 259 FFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 46/193 (23%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-------RAFTIPMNRY 222
           Y+  ++ A  Y H+R II+RDLKP+N+L++ +G +KL DFG +       + +T      
Sbjct: 98  YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF----- 152

Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                T  Y  PEI+L  K Y  +VD WS G +  E++T +  F  D E      I+   
Sbjct: 153 ---CGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYN-- 204

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV---- 338
                D+  G       K +FP +  K            A D+  +++  +P++R+    
Sbjct: 205 -----DILKG-----NGKLEFPNYIDKA-----------AKDLIKQLLRRNPEERLGNLK 243

Query: 339 -SAKTILQHEYFN 350
              K I +H++FN
Sbjct: 244 GGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 30/177 (16%)

Query: 21  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
              E  VL  L  HP +I+L+     +  L+ V E+    +L  +++     +     + 
Sbjct: 48  VKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRF 106

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-------------- 124
           Y  ++L AL Y HS+ IIHRDLKP+NIL++K   +K+ DFG ++                
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 125 ----TIPMNRYTHE--VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                I  NR      V T  Y  PE+L        + D+W+ GCI      +YQ+L
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCI------IYQML 216

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 99.7 bits (248), Expect = 9e-23
 Identities = 59/154 (38%), Positives = 84/154 (54%), Gaps = 11/154 (7%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ +LK + H N+I L +V        +F+ ++LV E +  +L    Q   + +   
Sbjct: 67  AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHE 123

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPY 182

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT +YR PE++LG   Y   VDIWS GCI  E+
Sbjct: 183 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 56/176 (31%), Positives = 81/176 (46%), Gaps = 26/176 (14%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  QL  AL + HS+RI+HRD+KP N+ I  +G +KL D GL R F+         V T 
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           +Y  PE +     Y+   DIWS GC+  EM   ++ F GD     L+ + +         
Sbjct: 171 YYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK-------- 219

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   I K D+P      +SE L        D+ S+ +  DP++R     +LQ
Sbjct: 220 --------IEKCDYPPLPADHYSEELR-------DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 36/181 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  Q+L  L Y H R  +HRD+K  NIL++ +G +KLADFG+++   +    +      +
Sbjct: 107 YTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGS 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            ++  PE++     Y    DIWS GC   EM T K  ++    +  +F+I R+   P   
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP--- 221

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL---AVDVFSKIMALDPKQRVSAKTILQ 345
                   PI                   PD L   A D   K +  DP  R +A  +L+
Sbjct: 222 --------PI-------------------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Query: 346 H 346
           H
Sbjct: 255 H 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 4/159 (2%)

Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 70
           V VE      ++EIS+LK+   P +++ +     +  L++V E+     + D ++ T   
Sbjct: 36  VPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT 95

Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
           +      + LYQ L+ L Y HS + IHRD+K  NIL+N+ G  KLADFG+S   T  M  
Sbjct: 96  LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-A 154

Query: 131 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             + V+ T ++  PE++     Y+   DIWS G    EM
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 96.1 bits (239), Expect = 3e-22
 Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 14/179 (7%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-D 59
           K+S + R  SR           +E++VL  +KHPN+++  +    +  L++V ++    D
Sbjct: 37  KMSPKEREESR-----------KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85

Query: 60  L-KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
           L K       V  P      +  Q+  AL++ H R+I+HRD+K QNI + K G +KL DF
Sbjct: 86  LYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDF 145

Query: 119 GLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
           G++R     +      + T +Y  PEI    + Y+   DIW+ GC+  EM  L    EA
Sbjct: 146 GIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 24/162 (14%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYL 80
             E  +L+E  HP +++L+        ++++ E+ L  +L   L+          A+ Y+
Sbjct: 41  FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYI 99

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-------RAFTIPMNRYTH 133
             ++ A  Y H+R II+RDLKP+N+L++ +G +KL DFG +       + +T        
Sbjct: 100 ACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF------- 152

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
              T  Y  PEI+L  K Y  +VD WS G +      LY+LL
Sbjct: 153 -CGTPEYVAPEIILN-KGYDFSVDYWSLGIL------LYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.8 bits (236), Expect = 7e-22
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 75
           A+ EI +L  + HPN+I   +      KL +V E+     L + +    +     +P   
Sbjct: 46  AVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK-RKKKRKLIPEQE 104

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
                 QLL  L+  H ++I+HRDLK  NIL+  +  +K+ D G+S+     M +   ++
Sbjct: 105 IWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--QI 162

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T  Y  PE+  G + YS   DIWS GC+  EM
Sbjct: 163 GTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 7/145 (4%)

Query: 34  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 92
           P V +L+        L+LV E+L   D    ++T    +P   AK Y+ +++  +   H 
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 93  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 152
           R IIHRD+KP+N+LI+++G LKL DFGLSR       ++   V T  Y  PE +LG    
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-KKF---VGTPDYLAPETILG-VGD 170

Query: 153 STTVDIWSAGCIFSEMSYLYQLLEA 177
               D WS GC+  E  + Y    A
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 39/71 (54%), Positives = 46/71 (64%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E  TKK LF GDSEIDQLFRIFR LGTP EDVWPGV+ LP YK  FP+W+       +  
Sbjct: 194 EMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKN 253

Query: 551 PDPLAVDVFSR 561
            D   +D+  +
Sbjct: 254 LDEDGLDLLEK 264

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 39/183 (21%)

Query: 4   DESRPRSRVQVEGVPSTALR-EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD 62
            +SR +  V+       ALR EI  LK+L H N+++           +L FE   + L  
Sbjct: 44  HDSRQKDMVK-------ALRSEIETLKDLDHLNIVQ-----------YLGFETTEEYLSI 85

Query: 63  FLQ-----------TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 111
           FL+            T       L + +  Q+LE L Y HS+ I+HRDLK  N+L++  G
Sbjct: 86  FLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG 145

Query: 112 ALKLADFGLSRAFTIPMNRYTHEVVT------LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             K++DFG+S+      + Y ++          W  P  I   ++ YS  VDIWS GC+ 
Sbjct: 146 ICKISDFGISKK---SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202

Query: 166 SEM 168
            EM
Sbjct: 203 LEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 37/74 (50%), Positives = 54/74 (72%)

Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E + +K LF GDSEID+LF+IFR LGTP+E+ WPGV+ LP YK+ FP+W PK  + ++
Sbjct: 194 FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVV 253

Query: 549 NLPDPLAVDVFSRV 562
              +P  VD+ S++
Sbjct: 254 PTLEPAGVDLLSKM 267

Length = 294

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 19/167 (11%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF----------LRQDLKDFLQTTPVP 70
           AL EI +L  L+HPN+I  ++    D  L +  E+          +RQ  + F       
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF------- 98

Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
               +   YL+Q++ A+ Y H   I+HRD+K  NI + K+G +KL DFG+S+      + 
Sbjct: 99  -EEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
               V T +Y  PE+  G K Y+   DIW+ GC+  E+  L +  +A
Sbjct: 158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 6/149 (4%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK L+H  +++ +  +  D  L +  E++    +KD L+     +   + + Y  Q
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQ 112

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV--TLW 139
           +LE + Y HS  I+HRD+K  NIL + +G +KL DFG S R  TI  +    + V  T +
Sbjct: 113 ILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +  PE++ G + Y    D+WS GC   EM
Sbjct: 173 WMSPEVISG-EGYGRKADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 6/151 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+EL HP ++ L      +  ++LV + L   DL+  L    V       K ++
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWI 106

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 139
            +++ AL Y HS+ IIHRD+KP NIL+++ G + + DF ++       +  T     T  
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPG 164

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
           Y  PE+L   + YS  VD WS G    E   
Sbjct: 165 YMAPEVLC-RQGYSVAVDWWSLGVTAYECLR 194

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 35/187 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y+ +++  +   H R IIHRD+KP+N+LI+++G LKL DFGLSR       ++   V T 
Sbjct: 102 YIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-KKF---VGTP 157

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF-RIFRTLGTPHED 288
            Y  PE +LG        D WS GC+  E +     F  ++  D +F  I        E+
Sbjct: 158 DYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNILSRRINWPEE 215

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK---TILQ 345
           V    S                         P AVD+ ++++ +DP +R+ A     I  
Sbjct: 216 VKEFCS-------------------------PEAVDLINRLLCMDPAKRLGANGYQEIKS 250

Query: 346 HEYFNQV 352
           H +F  +
Sbjct: 251 HPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 53/149 (35%), Positives = 75/149 (50%), Gaps = 8/149 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L   K   +++L      D  L+L  E++   D +  L    V +    A+ Y+
Sbjct: 49  LTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYM 107

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 139
            ++ EA+   H    IHRDLKP+N LI+ SG +KL DFGLS+        Y + VV +  
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV----TYANSVVGSPD 163

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           Y  PE+L G   Y  TVD WS GC+  E 
Sbjct: 164 YMAPEVLRGKG-YDFTVDYWSLGCMLYEF 191

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 91.8 bits (228), Expect = 8e-21
 Identities = 56/161 (34%), Positives = 85/161 (52%), Gaps = 5/161 (3%)

Query: 20  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP-VPPALAK 77
            A  E  VLK L HPN+I  ++    D  L +V E+     L +++Q      +      
Sbjct: 45  AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV 136
            +  Q+L AL + H++ I+HRDLK QNIL++K    +K+ DFG+S+  +     YT  V 
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVG 163

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
           T  Y  PE+  G K Y+   DIW+ GC+  E++ L +  EA
Sbjct: 164 TPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 93.6 bits (232), Expect = 1e-20
 Identities = 62/169 (36%), Positives = 90/169 (53%), Gaps = 14/169 (8%)

Query: 6   SRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQD 59
           SRP    Q +     A RE+ ++K + H N+I L +V        +F+ +++V E +  +
Sbjct: 58  SRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN 114

Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           L   +Q   + +        LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFG
Sbjct: 115 LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171

Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L+R         T  VVT +YR PE++LG   Y   VDIWS GCI  EM
Sbjct: 172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 57/186 (30%), Positives = 81/186 (43%), Gaps = 32/186 (17%)

Query: 172 YQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTL 229
            Q+L+ L Y H+ R IIHRD+KP N+LIN  G +K+ADFG+S+     +    T  V T+
Sbjct: 106 RQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTV 164

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID--QLFRIFRTLGTPHE 287
            Y  PE + G + YS   DIWS G    E    K  F    +    +L +          
Sbjct: 165 TYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------- 214

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                     I     P    ++FS           D  S  +  DPK+R SA  +LQH 
Sbjct: 215 ----------ICDGPPPSLPAEEFSPEFR-------DFISACLQKDPKKRPSAAELLQHP 257

Query: 348 YFNQVE 353
           +  + +
Sbjct: 258 FIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 93.4 bits (232), Expect = 1e-20
 Identities = 53/153 (34%), Positives = 78/153 (50%), Gaps = 2/153 (1%)

Query: 16  GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPAL 75
           G   T L E  +L+ + HP+VIR+ D +       +V      DL  +L     P+P   
Sbjct: 99  GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
           A     Q+LE LRY H++RIIHRD+K +NI IN    + + D G ++ F +    +    
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLGLA 217

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T+    PE+L   K Y++  DIWSAG +  EM
Sbjct: 218 GTVETNAPEVLARDK-YNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 58/165 (35%), Positives = 88/165 (53%), Gaps = 26/165 (15%)

Query: 13  QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---P 68
           QVE V    L E  +L+ ++HP ++ L+     D  L+LV E++   +L   L+ +   P
Sbjct: 44  QVEHV----LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP 99

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-----RA 123
            PV    A+ Y  Q++ AL Y HS  I++RDLKP+N+L++  G +K+ DFG +     R 
Sbjct: 100 EPV----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155

Query: 124 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +T+     T E     Y  PEI+L  K Y   VD W+ G +  EM
Sbjct: 156 YTLCG---TPE-----YLAPEIILS-KGYGKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 29/180 (16%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 229
           LYQ L+ L Y HS + IHRD+K  NIL+N+ G  KLADFG+S   T  M    + V+ T 
Sbjct: 105 LYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AKRNTVIGTP 163

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           ++  PE++     Y+   DIWS G    EM   K  ++    +  +F I      P    
Sbjct: 164 FWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PP---- 216

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
            P +S             P+K+S   N       D   K +  DP++R SA  +LQH + 
Sbjct: 217 -PTLSD------------PEKWSPEFN-------DFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 92.5 bits (229), Expect = 3e-20
 Identities = 59/154 (38%), Positives = 82/154 (53%), Gaps = 11/154 (7%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ ++K + H N+I L +V      L      +LV E +  +L   +Q   + +   
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHE 119

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 178

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT +YR PE++LG   Y   VDIWS GCI  EM
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 11/174 (6%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT 67
           P+S   VE     + +E  +L ++KHPN++   +    D  L++V E+   D  D +Q  
Sbjct: 36  PKSSSAVE----DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC--DGGDLMQKI 89

Query: 68  PVP----VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 123
            +      P      +  Q+   +++ H +R++HRD+K +NI + ++G +KL DFG +R 
Sbjct: 90  KLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149

Query: 124 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
            T P       V T +Y PPEI      Y+   DIWS GCI  E+  L    +A
Sbjct: 150 LTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 31/183 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV- 227
           Y  Q+LE + Y HS  I+HRD+K  NIL + +G +KL DFG S R  TI  +    + V 
Sbjct: 109 YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T ++  PE++ G + Y    D+WS GC   EM+T+K  +A    +  +F+I      P 
Sbjct: 169 GTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP- 226

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                   +LP +                    P A +   +    + K+R SA+ +L+H
Sbjct: 227 --------QLPSHV------------------SPDARNFLRRTFVENAKKRPSAEELLRH 260

Query: 347 EYF 349
            + 
Sbjct: 261 FFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 4/147 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI  L + + P + + +       KL+++ E+       D L+  P  +        L 
Sbjct: 48  QEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILR 105

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L  L Y H    IHRD+K  NIL+++ G +KLADFG+S   T  M++    V T ++ 
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE++  +  Y    DIWS G    E+
Sbjct: 166 APEVIKQSG-YDEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 89.1 bits (221), Expect = 8e-20
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 32/186 (17%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            +  Q+LE L Y HS+ I+HRDLK  N+L++  G  K++DFG+S+      + Y ++   
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNM 168

Query: 229 ------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                  W  P  I   ++ YS  VDIWS GC+  EM   +  ++ +  I  +F++    
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR 228

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
             P           PI     P        ++     P+A+D  +    ++P  R +A+ 
Sbjct: 229 SAP-----------PI-----PP-------DVSMNLSPVALDFLNACFTINPDNRPTARE 265

Query: 343 ILQHEY 348
           +LQH +
Sbjct: 266 LLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 14/156 (8%)

Query: 23  REISVLKELKH---PNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPA 74
           RE+++L +L+    PN+ + +       +L+++ E+     +R  +K        P+   
Sbjct: 48  REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK------AGPIAEK 101

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
                + ++L AL+Y H   +IHRD+K  NIL+  +G +KL DFG++       ++ +  
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
           V T ++  PE++   K Y T  DIWS G    EM+ 
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 54/178 (30%), Positives = 79/178 (44%), Gaps = 28/178 (15%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L  L Y H    IHRD+K  NIL+++ G +KLADFG+S   T  M++    V T +
Sbjct: 104 LREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF 163

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           +  PE++  +  Y    DIWS G    E+   +                     P  D+ 
Sbjct: 164 WMAPEVIKQSG-YDEKADIWSLGITAIELAKGEP--------------------PLSDLH 202

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           P      I K + P     KFS           D  S  +  DPK+R SAK +L+H++
Sbjct: 203 PMRVLFLIPKNNPPSLEGNKFS-------KPFKDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 7/152 (4%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REI++LKEL+H N+++          L +  E++       L          L ++++ Q
Sbjct: 55  REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---AFTIPMNRYTHEVV--- 136
           +L+ L Y H+R IIHRD+K  NIL++  G +K++DFG+S+   A ++             
Sbjct: 115 ILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           ++++  PE+ +    Y+   DIWS GC+  EM
Sbjct: 175 SVFWMAPEV-VKQTSYTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 18/180 (10%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           EI +L E KHPN++ L++    + KL+++ EF     L   +      +     +    Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +LEAL + HS ++IHRDLK  NIL+   G +KLADFG+S      + +    + T ++  
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 143 PEILL----GAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILI 198
           PE++         Y    DIWS G    E++                  H +L P  +L+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELA-------------QMEPPHHELNPMRVLL 218

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 6/154 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL+Q++ A+ Y H   I+HRD+K  NI + K+G +KL DFG+S+      +     V T 
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           +Y  PE+  G K Y+   DIW+ GC+  E++T K  F   + ++ + +I +   TP   V
Sbjct: 166 YYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV 224

Query: 290 WPGVSKLPIY---KTDFPEWRPKKFSEILNLPDP 320
           +       ++   + D PE RP    E+L+ P  
Sbjct: 225 YSSELISLVHSLLQQD-PEKRPTA-DEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 7/149 (4%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPV-PPALAK 77
             +E+  + +  HPNV++ +    V  +L+LV  +L    L D ++++ P      A+  
Sbjct: 46  LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA 105

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HE 134
           + L ++L+ L Y HS   IHRD+K  NIL+ + G++K+ADFG+S +     +R       
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 135 VV-TLWYRPPEILLGAKVYSTTVDIWSAG 162
            V T  +  PE++     Y    DIWS G
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 51/148 (34%), Positives = 80/148 (54%), Gaps = 4/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + EI V++E KHPN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 64  INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 121

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++   K Y   VDIWS G +  EM
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 12/162 (7%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVP 72
           E V     +EI ++  L HP++IR+      D  F LF+  E++       L +      
Sbjct: 44  EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFK 101

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 131
            A+  +Y  QLL  L Y H  +IIHRD+K  N+LI+ +G  L++ADFG +          
Sbjct: 102 EAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG- 160

Query: 132 THE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             E     + T+ +  PE+L G + Y  + D+WS GC+  EM
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEM 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 3/149 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
           +EIS+LKE +HPN++          KL++V E+     L+D  Q T  P+          
Sbjct: 49  QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR 108

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           + L+ L Y H    IHRD+K  NIL+ + G +KLADFG+S   T  + +    + T ++ 
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168

Query: 142 PPEILLGAKV--YSTTVDIWSAGCIFSEM 168
            PE+    +   Y    DIW+ G    E+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 4/122 (3%)

Query: 162 GCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G +F E   + +  Q+  AL++ H R+I+HRD+K QNI + K G +KL DFG++R     
Sbjct: 95  GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           +      + T +Y  PEI    + Y+   DIW+ GC+  EM T K  F   +  + + +I
Sbjct: 155 VELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213

Query: 279 FR 280
            R
Sbjct: 214 IR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 39/193 (20%)

Query: 165 FSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           FSE     ++ +++ AL Y HS+ IIHRD+KP NIL+++ G + + DF ++       + 
Sbjct: 97  FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDT 154

Query: 222 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS--EIDQLFRI 278
            T     T  Y  PE+L   + YS  VD WS G    E +  K  + G S    DQ+   
Sbjct: 155 LTTSTSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
             T    +   W                               A+D  +K++  DP++R+
Sbjct: 214 QETADVLYPATWS----------------------------TEAIDAINKLLERDPQKRL 245

Query: 339 S--AKTILQHEYF 349
               K +  H YF
Sbjct: 246 GDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 153 STTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 212
           S  + I  A  I        Q+LE LRY H++RIIHRD+K +NI IN    + + D G +
Sbjct: 151 SRPLPIDQALIIEK------QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA 204

Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGD-- 269
           + F +    +     T+    PE+L   K Y++  DIWSAG +  EM+    T+F     
Sbjct: 205 Q-FPVVAPAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262

Query: 270 -------SEIDQLFRIFRTLGTPHEDVWPGV--SKLPIYKTDF------PEWRPKKFSEI 314
                  S    L +I  TL   H + +P    S+L     ++      P  R   F   
Sbjct: 263 TPEEYVKSCHSHLLKIISTLKV-HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQR- 320

Query: 315 LNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
           +NLP      V  K++  D   R SA+ IL +  F Q+
Sbjct: 321 VNLPIDGEFLVH-KMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 32/191 (16%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 231
            Q+LEAL + HS ++IHRDLK  NIL+   G +KLADFG+S      + +    + T ++
Sbjct: 110 RQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW 169

Query: 232 RPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
             PE++         Y    DIWS G    E+   +                     PH 
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQME--------------------PPHH 209

Query: 288 DVWPGVSKLPIYKTDFPEW-RPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           ++ P    L I K++ P   +P K+S   N       D     +  DP  R +A  +L+H
Sbjct: 210 ELNPMRVLLKILKSEPPTLDQPSKWSSSFN-------DFLKSCLVKDPDDRPTAAELLKH 262

Query: 347 EYFNQVEMVKP 357
            + +     K 
Sbjct: 263 PFVSDQSDNKA 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 30/202 (14%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ I  T GTP       
Sbjct: 184 APEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQ---- 237

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S I         D  ++ + +D ++R SAK +LQH++   +
Sbjct: 238 --------------NPEKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQF---L 273

Query: 353 EMVKPTLAVFPELGYGGNGCKD 374
           ++ KP  ++ P +       K+
Sbjct: 274 KIAKPLSSLTPLIAAAKEATKN 295

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 7/164 (4%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF--LRQDLKDFLQTT 67
              ++  +    L+E +++  L H N+IRL+ V+ +   L +V E   L   L    +  
Sbjct: 32  KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVV-LTHPLMMVTELAPLGSLLDRLRKDA 90

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                 +    Y  Q+   +RY  S+R IHRDL  +NIL+     +K+ DFGL RA    
Sbjct: 91  LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150

Query: 128 MNRYT---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            + Y    H  V   +  PE L     +S   D+W  G    EM
Sbjct: 151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 55/193 (28%), Positives = 97/193 (50%), Gaps = 17/193 (8%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +HPN++ ++    V  +L++V EFL    L D +  T +     +A +    
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIA-TVCLA 123

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL + H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEMS------YLYQLLEALRYCHSRRIIHRDLKPQNI 196
           PE ++    Y T VDIWS G +  EM       +    L+A+     +RI  RD  P  +
Sbjct: 184 PE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-----KRI--RDNLPPKL 235

Query: 197 LINKSGALKLADF 209
                 + +L  F
Sbjct: 236 KNLHKVSPRLRSF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 31/178 (17%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
               QLL  L+  H ++I+HRDLK  NIL+  +  +K+ D G+S+     M +   ++ T
Sbjct: 107 RIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--QIGT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+  G + YS   DIWS GC+  EM T    F   S  D  +++ R    P   
Sbjct: 165 PHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP--- 220

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                              P  +S+ L        +    ++ + PK R +   IL  
Sbjct: 221 ------------------IPPIYSQDLQ-------NFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 4/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + EI V+KELK+PN++   D   V  +LF+V E+L    L D +  T   +  A   +  
Sbjct: 64  INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVC 121

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            + L+AL + H+ ++IHRD+K  N+L+   G++KL DFG     T   ++ +  V T ++
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++   K Y   VDIWS G +  EM
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 53/214 (24%), Positives = 76/214 (35%), Gaps = 63/214 (29%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----------------- 212
           Y+ +L+ AL   H    IHRD+KP NILI+  G +KLADFGL                  
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165

Query: 213 --------RAFTIPMNRYTH----EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
                           +        V T  Y  PE+L G   Y    D WS G I  EM+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224

Query: 261 TKKTLFAGDSEIDQLFRIFR---TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 317
                F  D+  +   +I     +L  P +                              
Sbjct: 225 YGFPPFYSDTLQETYNKIINWKESLRFPPDPPVS-------------------------- 258

Query: 318 PDPLAVDVFSKIMALDPKQRV-SAKTILQHEYFN 350
             P A+D+  +++  DP+ R+ S + I  H +F 
Sbjct: 259 --PEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 31/184 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++  L++ HS+ II+RDLK  N+++++ G +K+ADFG+ +      NR +    T 
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEIL G K Y+ +VD WS G +  EM+  ++ F GD E D+LF   R + TPH   
Sbjct: 161 DYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIR-VDTPH--- 214

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS-AKTILQHEY 348
                        +P W  K+           + D+  K+   DP +R+     I  H +
Sbjct: 215 -------------YPRWITKE-----------SKDILEKLFERDPTRRLGVVGNIRGHPF 250

Query: 349 FNQV 352
           F  +
Sbjct: 251 FKTI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 30/191 (15%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EM+  +  +  ++ +  L+ I  T GTP       
Sbjct: 183 APEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP------- 233

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                    +     P+K S I         D  ++ + +D ++R SAK +LQH +   +
Sbjct: 234 ---------ELQN--PEKLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHPF---L 272

Query: 353 EMVKPTLAVFP 363
           ++ KP  ++ P
Sbjct: 273 KIAKPLSSLTP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 75
           A+ E  VL +L    +IR ++      KL +V E+     L + LK        P+P   
Sbjct: 46  AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQ 102

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
              +  Q+L  L + HS++I+HRD+K  N+ ++    +K+ D G+++  +   N     V
Sbjct: 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T +Y  PE L   K Y+   D+W+ G +  E 
Sbjct: 163 GTPYYLSPE-LCEDKPYNEKSDVWALGVVLYEC 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 14/172 (8%)

Query: 11  RVQVEGVPSTALR-------EISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKD 62
           R+ ++ +P    R       EI++   LKH N+++ L       F    + +     L  
Sbjct: 35  RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA 94

Query: 63  FLQTT--PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFG 119
            L++   P+         Y  Q+LE L+Y H  +I+HRD+K  N+L+N  SG +K++DFG
Sbjct: 95  LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG 154

Query: 120 LSRAFTIPMNRYTHEVV-TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMS 169
            S+     +N  T     TL Y  PE++  G + Y    DIWS GC   EM+
Sbjct: 155 TSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA 205

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.5 bits (209), Expect = 8e-18
 Identities = 53/146 (36%), Positives = 81/146 (55%), Gaps = 3/146 (2%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 106

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +  + ++ + D WS G +  EM
Sbjct: 167 PEV-VNRRGHTQSADWWSFGVLMFEM 191

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 8/154 (5%)

Query: 24  EISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLR----QDLKDFLQTTPVPVPPALAKS 78
           E++++KE L+HPN++R +     + +L++V + +      +  + L+            +
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 79  YLYQLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
              Q++ ALRY H  +RI+HRDL P NI++ +   + + DFGL++    P ++ T  V T
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGT 176

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
           + Y  PEI+     Y    D+W+ GCI  +M  L
Sbjct: 177 ILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTL 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 8e-18
 Identities = 51/144 (35%), Positives = 78/144 (54%), Gaps = 8/144 (5%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REI +L+++ HPNV++ HD+   + ++ ++ EF+       L+ T +     LA     Q
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG---SLEGTHIADEQFLA-DVARQ 176

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L  + Y H R I+HRD+KP N+LIN +  +K+ADFG+SR     M+     V T+ Y  
Sbjct: 177 ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMS 236

Query: 143 PEIL---LGAKVYSTTV-DIWSAG 162
           PE +   L    Y     DIWS G
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLG 260

Length = 353

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 57/185 (30%), Positives = 88/185 (47%), Gaps = 31/185 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++  L++ H + II+RDLK  N+L++K G +K+ADFG+ +       + +    T 
Sbjct: 101 YAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEIL G K Y+ +VD WS G +  EM+  ++ F G+ E D+LF        PH   
Sbjct: 161 DYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILN-DRPH--- 214

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK-TILQHEY 348
                        FP W  K+           A D  SK+   DP +R+     I QH +
Sbjct: 215 -------------FPRWISKE-----------AKDCLSKLFERDPTKRLGVDGDIRQHPF 250

Query: 349 FNQVE 353
           F  ++
Sbjct: 251 FRGID 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 52/156 (33%), Positives = 82/156 (52%), Gaps = 23/156 (14%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL----------RQDLKDFLQTTPVPVPP 73
           E ++L+ +KHP ++ L        KL+L+ E+L          R+ +  F++ T      
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDT------ 101

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
             A  YL ++  AL + H + II+RDLKP+NIL++  G +KL DFGL +  +I     TH
Sbjct: 102 --ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTH 158

Query: 134 EVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               T+ Y  PEIL+ +  +   VD WS G +  +M
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDM 193

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 8/160 (5%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP----VPVPPALAKS 78
           +E+ +L ++KHPN++        + +LF+V E+   D  D ++       V        S
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC--DGGDLMKRINRQRGVLFSEDQILS 105

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTIPMNRYTHEVVT 137
           +  Q+   L++ H R+I+HRD+K QNI ++K+G + KL DFG++R     M      V T
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
            +Y  PEI    + Y+   DIWS GC+  E+  L    E 
Sbjct: 166 PYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 38/116 (32%), Positives = 68/116 (58%), Gaps = 7/116 (6%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---AFTIPMNRYTHE 225
           +++ Q+L+ L Y H+R IIHRD+K  NIL++  G +K++DFG+S+   A ++        
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169

Query: 226 VV---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
                ++++  PE+ +    Y+   DIWS GC+  EM+T K  F   +++  +F+I
Sbjct: 170 PSLQGSVFWMAPEV-VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 27/180 (15%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
            +L+AL + H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++ 
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWM 182

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE ++    Y T VDIWS G +  EM+  +  +  +  +  + RI R    P       
Sbjct: 183 APE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLK---- 236

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                            K S  L            +++  DP QR +A  +L H +  + 
Sbjct: 237 --------------NLHKVSPRLR-------SFLDRMLVRDPAQRATAAELLNHPFLAKA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 57/190 (30%), Positives = 88/190 (46%), Gaps = 32/190 (16%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+LEAL+Y HS +IIHRDLK  N+L+   G +KLADFG+S      + R    + T ++ 
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177

Query: 233 PPEILLGAKV----YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            PE+++   +    Y    DIWS G    EM          ++I+           PH +
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM----------AQIE----------PPHHE 217

Query: 289 VWPGVSKLPIYKTDFPEW-RPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           + P    L I K++ P   +P K+S           D     +   P+ R SA  +L+H 
Sbjct: 218 LNPMRVLLKIAKSEPPTLSQPSKWSMEFR-------DFLKTALDKHPETRPSAAQLLEHP 270

Query: 348 YFNQVEMVKP 357
           + + V   +P
Sbjct: 271 FVSSVTSNRP 280

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +L+ L H N+++   V   P    L L+ E+L    L+D+LQ     +       +
Sbjct: 55  REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  S+R IHRDL  +NIL+     +K++DFGL++      + Y      E 
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              WY  PE L  +K  S + D+WS G    E+
Sbjct: 175 PIFWY-APECLRTSKFSSAS-DVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.1 bits (213), Expect = 2e-17
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 16/158 (10%)

Query: 23  REISVLKELKHPNVIRLHD--VIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 79
           RE ++   L HPN++ L D    P    LF VFE++  + L++ L      +P       
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADG-ALPAGETGRL 84

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLS------RAFTIPMNR 130
           + Q+L+AL   H++ I+HRDLKPQNI+++++G     K+ DFG+       R   +    
Sbjct: 85  MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 131 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
            T EV+ T  Y  PE L G  V   + D+++ G IF E
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 82.1 bits (202), Expect = 3e-17
 Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 30/191 (15%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + H+ ++IHRD+K  N+L+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EM+  +  +  ++ +  L+ I  T GTP       
Sbjct: 183 APEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQ---- 236

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S       P+  D  ++ + +D ++R SAK +LQH +   +
Sbjct: 237 --------------NPEKLS-------PIFRDFLNRCLEMDVEKRGSAKELLQHPF---L 272

Query: 353 EMVKPTLAVFP 363
           ++ KP  ++ P
Sbjct: 273 KLAKPLSSLTP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 59/185 (31%), Positives = 88/185 (47%), Gaps = 36/185 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV- 227
           Y  Q+LE L+Y H  +I+HRD+K  N+L+N  SG +K++DFG S+     +N  T     
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTG 171

Query: 228 TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           TL Y  PE++  G + Y    DIWS GC   EM T K  F               LG P 
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-------------ELGEPQ 218

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM---ALDPKQRVSAKTI 343
             ++    K+ ++K   PE           +P+ L+ +  + I+     DP +R SA  +
Sbjct: 219 AAMF----KVGMFKIH-PE-----------IPESLSAEAKNFILRCFEPDPDKRASAHDL 262

Query: 344 LQHEY 348
           LQ  +
Sbjct: 263 LQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 31/185 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++  L++ HS+ I++RDLK  NIL++  G +K+ADFG+ +   +   +      T 
Sbjct: 101 YAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEILLG K Y+T+VD WS G +  EM+  ++ F G  E ++LF+  R         
Sbjct: 161 DYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRM-------- 210

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK-TILQHEY 348
                  P Y    P W  ++           A D+  K+   +P++R+  K  I QH +
Sbjct: 211 -----DNPCY----PRWLTRE-----------AKDILVKLFVREPERRLGVKGDIRQHPF 250

Query: 349 FNQVE 353
           F +++
Sbjct: 251 FREID 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 40/188 (21%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-------QTTPVPVPP 73
           L E SV+KE    +V+RL  V+       +V E + + DLK +L       +  P   PP
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116

Query: 74  ALAKSYLY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
            L K      ++ + + Y  +++ +HRDL  +N ++ +   +K+ DFG++R      + Y
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR------DIY 170

Query: 132 THEVVTLWYRP------------PEILLGAKVYSTTVDIWSAGCIFSEMSYL----YQLL 175
             +    +YR             PE L    V++T  D+WS G +  EM+ L    YQ L
Sbjct: 171 ETD----YYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGL 225

Query: 176 ---EALRY 180
              E L++
Sbjct: 226 SNEEVLKF 233

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 83.1 bits (205), Expect = 4e-17
 Identities = 68/195 (34%), Positives = 95/195 (48%), Gaps = 25/195 (12%)

Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYR 232
           +L A++Y H  RIIHRD+K +NI IN  G + L DFG +     I  N+Y     T+   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFA-----GDSEID-QLFRIFRTLGT- 284
            PE LL    Y   VDIWSAG +  EM T   +LF      GD + D Q+  I R  GT 
Sbjct: 251 APE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309

Query: 285 PHE----------DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
           P+E          +++ G++K    K   P  RP  ++ +  LP  L   +  K++A D 
Sbjct: 310 PNEFPIDAQANLDEIYIGLAKKSSRK---PGSRP-LWTNLYELPIDLEY-LICKMLAFDA 364

Query: 335 KQRVSAKTILQHEYF 349
             R SA+ +L    F
Sbjct: 365 HHRPSAEALLDFAAF 379

Length = 391

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 35/185 (18%)

Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            L++ H R II+RDLK  N+L++  G +K+ADFG+ +   +     +    T  Y  PEI
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167

Query: 237 LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL 296
           L     Y   VD W+ G +  EM+  ++ F GD E D+LF+         ++V       
Sbjct: 168 LSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL-----EDEVR------ 214

Query: 297 PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT-----ILQHEYFNQ 351
                 +P W  K+           A  +    +  +P++R+         I  H +F +
Sbjct: 215 ------YPRWLSKE-----------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Query: 352 VEMVK 356
           ++  K
Sbjct: 258 IDWDK 262

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 6/150 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           ++E+  L++LKHPN I        +   +LV E+      D L+    P+      +  +
Sbjct: 69  IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 128

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
             L+ L Y HS  +IHRD+K  NIL+ + G +KLADFG S + + P N +   V T ++ 
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSF---VGTPYWM 184

Query: 142 PPEILLGAK--VYSTTVDIWSAGCIFSEMS 169
            PE++L      Y   VD+WS G    E++
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELA 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 58/191 (30%), Positives = 82/191 (42%), Gaps = 33/191 (17%)

Query: 161 AGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 217
            G   SE     +  QLL  + Y H RRI+HRDLK +NI + K+  LK+ DFG+SR    
Sbjct: 99  TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMG 157

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
             +  T    T +Y  PE  L  + Y +  DIWS GCI  EM      F G + +  + R
Sbjct: 158 SCDLATTFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           I     TP                  PE   ++ + I+             ++  DP  R
Sbjct: 217 IVEG-PTP----------------SLPETYSRQLNSIMQ-----------SMLNKDPSLR 248

Query: 338 VSAKTILQHEY 348
            SA  IL++ +
Sbjct: 249 PSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 41/100 (41%), Positives = 55/100 (55%), Gaps = 1/100 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V T 
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
           +Y  PE  +    Y+   DIWS GC+  EM   ++ F GD
Sbjct: 171 YYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 56/193 (29%), Positives = 78/193 (40%), Gaps = 44/193 (22%)

Query: 172 YQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
             +L+ L Y H   +IIHRD+KP NIL+N  G +KL DFG+S      + +    V T  
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSS 164

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           Y  PE + G   YS   DIWS G    E+ T +  +                  P  D  
Sbjct: 165 YMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYP-----------------PENDPP 206

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDP-LAVDVFSKIMAL--------DPKQRVSAK 341
            G+ +L                 I+N P P L    FS             DP++R S K
Sbjct: 207 DGIFEL--------------LQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK 252

Query: 342 TILQHEYFNQVEM 354
            +L+H +  + E 
Sbjct: 253 ELLEHPFIKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 66/249 (26%), Positives = 100/249 (40%), Gaps = 65/249 (26%)

Query: 128 MNRYTHEVVTLWYRPPEI--LLGAKVYSTTVDI---WSAGCIFSEM-------------S 169
           M R  H         P I  +LGA    +  ++   W AG   S +             +
Sbjct: 57  MARLNH---------PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN 107

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHE--- 225
           Y  QLL  L Y H  +IIHRD+K  N+LI+ +G  L++ADFG +            E   
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-AGEFQG 166

Query: 226 --VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQL---FRIFR 280
             + T+ +  PE+L G + Y  + D+WS GC+  EM T K  +  +   + L   F+I  
Sbjct: 167 QLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS 225

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA 340
               P                  PE         L+   P   DV  + + L P+ R  +
Sbjct: 226 ATTAP----------------SIPEH--------LS---PGLRDVTLRCLELQPEDRPPS 258

Query: 341 KTILQHEYF 349
           + +L+H  F
Sbjct: 259 RELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 40/100 (40%), Positives = 55/100 (55%), Gaps = 1/100 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  QL  A+ + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V T 
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
           +Y  PE  +    Y+   DIWS GC+  EM   ++ F GD
Sbjct: 171 YYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 50/148 (33%), Positives = 80/148 (54%), Gaps = 4/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 122

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++   K Y   VDIWS G +  EM
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 82.4 bits (203), Expect = 8e-17
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 6/168 (3%)

Query: 5   ESRPRSRVQVE-GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDF 63
           +++    V ++ G       E  +L+ + HP++I+L      +    L+    + DL  +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY 172

Query: 64  LQTT-PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS- 121
           L     + +   LA      +L A++Y H  RIIHRD+K +NI IN  G + L DFG + 
Sbjct: 173 LAAKRNIAICDILAIER--SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Query: 122 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               I  N+Y     T+    PE LL    Y   VDIWSAG +  EM+
Sbjct: 231 FPVDINANKYYGWAGTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMA 277

Length = 391

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 5/151 (3%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 82
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+     +    Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
            LEAL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171

Query: 143 PEILL----GAKVYSTTVDIWSAGCIFSEMS 169
           PE+++      + Y    D+WS G    EM+
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 30/191 (15%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EM+  +  +  ++ +  L+ I  T GTP       
Sbjct: 183 APEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQ---- 236

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P++ S +         D  ++ + +D  +R SAK +LQH +   +
Sbjct: 237 --------------NPERLSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPF---L 272

Query: 353 EMVKPTLAVFP 363
           ++ KP  ++ P
Sbjct: 273 KLAKPLSSLTP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 15/154 (9%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL- 80
           +E+  LK L+H ++I L  V  V   ++++ E + +  L  FL++   P    L  + L 
Sbjct: 51  KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLI 107

Query: 81  ---YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HE 134
               Q+ E + Y   +  IHRDL  +NIL+ +    K+ADFGL+R     +  Y     +
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKK 165

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +   W  P         +ST  D+WS G +  EM
Sbjct: 166 IPYKWTAPEAA--SHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 6/161 (3%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT---TPVPVPPALA 76
           A +E  +L +L HP +++ H          ++ E+   +DL   L+    T   +     
Sbjct: 49  ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV 108

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
             +  QLL  + Y H RRI+HRDLK +NI + K+  LK+ DFG+SR      +  T    
Sbjct: 109 CEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTG 167

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
           T +Y  PE  L  + Y +  DIWS GCI  EM  L    E 
Sbjct: 168 TPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 30/189 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y+ +++ AL + H   II+RD+K +NIL++  G + L DFGLS+ F        +    T
Sbjct: 110 YIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169

Query: 229 LWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + Y  PE++ G    +   VD WS G +  E++T  + F  D E +    I R +     
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV---SAKTIL 344
                 SK P          PK  S         A D   K++  DPK+R+    A  I 
Sbjct: 227 ------SKPPF---------PKTMS-------AEARDFIQKLLEKDPKKRLGANGADEIK 264

Query: 345 QHEYFNQVE 353
            H +F  ++
Sbjct: 265 NHPFFQGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 34/89 (38%), Positives = 51/89 (57%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           ++L AL+Y H   +IHRD+K  NIL+  +G +KL DFG++       ++ +  V T ++ 
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            PE++   K Y T  DIWS G    EM T
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 48/138 (34%), Positives = 75/138 (54%), Gaps = 8/138 (5%)

Query: 162 GCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTI 217
           G +FSE   +S+  Q+   L++ H R+I+HRD+K QNI ++K+G + KL DFG++R    
Sbjct: 95  GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            M      V T +Y  PEI    + Y+   DIWS GC+  E+ T K  F G++    + +
Sbjct: 155 SMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213

Query: 278 IFRTLGTPHEDVWPGVSK 295
           I +    P   + P  S+
Sbjct: 214 ICQGYFAP---ISPNFSR 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 51/152 (33%), Positives = 77/152 (50%), Gaps = 7/152 (4%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD--FLQTTPVPVPPALAKSYLY 81
           EI +L    HP +++L      D KL+++ EF      D   L+       P + +    
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVICR 117

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           Q+LEAL+Y HS +IIHRDLK  N+L+   G +KLADFG+S      + R    + T ++ 
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177

Query: 142 PPEILLGAKV----YSTTVDIWSAGCIFSEMS 169
            PE+++   +    Y    DIWS G    EM+
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 19/168 (11%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           ++E+  L++L+HPN I        +   +LV E+      D L+    P+      +  +
Sbjct: 63  IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH 122

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
             L+ L Y HS   IHRD+K  NIL+ + G +KLADFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSF---VGTPYWM 178

Query: 142 PPEILLGAK--VYSTTVDIWSAG--CI-----------FSEMSYLYQL 174
            PE++L      Y   VD+WS G  CI            + MS LY +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 49/144 (34%), Positives = 71/144 (49%), Gaps = 1/144 (0%)

Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 86
           +LK +KHP ++ LH       KL+ V +F+      F        P   A+ Y  ++  A
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA 108

Query: 87  LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL 146
           L Y HS  I++RDLKP+NIL++  G + L DFGL +      +  T    T  Y  PE++
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 147 LGAKVYSTTVDIWSAGCIFSEMSY 170
              + Y  TVD W  G +  EM Y
Sbjct: 169 R-KQPYDNTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 57/193 (29%), Positives = 83/193 (43%), Gaps = 39/193 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +LL AL   H   +I+RDLKP+NIL++  G + L DFGL +      ++      T 
Sbjct: 98  YTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+LLG   Y+  VD W+ G +  EM+T                     G P    
Sbjct: 158 EYLAPELLLGHG-YTKAVDWWTLGVLLYEMLT---------------------GLP---- 191

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL---AVDVFSKIMALDPKQRV---SAKTI 343
                  P Y  +  E   K   E L  PD     A D+   +++ DP +R+    A+ I
Sbjct: 192 -------PFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244

Query: 344 LQHEYFNQVEMVK 356
             H +F+Q+   K
Sbjct: 245 KNHPFFSQLSWKK 257

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 8/155 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEV 226
           + +  Q+L AL + H++ I+HRDLK QNIL++K    +K+ DFG+S+  +     YT  V
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VV 162

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE+  G K Y+   DIW+ GC+  E+ + K  F   +    + +I      P 
Sbjct: 163 GTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI 221

Query: 287 ED-VWPGVSKL--PIYKTDFPEWRPKKFSEILNLP 318
            D   P + +L   +   D P  RP + S+I+  P
Sbjct: 222 SDRYSPDLRQLILSMLNLD-PSKRP-QLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 41/112 (36%), Positives = 62/112 (55%), Gaps = 4/112 (3%)

Query: 162 GCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G +F E   + +  Q+   +++ H +R++HRD+K +NI + ++G +KL DFG +R  T P
Sbjct: 94  GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
                  V T +Y PPEI      Y+   DIWS GCI  E+ T K  F  +S
Sbjct: 154 GAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 79.0 bits (194), Expect = 3e-16
 Identities = 50/148 (33%), Positives = 80/148 (54%), Gaps = 4/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 64  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 121

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++   K Y   VDIWS G +  EM
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 11/152 (7%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E  V+ +L HPN+++L+ V      +F+V E++    L ++L+     +           
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 139
           + EA+ Y  S   IHRDL  +N L+ +   +K++DFGL+R + +  ++YT    T +   
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLD-DQYTSSQGTKFPVK 166

Query: 140 YRPPEILLGAKVYSTTVDIWSAGC----IFSE 167
           + PPE+   ++ +S+  D+WS G     +FSE
Sbjct: 167 WAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 44/154 (28%), Positives = 83/154 (53%), Gaps = 7/154 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L H  +++L+ V      +++V E++    L ++L+       P+      
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y  S++ IHRDL  +N L++  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSSVGSKFP 164

Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
             + PPE+LL +K +S+  D+W+ G +  E+  L
Sbjct: 165 VRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSL 197

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 80.7 bits (199), Expect = 3e-16
 Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 10/173 (5%)

Query: 2   VSDESRPR--SRVQVE-GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ 58
           V + S P    RV V+ G  ++++ E  +L+ L HP V+ L DV  V     LV    R 
Sbjct: 185 VFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS 244

Query: 59  DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
           DL  +L     P+  A   +   QLL A+ Y H   IIHRD+K +N+L+N    + L DF
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304

Query: 119 GLS----RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
           G +     +++ P   +     T+    PE+L G   Y+ +VDIWSAG +  E
Sbjct: 305 GAACFARGSWSTPF--HYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 29/181 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+  AL+Y H + I+HRDLK QN+ + ++  +K+ D G++R      +  +  + 
Sbjct: 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG 164

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T +Y  PE L   K Y+   D+W+ GC   EM T K  F        ++RI         
Sbjct: 165 TPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE------- 216

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                  KLP    D+                P   ++ + +++  P++R S K+IL+  
Sbjct: 217 ------GKLPPMPKDY---------------SPELGELIATMLSKRPEKRPSVKSILRQP 255

Query: 348 Y 348
           Y
Sbjct: 256 Y 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 49/151 (32%), Positives = 81/151 (53%), Gaps = 16/151 (10%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  VLKE+ HP +IRL         L+++ E++   +L  +L+ +      +    Y  +
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASE 109

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-----RAFTIPMNRYTHEVVT 137
           ++ AL Y HS+ I++RDLKP+NIL++K G +KL DFG +     R +T+          T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL--------CGT 161

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  PE+ + +K ++  VD W+ G +  EM
Sbjct: 162 PEYLAPEV-IQSKGHNKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 14/159 (8%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPP 73
           P   L+E  ++K+L+H  +++L+ V   +  +++V E++ +  L DFL++     + +P 
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ 104

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+ E + Y  SR  IHRDL  +NIL+ ++   K+ADFGL+R   I  + YT 
Sbjct: 105 LVDMAA--QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTA 160

Query: 133 HEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            E       W  P     G   ++   D+WS G + +E+
Sbjct: 161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.8 bits (191), Expect = 9e-16
 Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 27/178 (15%)

Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL Y HS+ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE+ +    Y T VDIWS G +  EM+  +  +  DS +  + R+               
Sbjct: 186 PEV-ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------------- 229

Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                   D P  + K   +I     P+  D   +++  +P++R +A+ +L H +  Q
Sbjct: 230 -------RDSPPPKLKNAHKI----SPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 6/150 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           ++E+  L+ +KHPN I        +   +LV E+      D L+    P+      +  +
Sbjct: 73  IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 132

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
             L+ L Y HS  +IHRD+K  NIL+ + G +KLADFG S +   P N +   V T ++ 
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSF---VGTPYWM 188

Query: 142 PPEILLGAK--VYSTTVDIWSAGCIFSEMS 169
            PE++L      Y   VD+WS G    E++
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELA 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 35/187 (18%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEVV 227
           L ++L+ L Y HS   IHRD+K  NIL+ + G++K+ADFG+S +     +R        V
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  +  PE++     Y    DIWS G    E+ T                       P+
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA--------------------APY 207

Query: 287 EDVWPGVSKLPIYKTDFP----EWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
               P    +   + D P        KK+S+           + S  +  DP +R +A+ 
Sbjct: 208 SKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR-------KMISLCLQKDPSKRPTAEE 260

Query: 343 ILQHEYF 349
           +L+H++F
Sbjct: 261 LLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 44/138 (31%), Positives = 69/138 (50%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           KHP + +LH       +LF V E++   DL   +Q +        A+ Y  +++  L++ 
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFL 112

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           H R II+RDLK  N+L++  G +K+ADFG+ +   +     +    T  Y  PEIL    
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y   VD W+ G +  EM
Sbjct: 173 -YGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALA 76
           LRE+ +L +   P ++  +     +  + +  E+     L + LK+     P  +   +A
Sbjct: 47  LRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA 106

Query: 77  KSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
                 +L+ L Y H   +IIHRD+KP NIL+N  G +KL DFG+S      + +    V
Sbjct: 107 ----VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFV 160

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T  Y  PE + G   YS   DIWS G    E+
Sbjct: 161 GTSSYMAPERIQGND-YSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 68/257 (26%), Positives = 105/257 (40%), Gaps = 82/257 (31%)

Query: 160 SAGCIFSEMSYLY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----- 212
           ++G   +     Y  +++ AL Y HS+ I++RDLKP+NIL++K G +KL DFG +     
Sbjct: 94  NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153

Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           R +T+          T  Y  PE+ + +K ++  VD W+ G +  EM+     F      
Sbjct: 154 RTWTL--------CGTPEYLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPPFFD---- 200

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL 332
           D  F I+               K+   K +F    P+         D  A D+  K++ +
Sbjct: 201 DNPFGIYE--------------KILAGKLEF----PRHL-------DLYAKDLIKKLLVV 235

Query: 333 DPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRS-- 390
           D  +R                           LG   NG  D K         +W +S  
Sbjct: 236 DRTRR---------------------------LGNMKNGADDVK-------NHRWFKSVD 261

Query: 391 WDDIPNNKLK-RIKPKI 406
           WDD+P  KLK  I PK+
Sbjct: 262 WDDVPQRKLKPPIVPKV 278

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E  ++++  HP++++L  VI  +  +++V E     +L+ +LQ     +  A    Y 
Sbjct: 55  LQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++    +KL DFGLSR      + Y      L  
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPI 172

Query: 139 -WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMSY 170
            W  P  I    + +++  D+W  G C++  +  
Sbjct: 173 KWMAPESI--NFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 6/150 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
             L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWM 178

Query: 142 PPEILLGAK--VYSTTVDIWSAGCIFSEMS 169
            PE++L      Y   VD+WS G    E++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 41/94 (43%), Positives = 59/94 (62%), Gaps = 2/94 (2%)

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
           AK Y+ +L+ AL + H   I++RDLKP+NIL++ +G + L DFGLS+A  +  N+ T+  
Sbjct: 98  AKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTF 156

Query: 136 V-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  Y  PE+LL  K Y+  VD WS G +  EM
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 32/181 (17%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPV-PPALAKS 78
            L E  +L  L HP +  L+     +  L LV ++    +L   LQ  P       +A+ 
Sbjct: 48  VLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF 107

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----------------R 122
           Y  ++L AL Y H   I++RDLKP+NIL+++SG + L+DF LS                 
Sbjct: 108 YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 123 AFTIPMNRYTHEVV-------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           +    +N    E               T  Y  PE++ G   + + VD W+ G +  EM 
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEML 226

Query: 170 Y 170
           Y
Sbjct: 227 Y 227

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 52/145 (35%), Positives = 75/145 (51%), Gaps = 3/145 (2%)

Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 85
           +LK LKHP ++ LH       KL+ V +++   +L   LQ     + P  A+ Y  ++  
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFYAAEVAS 107

Query: 86  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 145
           A+ Y HS  II+RDLKP+NIL++  G + L DFGL +    P    +    T  Y  PE+
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV 167

Query: 146 LLGAKVYSTTVDIWSAGCIFSEMSY 170
            L  + Y  TVD W  G +  EM Y
Sbjct: 168 -LRKEPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 58/173 (33%), Positives = 81/173 (46%), Gaps = 8/173 (4%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDL 60
           K  DE R +  V+      T  REI +LK + H  +I L         + +V    + DL
Sbjct: 113 KHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172

Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             ++  +  P+P   A +   +LLEAL Y H R IIHRD+K +NI +++     L DFG 
Sbjct: 173 FTYVDRSG-PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG- 230

Query: 121 SRAFTIPMNRYTHE----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
             A  +  +  T +      TL    PE LL    Y    DIWSAG +  EMS
Sbjct: 231 -AACKLDAHPDTPQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 37/80 (46%), Positives = 49/80 (61%), Gaps = 5/80 (6%)

Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRP 142
           L+ L Y HSR+IIHRD+KP NIL+ + G +KL DFG+S      +   +T    T +Y  
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMA 171

Query: 143 PEILLGAKVYSTTVDIWSAG 162
           PE + G K YS T D+WS G
Sbjct: 172 PERIQG-KPYSITSDVWSLG 190

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 37/80 (46%), Positives = 49/80 (61%), Gaps = 5/80 (6%)

Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRP 233
           L+ L Y HSR+IIHRD+KP NIL+ + G +KL DFG+S      +   +T    T +Y  
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMA 171

Query: 234 PEILLGAKVYSTTVDIWSAG 253
           PE + G K YS T D+WS G
Sbjct: 172 PERIQG-KPYSITSDVWSLG 190

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 21/173 (12%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 109

Query: 81  -YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---V 136
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT       
Sbjct: 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 167

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-------------MSYLYQLLE 176
            + +  PE L   K +S   D+W+ G +  E             +S +Y+LLE
Sbjct: 168 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 15/159 (9%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPP 73
           P   L E +++K+L+HP ++RL+ V+  +  ++++ E++    L DFL+T     + +  
Sbjct: 45  PEAFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINK 103

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
            +  +   Q+ E + +   +  IHRDL+  NIL++++   K+ADFGL+R   I  N YT 
Sbjct: 104 LIDMAA--QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTA 159

Query: 134 E----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                    W  P  I  G   ++   D+WS G + +E+
Sbjct: 160 REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 32/182 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV- 227
           Y  Q+LE + Y HS  I+HRD+K  NIL +  G +KL DFG S+   TI ++    + V 
Sbjct: 111 YTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T ++  PE++ G + Y    DIWS GC   EM+T+K  +A   E + +  IF+    P 
Sbjct: 171 GTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPT 226

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                    LP + +D                     D   +I  ++ K R SA  +L+H
Sbjct: 227 N------PVLPPHVSDH------------------CRDFLKRIF-VEAKLRPSADELLRH 261

Query: 347 EY 348
            +
Sbjct: 262 TF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 19/184 (10%)

Query: 21  ALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPA 74
           A +E  +L +LKHPN++   +     D  L++V  F     L   LK   +     +P  
Sbjct: 46  AEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK---EQKGKLLPEN 102

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
               +  Q+  AL+Y H + I+HRDLK QN+ + ++  +K+ D G++R      +  +  
Sbjct: 103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL 162

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA-----LRYCHSRRIIHR 189
           + T +Y  PE L   K Y+   D+W+ GC   EM+ L     A     L Y    RII  
Sbjct: 163 IGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY----RIIEG 217

Query: 190 DLKP 193
            L P
Sbjct: 218 KLPP 221

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 10/155 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           LRE SV+ +L HP ++RL  V   +  L LV E      L  +L+     +P +  K   
Sbjct: 44  LREASVMAQLDHPCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELA 101

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---- 136
           +Q+   + Y  S+  +HRDL  +N+L+      K++DFG+SRA     + Y         
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM-SY 170
             WY P  I  G   +S+  D+WS G    E  SY
Sbjct: 162 LKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        +    T
Sbjct: 110 YSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 229 LWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + Y  P+I+ G    +   VD WS G +  E++T  + F  D E +    I R       
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR------ 223

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKT 342
                     I K++ P   P++ S        LA D+  +++  DPK+R+      A  
Sbjct: 224 ----------ILKSEPP--YPQEMS-------ALAKDIIQRLLMKDPKKRLGCGPSDADE 264

Query: 343 ILQHEYFNQV 352
           I +H +F ++
Sbjct: 265 IKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 75.8 bits (186), Expect = 6e-15
 Identities = 50/145 (34%), Positives = 74/145 (51%), Gaps = 3/145 (2%)

Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 85
           +LK +KHP ++ LH       KL+ V +++   +L   LQ     + P  A+ Y  ++  
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS 107

Query: 86  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 145
           AL Y HS  I++RDLKP+NIL++  G + L DFGL +         +    T  Y  PE+
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 146 LLGAKVYSTTVDIWSAGCIFSEMSY 170
            L  + Y  TVD W  G +  EM Y
Sbjct: 168 -LHKQPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 77.9 bits (191), Expect = 6e-15
 Identities = 58/177 (32%), Positives = 83/177 (46%), Gaps = 34/177 (19%)

Query: 24  EISVLKELKHPNVIRLHD--VIPVDFKLFLVFEFLRQ-DLKDFLQTTPV---PVPPALAK 77
           E++V++ELKH N++R  D  +   + KL+++ EF    DL   +Q        +      
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 78  SYLYQLLEALRYCHS-------RRIIHRDLKPQNIL-----------------INKSGAL 113
               QLL AL YCH+        R++HRDLKPQNI                  +N     
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 114 KLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEM 168
           K+ DFGLS+   I +    H  V T +Y  PE+LL   K Y    D+W+ GCI  E+
Sbjct: 182 KIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 17/152 (11%)

Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPALAKS 78
           +LK +KHP ++ LH       KL+ V +++         Q  + F +          A+ 
Sbjct: 49  LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR--------ARF 100

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  ++  AL Y HS  II+RDLKP+NIL++  G + L DFGL +         +    T 
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            Y  PE+L   + Y  TVD W  G +  EM Y
Sbjct: 161 EYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 32/73 (43%), Positives = 45/73 (61%), Gaps = 1/73 (1%)

Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E   K+ LF GDSE+ QL  IF+ LGTP E VWPGVSKL  +  +FP+W+P+  S  +
Sbjct: 202 FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH-EFPQWKPQDLSRAV 260

Query: 549 NLPDPLAVDVFSR 561
               P  +D+  +
Sbjct: 261 PDLSPEGLDLLQK 273

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.9 bits (184), Expect = 8e-15
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 30/178 (16%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ---------------T 66
           RE +++ E  HPN+++L  V  V   + L+FE++   DL +FL+               +
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 67  TPVPVPPALAKSYLYQLLEALR------YCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
                   L  S   QL  A +      Y   R+ +HRDL  +N L+ ++  +K+ADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 121 SRAFTIPMNRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM-SYLYQ 173
           SR   I    Y     ++ + + + PPE +   + Y+T  D+W+ G +  E+ SY  Q
Sbjct: 177 SR--NIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQ 231

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.5 bits (183), Expect = 9e-15
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 3/95 (3%)

Query: 173 QLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 231
           Q++ ALRY H  +RI+HRDL P NI++ +   + + DFGL++    P ++ T  V T+ Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILY 179

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
             PEI+     Y    D+W+ GCI  +M T +  F
Sbjct: 180 SCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+  Q+   + Y  S+  IHRDL  +N L+ ++  +K++DFGLSR   +  + Y  +   
Sbjct: 106 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYRKRGG 163

Query: 229 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                W   PE L     +++  D+WS G +  E+ T
Sbjct: 164 KLPIRWM-APESLK-EGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 39/91 (42%), Positives = 57/91 (62%), Gaps = 2/91 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y+ +L+ AL + H   I++RDLKP+NIL++ +G + L DFGLS+A  +  N+ T+    T
Sbjct: 101 YIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGT 159

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
             Y  PE+LL  K Y+  VD WS G +  EM
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 43/112 (38%), Positives = 64/112 (57%), Gaps = 4/112 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV- 227
           Y  Q+LE + Y HS  I+HRD+K  NIL + +G +KL DFG S+   TI M+      V 
Sbjct: 111 YTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            T ++  PE++ G + Y    D+WS GC   EM+T+K  +A    +  +F+I
Sbjct: 171 GTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 15/158 (9%)

Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPA 74
              L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  
Sbjct: 46  EAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 104

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           +   +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT  
Sbjct: 105 I--DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAR 160

Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +    W  P  I  G+  ++   D+WS G +  E+
Sbjct: 161 EGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 76.2 bits (187), Expect = 1e-14
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 17/164 (10%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF---------LRQDLKDFLQTTPVPV 71
           A  E+  L    H  +++  D    D KL L+ E+         ++Q LK+ L     P 
Sbjct: 112 ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL-----PF 166

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMN 129
                    YQ++ AL   HSR+++HRDLK  NI +  +G +KL DFG S+ ++  + ++
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ 173
             +    T +Y  PE L   K YS   D+WS G I  E+  L++
Sbjct: 227 VASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 18/168 (10%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           +EI +L+ L H N+++   +   D    + L+ EFL    LK++L      +       Y
Sbjct: 55  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A       YT     + 
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS 183
              WY  PE L+ +K Y  + D+WS G        LY+LL    YC S
Sbjct: 175 PVFWY-APECLIQSKFYIAS-DVWSFGVT------LYELLT---YCDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 4/148 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 108

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y +  DIWS G    E++
Sbjct: 169 APEV-IKQSAYDSKADIWSLGITAIELA 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 35/84 (41%), Positives = 50/84 (59%), Gaps = 4/84 (4%)

Query: 483 SIDVVT----YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 538
           SID+ +      E IT + LF G +  DQL +IFR +GTP E  WPG+S+LP YK  FP 
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR 240

Query: 539 WRPKKFSEILNLPDPLAVDVFSRV 562
           + P+   ++    DPL +D+  R+
Sbjct: 241 YPPQDLQQLFPHADPLGIDLLHRL 264

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTIPMNRYTHEVV 227
           S+  Q+   + Y  S+  IHRDL  +N L+ ++  +K++DFGLSR  +     +     +
Sbjct: 107 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 228 TL-WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + W   PE L     +++  D+WS G +  E+ T
Sbjct: 167 PIRWM-APESLK-EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 29/173 (16%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+L  L + HS++I+HRD+K  N+ ++    +K+ D G+++  +   N     V T +Y 
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYL 168

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE L   K Y+   D+W+ G +  E  T K  F  +++   + +I R           G
Sbjct: 169 SPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-----------G 216

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           V   P+          + +S+ L         +  + +  D +QR     +L+
Sbjct: 217 VFP-PV---------SQMYSQQL-------AQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 37/189 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           YL ++  AL + H + II+RDLKP+NIL++  G +KL DFGL +  +I     TH    T
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGT 163

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PEIL+ +  +   VD WS G +  +M+T    F  ++    + +I +        
Sbjct: 164 IEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-------- 214

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
              G   LP Y T                  P A D+  K++  +P  R+      A  +
Sbjct: 215 ---GKLNLPPYLT------------------PEARDLLKKLLKRNPSSRLGAGPGDAAEV 253

Query: 344 LQHEYFNQV 352
             H +F  V
Sbjct: 254 QSHPFFRHV 262

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 50/151 (33%), Positives = 81/151 (53%), Gaps = 8/151 (5%)

Query: 24  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           EI +LK L H  +++ +  +  P++  L +  E +    +KD L++    +   + + Y 
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYT 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV--T 137
            Q+LE + Y HS  I+HRD+K  NIL +  G +KL DFG S+   TI ++    + V  T
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            ++  PE++ G + Y    DIWS GC   EM
Sbjct: 173 PYWMSPEVISG-EGYGRKADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 8/151 (5%)

Query: 24  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           EI +LK L+H  +++ +  +  P + KL +  E++    +KD L+     +   + + Y 
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYT 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV--T 137
            Q+L+ + Y HS  I+HRD+K  NIL + +G +KL DFG S R  TI M+    + V  T
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            ++  PE++ G + Y    D+WS  C   EM
Sbjct: 173 PYWMSPEVISG-EGYGRKADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 22/163 (13%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E  ++K+L+HP +I+L+ V  ++  +++V E ++   L ++LQ        A  
Sbjct: 45  PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG------AGR 98

Query: 77  KSYLYQLLE-------ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
              L QL++        + Y  ++  IHRDL  +N+L+ ++   K+ADFGL+R      +
Sbjct: 99  ALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK--ED 156

Query: 130 RYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y           W  P   L     +S   D+WS G + +E+
Sbjct: 157 IYEAREGAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 35/98 (35%), Positives = 57/98 (58%), Gaps = 4/98 (4%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  Q++  L + H RRI++RDLKP+N+L++  G ++++D GL  A  +   +       T
Sbjct: 100 YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL--AVELKGGKKIKGRAGT 157

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
             Y  PE+L G +VY  +VD ++ GC   EMI  ++ F
Sbjct: 158 PGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 73.3 bits (181), Expect = 3e-14
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 14/96 (14%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-----RAFTIPMNRYTH 224
           Y  Q++ AL Y HS  I++RDLKP+N+L++  G +K+ DFG +     R +T+     T 
Sbjct: 106 YAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG---TP 162

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
           E     Y  PEI+L  K Y   VD W+ G +  EM+
Sbjct: 163 E-----YLAPEIILS-KGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 49/138 (35%), Positives = 74/138 (53%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           +HP +  L+        LF V E+L   DL   +Q+      P  A  Y  +++  L++ 
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR-ATFYAAEIICGLQFL 112

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           HS+ I++RDLK  NIL++  G +K+ADFG+ +   +   +      T  Y  PEILLG K
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y+T+VD WS G +  EM
Sbjct: 173 -YNTSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 58/197 (29%), Positives = 85/197 (43%), Gaps = 33/197 (16%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q LEAL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++ 
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 233 PPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            PE+++      + Y    D+WS G    EM          ++I+           PH +
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM----------AQIE----------PPHHE 210

Query: 289 VWPGVSKLPIYKTDFPEW-RPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           + P    L I K++ P   +P ++S           D   K +  +   R +   +LQH 
Sbjct: 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFK-------DFLKKCLEKNVDARWTTTQLLQHP 263

Query: 348 YFNQVEMVKPTLAVFPE 364
            F  V   KP   +  E
Sbjct: 264 -FVTVNSNKPIRELIAE 279

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 49/151 (32%), Positives = 81/151 (53%), Gaps = 8/151 (5%)

Query: 24  EISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           EI +LK L+H  +++ +  +    +  L +  E++    +KD L+     +  ++ + Y 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV--T 137
            Q+LE + Y HS  I+HRD+K  NIL + +G +KL DFG S+   TI M+      V  T
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            ++  PE++ G + Y    D+WS GC   EM
Sbjct: 173 PYWMSPEVISG-EGYGRKADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 45/136 (33%), Positives = 68/136 (50%), Gaps = 1/136 (0%)

Query: 33  HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 92
           HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 93  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 152
           R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-Y 173

Query: 153 STTVDIWSAGCIFSEM 168
             +VD W+ G +  EM
Sbjct: 174 GFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 11/151 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAK 77
           L E +V+ +L H N++RL  VI +   L++V E + + +L +FL+T     V V   L  
Sbjct: 47  LEETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL-- 103

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            +   + E + Y  S++++HRDL  +NIL+++ G  K++DFGL+R     M     ++  
Sbjct: 104 QFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPV 161

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W   PE L   K +S+  D+WS G +  E+
Sbjct: 162 KW-TAPEALKHKK-FSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 42/118 (35%), Positives = 64/118 (54%), Gaps = 2/118 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL +L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+
Sbjct: 103 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT-LGTPH 286
            Y  PE+ +  + ++ + D WS G +  EM+T    F G    + +  I +  LG P 
Sbjct: 163 EYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ 219

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 6/163 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           + R++       AL E  +L+++    ++ L         L LV   +   DLK  +   
Sbjct: 28  KKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV 87

Query: 68  PVPV-PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             P  P A A  Y  Q++  L + H RRI++RDLKP+N+L++  G ++++D GL  A  +
Sbjct: 88  GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL--AVEL 145

Query: 127 PMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +       T  Y  PE+L G +VY  +VD ++ GC   EM
Sbjct: 146 KGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 26/178 (14%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+ L Y H    IHRD+K  NIL+ + G +KLADFG+S   T  + +    + T ++ 
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168

Query: 233 PPEILLGAKV--YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
            PE+    +   Y    DIW+ G    E+          +E          L  P  D+ 
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL----------AE----------LQPPMFDLH 208

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           P  +   I K++FP   P K  +      P+  D   K +  DPK+R +A  +LQH +
Sbjct: 209 PMRALFLISKSNFP---PPKLKD-KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 48/129 (37%), Positives = 72/129 (55%), Gaps = 8/129 (6%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV- 227
           Y  Q+L+ + Y HS  I+HRD+K  NIL + +G +KL DFG S R  TI M+    + V 
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T ++  PE++ G + Y    D+WS  C   EM+T+K  +A   E + +  IF+    P 
Sbjct: 171 GTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQPT 226

Query: 287 EDVWP-GVS 294
           + + P GVS
Sbjct: 227 KPMLPDGVS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 47/148 (31%), Positives = 77/148 (52%), Gaps = 4/148 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P + R +       KL+++ E+L      D L+  P P+      + L 
Sbjct: 51  QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR 108

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS R IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y    DIWS G    E++
Sbjct: 169 APEV-IKQSAYDFKADIWSLGITAIELA 195

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 34/189 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVT 228
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  IP        V T
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL--AVEIPEGETIRGRVGT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PE++   + Y+ + D W  GC+  EMI  K+ F    E     ++ R      E+
Sbjct: 165 VGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KVKR------EE 212

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
           V   V      K D  E   +KFSE        A  +  +++  DP  R+      A+ +
Sbjct: 213 VERRV------KED-QEEYSEKFSE-------AARSICRQLLTKDPGFRLGCRGEGAEEV 258

Query: 344 LQHEYFNQV 352
             H +F   
Sbjct: 259 KAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 15/160 (9%)

Query: 24  EISVLKEL-KHPNVIRLH------DVIPVDFKLFLVFEFLR----QDLKDFLQTTPVPVP 72
           E ++L++   HPN+   +      +    D +L+LV E        DL   L+     + 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
                  L + L  L Y H  ++IHRD+K QNIL+ K+  +KL DFG+S      + R  
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 133 HEVVTLWYRPPEILLGAK----VYSTTVDIWSAGCIFSEM 168
             + T ++  PE++   +     Y    D+WS G    E+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPV-PPALAKSY 79
           L E SV+  L+HPN+++L  V+     L++V E++ +  L D+L++    V   A    +
Sbjct: 48  LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 138
              + E + Y   +  +HRDL  +N+L+++    K++DFGL++           +   L 
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-----ASQGQDSGKLP 162

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGC----IFS 166
             W  P  +    K +ST  D+WS G     I+S
Sbjct: 163 VKWTAPEALRE--KKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.4 bits (180), Expect = 9e-14
 Identities = 94/388 (24%), Positives = 164/388 (42%), Gaps = 104/388 (26%)

Query: 161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           AG +F       Q+L A+ + HS+ +IHRD+K  NIL+  +G +KL DFG S+ +     
Sbjct: 145 AGLLF------IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA---A 195

Query: 221 RYTHEV-----VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQL 275
             + +V      T +Y  PEI    K YS   D++S G +  E++T K  F G++ ++++
Sbjct: 196 TVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEV 253

Query: 276 FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK 335
               +TL   ++ + P +S         PE +                ++ + +++ DPK
Sbjct: 254 MH--KTLAGRYDPLPPSIS---------PEMQ----------------EIVTALLSSDPK 286

Query: 336 QRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQ--WQRSWDD 393
           +R S+  +L            P              CK F   + ++++TQ  +     D
Sbjct: 287 RRPSSSKLLN----------MPI-------------CKLFISGLLEIVQTQPGFSGPLRD 323

Query: 394 IPNNKLKRIKPKIEEWPSSQRST--RMEEVVLTRLRI----GHTRLTHKYLFTREPQPVC 447
             + ++++ K   +     +R    +MEE + T        G T LT     T     V 
Sbjct: 324 TISRQIQQTK---QLLQVERRRIVRQMEESLSTAASTTILEGATPLTTLGGLTLYEGIVK 380

Query: 448 QCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDA----VSIDVVTYHESITKKTLFAGDS 503
           +    LS +   +C     IR  L    +L+ D      S+D+V    +++K TL     
Sbjct: 381 KQSSDLSWKRRYLC-----IRGELEKGETLTVDVAPKFKSLDLV---LAVSKDTL----- 427

Query: 504 EIDQLFRIFRTLGTPH---EDVWPGVSK 528
             +Q     + + TP    EDV+P  SK
Sbjct: 428 --EQ-----QCISTPFSDLEDVFPVPSK 448

Length = 496

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 26/160 (16%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------TTPVPVPP 73
           L+E+ +L  L  PN+ RL  V  VD  L ++ E++   DL  FLQ               
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 74  ALAKSYLY---QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
               + LY   Q+   +RY  S   +HRDL  +N L+ K+  +K+ADFG+SR      N 
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NL 180

Query: 131 YTHEVVTLWYRPP--------EILLGAKVYSTTVDIWSAG 162
           Y+ +   +  R P        E +L  K ++T  D+W+ G
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFG 219

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 70.6 bits (174), Expect = 1e-13
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 7/97 (7%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
               Q+ + + Y  S+  +HRDL  +N L+ ++  +K++DFGLSR      + Y      
Sbjct: 106 QMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGG 164

Query: 229 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                W   PE L     +++  D+WS G +  E+ T
Sbjct: 165 KLPIKWM-APESLK-DGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 59/190 (31%), Positives = 82/190 (43%), Gaps = 29/190 (15%)

Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE----VVTL 229
           LLEAL Y H R IIHRD+K +NI +++     L DFG   A  +  +  T +      TL
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTL 251

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG---DSEIDQLFRIFRTLGTPH 286
               PE LL    Y    DIWSAG +  EM  K     G    S   QL  I R +   H
Sbjct: 252 ETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV-H 309

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---------DPLAVDV---FSKIMALDP 334
              +P      + K        K+++ +L  P           + +DV    +K++  D 
Sbjct: 310 PLEFPQNGSTNLCK------HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363

Query: 335 KQRVSAKTIL 344
           + R SA+ IL
Sbjct: 364 EFRPSAQDIL 373

Length = 392

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 73.6 bits (180), Expect = 1e-13
 Identities = 47/129 (36%), Positives = 61/129 (47%), Gaps = 28/129 (21%)

Query: 173 QLLEALRYCHS-------RRIIHRDLKPQNILI-----------------NKSGALKLAD 208
           QLL AL YCH+        R++HRDLKPQNI +                 N     K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 209 FGLSRAFTIPMNRYTHEVV-TLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEMITKKTLF 266
           FGLS+   I +    H  V T +Y  PE+LL   K Y    D+W+ GCI  E+ + KT F
Sbjct: 186 FGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Query: 267 AGDSEIDQL 275
              +   QL
Sbjct: 244 HKANNFSQL 252

Length = 1021

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 17/157 (10%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALAKS 78
           E+ +LK LKH N+++       D  + +  EF     +   L  F      P+P  +   
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCK 106

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 136
           Y  Q+L+ + Y H+  ++HRD+K  N+++  +G +KL DFG +R         TH  +  
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 137 ----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               T ++  PE+ +    Y    DIWS GC   EM+
Sbjct: 167 SMHGTPYWMAPEV-INESGYGRKSDIWSIGCTVFEMA 202

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 49/140 (35%), Positives = 70/140 (50%), Gaps = 7/140 (5%)

Query: 34  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 92
             +++LH     D  L++V E++   DL + +  +   +P   A+ Y  +++ AL   HS
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIHS 160

Query: 93  RRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYRPPEILL---G 148
              IHRD+KP N+L++KSG LKLADFG   +     M R    V T  Y  PE+L    G
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 149 AKVYSTTVDIWSAGCIFSEM 168
              Y    D WS G    EM
Sbjct: 221 DGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 47/138 (34%), Positives = 73/138 (52%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           +HP +  L         LF V E+L   DL   +Q++      A A+ Y  +++  L++ 
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFL 112

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           H + II+RDLK  N+L++K G +K+ADFG+ +       + +    T  Y  PEIL G K
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y+ +VD WS G +  EM
Sbjct: 173 -YNESVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 47/137 (34%), Positives = 71/137 (51%), Gaps = 3/137 (2%)

Query: 33  HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
           HP ++ LH     + +LF V EF+   DL   +Q     +P   A+ Y  ++  AL + H
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH 113

Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED- 172

Query: 152 YSTTVDIWSAGCIFSEM 168
           Y  +VD W+ G +  EM
Sbjct: 173 YGFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 14/152 (9%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYL 80
            +E S+L EL HP ++ +      + +++ + EF +  +L   L+      P  +AK Y 
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYH 124

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
            +L+ A  Y HS+ II+RDLKP+N+L++  G +K+ DFG ++       +      TL  
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTLCG 177

Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              Y  PE+ + +K +   VD W+ G +  E 
Sbjct: 178 TPEYLAPEV-IQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 36/192 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVT 228
           YL +L+ A+   H    +HRD+KP+N+LI+++G +KLADFG +   T   M      V T
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166

Query: 229 LWYRPPEILL-----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
             Y  PE+L      G   Y    D WS G I  EMI  ++ F   +         +T  
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-------SAKTY- 218

Query: 284 TPHEDVWPGVSKLPIYKT--DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
                     + +  ++    FPE  PK  S+ L+L   L             K+R+  +
Sbjct: 219 ----------NNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC---------GQKERLGYE 258

Query: 342 TILQHEYFNQVE 353
            +  H +F++++
Sbjct: 259 GLCCHPFFSKID 270

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 46/129 (35%), Positives = 63/129 (48%), Gaps = 7/129 (5%)

Query: 49  LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 107
           L+LV E+    DL   L          +A+ YL +L+ A+   H    +HRD+KP+N+LI
Sbjct: 76  LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 108 NKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWYRPPEILL-----GAKVYSTTVDIWSA 161
           +++G +KLADFG +   T   M      V T  Y  PE+L      G   Y    D WS 
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195

Query: 162 GCIFSEMSY 170
           G I  EM Y
Sbjct: 196 GVIAYEMIY 204

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 51/212 (24%)

Query: 160 SAGCIFSEMSYLY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 217
           + G +  +M+ +Y  + + AL Y H+  I+HRDLKP N+LI   G +KL DFGLS+   +
Sbjct: 94  NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153

Query: 218 PM--NRYTHEVV-------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            +  N Y   +              T  Y  PE++L  + Y   VD W+ G I  E +  
Sbjct: 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVG 212

Query: 263 KTLFAGDSEIDQLFRIFRTLGTPHEDV-WP-GVSKLPIYKTDFPEWRPKKFSEILNLPDP 320
              F GD+  ++LF          +D+ WP G   LP                       
Sbjct: 213 CVPFFGDTP-EELFG-----QVISDDIEWPEGDEALP----------------------A 244

Query: 321 LAVDVFSKIMALDPKQRV---SAKTILQHEYF 349
            A D+ S+++  +P +R+    A  + QH +F
Sbjct: 245 DAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 24/166 (14%)

Query: 24  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-----------TTPVP 70
           E+ ++K + KH N+I L  V   +  L++V E+    +L+DFL+             P P
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 71  VPPALAK----SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               L +    S+ YQ+   + +  S++ IHRDL  +N+L+ +   +K+ADFGL+R   I
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DI 182

Query: 127 PMNRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               Y    T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 29/168 (17%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP--------VP 72
           L+EI ++  LK+PN+IRL  V   D  L ++ E++   DL  FL    +         +P
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 73  PALAKSYLY---QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
                + LY   Q+   ++Y  S   +HRDL  +N L+     +K+ADFG+SR      N
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR------N 178

Query: 130 RYTHEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y+ +   +         W     ILLG   ++T  D+W+ G    EM
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 44/146 (30%), Positives = 79/146 (54%), Gaps = 4/146 (2%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ ++    V  +L+++ EFL+   L D +  +   +      +    
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCES 125

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL Y HS+ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +    Y T VDIWS G +  EM
Sbjct: 186 PEV-ISRTPYGTEVDIWSLGIMVIEM 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 72.0 bits (176), Expect = 3e-13
 Identities = 39/103 (37%), Positives = 59/103 (57%), Gaps = 3/103 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVT 228
            YQ++ AL   HSR+++HRDLK  NI +  +G +KL DFG S+ ++  + ++  +    T
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
            +Y  PE L   K YS   D+WS G I  E++T    F G S+
Sbjct: 235 PYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276

Length = 478

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 43/105 (40%), Positives = 53/105 (50%), Gaps = 4/105 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVT 228
           Y  +++ AL   HS   IHRD+KP N+L++KSG LKLADFG   +     M R    V T
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGT 206

Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
             Y  PE+L    G   Y    D WS G    EM+   T F  DS
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 14/154 (9%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T      P L    L
Sbjct: 41  LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----PRLKVKEL 96

Query: 81  YQLLE----ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---H 133
            Q++E     + Y  S+  IHRDL  +N L+ +   LK++DFG+SR     +   T    
Sbjct: 97  IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
           ++   W  P  +  G   YS+  D+WS G +  E
Sbjct: 157 QIPVKWTAPEALNYGR--YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 30/57 (52%), Positives = 38/57 (66%), Gaps = 4/57 (7%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK----TDFPEWRPKK 543
           E +TKK LF G SEIDQL +IF+ LGTP E +WPG S+LP  K    T +P  + +K
Sbjct: 199 ELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK 255

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 11/152 (7%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E  V+ +L HP +++L+ V      + LVFEF+    L D+L+                 
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 139
           + E + Y  S  +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 166

Query: 140 YRPPEILLGAKVYSTTVDIWSAGC----IFSE 167
           +  PE+   +K YS+  D+WS G     +FSE
Sbjct: 167 WSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 55/194 (28%), Positives = 83/194 (42%), Gaps = 37/194 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL + H   +I+RDLK  NIL++  G  KLADFG+ +   +     T    T 
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEIL   + Y  +VD W+ G +  EM+  +  F  D+E D LF         H+DV
Sbjct: 161 DYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFE-----SILHDDV 213

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA-------KT 342
                        +P W  K+           AV +    M  +P +R+           
Sbjct: 214 L------------YPVWLSKE-----------AVSILKAFMTKNPNKRLGCVASQGGEDA 250

Query: 343 ILQHEYFNQVEMVK 356
           I QH +F +++ V 
Sbjct: 251 IKQHPFFKEIDWVL 264

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 49/198 (24%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---------------QT 66
           +E  ++ +L+HPN++ L  V   +    ++FE+L   DL +FL               +T
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               +  +       Q+   + Y  S   +HRDL  +N L+ +   +K++DFGLSR    
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI-- 174

Query: 127 PMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEM-SYLYQ 173
               Y+ +    +YR            PPE +L  K ++T  DIWS G +  E+ SY  Q
Sbjct: 175 ----YSAD----YYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQ 225

Query: 174 ---------LLEALRYCH 182
                    ++E +R   
Sbjct: 226 PYYGFSNQEVIEMIRSRQ 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 1/136 (0%)

Query: 33  HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 92
           +P ++ LH       +LFLV E++      F       +P   A+ Y  ++  AL + H 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 93  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 152
           R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G + Y
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-Y 173

Query: 153 STTVDIWSAGCIFSEM 168
             +VD W+ G +  EM
Sbjct: 174 GFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 46/155 (29%), Positives = 84/155 (54%), Gaps = 14/155 (9%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 77
           L E +++K L+H  ++RL+ V+  +  ++++ E++ +  L DFL++     V +P  +  
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-- 106

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----H 133
            +  Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     
Sbjct: 107 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGA 164

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    W  P  I  G+  ++   D+WS G +  E+
Sbjct: 165 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 4/146 (2%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++  H NV+ +++   V  +L++V EFL    L D +  T   +      +    
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLS 126

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +    Y T VDIWS G +  EM
Sbjct: 187 PEV-ISRLPYGTEVDIWSLGIMVIEM 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           ++P +  L+        LF V EFL   DL   +Q          A  Y  +++  L++ 
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL 112

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           HS+ II+RDLK  N+++++ G +K+ADFG+ +      NR +    T  Y  PEIL G K
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y+ +VD WS G +  EM
Sbjct: 173 -YTFSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 33/185 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 227
           Y  Q+L+ + Y H+  ++HRD+K  N+++  +G +KL DFG +R         TH  +  
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 228 ----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
               T ++  PE+ +    Y    DIWS GC   EM T K   A    +  +F I     
Sbjct: 167 SMHGTPYWMAPEV-INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----- 220

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
             H  + P +              P  FS         A+D  +  +  D  +R SA  +
Sbjct: 221 GAHRGLMPRL--------------PDSFSAA-------AIDFVTSCLTRDQHERPSALQL 259

Query: 344 LQHEY 348
           L+H++
Sbjct: 260 LRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + ++ E++    L  FL+              L
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVVT 137
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR        YT    ++  
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
            W  P  I    + +++  D+WS G +  E MSY
Sbjct: 173 RWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSY 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 23/190 (12%)

Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 31  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 88

Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L K      ++ + + Y ++ + +HRDL  +
Sbjct: 89  ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAAR 148

Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 149 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 207

Query: 162 GCIFSEMSYL 171
           G +  E++ L
Sbjct: 208 GVVLWEIATL 217

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 55/191 (28%), Positives = 78/191 (40%), Gaps = 32/191 (16%)

Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 231
           ++E L Y ++  RI+HRD+KP NIL+N  G +KL DFG+S      +N      V T  Y
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTY 168

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR-----IFRTLGTPH 286
             PE + G K Y+   D+WS G    E+   K  FA  S ID   +     I   L    
Sbjct: 169 MSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFA-FSNIDDDGQDDPMGILDLL---Q 223

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           + V     +LP   +DFP                   D     +  DP +R + + +   
Sbjct: 224 QIVQEPPPRLP--SSDFP---------------EDLRDFVDACLLKDPTERPTPQQLCAM 266

Query: 347 EYFNQVEMVKP 357
             F Q      
Sbjct: 267 PPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V        L LV E+L    L+D+LQ     +       Y
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--- 136
             Q+ + + Y  S+R +HRDL  +NIL+     +K+ DFGL++   +P ++  ++V    
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK--VLPQDKEYYKVREPG 171

Query: 137 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY P    L    +S   D+WS G +  E+
Sbjct: 172 ESPIFWYAPES--LTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 33/71 (46%), Positives = 42/71 (59%), Gaps = 1/71 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E +T K LF G++EIDQL RIF  LGTP+ED WP   KLP+Y T+F   +PK    I   
Sbjct: 226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY-TEFTPRKPKDLKTIFPN 284

Query: 551 PDPLAVDVFSR 561
               A+D+   
Sbjct: 285 ASDDAIDLLQS 295

Length = 335

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 68.3 bits (168), Expect = 8e-13
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 50/190 (26%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+  Q+ + + Y  S++ +HRDL  +N L+ +   +K++DFGLSR      + Y  +   
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGG 167

Query: 229 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG- 283
                W   PE L    ++++  D+WS G +                   L+ IF TLG 
Sbjct: 168 KLPIRWM-APESLKD-GIFTSKSDVWSFGVL-------------------LWEIF-TLGA 205

Query: 284 TPHEDVWPGVSKLPIYKT-------DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           TP    +PG+S   + +          PE+ P +  E++                LDP+ 
Sbjct: 206 TP----YPGLSNEEVLEYLRKGYRLPKPEYCPDELYELML-----------SCWQLDPED 250

Query: 337 RVSAKTILQH 346
           R +   +++ 
Sbjct: 251 RPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 25/159 (15%)

Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-----------RQDLKDFLQTTPVPV 71
           E  VL+ ++  P ++ LH     D KL L+ +++           R+   +         
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE--------- 104

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
             +  + Y+ +++ AL + H   II+RD+K +NIL++  G + L DFGLS+ F       
Sbjct: 105 --SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162

Query: 132 THEVV-TLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEM 168
            +    T+ Y  PE++ G    +   VD WS G +  E+
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 39/113 (34%), Positives = 56/113 (49%), Gaps = 16/113 (14%)

Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM- 128
            +P  +A+ Y  + + AL Y H+  I+HRDLKP N+LI   G +KL DFGLS+   + + 
Sbjct: 97  ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Query: 129 -NRYTHEVV-------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
            N Y   +              T  Y  PE++L  + Y   VD W+ G I  E
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 6/163 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           + R++     + AL E  +L+++    V+ L         L LV   +   DLK  +   
Sbjct: 35  KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM 94

Query: 68  PVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             P      A  Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  I
Sbjct: 95  GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL--AVEI 152

Query: 127 PMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           P        V T+ Y  PE++   + Y+ + D W  GC+  EM
Sbjct: 153 PEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 30/65 (46%), Positives = 42/65 (64%), Gaps = 1/65 (1%)

Query: 498 LFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAV 556
           LF G+++I+QL  +FRTLGTP+E+ WPG++ LP Y K  FPE +P    EI     P A+
Sbjct: 200 LFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL 259

Query: 557 DVFSR 561
           D+   
Sbjct: 260 DLLKG 264

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 30/182 (16%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L + L  L Y H  ++IHRD+K QNIL+ K+  +KL DFG+S      + R    + T +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 231 YRPPEILLGAK----VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           +  PE++   +     Y    D+WS G    E+   K        +  LF+I R      
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
            +  P +              P+ +S+  N       D  S+ +  + +QR   + +L+H
Sbjct: 233 -NPPPTLK------------SPENWSKKFN-------DFISECLIKNYEQRPFMEELLEH 272

Query: 347 EY 348
            +
Sbjct: 273 PF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 42/120 (35%), Positives = 60/120 (50%), Gaps = 5/120 (4%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 231
           QLL A+ Y H +++IHRD+K +NI +N  G + L DFG +  F      + +  V T+  
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID---QLFRIFRTLGTPHED 288
             PEIL G   Y    DIWS G I  +M++      GD       QL +I  +L    E+
Sbjct: 335 NSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEE 393

Length = 501

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 38/114 (33%), Positives = 59/114 (51%), Gaps = 8/114 (7%)

Query: 158 IWSAGCIFSEMS----YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
           I++ G    EM     Y  Q+   + + HS  I++RD+KP+N+L++  G  +L+D GL  
Sbjct: 84  IYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL-- 141

Query: 214 AFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           A  +   +  T    T  Y  PEIL   + YS  VD ++ GC   EM+  +T F
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 50/148 (33%), Positives = 74/148 (50%), Gaps = 3/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E +VL ++  P ++ L        KL+LV  F+   +L   LQ        + A+ Y 
Sbjct: 41  LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYT 99

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            +LL AL   H   +I+RDLKP+NIL++  G + L DFGL +      ++      T  Y
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE+LLG   Y+  VD W+ G +  EM
Sbjct: 160 LAPELLLGHG-YTKAVDWWTLGVLLYEM 186

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 6/143 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           LRE+ ++ E + P ++  +     +  + +  EF+     D +     P+P  +      
Sbjct: 51  LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAV 110

Query: 82  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 139
            ++E L Y ++  RI+HRD+KP NIL+N  G +KL DFG+S      +N      V T  
Sbjct: 111 AVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTST 167

Query: 140 YRPPEILLGAKVYSTTVDIWSAG 162
           Y  PE + G K Y+   D+WS G
Sbjct: 168 YMSPERIQGGK-YTVKSDVWSLG 189

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP--PAL--AKSY 79
           EI  L  L H N++++ +++  +   +++ +    DL  F+          P L   ++ 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 138
           + QLL A+ Y H +++IHRD+K +NI +N  G + L DFG +  F      + +  V T+
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               PEIL G   Y    DIWS G I  +M
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E+ +L +   P +I  +    V+ ++ +  EF+     D  +  P  V   +A +   
Sbjct: 47  MSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--- 103

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
            +++ L Y  S +I+HRD+KP N+L+N  G +KL DFG+S      +      V T  Y 
Sbjct: 104 -VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYM 160

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE + G + Y    D+WS G  F E++
Sbjct: 161 APERISGEQ-YGIHSDVWSLGISFMELA 187

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 28/167 (16%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA---- 76
           L+EI ++  LK PN+IRL  V      L ++ E++   DL  FL           A    
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 77  ------KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
                      Q+   ++Y  S   +HRDL  +N L+ K+  +K+ADFG+SR      N 
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NL 180

Query: 131 YTHEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           Y+ +   +         W     ILLG   ++T  D+W+ G    E+
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 4/146 (2%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T   +      +    
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLA 124

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 34/189 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH-EVVT 228
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +P  +     V T
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PE++   + Y+ + D W+ GC+  EMI      AG S   Q     R      E+
Sbjct: 165 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQ-----RKKKIKREE 212

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
           V   V        +  E   +KFS       P A  +   ++  DPK+R+      A+ +
Sbjct: 213 VERLVK-------EVQEEYSEKFS-------PDARSLCKMLLCKDPKERLGCQGGGAREV 258

Query: 344 LQHEYFNQV 352
            +H  F Q+
Sbjct: 259 KEHPLFKQI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 62/194 (31%), Positives = 86/194 (44%), Gaps = 26/194 (13%)

Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRP 233
           L  LR  H   I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y  
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMS 166

Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEM-ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
           PE L G   Y+   DIWS G    EM I +  +   D++  +L  +F    +  E     
Sbjct: 167 PERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAK-ES 222

Query: 293 VSKLPIYKTDFPEWRPKKFSE----ILNLPDP-LAVDVFS--------KIMALDPKQRVS 339
              +  +  D P  RP    E    I+N P P L    FS        K +  +PK+R  
Sbjct: 223 HRPVSGHPPDSP--RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD 280

Query: 340 AKTILQHEYFNQVE 353
            K + +H +  + E
Sbjct: 281 LKELTKHPFIKRAE 294

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 38/116 (32%), Positives = 64/116 (55%), Gaps = 5/116 (4%)

Query: 164 IFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE   + Y   ++  L+Y H  +I++RDLK  N+L++  G +K+ADFGL +      +
Sbjct: 97  VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156

Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
           R +    T  +  PE+L     Y+  VD W  G +  EM+  ++ F GD E +++F
Sbjct: 157 RTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 16/161 (9%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPV-------PP 73
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+   P  V       P 
Sbjct: 56  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA 115

Query: 74  ALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPM 128
            L +S +     Q+   + Y  S+  +HRDL  +N L+ ++  +K+ DFG+SR  ++   
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175

Query: 129 NRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            R   H ++ + + PPE ++  K ++T  D+WS G +  E+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 25/57 (43%), Positives = 34/57 (59%), Gaps = 1/57 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEI 547
           E + +     GDS+IDQL +IF  LGTP E+ WPGV+ LP Y  +F  + P    +I
Sbjct: 195 ELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY-VEFKPFPPTPLKQI 250

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 13/159 (8%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +       P 
Sbjct: 45  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 103

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 104 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 160

Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +    W  P   L G   ++   D+WS G + +E++
Sbjct: 161 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 197

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 31/186 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  +++ AL + H   I++RD+K +NIL++  G + L DFGLS+ F       T+    T
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PEI+ G   +   VD WS G +  E++T  + F  + E +    + R        
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR------- 222

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
                    I K D P      F   +    P A D+  K++  DPK+R+      A  I
Sbjct: 223 ---------ILKCDPP------FPSFIG---PEAQDLLHKLLRKDPKKRLGAGPQGASEI 264

Query: 344 LQHEYF 349
            +H +F
Sbjct: 265 KEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 51/140 (36%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 34  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 92
           P V++L      D  L++V E++   DL + +      VP   AK Y  +++ AL   HS
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS 160

Query: 93  RRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVVTLWYRPPEILL---G 148
             +IHRD+KP N+L++K G LKLADFG         M R    V T  Y  PE+L    G
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 149 AKVYSTTVDIWSAGCIFSEM 168
              Y    D WS G    EM
Sbjct: 221 DGYYGRECDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 36/87 (41%), Positives = 48/87 (55%), Gaps = 8/87 (9%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
             L+ L Y HS   IHRD+K  NIL+ + G +KLADFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSF---VGTPYWM 178

Query: 233 PPEILLGAK--VYSTTVDIWSAG--CI 255
            PE++L      Y   VD+WS G  CI
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCI 205

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 31/193 (16%)

Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           +++AL Y HS+  +IHRD+KP N+LIN++G +KL DFG+S      + + T +     Y 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-TIDAGCKPYM 170

Query: 233 PPEIL---LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            PE +   L  K Y    D+WS G    E+ T +  +              +  TP + +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-------------SWKTPFQQL 217

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
              V +        P+   +KFS       P   D  +K +  + K+R +   +LQH +F
Sbjct: 218 KQVVEEPS------PQLPAEKFS-------PEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Query: 350 NQVEMVKPTLAVF 362
                    +A F
Sbjct: 265 ELHLSKNTDVASF 277

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 19/157 (12%)

Query: 23  REISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 79
           +EI++LK L H N+++            L L+ E++    L+D+L    +     LA+  
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL----NLAQLL 110

Query: 80  LY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
           L+  Q+ E + Y HS+  IHRDL  +N+L++    +K+ DFGL++A  +P     + V  
Sbjct: 111 LFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVRE 168

Query: 137 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  WY   E L   K    + D+WS G    E+
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 4/152 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI ++K+ KH N++          KL++  EF     L+D    T  P+  +       
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSR 113

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           + L+ L Y HS+  +HRD+K  NIL+  +G +KLADFG+S   T  + +    + T ++ 
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWM 173

Query: 142 PPEILLGAKV--YSTTVDIWSAGCIFSEMSYL 171
            PE+    +   Y+   DIW+ G    E++ L
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 4/148 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P V + +       KL+++ E+L      D L+  P         + L 
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLK 108

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y +  DIWS G    E++
Sbjct: 169 APEV-IQQSAYDSKADIWSLGITAIELA 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 10/157 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+I L  V+     + ++ EF+    L  FL+              L
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 134
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
           +   W  P  I    + +++  D+WS G +  E MSY
Sbjct: 173 IPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSY 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)

Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 41  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 93

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 94  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153

Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 154 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 196

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 24/168 (14%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVP------- 72
           + E+ ++K + KH N+I L  V   +  L+++ E+  + +L++FL+    P P       
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 73  ---------PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 123
                      L  S  YQ+   + Y  SRR IHRDL  +N+L+ +   +K+ADFGL+R 
Sbjct: 125 KVPEEQLSFKDLV-SCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 124 FTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               ++ Y   ++  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 184 VH-DIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 51/140 (36%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 34  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 92
           P V++L      D  L++V E++   DL + +      VP   A+ Y  +++ AL   HS
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS 160

Query: 93  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILL---G 148
              IHRD+KP N+L++KSG LKLADFG         M R    V T  Y  PE+L    G
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 149 AKVYSTTVDIWSAGCIFSEM 168
              Y    D WS G    EM
Sbjct: 221 DGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 29/177 (16%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK--- 77
           L E ++LK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 51  LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110

Query: 78  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                               S+ +Q+   ++Y    +++HRDL  +N+L+ +   +K++D
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISD 170

Query: 118 FGLSRAF---TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
           FGLSR        + R    +   W       L   +Y+T  D+WS G +  E+  L
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIES--LFDHIYTTQSDVWSFGVLLWEIVTL 225

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 8/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+I L  V+     + +V E++    L  FL+              L
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTH---EVV 136
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 173 IRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSY 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 35/85 (41%), Positives = 47/85 (55%), Gaps = 4/85 (4%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+L  + Y H R I+HRD+KP N+LIN +  +K+ADFG+SR     M+     V T+ Y 
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 235

Query: 233 PPEIL---LGAKVYSTTV-DIWSAG 253
            PE +   L    Y     DIWS G
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLG 260

Length = 353

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 52/155 (33%), Positives = 76/155 (49%), Gaps = 18/155 (11%)

Query: 24  EISVLKELK-HPNVIRLH------DVIPVDFKLFLVFEFLR----QDL-KDFLQTTPVPV 71
           E ++LK L  HPNV++ +      DV   D +L+LV E        DL K FL+      
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGD-QLWLVLELCNGGSVTDLVKGFLKRGERME 122

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
            P +A   L++ L  L++ H  + IHRD+K  NIL+   G +KL DFG+S   T    R 
Sbjct: 123 EPIIA-YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 132 THEVVTLWYRPPEILLGAK----VYSTTVDIWSAG 162
              V T ++  PE++   +     Y    D+WS G
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 31/71 (43%), Positives = 43/71 (60%), Gaps = 1/71 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI-YKTDFPEWRPKKFSEILN 549
           E ++++ LF G SEIDQLF+IFRTLGTP  +VWP  + L   YK  FP+       ++  
Sbjct: 191 ELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250

Query: 550 LPDPLAVDVFS 560
              P A+D+ S
Sbjct: 251 NASPQALDLLS 261

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---- 223
           + +  Q+ + + Y  S+R IHRDL  +NIL+     +K++DFGL++      + Y     
Sbjct: 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP 171

Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            E    WY  PE L  +K  S + D+WS G    E+ T
Sbjct: 172 GESPIFWY-APECLRTSKFSSAS-DVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 1/91 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y HS  II+RDLKP+NIL++  G + L DFGL +         +    T 
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            Y  PE+L   + Y  TVD W  G +  EM+
Sbjct: 161 EYLAPEVLR-KQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 44/113 (38%), Positives = 55/113 (48%), Gaps = 4/113 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVT 228
           Y  +++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206

Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             Y  PE+L    G   Y    D WS G    EM+   T F  DS +    +I
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI ++KE KH N++          KL++  E+     L+D    T  P+          
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCR 113

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           + L+ L Y HS+  +HRD+K  NIL+  +G +KLADFG++   T  + +    + T ++ 
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173

Query: 142 PPEILLGAKV--YSTTVDIWSAGCIFSEMSYL 171
            PE+    K   Y+   DIW+ G    E++ L
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 14/160 (8%)

Query: 24  EISVLKEL-KHPNVIRLHDVI-----PVDFKLFLVFEFLR----QDLKDFLQTTPVPVPP 73
           E ++L+ L  HPNV++ + +       V  +L+LV E        +L   L      +  
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           A+    LY  L  L++ H+ RIIHRD+K  NIL+   G +KL DFG+S   T    R   
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 134 EVVTLWYRPPEILLGAKVYSTT----VDIWSAGCIFSEMS 169
            V T ++  PE++   + Y  +     D+WS G    E+ 
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 1/97 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++  L + H RRII+RDLKP+N+L++  G ++++D GL+       ++      T 
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            +  PE+L G + Y  +VD ++ G    EMI  +  F
Sbjct: 162 GFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 44/172 (25%), Positives = 83/172 (48%), Gaps = 26/172 (15%)

Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 68  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR---ARRPPGME 124

Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
             Y                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 184

Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 185 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 7/151 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      L++V EF+    L ++L+     +   +  S  
Sbjct: 47  IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---VT 137
             + E + Y      IHRDL  +N L++ +G +K++DFG++R + +  + YT        
Sbjct: 107 QDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLD-DEYTSSSGAKFP 164

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + + PPE+   +K YS+  D+WS G +  E+
Sbjct: 165 VKWSPPEVFNFSK-YSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 4/103 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH-EVVT 228
           Y  ++L  L   H    ++RDLKP+NIL++  G ++++D GL  A  IP        V T
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL--AVKIPEGESIRGRVGT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
           + Y  PE+L   + Y+ + D W  GC+  EMI  ++ F G  E
Sbjct: 165 VGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 34/95 (35%), Positives = 45/95 (47%), Gaps = 4/95 (4%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEV 226
           Y  Q+   +RY  S+R IHRDL  +NIL+     +K+ DFGL RA     + Y    H  
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V   +  PE L     +S   D+W  G    EM T
Sbjct: 162 VPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 32/93 (34%), Positives = 56/93 (60%), Gaps = 6/93 (6%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 230
             + E + Y  S++ IHRDL  +N L++  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSSVGSKFP 164

Query: 231 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             + PPE+LL +K +S+  D+W+ G +  E+ +
Sbjct: 165 VRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 46/192 (23%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +L+ A  Y HS+ II+RDLKP+N+L++  G +K+ DFG ++       +      TL
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTL 175

Query: 230 W----YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
                Y  PE+ + +K +   VD W+ G +  E I     F  D+     FRI+      
Sbjct: 176 CGTPEYLAPEV-IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIY------ 224

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA----- 340
            E +  G       +  FP W            D  A D+   ++  D  +R+       
Sbjct: 225 -EKILAG-------RLKFPNWF-----------DGRARDLVKGLLQTDHTKRLGTLKGGV 265

Query: 341 KTILQHEYFNQV 352
             +  H YF+  
Sbjct: 266 ADVKNHPYFHGA 277

Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           KHP +  LH       +LF V E++   DL   +Q +        ++ Y  ++  AL + 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL 112

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           H   +I+RDLK  NIL++  G  KLADFG+ +   +     T    T  Y  PEIL   +
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y  +VD W+ G +  EM
Sbjct: 173 -YGPSVDWWALGVLMYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 30/190 (15%)

Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE+ +    Y T VDIWS G +  EMI  +  +  +  +  + RI        +++ P V
Sbjct: 187 PEV-ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RDNLPPRV 238

Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE 353
                           K S +L             ++  +P QR +A+ +LQH +   ++
Sbjct: 239 KDS------------HKVSSVLR-------GFLDLMLVREPSQRATAQELLQHPF---LK 276

Query: 354 MVKPTLAVFP 363
           +  P   + P
Sbjct: 277 LAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 27/178 (15%)

Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE L+    Y   VDIWS G +  EM+                      G P     P +
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPL 222

Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             + + + + P  + K   ++     P       +++  DP QR +A  +L+H +  +
Sbjct: 223 KAMKMIRDNLPP-KLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 9/109 (8%)

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
            T P  +   +A S    +++AL Y HS+  +IHRD+KP N+LIN++G +KL DFG+S  
Sbjct: 98  LTIPEDILGKIAVS----IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153

Query: 124 FTIPMNRYTHEVVTLWYRPPEIL---LGAKVYSTTVDIWSAGCIFSEMS 169
               + + T +     Y  PE +   L  K Y    D+WS G    E++
Sbjct: 154 LVDSVAK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 13/167 (7%)

Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 41  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 93

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +L  L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 94  LKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153

Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    E++
Sbjct: 154 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELA 196

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 43/176 (24%)

Query: 22  LREISVLKELKHPNVIRLHDVI-----------PVDFKLFLVFEFLRQ-DLKDFL----- 64
           L E   +KE  HPNV+RL  V            PV     ++  F++  DL  FL     
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV-----VILPFMKHGDLHSFLLYSRL 102

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
              P  +P  +   ++  +   + Y  S+  IHRDL  +N ++N++  + +ADFGLS+  
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Query: 125 TIPMNRYTHEVVTLWYRPPEIL-----------LGAKVYSTTVDIWSAGCIFSEMS 169
                 Y  +    +YR   I            L  +VY+T  D+WS G    E++
Sbjct: 163 ------YNGD----YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIA 208

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 20/165 (12%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-QTTP------VPVPPA 74
           +E S++ EL HPN++ L  V+  +  + ++FE+L Q DL +FL   +P            
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 75  LAKSYL---------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-F 124
             KS L          Q+   + Y  S   +H+DL  +NILI +   +K++D GLSR  +
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 125 TIPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    R     ++ + + PPE ++  K +S+  DIWS G +  E+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 6/146 (4%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L  + HP  + L+     +  L+LV EF +  +   FL+      P  +   Y  Q
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQ 139

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           ++    Y  S  I++RDLKP+N+L++K G +K+ DFG ++   +    YT    T  Y  
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTL-CGTPEYIA 196

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PEILL    +    D W+ G    E+
Sbjct: 197 PEILLNVG-HGKAADWWTLGIFIYEI 221

Length = 340

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 19/165 (11%)

Query: 24  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKSY- 79
           E+ VL +L  HPN+I L         L++  E+    +L DFL+ + V    PA AK + 
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 80  ------LYQLLE-------ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                   QLL+        ++Y   ++ IHRDL  +N+L+ ++ A K+ADFGLSR   +
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
            + +    +   W       L   VY+T  D+WS G +  E+  L
Sbjct: 172 YVKKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSL 214

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 6/141 (4%)

Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 95  IIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYRPPEILL----GA 149
            +HRD+KP N+L++K+G ++LADFG   R       +    V T  Y  PEIL     G 
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 150 KVYSTTVDIWSAGCIFSEMSY 170
             Y    D WS G    EM Y
Sbjct: 183 GRYGPECDWWSLGVCMYEMLY 203

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEIL- 548
           E    K +F G +E++QL +IF   G+P ++ WPGVSKLP ++     +   ++  E   
Sbjct: 194 ELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK 253

Query: 549 NLPDPLAVDVFSR 561
           +L DP A+D+  +
Sbjct: 254 HLIDPSALDLLDK 266

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 16/155 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E  +LK+  HPN+++L  V      +++V E +    L  FL+     +     K  L
Sbjct: 40  LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLL 96

Query: 81  YQLLEA---LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----- 132
              L+A   + Y  S+  IHRDL  +N L+ ++  LK++DFG+SR     +  YT     
Sbjct: 97  QMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI--YTVSDGL 154

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
            ++   W  P  +  G   Y++  D+WS G +  E
Sbjct: 155 KQIPIKWTAPEALNYGR--YTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 38/198 (19%)

Query: 4   DESRPRSRVQV----------EGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLV 52
           D+ +P+  V V          E   S  + E+ ++K + KH N+I L      D  L+++
Sbjct: 40  DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99

Query: 53  FEFL-RQDLKDFLQTTPVPVPPALAKSY------------------LYQLLEALRYCHSR 93
            E+  + +L+++L+      PP +  SY                   YQ+   + Y  S+
Sbjct: 100 VEYASKGNLREYLRARR---PPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ 156

Query: 94  RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTLWYRPPEILLGAK 150
           + IHRDL  +N+L+ ++  +K+ADFGL+R     ++ Y   T+  + + +  PE L   +
Sbjct: 157 KCIHRDLAARNVLVTENNVMKIADFGLARDVN-NIDYYKKTTNGRLPVKWMAPEALFD-R 214

Query: 151 VYSTTVDIWSAGCIFSEM 168
           VY+   D+WS G +  E+
Sbjct: 215 VYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 48/152 (31%), Positives = 84/152 (55%), Gaps = 11/152 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPV--PPALA 76
           L E SV+ +L+H N+++L  VI V+ K  L++V E++ +  L D+L++    V     L 
Sbjct: 47  LAEASVMTQLRHSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           K  L  + EA+ Y  +   +HRDL  +N+L+++    K++DFGL++  +   +  T ++ 
Sbjct: 106 KFSL-DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP 162

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             W  P    L  K +ST  D+WS G +  E+
Sbjct: 163 VKWTAPEA--LREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 38/86 (44%), Positives = 45/86 (52%), Gaps = 7/86 (8%)

Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRP 142
           L  LR  H   I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y  
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMS 166

Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L G   Y+   DIWS G    EM
Sbjct: 167 PERLQGTH-YTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 19/165 (11%)

Query: 24  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKSY- 79
           E+ VL +L  HPN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 80  ------LYQLLE-------ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                   QLL         + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
            + +    +   W       L   VY+T  D+WS G +  E+  L
Sbjct: 165 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 207

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 44/200 (22%)

Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++ AL Y HS  +++RDLK +N++++K G +K+ DFGL +       
Sbjct: 91  VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA 150

Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
                  T  Y  PE+L     Y   VD W  G +  EM+                    
Sbjct: 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM-------------------- 189

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL---AVDVFSKIMALDPKQR 337
                         +LP Y  D  +       E +  P  L   A  + + ++  DPKQR
Sbjct: 190 ------------CGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 338 V-----SAKTILQHEYFNQV 352
           +      AK I++H +F  +
Sbjct: 238 LGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 2/107 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L + HS+ II+RDLK  N++++  G +K+ADFG+ +              T 
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP 165

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            Y  PEI+   + Y  +VD W+ G +  EM+  +  F G+ E D+LF
Sbjct: 166 DYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELF 210

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 43/113 (38%), Positives = 55/113 (48%), Gaps = 4/113 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVVT 228
           Y  +++ AL   HS  +IHRD+KP N+L++K G LKLADFG         M R    V T
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206

Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             Y  PE+L    G   Y    D WS G    EM+   T F  DS +    +I
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVT 228
           Y  +L   L      RI++RDLKP+NIL++  G ++++D GL  A  IP        V T
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PE++   K Y+ + D W  GC+  EMI  ++ F    E  +   + R +      
Sbjct: 165 VGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV------ 217

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
                      K D  E+  +KFSE        A  +   ++  +PK+R+      A  +
Sbjct: 218 -----------KEDQEEYS-EKFSED-------AKSICRMLLTKNPKERLGCRGNGAAGV 258

Query: 344 LQHEYFNQV 352
            QH  F  +
Sbjct: 259 KQHPIFKNI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVT 137
           Y  Q+   + + HS  I++RD+KP+N+L++  G  +L+D GL  A  +   +  T    T
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGT 157

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  PEIL   + YS  VD ++ GC   EM
Sbjct: 158 NGYMAPEILK-EEPYSYPVDWFAMGCSIYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-----------TPVP 70
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+             P  
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 71  VPPALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFT 125
               L  S +     Q+   + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR  ++
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175

Query: 126 IPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               R   H ++ + + PPE ++  K ++T  D+WS G I  E+
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 21/164 (12%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---------TPVPVP 72
           RE  +L   +H N+++ + V        +VFE++   DL  FL++         +P    
Sbjct: 57  REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 73  PALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 128
             L  S L     Q+   + Y  S+  +HRDL  +N L+     +K+ DFG+SR   +  
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYT 174

Query: 129 NRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y     H ++ + + PPE ++  K ++T  D+WS G +  E+
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 40/118 (33%), Positives = 58/118 (49%), Gaps = 5/118 (4%)

Query: 168 MSY-LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           +SY LY  L  L++ H+ RIIHRD+K  NIL+   G +KL DFG+S   T    R    V
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 227 VTLWYRPPEILLGAKVYSTT----VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            T ++  PE++   + Y  +     D+WS G    E+            +  LF+I R
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 36/190 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL + H + II+RDLK  N+L++  G  KLADFG+ +         +    T 
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEI L   +Y  +VD W+ G +  EM+     F  ++E D LF          E V
Sbjct: 161 DYIAPEI-LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILN----DEVV 214

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA------KTI 343
           +P              W  +            AVD+    M  +P  R+ +      + I
Sbjct: 215 YPT-------------WLSQD-----------AVDILKAFMTKNPTMRLGSLTLGGEEAI 250

Query: 344 LQHEYFNQVE 353
           L+H +F +++
Sbjct: 251 LRHPFFKELD 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 9e-11
 Identities = 40/115 (34%), Positives = 64/115 (55%), Gaps = 11/115 (9%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLS------RAFTIPMNRYT 223
           Q+L+AL   H++ I+HRDLKPQNI+++++G     K+ DFG+       R   +     T
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146

Query: 224 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            EV+ T  Y  PE L G  V   + D+++ G IF E +T + +  G S  + L++
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNS-DLYAWGLIFLECLTGQRVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 1/91 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y HS  I++RDLKP+NIL++  G + L DFGL +      +  T    T 
Sbjct: 101 YAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            Y  PE++   + Y  TVD W  G +  EM+
Sbjct: 161 EYLAPEVIR-KQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 6/106 (5%)

Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 234
           L+ L Y HS  +IHRD+K  NIL+ + G +KLADFG S +   P N +   V T ++  P
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSF---VGTPYWMAP 190

Query: 235 EILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           E++L      Y   VD+WS G    E+  +K      + +  L+ I
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 1/91 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  A+ Y HS  II+RDLKP+NIL++  G + L DFGL +    P    +    T 
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            Y  PE+ L  + Y  TVD W  G +  EM+
Sbjct: 161 EYLAPEV-LRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 223
            ++ Y  Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A       YT  
Sbjct: 110 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169

Query: 224 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              +    WY  PE L+ +K Y  + D+WS G    E++T
Sbjct: 170 DDLDSPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 3/86 (3%)

Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +++ L Y  S +I+HRD+KP N+L+N  G +KL DFG+S      +      V T  Y  
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMA 161

Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEM 259
           PE + G + Y    D+WS G  F E+
Sbjct: 162 PERISGEQ-YGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 4/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           +HP ++ L      +  +  V E+    DL   + T     P A    Y   ++  L+Y 
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA--VFYAACVVLGLQYL 117

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           H  +I++RDLK  N+L++  G +K+ADFGL +      +R +    T  +  PE+L    
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y+  VD W  G +  EM
Sbjct: 178 -YTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 19/161 (11%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-----TTPVPV 71
           P + L E  ++K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 45  PESFLEEAQIMKKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPN 103

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
              +A     Q+   + Y      IHRDL+  NIL+      K+ADFGL+R   I  N Y
Sbjct: 104 LVDMAA----QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEY 157

Query: 132 T----HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T     +    W  P   L G   ++   D+WS G + +E+
Sbjct: 158 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 44/200 (22%)

Query: 164 IFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++ AL Y HS +I++RDLK +N++++K G +K+ DFGL +       
Sbjct: 91  VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA 150

Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
                  T  Y  PE+L     Y   VD W  G +  EM+                    
Sbjct: 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM-------------------- 189

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD---VFSKIMALDPKQR 337
                         +LP Y  D  +       E +  P  L+ D   + S ++  DP +R
Sbjct: 190 ------------CGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237

Query: 338 V-----SAKTILQHEYFNQV 352
           +      AK I++H +F  V
Sbjct: 238 LGGGPDDAKEIMRHSFFTGV 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 26/63 (41%), Positives = 37/63 (58%), Gaps = 2/63 (3%)

Query: 489 YHESITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSE 546
           ++E  T + LF G +++ DQL +IFR LGTP E+ WPGVS  P +K   FP + P+    
Sbjct: 194 FYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLIN 253

Query: 547 ILN 549
              
Sbjct: 254 HAP 256

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)

Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 234
           L+ L Y HS  +IHRD+K  NIL+ + G +KLADFG S + + P N +   V T ++  P
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSF---VGTPYWMAP 186

Query: 235 EILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           E++L      Y   VD+WS G    E+  +K      + +  L+ I
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 40/137 (29%), Positives = 61/137 (44%), Gaps = 31/137 (22%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----------------R 213
           Y  ++L AL Y H   I++RDLKP+NIL+++SG + L+DF LS                 
Sbjct: 108 YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 214 AFTIPMNRYTHEVV-------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
           +    +N    E               T  Y  PE++ G   + + VD W+ G +  EM+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEML 226

Query: 261 TKKTLFAGDSEIDQLFR 277
              T F G +  D+ F 
Sbjct: 227 YGTTPFKGSN-RDETFS 242

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 1/91 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y HS  I++RDLKP+NIL++  G + L DFGL +         +    T 
Sbjct: 101 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            Y  PE+ L  + Y  TVD W  G +  EM+
Sbjct: 161 EYLAPEV-LHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 6/163 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLK-DFLQT 66
           + R++     S AL E  +L+++    V+ L         L LV   +   DLK      
Sbjct: 35  KKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 94

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                    A  Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +
Sbjct: 95  GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL--AVHV 152

Query: 127 PMNRYTH-EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           P  +     V T+ Y  PE++   + Y+ + D W+ GC+  EM
Sbjct: 153 PEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 3/108 (2%)

Query: 154 TTVDIWSAGCI--FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 211
           + +D+  AG    F   + L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG+
Sbjct: 88  SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGV 147

Query: 212 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           +   T    +    V T ++  PE+ +    Y +  DIWS G    E+
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEV-IQQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  Q++  L + H RRII+RDLKP+N+L++  G ++++D GL+       ++      T 
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  PE+L G + Y  +VD ++ G    EM
Sbjct: 162 GFMAPELLQGEE-YDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
            HP + +L+       +LF V EF+   DL   +Q +      A A+ Y  ++  AL + 
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFL 112

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           H + II+RDLK  N+L++  G  KLADFG+ +         +    T  Y  PEI L   
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI-LQEM 171

Query: 151 VYSTTVDIWSAGCIFSEM 168
           +Y  +VD W+ G +  EM
Sbjct: 172 LYGPSVDWWAMGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 7/112 (6%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E  +  V++L+        L+ V +++   D+   L    +     LA+ Y+ +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAE 109

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L  A+   H    IHRD+KP NILI++ G +KL DFGL   F     R+TH+
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 45/202 (22%)

Query: 164 IFSEMS---YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           +FSE     Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +      
Sbjct: 91  VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150

Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  Y  PE+L     Y   VD W  G +  EM+                   
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM------------------- 190

Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQ 336
                          +LP Y  D  +       E +  P    P A  + S ++  DPKQ
Sbjct: 191 -------------CGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237

Query: 337 RV-----SAKTILQHEYFNQVE 353
           R+      AK I+QH++F  + 
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGIV 259

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 41/192 (21%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 189

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRV-----SAK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 190 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 246

Query: 342 TILQHEYFNQVE 353
            +++H +F  + 
Sbjct: 247 EVMEHRFFLSIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ Y+ +++ A+   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 95  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILL-- 147
            +HRD+KP N+L++ +G ++LADFG      + MN     + +  V T  Y  PEIL   
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG----SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178

Query: 148 --GAKVYSTTVDIWSAGCIFSEMSY 170
             G   Y    D WS G    EM Y
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLY 203

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 33/107 (30%), Positives = 61/107 (57%), Gaps = 7/107 (6%)

Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    
Sbjct: 93  VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---K 149

Query: 221 RYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           +  H  V T  Y  PE+L     Y ++ D +S GC+  +++   + F
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 34/84 (40%), Positives = 48/84 (57%), Gaps = 5/84 (5%)

Query: 48  KLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
            ++LV E+L   D+K  L          +A  Y+ ++  AL Y H   IIHRDLKP N+L
Sbjct: 78  NVYLVMEYLIGGDVKSLLHIYGYFDEE-MAVKYISEVALALDYLHRHGIIHRDLKPDNML 136

Query: 107 INKSGALKLADFGLSRAFTIPMNR 130
           I+  G +KL DFGLS+   + +NR
Sbjct: 137 ISNEGHIKLTDFGLSK---VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 7/92 (7%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEVVTL 229
           Q+ E + Y   +  IHRDL  +NIL+ +    K+ADFGL+R     +  Y     ++   
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYK 169

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           W  P         +ST  D+WS G +  EM T
Sbjct: 170 WTAPEAA--SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 3/148 (2%)

Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           E  VL+ ++  P ++ LH     D KL L+ +++         +          + Y  +
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 141
           ++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        +    T+ Y 
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 142 PPEILLGAKV-YSTTVDIWSAGCIFSEM 168
            P+I+ G    +   VD WS G +  E+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 29/180 (16%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           + L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T
Sbjct: 105 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            ++  PE+ +    Y +  DIWS G      IT   L  G+               PH +
Sbjct: 165 PFWMAPEV-IKQSAYDSKADIWSLG------ITAIELAKGEP--------------PHSE 203

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           + P      I K + P           N   PL  +     +  +P  R +AK +L+H++
Sbjct: 204 LHPMKVLFLIPKNNPPTLEG-------NYSKPLK-EFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 1/97 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 101 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PEIL G   Y  +VD W+ G +  EM+  ++ F
Sbjct: 161 NYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 31/198 (15%)

Query: 157 DIWSAGCIFSEMSYLY---QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
           DI+      SE+   Y   + L+ L Y HS+  +HRD+K  NIL+  +G +KLADFG++ 
Sbjct: 95  DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA 154

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
             T  + +    + T ++  PE+    K   Y+   DIW+ G    E+            
Sbjct: 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL------------ 202

Query: 272 IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI-M 330
                     L  P  D+ P  +   + K++F   +P K  +            F KI +
Sbjct: 203 --------AELQPPMFDLHPMRALFLMSKSNF---QPPKLKDKTKWSS--TFHNFVKISL 249

Query: 331 ALDPKQRVSAKTILQHEY 348
             +PK+R +A+ +L H +
Sbjct: 250 TKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 19/165 (11%)

Query: 24  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYL 80
           E+ VL +L  HPN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 57  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116

Query: 81  -------YQLL-------EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                   QLL         + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
            + +    +   W       L   VY+T  D+WS G +  E+  L
Sbjct: 177 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 219

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 15/130 (11%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----RAFTIPMNRYTHEVVT 228
           QLL A+ Y H   IIHRD+K +N+L+N    + L DFG +     +++ P   +     T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF--HYGIAGT 325

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEID------QLFRIFRT 281
           +    PE+L G   Y+ +VDIWSAG  IF   +   +LF+     +      Q+ RI R 
Sbjct: 326 VDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384

Query: 282 LGTPHEDVWP 291
               H D +P
Sbjct: 385 -AQVHVDEFP 393

Length = 461

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 9/117 (7%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL + H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF--AGDSEI------DQLFRI 278
            Y  PEIL G   Y  +VD W+ G +  EM+  ++ F   G S+       D LF++
Sbjct: 161 NYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 8/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  H N+IRL  V+       ++ E++    L  +L+              L
Sbjct: 54  LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTH---EVV 136
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MS+
Sbjct: 174 IRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSF 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 15/159 (9%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  ++K+L+H  ++ L+ V+  +  +++V EF+ +  L DFL+      + +P 
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ 103

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+ + + Y      IHRDL+  NIL+  +   K+ADFGL+R   I  N YT 
Sbjct: 104 LVDMAA--QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTA 159

Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               +    W  P   L G   ++   D+WS G + +E+
Sbjct: 160 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---------------- 64
           L+E+ +L  LK PN+IRL  V   +  L ++ E++   DL  FL                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 65  -QTTPVPVP--PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 121
                +P     +L      Q+   ++Y  S   +HRDL  +N L+ ++  +K+ADFG+S
Sbjct: 127 PPAHCLPAISYSSLL-HVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 122 RAFTIPMNRYTHEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
           R      N Y  +   +         W     IL+G   ++T  D+W+ G    E+  L 
Sbjct: 186 R------NLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLC 237

Query: 173 Q 173
           +
Sbjct: 238 K 238

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 34/116 (29%), Positives = 63/116 (54%), Gaps = 7/116 (6%)

Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    
Sbjct: 93  VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---K 149

Query: 221 RYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQL 275
           +  H  V T  Y  PE+L     Y ++ D +S GC+  +++   + F      D+ 
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 25/201 (12%)

Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEM-ITKKTLFAGDS-EIDQLFRIFRTLGTPHEDV 289
             PE L G   YS   DIWS G    EM I +  +   D+ E++ +F      G P E  
Sbjct: 169 MSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC-PVEGDPAESE 226

Query: 290 WPGVSKLP--IYKTDFPEWRP-----KKFSEILNLPDP-LAVDVFS--------KIMALD 333
                + P     +  P+ RP     +    I+N P P L   VF         K +  +
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286

Query: 334 PKQRVSAKTILQHEYFNQVEM 354
           P +R   K ++ H +  + E 
Sbjct: 287 PAERADLKQLMVHAFIKRSEA 307

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 6/163 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           + R++     S AL E  +L+++    V+ L         L LV   +   DLK  +   
Sbjct: 35  KKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM 94

Query: 68  PVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             P      A  Y  ++L  L   H    ++RDLKP+NIL++  G ++++D GL  A  I
Sbjct: 95  GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL--AVKI 152

Query: 127 PMNRYTH-EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           P        V T+ Y  PE+L   + Y+ + D W  GC+  EM
Sbjct: 153 PEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 14/141 (9%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVT 228
           YL +++ A+   H    +HRD+KP N+L++K+G ++LADFG   R       +    V T
Sbjct: 107 YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGT 166

Query: 229 LWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
             Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++   +I      
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---- 222

Query: 285 PHEDVWPGVSKLPIYKTDFPE 305
            H++ +    + P   TD  E
Sbjct: 223 -HKEHF----QFPPDVTDVSE 238

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.9 bits (147), Expect = 5e-10
 Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 1/147 (0%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           L E  VLK  +HP +  L        +L  V E++      F  +          + Y  
Sbjct: 43  LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA 102

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           +++ AL Y HS +I++RDLK +N++++K G +K+ DFGL +              T  Y 
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYL 162

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE+L     Y   VD W  G +  EM
Sbjct: 163 APEVLEDND-YGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 12/144 (8%)

Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 95  IIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEVVTLWYRPPEILL--- 147
            +HRD+KP NIL++ +G ++LADFG    L    T+   + +  V T  Y  PEIL    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAME 179

Query: 148 -GAKVYSTTVDIWSAGCIFSEMSY 170
            G   Y    D WS G    EM Y
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLY 203

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVVTL-- 229
           Q+ E + Y  SR  IHRDL  +NIL+ ++   K+ADFGL+R   I  + YT  E      
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPI 168

Query: 230 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            W  P     G   ++   D+WS G + +E++T 
Sbjct: 169 KWTAPEAANYG--RFTIKSDVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 35/181 (19%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS R IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           +  PE+ +    Y    DIWS G      IT   L  G+               P+ D+ 
Sbjct: 167 WMAPEV-IKQSAYDFKADIWSLG------ITAIELAKGEP--------------PNSDLH 205

Query: 291 PGVSKLPIYKTDFPEWR---PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           P      I K   P       K F E +              +  DP+ R +AK +L+H+
Sbjct: 206 PMRVLFLIPKNSPPTLEGQYSKPFKEFV-----------EACLNKDPRFRPTAKELLKHK 254

Query: 348 Y 348
           +
Sbjct: 255 F 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 33/199 (16%)

Query: 157 DIWSAGCIFSEMSYLY---QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
           DI+      SE    Y   + L+ L Y HS+  +HRD+K  NIL+  +G +KLADFG+S 
Sbjct: 95  DIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA 154

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
             T  + +    + T ++  PE+    +   Y+   DIW+ G    E+            
Sbjct: 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA----------- 203

Query: 272 IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA 331
                     L  P  D+ P  +   + K++F   +P K  + +   +  +   F K MA
Sbjct: 204 ---------ELQPPMFDLHPMRALFLMTKSNF---QPPKLKDKMKWSN--SFHHFVK-MA 248

Query: 332 L--DPKQRVSAKTILQHEY 348
           L  +PK+R +A+ +LQH +
Sbjct: 249 LTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 28/57 (49%), Positives = 38/57 (66%), Gaps = 5/57 (8%)

Query: 167 EMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           EM+  Y+ ++  AL Y H   IIHRDLKP N+LI+  G +KL DFGLS+   + +NR
Sbjct: 104 EMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 24/158 (15%)

Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-----------RQDLKDFLQTTPVPV 71
           E +VL+ ++  P ++ LH     + KL L+ +++           R +  +         
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE--------- 104

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
                + Y  +++ AL + H   I++RD+K +NIL++  G + L DFGLS+ F       
Sbjct: 105 --DEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 132 THEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T+    T+ Y  PEI+ G   +   VD WS G +  E+
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 32/183 (17%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L++ L  L++ H  + IHRD+K  NIL+   G +KL DFG+S   T    R    V T +
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 231 YRPPEILLGAK----VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           +  PE++   +     Y    D+WS G      IT   L  GD               P 
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLG------ITAIELGDGDP--------------PL 229

Query: 287 EDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            D+ P  +   I +   P    P+ +S   N       D   K +  D ++R +   +LQ
Sbjct: 230 ADLHPMRALFKIPRNPPPTLHQPELWSNEFN-------DFIRKCLTKDYEKRPTVSDLLQ 282

Query: 346 HEY 348
           H +
Sbjct: 283 HVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 6/163 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           + R++     + AL E  +L+++    V+ L         L LV   +   DLK  +   
Sbjct: 35  KKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 94

Query: 68  PVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             P      A  Y  +L   L      RI++RDLKP+NIL++  G ++++D GL  A  I
Sbjct: 95  GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL--AVQI 152

Query: 127 PM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           P        V T+ Y  PE++   K Y+ + D W  GC+  EM
Sbjct: 153 PEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 6/106 (5%)

Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 234
           L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++  P
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWMAP 180

Query: 235 EILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           E++L      Y   VD+WS G    E+  +K      + +  L+ I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 9e-10
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 16/129 (12%)

Query: 56  LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 115
           LRQ++K   +T         A     Q+L A+ + HS+ +IHRD+K  NIL+  +G +KL
Sbjct: 126 LRQEIKSRAKTNR-TFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 116 ADFGLSRAFTIPMNRYTHEV-----VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            DFG S+ +       + +V      T +Y  PEI    K YS   D++S G +      
Sbjct: 185 GDFGFSKMYA---ATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVL------ 234

Query: 171 LYQLLEALR 179
           LY+LL   R
Sbjct: 235 LYELLTLKR 243

Length = 496

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 1/97 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL + H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PEIL G + Y  +VD W+ G +  EM+  ++ F
Sbjct: 161 NYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 26/172 (15%)

Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 62  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR---PPGMD 118

Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            S+                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178

Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 5/149 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +LK+  HPN+++L  V      +++V E +   D   FL+     +       + 
Sbjct: 40  LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFA 99

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTL 138
                 + Y  S+  IHRDL  +N L+ ++  LK++DFG+SR     I  +    ++   
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
           W  P  +  G   YS+  D+WS G +  E
Sbjct: 160 WTAPEALNYGR--YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 23/149 (15%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT     +   
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPI 167

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSE------IDQLFRIFRT 281
            W  P  I  G+  ++   D+WS G +  E++T  +  + G S       +++ +R+ R 
Sbjct: 168 KWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225

Query: 282 LGTPHE--DVWPGVSKLPIYKTDFPEWRP 308
              P E  ++      +  +K   PE RP
Sbjct: 226 ENCPEELYNI-----MMRCWKNR-PEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 10/101 (9%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ E + Y HS+  IHRDL  +N+L++    +K+ DFGL++A  +P     + V 
Sbjct: 110 LLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVR 167

Query: 228 ------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                   WY   E L   K    + D+WS G    E++T 
Sbjct: 168 EDGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 3/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  VL+  +HP +  L        +L  V E+    +L   L    V      A+ Y 
Sbjct: 43  LTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-ARFYG 101

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            +++ AL Y HS  +++RDLK +N++++K G +K+ DFGL +              T  Y
Sbjct: 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE+L     Y   VD W  G +  EM
Sbjct: 162 LAPEVLEDND-YGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 29/91 (31%), Positives = 54/91 (59%), Gaps = 4/91 (4%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 137
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +  H  V T
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGT 158

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  PE+L     Y ++ D +S GC+  ++
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 10/98 (10%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 137
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +  H  V T
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGT 158

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
             Y  PE+L     Y ++ D +S GC+      L++LL
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCM------LFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 22/165 (13%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------------- 66
           RE  +L  L+H +++R + V      L +VFE++R  DL  FL++               
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AF 124
              + +   LA +   Q+   + Y  S   +HRDL  +N L+ +   +K+ DFG+SR  +
Sbjct: 116 PGQLTLGQMLAIAS--QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173

Query: 125 TIPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    R     ++ + + PPE +L  K ++T  DIWS G +  E+
Sbjct: 174 STDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 7/154 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           +RE  ++ +L +P ++R+  V   +  L LV E      L  FL      +  +     +
Sbjct: 43  MREAEIMHQLDNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM 101

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + Y       W 
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161

Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             +  PE +   K +S+  D+WS G    E  SY
Sbjct: 162 LKWYAPECINFRK-FSSRSDVWSYGITMWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 39/178 (21%)

Query: 22  LREISVLKELKHPNVIRLHDV---------IPVDFKLFLVFEFLRQ-DLKDFLQTT---- 67
           LRE + +KE  HPNVI+L  V         +P+     ++  F++  DL  FL  +    
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM---VILPFMKHGDLHTFLLMSRIGE 105

Query: 68  -PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
            P  +P      ++  +   + Y  S+  IHRDL  +N ++N++  + +ADFGLS+    
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI-- 163

Query: 127 PMNRYTHEVVTLWYR-------PPEIL----LGAKVYSTTVDIWSAGCIFSEMSYLYQ 173
               Y+ +    +YR       P + L    L   VY+T  D+W+ G    E+    Q
Sbjct: 164 ----YSGD----YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 29/96 (30%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
            + EA+ Y  S   IHRDL  +N L+ +   +K++DFGL+R + +  ++YT    T +  
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLD-DQYTSSQGTKFPV 165

Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
            + PPE+   ++ +S+  D+WS G +  E+ ++  +
Sbjct: 166 KWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKM 200

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 30/156 (19%)

Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---VTLWYR 232
           E + Y      IHRDL  +N L++ +G +K++DFG++R + +  + YT        + + 
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLD-DEYTSSSGAKFPVKWS 168

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITK-KTLFAGDS------EIDQLFRIFRTLGTP 285
           PPE+   +K YS+  D+WS G +  E+ T+ K  F   S       I + FR++R     
Sbjct: 169 PPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----- 222

Query: 286 HEDVWPGVSKLPIYKTDF------PEWRPKKFSEIL 315
                P ++ + +Y+  +      PE RP  F+E+L
Sbjct: 223 -----PKLASMTVYEVMYSCWHEKPEGRP-TFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 4/94 (4%)

Query: 185 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKV 242
           +IIHRD+KP NIL++++G +KL DFG+S      + + T +     Y  PE +       
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARDG 186

Query: 243 YSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQL 275
           Y    D+WS G    E+ T K  +   +S  DQL
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 33/109 (30%), Positives = 60/109 (55%), Gaps = 6/109 (5%)

Query: 157 DIWSAGCIFSEM-SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-A 214
           D+W +     ++  Y +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  
Sbjct: 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 215 FTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  P  + + +  +   W  P  I    KVY+T  D+WS G +  E+ +
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 40/211 (18%)

Query: 171 LYQLLEALRYCHSR-RIIHRDLKPQNILINKSGA----------------LKLADFGLSR 213
           ++Q   AL Y H+   ++H DLKP+NIL+  S                  +++ D G   
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--- 293

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
                 +  T  V T  YR PE++LG   +YST  D+WS GCI  E+ T K L+     +
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNL 351

Query: 273 DQLFRIFRTLGT-PHEDVWP---GVSKLPIYKTDFPEWR----PKKFSEILN-------L 317
           + L  + +TLG  P E  W    G  +  +      + R    PK  + I         +
Sbjct: 352 EHLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409

Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            D L  D+   ++  D ++R++A+ +  H Y
Sbjct: 410 RDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 26/44 (59%), Positives = 30/44 (68%), Gaps = 1/44 (2%)

Query: 498 LFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP 541
           LF G+   DQL RIFR LGTP E+ WPGVSKLP YK  +P +  
Sbjct: 200 LFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK-PYPMYPA 242

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE----VVT 228
           Q+ E + +   +  IHRDL+  NIL++++   K+ADFGL+R   I  N YT         
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPI 167

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 168 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 34/116 (29%), Positives = 64/116 (55%), Gaps = 5/116 (4%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
           +S  YQ+   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R     ++ Y   T+
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN-NIDYYKKTTN 198

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
             + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 199 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           K P + +LH       +L+ V E++   DL   +Q       P  A  Y  ++   L + 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH-AVFYAAEIAIGLFFL 117

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           HS+ II+RDLK  N++++  G +K+ADFG+ +              T  Y  PEI+   +
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA-YQ 176

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y  +VD W+ G +  EM
Sbjct: 177 PYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 1/147 (0%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 102

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y 
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE+L     Y   VD W  G +  EM
Sbjct: 163 APEVLEDND-YGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 43/179 (24%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKL---------FLVFEFLRQ-D 59
           +  ++E      L E + +K+  HPNV++L   I V F+           ++  F++  D
Sbjct: 41  TYSEIEEF----LSEAACMKDFDHPNVMKL---IGVCFEASSLQKIPKPMVILPFMKHGD 93

Query: 60  LKDFL-----QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALK 114
           L  FL        P  +P      ++  +   + Y  +R  IHRDL  +N ++ +   + 
Sbjct: 94  LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC 153

Query: 115 LADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL-----------LGAKVYSTTVDIWSAG 162
           +ADFGLS+   I    Y        YR   I            L  +VY++  D+W+ G
Sbjct: 154 VADFGLSK--KIYSGDY--------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 2/108 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L + H R II+RDLK  N++++  G +K+ADFG+ +   +          T 
Sbjct: 106 YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP 165

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            Y  PEI +  + Y  +VD W+ G +  EM+  +  F G+ E D+LF+
Sbjct: 166 DYIAPEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 38/112 (33%), Positives = 58/112 (51%), Gaps = 7/112 (6%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E  +  V+RL+        L+ V +++   D+   L    +  P  LA+ Y+ +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAE 109

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L  A+   H    IHRD+KP NILI++ G +KL DFGL   F     R+TH+
Sbjct: 110 LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 22/145 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTH 224
           Y+ +++ A+   H    +HRD+KP N+L++ +G ++LADFG      + MN     + + 
Sbjct: 107 YIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG----SCLKMNQDGTVQSSV 162

Query: 225 EVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            V T  Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++   +I  
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPE 305
                HE+ +    + P + TD  E
Sbjct: 223 -----HEERF----QFPSHITDVSE 238

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++    +KL DFGLSR      + Y      L
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKL 170

Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAG 268
              W  P  I    + +++  D+W  G C++  ++     F G
Sbjct: 171 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 13/144 (9%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     +   
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPI 168

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHE 287
            W  P  I  G+  ++   D+WS G +  E++T  K  + G S  D +  + R    P  
Sbjct: 169 KWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226

Query: 288 DVWPGVSKLPIYKT---DFPEWRP 308
           +  P      I KT   +  E RP
Sbjct: 227 ENCP-DELYDIMKTCWKEKAEERP 249

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
           +S  YQ+   + Y  SRR IHRDL  +N+L+ +   +K+ADFGL+R     ++ Y   ++
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSN 195

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             + + +  PE L   +VY+   D+WS G +  E+ T
Sbjct: 196 GRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 42/157 (26%), Positives = 59/157 (37%), Gaps = 54/157 (34%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           Y+ +L  A+   H    IHRD+KP NILI++ G +KL DFGL   F     R+TH+    
Sbjct: 106 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHDSKYY 160

Query: 226 --------------------------------------------VVTLWYRPPEILLGAK 241
                                                       V T  Y  PE+LL   
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RT 219

Query: 242 VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            Y+   D WS G I  EM+  +  F  D+  +   ++
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 13/160 (8%)

Query: 23  REISVLKELKHPNVIRLH-------DVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPA 74
           +EI++LK+  H   I  +       +   +D +L+LV EF     + D ++ T       
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 75  LAKSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
              +Y+  ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R   
Sbjct: 111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 170

Query: 134 EVVTLWYRPPEILLGAK----VYSTTVDIWSAGCIFSEMS 169
            + T ++  PE++   +     Y    D+WS G    EM+
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 8/133 (6%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
            +PN I+L+  +       L+ ++++  DL D L+     +  A  K  + QL+EAL   
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL 125

Query: 91  HSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 149
           H   IIH D+K +N+L +++   + L D+GL +    P     ++  TL Y  PE + G 
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYD-GTLDYFSPEKIKG- 180

Query: 150 KVYSTTVDIWSAG 162
             Y  + D W+ G
Sbjct: 181 HNYDVSFDWWAVG 193

Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 7/98 (7%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----T 223
           +S+ YQ+   + +  S++ IHRDL  +N+L+ +   +K+ADFGL+R   I    Y    T
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTT 192

Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  + + +  PE L   +VY+   D+WS G +  E+ T
Sbjct: 193 NGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 23/152 (15%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-----HEVVTLWYR 232
           + Y  S+  IHRDL  +N L+ ++  LK++DFG+SR     +  YT      ++   W  
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI--YTVSDGLKQIPIKWTA 163

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITK-KTLFAGDS------EIDQLFRIFRTLGTP 285
           P  +  G   Y++  D+WS G +  E  +   T + G S       I+  +R+      P
Sbjct: 164 PEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCP 221

Query: 286 HEDVWPGVSKLPIYKTDF-PEWRPKKFSEILN 316
            E     + +L +    + PE RP  FSEI N
Sbjct: 222 EE-----IYRLMLQCWAYDPENRP-SFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP--MNRYTHEV 135
           Y +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + + +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              W  P  I    KVY+T  D+WS G +  E+
Sbjct: 239 PLKWMAPESIF--DKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 1/96 (1%)

Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 86
           VLK    P +++ +     D  +F+  E +   L   L+    P+P  +       +++A
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126

Query: 87  LRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLS 121
           L Y   +  +IHRD+KP NIL++ SG +KL DFG+S
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 34/138 (24%), Positives = 49/138 (35%), Gaps = 42/138 (30%)

Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----- 215
            F+E     Y+ + + A+   H    IHRD+KP N+L++  G +KL+DFGL         
Sbjct: 97  TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Query: 216 -----------------TIPMNRYTHEVVTLW----------------YRPPEILLGAKV 242
                             I     +      W                Y  PE+ L    
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTG 215

Query: 243 YSTTVDIWSAGCIFSEMI 260
           Y+   D WS G I  EM+
Sbjct: 216 YNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 22/179 (12%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQ-DLKDFLQT- 66
           S +QV    +  L+E  +L  L H N++  LH  I      F+++ ++   +LK FLQ  
Sbjct: 48  SEIQV----TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC 103

Query: 67  --TPVPVPPALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
                  P AL+   L     Q+   + Y H R +IH+D+  +N +I++   +K+ D  L
Sbjct: 104 RLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163

Query: 121 SRAFTIPMNRYTHEVVTLWYRP-----PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
           SR    PM+ Y H +     RP      E L+  K YS+  D+WS G +  E+  L Q 
Sbjct: 164 SRDL-FPMD-Y-HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQT 218

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 10/98 (10%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 227
           Y  Q+ + + Y  S+R +HRDL  +NIL+     +K+ DFGL++   +P ++  ++V   
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK--VLPQDKEYYKVREP 170

Query: 228 ----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 WY P    L    +S   D+WS G +  E+ T
Sbjct: 171 GESPIFWYAPES--LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 40/172 (23%), Positives = 77/172 (44%), Gaps = 17/172 (9%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT- 67
            + + E + S   RE+ + ++L H NV+RL  +       +++ E+    DLK FL+ T 
Sbjct: 44  QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATK 103

Query: 68  -------PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
                  P P+      +   Q+   + +  + R +HRDL  +N L++    +K++   L
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163

Query: 121 SRAFTIPMNRYTHEVVTLW----YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S+      N   +++        +  PE +     +ST  D+WS G +  E+
Sbjct: 164 SKD---VYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKL---FLVFEFLRQ-DLKDFL-QTTPVPV-PPAL 75
           L E  ++ +  H N++RL   I V F+    F++ E +   DLK FL +  P P  P +L
Sbjct: 57  LMEALIMSKFNHQNIVRL---IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL 113

Query: 76  AKSYLYQL----LEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPM 128
               L        +  +Y      IHRD+  +N L+   G     K+ADFG++R   I  
Sbjct: 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYR 171

Query: 129 NRYTHE----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  +    ++ + + PPE  L   ++++  D+WS G +  E+
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 32/128 (25%), Positives = 45/128 (35%), Gaps = 39/128 (30%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-------------- 124
           Y+ + + A+   H    IHRD+KP N+L++  G +KL+DFGL                  
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 125 --------TIPMNRYTHEVVTLW----------------YRPPEILLGAKVYSTTVDIWS 160
                    I     +      W                Y  PE+ L    Y+   D WS
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWS 224

Query: 161 AGCIFSEM 168
            G I  EM
Sbjct: 225 LGVIMYEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 2/108 (1%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L + HS+ II+RDLK  N++++  G +K+ADFG+ +              T 
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP 165

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            Y  PEI +  + Y  +VD W+ G +  EM+  +  F G+ E D+LF+
Sbjct: 166 DYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 23/101 (22%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           ++ + + Y  +++ +HRDL  +N ++ +   +K+ DFG++R      + Y  +    +YR
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR------DIYETD----YYR 176

Query: 233 P------------PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                        PE L    V++T  D+WS G +  EM T
Sbjct: 177 KGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 34/174 (19%)

Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPE 235
           EA+ Y  +   +HRDL  +N+L+++    K++DFGL++  +   +  T ++   W  P  
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEA 170

Query: 236 ILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK 295
             L  K +ST  D+WS G +  E+ +              F        P +DV P V K
Sbjct: 171 --LREKKFSTKSDVWSFGILLWEIYS--------------FGRVPYPRIPLKDVVPRVEK 214

Query: 296 LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI---LQH 346
              YK D P+  P           P+  DV  +   LD   R S   +   L+H
Sbjct: 215 G--YKMDAPDGCP-----------PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 2/85 (2%)

Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   + + +    +   W      
Sbjct: 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES- 182

Query: 237 LLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   VY+T  D+WS G +  E+++
Sbjct: 183 -LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 3/78 (3%)

Query: 94  RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKV 151
           +IIHRD+KP NIL++++G +KL DFG+S      + + T +     Y  PE +       
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARDG 186

Query: 152 YSTTVDIWSAGCIFSEMS 169
           Y    D+WS G    E++
Sbjct: 187 YDVRSDVWSLGITLYEVA 204

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 21/184 (11%)

Query: 8   PRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ- 58
             +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   
Sbjct: 35  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94

Query: 59  DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINK 109
           DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++  
Sbjct: 95  DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154

Query: 110 SGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
              +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWE 213

Query: 168 MSYL 171
           ++ L
Sbjct: 214 ITSL 217

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 7/111 (6%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E  +  V++L+        L+ V +++   D+   L    V  P  LA+ Y+ +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAE 109

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           L  A+   H    IHRD+KP NILI+  G +KL DFGL   F     R+TH
Sbjct: 110 LTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF-----RWTH 155

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP--MNRYTH 224
           +SY +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + +   
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W  P  I    KVY+T  D+WS G +  E+ +
Sbjct: 236 RLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 4/92 (4%)

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L  L + H+ ++IHRD+K QN+L+ ++  +KL DFG+S      + R    + T ++ 
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 142 PPEILLGAK----VYSTTVDIWSAGCIFSEMS 169
            PE++   +     Y    DIWS G    EM+
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 2/66 (3%)

Query: 496 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA 555
           + LF G SE DQL +IF  +G P E+ WP    LP  ++ FP + P+ F   +       
Sbjct: 203 RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP--RSSFPSYTPRSFKSFVPEICEEG 260

Query: 556 VDVFSR 561
           +D+  +
Sbjct: 261 LDLLKK 266

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 8/93 (8%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 229
           Q+   + Y  ++  IHRDL  +N+L+ ++   K+ADFGL+R      + Y          
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK--EDIYEAREGAKFPI 168

Query: 230 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P   L     +S   D+WS G + +E++T
Sbjct: 169 KWTAPEAALYNR--FSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 203 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 37/88 (42%), Positives = 47/88 (53%), Gaps = 6/88 (6%)

Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +L  L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEM 259
             PE L G   YS   DIWS G    E+
Sbjct: 169 MSPERLQGTH-YSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 33/115 (28%), Positives = 61/115 (53%), Gaps = 3/115 (2%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 197 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R    + T ++ 
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 233 PPEILLGAK----VYSTTVDIWSAGCIFSEM 259
            PE++   +     Y    D+WS G    EM
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           ++L  L + H+ ++IHRD+K QN+L+ ++  +KL DFG+S      + R    + T ++ 
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 233 PPEILLGAK----VYSTTVDIWSAGCIFSEM 259
            PE++   +     Y    DIWS G    EM
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 30/94 (31%), Positives = 54/94 (57%), Gaps = 3/94 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP-MNRYTHEVV 227
           Y +Q+ + + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P   R     +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           LRE +V+++L +P ++R+  +   +    LV E      L  FLQ     V        +
Sbjct: 44  LREANVMQQLDNPYIVRMIGICEAE-SWMLVMELAELGPLNKFLQKNK-HVTEKNITELV 101

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 102 HQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161

Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             +  PE +   K +S+  D+WS G +  E  SY
Sbjct: 162 VKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----THEVVT 228
           Q+   + Y   R+ +HRDL  +N L+ ++  +K+ADFGLSR   I    Y     ++ + 
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR--NIYSADYYKASENDAIP 195

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + + PPE +   + Y+T  D+W+ G +  E+ +
Sbjct: 196 IRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP--MNRYTHE 134
           SY +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + +    
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +   W  P  I    KVY+T  D+WS G +  E+
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP-MNRYTHEVV 136
           Y +Q+ + + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P   R     +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            L +  PE +   +VY+   D+WS G +  E+
Sbjct: 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 11/160 (6%)

Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP---VPPAL 75
           +  + E+ +L +   P ++  +    ++  +++  E++     D L    V    +P  +
Sbjct: 44  NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV 103

Query: 76  AKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
            +   Y +++ L++      IIHRD+KP N+L+N +G +KL DFG+S      + +    
Sbjct: 104 LRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-- 161

Query: 135 VVTLWYRPPEIL-----LGAKVYSTTVDIWSAGCIFSEMS 169
           +    Y  PE +          Y+   D+WS G    EM+
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 8/105 (7%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---QTTPVPVPPALAKSY 79
           E  VL E   P V+ L+        L+L+ EFL   DL   L    T    V     + Y
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFY 106

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
           + + + A+   H    IHRD+KP NILI++ G +KL+DFGLS  F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 7/145 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L E  V+  + HP+V+RL  +     ++ L+ + +    L D+++     +      ++ 
Sbjct: 57  LDEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC 115

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVT 137
            Q+ + + Y   +R++HRDL  +N+L+     +K+ DFGL++   +    Y  E   V  
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAG 162
            W     IL    +Y+   D+WS G
Sbjct: 176 KWMALESILHR--IYTHKSDVWSYG 198

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV----T 228
           Q+   + Y  S+  +HRDL  +N+L+      K++DFG+SRA     + Y          
Sbjct: 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            WY P  I  G   +S+  D+WS G    E  +
Sbjct: 163 KWYAPECINYG--KFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 43/179 (24%), Positives = 70/179 (39%), Gaps = 49/179 (27%)

Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL---WYR 232
           E + Y   +  +HRDL  +N+L+++    K++DFGL++           +   L   W  
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-----ASQGQDSGKLPVKWTA 167

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG------TPH 286
           P  +    K +ST  D+WS G +                   L+ I+ + G       P 
Sbjct: 168 PEALRE--KKFSTKSDVWSFGIL-------------------LWEIY-SFGRVPYPRIPL 205

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +DV P V K   Y+ + PE  P           P    V      LDP +R + K + +
Sbjct: 206 KDVVPHVEKG--YRMEAPEGCP-----------PEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 2/85 (2%)

Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            ++Y   ++ IHRDL  +N+L+ ++ A K+ADFGLSR   + + +    +   W      
Sbjct: 131 GMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIES- 189

Query: 237 LLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   VY+T  D+WS G +  E+++
Sbjct: 190 -LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 11/118 (9%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHE 225
           YL +++ A+   H    +HRD+KP NIL++ +G ++LADFG    L    T+   + +  
Sbjct: 107 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV---QSSVA 163

Query: 226 VVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
           V T  Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++   +I 
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 29/86 (33%), Positives = 49/86 (56%), Gaps = 4/86 (4%)

Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPE 235
           E + Y  S++++HRDL  +NIL+++ G  K++DFGL+R     M     ++   W   PE
Sbjct: 111 EGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKW-TAPE 167

Query: 236 ILLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   K +S+  D+WS G +  E+ +
Sbjct: 168 ALKHKK-FSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF---TIPMNRYTH 224
           +S+ +Q+   ++Y    +++HRDL  +N+L+ +   +K++DFGLSR        + R   
Sbjct: 130 ISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W       L   +Y+T  D+WS G +  E++T
Sbjct: 190 RIPVKWMAIES--LFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 3/158 (1%)

Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 70
           +Q + V  T + +  +  + K P + +LH       +L+ V E++   DL   +Q     
Sbjct: 39  IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF 98

Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
             P  A  Y  ++   L + H R II+RDLK  N++++  G +K+ADFG+ +   +    
Sbjct: 99  KEPQ-AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 T  Y  PEI +  + Y  +VD W+ G +  EM
Sbjct: 158 TRTFCGTPDYIAPEI-IAYQPYGKSVDWWAYGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 58/224 (25%), Positives = 83/224 (37%), Gaps = 78/224 (34%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 231
           Q+L AL   HS  I+HRD+KPQNI+ +  SG+ K+ D G +    + +N          Y
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------Y 312

Query: 232 RPPEILLGAK-------VYSTTV-------------------------DIWSAGCIFSEM 259
            P E LL  +       + ST                           DI+SAG IF +M
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 260 ITKKTLFAG---DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR---PKKFS- 312
                 F     DS + Q  R  +                     D   WR     + S 
Sbjct: 373 A-----FPNLRSDSNLIQFNRQLKRND-----------------YDLVAWRKLVEPRASP 410

Query: 313 ------EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
                 E+L+L      ++   +M    +QR+SAK  L H YF+
Sbjct: 411 DLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 2/85 (2%)

Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   + + +    +   W      
Sbjct: 136 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES- 194

Query: 237 LLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   VY+T  D+WS G +  E+++
Sbjct: 195 -LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 26/181 (14%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLY 81
           EI   ++L+HPN++       VD +L++V   +     +D L+T  P  +P       L 
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-------HE 134
            +L AL Y HS+  IHR +K  +IL++  G + L+    S +      R           
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168

Query: 135 VVTLWYRPPEIL----LGAKVYSTTVDIWSA---------GCI-FSEMSYLYQLLEALRY 180
           V  L +  PE+L     G   Y+   DI+S          G + F +M     LLE +R 
Sbjct: 169 VKNLPWLSPEVLQQNLQG---YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG 225

Query: 181 C 181
            
Sbjct: 226 T 226

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 31/99 (31%), Positives = 58/99 (58%), Gaps = 4/99 (4%)

Query: 166 SEMSYLYQLLEA-LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRY- 222
           S+M ++ Q + A + Y  S+  +HRDL  +N L+ ++  +K+ DFG+SR  ++    R  
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            H ++ + + PPE ++  K ++T  D+WS G +  E+ T
Sbjct: 180 GHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 6/112 (5%)

Query: 172 YQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
             +++AL Y   +  +IHRD+KP NIL++ SG +KL DFG+S        + T       
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-TRSAGCAA 179

Query: 231 YRPPEILLGAKV---YSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRI 278
           Y  PE +        Y    D+WS G    E+ T +  +    +E + L +I
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 45/186 (24%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R      N       
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            L   W  P  I     VY+   D+WS G +                   L+ IF    +
Sbjct: 277 RLPVKWMAPESIF--NCVYTFESDVWSYGIL-------------------LWEIFSLGSS 315

Query: 285 PHEDVWPGVSKLPI-----------YKTDFPEWRPKKFSEILNL---PDPLAVDVFSKIM 330
           P    +PG   +P+           Y+   PE  P +  +I+      DPL    F +I+
Sbjct: 316 P----YPG---MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Query: 331 ALDPKQ 336
            L  +Q
Sbjct: 369 QLIEQQ 374

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y  S  I++RDLKP+N+L++K G +K+ DFG ++   +    YT    T 
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTL-CGTP 192

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            Y  PEILL    +    D W+ G    E++
Sbjct: 193 EYIAPEILLNVG-HGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 35/118 (29%), Positives = 62/118 (52%), Gaps = 6/118 (5%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRY-THEVVTLW 230
           Q+   + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR  ++    R   H ++ + 
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT--KKTLFA-GDSEIDQLFRIFRTLGTP 285
           + PPE ++  K ++T  D+WS G I  E+ T  K+  F   ++E+ +     R L  P
Sbjct: 191 WMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      IHRDL+  NIL+      K+ADFGL+R   I  N YT     +   
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPI 167

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            W  P   L G   ++   D+WS G + +E++TK
Sbjct: 168 KWTAPEAALYGR--FTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 2/148 (1%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  
Sbjct: 43  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102

Query: 82  QLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  Y
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE+L     Y   VD W  G +  EM
Sbjct: 163 LAPEVLEDND-YGRAVDWWGLGVVMYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 25/55 (45%), Positives = 34/55 (61%), Gaps = 3/55 (5%)

Query: 164 IFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 215
            FSE     Y+ + + A+   H    IHRD+KP NILI++ G +KL+DFGLS  F
Sbjct: 97  TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 52.9 bits (128), Expect = 2e-07
 Identities = 24/73 (32%), Positives = 34/73 (46%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDV--WPGVSKLPIYKTDFPEWRPKKFSEIL 548
           E +T+K LF G   IDQL  I   LGTP E+   +    K   Y    P+   K  S++ 
Sbjct: 199 ELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLF 258

Query: 549 NLPDPLAVDVFSR 561
               P A+D+  +
Sbjct: 259 PGASPEAIDLLEK 271

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 25/52 (48%), Positives = 32/52 (61%), Gaps = 4/52 (7%)

Query: 491 ESITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP 541
           E +  +  F G S++ +QL +I+  LG P ED WPGVSKLP YK   PEW  
Sbjct: 196 EMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK---PEWFL 244

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 23/100 (23%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 231
            Q+   + Y  S   +HRDL  +N L+ +   +K++DFGLSR        Y+ +    +Y
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI------YSAD----YY 180

Query: 232 R------------PPEILLGAKVYSTTVDIWSAGCIFSEM 259
           R            PPE +L  K ++T  DIWS G +  E+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ + + Y      IHRDL+  NIL+  +   K+ADFGL+R   I  N YT     +   
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPI 167

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            W  P   L G   ++   D+WS G + +E++TK
Sbjct: 168 KWTAPEAALYGR--FTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +S+ YQ+   + +  S+  +HRDL  +N+L+ +   +K+ DFGL+R      N  +    
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   W  P  I     +Y+T  D+WS G +  E+ +
Sbjct: 300 FLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 22/57 (38%), Positives = 35/57 (61%), Gaps = 1/57 (1%)

Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKF 544
           + E  + + LF G +  D+L  IFR LGTP E+ WPG+S    +K  +FP+++P+  
Sbjct: 195 FFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPL 251

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 5/56 (8%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 225
           Y+ +L  A+   H    IHRD+KP NILI++ G +KL DFGL   F     R+TH+
Sbjct: 106 YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 38/179 (21%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+   + Y H R +IH+D+  +N +I++   +K+ D  LSR    PM+ Y H +     R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL-FPMD-Y-HCLGDNENR 181

Query: 233 P-----PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG-TPH 286
           P      E L+  K YS+  D+WS G +  E++                    TLG TP+
Sbjct: 182 PVKWMALESLVN-KEYSSASDVWSFGVLLWELM--------------------TLGQTPY 220

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ++ P   ++  Y  D       + ++ +N PD L   V +   ALDP++R S   ++Q
Sbjct: 221 VEIDP--FEMAAYLKD-----GYRLAQPINCPDEL-FAVMACCWALDPEERPSFSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 7/79 (8%)

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL-----LGA 240
           IIHRD+KP N+L+N +G +KL DFG+S      + +    +    Y  PE +        
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQN 181

Query: 241 KVYSTTVDIWSAGCIFSEM 259
             Y+   D+WS G    EM
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 21/44 (47%), Positives = 27/44 (61%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT 534
           E +  K L  G SEI+QL  I + LGTP+E +WPG S LP+   
Sbjct: 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVV 227
           L  +   ++Y      +HRDL  +NIL+N +   K++DFGLSR        YT    ++ 
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             W  P  I    + +++  D+WS G +  E+++
Sbjct: 172 IRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 3/138 (2%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           K P + +LH       +L+ V E++   DL   +Q       P  A  Y  ++   L + 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH-AVFYAAEIAIGLFFL 117

Query: 91  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 150
           HS+ II+RDLK  N++++  G +K+ADFG+ +              T  Y  PEI +  +
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQ 176

Query: 151 VYSTTVDIWSAGCIFSEM 168
            Y  +VD W+ G +  EM
Sbjct: 177 PYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 30/184 (16%)

Query: 6   SRPRSRVQVEGVPSTA--------LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE-- 54
           S    +V V+ +  TA        + E+ ++  L  H N++ L     +   + ++ E  
Sbjct: 62  SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC 121

Query: 55  -------FLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 107
                  FLR+  + FL    +        S+ YQ+ + + +  S+  IHRDL  +N+L+
Sbjct: 122 CYGDLLNFLRRKRESFLTLEDL-------LSFSYQVAKGMAFLASKNCIHRDLAARNVLL 174

Query: 108 NKSGALKLADFGLSRAFTIPMNRYTHEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCI 164
                +K+ DFGL+R      N        L   W  P  I     VY+   D+WS G +
Sbjct: 175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIL 232

Query: 165 FSEM 168
             E+
Sbjct: 233 LWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 6/90 (6%)

Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW---YR 232
           E + Y  S  +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   + 
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWS 168

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            PE+   +K YS+  D+WS G +  E+ ++
Sbjct: 169 SPEVFSFSK-YSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
           S+ YQ+   + +  S+  +HRDL  +N+L+ +   +K+ DFGL+R      N  +     
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 138 L---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L   W  P  I     +Y+T  D+WS G +  E+
Sbjct: 301 LPVKWMAPESIF--DNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + + YQ+   + +  S+  +HRDL  +N+LI +   +K+ DFGL+R      N  +    
Sbjct: 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   W  P  I     +Y+T  D+WS G +  E+ T
Sbjct: 302 FLPLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 36/183 (19%)

Query: 22  LREISVLKELKHPNVIRLH----DVIPVDFKL-FLVFEFLRQDLKDFLQTTPVPVPPALA 76
           LRE  +  +L HP ++ ++    D  PV + + ++    L+  LK   Q   +    A  
Sbjct: 50  LREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK 109

Query: 77  KSY------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA------- 123
            S        +++   + Y HS+ ++HRDLKP NIL+   G + + D+G +         
Sbjct: 110 TSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169

Query: 124 ---FTIPMNRYTHE--------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
                +      +         V T  Y  PE LLG    S + DI++ G I      LY
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVI------LY 222

Query: 173 QLL 175
           Q+L
Sbjct: 223 QML 225

Length = 932

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 25/86 (29%), Positives = 44/86 (51%), Gaps = 4/86 (4%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + Y       W
Sbjct: 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160

Query: 231 ---YRPPEILLGAKVYSTTVDIWSAG 253
              +  PE +   K +S+  D+WS G
Sbjct: 161 PLKWYAPECINFRK-FSSRSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 172 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 8/94 (8%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 167

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            W  P   L G   ++   D+WS G + +E+ TK
Sbjct: 168 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTK 199

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 45/169 (26%), Positives = 60/169 (35%), Gaps = 58/169 (34%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH----- 224
           Y+ +L  A+   H    IHRD+KP NILI+  G +KL DFGL   F     R+TH     
Sbjct: 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF-----RWTHNSKYY 160

Query: 225 -----------EVVTLW------------------------------------YRPPEIL 237
                      E   LW                                    Y  PE+L
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220

Query: 238 LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           L  K Y+   D WS G I  EM+  +  F   +  +   ++     T H
Sbjct: 221 L-RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH 268

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 41/186 (22%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +S+ YQ+ + + +  S+  IHRDL  +N+L+     +K+ DFGL+R      N       
Sbjct: 144 LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            L   W  P  I     VY+   D+WS G +                   L+ IF     
Sbjct: 204 RLPVKWMAPESIFNC--VYTFESDVWSYGIL-------------------LWEIFSLGSN 242

Query: 285 PHEDVWPGVSKL--PI---YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
           P+  + P  SK    I   Y+   PE  P +  +I+                 DP +R +
Sbjct: 243 PYPGM-PVDSKFYKLIKEGYRMAQPEHAPAEIYDIM-----------KTCWDADPLKRPT 290

Query: 340 AKTILQ 345
            K I+Q
Sbjct: 291 FKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 32/104 (30%), Positives = 64/104 (61%), Gaps = 4/104 (3%)

Query: 22  LREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKS 78
           L+E  ++K+  HPNV+ L  + +P +    +V  +++  DL++F+++ T  P    L   
Sbjct: 44  LKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-G 102

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
           +  Q+ + + Y  S++ +HRDL  +N ++++S  +K+ADFGL+R
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 54/224 (24%), Positives = 85/224 (37%), Gaps = 52/224 (23%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV-- 226
           + L+  L  L Y H    IHR++K  +ILI+  G + L+  GLS  +++  N    +V  
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY 162

Query: 227 --------VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
                   V  W  P  +      Y+   DI+S G    E+ T +  F        L + 
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFP--EWRPKK----------------------FSEI 314
            +  G P+          P+  T FP  E R K                        SE 
Sbjct: 223 LK--GPPYS---------PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER 271

Query: 315 LNLPDP--LAVDVFSKI---MALDPKQRVSAKTILQHEYFNQVE 353
           L  P     +    + +   +  DP++R SA ++L H +F QV+
Sbjct: 272 LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 24/132 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + ++  +   + Y  S+  IHRDL  +N ++N++  + +ADFGLS+        Y  +  
Sbjct: 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI------YNGD-- 166

Query: 228 TLWYRPPEIL-----------LGAKVYSTTVDIWSAGCIFSEMITK-KTLFAG--DSEID 273
             +YR   I            L  +VY+T  D+WS G    E+ T+ +T + G  +SEI 
Sbjct: 167 --YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Query: 274 QLFRIFRTLGTP 285
              R    L  P
Sbjct: 225 DYLRQGNRLKQP 236

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 14/146 (9%)

Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLWYRPP 234
            + Y  S+  IHRDL  +N L+ ++  LK++DFG+SR     I  +    ++   W  P 
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE 164

Query: 235 EILLGAKVYSTTVDIWSAGCI----FSEMITKKTLFAGDSEIDQLFRIFRTLGTPH--ED 288
            +  G   YS+  D+WS G +    FS  +            +Q+ + +R        +D
Sbjct: 165 ALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD 222

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEI 314
           V+  + +   YK   PE RP KFSE+
Sbjct: 223 VYKVMQRCWDYK---PENRP-KFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 6/102 (5%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTL 229
           + QL+EAL   H   IIH D+K +N+L +++   + L D+GL +    P     ++  TL
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYD-GTL 170

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
            Y  PE + G   Y  + D W+ G +  E++T K  F  D +
Sbjct: 171 DYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211

Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 27/172 (15%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-----QTTPVPVPPAL 75
           L+E  ++    HPN+++L  V  ++   +++ E +   DL  +L     +      PP L
Sbjct: 47  LKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFG---PPLL 103

Query: 76  AKSYLYQL-LEALRYCH---SRRIIHRDLKPQNILINKSG-----ALKLADFGLSRAFTI 126
               L  + L+  + C        IHRDL  +N L+++ G      +K+ DFGL+R   I
Sbjct: 104 TLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DI 161

Query: 127 PMNRYTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ 173
             + Y  +     +   W  P  +L G   ++T  D+WS G +  E+  L Q
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQ 211

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 7/72 (9%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG----VSKLPIYKTDFPEWRPKKFSE 546
           E  T + LF G SEIDQL++I   LGTP +  WP      SKL      FP++ P    +
Sbjct: 191 ELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF---RFPQFAPTSLHQ 247

Query: 547 ILNLPDPLAVDV 558
           ++    P A+D+
Sbjct: 248 LIPNASPEAIDL 259

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTIPMNRY-THEVVTLW 230
           Q+   + Y  S   +H+DL  +NILI +   +K++D GLSR  ++    R     ++ + 
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + PPE ++  K +S+  DIWS G +  E+ +
Sbjct: 192 WMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----THEVVT 228
           Q+   + Y  S+  +HRDL  +N L+     +K+ DFG+SR   +    Y     H ++ 
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTMLP 187

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + + PPE ++  K ++T  D+WS G +  E+ T
Sbjct: 188 IRWMPPESIMYRK-FTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 101 VHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160

Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSE 258
              +  PE +   K +S+  D+WS G +  E
Sbjct: 161 PVKWYAPECMNYYK-FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 5/94 (5%)

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
           S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R      N        
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 138 L---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L   W  P  I     VY+   D+WS G +  E+
Sbjct: 278 LPVKWMAPESIF--NCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 24/157 (15%)

Query: 34  PNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALR 88
           PN++ LH  I  +  +FLV +      L   +  FL      +P    K +  +++ AL 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-----IPEECVKRWAAEMVVALD 99

Query: 89  YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG 148
             H   I+ RDL P NIL++  G ++L  F          +    E V   Y  PE+  G
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG---EAVENMYCAPEV--G 154

Query: 149 AKVYSTTV-DIWSAGCIFSEMSYLYQLL--EALRYCH 182
                T   D WS G I      L++LL  + L  CH
Sbjct: 155 GISEETEACDWWSLGAI------LFELLTGKTLVECH 185

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 19/40 (47%), Positives = 25/40 (62%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP 530
           E  T++ +  G S+IDQL  IF+  GTP E+ WPG   LP
Sbjct: 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLP 258

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---VTL 229
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT        +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 169

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 170 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 22/125 (17%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 229
           Q+   ++Y  S   +HRDL  +N L+     +K+ADFG+SR      N Y+ +   +   
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR------NLYSGDYYRIQGR 190

Query: 230 ------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-----KKTLFAGDSEIDQLFRI 278
                 W     ILLG   ++T  D+W+ G    EM T       +L + +  I+     
Sbjct: 191 AVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248

Query: 279 FRTLG 283
           FR  G
Sbjct: 249 FRNQG 253

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 18/107 (16%)

Query: 165 FSEMSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 223
           +S + ++  Q+   ++Y  S   +HRDL  +N L+ K+  +K+ADFG+SR      N Y+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NLYS 182

Query: 224 HEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   +         W     ILLG   ++T  D+W+ G    E++T
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 229
           Q+ + + Y   +R++HRDL  +N+L+     +K+ DFGL++   +    Y  E   V   
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           W     IL    +Y+   D+WS G    E++T
Sbjct: 177 WMALESILHR--IYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 26/67 (38%), Positives = 36/67 (53%), Gaps = 11/67 (16%)

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           Q+L AL   HS  I+HRD+KPQNI+ +  SG+ K+ D G +    + +N          Y
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------Y 312

Query: 141 RPPEILL 147
            P E LL
Sbjct: 313 IPKEFLL 319

Length = 566

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           + YQ+   + +  S+  +HRDL  +N+LI +   +K+ DFGL+R      N  +     L
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              W  P  I     +Y+T  D+WS G +  E+
Sbjct: 304 PLKWMAPESIF--NNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y    R++HRDL  +N+L+     +K+ DFGL+R   I    Y  +  
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 171

Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   + ++   D+WS G    E++T
Sbjct: 172 KVPIKWMALESIL--HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 19/55 (34%), Positives = 34/55 (61%), Gaps = 1/55 (1%)

Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPK 542
            +E  T + +F G +  ++L  IFR LGTP E+ WPG++    +++  FP++R +
Sbjct: 194 LYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQ 248

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 17/90 (18%)

Query: 489 YHESITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW 539
           + E +T + +F G             DQL RIF  LGTP E  WP + K+P Y T   ++
Sbjct: 206 FAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDF 265

Query: 540 RPKKFS--------EILNLPDPLAVDVFSR 561
           + K +         E    PD    D+  +
Sbjct: 266 KTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 13/101 (12%)

Query: 172 YQLLEALR-------YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT 223
           YQL+  LR       Y      +HRDL  +NIL+N +   K++DFGLSR     P   YT
Sbjct: 107 YQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166

Query: 224 H---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
               ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 167 TSGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 19/100 (19%)

Query: 180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA----------FTIPMNRYTHE---- 225
           Y HS+ ++HRDLKP NIL+   G + + D+G +              +      +     
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 226 ----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
               V T  Y  PE LLG    S + DI++ G I  +M+T
Sbjct: 188 PGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 20/154 (12%)

Query: 31  LKHPNVIRLHDVIPVDFKLFLVFEFL-----RQDLKDFLQTTPVPVPPALAKSYLYQLLE 85
            +HPN++    V      L+++  F+        LK +    P  +  AL  + L+  L 
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALR 112

Query: 86  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---------- 135
            L Y H    IHR++K  +ILI+  G + L+  GLS  +++  N    +V          
Sbjct: 113 GLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS 170

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           V  W  P  +      Y+   DI+S G    E++
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 1/72 (1%)

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEV 135
           K  + Q+L  LR  H   I+HRD+KP+N+L+   G +K+ DFG +      +N    + +
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371

Query: 136 VTLWYRPPEILL 147
           +   Y PPE L+
Sbjct: 372 LDPRYSPPEELV 383

Length = 507

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 20/160 (12%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYL 80
           L E   L +  H N++RL  VI     + +V E++     D FL+     +        L
Sbjct: 54  LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---- 136
             L   ++Y      +H+ L    +L+N     K++ F         +     E +    
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTM 166

Query: 137 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
                 LW  P  I      +S+  D+WS G +  E MSY
Sbjct: 167 SGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSY 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 9/77 (11%)

Query: 474 PPSL----SDDAVSIDV----VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 525
           PP +    +D +  ID+      ++E  T + LF G +  +QL  IFR LGTP E+ WPG
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231

Query: 526 VSKLPIYKT-DFPEWRP 541
           +     +K+ ++P++R 
Sbjct: 232 ILSNEEFKSYNYPKYRA 248

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 23/53 (43%), Positives = 29/53 (54%), Gaps = 4/53 (7%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 543
           E  TKK +F  + E+ QL  I R  G+P   VWP V KLP + T     +PKK
Sbjct: 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNT----MKPKK 258

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 5/84 (5%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEVVTLWYRPP 234
           + Y  S+  IHRDL  +N L+ +   LK++DFG+SR     +   T    ++   W  P 
Sbjct: 107 MEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166

Query: 235 EILLGAKVYSTTVDIWSAGCIFSE 258
            +  G   YS+  D+WS G +  E
Sbjct: 167 ALNYGR--YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 34/169 (20%)

Query: 31  LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---------------QTTPVPVPPA 74
           L+HPN++ L  V+  +  L ++F +    DL +FL               +T    + PA
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
                + Q+   + +  S  ++H+DL  +N+L+     +K++D GL R        Y  +
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV------YAAD 178

Query: 135 VVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEM-SYLYQ 173
              L         W  P  I+ G   +S   DIWS G +  E+ SY  Q
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQ 225

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTH---EVVTLWYRP 233
           ++Y      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++   W  P
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178

Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             I    + +++  D+WS G +  E+++
Sbjct: 179 EAI--AYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 5/90 (5%)

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 138
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           W     IL   ++Y+   D+WS G    E+
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 15/97 (15%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+   +RY  S   +HRDL  +N L+ K+  +K+ADFG+SR      N Y+ +   +  R
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NLYSSDYYRVQGR 191

Query: 233 PP--------EILLGAKVYSTTVDIWSAGCIFSEMIT 261
            P        E +L  K ++T  D+W+ G    E++T
Sbjct: 192 APLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRY-THEVVTLW 230
           Q+   + Y  S   +HRDL  +N L+ +   +K+ DFG+SR  ++    R     ++ + 
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + PPE +L  K ++T  DIWS G +  E+ T
Sbjct: 190 WMPPESILYRK-FTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 24/73 (32%), Positives = 35/73 (47%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWP--GVSKLPIYKTDFPEWRPKKFSEIL 548
           E + +K +F G   +DQL +I + LGTP E+     G  K   Y    P    K F  I 
Sbjct: 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF 261

Query: 549 NLPDPLAVDVFSR 561
              +PLA+D+  +
Sbjct: 262 PNANPLALDLLEK 274

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 35/119 (29%), Positives = 62/119 (52%), Gaps = 24/119 (20%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + ++  +   + Y  S+  IHRDL  +N ++N++  + +ADFGLS+        Y+ +  
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI------YSGD-- 167

Query: 228 TLWYR-------PPEIL----LGAKVYSTTVDIWSAGCIFSEMITK-KTLFAG--DSEI 272
             +YR       P + L    L   VY+T  D+W+ G    E++T+ +T +AG  +SEI
Sbjct: 168 --YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 26/124 (20%)

Query: 80  LYQLLEALRYCHSR-RIIHRDLKPQNILINKSGA----------------LKLADFGLSR 122
           ++Q   AL Y H+   ++H DLKP+NIL+  S                  +++ D G   
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--- 293

Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEM---SYLYQLLEAL 178
                 +  T  V T  YR PE++LG   +YST  D+WS GCI  E+     LY   + L
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNL 351

Query: 179 RYCH 182
            + H
Sbjct: 352 EHLH 355

Length = 467

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 24/71 (33%), Positives = 39/71 (54%), Gaps = 1/71 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVV 227
             + Q+L  LR  H   I+HRD+KP+N+L+   G +K+ DFG +      +N    + ++
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGML 372

Query: 228 TLWYRPPEILL 238
              Y PPE L+
Sbjct: 373 DPRYSPPEELV 383

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 7/142 (4%)

Query: 31  LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRY 89
           L H  ++RL  + P    L LV +      L D ++     + P    ++  Q+ + + Y
Sbjct: 66  LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 90  CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTLWYRPPEIL 146
               R++HR+L  +NIL+     +++ADFG++        +Y    H+    W     IL
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 147 LGAKVYSTTVDIWSAGCIFSEM 168
            G   Y+   D+WS G    EM
Sbjct: 185 FGR--YTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 11/100 (11%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + + +  S+  IHRD+  +N+L+      K+ DFGL+R     MN   + V 
Sbjct: 215 LRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYVVK 271

Query: 228 ------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   W  P  I     VY+   D+WS G +  E+ +
Sbjct: 272 GNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 34/124 (27%), Positives = 54/124 (43%), Gaps = 24/124 (19%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL 237
           + Y  +R  IHRDL  +N ++ +   + +ADFGLS+   I    Y        YR   I 
Sbjct: 126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--KIYSGDY--------YRQGRIA 175

Query: 238 -----------LGAKVYSTTVDIWSAGCIFSEMITK-KTLFAG--DSEIDQLFRIFRTLG 283
                      L  +VY++  D+W+ G    E+ T+ +T + G  + EI    R    L 
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235

Query: 284 TPHE 287
            P +
Sbjct: 236 QPED 239

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 11/97 (11%)

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
            +  Q+ + + +  S+  IHRD+  +N+L+      K+ DFGL+R     MN   + V  
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYVVKG 272

Query: 137 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  W  P  I     VY+   D+WS G +  E+
Sbjct: 273 NARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 27/102 (26%), Positives = 54/102 (52%), Gaps = 2/102 (1%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  ++  + HP+++RL  V  +   + LV + +    L D++      +   L  ++ 
Sbjct: 57  MDEALIMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
            Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL+R
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 26/56 (46%), Positives = 32/56 (57%), Gaps = 8/56 (14%)

Query: 491 ESITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS 545
           E I     F G  +I DQL RIF  LGTP+ED WPGV  LP +K       P++F+
Sbjct: 196 EMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK-------PERFT 244

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 27/77 (35%), Positives = 38/77 (49%), Gaps = 8/77 (10%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI-----YKTDFPEWRPKKFS 545
           E +T K LF G   +DQL  I +  GTP ++    V KL       Y    P +R K F 
Sbjct: 208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF---VQKLQSEDAKNYVKKLPRFRKKDFR 264

Query: 546 EILNLPDPLAVDVFSRV 562
            +L   +PLAV+V  ++
Sbjct: 265 SLLPNANPLAVNVLEKM 281

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 5/94 (5%)

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--- 134
           ++  Q+ + + Y    R++HRDL  +N+L+     +K+ DFGL+R   I    Y  +   
Sbjct: 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           V   W     IL   + ++   D+WS G    E+
Sbjct: 173 VPIKWMALESIL--HRRFTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 14/157 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
              S++ +L H ++++L+ V   D +  +V E+++   L  FL      V          
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK 108

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-------LKLADFGLSRAFTIPMNRYTHE 134
           QL  AL Y   ++++H ++  +NIL+ + G        +KL+D G+     I +      
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSREER 164

Query: 135 VVTLWYRPPEILLGAKVYSTT-VDIWSAGCIFSEMSY 170
           V  + +  PE +   +   T   D WS G    E+  
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI--YKTDFPEWRPKKFSEIL 548
           E +T KTLF G   IDQL RI   +GTP E++   +S      Y    P+   K F E+ 
Sbjct: 208 ELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF 267

Query: 549 NLPDPLAVDVFSR 561
           +  +PLA+D+  +
Sbjct: 268 SGANPLAIDLLEK 280

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           +++ AL   H   I+ RDL P NIL++  G ++L  F          +    E V   Y 
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG---EAVENMYC 149

Query: 233 PPEILLGAKVYSTTV-DIWSAGCIFSEMITKKTL 265
            PE+  G     T   D WS G I  E++T KTL
Sbjct: 150 APEV--GGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 45.1 bits (106), Expect = 5e-05
 Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL+R        Y  +  
Sbjct: 112 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + + +   E +   K ++   D+WS G    E++T
Sbjct: 172 KMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 26/100 (26%), Positives = 53/100 (53%), Gaps = 7/100 (7%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + + Y  S++ +HRDL  +N ++++S  +K+ADFGL+R      +    N  
Sbjct: 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
             ++   W       L  + ++T  D+WS G +  E++T+
Sbjct: 161 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 22/54 (40%), Positives = 29/54 (53%), Gaps = 2/54 (3%)

Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK 542
           + E   +K LF G+SE DQL +IF  +G P ED WP    LP  +  F    P+
Sbjct: 197 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP--RGAFSPRGPR 248

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.6 bits (106), Expect = 8e-05
 Identities = 50/231 (21%), Positives = 79/231 (34%), Gaps = 71/231 (30%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT------- 223
           L  +L AL Y HS+  IHR +K  +IL++  G + L+    S +      R         
Sbjct: 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 224 HEVVTLWYRPPEIL----LGAKVYSTTVDIWSA---------GCI-FSE-----MITKK- 263
             V  L +  PE+L     G   Y+   DI+S          G + F +     M+ +K 
Sbjct: 167 SSVKNLPWLSPEVLQQNLQG---YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV 223

Query: 264 -----------TLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS 312
                      T    +  + Q           H +       +    T       + FS
Sbjct: 224 RGTVPCLLDKSTYPLYEDSMSQ-----SRSSNEHPN---NRDSVDHPYT-------RTFS 268

Query: 313 EILNLPDPLAVDVFSKIMAL----DPKQRVSAKTILQHEYFNQVEMVKPTL 359
           E            F + + L    DP+ R SA  +L H +F Q +    +L
Sbjct: 269 E-----------HFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSL 308

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 187 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------EVVTLWY 231
           ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+      ++   W 
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            P  I    + +++  D+WS G +  E+++
Sbjct: 179 APEAIAY--RKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 17/97 (17%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 229
           Q+   ++Y  S   +HRDL  +N L+ ++  +K+ADFG+SR      N Y  +   +   
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR------NLYAGDYYRIQGR 199

Query: 230 ------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
                 W     IL+G   ++T  D+W+ G    E++
Sbjct: 200 AVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 12/132 (9%)

Query: 50  FLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK 109
           F++ E L ++ K+  +         L K+ +  +L  L Y H   I H D+KP+NI+++ 
Sbjct: 103 FILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161

Query: 110 SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           +    + D+G++  F I      H     + +  + L    +Y   +D  +  C+     
Sbjct: 162 NNRGYIIDYGIASHFII------HGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGD 215

Query: 170 YLYQLLEALRYC 181
                LE+L YC
Sbjct: 216 -----LESLGYC 222

Length = 294

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 2/73 (2%)

Query: 49  LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 107
           L+L+ EFL   D+   L            + Y+ + + A+   H    IHRD+KP N+L+
Sbjct: 76  LYLIMEFLPGGDMMTLLMKKDTLTEEE-TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134

Query: 108 NKSGALKLADFGL 120
           +  G +KL+DFGL
Sbjct: 135 DSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 33/173 (19%)

Query: 20  TALREISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPA 74
             L+E+   +EL HPNV++      + IP      LV EF    DLK++L++    V   
Sbjct: 41  LFLQEVQPYRELNHPNVLQCLGQCIESIP----YLLVLEFCPLGDLKNYLRSNRGMVAQM 96

Query: 75  LAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
             K  L     ++   L + H    IH DL  +N  +    ++K+ D+GL+      + +
Sbjct: 97  AQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA------LEQ 150

Query: 131 YTHE--------VVTLWYRPPEIL------LGAKVYSTTVDIWSAGCIFSEMS 169
           Y  +         V L +  PE++      L  K  +   +IWS G    E+ 
Sbjct: 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 24/159 (15%)

Query: 26  SVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR---QDLKDFLQTTPVPVPPA--LAKSYL 80
           S+++++ H +++ L+ V   D +  +V EF+     DL    ++  +  P    +AK   
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAK--- 112

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGA-------LKLADFGLSRAFTIPMNRYTH 133
            QL  AL Y   + ++H ++  +NIL+ + G        +KL+D G      IP+   + 
Sbjct: 113 -QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG------IPITVLSR 165

Query: 134 E--VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
           +  V  + +  PE +  +K  S   D WS G    E+ Y
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 16/159 (10%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E+ V K   HPN++        D +L++V  F+     KD + T  +     LA +Y+ Q
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108

Query: 83  -LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-----------PMNR 130
            +L+AL Y H    +HR +K  +ILI+  G + L+  GL    ++              +
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           Y+ +V+  W  P  +    + Y    DI+S G    E++
Sbjct: 167 YSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELA 204

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 2/73 (2%)

Query: 49  LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 107
           L+L+ EFL   D+   L         A  + Y+ + + A+   H    IHRD+KP N+L+
Sbjct: 76  LYLIMEFLPGGDMMTLLMKKDTLSEEA-TQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134

Query: 108 NKSGALKLADFGL 120
           +  G +KL+DFGL
Sbjct: 135 DAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 23/74 (31%), Positives = 35/74 (47%), Gaps = 2/74 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEIL 548
           E +  K LF G+  IDQL RI   +GTP  +V   +S      Y    P    +   +I 
Sbjct: 208 ELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF 267

Query: 549 NLPDPLAVDVFSRV 562
              +PLA+D+  ++
Sbjct: 268 RGANPLAIDLLEKM 281

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 10/88 (11%)

Query: 179 RYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHE----VVTLWY 231
           +Y      IHRD+  +N L+   G     K+ADFG++R   I    Y  +    ++ + +
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRAMLPIKW 187

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            PPE  L   ++++  D+WS G +  E+
Sbjct: 188 MPPEAFLDG-IFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 18/42 (42%), Positives = 28/42 (66%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 211
           Y+ + + A+   H    IHRD+KP N+L++  G +KL+DFGL
Sbjct: 106 YIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 18/42 (42%), Positives = 28/42 (66%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 211
           Y+ + + A+   H    IHRD+KP N+L++  G +KL+DFGL
Sbjct: 106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.6 bits (101), Expect = 5e-04
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 13/85 (15%)

Query: 39  LHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH 97
           ++DV P +  +  V E++  +DLKD L+  P           + ++ E +   H   I+H
Sbjct: 403 IYDVDPEEKTI--VMEYIGGKDLKDVLEGNP---------ELVRKVGEIVAKLHKAGIVH 451

Query: 98  RDLKPQNILINKSGALKLADFGLSR 122
            DL   N ++ +   L L DFGL +
Sbjct: 452 GDLTTSNFIV-RDDRLYLIDFGLGK 475

Length = 535

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 26/97 (26%), Positives = 48/97 (49%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
           +++  Q+ + + Y    R++HR+L  +NIL+     +++ADFG++        +Y    H
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +    W     IL G   Y+   D+WS G    EM++
Sbjct: 172 KTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 17/42 (40%), Positives = 24/42 (57%)

Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP 530
           + E   +K LF G S++DQL +I   +G P E+ WP    LP
Sbjct: 199 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 14/92 (15%)

Query: 180 YCHSRRIIHRDLKPQNILINKSG-----ALKLADFGLSRAFTIPMNRYTHE-----VVTL 229
           Y      IHRDL  +N L+++ G      +K+ DFGL+R   I  + Y  +     +   
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLLPVR 178

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           W  P  +L G   ++T  D+WS G +  E++T
Sbjct: 179 WMAPESLLDG--KFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 187 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 8/77 (10%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP-----IYKTDFPEWRPKKFS 545
           E +T +TLF G   IDQL  I R +GTP  ++   + K+       Y     +     F+
Sbjct: 210 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL---LKKISSESARNYIQSLTQMPKMNFA 266

Query: 546 EILNLPDPLAVDVFSRV 562
            +    +PLAVD+  ++
Sbjct: 267 NVFIGANPLAVDLLEKM 283

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 23/98 (23%), Positives = 45/98 (45%), Gaps = 8/98 (8%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 230
            Q+   + +  + R +HRDL  +N L++    +K++   LS+      N   +++     
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD---VYNSEYYKLRNALI 180

Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
              +  PE +     +ST  D+WS G +  E+ T+  L
Sbjct: 181 PLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 17/98 (17%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 229
           Q+   + +  S  ++H+DL  +N+L+     +K++D GL R        Y  +   L   
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV------YAADYYKLMGN 185

Query: 230 ------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 W  P  I+ G   +S   DIWS G +  E+ +
Sbjct: 186 SLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	562
KOG0659|consensus	318		100.0
KOG0663|consensus	419		100.0
KOG0594|consensus	323		100.0
KOG0600|consensus	560		100.0
KOG0661|consensus	538		100.0
KOG0660|consensus	359		100.0
KOG0593|consensus	396		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0658|consensus	364		100.0
KOG0662|consensus	292		100.0
KOG0603|consensus	612		100.0
KOG0666|consensus	438		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0592|consensus	604		100.0
KOG0667|consensus	586		100.0
KOG0669|consensus	376		100.0
KOG0605|consensus	550		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0033|consensus	355		100.0
KOG0610|consensus	459		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
KOG0588|consensus	786		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599|consensus	411		100.0
KOG0578|consensus	550		100.0
KOG0595|consensus	429		100.0
KOG0032|consensus	382		100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0665|consensus	369		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0198|consensus	313		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0591|consensus	375		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694|consensus	694		100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0585|consensus	576		100.0
KOG0671|consensus	415		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0597|consensus	808		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0582|consensus	516		100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4717|consensus	864		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0659|consensus	318		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0611|consensus	668		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594|consensus	323		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0604|consensus	400		100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0580|consensus	281		100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0664|consensus	449		100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574|consensus	502		100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0589|consensus	426		100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0596|consensus	677		100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG1290|consensus	590		100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0192|consensus	362		100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0608|consensus	1034		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0579|consensus	1187		100.0
KOG0986|consensus	591		100.0
KOG0201|consensus	467		100.0
KOG0612|consensus	1317		100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0663|consensus	419		100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0607|consensus	463		100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0662|consensus	292		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0690|consensus	516		100.0
KOG0668|consensus	338		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0614|consensus	732		100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0577|consensus	948		100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4279|consensus	1226		100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0586|consensus	596		100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4236|consensus	888		100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0670|consensus	752		100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0197|consensus	468		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0590|consensus	601		100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG0584|consensus	632		100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.98
KOG0696|consensus	683		99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
KOG4721|consensus	904		99.98
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.98
KOG0983|consensus	391		99.98
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.98
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.98
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
KOG4645|consensus	1509		99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
KOG1989|consensus	738		99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
KOG1167|consensus	418		99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
KOG0600|consensus	560		99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
KOG0695|consensus	593		99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
KOG1027|consensus	903		99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
KOG0661|consensus	538		99.96
KOG2345|consensus	302		99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
KOG0660|consensus	359		99.96
KOG1026|consensus	774		99.96
KOG0194|consensus	474		99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0193|consensus	678		99.96
KOG1151|consensus	775		99.96
KOG0593|consensus	396		99.96
KOG1187|consensus	361		99.95
KOG0587|consensus	953		99.95
KOG1035|consensus	1351		99.95
KOG4250|consensus	732		99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG1006|consensus	361		99.95
KOG1095|consensus	1025		99.94
KOG1094|consensus	807		99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG0984|consensus	282		99.93
KOG4257|consensus	974		99.93
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.93
KOG0666|consensus	438		99.93
KOG0196|consensus	996		99.93
KOG0658|consensus	364		99.93
KOG1152|consensus	772		99.92
KOG0576|consensus	829		99.92
KOG0199|consensus	1039		99.92
KOG4278|consensus	1157		99.91
KOG0200|consensus	609		99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
KOG0603|consensus	612		99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG3653|consensus	534		99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG0669|consensus	376		99.85
KOG1025|consensus	1177		99.85
KOG2052|consensus	513		99.84
KOG1345|consensus	378		99.83
KOG0606|consensus	1205		99.82
KOG0601|consensus	524		99.8
KOG0576|consensus	829		99.79
KOG1024|consensus	563		99.78
KOG4158|consensus	598		99.77
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.77
KOG0665|consensus	369		99.76
KOG0591|consensus	375		99.76
KOG0664|consensus	449		99.76
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.75
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.74
KOG1240|consensus	1431		99.74
PRK09188	365	serine/threonine protein kinase; Provisional	99.73
KOG0615|consensus	475		99.71
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.7
PRK12274	218	serine/threonine protein kinase; Provisional	99.7
KOG1164|consensus	322		99.69
KOG0581|consensus	364		99.69
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.67
KOG1033|consensus	516		99.67
PTZ00036	440	glycogen synthase kinase; Provisional	99.67
KOG0590|consensus	601		99.67
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.66
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.65
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.65
PRK10345	210	hypothetical protein; Provisional	99.65
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.64
KOG0667|consensus	586		99.64
KOG0668|consensus	338		99.64
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.63
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.63
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.63
KOG0599|consensus	411		99.62
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.62
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.6
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.6
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.6
KOG0589|consensus	426		99.59
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.58
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.58
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.58
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.58
KOG1165|consensus	449		99.57
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.57
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.57
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.57
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.56
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.56
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.56
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.56
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.56
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.55
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.55
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.55
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.55
KOG1163|consensus	341		99.52
KOG1023|consensus	484		99.52
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.52
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.52
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.5
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.5
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.5
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.49
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.49
PTZ00284	467	protein kinase; Provisional	99.49
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.49
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.49
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.49
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.48
KOG0579|consensus	1187		99.47
KOG0597|consensus	808		99.47
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.46
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.46
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.46
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.45
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.45
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.44
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.44
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.44
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.44
KOG0606|consensus	1205		99.44
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.44

>KOG0659|consensus

Probab=100.00  E-value=1.8e-52  Score=407.83  Aligned_cols=253  Identities=45%  Similarity=0.834  Sum_probs=225.7

Q ss_pred             cccCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         12 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        12 ~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..++|+..+++|||++|+.++||||++|.|+|...+.+.||+|||+.||..+|+.....++..+++.|+.|+++||+|||
T Consensus        39 ~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H  118 (318)
T KOG0659|consen   39 NAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH  118 (318)
T ss_pred             ccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH
Confidence            36789999999999999999999999999999999999999999999999999998888999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++.|+||||||+|+||+.+|.+||+|||+|+.+..+...                                         
T Consensus       119 ~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-----------------------------------------  157 (318)
T KOG0659|consen  119 SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-----------------------------------------  157 (318)
T ss_pred             hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-----------------------------------------
Confidence            999999999999999999999999999999876543221                                         


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        ....|.|+||||||++.|++.|+..+||||
T Consensus       158 --------------------------------------------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWa  187 (318)
T KOG0659|consen  158 --------------------------------------------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWA  187 (318)
T ss_pred             --------------------------------------------------cccceeeeeccChHHhccchhcCCcchhhh
Confidence                                                              122367899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +|||++||+.|.+.|.|+++.+|+..|++.+|+|.++.||.+..++.|..-. ...+.....+++..+.++.||+.+||.
T Consensus       188 vGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~  266 (318)
T KOG0659|consen  188 VGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLT  266 (318)
T ss_pred             HHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-cCCCCccccccccccHHHHHHHHhhhc
Confidence            9999999999999999999999999999999999999999999988775321 111222333777888899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCcccC
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      +||.+|+||.|+|+|+||++.....
T Consensus       267 ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  267 YNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             cCchhcccHHHHhcchhhhcCCCCC
Confidence            9999999999999999999865443

>KOG0663|consensus

Probab=100.00  E-value=7.1e-52  Score=414.21  Aligned_cols=259  Identities=44%  Similarity=0.810  Sum_probs=229.3

Q ss_pred             CCccccccCCchhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy10954          7 RPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLL   84 (562)
Q Consensus         7 ~~~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll   84 (562)
                      |.++...++|++-..+|||.+|.+++|||||.+.++....  +.+|||||||+.||..++...+.+|.+.+++.++.|++
T Consensus       108 r~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL  187 (419)
T KOG0663|consen  108 RLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLL  187 (419)
T ss_pred             ecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHH
Confidence            3444558899999999999999999999999999998754  67999999999999999999888899999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      .||+|||.+.|+||||||+|+|++..|.+||+|||+||.++.+..                                   
T Consensus       188 ~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k-----------------------------------  232 (419)
T KOG0663|consen  188 RGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK-----------------------------------  232 (419)
T ss_pred             HHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc-----------------------------------
Confidence            999999999999999999999999999999999999987764422                                   


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                                              .++..|.|+||||||+++|.+.|+
T Consensus       233 --------------------------------------------------------~~T~lVVTLWYRaPELLLG~~tys  256 (419)
T KOG0663|consen  233 --------------------------------------------------------PYTPLVVTLWYRAPELLLGAKTYS  256 (419)
T ss_pred             --------------------------------------------------------cCcceEEEeeecCHHHhcCCcccC
Confidence                                                                    223456788888899898888999


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCCCCccchhhhcCCCC--HH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNLPD--PL  321 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~--~~  321 (562)
                      +++|+||+|||++||++++++|.|.++.+|+.+|++.+|+|.+..|++...++... ..++......+...+....  ..
T Consensus       257 t~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~  336 (419)
T KOG0663|consen  257 TAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQ  336 (419)
T ss_pred             cchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchh
Confidence            99999999999999999999999999999999999999999999999999887663 5566655555665665543  88


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHcCccccCCcccC
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      +.||+.++|.+||.+|+||.|+|+|+||.+.....
T Consensus       337 g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~  371 (419)
T KOG0663|consen  337 GFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI  371 (419)
T ss_pred             HHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence            99999999999999999999999999999876443

>KOG0594|consensus

Probab=100.00  E-value=2.7e-51  Score=415.86  Aligned_cols=250  Identities=61%  Similarity=1.068  Sum_probs=229.2

Q ss_pred             cCCchhhHHHHHHHHHccCCCC-cceEEEEEEeCC------EEEEEeecCcCCHHHHHhhCC---CCCCHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPN-VIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTP---VPVPPALAKSYLYQL   83 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~Hpn-Iv~L~~~~~~~~------~i~lV~Ey~~~~L~~~i~~~~---~~l~e~~i~~i~~ql   83 (562)
                      .||+|..+.||+.+|++|+|+| ||.|++++.+..      .+|+|+||++.||..++....   ..++...++.+|+||
T Consensus        50 ~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Ql  129 (323)
T KOG0594|consen   50 EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQL  129 (323)
T ss_pred             ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHH
Confidence            3789999999999999999999 999999998877      899999999999999998866   358889999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         84 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        84 l~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      +.||+|||++||+||||||+||||+.+|.+||+|||+|+.+..+                                    
T Consensus       130 l~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip------------------------------------  173 (323)
T KOG0594|consen  130 LRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP------------------------------------  173 (323)
T ss_pred             HHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC------------------------------------
Confidence            99999999999999999999999999888888888888755433                                    


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                             ...+++.++|.||||||+++|...|
T Consensus       174 -------------------------------------------------------~~~yt~evvTlWYRaPEvLlGs~~Y  198 (323)
T KOG0594|consen  174 -------------------------------------------------------MRTYTPEVVTLWYRAPEVLLGSTSY  198 (323)
T ss_pred             -------------------------------------------------------cccccccEEEeeccCHHHhcCCCcC
Confidence                                                                   2224556789999999999999889


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCC-ccchhhhcCCCCHHH
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLA  322 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~  322 (562)
                      ++.+||||+|||++||++++++|.|.++.+++.+|++.+|+|.++.||++...+.|...++.|. ++.+....+..++.+
T Consensus       199 s~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~  278 (323)
T KOG0594|consen  199 STSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDG  278 (323)
T ss_pred             CCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccH
Confidence            9999999999999999999999999999999999999999999999999999999999999998 888888888888999


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      .|++.+||++||++|+||+.+|.||||...+.
T Consensus       279 ~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  279 IELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             HHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            99999999999999999999999999998753

>KOG0600|consensus

Probab=100.00  E-value=1e-50  Score=424.02  Aligned_cols=250  Identities=45%  Similarity=0.824  Sum_probs=220.3

Q ss_pred             cccCCchhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy10954         12 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        12 ~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ...++.+..+.|||.||++|+|||||+|.+.....  ..+|||+|||+.||..++......|++.+++.||+||+.||+|
T Consensus       154 ~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~  233 (560)
T KOG0600|consen  154 NEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEY  233 (560)
T ss_pred             cCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHH
Confidence            34678899999999999999999999999998876  7899999999999999998887789999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+|||||..|||||.+|.+||+|||||+.+....                                         
T Consensus       234 cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-----------------------------------------  272 (560)
T KOG0600|consen  234 CHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-----------------------------------------  272 (560)
T ss_pred             HhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-----------------------------------------
Confidence            999999999999999999999999999999988664211                                         


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                       ...++..|.|+||||||+|+|...|+.++|+
T Consensus       273 -------------------------------------------------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDl  303 (560)
T KOG0600|consen  273 -------------------------------------------------SAPYTSRVVTLWYRPPELLLGATSYGTAVDL  303 (560)
T ss_pred             -------------------------------------------------CcccccceEEeeccChHHhcCCcccccceee
Confidence                                                             0113456789999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCC-CccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW-RPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+||||.||+.|++.|.|.++.+|+..|+..+|.|.++.|+ ..+++.+..-.+.. .+..+.+.+...++.+.+|+..
T Consensus       304 WS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~  382 (560)
T KOG0600|consen  304 WSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEK  382 (560)
T ss_pred             hhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHH
Confidence            999999999999999999999999999999999999999999 76776443322222 2445666778889999999999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCC
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||..||.+|.||.++|+|+||...
T Consensus       383 lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  383 LLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             HhccCccccccHHHHhcCcccccC
Confidence            999999999999999999999543

>KOG0661|consensus

Probab=100.00  E-value=9e-52  Score=429.24  Aligned_cols=243  Identities=37%  Similarity=0.711  Sum_probs=220.1

Q ss_pred             hhHHHHHHHHHccC-CCCcceEEEEEEeCC-EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELK-HPNVIRLHDVIPVDF-KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~-~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..-+||++.|++|+ |||||+|.+++.+++ .+|+|||||+.+|+++++.++..|+|..++.||+||+.||+|+|.+|+.
T Consensus        53 ~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfF  132 (538)
T KOG0661|consen   53 CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFF  132 (538)
T ss_pred             HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence            34589999999999 999999999999888 9999999999999999998888899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||+||||||+.....+||+|||+||.+..                                                  
T Consensus       133 HRDlKPENiLi~~~~~iKiaDFGLARev~S--------------------------------------------------  162 (538)
T KOG0661|consen  133 HRDLKPENILISGNDVIKIADFGLAREVRS--------------------------------------------------  162 (538)
T ss_pred             cccCChhheEecccceeEeccccccccccc--------------------------------------------------
Confidence            999999999999888888888888875431                                                  


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                ...++.+|.|+||||||+|+....|+.++|+||+|||+
T Consensus       163 ------------------------------------------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~  200 (538)
T KOG0661|consen  163 ------------------------------------------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIM  200 (538)
T ss_pred             ------------------------------------------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHH
Confidence                                                      12345678899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+++-+++|.|.++.+++.+|.+.+|+|..+.|+....+ ......+|...+..+..+++...+++.++|.+||.|||.
T Consensus       201 aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~  280 (538)
T KOG0661|consen  201 AELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPD  280 (538)
T ss_pred             HHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCc
Confidence            9999999999999999999999999999999999875432 234567888888899999998999999999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||||+|+|+||||+...
T Consensus       281 kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  281 KRPTASQALQHPFFQVGR  298 (538)
T ss_pred             cCccHHHHhcCccccccc
Confidence            999999999999998654

>KOG0660|consensus

Probab=100.00  E-value=2.9e-51  Score=414.97  Aligned_cols=250  Identities=37%  Similarity=0.664  Sum_probs=221.4

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEe-----CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~-----~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      -..++++||+++|++++|+||+.+++++..     -..+|+|+|+|+.||.++++..+ .+++..++.+++|++.||+|+
T Consensus        63 ~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyi  141 (359)
T KOG0660|consen   63 IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYI  141 (359)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchh
Confidence            345789999999999999999999999976     25799999999999999998754 599999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |+.+|+||||||.|+|++.++.+||+|||+||..... .                                         
T Consensus       142 HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~-----------------------------------------  179 (359)
T KOG0660|consen  142 HSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-F-----------------------------------------  179 (359)
T ss_pred             hcccccccccchhheeeccCCCEEeccccceeecccc-C-----------------------------------------
Confidence            9999999999999999999999999999999865321 0                                         


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                     .....+.+|.|+||||||+++....|+.++|||
T Consensus       180 -----------------------------------------------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiW  212 (359)
T KOG0660|consen  180 -----------------------------------------------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIW  212 (359)
T ss_pred             -----------------------------------------------cccchhcceeeeeecCHHHHhccccccchhhhh
Confidence                                                           011124568899999999999888899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--CCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |+|||++||++|+++|.|.+..+|+..|++.+|+|.++.+..+..  ...|....|...+..++.+++..++.|.||+.+
T Consensus       213 SvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlek  292 (359)
T KOG0660|consen  213 SVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEK  292 (359)
T ss_pred             hhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHH
Confidence            999999999999999999999999999999999998887766552  223667788888889999999999999999999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ||++||.+|+||+|+|+||||......
T Consensus       293 mL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  293 MLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HhccCccccCCHHHHhcChhhhhhcCC
Confidence            999999999999999999999987643

>KOG0593|consensus

Probab=100.00  E-value=4.2e-50  Score=397.05  Aligned_cols=245  Identities=41%  Similarity=0.749  Sum_probs=205.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      +.+-++|||+.|++++|||+|.|+++|.....+|||+|||+.++.+.+...+..++++.++.|++|++.|+.|||++++|
T Consensus        44 VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~I  123 (396)
T KOG0593|consen   44 VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCI  123 (396)
T ss_pred             HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCee
Confidence            45678999999999999999999999999999999999999998888888887899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||||||||||+.+|.+||||||+||.+..+.                                                
T Consensus       124 HRDIKPENILit~~gvvKLCDFGFAR~L~~pg------------------------------------------------  155 (396)
T KOG0593|consen  124 HRDIKPENILITQNGVVKLCDFGFARTLSAPG------------------------------------------------  155 (396)
T ss_pred             cccCChhheEEecCCcEEeccchhhHhhcCCc------------------------------------------------
Confidence            99999999999988888888888887664332                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ..++.+|.|+||||||.+.|...||.++||||+||++
T Consensus       156 -------------------------------------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~  192 (396)
T KOG0593|consen  156 -------------------------------------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVF  192 (396)
T ss_pred             -------------------------------------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHH
Confidence                                                       2345567888888888888888899999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCCC-CccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEW-RPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +||++|.++|.|.++.++++.|...+|.....-..-...-+.|. ..+|+. .++.+.+-++..+..+.||+++||+.||
T Consensus       193 aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP  272 (396)
T KOG0593|consen  193 AELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDP  272 (396)
T ss_pred             HHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999976543322222222221 123332 2344555566667789999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      .+|++.+|+|.|+||++.
T Consensus       273 ~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  273 DDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             cccccHHHHhcChHHHHH
Confidence            999999999999999654

>KOG0575|consensus

Probab=100.00  E-value=1.5e-46  Score=401.15  Aligned_cols=229  Identities=28%  Similarity=0.462  Sum_probs=196.9

Q ss_pred             CCCCCCCccccccCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHH
Q psy10954          2 VSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL   80 (562)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~   80 (562)
                      ||-|+=|+..+++.+......+||+|.+.|+|||||++|++|++.+++|||+|+|.. +|..+++ ..+.++|..|+.|+
T Consensus        46 ~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l  124 (592)
T KOG0575|consen   46 VAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFL  124 (592)
T ss_pred             EEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHH
Confidence            456777888888899999999999999999999999999999999999999999984 8888887 44589999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      +||+.||.|||+++|||||||..|++++.+.+|||+|||||..+..                                  
T Consensus       125 ~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~----------------------------------  170 (592)
T KOG0575|consen  125 RQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY----------------------------------  170 (592)
T ss_pred             HHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC----------------------------------
Confidence            9999999999999999999999999999888888888888765432                                  


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                               +..+..+.||||+|+||||+.+.
T Consensus       171 ---------------------------------------------------------~~Erk~TlCGTPNYIAPEVl~k~  193 (592)
T KOG0575|consen  171 ---------------------------------------------------------DGERKKTLCGTPNYIAPEVLNKS  193 (592)
T ss_pred             ---------------------------------------------------------cccccceecCCCcccChhHhccC
Confidence                                                                     22334567999999999999854


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        241 KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       .+++.+||||+|||||.||.|+|||...+-.+.+.+|...--.                  +|           ...+.
T Consensus       194 -gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~------------------~P-----------~~ls~  243 (592)
T KOG0575|consen  194 -GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS------------------MP-----------SHLSA  243 (592)
T ss_pred             -CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc------------------cc-----------cccCH
Confidence             4999999999999999999999999998888888877542111                  00           12357


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .|+|||.+||+.||.+|||++++|.|+||+.-
T Consensus       244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            89999999999999999999999999999543

>KOG0615|consensus

Probab=100.00  E-value=1.5e-47  Score=392.07  Aligned_cols=215  Identities=31%  Similarity=0.521  Sum_probs=173.2

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      +.+|++||++|+|||||+++++|+..+..||||||+++ +|++.+...+ .+.|...+.+++|++.||.|||++||+|||
T Consensus       223 v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRD  301 (475)
T KOG0615|consen  223 VQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRD  301 (475)
T ss_pred             hHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence            57999999999999999999999999999999999975 9999987754 588999999999999999999999999999


Q ss_pred             CCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954        100 LKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus       100 LKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||+|||++.+   ..+||+|||+|+....                                                  
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~--------------------------------------------------  331 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGE--------------------------------------------------  331 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhcccc--------------------------------------------------
Confidence            99999999876   5678888888765431                                                  


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGC  254 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIWSlG~  254 (562)
                                                                .....+.||||.|.||||+.+.  ..|+.++||||+||
T Consensus       332 ------------------------------------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGc  369 (475)
T KOG0615|consen  332 ------------------------------------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGC  369 (475)
T ss_pred             ------------------------------------------ceehhhhcCCccccChhheecCCeecccchheeeeccc
Confidence                                                      1223456777777788877543  34666899999999


Q ss_pred             HHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSEID-QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~-~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|-+++|.+||.+..... ...+|...                .|....+.|         ...+..+.|||.+||+.|
T Consensus       370 vLfvcLsG~pPFS~~~~~~sl~eQI~~G----------------~y~f~p~~w---------~~Iseea~dlI~~mL~Vd  424 (475)
T KOG0615|consen  370 VLFVCLSGYPPFSEEYTDPSLKEQILKG----------------RYAFGPLQW---------DRISEEALDLINWMLVVD  424 (475)
T ss_pred             eEEEEeccCCCcccccCCccHHHHHhcC----------------cccccChhh---------hhhhHHHHHHHHHhhEeC
Confidence            9999999999998776544 33334321                111111112         123578999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|+|++|+|+||||+...
T Consensus       425 P~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  425 PENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cccCcCHHHHhcChhhhccc
Confidence            99999999999999999765

>KOG0658|consensus

Probab=100.00  E-value=5e-47  Score=384.77  Aligned_cols=242  Identities=33%  Similarity=0.641  Sum_probs=205.0

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeC--C---EEEEEeecCcCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVD--F---KLFLVFEFLRQDLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~--~---~i~lV~Ey~~~~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..+|+++|+.++|||||+|.-+|...  .   ...+|||||+.+|.++++..   +..++.-.++-|++||++||.|||+
T Consensus        64 knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~  143 (364)
T KOG0658|consen   64 KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS  143 (364)
T ss_pred             CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence            45899999999999999999988753  2   34699999999999999842   3468888999999999999999999


Q ss_pred             CCceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 RRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      .||+||||||+|+|+|.+ |.+||||||.|+.+...+.                                          
T Consensus       144 ~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep------------------------------------------  181 (364)
T KOG0658|consen  144 HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP------------------------------------------  181 (364)
T ss_pred             cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC------------------------------------------
Confidence            999999999999999976 8899999998876642211                                          


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        ..++..|++|||||.++|...|++++||||
T Consensus       182 --------------------------------------------------niSYicSRyYRaPELifga~~Yt~~IDiWS  211 (364)
T KOG0658|consen  182 --------------------------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWS  211 (364)
T ss_pred             --------------------------------------------------ceeEEEeccccCHHHHcCccccCceeEEhh
Confidence                                                              124566899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhh-hcCCCCHHHHHHHHHcc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE-ILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~dLi~~mL  330 (562)
                      .||+++||+-|+++|.|++..+|+..|++.+|+|..+....+... .....+|...+..+.+ .....++++.||+.++|
T Consensus       212 aGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~-y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L  290 (364)
T KOG0658|consen  212 AGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN-YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLL  290 (364)
T ss_pred             hhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc-cccccCcccccccceeecccCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999998877655432 1234455555555555 44567899999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +++|.+|.+|.|+|+||||++....
T Consensus       291 ~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  291 QYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccChhhcCCHHHHhcchhhHHhhCc
Confidence            9999999999999999999987644

>KOG0662|consensus

Probab=100.00  E-value=2.6e-46  Score=346.50  Aligned_cols=250  Identities=53%  Similarity=0.920  Sum_probs=221.2

Q ss_pred             cccCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         12 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        12 ~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      -.-+|++++++|||-+|+.++|.|||+|+++...+.++-+|+|||.++|..+..+..+.+..+.++.+|.|+++||.+||
T Consensus        39 dddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch  118 (292)
T KOG0662|consen   39 DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH  118 (292)
T ss_pred             CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh
Confidence            34679999999999999999999999999999999999999999999999999998888999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +++++||||||+|.||+.+|.+||+|||+|+.++.|..-                                         
T Consensus       119 shnvlhrdlkpqnllin~ngelkladfglarafgipvrc-----------------------------------------  157 (292)
T KOG0662|consen  119 SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-----------------------------------------  157 (292)
T ss_pred             hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-----------------------------------------
Confidence            999999999999999999999999999999877654322                                         


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        ++..+.|.||++|.++.|.+-|++++|+||
T Consensus       158 --------------------------------------------------ysaevvtlwyrppdvlfgakly~tsidmws  187 (292)
T KOG0662|consen  158 --------------------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  187 (292)
T ss_pred             --------------------------------------------------eeceeeeeeccCcceeeeeehhccchHhhh
Confidence                                                              233466778888888888888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        252 AGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       252 lG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      .|||++|+.. |+++|.|.+..+++.+|+..+|+|.++.||++..++.|..-..-.....++.+.+......+|+++++|
T Consensus       188 agcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll  267 (292)
T KOG0662|consen  188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLL  267 (292)
T ss_pred             cchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHh
Confidence            9999999975 899999999999999999999999999999999988776422222223456666666778899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCC
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .-+|..|++|+++|+||||.+.
T Consensus       268 ~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  268 KCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCcccccCHHHHhcCcccccc
Confidence            9999999999999999999864

>KOG0603|consensus

Probab=100.00  E-value=1.2e-45  Score=396.24  Aligned_cols=288  Identities=33%  Similarity=0.502  Sum_probs=247.5

Q ss_pred             hHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ....|..++..++ ||.+|+++..|+++.+.|++++|..+ +|+..+.... .+.+..++.+...++.|++++|+.||+|
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiy  120 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAY  120 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHH
Confidence            4557888899886 99999999999999999999999975 8887776543 5888899999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh---------
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---------  168 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em---------  168 (562)
                      ||+|++||+++.+|++|+.|||+++.....    +..+||..|||||++.+   ...++|.||+|++.+||         
T Consensus       121 rd~k~enilld~~Ghi~~tdfglske~v~~----~~~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKE----KIACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hcccccceeecccCccccCCchhhhHhHhh----hhcccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch
Confidence            999999999999999999999998866422    22389999999999973   57789999999988775         


Q ss_pred             --------------------------------------------------------------------------------
Q psy10954        169 --------------------------------------------------------------------------------  168 (562)
Q Consensus       169 --------------------------------------------------------------------------------  168 (562)
                                                                                                      
T Consensus       194 ~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~  273 (612)
T KOG0603|consen  194 DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDV  273 (612)
T ss_pred             HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhh
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q psy10954        169 --------------------------------------------------------------------------------  168 (562)
Q Consensus       169 --------------------------------------------------------------------------------  168 (562)
                                                                                                      
T Consensus       274 ~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vk  353 (612)
T KOG0603|consen  274 AQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVK  353 (612)
T ss_pred             hhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhhe
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------hhHHHHHHHHHhhhc
Q psy10954        169 -----------------------------------------------------------------SYLYQLLEALRYCHS  183 (562)
Q Consensus       169 -----------------------------------------------------------------~~l~QIl~gL~yLHs  183 (562)
                                                                                       .|++||+.|+.|||+
T Consensus       354 ii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~  433 (612)
T KOG0603|consen  354 IISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHE  433 (612)
T ss_pred             eccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHh
Confidence                                                                             158899999999999


Q ss_pred             CceeecCCCCcceee-cCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhC
Q psy10954        184 RRIIHRDLKPQNILI-NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK  262 (562)
Q Consensus       184 ~~IIHRDLKPeNILl-~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG  262 (562)
                      +||+||||||+|||+ ++.|+++|+|||.++.....   ..+.+-|..|.|||++.. ..|+.++||||+|++||+|++|
T Consensus       434 ~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G  509 (612)
T KOG0603|consen  434 QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTG  509 (612)
T ss_pred             cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhC
Confidence            999999999999999 69999999999999877644   456678999999999984 4599999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHH
Q psy10954        263 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT  342 (562)
Q Consensus       263 ~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~e  342 (562)
                      ++||...+....+.   ..++.+..                        +   ...+..|+|||++||+.||.+|+|+.+
T Consensus       510 ~tp~~~~P~~~ei~---~~i~~~~~------------------------s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  510 RTLFAAHPAGIEIH---TRIQMPKF------------------------S---ECVSDEAKDLLQQLLQVDPALRLGADE  559 (612)
T ss_pred             CCccccCCchHHHH---HhhcCCcc------------------------c---cccCHHHHHHHHHhccCChhhCcChhh
Confidence            99998877653322   22222211                        1   234678999999999999999999999


Q ss_pred             HHcCccc
Q psy10954        343 ILQHEYF  349 (562)
Q Consensus       343 lL~Hp~f  349 (562)
                      ++.||||
T Consensus       560 i~~h~w~  566 (612)
T KOG0603|consen  560 IGAHPWF  566 (612)
T ss_pred             hccCcch
Confidence            9999999

>KOG0666|consensus

Probab=100.00  E-value=1.3e-45  Score=365.88  Aligned_cols=252  Identities=42%  Similarity=0.803  Sum_probs=209.6

Q ss_pred             cCCchhhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCcCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQDLKDFLQTTP----VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~~~L~~~i~~~~----~~l~e~~i~~i~~qll~aL~   88 (562)
                      .+|+..++.||+.++|.|+|||||.|..+|.. +..++|++||.+.||.++|+-+.    ..+|...++++++||+.|+.
T Consensus        67 ~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~  146 (438)
T KOG0666|consen   67 GTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVH  146 (438)
T ss_pred             CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhH
Confidence            44889999999999999999999999999987 78999999999999999996432    35999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccC----CCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         89 YCHSRRIIHRDLKPQNILINKS----GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~----~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      |||++-|+||||||.||||..+    |.|||+|||+||.+..+....                                 
T Consensus       147 YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl---------------------------------  193 (438)
T KOG0666|consen  147 YLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPL---------------------------------  193 (438)
T ss_pred             HHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccc---------------------------------
Confidence            9999999999999999999877    677777777777654331110                                 


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                                             ......|.|.||||||+++|.+.|+
T Consensus       194 -------------------------------------------------------~s~d~VVVTiWYRAPELLLGa~hYT  218 (438)
T KOG0666|consen  194 -------------------------------------------------------ASLDPVVVTIWYRAPELLLGARHYT  218 (438)
T ss_pred             -------------------------------------------------------ccCCceEEEEEecChHHhccccccc
Confidence                                                                   0112346799999999999999999


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhcCCCCCCCCCCCCCCCCccC---CCCC--CCccc
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKT---DFPE--WRPKK  310 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~---~~~~--~~~~~  310 (562)
                      .++|+||+|||++||++-+++|.|..+         .+++.+|++.+|+|..+.||.+.++|.+..   +++.  +..-.
T Consensus       219 ~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~s  298 (438)
T KOG0666|consen  219 KAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVS  298 (438)
T ss_pred             chhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcch
Confidence            999999999999999999999988653         478999999999999999999999887743   2221  11111


Q ss_pred             hhh---hcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        311 FSE---ILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       311 ~~~---~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +..   .....++.+.||+.+||++||.+|+||+++|+|+||..-+
T Consensus       299 L~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~  344 (438)
T KOG0666|consen  299 LHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP  344 (438)
T ss_pred             HHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence            222   2234566799999999999999999999999999998754

>KOG0598|consensus

Probab=100.00  E-value=1.6e-44  Score=367.04  Aligned_cols=219  Identities=32%  Similarity=0.474  Sum_probs=187.0

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .......|..||..++||+||+|+..|++.+++|||+||+.| +|+..|++. +.++|..++.|+.+|+.||.|||++||
T Consensus        68 e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gI  146 (357)
T KOG0598|consen   68 EVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGI  146 (357)
T ss_pred             hHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCe
Confidence            355678999999999999999999999999999999999975 999998765 479999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||||||++.+|+++|+|||+|+..-.                                                 
T Consensus       147 iyRDlKPENILLd~~GHi~LtDFgL~k~~~~-------------------------------------------------  177 (357)
T KOG0598|consen  147 IYRDLKPENILLDEQGHIKLTDFGLCKEDLK-------------------------------------------------  177 (357)
T ss_pred             eeccCCHHHeeecCCCcEEEeccccchhccc-------------------------------------------------
Confidence            9999999999999999999999998763211                                                 


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                ......++|||+.|||||++++.+ |+..||+||+||+
T Consensus       178 ------------------------------------------~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGil  214 (357)
T KOG0598|consen  178 ------------------------------------------DGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGIL  214 (357)
T ss_pred             ------------------------------------------CCCccccccCCccccChHHHhcCC-CCcccchHhHHHH
Confidence                                                      111234579999999999999875 9999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|.+||.+.+......+|...-...                            .-...++.++|+++++|+.||+
T Consensus       215 lYeML~G~pPF~~~~~~~~~~~I~~~k~~~----------------------------~p~~ls~~ardll~~LL~rdp~  266 (357)
T KOG0598|consen  215 LYEMLTGKPPFYAEDVKKMYDKILKGKLPL----------------------------PPGYLSEEARDLLKKLLKRDPR  266 (357)
T ss_pred             HHHHhhCCCCCcCccHHHHHHHHhcCcCCC----------------------------CCccCCHHHHHHHHHHhccCHH
Confidence            999999999999999888888886531100                            0012357899999999999999


Q ss_pred             CCC----CHHHHHcCccccCCcccC
Q psy10954        336 QRV----SAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       336 ~R~----Ta~elL~Hp~f~~~~~~~  356 (562)
                      +|+    ++.++.+||||..++|..
T Consensus       267 ~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  267 QRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             HhcCCCCChHHhhcCcccccCCHHH
Confidence            996    588999999999998754

>KOG0581|consensus

Probab=100.00  E-value=3.8e-44  Score=364.45  Aligned_cols=215  Identities=28%  Similarity=0.472  Sum_probs=176.6

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCE-EEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFK-LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-R   93 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~-i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~   93 (562)
                      ..+++.||+++++..+|||||++|++|..+.. ++|+||||++ +|.+++... +.++|.....++.|+++||.|||. .
T Consensus       120 ~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~  198 (364)
T KOG0581|consen  120 LQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEER  198 (364)
T ss_pred             HHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhcc
Confidence            35667999999999999999999999999984 9999999985 999988765 469999999999999999999995 7


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      +||||||||+||||+..|.|||||||.++.+.                                                
T Consensus       199 ~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv------------------------------------------------  230 (364)
T KOG0581|consen  199 KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV------------------------------------------------  230 (364)
T ss_pred             CeeeccCCHHHeeeccCCCEEeccccccHHhh------------------------------------------------
Confidence            88888888888888888888888888765332                                                


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                 ..  ...+++||..|||||.+.+.. |+.++||||||
T Consensus       231 -------------------------------------------nS--~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLG  264 (364)
T KOG0581|consen  231 -------------------------------------------NS--IANTFVGTSAYMSPERISGES-YSVKSDIWSLG  264 (364)
T ss_pred             -------------------------------------------hh--hcccccccccccChhhhcCCc-CCcccceeccc
Confidence                                                       11  235789999999999998875 99999999999


Q ss_pred             HHHHHHHhCCCCCCCC-----CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        254 CIFSEMITKKTLFAGD-----SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       254 ~il~eLltG~~pF~~~-----~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      +++.||++|+.||...     +..+.+..|+.  +.|+ .                 . |.      ...++++++|+..
T Consensus       265 LsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP-~-----------------l-P~------~~fS~ef~~FV~~  317 (364)
T KOG0581|consen  265 LSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPP-R-----------------L-PE------GEFSPEFRSFVSC  317 (364)
T ss_pred             HHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCC-C-----------------C-Cc------ccCCHHHHHHHHH
Confidence            9999999999999875     34455555543  1111 1                 0 00      0235789999999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCCc
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++||.+|+|++|+++|||++...
T Consensus       318 CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  318 CLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HhcCCcccCCCHHHHhcCHHHhhcc
Confidence            9999999999999999999998754

>KOG0592|consensus

Probab=100.00  E-value=4.6e-43  Score=369.19  Aligned_cols=230  Identities=30%  Similarity=0.482  Sum_probs=193.1

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|-.+|.+| +||.||+||-.|++...+|+|+||++ |+|.++|.+. +.|+|..++.|+.||+.||+|||++||
T Consensus       117 vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GI  195 (604)
T KOG0592|consen  117 VKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGI  195 (604)
T ss_pred             cchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCc
Confidence            34567899999999 89999999999999999999999997 5999999886 479999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||||||++.||++||+|||.|+.+.......            |    .....                      
T Consensus       196 IHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~------------~----~~~~~----------------------  237 (604)
T KOG0592|consen  196 IHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ------------E----NPVDP----------------------  237 (604)
T ss_pred             eeccCChhheeEcCCCcEEEeeccccccCChhhccc------------c----CccCc----------------------
Confidence            999999999999999999999999998775221100            0    00000                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                              ........++|||..|.+||+|.... -++.+|||+||||
T Consensus       238 ----------------------------------------~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCi  276 (604)
T KOG0592|consen  238 ----------------------------------------NQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCI  276 (604)
T ss_pred             ----------------------------------------ccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHH
Confidence                                                    00111236789999999999998665 7999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|+.|.+||.+.++.-.+++|+..--                  .||+           ..++.+.||++++|+.||+
T Consensus       277 lyQmlaG~PPFra~NeyliFqkI~~l~y------------------~fp~-----------~fp~~a~dLv~KLLv~dp~  327 (604)
T KOG0592|consen  277 LYQMLAGQPPFRAANEYLIFQKIQALDY------------------EFPE-----------GFPEDARDLIKKLLVRDPS  327 (604)
T ss_pred             HHHHhcCCCCCccccHHHHHHHHHHhcc------------------cCCC-----------CCCHHHHHHHHHHHccCcc
Confidence            9999999999999999999999987521                  1111           2246899999999999999


Q ss_pred             CCCCHHHHHcCccccCCcccC
Q psy10954        336 QRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      +|+|++|+.+||||.+++|..
T Consensus       328 ~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  328 DRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             ccccHHHHhhCcccccCChhh
Confidence            999999999999999998754

>KOG0667|consensus

Probab=100.00  E-value=1.8e-43  Score=380.90  Aligned_cols=243  Identities=33%  Similarity=0.558  Sum_probs=194.8

Q ss_pred             hhhHHHHHHHHHccC-C-----CCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELK-H-----PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-H-----pnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ...+..|+.||..|+ |     -|+|+++|+|..++++|||+|.++.+|+++++.++ .+++...++.++.||+.||.+|
T Consensus       226 ~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L  305 (586)
T KOG0667|consen  226 LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFL  305 (586)
T ss_pred             HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            346788999999997 4     38999999999999999999999999999998765 3599999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCC--CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~--~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |+.||||+||||||||+...+  .+||+|||+|.                                              
T Consensus       306 ~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc----------------------------------------------  339 (586)
T KOG0667|consen  306 HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC----------------------------------------------  339 (586)
T ss_pred             HhCCeeeccCChhheeeccCCcCceeEEeccccc----------------------------------------------
Confidence            999999999999999997543  46666666543                                              


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                   ......  + +++++++|||||||+|.+ |+.++|
T Consensus       340 ---------------------------------------------~~~q~v--y-tYiQSRfYRAPEVILGlp-Y~~~ID  370 (586)
T KOG0667|consen  340 ---------------------------------------------FESQRV--Y-TYIQSRFYRAPEVILGLP-YDTAID  370 (586)
T ss_pred             ---------------------------------------------ccCCcc--e-eeeeccccccchhhccCC-CCCccc
Confidence                                                         222111  1 568899999999999987 999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCC-CCCCC--------------------
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWR--------------------  307 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~--------------------  307 (562)
                      |||||||++||++|.++|.|+++.+++..|++.+|.|+..++....+...|... ...++                    
T Consensus       371 mWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~  450 (586)
T KOG0667|consen  371 MWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYY  450 (586)
T ss_pred             eeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhh
Confidence            999999999999999999999999999999999999987665444333222222 00000                    


Q ss_pred             ---------c---cchhhhcC-CCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        308 ---------P---KKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       308 ---------~---~~~~~~l~-~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                               |   +.+...+. ..+..+.|||.+||.+||.+|+|+.|+|+||||......
T Consensus       451 ~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  451 RKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLE  511 (586)
T ss_pred             hhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccccc
Confidence                     0   01111122 335678999999999999999999999999999976543

>KOG0669|consensus

Probab=100.00  E-value=2.5e-43  Score=341.19  Aligned_cols=252  Identities=42%  Similarity=0.750  Sum_probs=217.4

Q ss_pred             cCCchhhHHHHHHHHHccCCCCcceEEEEEEe--------CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPNVIRLHDVIPV--------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLE   85 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~--------~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~   85 (562)
                      ++|.+..++||+++|..|.|+|++.|++.+..        ...+|+||++|+.||..++.+....++...++.+|.++++
T Consensus        56 KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~  135 (376)
T KOG0669|consen   56 KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMN  135 (376)
T ss_pred             ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHH
Confidence            78999999999999999999999999887643        2469999999999999999887778999999999999999


Q ss_pred             HHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccc
Q psy10954         86 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  165 (562)
Q Consensus        86 aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il  165 (562)
                      ||.|+|++.|+|||+||+|+||+.+|.+||+|||+++.++.+...                                   
T Consensus       136 GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~-----------------------------------  180 (376)
T KOG0669|consen  136 GLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNV-----------------------------------  180 (376)
T ss_pred             HHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceeccccc-----------------------------------
Confidence            999999999999999999999999999999999999876532110                                   


Q ss_pred             hhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       166 ~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                                                                          ...+++..|.|+||++||.++|.+.|++
T Consensus       181 ----------------------------------------------------~kprytnrvvTLwYrppEllLG~r~yg~  208 (376)
T KOG0669|consen  181 ----------------------------------------------------VKPRYTNRVVTLWYRPPELLLGDREYGP  208 (376)
T ss_pred             ----------------------------------------------------CCCCcccceeeeecCCHHHhhcccccCC
Confidence                                                                1123566788999999999999999999


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCC-CCCCCcc---chhhhcC--CCC
Q psy10954        246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWRPK---KFSEILN--LPD  319 (562)
Q Consensus       246 ~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~l~--~~~  319 (562)
                      ++|||..|||++||++|.+.|.|.++..++..|...+|....++||.+.+++.+..- .++....   .+...+.  ..+
T Consensus       209 ~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd  288 (376)
T KOG0669|consen  209 PIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKD  288 (376)
T ss_pred             cchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCC
Confidence            999999999999999999999999999999999999999999999999998877543 2223222   2222222  237


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +.+.||+.+||.+||.+|++++++|+|.||..-
T Consensus       289 ~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  289 DEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             hhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            789999999999999999999999999999753

>KOG0605|consensus

Probab=100.00  E-value=9.5e-43  Score=367.06  Aligned_cols=259  Identities=28%  Similarity=0.405  Sum_probs=195.3

Q ss_pred             ccCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         13 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        13 ~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+...-+..|-.||...++|+||+||..|++.+++||||||++| |+..+|.+.+ .|+|..+++|+.+++.|++.||
T Consensus       180 ~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH  258 (550)
T KOG0605|consen  180 LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH  258 (550)
T ss_pred             HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH
Confidence            3444555678899999999999999999999999999999999985 9999987765 7999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +.|+|||||||+|+|||..|++||+||||+..+.....       +-.|.--+...                        
T Consensus       259 ~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~-------~~~~~~~~~~~------------------------  307 (550)
T KOG0605|consen  259 QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR-------IESYRLDEQMQ------------------------  307 (550)
T ss_pred             HcCcccccCChhheeecCCCCEeeccccccchhhhhhh-------hhhhcchhhhh------------------------
Confidence            99999999999999999999999999999854431110       00000000000                        


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccc---ccc-----------ccCCCcccccccCCCccchhhh
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS---RAF-----------TIPMNRYTHEVVTLWYRPPEIL  237 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla---~~~-----------~~~~~~~~~~vgT~~Y~APEvl  237 (562)
                                                 ......+-.||.-.   +..           .......-+.||||.||||||+
T Consensus       308 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  308 ---------------------------INLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             ---------------------------hhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence                                       00000111122210   000           0001112347999999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC
Q psy10954        238 LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL  317 (562)
Q Consensus       238 ~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  317 (562)
                      ++.+ |+..+|+||||||+||||.|.+||.+++..+...+|.+.--.         -       .+|.-         ..
T Consensus       361 l~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------l-------~fP~~---------~~  414 (550)
T KOG0605|consen  361 LGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------L-------KFPEE---------VD  414 (550)
T ss_pred             hcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------c-------cCCCc---------Cc
Confidence            9877 999999999999999999999999999999999988763110         0       01110         11


Q ss_pred             CCHHHHHHHHHccccCCCCCCC---HHHHHcCccccCCcccCC
Q psy10954        318 PDPLAVDVFSKIMALDPKQRVS---AKTILQHEYFNQVEMVKP  357 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R~T---a~elL~Hp~f~~~~~~~~  357 (562)
                      .+.+|+|||.++|. ||++|+.   ++|+.+||||++++|...
T Consensus       415 ~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  415 LSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             ccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            24789999999999 9999996   789999999999998653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.1e-42  Score=350.63  Aligned_cols=241  Identities=46%  Similarity=0.881  Sum_probs=202.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+.+|+.+|+.++||||+++++++......|+||||++++|.+++......+++..++.++.|++.||+|||++||+|
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  126 (288)
T cd07871          47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH  126 (288)
T ss_pred             chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            45678999999999999999999999999999999999999999998876666899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       127 ~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-------------------------------------------------  157 (288)
T cd07871         127 RDLKPQNLLINEKGELKLADFGLARAKSVPT-------------------------------------------------  157 (288)
T ss_pred             CCCCHHHEEECCCCCEEECcCcceeeccCCC-------------------------------------------------
Confidence            9999999999999999999999875321100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+...++.++||||+||++|
T Consensus       158 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  195 (288)
T cd07871         158 ------------------------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILY  195 (288)
T ss_pred             ------------------------------------------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHH
Confidence                                                      00112357889999999987667899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++|++||.+.+..+.+..+...++.+..+.|+.......+. ..++.+............++.++|||++||++||++
T Consensus       196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~  275 (288)
T cd07871         196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS  275 (288)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCccc
Confidence            9999999999999999999999999999999888765433322 223333333333344455788999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      |+|++|+|+||||
T Consensus       276 R~t~~~~l~hp~f  288 (288)
T cd07871         276 RISAEAALRHSYF  288 (288)
T ss_pred             CCCHHHHhcCCCC
Confidence            9999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0033|consensus

Probab=100.00  E-value=8.3e-43  Score=336.52  Aligned_cols=217  Identities=32%  Similarity=0.518  Sum_probs=177.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+-||+.|.+.|+|||||+|++.+...+..|||+|+|.+ +|..-|-++ ..++|..+--+++||++||+|||.+|||
T Consensus        54 ~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~Iv  132 (355)
T KOG0033|consen   54 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIV  132 (355)
T ss_pred             HHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCce
Confidence            45678999999999999999999999999999999999986 888666543 3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |||+||+|+|+....   -+||+|||+|..+                                                 
T Consensus       133 HRDvkP~nllLASK~~~A~vKL~~FGvAi~l-------------------------------------------------  163 (355)
T KOG0033|consen  133 HRDLKPENLLLASKAKGAAVKLADFGLAIEV-------------------------------------------------  163 (355)
T ss_pred             eccCChhheeeeeccCCCceeecccceEEEe-------------------------------------------------
Confidence            999999999986432   3666666665433                                                 


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                . .......++|||.|||||++...+ |+.++||||.|
T Consensus       164 ------------------------------------------~-~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cG  199 (355)
T KOG0033|consen  164 ------------------------------------------N-DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACG  199 (355)
T ss_pred             ------------------------------------------C-CccccccccCCCcccCHHHhhcCC-CCCcchhhhhh
Confidence                                                      2 122233568999999999998766 99999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ||||.|+.|.+||.+++......+|...--                ..+.+.|         ...++.++||+++||..|
T Consensus       200 ViLfiLL~G~~PF~~~~~~rlye~I~~g~y----------------d~~~~~w---------~~is~~Ak~LvrrML~~d  254 (355)
T KOG0033|consen  200 VILYILLVGYPPFWDEDQHRLYEQIKAGAY----------------DYPSPEW---------DTVTPEAKSLIRRMLTVN  254 (355)
T ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHhcccc----------------CCCCccc---------CcCCHHHHHHHHHHhccC
Confidence            999999999999999888777777765321                1222222         234578999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|+||.|+|+|||+.+-+
T Consensus       255 P~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  255 PKKRITADEALKHPWICNRE  274 (355)
T ss_pred             hhhhccHHHHhCCchhcchH
Confidence            99999999999999998743

>KOG0610|consensus

Probab=100.00  E-value=6.3e-42  Score=351.23  Aligned_cols=274  Identities=28%  Similarity=0.352  Sum_probs=200.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..++..|-+||+.++||.+++||..|+.+...|+|||||.| +|..+++++.+ .|++..+++|+.+++.||+|||-+||
T Consensus       121 l~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGi  200 (459)
T KOG0610|consen  121 LKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGI  200 (459)
T ss_pred             HHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhce
Confidence            45788999999999999999999999999999999999975 99998877654 59999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |.||||||||||-.+|++.|+||.|+.......+..    .   -..|+.-...    .+.-.-..+|..-.+       
T Consensus       201 vYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~----~---s~~~~~~~~~----~~~~~~~~s~f~~r~-------  262 (459)
T KOG0610|consen  201 VYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV----K---SSSPRSSGSQ----PSCRSRQPSCFSPRC-------  262 (459)
T ss_pred             eeccCCcceeEEecCCcEEeeeccccccCCCCCeee----c---cCCCCCCCCC----cccccccccccccch-------
Confidence            999999999999999999999999987652110000    0   0001100000    000000011110000       


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc-----ccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-----TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~-----~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                           +......-| .|++..+..     .....+..++|||-.|.|||+|.|.+ ++.+||||
T Consensus       263 ---------------------~~~~~~~~k-~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWW  319 (459)
T KOG0610|consen  263 ---------------------LSSSKKRKK-KDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWW  319 (459)
T ss_pred             ---------------------hcccccccc-ccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHH
Confidence                                 000000011 233322111     11234556889999999999999876 89999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ++||.+|||+.|.+||.|.+..+.+.+|+..--.                  +|+.         +..+..++|||+++|
T Consensus       320 tfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~------------------Fp~~---------~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  320 TFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK------------------FPEE---------PEVSSAAKDLIRKLL  372 (459)
T ss_pred             HHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc------------------CCCC---------CcchhHHHHHHHHHh
Confidence            9999999999999999999999999888643111                  1111         123467999999999


Q ss_pred             ccCCCCCCC----HHHHHcCccccCCcccCCcc
Q psy10954        331 ALDPKQRVS----AKTILQHEYFNQVEMVKPTL  359 (562)
Q Consensus       331 ~~DP~~R~T----a~elL~Hp~f~~~~~~~~~~  359 (562)
                      .+||++|+.    |.|+.+||||+.++|.-...
T Consensus       373 vKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~  405 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRC  405 (459)
T ss_pred             ccChhhhhccccchHHhhcCccccCCChhheec
Confidence            999999998    99999999999999874333

>KOG0583|consensus

Probab=100.00  E-value=7.6e-42  Score=361.87  Aligned_cols=216  Identities=33%  Similarity=0.568  Sum_probs=183.9

Q ss_pred             chhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.||+.+|+.++ ||||+++++++....++|+|||||.+ +|++++.+ .+.+.|..++.+++|++.||+|||++|
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g  140 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG  140 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC
Confidence            4556669999999998 99999999999999999999999985 99999998 668999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 IIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 IiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |+||||||||||++.+ +++||+|||++.....                                               
T Consensus       141 i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~-----------------------------------------------  173 (370)
T KOG0583|consen  141 IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG-----------------------------------------------  173 (370)
T ss_pred             EeeCCCCHHHEEecCCCCCEEEeccccccccCC-----------------------------------------------
Confidence            9999999999999998 9999999998754310                                               


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-CCCchhhHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSA  252 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-~y~~~~DIWSl  252 (562)
                                                                  ......+.+||+.|+|||++.+.. +-+.++||||+
T Consensus       174 --------------------------------------------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~  209 (370)
T KOG0583|consen  174 --------------------------------------------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL  209 (370)
T ss_pred             --------------------------------------------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence                                                        011235679999999999999877 55799999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||+||.|++|+.||...+.......|...-                  ..+|.+        +.  ++.+++|+++||+.
T Consensus       210 GViLy~ml~G~~PF~d~~~~~l~~ki~~~~------------------~~~p~~--------~~--S~~~~~Li~~mL~~  261 (370)
T KOG0583|consen  210 GVILYVLLCGRLPFDDSNVPNLYRKIRKGE------------------FKIPSY--------LL--SPEARSLIEKMLVP  261 (370)
T ss_pred             HHHHHHHHhCCCCCCCccHHHHHHHHhcCC------------------ccCCCC--------cC--CHHHHHHHHHHcCC
Confidence            999999999999999987776666654320                  112221        11  67899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCC
Q psy10954        333 DPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||.+|+|+.++++||||+..
T Consensus       262 ~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  262 DPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CcccCCCHHHHhhChhhccC
Confidence            99999999999999999963

>KOG0616|consensus

Probab=100.00  E-value=2.4e-42  Score=341.38  Aligned_cols=214  Identities=29%  Similarity=0.478  Sum_probs=185.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+...+|..+|+.+.||++++|++.|.+.+++||||||+++ .|+.++++.+ .++|..+++|+.||+.||+|||+++||
T Consensus        88 veH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~ii  166 (355)
T KOG0616|consen   88 VEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDII  166 (355)
T ss_pred             HHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCee
Confidence            34568999999999999999999999999999999999985 9999998765 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      +|||||||||++.+|.+||+|||.|+....                                                  
T Consensus       167 YRDLKPENiLlD~~G~iKitDFGFAK~v~~--------------------------------------------------  196 (355)
T KOG0616|consen  167 YRDLKPENLLLDQNGHIKITDFGFAKRVSG--------------------------------------------------  196 (355)
T ss_pred             eccCChHHeeeccCCcEEEEeccceEEecC--------------------------------------------------
Confidence            999999999999999999999998875431                                                  


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  +..+.||||.|+|||++...+ |+.++|+||+||++
T Consensus       197 --------------------------------------------rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLI  231 (355)
T KOG0616|consen  197 --------------------------------------------RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLI  231 (355)
T ss_pred             --------------------------------------------cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHH
Confidence                                                        123458999999999998655 99999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||+.|.+||.+.+......+|++.--.                  +|.           ..+++++||++++|+.|-.+
T Consensus       232 YEMlaG~pPF~~~~~~~iY~KI~~~~v~------------------fP~-----------~fs~~~kdLl~~LL~vD~t~  282 (355)
T KOG0616|consen  232 YEMLAGYPPFYDDNPIQIYEKILEGKVK------------------FPS-----------YFSSDAKDLLKKLLQVDLTK  282 (355)
T ss_pred             HHHHcCCCCCcCCChHHHHHHHHhCccc------------------CCc-----------ccCHHHHHHHHHHHhhhhHh
Confidence            9999999999999998888888763111                  111           12578999999999999999


Q ss_pred             CC-----CHHHHHcCccccCCcccC
Q psy10954        337 RV-----SAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~~~  356 (562)
                      |.     +..++.+||||+++.|..
T Consensus       283 R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  283 RFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             hhcCcCCCccccccCcccccccHHH
Confidence            95     467999999999998754

>KOG0588|consensus

Probab=100.00  E-value=3.6e-42  Score=368.82  Aligned_cols=218  Identities=31%  Similarity=0.559  Sum_probs=187.6

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      +..+..+-+||-||+-|+||||++|||+++...++|+|+||++ |.|++++...+ +++|..++.+++||+.|+.|||..
T Consensus        53 ~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~  131 (786)
T KOG0588|consen   53 SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF  131 (786)
T ss_pred             cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh
Confidence            3456678899999999999999999999999999999999997 59999997754 799999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      +|+||||||||+|++..+.+||+|||+|....                                                
T Consensus       132 ~icHRDLKpENlLLd~~~nIKIADFGMAsLe~------------------------------------------------  163 (786)
T KOG0588|consen  132 NICHRDLKPENLLLDVKNNIKIADFGMASLEV------------------------------------------------  163 (786)
T ss_pred             cceeccCCchhhhhhcccCEeeeccceeeccc------------------------------------------------
Confidence            99999999999999998889999999875321                                                


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                  +.....+.||+|+|.|||++.|.++.|.++||||+|
T Consensus       164 --------------------------------------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCG  199 (786)
T KOG0588|consen  164 --------------------------------------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCG  199 (786)
T ss_pred             --------------------------------------------CCccccccCCCcccCCchhhcCCCCCCCccccchhH
Confidence                                                        112235679999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ||||.||+|+.||.+++-...+.++.+..-                  +           .-...+++|+|||++||..|
T Consensus       200 VILfALLtG~LPFdDdNir~LLlKV~~G~f------------------~-----------MPs~Is~eaQdLLr~ml~VD  250 (786)
T KOG0588|consen  200 VILFALLTGKLPFDDDNIRVLLLKVQRGVF------------------E-----------MPSNISSEAQDLLRRMLDVD  250 (786)
T ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHHcCcc------------------c-----------CCCcCCHHHHHHHHHHhccC
Confidence            999999999999998877666666643210                  0           11224679999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCcc
Q psy10954        334 PKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++|+|.+|+++|||+.....
T Consensus       251 p~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  251 PSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             ccccccHHHHhhCchhhcCCC
Confidence            999999999999999987653

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.4e-41  Score=345.22  Aligned_cols=245  Identities=50%  Similarity=0.862  Sum_probs=197.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+.+|+.+|+.++||||+++++++......|+||||++++|.+++......+++..++.++.|++.||+|||++||+|
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  126 (303)
T cd07869          47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH  126 (303)
T ss_pred             chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34578999999999999999999999999999999999999999998876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       127 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  157 (303)
T cd07869         127 RDLKPQNLLISDTGELKLADFGLARAKSVPS-------------------------------------------------  157 (303)
T ss_pred             CCCCHHHEEECCCCCEEECCCCcceeccCCC-------------------------------------------------
Confidence            9999999999999999999999875321100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+...++.++||||+||++|
T Consensus       158 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  195 (303)
T cd07869         158 ------------------------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFV  195 (303)
T ss_pred             ------------------------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHH
Confidence                                                      00112357899999999987777899999999999999


Q ss_pred             HHHhCCCCCCCCC-HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCC-CCCCCccchhhhcCC--CCHHHHHHHHHccccC
Q psy10954        258 EMITKKTLFAGDS-EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWRPKKFSEILNL--PDPLAVDVFSKIMALD  333 (562)
Q Consensus       258 eLltG~~pF~~~~-~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~--~~~~~~dLi~~mL~~D  333 (562)
                      ||++|..||.+.. ..+.+..+...++.+....|+.....+.+... +....+..+....+.  ....+.||+++||++|
T Consensus       196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  275 (303)
T cd07869         196 EMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF  275 (303)
T ss_pred             HHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccC
Confidence            9999999998764 34677788888888888877766543332211 111122222222221  2467899999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|+|++|+|+||||+++.
T Consensus       276 p~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         276 PKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             chhccCHHHHhcCcccccCC
Confidence            99999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599|consensus

Probab=100.00  E-value=2.9e-42  Score=336.98  Aligned_cols=224  Identities=30%  Similarity=0.531  Sum_probs=182.7

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ......+|+.||+++ .||||++|.|+|+++..+++|+|.|+ |.|++++... ..++|...+.+|+|+++|++|||.++
T Consensus        65 ~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~  143 (411)
T KOG0599|consen   65 MREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN  143 (411)
T ss_pred             HHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh
Confidence            345678999999998 79999999999999999999999997 6999999764 36999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++++..+||+|||+|..+.. ..+....||||+|.|||.+.-.               ++        
T Consensus       144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~---------------m~--------  199 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMNIKISDFGFACQLEP-GEKLRELCGTPGYLAPETIKCS---------------MY--------  199 (411)
T ss_pred             hhhcccChhheeeccccceEEeccceeeccCC-chhHHHhcCCCcccChhheeee---------------cc--------
Confidence            99999999999999999999999999887642 2333444555555555544210               00        


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                                     .+.++|+..+|+||+||
T Consensus       200 ---------------------------------------------------------------e~~pGYs~EVD~Wa~GV  216 (411)
T KOG0599|consen  200 ---------------------------------------------------------------ENHPGYSKEVDEWACGV  216 (411)
T ss_pred             ---------------------------------------------------------------cCCCCccchhhHHHHHH
Confidence                                                                           12456999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |+|.|+.|.+||.-....-++..|.+.                .|....|+|.         ..+..++|||+++|+.||
T Consensus       217 ImyTLLaGcpPFwHRkQmlMLR~ImeG----------------kyqF~speWa---------dis~~~KdLIsrlLqVdp  271 (411)
T KOG0599|consen  217 IMYTLLAGCPPFWHRKQMLMLRMIMEG----------------KYQFRSPEWA---------DISATVKDLISRLLQVDP  271 (411)
T ss_pred             HHHHHHcCCCchhHHHHHHHHHHHHhc----------------ccccCCcchh---------hccccHHHHHHHHHeeCc
Confidence            999999999999877666677777653                2333444442         234578999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+|+|++|+|+||||.++.
T Consensus       272 ~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  272 TKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             hhcccHHHHhcChHHHHHH
Confidence            9999999999999997654

>KOG0578|consensus

Probab=100.00  E-value=2.9e-41  Score=358.16  Aligned_cols=214  Identities=29%  Similarity=0.529  Sum_probs=183.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+-+++|+.+|+..+|+|||.+++.|...+.+|+|||||++ +|.+++...  .++|.+++.++++++.||+|||.+|||
T Consensus       314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIi  391 (550)
T KOG0578|consen  314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGII  391 (550)
T ss_pred             hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhccee
Confidence            34578999999999999999999999999999999999985 899988654  489999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||||.+|||++.+|.+||+|||++..+...                                                 
T Consensus       392 HrDIKSDnILL~~~g~vKltDFGFcaqi~~~-------------------------------------------------  422 (550)
T KOG0578|consen  392 HRDIKSDNILLTMDGSVKLTDFGFCAQISEE-------------------------------------------------  422 (550)
T ss_pred             eeccccceeEeccCCcEEEeeeeeeeccccc-------------------------------------------------
Confidence            9999999999999999999999887654321                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                ....++.||||+|||||++.... |++++||||||++.
T Consensus       423 ------------------------------------------~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMa  459 (550)
T KOG0578|consen  423 ------------------------------------------QSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMA  459 (550)
T ss_pred             ------------------------------------------cCccccccCCCCccchhhhhhcc-cCccccchhhhhHH
Confidence                                                      11235679999999999997554 99999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      .||+.|++||..++....++.|.. .|+|....+                         ...++.++||+.+||+.|+.+
T Consensus       460 IEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~-------------------------~klS~~~kdFL~~cL~~dv~~  513 (550)
T KOG0578|consen  460 IEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNP-------------------------EKLSPELKDFLDRCLVVDVEQ  513 (550)
T ss_pred             HHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCc-------------------------cccCHHHHHHHHHHhhcchhc
Confidence            999999999999999888888754 344322211                         223578999999999999999


Q ss_pred             CCCHHHHHcCccccC
Q psy10954        337 RVSAKTILQHEYFNQ  351 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~  351 (562)
                      |++|.|+|+||||+.
T Consensus       514 RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  514 RASAKELLEHPFLKM  528 (550)
T ss_pred             CCCHHHHhcChhhhh
Confidence            999999999999953

>KOG0595|consensus

Probab=100.00  E-value=2.6e-40  Score=339.22  Aligned_cols=224  Identities=32%  Similarity=0.535  Sum_probs=177.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+..||+||+.++|||||+|+|+++.++.+|||||||. |||.++|++++ .++|..++.+|.||+.||++||+++||
T Consensus        53 ~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~Ii  131 (429)
T KOG0595|consen   53 VELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNII  131 (429)
T ss_pred             HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3456799999999999999999999999999999999998 69999998865 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.....+                                                              
T Consensus       132 HRDLKPQNiLLs~~~~~~--------------------------------------------------------------  149 (429)
T KOG0595|consen  132 HRDLKPQNILLSTTARND--------------------------------------------------------------  149 (429)
T ss_pred             eccCCcceEEeccCCCCC--------------------------------------------------------------
Confidence            999999999997531000                                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                             ..-.+||+|||+||.+. +.....+.||||.||||||+...+ |+.|+|+||+|+|+
T Consensus       150 -----------------------~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Il  204 (429)
T KOG0595|consen  150 -----------------------TSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTIL  204 (429)
T ss_pred             -----------------------CCceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHH
Confidence                                   00135666666666554 223345679999999999997554 99999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|++||...+..+.+..+-..-...                  +.        .-...+....+++...|+.||..
T Consensus       205 yq~l~g~~Pf~a~t~~eL~~~~~k~~~~~------------------~~--------~~~~~s~~~~~Ll~~ll~~~~~~  258 (429)
T KOG0595|consen  205 YQCLTGKPPFDAETPKELLLYIKKGNEIV------------------PV--------LPAELSNPLRELLISLLQRNPKD  258 (429)
T ss_pred             HHHHhCCCCccccCHHHHHHHHhcccccc------------------Cc--------hhhhccCchhhhhhHHHhcCccc
Confidence            99999999999998877766442211000                  00        00111234558899999999999


Q ss_pred             CCCHHHHHcCccccCCccc
Q psy10954        337 RVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~~~  355 (562)
                      |.+..+-+.|+++..-...
T Consensus       259 ~~~~~~~~~~~~l~~~p~~  277 (429)
T KOG0595|consen  259 RISFEDFFDHPFLAANPQD  277 (429)
T ss_pred             cCchHHhhhhhhcccCccc
Confidence            9999999999999765533

>KOG0032|consensus

Probab=100.00  E-value=3.6e-40  Score=349.60  Aligned_cols=217  Identities=31%  Similarity=0.527  Sum_probs=181.5

Q ss_pred             chhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.+|+.||+++. |||||.++++|++...+|+|||+|. ++|++.|...  .++|..+..+++|++.|++|||+.|
T Consensus        78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g  155 (382)
T KOG0032|consen   78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG  155 (382)
T ss_pred             cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4467889999999998 9999999999999999999999998 5999998876  3999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccC----CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         95 IIHRDLKPQNILINKS----GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        95 IiHRDLKP~NILl~~~----~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |+||||||+|+|+...    +.+|++|||+|                                                 
T Consensus       156 vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla-------------------------------------------------  186 (382)
T KOG0032|consen  156 VVHRDLKPENLLLASKDEGSGRIKLIDFGLA-------------------------------------------------  186 (382)
T ss_pred             ceeccCCHHHeeeccccCCCCcEEEeeCCCc-------------------------------------------------
Confidence            9999999999998632    24555555554                                                 


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                ..... .......+||+.|+|||++.+. .|+..+|||
T Consensus       187 ------------------------------------------~~~~~-~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiW  222 (382)
T KOG0032|consen  187 ------------------------------------------KFIKP-GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVW  222 (382)
T ss_pred             ------------------------------------------eEccC-CceEeeecCCccccCchhhcCC-CCCcccchh
Confidence                                                      44333 3344567899999999999764 499999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|.|++|.+||.+.++......|...--......|+                         ..+..++||+++||
T Consensus       223 S~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~-------------------------~is~~akd~i~~ll  277 (382)
T KOG0032|consen  223 SIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD-------------------------DISESAKDFIRKLL  277 (382)
T ss_pred             HHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc-------------------------ccCHHHHHHHHHhc
Confidence            99999999999999999999888888776543333333332                         23568999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ..||.+|+||.++|+|||+++..
T Consensus       278 ~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  278 EFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             ccCcccCCCHHHHhcCccccCCc
Confidence            99999999999999999998753

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.2e-40  Score=338.75  Aligned_cols=245  Identities=40%  Similarity=0.794  Sum_probs=187.0

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQDLKDFLQTT--------PVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~~L~~~i~~~--------~~~l~e~~i~~i~~qll~a   86 (562)
                      ....+.+|+++|++++||||++++++|..  +..+|+||||++++|.+++...        ...+++..++.++.|++.|
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          41 ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            34567899999999999999999999864  4678999999999998887532        1248999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEc----cCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         87 LRYCHSRRIIHRDLKPQNILIN----KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~----~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      |+|||++||+||||||+|||+.    .++.+||+|||+|+.......                                 
T Consensus       121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~---------------------------------  167 (317)
T cd07868         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK---------------------------------  167 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc---------------------------------
Confidence            9999999999999999999994    456788888888754321100                                 


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                             ........+||+.|+|||++.+...
T Consensus       168 -------------------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~  192 (317)
T cd07868         168 -------------------------------------------------------PLADLDPVVVTFWYRAPELLLGARH  192 (317)
T ss_pred             -------------------------------------------------------cccccCCccccccccCCHHHcCCCC
Confidence                                                                   0001123468999999999988777


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCC-----c
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-----P  308 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-----~  308 (562)
                      |+.++||||+||++|||++|++||.+..+         .+++..++..+|.+....|......+..........     .
T Consensus       193 ~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (317)
T cd07868         193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN  272 (317)
T ss_pred             cCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCc
Confidence            99999999999999999999999976543         467788889999888777765543322111100000     0


Q ss_pred             ----cchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q psy10954        309 ----KKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       309 ----~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                          ..+.......++.+.|||.+||++||++|+|++|+|+||||
T Consensus       273 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         273 CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                00111112246679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0665|consensus

Probab=100.00  E-value=3.2e-41  Score=336.46  Aligned_cols=248  Identities=37%  Similarity=0.640  Sum_probs=200.0

Q ss_pred             CCCCCccccccCCchhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHH
Q psy10954          4 DESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAK   77 (562)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~   77 (562)
                      |-++|   .+.....+++.||..+|..++|+||++++.+|...      ..+|+|||||..+|.+++..   .+..+.++
T Consensus        48 k~~~p---f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~---elDH~tis  121 (369)
T KOG0665|consen   48 KLSRP---FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM---ELDHETIS  121 (369)
T ss_pred             hhcCc---cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH---hcchHHHH
Confidence            44555   23334567899999999999999999999999754      35799999999999999874   37888899


Q ss_pred             HHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccc
Q psy10954         78 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  157 (562)
Q Consensus        78 ~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~D  157 (562)
                      ++++|++.|++|||++||+||||||+||+++.++.+||.|||+|+.-...                              
T Consensus       122 ~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~------------------------------  171 (369)
T KOG0665|consen  122 YILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD------------------------------  171 (369)
T ss_pred             HHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc------------------------------
Confidence            99999999999999999999999999999999999999999998643210                              


Q ss_pred             cccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhh
Q psy10954        158 IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL  237 (562)
Q Consensus       158 vwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl  237 (562)
                                                                         |           ..+.+++|++|+|||++
T Consensus       172 ---------------------------------------------------~-----------~mtpyVvtRyyrapevi  189 (369)
T KOG0665|consen  172 ---------------------------------------------------F-----------MMTPYVVTRYYRAPEVI  189 (369)
T ss_pred             ---------------------------------------------------c-----------ccCchhheeeccCchhe
Confidence                                                               0           12456889999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchhhhcC
Q psy10954        238 LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFSEILN  316 (562)
Q Consensus       238 ~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~  316 (562)
                      ++.+ |...+||||+|||++||++|+.+|.|.+..++..++.+.+|+|.......+.. ...|....++.....++++++
T Consensus       190 l~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fp  268 (369)
T KOG0665|consen  190 LGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFP  268 (369)
T ss_pred             eccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCC
Confidence            9988 99999999999999999999999999999999999999999998765433221 011111222222222222222


Q ss_pred             ------------CCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q psy10954        317 ------------LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       317 ------------~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                                  .....+.|++.+||..||++|++++++|+|||++
T Consensus       269 D~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  269 DSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             cccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                        2345789999999999999999999999999998

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-39  Score=335.39  Aligned_cols=245  Identities=46%  Similarity=0.898  Sum_probs=202.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .....+|++++++++||||+++++++..++..|+||||++++|.+++......+++..++.++.|++.||.|||++||+|
T Consensus        48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH  127 (309)
T cd07872          48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH  127 (309)
T ss_pred             chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34677999999999999999999999999999999999999999998776666899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++....+.                                                 
T Consensus       128 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  158 (309)
T cd07872         128 RDLKPQNLLINERGELKLADFGLARAKSVPT-------------------------------------------------  158 (309)
T ss_pred             CCCCHHHEEECCCCCEEECccccceecCCCc-------------------------------------------------
Confidence            9999999999999999999999875321100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......++|+.|+|||++.+...++.++||||+||++|
T Consensus       159 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  196 (309)
T cd07872         159 ------------------------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFF  196 (309)
T ss_pred             ------------------------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHH
Confidence                                                      00112356889999999987667899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCc-cCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++|++||.+.+..+.+..+.+.+|.+..+.|+.......+ ...++...+..........++.+.|||.+||+.||.+
T Consensus       197 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  276 (309)
T cd07872         197 EMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKK  276 (309)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhh
Confidence            999999999999988888999999999888888765433222 1223333333332333445778999999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |+|++|+|+||||+...
T Consensus       277 R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         277 RISAEEAMKHAYFRSLG  293 (309)
T ss_pred             CCCHHHHhcChhhhhcc
Confidence            99999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-39  Score=337.78  Aligned_cols=247  Identities=36%  Similarity=0.652  Sum_probs=193.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+++|+.++||||+++++++...     ..+|+|||||+++|.+++.... .+++..++.++.|++.||.|||++
T Consensus        44 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~  122 (338)
T cd07859          44 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA  122 (338)
T ss_pred             HHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4578999999999999999999988643     3589999999999999887644 589999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++.......                                            
T Consensus       123 ~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------  158 (338)
T cd07859         123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--------------------------------------------  158 (338)
T ss_pred             CeecCCCCHHHeEECCCCcEEEccCccccccccccC--------------------------------------------
Confidence            999999999999999999999999998754321000                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSA  252 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSl  252 (562)
                                                                  ........+||+.|+|||++.+. ..++.++||||+
T Consensus       159 --------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSl  194 (338)
T cd07859         159 --------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI  194 (338)
T ss_pred             --------------------------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHH
Confidence                                                        00001234689999999998652 458999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|||++|++||.+.+...++..+...+|.++...+..+....  .+........+..+...++..++.+.+++.+||
T Consensus       195 Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  274 (338)
T cd07859         195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLL  274 (338)
T ss_pred             HHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHc
Confidence            999999999999999998888888888888877655433222100  001111111222233344455678899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCcc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      +.||++|||++|+|+||||+++..
T Consensus       275 ~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         275 AFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             CcCcccCCCHHHHhcCchhhhcCc
Confidence            999999999999999999988764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0198|consensus

Probab=100.00  E-value=6.1e-40  Score=336.91  Aligned_cols=221  Identities=31%  Similarity=0.501  Sum_probs=175.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC--EEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~--~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .+...+|+.+|++++|||||++++......  .+++.|||+. ++|.+++.+.++.++|..++.|.+|+++||+|||++|
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g  137 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG  137 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345789999999999999999999755444  6999999997 4999999987767999999999999999999999999


Q ss_pred             ceeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 IIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 IiHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||||+|||++. ++.+||+|||+++..... ..                                           
T Consensus       138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~-~~-------------------------------------------  173 (313)
T KOG0198|consen  138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK-GT-------------------------------------------  173 (313)
T ss_pred             EeccCcccceEEEeCCCCeEEeccCccccccccc-cc-------------------------------------------
Confidence            999999999999999 699999999987654310 00                                           


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                  .........||+.|||||++.....-+.++||||+|
T Consensus       174 --------------------------------------------~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlG  209 (313)
T KOG0198|consen  174 --------------------------------------------KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLG  209 (313)
T ss_pred             --------------------------------------------cccccccccCCccccCchhhcCCCcCCccchhhhcC
Confidence                                                        000112457899999999998532234599999999


Q ss_pred             HHHHHHHhCCCCCCC-CCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMITKKTLFAG-DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLltG~~pF~~-~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++.||+||++||.. ....+.+..+...--                   .|.        +....+..++|||.+||++
T Consensus       210 CtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~-------------------~P~--------ip~~ls~~a~~Fl~~C~~~  262 (313)
T KOG0198|consen  210 CTVVEMLTGKPPWSEFFEEAEALLLIGREDS-------------------LPE--------IPDSLSDEAKDFLRKCFKR  262 (313)
T ss_pred             CEEEeccCCCCcchhhcchHHHHHHHhccCC-------------------CCC--------CCcccCHHHHHHHHHHhhc
Confidence            999999999999987 333443444322110                   010        1123467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++||||+++|+|||..+..
T Consensus       263 ~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  263 DPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CcccCcCHHHHhhChhhhccc
Confidence            999999999999999998754

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=350.91  Aligned_cols=242  Identities=36%  Similarity=0.637  Sum_probs=191.3

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeC--------CEEEEEeecCcCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHH
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~--------~~i~lV~Ey~~~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~   88 (562)
                      ...+|+.+|+.++|||||+++++|...        ..+|+||||++++|.+++..   ....+++..++.++.|++.||+
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~  184 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA  184 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            456899999999999999999987542        25789999999988877753   3346999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      |||++||+||||||+|||++.++ .+||+|||+|+.....                                        
T Consensus       185 yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~----------------------------------------  224 (440)
T PTZ00036        185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG----------------------------------------  224 (440)
T ss_pred             HHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC----------------------------------------
Confidence            99999999999999999998665 6999999987543210                                        


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                          ......+||+.|+|||++.+...|+.++
T Consensus       225 ----------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  252 (440)
T PTZ00036        225 ----------------------------------------------------QRSVSYICSRFYRAPELMLGATNYTTHI  252 (440)
T ss_pred             ----------------------------------------------------CCcccCCCCcCccCHHHhcCCCCCCcHH
Confidence                                                                0011246789999999998877799999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC-CCHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLAVDVF  326 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~dLi  326 (562)
                      ||||+||++|||++|.+||.+.+..+++.++...+|.+..+.+..... ......++...+..+...++. .++.+++||
T Consensus       253 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li  331 (440)
T PTZ00036        253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP-NYADIKFPDVKPKDLKKVFPKGTPDDAINFI  331 (440)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch-hhhcccCCccCchhHHHHhccCCCHHHHHHH
Confidence            999999999999999999999999999999999999876654332211 000112333333333333332 467899999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      .+||++||.+|+|+.|+|+||||.++..
T Consensus       332 ~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        332 SQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            9999999999999999999999988654

>KOG0591|consensus

Probab=100.00  E-value=9.6e-41  Score=327.80  Aligned_cols=211  Identities=31%  Similarity=0.530  Sum_probs=158.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEE-EEEeCCE-EEEEeecCc-CCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHD-VIPVDFK-LFLVFEFLR-QDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~-~~~~~~~-i~lV~Ey~~-~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      .+....|+.+|++|+|||||++|+ .|.++.. ++||||||+ |||.++|+.   .+..+||..++.++.|++.||..||
T Consensus        62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH  141 (375)
T KOG0591|consen   62 RQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH  141 (375)
T ss_pred             HHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh
Confidence            445689999999999999999998 5655544 899999997 699999864   3345999999999999999999999


Q ss_pred             H--CC--ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         92 S--RR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        92 ~--~g--IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +  ..  |+||||||.||+++.+|.+||.|||+++                                             
T Consensus       142 ~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r---------------------------------------------  176 (375)
T KOG0591|consen  142 SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR---------------------------------------------  176 (375)
T ss_pred             ccccccceeeccCcchheEEcCCCceeeccchhHh---------------------------------------------
Confidence            7  22  5555555555555555555555555554                                             


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                    .+........+.||||+||+||++.+.+ |++++
T Consensus       177 ----------------------------------------------~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kS  209 (375)
T KOG0591|consen  177 ----------------------------------------------FLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKS  209 (375)
T ss_pred             ----------------------------------------------HhcchhHHHHhhcCCCcccCHHHHhcCC-CCcch
Confidence                                                          4443333345679999999999998776 99999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      ||||+||++|||+.-++||.|++-.+...+|.+.                    ++++....       ..+.+...+|.
T Consensus       210 DiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg--------------------d~~~~p~~-------~YS~~l~~li~  262 (375)
T KOG0591|consen  210 DIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG--------------------DYPPLPDE-------HYSTDLRELIN  262 (375)
T ss_pred             hHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC--------------------CCCCCcHH-------HhhhHHHHHHH
Confidence            9999999999999999999999766655555432                    11111101       11356778999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCC
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .|+..||+.||+.     +|++.++
T Consensus       263 ~ci~vd~~~RP~t-----~~~v~di  282 (375)
T KOG0591|consen  263 MCIAVDPEQRPDT-----VPYVQDI  282 (375)
T ss_pred             HHccCCcccCCCc-----chHHHHH
Confidence            9999999999986     5555443

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.6e-39  Score=325.76  Aligned_cols=239  Identities=46%  Similarity=0.835  Sum_probs=191.9

Q ss_pred             CchhhHHHHHHHHHcc---CCCCcceEEEEEEe-----CCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKEL---KHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l---~HpnIv~L~~~~~~-----~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~a   86 (562)
                      +......+|+.+++.+   +||||+++++++..     ...+|+||||++++|.+++.... ..+++..++.++.|++.|
T Consensus        43 ~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a  122 (290)
T cd07862          43 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG  122 (290)
T ss_pred             CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHH
Confidence            3345677898888776   69999999999852     45699999999999999987643 358999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++||+||||||+|||++.++.+||+|||+++.....                                       
T Consensus       123 L~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---------------------------------------  163 (290)
T cd07862         123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---------------------------------------  163 (290)
T ss_pred             HHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---------------------------------------
Confidence            99999999999999999999999999999999987533100                                       


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           .......||+.|+|||++.+.. ++.+
T Consensus       164 -----------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~  189 (290)
T cd07862         164 -----------------------------------------------------MALTSVVVTLWYRAPEVLLQSS-YATP  189 (290)
T ss_pred             -----------------------------------------------------cccccccccccccChHHHhCCC-CCCc
Confidence                                                                 0011235789999999997654 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|||++|++||.+.+..+.+..+++..+.+....|+.....+..  .+....+..+....+..++.+.+|+
T Consensus       190 ~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li  267 (290)
T cd07862         190 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ--AFHSKSAQPIEKFVTDIDELGKDLL  267 (290)
T ss_pred             cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccch--hccCCCCCCHHHHccCCCHHHHHHH
Confidence            99999999999999999999999999999999998888777666543322111  1111222334444555678899999


Q ss_pred             HHccccCCCCCCCHHHHHcCccc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      .+||+.||++|||+.|+|+||||
T Consensus       268 ~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         268 LKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHhccCchhcCCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-39  Score=327.50  Aligned_cols=242  Identities=38%  Similarity=0.741  Sum_probs=187.3

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+.+|+++++.++||||+++++++..++.+|+||||+++++.+.+......+++..++.++.|++.||.|||++||+
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~  122 (287)
T cd07848          43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV  122 (287)
T ss_pred             chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34567899999999999999999999999999999999999876666665555799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||+++.......                                               
T Consensus       123 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  155 (287)
T cd07848         123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-----------------------------------------------  155 (287)
T ss_pred             cCCCCHHHEEEcCCCcEEEeeccCccccccccc-----------------------------------------------
Confidence            999999999999999999999998754321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       156 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil  191 (287)
T cd07848         156 -------------------------------------------ANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCIL  191 (287)
T ss_pred             -------------------------------------------ccccccccccccCCcHHHcCCC-CCCchhHHhHHHHH
Confidence                                                       0011235789999999998765 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCc-cCCCCCCC-ccc-hhhhcCCCCHHHHHHHHHccccC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWR-PKK-FSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~-~~~~~~~~-~~~-~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |||++|++||.+.+..+.+..+.+..|..+.+.+......+.+ ....+... +.. ........+..+.||+++||++|
T Consensus       192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~  271 (287)
T cd07848         192 GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN  271 (287)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC
Confidence            9999999999999888888887777766543322211110100 00111110 000 11122334678999999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy10954        334 PKQRVSAKTILQHEYF  349 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f  349 (562)
                      |++|+|++|+|+||||
T Consensus       272 P~~R~s~~~~l~hp~f  287 (287)
T cd07848         272 PTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694|consensus

Probab=100.00  E-value=5.1e-40  Score=354.69  Aligned_cols=219  Identities=24%  Similarity=0.454  Sum_probs=183.4

Q ss_pred             CCchhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         15 EGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      +......+.|..|+... +||.++.|+..|++++++|+||||+.| |+..+++  ...|+|..+++|+..|+.||+|||+
T Consensus       409 ~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~  486 (694)
T KOG0694|consen  409 RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHE  486 (694)
T ss_pred             cccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHh
Confidence            34456688999999877 499999999999999999999999975 7444333  2369999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|||+||||.+|||+|.+|++||+||||++..-                                               
T Consensus       487 ~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-----------------------------------------------  519 (694)
T KOG0694|consen  487 NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-----------------------------------------------  519 (694)
T ss_pred             cCceeeecchhheEEcccCcEEecccccccccC-----------------------------------------------
Confidence            999999999999999999999999999876321                                               


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                  ....+.+++||||.|||||++.+.. |+.++|+||+
T Consensus       520 --------------------------------------------~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~l  554 (694)
T KOG0694|consen  520 --------------------------------------------GQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGL  554 (694)
T ss_pred             --------------------------------------------CCCCccccccCChhhcChhhhccCc-ccchhhHHHH
Confidence                                                        0122456889999999999998876 9999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||+||||+.|.+||.|+++.+.+..|+.--                  ..+|.|           .+.++++++++||..
T Consensus       555 GVLlyeML~Gq~PF~gddEee~FdsI~~d~------------------~~yP~~-----------ls~ea~~il~~ll~k  605 (694)
T KOG0694|consen  555 GVLLYEMLVGESPFPGDDEEEVFDSIVNDE------------------VRYPRF-----------LSKEAIAIMRRLLRK  605 (694)
T ss_pred             HHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------CCCCCc-----------ccHHHHHHHHHHhcc
Confidence            999999999999999999999998886420                  012222           246899999999999


Q ss_pred             CCCCCCCH-----HHHHcCccccCCcccC
Q psy10954        333 DPKQRVSA-----KTILQHEYFNQVEMVK  356 (562)
Q Consensus       333 DP~~R~Ta-----~elL~Hp~f~~~~~~~  356 (562)
                      ||++|+.+     .++.+||||+.++|..
T Consensus       606 ~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  606 NPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             CcccccCCCCCCchhhhhCCccccCCHHH
Confidence            99999975     7899999999998643

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-38  Score=325.85  Aligned_cols=245  Identities=47%  Similarity=0.878  Sum_probs=201.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .....+|+.+++.++||||+++++++..+...|+||||++++|.+++......+++..++.++.|++.||+|||++||+|
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H  127 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH  127 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            45678999999999999999999999999999999999999999998876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++.....+.                                                 
T Consensus       128 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------------  158 (301)
T cd07873         128 RDLKPQNLLINERGELKLADFGLARAKSIPT-------------------------------------------------  158 (301)
T ss_pred             CCCCHHHEEECCCCcEEECcCcchhccCCCC-------------------------------------------------
Confidence            9999999999999999999999875322100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+++.|+|||++.+...++.++||||+||++|
T Consensus       159 ------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~  196 (301)
T cd07873         159 ------------------------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY  196 (301)
T ss_pred             ------------------------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHH
Confidence                                                      00012245788999999987777899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCc-cCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++|++||.+.+..+++..+.+.++.+....|+.......+ ....+.+............++.++|||.+||+.||.+
T Consensus       197 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~  276 (301)
T cd07873         197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRK  276 (301)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCccc
Confidence            999999999999888888888999998888877654332221 1222333222222233345678999999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |+|++|+|+||||....
T Consensus       277 R~t~~eil~h~~f~~~~  293 (301)
T cd07873         277 RISAEEAMKHPYFHCLG  293 (301)
T ss_pred             CcCHHHHhcCccccccc
Confidence            99999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-38  Score=322.59  Aligned_cols=242  Identities=60%  Similarity=1.060  Sum_probs=202.9

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~--~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.+|+.+++.++||||+++++++..+...|+||||+.++|.+++....  ..+++..++.++.|++.||+|||++|
T Consensus        42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  121 (285)
T cd07861          42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR  121 (285)
T ss_pred             chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456789999999999999999999999999999999999989998886543  46899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||++.....+.                                              
T Consensus       122 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----------------------------------------------  155 (285)
T cd07861         122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----------------------------------------------  155 (285)
T ss_pred             eeecCCCHHHEEEcCCCcEEECcccceeecCCCc----------------------------------------------
Confidence            9999999999999999999999999875322100                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......+++.|+|||++.+...++.++|+||+||
T Consensus       156 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  190 (285)
T cd07861         156 ---------------------------------------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGT  190 (285)
T ss_pred             ---------------------------------------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHH
Confidence                                                         00112356788999999987666899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|++||.+.+..+.+..+.+.++.+....|+.......+...++.+....+.......++.+.+||++||+.||
T Consensus       191 il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  270 (285)
T cd07861         191 IFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDP  270 (285)
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCCh
Confidence            99999999999999998888888888888888887877666555555555554444444445567889999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy10954        335 KQRVSAKTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f  349 (562)
                      ++|||+.+++.||||
T Consensus       271 ~~Rpt~~~ll~~~~~  285 (285)
T cd07861         271 AKRISAKKALNHPYF  285 (285)
T ss_pred             hhCCCHHHHhcCCCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0585|consensus

Probab=100.00  E-value=6.9e-39  Score=332.93  Aligned_cols=221  Identities=28%  Similarity=0.472  Sum_probs=177.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      +...+||.||++++|||||+|+++..+.  +++|||+|||...-..+.......+++.+++.|++.++.||+|||.+|||
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii  232 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGII  232 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            5789999999999999999999998764  68999999998533334433322299999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||.|+||+.+|++||+|||.+-......                        ...                     
T Consensus       233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~------------------------~~~---------------------  267 (576)
T KOG0585|consen  233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGS------------------------DEG---------------------  267 (576)
T ss_pred             ccccchhheEEcCCCcEEeeccceeeecccCC------------------------ccc---------------------
Confidence            99999999999999999999999864332100                        000                     


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC---CCCCCchhhHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG---AKVYSTTVDIWSAG  253 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~---~~~y~~~~DIWSlG  253 (562)
                                                               ........+|||.|+|||.+.+   ...-+.+.||||+|
T Consensus       268 -----------------------------------------~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG  306 (576)
T KOG0585|consen  268 -----------------------------------------SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG  306 (576)
T ss_pred             -----------------------------------------cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence                                                     0001122588999999999877   33457889999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |+||.|+.|+.||.++.+.+...+|++.--                  .+|.         .+...+.++|||.+||++|
T Consensus       307 VTLYCllfG~~PF~~~~~~~l~~KIvn~pL------------------~fP~---------~pe~~e~~kDli~~lL~Kd  359 (576)
T KOG0585|consen  307 VTLYCLLFGQLPFFDDFELELFDKIVNDPL------------------EFPE---------NPEINEDLKDLIKRLLEKD  359 (576)
T ss_pred             hhHHHhhhccCCcccchHHHHHHHHhcCcc------------------cCCC---------cccccHHHHHHHHHHhhcC
Confidence            999999999999999999999888875311                  1111         1233578999999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy10954        334 PKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~  352 (562)
                      |.+|++..++..|||...-
T Consensus       360 P~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  360 PEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hhheeehhhheecceeccC
Confidence            9999999999999999764

>KOG0671|consensus

Probab=100.00  E-value=1.3e-39  Score=331.40  Aligned_cols=263  Identities=29%  Similarity=0.494  Sum_probs=204.9

Q ss_pred             CCchhhHHHHHHHHHccCC--CC----cceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHH
Q psy10954         15 EGVPSTALREISVLKELKH--PN----VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~H--pn----Iv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL   87 (562)
                      +...++++-|+++|++|++  |+    +|.+.++|.-.+++|||+|.++.++++++.+++ .++|-.+++.+.+|+++++
T Consensus       126 ~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv  205 (415)
T KOG0671|consen  126 DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESV  205 (415)
T ss_pred             HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence            3456678899999999943  43    789999999999999999999999999998755 4699999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +|||+.+++|.||||||||+......+.-+-+..                                              
T Consensus       206 ~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~----------------------------------------------  239 (415)
T KOG0671|consen  206 AFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK----------------------------------------------  239 (415)
T ss_pred             HHHHhcceeecCCChheEEEeccceEEEeccCCc----------------------------------------------
Confidence            9999999999999999999987666554332210                                              


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                          ++++++     .++-.||++|||.|......   .++.|.|+.||||||++|.+ |+.++
T Consensus       240 --------------------~~~~r~-----~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLG-wS~pC  290 (415)
T KOG0671|consen  240 --------------------VCFIRP-----LKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLG-WSQPC  290 (415)
T ss_pred             --------------------cceecc-----CCCcceEEEecCCcceeccC---cceeeeccccCCchheeccC-cCCcc
Confidence                                122222     13457999999998764432   36778999999999999987 99999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCC--------------ccchhh
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR--------------PKKFSE  313 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~  313 (562)
                      ||||+||||+|+++|..+|++.++.++|..+.+.+|+.+..+........++....-.|.              ++.+..
T Consensus       291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~  370 (415)
T KOG0671|consen  291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK  370 (415)
T ss_pred             CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence            999999999999999999999999999999999999877765544322222211111111              122222


Q ss_pred             hcCCCC---HHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        314 ILNLPD---PLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       314 ~l~~~~---~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .....+   ..+.||+++||.+||.+|+|+.|+|+||||+..
T Consensus       371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  371 YMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence            222222   346899999999999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-38  Score=338.69  Aligned_cols=242  Identities=28%  Similarity=0.379  Sum_probs=184.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+.+|+++|++++|||||+++++|..+...|+|||++.++|.+++.... .+++..++.++.|++.||.|||++||||
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvH  205 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIH  205 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            345789999999999999999999999999999999999999999887643 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+|+......                                                 
T Consensus       206 rDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-------------------------------------------------  236 (391)
T PHA03212        206 RDIKAENIFINHPGDVCLGDFGAACFPVDIN-------------------------------------------------  236 (391)
T ss_pred             CCCChHhEEEcCCCCEEEEeCCccccccccc-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                               .......+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       237 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~  274 (391)
T PHA03212        237 -----------------------------------------ANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLF  274 (391)
T ss_pred             -----------------------------------------ccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHH
Confidence                                                     00012346899999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCC-------HHHHHHHHHHhcCCCCCCCCCCCC-CCC-Ccc------CCCCCCCccchhhhcCCCCHHH
Q psy10954        258 EMITKKTLFAGDS-------EIDQLFRIFRTLGTPHEDVWPGVS-KLP-IYK------TDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       258 eLltG~~pF~~~~-------~~~~l~~i~~~lg~~~~~~~~~~~-~~~-~~~------~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      ||++|..||.+..       ...++..++..+|.++.+...... ... .+.      ...+..++ .+. .+...+..+
T Consensus       275 elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l  352 (391)
T PHA03212        275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP-LWT-NLYELPIDL  352 (391)
T ss_pred             HHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCC-CHH-HHhhhhhhH
Confidence            9999998875432       345777888888876654321110 000 000      00000000 011 111224568


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+||.+||++||++||||+|+|+||||+++.
T Consensus       353 ~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        353 EYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            8999999999999999999999999998864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.3e-38  Score=324.72  Aligned_cols=244  Identities=39%  Similarity=0.787  Sum_probs=186.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQDLKDFLQTT--------PVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~~L~~~i~~~--------~~~l~e~~i~~i~~qll~aL   87 (562)
                      ...+.+|+++|+.++||||+++++++..  +..+|+||||++++|.+++...        ...+++..++.++.|++.||
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  121 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI  121 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence            4467899999999999999999999854  5678999999999998887532        12488999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEE----ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         88 RYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl----~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      .|||++||+||||||+|||+    +.++.+||+|||+++.......                                  
T Consensus       122 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~----------------------------------  167 (317)
T cd07867         122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK----------------------------------  167 (317)
T ss_pred             HHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc----------------------------------
Confidence            99999999999999999999    4456788999988764421100                                  


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                            ........+||+.|+|||++.+...+
T Consensus       168 ------------------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~  193 (317)
T cd07867         168 ------------------------------------------------------PLADLDPVVVTFWYRAPELLLGARHY  193 (317)
T ss_pred             ------------------------------------------------------cccccCcceecccccCcHHhcCCCcc
Confidence                                                                  00001234678999999999887778


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCC-----CCcc
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE-----WRPK  309 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-----~~~~  309 (562)
                      +.++||||+||++|||++|++||.+..+         ..++.+++..+|.+..+.|......+.+......     ....
T Consensus       194 ~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (317)
T cd07867         194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANS  273 (317)
T ss_pred             CcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCc
Confidence            9999999999999999999999976542         3567788888898888777665443322111000     0000


Q ss_pred             ch----hhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q psy10954        310 KF----SEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       310 ~~----~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      ..    .......+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       274 ~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         274 SLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            01    11112245678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0597|consensus

Probab=100.00  E-value=1.6e-39  Score=342.60  Aligned_cols=213  Identities=31%  Similarity=0.529  Sum_probs=180.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      -+...+|++|++.++|||||+++++|++..++|+|.|||.++|+.++... +.+||+.++.+.+|++.||.|||+++|+|
T Consensus        45 l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilh  123 (808)
T KOG0597|consen   45 LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILH  123 (808)
T ss_pred             HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            34588999999999999999999999999999999999999999999764 47999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      ||+||.|||++..|++|+||||+|+..+..                                                  
T Consensus       124 rd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--------------------------------------------------  153 (808)
T KOG0597|consen  124 RDMKPQNILLEKGGTLKLCDFGLARAMSTN--------------------------------------------------  153 (808)
T ss_pred             ccCCcceeeecCCCceeechhhhhhhcccC--------------------------------------------------
Confidence            999999999999999999999998865321                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                               ....+..-|||.|||||++.+.. |+..+|.||+|||+|
T Consensus       154 -----------------------------------------t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilY  191 (808)
T KOG0597|consen  154 -----------------------------------------TSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILY  191 (808)
T ss_pred             -----------------------------------------ceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHH
Confidence                                                     00012346899999999998654 999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||+.|++||+..+-.+....|..-                     ...|.        ...++.+++|+..+|.+||.+|
T Consensus       192 E~~~G~PPF~a~si~~Lv~~I~~d---------------------~v~~p--------~~~S~~f~nfl~gLL~kdP~~R  242 (808)
T KOG0597|consen  192 ELYVGQPPFYARSITQLVKSILKD---------------------PVKPP--------STASSSFVNFLQGLLIKDPAQR  242 (808)
T ss_pred             HHhcCCCCchHHHHHHHHHHHhcC---------------------CCCCc--------ccccHHHHHHHHHHhhcChhhc
Confidence            999999999987655554444321                     11111        1235689999999999999999


Q ss_pred             CCHHHHHcCccccCC
Q psy10954        338 VSAKTILQHEYFNQV  352 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~  352 (562)
                      +|..+++.|||++..
T Consensus       243 ltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  243 LTWTDLLGHPFWKGK  257 (808)
T ss_pred             ccHHHHhcChHHhhh
Confidence            999999999999863

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-38  Score=357.10  Aligned_cols=143  Identities=29%  Similarity=0.358  Sum_probs=118.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++.....+||||||+. ++|.+++.... .+++..++.++.||+.||+|||++||||
T Consensus        49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiH  127 (669)
T cd05610          49 HQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIH  127 (669)
T ss_pred             HHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence            567889999999999999999999999999999999996 59999987643 5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      |||||+|||++.++.+||+|||+++.............+|+.|++||.......-...+++|++|
T Consensus       128 rDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g  192 (669)
T cd05610         128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLG  192 (669)
T ss_pred             CCccHHHEEEcCCCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeeeeeecC
Confidence            99999999999999999999999987654333344556788888887654333223344555555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0582|consensus

Probab=100.00  E-value=2.4e-38  Score=327.17  Aligned_cols=229  Identities=26%  Similarity=0.433  Sum_probs=184.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+..|+.++||||++++..|..+..+|+||.||. |++.+++... ...++|..++.++++++.||.|||++|-|
T Consensus        69 d~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~I  148 (516)
T KOG0582|consen   69 DALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHI  148 (516)
T ss_pred             HHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCce
Confidence            457899999999999999999999999999999999997 5999988753 34599999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||||+.||||+.+|.|||+|||.+..+...                                                 
T Consensus       149 HRdvKAgnILi~~dG~VkLadFgvsa~l~~~-------------------------------------------------  179 (516)
T KOG0582|consen  149 HRDVKAGNILIDSDGTVKLADFGVSASLFDS-------------------------------------------------  179 (516)
T ss_pred             ecccccccEEEcCCCcEEEcCceeeeeeccc-------------------------------------------------
Confidence            9999999999999999999999975433211                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhh-hcCCCCCCchhhHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI-LLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEv-l~~~~~y~~~~DIWSlG~i  255 (562)
                                               |.=...+             ..+++||++|||||+ .....+|++|+||||+|++
T Consensus       180 -------------------------G~R~~~r-------------f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGIT  221 (516)
T KOG0582|consen  180 -------------------------GDRQVTR-------------FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGIT  221 (516)
T ss_pred             -------------------------CceeeEe-------------eccccCcccccChHHhhhcccCccchhhhhhhhHH
Confidence                                     0000111             146799999999999 5566779999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ..||++|..||..-.....|...++  |.|+.-. .+..+         .       +.....+..++.++..||+.||.
T Consensus       222 A~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~-t~~~~---------~-------d~~k~~~ksf~e~i~~CL~kDP~  282 (516)
T KOG0582|consen  222 ACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL-TSGLD---------K-------DEDKKFSKSFREMIALCLVKDPS  282 (516)
T ss_pred             HHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc-cccCC---------h-------HHhhhhcHHHHHHHHHHhhcCcc
Confidence            9999999999999888877765543  2332111 00000         0       01112234789999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||||.++|+|+||+...
T Consensus       283 kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  283 KRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             cCCCHHHHhccHHHhhcc
Confidence            999999999999999865

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.4e-38  Score=317.41  Aligned_cols=239  Identities=43%  Similarity=0.810  Sum_probs=191.2

Q ss_pred             CchhhHHHHHHHHHcc---CCCCcceEEEEEEe-----CCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKEL---KHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l---~HpnIv~L~~~~~~-----~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~a   86 (562)
                      +......+|+++++.+   +||||+++++++..     ...+++||||+.++|.+++.... ..+++..++.++.|++.|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~a  120 (288)
T cd07863          41 GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG  120 (288)
T ss_pred             CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            3345567888888766   79999999999864     35689999999999999887643 348999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |+|||++||+||||||+|||++.++.+||+|||+++......                                      
T Consensus       121 l~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~--------------------------------------  162 (288)
T cd07863         121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--------------------------------------  162 (288)
T ss_pred             HHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcc--------------------------------------
Confidence            999999999999999999999999999999999875332100                                      


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                            .....+||+.|+|||++.+.. ++.+
T Consensus       163 ------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~  187 (288)
T cd07863         163 ------------------------------------------------------ALTPVVVTLWYRAPEVLLQST-YATP  187 (288)
T ss_pred             ------------------------------------------------------cCCCccccccccCchHhhCCC-CCCc
Confidence                                                                  001235688999999997654 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|+|++|++||.+.+..+.+.++....+.+....|+.....+.  ..+....+.......+..+..+.||+
T Consensus       188 ~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li  265 (288)
T cd07863         188 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR--GAFSPRGPRPVQSVVPEIEESGAQLL  265 (288)
T ss_pred             chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc--cccCCCCCCchHHhCcCcCHHHHHHH
Confidence            9999999999999999999999999889999999888877766654322211  11222223334444555677899999


Q ss_pred             HHccccCCCCCCCHHHHHcCccc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      .+||+.||++|+|+.|+++||||
T Consensus       266 ~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         266 LEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4717|consensus

Probab=100.00  E-value=1.1e-38  Score=332.58  Aligned_cols=243  Identities=30%  Similarity=0.500  Sum_probs=197.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..++.|+..|+-++|||||+||++..+..++|||+|+-.+ ||+++|.++...+.|..++.|+.||+.|+.|||+..|||
T Consensus        62 ~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVH  141 (864)
T KOG4717|consen   62 GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVH  141 (864)
T ss_pred             hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhc
Confidence            4578999999999999999999999999999999999875 999999998888999999999999999999999999999


Q ss_pred             ccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         98 RDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        98 RDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||||||+..- .-|-|||.|||++..+.                                                   
T Consensus       142 RDLKPENVVFFEKlGlVKLTDFGFSNkf~---------------------------------------------------  170 (864)
T KOG4717|consen  142 RDLKPENVVFFEKLGLVKLTDFGFSNKFQ---------------------------------------------------  170 (864)
T ss_pred             ccCCcceeEEeeecCceEeeeccccccCC---------------------------------------------------
Confidence            99999999653 44666666666653331                                                   


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                               +....++.||++.|-|||+|+|..+..+++|||||||||
T Consensus       171 -----------------------------------------PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVIL  209 (864)
T KOG4717|consen  171 -----------------------------------------PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVIL  209 (864)
T ss_pred             -----------------------------------------CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHH
Confidence                                                     233456779999999999999988667789999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |-|++|++||...++.+.+..|+..--+.                             -...+.+++|||..||+.||++
T Consensus       210 yMLVCGq~PFqeANDSETLTmImDCKYtv-----------------------------PshvS~eCrdLI~sMLvRdPkk  260 (864)
T KOG4717|consen  210 YMLVCGQPPFQEANDSETLTMIMDCKYTV-----------------------------PSHVSKECRDLIQSMLVRDPKK  260 (864)
T ss_pred             HHHHhCCCccccccchhhhhhhhcccccC-----------------------------chhhhHHHHHHHHHHHhcCchh
Confidence            99999999999999999998887531110                             1123468999999999999999


Q ss_pred             CCCHHHHHcCccccCCcccCCccccCCCCCCCCCCCCCchHHHHHHHH
Q psy10954        337 RVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIK  384 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (562)
                      |.|.+|+..|+|++.++....+  ..|-..+..-+-.+...+|.++..
T Consensus       261 RAslEeI~s~~Wlq~~D~~~sT--~iPLvsr~~L~ee~Ha~IIq~Mv~  306 (864)
T KOG4717|consen  261 RASLEEIVSTSWLQAGDRGLST--AIPLVSRHHLPEEAHATIIQQMVA  306 (864)
T ss_pred             hccHHHHhccccccCCCCCccc--cCceeehhhCChHHHHHHHHHHhc
Confidence            9999999999999987643322  244444444445555666666644

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.9e-38  Score=319.70  Aligned_cols=240  Identities=53%  Similarity=0.967  Sum_probs=193.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+.+|++++++++||||+++++++......|+|+||++++|.+++......+++..++.++.|++.||.|||++||+|
T Consensus        43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H  122 (284)
T cd07839          43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH  122 (284)
T ss_pred             ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            45577899999999999999999999999999999999999999988776667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++......                                                 
T Consensus       123 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------------  153 (284)
T cd07839         123 RDLKPQNLLINKNGELKLADFGLARAFGIPV-------------------------------------------------  153 (284)
T ss_pred             CCCCHHHEEEcCCCcEEECccchhhccCCCC-------------------------------------------------
Confidence            9999999999999999999999875332100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+|+.|+|||++.+...++.++||||+||++|
T Consensus       154 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  191 (284)
T cd07839         154 ------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA  191 (284)
T ss_pred             ------------------------------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHH
Confidence                                                      00112356788999999988777899999999999999


Q ss_pred             HHHhCCCC-CCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCc-cchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        258 EMITKKTL-FAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP-KKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       258 eLltG~~p-F~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|++|..| |.+.+..+.+..+.+.++.+....|+.....+.+. .++.... ..+....+..++.+.||+.+||+.||.
T Consensus       192 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  270 (284)
T cd07839         192 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK-PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV  270 (284)
T ss_pred             HHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc-ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChh
Confidence            99998877 56666677788888888887777666554433321 1111111 112233444578899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||++|+++||||
T Consensus       271 ~R~t~~~il~h~~f  284 (284)
T cd07839         271 QRISAEEALQHPYF  284 (284)
T ss_pred             hcCCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-38  Score=336.25  Aligned_cols=243  Identities=35%  Similarity=0.635  Sum_probs=192.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCC-----EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-----~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+++|+.++||||+++++++....     .+|+||||+.++|.+++... ..+++..++.+++|++.||.|||++
T Consensus        44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~  122 (372)
T cd07853          44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSA  122 (372)
T ss_pred             HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            46789999999999999999999998776     89999999999999888654 3699999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++......                                             
T Consensus       123 ~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~---------------------------------------------  157 (372)
T cd07853         123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE---------------------------------------------  157 (372)
T ss_pred             CeeCCCCChHHEEECCCCCEEeccccceeecccCc---------------------------------------------
Confidence            99999999999999999999999999875431100                                             


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                   .......++|+.|+|||++.+...|+.++||||+|
T Consensus       158 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  192 (372)
T cd07853         158 ---------------------------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG  192 (372)
T ss_pred             ---------------------------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHH
Confidence                                                         00011235789999999998877789999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchh---hhcCCCCHHHHHHHHHc
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFS---EILNLPDPLAVDVFSKI  329 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~l~~~~~~~~dLi~~m  329 (562)
                      |++|||++|++||.+.+..+++..+.+.+|.+..+.+..... ...+....+. .+....   ......++.+.+||.+|
T Consensus       193 ~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~m  271 (372)
T cd07853         193 CIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRM  271 (372)
T ss_pred             HHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHh
Confidence            999999999999999999999999999888776543321110 0000000000 000111   11223467899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |+.||++|+|+.|+|+||||.+..
T Consensus       272 L~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         272 LVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             CCCChhhCcCHHHHhcCHhhCCCc
Confidence            999999999999999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-38  Score=328.94  Aligned_cols=239  Identities=39%  Similarity=0.686  Sum_probs=191.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..+.+|+.+|+.++||||++++++|...      ...|++||+++++|.+++..  ..+++..++.++.|++.||.|||+
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~  136 (343)
T cd07878          59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS  136 (343)
T ss_pred             HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999988643      45799999998899888764  359999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+|||++.++.+||+|||+++....                                              
T Consensus       137 ~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----------------------------------------------  170 (343)
T cd07878         137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----------------------------------------------  170 (343)
T ss_pred             CCeecccCChhhEEECCCCCEEEcCCccceecCC----------------------------------------------
Confidence            9999999999999999999999999998653210                                              


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                      .....+||+.|+|||++.+...++.++||||+
T Consensus       171 ------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  202 (343)
T cd07878         171 ------------------------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  202 (343)
T ss_pred             ------------------------------------------------CcCCccccccccCchHhcCCccCCchhhhHhH
Confidence                                                            00123578899999999876668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|+|++|+.||.+.+..+.+..+.+..|.+..+.+..+...  ..+....+......+...+...++.+.||+.+||
T Consensus       203 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL  282 (343)
T cd07878         203 GCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKML  282 (343)
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHc
Confidence            99999999999999998888888888888777665443322210  0111122222233344445556778999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +.||++|+|+.|+|+||||....
T Consensus       283 ~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         283 VLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             CCChhhCCCHHHHhcCcchhccC
Confidence            99999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-37  Score=328.32  Aligned_cols=239  Identities=36%  Similarity=0.596  Sum_probs=186.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+++.++||||+++++++...      ..+|+||||++++|.+.+..   .+++..++.++.|++.||.|||
T Consensus        67 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH  143 (364)
T cd07875          67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  143 (364)
T ss_pred             HHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh
Confidence            45678999999999999999999988643      36899999999999888754   4889999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++.....                                            
T Consensus       144 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--------------------------------------------  179 (364)
T cd07875         144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------------------------------------  179 (364)
T ss_pred             hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--------------------------------------------
Confidence            999999999999999999999999999987532100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+.. ++.++||||
T Consensus       180 ------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwS  210 (364)
T cd07875         180 ------------------------------------------------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWS  210 (364)
T ss_pred             ------------------------------------------------CcccCCcccCCcCCHHHHhCCC-CCchhhHHh
Confidence                                                            0001236789999999998754 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCCccchh------------hhcCCC
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWRPKKFS------------EILNLP  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------------~~l~~~  318 (562)
                      +||++|+|++|+.||.+.+..+.+..++..+|.+..+.+...... ..+..+.+......+.            ......
T Consensus       211 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (364)
T cd07875         211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK  290 (364)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccc
Confidence            999999999999999999999999999888887765443322210 0001111111000000            011123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +..++|||.+||+.||++|||+.|+|+||||...
T Consensus       291 ~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         291 ASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             cHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            4678999999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0659|consensus

Probab=100.00  E-value=4e-39  Score=314.51  Aligned_cols=102  Identities=29%  Similarity=0.567  Sum_probs=94.8

Q ss_pred             ccccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhh
Q psy10954        412 SQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHE  491 (562)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (562)
                      .|||-|+||+++|+.+||                                               -.+|.||.||| |||
T Consensus       163 ~TRWYRAPELLfGsr~Yg-----------------------------------------------~~VDmWavGCI-~AE  194 (318)
T KOG0659|consen  163 VTRWYRAPELLFGSRQYG-----------------------------------------------TGVDMWAVGCI-FAE  194 (318)
T ss_pred             eeeeccChHHhccchhcC-----------------------------------------------CcchhhhHHHH-HHH
Confidence            479999999999999999                                               77999999999 999


Q ss_pred             cccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHHHHhcC
Q psy10954        492 SITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                      ++-+.|+|||+||||||.+|||+||||++++||.++.||||.+ |-++++.....+++.....+.|++++|
T Consensus       195 Lllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m  264 (318)
T KOG0659|consen  195 LLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK-IQQFPKPPLNNLFPAASSDALDLLSKM  264 (318)
T ss_pred             HHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH-HhcCCCCccccccccccHHHHHHHHhh
Confidence            9999999999999999999999999999999999999999987 556666677779999999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.8e-38  Score=324.93  Aligned_cols=214  Identities=27%  Similarity=0.414  Sum_probs=176.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ....+|+.+|+.++||||++++++|..++.+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+|
T Consensus        40 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH  118 (323)
T cd05571          40 AHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVY  118 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            4567899999999999999999999999999999999975 898888764 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       119 rDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-------------------------------------------------  149 (323)
T cd05571         119 RDLKLENLMLDKDGHIKITDFGLCKEGISDG-------------------------------------------------  149 (323)
T ss_pred             CCCCHHHEEECCCCCEEEeeCCCCcccccCC-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       150 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~  186 (323)
T cd05571         150 ------------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMY  186 (323)
T ss_pred             ------------------------------------------CcccceecCccccChhhhcCCC-CCccccCcccchhhh
Confidence                                                      0011346899999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||.+.+.......+....  .                .+           -...++.+.+||.+||+.||++|
T Consensus       187 elltg~~Pf~~~~~~~~~~~~~~~~--~----------------~~-----------p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         187 EMMCGRLPFYNQDHEKLFELILMEE--I----------------RF-----------PRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHcCC--C----------------CC-----------CCCCCHHHHHHHHHHccCCHHHc
Confidence            9999999999877655544443210  0                00           01235678999999999999999


Q ss_pred             C-----CHHHHHcCccccCCcc
Q psy10954        338 V-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~-----Ta~elL~Hp~f~~~~~  354 (562)
                      +     ++.++++||||.++.+
T Consensus       238 ~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         238 LGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCCCCH
Confidence            9     8999999999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-37  Score=315.05  Aligned_cols=242  Identities=63%  Similarity=1.123  Sum_probs=206.0

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|++++++++||||+++++++..++..|+||||+.++|.+++.... ..+++..++.++.|++.||+|||++|+
T Consensus        42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (284)
T cd07860          42 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV  121 (284)
T ss_pred             cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3456789999999999999999999999999999999999889998886543 458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++........                                              
T Consensus       122 ~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------  155 (284)
T cd07860         122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR----------------------------------------------  155 (284)
T ss_pred             ecCCCCHHHEEECCCCCEEEeeccchhhcccCcc----------------------------------------------
Confidence            9999999999999999999999998754321100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+++.|+|||++.+...++.++||||+||+
T Consensus       156 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i  190 (284)
T cd07860         156 ---------------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI  190 (284)
T ss_pred             ---------------------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHH
Confidence                                                         00112357789999988776667889999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.++.+.+.++.+..+.+....|+.....+.+...++.+....+.......++.+.++|.+||+.||+
T Consensus       191 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  270 (284)
T cd07860         191 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN  270 (284)
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcc
Confidence            99999999999999998899999999998888888776666666666777766666666666678899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||++++++||||
T Consensus       271 ~Rpt~~~~l~~~~f  284 (284)
T cd07860         271 KRISAKAALAHPFF  284 (284)
T ss_pred             cCCCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-37  Score=325.53  Aligned_cols=239  Identities=35%  Similarity=0.614  Sum_probs=184.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+++.++||||++++++|...      ..+|+||||++++|.+.+..   .+++..+..++.|++.||.|||
T Consensus        64 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH  140 (359)
T cd07876          64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH  140 (359)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999998654      35799999999998887753   4889999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++.....                                            
T Consensus       141 ~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------  176 (359)
T cd07876         141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------------------------------------  176 (359)
T ss_pred             hCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--------------------------------------------
Confidence            999999999999999999999999999987532100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      .......||+.|+|||++.+.. |+.++||||
T Consensus       177 ------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwS  207 (359)
T cd07876         177 ------------------------------------------------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWS  207 (359)
T ss_pred             ------------------------------------------------ccCCCCcccCCCCCchhccCCC-CCcchhhHH
Confidence                                                            0011235788999999997754 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--------CCC-----ccCCCCCCCccchhhhcCCC
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--------LPI-----YKTDFPEWRPKKFSEILNLP  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--------~~~-----~~~~~~~~~~~~~~~~l~~~  318 (562)
                      +||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+.....        .+.     +...++.|.-..........
T Consensus       208 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (359)
T cd07876         208 VGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLK  287 (359)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccccccccccc
Confidence            99999999999999999988888888888888766433221110        000     00111111111011111223


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++.+.+||.+||++||++|+|+.|+|+||||...
T Consensus       288 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         288 TSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             chhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            5678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.7e-37  Score=311.94  Aligned_cols=246  Identities=58%  Similarity=1.104  Sum_probs=204.3

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|++++++++||||+++++++..+...|+||||++++|.+.+..... .+++..++.++.|++.||+|||++||
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  123 (294)
T PLN00009         44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV  123 (294)
T ss_pred             chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567899999999999999999999999999999999999899888765432 36888999999999999999999999


Q ss_pred             eeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         96 IHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        96 iHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      +||||||+||+++. ++.+||+|||++......                                               
T Consensus       124 ~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-----------------------------------------------  156 (294)
T PLN00009        124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-----------------------------------------------  156 (294)
T ss_pred             eCCCCCcceEEEECCCCEEEEcccccccccCCC-----------------------------------------------
Confidence            99999999999985 456899999987533210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .......++++.|+|||++.+...++.++||||+||
T Consensus       157 --------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~  192 (294)
T PLN00009        157 --------------------------------------------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGC  192 (294)
T ss_pred             --------------------------------------------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHH
Confidence                                                        000112356788999999877666899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|.+||.+.+..+.+.+++...+.+....|......+.+....+.+............++.+.+++.+||+.||
T Consensus       193 i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P  272 (294)
T PLN00009        193 IFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDP  272 (294)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCCh
Confidence            99999999999999988888999999999998888887777666655555555444443444557789999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++||++.++++||||.+++
T Consensus       273 ~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        273 SKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhCcCHHHHhcCchHhHHh
Confidence            9999999999999998865

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-37  Score=325.56  Aligned_cols=213  Identities=25%  Similarity=0.441  Sum_probs=177.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++..+..+|+||||+. ++|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        75 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  153 (340)
T PTZ00426         75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIV  153 (340)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3456789999999999999999999999999999999997 58999987654 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.....                                                 
T Consensus       154 HrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-------------------------------------------------  184 (340)
T PTZ00426        154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-------------------------------------------------  184 (340)
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCCeecCCC-------------------------------------------------
Confidence            9999999999999999999999986532100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                   ..+.+||+.|+|||++.+.. ++.++||||+||++
T Consensus       185 ---------------------------------------------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  218 (340)
T PTZ00426        185 ---------------------------------------------TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFI  218 (340)
T ss_pred             ---------------------------------------------cceecCChhhcCHHHHhCCC-CCccccccchhhHH
Confidence                                                         01235789999999997654 79999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+.......+......                  ++           ...++.+.+++++||+.||++
T Consensus       219 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~~l~~dp~~  269 (340)
T PTZ00426        219 YEILVGCPPFYANEPLLIYQKILEGIIY------------------FP-----------KFLDNNCKHLMKKLLSHDLTK  269 (340)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHhcCCCC------------------CC-----------CCCCHHHHHHHHHHcccCHHH
Confidence            9999999999988776655555431100                  00           112467899999999999999


Q ss_pred             CC-----CHHHHHcCccccCCccc
Q psy10954        337 RV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      |+     |++++++||||+++++.
T Consensus       270 R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        270 RYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             cCCCCCCCHHHHHcCCCcCCCCHH
Confidence            96     89999999999987643

>KOG0611|consensus

Probab=100.00  E-value=3.7e-38  Score=321.31  Aligned_cols=209  Identities=26%  Similarity=0.487  Sum_probs=181.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      -.+.|||+||..|+||||+.+|++|+..+++.|||||.. ++|++++...+ .|+|..++.|++||+.|+.|||.++|+|
T Consensus        98 vhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvH  176 (668)
T KOG0611|consen   98 VHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVH  176 (668)
T ss_pred             HHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcccee
Confidence            457899999999999999999999999999999999997 59999997654 7999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      ||||.+|||++.++.+||+|||++..+..                                                   
T Consensus       177 RDLKLENILLD~N~NiKIADFGLSNly~~---------------------------------------------------  205 (668)
T KOG0611|consen  177 RDLKLENILLDQNNNIKIADFGLSNLYAD---------------------------------------------------  205 (668)
T ss_pred             cccchhheeecCCCCeeeeccchhhhhcc---------------------------------------------------
Confidence            99999999999999999999998754321                                                   


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                               .+...++||+|-|.+||++.|.++-++.+|.|||||+||
T Consensus       206 -----------------------------------------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLY  244 (668)
T KOG0611|consen  206 -----------------------------------------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLY  244 (668)
T ss_pred             -----------------------------------------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHH
Confidence                                                     011246799999999999999998899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      .|+.|..||.|.+......+|.+.-                    +.          -+..+.++..||+.||..||++|
T Consensus       245 tLVyGtMPFDG~Dhk~lvrQIs~Ga--------------------Yr----------EP~~PSdA~gLIRwmLmVNP~RR  294 (668)
T KOG0611|consen  245 TLVYGTMPFDGRDHKRLVRQISRGA--------------------YR----------EPETPSDASGLIRWMLMVNPERR  294 (668)
T ss_pred             HHhhcccccCCchHHHHHHHhhccc--------------------cc----------CCCCCchHHHHHHHHHhcCcccc
Confidence            9999999999998877777764321                    00          01234578899999999999999


Q ss_pred             CCHHHHHcCcccc
Q psy10954        338 VSAKTILQHEYFN  350 (562)
Q Consensus       338 ~Ta~elL~Hp~f~  350 (562)
                      .|..++-.|=|++
T Consensus       295 ATieDiAsHWWvN  307 (668)
T KOG0611|consen  295 ATIEDIASHWWVN  307 (668)
T ss_pred             hhHHHHhhhheee
Confidence            9999999997774

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=317.73  Aligned_cols=211  Identities=28%  Similarity=0.456  Sum_probs=176.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++.+...+|+||||+.+ +|.+++...+ .+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H  124 (291)
T cd05612          46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVY  124 (291)
T ss_pred             HHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            4567899999999999999999999999999999999974 8999987654 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.....                                                  
T Consensus       125 ~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--------------------------------------------------  154 (291)
T cd05612         125 RDLKPENILLDKEGHIKLTDFGFAKKLRDR--------------------------------------------------  154 (291)
T ss_pred             cCCCHHHeEECCCCCEEEEecCcchhccCC--------------------------------------------------
Confidence            999999999999999999999986432100                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                  ....+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       155 --------------------------------------------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~  189 (291)
T cd05612         155 --------------------------------------------TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIY  189 (291)
T ss_pred             --------------------------------------------cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHH
Confidence                                                        01235788999999987654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+..+....+....  .                .+           ....++.+++|+++||+.||.+|
T Consensus       190 ~l~~g~~pf~~~~~~~~~~~i~~~~--~----------------~~-----------~~~~~~~~~~li~~~l~~dp~~R  240 (291)
T cd05612         190 EMLVGYPPFFDDNPFGIYEKILAGK--L----------------EF-----------PRHLDLYAKDLIKKLLVVDRTRR  240 (291)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHhCC--c----------------CC-----------CccCCHHHHHHHHHHcCCCHHHc
Confidence            9999999999887766555554310  0                00           01125678999999999999999


Q ss_pred             CC-----HHHHHcCccccCCcc
Q psy10954        338 VS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~T-----a~elL~Hp~f~~~~~  354 (562)
                      ++     ++|+++||||..+++
T Consensus       241 ~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         241 LGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             cCCccCCHHHHhcCccccCCCH
Confidence            95     999999999988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594|consensus

Probab=100.00  E-value=4.1e-39  Score=327.00  Aligned_cols=103  Identities=48%  Similarity=0.797  Sum_probs=98.5

Q ss_pred             ccccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhh
Q psy10954        412 SQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHE  491 (562)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (562)
                      .|-|.|+||+|++++.|.                                               -+.|.||+||+ |+|
T Consensus       182 vTlWYRaPEvLlGs~~Ys-----------------------------------------------~~vDiWs~GcI-faE  213 (323)
T KOG0594|consen  182 VTLWYRAPEVLLGSTSYS-----------------------------------------------TSVDIWSLGCI-FAE  213 (323)
T ss_pred             EEeeccCHHHhcCCCcCC-----------------------------------------------CCcchHhHHHH-HHH
Confidence            356899999999999999                                               78999999999 999


Q ss_pred             cccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCccc-CccccccCCCCChhHHHHHhcC
Q psy10954        492 SITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                      +++++|||||+||+|||+|||++||||+|+.|||++++|+|+..||.|. |+.++.+++..++.|+|++++|
T Consensus       214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~  285 (323)
T KOG0594|consen  214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKL  285 (323)
T ss_pred             HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHH
Confidence            9999999999999999999999999999999999999999999999999 9999999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-37  Score=322.74  Aligned_cols=211  Identities=27%  Similarity=0.459  Sum_probs=175.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++||||+++++++..++.+|+||||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+|
T Consensus        63 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  141 (329)
T PTZ00263         63 QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIY  141 (329)
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            4577999999999999999999999999999999999975 899988764 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.....                                                  
T Consensus       142 ~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------------------------------------------------  171 (329)
T PTZ00263        142 RDLKPENLLLDNKGHVKVTDFGFAKKVPDR--------------------------------------------------  171 (329)
T ss_pred             cCCCHHHEEECCCCCEEEeeccCceEcCCC--------------------------------------------------
Confidence            999999999999999999999987532100                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                  ....+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       172 --------------------------------------------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~  206 (329)
T PTZ00263        172 --------------------------------------------TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLY  206 (329)
T ss_pred             --------------------------------------------cceecCChhhcCHHHHcCCC-CCCcceeechHHHHH
Confidence                                                        01235788999999997655 799999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|..||.+.+..+....+...  ..                .++           ...+..+.+|+.+||+.||++|
T Consensus       207 elltg~~pf~~~~~~~~~~~i~~~--~~----------------~~p-----------~~~~~~~~~li~~~L~~dP~~R  257 (329)
T PTZ00263        207 EFIAGYPPFFDDTPFRIYEKILAG--RL----------------KFP-----------NWFDGRARDLVKGLLQTDHTKR  257 (329)
T ss_pred             HHHcCCCCCCCCCHHHHHHHHhcC--Cc----------------CCC-----------CCCCHHHHHHHHHHhhcCHHHc
Confidence            999999999988776655555321  00                011           1134678999999999999999


Q ss_pred             CC-----HHHHHcCccccCCcc
Q psy10954        338 VS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~T-----a~elL~Hp~f~~~~~  354 (562)
                      ++     ++++++||||++..+
T Consensus       258 ~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        258 LGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             CCCCCCCHHHHhcCCccCCCCH
Confidence            97     799999999987653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=309.73  Aligned_cols=241  Identities=49%  Similarity=0.909  Sum_probs=193.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .....+|++++++++||||+++++++..+...|+||||+.++|.+++......+++..++.++.|++.||.|||++||+|
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H  126 (291)
T cd07844          47 PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH  126 (291)
T ss_pred             chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            34567899999999999999999999999999999999999999998776667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++....+..                                                
T Consensus       127 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~------------------------------------------------  158 (291)
T cd07844         127 RDLKPQNLLISERGELKLADFGLARAKSVPSK------------------------------------------------  158 (291)
T ss_pred             ccCCHHHEEEcCCCCEEECccccccccCCCCc------------------------------------------------
Confidence            99999999999999999999998653211000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||++.+...++.++||||+||++|
T Consensus       159 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~  195 (291)
T cd07844         159 -------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFY  195 (291)
T ss_pred             -------------------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHH
Confidence                                                       0011245778999999887666899999999999999


Q ss_pred             HHHhCCCCCCCCC-HHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhcCCCC--HHHHHHHHHccccC
Q psy10954        258 EMITKKTLFAGDS-EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPD--PLAVDVFSKIMALD  333 (562)
Q Consensus       258 eLltG~~pF~~~~-~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~--~~~~dLi~~mL~~D  333 (562)
                      +|++|+.||.+.. ..+++..+.+.++.+..+.|+.......+.. ..+...+..+.......+  ..+.+++.+||+.|
T Consensus       196 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  275 (291)
T cd07844         196 EMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYE  275 (291)
T ss_pred             HHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccC
Confidence            9999999998776 5667777888888887777766554332221 112222222222222333  67899999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy10954        334 PKQRVSAKTILQHEYF  349 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f  349 (562)
                      |++|||+.|+++||||
T Consensus       276 p~~Rps~~e~l~~~~f  291 (291)
T cd07844         276 PKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-36  Score=312.59  Aligned_cols=245  Identities=40%  Similarity=0.778  Sum_probs=198.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+|+++|++++|+||+++++++...  +.+|+||||++++|.+++......+++..+..++.|++.||.|||++|+
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  129 (309)
T cd07845          50 PISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI  129 (309)
T ss_pred             cchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567899999999999999999998755  5789999999999999887765679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++.......                                               
T Consensus       130 ~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-----------------------------------------------  162 (309)
T cd07845         130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-----------------------------------------------  162 (309)
T ss_pred             ecCCCCHHHEEECCCCCEEECccceeeecCCcc-----------------------------------------------
Confidence            999999999999999999999999875432100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......+++.|+|||++.+...++.++||||+||+
T Consensus       163 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i  198 (309)
T cd07845         163 --------------------------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI  198 (309)
T ss_pred             --------------------------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHH
Confidence                                                        000112347789999999877778999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++|++||.+.+..+.+..+...++.+....|+.....+... ...+......+...+...++.+.|||.+||++||
T Consensus       199 l~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp  278 (309)
T cd07845         199 LAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDP  278 (309)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCCh
Confidence            999999999999999999999999999988888877655433211 1111111112222333346788999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++|||++|+++||||++..
T Consensus       279 ~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         279 KKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hhCcCHHHHhcChhhccCC
Confidence            9999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-37  Score=313.70  Aligned_cols=218  Identities=26%  Similarity=0.376  Sum_probs=174.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|++++|+||+++++++..++..|+|||||.+ +|.+.+.... ..+++..+..++.|++.||+|||++||+
T Consensus        45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii  124 (285)
T cd05631          45 AMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV  124 (285)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3467899999999999999999999999999999999975 8887775433 3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++......                                                 
T Consensus       125 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------  155 (285)
T cd05631         125 YRDLKPENILLDDRGHIRISDLGLAVQIPEG-------------------------------------------------  155 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-------------------------------------------------
Confidence            9999999999999999999999987532100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       156 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil  191 (285)
T cd05631         156 -------------------------------------------ETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLI  191 (285)
T ss_pred             -------------------------------------------CeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHH
Confidence                                                       0001236789999999998654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.........+..........                         .....++.+.+|+++||+.||++
T Consensus       192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~l~~~P~~  246 (285)
T cd05631         192 YEMIQGQSPFRKRKERVKREEVDRRVKEDQEE-------------------------YSEKFSEDAKSICRMLLTKNPKE  246 (285)
T ss_pred             HHHHhCCCCCCCCCcchhHHHHHHHhhccccc-------------------------CCccCCHHHHHHHHHHhhcCHHH
Confidence            99999999998766533322222221111000                         11123568899999999999999


Q ss_pred             CCC-----HHHHHcCccccCCcc
Q psy10954        337 RVS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~T-----a~elL~Hp~f~~~~~  354 (562)
                      |+|     ++++++||||.++++
T Consensus       247 R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         247 RLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             hcCCCCCCHHHHhcCHhhcCCCH
Confidence            997     899999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9e-37  Score=308.42  Aligned_cols=245  Identities=45%  Similarity=0.876  Sum_probs=201.9

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      +....+.+|+.++++++||||+++++++..+...|+||||++++|.+++......+++..++.++.|++.||+|||++||
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  120 (286)
T cd07832          41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI  120 (286)
T ss_pred             hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999779999987766679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.++|+|||++........                                              
T Consensus       121 ~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------  154 (286)
T cd07832         121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEP----------------------------------------------  154 (286)
T ss_pred             ecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----------------------------------------------
Confidence            9999999999999999999999998754321100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||..|+|||++.+...++.++||||+||+
T Consensus       155 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~  190 (286)
T cd07832         155 --------------------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI  190 (286)
T ss_pred             --------------------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHH
Confidence                                                        001123578889999998776668999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++|.++|.+.++...+..+...++.+....|+.......+.. .++......+...++..+..+.+||.+||..||
T Consensus       191 l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  270 (286)
T cd07832         191 FAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDP  270 (286)
T ss_pred             HHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccCh
Confidence            9999999999999998889999999999888777776554433321 122222233344455566889999999999999


Q ss_pred             CCCCCHHHHHcCcccc
Q psy10954        335 KQRVSAKTILQHEYFN  350 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~  350 (562)
                      ++|||++++|+||||.
T Consensus       271 ~~R~~~~~~l~h~~~~  286 (286)
T cd07832         271 SKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhCCCHHHHhhCcCcC
Confidence            9999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-36  Score=321.64  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=181.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.++++++||||+++++.+.+...+|+|||||++ +|.+++.+. ..+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givH  124 (363)
T cd05628          46 GHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIH  124 (363)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            3567899999999999999999999999999999999975 899998764 36999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.......       +..|..-..       .                        
T Consensus       125 rDlKp~NILi~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~~~-------~------------------------  166 (363)
T cd05628         125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR-------TEFYRNLNH-------S------------------------  166 (363)
T ss_pred             cCCCHHHeEECCCCCEEEeeccCccccccccc-------ccccccccc-------c------------------------
Confidence            99999999999999999999999875532110       000000000       0                        


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                    .|..........-...+.+-    ..........+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       167 --------------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~  227 (363)
T cd05628         167 --------------LPSDFTFQNMNSKRKAETWK----RNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMY  227 (363)
T ss_pred             --------------ccccccccccccccccchhh----hccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHH
Confidence                          00000000000000000000    00011123468999999999998754 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC-
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ-  336 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~-  336 (562)
                      ||++|++||.+.+..+...++.......                .++..         ...++.++|||.+|+. +|.+ 
T Consensus       228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~~---------~~~s~~~~~li~~l~~-~~~~r  281 (363)
T cd05628         228 EMLIGYPPFCSETPQETYKKVMNWKETL----------------IFPPE---------VPISEKAKDLILRFCC-EWEHR  281 (363)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcCcCcc----------------cCCCc---------CCCCHHHHHHHHHHcC-Chhhc
Confidence            9999999999888777666665321110                01110         0124688999999875 5554 


Q ss_pred             --CCCHHHHHcCccccCCccc
Q psy10954        337 --RVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 --R~Ta~elL~Hp~f~~~~~~  355 (562)
                        |++++|+++||||+++++.
T Consensus       282 ~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         282 IGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCCCHHHHhCCCCCCCCCHH
Confidence              5799999999999988654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=325.14  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=184.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|++++||||++++++|..+..+|+|||||+ ++|.+++... ..+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givH  124 (377)
T cd05629          46 AHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIH  124 (377)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            456789999999999999999999999999999999997 5999998764 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.+.....       +..|....  .+... ....+-.                  
T Consensus       125 rDlkp~NIll~~~~~~kl~DfGla~~~~~~~~-------~~~~~~~~--~~~~~-~~~~~~~------------------  176 (377)
T cd05629         125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD-------SAYYQKLL--QGKSN-KNRIDNR------------------  176 (377)
T ss_pred             cCCCHHHEEECCCCCEEEeecccccccccccc-------cccccccc--ccccc-ccccccc------------------
Confidence            99999999999999999999999875431100       00010000  00000 0000000                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                 +....+.+-.......++.+++.++..     .....+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       177 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~  239 (377)
T cd05629         177 -----------NSVAVDSINLTMSSKDQIATWKKNRRL-----MAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMF  239 (377)
T ss_pred             -----------cccccccccccccchhhhhhhhhcccc-----cccccCCCccccCHHHHccCC-CCCceeeEecchhhh
Confidence                       000000000000111233444432221     112458999999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.+..+.+..+.......                .++..         ...+..+.|||.+||. +|.+|
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~~---------~~~s~~~~dli~~lL~-~~~~r  293 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETL----------------YFPDD---------IHLSVEAEDLIRRLIT-NAENR  293 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCcc----------------CCCCC---------CCCCHHHHHHHHHHhc-CHhhc
Confidence            9999999999888766666554311000                00100         1134678999999998 77775


Q ss_pred             ---CCHHHHHcCccccCCcc
Q psy10954        338 ---VSAKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ---~Ta~elL~Hp~f~~~~~  354 (562)
                         +|+.|+++||||+++++
T Consensus       294 ~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         294 LGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             CCCCCHHHHhcCCCcCCCCH
Confidence               59999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.4e-37  Score=321.70  Aligned_cols=239  Identities=37%  Similarity=0.625  Sum_probs=183.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+++.++||||+++++++...      ...|+||||++++|.+.+..   .+++..++.++.|++.||.|||
T Consensus        60 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH  136 (355)
T cd07874          60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  136 (355)
T ss_pred             HHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH
Confidence            35677999999999999999999998643      35799999999998887754   4889999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++......                                           
T Consensus       137 ~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------  173 (355)
T cd07874         137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-------------------------------------------  173 (355)
T ss_pred             hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc-------------------------------------------
Confidence            9999999999999999999999999999875321100                                           


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                       .....+||+.|+|||++.+.. |+.++||||
T Consensus       174 -------------------------------------------------~~~~~~~t~~y~aPE~~~~~~-~~~~~Diws  203 (355)
T cd07874         174 -------------------------------------------------MMTPYVVTRYYRAPEVILGMG-YKENVDIWS  203 (355)
T ss_pred             -------------------------------------------------ccCCccccCCccCHHHHcCCC-CCchhhHHH
Confidence                                                             001235789999999997754 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCC--------ccch----hhhcCCC
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWR--------PKKF----SEILNLP  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~~----~~~l~~~  318 (562)
                      +||++|+|++|+.||.+.+..+.+..+++.++.+..+.+...... ..+....+...        +...    .......
T Consensus       204 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (355)
T cd07874         204 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK  283 (355)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccccccccc
Confidence            999999999999999999988888888888877654433221100 00000000000        0000    0011122


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +..+++||.+||+.||++|||+.|+|+||||...
T Consensus       284 ~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         284 ASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             chHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            4578999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=317.28  Aligned_cols=213  Identities=30%  Similarity=0.442  Sum_probs=176.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++||||+++++++...+.+|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+|
T Consensus        38 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  116 (312)
T cd05585          38 THTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIY  116 (312)
T ss_pred             HHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            4567899999999999999999999999999999999975 899988764 36999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       117 rDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  147 (312)
T cd05585         117 RDLKPENILLDYQGHIALCDFGLCKLNMKDD-------------------------------------------------  147 (312)
T ss_pred             CCCCHHHeEECCCCcEEEEECcccccCccCC-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       148 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~  184 (312)
T cd05585         148 ------------------------------------------DKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLY  184 (312)
T ss_pred             ------------------------------------------CccccccCCcccCCHHHHcCCC-CCCccceechhHHHH
Confidence                                                      0012246899999999998754 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||.+.+..+.+..+....  .                .           .....++.+.+|+.+||+.||++|
T Consensus       185 el~tg~~pf~~~~~~~~~~~~~~~~--~----------------~-----------~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         185 EMLTGLPPFYDENVNEMYRKILQEP--L----------------R-----------FPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             HHHhCCCCcCCCCHHHHHHHHHcCC--C----------------C-----------CCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999999999887666555543210  0                0           001235678999999999999999


Q ss_pred             C---CHHHHHcCccccCCc
Q psy10954        338 V---SAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~---Ta~elL~Hp~f~~~~  353 (562)
                      +   ++.|+|+||||.+..
T Consensus       236 ~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CCCCCHHHHHcCCCcCCCC
Confidence            7   589999999998764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.3e-37  Score=324.86  Aligned_cols=264  Identities=26%  Similarity=0.401  Sum_probs=181.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++|||||+++++|..+..+|+|||||++ +|.+++.+. ..+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivH  124 (382)
T cd05625          46 AHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIH  124 (382)
T ss_pred             HHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4577899999999999999999999999999999999975 899988764 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.+|.+||+|||+|+.+.......       .|. +......     ..+-++                 
T Consensus       125 rDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~-------~~~-~~~~~~~-----~~~~~~-----------------  174 (382)
T cd05625         125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK-------YYQ-SGDHVRQ-----DSMDFS-----------------  174 (382)
T ss_pred             CCCCHHHEEECCCCCEEEeECCCCcccccccccc-------ccc-ccccccc-----cccccc-----------------
Confidence            9999999999999999999999986542110000       000 0000000     000000                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                +.--.|.+.  ......+-.....++.  .......+.+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       175 ----------~~~~~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~  239 (382)
T cd05625         175 ----------NEWGDPANC--RCGDRLKPLERRAARQ--HQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILY  239 (382)
T ss_pred             ----------ccccccccc--cccccccchhhhhccc--cccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHH
Confidence                      000000000  0000000000000000  0111123468999999999998765 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|++||.+.+..+....+.......                ..+.         ....++.+.|+|.+|+. ||++|
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~---------~~~~s~~~~~li~~l~~-~p~~R  293 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSL----------------HIPP---------QAKLSPEASDLIIKLCR-GPEDR  293 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCc----------------CCCC---------cccCCHHHHHHHHHHcc-CHhHc
Confidence            9999999999888766665554321100                0000         01235789999999874 99999


Q ss_pred             CC---HHHHHcCccccCCcc
Q psy10954        338 VS---AKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~T---a~elL~Hp~f~~~~~  354 (562)
                      ++   ++|+++||||+.+.+
T Consensus       294 ~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         294 LGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             CCCCCHHHHhcCCCcCCcCh
Confidence            97   999999999988754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.8e-37  Score=324.50  Aligned_cols=265  Identities=26%  Similarity=0.403  Sum_probs=181.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++.+.+.+|+|||||++ +|.+++.+.. .+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givH  124 (381)
T cd05626          46 AHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIH  124 (381)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            3567899999999999999999999999999999999975 9999987654 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.+......       ..|.....+....  ....++|.-.-              
T Consensus       125 rDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~-------~~~~~~~~~~~~~--~~~~~~~~~~~--------------  181 (381)
T cd05626         125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS-------KYYQKGSHIRQDS--MEPSDLWDDVS--------------  181 (381)
T ss_pred             cCCcHHHEEECCCCCEEEeeCcCCccccccccc-------ccccccccccccc--cCccccccccc--------------
Confidence            999999999999999999999998754321100       0010000000000  00011111000              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                       +...    .....+.+.............+.+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       182 -----------------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~  239 (381)
T cd05626         182 -----------------NCRC----GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILF  239 (381)
T ss_pred             -----------------cccc----ccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHH
Confidence                             0000    000000000000000011123468999999999998654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc--CCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL--DPK  335 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~--DP~  335 (562)
                      ||++|++||.+.+..+....+....+...                .+.         ....++.++|||.+||..  +|.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------~~~---------~~~~s~~~~dli~~ll~~~~~~~  294 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLH----------------IPP---------QVKLSPEAVDLITKLCCSAEERL  294 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccC----------------CCC---------CCCCCHHHHHHHHHHccCccccc
Confidence            99999999998876655555543111100                000         012357899999997755  445


Q ss_pred             CCCCHHHHHcCccccCCcc
Q psy10954        336 QRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~~  354 (562)
                      .|+|++|+++||||+++.+
T Consensus       295 ~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         295 GRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             CCCCHHHHhcCcccCCCCh
Confidence            5999999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-36  Score=308.35  Aligned_cols=242  Identities=44%  Similarity=0.837  Sum_probs=195.1

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.+|+++++.++||||+++++++...  ...|+||||++++|.+++......+++..++.++.|++.||+|||++|
T Consensus        47 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  126 (293)
T cd07843          47 FPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW  126 (293)
T ss_pred             chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            344567999999999999999999998877  899999999999999988776556999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||++........                                             
T Consensus       127 i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---------------------------------------------  161 (293)
T cd07843         127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK---------------------------------------------  161 (293)
T ss_pred             eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc---------------------------------------------
Confidence            99999999999999999999999998754321100                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    ......+++.|+|||++.+...++.++|+||+||
T Consensus       162 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  195 (293)
T cd07843         162 ----------------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGC  195 (293)
T ss_pred             ----------------------------------------------ccccccccccccCchhhcCCccccchhhHHHHHH
Confidence                                                          0012245788999999887666789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhcCC--CCHHHHHHHHHccc
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNL--PDPLAVDVFSKIMA  331 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~--~~~~~~dLi~~mL~  331 (562)
                      ++|+|++|.+||.+.+..+.+.++...++.+....|+.....+.... .........+...++.  .++.+.++|++||+
T Consensus       196 ~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  275 (293)
T cd07843         196 IFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLT  275 (293)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhc
Confidence            99999999999999998888888988888887777765544332221 1111111122222332  26778999999999


Q ss_pred             cCCCCCCCHHHHHcCccc
Q psy10954        332 LDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f  349 (562)
                      .||++|||+.|+|+||||
T Consensus       276 ~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         276 YDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cCccccCCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=332.05  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=187.5

Q ss_pred             hHHHHHHHHHccCC------CCcceEEEEEEeC-CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         20 TALREISVLKELKH------PNVIRLHDVIPVD-FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        20 ~~~rEi~iL~~l~H------pnIv~L~~~~~~~-~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+|+++++.++|      ++|++++++|... .++|+|||+++++|.+++.+. +.+++..++.++.||+.||+|||+
T Consensus       171 ~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~  249 (467)
T PTZ00284        171 DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT  249 (467)
T ss_pred             HHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45678888887755      4589999998764 589999999999999988765 469999999999999999999998


Q ss_pred             -CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 -RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 -~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                       .|||||||||+|||++.++..  ++++..                                                  
T Consensus       250 ~~gIiHrDlKP~NILl~~~~~~--~~~~~~--------------------------------------------------  277 (467)
T PTZ00284        250 ELHLMHTDLKPENILMETSDTV--VDPVTN--------------------------------------------------  277 (467)
T ss_pred             cCCeecCCCCHHHEEEecCCcc--cccccc--------------------------------------------------
Confidence             599999999999999865531  111110                                                  


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                       +.+.      ...+.+||+|||.++...   ......+||+.|+|||++.+.. |+.++||||
T Consensus       278 -----------------~~~~------~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwS  330 (467)
T PTZ00284        278 -----------------RALP------PDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWS  330 (467)
T ss_pred             -----------------cccC------CCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCC-CCcHHHHHH
Confidence                             0001      123579999999876432   2234568999999999998765 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--CCCccCC----CCCCCccchhhhc-------CCC
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTD----FPEWRPKKFSEIL-------NLP  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~l-------~~~  318 (562)
                      +||++|||++|++||.+.+..+++..+...+|.++..+......  ...+...    .+...++.+....       ...
T Consensus       331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (467)
T PTZ00284        331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR  410 (467)
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence            99999999999999999999999988988888776543221100  0000000    0111111111111       113


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++.+.|||.+||++||++|+||+|+|+||||.+..
T Consensus       411 ~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY  445 (467)
T ss_pred             hHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence            56788999999999999999999999999998754

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-36  Score=305.73  Aligned_cols=241  Identities=54%  Similarity=1.049  Sum_probs=200.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~--~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|++++++++||||+++++++...+..|+||||++++|.+++....  ..+++..+..++.|++.||.|||++|+
T Consensus        42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (284)
T cd07836          42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV  121 (284)
T ss_pred             hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356778999999999999999999999999999999999999999887644  458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++......                                               
T Consensus       122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-----------------------------------------------  154 (284)
T cd07836         122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPV-----------------------------------------------  154 (284)
T ss_pred             eeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-----------------------------------------------
Confidence            999999999999999999999999865332100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......++|..|+|||++.+...++.++|+||+||+
T Consensus       155 --------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~  190 (284)
T cd07836         155 --------------------------------------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCI  190 (284)
T ss_pred             --------------------------------------------cccccccccccccChHHhcCCCCCCcHHHHHHHHHH
Confidence                                                        001123467889999998877678999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+.+..+.+.++.+..+.+....|......+.+...++...........+..+..+.+++.+||+.||.
T Consensus       191 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  270 (284)
T cd07836         191 MAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPE  270 (284)
T ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcc
Confidence            99999999999999888888888888888877777666555544444444433333334445578899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|+|+.|+++||||
T Consensus       271 ~R~~~~~~l~~~~f  284 (284)
T cd07836         271 LRISAHDALQHPWF  284 (284)
T ss_pred             cCCCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=321.04  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=181.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||++++++|..+..+|+|||||++ +|.+++.... .+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH  124 (364)
T cd05599          46 AHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIH  124 (364)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3467899999999999999999999999999999999974 8999887644 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||++..+...... ........+..+..                                
T Consensus       125 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~--------------------------------  171 (364)
T cd05599         125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT-EFYRILSHALPSNF--------------------------------  171 (364)
T ss_pred             ccCCHHHeEECCCCCEEEeecccceeccccccc-cccccccccccccc--------------------------------
Confidence            999999999999999999999998755321100 00000000000000                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                               .+....|-      ........+...+     .......+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       172 ---------~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~  230 (364)
T cd05599         172 ---------LDFISKPM------SSKRKAETWKRNR-----RALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMY  230 (364)
T ss_pred             ---------cccccccc------cccccccchhhcc-----cccccccccCccccCHHHHcCCC-CCCeeeeecchhHHH
Confidence                     00000000      0000000000000     00112357999999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.+..+.+..+.......                .++..         ...++.+.+||.+||. ||.+|
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~~~~----------------~~~~~---------~~~s~~~~~li~~ll~-~p~~R  284 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWKETL----------------QFPDE---------VPLSPEAKDLIKRLCC-EAERR  284 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCCCcc----------------CCCCC---------CCCCHHHHHHHHHHcc-CHhhc
Confidence            9999999999888776665554311000                00000         0135688999999997 99999


Q ss_pred             CC---HHHHHcCccccCCcc
Q psy10954        338 VS---AKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~T---a~elL~Hp~f~~~~~  354 (562)
                      ++   ++|+++||||+.+.+
T Consensus       285 ~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         285 LGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCHHHHhcCCCcCCCCH
Confidence            98   999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-36  Score=317.36  Aligned_cols=214  Identities=27%  Similarity=0.421  Sum_probs=175.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++..++.+|+||||+++ +|..++... ..+++..++.++.||+.||+|||++||+|
T Consensus        40 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  118 (328)
T cd05593          40 AHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVY  118 (328)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            4567899999999999999999999999999999999975 888887654 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       119 rDikp~NIll~~~~~~kL~DfG~~~~~~~~~-------------------------------------------------  149 (328)
T cd05593         119 RDLKLENLMLDKDGHIKITDFGLCKEGITDA-------------------------------------------------  149 (328)
T ss_pred             cccCHHHeEECCCCcEEEecCcCCccCCCcc-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       150 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~  186 (328)
T cd05593         150 ------------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMY  186 (328)
T ss_pred             ------------------------------------------cccccccCCcCccChhhhcCCC-CCccCCccccchHHH
Confidence                                                      0011236899999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+..+....+...  ..                .+           ....++.+.+||.+||+.||++|
T Consensus       187 elltG~~Pf~~~~~~~~~~~~~~~--~~----------------~~-----------p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         187 EMMCGRLPFYNQDHEKLFELILME--DI----------------KF-----------PRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             HHhhCCCCCCCCCHHHHHHHhccC--Cc----------------cC-----------CCCCCHHHHHHHHHHcCCCHHHc
Confidence            999999999887765544433210  00                00           01235678999999999999999


Q ss_pred             C-----CHHHHHcCccccCCcc
Q psy10954        338 V-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~-----Ta~elL~Hp~f~~~~~  354 (562)
                      +     ++.|+++||||....+
T Consensus       238 ~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         238 LGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             CCCCCCCHHHHhcCCCcCCCCH
Confidence            7     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.7e-36  Score=305.22  Aligned_cols=242  Identities=53%  Similarity=0.996  Sum_probs=196.2

Q ss_pred             chhhHHHHHHHHHccC-CCCcceEEEEEEeCCE-----EEEEeecCcCCHHHHHhhCC----CCCCHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELK-HPNVIRLHDVIPVDFK-----LFLVFEFLRQDLKDFLQTTP----VPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~-----i~lV~Ey~~~~L~~~i~~~~----~~l~e~~i~~i~~qll~a   86 (562)
                      ....+.+|+.+++.++ ||||+++++++.....     +|+||||++++|.+++....    ..+++..++.++.|++.|
T Consensus        43 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  122 (295)
T cd07837          43 IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG  122 (295)
T ss_pred             CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence            4456789999999995 6999999999987665     89999999999998886532    358999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccc
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  165 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il  165 (562)
                      |.|||++||+||||||+||+++. ++.+||+|||+++.+..+.                                     
T Consensus       123 L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-------------------------------------  165 (295)
T cd07837         123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-------------------------------------  165 (295)
T ss_pred             HHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc-------------------------------------
Confidence            99999999999999999999998 7889999999875432110                                     


Q ss_pred             hhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       166 ~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                                                                            .......+++.|+|||++.+...++.
T Consensus       166 ------------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~  191 (295)
T cd07837         166 ------------------------------------------------------KSYTHEIVTLWYRAPEVLLGSTHYST  191 (295)
T ss_pred             ------------------------------------------------------cccCCcccccCCCChHHhhCCCCCCc
Confidence                                                                  00112245788999999877666899


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       246 ~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      ++||||+||++|+|++|.+||.+.+....+..++..++.+....|+.......+. .++.+.+.......+..+..+.+|
T Consensus       192 ~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  270 (295)
T cd07837         192 PVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH-EFPQWKPQDLSRAVPDLSPEGLDL  270 (295)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh-hcCcccchhHHHhccccCHHHHHH
Confidence            9999999999999999999999999999899999988888877776655433222 133333334444445567889999


Q ss_pred             HHHccccCCCCCCCHHHHHcCcccc
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      |.+||+.||++|||+.|+++||||+
T Consensus       271 i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         271 LQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHccCChhhcCCHHHHhcCCCcC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-36  Score=322.23  Aligned_cols=240  Identities=28%  Similarity=0.361  Sum_probs=184.7

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      ...+|+++|+.++|||||+++++|.....+|+|||++.++|.+++.. ...+++..++.++.|++.||.|||++||||||
T Consensus       132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrD  210 (392)
T PHA03207        132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRD  210 (392)
T ss_pred             cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            45689999999999999999999999999999999999999999854 34699999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHH
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALR  179 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~  179 (562)
                      |||+|||++.++.+||+|||+++.......                                                  
T Consensus       211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~--------------------------------------------------  240 (392)
T PHA03207        211 VKTENIFLDEPENAVLGDFGAACKLDAHPD--------------------------------------------------  240 (392)
T ss_pred             CCHHHEEEcCCCCEEEccCccccccCcccc--------------------------------------------------
Confidence            999999999999999999998754321000                                                  


Q ss_pred             hhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHH
Q psy10954        180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       180 yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eL  259 (562)
                                                             .......+||+.|+|||++.+.. |+.++||||+||++|||
T Consensus       241 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el  280 (392)
T PHA03207        241 ---------------------------------------TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEM  280 (392)
T ss_pred             ---------------------------------------cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHH
Confidence                                                   00011246899999999997654 89999999999999999


Q ss_pred             HhCCCCCCCCC---HHHHHHHHHHhcCCCCCCCCCCCCC-----CCCccC-CCCCCCccchhhhc--CCCCHHHHHHHHH
Q psy10954        260 ITKKTLFAGDS---EIDQLFRIFRTLGTPHEDVWPGVSK-----LPIYKT-DFPEWRPKKFSEIL--NLPDPLAVDVFSK  328 (562)
Q Consensus       260 ltG~~pF~~~~---~~~~l~~i~~~lg~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~l--~~~~~~~~dLi~~  328 (562)
                      ++|+.||.+..   ...++..+++.++..+.+.......     ...+.. ..+.+   .....+  ...+..+.+||++
T Consensus       281 ~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~  357 (392)
T PHA03207        281 SVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY---TIPPVIRKYGMHMDVEYLIAK  357 (392)
T ss_pred             HHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCc---cccchhhccCcchhHHHHHHH
Confidence            99999998754   3567777777777654433221100     000000 00000   011111  1235678899999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCCc
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++||.+|||+.|+|+||||...+
T Consensus       358 ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        358 MLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HhccChhhCCCHHHHhhCchhhccc
Confidence            9999999999999999999998754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.8e-36  Score=314.89  Aligned_cols=213  Identities=27%  Similarity=0.429  Sum_probs=175.3

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ...+|+++|+.++||||++++++|..++.+|+||||+++ +|..++... ..+++..++.++.|++.||+|||++||+||
T Consensus        41 ~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  119 (323)
T cd05595          41 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR  119 (323)
T ss_pred             HHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            456899999999999999999999999999999999975 898887654 368999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++......                                                  
T Consensus       120 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--------------------------------------------------  149 (323)
T cd05595         120 DIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------------------------------------  149 (323)
T ss_pred             CCCHHHEEEcCCCCEEecccHHhccccCCC--------------------------------------------------
Confidence            999999999999999999999865321000                                                  


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                               ......+||+.|+|||++.+.. ++.++||||+||++||
T Consensus       150 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~e  187 (323)
T cd05595         150 -----------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYE  187 (323)
T ss_pred             -----------------------------------------CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHH
Confidence                                                     0001235789999999987654 8999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      |++|+.||.+.+.......+.....                  .++           ...++.+.+||.+||+.||++|+
T Consensus       188 ll~g~~Pf~~~~~~~~~~~~~~~~~------------------~~p-----------~~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         188 MMCGRLPFYNQDHERLFELILMEEI------------------RFP-----------RTLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             HHhCCCCCCCCCHHHHHHHHhcCCC------------------CCC-----------CCCCHHHHHHHHHHccCCHHHhC
Confidence            9999999988776655554432100                  000           12356789999999999999998


Q ss_pred             -----CHHHHHcCccccCCcc
Q psy10954        339 -----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       339 -----Ta~elL~Hp~f~~~~~  354 (562)
                           ++.++++|+||.+..+
T Consensus       239 ~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         239 GGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             CCCCCCHHHHHcCCCcCCCCH
Confidence                 8999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0604|consensus

Probab=100.00  E-value=3.4e-37  Score=304.90  Aligned_cols=219  Identities=28%  Similarity=0.454  Sum_probs=169.5

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeC----CEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVD----FKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~----~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ...+.||+++.-.. .|||||.++|+|+..    .-+.+|||.|+| +|++.|+.++ ..++|.++..|++||..|+.||
T Consensus        98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l  177 (400)
T KOG0604|consen   98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL  177 (400)
T ss_pred             CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH
Confidence            45688999987555 799999999998753    457899999985 9999998765 4599999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         91 HSRRIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      |+.+|.||||||||+|....   ..+||+|||+|+.                                            
T Consensus       178 H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~--------------------------------------------  213 (400)
T KOG0604|consen  178 HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE--------------------------------------------  213 (400)
T ss_pred             HhcchhhccCChhheeeecCCCCcceEecccccccc--------------------------------------------
Confidence            99999999999999998643   3456666665542                                            


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                     -.. .....+.|-||+|.|||++-..+ |+..+
T Consensus       214 -----------------------------------------------t~~-~~~L~TPc~TPyYvaPevlg~eK-ydksc  244 (400)
T KOG0604|consen  214 -----------------------------------------------TQE-PGDLMTPCFTPYYVAPEVLGPEK-YDKSC  244 (400)
T ss_pred             -----------------------------------------------cCC-CccccCCcccccccCHHHhCchh-cCCCC
Confidence                                                           221 12234567799999999985544 99999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEI----DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~----~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      |+||+||++|.|++|.+||+.....    .+-.+|..                .+|.+..++|         ...++.++
T Consensus       245 dmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----------------gqy~FP~pEW---------s~VSe~aK  299 (400)
T KOG0604|consen  245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----------------GQYEFPEPEW---------SCVSEAAK  299 (400)
T ss_pred             CccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc----------------cCccCCChhH---------hHHHHHHH
Confidence            9999999999999999999876431    12222221                1222223333         22357899


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |+|+++|..+|.+|+|++|++.|||+.+...
T Consensus       300 dlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  300 DLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             HHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            9999999999999999999999999988653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-36  Score=315.63  Aligned_cols=220  Identities=27%  Similarity=0.425  Sum_probs=172.9

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|+.+|+.+ +||||+++++++..++.+|+||||+.+ +|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iv  127 (332)
T cd05614          49 EHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIV  127 (332)
T ss_pred             HHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            4567899999999 599999999999999999999999975 8999887643 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       128 HrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~------------------------------------------------  159 (332)
T cd05614         128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEE------------------------------------------------  159 (332)
T ss_pred             ecCCCHHHeEECCCCCEEEeeCcCCccccccC------------------------------------------------
Confidence            99999999999999999999999875431100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .......+||+.|+|||++.+...++.++||||+||++
T Consensus       160 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  197 (332)
T cd05614         160 ------------------------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI  197 (332)
T ss_pred             ------------------------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhh
Confidence                                                      00011246899999999998766688999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||...........+........                 +.        .-...++.+.+|+.+||+.||++
T Consensus       198 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----------------~~--------~~~~~~~~~~~li~~~l~~dp~~  252 (332)
T cd05614         198 FELLTGASPFTLEGERNTQSEVSRRILKCD-----------------PP--------FPSFIGPEAQDLLHKLLRKDPKK  252 (332)
T ss_pred             hhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-----------------CC--------CCCCCCHHHHHHHHHHcCCCHHH
Confidence            999999999975432211111111100000                 00        01123567899999999999999


Q ss_pred             CC-----CHHHHHcCccccCCcc
Q psy10954        337 RV-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~  354 (562)
                      |+     +++++++||||++..+
T Consensus       253 R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         253 RLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             cCCCCCCCHHHHHcCCCcCCCCH
Confidence            99     8899999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.4e-36  Score=305.01  Aligned_cols=248  Identities=45%  Similarity=0.828  Sum_probs=199.2

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+.+|+++++.++||||+++++++......|+||||+.++|.+++......+++..+..++.|+++||.|||++||+
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  124 (298)
T cd07841          45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL  124 (298)
T ss_pred             hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34556789999999999999999999999999999999997799999976554699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||||+||+++.++.+||+|||+++......                                                
T Consensus       125 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~------------------------------------------------  156 (298)
T cd07841         125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPN------------------------------------------------  156 (298)
T ss_pred             ecCCChhhEEEcCCCCEEEccceeeeeccCCC------------------------------------------------
Confidence            99999999999999999999999875432110                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+++.|+|||.+.+...++.++|+||+||++
T Consensus       157 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il  193 (298)
T cd07841         157 -------------------------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIF  193 (298)
T ss_pred             -------------------------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHH
Confidence                                                       0011124577899999987766789999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.++|.+.+..+.+.++.+.++.+....|+.....+.+... ....+......+...+..+.+|+.+||+.||++
T Consensus       194 ~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  272 (298)
T cd07841         194 AELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF-KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK  272 (298)
T ss_pred             HHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc-cccCCcchhhhcccccHHHHHHHHHHhcCCccc
Confidence            9999999999998888888888888887777666554443322111 111112222333445678899999999999999


Q ss_pred             CCCHHHHHcCccccCCcccC
Q psy10954        337 RVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      |+|+.|+++|+||++.....
T Consensus       273 R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         273 RITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             CcCHHHHhhCccccCCCCCC
Confidence            99999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-36  Score=322.50  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=181.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++||||+++++.|..++.+|+|||||+ ++|.+++...+ .+++..++.++.||+.||+|||++||+
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iv  123 (376)
T cd05598          45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFI  123 (376)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3456789999999999999999999999999999999997 49999987653 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|..+......        .|..+...       ...|.....-...+.        
T Consensus       124 HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~--------~~~~~~~~-------~~~~~~~~~~~~~~~--------  180 (376)
T cd05598         124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS--------KYYQKGDH-------HRQDSMEPSEEWSEI--------  180 (376)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCCCccccccccc--------cccccccc-------ccccccccccccccc--------
Confidence            9999999999999999999999998654211000        00000000       000000000000000        


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                -....++               .................+||+.|||||++.+.. ++.++||||+||++
T Consensus       181 ----------~~~~~~~---------------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  234 (376)
T cd05598         181 ----------DRCRLKP---------------LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL  234 (376)
T ss_pred             ----------ccccccc---------------hhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeecccee
Confidence                      0000000               000000000001123458999999999997655 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+....+.......                ..+.         ....++.+.++|.+|+ .||.+
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------~~~~---------~~~~s~~~~~li~~l~-~~p~~  288 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKVINWETTL----------------HIPS---------QAKLSREASDLILRLC-CGAED  288 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHHhccCccc----------------cCCC---------CCCCCHHHHHHHHHHh-cCHhh
Confidence            99999999999888766555443211000                0000         0123567899999976 59999


Q ss_pred             CC---CHHHHHcCccccCCcc
Q psy10954        337 RV---SAKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~---Ta~elL~Hp~f~~~~~  354 (562)
                      |+   |+.|+++||||+.++.
T Consensus       289 R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         289 RLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             cCCCCCHHHHhCCCCcCCCCH
Confidence            99   9999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.3e-36  Score=302.14  Aligned_cols=237  Identities=39%  Similarity=0.701  Sum_probs=188.2

Q ss_pred             hHHHHHHHHHccC-CCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         20 TALREISVLKELK-HPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        20 ~~~rEi~iL~~l~-HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+|+.+++++. ||||+++++++.++  +.+|+||||++++|.+.+......+++..+..++.|++.||+|||++||+
T Consensus        43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~  122 (282)
T cd07831          43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF  122 (282)
T ss_pred             hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            3468999999885 99999999999987  89999999999999998877655789999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++. +.+||+|||+++......                                                
T Consensus       123 H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~------------------------------------------------  153 (282)
T cd07831         123 HRDIKPENILIKD-DILKLADFGSCRGIYSKP------------------------------------------------  153 (282)
T ss_pred             ecccCHHHEEEcC-CCeEEEecccccccccCC------------------------------------------------
Confidence            9999999999999 999999999875331100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......+|+.|+|||++.+...++.++||||+||++
T Consensus       154 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l  189 (282)
T cd07831         154 --------------------------------------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVF  189 (282)
T ss_pred             --------------------------------------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHH
Confidence                                                        001124678899999887666678999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+..+.+..+...+|.+.................++......+.......+..+.+++.+||..||++
T Consensus       190 ~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  269 (282)
T cd07831         190 FEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDE  269 (282)
T ss_pred             HHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccc
Confidence            99999999999999888888888877766653321111111111122332233333344455788999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      |||++++++||||
T Consensus       270 R~~~~~~l~~~~~  282 (282)
T cd07831         270 RITAKQALRHPYF  282 (282)
T ss_pred             ccCHHHHhhCCCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=313.74  Aligned_cols=219  Identities=28%  Similarity=0.412  Sum_probs=178.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++..+..+|+||||+++ +|.+++.... .+++..++.++.|++.||.|||++||+|
T Consensus        46 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH  124 (333)
T cd05600          46 RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIH  124 (333)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4577899999999999999999999999999999999975 9999987643 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++....                                                   
T Consensus       125 ~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---------------------------------------------------  153 (333)
T cd05600         125 RDLKPENFLIDASGHIKLTDFGLSKGIVT---------------------------------------------------  153 (333)
T ss_pred             cCCCHHHEEECCCCCEEEEeCcCCccccc---------------------------------------------------
Confidence            99999999999999999999998653210                                                   


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 .....+||+.|+|||++.+. .++.++||||+||++|
T Consensus       154 -------------------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~  189 (333)
T cd05600         154 -------------------------------------------YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLY  189 (333)
T ss_pred             -------------------------------------------ccCCcccCccccChhHhcCC-CCCCccceecchHHHh
Confidence                                                       01124678999999999876 4899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.+..+....+........                .+....     .....++.+.+|+.+||..+|.+|
T Consensus       190 ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------------~~~~~~-----~~~~~s~~~~~li~~~l~~~~~rr  248 (333)
T cd05600         190 EFLCGFPPFSGSTPNETWENLKYWKETLQ----------------RPVYDD-----PRFNLSDEAWDLITKLINDPSRRF  248 (333)
T ss_pred             hhhhCCCCCCCCCHHHHHHHHHhcccccc----------------CCCCCc-----cccccCHHHHHHHHHHhhChhhhc
Confidence            99999999998877666555533211000                000000     001235678999999999999999


Q ss_pred             CCHHHHHcCccccCCcc
Q psy10954        338 VSAKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~~  354 (562)
                      +|++++++||||.++.+
T Consensus       249 ~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         249 GSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             CCHHHHHhCcccCCCCH
Confidence            99999999999998754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-36  Score=314.13  Aligned_cols=213  Identities=29%  Similarity=0.440  Sum_probs=176.0

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ...+|+.+|+.++||||++++++|..++.+|+||||+.+ +|.+++.... .+++..++.++.|++.||+|||++||+||
T Consensus        46 ~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  124 (323)
T cd05584          46 HTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYR  124 (323)
T ss_pred             HHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            456899999999999999999999999999999999985 8999887643 68999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++......                                                  
T Consensus       125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------------  154 (323)
T cd05584         125 DLKPENILLDAQGHVKLTDFGLCKESIHEG--------------------------------------------------  154 (323)
T ss_pred             CCCHHHeEECCCCCEEEeeCcCCeecccCC--------------------------------------------------
Confidence            999999999999999999999875321000                                                  


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                               ......+||+.|+|||++.+.. ++.++||||+||++||
T Consensus       155 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~e  192 (323)
T cd05584         155 -----------------------------------------TVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYD  192 (323)
T ss_pred             -----------------------------------------CcccccCCCccccChhhccCCC-CCCcceecccHHHHHH
Confidence                                                     0001235789999999997654 7899999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      |++|+.||.+.+....+..+.....                  .           +....++.+.+||.+||+.||++|+
T Consensus       193 ll~G~~pf~~~~~~~~~~~~~~~~~------------------~-----------~~~~~~~~~~~li~~~l~~~p~~R~  243 (323)
T cd05584         193 MLTGAPPFTAENRKKTIDKILKGKL------------------N-----------LPPYLTPEARDLLKKLLKRNPSSRL  243 (323)
T ss_pred             HhcCCCCCCCCCHHHHHHHHHcCCC------------------C-----------CCCCCCHHHHHHHHHHcccCHhHcC
Confidence            9999999998887666655543100                  0           0012346789999999999999999


Q ss_pred             -----CHHHHHcCccccCCcc
Q psy10954        339 -----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       339 -----Ta~elL~Hp~f~~~~~  354 (562)
                           +++++++||||....+
T Consensus       244 ~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         244 GAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CCCCCCHHHHhcCCCcCCCCH
Confidence                 8999999999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=303.78  Aligned_cols=243  Identities=63%  Similarity=1.142  Sum_probs=203.3

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      +....+.+|+++++.++||||+++++++..++..|+||||++++|.+++.... ..+++..+..++.|++.||+|||+++
T Consensus        40 ~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~  119 (283)
T cd07835          40 GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR  119 (283)
T ss_pred             cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34456789999999999999999999999999999999999889999887654 35899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ++||||+|+||+++.++.++|+|||++........                                             
T Consensus       120 ~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---------------------------------------------  154 (283)
T cd07835         120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---------------------------------------------  154 (283)
T ss_pred             eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc---------------------------------------------
Confidence            99999999999999999999999998753321000                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    .....+++..|+|||++.+...++.++|+||+||
T Consensus       155 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  188 (283)
T cd07835         155 ----------------------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGC  188 (283)
T ss_pred             ----------------------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHH
Confidence                                                          0011245778999998877666789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|++||.+.+..+.+..+.+..+.+....|+.....+.+...++.+............+..+.+++.+||+.||
T Consensus       189 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  268 (283)
T cd07835         189 IFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDP  268 (283)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCCh
Confidence            99999999999999988888889999999888888877666655555555554444444445556789999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy10954        335 KQRVSAKTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f  349 (562)
                      ++|||++|+++||||
T Consensus       269 ~~Rpt~~~il~~~~~  283 (283)
T cd07835         269 AKRISAKAALQHPYF  283 (283)
T ss_pred             hhCcCHHHHhcCCCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-36  Score=313.28  Aligned_cols=215  Identities=29%  Similarity=0.447  Sum_probs=176.8

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+|+.+++.+ +||||+++++++...+.+|+|||||++ +|.+++.... .+++..++.++.|++.||.|||++||
T Consensus        39 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~i  117 (320)
T cd05590          39 VECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGI  117 (320)
T ss_pred             HHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567899998876 799999999999999999999999985 8988887643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++......                                               
T Consensus       118 vH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-----------------------------------------------  150 (320)
T cd05590         118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-----------------------------------------------  150 (320)
T ss_pred             EeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-----------------------------------------------
Confidence            999999999999999999999999865321000                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       151 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  185 (320)
T cd05590         151 --------------------------------------------KTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVL  185 (320)
T ss_pred             --------------------------------------------CcccccccCccccCHHHHcCCC-CCCccchhhhHHH
Confidence                                                        0011236899999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+..+.+..+.....                  .++           ...+..+.+|+++||+.||+
T Consensus       186 l~el~~g~~Pf~~~~~~~~~~~i~~~~~------------------~~~-----------~~~~~~~~~li~~~L~~dP~  236 (320)
T cd05590         186 LYEMLCGHAPFEAENEDDLFEAILNDEV------------------VYP-----------TWLSQDAVDILKAFMTKNPT  236 (320)
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHhcCCC------------------CCC-----------CCCCHHHHHHHHHHcccCHH
Confidence            9999999999998887766665543110                  001           11346789999999999999


Q ss_pred             CCCCH------HHHHcCccccCCcc
Q psy10954        336 QRVSA------KTILQHEYFNQVEM  354 (562)
Q Consensus       336 ~R~Ta------~elL~Hp~f~~~~~  354 (562)
                      +|+++      +++++||||..+.+
T Consensus       237 ~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         237 MRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             HCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99998      89999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-36  Score=318.70  Aligned_cols=241  Identities=28%  Similarity=0.410  Sum_probs=177.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ....+|+.+|++++||||+++++++......|+||||+.++|.+++......+++..++.++.||+.||.|||++|||||
T Consensus       102 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        102 GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            34578999999999999999999999999999999999999999998766679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++.....                                                   
T Consensus       182 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~---------------------------------------------------  210 (357)
T PHA03209        182 DVKTENIFINDVDQVCIGDLGAAQFPVVA---------------------------------------------------  210 (357)
T ss_pred             CCCHHHEEECCCCCEEEecCccccccccC---------------------------------------------------
Confidence            99999999999999999999986422100                                                   


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                               .......||+.|+|||++.+.. |+.++||||+||++||
T Consensus       211 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~e  248 (357)
T PHA03209        211 -----------------------------------------PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFE  248 (357)
T ss_pred             -----------------------------------------cccccccccccccCCeecCCCC-CCchhhHHHHHHHHHH
Confidence                                                     0001235788999999987654 8999999999999999


Q ss_pred             HHhCC-CCCCCCC---------HHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchh--hhc--CCCCHHHH
Q psy10954        259 MITKK-TLFAGDS---------EIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFS--EIL--NLPDPLAV  323 (562)
Q Consensus       259 LltG~-~pF~~~~---------~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~l--~~~~~~~~  323 (562)
                      |+++. ++|.+..         ...++..++..++..+......... .......+.........  ..+  ...+..+.
T Consensus       249 ll~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (357)
T PHA03209        249 MLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGE  328 (357)
T ss_pred             HHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHH
Confidence            99854 4444322         1245556666666544432211000 00000000000000000  000  12345778


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +||.+||++||++||||.|+|+||||+++
T Consensus       329 ~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        329 FLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             HHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            99999999999999999999999999863

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-36  Score=320.18  Aligned_cols=218  Identities=28%  Similarity=0.422  Sum_probs=177.0

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+.+|+.++||||+++++++.++..+|+|||||++ +|.+++...  .+++..++.++.|++.||+|||++||+||
T Consensus        89 ~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  166 (370)
T cd05596          89 FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHR  166 (370)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            456899999999999999999999999999999999974 899988654  58999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||++.......                                                  
T Consensus       167 DLkp~NILl~~~~~~kL~DfG~~~~~~~~~--------------------------------------------------  196 (370)
T cd05596         167 DVKPDNMLLDKSGHLKLADFGTCMKMDANG--------------------------------------------------  196 (370)
T ss_pred             CCCHHHEEEcCCCCEEEEeccceeeccCCC--------------------------------------------------
Confidence            999999999999999999999875432100                                                  


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC---CCCchhhHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK---VYSTTVDIWSAGCI  255 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~---~y~~~~DIWSlG~i  255 (562)
                                                              .......+||+.|+|||++.+..   .++.++||||+||+
T Consensus       197 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi  236 (370)
T cd05596         197 ----------------------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF  236 (370)
T ss_pred             ----------------------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence                                                    00011346899999999987542   47899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+....+..+.......                .++.         ....+..+.+||.+||+.+|+
T Consensus       237 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~~~---------~~~~s~~~~~li~~~L~~~p~  291 (370)
T cd05596         237 LYEMLVGDTPFYADSLVGTYSKIMDHKNSL----------------TFPD---------DIEISKQAKDLICAFLTDREV  291 (370)
T ss_pred             HHHHHhCCCCcCCCCHHHHHHHHHcCCCcC----------------CCCC---------cCCCCHHHHHHHHHHccChhh
Confidence            999999999999988776666664321100                0010         012356899999999999999


Q ss_pred             C--CCCHHHHHcCccccCCcc
Q psy10954        336 Q--RVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       336 ~--R~Ta~elL~Hp~f~~~~~  354 (562)
                      +  |+|++|+++||||++..+
T Consensus       292 r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         292 RLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ccCCCCHHHHhcCcccCCCCh
Confidence            8  999999999999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-36  Score=305.32  Aligned_cols=220  Identities=23%  Similarity=0.362  Sum_probs=172.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+++|+.++||||++++++|..+..+|+||||+++ +|...+..   ....+++..++.++.|++.||+|||++|
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3457899999999999999999999999999999999975 88877743   2345899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||++.......                                              
T Consensus       118 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----------------------------------------------  151 (280)
T cd05608         118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----------------------------------------------  151 (280)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCccceecCCCC----------------------------------------------
Confidence            9999999999999999999999999875332100                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......||+.|+|||++.+.. ++.++|+||+||
T Consensus       152 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~  185 (280)
T cd05608         152 ---------------------------------------------SKTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGV  185 (280)
T ss_pred             ---------------------------------------------ccccccCCCcCccCHHHhcCCC-CCccccHHHHHH
Confidence                                                         0001235789999999998764 889999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.........+....-....              .           .....++.+.+++.+||+.||
T Consensus       186 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~-----------~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         186 TLYEMIAARGPFRARGEKVENKELKQRILNDSV--------------T-----------YPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             HHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--------------C-----------CcccCCHHHHHHHHHHhcCCH
Confidence            999999999999875432222222111100000              0           001234678999999999999


Q ss_pred             CCCC-----CHHHHHcCccccCCccc
Q psy10954        335 KQRV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      ++|+     |++++++||||+++.+.
T Consensus       241 ~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         241 EKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             HHhcCCCCCCHHHHhcChhhhcCCHh
Confidence            9999     88999999999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-36  Score=325.10  Aligned_cols=242  Identities=27%  Similarity=0.363  Sum_probs=180.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ....+|+++|++++|||||++++++..++..|+|||++.++|.+++......+++..++.++.|++.||.|||++|||||
T Consensus       205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr  284 (461)
T PHA03211        205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHR  284 (461)
T ss_pred             cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
Confidence            45679999999999999999999999999999999999999999987766679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++.......                                                 
T Consensus       285 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~-------------------------------------------------  315 (461)
T PHA03211        285 DIKTENVLVNGPEDICLGDFGAACFARGSWS-------------------------------------------------  315 (461)
T ss_pred             cCCHHHEEECCCCCEEEcccCCceecccccc-------------------------------------------------
Confidence            9999999999999999999998764321000                                                 


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                              .......+||+.|+|||++.+.. ++.++||||+||++||
T Consensus       316 ----------------------------------------~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~E  354 (461)
T PHA03211        316 ----------------------------------------TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE  354 (461)
T ss_pred             ----------------------------------------cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHH
Confidence                                                    00001236899999999998765 8999999999999999


Q ss_pred             HHhCCCCCCCCC-------HHHHHHHHHHhcCCCCCCCCCCCCC--CCCc-----cCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        259 MITKKTLFAGDS-------EIDQLFRIFRTLGTPHEDVWPGVSK--LPIY-----KTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       259 LltG~~pF~~~~-------~~~~l~~i~~~lg~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      |++|..++.+..       ...++.++++..+....+..+....  ...+     ....+.+....+.+. ...+..+.+
T Consensus       355 l~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d  433 (461)
T PHA03211        355 AAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEY  433 (461)
T ss_pred             HHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHH
Confidence            999876543321       2345666666554332221110000  0000     000111111111111 123567899


Q ss_pred             HHHHccccCCCCCCCHHHHHcCccccC
Q psy10954        325 VFSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      ||.+||++||++|||+.|+|+||||++
T Consensus       434 li~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        434 LVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHcccChhhCcCHHHHhhCcccCC
Confidence            999999999999999999999999974

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-36  Score=314.81  Aligned_cols=221  Identities=27%  Similarity=0.380  Sum_probs=178.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++.....+|+||||++ ++|.+++......+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H  125 (330)
T cd05601          46 SFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH  125 (330)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence            346789999999999999999999999999999999997 5999999877667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||++.........                                               
T Consensus       126 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-----------------------------------------------  158 (330)
T cd05601         126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMV-----------------------------------------------  158 (330)
T ss_pred             ccCchHheEECCCCCEEeccCCCCeECCCCCce-----------------------------------------------
Confidence            999999999999999999999987644211000                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC-----CCCCCchhhHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-----AKVYSTTVDIWSA  252 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~-----~~~y~~~~DIWSl  252 (562)
                                                                 .....+||+.|+|||++.+     ...++.++||||+
T Consensus       159 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl  195 (330)
T cd05601         159 -------------------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL  195 (330)
T ss_pred             -------------------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence                                                       0012356888888888863     3457899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|||++|+.||.+.+....+.++.......                .++.         ....++.+.+|+.+||+ 
T Consensus       196 G~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------~~~~---------~~~~~~~~~~li~~ll~-  249 (330)
T cd05601         196 GVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL----------------KFPE---------DPKVSSDFLDLIQSLLC-  249 (330)
T ss_pred             cceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------------CCCC---------CCCCCHHHHHHHHHHcc-
Confidence            999999999999999887776666654321000                0010         01235678999999998 


Q ss_pred             CCCCCCCHHHHHcCccccCCccc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ||++|+|++++++||||..+++.
T Consensus       250 ~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         250 GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             ChhhCCCHHHHhCCCCcCCCCHH
Confidence            99999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-35  Score=307.87  Aligned_cols=237  Identities=26%  Similarity=0.404  Sum_probs=175.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~-gI   95 (562)
                      ...+.+|+++|+.++||||+++++++..++.+|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++ +|
T Consensus        47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~i  125 (331)
T cd06649          47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQI  125 (331)
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence            35688999999999999999999999999999999999985 9999987643 589999999999999999999986 69


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.....                                                
T Consensus       126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------------------------------------------------  157 (331)
T cd06649         126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------------------------------------------  157 (331)
T ss_pred             EcCCCChhhEEEcCCCcEEEccCccccccccc------------------------------------------------
Confidence            99999999999999999999999986432100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   .....+||+.|+|||++.+.. ++.++||||+||+
T Consensus       158 ---------------------------------------------~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~i  191 (331)
T cd06649         158 ---------------------------------------------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLS  191 (331)
T ss_pred             ---------------------------------------------ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHH
Confidence                                                         001235789999999998764 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCC----CCCCCCCCCCC------ccCCCCCCCccc----hhhh-------
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE----DVWPGVSKLPI------YKTDFPEWRPKK----FSEI-------  314 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~----~~~~~~~~~~~------~~~~~~~~~~~~----~~~~-------  314 (562)
                      +|||++|+.||.+.+..+ +..++   +.+..    ..+........      ............    +..+       
T Consensus       192 l~el~tg~~p~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (331)
T cd06649         192 LVELAIGRYPIPPPDAKE-LEAIF---GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK  267 (331)
T ss_pred             HHHHHhCCCCCCCCCHHH-HHHHh---cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcC
Confidence            999999999998766543 22222   22111    00100000000      000000000000    0000       


Q ss_pred             --cCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        315 --LNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       315 --l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                        ....++++++|+.+||++||++|||++|+|+||||+...
T Consensus       268 ~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         268 LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence              012356889999999999999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580|consensus

Probab=100.00  E-value=3.6e-37  Score=297.06  Aligned_cols=217  Identities=31%  Similarity=0.521  Sum_probs=184.5

Q ss_pred             cccCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHH
Q psy10954         12 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        12 ~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ..+.++++...||++|-.+|+||||.++|++|.++..+||++||.. ++|+..++... ..+++..+..|++|++.||.|
T Consensus        60 i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y  139 (281)
T KOG0580|consen   60 ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLY  139 (281)
T ss_pred             HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHH
Confidence            4566788889999999999999999999999999999999999997 69999888544 359999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||.++||||||||+|+|++.+|.+|++|||-+..-                                             
T Consensus       140 ~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~---------------------------------------------  174 (281)
T KOG0580|consen  140 CHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------------------------------------------  174 (281)
T ss_pred             hccCCcccCCCCHHHhccCCCCCeeccCCCceeec---------------------------------------------
Confidence            99999999999999999998888888888853211                                             


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                      +.++..+.|||..|.+||...+.. ++..+|+
T Consensus       175 ------------------------------------------------p~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~  205 (281)
T KOG0580|consen  175 ------------------------------------------------PSNKRKTLCGTLDYLPPEMVEGRG-HDKFVDL  205 (281)
T ss_pred             ------------------------------------------------CCCCceeeecccccCCHhhcCCCC-ccchhhH
Confidence                                                            122335678899999999887765 8999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |++|++.||++.|.+||...+..+...+|...--.                  +|           ...+..+.|+|++|
T Consensus       206 w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------------------~p-----------~~is~~a~dlI~~l  256 (281)
T KOG0580|consen  206 WSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------------------FP-----------STISGGAADLISRL  256 (281)
T ss_pred             HHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc------------------CC-----------cccChhHHHHHHHH
Confidence            99999999999999999999988888877653111                  11           12356899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccC
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      |..+|.+|.+..|++.|||...
T Consensus       257 l~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  257 LVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             hccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999864

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-35  Score=301.47  Aligned_cols=242  Identities=48%  Similarity=0.856  Sum_probs=190.9

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ......+|+.+|+.++|+||+++++++..+...|+||||+.++|.+++......+++..++.++.|++.||.|||++||+
T Consensus        46 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~  125 (291)
T cd07870          46 VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL  125 (291)
T ss_pred             CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34467899999999999999999999999999999999999899888776555688999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......                                               
T Consensus       126 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-----------------------------------------------  158 (291)
T cd07870         126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-----------------------------------------------  158 (291)
T ss_pred             cCCCChHHEEEcCCCcEEEeccccccccCCCCC-----------------------------------------------
Confidence            999999999999999999999998753211000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  .....++++.|+|||++.+...++.++||||+||++
T Consensus       159 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  194 (291)
T cd07870         159 --------------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIF  194 (291)
T ss_pred             --------------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHH
Confidence                                                        001124578899999987766688999999999999


Q ss_pred             HHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCC-CccchhhhcC--CCCHHHHHHHHHcccc
Q psy10954        257 SEMITKKTLFAGDS-EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW-RPKKFSEILN--LPDPLAVDVFSKIMAL  332 (562)
Q Consensus       257 ~eLltG~~pF~~~~-~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~--~~~~~~~dLi~~mL~~  332 (562)
                      |+|++|..||.+.+ ..+.+.++...+|.|....++.....+.+....... .+..+.....  ..++.+.+++.+||+.
T Consensus       195 ~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~  274 (291)
T cd07870         195 IEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMM  274 (291)
T ss_pred             HHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCc
Confidence            99999999997655 446777788888888777766555444333222111 1111111111  1256789999999999


Q ss_pred             CCCCCCCHHHHHcCccc
Q psy10954        333 DPKQRVSAKTILQHEYF  349 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f  349 (562)
                      ||++|||++|++.||||
T Consensus       275 dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         275 FPKDRISAQDALLHPYF  291 (291)
T ss_pred             CcccCcCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.4e-36  Score=317.87  Aligned_cols=218  Identities=30%  Similarity=0.422  Sum_probs=175.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..+..+|+|||||++ +|.+++...  .+++..++.++.|++.||+|||++||+|
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvH  165 (370)
T cd05621          88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIH  165 (370)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3467899999999999999999999999999999999974 999988654  5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+|.......                                                 
T Consensus       166 rDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-------------------------------------------------  196 (370)
T cd05621         166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-------------------------------------------------  196 (370)
T ss_pred             cCCCHHHEEECCCCCEEEEecccceecccCC-------------------------------------------------
Confidence            9999999999999999999999875432100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC---CCCchhhHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK---VYSTTVDIWSAGC  254 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~---~y~~~~DIWSlG~  254 (562)
                                                               .....+.+||+.|+|||++.+.+   .++.++||||+||
T Consensus       197 -----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~  235 (370)
T cd05621         197 -----------------------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  235 (370)
T ss_pred             -----------------------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehH
Confidence                                                     00012346899999999997543   3789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+....+.++........                ++..         ...+..+++++.+||+.++
T Consensus       236 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------~p~~---------~~~s~~~~~li~~~L~~~~  290 (370)
T cd05621         236 FLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN----------------FPED---------VEISKHAKNLICAFLTDRE  290 (370)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC----------------CCCc---------ccCCHHHHHHHHHHccCch
Confidence            99999999999999887776666654221100                0000         1135678999999998665


Q ss_pred             CC--CCCHHHHHcCccccCCc
Q psy10954        335 KQ--RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~--R~Ta~elL~Hp~f~~~~  353 (562)
                      .+  |+|+.|+++||||+...
T Consensus       291 ~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         291 VRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             hccCCCCHHHHhcCcccCCCC
Confidence            44  89999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-36  Score=314.18  Aligned_cols=214  Identities=29%  Similarity=0.434  Sum_probs=174.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gIi   96 (562)
                      ....+|+++++.++||||+++++++..++.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||+ +||+
T Consensus        40 ~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~iv  118 (325)
T cd05594          40 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVV  118 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEE
Confidence            3567899999999999999999999999999999999985 888887654 368999999999999999999997 7999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 HrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~------------------------------------------------  150 (325)
T cd05594         119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG------------------------------------------------  150 (325)
T ss_pred             ecCCCCCeEEECCCCCEEEecCCCCeecCCCC------------------------------------------------
Confidence            99999999999999999999999875321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       151 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  186 (325)
T cd05594         151 -------------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVM  186 (325)
T ss_pred             -------------------------------------------cccccccCCcccCCHHHHccCC-CCCcccccccccee
Confidence                                                       0011235899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+....+....  .                .++           ...++.+.+|+.+||+.||++
T Consensus       187 ~el~tG~~Pf~~~~~~~~~~~i~~~~--~----------------~~p-----------~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         187 YEMMCGRLPFYNQDHEKLFELILMEE--I----------------RFP-----------RTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             eeeccCCCCCCCCCHHHHHHHHhcCC--C----------------CCC-----------CCCCHHHHHHHHHHhhcCHHH
Confidence            99999999998877655444432110  0                000           123567899999999999999


Q ss_pred             CC-----CHHHHHcCccccCCcc
Q psy10954        337 RV-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~  354 (562)
                      |+     ++.++++||||.++.+
T Consensus       238 R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         238 RLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             hCCCCCCCHHHHhcCCCcCCCCH
Confidence            97     8999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.6e-36  Score=311.17  Aligned_cols=215  Identities=29%  Similarity=0.438  Sum_probs=177.2

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .....|.++++.+ +||||++++++|..++.+|+||||+++ +|..++.... .+++..++.++.|++.||.|||++||+
T Consensus        40 ~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  118 (321)
T cd05591          40 DCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVI  118 (321)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4467899999866 899999999999999999999999975 8988886543 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 HrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~------------------------------------------------  150 (321)
T cd05591         119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNG------------------------------------------------  150 (321)
T ss_pred             ccCCCHHHeEECCCCCEEEeecccceecccCC------------------------------------------------
Confidence            99999999999999999999999875321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       151 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il  186 (321)
T cd05591         151 -------------------------------------------VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLM  186 (321)
T ss_pred             -------------------------------------------ccccccccCccccCHHHHcCCC-CCCccceechhHHH
Confidence                                                       0011235799999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+.+..+....-                  .++           ...++.+.+++.+||+.||++
T Consensus       187 ~el~tg~~Pf~~~~~~~~~~~i~~~~~------------------~~p-----------~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         187 YEMMAGQPPFEADNEDDLFESILHDDV------------------LYP-----------VWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHcCCC------------------CCC-----------CCCCHHHHHHHHHHhccCHHH
Confidence            999999999999888777766643110                  001           112467899999999999999


Q ss_pred             CC-------CHHHHHcCccccCCccc
Q psy10954        337 RV-------SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~-------Ta~elL~Hp~f~~~~~~  355 (562)
                      |+       +++++++||||..+.+.
T Consensus       238 R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         238 RLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             cCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            99       89999999999886543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-35  Score=301.43  Aligned_cols=245  Identities=45%  Similarity=0.815  Sum_probs=190.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC--------EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF--------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~--------~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      .....+|+++++.++||||+++++++....        ..|+||||++++|.+++......+++..++.++.|++.||+|
T Consensus        55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~  134 (310)
T cd07865          55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY  134 (310)
T ss_pred             hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            445678999999999999999999986543        469999999999999887765579999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+||||||+||+++.++.+||+|||++..........                                      
T Consensus       135 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--------------------------------------  176 (310)
T cd07865         135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK--------------------------------------  176 (310)
T ss_pred             HHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccC--------------------------------------
Confidence            999999999999999999999999999999876442110000                                      


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                       .......+++..|+|||.+.+...++.++||
T Consensus       177 -------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  207 (310)
T cd07865         177 -------------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDM  207 (310)
T ss_pred             -------------------------------------------------CCCccCcccCccccCcHHhcCCcccCchhhh
Confidence                                                             0001123568899999998876668899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhc--CCCCHHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEIL--NLPDPLAVDVF  326 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l--~~~~~~~~dLi  326 (562)
                      ||+||++|||++|.+||.+.+....+..+....|..+.+.++.......+.. .++..........+  ...+..+.|||
T Consensus       208 ~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli  287 (310)
T cd07865         208 WGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLI  287 (310)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHH
Confidence            9999999999999999999888877777777778777776665543222111 11111111111111  12356789999


Q ss_pred             HHccccCCCCCCCHHHHHcCccc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      .+||..||.+|||++|+|+||||
T Consensus       288 ~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         288 DKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHhcCChhhccCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-35  Score=302.69  Aligned_cols=252  Identities=43%  Similarity=0.774  Sum_probs=195.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC--------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      .....+|+++++.++||||+++++++...        ..+|+||||+.++|.+.+......+++..++.++.|++.||+|
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~  130 (311)
T cd07866          51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY  130 (311)
T ss_pred             chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence            44678999999999999999999987543        3579999999999988887665679999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+||||||+||+++.++.+||+|||+++..........         .+                          
T Consensus       131 lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---------~~--------------------------  175 (311)
T cd07866         131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK---------GG--------------------------  175 (311)
T ss_pred             HHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccc---------cC--------------------------
Confidence            9999999999999999999999999999999865432100000         00                          


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                              +     ..........+||+.|+|||++.+...++.++||
T Consensus       176 ----------------------------------------~-----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  210 (311)
T cd07866         176 ----------------------------------------G-----GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI  210 (311)
T ss_pred             ----------------------------------------C-----cccccccccceeccCcCChHHhhCCCccCchhHh
Confidence                                                    0     0001122345779999999999876668999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+||++|||++|++||.+.+....+..+....+.+....|+.....+.... ......+..+...+....+.+.+|+.+
T Consensus       211 ~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  290 (311)
T cd07866         211 WGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK  290 (311)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHH
Confidence            9999999999999999999999888888888888777666654433332211 111111122222333445778999999


Q ss_pred             ccccCCCCCCCHHHHHcCccc
Q psy10954        329 IMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      ||+.||++|||+.|++.||||
T Consensus       291 ~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         291 LLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HcccCcccCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0664|consensus

Probab=100.00  E-value=2.1e-38  Score=309.77  Aligned_cols=244  Identities=35%  Similarity=0.662  Sum_probs=195.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      +++.||+++|...+|.||..+.|..+..     ..+|+|+|+|..||.++|-+.+ .++.+.++-+++||++||+|||+.
T Consensus        97 krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA  175 (449)
T KOG0664|consen   97 KRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTA  175 (449)
T ss_pred             HHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhc
Confidence            4678999999999999999999988755     3579999999999999887644 799999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||.|.|++.++.+||||||+||.......                                            
T Consensus       176 ~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--------------------------------------------  211 (449)
T KOG0664|consen  176 NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--------------------------------------------  211 (449)
T ss_pred             chhhccCCCccEEeccCceEEecccccccccchhhh--------------------------------------------
Confidence            999999999999999999999999999875432110                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ...+..+.|.+|||||++.|.+.|+.++||||+|
T Consensus       212 ----------------------------------------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVG  245 (449)
T KOG0664|consen  212 ----------------------------------------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVG  245 (449)
T ss_pred             ----------------------------------------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhh
Confidence                                                          1123457788999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchhhhcCC-----CCHHHHHHHH
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFSEILNL-----PDPLAVDVFS  327 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~-----~~~~~~dLi~  327 (562)
                      ||+.||+..+.+|...+..+++..|.+.+|+|..+....... .+.... ....++..+..+...     ....+.+++.
T Consensus       246 CIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L-R~~~k~Ps~~vLYtlsS~~~~~heav~~~~  324 (449)
T KOG0664|consen  246 CIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL-RAGLRAPDTQRLYKIASPDDKNHEAVDLLQ  324 (449)
T ss_pred             HHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh-ccCCCCCCccceeeecCCcccchHHHHHHH
Confidence            999999999999999999999999999999998654321111 000000 011111122222221     2456899999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      +||.+||++|++.+++++|+|..+...
T Consensus       325 ~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  325 KLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHhCCCCcccccHhhhcccccccccce
Confidence            999999999999999999999987653

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.4e-36  Score=314.70  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=182.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.++..++||||+++++.+.....+|+|||||++ +|.+++.+.. .+++..++.++.|++.||+|||++||+
T Consensus        45 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~giv  123 (360)
T cd05627          45 VAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFI  123 (360)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34567899999999999999999999999999999999975 8999987643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.........  .........|             +-+++...            
T Consensus       124 HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~--~~~~~~~~~~-------------~~~~~~~~------------  176 (360)
T cd05627         124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE--FYRNLTHNPP-------------SDFSFQNM------------  176 (360)
T ss_pred             ccCCCHHHEEECCCCCEEEeeccCCcccccccccc--cccccccCCc-------------cccccccc------------
Confidence            99999999999999999999999987553211000  0000000000             00111000            


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                           .                   ...+...+.     ..........+||+.|+|||++.+.. |+.++||||+||++
T Consensus       177 -----~-------------------~~~~~~~~~-----~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil  226 (360)
T cd05627         177 -----N-------------------SKRKAETWK-----KNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIM  226 (360)
T ss_pred             -----c-------------------ccccccccc-----ccccccccccCCCccccCHHHHcCCC-CCCcceecccccee
Confidence                 0                   000000000     00011122458999999999998755 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|++||.+.+..+....+.......                .++..         ...++.++|||.+|+. ||.+
T Consensus       227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~~---------~~~s~~~~~li~~l~~-~p~~  280 (360)
T cd05627         227 YEMLIGYPPFCSETPQETYRKVMNWKETL----------------VFPPE---------VPISEKAKDLILRFCT-DSEN  280 (360)
T ss_pred             eecccCCCCCCCCCHHHHHHHHHcCCCce----------------ecCCC---------CCCCHHHHHHHHHhcc-Chhh
Confidence            99999999999888766665554311000                01100         0135689999999875 9999


Q ss_pred             CCC---HHHHHcCccccCCccc
Q psy10954        337 RVS---AKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~T---a~elL~Hp~f~~~~~~  355 (562)
                      |++   ++|+++||||+++++.
T Consensus       281 R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         281 RIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             cCCCCCHHHHhcCCCCCCCCHH
Confidence            994   7999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9e-36  Score=308.76  Aligned_cols=214  Identities=31%  Similarity=0.475  Sum_probs=173.5

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .....|..++..+ +||||+++++++..++.+|+||||+.+ +|..++... ..+++..++.++.|++.||+|||++||+
T Consensus        40 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iv  118 (316)
T cd05620          40 ECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGII  118 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4567788888754 899999999999999999999999975 898888764 4689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.....                                                 
T Consensus       119 HrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------  149 (316)
T cd05620         119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFG-------------------------------------------------  149 (316)
T ss_pred             ecCCCHHHeEECCCCCEEeCccCCCeecccC-------------------------------------------------
Confidence            9999999999999999999999986421100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       150 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil  186 (316)
T cd05620         150 ------------------------------------------DNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLL  186 (316)
T ss_pred             ------------------------------------------CCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHH
Confidence                                                      00012346899999999998654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+.+..+...  .+                .++           ...+..+.+|+.+||+.||++
T Consensus       187 ~el~~g~~Pf~~~~~~~~~~~~~~~--~~----------------~~~-----------~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         187 YEMLIGQSPFHGDDEDELFESIRVD--TP----------------HYP-----------RWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhC--CC----------------CCC-----------CCCCHHHHHHHHHHccCCHHH
Confidence            9999999999988776555444221  10                011           113467899999999999999


Q ss_pred             CCCH-HHHHcCccccCCcc
Q psy10954        337 RVSA-KTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~Ta-~elL~Hp~f~~~~~  354 (562)
                      |+++ +++++||||+.+.+
T Consensus       238 R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         238 RLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             cCCChHHHHcCCCcCCCCH
Confidence            9997 58999999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=303.94  Aligned_cols=247  Identities=40%  Similarity=0.824  Sum_probs=188.6

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHH
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTP----VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~----~~l~e~~i~~i~~qll~aL~   88 (562)
                      ++......+|+.+++.++||||+++++++...  ..+|+||||++++|.+++....    ..+++..++.++.|++.||.
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  122 (316)
T cd07842          43 TGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH  122 (316)
T ss_pred             cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHH
Confidence            34456778999999999999999999999988  8899999999988888775322    25899999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEcc----CCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         89 YCHSRRIIHRDLKPQNILINK----SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~----~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      |||++||+||||||+||+++.    ++.+||+|||++.........                                  
T Consensus       123 ~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----------------------------------  168 (316)
T cd07842         123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP----------------------------------  168 (316)
T ss_pred             HHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc----------------------------------
Confidence            999999999999999999998    888999999987643211000                                  


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                                            .......++|+.|+|||++.+...++
T Consensus       169 ------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (316)
T cd07842         169 ------------------------------------------------------LADLDPVVVTIWYRAPELLLGARHYT  194 (316)
T ss_pred             ------------------------------------------------------ccccCCccccccccCHHHHhCCCCCC
Confidence                                                                  00011235788999999998777789


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHhcCCCCCCCCCCCCCCCCccCC---CC--CCCccc
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEI---------DQLFRIFRTLGTPHEDVWPGVSKLPIYKTD---FP--EWRPKK  310 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~---------~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~---~~--~~~~~~  310 (562)
                      .++||||+||++|+|++|++||.+....         ..+..++..++.+....|......+.+...   ..  ......
T Consensus       195 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (316)
T cd07842         195 KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNS  274 (316)
T ss_pred             cHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCcc
Confidence            9999999999999999999999866532         456677777877766655443333322210   00  000011


Q ss_pred             hhhhc---CCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q psy10954        311 FSEIL---NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       311 ~~~~l---~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      .....   ...+..+.+++.+||+.||++|||+.|+++||||
T Consensus       275 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         275 LAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            11111   1346788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0574|consensus

Probab=100.00  E-value=2.2e-37  Score=305.91  Aligned_cols=223  Identities=26%  Similarity=0.445  Sum_probs=184.4

Q ss_pred             ccccCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q psy10954         11 RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        11 ~~~~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      .+.++...+.+..||.||++.+.|+||++|+.|.....+++|||||+ ++..++++.++.+++|..+..+++..+.||+|
T Consensus        65 ~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~Y  144 (502)
T KOG0574|consen   65 KVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQY  144 (502)
T ss_pred             ecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHH
Confidence            45567778899999999999999999999999999999999999998 69999999888899999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||...-||||||..|||++.+|..||+|||.|..++                                            
T Consensus       145 LH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--------------------------------------------  180 (502)
T KOG0574|consen  145 LHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--------------------------------------------  180 (502)
T ss_pred             HHHHHHHHhhcccccEEEcccchhhhhhccccchhh--------------------------------------------
Confidence            999999999999999999888888888888764432                                            


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                     ..+....+.+|||.||||||+..-+ |++++||
T Consensus       181 -----------------------------------------------DTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADI  212 (502)
T KOG0574|consen  181 -----------------------------------------------DTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADI  212 (502)
T ss_pred             -----------------------------------------------hhHHhhCccccCcccccHHHHHHhc-cchhhhH
Confidence                                                           1222334668999999999997655 9999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCC-ccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+|++..||..|++||.+-.....++.|-   ..|+                 |.++ |..       -+..+-||+++
T Consensus       213 WSLGITaIEMAEG~PPYsDIHPMRAIFMIP---T~PP-----------------PTF~KPE~-------WS~~F~DFi~~  265 (502)
T KOG0574|consen  213 WSLGITAIEMAEGRPPYSDIHPMRAIFMIP---TKPP-----------------PTFKKPEE-------WSSEFNDFIRS  265 (502)
T ss_pred             hhhcchhhhhhcCCCCcccccccceeEecc---CCCC-----------------CCCCChHh-------hhhHHHHHHHH
Confidence            999999999999999998766544333221   1111                 0110 111       13578899999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCC
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||..+|++|.||.++++|||.++.
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCC
Confidence            999999999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-35  Score=308.15  Aligned_cols=213  Identities=24%  Similarity=0.428  Sum_probs=173.1

Q ss_pred             hhHHHHHHHH---HccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVL---KELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL---~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+.++   +.++||||+++++++..+..+|+||||+.+ +|...+..  ..+++..++.++.|++.||+|||++|
T Consensus        44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05589          44 ESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK  121 (324)
T ss_pred             HHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456676665   567899999999999999999999999985 88877754  36999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.++.+||+|||+++.....                                               
T Consensus       122 ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-----------------------------------------------  154 (324)
T cd05589         122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-----------------------------------------------  154 (324)
T ss_pred             eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----------------------------------------------
Confidence            999999999999999999999999986432100                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .......+||+.|+|||++.+.. ++.++||||+||
T Consensus       155 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~  189 (324)
T cd05589         155 --------------------------------------------GDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGV  189 (324)
T ss_pred             --------------------------------------------CCcccccccCccccCHhHhcCCC-CCcccchhhHHH
Confidence                                                        00012346899999999997654 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.+..+.+..+......                  ++           ...++.+.++|.+||+.||
T Consensus       190 il~el~~G~~pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~~L~~dP  240 (324)
T cd05589         190 LIYEMLVGESPFPGDDEEEVFDSIVNDEVR------------------YP-----------RFLSREAISIMRRLLRRNP  240 (324)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------CCCCHHHHHHHHHHhhcCH
Confidence            999999999999988877666655432100                  00           1124678899999999999


Q ss_pred             CCCC-----CHHHHHcCccccCCcc
Q psy10954        335 KQRV-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       335 ~~R~-----Ta~elL~Hp~f~~~~~  354 (562)
                      ++|+     +++++++||||+++.+
T Consensus       241 ~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         241 ERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             hHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            9999     6999999999988653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-36  Score=311.44  Aligned_cols=214  Identities=30%  Similarity=0.462  Sum_probs=176.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ....+|+++|++++||||+++++++..++.+|+||||+. ++|.+++.+. ..+++..++.++.|++.||.|||++||+|
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  121 (318)
T cd05582          43 VRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIY  121 (318)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            345789999999999999999999999999999999997 5999988654 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       122 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------------  152 (318)
T cd05582         122 RDLKPENILLDEEGHIKLTDFGLSKESIDHE-------------------------------------------------  152 (318)
T ss_pred             CCCCHHHeEECCCCcEEEeeccCCcccCCCC-------------------------------------------------
Confidence            9999999999999999999999875321100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       153 ------------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~  189 (318)
T cd05582         153 ------------------------------------------KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMF  189 (318)
T ss_pred             ------------------------------------------CceecccCChhhcCHHHHcCCC-CCCccceeccceEee
Confidence                                                      0011235789999999997654 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||.+.+..+.+..+......                             +....++.+.+|+++||+.||++|
T Consensus       190 el~tg~~p~~~~~~~~~~~~i~~~~~~-----------------------------~p~~~~~~~~~li~~~l~~~P~~R  240 (318)
T cd05582         190 EMLTGSLPFQGKDRKETMTMILKAKLG-----------------------------MPQFLSPEAQSLLRALFKRNPANR  240 (318)
T ss_pred             eeccCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCHHHHHHHHHHhhcCHhHc
Confidence            999999999988876666655431100                             001235678999999999999999


Q ss_pred             CC-----HHHHHcCccccCCcc
Q psy10954        338 VS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~T-----a~elL~Hp~f~~~~~  354 (562)
                      +|     ++++++||||..+.+
T Consensus       241 ~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         241 LGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             CCCCCCCHHHHhCCCCcCCCCH
Confidence            99     678999999987653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=297.78  Aligned_cols=243  Identities=64%  Similarity=1.128  Sum_probs=207.2

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .......+|+.+++.++||||+++++++......|+||||++++|.+++.+....+++..+..++.|++.||.|||++||
T Consensus        40 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (282)
T cd07829          40 GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI  119 (282)
T ss_pred             cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34556788999999999999999999999999999999999999999998764569999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++.......                                              
T Consensus       120 ~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----------------------------------------------  153 (282)
T cd07829         120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----------------------------------------------  153 (282)
T ss_pred             ccCCCChheEEEcCCCCEEEecCCcccccCCCcc----------------------------------------------
Confidence            9999999999999999999999998754321100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||.+.+...++.++|+||+||+
T Consensus       154 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~  188 (282)
T cd07829         154 ---------------------------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCI  188 (282)
T ss_pred             ---------------------------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHH
Confidence                                                         01122346789999998776568999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ++||++|.+||.+.+..+.+.++.+.++.+....|+.......+...++.+........++..+..+.+++.+||+.||+
T Consensus       189 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  268 (282)
T cd07829         189 FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA  268 (282)
T ss_pred             HHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcc
Confidence            99999999999999999999999999999888888777766655566666665555555555678899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +||++.++++||||
T Consensus       269 ~Rp~~~~~l~~p~~  282 (282)
T cd07829         269 KRISAKEALKHPYF  282 (282)
T ss_pred             cCCCHHHHhhCcCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6e-35  Score=303.89  Aligned_cols=256  Identities=41%  Similarity=0.735  Sum_probs=202.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+++|+.++||||+++++++..+...|+||||+.++|.+++... ..+++..+..++.|++.||+|||++||+||
T Consensus        65 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~  143 (335)
T PTZ00024         65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHR  143 (335)
T ss_pred             hhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            3578999999999999999999999999999999999999999998754 358999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||+++.......           . +...                                
T Consensus       144 dl~~~nill~~~~~~kl~dfg~~~~~~~~~~-----------~-~~~~--------------------------------  179 (335)
T PTZ00024        144 DLSPANIFINSKGICKIADFGLARRYGYPPY-----------S-DTLS--------------------------------  179 (335)
T ss_pred             cccHHHeEECCCCCEEECCccceeecccccc-----------c-cccc--------------------------------
Confidence            9999999999999999999998765431100           0 0000                                


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                .+                  .+.     ..........+++.|+|||.+.+...++.++|+||+||++||
T Consensus       180 ----------~~------------------~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~e  226 (335)
T PTZ00024        180 ----------KD------------------ETM-----QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE  226 (335)
T ss_pred             ----------cc------------------ccc-----cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHH
Confidence                      00                  000     000011233568899999999877668999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      |++|.+||.+.+..+.+..+...++.+....|+.....+.+.. +....+..+.......+..+.++|.+||+.||++|+
T Consensus       227 l~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  305 (335)
T PTZ00024        227 LLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE-FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI  305 (335)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc-cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence            9999999999999999999999998888777765544333221 111122333344455577899999999999999999


Q ss_pred             CHHHHHcCccccCCc
Q psy10954        339 SAKTILQHEYFNQVE  353 (562)
Q Consensus       339 Ta~elL~Hp~f~~~~  353 (562)
                      |++|+|.||||+...
T Consensus       306 s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        306 SAKEALKHEYFKSDP  320 (335)
T ss_pred             CHHHHhcCcccCCCC
Confidence            999999999998653

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-36  Score=311.24  Aligned_cols=214  Identities=28%  Similarity=0.423  Sum_probs=173.0

Q ss_pred             hHHHHHHHHHcc---CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         20 TALREISVLKEL---KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        20 ~~~rEi~iL~~l---~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+|..++...   +||||++++++|.....+|+||||+.+ +|..++... ..+++..++.++.|++.||+|||++||
T Consensus        39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~i  117 (330)
T cd05586          39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDI  117 (330)
T ss_pred             HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345677777665   699999999999999999999999975 898888754 469999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.....                                                
T Consensus       118 vHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~------------------------------------------------  149 (330)
T cd05586         118 VYRDLKPENILLDATGHIALCDFGLSKANLTD------------------------------------------------  149 (330)
T ss_pred             EeccCCHHHeEECCCCCEEEecCCcCcCCCCC------------------------------------------------
Confidence            99999999999999999999999987532100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .......+||+.|+|||++.+...++.++||||+||+
T Consensus       150 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvi  186 (330)
T cd05586         150 -------------------------------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL  186 (330)
T ss_pred             -------------------------------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccE
Confidence                                                       0001234689999999999876668999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+.+..+.+..+...  ..                .++.          ...++.+.+|+++||..||+
T Consensus       187 l~elltG~~Pf~~~~~~~~~~~i~~~--~~----------------~~~~----------~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         187 VFEMCCGWSPFYAEDTQQMYRNIAFG--KV----------------RFPK----------NVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             EEEeccCCCCCCCCCHHHHHHHHHcC--CC----------------CCCC----------ccCCHHHHHHHHHHcCCCHH
Confidence            99999999999988766555444321  00                0000          11346789999999999999


Q ss_pred             CCC----CHHHHHcCccccCCc
Q psy10954        336 QRV----SAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~----Ta~elL~Hp~f~~~~  353 (562)
                      +|+    ++.++++||||.+..
T Consensus       239 ~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         239 HRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HCCCCCCCHHHHhcCccccCCC
Confidence            998    689999999998764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.7e-35  Score=293.90  Aligned_cols=241  Identities=39%  Similarity=0.703  Sum_probs=181.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+.+|+++++.++||||+++++++......|+||||+++++.+.+......+++..++.++.|++.||+|||++||+|
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H  123 (286)
T cd07847          44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH  123 (286)
T ss_pred             cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            34567999999999999999999999999999999999997544444434446999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++........                                                
T Consensus       124 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------  155 (286)
T cd07847         124 RDVKPENILITKQGQIKLCDFGFARILTGPGD------------------------------------------------  155 (286)
T ss_pred             cCCChhhEEEcCCCcEEECccccceecCCCcc------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||++.+...++.++||||+||++|
T Consensus       156 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~  192 (286)
T cd07847         156 -------------------------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFA  192 (286)
T ss_pred             -------------------------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHH
Confidence                                                       0012246788999999987666899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCC-CCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPE-WRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|++|++||.+.+..+.+..+...++...............+. ...+. .........+...+..+.+|+.+||+.||+
T Consensus       193 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  272 (286)
T cd07847         193 ELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPT  272 (286)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcc
Confidence            9999999999988877777666655432211000000000000 00000 001112223344567899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||+.|+++||||
T Consensus       273 ~Rp~~~eil~~~~f  286 (286)
T cd07847         273 ERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-35  Score=309.18  Aligned_cols=250  Identities=34%  Similarity=0.689  Sum_probs=197.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+.+|+.++||||++++++|..    ...+|+||||++++|.+++.... .+++..++.++.|++.||.|||++
T Consensus        48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~  126 (334)
T cd07855          48 AKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA  126 (334)
T ss_pred             hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3457789999999999999999998863    35789999999989999886543 599999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+||+++.++.+||+|||++.........                                           
T Consensus       127 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------------------------------------------  163 (334)
T cd07855         127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE-------------------------------------------  163 (334)
T ss_pred             CeecCCCCHHHEEEcCCCcEEecccccceeecccCcC-------------------------------------------
Confidence            9999999999999999999999999987543211000                                           


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                  ........+||.+|+|||++.+...++.++||||+|
T Consensus       164 --------------------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG  199 (334)
T cd07855         164 --------------------------------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG  199 (334)
T ss_pred             --------------------------------------------CCcccccccccccccChHHhcCCcccccccchHHHH
Confidence                                                        000011246788999999987766689999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      |++|||++|++||.+.+...++..+...+|.++...+......  ..+...++......+....+..++.+.++|++||+
T Consensus       200 ~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  279 (334)
T cd07855         200 CIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQ  279 (334)
T ss_pred             HHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHcc
Confidence            9999999999999999888888888888998877665433221  11111222222223334445567889999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCccc
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      .||++|||+.++++||||.+....
T Consensus       280 ~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         280 FDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             CChhhCcCHHHHHhChhhhhccCC
Confidence            999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0589|consensus

Probab=100.00  E-value=3.2e-36  Score=317.47  Aligned_cols=218  Identities=30%  Similarity=0.487  Sum_probs=188.6

Q ss_pred             cCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCE-EEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFK-LFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~-i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      .+..+..+..|+.++++++|||||.+++.|..++. +||||+||+| +|.+.|...+ ..++|+.+..++.|++.||+||
T Consensus        43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl  122 (426)
T KOG0589|consen   43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL  122 (426)
T ss_pred             CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            34445688999999999999999999999998887 9999999985 9999987766 5699999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |+++|+|||||+.||++..++.|||.|||+|+.+....                                          
T Consensus       123 H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~------------------------------------------  160 (426)
T KOG0589|consen  123 HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED------------------------------------------  160 (426)
T ss_pred             HhhhhhcccchhhhhhccccCceeecchhhhhhcCCch------------------------------------------
Confidence            99999999999999999999999999999988664221                                          


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                       ....+.+||++||+||++.+.+ |+.++|||
T Consensus       161 -------------------------------------------------~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiW  190 (426)
T KOG0589|consen  161 -------------------------------------------------SLASTVVGTPYYMCPEILSDIP-YNEKSDIW  190 (426)
T ss_pred             -------------------------------------------------hhhheecCCCcccCHHHhCCCC-CCccCcch
Confidence                                                             1124568999999999998876 99999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|||++-+++|.+.+-.....+|.+....|..                            ...+.+++.+++.||
T Consensus       191 sLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----------------------------~~ys~el~~lv~~~l  242 (426)
T KOG0589|consen  191 SLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----------------------------SMYSSELRSLVKSML  242 (426)
T ss_pred             hhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC----------------------------ccccHHHHHHHHHHh
Confidence            9999999999999999999988888888776533321                            223467889999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      ..+|..||+|.++|.+|....
T Consensus       243 ~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  243 RKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             hcCCccCCCHHHHhhChhhhh
Confidence            999999999999999987763

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6e-35  Score=303.35  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=175.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+++.++||||++++++|..++..|+||||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+
T Consensus        44 ~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ii  123 (327)
T cd08227          44 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYV  123 (327)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            4566899999999999999999999999999999999984 8999886542 3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.++++|||.+..........                                             
T Consensus       124 H~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~---------------------------------------------  158 (327)
T cd08227         124 HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL---------------------------------------------  158 (327)
T ss_pred             cCCCChhhEEEecCCcEEEcccchhhccccccccc---------------------------------------------
Confidence            99999999999999999999998643221000000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCI  255 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~i  255 (562)
                                                 -.+.||            ....+++..|+|||++.+. ..|+.++||||+||+
T Consensus       159 ---------------------------~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~i  199 (327)
T cd08227         159 ---------------------------RVVHDF------------PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT  199 (327)
T ss_pred             ---------------------------cccccc------------cccccceecccChHHhhcccCCCCchhhHHHHHHH
Confidence                                       000011            0123567889999999764 358999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCC----------CCCCCCCCCCCccCCC----------CCCCccchhhhc
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE----------DVWPGVSKLPIYKTDF----------PEWRPKKFSEIL  315 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~----------~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l  315 (562)
                      +|||++|+.||.+............  +..+.          +....... .......          +...........
T Consensus       200 l~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (327)
T cd08227         200 ACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSR-SGANSGLGESTTVSTPRPSNGESSSHPYN  276 (327)
T ss_pred             HHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcccCCcc-cCCcCCCCcccccCCcCccccCCcccccc
Confidence            9999999999987655443332221  11110          00000000 0000000          000000001111


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        316 NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       316 ~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ...++.+.+|+.+||++||++|||++|+++||||+++.
T Consensus       277 ~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         277 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            22357889999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-35  Score=308.41  Aligned_cols=213  Identities=28%  Similarity=0.410  Sum_probs=173.1

Q ss_pred             hHHHHHH-HHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~-iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..++|.. +++.++||||+++++++...+.+|+||||+.+ +|..++... ..+++..++.++.||+.||+|||++||+|
T Consensus        41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH  119 (323)
T cd05575          41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIY  119 (323)
T ss_pred             HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3455655 45789999999999999999999999999975 898888764 36899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       120 ~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  150 (323)
T cd05575         120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHS-------------------------------------------------  150 (323)
T ss_pred             CCCCHHHeEECCCCcEEEeccCCCcccccCC-------------------------------------------------
Confidence            9999999999999999999999865321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       151 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~  187 (323)
T cd05575         151 ------------------------------------------KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLY  187 (323)
T ss_pred             ------------------------------------------CccccccCChhhcChhhhcCCC-CCccccccccchhhh
Confidence                                                      0011236799999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|..||.+.+..+....+....-                     .        .....+..+.++|.+||+.||++|
T Consensus       188 ell~g~~pf~~~~~~~~~~~i~~~~~---------------------~--------~~~~~~~~~~~li~~~l~~~p~~R  238 (323)
T cd05575         188 EMLYGLPPFYSRDTAEMYDNILNKPL---------------------R--------LKPNISVSARHLLEGLLQKDRTKR  238 (323)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHcCCC---------------------C--------CCCCCCHHHHHHHHHHhhcCHHhC
Confidence            99999999998877665555543100                     0        111235678999999999999999


Q ss_pred             CCH----HHHHcCccccCCcc
Q psy10954        338 VSA----KTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~Ta----~elL~Hp~f~~~~~  354 (562)
                      +++    .|+++||||..+.+
T Consensus       239 ~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         239 LGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CCCCCCHHHHHcCCCcCCCCH
Confidence            998    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=306.01  Aligned_cols=248  Identities=34%  Similarity=0.644  Sum_probs=192.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      .....+|+.+++.++||||+++++++...     ..+|+||||++++|.+++...  .+++..++.++.|++.||+|||+
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~  124 (336)
T cd07849          47 CQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHS  124 (336)
T ss_pred             HHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999987644     368999999999999888653  58999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+||+++.++.+||+|||+++........                                          
T Consensus       125 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------  162 (336)
T cd07849         125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH------------------------------------------  162 (336)
T ss_pred             CCeeccCCCHHHEEECCCCCEEECcccceeeccccccc------------------------------------------
Confidence            99999999999999999999999999987643210000                                          


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                    .......+||+.|+|||++.+...++.++||||+
T Consensus       163 ----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  196 (336)
T cd07849         163 ----------------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV  196 (336)
T ss_pred             ----------------------------------------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence                                                          0001124678999999998776668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|+|++|++||.+.+...++..+...++.+..+.+..+....  .+....+......+....+..++.+.||+.+||
T Consensus       197 Gvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  276 (336)
T cd07849         197 GCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKML  276 (336)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHc
Confidence            999999999999999988888888888888876655443222110  011111111112222333445678999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +.||++|||+.|+++||||+.....
T Consensus       277 ~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         277 TFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             CCChhhCcCHHHHhcCccccccCCC
Confidence            9999999999999999999987643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-35  Score=306.01  Aligned_cols=214  Identities=28%  Similarity=0.464  Sum_probs=175.4

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|+++++.+ +||||+++++++...+.+|+||||+.+ +|..++.+. ..+++..++.++.|++.||.|||++||+
T Consensus        40 ~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~iv  118 (318)
T cd05570          40 ECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGII  118 (318)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            4567899999888 799999999999999999999999975 898888664 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------  150 (318)
T cd05570         119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGG------------------------------------------------  150 (318)
T ss_pred             ccCCCHHHeEECCCCcEEecccCCCeecCcCC------------------------------------------------
Confidence            99999999999999999999999864211000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       151 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil  186 (318)
T cd05570         151 -------------------------------------------VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLL  186 (318)
T ss_pred             -------------------------------------------CcccceecCccccCHHHhcCCC-CCcchhhhhHHHHH
Confidence                                                       0011235788999999997755 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+..+....+.....                  .++           ...+..+.+|+++||+.||++
T Consensus       187 ~~l~~G~~pf~~~~~~~~~~~i~~~~~------------------~~~-----------~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         187 YEMLAGQSPFEGDDEDELFQSILEDEV------------------RYP-----------RWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             HHHhhCCCCCCCCCHHHHHHHHHcCCC------------------CCC-----------CcCCHHHHHHHHHHccCCHHH
Confidence            999999999998876655554432100                  000           112467899999999999999


Q ss_pred             CCCH-----HHHHcCccccCCcc
Q psy10954        337 RVSA-----KTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~Ta-----~elL~Hp~f~~~~~  354 (562)
                      |+|+     .++++||||+.+.+
T Consensus       238 R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         238 RLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             cCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999     99999999988754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-35  Score=308.29  Aligned_cols=215  Identities=29%  Similarity=0.465  Sum_probs=170.0

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+++.+ +||||++++++|.....+|+|||||++ +|..++... ..+++..++.++.|++.||.|||++||+
T Consensus        40 ~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv  118 (329)
T cd05588          40 DWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3467899999888 799999999999999999999999975 898888654 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~------------------------------------------------  150 (329)
T cd05588         119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG------------------------------------------------  150 (329)
T ss_pred             ecCCCHHHeEECCCCCEEECcCccccccccCC------------------------------------------------
Confidence            99999999999999999999999875211000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++|+||+||++
T Consensus       151 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l  186 (329)
T cd05588         151 -------------------------------------------DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLM  186 (329)
T ss_pred             -------------------------------------------CccccccCCccccCHHHHcCCC-CCCccceechHHHH
Confidence                                                       0012346899999999998654 89999999999999


Q ss_pred             HHHHhCCCCCCCCC--------HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        257 SEMITKKTLFAGDS--------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       257 ~eLltG~~pF~~~~--------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |+|++|+.||....        ..+.+.+.+....                 ..           +-...+..+.+++++
T Consensus       187 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~-----------~p~~~~~~~~~li~~  238 (329)
T cd05588         187 FEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-----------------IR-----------IPRSLSVKASSVLKG  238 (329)
T ss_pred             HHHHHCCCCcccccccccccccchHHHHHHHHcCC-----------------CC-----------CCCCCCHHHHHHHHH
Confidence            99999999996321        1111221111000                 00           001234678999999


Q ss_pred             ccccCCCCCCC------HHHHHcCccccCCcc
Q psy10954        329 IMALDPKQRVS------AKTILQHEYFNQVEM  354 (562)
Q Consensus       329 mL~~DP~~R~T------a~elL~Hp~f~~~~~  354 (562)
                      ||+.||.+|+|      ++++++||||..+.+
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         239 FLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999997      789999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-35  Score=306.47  Aligned_cols=214  Identities=31%  Similarity=0.489  Sum_probs=173.8

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|..++..+ +||||+++++++..+..+|+||||+++ +|..++.... .+++..++.++.|++.||.|||++||+
T Consensus        40 ~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05592          40 ECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGII  118 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3456777777654 899999999999999999999999974 8988887643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~------------------------------------------------  150 (316)
T cd05592         119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGE------------------------------------------------  150 (316)
T ss_pred             eCCCCHHHeEECCCCCEEEccCcCCeECCCCC------------------------------------------------
Confidence            99999999999999999999999875321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       151 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il  186 (316)
T cd05592         151 -------------------------------------------GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLL  186 (316)
T ss_pred             -------------------------------------------CccccccCCccccCHHHHcCCC-CCCcccchhHHHHH
Confidence                                                       0011246899999999998765 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+.+..+.....                  .++           ...+..+.+|+.+||+.||++
T Consensus       187 ~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------~~~-----------~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         187 YEMLIGQSPFHGEDEDELFDSILNDRP------------------HFP-----------RWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHcCCC------------------CCC-----------CCCCHHHHHHHHHHccCCHHH
Confidence            999999999999887666555432100                  000           113467899999999999999


Q ss_pred             CCCH-HHHHcCccccCCcc
Q psy10954        337 RVSA-KTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~Ta-~elL~Hp~f~~~~~  354 (562)
                      |+++ .++++||||..+++
T Consensus       238 R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         238 RLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             cCCChHHHHcCcccCCCCH
Confidence            9986 58899999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.4e-35  Score=306.21  Aligned_cols=215  Identities=25%  Similarity=0.401  Sum_probs=175.9

Q ss_pred             hhhHHHHHHHHHccCCC-CcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHP-NVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~Hp-nIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ......|+++++.++|+ +|+++++++...+.+|+||||+++ +|.+++.... .+++..++.++.|++.||.|||++||
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~i  122 (324)
T cd05587          44 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGI  122 (324)
T ss_pred             HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34577899999999765 588999999999999999999974 9998887643 68999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++......                                               
T Consensus       123 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-----------------------------------------------  155 (324)
T cd05587         123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-----------------------------------------------  155 (324)
T ss_pred             EecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----------------------------------------------
Confidence            999999999999999999999999864221000                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. ++.++||||+||+
T Consensus       156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvi  190 (324)
T cd05587         156 --------------------------------------------KTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVL  190 (324)
T ss_pred             --------------------------------------------CceeeecCCccccChhhhcCCC-CCcccchhhhHHH
Confidence                                                        0011236799999999998755 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+..+.+..+......                  +           ....++.+.+++++||..||.
T Consensus       191 l~elltG~~pf~~~~~~~~~~~i~~~~~~------------------~-----------~~~~~~~~~~li~~~l~~~P~  241 (324)
T cd05587         191 LYEMLAGQPPFDGEDEDELFQSIMEHNVS------------------Y-----------PKSLSKEAVSICKGLLTKHPA  241 (324)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------------C-----------CCCCCHHHHHHHHHHhhcCHH
Confidence            99999999999988877666665432100                  0           012356789999999999999


Q ss_pred             CCCCH-----HHHHcCccccCCcc
Q psy10954        336 QRVSA-----KTILQHEYFNQVEM  354 (562)
Q Consensus       336 ~R~Ta-----~elL~Hp~f~~~~~  354 (562)
                      +|+++     +++++||||..+++
T Consensus       242 ~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         242 KRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99986     89999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-35  Score=297.97  Aligned_cols=219  Identities=25%  Similarity=0.352  Sum_probs=170.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+..|+++|++++||||+++++++..+..+|+||||+.+ +|.+++.... ..+++..+..++.|++.||+|||++||+
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  117 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV  117 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3456799999999999999999999999999999999975 8988875533 3588999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++.......                                                
T Consensus       118 H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------------------------------------------------  149 (277)
T cd05607         118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------------------------------------------------  149 (277)
T ss_pred             EccCChHhEEEcCCCCEEEeeceeeeecCCCc------------------------------------------------
Confidence            99999999999999999999999865331000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......||+.|+|||++.+.. ++.++|+||+||++
T Consensus       150 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l  184 (277)
T cd05607         150 --------------------------------------------TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSI  184 (277)
T ss_pred             --------------------------------------------eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHH
Confidence                                                        001124688999999998766 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+..+......+....-..                .. ..       .....++.+.||+++||+.||++
T Consensus       185 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~-~~-------~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         185 YEMVAGRTPFKDHKEKVAKEELKRRTLED----------------EV-KF-------EHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             HHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------cc-cc-------ccccCCHHHHHHHHHHhccCHhh
Confidence            99999999997654321111111110000                00 00       01123567899999999999999


Q ss_pred             CCCH----HHHHcCccccCCcc
Q psy10954        337 RVSA----KTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~Ta----~elL~Hp~f~~~~~  354 (562)
                      |+|+    +++++||||+.+++
T Consensus       241 R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         241 RLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             CCCCccchhhhhcChhhcCCCH
Confidence            9999    67889999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0596|consensus

Probab=100.00  E-value=2.1e-35  Score=311.36  Aligned_cols=219  Identities=32%  Similarity=0.480  Sum_probs=165.1

Q ss_pred             hHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ...+||++|..| .|.+||+|||+-..++.+||||||-+.||.+++++.....+.-.+++|.+|+|.|++++|..||||.
T Consensus       405 gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHS  484 (677)
T KOG0596|consen  405 GYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHS  484 (677)
T ss_pred             HHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeec
Confidence            467999999999 5899999999999999999999998899999999877656655899999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||.|+|+- .|.+||+|||+|..+....+..-                                              
T Consensus       485 DLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~----------------------------------------------  517 (677)
T KOG0596|consen  485 DLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIV----------------------------------------------  517 (677)
T ss_pred             CCCcccEEEE-eeeEEeeeechhcccCcccccee----------------------------------------------
Confidence            9999999985 68899999999876643321110                                              


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC----------CCCchhh
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK----------VYSTTVD  248 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~----------~y~~~~D  248 (562)
                                                                 ..+.+||+.|||||.+....          ..+.++|
T Consensus       518 -------------------------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SD  554 (677)
T KOG0596|consen  518 -------------------------------------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSD  554 (677)
T ss_pred             -------------------------------------------eccccCcccccCHHHHhhccccccCCCcceeecCccc
Confidence                                                       01235555555555554321          1467899


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |||+|||||+|+.|++||..-.  ....++. .+-.|..            ...||...         . .-.+.|+++.
T Consensus       555 vWSLGCILYqMvYgktPf~~~~--n~~aKl~-aI~~P~~------------~Iefp~~~---------~-~~~li~~mK~  609 (677)
T KOG0596|consen  555 VWSLGCILYQMVYGKTPFGQII--NQIAKLH-AITDPNH------------EIEFPDIP---------E-NDELIDVMKC  609 (677)
T ss_pred             hhhhhhHHHHHHhcCCchHHHH--HHHHHHH-hhcCCCc------------cccccCCC---------C-chHHHHHHHH
Confidence            9999999999999999995321  1222222 2222211            11222211         1 1238999999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCCc
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||.+||++|+|+.++|+|||+.-..
T Consensus       610 CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  610 CLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             HHhcCcccCCCcHHHhcCccccccc
Confidence            9999999999999999999998643

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=311.83  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=184.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++..+..+|+||||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gii  123 (350)
T cd05573          45 IAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFI  123 (350)
T ss_pred             HHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34577899999999999999999999999999999999974 999998765 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++............     .+.....          .+                   
T Consensus       124 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~-----~~~~~~~----------~~-------------------  169 (350)
T cd05573         124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY-----LNDSHNL----------LF-------------------  169 (350)
T ss_pred             ccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc-----ccccccc----------cc-------------------
Confidence            9999999999999999999999998765422110000     0000000          00                   


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                    ..+..+...              ............+||+.|+|||++.+. .++.++||||+||++
T Consensus       170 --------------~~~~~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il  220 (350)
T cd05573         170 --------------RDNVLVRRR--------------DHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVIL  220 (350)
T ss_pred             --------------ccccccccc--------------ccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhh
Confidence                          000000000              000001112345789999999999876 489999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+...++.......                .++.         ....++.+.+||.+||. ||.+
T Consensus       221 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~---------~~~~~~~~~~li~~ll~-dp~~  274 (350)
T cd05573         221 YEMLYGFPPFYSDTLQETYNKIINWKESL----------------RFPP---------DPPVSPEAIDLICRLLC-DPED  274 (350)
T ss_pred             hhhccCCCCCCCCCHHHHHHHHhccCCcc----------------cCCC---------CCCCCHHHHHHHHHHcc-Chhh
Confidence            99999999999888766665554311100                0000         01135788999999998 9999


Q ss_pred             CCC-HHHHHcCccccCCccc
Q psy10954        337 RVS-AKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~T-a~elL~Hp~f~~~~~~  355 (562)
                      |++ ++|+++||||+++.+.
T Consensus       275 R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         275 RLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             cCCCHHHHhcCCCcCCCCHH
Confidence            999 9999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-35  Score=304.99  Aligned_cols=215  Identities=31%  Similarity=0.494  Sum_probs=174.2

Q ss_pred             hhhHHHHHHHHHc-cCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~-l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+|..+++. ++||||+++++++.+.+.+|+||||+++ +|.+++... ..+++..+..++.|++.||.|||++||
T Consensus        39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i  117 (316)
T cd05619          39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGI  117 (316)
T ss_pred             HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3456778888876 4999999999999999999999999974 999988764 368999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++......                                               
T Consensus       118 vHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------------  150 (316)
T cd05619         118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-----------------------------------------------  150 (316)
T ss_pred             EeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----------------------------------------------
Confidence            999999999999999999999999875321000                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       151 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~i  185 (316)
T cd05619         151 --------------------------------------------AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVL  185 (316)
T ss_pred             --------------------------------------------CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHH
Confidence                                                        0011235789999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+..+.+..+... . +                .++           ...+..+.+|+.+||+.||+
T Consensus       186 l~el~~G~~pf~~~~~~~~~~~i~~~-~-~----------------~~~-----------~~~~~~~~~li~~~l~~~P~  236 (316)
T cd05619         186 LYEMLIGQSPFHGHDEEELFQSIRMD-N-P----------------CYP-----------RWLTREAKDILVKLFVREPE  236 (316)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhC-C-C----------------CCC-----------ccCCHHHHHHHHHHhccCHh
Confidence            99999999999988766555444211 0 0                000           11245789999999999999


Q ss_pred             CCCCHH-HHHcCccccCCcc
Q psy10954        336 QRVSAK-TILQHEYFNQVEM  354 (562)
Q Consensus       336 ~R~Ta~-elL~Hp~f~~~~~  354 (562)
                      +|+++. ++++||||+++.+
T Consensus       237 ~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         237 RRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             hcCCChHHHHcCcccCCCCH
Confidence            999996 8999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.6e-35  Score=320.98  Aligned_cols=215  Identities=26%  Similarity=0.440  Sum_probs=176.3

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .+.+|+.+|+.++|||||+++++|..++.+||||||+. ++|.+++..   ...++++..+..++.|++.||.|||++||
T Consensus       111 ~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i  190 (478)
T PTZ00267        111 YARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM  190 (478)
T ss_pred             HHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            46789999999999999999999999999999999997 599987754   23468999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.......                                              
T Consensus       191 vHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~----------------------------------------------  224 (478)
T PTZ00267        191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS----------------------------------------------  224 (478)
T ss_pred             EECCcCHHhEEECCCCcEEEEeCcCceecCCccc----------------------------------------------
Confidence            9999999999999999999999998764321000                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .......+||+.|+|||++.+. .++.++||||+||+
T Consensus       225 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~  260 (478)
T PTZ00267        225 -------------------------------------------LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVI  260 (478)
T ss_pred             -------------------------------------------cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHH
Confidence                                                       0001234689999999999765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+..+.+..+......+                            .....+..+.+||.+||..||+
T Consensus       261 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~dP~  312 (478)
T PTZ00267        261 LYELLTLHRPFKGPSQREIMQQVLYGKYDP----------------------------FPCPVSSGMKALLDPLLSKNPA  312 (478)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------------------CCccCCHHHHHHHHHHhccChh
Confidence            999999999999887766666554311000                            0011245789999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy10954        336 QRVSAKTILQHEYFNQV  352 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~  352 (562)
                      +|||+.++++|+|++.+
T Consensus       313 ~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        313 LRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             hCcCHHHHHhCHHHHHH
Confidence            99999999999999764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=305.37  Aligned_cols=222  Identities=25%  Similarity=0.382  Sum_probs=175.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||++++++|..++++|+||||+. ++|.+++.+....+++..++.++.|++.||+|||++||+|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  125 (331)
T cd05597          46 ACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH  125 (331)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEE
Confidence            346789999999999999999999999999999999997 4999999776667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||++........                                                
T Consensus       126 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------  157 (331)
T cd05597         126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT------------------------------------------------  157 (331)
T ss_pred             CCCCHHHEEECCCCCEEEEECCceeecCCCCC------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAG  253 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSlG  253 (562)
                                                                ......+||+.|+|||++.+    ...++.++||||+|
T Consensus       158 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  195 (331)
T cd05597         158 ------------------------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG  195 (331)
T ss_pred             ------------------------------------------ccccceeccccccCHHHHhhccccccCCCCcceeehhh
Confidence                                                      00011357888999999863    34578899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.+..+....+.......                .++.        .....+..+++|+++||..+
T Consensus       196 ~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------~~~~--------~~~~~~~~~~~li~~ll~~~  251 (331)
T cd05597         196 VCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------------QFPP--------DVTDVSEEAKDLIRRLICSP  251 (331)
T ss_pred             hHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc----------------cCCC--------ccCCCCHHHHHHHHHHccCc
Confidence            99999999999999887766665554321100                0000        01123567899999999765


Q ss_pred             CCC--CCCHHHHHcCccccCCcc
Q psy10954        334 PKQ--RVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~--R~Ta~elL~Hp~f~~~~~  354 (562)
                      +++  |++++++++||||.++.+
T Consensus       252 ~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         252 ETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ccccCCCCHHHHhcCCCCCCCCH
Confidence            544  789999999999988654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG1290|consensus

Probab=100.00  E-value=1.6e-35  Score=308.63  Aligned_cols=333  Identities=26%  Similarity=0.335  Sum_probs=207.8

Q ss_pred             chhhHHHHHHHHHccC-----CC---CcceEEEEEEe----CCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELK-----HP---NVIRLHDVIPV----DFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQL   83 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~-----Hp---nIv~L~~~~~~----~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~ql   83 (562)
                      ..++++.||++|++++     |+   +||+|+|.|..    +.++|||+|+++.+|..+|+... ..+|...++.|++||
T Consensus       117 YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qv  196 (590)
T KOG1290|consen  117 YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQV  196 (590)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHH
Confidence            3567899999999983     33   59999999975    36899999999999999997655 359999999999999


Q ss_pred             HHHHHHHHHC-CceeccCCCCcEEEccCCCeeEeeccc---cccccccCcccceeeee----ccCCccceec--------
Q psy10954         84 LEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGL---SRAFTIPMNRYTHEVVT----LWYRPPEILL--------  147 (562)
Q Consensus        84 l~aL~yLH~~-gIiHRDLKP~NILl~~~~~vKL~DFGl---a~~~~~~~~~~~~~~~t----~~y~aPE~l~--------  147 (562)
                      |.||.|||+. ||||.||||+|||+.....--..|-.-   ++........  ..+.|    ..+++-+...        
T Consensus       197 L~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~--s~~~t~~d~~~~~~~~~~s~~~~k~~~  274 (590)
T KOG1290|consen  197 LTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSP--SAVSTRPDALQRMAAEPMSKSKFKKMK  274 (590)
T ss_pred             HHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCc--ccccccccccchhhccccchhhHHHHH
Confidence            9999999975 999999999999997652110111111   1110000000  00000    0000000000        


Q ss_pred             ---------------cccc--ccccccccccccc------chhhhhHHHH----HHHHHhhhcC-----cee----e---
Q psy10954        148 ---------------GAKV--YSTTVDIWSAGCI------FSEMSYLYQL----LEALRYCHSR-----RII----H---  188 (562)
Q Consensus       148 ---------------~~~~--~s~~~DvwSlG~i------l~Em~~l~QI----l~gL~yLHs~-----~II----H---  188 (562)
                                     +...  -....|-++.+.-      ..+...+.+.    ..+-+-.++.     +.-    -   
T Consensus       275 kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~  354 (590)
T KOG1290|consen  275 KKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQL  354 (590)
T ss_pred             HHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhc
Confidence                           0000  0001111221111      0111000000    0000111110     000    0   


Q ss_pred             c---------CCCC-------cceee----c---CCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        189 R---------DLKP-------QNILI----N---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       189 R---------DLKP-------eNILl----~---~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                      |         ...|       .|-++    .   .+-.|||+|||-|+...   +.++..++|+.|||||||+|.+ |++
T Consensus       355 ~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllGsg-Y~~  430 (590)
T KOG1290|consen  355 RDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSG-YST  430 (590)
T ss_pred             ccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh---hhhchhhhhhhccCcceeecCC-CCC
Confidence            0         0011       12222    1   12469999999998753   4567779999999999999987 999


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCC------CCCccchhh
Q psy10954        246 TVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFP------EWRPKKFSE  313 (562)
Q Consensus       246 ~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~  313 (562)
                      ++||||++|+++||+||..+|...+      +.++++.|++++|..+....-+-...+.|+....      .+++..+.+
T Consensus       431 ~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~  510 (590)
T KOG1290|consen  431 SADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYE  510 (590)
T ss_pred             chhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHH
Confidence            9999999999999999999996432      5689999999999877655433333333333222      223333333


Q ss_pred             hcC----CC---CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        314 ILN----LP---DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       314 ~l~----~~---~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ++.    ..   ..++.|||.-||+++|++|+||.++|+|||+..+...
T Consensus       511 VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  511 VLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            332    22   2357899999999999999999999999999987654

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=298.45  Aligned_cols=218  Identities=25%  Similarity=0.388  Sum_probs=173.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.++++++||||+++++++..++.+|+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++||+
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  124 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV  124 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            3467899999999999999999999999999999999974 8988876543 4599999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.++|+|||++......                                                 
T Consensus       125 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-------------------------------------------------  155 (285)
T cd05605         125 YRDLKPENILLDDYGHIRISDLGLAVEIPEG-------------------------------------------------  155 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEeeCCCceecCCC-------------------------------------------------
Confidence            9999999999999999999999986532100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       156 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l  191 (285)
T cd05605         156 -------------------------------------------ETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLI  191 (285)
T ss_pred             -------------------------------------------CccccccCCCCccCcHHhcCCC-CCccccchhHHHHH
Confidence                                                       0001235789999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+.......+...+......                         .....+..+.+|+.+||+.||++
T Consensus       192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~  246 (285)
T cd05605         192 YEMIEGKSPFRQRKEKVKREEVERRVKEDQEE-------------------------YSEKFSEAARSICRQLLTKDPGF  246 (285)
T ss_pred             HHHHHCCCCCCCCchhhHHHHHHHHhhhcccc-------------------------cCcccCHHHHHHHHHHccCCHHH
Confidence            99999999998876544333332221100000                         01123467899999999999999


Q ss_pred             CC-----CHHHHHcCccccCCcc
Q psy10954        337 RV-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~  354 (562)
                      |+     +++++++||||...++
T Consensus       247 R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         247 RLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             hcCCCCCCHHHHhcCcCccCCCH
Confidence            99     8999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5e-35  Score=310.49  Aligned_cols=218  Identities=29%  Similarity=0.425  Sum_probs=174.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..+..+|+|||||+ ++|.+++...  .+++..++.++.|++.||+|||++||+|
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH  165 (371)
T cd05622          88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIH  165 (371)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            345689999999999999999999999999999999997 4899988654  4899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       166 rDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-------------------------------------------------  196 (371)
T cd05622         166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-------------------------------------------------  196 (371)
T ss_pred             CCCCHHHEEECCCCCEEEEeCCceeEcCcCC-------------------------------------------------
Confidence            9999999999999999999999875432100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC---CCCchhhHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK---VYSTTVDIWSAGC  254 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~---~y~~~~DIWSlG~  254 (562)
                                                               .......+||+.|+|||++.+..   .|+.++||||+||
T Consensus       197 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGv  235 (371)
T cd05622         197 -----------------------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  235 (371)
T ss_pred             -----------------------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhH
Confidence                                                     00011346899999999987543   3789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|.+||.+.+.......+........                ++.         ....+..++++|.+||..++
T Consensus       236 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------~~~---------~~~~s~~~~~li~~~L~~~~  290 (371)
T cd05622         236 FLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------------FPD---------DNDISKEAKNLICAFLTDRE  290 (371)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc----------------CCC---------cCCCCHHHHHHHHHHcCChh
Confidence            99999999999999887766666653211100                000         01235678999999998444


Q ss_pred             CC--CCCHHHHHcCccccCCc
Q psy10954        335 KQ--RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~--R~Ta~elL~Hp~f~~~~  353 (562)
                      .+  |++++|+++|+||++..
T Consensus       291 ~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         291 VRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             hhcCCCCHHHHhcCcccCCCC
Confidence            33  78999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0192|consensus

Probab=100.00  E-value=5.9e-35  Score=307.51  Aligned_cols=210  Identities=28%  Similarity=0.415  Sum_probs=172.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC-EEEEEeecCc-CCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLR-QDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-~i~lV~Ey~~-~~L~~~i~~-~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+.+|++++|||||++++++.... ..+|||||++ |+|.+++.. .+..++...+..++.||++|++|||+++
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~  162 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG  162 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            457899999999999999999999998877 7999999998 599999987 3668999999999999999999999999


Q ss_pred             -ceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         95 -IIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        95 -IiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                       ||||||||+|||++.++ ++||+|||+++......                                            
T Consensus       163 ~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--------------------------------------------  198 (362)
T KOG0192|consen  163 PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--------------------------------------------  198 (362)
T ss_pred             CeeecccChhhEEEcCCCCEEEECCCccceeecccc--------------------------------------------
Confidence             99999999999999997 99999999986442100                                            


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC-CCCCCchhhHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWS  251 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~-~~~y~~~~DIWS  251 (562)
                                                                     ...+...||+.|||||++.+ ...|+.++||||
T Consensus       199 -----------------------------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvyS  231 (362)
T KOG0192|consen  199 -----------------------------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYS  231 (362)
T ss_pred             -----------------------------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhh
Confidence                                                           00122478999999999985 345999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +|+++|||++|+.||.+....+....+......|.                           +-...++....++.+|+.
T Consensus       232 FgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---------------------------~p~~~~~~l~~l~~~CW~  284 (362)
T KOG0192|consen  232 FGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---------------------------IPKECPPHLSSLMERCWL  284 (362)
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHhCC
Confidence            99999999999999999988554444443211111                           001134678899999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy10954        332 LDPKQRVSAKTILQ  345 (562)
Q Consensus       332 ~DP~~R~Ta~elL~  345 (562)
                      .||++||+..+++.
T Consensus       285 ~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  285 VDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCcCCCHHHHHH
Confidence            99999999998763

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.1e-35  Score=307.99  Aligned_cols=238  Identities=37%  Similarity=0.640  Sum_probs=184.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..+.+|+.+++.++||||++++++|...      ...|+||||+.++|.+.+...   +++..+..++.|++.||+|||+
T Consensus        60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~  136 (353)
T cd07850          60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS  136 (353)
T ss_pred             HHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999999999998644      357999999999999887643   8999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+||+++.++.+||+|||+++......                                            
T Consensus       137 ~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--------------------------------------------  172 (353)
T cd07850         137 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------------------------------------------  172 (353)
T ss_pred             CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--------------------------------------------
Confidence            999999999999999999999999999875332100                                            


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                      ......+|+.|+|||++.+.. ++.++||||+
T Consensus       173 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvwsl  203 (353)
T cd07850         173 ------------------------------------------------MMTPYVVTRYYRAPEVILGMG-YKENVDIWSV  203 (353)
T ss_pred             ------------------------------------------------CCCCCcccccccCHHHHhCCC-CCCchhhHhH
Confidence                                                            001124678899999997754 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCCccchhhhc-------------CCC
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWRPKKFSEIL-------------NLP  318 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l-------------~~~  318 (562)
                      ||++|+|++|+.||.+.+..+....+...+|.+..+........ ..+....+......+.+.+             ...
T Consensus       204 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (353)
T cd07850         204 GCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK  283 (353)
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccc
Confidence            99999999999999999888888888888888765433221110 0001111111111111111             123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       284 ~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         284 ASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            4568999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-35  Score=323.55  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=178.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP----VPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~----~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+.+|++++|||||++++++...+..|+|+|++..+|.+++....    .......++.++.||+.||+|||++|
T Consensus       208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g  287 (501)
T PHA03210        208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK  287 (501)
T ss_pred             HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            44679999999999999999999999999999999999999988875432    12346678899999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.++.+||+|||+++.+.....                                             
T Consensus       288 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---------------------------------------------  322 (501)
T PHA03210        288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE---------------------------------------------  322 (501)
T ss_pred             eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc---------------------------------------------
Confidence            99999999999999999999999998764421000                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+.. |+.++||||+||
T Consensus       323 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGv  356 (501)
T PHA03210        323 ---------------------------------------------AFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGL  356 (501)
T ss_pred             ---------------------------------------------cccccccCCcCCCCchhhcCCC-CCcHHHHHHHHH
Confidence                                                         0011246899999999998755 899999999999


Q ss_pred             HHHHHHhCCCCCCC---CCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCC-CCCCCccchhhhcC--CCCHHHHHHHHH
Q psy10954        255 IFSEMITKKTLFAG---DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWRPKKFSEILN--LPDPLAVDVFSK  328 (562)
Q Consensus       255 il~eLltG~~pF~~---~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~--~~~~~~~dLi~~  328 (562)
                      ++|||++|..++.+   .....++.+++..++....+..........+... .....+..+..++.  ..+..+.++|.+
T Consensus       357 il~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k  436 (501)
T PHA03210        357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK  436 (501)
T ss_pred             HHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH
Confidence            99999998765432   2355677777776665433321110000000000 00000111111111  135678899999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCCc
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++||++||||.|+|+||||....
T Consensus       437 mL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        437 MLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HhccCcccCcCHHHHhhChhhhcCC
Confidence            9999999999999999999998754

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-35  Score=308.16  Aligned_cols=221  Identities=25%  Similarity=0.381  Sum_probs=176.8

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+.+++.++|+||+++++++.....+|+||||+. ++|.+++.+....+++..++.++.|++.||+|||++||+||
T Consensus        47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHr  126 (332)
T cd05623          47 CFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR  126 (332)
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            46689999999999999999999999999999999997 59999998765679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||++........                                                 
T Consensus       127 Dlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-------------------------------------------------  157 (332)
T cd05623         127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGT-------------------------------------------------  157 (332)
T ss_pred             CCCHHHEEECCCCCEEEeecchheecccCCc-------------------------------------------------
Confidence            9999999999999999999998753321000                                                 


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGC  254 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSlG~  254 (562)
                                                               ......+||+.|+|||++.+    ...|+.++||||+||
T Consensus       158 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGv  196 (332)
T cd05623         158 -----------------------------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV  196 (332)
T ss_pred             -----------------------------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHH
Confidence                                                     00012367899999999863    345889999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.+..+.+..+.......                .++.        .....++.+.||+++||..++
T Consensus       197 il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~--------~~~~~s~~~~~li~~ll~~~~  252 (332)
T cd05623         197 CMYEMLYGETPFYAESLVETYGKIMNHKERF----------------QFPA--------QVTDVSEDAKDLIRRLICSRE  252 (332)
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhCCCccc----------------cCCC--------ccccCCHHHHHHHHHHccChh
Confidence            9999999999999888777666654321000                0000        112235789999999997655


Q ss_pred             CC--CCCHHHHHcCccccCCcc
Q psy10954        335 KQ--RVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       335 ~~--R~Ta~elL~Hp~f~~~~~  354 (562)
                      ++  |+|++|+++||||.++.+
T Consensus       253 ~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         253 HRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             hhcCCCCHHHHhCCCCcCCCCH
Confidence            55  689999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=294.72  Aligned_cols=242  Identities=53%  Similarity=0.971  Sum_probs=197.4

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ......+|+++|+.++||||+++++++..+..+|+||||++++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  120 (283)
T cd05118          41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL  120 (283)
T ss_pred             hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34567899999999999999999999999999999999999999999887656799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||||+||+++.++.+||+|||.+.......                                                
T Consensus       121 H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------------------------------------------------  152 (283)
T cd05118         121 HRDLKPENLLINTEGVLKLADFGLARSFGSPV------------------------------------------------  152 (283)
T ss_pred             ecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------------------------------------------------
Confidence            99999999999999999999999865432110                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......++..|+|||.+.+...++.++|+||+||++
T Consensus       153 -------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l  189 (283)
T cd05118         153 -------------------------------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF  189 (283)
T ss_pred             -------------------------------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence                                                       0001124577899999998765689999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++|+.||.+.+..+++..+.+.++.+....|+..... ......++..............+..+.+||.+||+.||.
T Consensus       190 ~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  269 (283)
T cd05118         190 AELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH  269 (283)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcc
Confidence            9999999999999988899999888888777666654431 111122222222222333344577899999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +||++.++++||||
T Consensus       270 ~Rp~~~~ll~~~~~  283 (283)
T cd05118         270 KRITAEQALAHPYF  283 (283)
T ss_pred             cCcCHHHHhhCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.9e-35  Score=305.82  Aligned_cols=215  Identities=30%  Similarity=0.467  Sum_probs=168.9

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.++.++ +||||+++++++..++.+|+||||+.+ +|..++... ..+++..++.++.|++.||+|||++||+
T Consensus        40 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iv  118 (329)
T cd05618          40 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3467899988776 899999999999999999999999985 888887654 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 H~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~------------------------------------------------  150 (329)
T cd05618         119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG------------------------------------------------  150 (329)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCccccccCCC------------------------------------------------
Confidence            99999999999999999999999875321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       151 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  186 (329)
T cd05618         151 -------------------------------------------DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLM  186 (329)
T ss_pred             -------------------------------------------CccccccCCccccCHHHHcCCC-CCCccceecccHHH
Confidence                                                       0011246899999999998654 89999999999999


Q ss_pred             HHHHhCCCCCCCCC--------HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        257 SEMITKKTLFAGDS--------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       257 ~eLltG~~pF~~~~--------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |||++|+.||....        ....+.+.+....                 ..           +-...+..+.+|+++
T Consensus       187 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------------~~-----------~p~~~~~~~~~ll~~  238 (329)
T cd05618         187 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------------IR-----------IPRSLSVKAASVLKS  238 (329)
T ss_pred             HHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------------CC-----------CCCCCCHHHHHHHHH
Confidence            99999999995211        1111111111000                 00           011235678999999


Q ss_pred             ccccCCCCCCC------HHHHHcCccccCCcc
Q psy10954        329 IMALDPKQRVS------AKTILQHEYFNQVEM  354 (562)
Q Consensus       329 mL~~DP~~R~T------a~elL~Hp~f~~~~~  354 (562)
                      ||+.||++|+|      +.++++||||+++.+
T Consensus       239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         239 FLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999998      479999999988754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-35  Score=305.22  Aligned_cols=213  Identities=28%  Similarity=0.402  Sum_probs=172.9

Q ss_pred             hHHHHHH-HHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~-iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+|.. +++.++||||+++++++...+.+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+|
T Consensus        41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiH  119 (325)
T cd05602          41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVY  119 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3444544 56789999999999999999999999999985 898888764 36889999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       120 rDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-------------------------------------------------  150 (325)
T cd05602         120 RDLKPENILLDSQGHIVLTDFGLCKENIEHN-------------------------------------------------  150 (325)
T ss_pred             cCCCHHHeEECCCCCEEEccCCCCcccccCC-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       151 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~  187 (325)
T cd05602         151 ------------------------------------------GTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLY  187 (325)
T ss_pred             ------------------------------------------CCcccccCCccccCHHHHcCCC-CCCccccccccHHHH
Confidence                                                      0011346899999999998654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.+..+.+..+...-.    .                         ..+..+..+.++|.+||+.||.+|
T Consensus       188 el~~g~~pf~~~~~~~~~~~i~~~~~----~-------------------------~~~~~~~~~~~li~~~l~~~p~~R  238 (325)
T cd05602         188 EMLYGLPPFYSRNTAEMYDNILNKPL----Q-------------------------LKPNITNSARHLLEGLLQKDRTKR  238 (325)
T ss_pred             HHhcCCCCCCCCCHHHHHHHHHhCCc----C-------------------------CCCCCCHHHHHHHHHHcccCHHHC
Confidence            99999999998887766665543100    0                         011235678999999999999999


Q ss_pred             CCHH----HHHcCccccCCcc
Q psy10954        338 VSAK----TILQHEYFNQVEM  354 (562)
Q Consensus       338 ~Ta~----elL~Hp~f~~~~~  354 (562)
                      +++.    ++++|+||..+.+
T Consensus       239 ~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         239 LGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             CCCCCCHHHHhcCcccCCCCH
Confidence            9876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-35  Score=306.03  Aligned_cols=213  Identities=28%  Similarity=0.422  Sum_probs=172.1

Q ss_pred             hHHHHHH-HHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~-iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+|.. +++.++||||+++++++..++.+|+||||+.+ +|..++... ..+++..++.++.||+.||+|||++||+|
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH  119 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVY  119 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            4455655 46789999999999999999999999999975 888887654 46999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.....                                                  
T Consensus       120 ~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------------------------------------------------  149 (325)
T cd05604         120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------------------------------------------------  149 (325)
T ss_pred             cCCCHHHeEECCCCCEEEeecCCcccCCCC--------------------------------------------------
Confidence            999999999999999999999987532100                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                               .......+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       150 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~  187 (325)
T cd05604         150 -----------------------------------------SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLY  187 (325)
T ss_pred             -----------------------------------------CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceeh
Confidence                                                     00011246899999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.+..+....+....-                     .        ..+..+..+.+++++||+.||.+|
T Consensus       188 el~~G~~pf~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~~ll~~ll~~~p~~R  238 (325)
T cd05604         188 EMLYGLPPFYCRDVAEMYDNILHKPL---------------------V--------LRPGASLTAWSILEELLEKDRQRR  238 (325)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHcCCc---------------------c--------CCCCCCHHHHHHHHHHhccCHHhc
Confidence            99999999998877665555543100                     0        011234678899999999999999


Q ss_pred             CCH----HHHHcCccccCCcc
Q psy10954        338 VSA----KTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~Ta----~elL~Hp~f~~~~~  354 (562)
                      +++    .++++||||+...+
T Consensus       239 ~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         239 LGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             CCCCCCHHHHhcCCCcCCCCH
Confidence            987    59999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.5e-35  Score=302.85  Aligned_cols=215  Identities=26%  Similarity=0.404  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .....|..++..+ +|++|+++++++...+.+|+||||++ ++|.+.+.... .+++..+..++.|++.||.|||++||+
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  123 (323)
T cd05616          45 ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGII  123 (323)
T ss_pred             HHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3467788888877 58999999999999999999999997 49998886643 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       124 HrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~------------------------------------------------  155 (323)
T cd05616         124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDG------------------------------------------------  155 (323)
T ss_pred             ecCCCHHHeEECCCCcEEEccCCCceecCCCC------------------------------------------------
Confidence            99999999999999999999999875321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       156 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  191 (323)
T cd05616         156 -------------------------------------------VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLL  191 (323)
T ss_pred             -------------------------------------------CccccCCCChhhcCHHHhcCCC-CCCccchhchhHHH
Confidence                                                       0011246899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+.+..+......                  ++           ...+..+.+++.+||+.||.+
T Consensus       192 ~elltg~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~~l~~~p~~  242 (323)
T cd05616         192 YEMLAGQAPFEGEDEDELFQSIMEHNVA------------------YP-----------KSMSKEAVAICKGLMTKHPGK  242 (323)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------CcCCHHHHHHHHHHcccCHHh
Confidence            9999999999998877666666532110                  00           123467899999999999999


Q ss_pred             CCCH-----HHHHcCccccCCccc
Q psy10954        337 RVSA-----KTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~Ta-----~elL~Hp~f~~~~~~  355 (562)
                      |+++     .++++||||+.+.+.
T Consensus       243 R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         243 RLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             cCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9984     899999999987643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.1e-35  Score=303.85  Aligned_cols=213  Identities=29%  Similarity=0.433  Sum_probs=171.4

Q ss_pred             hHHHHHH-HHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~-iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .+.+|.. +++.++||||+++++++...+.+|+|||||++ +|...+... ..+++..++.++.||+.||.|||++||+|
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH  119 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIY  119 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3455654 57889999999999999999999999999985 888877654 46899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++....+.                                                 
T Consensus       120 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  150 (321)
T cd05603         120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPE-------------------------------------------------  150 (321)
T ss_pred             ccCCHHHeEECCCCCEEEccCCCCccCCCCC-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       151 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~  187 (321)
T cd05603         151 ------------------------------------------ETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLY  187 (321)
T ss_pred             ------------------------------------------CccccccCCcccCCHHHhcCCC-CCCcCcccccchhhh
Confidence                                                      0011236789999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.+.......+...   +.               .           .....+..+.+++.+||+.||++|
T Consensus       188 el~~g~~pf~~~~~~~~~~~i~~~---~~---------------~-----------~~~~~~~~~~~li~~~l~~~p~~R  238 (321)
T cd05603         188 EMLYGLPPFYSRDVSQMYDNILHK---PL---------------Q-----------LPGGKTVAACDLLVGLLHKDQRRR  238 (321)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHhcC---CC---------------C-----------CCCCCCHHHHHHHHHHccCCHhhc
Confidence            999999999988766555544321   00               0           011234578999999999999999


Q ss_pred             CCH----HHHHcCccccCCcc
Q psy10954        338 VSA----KTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~Ta----~elL~Hp~f~~~~~  354 (562)
                      +++    .++++|+||..+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         239 LGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCCCCCHHHHhCCCCcCCCCH
Confidence            976    49999999987664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=291.28  Aligned_cols=245  Identities=47%  Similarity=0.893  Sum_probs=196.6

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ++....+.+|+++++.++||||+++++++...  +..|+||||++++|.+++......+++..+..++.|++.||+|||+
T Consensus        39 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~  118 (287)
T cd07840          39 EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS  118 (287)
T ss_pred             ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34455678999999999999999999999987  8999999999999999987765579999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|++|+||||+||+++.++.+||+|||++........                                           
T Consensus       119 ~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-------------------------------------------  155 (287)
T cd07840         119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-------------------------------------------  155 (287)
T ss_pred             CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-------------------------------------------
Confidence            9999999999999999999999999998754321100                                           


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     .......++..|+|||.+.+...++.++||||+
T Consensus       156 -----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  188 (287)
T cd07840         156 -----------------------------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSV  188 (287)
T ss_pred             -----------------------------------------------ccccccccccccCCceeeEccccCChHHHHHHH
Confidence                                                           000112457789999988776668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCC-CCCccchhhhcCCC-CHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFP-EWRPKKFSEILNLP-DPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~-~~~~~dLi~~mL  330 (562)
                      ||++|||++|+.||.+.+....+..+.+..+.+....|+..........-.+ ...+..+...+... ++.+.+++.+||
T Consensus       189 G~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  268 (287)
T cd07840         189 GCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLL  268 (287)
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHc
Confidence            9999999999999999998888888888888887777766554322111111 11112222233333 778999999999


Q ss_pred             ccCCCCCCCHHHHHcCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f  349 (562)
                      ..||.+|||+.++++||||
T Consensus       269 ~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         269 TLDPKKRISADQALQHEYF  287 (287)
T ss_pred             CCChhhCcCHHHHhhCcCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-35  Score=302.38  Aligned_cols=249  Identities=38%  Similarity=0.690  Sum_probs=199.8

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCC-----EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-----~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+.+|+.+++.++||||+++++++....     .+|+||||++++|.+++.+.. .+++..++.++.|++.||+|||
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH  120 (330)
T cd07834          42 DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH  120 (330)
T ss_pred             hhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            3456889999999999999999999988765     799999999999999887654 7999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.++|+|||++.........                                         
T Consensus       121 ~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~-----------------------------------------  159 (330)
T cd07834         121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE-----------------------------------------  159 (330)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc-----------------------------------------
Confidence            999999999999999999999999999987644211000                                         


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                     ........+|+.|+|||++.+...++.++|+||
T Consensus       160 -----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s  192 (330)
T cd07834         160 -----------------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS  192 (330)
T ss_pred             -----------------------------------------------cccccccccccCcCCceeeecccCCCcchhHHH
Confidence                                                           000122357889999999987756899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--CCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|+|++|++||.+.+..+.+..+....|.+..+.+.....  ...+....+...+..+....+..++.+.+|+.+|
T Consensus       193 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  272 (330)
T cd07834         193 VGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKM  272 (330)
T ss_pred             HHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHH
Confidence            99999999999999999999888999999888887665542211  1111111222223333444455678899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |+.||++|||++++++||||+++..
T Consensus       273 l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         273 LVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccCChhhCCCHHHHHhCccHHhhcc
Confidence            9999999999999999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-34  Score=292.74  Aligned_cols=243  Identities=40%  Similarity=0.784  Sum_probs=193.3

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCC----------EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDF----------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~----------~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~a   86 (562)
                      ......+|++++++++||||+++++++....          .+|+||||+++++.+.+......+++..++.++.|++.|
T Consensus        49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~a  128 (302)
T cd07864          49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG  128 (302)
T ss_pred             chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            3456678999999999999999999987654          799999999999888887665579999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++||+||||||+||+++.++.+||+|||++........                                     
T Consensus       129 L~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-------------------------------------  171 (302)
T cd07864         129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-------------------------------------  171 (302)
T ss_pred             HHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-------------------------------------
Confidence            9999999999999999999999999999999998754421100                                     


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           .......++..|+|||.+.+...++.+
T Consensus       172 -----------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~  198 (302)
T cd07864         172 -----------------------------------------------------RPYTNKVITLWYRPPELLLGEERYGPA  198 (302)
T ss_pred             -----------------------------------------------------cccccceeccCccChHHhcCCCCCCch
Confidence                                                                 000112346789999988766667899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCC-CCccchhhhcCCCCHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE-WRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~dL  325 (562)
                      +||||+||+++||++|++||...+..+.+..+....+.+....|+.....+.+....+. .............+..+.++
T Consensus       199 ~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  278 (302)
T cd07864         199 IDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDL  278 (302)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHH
Confidence            99999999999999999999998888888888888888887777766544433211110 00011111223346789999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccc
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      +.+||+.||++|||+.+++.||||
T Consensus       279 i~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         279 LDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             HHHHccCChhhCCCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-34  Score=301.52  Aligned_cols=246  Identities=35%  Similarity=0.694  Sum_probs=191.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+.+|+.++||||+++++++...     ..+|+||||++++|.+++... ..+++..++.++.|++.||.|||+
T Consensus        48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34567899999999999999999988654     358999999999999988764 469999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|++||||||+||+++.++.+||+|||++.......                                            
T Consensus       127 ~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--------------------------------------------  162 (337)
T cd07858         127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--------------------------------------------  162 (337)
T ss_pred             CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--------------------------------------------
Confidence            999999999999999999999999999875432100                                            


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......++|..|+|||++.+...++.++||||+
T Consensus       163 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  195 (337)
T cd07858         163 -----------------------------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV  195 (337)
T ss_pred             -----------------------------------------------ccccccccccCccChHHHhcCCCCCCcccHHHH
Confidence                                                           000123567889999998765558999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--CCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|+|++|++||.+.+....+..+.+..|.+..+.+.....  ...+....+......+....+..++.+.+|+++||
T Consensus       196 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  275 (337)
T cd07858         196 GCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML  275 (337)
T ss_pred             HHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHh
Confidence            9999999999999999888888888888888776655432211  01111111111111122233345678899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +.||++|||++|+++||||..+...
T Consensus       276 ~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         276 VFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             cCChhhccCHHHHHcCcchhhhcCc
Confidence            9999999999999999999887543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0608|consensus

Probab=100.00  E-value=2.8e-35  Score=313.05  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=182.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .-+..|-.||...+++-||+||..|++.+.+|+||||++| |+..++.+.+ -|+|..+++|+.++..|+++.|.+|.||
T Consensus       674 aHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIH  752 (1034)
T KOG0608|consen  674 AHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIH  752 (1034)
T ss_pred             hhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcccee
Confidence            3456789999999999999999999999999999999975 9999988765 5999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc-c--ccchhhhhHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA-G--CIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl-G--~il~Em~~l~QI  174 (562)
                      |||||+|||||.+|++||+||||+..+.     +++  -+.+|.  |--.....--..++-|+- +  ...+|..-++|-
T Consensus       753 RDiKPDNILIDrdGHIKLTDFGLCTGfR-----WTH--dskYYq--~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h  823 (1034)
T KOG0608|consen  753 RDIKPDNILIDRDGHIKLTDFGLCTGFR-----WTH--DSKYYQ--EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQH  823 (1034)
T ss_pred             cccCccceEEccCCceeeeeccccccce-----ecc--cccccc--CCCccccccCCCchhhccccccchHHHHHHHhhh
Confidence            9999999999999999999999987552     111  112222  100000000011122221 1  001111111111


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                      -+.                                           ..-..|||+.|+|||||...+ |+..+|+||.||
T Consensus       824 ~r~-------------------------------------------~ahslvgt~nyiapevl~r~g-~~q~cdwws~gv  859 (1034)
T KOG0608|consen  824 QRI-------------------------------------------LAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGV  859 (1034)
T ss_pred             hhh-------------------------------------------hhhhhcCCCcccChHHhcccC-ccccchhhHhhH
Confidence            000                                           011358999999999998654 999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |||||+.|++||..++..+.-.++++         |...-       +++         .....+.++.|+|.++. .++
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~n---------w~~~l-------~~~---------~~~~ls~e~~~li~kLc-~sa  913 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVIN---------WRNFL-------HIP---------YQGNLSKEALDLIQKLC-CSA  913 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeee---------hhhcc-------ccc---------cccccCHHHHHHHHHHh-cCh
Confidence            99999999999988776543333322         11100       111         11234678999998854 578


Q ss_pred             CCCCC---HHHHHcCccccCCccc
Q psy10954        335 KQRVS---AKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~T---a~elL~Hp~f~~~~~~  355 (562)
                      +.|++   ++|+..||||+.+++.
T Consensus       914 d~RLGkng~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  914 DSRLGKNGADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             hhhhcccchhhhhcCccccccchH
Confidence            88885   6789999999998753

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8e-35  Score=306.03  Aligned_cols=213  Identities=28%  Similarity=0.422  Sum_probs=162.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++|+||+++++++..++.+|+|||||.+ +|.+.     ...++..+..++.||+.||+|||++||+
T Consensus       116 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iv  190 (353)
T PLN00034        116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIV  190 (353)
T ss_pred             HHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            34578999999999999999999999999999999999985 66432     2367888899999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++........                                              
T Consensus       191 HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~----------------------------------------------  224 (353)
T PLN00034        191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP----------------------------------------------  224 (353)
T ss_pred             ecCCCHHHEEEcCCCCEEEcccccceeccccccc----------------------------------------------
Confidence            9999999999999999999999987643211000                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSA  252 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSl  252 (562)
                                                                   ....+||..|+|||++..    ...++.++||||+
T Consensus       225 ---------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl  259 (353)
T PLN00034        225 ---------------------------------------------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL  259 (353)
T ss_pred             ---------------------------------------------ccccccCccccCccccccccccCcCCCcchhHHHH
Confidence                                                         012356777888887632    2235678999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRT-LGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~-lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      ||++|||++|+.||......+....+... .+.+.                  .        .....+..+.+||.+||+
T Consensus       260 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~l~~li~~~l~  313 (353)
T PLN00034        260 GVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP------------------E--------APATASREFRHFISCCLQ  313 (353)
T ss_pred             HHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC------------------C--------CCCccCHHHHHHHHHHcc
Confidence            99999999999999743322111111110 00000                  0        011235678999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCC
Q psy10954        332 LDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .||++|+|+.|+|+||||...
T Consensus       314 ~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        314 REPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CChhhCcCHHHHhcCcccccC
Confidence            999999999999999999874

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3e-34  Score=299.67  Aligned_cols=239  Identities=26%  Similarity=0.389  Sum_probs=173.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~-gIi   96 (562)
                      ..+.+|+++|+.++||||++++++|..++.+|+||||+.+ +|.+++.... .+++..+..++.|++.||.|||++ +|+
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~iv  126 (333)
T cd06650          48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIM  126 (333)
T ss_pred             HHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEE
Confidence            4578999999999999999999999999999999999975 9999987643 689999999999999999999985 799


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++......                                                 
T Consensus       127 H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-------------------------------------------------  157 (333)
T cd06650         127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------------------------------------------  157 (333)
T ss_pred             ecCCChhhEEEcCCCCEEEeeCCcchhhhhh-------------------------------------------------
Confidence            9999999999999999999999986432100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  .....+||+.|+|||++.+.. ++.++|+||+||++
T Consensus       158 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il  192 (333)
T cd06650         158 --------------------------------------------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSL  192 (333)
T ss_pred             --------------------------------------------ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHH
Confidence                                                        001235788999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHH--hcCCCCCCCCCCCC-CCCCcc-CCCCCCCccc----hhh-h---------cCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFR--TLGTPHEDVWPGVS-KLPIYK-TDFPEWRPKK----FSE-I---------LNLP  318 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~--~lg~~~~~~~~~~~-~~~~~~-~~~~~~~~~~----~~~-~---------l~~~  318 (562)
                      |+|++|+.||......+. ..++.  ..+.+......... ...... ...+..++..    ... +         ....
T Consensus       193 ~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (333)
T cd06650         193 VEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVF  271 (333)
T ss_pred             HHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCc
Confidence            999999999987654322 22221  11111111000000 000000 0000000000    000 0         0123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +..+.+|+.+||++||++|||+.|+++||||+...
T Consensus       272 ~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         272 GAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            56789999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.8e-35  Score=304.11  Aligned_cols=215  Identities=29%  Similarity=0.476  Sum_probs=170.3

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.++.++ +||||+++++++.....+|+||||+++ +|..++... ..+++..++.++.|++.||+|||++||+
T Consensus        40 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iv  118 (327)
T cd05617          40 DWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGII  118 (327)
T ss_pred             HHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3467899999888 699999999999999999999999975 898887654 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       119 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------  150 (327)
T cd05617         119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG------------------------------------------------  150 (327)
T ss_pred             ccCCCHHHEEEeCCCCEEEeccccceeccCCC------------------------------------------------
Confidence            99999999999999999999999865321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       151 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil  186 (327)
T cd05617         151 -------------------------------------------DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLM  186 (327)
T ss_pred             -------------------------------------------CceecccCCcccCCHHHHCCCC-CCchheeehhHHHH
Confidence                                                       0011246899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        257 SEMITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       257 ~eLltG~~pF~~~~------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |||++|+.||....      ..+.+.+....  .+.               .           +....+..+.+++.+||
T Consensus       187 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~---------------~-----------~p~~~~~~~~~li~~~L  238 (327)
T cd05617         187 FEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPI---------------R-----------IPRFLSVKASHVLKGFL  238 (327)
T ss_pred             HHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCC---------------C-----------CCCCCCHHHHHHHHHHh
Confidence            99999999996422      11222222211  000               0           00123467899999999


Q ss_pred             ccCCCCCCCH------HHHHcCccccCCcc
Q psy10954        331 ALDPKQRVSA------KTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~Ta------~elL~Hp~f~~~~~  354 (562)
                      +.||++|+++      +++++||||+.+.+
T Consensus       239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         239 NKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             ccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence            9999999984      69999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.3e-34  Score=297.60  Aligned_cols=249  Identities=36%  Similarity=0.669  Sum_probs=193.6

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeC----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVD----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      .+.+.+|+++++++ +||||+++++.+...    ..+|+++||++++|.+++... ..+++..++.++.|++.||+|||+
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34578899999999 599999999875432    468999999999999988654 368999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+||+++.++.+||+|||+++........                                          
T Consensus       124 ~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~------------------------------------------  161 (332)
T cd07857         124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE------------------------------------------  161 (332)
T ss_pred             CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccc------------------------------------------
Confidence            99999999999999999999999999987644211000                                          


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                   ........+||+.|+|||++.+...++.++||||+
T Consensus       162 ---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl  196 (332)
T cd07857         162 ---------------------------------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV  196 (332)
T ss_pred             ---------------------------------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence                                                         00001124679999999998776668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|+|++|++||.+.+....+..++..+|.++.+.+.......  .+...........+.......+..+.+|+.+||
T Consensus       197 Gv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  276 (332)
T cd07857         197 GCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLL  276 (332)
T ss_pred             HHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHc
Confidence            999999999999999998888999999999887665433222110  011111112222233334445778999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCcc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      +.||++|+|+.|+++||||.....
T Consensus       277 ~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         277 AFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             cCCcccCCCHHHHhcChhhhhhcC
Confidence            999999999999999999987653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0579|consensus

Probab=100.00  E-value=2.7e-35  Score=312.68  Aligned_cols=221  Identities=26%  Similarity=0.437  Sum_probs=181.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+-||+||...+||+||+|++.|...++++|+.|||+| ....++...+..|.+.+++.+.+|++.||+|||+++||
T Consensus        73 LEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iI  152 (1187)
T KOG0579|consen   73 LEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNII  152 (1187)
T ss_pred             HhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchh
Confidence            34567899999999999999999999999999999999986 67777777777899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |||||.+|||+..+|.++|+|||.+.......                                                
T Consensus       153 HRDLKAGNiL~TldGdirLADFGVSAKn~~t~------------------------------------------------  184 (1187)
T KOG0579|consen  153 HRDLKAGNILLTLDGDIRLADFGVSAKNKSTR------------------------------------------------  184 (1187)
T ss_pred             hhhccccceEEEecCcEeeecccccccchhHH------------------------------------------------
Confidence            99999999999999999999999864322110                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSA  252 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSl  252 (562)
                                                                 .+..+++|||+||||||...    ...|++++|||||
T Consensus       185 -------------------------------------------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl  221 (1187)
T KOG0579|consen  185 -------------------------------------------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL  221 (1187)
T ss_pred             -------------------------------------------hhhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence                                                       11235678888888888753    4569999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++|.||..+.+|-..-+....+.+|...  .|+.-                 ..|..|       +..+.||+.+||..
T Consensus       222 GITLIEMAqiEPPHhelnpMRVllKiaKS--ePPTL-----------------lqPS~W-------s~~F~DfLk~cL~K  275 (1187)
T KOG0579|consen  222 GITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPTL-----------------LQPSHW-------SRSFSDFLKRCLVK  275 (1187)
T ss_pred             hhHHHHHhccCCCccccchHHHHHHHhhc--CCCcc-----------------cCcchh-------hhHHHHHHHHHHhc
Confidence            99999999999999888887777776532  11100                 011112       34688999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCccc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ||..||++.++|+||||.++...
T Consensus       276 np~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  276 NPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             CCccCCCHHHHhhCcccccCCcc
Confidence            99999999999999999987643

>KOG0986|consensus

Probab=100.00  E-value=2.9e-35  Score=304.24  Aligned_cols=221  Identities=25%  Similarity=0.387  Sum_probs=179.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+++|-.||..++.+.||.|-..|++.+.+|+||..|.| ||.-.|.+.+. .|+|..+++|+.||+.||++||+.+|
T Consensus       229 e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~i  308 (591)
T KOG0986|consen  229 ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRI  308 (591)
T ss_pred             hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcce
Confidence            45689999999999999999999999999999999999975 99887877653 59999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |.|||||+|||+|+.|+++|+|.|+|..+...                                                
T Consensus       309 VYRDLKPeNILLDd~GhvRISDLGLAvei~~g------------------------------------------------  340 (591)
T KOG0986|consen  309 VYRDLKPENILLDDHGHVRISDLGLAVEIPEG------------------------------------------------  340 (591)
T ss_pred             eeccCChhheeeccCCCeEeeccceEEecCCC------------------------------------------------
Confidence            99999999999999999999999997544211                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......|||..|||||++.+.. |++++|+||+||+
T Consensus       341 --------------------------------------------~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCl  375 (591)
T KOG0986|consen  341 --------------------------------------------KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCL  375 (591)
T ss_pred             --------------------------------------------CccccccCcccccCHHHHcCCc-ccCCccHHHHHhH
Confidence                                                        1123458999999999998877 9999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||+.|+.||....+...-..+-+..-..+                      ..   .-...+++++++.+.+|+.||+
T Consensus       376 lYemi~G~sPFr~~KeKvk~eEvdrr~~~~~----------------------~e---y~~kFS~eakslc~~LL~Kdp~  430 (591)
T KOG0986|consen  376 LYEMIAGHSPFRQRKEKVKREEVDRRTLEDP----------------------EE---YSDKFSEEAKSLCEGLLTKDPE  430 (591)
T ss_pred             HHHHHcccCchhhhhhhhhHHHHHHHHhcch----------------------hh---cccccCHHHHHHHHHHHccCHH
Confidence            9999999999976544322111111100000                      00   1112357899999999999999


Q ss_pred             CCCC-----HHHHHcCccccCCcccC
Q psy10954        336 QRVS-----AKTILQHEYFNQVEMVK  356 (562)
Q Consensus       336 ~R~T-----a~elL~Hp~f~~~~~~~  356 (562)
                      +|++     ++++.+||||+++++..
T Consensus       431 ~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  431 KRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             HhccCCCcCcchhhhCcccccCCHhH
Confidence            9986     67999999999998654

>KOG0201|consensus

Probab=100.00  E-value=2.6e-36  Score=311.85  Aligned_cols=212  Identities=29%  Similarity=0.444  Sum_probs=161.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+..|+.+|.+++++||.++|+.|..+..++++||||.+ ++.+.++... .+.|..+.-++++++.||.|||.++.+|
T Consensus        56 ediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiH  134 (467)
T KOG0201|consen   56 EDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIH  134 (467)
T ss_pred             HHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceec
Confidence            3467899999999999999999999999999999999975 7777665432 3466666677777777777777777777


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      ||||+.|||+..+|.+||+|||.+.                                                       
T Consensus       135 rDIKaanil~s~~g~vkl~DfgVa~-------------------------------------------------------  159 (467)
T KOG0201|consen  135 RDIKAANILLSESGDVKLADFGVAG-------------------------------------------------------  159 (467)
T ss_pred             ccccccceeEeccCcEEEEecceee-------------------------------------------------------
Confidence            7777777777666666666666543                                                       


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                          ..+....+..+++|||+||||||+.+. .|+.++||||||++.+
T Consensus       160 ------------------------------------ql~~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITai  202 (467)
T KOG0201|consen  160 ------------------------------------QLTNTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAI  202 (467)
T ss_pred             ------------------------------------eeechhhccccccccccccchhhhccc-cccchhhhhhhhHHHH
Confidence                                                333333334678999999999999954 5999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||........++.|                         |.-.|..   +-+..++.+++|+..||.+||+.|
T Consensus       203 Ela~GePP~s~~hPmrvlflI-------------------------pk~~PP~---L~~~~S~~~kEFV~~CL~k~P~~R  254 (467)
T KOG0201|consen  203 ELAKGEPPHSKLHPMRVLFLI-------------------------PKSAPPR---LDGDFSPPFKEFVEACLDKNPEFR  254 (467)
T ss_pred             HHhcCCCCCcccCcceEEEec-------------------------cCCCCCc---cccccCHHHHHHHHHHhhcCcccC
Confidence            999999999877653222222                         1111111   112235679999999999999999


Q ss_pred             CCHHHHHcCccccC
Q psy10954        338 VSAKTILQHEYFNQ  351 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~  351 (562)
                      |||.++|+|+|++.
T Consensus       255 psA~~LLKh~FIk~  268 (467)
T KOG0201|consen  255 PSAKELLKHKFIKR  268 (467)
T ss_pred             cCHHHHhhhHHHHh
Confidence            99999999999986

>KOG0612|consensus

Probab=100.00  E-value=3.3e-35  Score=329.75  Aligned_cols=221  Identities=28%  Similarity=0.421  Sum_probs=183.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .-+..|-.+|..-+.+-|+.|+..|+++.++|+|||||+ |||..++.+.. .+||..+++|+..|+.||.-||+.|.||
T Consensus       120 A~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVH  198 (1317)
T KOG0612|consen  120 ACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVH  198 (1317)
T ss_pred             HHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcccee
Confidence            346678999999999999999999999999999999997 49999998877 8999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++..|++||+|||.+-.+...                                                  
T Consensus       199 RDiKPDNvLld~~GHikLADFGsClkm~~d--------------------------------------------------  228 (1317)
T KOG0612|consen  199 RDIKPDNVLLDKSGHIKLADFGSCLKMDAD--------------------------------------------------  228 (1317)
T ss_pred             ccCCcceeEecccCcEeeccchhHHhcCCC--------------------------------------------------
Confidence            999999999999999999999976443211                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAG  253 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSlG  253 (562)
                                              |.                -..+..||||.|++||+|..    .+.||..+|+||+|
T Consensus       229 ------------------------G~----------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlG  268 (1317)
T KOG0612|consen  229 ------------------------GT----------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLG  268 (1317)
T ss_pred             ------------------------Cc----------------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhH
Confidence                                    11                11234588999999998852    24699999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||+.|.+||+.++-.+..-+|.+.-.                ...||..         ...++.++|||.++| -+
T Consensus       269 V~~YEMlyG~TPFYadslveTY~KIm~hk~----------------~l~FP~~---------~~VSeeakdLI~~ll-~~  322 (1317)
T KOG0612|consen  269 VFMYEMLYGETPFYADSLVETYGKIMNHKE----------------SLSFPDE---------TDVSEEAKDLIEALL-CD  322 (1317)
T ss_pred             HHHHHHHcCCCcchHHHHHHHHHHHhchhh----------------hcCCCcc---------cccCHHHHHHHHHHh-cC
Confidence            999999999999999998888888875310                0112210         124678999999866 57


Q ss_pred             CCCCCC---HHHHHcCccccCCcccC
Q psy10954        334 PKQRVS---AKTILQHEYFNQVEMVK  356 (562)
Q Consensus       334 P~~R~T---a~elL~Hp~f~~~~~~~  356 (562)
                      |+.|.+   ++++.+||||.+++|..
T Consensus       323 ~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  323 REVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             hhhhcccccHHHHHhCccccCCChhh
Confidence            888988   99999999999999854

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.7e-34  Score=291.04  Aligned_cols=224  Identities=27%  Similarity=0.401  Sum_probs=175.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .....+|+++++.++||||+++++.+..++..|+||||+++ +|..++.+....+++..+..++.|++.||.|||++||+
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~  132 (292)
T cd06644          53 LEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII  132 (292)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence            34567899999999999999999999999999999999986 78777766556799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++..........                                             
T Consensus       133 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------------  167 (292)
T cd06644         133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR---------------------------------------------  167 (292)
T ss_pred             ecCCCcceEEEcCCCCEEEccCccceecccccccc---------------------------------------------
Confidence            99999999999999999999999865432110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSA  252 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSl  252 (562)
                                                                    ....+++.|+|||++.+    ...++.++|+||+
T Consensus       168 ----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  201 (292)
T cd06644         168 ----------------------------------------------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  201 (292)
T ss_pred             ----------------------------------------------ceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence                                                          11235667777777642    2347889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|||++|.+||...+......++....  ++.                  ..      .....+..+.+++.+||+.
T Consensus       202 G~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~------------------~~------~~~~~~~~~~~li~~~l~~  255 (292)
T cd06644         202 GITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT------------------LS------QPSKWSMEFRDFLKTALDK  255 (292)
T ss_pred             HHHHHHHhcCCCCCccccHHHHHHHHhcCC--Ccc------------------CC------CCcccCHHHHHHHHHHhcC
Confidence            999999999999998776554444432210  000                  00      0011245788999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCcccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVEMVKPT  358 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~~~~~~  358 (562)
                      ||++||+++|+++||||..+...++.
T Consensus       256 ~p~~Rp~~~~il~~~~~~~~~~~~~~  281 (292)
T cd06644         256 HPETRPSAAQLLEHPFVSSVTSNRPL  281 (292)
T ss_pred             CcccCcCHHHHhcCccccccccchhH
Confidence            99999999999999999988765543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.4e-34  Score=293.15  Aligned_cols=214  Identities=27%  Similarity=0.442  Sum_probs=171.1

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+|+.+|++++|+||+.+++.+..++.+|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+|
T Consensus        46 ~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH  125 (285)
T cd05630          46 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY  125 (285)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence            46789999999999999999999999999999999997 48988885533 35899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.++|+|||++......                                                  
T Consensus       126 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--------------------------------------------------  155 (285)
T cd05630         126 RDLKPENILLDDHGHIRISDLGLAVHVPEG--------------------------------------------------  155 (285)
T ss_pred             CCCCHHHEEECCCCCEEEeeccceeecCCC--------------------------------------------------
Confidence            999999999999999999999986432100                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       156 ------------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~  192 (285)
T cd05630         156 ------------------------------------------QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLY  192 (285)
T ss_pred             ------------------------------------------ccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHH
Confidence                                                      0001235789999999997755 899999999999999


Q ss_pred             HHHhCCCCCCCCCHH---HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        258 EMITKKTLFAGDSEI---DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       258 eLltG~~pF~~~~~~---~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|++|++||.+....   +....+.....                     .       ......++.+.+|+.+||+.||
T Consensus       193 ~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------------~-------~~~~~~~~~~~~li~~~l~~~p  244 (285)
T cd05630         193 EMIAGQSPFQQRKKKIKREEVERLVKEVQ---------------------E-------EYSEKFSPDARSLCKMLLCKDP  244 (285)
T ss_pred             HHHhCCCCCCCCCccchHHHHHhhhhhhh---------------------h-------hcCccCCHHHHHHHHHHhhcCH
Confidence            999999999865432   11111111000                     0       0112235678999999999999


Q ss_pred             CCCCC-----HHHHHcCccccCCcc
Q psy10954        335 KQRVS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       335 ~~R~T-----a~elL~Hp~f~~~~~  354 (562)
                      ++|+|     ++|+++||||+++.+
T Consensus       245 ~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         245 KERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             HHccCCCCCchHHHHcChhhhccCH
Confidence            99999     999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-34  Score=300.46  Aligned_cols=214  Identities=26%  Similarity=0.429  Sum_probs=174.7

Q ss_pred             hhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .....|+.+++.+. |++|+++++++...+.+|+||||+++ +|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iv  123 (323)
T cd05615          45 ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGII  123 (323)
T ss_pred             HHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678999998885 57788999999999999999999974 8998886643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       124 HrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~------------------------------------------------  155 (323)
T cd05615         124 YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG------------------------------------------------  155 (323)
T ss_pred             ccCCCHHHeEECCCCCEEEeccccccccCCCC------------------------------------------------
Confidence            99999999999999999999999875321000                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       156 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil  191 (323)
T cd05615         156 -------------------------------------------VTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLL  191 (323)
T ss_pred             -------------------------------------------ccccCccCCccccCHHHHcCCC-CCCccchhhhHHHH
Confidence                                                       0011235799999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|++||.+.+.......+......                  ++           ...+..+.+++.+||+.||++
T Consensus       192 ~elltG~~pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~~l~~~p~~  242 (323)
T cd05615         192 YEMLAGQPPFDGEDEDELFQSIMEHNVS------------------YP-----------KSLSKEAVSICKGLMTKHPSK  242 (323)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------ccCCHHHHHHHHHHcccCHhh
Confidence            9999999999988876666665432100                  00           122467899999999999999


Q ss_pred             CCC-----HHHHHcCccccCCcc
Q psy10954        337 RVS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~T-----a~elL~Hp~f~~~~~  354 (562)
                      |++     .+++++||||..+.+
T Consensus       243 R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         243 RLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             CCCCCCCCHHHHhcCcccCCCCH
Confidence            997     579999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-34  Score=300.20  Aligned_cols=221  Identities=24%  Similarity=0.377  Sum_probs=176.0

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+.+++.++|+||+++++++..++.+|+||||+. ++|.+++......+++..++.++.|++.||+|||++||+||
T Consensus        47 ~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHr  126 (331)
T cd05624          47 CFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR  126 (331)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            45678999999999999999999999999999999997 59999998755679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++.......                                                 
T Consensus       127 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-------------------------------------------------  157 (331)
T cd05624         127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-------------------------------------------------  157 (331)
T ss_pred             cCchHHEEEcCCCCEEEEeccceeeccCCCc-------------------------------------------------
Confidence            9999999999999999999998754321000                                                 


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC----CCCCchhhHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----KVYSTTVDIWSAGC  254 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~----~~y~~~~DIWSlG~  254 (562)
                                                               ......+||+.|+|||++.+.    ..++.++||||+||
T Consensus       158 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGv  196 (331)
T cd05624         158 -----------------------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV  196 (331)
T ss_pred             -----------------------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeeh
Confidence                                                     000123578899999988652    34788999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.+..+.+..+.......                .++        ......++.+.|++.+||..++
T Consensus       197 il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p--------~~~~~~~~~~~~li~~ll~~~~  252 (331)
T cd05624         197 CMYEMLYGETPFYAESLVETYGKIMNHEERF----------------QFP--------SHITDVSEEAKDLIQRLICSRE  252 (331)
T ss_pred             hhhhhhhCCCCccCCCHHHHHHHHHcCCCcc----------------cCC--------CccccCCHHHHHHHHHHccCch
Confidence            9999999999999887766665554311100                000        0112235689999999999766


Q ss_pred             CC--CCCHHHHHcCccccCCcc
Q psy10954        335 KQ--RVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       335 ~~--R~Ta~elL~Hp~f~~~~~  354 (562)
                      ++  |.+++++++||||+.+.+
T Consensus       253 ~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         253 RRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             hhcCCCCHHHHhcCCCcCCCCH
Confidence            55  568999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-34  Score=284.36  Aligned_cols=214  Identities=28%  Similarity=0.494  Sum_probs=171.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|++++++++||||+++++++..+..+|+||||+++ +|.+++.... .+++..++.+++|++.||.|||++||+|
T Consensus        49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H  127 (263)
T cd06625          49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVH  127 (263)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            3567899999999999999999999999999999999975 8999887643 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.++|+|||+++.......                                                
T Consensus       128 ~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------  159 (263)
T cd06625         128 RDIKGANILRDSAGNVKLGDFGASKRLQTICS------------------------------------------------  159 (263)
T ss_pred             CCCCHHHEEEcCCCCEEEeecccceecccccc------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                              .........|+..|+|||++.+.. ++.++||||+||++|
T Consensus       160 ----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  198 (263)
T cd06625         160 ----------------------------------------SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVV  198 (263)
T ss_pred             ----------------------------------------ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHH
Confidence                                                    000001235678899999998765 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||.+.+......++......+                   .        +....+..+.+++++||..||.+|
T Consensus       199 el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------~--------~~~~~~~~~~~li~~~l~~~p~~R  251 (263)
T cd06625         199 EMLTEKPPWAEFEAMAAIFKIATQPTNP-------------------Q--------LPSHVSPDARNFLRRTFVENAKKR  251 (263)
T ss_pred             HHHhCCCCccccchHHHHHHHhccCCCC-------------------C--------CCccCCHHHHHHHHHHhhcCcccC
Confidence            9999999998766554444332210000                   0        111235678999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy10954        338 VSAKTILQHEYF  349 (562)
Q Consensus       338 ~Ta~elL~Hp~f  349 (562)
                      ||+.|+++|+||
T Consensus       252 pt~~~ll~~~~~  263 (263)
T cd06625         252 PSAEELLRHFFV  263 (263)
T ss_pred             CCHHHHhhCCCC
Confidence            999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-34  Score=286.73  Aligned_cols=243  Identities=41%  Similarity=0.770  Sum_probs=186.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+.+|+++|+.++||||+++++++..++..|+||||+++++...+......+++..+..++.|++.||.|||++||+
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (288)
T cd07833          43 VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII  122 (288)
T ss_pred             chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34567899999999999999999999999999999999999866665555455699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........                                               
T Consensus       123 H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-----------------------------------------------  155 (288)
T cd07833         123 HRDIKPENILVSESGVLKLCDFGFARALRARPA-----------------------------------------------  155 (288)
T ss_pred             cCCCCHHHeEECCCCCEEEEeeecccccCCCcc-----------------------------------------------
Confidence            999999999999999999999998754321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+++..|+|||++.+...++.++|+||+||++
T Consensus       156 -------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l  192 (288)
T cd07833         156 -------------------------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM  192 (288)
T ss_pred             -------------------------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHH
Confidence                                                       0011235688899999998775689999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCC-ccchhhhcC-CCCHHHHHHHHHccccC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWR-PKKFSEILN-LPDPLAVDVFSKIMALD  333 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~l~-~~~~~~~dLi~~mL~~D  333 (562)
                      |+|++|++||.+.+..+.+..+...++......+......+.+.. .++... +..+..... ..++.+.+|+++||..|
T Consensus       193 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  272 (288)
T cd07833         193 AELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD  272 (288)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccC
Confidence            999999999999888887777777666544332221111111110 111110 111111122 22678999999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy10954        334 PKQRVSAKTILQHEYF  349 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f  349 (562)
                      |++|||++++++||||
T Consensus       273 p~~Rps~~~il~~~~f  288 (288)
T cd07833         273 PKERLTCDELLQHPYF  288 (288)
T ss_pred             chhcccHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0663|consensus

Probab=100.00  E-value=1.4e-35  Score=297.29  Aligned_cols=101  Identities=34%  Similarity=0.544  Sum_probs=90.2

Q ss_pred             cccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhhc
Q psy10954        413 QRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHES  492 (562)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  492 (562)
                      |-|.|+||+|+++..|.                                               -++|.||+||| +||+
T Consensus       240 TLWYRaPELLLG~~tys-----------------------------------------------t~iDMWSvGCI-~aE~  271 (419)
T KOG0663|consen  240 TLWYRAPELLLGAKTYS-----------------------------------------------TAVDMWSVGCI-FAEL  271 (419)
T ss_pred             EeeecCHHHhcCCcccC-----------------------------------------------cchhhhhHHHH-HHHH
Confidence            35899999999999998                                               78999999999 9999


Q ss_pred             ccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC-CCCCcccCccccccCCCC--ChhHHHHHhc
Q psy10954        493 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNLP--DPLAVDVFSR  561 (562)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  561 (562)
                      ++.+|||||+||+|||.|||+.||||+|..|||.+.||..+ -.||+.....+...+...  +..|.|++..
T Consensus       272 l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~  343 (419)
T KOG0663|consen  272 LTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNK  343 (419)
T ss_pred             HhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHH
Confidence            99999999999999999999999999999999999999885 679998887776666554  4888888765

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-34  Score=300.09  Aligned_cols=241  Identities=39%  Similarity=0.688  Sum_probs=188.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+++.++||||+++++++...      ...|+||||+..+|.+++.   ..+++..++.++.|++.||+|||
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH  134 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH  134 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH
Confidence            45578999999999999999999998754      3579999999888877653   25899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+||+++.++.+||+|||+++.....                                            
T Consensus       135 ~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--------------------------------------------  170 (342)
T cd07879         135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--------------------------------------------  170 (342)
T ss_pred             HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--------------------------------------------
Confidence            999999999999999999999999999986432100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        ....++|+.|+|||++.+...++.++|+||
T Consensus       171 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  200 (342)
T cd07879         171 --------------------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWS  200 (342)
T ss_pred             --------------------------------------------------CCCceeeecccChhhhcCccccCchHHHHH
Confidence                                                              011245778999999876555889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|||++|+.||.+.+....+..+....|.+....+......  ..+....+......+...++..++.+.+||.+|
T Consensus       201 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  280 (342)
T cd07879         201 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKM  280 (342)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHH
Confidence            999999999999999998888888888887776654433222111  011111122222333334455677889999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCccc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      |+.||++|+|++|+++||||+.+...
T Consensus       281 l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         281 LELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cCCChhhCcCHHHHhcCcchhhcccc
Confidence            99999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0607|consensus

Probab=100.00  E-value=5.8e-35  Score=291.02  Aligned_cols=229  Identities=26%  Similarity=0.414  Sum_probs=177.3

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+++||++++.+. .|+||++|+++|+++..+|||||-|.+ .|.+.|+++. .|+|..+..+++.|+.||.|||.+|
T Consensus       118 sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg  196 (463)
T KOG0607|consen  118 SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG  196 (463)
T ss_pred             HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC
Confidence            456889999999998 699999999999999999999999975 8888887754 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         95 IIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        95 IiHRDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      |.||||||+|||-...   .-+|||||.++..+.....      .+     |                            
T Consensus       197 IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~------~s-----p----------------------------  237 (463)
T KOG0607|consen  197 IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND------CS-----P----------------------------  237 (463)
T ss_pred             cccccCCccceeecCCCCcCceeeeccccccccccCCC------CC-----C----------------------------
Confidence            9999999999997544   3489999988654321000      00     0                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc----CCCCCCchh
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTV  247 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~----~~~~y~~~~  247 (562)
                                                                   .......+.||+..||||||.-    ....|+.++
T Consensus       238 ---------------------------------------------astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC  272 (463)
T KOG0607|consen  238 ---------------------------------------------ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC  272 (463)
T ss_pred             ---------------------------------------------CCCccccCcccchhhcchhHHhhhccccccccccc
Confidence                                                         0112234568999999999873    345799999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchh
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEI---------------DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS  312 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~---------------~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (562)
                      |.||||||+|.|++|.+||.|.-..               ..+..|.+.--..+++.|                      
T Consensus       273 DlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW----------------------  330 (463)
T KOG0607|consen  273 DLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW----------------------  330 (463)
T ss_pred             cHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh----------------------
Confidence            9999999999999999999875321               122223222111122111                      


Q ss_pred             hhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        313 EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       313 ~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                         ...+..++|+++.+|..|+..|.+|.++++|||++.+...
T Consensus       331 ---ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  331 ---AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ---HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence               1234689999999999999999999999999999987654

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=287.55  Aligned_cols=217  Identities=27%  Similarity=0.434  Sum_probs=173.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++.+..+...|+||||+++ +|.+++...+..+++..++.++.|++.||.|||++||+|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h  126 (280)
T cd06611          47 EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH  126 (280)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4577899999999999999999999999999999999986 899988876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.++|+|||++........                                                
T Consensus       127 ~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------------------------------------------------  158 (280)
T cd06611         127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ------------------------------------------------  158 (280)
T ss_pred             CCCChhhEEECCCCCEEEccCccchhhccccc------------------------------------------------
Confidence            99999999999999999999998643211000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAG  253 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSlG  253 (562)
                                                                 ......||+.|+|||++..    ...++.++|+||+|
T Consensus       159 -------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG  195 (280)
T cd06611         159 -------------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG  195 (280)
T ss_pred             -------------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHH
Confidence                                                       0012346778888888752    23477899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|+|++|++||.+.+....+..+.... .+...                         .-...+..+.+++.+||+.|
T Consensus       196 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~~li~~~l~~~  249 (280)
T cd06611         196 ITLIELAQMEPPHHELNPMRVLLKILKSE-PPTLD-------------------------QPSKWSSSFNDFLKSCLVKD  249 (280)
T ss_pred             HHHHHHHhCCCCcccCCHHHHHHHHhcCC-CCCcC-------------------------CcccCCHHHHHHHHHHhccC
Confidence            99999999999998876655444442210 00000                         00112457889999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy10954        334 PKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~  352 (562)
                      |++|||+.++++||||.+.
T Consensus       250 p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         250 PDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             hhhCcCHHHHhcChhhccc
Confidence            9999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-33  Score=286.66  Aligned_cols=217  Identities=26%  Similarity=0.403  Sum_probs=173.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ....+|+++++.++||||+++++.+......|+||||+++ +|..++.+....+++..+..++.|++.||.|||+.||+|
T Consensus        47 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H  126 (282)
T cd06643          47 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH  126 (282)
T ss_pred             HHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            4567899999999999999999999999999999999985 787777665557999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||++........                                                
T Consensus       127 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~------------------------------------------------  158 (282)
T cd06643         127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------------------------------------------------  158 (282)
T ss_pred             cCCCcccEEEccCCCEEEcccccccccccccc------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc----CCCCCCchhhHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAG  253 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~----~~~~y~~~~DIWSlG  253 (562)
                                                                 ......+|+.|+|||++.    ....++.++|+||+|
T Consensus       159 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  195 (282)
T cd06643         159 -------------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG  195 (282)
T ss_pred             -------------------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHH
Confidence                                                       001124677888888874    223477899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|++||.+.+..+....+.........                          .....+..+.+|+.+||..|
T Consensus       196 vil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~  249 (282)
T cd06643         196 ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA--------------------------QPSRWSSEFKDFLKKCLEKN  249 (282)
T ss_pred             HHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC--------------------------CccccCHHHHHHHHHHccCC
Confidence            9999999999999887766555554332110000                          00112457899999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy10954        334 PKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~  352 (562)
                      |.+|||+.++++||||...
T Consensus       250 p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         250 VDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             hhhCcCHHHHhcCCCEecc
Confidence            9999999999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=290.72  Aligned_cols=252  Identities=29%  Similarity=0.403  Sum_probs=186.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+.++||||+++++.+..+...|+||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++|+
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  124 (316)
T cd05574          45 VKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI  124 (316)
T ss_pred             HHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34578899999999999999999999999999999999975 9999887543 469999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||++...........         ..+.. .... ..                     
T Consensus       125 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~---------~~~~~-~~~~-~~---------------------  172 (316)
T cd05574         125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS---------KALRK-GSRR-SS---------------------  172 (316)
T ss_pred             eccCCChHHeEEcCCCCEEEeecchhhcccccccccc---------ccccc-cccc-cc---------------------
Confidence            9999999999999999999999999865432110000         00000 0000 00                     


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                           .+         ++...+        +.        ..........+||..|+|||++.+.. ++.++||||+||+
T Consensus       173 -----~~---------~~~~~~--------~~--------~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~l  221 (316)
T cd05574         173 -----VN---------SIPSET--------FS--------EEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGIL  221 (316)
T ss_pred             -----cc---------ccchhh--------hc--------ccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHH
Confidence                 00         000000        00        00111223457899999999998765 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+.+....+..+...-..                  ++.         ....+..+.+++.+||+.||+
T Consensus       222 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~---------~~~~~~~~~~li~~~l~~~p~  274 (316)
T cd05574         222 LYEMLYGTTPFKGSNRDETFSNILKKEVT------------------FPG---------SPPVSSSARDLIRKLLVKDPS  274 (316)
T ss_pred             HHHHhhCCCCCCCCchHHHHHHHhcCCcc------------------CCC---------ccccCHHHHHHHHHHccCCHh
Confidence            99999999999988877666555421100                  000         011356789999999999999


Q ss_pred             CCCC----HHHHHcCccccCCcccCCcc
Q psy10954        336 QRVS----AKTILQHEYFNQVEMVKPTL  359 (562)
Q Consensus       336 ~R~T----a~elL~Hp~f~~~~~~~~~~  359 (562)
                      +|+|    ++|+|+||||++..+.....
T Consensus       275 ~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         275 KRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HCCCchhhHHHHHcCchhhcCChhhccc
Confidence            9999    99999999999987655443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-33  Score=288.38  Aligned_cols=218  Identities=27%  Similarity=0.392  Sum_probs=175.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|+++|+.++|+||+.+++.+..++.+|+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++||+
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ii  124 (285)
T cd05632          45 SMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV  124 (285)
T ss_pred             HHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3467899999999999999999999999999999999985 8888876533 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++......                                                 
T Consensus       125 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------  155 (285)
T cd05632         125 YRDLKPENILLDDYGHIRISDLGLAVKIPEG-------------------------------------------------  155 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEecCCcceecCCC-------------------------------------------------
Confidence            9999999999999999999999986432100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||+.|+|||++.+.. ++.++|+||+||++
T Consensus       156 -------------------------------------------~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l  191 (285)
T cd05632         156 -------------------------------------------ESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLI  191 (285)
T ss_pred             -------------------------------------------CcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHH
Confidence                                                       0001235789999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|..||.+..+......+..........                         .....++.+.+|+.+||+.||++
T Consensus       192 ~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~  246 (285)
T cd05632         192 YEMIEGQSPFRGRKEKVKREEVDRRVLETEEV-------------------------YSAKFSEEAKSICKMLLTKDPKQ  246 (285)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhhhccccc-------------------------cCccCCHHHHHHHHHHccCCHhH
Confidence            99999999998876654444433321111000                         01123457899999999999999


Q ss_pred             CCC-----HHHHHcCccccCCcc
Q psy10954        337 RVS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~T-----a~elL~Hp~f~~~~~  354 (562)
                      |+|     +.++++|+||+++..
T Consensus       247 R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         247 RLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             cCCCcccChHHHHcChhhhcCCH
Confidence            999     889999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-34  Score=301.69  Aligned_cols=241  Identities=40%  Similarity=0.688  Sum_probs=191.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCE------EEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFK------LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~------i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..+.+|+.+++.++||||+++++++.....      +|+|+||++++|.+++...  .+++..+..++.|++.||.|||+
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~  136 (343)
T cd07851          59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHS  136 (343)
T ss_pred             HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999998876554      8999999998999988753  58999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+||+++.++.+||+|||++......                                             
T Consensus       137 ~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---------------------------------------------  171 (343)
T cd07851         137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---------------------------------------------  171 (343)
T ss_pred             CCeecCCCCHHHeEECCCCCEEEcccccccccccc---------------------------------------------
Confidence            99999999999999999999999999986432100                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                       .....+|..|+|||++.+...++.++||||+
T Consensus       172 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  202 (343)
T cd07851         172 -------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  202 (343)
T ss_pred             -------------------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence                                                             0122467889999998765568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|+|++|+.||.+.+..+.+..+.+..+.+....+......  ..+....+......+.......++.+.||+.+||
T Consensus       203 Gv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l  282 (343)
T cd07851         203 GCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML  282 (343)
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhC
Confidence            99999999999999998888888888888777665444332210  0111111222222333333445778999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ..||++|||+.|+++||||.+....
T Consensus       283 ~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         283 VLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             CCChhhCCCHHHHhcCCCccccCCC
Confidence            9999999999999999999987644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0662|consensus

Probab=100.00  E-value=1.6e-35  Score=274.74  Aligned_cols=84  Identities=37%  Similarity=0.642  Sum_probs=77.9

Q ss_pred             CCCCccccchhhhhhcc-cCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCcc-ccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESI-TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  554 (562)
                      -++|.||-||+ |||+. .++|||||..-.|||.|||+.||+|+||.||++++||||+. +|.|.+.. +++|+|..+..
T Consensus       181 tsidmwsagci-faelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~-yp~ypattswsqivp~lns~  258 (292)
T KOG0662|consen  181 TSIDMWSAGCI-FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP-YPIYPATTSWSQIVPKLNST  258 (292)
T ss_pred             cchHhhhcchH-HHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc-cCCccccchHHHHhhhhcch
Confidence            56899999998 99976 47999999999999999999999999999999999999987 99999875 99999999999


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|+++++
T Consensus       259 grdllqkl  266 (292)
T KOG0662|consen  259 GRDLLQKL  266 (292)
T ss_pred             hHHHHHHH
Confidence            99999863

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-34  Score=297.40  Aligned_cols=241  Identities=40%  Similarity=0.714  Sum_probs=188.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC------EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~------~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+++|++++||||+++++++....      ..|+||||++++|.+++..  ..+++..++.++.|++.||.|||
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH  135 (343)
T cd07880          58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH  135 (343)
T ss_pred             HHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            345789999999999999999999987653      4699999998899888864  35899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+||+++.++.+||+|||++......                                            
T Consensus       136 ~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--------------------------------------------  171 (343)
T cd07880         136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--------------------------------------------  171 (343)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--------------------------------------------
Confidence            999999999999999999999999999986532100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        .....+|+.|+|||++.+...++.++|+||
T Consensus       172 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  201 (343)
T cd07880         172 --------------------------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWS  201 (343)
T ss_pred             --------------------------------------------------ccccccCCcccCHHHHhCCCCCCcHHHHHH
Confidence                                                              001245788999999876555889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|+|++|++||.+.+....+..+....+.++.+.+..+...  ..+....+...+..+.......++.+.++|.+|
T Consensus       202 lG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  281 (343)
T cd07880         202 VGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM  281 (343)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence            999999999999999998887777777766555443322222110  111112222333333334455677899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |+.||++|+|+.++++||||+....
T Consensus       282 l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         282 LVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             cCCChhhCCCHHHHhcCccHhhhcC
Confidence            9999999999999999999998754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-33  Score=289.44  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=176.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++|+.++||||++++++|...+..|++|||++ ++|.+++... ...+++..++.+++|++.||+|||++||+
T Consensus        44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~iv  123 (314)
T cd08216          44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI  123 (314)
T ss_pred             HHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            467899999999999999999999999999999999998 4898888753 34589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||.+.........           ..                                 
T Consensus       124 H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~-----------~~---------------------------------  159 (314)
T cd08216         124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR-----------QR---------------------------------  159 (314)
T ss_pred             cCCCCcceEEEecCCceEEecCccceeecccccc-----------cc---------------------------------
Confidence            9999999999999999999999986543210000           00                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCI  255 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~i  255 (562)
                                                  ...+            ......++..|+|||++.+. ..|+.++|+||+||+
T Consensus       160 ----------------------------~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~i  199 (314)
T cd08216         160 ----------------------------VVHD------------FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT  199 (314)
T ss_pred             ----------------------------cccc------------ccccccccccccCHHHhcCCCCCCCcchhHHHHHHH
Confidence                                        0000            01223567889999999764 358899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCC--CCCCCCCC-CCCc--cCCCCCCCccchh-hhcCCCCHHHHHHHHHc
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE--DVWPGVSK-LPIY--KTDFPEWRPKKFS-EILNLPDPLAVDVFSKI  329 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~--~~~~~~~~-~~~~--~~~~~~~~~~~~~-~~l~~~~~~~~dLi~~m  329 (562)
                      ++||++|+.||........+............  ..++.... ....  ....+. ...... ......+..+.+|+.+|
T Consensus       200 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~  278 (314)
T cd08216         200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELC  278 (314)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHH
Confidence            99999999999877655443332221100000  00000000 0000  000000 000000 00011245788999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++||++|||++|+|+||||+.+.
T Consensus       279 l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         279 LQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCCcCcCHHHHhcCchHhhhc
Confidence            999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.2e-34  Score=287.55  Aligned_cols=240  Identities=39%  Similarity=0.748  Sum_probs=181.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++..+...|+||||+.+ .|..+... ...+++..++.++.|++.||.|||++||+
T Consensus        44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (286)
T cd07846          44 KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNII  122 (286)
T ss_pred             hHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            44577999999999999999999999999999999999987 45555443 34589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........                                               
T Consensus       123 h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-----------------------------------------------  155 (286)
T cd07846         123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-----------------------------------------------  155 (286)
T ss_pred             ccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-----------------------------------------------
Confidence            999999999999999999999998754321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  .....+++..|+|||++.+...++.++||||+||++
T Consensus       156 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  191 (286)
T cd07846         156 --------------------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLV  191 (286)
T ss_pred             --------------------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHH
Confidence                                                        011235678899999987766688999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCc-cCCCCCCC-ccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |||++|++||.+....+.+..+....+.............+.. ....+... ........+..+..+.+|+.+||+.||
T Consensus       192 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  271 (286)
T cd07846         192 TEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDP  271 (286)
T ss_pred             HHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCc
Confidence            9999999999988887777777766554322110000000000 00000000 011112233456789999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy10954        335 KQRVSAKTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f  349 (562)
                      ++|||+.++++||||
T Consensus       272 ~~Rp~~~~il~~~~~  286 (286)
T cd07846         272 DDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccchhHHHHhcCCCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0690|consensus

Probab=100.00  E-value=7.6e-35  Score=290.54  Aligned_cols=213  Identities=29%  Similarity=0.437  Sum_probs=172.4

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      .+.|-.+|+..+||.+..|...|++.+.+|+||||..+ +|+-.+.+. ..++|+.+++|-.+|+.||.|||+++||.||
T Consensus       215 TlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRD  293 (516)
T KOG0690|consen  215 TLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRD  293 (516)
T ss_pred             hhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeee
Confidence            56788999999999999999999999999999999975 888766553 3689998888888888888888888888888


Q ss_pred             CCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHH
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALR  179 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~  179 (562)
                      ||.+|.|++.+|++||+|||+++.                                                        
T Consensus       294 lKLENLlLDkDGHIKitDFGLCKE--------------------------------------------------------  317 (516)
T KOG0690|consen  294 LKLENLLLDKDGHIKITDFGLCKE--------------------------------------------------------  317 (516)
T ss_pred             chhhhheeccCCceEeeecccchh--------------------------------------------------------
Confidence            888888887777777777777542                                                        


Q ss_pred             hhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHH
Q psy10954        180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       180 yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eL  259 (562)
                                                         ........+++||||.|.||||+... .|+.++|+|.+||++|||
T Consensus       318 -----------------------------------~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEM  361 (516)
T KOG0690|consen  318 -----------------------------------EIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEM  361 (516)
T ss_pred             -----------------------------------cccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHH
Confidence                                               11122345789999999999999754 499999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCC
Q psy10954        260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS  339 (562)
Q Consensus       260 ltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~T  339 (562)
                      ++|+.||+..+....+..|+-.-                  ..||           +..+++++.|++.+|..||.+|+.
T Consensus       362 mCGRLPFyn~dh~kLFeLIl~ed------------------~kFP-----------r~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  362 MCGRLPFYNKDHEKLFELILMED------------------LKFP-----------RTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             HhccCcccccchhHHHHHHHhhh------------------ccCC-----------ccCCHHHHHHHHHHhhcChHhhcC
Confidence            99999999988765555543210                  0111           223678999999999999999996


Q ss_pred             -----HHHHHcCccccCCccc
Q psy10954        340 -----AKTILQHEYFNQVEMV  355 (562)
Q Consensus       340 -----a~elL~Hp~f~~~~~~  355 (562)
                           |.|+.+|+||..++|.
T Consensus       413 gGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  413 GGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             CCchhHHHHHhhhhhccCCHH
Confidence                 7899999999998864

>KOG0668|consensus

Probab=100.00  E-value=8.2e-35  Score=278.85  Aligned_cols=240  Identities=33%  Similarity=0.651  Sum_probs=181.4

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      .+.+.||+.||+.|. |||||+|+++..+.  ...-||+||+.+ |...+..    .++...++.+++|++.||.|||++
T Consensus        76 kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~  151 (338)
T KOG0668|consen   76 KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM  151 (338)
T ss_pred             HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc
Confidence            346889999999996 99999999998765  456899999987 5444332    478888999999999999999999


Q ss_pred             CceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         94 RIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ||+|||+||.|++|+... .++|+|.|+|..+. |...                                          
T Consensus       152 GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~~e------------------------------------------  188 (338)
T KOG0668|consen  152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE------------------------------------------  188 (338)
T ss_pred             CcccccCCcceeeechhhceeeeeecchHhhcC-CCce------------------------------------------
Confidence            999999999999999654 58899999887553 2122                                          


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                       ++..|.+++|-.||.+...+.|+.+.|+||+
T Consensus       189 -------------------------------------------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~  219 (338)
T KOG0668|consen  189 -------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSL  219 (338)
T ss_pred             -------------------------------------------------eeeeeehhhcCCchheeechhccccHHHHHH
Confidence                                                             2234556777777777777789999999999


Q ss_pred             HHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCCCCCC---CCCCCCCccCCCCCCCccchhhhcC-----CCCHHHH
Q psy10954        253 GCIFSEMITKKTL-FAGDSEIDQLFRIFRTLGTPHEDVWP---GVSKLPIYKTDFPEWRPKKFSEILN-----LPDPLAV  323 (562)
Q Consensus       253 G~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~-----~~~~~~~  323 (562)
                      ||+++.|+..+-| |.|.++.+|+.+|...+|+......-   .+.--+.+..-......+.++...+     ..++++.
T Consensus       220 GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peai  299 (338)
T KOG0668|consen  220 GCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAI  299 (338)
T ss_pred             HHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHH
Confidence            9999999987665 68999999999999999975431100   0000011111111112223333322     2368999


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||+.++|.+|-.+|+||+|++.||||..+.
T Consensus       300 DlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  300 DLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HHHHHHHhhccccccchHHHhcCchHHHHH
Confidence            999999999999999999999999997653

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-33  Score=288.52  Aligned_cols=205  Identities=18%  Similarity=0.173  Sum_probs=165.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-   92 (562)
                      ..+.+|+.+|++++||||+++++++..    ...+|+|||||.+ +|.+++.... .+++.....++.|++.||.|||+ 
T Consensus        63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc
Confidence            456699999999999999999999876    3578999999985 8999987653 68899999999999999999998 


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      .+++||||||+|||++.++.+||+|||+++....+                                             
T Consensus       142 ~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---------------------------------------------  176 (283)
T PHA02988        142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---------------------------------------------  176 (283)
T ss_pred             CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---------------------------------------------
Confidence            49999999999999999999999999987533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWS  251 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWS  251 (562)
                                                                       ....+||..|+|||++.+. ..|+.++||||
T Consensus       177 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~S  207 (283)
T PHA02988        177 -------------------------------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS  207 (283)
T ss_pred             -------------------------------------------------cccccCcccccCHHHhhhccccccchhhhhH
Confidence                                                             0012467789999988652 45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +||++|||++|+.||.+.+..+....+......+.                .           ....++.+.+|+.+||+
T Consensus       208 lGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------~-----------~~~~~~~l~~li~~cl~  260 (283)
T PHA02988        208 LGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------L-----------PLDCPLEIKCIVEACTS  260 (283)
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----------------C-----------CCcCcHHHHHHHHHHhc
Confidence            99999999999999998876665554433211110                0           01224678999999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy10954        332 LDPKQRVSAKTILQ  345 (562)
Q Consensus       332 ~DP~~R~Ta~elL~  345 (562)
                      .||++|||++|+++
T Consensus       261 ~dp~~Rps~~ell~  274 (283)
T PHA02988        261 HDSIKRPNIKEILY  274 (283)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999985

>KOG0614|consensus

Probab=100.00  E-value=4.1e-35  Score=306.03  Aligned_cols=220  Identities=25%  Similarity=0.413  Sum_probs=189.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+-+..|-.||...+.|.||+||..|.++..+||+||-|- ++|...++.++ .|.+..+++|+..+++|++|||++|||
T Consensus       464 qeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iI  542 (732)
T KOG0614|consen  464 QEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGII  542 (732)
T ss_pred             HHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCce
Confidence            3457889999999999999999999999999999999994 69999998764 799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      .|||||||.|++.+|.+||.|||+|+.+...                                                 
T Consensus       543 YRDLKPENllLd~~Gy~KLVDFGFAKki~~g-------------------------------------------------  573 (732)
T KOG0614|consen  543 YRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-------------------------------------------------  573 (732)
T ss_pred             eccCChhheeeccCCceEEeehhhHHHhccC-------------------------------------------------
Confidence            9999999999999999999999998765421                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .+..++||||.|.|||++++.+ ++.++|.||||+++
T Consensus       574 -------------------------------------------~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli  609 (732)
T KOG0614|consen  574 -------------------------------------------RKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILI  609 (732)
T ss_pred             -------------------------------------------CceeeecCCcccccchhhhccC-cchhhHHHHHHHHH
Confidence                                                       1235679999999999999765 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+.......|+..+..                .++|.           .....+.+|++++...+|.+
T Consensus       610 ~ELL~G~pPFs~~dpmktYn~ILkGid~----------------i~~Pr-----------~I~k~a~~Lik~LCr~~P~E  662 (732)
T KOG0614|consen  610 YELLTGSPPFSGVDPMKTYNLILKGIDK----------------IEFPR-----------RITKTATDLIKKLCRDNPTE  662 (732)
T ss_pred             HHHHcCCCCCCCCchHHHHHHHHhhhhh----------------hhccc-----------ccchhHHHHHHHHHhcCcHh
Confidence            9999999999999998888888764321                11221           12346899999999999999


Q ss_pred             CCC-----HHHHHcCccccCCcccCCc
Q psy10954        337 RVS-----AKTILQHEYFNQVEMVKPT  358 (562)
Q Consensus       337 R~T-----a~elL~Hp~f~~~~~~~~~  358 (562)
                      |+.     ..|+.+|.||.+.+|....
T Consensus       663 RLG~~~~gI~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  663 RLGYQKGGINDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             hhccccCChHHHHhhhhhhcCChhhhh
Confidence            997     7899999999999886543

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-33  Score=279.94  Aligned_cols=216  Identities=29%  Similarity=0.529  Sum_probs=172.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++++...+..|+||||+++ +|.+++... ..+++..++.++.|++.||+|||++|++|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH  129 (267)
T cd06628          51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIH  129 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            3567899999999999999999999999999999999975 899998765 46899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++........                  ..                           
T Consensus       130 ~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------------------~~---------------------------  164 (267)
T cd06628         130 RDIKGANILVDNKGGIKISDFGISKKLEANSLS------------------TK---------------------------  164 (267)
T ss_pred             ccCCHHHEEEcCCCCEEecccCCCccccccccc------------------CC---------------------------
Confidence            999999999999999999999987644211000                  00                           


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                              .........|+..|+|||.+.+.. ++.++|+||+||++|
T Consensus       165 ----------------------------------------~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~  203 (267)
T cd06628         165 ----------------------------------------TNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVV  203 (267)
T ss_pred             ----------------------------------------ccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHH
Confidence                                                    000011235788999999997654 788999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+....+..+.....                    +.        .....+..+.++|++||+.||.+|
T Consensus       204 ~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------~~--------~~~~~~~~~~~li~~~l~~~p~~R  255 (267)
T cd06628         204 EMLTGKHPFPDCTQLQAIFKIGENAS--------------------PE--------IPSNISSEAIDFLEKTFEIDHNKR  255 (267)
T ss_pred             HHhhCCCCCCCccHHHHHHHHhccCC--------------------Cc--------CCcccCHHHHHHHHHHccCCchhC
Confidence            99999999987765544443322100                    00        001234678999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy10954        338 VSAKTILQHEYF  349 (562)
Q Consensus       338 ~Ta~elL~Hp~f  349 (562)
                      |++.|+++||||
T Consensus       256 p~~~~il~~~~~  267 (267)
T cd06628         256 PTAAELLKHPFL  267 (267)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0577|consensus

Probab=100.00  E-value=8.9e-35  Score=307.45  Aligned_cols=211  Identities=26%  Similarity=0.455  Sum_probs=181.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      +.++.|+..|++++|||+|.+.++|-.+...|||||||-|+-.+++.-...++.|..+..|..+.+.||.|||+.+.|||
T Consensus        71 qDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHR  150 (948)
T KOG0577|consen   71 QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHR  150 (948)
T ss_pred             HHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence            46899999999999999999999999999999999999887777777667789999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      |||..|||++..|.|||+|||.|.....                                                    
T Consensus       151 DiKAGNILLse~g~VKLaDFGSAsi~~P----------------------------------------------------  178 (948)
T KOG0577|consen  151 DIKAGNILLSEPGLVKLADFGSASIMAP----------------------------------------------------  178 (948)
T ss_pred             hccccceEecCCCeeeeccccchhhcCc----------------------------------------------------
Confidence            9999999999999999999998754321                                                    


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                 ..++||||+|||||||+.  .+.|+-++||||+|++.
T Consensus       179 -------------------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITC  215 (948)
T KOG0577|consen  179 -------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  215 (948)
T ss_pred             -------------------------------------------hhcccCCccccchhHheeccccccCCccceeeccchh
Confidence                                                       135688888888888864  35599999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      .||...+||+...+....++.|...-                    .|.+....|       +..++.|+..||+.-|.+
T Consensus       216 IELAERkPPlFnMNAMSALYHIAQNe--------------------sPtLqs~eW-------S~~F~~Fvd~CLqKipqe  268 (948)
T KOG0577|consen  216 IELAERKPPLFNMNAMSALYHIAQNE--------------------SPTLQSNEW-------SDYFRNFVDSCLQKIPQE  268 (948)
T ss_pred             hhhhhcCCCccCchHHHHHHHHHhcC--------------------CCCCCCchh-------HHHHHHHHHHHHhhCccc
Confidence            99999999999999999999886531                    122222222       346889999999999999


Q ss_pred             CCCHHHHHcCccccC
Q psy10954        337 RVSAKTILQHEYFNQ  351 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~  351 (562)
                      |||++++|+|+|...
T Consensus       269 Rptse~ll~H~fv~R  283 (948)
T KOG0577|consen  269 RPTSEELLKHRFVLR  283 (948)
T ss_pred             CCcHHHHhhcchhcc
Confidence            999999999999864

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-33  Score=282.13  Aligned_cols=239  Identities=46%  Similarity=0.867  Sum_probs=185.5

Q ss_pred             CchhhHHHHHHHHHcc---CCCCcceEEEEEEeCCE-----EEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKEL---KHPNVIRLHDVIPVDFK-----LFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l---~HpnIv~L~~~~~~~~~-----i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~a   86 (562)
                      +......+|+.+++++   +||||+++++++.....     +|++|||+.++|.+++.... ..+++..++.++.|++.|
T Consensus        40 ~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~a  119 (287)
T cd07838          40 GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG  119 (287)
T ss_pred             hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence            3345567898888766   59999999999988776     99999999989998887643 358999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++|++|+||||+||+++.++.+||+|||++.......                                      
T Consensus       120 l~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~--------------------------------------  161 (287)
T cd07838         120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--------------------------------------  161 (287)
T ss_pred             HHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc--------------------------------------
Confidence            999999999999999999999999999999999865432100                                      


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                            ......++..|+|||++.+.. ++.+
T Consensus       162 ------------------------------------------------------~~~~~~~~~~~~~PE~~~~~~-~~~~  186 (287)
T cd07838         162 ------------------------------------------------------ALTSVVVTLWYRAPEVLLQSS-YATP  186 (287)
T ss_pred             ------------------------------------------------------ccccccccccccChHHhccCC-CCCc
Confidence                                                                  001124578899999997755 7899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +|+||+||++|+|++|.+||.+.+..+.+.++....+.+....|+......  ...++..............++.+.+++
T Consensus       187 ~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li  264 (287)
T cd07838         187 VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP--RSSFPSYTPRSFKSFVPEICEEGLDLL  264 (287)
T ss_pred             chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc--hhhcccccccchhhhhhhhhHHHHHHH
Confidence            999999999999999999999999888888888877665544443222100  001111111122223333457789999


Q ss_pred             HHccccCCCCCCCHHHHHcCccc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      .+||+.||++||+++|+++||||
T Consensus       265 ~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         265 KKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHhccCCccCCCHHHHhcCcCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-33  Score=278.71  Aligned_cols=212  Identities=24%  Similarity=0.398  Sum_probs=173.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++++.++||||+++++++......|+||||+.+ +|.+++... ...+++..+..++.|++.||.|||++||
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i  122 (256)
T cd08529          43 REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI  122 (256)
T ss_pred             HHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            45677899999999999999999999999999999999974 999998764 3468999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++.......                                              
T Consensus       123 ~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~----------------------------------------------  156 (256)
T cd08529         123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN----------------------------------------------  156 (256)
T ss_pred             ccCCCCcceEEEeCCCCEEEcccccceeccCccc----------------------------------------------
Confidence            9999999999999999999999998754321000                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......|++.|+|||++.+.. ++.++|+||+||+
T Consensus       157 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  190 (256)
T cd08529         157 ---------------------------------------------FANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVV  190 (256)
T ss_pred             ---------------------------------------------hhhccccCccccCHHHhcCCC-CCCccchHHHHHH
Confidence                                                         001224678899999997654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +++|++|+.||...+..+....+......                    .        .....+..+.+++.+||+.||+
T Consensus       191 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~~~~~~~~~i~~~l~~~p~  242 (256)
T cd08529         191 LYECCTGKHPFDANNQGALILKIIRGVFP--------------------P--------VSQMYSQQLAQLIDQCLTKDYR  242 (256)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------------C--------CccccCHHHHHHHHHHccCCcc
Confidence            99999999999888765555554321100                    0        0012346789999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +||++.++++|||+
T Consensus       243 ~Rp~~~~ll~~~~~  256 (256)
T cd08529         243 QRPDTFQLLRNPSL  256 (256)
T ss_pred             cCcCHHHHhhCCCC
Confidence            99999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-33  Score=294.67  Aligned_cols=248  Identities=37%  Similarity=0.675  Sum_probs=189.8

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeC--CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~--~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+|+.+++++ +||||+++++++...  ...|+||||++++|.+++...  .+++..++.++.|++.||.|||++||
T Consensus        51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i  128 (337)
T cd07852          51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNV  128 (337)
T ss_pred             hhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3467899999999 999999999998653  468999999999999988764  68888999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++..........                                            
T Consensus       129 ~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~--------------------------------------------  164 (337)
T cd07852         129 IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP--------------------------------------------  164 (337)
T ss_pred             ecCCCCHHHEEEcCCCcEEEeeccchhccccccccc--------------------------------------------
Confidence            999999999999999999999999876442110000                                            


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                ........+||+.|+|||++.+...++.++|+||+||+
T Consensus       165 ------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~  202 (337)
T cd07852         165 ------------------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI  202 (337)
T ss_pred             ------------------------------------------cCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence                                                      00001124678999999998776678899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--CCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      +|+|++|++||.+....+.+.++....+.+....+.....  ....................+..+..+.+++.+||+.|
T Consensus       203 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  282 (337)
T cd07852         203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN  282 (337)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC
Confidence            9999999999999888888888877777655432221110  00000001111111222333445678999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCcc
Q psy10954        334 PKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++|||+.++++||||++...
T Consensus       283 P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         283 PNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             cccccCHHHHhhChhhhhhcc
Confidence            999999999999999988754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4279|consensus

Probab=100.00  E-value=7.9e-35  Score=311.89  Aligned_cols=218  Identities=29%  Similarity=0.469  Sum_probs=173.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPV--PPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l--~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .+....||.+.++|+|.|||++.+.+..++++-|.||-++| +|.++++..=+++  .|..+-+|.+||++||+|||++.
T Consensus       616 ~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~  695 (1226)
T KOG4279|consen  616 VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK  695 (1226)
T ss_pred             hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc
Confidence            34567899999999999999999999999999999999985 9999998876777  88889999999999999999999


Q ss_pred             ceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 IIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 IiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |||||||-+|+||+.. |.+||+|||-++++.                                                
T Consensus       696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA------------------------------------------------  727 (1226)
T KOG4279|consen  696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA------------------------------------------------  727 (1226)
T ss_pred             eeeccccCCcEEEeeccceEEecccccchhhc------------------------------------------------
Confidence            9999999999999854 667777777655442                                                


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhh-cCCCCCCchhhHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL-LGAKVYSTTVDIWSA  252 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl-~~~~~y~~~~DIWSl  252 (562)
                                                                 .-.....++.||+.|||||+| .|-++||.++||||+
T Consensus       728 -------------------------------------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~  764 (1226)
T KOG4279|consen  728 -------------------------------------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSF  764 (1226)
T ss_pred             -------------------------------------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhc
Confidence                                                       112234567899999999999 456679999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++.||.||++||..-.....  .+++. |.              |+.+ |+        +-...+..++.||.+|+..
T Consensus       765 GCT~vEMATGrPPF~ElgspqA--AMFkV-Gm--------------yKvH-P~--------iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  765 GCTMVEMATGRPPFVELGSPQA--AMFKV-GM--------------YKVH-PP--------IPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             cceeEeeccCCCCeeecCChhH--hhhhh-cc--------------eecC-CC--------CcHHHHHHHHHHHHHHcCC
Confidence            9999999999999975433221  11111 10              0000 00        1112256899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCC
Q psy10954        333 DPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||..||+|.++|+.||++.-
T Consensus       819 d~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CcccCccHHHhccCcccccC
Confidence            99999999999999999865

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.5e-33  Score=287.70  Aligned_cols=238  Identities=25%  Similarity=0.365  Sum_probs=172.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gIi   96 (562)
                      ..+.+|++++++++||||+++++.|..++.+|+||||+++ +|.+++.+. ..+++..+..++.|++.||.|||+ ++++
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~  122 (308)
T cd06615          44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIM  122 (308)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEE
Confidence            4578999999999999999999999999999999999975 999998765 468999999999999999999997 5999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++......                                                 
T Consensus       123 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-------------------------------------------------  153 (308)
T cd06615         123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------------------------------------------  153 (308)
T ss_pred             ECCCChHHEEEecCCcEEEccCCCccccccc-------------------------------------------------
Confidence            9999999999999999999999986422100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  .....+|++.|+|||++.+.. ++.++|+||+||++
T Consensus       154 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l  188 (308)
T cd06615         154 --------------------------------------------MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSL  188 (308)
T ss_pred             --------------------------------------------ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHH
Confidence                                                        001235788999999987654 88999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCc--cchhh-------hc--CCCCHHHHHH
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP--KKFSE-------IL--NLPDPLAVDV  325 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-------~l--~~~~~~~~dL  325 (562)
                      |+|++|+.||.+.+.. .+..+.......... ............+.+....  .....       .+  ...+..+.+|
T Consensus       189 ~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (308)
T cd06615         189 VEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEA-KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF  266 (308)
T ss_pred             HHHHhCCCCCCCcchh-hHHHhhcCccccccc-cCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHH
Confidence            9999999999866532 222222211100000 0000000000000000000  00000       00  1135678999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +.+||..||++|||+.|+++||||.+..
T Consensus       267 i~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         267 VDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             HHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            9999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.5e-33  Score=279.73  Aligned_cols=218  Identities=27%  Similarity=0.449  Sum_probs=173.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|++++|+||+++++++...+..|+||||+.+ +|.+++.+.. .+++..+..++.|++.||+|||+.||+|
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H  125 (265)
T cd06631          47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVH  125 (265)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4577899999999999999999999999999999999975 9999987643 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.+||+|||++..........                      .                       
T Consensus       126 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~----------------------~-----------------------  160 (265)
T cd06631         126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG----------------------T-----------------------  160 (265)
T ss_pred             CCcCHHhEEECCCCeEEeccchhhHhhhhccccc----------------------c-----------------------
Confidence            9999999999999999999999876432100000                      0                       


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                              .........||..|+|||++.+.. ++.++|+||+||++|
T Consensus       161 ----------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~  199 (265)
T cd06631         161 ----------------------------------------HSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVF  199 (265)
T ss_pred             ----------------------------------------ccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHH
Confidence                                                    000011235789999999997654 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|..||.+.+.......+....+..                  +.        .....+..+.+++++||+.||++|
T Consensus       200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~--------~~~~~~~~~~~~i~~~l~~~p~~R  253 (265)
T cd06631         200 EMATGKPPLASMDRLAAMFYIGAHRGLM------------------PR--------LPDSFSAAAIDFVTSCLTRDQHER  253 (265)
T ss_pred             HHHhCCCccccCChHHHHHHhhhccCCC------------------CC--------CCCCCCHHHHHHHHHHhcCCcccC
Confidence            9999999998766554443332211110                  00        011234678999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy10954        338 VSAKTILQHEYF  349 (562)
Q Consensus       338 ~Ta~elL~Hp~f  349 (562)
                      ||+.|+++||||
T Consensus       254 p~~~~~l~~~~~  265 (265)
T cd06631         254 PSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHhcCCCC
Confidence            999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.7e-33  Score=293.12  Aligned_cols=246  Identities=33%  Similarity=0.637  Sum_probs=182.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--------------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--------------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLL   84 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--------------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll   84 (562)
                      ....+|+++|+.++||||+++++++...              ...|+||||++++|.+++..  ..+++..++.++.|++
T Consensus        47 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~  124 (342)
T cd07854          47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLL  124 (342)
T ss_pred             HHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHH
Confidence            4578899999999999999999877654              35899999999999888764  3589999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      .||+|||++||+||||||+||+++.+ +.+||+|||+++.......                  .               
T Consensus       125 ~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~------------------~---------------  171 (342)
T cd07854         125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS------------------H---------------  171 (342)
T ss_pred             HHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccc------------------c---------------
Confidence            99999999999999999999999854 5689999998754321000                  0               


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                             .......+||..|+|||++.+...+
T Consensus       172 -------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~  196 (342)
T cd07854         172 -------------------------------------------------------KGYLSEGLVTKWYRSPRLLLSPNNY  196 (342)
T ss_pred             -------------------------------------------------------ccccccccccccccCHHHHhCcccc
Confidence                                                                   0000112568899999998776668


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      +.++||||+||++|+|++|+.||.+.+..+....+.........+....... .+.................+...+..+
T Consensus       197 ~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (342)
T cd07854         197 TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEA  276 (342)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHH
Confidence            9999999999999999999999999888777776665544333221111100 000000000001112223344556789


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      .+|+.+||+.||.+|||+.|+++||||+.+..
T Consensus       277 ~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         277 LDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             HHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-33  Score=295.07  Aligned_cols=240  Identities=39%  Similarity=0.664  Sum_probs=186.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..+.+|+.++++++||||+++++++...      ..+|+++++++++|.+++...  .+++..++.++.|++.||+|||+
T Consensus        61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~  138 (345)
T cd07877          61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS  138 (345)
T ss_pred             HHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999998643      358999999988998887643  58999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+||+++.++.+||+|||+++.....                                             
T Consensus       139 ~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---------------------------------------------  173 (345)
T cd07877         139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---------------------------------------------  173 (345)
T ss_pred             CCeeecCCChHHEEEcCCCCEEEeccccccccccc---------------------------------------------
Confidence            99999999999999999999999999986422100                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                       .....+|+.|+|||++.+...++.++||||+
T Consensus       174 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  204 (345)
T cd07877         174 -------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  204 (345)
T ss_pred             -------------------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHH
Confidence                                                             0112467889999998776668999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|+|++|++||.+.+....+..+....+.+....+.......  .+....+......+.......++.+.|||.+||
T Consensus       205 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  284 (345)
T cd07877         205 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML  284 (345)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHc
Confidence            999999999999999888888888887777766554443322110  011111111111122222334678999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCcc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      +.||.+|+|+.++++||||.+...
T Consensus       285 ~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         285 VLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             CCChhhcCCHHHHhcChhhhhcCC
Confidence            999999999999999999997653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=284.82  Aligned_cols=238  Identities=39%  Similarity=0.770  Sum_probs=191.9

Q ss_pred             hHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+|+..+++++ ||||+++++++..++..|+||||++++|.+.+.... ..+++..+..++.|++.||.|||++|++|
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H  122 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH  122 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            3467999999998 999999999999999999999999889999887654 46899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.++|+|||++......                                                  
T Consensus       123 ~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--------------------------------------------------  152 (283)
T cd07830         123 RDLKPENLLVSGPEVVKIADFGLAREIRSR--------------------------------------------------  152 (283)
T ss_pred             CCCChhhEEEcCCCCEEEeecccceeccCC--------------------------------------------------
Confidence            999999999999999999999986432100                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+++..|+|||++.+...++.++|+||+||+++
T Consensus       153 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~  190 (283)
T cd07830         153 ------------------------------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMA  190 (283)
T ss_pred             ------------------------------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHH
Confidence                                                      00012356788999998876666889999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC-CccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP-IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++|++||.+.+..+.+.++...++.+....|....... ......+...+..........+..+.+|+.+||+.||++
T Consensus       191 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~  270 (283)
T cd07830         191 ELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKK  270 (283)
T ss_pred             HHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCccc
Confidence            9999999999999989999999988888776664432211 111122222222233333344678999999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      |||++|++.||||
T Consensus       271 Rpt~~ei~~~~~~  283 (283)
T cd07830         271 RPTASQALQHPYF  283 (283)
T ss_pred             CCCHHHHhhCCCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-33  Score=280.14  Aligned_cols=213  Identities=25%  Similarity=0.396  Sum_probs=167.1

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+.+++.++||||+++++.+...+.+|+||||+++ +|.+++...+ .+++..++.++.|++.||+|||++||+||
T Consensus        52 ~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  130 (267)
T cd06645          52 VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHR  130 (267)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            467899999999999999999999999999999999985 8999886644 69999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||++.......                                                  
T Consensus       131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~--------------------------------------------------  160 (267)
T cd06645         131 DIKGANILLTDNGHVKLADFGVSAQITATI--------------------------------------------------  160 (267)
T ss_pred             CCCHHHEEECCCCCEEECcceeeeEccCcc--------------------------------------------------
Confidence            999999999999999999999865332100                                                  


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc--CCCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~--~~~~y~~~~DIWSlG~il  256 (562)
                                                               .......||+.|+|||++.  ....++.++|+||+||++
T Consensus       161 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il  199 (267)
T cd06645         161 -----------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITA  199 (267)
T ss_pred             -----------------------------------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHH
Confidence                                                     0001235788899999874  233478899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|..||........+..+...  ....                +.+     ... ...+..+.+++.+||+.||++
T Consensus       200 ~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~----------------~~~-----~~~-~~~~~~~~~li~~~l~~~P~~  255 (267)
T cd06645         200 IELAELQPPMFDLHPMRALFLMTKS--NFQP----------------PKL-----KDK-MKWSNSFHHFVKMALTKNPKK  255 (267)
T ss_pred             HHHhcCCCCcccccchhhHHhhhcc--CCCC----------------Ccc-----ccc-CCCCHHHHHHHHHHccCCchh
Confidence            9999999999765544333222111  0000                000     000 012356889999999999999


Q ss_pred             CCCHHHHHcCcc
Q psy10954        337 RVSAKTILQHEY  348 (562)
Q Consensus       337 R~Ta~elL~Hp~  348 (562)
                      |||++++++|||
T Consensus       256 R~~~~~ll~~~~  267 (267)
T cd06645         256 RPTAEKLLQHPF  267 (267)
T ss_pred             CcCHHHHhcCCC
Confidence            999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-33  Score=292.27  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=175.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+++.++||||++++++|..++..|+||||+.+ +|.+++.+.. ..+++..++.++.|++.||+|||++||+
T Consensus        44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv  123 (328)
T cd08226          44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI  123 (328)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4567899999999999999999999999999999999985 9999887643 3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+|++|||.+.........           +.                                 
T Consensus       124 HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~-----------~~---------------------------------  159 (328)
T cd08226         124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK-----------AK---------------------------------  159 (328)
T ss_pred             cCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----------cc---------------------------------
Confidence            9999999999999999999999864322110000           00                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCI  255 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~i  255 (562)
                                         .         +.++.            ....++..|+|||++.+. ..++.++||||+||+
T Consensus       160 -------------------~---------~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~  199 (328)
T cd08226         160 -------------------V---------VYDFP------------QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGIT  199 (328)
T ss_pred             -------------------c---------ccccc------------ccccCccCccChhhhcCCCCCCCchhhHHHHHHH
Confidence                               0         00000            011345679999999764 347899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCC--CCCCCCC-C----CccCCCC------CCCccchhh-----hcCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV--WPGVSKL-P----IYKTDFP------EWRPKKFSE-----ILNL  317 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~--~~~~~~~-~----~~~~~~~------~~~~~~~~~-----~l~~  317 (562)
                      +|+|++|++||.+......+..+.......+...  ++..... .    .......      .+.......     ....
T Consensus       200 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (328)
T cd08226         200 ACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKT  279 (328)
T ss_pred             HHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhh
Confidence            9999999999988776555544433211111100  0000000 0    0000000      000000000     0011


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+..+.+|+++||++||++|||+.|+|+||||+++.
T Consensus       280 ~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         280 FSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            245789999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.9e-33  Score=276.78  Aligned_cols=211  Identities=27%  Similarity=0.483  Sum_probs=170.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|++++++++||||+++++.+.. +..+|+||||+++ +|.+++.... ..+++.+++.++.|++.||.|||++||
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i  123 (257)
T cd08223          44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI  123 (257)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            456789999999999999999998864 4578999999974 8999887643 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||++.......                                               
T Consensus       124 ~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------------------------  156 (257)
T cd08223         124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-----------------------------------------------  156 (257)
T ss_pred             eccCCCchhEEEecCCcEEEecccceEEecccC-----------------------------------------------
Confidence            999999999999999999999999875432100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......+++.|+|||++.+.. ++.++|+||+||+
T Consensus       157 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i  191 (257)
T cd08223         157 --------------------------------------------DMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCC  191 (257)
T ss_pred             --------------------------------------------CccccccCCcCccChhHhcCCC-CCchhhhHHHHHH
Confidence                                                        0001234688899999987654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +++|++|+.||.+.+.......+....  .+                  .        .....++.+.+|+.+||+.||+
T Consensus       192 l~~l~~g~~~~~~~~~~~~~~~~~~~~--~~------------------~--------~~~~~~~~~~~li~~~l~~~p~  243 (257)
T cd08223         192 VYEMATLKHAFNAKDMNSLVYRIIEGK--LP------------------P--------MPKDYSPELGELIATMLSKRPE  243 (257)
T ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHhcC--CC------------------C--------CccccCHHHHHHHHHHhccCcc
Confidence            999999999998877655544443211  00                  0        0012346789999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||+.++++||||
T Consensus       244 ~Rp~~~~~l~~~~~  257 (257)
T cd08223         244 KRPSVKSILRQPYI  257 (257)
T ss_pred             cCCCHHHHhcCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.5e-33  Score=285.71  Aligned_cols=213  Identities=28%  Similarity=0.490  Sum_probs=175.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .....+|+++|++++||||+++++++..+...|+||||+. ++|.+++... ..+++..+..++.|++.||+|||++||+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~  123 (290)
T cd05580          45 VEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIV  123 (290)
T ss_pred             HHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3457789999999999999999999999999999999995 6999998765 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||.||+++.++.+||+|||+++.....                                                 
T Consensus       124 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-------------------------------------------------  154 (290)
T cd05580         124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------------------------------------------------  154 (290)
T ss_pred             cCCCCHHHEEECCCCCEEEeeCCCccccCCC-------------------------------------------------
Confidence            9999999999999999999999986532100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                   .....||+.|+|||.+.+.. ++.++|+||+||++
T Consensus       155 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  188 (290)
T cd05580         155 ---------------------------------------------TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILI  188 (290)
T ss_pred             ---------------------------------------------CCCCCCCccccChhhhcCCC-CCccccHHHHHHHH
Confidence                                                         01124678899999887654 78899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+.......+...  .+.                           +....++.+.+++.+||..||.+
T Consensus       189 ~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~  239 (290)
T cd05580         189 YEMLAGYPPFFDDNPIQIYEKILEG--KVR---------------------------FPSFFSPDAKDLIRNLLQVDLTK  239 (290)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhcC--Ccc---------------------------CCccCCHHHHHHHHHHccCCHHH
Confidence            9999999999887755544444321  000                           00112567899999999999999


Q ss_pred             CC-----CHHHHHcCccccCCccc
Q psy10954        337 RV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      |+     +++|+++||||+.+.+.
T Consensus       240 R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         240 RLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             ccCcccCCHHHHHcCcccccCCHH
Confidence            99     89999999999887643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-33  Score=290.67  Aligned_cols=210  Identities=24%  Similarity=0.439  Sum_probs=161.9

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeC-CEEEEEeecCc-CCHHHHHhhCC---------------------------
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVD-FKLFLVFEFLR-QDLKDFLQTTP---------------------------   68 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~-~~i~lV~Ey~~-~~L~~~i~~~~---------------------------   68 (562)
                      ..+.+|+.+|+.+ +||||+++++++... ..+|+|||||+ ++|.+++....                           
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (338)
T cd05102          55 KALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD  134 (338)
T ss_pred             HHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence            4578999999999 899999999988754 56899999997 49999886531                           


Q ss_pred             ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCee
Q psy10954         69 ----------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALK  114 (562)
Q Consensus        69 ----------------------------------~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vK  114 (562)
                                                        ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~k  214 (338)
T cd05102         135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK  214 (338)
T ss_pred             cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEE
Confidence                                              2377788899999999999999999999999999999999999999


Q ss_pred             EeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCc
Q psy10954        115 LADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQ  194 (562)
Q Consensus       115 L~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPe  194 (562)
                      |+|||+++......               ...                                                
T Consensus       215 l~DfG~a~~~~~~~---------------~~~------------------------------------------------  231 (338)
T cd05102         215 ICDFGLARDIYKDP---------------DYV------------------------------------------------  231 (338)
T ss_pred             EeecccccccccCc---------------chh------------------------------------------------
Confidence            99999876432100               000                                                


Q ss_pred             ceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy10954        195 NILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEID  273 (562)
Q Consensus       195 NILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~  273 (562)
                                                ......+|+.|+|||++.+.. |+.++||||+||++|||++ |..||.+....+
T Consensus       232 --------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~  284 (338)
T cd05102         232 --------------------------RKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINE  284 (338)
T ss_pred             --------------------------cccCCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence                                      001123567899999997654 8999999999999999997 999998765433


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        274 QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       274 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+...+.. +...                  .        .....++.+.+++.+||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~-~~~~------------------~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         285 EFCQRLKD-GTRM------------------R--------APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHHHHhc-CCCC------------------C--------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            33332211 1000                  0        00123467899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-33  Score=281.83  Aligned_cols=217  Identities=19%  Similarity=0.383  Sum_probs=168.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH-CC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKSYLYQLLEALRYCHS-RR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~--~~~l~e~~i~~i~~qll~aL~yLH~-~g   94 (562)
                      ..+.+|+.++++++||||+++++.+..++..|+||||+++ +|.+++...  ...+++..++.++.|++.||.|||+ .|
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~  123 (286)
T cd06622          44 NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN  123 (286)
T ss_pred             HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4577999999999999999999999999999999999986 888888653  2368999999999999999999997 59


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||++......  ..                                           
T Consensus       124 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~-------------------------------------------  158 (286)
T cd06622         124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA-------------------------------------------  158 (286)
T ss_pred             EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc-------------------------------------------
Confidence            999999999999999999999999987543211  00                                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-----CCCchhhH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDI  249 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-----~y~~~~DI  249 (562)
                                                                      ...+|++.|+|||.+.+..     .++.++|+
T Consensus       159 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di  190 (286)
T cd06622         159 ------------------------------------------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDV  190 (286)
T ss_pred             ------------------------------------------------ccCCCccCccCcchhcCCCCCccCCCCcccch
Confidence                                                            0123455677777664322     36789999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      ||+||++|+|++|+.||...........+.......+..                         +....++.+.+|+.+|
T Consensus       191 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~  245 (286)
T cd06622         191 WSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-------------------------LPSGYSDDAQDFVAKC  245 (286)
T ss_pred             HhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-------------------------CCcccCHHHHHHHHHH
Confidence            999999999999999997655433332222211111110                         1112356789999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |+.||++||+++++++||||....
T Consensus       246 l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         246 LNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             cccCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.2e-33  Score=279.58  Aligned_cols=217  Identities=28%  Similarity=0.498  Sum_probs=174.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+++.++||||+++++.+..+..+|+||||++ ++|.+++.+.. .+++..++.++.|++.||+|||++|+
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~  114 (262)
T cd05572          36 QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGI  114 (262)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            34567899999999999999999999999999999999997 49999987653 58999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.+||+|||++.......                                               
T Consensus       115 ~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----------------------------------------------  147 (262)
T cd05572         115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----------------------------------------------  147 (262)
T ss_pred             ccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------------------------------------------
Confidence            999999999999999999999999865432100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......|++.|+|||.+.+.. ++.++|+||+||+
T Consensus       148 ---------------------------------------------~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~i  181 (262)
T cd05572         148 ---------------------------------------------KTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGIL  181 (262)
T ss_pred             ---------------------------------------------ccccccCCcCccChhHhcCCC-CCChhhhhhhHHH
Confidence                                                         001124678899999987654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        256 FSEMITKKTLFAGDS--EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       256 l~eLltG~~pF~~~~--~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      +|+|++|..||.+..  ..+....+......+                .++           ...+..+.+++.+||..|
T Consensus       182 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~~-----------~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         182 LYELLTGRPPFGEDDEDPMEIYNDILKGNGKL----------------EFP-----------NYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             HHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------CCC-----------cccCHHHHHHHHHHccCC
Confidence            999999999998776  433333333100000                000           112467899999999999


Q ss_pred             CCCCCC-----HHHHHcCccccCCcc
Q psy10954        334 PKQRVS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~T-----a~elL~Hp~f~~~~~  354 (562)
                      |++|+|     ++|+++||||++..+
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCCC
Confidence            999999     999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.8e-33  Score=278.36  Aligned_cols=214  Identities=23%  Similarity=0.381  Sum_probs=166.9

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeC------CEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVD------FKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~------~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~   88 (562)
                      .....+|+.+++++ +||||+++++++...      ..+|+||||+++ +|.+++.... ..+++..++.++.|++.||+
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~  125 (272)
T cd06637          46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS  125 (272)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence            34578999999998 799999999998753      468999999985 8999887643 45899999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||++||+||||||+||+++.++.+||+|||++........                                       
T Consensus       126 ~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~---------------------------------------  166 (272)
T cd06637         126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---------------------------------------  166 (272)
T ss_pred             HHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc---------------------------------------
Confidence            99999999999999999999999999999998754321000                                       


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYS  244 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~  244 (562)
                                                                          ......||+.|+|||++.+    ...|+
T Consensus       167 ----------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~  194 (272)
T cd06637         167 ----------------------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYD  194 (272)
T ss_pred             ----------------------------------------------------cCCcccccccccCHhHhccccCcCCCCC
Confidence                                                                0012346778888888853    23488


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      .++|+||+||++|||++|..||...........+...   +.                 ...       .....+..+.+
T Consensus       195 ~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-----------------~~~-------~~~~~~~~~~~  247 (272)
T cd06637         195 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA-----------------PRL-------KSKKWSKKFQS  247 (272)
T ss_pred             chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC-----------------CCC-------CCCCcCHHHHH
Confidence            8999999999999999999999766544333322110   00                 000       00112457899


Q ss_pred             HHHHccccCCCCCCCHHHHHcCccc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      |+.+||..||.+|||+.|+++||||
T Consensus       248 li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         248 FIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHcCCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.1e-33  Score=276.83  Aligned_cols=214  Identities=30%  Similarity=0.480  Sum_probs=172.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++||||+++++.+..+...|+++||+.+ +|.+++......+++..++.++.|++.||.|||++||+
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~  121 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678999999999999999999999999999999999985 89999877666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||+|+||+++.++.+||+|||++........                                               
T Consensus       122 H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-----------------------------------------------  154 (256)
T cd06612         122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-----------------------------------------------  154 (256)
T ss_pred             cCCCCcceEEECCCCcEEEcccccchhcccCcc-----------------------------------------------
Confidence            999999999999999999999998754321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......|+..|+|||++.+.. ++.++||||+||++
T Consensus       155 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il  189 (256)
T cd06612         155 --------------------------------------------KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITA  189 (256)
T ss_pred             --------------------------------------------ccccccCCccccCHHHHhcCC-CCchhhHHHHHHHH
Confidence                                                        001123577899999987654 78999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||...........+...   . .                +.+.      .....+..+.+++.+||+.||++
T Consensus       190 ~~l~~g~~p~~~~~~~~~~~~~~~~---~-~----------------~~~~------~~~~~~~~~~~~i~~~l~~~P~~  243 (256)
T cd06612         190 IEMAEGKPPYSDIHPMRAIFMIPNK---P-P----------------PTLS------DPEKWSPEFNDFVKKCLVKDPEE  243 (256)
T ss_pred             HHHHhCCCCCCCcchhhhhhhhccC---C-C----------------CCCC------chhhcCHHHHHHHHHHHhcChhh
Confidence            9999999999876554333222110   0 0                0000      00112457899999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      |||+.|+|+||||
T Consensus       244 Rps~~~il~~~~~  256 (256)
T cd06612         244 RPSAIQLLQHPFI  256 (256)
T ss_pred             CcCHHHHhcCCCC
Confidence            9999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.7e-33  Score=286.68  Aligned_cols=215  Identities=26%  Similarity=0.466  Sum_probs=173.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++.+..++..|+||||+++ +|.+++...  .+++..+..++.|++.||+|||++||+|
T Consensus        64 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH  141 (292)
T cd06658          64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIH  141 (292)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            4577999999999999999999999999999999999985 788877543  5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++.......                                                 
T Consensus       142 ~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-------------------------------------------------  172 (292)
T cd06658         142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-------------------------------------------------  172 (292)
T ss_pred             cCCCHHHEEEcCCCCEEEccCcchhhccccc-------------------------------------------------
Confidence            9999999999999999999999865321100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||..|+|||++.+.. ++.++|+||+||++|
T Consensus       173 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~  209 (292)
T cd06658         173 ------------------------------------------PKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVI  209 (292)
T ss_pred             ------------------------------------------ccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHH
Confidence                                                      0001235688899999986654 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|..||.+.+....+..+.........                          .....+....+++.+||..||.+|
T Consensus       210 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~P~~R  263 (292)
T cd06658         210 EMIDGEPPYFNEPPLQAMRRIRDNLPPRVK--------------------------DSHKVSSVLRGFLDLMLVREPSQR  263 (292)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcCCCccc--------------------------cccccCHHHHHHHHHHccCChhHC
Confidence            999999999887765554443321110000                          001234578899999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|+++||||....
T Consensus       264 pt~~~il~~~~~~~~~  279 (292)
T cd06658         264 ATAQELLQHPFLKLAG  279 (292)
T ss_pred             cCHHHHhhChhhhccC
Confidence            9999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.1e-33  Score=283.27  Aligned_cols=211  Identities=22%  Similarity=0.393  Sum_probs=164.5

Q ss_pred             HHHHHHHHHc---cCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         21 ALREISVLKE---LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        21 ~~rEi~iL~~---l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+|..+++.   .+||||+.+++.+..++..|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||++||+
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iv  119 (279)
T cd05633          41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVV  119 (279)
T ss_pred             HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcC
Confidence            4455544443   4799999999999999999999999985 8988887543 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++......                                                 
T Consensus       120 H~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------------------------------------------------  150 (279)
T cd05633         120 YRDLKPANILLDEHGHVRISDLGLACDFSKK-------------------------------------------------  150 (279)
T ss_pred             CCCCCHHHEEECCCCCEEEccCCcceecccc-------------------------------------------------
Confidence            9999999999999999999999986432100                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......||..|+|||++.+...++.++|+||+||++
T Consensus       151 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l  186 (279)
T cd05633         151 --------------------------------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCML  186 (279)
T ss_pred             --------------------------------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHH
Confidence                                                        001124788999999987555689999999999999


Q ss_pred             HHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        257 SEMITKKTLFAGDSE--IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       257 ~eLltG~~pF~~~~~--~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |+|++|..||.+...  ...+......   ...              .           +....+..+.++|.+||..||
T Consensus       187 ~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~--------------~-----------~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         187 FKLLRGHSPFRQHKTKDKHEIDRMTLT---VNV--------------E-----------LPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             HHHHhCCCCcCCCCCcCHHHHHHHhhc---CCc--------------C-----------CccccCHHHHHHHHHHhcCCH
Confidence            999999999975432  1122211100   000              0           111234678999999999999


Q ss_pred             CCCC-----CHHHHHcCccccCCc
Q psy10954        335 KQRV-----SAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~-----Ta~elL~Hp~f~~~~  353 (562)
                      ++|+     |++|+++||||+++.
T Consensus       239 ~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         239 SKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHhcCCCCCCHHHHHhCccccCCC
Confidence            9999     699999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-33  Score=279.49  Aligned_cols=215  Identities=37%  Similarity=0.587  Sum_probs=170.2

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      ..+|+.++++++||||+++++++......|+||||+.+ +|.+++... ..+++..+..++.|++.||.+||++||+|||
T Consensus        45 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~d  123 (260)
T PF00069_consen   45 NIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRD  123 (260)
T ss_dssp             HHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred             hhhhhhcccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence            35699999999999999999999999999999999997 999999732 3689999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHH
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALR  179 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~  179 (562)
                      |||+||+++.++.++|+|||++......                                                    
T Consensus       124 ikp~NIl~~~~~~~~l~Dfg~~~~~~~~----------------------------------------------------  151 (260)
T PF00069_consen  124 IKPENILLDENGEVKLIDFGSSVKLSEN----------------------------------------------------  151 (260)
T ss_dssp             BSGGGEEESTTSEEEESSGTTTEESTST----------------------------------------------------
T ss_pred             cccccccccccccccccccccccccccc----------------------------------------------------
Confidence            9999999999999999999986532100                                                    


Q ss_pred             hhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHH
Q psy10954        180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       180 yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eL  259 (562)
                                                             ........+|..|+|||++.....++.++||||+||++++|
T Consensus       152 ---------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  192 (260)
T PF00069_consen  152 ---------------------------------------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYEL  192 (260)
T ss_dssp             ---------------------------------------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHH
T ss_pred             ---------------------------------------ccccccccccccccccccccccccccccccccccccccccc
Confidence                                                   00112346788999999987445589999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCC
Q psy10954        260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS  339 (562)
Q Consensus       260 ltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~T  339 (562)
                      ++|..||......+....+...........             ..         ......+.+.+++.+||+.||++|||
T Consensus       193 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------~~---------~~~~~~~~l~~li~~~l~~~p~~R~~  250 (260)
T PF00069_consen  193 LTGKLPFEESNSDDQLEIIEKILKRPLPSS-------------SQ---------QSREKSEELRDLIKKMLSKDPEQRPS  250 (260)
T ss_dssp             HHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-------------TT---------SHTTSHHHHHHHHHHHSSSSGGGSTT
T ss_pred             cccccccccccchhhhhhhhhccccccccc-------------cc---------ccchhHHHHHHHHHHHccCChhHCcC
Confidence            999999998744443333332211100000             00         00001267899999999999999999


Q ss_pred             HHHHHcCccc
Q psy10954        340 AKTILQHEYF  349 (562)
Q Consensus       340 a~elL~Hp~f  349 (562)
                      +.++++||||
T Consensus       251 ~~~l~~~~~~  260 (260)
T PF00069_consen  251 AEELLKHPWF  260 (260)
T ss_dssp             HHHHHTSGGG
T ss_pred             HHHHhcCCCC
Confidence            9999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.2e-33  Score=281.20  Aligned_cols=221  Identities=27%  Similarity=0.405  Sum_probs=173.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+.++||||+++++++...+..|+||||+++ +|.+++.+.. ..+++..+..++.|++.||.|||++|+
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  116 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI  116 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567899999999999999999999999999999999985 9998887644 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++......                                                
T Consensus       117 ~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------------------------------------------  148 (277)
T cd05577         117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------------------------------------------  148 (277)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCcchhhhccC------------------------------------------------
Confidence            99999999999999999999999986432100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......++..|+|||++.+.. ++.++|+||+||+
T Consensus       149 --------------------------------------------~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i  183 (277)
T cd05577         149 --------------------------------------------KKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCT  183 (277)
T ss_pred             --------------------------------------------CccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHH
Confidence                                                        0001124577899999987765 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+.........+....-..                  +.       ......++.+.++|.+||+.||+
T Consensus       184 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~-------~~~~~~~~~~~~li~~~l~~~p~  238 (277)
T cd05577         184 LYEMIAGRSPFRQRKEKVEKEELKRRTLEM------------------AV-------EYPDKFSPEAKDLCEALLQKDPE  238 (277)
T ss_pred             HHHHhhCCCCCCCCcccccHHHHHhccccc------------------cc-------cCCccCCHHHHHHHHHHccCChh
Confidence            999999999997654321111111110000                  00       01112356789999999999999


Q ss_pred             CCC-----CHHHHHcCccccCCcccC
Q psy10954        336 QRV-----SAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       336 ~R~-----Ta~elL~Hp~f~~~~~~~  356 (562)
                      +|+     ++.++++||||.+.++..
T Consensus       239 ~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         239 KRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             HccCCCcccHHHHHhChhhhcCChhh
Confidence            999     899999999999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.9e-33  Score=288.80  Aligned_cols=241  Identities=39%  Similarity=0.696  Sum_probs=188.1

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ......+|+++++.++||||++++++|.. ....|+||||++++|.+++...  .+++..+..++.|+++||+|||++||
T Consensus        52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i  129 (328)
T cd07856          52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGV  129 (328)
T ss_pred             hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567799999999999999999999875 5689999999988998887643  58899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||.||+++.++.+||+|||++......                                                
T Consensus       130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~------------------------------------------------  161 (328)
T cd07856         130 VHRDLKPSNILINENCDLKICDFGLARIQDPQ------------------------------------------------  161 (328)
T ss_pred             ccCCCCHHHEeECCCCCEEeCccccccccCCC------------------------------------------------
Confidence            99999999999999999999999986422100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                    ....++++.|+|||++.+...++.++|+||+||+
T Consensus       162 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i  195 (328)
T cd07856         162 ----------------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCI  195 (328)
T ss_pred             ----------------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHH
Confidence                                                          0112457789999988765568999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      +|+|++|++||.+.........+.+.+|.++.+.+.......  .+....+...+..........+..+.+++++||+.|
T Consensus       196 l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  275 (328)
T cd07856         196 FAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD  275 (328)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCC
Confidence            999999999999888777777777888877655443221100  011111111112222333445678999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|||+++++.||||....
T Consensus       276 P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         276 PQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             hhhCCCHHHHhcCCcccccc
Confidence            99999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-33  Score=305.70  Aligned_cols=216  Identities=24%  Similarity=0.386  Sum_probs=173.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCC--------EEEEEeecCc-CCHHHHHhhC---CCCCCHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDF--------KLFLVFEFLR-QDLKDFLQTT---PVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~--------~i~lV~Ey~~-~~L~~~i~~~---~~~l~e~~i~~i~~qll~a   86 (562)
                      ..+.+|+.+|..++|+||+++++.+...+        .+++||||+. ++|.+++...   ...+++..+..++.|++.|
T Consensus        76 ~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~a  155 (496)
T PTZ00283         76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA  155 (496)
T ss_pred             HHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence            45678999999999999999998875432        4789999997 5999988653   2358999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++||+||||||+|||++.++.+||+|||+++.+.....                                     
T Consensus       156 L~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~-------------------------------------  198 (496)
T PTZ00283        156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS-------------------------------------  198 (496)
T ss_pred             HHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecccccc-------------------------------------
Confidence            9999999999999999999999999999999999764421000                                     


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                          .......+||+.|+|||++.+.. |+.+
T Consensus       199 ----------------------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k  225 (496)
T PTZ00283        199 ----------------------------------------------------DDVGRTFCGTPYYVAPEIWRRKP-YSKK  225 (496)
T ss_pred             ----------------------------------------------------ccccccccCCcceeCHHHhCCCC-CCcH
Confidence                                                                00012346899999999998754 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|||++|+.||.+.+..+.+..+....-.+                            +....++.+.+++
T Consensus       226 ~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li  277 (496)
T PTZ00283        226 ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP----------------------------LPPSISPEMQEIV  277 (496)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHH
Confidence            999999999999999999999887666555543211000                            0112356789999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccCC
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .+||..||++|||+.++++|||++..
T Consensus       278 ~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        278 TALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             HHHcccChhhCcCHHHHHhCHHHHHh
Confidence            99999999999999999999998764

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.3e-33  Score=318.96  Aligned_cols=233  Identities=31%  Similarity=0.460  Sum_probs=177.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|+.|+|||||+++++|..  ...+|||||||.+ +|.++|...   ...+++..++.++.||+.||.|||
T Consensus        56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH  135 (1021)
T PTZ00266         56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH  135 (1021)
T ss_pred             HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999864  4679999999985 999988652   246999999999999999999999


Q ss_pred             HC-------CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         92 SR-------RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        92 ~~-------gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      +.       +||||||||+||||+.+.. .+.+.-                                             
T Consensus       136 s~g~~~~~k~IVHRDLKPeNILL~s~~~-~lg~i~---------------------------------------------  169 (1021)
T PTZ00266        136 NLKDGPNGERVLHRDLKPQNIFLSTGIR-HIGKIT---------------------------------------------  169 (1021)
T ss_pred             hcccccccCCceeccCcHHHeEeecCcc-cccccc---------------------------------------------
Confidence            85       4999999999999974321 010000                                             


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVY  243 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y  243 (562)
                                                  ..-...+..+.+||+|||+++...... .....+||+.|+|||++.+. ..+
T Consensus       170 ----------------------------~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~  220 (1021)
T PTZ00266        170 ----------------------------AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSY  220 (1021)
T ss_pred             ----------------------------ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCC
Confidence                                        000012334568999999988654322 22345799999999999753 458


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      +.++||||||||+|||++|..||...+....+...+...  +.                   .       .+...+..+.
T Consensus       221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~-------------------l-------pi~~~S~eL~  272 (1021)
T PTZ00266        221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD-------------------L-------PIKGKSKELN  272 (1021)
T ss_pred             CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC-------------------C-------CcCCCCHHHH
Confidence            899999999999999999999998776655554443211  00                   0       0112346789


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||.+||..||.+|||+.|+|+|+|+..+.
T Consensus       273 dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        273 ILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            999999999999999999999999998764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.9e-33  Score=281.94  Aligned_cols=213  Identities=23%  Similarity=0.398  Sum_probs=164.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|++++||||+++++.+......++||||+++ +|..+     ..+++..+..++.|++.||.|||++||+|
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  118 (279)
T cd06619          44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILH  118 (279)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            4577999999999999999999999999999999999986 56443     24789999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+|||++.++.+||+|||++......                                                  
T Consensus       119 ~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--------------------------------------------------  148 (279)
T cd06619         119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--------------------------------------------------  148 (279)
T ss_pred             CCCCHHHEEECCCCCEEEeeCCcceecccc--------------------------------------------------
Confidence            999999999999999999999986432100                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 .....+||..|+|||++.+.. ++.++|+||+||++|
T Consensus       149 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~  184 (279)
T cd06619         149 -------------------------------------------IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFM  184 (279)
T ss_pred             -------------------------------------------cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHH
Confidence                                                       001235788899999887654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHH---HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        258 EMITKKTLFAGDSEID---QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       258 eLltG~~pF~~~~~~~---~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|++|+.||......+   .............                .+..       .....++.+.+++.+||+.||
T Consensus       185 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-------~~~~~~~~~~~li~~~l~~~P  241 (279)
T cd06619         185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDED----------------PPVL-------PVGQFSEKFVHFITQCMRKQP  241 (279)
T ss_pred             HHHhCCCCchhhcccccccchHHHHHHHhccC----------------CCCC-------CCCcCCHHHHHHHHHHhhCCh
Confidence            9999999996532111   0001111110000                0000       001235678999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++||+++|+++||||...+
T Consensus       242 ~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         242 KERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             hhCCCHHHHhcCccccccc
Confidence            9999999999999998653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.1e-33  Score=283.43  Aligned_cols=214  Identities=30%  Similarity=0.497  Sum_probs=172.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++.|..+...|+||||+.+ +|.+++...  .+++.++..++.|++.||.|||++||+|
T Consensus        62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H  139 (296)
T cd06654          62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIH  139 (296)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4577899999999999999999999999999999999975 899988653  5889999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++.......                                                 
T Consensus       140 ~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-------------------------------------------------  170 (296)
T cd06654         140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------------  170 (296)
T ss_pred             CCCCHHHEEEcCCCCEEECccccchhccccc-------------------------------------------------
Confidence            9999999999999999999999865331100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......|++.|+|||.+.+.. ++.++||||+||++|
T Consensus       171 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~  207 (296)
T cd06654         171 ------------------------------------------SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAI  207 (296)
T ss_pred             ------------------------------------------cccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHH
Confidence                                                      0001235688999999987644 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+....+..+.. .+.+...                         .....+..+.+++.+||..||++|
T Consensus       208 ~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~R  261 (296)
T cd06654         208 EMIEGEPPYLNENPLRALYLIAT-NGTPELQ-------------------------NPEKLSAIFRDFLNRCLDMDVEKR  261 (296)
T ss_pred             HHHhCCCCCCCCCHHHhHHHHhc-CCCCCCC-------------------------CccccCHHHHHHHHHHCcCCcccC
Confidence            99999999988776544433321 1111000                         001124568899999999999999


Q ss_pred             CCHHHHHcCccccCC
Q psy10954        338 VSAKTILQHEYFNQV  352 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~  352 (562)
                      ||+.++++||||...
T Consensus       262 pt~~eil~~~~~~~~  276 (296)
T cd06654         262 GSAKELLQHQFLKIA  276 (296)
T ss_pred             cCHHHHhhChhhhcc
Confidence            999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=273.99  Aligned_cols=216  Identities=29%  Similarity=0.429  Sum_probs=171.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++||||+++++++..+..+|+||||+++ +|.+++......+++..+..++.|++.||.|||++||+
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~  123 (262)
T cd06613          44 FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKI  123 (262)
T ss_pred             HHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            45678999999999999999999999999999999999985 89888877655799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||||+||+++.++.+||+|||++........                                               
T Consensus       124 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-----------------------------------------------  156 (262)
T cd06613         124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIA-----------------------------------------------  156 (262)
T ss_pred             ecCCChhhEEECCCCCEEECccccchhhhhhhh-----------------------------------------------
Confidence            999999999999999999999998753321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGC  254 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIWSlG~  254 (562)
                                                                  ......++..|+|||.+.+.  ..++.++|+||+||
T Consensus       157 --------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~  192 (262)
T cd06613         157 --------------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI  192 (262)
T ss_pred             --------------------------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHH
Confidence                                                        00123567789999988654  24788999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|++||.+.+.......+... +..+.                 ...      .....+..+.+|+.+||..||
T Consensus       193 ~l~~~~tg~~p~~~~~~~~~~~~~~~~-~~~~~-----------------~~~------~~~~~~~~~~~li~~~l~~~p  248 (262)
T cd06613         193 TAIELAELQPPMFDLHPMRALFLISKS-NFPPP-----------------KLK------DKEKWSPVFHDFIKKCLTKDP  248 (262)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCc-----------------ccc------chhhhhHHHHHHHHHHcCCCh
Confidence            999999999999887755544433221 00000                 000      000123568899999999999


Q ss_pred             CCCCCHHHHHcCcc
Q psy10954        335 KQRVSAKTILQHEY  348 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~  348 (562)
                      .+|||+.+++.|+|
T Consensus       249 ~~Rpt~~~il~~~~  262 (262)
T cd06613         249 KKRPTATKLLQHPF  262 (262)
T ss_pred             hhCCCHHHHhcCCC
Confidence            99999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-32  Score=275.68  Aligned_cols=211  Identities=17%  Similarity=0.232  Sum_probs=163.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++..+...++||||+++ +|.++++.....+++..+..++.|++.||+|||++||+|
T Consensus        44 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH  123 (258)
T cd05078          44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTH  123 (258)
T ss_pred             HHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4567899999999999999999999999999999999975 899999876667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++..++.+++                                                          
T Consensus       124 ~dlkp~nili~~~~~~~~~~~~----------------------------------------------------------  145 (258)
T cd05078         124 GNVCAKNVLLIREEDRKTGNPP----------------------------------------------------------  145 (258)
T ss_pred             CCCccceEEEecccccccCCCc----------------------------------------------------------
Confidence            9999999999877654433222                                                          


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                               .+|++|||++.....    .....+++.|+|||++.+...++.++||||+||++|
T Consensus       146 -------------------------~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  196 (258)
T cd05078         146 -------------------------FIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLW  196 (258)
T ss_pred             -------------------------eEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence                                     245666666543321    123467889999999987666899999999999999


Q ss_pred             HHHhCC-CCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKK-TLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~-~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++|. +||...+...... .......                             ........+.+++.+||+.||++
T Consensus       197 ~l~~g~~~~~~~~~~~~~~~-~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~  246 (258)
T cd05078         197 EIFSGGDKPLSALDSQKKLQ-FYEDRHQ-----------------------------LPAPKWTELANLINQCMDYEPDF  246 (258)
T ss_pred             HHHcCCCCChhhccHHHHHH-HHHcccc-----------------------------CCCCCcHHHHHHHHHHhccChhh
Confidence            999984 6665554433221 1110000                             00112356889999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||++++++.
T Consensus       247 Rps~~~il~~  256 (258)
T cd05078         247 RPSFRAIIRD  256 (258)
T ss_pred             CCCHHHHHHh
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0586|consensus

Probab=100.00  E-value=1.3e-33  Score=302.33  Aligned_cols=212  Identities=29%  Similarity=0.509  Sum_probs=177.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      +...+|+++|+.|+|||||+|+.+.++...+|+||||+. +++++++.+.+ ...+..++.++.|++.|++|||+++|||
T Consensus       100 ~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivH  178 (596)
T KOG0586|consen  100 QKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVH  178 (596)
T ss_pred             HHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceec
Confidence            347899999999999999999999999999999999996 59999998876 4666899999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      ||||.+|||++.+..+||+|||++..+..                                                   
T Consensus       179 rdLk~eNilL~~~mnikIaDfgfS~~~~~---------------------------------------------------  207 (596)
T KOG0586|consen  179 RDLKAENILLDENMNIKIADFGFSTFFDY---------------------------------------------------  207 (596)
T ss_pred             cccchhhcccccccceeeeccccceeecc---------------------------------------------------
Confidence            99999999999999999999998754421                                                   


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                               .....++||++.|.|||++.|.++.++.+|+||+|+++|
T Consensus       208 -----------------------------------------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly  246 (596)
T KOG0586|consen  208 -----------------------------------------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLY  246 (596)
T ss_pred             -----------------------------------------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhhe
Confidence                                                     011235789999999999999998899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhc---CCCCHHHHHHHHHccccCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL---NLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~dLi~~mL~~DP  334 (562)
                      -|+.|..||.|.+-.+.                                +++.+...+   ...+.++.++|++||..+|
T Consensus       247 ~LV~GsLPFDG~~lk~L--------------------------------r~rvl~gk~rIp~~ms~dce~lLrk~lvl~P  294 (596)
T KOG0586|consen  247 ALVEGSLPFDGQNLKEL--------------------------------RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNP  294 (596)
T ss_pred             eeeecccccCCcccccc--------------------------------cchheeeeecccceeechhHHHHHHhhccCc
Confidence            99999999998753211                                111111111   1124578999999999999


Q ss_pred             CCCCCHHHHHcCccccCCccc
Q psy10954        335 KQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      .+|++.++++.|.|.......
T Consensus       295 skr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  295 SKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             cccCCHHHhhhhcccchhhhh
Confidence            999999999999999765433

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-32  Score=279.00  Aligned_cols=208  Identities=22%  Similarity=0.395  Sum_probs=164.2

Q ss_pred             HHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q psy10954         25 ISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQ  103 (562)
Q Consensus        25 i~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  103 (562)
                      +.+++..+||||+++++++...+.+|+||||+.+ +|.+++... ..+++..++.++.|++.||+|||+++|+||||||+
T Consensus        48 ~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~  126 (278)
T cd05606          48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPA  126 (278)
T ss_pred             HHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHH
Confidence            3445556899999999999999999999999975 888887654 46999999999999999999999999999999999


Q ss_pred             cEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhc
Q psy10954        104 NILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS  183 (562)
Q Consensus       104 NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs  183 (562)
                      ||+++.++.+||+|||++......                                                        
T Consensus       127 nili~~~~~~kl~dfg~~~~~~~~--------------------------------------------------------  150 (278)
T cd05606         127 NILLDEHGHVRISDLGLACDFSKK--------------------------------------------------------  150 (278)
T ss_pred             HEEECCCCCEEEccCcCccccCcc--------------------------------------------------------
Confidence            999999999999999986432100                                                        


Q ss_pred             CceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCC
Q psy10954        184 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKK  263 (562)
Q Consensus       184 ~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~  263 (562)
                                                           .....+||..|+|||++.+...++.++||||+||++|+|++|+
T Consensus       151 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~  193 (278)
T cd05606         151 -------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH  193 (278)
T ss_pred             -------------------------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCC
Confidence                                                 0011257889999999976556899999999999999999999


Q ss_pred             CCCCCCCHHH--HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC---
Q psy10954        264 TLFAGDSEID--QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV---  338 (562)
Q Consensus       264 ~pF~~~~~~~--~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~---  338 (562)
                      .||.+.....  .......  .. ..                 .        .....+..+.+++.+||..||++|+   
T Consensus       194 ~p~~~~~~~~~~~~~~~~~--~~-~~-----------------~--------~~~~~s~~~~~li~~~l~~~p~~R~~~~  245 (278)
T cd05606         194 SPFRQHKTKDKHEIDRMTL--TM-AV-----------------E--------LPDSFSPELRSLLEGLLQRDVNRRLGCL  245 (278)
T ss_pred             CCCCCCCccchHHHHHHhh--cc-CC-----------------C--------CCCcCCHHHHHHHHHHhhcCHHhccCCC
Confidence            9998763221  1111110  00 00                 0        0112356799999999999999999   


Q ss_pred             --CHHHHHcCccccCCcc
Q psy10954        339 --SAKTILQHEYFNQVEM  354 (562)
Q Consensus       339 --Ta~elL~Hp~f~~~~~  354 (562)
                        ++.++++||||+...+
T Consensus       246 ~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         246 GRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             CCCHHHHHhCccccCCCc
Confidence              9999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-32  Score=282.73  Aligned_cols=212  Identities=26%  Similarity=0.439  Sum_probs=171.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+++++.++||||+++++++..++..|+||||+.+++.+++......+++..+..++.|++.||.|||++||+||
T Consensus        60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~  139 (307)
T cd06607          60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR  139 (307)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            35779999999999999999999999999999999999999888887655579999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||+|+||+++.++.+||+|||++......                                                   
T Consensus       140 dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---------------------------------------------------  168 (307)
T cd06607         140 DIKAGNILLTEPGTVKLADFGSASLVSPA---------------------------------------------------  168 (307)
T ss_pred             CCCcccEEECCCCCEEEeecCcceecCCC---------------------------------------------------
Confidence            99999999999999999999986432100                                                   


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                  ....+++.|+|||++.+  ...++.++||||+||++
T Consensus       169 --------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il  204 (307)
T cd06607         169 --------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  204 (307)
T ss_pred             --------------------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence                                                        01234567888887742  34478899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+.......+...  .+                  +...+       ...+..+.+++.+||..||++
T Consensus       205 ~el~tg~~p~~~~~~~~~~~~~~~~--~~------------------~~~~~-------~~~~~~~~~li~~~l~~~p~~  257 (307)
T cd06607         205 IELAERKPPLFNMNAMSALYHIAQN--DS------------------PTLSS-------NDWSDYFRNFVDSCLQKIPQD  257 (307)
T ss_pred             HHHHcCCCCCCCccHHHHHHHHhcC--CC------------------CCCCc-------hhhCHHHHHHHHHHhcCChhh
Confidence            9999999999887765554443211  00                  00000       012356899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||+.++++||||...
T Consensus       258 Rp~~~~il~~~~~~~~  273 (307)
T cd06607         258 RPSSEELLKHRFVLRE  273 (307)
T ss_pred             CcCHHHHhcChhhccc
Confidence            9999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-32  Score=281.91  Aligned_cols=216  Identities=31%  Similarity=0.529  Sum_probs=174.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++.+.....+|+||||+.+ +|.+++...  .+++.++..++.|++.||.|||++|++
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~  137 (296)
T cd06655          60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVI  137 (296)
T ss_pred             HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678899999999999999999999999999999999975 888887653  589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........                                               
T Consensus       138 H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------------  170 (296)
T cd06655         138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-----------------------------------------------  170 (296)
T ss_pred             cCCCCHHHEEECCCCCEEEccCccchhcccccc-----------------------------------------------
Confidence            999999999999999999999998654321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......|++.|+|||.+.+.. ++.++|+||+||++
T Consensus       171 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil  205 (296)
T cd06655         171 --------------------------------------------KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMA  205 (296)
T ss_pred             --------------------------------------------cCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHH
Confidence                                                        001224678899999987654 78899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+....+..+... +.+...                         .....++.+.+++.+||..||.+
T Consensus       206 ~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~  259 (296)
T cd06655         206 IEMVEGEPPYLNENPLRALYLIATN-GTPELQ-------------------------NPEKLSPIFRDFLNRCLEMDVEK  259 (296)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhc-CCcccC-------------------------CcccCCHHHHHHHHHHhhcChhh
Confidence            9999999999988766554443221 111000                         00123467889999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||+.++++||||+...
T Consensus       260 Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         260 RGSAKELLQHPFLKLAK  276 (296)
T ss_pred             CCCHHHHhhChHhhhcc
Confidence            99999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3e-32  Score=279.95  Aligned_cols=233  Identities=27%  Similarity=0.399  Sum_probs=177.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++.+..++.+|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++|++|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H  124 (305)
T cd05609          46 QQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVH  124 (305)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            3567899999999999999999999999999999999985 8999987653 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++........       ..|            ...                      
T Consensus       125 ~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~-------~~~------------~~~----------------------  163 (305)
T cd05609         125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT-------NLY------------EGH----------------------  163 (305)
T ss_pred             cCCchHHEEECCCCCEEEeeCCCccccCcCccc-------ccc------------ccc----------------------
Confidence            999999999999999999999987642111000       000            000                      


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                               +..+.                          .........|+..|+|||.+.+.. ++.++|+||+||++|
T Consensus       164 ---------~~~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~  207 (305)
T cd05609         164 ---------IEKDT--------------------------REFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILY  207 (305)
T ss_pred             ---------cccch--------------------------hhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHH
Confidence                     00000                          000001235688999999987654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|..||.+.+..+.+..+.......+                  .        .....+..+.+++.+||+.||++|
T Consensus       208 el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~~~li~~~l~~~P~~R  261 (305)
T cd05609         208 EFLVGCVPFFGDTPEELFGQVISDDIEWP------------------E--------GDEALPADAQDLISRLLRQNPLER  261 (305)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHhcccCCC------------------C--------ccccCCHHHHHHHHHHhccChhhc
Confidence            99999999998776555554432110000                  0        001234678999999999999999


Q ss_pred             CC---HHHHHcCccccCCccc
Q psy10954        338 VS---AKTILQHEYFNQVEMV  355 (562)
Q Consensus       338 ~T---a~elL~Hp~f~~~~~~  355 (562)
                      +|   +.++|+||||....+.
T Consensus       262 ~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         262 LGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             cCccCHHHHHhCccccCCCHH
Confidence            98   7899999999876543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-32  Score=275.83  Aligned_cols=220  Identities=29%  Similarity=0.499  Sum_probs=170.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++||||+++++++...+..++||||+.+ +|.+++.+.. .+++..+..++.|++.||+|||++|++
T Consensus        47 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~  125 (268)
T cd06630          47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQII  125 (268)
T ss_pred             HHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35678999999999999999999999999999999999985 8999887643 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         97 HRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        97 HRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      ||||||+||+++.++ .+||+|||++.........                  .                          
T Consensus       126 H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~------------------~--------------------------  161 (268)
T cd06630         126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG------------------A--------------------------  161 (268)
T ss_pred             cCCCCHHHEEEcCCCCEEEEccccccccccccccc------------------C--------------------------
Confidence            999999999998776 5899999987544211000                  0                          


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .......+||..|+|||++.+.. ++.++|+||+||+
T Consensus       162 -------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~  197 (268)
T cd06630         162 -------------------------------------------GEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCV  197 (268)
T ss_pred             -------------------------------------------CccccccccccceeCHhHhccCC-CCcccchHHHHHH
Confidence                                                       00001235788999999987654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +++|++|..||...........+....-...                .+.        .....++.+.+++.+||+.||+
T Consensus       198 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~~~--------~~~~~~~~~~~~i~~~l~~~p~  253 (268)
T cd06630         198 IIEMATAKPPWNAEKHSNHLALIFKIASATT----------------APS--------IPEHLSPGLRDVTLRCLELQPE  253 (268)
T ss_pred             HHHHHhCCCCCCCCCCcchHHHHHHHhccCC----------------CCC--------CchhhCHHHHHHHHHHcCCCcc
Confidence            9999999999975543222222221100000                000        0112356789999999999999


Q ss_pred             CCCCHHHHHcCcccc
Q psy10954        336 QRVSAKTILQHEYFN  350 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~  350 (562)
                      +|||+.++++||||+
T Consensus       254 ~R~~~~~ll~~~~~~  268 (268)
T cd06630         254 DRPPSRELLKHPVFR  268 (268)
T ss_pred             cCcCHHHHhcCcccC
Confidence            999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-32  Score=273.13  Aligned_cols=222  Identities=25%  Similarity=0.384  Sum_probs=175.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~--~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++|+.++|+||+++++.+......|+|||++.+ +|.+++....  ..+++..++.++.|++.||.|||++|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~  122 (267)
T cd06610          43 VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG  122 (267)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34578999999999999999999999999999999999975 8999987642  35899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||++..........                                           
T Consensus       123 i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~-------------------------------------------  159 (267)
T cd06610         123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT-------------------------------------------  159 (267)
T ss_pred             eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc-------------------------------------------
Confidence            9999999999999999999999999875442110000                                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .......+|+..|+|||++.....++.++|+||+||
T Consensus       160 --------------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~  195 (267)
T cd06610         160 --------------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI  195 (267)
T ss_pred             --------------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhHhH
Confidence                                                        000122357889999999987656899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++++|++|+.||...+....+.++...   .+.. +             +...      .....++.+.+++.+||+.||
T Consensus       196 i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~-------------~~~~------~~~~~~~~~~~li~~~l~~~p  252 (267)
T cd06610         196 TAIELATGAAPYSKYPPMKVLMLTLQN---DPPS-L-------------ETGA------DYKKYSKSFRKMISLCLQKDP  252 (267)
T ss_pred             HHHHHHhCCCCccccChhhhHHHHhcC---CCCC-c-------------CCcc------ccccccHHHHHHHHHHcCCCh
Confidence            999999999999877665544443321   0000 0             0000      011234678999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy10954        335 KQRVSAKTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f  349 (562)
                      ++|||+.++++||||
T Consensus       253 ~~Rp~~~~ll~~p~~  267 (267)
T cd06610         253 SKRPTAEELLKHKFF  267 (267)
T ss_pred             hhCcCHHHHhhCCCC
Confidence            999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-32  Score=276.97  Aligned_cols=197  Identities=25%  Similarity=0.426  Sum_probs=157.7

Q ss_pred             CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q psy10954         32 KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS  110 (562)
Q Consensus        32 ~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~  110 (562)
                      +||||+++++.|..++..|+||||++ ++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~  145 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA  145 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCC
Confidence            79999999999999999999999997 59999987654 79999999999999999999999999999999999999988


Q ss_pred             C-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeec
Q psy10954        111 G-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHR  189 (562)
Q Consensus       111 ~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHR  189 (562)
                      + .++|+|||+++.....                                                              
T Consensus       146 ~~~~~l~dfg~~~~~~~~--------------------------------------------------------------  163 (267)
T PHA03390        146 KDRIYLCDYGLCKIIGTP--------------------------------------------------------------  163 (267)
T ss_pred             CCeEEEecCccceecCCC--------------------------------------------------------------
Confidence            8 8999999976432100                                                              


Q ss_pred             CCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy10954        190 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD  269 (562)
Q Consensus       190 DLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~  269 (562)
                                                       ....||..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.
T Consensus       164 ---------------------------------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        164 ---------------------------------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             ---------------------------------ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                                             0123577899999997654 889999999999999999999999865


Q ss_pred             CHHHH-HHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCC-HHHHHcCc
Q psy10954        270 SEIDQ-LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS-AKTILQHE  347 (562)
Q Consensus       270 ~~~~~-l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~T-a~elL~Hp  347 (562)
                      ...+. ......... ...                         ...+..++.+.+||.+||+.||.+|++ ++|+|+||
T Consensus       210 ~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        210 EDEELDLESLLKRQQ-KKL-------------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             CcchhhHHHHHHhhc-ccC-------------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence            43221 111111110 000                         011234678999999999999999997 59999999


Q ss_pred             cccC
Q psy10954        348 YFNQ  351 (562)
Q Consensus       348 ~f~~  351 (562)
                      ||++
T Consensus       264 ~~~~  267 (267)
T PHA03390        264 FLKI  267 (267)
T ss_pred             cccC
Confidence            9964

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-32  Score=272.58  Aligned_cols=212  Identities=28%  Similarity=0.509  Sum_probs=174.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++++|+||+++++++.....+++|||||++ +|.+++... ...+++..+..++.|++.||.|||++|+
T Consensus        43 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  122 (256)
T cd08221          43 RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34578999999999999999999999999999999999975 999998765 3458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++........                                              
T Consensus       123 ~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~----------------------------------------------  156 (256)
T cd08221         123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS----------------------------------------------  156 (256)
T ss_pred             cccCCChHhEEEeCCCCEEECcCcceEEcccccc----------------------------------------------
Confidence            9999999999999999999999998754321000                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......||+.|+|||++.+.. ++.++|+||+||+
T Consensus       157 ---------------------------------------------~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i  190 (256)
T cd08221         157 ---------------------------------------------MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCV  190 (256)
T ss_pred             ---------------------------------------------cccccCCCccccCHhhcCCCC-CCCcchhHHHHHH
Confidence                                                         001235688999999987765 7889999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ++||++|..||.+.+..+....+...  ....                          .....+..+.+++.+||..||.
T Consensus       191 ~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~~i~~~l~~~p~  242 (256)
T cd08221         191 LYELLTLKRTFDATNPLNLVVKIVQG--NYTP--------------------------VVSVYSSELISLVHSLLQQDPE  242 (256)
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHcC--CCCC--------------------------CccccCHHHHHHHHHHcccCcc
Confidence            99999999999887776666555421  1000                          0012346789999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||+.++|+|+|+
T Consensus       243 ~R~s~~~ll~~~~l  256 (256)
T cd08221         243 KRPTADEVLDQPLL  256 (256)
T ss_pred             cCCCHHHHhhCcCC
Confidence            99999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=276.71  Aligned_cols=212  Identities=27%  Similarity=0.421  Sum_probs=173.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++.+..+...|+|+||+++ +|.+++...  .+++..+..++.|++.||.|||++||+|
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h  121 (274)
T cd06609          44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIH  121 (274)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4567899999999999999999999999999999999975 899988764  6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.++|+|||+++......                                                 
T Consensus       122 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-------------------------------------------------  152 (274)
T cd06609         122 RDIKAANILLSEEGDVKLADFGVSGQLTSTM-------------------------------------------------  152 (274)
T ss_pred             CCCCHHHEEECCCCCEEEcccccceeecccc-------------------------------------------------
Confidence            9999999999999999999999876442110                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+++.|+|||++.+.. ++.++|+||+||++|
T Consensus       153 ------------------------------------------~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~  189 (274)
T cd06609         153 ------------------------------------------SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAI  189 (274)
T ss_pred             ------------------------------------------cccccccCCccccChhhhccCC-CCchhhHHHHHHHHH
Confidence                                                      0011235678899999998766 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC-CCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++|.+||.+.+.......+.....                    +.        .... .++.+.+++.+||..||++
T Consensus       190 ~l~tg~~p~~~~~~~~~~~~~~~~~~--------------------~~--------~~~~~~~~~~~~~l~~~l~~~p~~  241 (274)
T cd06609         190 ELAKGEPPLSDLHPMRVLFLIPKNNP--------------------PS--------LEGNKFSKPFKDFVSLCLNKDPKE  241 (274)
T ss_pred             HHHhCCCCcccCchHHHHHHhhhcCC--------------------CC--------CcccccCHHHHHHHHHHhhCChhh
Confidence            99999999987665444333322100                    00        0001 3457899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++++++||||.+.
T Consensus       242 Rpt~~~il~~~~~~~~  257 (274)
T cd06609         242 RPSAKELLKHKFIKKA  257 (274)
T ss_pred             CcCHHHHhhChhhcCC
Confidence            9999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-32  Score=274.39  Aligned_cols=214  Identities=28%  Similarity=0.501  Sum_probs=166.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+.+++.++||||+++++.+..  +..+|+||||+++ +|.+++.+.. .+++..++.++.|++.||+|||++||
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i  127 (266)
T cd06651          49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMI  127 (266)
T ss_pred             HHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            356789999999999999999999875  3678999999975 8999887644 58999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++........                                             
T Consensus       128 ~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---------------------------------------------  162 (266)
T cd06651         128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS---------------------------------------------  162 (266)
T ss_pred             eeCCCCHHHEEECCCCCEEEccCCCcccccccccc---------------------------------------------
Confidence            99999999999999999999999987643210000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 ........++..|+|||.+.+.. ++.++|+||+||+
T Consensus       163 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i  198 (266)
T cd06651         163 -------------------------------------------GTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCT  198 (266)
T ss_pred             -------------------------------------------CCccccCCccccccCHHHhCCCC-CCchhhhHHHHHH
Confidence                                                       00001234688899999997654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||...........+...   +..                +.        +-...++.+.+++ +|+..||+
T Consensus       199 ~~el~~g~~pf~~~~~~~~~~~~~~~---~~~----------------~~--------~~~~~~~~~~~li-~~~~~~p~  250 (266)
T cd06651         199 VVEMLTEKPPWAEYEAMAAIFKIATQ---PTN----------------PQ--------LPSHISEHARDFL-GCIFVEAR  250 (266)
T ss_pred             HHHHHHCCCCccccchHHHHHHHhcC---CCC----------------CC--------CchhcCHHHHHHH-HHhcCChh
Confidence            99999999999876544433332211   000                00        0012346678888 56778999


Q ss_pred             CCCCHHHHHcCcccc
Q psy10954        336 QRVSAKTILQHEYFN  350 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~  350 (562)
                      +|||++|+++||||+
T Consensus       251 ~Rp~~~eil~hp~~~  265 (266)
T cd06651         251 HRPSAEELLRHPFAQ  265 (266)
T ss_pred             hCcCHHHHhcCcccc
Confidence            999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-32  Score=275.41  Aligned_cols=213  Identities=29%  Similarity=0.437  Sum_probs=165.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPV--PPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l--~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      +.+.+|+++++.++||||+++++++..++.+|+||||+.+ +|.+++......+  ++..+..++.|++.||.|||++||
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i  129 (268)
T cd06624          50 QPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI  129 (268)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4577999999999999999999999999999999999975 9999998654455  888899999999999999999999


Q ss_pred             eeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         96 IHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        96 iHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      +||||||+||+++. ++.+||+|||++.......                                              
T Consensus       130 ~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~----------------------------------------------  163 (268)
T cd06624         130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN----------------------------------------------  163 (268)
T ss_pred             eecCCCHHHEEEcCCCCeEEEecchhheecccCC----------------------------------------------
Confidence            99999999999986 5789999999864321000                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAG  253 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG  253 (562)
                                                                   .......|++.|+|||++.+. ..++.++|+||+|
T Consensus       164 ---------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG  198 (268)
T cd06624         164 ---------------------------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG  198 (268)
T ss_pred             ---------------------------------------------CccccCCCCccccChhhhccccccCCchhhhHHHH
Confidence                                                         000112467889999998653 3478899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMITKKTLFAGDSEID-QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++|+|++|++||....... ....+ ...+.                  .+.        +-...++.+.+|+.+||..
T Consensus       199 vvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~------------------~~~--------~~~~~~~~~~~li~~~l~~  251 (268)
T cd06624         199 CTIVEMATGKPPFIELGEPQAAMFKV-GMFKI------------------HPE--------IPESLSAEAKNFILRCFEP  251 (268)
T ss_pred             HHHHHHHhCCCCCccccChhhhHhhh-hhhcc------------------CCC--------CCcccCHHHHHHHHHHcCC
Confidence            99999999999997543221 11111 00000                  000        0112346789999999999


Q ss_pred             CCCCCCCHHHHHcCccc
Q psy10954        333 DPKQRVSAKTILQHEYF  349 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f  349 (562)
                      +|++|||+.|++.||||
T Consensus       252 ~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         252 DPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CchhCCCHHHHHhCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=275.87  Aligned_cols=214  Identities=24%  Similarity=0.387  Sum_probs=167.1

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCC------EEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDF------KLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~------~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL   87 (562)
                      ..+.+|+.+++++ +||||+++++++....      .+|+||||+++ +|.+++...   +..+++..++.++.|++.||
T Consensus        47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al  126 (275)
T cd06608          47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL  126 (275)
T ss_pred             HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            4578999999999 7999999999997643      58999999985 888887642   35689999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +|||++|++|+||+|+||+++.++.+||+|||++.........                                     
T Consensus       127 ~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~-------------------------------------  169 (275)
T cd06608         127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR-------------------------------------  169 (275)
T ss_pred             HHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhh-------------------------------------
Confidence            9999999999999999999999999999999987543211000                                     


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC----CCC
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----KVY  243 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~----~~y  243 (562)
                                                                            .....||..|+|||++.+.    ..+
T Consensus       170 ------------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~  195 (275)
T cd06608         170 ------------------------------------------------------RNTFIGTPYWMAPEVIACDEQPDASY  195 (275)
T ss_pred             ------------------------------------------------------hcCccccccccCHhHhcccccccCCc
Confidence                                                                  0112467778888887532    347


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      +.++||||+||++|+|++|.+||.+......+.++....   ..                 ....      ....+..+.
T Consensus       196 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-----------------~~~~------~~~~~~~~~  249 (275)
T cd06608         196 DARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP-----------------TLKS------PENWSKKFN  249 (275)
T ss_pred             cccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC-----------------CCCc------hhhcCHHHH
Confidence            789999999999999999999998766555555443210   00                 0000      001245788


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      +|+.+||..||++|||+.|+++|||+
T Consensus       250 ~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         250 DFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-32  Score=276.10  Aligned_cols=213  Identities=24%  Similarity=0.372  Sum_probs=165.4

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+.+++.++||||+++++++..+...|+||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+||
T Consensus        52 ~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  130 (267)
T cd06646          52 LIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHR  130 (267)
T ss_pred             HHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            467899999999999999999999999999999999985 898888654 368999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||+++.......                                                 
T Consensus       131 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------  161 (267)
T cd06646         131 DIKGANILLTDNGDVKLADFGVAAKITATIA-------------------------------------------------  161 (267)
T ss_pred             CCCHHHEEECCCCCEEECcCccceeeccccc-------------------------------------------------
Confidence            9999999999999999999998754321000                                                 


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                ......|++.|+|||.+.+  ...++.++|+||+||++
T Consensus       162 ------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il  199 (267)
T cd06646         162 ------------------------------------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA  199 (267)
T ss_pred             ------------------------------------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHH
Confidence                                                      0012346788999998753  33477899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||......+....+....                +  ..+.+.      .....+..+.+|+++||..||++
T Consensus       200 ~el~~g~~p~~~~~~~~~~~~~~~~~----------------~--~~~~~~------~~~~~~~~~~~li~~~l~~~P~~  255 (267)
T cd06646         200 IELAELQPPMFDLHPMRALFLMSKSN----------------F--QPPKLK------DKTKWSSTFHNFVKISLTKNPKK  255 (267)
T ss_pred             HHHHhCCCCccccchhhhheeeecCC----------------C--CCCCCc------cccccCHHHHHHHHHHhhCChhh
Confidence            99999999997554332221111000                0  000000      00112467899999999999999


Q ss_pred             CCCHHHHHcCcc
Q psy10954        337 RVSAKTILQHEY  348 (562)
Q Consensus       337 R~Ta~elL~Hp~  348 (562)
                      |||++++|+|+|
T Consensus       256 Rp~~~~il~~l~  267 (267)
T cd06646         256 RPTAERLLTHLF  267 (267)
T ss_pred             CcCHHHHhcCCC
Confidence            999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4236|consensus

Probab=100.00  E-value=6.3e-34  Score=297.74  Aligned_cols=214  Identities=28%  Similarity=0.484  Sum_probs=173.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~-~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ....+|++||+++.||.||.|.-.|++.+.+++|||-+.+|+.++|.. ..+.++|...++++.||+.||+|||.++|+|
T Consensus       608 sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvH  687 (888)
T KOG4236|consen  608 SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVH  687 (888)
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceee
Confidence            567789999999999999999999999999999999999998888754 4467999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      +||||||||+....   .+||||||+||.+.+                                                
T Consensus       688 CDLKPENVLLas~~~FPQvKlCDFGfARiIgE------------------------------------------------  719 (888)
T KOG4236|consen  688 CDLKPENVLLASASPFPQVKLCDFGFARIIGE------------------------------------------------  719 (888)
T ss_pred             ccCCchheeeccCCCCCceeeccccceeecch------------------------------------------------
Confidence            99999999997543   366666666655431                                                


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                 . ....+.||||.|.||||+.+.+ |+.+.|+||+||
T Consensus       720 -------------------------------------------k-sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGV  754 (888)
T KOG4236|consen  720 -------------------------------------------K-SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGV  754 (888)
T ss_pred             -------------------------------------------h-hhhhhhcCCccccCHHHHhhcc-ccccccceeeeE
Confidence                                                       1 1123568999999999998655 999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |+|--++|..||..+.++ ++++   +.--..+.                     ..++    ..++.|.|||.++|+..
T Consensus       755 IiYVsLSGTFPFNEdEdIndQIQ---NAaFMyPp---------------------~PW~----eis~~AidlIn~LLqVk  806 (888)
T KOG4236|consen  755 IIYVSLSGTFPFNEDEDINDQIQ---NAAFMYPP---------------------NPWS----EISPEAIDLINNLLQVK  806 (888)
T ss_pred             EEEEEecccccCCCccchhHHhh---ccccccCC---------------------Cchh----hcCHHHHHHHHHHHHHH
Confidence            999999999999765443 2322   11111111                     1122    23468999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      -++|.|.+..|.|||+++..
T Consensus       807 m~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  807 MRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHhcchHhhccchhhhcch
Confidence            99999999999999998753

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-32  Score=282.09  Aligned_cols=216  Identities=26%  Similarity=0.490  Sum_probs=173.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++.+..++..|+||||+++ +|.+++..  ..+++..++.++.|++.||.|||++||+
T Consensus        62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iv  139 (297)
T cd06659          62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVI  139 (297)
T ss_pred             HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34577999999999999999999999999999999999985 88887754  3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++.......                                                
T Consensus       140 H~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------------------------------------------------  171 (297)
T cd06659         140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------------------------------  171 (297)
T ss_pred             cCCCCHHHeEEccCCcEEEeechhHhhccccc------------------------------------------------
Confidence            99999999999999999999999865321100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+|+..|+|||++.+.. ++.++|+||+||++
T Consensus       172 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il  207 (297)
T cd06659         172 -------------------------------------------PKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMV  207 (297)
T ss_pred             -------------------------------------------ccccceecCccccCHHHHccCC-CCchhhHHHHHHHH
Confidence                                                       0001235788999999997654 79999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||...+..+.+..+...   + ...+.                      .....+..+.+++.+||+.||.+
T Consensus       208 ~el~~g~~p~~~~~~~~~~~~~~~~---~-~~~~~----------------------~~~~~~~~l~~~i~~~l~~~P~~  261 (297)
T cd06659         208 IEMVDGEPPYFSDSPVQAMKRLRDS---P-PPKLK----------------------NAHKISPVLRDFLERMLTREPQE  261 (297)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhcc---C-CCCcc----------------------ccCCCCHHHHHHHHHHhcCCccc
Confidence            9999999999887766555443211   0 00000                      01123457889999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||+.++++||||.+..
T Consensus       262 Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         262 RATAQELLDHPFLLQTG  278 (297)
T ss_pred             CcCHHHHhhChhhccCC
Confidence            99999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=273.38  Aligned_cols=212  Identities=31%  Similarity=0.512  Sum_probs=167.7

Q ss_pred             HHHHHHHH-HccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         21 ALREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        21 ~~rEi~iL-~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ...|..++ ...+||||+++++++..++.+|+||||+++ +|.+++.... .+++..+..++.|++.||.|||+.|++||
T Consensus        43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~  121 (260)
T cd05611          43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHR  121 (260)
T ss_pred             HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            34455444 455899999999999999999999999975 8999887643 68999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||+++....                                                    
T Consensus       122 dl~p~nil~~~~~~~~l~dfg~~~~~~~----------------------------------------------------  149 (260)
T cd05611         122 DIKPENLLIDQTGHLKLTDFGLSRNGLE----------------------------------------------------  149 (260)
T ss_pred             CCCHHHeEECCCCcEEEeecccceeccc----------------------------------------------------
Confidence            9999999999999999999997642210                                                    


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                                 .....|++.|+|||.+.+.. ++.++||||+||++|+
T Consensus       150 -------------------------------------------~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~  185 (260)
T cd05611         150 -------------------------------------------NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFE  185 (260)
T ss_pred             -------------------------------------------cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHH
Confidence                                                       01124577899999987765 8999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      |++|.+||.+.+.......+......                  ++.       ......++.+.+++.+||+.||++|+
T Consensus       186 l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~  240 (260)
T cd05611         186 FLFGYPPFHAETPDAVFDNILSRRIN------------------WPE-------EVKEFCSPEAVDLINRLLCMDPAKRL  240 (260)
T ss_pred             HHHCCCCCCCCCHHHHHHHHHhcccC------------------CCC-------cccccCCHHHHHHHHHHccCCHHHcc
Confidence            99999999887765544443221100                  000       01112356789999999999999999


Q ss_pred             CH---HHHHcCccccCCcc
Q psy10954        339 SA---KTILQHEYFNQVEM  354 (562)
Q Consensus       339 Ta---~elL~Hp~f~~~~~  354 (562)
                      |+   +|+|.||||+++.+
T Consensus       241 ~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         241 GANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             CCCcHHHHHcChHhhcCCC
Confidence            55   79999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-32  Score=273.83  Aligned_cols=208  Identities=18%  Similarity=0.269  Sum_probs=166.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++..++.+|+||||+++ +|.+++......+++..+..++.|++.||+|||++|++|
T Consensus        51 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH  130 (266)
T cd05064          51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH  130 (266)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            3567899999999999999999999999999999999985 899898876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+|++|||.+......                 ..     +                         
T Consensus       131 ~dikp~nili~~~~~~~l~dfg~~~~~~~~-----------------~~-----~-------------------------  163 (266)
T cd05064         131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSE-----------------AI-----Y-------------------------  163 (266)
T ss_pred             ccccHhhEEEcCCCcEEECCCccccccccc-----------------ch-----h-------------------------
Confidence            999999999999999999999975321100                 00     0                         


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......+|..|+|||++.+.. ++.++||||+||++|
T Consensus       164 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~  199 (266)
T cd05064         164 -------------------------------------------TTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMW  199 (266)
T ss_pred             -------------------------------------------cccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHH
Confidence                                                       000123467899999987654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+.+..+.+..+.+....+                            .....+..+.+++.+|++.||++
T Consensus       200 ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~  251 (266)
T cd05064         200 EVMSYGERPYWDMSGQDVIKAVEDGFRLP----------------------------APRNCPNLLHQLMLDCWQKERGE  251 (266)
T ss_pred             HHhcCCCCCcCcCCHHHHHHHHHCCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCchh
Confidence            9774 999999887766555543221100                            00122457889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||++++++
T Consensus       252 RP~~~~i~~  260 (266)
T cd05064         252 RPRFSQIHS  260 (266)
T ss_pred             CCCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-32  Score=282.20  Aligned_cols=215  Identities=29%  Similarity=0.489  Sum_probs=171.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++.+..+...|+||||+++ +|.+++...  .+++..+..++.|++.||.|||+.||+|
T Consensus        61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H  138 (297)
T cd06656          61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIH  138 (297)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4567899999999999999999999999999999999975 899988653  5889999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||++.......                                                 
T Consensus       139 ~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-------------------------------------------------  169 (297)
T cd06656         139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------------  169 (297)
T ss_pred             CCCCHHHEEECCCCCEEECcCccceEccCCc-------------------------------------------------
Confidence            9999999999999999999999865331100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+++.|+|||.+.+.. ++.++|+||+||++|
T Consensus       170 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~  206 (297)
T cd06656         170 ------------------------------------------SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAI  206 (297)
T ss_pred             ------------------------------------------cCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHH
Confidence                                                      0001224678899999997644 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|..||.+.+....+..+.. .+.+...                         .....+..+.+|+.+||+.||++|
T Consensus       207 ~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R  260 (297)
T cd06656         207 EMVEGEPPYLNENPLRALYLIAT-NGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRR  260 (297)
T ss_pred             HHHhCCCCCCCCCcchheeeecc-CCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhC
Confidence            99999999987654333222111 0111000                         001234568899999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      ||+.++++||||....
T Consensus       261 ps~~~il~~~~~~~~~  276 (297)
T cd06656         261 GSAKELLQHPFLKLAK  276 (297)
T ss_pred             cCHHHHhcCchhcccc
Confidence            9999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.1e-32  Score=276.90  Aligned_cols=213  Identities=25%  Similarity=0.390  Sum_probs=165.9

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEe------CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPV------DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~------~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ..+.+|+.+++++ +||||+++++++..      ...+|+||||+++ +|.+++.... ..+++..+..++.|++.||.|
T Consensus        57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  136 (282)
T cd06636          57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH  136 (282)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999988 79999999999853      4678999999985 8998887643 358899999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+||||||+||+++.++.++|+|||++........                                        
T Consensus       137 LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~----------------------------------------  176 (282)
T cd06636         137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG----------------------------------------  176 (282)
T ss_pred             HHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc----------------------------------------
Confidence            9999999999999999999999999999998654321000                                        


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCc
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYST  245 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~  245 (562)
                                                                         .....+|++.|+|||++..    ...++.
T Consensus       177 ---------------------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~  205 (282)
T cd06636         177 ---------------------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDY  205 (282)
T ss_pred             ---------------------------------------------------CCCcccccccccCHhhcCcccCcCcCCCc
Confidence                                                               0012356778888888753    234788


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       246 ~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      ++|+||+||++|||++|.+||........+..+...   ..                 +..       .....+..+.+|
T Consensus       206 ~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-----------------~~~-------~~~~~~~~~~~l  258 (282)
T cd06636         206 RSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP-----------------PKL-------KSKKWSKKFIDF  258 (282)
T ss_pred             ccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-----------------CCC-------cccccCHHHHHH
Confidence            999999999999999999999876544333322110   00                 000       011235678999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccc
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      +++||+.||.+|||+.|+|+||||
T Consensus       259 i~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         259 IEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.3e-32  Score=279.22  Aligned_cols=213  Identities=26%  Similarity=0.424  Sum_probs=173.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+++++.++||||+++++++......|+||||+.++|.+++......+++..+..++.|++.||.|||++||+||
T Consensus        66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~  145 (313)
T cd06633          66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR  145 (313)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            35678999999999999999999999999999999999999998887766679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||++.....                                                    
T Consensus       146 dl~p~nili~~~~~~kL~dfg~~~~~~~----------------------------------------------------  173 (313)
T cd06633         146 DIKAGNILLTEPGQVKLADFGSASKSSP----------------------------------------------------  173 (313)
T ss_pred             CCChhhEEECCCCCEEEeecCCCcccCC----------------------------------------------------
Confidence            9999999999999999999997532100                                                    


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                 .....|+..|+|||++.+  ...++.++|+||+||++
T Consensus       174 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil  210 (313)
T cd06633         174 -------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  210 (313)
T ss_pred             -------------------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHH
Confidence                                                       011245777888888753  24478899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|.+||.+.+....+..+.... .+                   ..       .....+..+.+|+.+||+.+|.+
T Consensus       211 ~el~~g~~p~~~~~~~~~~~~~~~~~-~~-------------------~~-------~~~~~~~~l~~li~~~l~~~P~~  263 (313)
T cd06633         211 IELAERKPPLFNMNAMSALYHIAQND-SP-------------------TL-------QSNEWTDSFRGFVDYCLQKIPQE  263 (313)
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcC-CC-------------------CC-------CccccCHHHHHHHHHHccCChhh
Confidence            99999999998877666555543211 00                   00       00112346889999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||+.++++||||....
T Consensus       264 Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         264 RPASAELLRHDFVRRDR  280 (313)
T ss_pred             CcCHHHHhcCcccCCCc
Confidence            99999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.3e-32  Score=277.25  Aligned_cols=215  Identities=26%  Similarity=0.499  Sum_probs=174.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++...+..|+|+||+.+ +|.+++..  ..+++..+..++.|++.||+|||++||+|
T Consensus        61 ~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H  138 (285)
T cd06648          61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIH  138 (285)
T ss_pred             HHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4578999999999999999999999999999999999975 99998876  35899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.++|+|||++.......                                                 
T Consensus       139 ~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-------------------------------------------------  169 (285)
T cd06648         139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-------------------------------------------------  169 (285)
T ss_pred             CCCChhhEEEcCCCcEEEcccccchhhccCC-------------------------------------------------
Confidence            9999999999999999999999764321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......|++.|+|||++.+.. ++.++|+||+||++|
T Consensus       170 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~  206 (285)
T cd06648         170 ------------------------------------------PRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVI  206 (285)
T ss_pred             ------------------------------------------cccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHH
Confidence                                                      0001235688899999987654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+....+..+... ..+..                   .      .....+..+.+|+.+||..||++|
T Consensus       207 ell~g~~p~~~~~~~~~~~~~~~~-~~~~~-------------------~------~~~~~~~~l~~li~~~l~~~p~~R  260 (285)
T cd06648         207 EMVDGEPPYFNEPPLQAMKRIRDN-LPPKL-------------------K------NLHKVSPRLRSFLDRMLVRDPAQR  260 (285)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHhc-CCCCC-------------------c------ccccCCHHHHHHHHHHcccChhhC
Confidence            999999999887766555544321 00000                   0      001134678999999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      ||+.++++||||+...
T Consensus       261 pt~~~il~~~~~~~~~  276 (285)
T cd06648         261 ATAAELLNHPFLAKAG  276 (285)
T ss_pred             cCHHHHccCcccccCC
Confidence            9999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0670|consensus

Probab=100.00  E-value=3.3e-34  Score=299.96  Aligned_cols=239  Identities=32%  Similarity=0.529  Sum_probs=188.1

Q ss_pred             hhHHHHHHHHHccCC------CCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKH------PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV--PVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        19 ~~~~rEi~iL~~l~H------pnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yL   90 (562)
                      +.-++|++||+.|+.      -|+++|+..|...+++|||+|-+..+|.+++.+.+.  .|....++.|++|++.||..|
T Consensus       473 KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL  552 (752)
T KOG0670|consen  473 KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL  552 (752)
T ss_pred             hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH
Confidence            456899999999963      379999999999999999999999999999988653  488899999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ...||+|.||||.||||+.. ..+||||||.|...+..                                          
T Consensus       553 K~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en------------------------------------------  590 (752)
T KOG0670|consen  553 KKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN------------------------------------------  590 (752)
T ss_pred             HhcCeeecccCccceEeccCcceeeeccCccccccccc------------------------------------------
Confidence            99999999999999999965 45799999987543211                                          


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                         ..+.+..+.+|+|||+|+|.+ |++++|+
T Consensus       591 ---------------------------------------------------eitPYLVSRFYRaPEIiLG~~-yd~~iD~  618 (752)
T KOG0670|consen  591 ---------------------------------------------------EITPYLVSRFYRAPEIILGLP-YDYPIDT  618 (752)
T ss_pred             ---------------------------------------------------cccHHHHHHhccCcceeecCc-ccCCccc
Confidence                                                               112345578899999999887 9999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC-CccCCC-------------------CCCCc-
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP-IYKTDF-------------------PEWRP-  308 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~-~~~~~~-------------------~~~~~-  308 (562)
                      ||+||+||||+||+.+|.|.+..++|....++-|..+..+........ .|..++                   ....| 
T Consensus       619 WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt  698 (752)
T KOG0670|consen  619 WSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT  698 (752)
T ss_pred             eeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc
Confidence            999999999999999999999999999999999988766543221111 111110                   01111 


Q ss_pred             cch-hhhcC---CCC------HHHHHHHHHccccCCCCCCCHHHHHcCccccC
Q psy10954        309 KKF-SEILN---LPD------PLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       309 ~~~-~~~l~---~~~------~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      +.+ +.+..   .++      ..+.|||.+||..||++|+|..|+|+||||..
T Consensus       699 kdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  699 KDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             hhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            111 22222   122      24789999999999999999999999999964

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-32  Score=275.74  Aligned_cols=220  Identities=21%  Similarity=0.344  Sum_probs=167.3

Q ss_pred             hhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL---QT-TPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i---~~-~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+.++.++. ||||+++++++..+...++||||+..++.++.   .. ....+++..+..++.|++.||+|||+.
T Consensus        47 ~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~  126 (288)
T cd06616          47 KRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE  126 (288)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            45678999999996 99999999999999999999999987655433   22 234699999999999999999999975


Q ss_pred             -CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         94 -RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        94 -gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                       ||+||||||+||+++.++.+||+|||+++......                                            
T Consensus       127 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--------------------------------------------  162 (288)
T cd06616         127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--------------------------------------------  162 (288)
T ss_pred             CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--------------------------------------------
Confidence             99999999999999999999999999875331100                                            


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIW  250 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIW  250 (562)
                                                                      ......||+.|+|||++.+.  ..++.++|||
T Consensus       163 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~  194 (288)
T cd06616         163 ------------------------------------------------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVW  194 (288)
T ss_pred             ------------------------------------------------ccccccCccCccCHHHhccccccCCcchhhhh
Confidence                                                            00112467889999998765  3689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|+|++|++||.....  ....+.+.........                 ...    .....+..+.+|+++||
T Consensus       195 slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-----------------~~~----~~~~~~~~l~~li~~~l  251 (288)
T cd06616         195 SLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL-----------------SNS----EEREFSPSFVNFINLCL  251 (288)
T ss_pred             HHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC-----------------CCc----CCCccCHHHHHHHHHHc
Confidence            999999999999999976542  1122222111110000                 000    00123567899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +.||++|||++++++||||+...
T Consensus       252 ~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         252 IKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCChhhCcCHHHHhcChhhhchh
Confidence            99999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.9e-32  Score=276.45  Aligned_cols=216  Identities=26%  Similarity=0.380  Sum_probs=167.3

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeC-----CEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVD-----FKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL   87 (562)
                      .....+|+.+++++ +||||+++++++...     ...|+||||+++ +|.+++..   ....+++..++.++.|++.||
T Consensus        62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  141 (291)
T cd06639          62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL  141 (291)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence            45567899999999 899999999998753     368999999975 89888753   234689999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +|||++||+||||||+||+++.++.+||+|||++.........                                     
T Consensus       142 ~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-------------------------------------  184 (291)
T cd06639         142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR-------------------------------------  184 (291)
T ss_pred             HHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc-------------------------------------
Confidence            9999999999999999999999999999999987543210000                                     


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC----CC
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK----VY  243 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~----~y  243 (562)
                                                                            ....+|+..|+|||++....    .+
T Consensus       185 ------------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~  210 (291)
T cd06639         185 ------------------------------------------------------RNTSVGTPFWMAPEVIACEQQYDYSY  210 (291)
T ss_pred             ------------------------------------------------------ccCccCCccccChhhhcCCCCccccc
Confidence                                                                  01124577788888875432    26


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      +.++||||+||++|||++|++||........+..+.+..   ....    .                   ........+.
T Consensus       211 ~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~----~-------------------~~~~~~~~l~  264 (291)
T cd06639         211 DARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PPTL----L-------------------HPEKWCRSFN  264 (291)
T ss_pred             CCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CCCC----C-------------------cccccCHHHH
Confidence            789999999999999999999998876655554442210   0000    0                   0011234688


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCcccc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      +|+.+||+.||++|||+.|+++||||+
T Consensus       265 ~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         265 HFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.3e-32  Score=277.16  Aligned_cols=216  Identities=23%  Similarity=0.332  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC------------------CCCCHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------------------VPVPPALAKSY   79 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~------------------~~l~e~~i~~i   79 (562)
                      ..+.+|+++|+.++||||+++++++...+..|+||||+.+ +|.+++....                  ..+++..+..+
T Consensus        64 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  143 (304)
T cd05096          64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHV  143 (304)
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHH
Confidence            3577999999999999999999999999999999999975 9999886532                  13677888999


Q ss_pred             HHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccc
Q psy10954         80 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  159 (562)
Q Consensus        80 ~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~Dvw  159 (562)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......                      +       
T Consensus       144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----------------------~-------  194 (304)
T cd05096         144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----------------------Y-------  194 (304)
T ss_pred             HHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCce----------------------e-------
Confidence            99999999999999999999999999999999999999998754321000                      0       


Q ss_pred             cccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC
Q psy10954        160 SAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG  239 (562)
Q Consensus       160 SlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~  239 (562)
                                                                                  .......+|..|+|||++.+
T Consensus       195 ------------------------------------------------------------~~~~~~~~~~~y~aPE~~~~  214 (304)
T cd05096         195 ------------------------------------------------------------RIQGRAVLPIRWMAWECILM  214 (304)
T ss_pred             ------------------------------------------------------------EecCcCCCCccccCHHHHhc
Confidence                                                                        00011245778999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC
Q psy10954        240 AKVYSTTVDIWSAGCIFSEMIT--KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL  317 (562)
Q Consensus       240 ~~~y~~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  317 (562)
                      .. ++.++||||+||++|||++  +..||.+.+..+.+..+...+........         . .           ..+.
T Consensus       215 ~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~-----------~~~~  272 (304)
T cd05096         215 GK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY---------L-F-----------RPPP  272 (304)
T ss_pred             CC-CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc---------c-c-----------CCCC
Confidence            54 8999999999999999986  56788876655544443322110000000         0 0           0012


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        318 PDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+..+.+|+.+||+.||++|||+.|+.+
T Consensus       273 ~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         273 CPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            2457899999999999999999999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6e-32  Score=279.66  Aligned_cols=212  Identities=25%  Similarity=0.410  Sum_probs=173.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+++++.++|||++++++++..+...|+||||+.++|.+.+......+++..+..++.|++.||.|||++||+||
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (317)
T cd06635          70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR  149 (317)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            45788999999999999999999999999999999999999888887666679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||++.....                                                    
T Consensus       150 dL~p~Nil~~~~~~~kl~dfg~~~~~~~----------------------------------------------------  177 (317)
T cd06635         150 DIKAGNILLTEPGQVKLADFGSASIASP----------------------------------------------------  177 (317)
T ss_pred             CCCcccEEECCCCCEEEecCCCccccCC----------------------------------------------------
Confidence            9999999999999999999997542210                                                    


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                 .....|++.|+|||.+.+  .+.++.++|+||+||++
T Consensus       178 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil  214 (317)
T cd06635         178 -------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  214 (317)
T ss_pred             -------------------------------------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHH
Confidence                                                       001245677899998752  34478899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|++||.+......+..+......+                    .       .....++.+.+++.+||+.||.+
T Consensus       215 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~-------~~~~~~~~l~~li~~~l~~~p~~  267 (317)
T cd06635         215 IELAERKPPLFNMNAMSALYHIAQNESPT--------------------L-------QSNEWSDYFRNFVDSCLQKIPQD  267 (317)
T ss_pred             HHHHhCCCCCCCccHHHHHHHHHhccCCC--------------------C-------CCccccHHHHHHHHHHccCCccc
Confidence            99999999998876665555554321100                    0       00112456899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||+.++++|+|+...
T Consensus       268 Rpt~~~il~~~~~~~~  283 (317)
T cd06635         268 RPTSEELLKHMFVLRE  283 (317)
T ss_pred             CcCHHHHHhChhhhcc
Confidence            9999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.5e-32  Score=273.14  Aligned_cols=210  Identities=23%  Similarity=0.341  Sum_probs=167.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLYQ   82 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~q   82 (562)
                      ..+.+|+.+|+.++||||+++++++......|++|||++ ++|.+++....               ..+++..+..++.|
T Consensus        53 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  132 (283)
T cd05048          53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ  132 (283)
T ss_pred             HHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHH
Confidence            456789999999999999999999999899999999997 49999986532               34788899999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         83 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        83 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      ++.||.|||++||+||||||+||+++.++.+||+|||+++.......                                 
T Consensus       133 l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~---------------------------------  179 (283)
T cd05048         133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---------------------------------  179 (283)
T ss_pred             HHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeecccccc---------------------------------
Confidence            99999999999999999999999999999999999998753311000                                 


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                              ........+|+.|+|||.+.+.. 
T Consensus       180 --------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-  202 (283)
T cd05048         180 --------------------------------------------------------YRVQSKSLLPVRWMPPEAILYGK-  202 (283)
T ss_pred             --------------------------------------------------------ccccCCCcccccccCHHHhccCc-
Confidence                                                                    00001234578899999987654 


Q ss_pred             CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHH
Q psy10954        243 YSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL  321 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  321 (562)
                      ++.++||||+||++|||++ |..||.+.+..+....+....  ..                  .        .....+..
T Consensus       203 ~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~--~~------------------~--------~~~~~~~~  254 (283)
T cd05048         203 FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ--LL------------------P--------CPEDCPAR  254 (283)
T ss_pred             CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--cC------------------C--------CcccCCHH
Confidence            8999999999999999997 999999877665444433210  00                  0        00123467


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+|+.+||..||++|||++|++++
T Consensus       255 ~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         255 VYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            8999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-32  Score=270.47  Aligned_cols=211  Identities=27%  Similarity=0.523  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+++.++||||+++++++...+..|+||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||++|++
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  123 (256)
T cd08218          44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL  123 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            4678999999999999999999999999999999999975 8999887643 3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||+|+||+++.++.++|+|||++.......                                                
T Consensus       124 h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~------------------------------------------------  155 (256)
T cd08218         124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV------------------------------------------------  155 (256)
T ss_pred             cCCCCHHHEEEcCCCCEEEeeccceeecCcch------------------------------------------------
Confidence            99999999999999999999999875332100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......|++.|+|||++.+.. ++.++|+||+||++
T Consensus       156 -------------------------------------------~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~  191 (256)
T cd08218         156 -------------------------------------------ELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVL  191 (256)
T ss_pred             -------------------------------------------hhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHH
Confidence                                                       0001124678899999987654 78899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ++|++|+.||...+..+....+...  ..+                  .        .....+..+.+++.+||+.||++
T Consensus       192 ~~l~~g~~~~~~~~~~~~~~~~~~~--~~~------------------~--------~~~~~~~~~~~li~~~l~~~p~~  243 (256)
T cd08218         192 YEMCTLKHAFEAGNMKNLVLKIIRG--SYP------------------P--------VSSHYSYDLRNLVSQLFKRNPRD  243 (256)
T ss_pred             HHHHcCCCCccCCCHHHHHHHHhcC--CCC------------------C--------CcccCCHHHHHHHHHHhhCChhh
Confidence            9999999999877766655554321  100                  0        00122467899999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      ||++.++++||||
T Consensus       244 Rp~~~~vl~~~~~  256 (256)
T cd08218         244 RPSVNSILEKNFI  256 (256)
T ss_pred             CcCHHHHhhCcCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9e-32  Score=268.47  Aligned_cols=209  Identities=25%  Similarity=0.397  Sum_probs=168.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++..++..|+||||++ ++|.+++......+++..++.++.|++.||+|||++||+
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI  122 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567899999999999999999999999999999999997 589999876555689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||+++......                ..                              
T Consensus       123 H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~----------------~~------------------------------  156 (256)
T cd05114         123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE----------------YT------------------------------  156 (256)
T ss_pred             ccccCcceEEEcCCCeEEECCCCCccccCCCc----------------ee------------------------------
Confidence            99999999999999999999999875431100                00                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||++.+.. ++.++|+||+||++
T Consensus       157 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l  191 (256)
T cd05114         157 --------------------------------------------SSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLM  191 (256)
T ss_pred             --------------------------------------------ccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHH
Confidence                                                        000112456799999987554 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |+.||.+.+..+.+..+.+.....                 .+           ...+..+.+++.+|++.||+
T Consensus       192 ~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-----------------~~-----------~~~~~~~~~li~~c~~~~p~  243 (256)
T cd05114         192 WEVFTEGKMPFEKKSNYEVVEMISRGFRLY-----------------RP-----------KLASMTVYEVMYSCWHEKPE  243 (256)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-----------------CC-----------CCCCHHHHHHHHHHccCCcc
Confidence            99999 899998887766665554311000                 00           11235688999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||++++++
T Consensus       244 ~Rps~~~l~~  253 (256)
T cd05114         244 GRPTFAELLR  253 (256)
T ss_pred             cCcCHHHHHH
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.6e-32  Score=272.80  Aligned_cols=210  Identities=20%  Similarity=0.282  Sum_probs=158.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..+...++||||+++ +|..++......+++..+..++.|++.||+|||++||+|
T Consensus        49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  128 (262)
T cd05077          49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVH  128 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeEC
Confidence            4567889999999999999999999998899999999985 788877765567999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++..+                                                               
T Consensus       129 ~dlkp~Nill~~~~~~~---------------------------------------------------------------  145 (262)
T cd05077         129 GNVCTKNILLAREGIDG---------------------------------------------------------------  145 (262)
T ss_pred             CCCCcccEEEecCCccC---------------------------------------------------------------
Confidence            99999999997654200                                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                           ...+.+|++|||++.....    ....++|..|+|||++.+...++.++||||+||++|
T Consensus       146 ---------------------~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  200 (262)
T cd05077         146 ---------------------ECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLW  200 (262)
T ss_pred             ---------------------CCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHH
Confidence                                 0011244555555433211    122356788999999876667899999999999999


Q ss_pred             HHH-hCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMI-TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLl-tG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||+ .|..||.+....+. .......                    ..         ........+.+|+.+||+.||.+
T Consensus       201 el~~~~~~p~~~~~~~~~-~~~~~~~--------------------~~---------~~~~~~~~~~~li~~cl~~dp~~  250 (262)
T cd05077         201 EICYNGEIPLKDKTLAEK-ERFYEGQ--------------------CM---------LVTPSCKELADLMTHCMNYDPNQ  250 (262)
T ss_pred             HHHhCCCCCCCCcchhHH-HHHHhcC--------------------cc---------CCCCChHHHHHHHHHHcCCChhh
Confidence            997 58888876543322 1111100                    00         00111356789999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      ||++.+++++
T Consensus       251 Rp~~~~il~~  260 (262)
T cd05077         251 RPFFRAIMRD  260 (262)
T ss_pred             CcCHHHHHHh
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.2e-32  Score=270.51  Aligned_cols=214  Identities=28%  Similarity=0.467  Sum_probs=167.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+.+++.++||||+++++++...  ..+|+||||+++ +|.+++.+.. .+++..+..++.|++.||+|||++||
T Consensus        49 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i  127 (265)
T cd06652          49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMI  127 (265)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3567899999999999999999998763  578999999975 8999887653 58899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.+||+|||+++.......            +                                 
T Consensus       128 ~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~------------~---------------------------------  162 (265)
T cd06652         128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICL------------S---------------------------------  162 (265)
T ss_pred             ecCCCCHHHEEecCCCCEEECcCccccccccccc------------c---------------------------------
Confidence            9999999999999999999999998754321000            0                                 


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 ........||..|+|||++.+.. ++.++|+||+||+
T Consensus       163 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i  198 (265)
T cd06652         163 -------------------------------------------GTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCT  198 (265)
T ss_pred             -------------------------------------------ccccccCCCCccccChhhhcCCC-CCcchhHHHHHHH
Confidence                                                       00011235788999999997754 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+......++.   ..+...                .        .....+..+.+++++|+. +|+
T Consensus       199 l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~----------------~--------~~~~~~~~~~~~i~~~l~-~p~  250 (265)
T cd06652         199 VVEMLTEKPPWAEFEAMAAIFKIA---TQPTNP----------------V--------LPPHVSDHCRDFLKRIFV-EAK  250 (265)
T ss_pred             HHHHhhCCCCCCccchHHHHHHHh---cCCCCC----------------C--------CchhhCHHHHHHHHHHhc-Chh
Confidence            999999999998765544433322   111000                0        001124568899999995 999


Q ss_pred             CCCCHHHHHcCcccc
Q psy10954        336 QRVSAKTILQHEYFN  350 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~  350 (562)
                      +|||++|+++|||++
T Consensus       251 ~Rp~~~~il~~~~~~  265 (265)
T cd06652         251 LRPSADELLRHTFVH  265 (265)
T ss_pred             hCCCHHHHhcCcccC
Confidence            999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0197|consensus

Probab=100.00  E-value=2.6e-32  Score=289.10  Aligned_cols=211  Identities=26%  Similarity=0.414  Sum_probs=171.9

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~-~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...++.+++|+++|+.|+|+|||+||+++..++.+|||||||. |+|.++++. .+..+...+...++.||++|++||.+
T Consensus       242 ~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes  321 (468)
T KOG0197|consen  242 SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES  321 (468)
T ss_pred             ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh
Confidence            3445778899999999999999999999999889999999997 699999997 44568888999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +++|||||-..||||+.+..+||+|||||+.....  .++                     .+.                
T Consensus       322 ~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~---------------------~~~----------------  362 (468)
T KOG0197|consen  322 KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYT---------------------ASE----------------  362 (468)
T ss_pred             CCccchhhhhhheeeccCceEEEcccccccccCCC--cee---------------------ecC----------------
Confidence            99999999999999999999999999999843211  110                     000                


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                         ..--..-|.|||.+.... ++.++||||+
T Consensus       363 ---------------------------------------------------~~kfPIkWtAPEa~~~~~-FS~kSDVWSF  390 (468)
T KOG0197|consen  363 ---------------------------------------------------GGKFPIKWTAPEALNYGK-FSSKSDVWSF  390 (468)
T ss_pred             ---------------------------------------------------CCCCCceecCHHHHhhCC-cccccceeeh
Confidence                                                               000133588999997655 8999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        253 GCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       253 G~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      ||+|+||+| |+.||.+.+..+.+..+-+....|.+                            ...++..-+++..|+.
T Consensus       391 GVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P----------------------------~~CP~~vY~lM~~CW~  442 (468)
T KOG0197|consen  391 GVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP----------------------------EGCPDEVYELMKSCWH  442 (468)
T ss_pred             hhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC----------------------------CCCCHHHHHHHHHHhh
Confidence            999999998 89999999998888877654322211                            1124567789999999


Q ss_pred             cCCCCCCCHHHHH
Q psy10954        332 LDPKQRVSAKTIL  344 (562)
Q Consensus       332 ~DP~~R~Ta~elL  344 (562)
                      .+|++|||.+.+.
T Consensus       443 ~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  443 EDPEDRPTFETLR  455 (468)
T ss_pred             CCcccCCCHHHHH
Confidence            9999999998654

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.6e-32  Score=268.13  Aligned_cols=211  Identities=29%  Similarity=0.459  Sum_probs=169.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+.++||||+++++.+..+...++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i  122 (256)
T cd08220          43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI  122 (256)
T ss_pred             HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34678999999999999999999999999999999999975 9999997653 348999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         96 IHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        96 iHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      +|+||||+||+++.++ .+||+|||++.......                                              
T Consensus       123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~----------------------------------------------  156 (256)
T cd08220         123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----------------------------------------------  156 (256)
T ss_pred             ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----------------------------------------------
Confidence            9999999999998654 57999999865432100                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    .....+|+..|+|||.+.+.. ++.++|+||+||
T Consensus       157 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~  189 (256)
T cd08220         157 ----------------------------------------------KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGC  189 (256)
T ss_pred             ----------------------------------------------cccccccCCcccCchhccCCC-CCcccchHHHHH
Confidence                                                          001124678899999987654 788999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|+.||.+.+.......+......+                            .....++.+.+++.+||..||
T Consensus       190 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p  241 (256)
T cd08220         190 VLYELASLKRAFEAANLPALVLKIMSGTFAP----------------------------ISDRYSPDLRQLILSMLNLDP  241 (256)
T ss_pred             HHHHHHhCCCCcccCchHHHHHHHHhcCCCC----------------------------CCCCcCHHHHHHHHHHccCCh
Confidence            9999999999998876655444443211000                            001124578999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy10954        335 KQRVSAKTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f  349 (562)
                      ++|||+.|+++||||
T Consensus       242 ~~Rpt~~~ll~~p~~  256 (256)
T cd08220         242 SKRPQLSQIMAQPIC  256 (256)
T ss_pred             hhCCCHHHHhhCCCC
Confidence            999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.1e-32  Score=275.01  Aligned_cols=214  Identities=27%  Similarity=0.402  Sum_probs=164.6

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEE-----eCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIP-----VDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~-----~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~   88 (562)
                      ..+.+|+.+++.+ +||||+++++++.     .+...|+||||+++ +|.+++..   ....+++..++.++.|++.||.
T Consensus        59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~  138 (286)
T cd06638          59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ  138 (286)
T ss_pred             HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence            4567899999999 7999999999874     34679999999975 89888753   2345899999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||+++|+||||||+||+++.++.+||+|||+++........                                      
T Consensus       139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--------------------------------------  180 (286)
T cd06638         139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--------------------------------------  180 (286)
T ss_pred             HHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCc--------------------------------------
Confidence            999999999999999999999999999999987543210000                                      


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYS  244 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~  244 (562)
                                                                           ....+||+.|+|||++.+    ...|+
T Consensus       181 -----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~  207 (286)
T cd06638         181 -----------------------------------------------------RNTSVGTPFWMAPEVIACEQQLDSTYD  207 (286)
T ss_pred             -----------------------------------------------------cccccCCCcccChhhhchhhhcccccc
Confidence                                                                 011246788888888753    23478


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      .++||||+||++|||++|+.||.+......+..+...  .+.                  ...      .-...+..+.+
T Consensus       208 ~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~------------------~~~------~~~~~~~~~~~  261 (286)
T cd06638         208 ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP------------------TLH------QPELWSNEFND  261 (286)
T ss_pred             chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC------------------ccc------CCCCcCHHHHH
Confidence            8999999999999999999999876654433322110  000                  000      00112456899


Q ss_pred             HHHHccccCCCCCCCHHHHHcCccc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      |+.+||+.||++|||+.|+++|+||
T Consensus       262 li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         262 FIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHccCCcccCCCHHHHhhcccC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.7e-32  Score=268.78  Aligned_cols=211  Identities=28%  Similarity=0.483  Sum_probs=169.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++++.++||||+++++.+......|+|+||+.+ +|.+++..... .+++..++.++.|++.||.|||+++++
T Consensus        44 ~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  123 (257)
T cd08225          44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL  123 (257)
T ss_pred             HHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567999999999999999999999999999999999975 99998866443 489999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCC-eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         97 HRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        97 HRDLKP~NILl~~~~~-vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |+||||+||+++.++. +||+|||.+.......                                               
T Consensus       124 H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-----------------------------------------------  156 (257)
T cd08225         124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-----------------------------------------------  156 (257)
T ss_pred             cccCCHHHEEEcCCCCeEEecccccchhccCCc-----------------------------------------------
Confidence            9999999999988764 6999999765332100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......|++.|+|||++.+.. ++.++|+||+||+
T Consensus       157 --------------------------------------------~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~i  191 (257)
T cd08225         157 --------------------------------------------ELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCV  191 (257)
T ss_pred             --------------------------------------------ccccccCCCccccCHHHHcCCC-CCchhhHHHHHHH
Confidence                                                        0001124688899999987654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ++||++|..||.+.+..+....+....  .                  +        ...+..+..+.+++.+||..+|+
T Consensus       192 l~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------~--------~~~~~~~~~~~~~i~~~l~~~p~  243 (257)
T cd08225         192 LYELCTLKHPFEGNNLHQLVLKICQGY--F------------------A--------PISPNFSRDLRSLISQLFKVSPR  243 (257)
T ss_pred             HHHHHhCCCCCCCccHHHHHHHHhccc--C------------------C--------CCCCCCCHHHHHHHHHHhccChh
Confidence            999999999998776555444332210  0                  0        01122346789999999999999


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||+.|+++||||
T Consensus       244 ~Rpt~~~ll~~~~~  257 (257)
T cd08225         244 DRPSITSILKRPFL  257 (257)
T ss_pred             hCcCHHHHhhCCCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-31  Score=266.66  Aligned_cols=211  Identities=28%  Similarity=0.478  Sum_probs=170.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++++......|+||||+++ +|.+++.+.. .+++..+..++.|++.||.|||++||+|
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H  125 (258)
T cd06632          47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVH  125 (258)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4578999999999999999999999999999999999975 8999987653 5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.+||+|||++.......                                                 
T Consensus       126 ~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-------------------------------------------------  156 (258)
T cd06632         126 RDIKGANILVDTNGVVKLADFGMAKQVVEFS-------------------------------------------------  156 (258)
T ss_pred             CCCCHHHEEECCCCCEEEccCccceeccccc-------------------------------------------------
Confidence            9999999999999999999999865331100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......|+..|+|||.+.....++.++|+||+||++|
T Consensus       157 -------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~  193 (258)
T cd06632         157 -------------------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVL  193 (258)
T ss_pred             -------------------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHH
Confidence                                                       0012346788999999865444789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||......+....+......+                   .        .....++.+.+++++||+.||.+|
T Consensus       194 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~--------~~~~~~~~~~~li~~~l~~~p~~R  246 (258)
T cd06632         194 EMATGKPPWSQLEGVAAVFKIGRSKELP-------------------P--------IPDHLSDEAKDFILKCLQRDPSLR  246 (258)
T ss_pred             HHHhCCCCcccCcHHHHHHHHHhcccCC-------------------C--------cCCCcCHHHHHHHHHHhhcCcccC
Confidence            9999999998766544443332110000                   0        111235678999999999999999


Q ss_pred             CCHHHHHcCccc
Q psy10954        338 VSAKTILQHEYF  349 (562)
Q Consensus       338 ~Ta~elL~Hp~f  349 (562)
                      ||+.++++|||+
T Consensus       247 p~~~~~l~~~~~  258 (258)
T cd06632         247 PTAAELLEHPFV  258 (258)
T ss_pred             cCHHHHhcCCCC
Confidence            999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.5e-32  Score=267.71  Aligned_cols=209  Identities=26%  Similarity=0.393  Sum_probs=164.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++......|+||||+.+ +|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  117 (252)
T cd05084          38 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH  117 (252)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4678999999999999999999999999999999999975 999998766556899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++.....  ..                     ..                       
T Consensus       118 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~---------------------~~-----------------------  151 (252)
T cd05084         118 RDLAARNCLVTEKNVLKISDFGMSREEEDG--VY---------------------AS-----------------------  151 (252)
T ss_pred             cccchheEEEcCCCcEEECccccCcccccc--cc---------------------cc-----------------------
Confidence            999999999999999999999987532100  00                     00                       


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+.. ++.++||||+||++|
T Consensus       152 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~  187 (252)
T cd05084         152 -------------------------------------------TGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLW  187 (252)
T ss_pred             -------------------------------------------cCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHH
Confidence                                                       000011245699999987654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |.+||...+.......+......+                            .....+..+.+|+.+||+.||++
T Consensus       188 e~~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~  239 (252)
T cd05084         188 EAFSLGAVPYANLSNQQTREAIEQGVRLP----------------------------CPELCPDAVYRLMERCWEYDPGQ  239 (252)
T ss_pred             HHHhCCCCCccccCHHHHHHHHHcCCCCC----------------------------CcccCCHHHHHHHHHHcCCChhh
Confidence            9997 889997666544333332110000                            00112457899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.++++
T Consensus       240 Rps~~~~~~  248 (252)
T cd05084         240 RPSFSTVHQ  248 (252)
T ss_pred             CcCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-31  Score=273.48  Aligned_cols=210  Identities=23%  Similarity=0.358  Sum_probs=167.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC------------CCCCHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP------------VPVPPALAKSYLYQLL   84 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~------------~~l~e~~i~~i~~qll   84 (562)
                      ...+.+|+++|++++||||+++++++......|+||||+. ++|.+++....            ..+++..+..++.|++
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~  130 (288)
T cd05093          51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA  130 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHH
Confidence            3457899999999999999999999999999999999997 59999987543            2489999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      .||+|||++|++||||||+|||++.++.+||+|||+++.......                      .            
T Consensus       131 ~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~----------------------~------------  176 (288)
T cd05093         131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY----------------------Y------------  176 (288)
T ss_pred             HHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCce----------------------e------------
Confidence            999999999999999999999999999999999998753321000                      0            


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                                             .......++..|+|||++.+. .++
T Consensus       177 -------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~-~~~  200 (288)
T cd05093         177 -------------------------------------------------------RVGGHTMLPIRWMPPESIMYR-KFT  200 (288)
T ss_pred             -------------------------------------------------------ecCCCCCccccccCHHHhccC-CCC
Confidence                                                                   000122456789999998764 489


Q ss_pred             chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        245 TTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       245 ~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      .++||||+||++|+|++ |.+||.+....+.+..+......                    .        .....+..+.
T Consensus       201 ~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~--------------------~--------~~~~~~~~l~  252 (288)
T cd05093         201 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL--------------------Q--------RPRTCPKEVY  252 (288)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC--------------------C--------CCCCCCHHHH
Confidence            99999999999999998 99999887766555554321100                    0        0012346789


Q ss_pred             HHHHHccccCCCCCCCHHHHHc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      +|+.+||+.||.+|||+.|+++
T Consensus       253 ~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         253 DLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-31  Score=269.85  Aligned_cols=218  Identities=27%  Similarity=0.514  Sum_probs=171.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++.....+++||||+.+ +|.++++.. ..+++..++.++.|++.||.|||++|++|
T Consensus        53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  131 (272)
T cd06629          53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILH  131 (272)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence            3467899999999999999999999999999999999975 899998765 46899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.++|+|||+++......                        ..                       
T Consensus       132 ~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------------------------~~-----------------------  164 (272)
T cd06629         132 RDLKADNLLVDADGICKISDFGISKKSDDIY------------------------DN-----------------------  164 (272)
T ss_pred             cCCChhhEEEcCCCeEEEeeccccccccccc------------------------cc-----------------------
Confidence            9999999999999999999999875321000                        00                       


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-CCCchhhHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIF  256 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-~y~~~~DIWSlG~il  256 (562)
                                                                .......|+..|+|||++.+.. .++.++|+||+||++
T Consensus       165 ------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l  202 (272)
T cd06629         165 ------------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV  202 (272)
T ss_pred             ------------------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence                                                      0001234678899999987643 478999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ++|++|..||......+.+..+......+                .++.       ......+..+.+++.+||..||++
T Consensus       203 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~  259 (272)
T cd06629         203 LEMFAGRRPWSDEEAIAAMFKLGNKRSAP----------------PIPP-------DVSMNLSPVALDFLNACFTINPDN  259 (272)
T ss_pred             HHHHhCCCCCcCcchHHHHHHhhccccCC----------------cCCc-------cccccCCHHHHHHHHHHhcCChhh
Confidence            99999999997665554443322110000                0000       011223567899999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      |||++++|+||||
T Consensus       260 Rps~~~il~~~~~  272 (272)
T cd06629         260 RPTARELLQHPFI  272 (272)
T ss_pred             CCCHHHHhhCCCC
Confidence            9999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0590|consensus

Probab=100.00  E-value=4.7e-34  Score=318.56  Aligned_cols=313  Identities=30%  Similarity=0.500  Sum_probs=252.3

Q ss_pred             hHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCc
Q psy10954         20 TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-QTTPVPVPPALAKSYLYQLLEALRYCH-SRRI   95 (562)
Q Consensus        20 ~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i-~~~~~~l~e~~i~~i~~qll~aL~yLH-~~gI   95 (562)
                      .+..|..+-+.+. |+|++++++........+++++|..+ +++..+ .......+...+..++.|+..|+.|+| ..++
T Consensus        66 ~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~  145 (601)
T KOG0590|consen   66 HIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGV  145 (601)
T ss_pred             hcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccccc
Confidence            3445777777776 99999999999999999999999865 888877 433225777888999999999999999 9999


Q ss_pred             eeccCCCCcEEEccCC-CeeEeeccccccccc-c--Ccccceeee-eccCCccceeccccccccccccccccccchhh--
Q psy10954         96 IHRDLKPQNILINKSG-ALKLADFGLSRAFTI-P--MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM--  168 (562)
Q Consensus        96 iHRDLKP~NILl~~~~-~vKL~DFGla~~~~~-~--~~~~~~~~~-t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em--  168 (562)
                      .|||+||+|.+++..+ .+|+.|||+|..+.. .  .......++ ++.|+|||...+........|+||.|+++.-+  
T Consensus       146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~  225 (601)
T KOG0590|consen  146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT  225 (601)
T ss_pred             ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc
Confidence            9999999999999999 999999999987754 2  222345578 99999999998876677888999988554322  


Q ss_pred             --------------------------------------------------------------------------------
Q psy10954        169 --------------------------------------------------------------------------------  168 (562)
Q Consensus       169 --------------------------------------------------------------------------------  168 (562)
                                                                                                      
T Consensus       226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~  305 (601)
T KOG0590|consen  226 GELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADS  305 (601)
T ss_pred             CCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q psy10954        169 --------------------------------------------------------------------------------  168 (562)
Q Consensus       169 --------------------------------------------------------------------------------  168 (562)
                                                                                                      
T Consensus       306 ~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e  385 (601)
T KOG0590|consen  306 LTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIE  385 (601)
T ss_pred             cccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhh
Confidence                                                                                            


Q ss_pred             --------------------------------------hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecc
Q psy10954        169 --------------------------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG  210 (562)
Q Consensus       169 --------------------------------------~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFG  210 (562)
                                                            .+++|++.||+|+|++||.|||+||+|++++.+|.+||+|||
T Consensus       386 ~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  386 TLDIVQEIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hHHHHhhcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence                                                  247899999999999999999999999999999999999999


Q ss_pred             cccccccCCCc----ccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy10954        211 LSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH  286 (562)
Q Consensus       211 la~~~~~~~~~----~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~  286 (562)
                      .+..+..+...    ....+|+..|+|||++.+...-...+||||.|+++..|.+|+.||.-....+..+.-        
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--------  537 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--------  537 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--------
Confidence            99988766543    456789999999999998886677899999999999999999999765433222100        


Q ss_pred             CCCCCCCCCCCCccCCCCCCC--ccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        287 EDVWPGVSKLPIYKTDFPEWR--PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                                    .....+.  ......++...+...+.+|.+||+.||.+|+|++++++.+||+.+..
T Consensus       538 --------------~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  538 --------------NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --------------hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                          0000110  01112244445567889999999999999999999999999998763

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.1e-32  Score=273.38  Aligned_cols=213  Identities=27%  Similarity=0.435  Sum_probs=171.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++.+..+...|+||||+++ +|.+++...  .+++..+..++.|++.||+|||+++++|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH  124 (277)
T cd06640          47 EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIH  124 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            4577899999999999999999999999999999999975 899988653  5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||+|+||+++.++.++|+|||++.......                                                 
T Consensus       125 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------------  155 (277)
T cd06640         125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-------------------------------------------------  155 (277)
T ss_pred             cCCChhhEEEcCCCCEEEcccccceeccCCc-------------------------------------------------
Confidence            9999999999999999999999875332100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......++..|+|||++.+.. ++.++|+||+||++|
T Consensus       156 ------------------------------------------~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~  192 (277)
T cd06640         156 ------------------------------------------IKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAI  192 (277)
T ss_pred             ------------------------------------------cccccccCcccccCHhHhccCC-CccHHHHHHHHHHHH
Confidence                                                      0001124678899999987654 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|.+||.+.........+...  .+                  +.        .....+..+.+++.+||+.||++|
T Consensus       193 el~tg~~p~~~~~~~~~~~~~~~~--~~------------------~~--------~~~~~~~~~~~li~~~l~~~p~~R  244 (277)
T cd06640         193 ELAKGEPPNSDMHPMRVLFLIPKN--NP------------------PT--------LTGEFSKPFKEFIDACLNKDPSFR  244 (277)
T ss_pred             HHHHCCCCCCCcChHhHhhhhhcC--CC------------------CC--------CchhhhHHHHHHHHHHcccCcccC
Confidence            999999999876654433222110  00                  00        111224568899999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      ||+.++++|+||.+..
T Consensus       245 p~~~~il~~~~~~~~~  260 (277)
T cd06640         245 PTAKELLKHKFIVKNA  260 (277)
T ss_pred             cCHHHHHhChHhhhcc
Confidence            9999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-31  Score=276.92  Aligned_cols=212  Identities=25%  Similarity=0.429  Sum_probs=171.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+++++.++|+|++++++++......|+||||+.++|.+++......+++..+..++.|++.||.|||++|++||
T Consensus        60 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~  139 (308)
T cd06634          60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  139 (308)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            35678999999999999999999999999999999999989888886655678999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||++......                                                   
T Consensus       140 dl~p~nil~~~~~~~kl~dfg~~~~~~~~---------------------------------------------------  168 (308)
T cd06634         140 DVKAGNILLSEPGLVKLGDFGSASIMAPA---------------------------------------------------  168 (308)
T ss_pred             CCCHHhEEECCCCcEEECCcccceeecCc---------------------------------------------------
Confidence            99999999999999999999986432100                                                   


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                  ....||+.|+|||.+.+  ...++.++||||+||++
T Consensus       169 --------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il  204 (308)
T cd06634         169 --------------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  204 (308)
T ss_pred             --------------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHH
Confidence                                                        01245778999998753  23478899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|..||.+.+..+.+..+.....                    +..       .....+..+.+||.+||..+|++
T Consensus       205 ~el~~g~~p~~~~~~~~~~~~~~~~~~--------------------~~~-------~~~~~~~~~~~li~~cl~~~P~~  257 (308)
T cd06634         205 IELAERKPPLFNMNAMSALYHIAQNES--------------------PAL-------QSGHWSEYFRNFVDSCLQKIPQD  257 (308)
T ss_pred             HHHHcCCCCCccccHHHHHHHHhhcCC--------------------CCc-------CcccccHHHHHHHHHHhhCCccc
Confidence            999999999987665554444332110                    000       00123456889999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++++++|||+...
T Consensus       258 Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         258 RPTSEVLLKHRFVLRE  273 (308)
T ss_pred             CCCHHHHhhCcccccc
Confidence            9999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3e-32  Score=272.37  Aligned_cols=215  Identities=27%  Similarity=0.454  Sum_probs=172.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gI   95 (562)
                      ...+.+|++++++++||||+++++.+......|+|+||++ ++|.+++......+++..+..++.|++.||+|||+ .|+
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i  122 (265)
T cd06605          43 QKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI  122 (265)
T ss_pred             HHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCe
Confidence            3457899999999999999999999999999999999998 59999998765679999999999999999999999 999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.+||+|||.+.......                                               
T Consensus       123 ~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----------------------------------------------  155 (265)
T cd06605         123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----------------------------------------------  155 (265)
T ss_pred             ecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----------------------------------------------
Confidence            999999999999999999999999864321000                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                    .....++..|+|||.+.+. .++.++|+||+||+
T Consensus       156 ----------------------------------------------~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~  188 (265)
T cd06605         156 ----------------------------------------------AKTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLS  188 (265)
T ss_pred             ----------------------------------------------hhcccCChhccCHHHHcCC-CCCchhhHHHHHHH
Confidence                                                          0002457789999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        256 FSEMITKKTLFAGDS-----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       256 l~eLltG~~pF~~~~-----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      +|+|++|..||....     ..+.+..+..   ....                 ....       ...+..+.++|.+||
T Consensus       189 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-----------------~~~~-------~~~~~~~~~li~~~l  241 (265)
T cd06605         189 LIELATGRFPYPPENDPPDGIFELLQYIVN---EPPP-----------------RLPS-------GKFSPDFQDFVNLCL  241 (265)
T ss_pred             HHHHHhCCCCCCccccccccHHHHHHHHhc---CCCC-----------------CCCh-------hhcCHHHHHHHHHHc
Confidence            999999999997542     2222222221   1000                 0000       003567899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ..||++|||+.+++.||||+..+
T Consensus       242 ~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         242 IKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             CCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=3.6e-33  Score=323.59  Aligned_cols=223  Identities=18%  Similarity=0.221  Sum_probs=170.8

Q ss_pred             HHHccCC-CCcceEEEEE-------EeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         27 VLKELKH-PNVIRLHDVI-------PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        27 iL~~l~H-pnIv~L~~~~-------~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      -++.++| +||+.++++|       .....++++|||++.+|.+++......+++..++.+++||+.||+|||++|||||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             ccchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            3466777 6999999988       2334688999999999999997655679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||||+..|.+|++|||++.....                                                    
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~----------------------------------------------------  132 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGS----------------------------------------------------  132 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccc----------------------------------------------------
Confidence            9999999999999999999998642210                                                    


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCC----------------CcccccccCCCccchhhhcCCCC
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM----------------NRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~----------------~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                          +.++.+|++|||+++......                ......+||++|||||++.+.. 
T Consensus       133 --------------------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-  191 (793)
T PLN00181        133 --------------------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-  191 (793)
T ss_pred             --------------------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-
Confidence                                123568999999997542100                0112247899999999998765 


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      |+.++||||+||++|||++|.+||.....  .+..+.... .++                           ......+..
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~---------------------------~~~~~~~~~  241 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPP---------------------------QILLNWPKE  241 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cCh---------------------------hhhhcCHHH
Confidence            89999999999999999999888754321  111111110 000                           000112456


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .+++.+||+.||.+|||+.|+|+||||.+.
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            789999999999999999999999999764

>KOG0584|consensus

Probab=100.00  E-value=1.3e-32  Score=295.02  Aligned_cols=216  Identities=28%  Similarity=0.453  Sum_probs=173.4

Q ss_pred             cCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCE--EEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~--i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      .+...++++.|+.+|+.|+|||||++|+++.+..+  +.+|+|.+. |+|..++++.+ ......++.+++|||+||.||
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yL  159 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYL  159 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhh
Confidence            33445789999999999999999999999987654  899999996 69999998765 588889999999999999999


Q ss_pred             HHC--CceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         91 HSR--RIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        91 H~~--gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      |++  .|||||||.+||+|+.+ |.|||+|.|||....                                          
T Consensus       160 Hs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r------------------------------------------  197 (632)
T KOG0584|consen  160 HSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR------------------------------------------  197 (632)
T ss_pred             hcCCCCccccccccceEEEcCCcCceeecchhHHHHhh------------------------------------------
Confidence            998  58888888888888743 666666666664332                                          


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                       .  ....+.+|||.|||||++-  ..|+..+
T Consensus       198 -------------------------------------------------~--s~aksvIGTPEFMAPEmYE--E~YnE~V  224 (632)
T KOG0584|consen  198 -------------------------------------------------K--SHAKSVIGTPEFMAPEMYE--ENYNELV  224 (632)
T ss_pred             -------------------------------------------------c--cccceeccCccccChHHHh--hhcchhh
Confidence                                                             1  1123458999999999995  5699999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      ||||||..+.||+|+..||.-.....++++-+.. |..                      |..   +....++.+++||.
T Consensus       225 DVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiK----------------------P~s---l~kV~dPevr~fIe  278 (632)
T KOG0584|consen  225 DVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIK----------------------PAA---LSKVKDPEVREFIE  278 (632)
T ss_pred             hhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCC----------------------HHH---hhccCCHHHHHHHH
Confidence            9999999999999999999877666665544321 111                      111   22445899999999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCC
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +||.. .++|+||.|+|+||||..-
T Consensus       279 kCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  279 KCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHhcC-chhccCHHHHhhChhhccc
Confidence            99999 9999999999999999874

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.6e-32  Score=272.78  Aligned_cols=216  Identities=24%  Similarity=0.425  Sum_probs=166.0

Q ss_pred             hhHHHHHHH-HHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy10954         19 STALREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR-   93 (562)
Q Consensus        19 ~~~~rEi~i-L~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~-   93 (562)
                      .....|+.+ ++.++||||+++++++..++.+|+||||++++|.+++..   ....+++..+..++.|++.||+|||++ 
T Consensus        44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  123 (283)
T cd06617          44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL  123 (283)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            345667775 566799999999999999999999999999988887754   234589999999999999999999997 


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      +++||||||+||+++.++.+||+|||+++......                                             
T Consensus       124 ~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---------------------------------------------  158 (283)
T cd06617         124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---------------------------------------------  158 (283)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeeccccccccccc---------------------------------------------
Confidence            99999999999999999999999999875331100                                             


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC---CCCCchhhHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA---KVYSTTVDIW  250 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~---~~y~~~~DIW  250 (562)
                                                                     ......||..|+|||++.+.   ..++.++|+|
T Consensus       159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~  191 (283)
T cd06617         159 -----------------------------------------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVW  191 (283)
T ss_pred             -----------------------------------------------ccccccCCccccChhhcCCcccccccCccccch
Confidence                                                           00112456778888887542   3478899999


Q ss_pred             HHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMITKKTLFAGD-SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |+||++|+|++|+.||... ...+.+..+....  .. .              .+          ....+..+.+|+.+|
T Consensus       192 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~-~--------------~~----------~~~~~~~l~~li~~~  244 (283)
T cd06617         192 SLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SP-Q--------------LP----------AEKFSPEFQDFVNKC  244 (283)
T ss_pred             hhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--CC-C--------------CC----------ccccCHHHHHHHHHH
Confidence            9999999999999999643 2233333332210  00 0              00          001245789999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |..||++|||++++++||||....
T Consensus       245 l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         245 LKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ccCChhhCcCHHHHhcCchhhhcc
Confidence            999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-31  Score=268.41  Aligned_cols=209  Identities=22%  Similarity=0.379  Sum_probs=168.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++.....+|+||||+.+ +|.+++......+++..+..++.|++.||.|||+.|++|
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  123 (256)
T cd05113          44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH  123 (256)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4578999999999999999999999988899999999974 899998775557899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.+||+|||+++....+                +..                               
T Consensus       124 ~dl~p~nili~~~~~~kl~d~g~~~~~~~~----------------~~~-------------------------------  156 (256)
T cd05113         124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDD----------------EYT-------------------------------  156 (256)
T ss_pred             cccCcceEEEcCCCCEEECCCccceecCCC----------------cee-------------------------------
Confidence            999999999999999999999986533110                000                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+.. ++.++||||+||++|
T Consensus       157 -------------------------------------------~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~  192 (256)
T cd05113         157 -------------------------------------------SSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMW  192 (256)
T ss_pred             -------------------------------------------ecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHH
Confidence                                                       000113466799999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++ |..||...+..+....+.+....+                            .....+..+.+++.+||+.||.+
T Consensus       193 ~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~  244 (256)
T cd05113         193 EVYSLGKMPYERFNNSETVEKVSQGLRLY----------------------------RPHLASEKVYAIMYSCWHEKAEE  244 (256)
T ss_pred             HHhcCCCCCcCcCCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCccc
Confidence            9998 999998777655555443321100                            00112467899999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.+++++
T Consensus       245 Rp~~~~ll~~  254 (256)
T cd05113         245 RPTFQQLLSS  254 (256)
T ss_pred             CCCHHHHHHh
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.4e-32  Score=287.59  Aligned_cols=210  Identities=21%  Similarity=0.384  Sum_probs=163.6

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC----------------------------
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP----------------------------   68 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~----------------------------   68 (562)
                      ..+.+|+++|+.+ +|||||++++++.....+|+|||||. ++|.++++...                            
T Consensus        86 ~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (374)
T cd05106          86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK  165 (374)
T ss_pred             HHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcc
Confidence            4577999999999 89999999999999999999999997 49999885421                            


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q psy10954         69 -----------------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI  107 (562)
Q Consensus        69 -----------------------------------------~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl  107 (562)
                                                               ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~  245 (374)
T cd05106         166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL  245 (374)
T ss_pred             cccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE
Confidence                                                     237788899999999999999999999999999999999


Q ss_pred             ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCcee
Q psy10954        108 NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRII  187 (562)
Q Consensus       108 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~II  187 (562)
                      +.++.+||+|||+++........                                                         
T Consensus       246 ~~~~~~kL~DfGla~~~~~~~~~---------------------------------------------------------  268 (374)
T cd05106         246 TDGRVAKICDFGLARDIMNDSNY---------------------------------------------------------  268 (374)
T ss_pred             eCCCeEEEeeceeeeeccCCcce---------------------------------------------------------
Confidence            99999999999987543210000                                                         


Q ss_pred             ecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q psy10954        188 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLF  266 (562)
Q Consensus       188 HRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF  266 (562)
                                                      .......++..|||||++.+.. |+.++||||+||++|||++ |+.||
T Consensus       269 --------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf  315 (374)
T cd05106         269 --------------------------------VVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPY  315 (374)
T ss_pred             --------------------------------eeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCC
Confidence                                            0000113466799999997654 8999999999999999997 99999


Q ss_pred             CCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        267 AGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       267 ~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+......+..+......+                ..+           ...++.+.+++.+||+.||++|||+.++++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~----------------~~~-----------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         316 PGILVNSKFYKMVKRGYQM----------------SRP-----------DFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ccccccHHHHHHHHcccCc----------------cCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8765544444333211000                000           112467899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4e-32  Score=269.96  Aligned_cols=224  Identities=35%  Similarity=0.565  Sum_probs=177.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|++++++++||||+++++.+..+...|+||||+.+ +|.+++.+.. .+++..+..++.|++.||.|||++|++
T Consensus        37 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~  115 (265)
T cd05579          37 VDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGII  115 (265)
T ss_pred             HHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCee
Confidence            44678899999999999999999999999999999999975 9999987654 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||+|+||+++.++.+||+|||++..........               ..                            
T Consensus       116 H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------------~~----------------------------  152 (265)
T cd05579         116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN---------------LN----------------------------  152 (265)
T ss_pred             cCCCCHHHeEEcCCCCEEEEecccchhcccCcccc---------------cc----------------------------
Confidence            99999999999999999999999875432110000               00                            


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                              ..........++..|+|||.+.+.. ++.++|+||+||++
T Consensus       153 ----------------------------------------~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~  191 (265)
T cd05579         153 ----------------------------------------DDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCIL  191 (265)
T ss_pred             ----------------------------------------cccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHH
Confidence                                                    0000112235678899999997765 78999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|..||......+....+..  +...   ++             .        . ...+..+.+|+.+||+.||++
T Consensus       192 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---~~-------------~--------~-~~~~~~~~~~i~~~l~~~p~~  244 (265)
T cd05579         192 YEFLVGIPPFHGETPEEIFQNILN--GKIE---WP-------------E--------D-VEVSDEAIDLISKLLVPDPEK  244 (265)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhc--CCcC---CC-------------c--------c-ccCCHHHHHHHHHHhcCCHhh
Confidence            999999999988776555444432  1000   00             0        0 012467899999999999999


Q ss_pred             CCCH---HHHHcCccccCCc
Q psy10954        337 RVSA---KTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta---~elL~Hp~f~~~~  353 (562)
                      |||+   .++|+||||+++.
T Consensus       245 Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         245 RLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             cCCCccHHHHhcCccccCCC
Confidence            9999   9999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-31  Score=270.14  Aligned_cols=210  Identities=24%  Similarity=0.370  Sum_probs=167.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-------------CCCCHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-------------VPVPPALAKSYLYQL   83 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-------------~~l~e~~i~~i~~ql   83 (562)
                      ...+.+|+++|+.++||||+++++++......|+||||+.+ +|.+++....             ..+++..+..++.|+
T Consensus        52 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  131 (280)
T cd05049          52 RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI  131 (280)
T ss_pred             HHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHH
Confidence            35678999999999999999999999999999999999975 9999987542             247888999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         84 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        84 l~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      +.||.|||++|++||||||+||+++.++.+||+|||+++.......                                  
T Consensus       132 ~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~----------------------------------  177 (280)
T cd05049         132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY----------------------------------  177 (280)
T ss_pred             HHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcc----------------------------------
Confidence            9999999999999999999999999999999999998753211000                                  


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                   +          .......+++.|+|||++.+.. +
T Consensus       178 ---------------------------------------------~----------~~~~~~~~~~~y~aPE~~~~~~-~  201 (280)
T cd05049         178 ---------------------------------------------Y----------RVGGHTMLPIRWMPPESIMYRK-F  201 (280)
T ss_pred             ---------------------------------------------e----------ecCCCCcccceecChhhhccCC-c
Confidence                                                         0          0001123567899999997655 8


Q ss_pred             CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        244 STTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      +.++||||+||++|||++ |..||.+.+..+....+.......                            .....+..+
T Consensus       202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~  253 (280)
T cd05049         202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ----------------------------RPRTCPSEV  253 (280)
T ss_pred             chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CCCCCCHHH
Confidence            999999999999999998 999998877665554443211000                            001234678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+++.+||+.||++|||+.|+++
T Consensus       254 ~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         254 YDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-31  Score=267.28  Aligned_cols=209  Identities=22%  Similarity=0.345  Sum_probs=167.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|++++++++||||+++++++...+..|+||||+++ +|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  123 (256)
T cd05059          44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH  123 (256)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4678999999999999999999999999999999999975 899999876667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++......                ..                               
T Consensus       124 ~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~----------------~~-------------------------------  156 (256)
T cd05059         124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----------------YT-------------------------------  156 (256)
T ss_pred             ccccHhhEEECCCCcEEECCcccceeccccc----------------cc-------------------------------
Confidence            9999999999999999999999875331100                00                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+.. ++.++|+||+||++|
T Consensus       157 -------------------------------------------~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~  192 (256)
T cd05059         157 -------------------------------------------SSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMW  192 (256)
T ss_pred             -------------------------------------------ccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHH
Confidence                                                       000112345799999987654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++ |..||.+.+..+....+......+                            .....+..+.+++.+||..+|++
T Consensus       193 ~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~  244 (256)
T cd05059         193 EVFSEGKMPYERFSNSEVVESVSAGYRLY----------------------------RPKLAPTEVYTIMYSCWHEKPED  244 (256)
T ss_pred             HHhccCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CCCCCCHHHHHHHHHHhcCChhh
Confidence            9998 899998776655544443211100                            00123567899999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.|+++.
T Consensus       245 Rpt~~~~l~~  254 (256)
T cd05059         245 RPAFKKLLSQ  254 (256)
T ss_pred             CcCHHHHHHH
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.2e-32  Score=275.15  Aligned_cols=213  Identities=27%  Similarity=0.430  Sum_probs=170.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++++..+...|+||||+++ +|.+++..  ..+++..++.++.|++.||.|||++|++|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH  124 (277)
T cd06642          47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIH  124 (277)
T ss_pred             HHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence            4577999999999999999999999999999999999985 88888764  35899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.++|+|||++........                                                
T Consensus       125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------  156 (277)
T cd06642         125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQI------------------------------------------------  156 (277)
T ss_pred             cCCChheEEEeCCCCEEEccccccccccCcch------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......|+..|+|||.+.+.. ++.++|+||+||++|
T Consensus       157 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~  192 (277)
T cd06642         157 -------------------------------------------KRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAI  192 (277)
T ss_pred             -------------------------------------------hhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHH
Confidence                                                       001124678899999987654 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||...........+...  .                  .+.        .....+..+.+++.+||+.+|++|
T Consensus       193 el~tg~~p~~~~~~~~~~~~~~~~--~------------------~~~--------~~~~~~~~~~~li~~~l~~~p~~R  244 (277)
T cd06642         193 ELAKGEPPNSDLHPMRVLFLIPKN--S------------------PPT--------LEGQYSKPFKEFVEACLNKDPRFR  244 (277)
T ss_pred             HHHhCCCCCcccchhhHHhhhhcC--C------------------CCC--------CCcccCHHHHHHHHHHccCCcccC
Confidence            999999999765543332221110  0                  000        111234578899999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      ||+.++++||||....
T Consensus       245 p~~~~il~~~~~~~~~  260 (277)
T cd06642         245 PTAKELLKHKFITRYT  260 (277)
T ss_pred             cCHHHHHHhHHHHHHh
Confidence            9999999999997643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-31  Score=272.38  Aligned_cols=209  Identities=25%  Similarity=0.369  Sum_probs=166.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLYQ   82 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~q   82 (562)
                      ..+.+|+++++.++||||+++++++......++||||++ ++|.+++....               ..+++..+..++.|
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  131 (291)
T cd05094          52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ  131 (291)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHH
Confidence            457799999999999999999999999999999999997 59999987532               24789999999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         83 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        83 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      ++.||+|||++||+||||||+|||++.++.+||+|||++........                    .            
T Consensus       132 i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~--------------------~------------  179 (291)
T cd05094         132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY--------------------Y------------  179 (291)
T ss_pred             HHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCce--------------------e------------
Confidence            99999999999999999999999999999999999998753321000                    0            


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                               .......++..|+|||++.+.. 
T Consensus       180 ---------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-  201 (291)
T cd05094         180 ---------------------------------------------------------RVGGHTMLPIRWMPPESIMYRK-  201 (291)
T ss_pred             ---------------------------------------------------------ecCCCCCcceeecChHHhccCC-
Confidence                                                                     0001234678899999987654 


Q ss_pred             CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHH
Q psy10954        243 YSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL  321 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  321 (562)
                      ++.++||||+||++|||++ |..||...+..+.+..+...  ...                  .        .....+..
T Consensus       202 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~------------------~--------~~~~~~~~  253 (291)
T cd05094         202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVL------------------E--------RPRVCPKE  253 (291)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CCC------------------C--------CCccCCHH
Confidence            8899999999999999998 99999877765544433211  000                  0        00112457


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHc
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      +.+++.+||+.||++|||+.++++
T Consensus       254 ~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         254 VYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHHHcccChhhCcCHHHHHH
Confidence            889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-31  Score=275.05  Aligned_cols=215  Identities=26%  Similarity=0.471  Sum_probs=172.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++.+..++..|+||||+++ +|.+++...  .+++..++.++.|++.||+|||++|++|
T Consensus        62 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH  139 (292)
T cd06657          62 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIH  139 (292)
T ss_pred             HHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4577899999999999999999999999999999999986 888876543  5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.++|+|||++.......                                                 
T Consensus       140 ~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------------------------------------------------  170 (292)
T cd06657         140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------------------------------------------------  170 (292)
T ss_pred             CCCCHHHEEECCCCCEEEcccccceeccccc-------------------------------------------------
Confidence            9999999999999999999999764321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......||+.|+|||.+.+.. ++.++|+||+||++|
T Consensus       171 ------------------------------------------~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~  207 (292)
T cd06657         171 ------------------------------------------PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVI  207 (292)
T ss_pred             ------------------------------------------ccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHH
Confidence                                                      0001234678899999886544 789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|.+||.+....+.+..+.......                         +. .....++...+++.+||+.||.+|
T Consensus       208 el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~-~~~~~~~~l~~li~~~l~~~P~~R  261 (292)
T cd06657         208 EMVDGEPPYFNEPPLKAMKMIRDNLPPK-------------------------LK-NLHKVSPSLKGFLDRLLVRDPAQR  261 (292)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------------------cC-CcccCCHHHHHHHHHHHhCCcccC
Confidence            9999999998877665544432211000                         00 012235678899999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      +++.++++||||....
T Consensus       262 ~~~~~ll~~~~~~~~~  277 (292)
T cd06657         262 ATAAELLKHPFLAKAG  277 (292)
T ss_pred             cCHHHHhcChHHhccC
Confidence            9999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=270.26  Aligned_cols=214  Identities=25%  Similarity=0.473  Sum_probs=170.8

Q ss_pred             hhHHHHHHHHHccC---CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~---HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+++++.++   ||||+++++++..+...|+||||+.+ +|.++++..  .+++..+..++.|++.||.|||++|
T Consensus        44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~  121 (277)
T cd06917          44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG  121 (277)
T ss_pred             HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            45778999999996   99999999999999999999999975 899888653  6899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+|+||+|+||+++.++.++|+|||++.......                                              
T Consensus       122 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~----------------------------------------------  155 (277)
T cd06917         122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS----------------------------------------------  155 (277)
T ss_pred             cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc----------------------------------------------
Confidence            9999999999999999999999999875432110                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......|+..|+|||.+.+...++.++|+||+||
T Consensus       156 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  190 (277)
T cd06917         156 ---------------------------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI  190 (277)
T ss_pred             ---------------------------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHH
Confidence                                                         00112356788999999876666789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|..||.+.........+...                    ..+....       ...+..+.+++.+||+.||
T Consensus       191 ~l~~ll~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~-------~~~~~~~~~~i~~~l~~~p  243 (277)
T cd06917         191 TIYEMATGNPPYSDVDAFRAMMLIPKS--------------------KPPRLED-------NGYSKLLREFVAACLDEEP  243 (277)
T ss_pred             HHHHHHhCCCCCCCCChhhhhhccccC--------------------CCCCCCc-------ccCCHHHHHHHHHHcCCCc
Confidence            999999999999876543322111000                    0000000       0134678999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++|||+.|+++|+||++.
T Consensus       244 ~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         244 KERLSAEELLKSKWIKAH  261 (277)
T ss_pred             ccCcCHHHHhhChHhhcc
Confidence            999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.98  E-value=1.8e-31  Score=271.65  Aligned_cols=216  Identities=22%  Similarity=0.374  Sum_probs=169.3

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHH
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------VPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------~~l~e~~i~~i~~qll~aL~y   89 (562)
                      .+.+|+.+++.++||||+++++++......|+||||+. ++|.+++....         ..++...+..++.|++.||.|
T Consensus        55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  134 (288)
T cd05061          55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY  134 (288)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999997 59999997532         124567788999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+||||||+|||++.++.+||+|||+++.......                .                       
T Consensus       135 lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~----------------~-----------------------  175 (288)
T cd05061         135 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY----------------Y-----------------------  175 (288)
T ss_pred             HHhCCCcCCCCChheEEEcCCCcEEECcCCcccccccccc----------------c-----------------------
Confidence            9999999999999999999999999999998764321000                0                       


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                        .......++..|+|||.+.+.. ++.++|+
T Consensus       176 --------------------------------------------------~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv  204 (288)
T cd05061         176 --------------------------------------------------RKGGKGLLPVRWMAPESLKDGV-FTTSSDM  204 (288)
T ss_pred             --------------------------------------------------cccCCCcccccccCHHHhccCC-CChHhHH
Confidence                                                              0001123467799999987654 7999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+||++|||++ |..||.+....+....+... +.+                   .        .....++.+.+++.+
T Consensus       205 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~-------------------~--------~~~~~~~~~~~li~~  256 (288)
T cd05061         205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYL-------------------D--------QPDNCPERVTDLMRM  256 (288)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC-------------------C--------CCCCCCHHHHHHHHH
Confidence            999999999998 78999887665544433221 000                   0        001124678999999


Q ss_pred             ccccCCCCCCCHHHHHc------CccccCCc
Q psy10954        329 IMALDPKQRVSAKTILQ------HEYFNQVE  353 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~------Hp~f~~~~  353 (562)
                      ||+.||++|||+.++++      ||||+++.
T Consensus       257 ~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         257 CWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             HcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            99999999999999886      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0696|consensus

Probab=99.98  E-value=8e-33  Score=282.91  Aligned_cols=214  Identities=26%  Similarity=0.420  Sum_probs=179.6

Q ss_pred             HHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         21 ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        21 ~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.|-++|... +-|.+++|+.+|++-+.+|+||||+.+ +|.-.|++.+ .+.|..+.+|+.+|+-||-+||++|||.|
T Consensus       396 tm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYR  474 (683)
T KOG0696|consen  396 TMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYR  474 (683)
T ss_pred             eehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeee
Confidence            45666666655 468999999999999999999999975 9988887754 68999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      |||.+|||++.+|++||+|||+++.--..                                                   
T Consensus       475 DLKLDNvmLd~eGHiKi~DFGmcKEni~~---------------------------------------------------  503 (683)
T KOG0696|consen  475 DLKLDNVMLDSEGHIKIADFGMCKENIFD---------------------------------------------------  503 (683)
T ss_pred             eccccceEeccCCceEeeecccccccccC---------------------------------------------------
Confidence            99999999999999999999997532100                                                   


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                              .....++||||.|+|||++.-.+ |+.++|+||+||+|||
T Consensus       504 ----------------------------------------~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyE  542 (683)
T KOG0696|consen  504 ----------------------------------------GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYE  542 (683)
T ss_pred             ----------------------------------------CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHH
Confidence                                                    11234678999999999987554 9999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      |+.|++||.|+++.+.++.|.+..-..                      |       ...+.+|.++...+|...|.+|+
T Consensus       543 mlaGQpPFdGeDE~elF~aI~ehnvsy----------------------P-------KslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  543 MLAGQPPFDGEDEDELFQAIMEHNVSY----------------------P-------KSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHcCCCCCCCCCHHHHHHHHHHccCcC----------------------c-------ccccHHHHHHHHHHhhcCCcccc
Confidence            999999999999999999887642211                      1       12246899999999999999999


Q ss_pred             CH-----HHHHcCccccCCcccC
Q psy10954        339 SA-----KTILQHEYFNQVEMVK  356 (562)
Q Consensus       339 Ta-----~elL~Hp~f~~~~~~~  356 (562)
                      .+     .++-.||||+.++|.+
T Consensus       594 Gcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  594 GCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             CCCCccccchhhCcchhhccHHH
Confidence            75     5899999999988755

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=1.6e-31  Score=270.09  Aligned_cols=209  Identities=23%  Similarity=0.388  Sum_probs=164.6

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC---------CCCHHHHHHHHHHHHHHHHH
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV---------PVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~---------~l~e~~i~~i~~qll~aL~y   89 (562)
                      .+.+|+.+++.++||||+++++++..+...|+||||+++ +|.+++.+...         .++...+..++.|++.||.|
T Consensus        55 ~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  134 (277)
T cd05062          55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY  134 (277)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999999999999999974 99999875321         35677889999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++|++||||||+||+++.++.+||+|||+++.......          +.                            
T Consensus       135 lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~----------~~----------------------------  176 (277)
T cd05062         135 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY----------YR----------------------------  176 (277)
T ss_pred             HHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcce----------ee----------------------------
Confidence            9999999999999999999999999999998764321000          00                            


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                         ......+++.|+|||++.+.. ++.++||
T Consensus       177 ---------------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di  204 (277)
T cd05062         177 ---------------------------------------------------KGGKGLLPVRWMSPESLKDGV-FTTYSDV  204 (277)
T ss_pred             ---------------------------------------------------cCCCCccCHhhcChhHhhcCC-cCchhHH
Confidence                                                               000123467899999997654 8999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+||++|||++ |..||.+.+..+.+..+... +.+.                           .....+..+.+++.+
T Consensus       205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~li~~  256 (277)
T cd05062         205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLLD---------------------------KPDNCPDMLFELMRM  256 (277)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC---------------------------CCCCCCHHHHHHHHH
Confidence            999999999998 78999887765554443321 1000                           001124578999999


Q ss_pred             ccccCCCCCCCHHHHHcC
Q psy10954        329 IMALDPKQRVSAKTILQH  346 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~H  346 (562)
                      ||+.||++|||+.|++++
T Consensus       257 ~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         257 CWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=2.3e-31  Score=269.66  Aligned_cols=210  Identities=23%  Similarity=0.323  Sum_probs=159.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..+...|+||||+++ +|..++......+++..+..++.|++.||+|||++||+|
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH  140 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH  140 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccC
Confidence            3567889999999999999999999999999999999985 888888765667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++...                                                               
T Consensus       141 ~dlkp~Nill~~~~~~~---------------------------------------------------------------  157 (274)
T cd05076         141 GNVCAKNILLARLGLAE---------------------------------------------------------------  157 (274)
T ss_pred             CCCCcccEEEeccCccc---------------------------------------------------------------
Confidence            99999999997543100                                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                           +..+.+|++|||++.....    .....++..|+|||.+.+...++.++||||+||++|
T Consensus       158 ---------------------~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~  212 (274)
T cd05076         158 ---------------------GTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL  212 (274)
T ss_pred             ---------------------CccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence                                 0011245566665433211    112356788999999977666899999999999999


Q ss_pred             HHH-hCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMI-TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLl-tG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||+ +|..||.+....+.. ........                  .+           ....+.+.+++.+||+.||++
T Consensus       213 el~~~g~~p~~~~~~~~~~-~~~~~~~~------------------~~-----------~~~~~~~~~li~~cl~~~p~~  262 (274)
T cd05076         213 EICFDGEVPLKERTPSEKE-RFYEKKHR------------------LP-----------EPSCKELATLISQCLTYEPTQ  262 (274)
T ss_pred             HHHhCCCCCccccChHHHH-HHHHhccC------------------CC-----------CCCChHHHHHHHHHcccChhh
Confidence            994 799999876543322 12111000                  00           011346889999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.+++++
T Consensus       263 Rps~~~il~~  272 (274)
T cd05076         263 RPSFRTILRD  272 (274)
T ss_pred             CcCHHHHHHh
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=1.3e-31  Score=266.92  Aligned_cols=208  Identities=28%  Similarity=0.482  Sum_probs=167.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+|+.+++.++||||+++++.+..+..+|+||||+++ +|.+++... ...+++..+..++.|++.||.|||++||
T Consensus        42 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i  121 (255)
T cd08219          42 VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV  121 (255)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            35677899999999999999999999999999999999974 899888653 3458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.++++|||+++.......                                              
T Consensus       122 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------  155 (255)
T cd08219         122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----------------------------------------------  155 (255)
T ss_pred             ccCCCCcceEEECCCCcEEEcccCcceeeccccc----------------------------------------------
Confidence            9999999999999999999999998753321000                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......|++.|+|||++.+.. ++.++|+||+||+
T Consensus       156 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i  189 (255)
T cd08219         156 ---------------------------------------------YACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCI  189 (255)
T ss_pred             ---------------------------------------------ccccccCCccccCHHHHccCC-cCchhhhhhhchh
Confidence                                                         001235688899999987654 8899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|..||.+.+.......+...  ...                  .        .....+..+.+|+.+||+.||+
T Consensus       190 ~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------------------~--------~~~~~~~~~~~li~~~l~~~P~  241 (255)
T cd08219         190 LYELCTLKHPFQANSWKNLILKVCQG--SYK------------------P--------LPSHYSYELRSLIKQMFKRNPR  241 (255)
T ss_pred             heehhhccCCCCCCCHHHHHHHHhcC--CCC------------------C--------CCcccCHHHHHHHHHHHhCCcc
Confidence            99999999999887765544443221  000                  0        0011245688999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.+++.
T Consensus       242 ~Rp~~~~il~  251 (255)
T cd08219         242 SRPSATTILS  251 (255)
T ss_pred             cCCCHHHHhh
Confidence            9999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=2.8e-31  Score=266.28  Aligned_cols=208  Identities=26%  Similarity=0.396  Sum_probs=164.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++|+.++||||+++++++..+..+++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~  126 (263)
T cd05052          47 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI  126 (263)
T ss_pred             HHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            457899999999999999999999999999999999997 59999986543 3589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||+++......  .                     .                       
T Consensus       127 H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~--~---------------------~-----------------------  160 (263)
T cd05052         127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--Y---------------------T-----------------------  160 (263)
T ss_pred             ecccCcceEEEcCCCcEEeCCCccccccccce--e---------------------e-----------------------
Confidence            99999999999999999999999875432100  0                     0                       


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||++.+.. ++.++||||+||++
T Consensus       161 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il  195 (263)
T cd05052         161 --------------------------------------------AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLL  195 (263)
T ss_pred             --------------------------------------------ccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHH
Confidence                                                        000112356799999887654 78999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |..||.+.+..+....+......                 ..           ....+..+.+++.+||+.||+
T Consensus       196 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~-----------~~~~~~~~~~li~~cl~~~p~  247 (263)
T cd05052         196 WEIATYGMSPYPGIDLSQVYELLEKGYRM-----------------ER-----------PEGCPPKVYELMRACWQWNPS  247 (263)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------------CC-----------CCCCCHHHHHHHHHHccCCcc
Confidence            99998 99999887655443333221100                 00           012346789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.++++
T Consensus       248 ~Rp~~~~l~~  257 (263)
T cd05052         248 DRPSFAEIHQ  257 (263)
T ss_pred             cCCCHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4721|consensus

Probab=99.98  E-value=1.3e-32  Score=290.13  Aligned_cols=212  Identities=28%  Similarity=0.427  Sum_probs=166.7

Q ss_pred             cCCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ++.+.+.--.+|+-|++|+|||||.+.++|...--+|||||||. +.|+.+++..+ .+.......+..+|+.|++|||.
T Consensus       152 VKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~  230 (904)
T KOG4721|consen  152 VKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHL  230 (904)
T ss_pred             hHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHH
Confidence            33444444467888999999999999999999999999999997 58999998765 57777888999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +.|||||||.-||||..+..|||+|||-++....-                         +                   
T Consensus       231 hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-------------------------S-------------------  266 (904)
T KOG4721|consen  231 HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-------------------------S-------------------  266 (904)
T ss_pred             hhHhhhccCCCceEeeccceEEeccccchHhhhhh-------------------------h-------------------
Confidence            99999999999999999999999999976544211                         0                   


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                      ..-+++||..|||||+|.+.+ .+.|+||||+
T Consensus       267 ------------------------------------------------TkMSFaGTVaWMAPEvIrneP-csEKVDIwSf  297 (904)
T KOG4721|consen  267 ------------------------------------------------TKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSF  297 (904)
T ss_pred             ------------------------------------------------hhhhhhhhHhhhCHHHhhcCC-cccccceehh
Confidence                                                            012468999999999998766 7999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||+||||+||..||.+-+...   -|+ ..|.....+            -.|           ...+.-++=|+++|++-
T Consensus       298 GVVLWEmLT~EiPYkdVdssA---IIw-GVGsNsL~L------------pvP-----------stcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  298 GVVLWEMLTGEIPYKDVDSSA---IIW-GVGSNSLHL------------PVP-----------STCPDGFKLLLKQCWNS  350 (904)
T ss_pred             HHHHHHHHhcCCCccccchhe---eEE-eccCCcccc------------cCc-----------ccCchHHHHHHHHHHhc
Confidence            999999999999997654321   111 111111000            000           11234577889999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy10954        333 DPKQRVSAKTILQH  346 (562)
Q Consensus       333 DP~~R~Ta~elL~H  346 (562)
                      .|..||+..++|.|
T Consensus       351 KpRNRPSFrqil~H  364 (904)
T KOG4721|consen  351 KPRNRPSFRQILLH  364 (904)
T ss_pred             CCCCCccHHHHHHH
Confidence            99999999999988

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=2.4e-31  Score=270.00  Aligned_cols=216  Identities=25%  Similarity=0.393  Sum_probs=168.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gI   95 (562)
                      ...+.+|+++++.++||||+++++.+......|+||||+++ +|.+++... +.+++..++.++.|++.||.|||+ .|+
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i  125 (284)
T cd06620          47 RKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRI  125 (284)
T ss_pred             HHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCe
Confidence            45678999999999999999999999999999999999985 888887664 368999999999999999999997 599


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||++......                                                
T Consensus       126 ~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~------------------------------------------------  157 (284)
T cd06620         126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS------------------------------------------------  157 (284)
T ss_pred             eccCCCHHHEEECCCCcEEEccCCcccchhhh------------------------------------------------
Confidence            99999999999999999999999986422100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   .....+||..|+|||++.+. .++.++|+||+||+
T Consensus       158 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~  191 (284)
T cd06620         158 ---------------------------------------------IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGIS  191 (284)
T ss_pred             ---------------------------------------------ccCccccCcccCCHHHHccC-CCCccchHHHHHHH
Confidence                                                         00113578899999998765 48899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHH-------HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        256 FSEMITKKTLFAGDSEID-------QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~-------~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      +|+|++|..||......+       .+.......-..                ..+....       ...+..+.+|+.+
T Consensus       192 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~-------~~~~~~~~~li~~  248 (284)
T cd06620         192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE----------------PPPRLPS-------SDFPEDLRDFVDA  248 (284)
T ss_pred             HHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc----------------cCCCCCc-------hhcCHHHHHHHHH
Confidence            999999999998655421       011111110000                0000000       0123568899999


Q ss_pred             ccccCCCCCCCHHHHHcCccccC
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      ||+.||++|||+.|+++|+||.+
T Consensus       249 ~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         249 CLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             HhcCCcccCcCHHHHhcCccccc
Confidence            99999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0983|consensus

Probab=99.98  E-value=2.5e-32  Score=267.63  Aligned_cols=235  Identities=21%  Similarity=0.400  Sum_probs=182.9

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-R   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~-g   94 (562)
                      ..+++++.+.++..- +.|+||+.+++|..+..+++.||.|..-+..++++-.+++||..+-.+...++.||.||.++ |
T Consensus       133 e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~  212 (391)
T KOG0983|consen  133 ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG  212 (391)
T ss_pred             HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc
Confidence            346677888777655 47999999999999999999999998777777777677899999999999999999999975 9


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+||+|||++..|.+||||||++..+.... ..                                           
T Consensus       213 viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-Ah-------------------------------------------  248 (391)
T KOG0983|consen  213 VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-AH-------------------------------------------  248 (391)
T ss_pred             eeecccCccceEEccCCCEEeecccccceeeccc-cc-------------------------------------------
Confidence            9999999999999999999999999976553210 01                                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc--CCCCCCchhhHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSA  252 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~--~~~~y~~~~DIWSl  252 (562)
                                                                      +...|-+.|||||.|-  ....|+-.+||||+
T Consensus       249 ------------------------------------------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSl  280 (391)
T KOG0983|consen  249 ------------------------------------------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSL  280 (391)
T ss_pred             ------------------------------------------------ccccCCccccCccccCCCCCCccchhhhhhhh
Confidence                                                            1123455566666552  23458999999999


Q ss_pred             HHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        253 GCIFSEMITKKTLFAGD-SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       253 G~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      |++++||+||+.||.+. .+.+.+.++++..  |                  |.+++.      ...++++.+|+..||+
T Consensus       281 GITlveLaTg~yPy~~c~tdFe~ltkvln~e--P------------------P~L~~~------~gFSp~F~~fv~~CL~  334 (391)
T KOG0983|consen  281 GITLVELATGQYPYKGCKTDFEVLTKVLNEE--P------------------PLLPGH------MGFSPDFQSFVKDCLT  334 (391)
T ss_pred             ccchhhhhcccCCCCCCCccHHHHHHHHhcC--C------------------CCCCcc------cCcCHHHHHHHHHHhh
Confidence            99999999999999985 4667777776521  1                  111110      0135789999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCcccCCccccCCCCCCCCCCCCCchHHHHHHHHH
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKT  385 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (562)
                      .|+.+||.-.++|+|||+...+.                .-.|...|..+.+..
T Consensus       335 kd~r~RP~Y~~Ll~h~Fi~~ye~----------------a~~dVa~WF~dV~~~  372 (391)
T KOG0983|consen  335 KDHRKRPKYNKLLEHPFIKRYET----------------AEVDVASWFKDVMAK  372 (391)
T ss_pred             cCcccCcchHHHhcCcceeecch----------------hhccHHHHHHHHHhc
Confidence            99999999999999999987652                224566777776553

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.98  E-value=2e-31  Score=264.91  Aligned_cols=211  Identities=30%  Similarity=0.484  Sum_probs=168.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH-
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH-   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH-   91 (562)
                      ....+|+++++.++||||+++++.+..  +...|++|||+++ +|.+++...   ...+++..+..++.|++.||.||| 
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~  123 (265)
T cd08217          44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN  123 (265)
T ss_pred             HHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhc
Confidence            356789999999999999999998754  4578999999975 899988653   346899999999999999999999 


Q ss_pred             ----HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         92 ----SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        92 ----~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                          +.+++|+||||+||+++.++.+||+|||++.......                                       
T Consensus       124 ~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---------------------------------------  164 (265)
T cd08217         124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS---------------------------------------  164 (265)
T ss_pred             CccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc---------------------------------------
Confidence                8999999999999999999999999999875432100                                       


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                          .......|++.|+|||++.+.. ++.++
T Consensus       165 ----------------------------------------------------~~~~~~~~~~~~~~pE~~~~~~-~~~~~  191 (265)
T cd08217         165 ----------------------------------------------------SFAKTYVGTPYYMSPEQLNHMS-YDEKS  191 (265)
T ss_pred             ----------------------------------------------------ccccccccCCCccChhhhcCCC-CCchh
Confidence                                                                0001235688899999987655 78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |+||+||++++|++|..||.+.+..+....+...  ..                  +.        +....+..+.+++.
T Consensus       192 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------~~--------~~~~~~~~~~~l~~  243 (265)
T cd08217         192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KF------------------RR--------IPYRYSSELNEVIK  243 (265)
T ss_pred             HHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--CC------------------CC--------CccccCHHHHHHHH
Confidence            9999999999999999999887644433333211  00                  00        01123467899999


Q ss_pred             HccccCCCCCCCHHHHHcCccc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      +||+.||++|||+.++++|||+
T Consensus       244 ~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         244 SMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHccCCcccCCCHHHHhhCCCC
Confidence            9999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.98  E-value=1.6e-31  Score=284.00  Aligned_cols=211  Identities=23%  Similarity=0.361  Sum_probs=164.7

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC----------------------------
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP----------------------------   68 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~----------------------------   68 (562)
                      ..+.+|+.+|+.+ +||||+++++++..++..|+|||||+ ++|.++++...                            
T Consensus        83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (375)
T cd05104          83 EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC  162 (375)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence            4578999999999 89999999999999999999999997 49998886432                            


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy10954         69 ----------------------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKP  102 (562)
Q Consensus        69 ----------------------------------------------~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP  102 (562)
                                                                    ..+++..+..++.|++.||.|||++||+||||||
T Consensus       163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  242 (375)
T cd05104         163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA  242 (375)
T ss_pred             hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence                                                          1367888999999999999999999999999999


Q ss_pred             CcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhh
Q psy10954        103 QNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH  182 (562)
Q Consensus       103 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLH  182 (562)
                      +|||++.++.+||+|||+++........                                                    
T Consensus       243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~----------------------------------------------------  270 (375)
T cd05104         243 RNILLTHGRITKICDFGLARDIRNDSNY----------------------------------------------------  270 (375)
T ss_pred             hhEEEECCCcEEEecCccceeccCcccc----------------------------------------------------
Confidence            9999999999999999987643210000                                                    


Q ss_pred             cCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh-
Q psy10954        183 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-  261 (562)
Q Consensus       183 s~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt-  261 (562)
                                                           .......++..|+|||++.+.. ++.++||||+||++|||++ 
T Consensus       271 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~  312 (375)
T cd05104         271 -------------------------------------VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSL  312 (375)
T ss_pred             -------------------------------------cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhc
Confidence                                                 0000123466799999997654 8999999999999999997 


Q ss_pred             CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHH
Q psy10954        262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK  341 (562)
Q Consensus       262 G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~  341 (562)
                      |..||.+......+.+.+.....+                ..           ....+..+.+|+.+||+.||++|||+.
T Consensus       313 g~~p~~~~~~~~~~~~~~~~~~~~----------------~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~  365 (375)
T cd05104         313 GSSPYPGMPVDSKFYKMIKEGYRM----------------LS-----------PECAPSEMYDIMKSCWDADPLKRPTFK  365 (375)
T ss_pred             CCCCCCCCCchHHHHHHHHhCccC----------------CC-----------CCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            899998766554444433210000                00           011246789999999999999999999


Q ss_pred             HHHcC
Q psy10954        342 TILQH  346 (562)
Q Consensus       342 elL~H  346 (562)
                      |+++.
T Consensus       366 eil~~  370 (375)
T cd05104         366 QIVQL  370 (375)
T ss_pred             HHHHH
Confidence            99863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=7.5e-32  Score=269.04  Aligned_cols=210  Identities=31%  Similarity=0.475  Sum_probs=169.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|++++++++||||+++++.+..+...|+||||+.+ +|.+++... ..+++..+..++.|+++||.|||++|++
T Consensus        44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~  122 (258)
T cd05578          44 VRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGII  122 (258)
T ss_pred             HHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45678999999999999999999999999999999999975 899988765 4799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||||+||+++.++.++|+|||++.......                                                
T Consensus       123 h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------------------------------------------------  154 (258)
T cd05578         123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT------------------------------------------------  154 (258)
T ss_pred             ccCCCHHHeEEcCCCCEEEeecccccccCCCc------------------------------------------------
Confidence            99999999999999999999999864331100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......|+..|+|||++.+.. ++.++|+||+||++
T Consensus       155 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l  189 (258)
T cd05578         155 --------------------------------------------LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTA  189 (258)
T ss_pred             --------------------------------------------cccccCCChhhcCHHHHcccC-CCCcccchhhHHHH
Confidence                                                        000123577899999987655 89999999999999


Q ss_pred             HHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        257 SEMITKKTLFAGDSE--IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       257 ~eLltG~~pF~~~~~--~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |+|++|..||...+.  .+.+...... .  ..              .           .....+..+.++|.+||+.||
T Consensus       190 ~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~--------------~-----------~~~~~~~~~~~~i~~~l~~~p  241 (258)
T cd05578         190 YECLRGKRPYRGHSRTIRDQIRAKQET-A--DV--------------L-----------YPATWSTEAIDAINKLLERDP  241 (258)
T ss_pred             HHHHhCCCCCCCCCccHHHHHHHHhcc-c--cc--------------c-----------CcccCcHHHHHHHHHHccCCh
Confidence            999999999987664  2222222110 0  00              0           001123678999999999999


Q ss_pred             CCCCCH--HHHHcCccc
Q psy10954        335 KQRVSA--KTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta--~elL~Hp~f  349 (562)
                      .+|+++  +|+++||||
T Consensus       242 ~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         242 QKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             hHcCCccHHHHhcCCCC
Confidence            999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.98  E-value=2.4e-31  Score=272.19  Aligned_cols=207  Identities=24%  Similarity=0.342  Sum_probs=164.1

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      +.+.+|+++++++ +||||+++++++...+.+|+||||++ ++|.+++....               ..+++..++.++.
T Consensus        47 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  126 (297)
T cd05089          47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS  126 (297)
T ss_pred             HHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHH
Confidence            4578899999999 79999999999999999999999997 59999986532               2488999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++||+||||||+|||++.++.+||+|||++......                  .   .           
T Consensus       127 qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------------------~---~-----------  174 (297)
T cd05089         127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY------------------V---K-----------  174 (297)
T ss_pred             HHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce------------------e---c-----------
Confidence            9999999999999999999999999999999999999986421100                  0   0           


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                  ......+..|+|||++.+..
T Consensus       175 ------------------------------------------------------------~~~~~~~~~y~aPE~~~~~~  194 (297)
T cd05089         175 ------------------------------------------------------------KTMGRLPVRWMAIESLNYSV  194 (297)
T ss_pred             ------------------------------------------------------------cCCCCcCccccCchhhccCC
Confidence                                                                        00011245699999887654


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++||||+||++|||++ |.+||.+.+..+....+......+                            .....+.
T Consensus       195 -~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  245 (297)
T cd05089         195 -YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME----------------------------KPRNCDD  245 (297)
T ss_pred             -CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC----------------------------CCCCCCH
Confidence             8999999999999999997 999998887665555443211000                            0012346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||+.||.+|||++++++.
T Consensus       246 ~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         246 EVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=2e-31  Score=271.14  Aligned_cols=221  Identities=28%  Similarity=0.436  Sum_probs=171.1

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|+++|+++ +|+||++++++|+.+..+|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++|++
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~  127 (290)
T cd05613          49 EHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGII  127 (290)
T ss_pred             HHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4567899999999 699999999999999999999999985 8999987653 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......                                               
T Consensus       128 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------------  160 (290)
T cd05613         128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-----------------------------------------------  160 (290)
T ss_pred             ccCCCHHHeEECCCCCEEEeeCccceecccccc-----------------------------------------------
Confidence            999999999999999999999998754321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCI  255 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~i  255 (562)
                                                                 .......|+..|+|||.+.+. ..++.++||||+||+
T Consensus       161 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~  197 (290)
T cd05613         161 -------------------------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL  197 (290)
T ss_pred             -------------------------------------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHH
Confidence                                                       000123567889999998653 346789999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|..||...+.......+....-...                 +.        .-...++.+.+++.+||+.||+
T Consensus       198 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~~--------~~~~~~~~~~~ll~~~l~~~p~  252 (290)
T cd05613         198 MYELLTGASPFTVDGEKNSQAEISRRILKSE-----------------PP--------YPQEMSALAKDIIQRLLMKDPK  252 (290)
T ss_pred             HHHHhcCCCCCCcCCccccHHHHHHHhhccC-----------------CC--------CCccCCHHHHHHHHHHhcCCHH
Confidence            9999999999975433222222221110000                 00        0011346788999999999999


Q ss_pred             CCC-----CHHHHHcCccccCCccc
Q psy10954        336 QRV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       336 ~R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      +|+     ++++++.||||....+.
T Consensus       253 ~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         253 KRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             HhcCCCCCCHHHHHcCcccccCCHH
Confidence            997     78999999999987643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=6.7e-31  Score=267.37  Aligned_cols=219  Identities=25%  Similarity=0.394  Sum_probs=165.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|++++++++||||++++++|...  +.+|+||||+++ +|.+++..   ....+++..+..++.|++.||.|||
T Consensus        43 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH  122 (287)
T cd06621          43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH  122 (287)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999998653  479999999975 88877643   3345899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +.|++|+||+|+||+++.++.++|+|||++.......                                           
T Consensus       123 ~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------  159 (287)
T cd06621         123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-------------------------------------------  159 (287)
T ss_pred             HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-------------------------------------------
Confidence            9999999999999999999999999999864321000                                           


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        .....++..|+|||.+.+.. ++.++|+||
T Consensus       160 --------------------------------------------------~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~s  188 (287)
T cd06621         160 --------------------------------------------------AGTFTGTSFYMAPERIQGKP-YSITSDVWS  188 (287)
T ss_pred             --------------------------------------------------cccccCCccccCHHHhcCCC-CCchhhHHH
Confidence                                                              00123467799999987654 889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        252 AGCIFSEMITKKTLFAGDS-----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~-----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||++|+|++|..||....     ..+....+...   .... .             +....     .-...++.+.+|+
T Consensus       189 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-~-------------~~~~~-----~~~~~~~~~~~li  246 (287)
T cd06621         189 LGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPE-L-------------KDEPG-----NGIKWSEEFKDFI  246 (287)
T ss_pred             HHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchh-h-------------ccCCC-----CCCchHHHHHHHH
Confidence            9999999999999998652     12222221110   0000 0             00000     0001235688999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccCC
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .+||+.||++|||+.|+++||||.+.
T Consensus       247 ~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         247 KQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             HHHcCCCcccCCCHHHHHhCcccccc
Confidence            99999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.98  E-value=3.6e-31  Score=268.27  Aligned_cols=210  Identities=24%  Similarity=0.377  Sum_probs=165.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC----------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~----------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|++++++++||||+++++++..+...|+||||+.+ +|.+++....                ..+++..+..++.
T Consensus        52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  131 (283)
T cd05090          52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI  131 (283)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence            3567899999999999999999999999999999999974 9999885321                2378888999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++........                               
T Consensus       132 ~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-------------------------------  180 (283)
T cd05090         132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY-------------------------------  180 (283)
T ss_pred             HHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcce-------------------------------
Confidence            9999999999999999999999999999999999999987643210000                               


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                .......++..|+|||++.+..
T Consensus       181 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05090         181 ----------------------------------------------------------RVQPKSLLPIRWMPPEAIMYGK  202 (283)
T ss_pred             ----------------------------------------------------------ecccCCCccceecChHHhccCC
Confidence                                                                      0001223467799999997654


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++|+||+||++|||++ |.+||.+.+..+....+... ..++                           .....++
T Consensus       203 -~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~  253 (283)
T cd05090         203 -FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLP---------------------------CSEDCPP  253 (283)
T ss_pred             -CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC---------------------------CCCCCCH
Confidence             8999999999999999998 99999887654443333211 0000                           0012346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+++.+||+.||++||++.+++++
T Consensus       254 ~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         254 RMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHH
Confidence            78999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=4.4e-31  Score=267.40  Aligned_cols=210  Identities=22%  Similarity=0.335  Sum_probs=165.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC---------------CCCCCHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---------------PVPVPPALAKSYLYQ   82 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~---------------~~~l~e~~i~~i~~q   82 (562)
                      ..+.+|+.+++.++||||+++++++......++++||+.+ +|.+++...               ...+++..+..++.|
T Consensus        53 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  132 (283)
T cd05091          53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ  132 (283)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence            4567899999999999999999999999999999999974 898887532               124788889999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         83 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        83 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      ++.||.|||++||+||||||+|||++.++.+||+|||+++........                                
T Consensus       133 l~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--------------------------------  180 (283)
T cd05091         133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY--------------------------------  180 (283)
T ss_pred             HHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchhe--------------------------------
Confidence            999999999999999999999999999999999999987643210000                                


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                               .......+++.|+|||.+.+.. 
T Consensus       181 ---------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-  202 (283)
T cd05091         181 ---------------------------------------------------------KLMGNSLLPIRWMSPEAIMYGK-  202 (283)
T ss_pred             ---------------------------------------------------------eeccCccCCccccCHHHHhcCC-
Confidence                                                                     0001123567899999987654 


Q ss_pred             CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHH
Q psy10954        243 YSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL  321 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  321 (562)
                      ++.++||||+||++|||++ |..||.+....+.+..+......+                            .....+..
T Consensus       203 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~  254 (283)
T cd05091         203 FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP----------------------------CPDDCPAW  254 (283)
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CCCCCCHH
Confidence            8999999999999999998 889998877665555543321100                            00123456


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+|+.+||+.||++||+++++++.
T Consensus       255 ~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         255 VYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHHhCCCcccCCCHHHHHHH
Confidence            8899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=3.3e-31  Score=269.02  Aligned_cols=217  Identities=30%  Similarity=0.517  Sum_probs=175.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++|+||+++++.+......|+|+||++ ++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~  138 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI  138 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3467899999999999999999999999999999999998 599999987654699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||||+||+++.++.++|+|||++........                                               
T Consensus       139 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----------------------------------------------  171 (286)
T cd06614         139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-----------------------------------------------  171 (286)
T ss_pred             eCCCChhhEEEcCCCCEEECccchhhhhccchh-----------------------------------------------
Confidence            999999999999999999999998643211000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||++.+.. ++.++|+||+||++
T Consensus       172 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil  206 (286)
T cd06614         172 --------------------------------------------KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMC  206 (286)
T ss_pred             --------------------------------------------hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHH
Confidence                                                        001123577899999987654 79999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+.......+... +.+..                   .      .....+..+.+|+.+||+.||.+
T Consensus       207 ~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~-------------------~------~~~~~~~~l~~li~~~l~~~p~~  260 (286)
T cd06614         207 IEMAEGEPPYLREPPLRALFLITTK-GIPPL-------------------K------NPEKWSPEFKDFLNKCLVKDPEK  260 (286)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhc-CCCCC-------------------c------chhhCCHHHHHHHHHHhccChhh
Confidence            9999999999877665444443221 10000                   0      00112457889999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||+.++++|+||...
T Consensus       261 Rpt~~~il~~~~~~~~  276 (286)
T cd06614         261 RPSAEELLQHPFLKKA  276 (286)
T ss_pred             CcCHHHHhhChHhhcc
Confidence            9999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=4.8e-31  Score=266.82  Aligned_cols=210  Identities=22%  Similarity=0.370  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP------VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~------~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|+.+++.++||||+++++++......|+||||+. ++|.+++....      ..+++..+..++.|++.||+|||
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  133 (277)
T cd05036          54 SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357899999999999999999999998889999999997 59999987643      24889999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      +++++||||||+||+++.++   .+||+|||+++......  .                     .               
T Consensus       134 ~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~---------------------~---------------  175 (277)
T cd05036         134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS--Y---------------------Y---------------  175 (277)
T ss_pred             HCCEeecccchheEEEeccCCCcceEeccCccccccCCcc--c---------------------e---------------
Confidence            99999999999999998665   58999999876431100  0                     0               


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         .......++..|+|||++.+.. ++.++|
T Consensus       176 ---------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  203 (277)
T cd05036         176 ---------------------------------------------------RKGGRAMLPIKWMPPEAFLDGI-FTSKTD  203 (277)
T ss_pred             ---------------------------------------------------ecCCCCCccHhhCCHHHHhcCC-cCchhH
Confidence                                                               0000112346799999997655 899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|||++ |..||.+.+..+....+... +.+.                .           ....+..+.+++.
T Consensus       204 iwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~----------------~-----------~~~~~~~~~~~i~  255 (277)
T cd05036         204 VWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLD----------------P-----------PKGCPGPVYRIMT  255 (277)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC----------------C-----------CCCCCHHHHHHHH
Confidence            9999999999996 99999887765443333211 1000                0           0112457889999


Q ss_pred             HccccCCCCCCCHHHHHcC
Q psy10954        328 KIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~H  346 (562)
                      +||+.||++|||+.++++|
T Consensus       256 ~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         256 DCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHcCCCcccCcCHHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=4e-31  Score=263.33  Aligned_cols=215  Identities=31%  Similarity=0.504  Sum_probs=173.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gI   95 (562)
                      ...+.+|+.+++.++||||+++++++......|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+ +|+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~  121 (264)
T cd06623          43 RKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHI  121 (264)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence            4568899999999999999999999999999999999998 5999998765 468999999999999999999999 999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||+|+||+++.++.++|+|||++........                                              
T Consensus       122 ~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~----------------------------------------------  155 (264)
T cd06623         122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLD----------------------------------------------  155 (264)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCccceecccCCC----------------------------------------------
Confidence            9999999999999999999999998754321100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||.+.+. .++.++|+||+||+
T Consensus       156 ---------------------------------------------~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~i  189 (264)
T cd06623         156 ---------------------------------------------QCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLT  189 (264)
T ss_pred             ---------------------------------------------cccceeecccccCHhhhCCC-CCCchhhHHHHHHH
Confidence                                                         00122457789999988665 58899999999999


Q ss_pred             HHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC-CCHHHHHHHHHccc
Q psy10954        256 FSEMITKKTLFAGDS---EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLAVDVFSKIMA  331 (562)
Q Consensus       256 l~eLltG~~pF~~~~---~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~dLi~~mL~  331 (562)
                      +|+|++|+.||....   ..+....+...   ..                 +.        .... .+..+.+++.+||.
T Consensus       190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~-----------------~~--------~~~~~~~~~l~~li~~~l~  241 (264)
T cd06623         190 LLECALGKFPFLPPGQPSFFELMQAICDG---PP-----------------PS--------LPAEEFSPEFRDFISACLQ  241 (264)
T ss_pred             HHHHHhCCCCCccccccCHHHHHHHHhcC---CC-----------------CC--------CCcccCCHHHHHHHHHHcc
Confidence            999999999997764   22222222210   00                 00        0011 34678999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCc
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+|++|||+.|+++||||+..+
T Consensus       242 ~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         242 KDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             CChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=5.8e-31  Score=264.09  Aligned_cols=210  Identities=22%  Similarity=0.359  Sum_probs=167.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++.+..++..|+||||+.+ +|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H  129 (266)
T cd05033          50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH  129 (266)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4567899999999999999999999999999999999975 999999876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++.........                     .                        
T Consensus       130 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~---------------------~------------------------  164 (266)
T cd05033         130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY---------------------T------------------------  164 (266)
T ss_pred             CCCCcceEEEcCCCCEEECccchhhcccccccce---------------------e------------------------
Confidence            9999999999999999999999876542100000                     0                        


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                  .....++..|+|||.+.+.. ++.++||||+||++|
T Consensus       165 --------------------------------------------~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~  199 (266)
T cd05033         165 --------------------------------------------TKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMW  199 (266)
T ss_pred             --------------------------------------------ccCCCCCccccChhhhccCC-CccccchHHHHHHHH
Confidence                                                        00112367799999887644 889999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++ |..||......+....+......+.                            ....++.+.+++.+||+.||++
T Consensus       200 ~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~~p~~  251 (266)
T cd05033         200 EVMSYGERPYWDMSNQDVIKAVEDGYRLPP----------------------------PMDCPSALYQLMLDCWQKDRNE  251 (266)
T ss_pred             HHHccCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CCCCCHHHHHHHHHHcCCCccc
Confidence            9997 9999977665554444432110000                            0122467889999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      ||++.|++++
T Consensus       252 Rp~~~ei~~~  261 (266)
T cd05033         252 RPTFSQIVST  261 (266)
T ss_pred             CcCHHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=5e-31  Score=263.53  Aligned_cols=209  Identities=23%  Similarity=0.367  Sum_probs=166.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+++.++||||+++++.+......|+||||+. ++|.+++... ...+++..+..++.|++.||+|||++|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i  124 (261)
T cd05072          45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY  124 (261)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3567899999999999999999999999999999999997 5999998754 3458889999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++.......                                              
T Consensus       125 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------  158 (261)
T cd05072         125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----------------------------------------------  158 (261)
T ss_pred             eccccchhhEEecCCCcEEECCCccceecCCCce----------------------------------------------
Confidence            9999999999999999999999998764321000                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......++..|+|||.+.+.. ++.++||||+||+
T Consensus       159 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  193 (261)
T cd05072         159 --------------------------------------------TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGIL  193 (261)
T ss_pred             --------------------------------------------eccCCCccceecCCHHHhccCC-CChhhhhhhhHHH
Confidence                                                        0000123466799999987654 7889999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++ |..||.+....+....+.+....+                            .....+..+.+++.+||..||
T Consensus       194 l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p  245 (261)
T cd05072         194 LYEIVTYGKIPYPGMSNSDVMSALQRGYRMP----------------------------RMENCPDELYDIMKTCWKEKA  245 (261)
T ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCCc
Confidence            999998 999998877665555443221100                            001224578899999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++++++
T Consensus       246 ~~Rp~~~~i~~  256 (261)
T cd05072         246 EERPTFDYLQS  256 (261)
T ss_pred             ccCcCHHHHHH
Confidence            99999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=7.2e-31  Score=263.15  Aligned_cols=209  Identities=21%  Similarity=0.303  Sum_probs=163.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++||||+++++++. ....|+||||+++ +|.+++......+++..+..++.|++.||.|||++|++|
T Consensus        40 ~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  118 (257)
T cd05115          40 DEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH  118 (257)
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeee
Confidence            45789999999999999999999886 4578999999974 999998766667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.........         .                                    
T Consensus       119 ~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---------~------------------------------------  153 (257)
T cd05115         119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---------K------------------------------------  153 (257)
T ss_pred             cccchheEEEcCCCcEEeccCCccccccCCccce---------e------------------------------------
Confidence            9999999999999999999999876432110000         0                                    


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+.. ++.++||||+||++|
T Consensus       154 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~  189 (257)
T cd05115         154 -------------------------------------------ARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMW  189 (257)
T ss_pred             -------------------------------------------ccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHH
Confidence                                                       000112356799999987654 789999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+....+....+... ..+                .           .....++.+.+++.+|+..||++
T Consensus       190 el~~~g~~p~~~~~~~~~~~~~~~~-~~~----------------~-----------~~~~~~~~l~~li~~c~~~~~~~  241 (257)
T cd05115         190 EAFSYGQKPYKKMKGPEVMSFIEQG-KRL----------------D-----------CPAECPPEMYALMKDCWIYKWED  241 (257)
T ss_pred             HHhcCCCCCcCcCCHHHHHHHHHCC-CCC----------------C-----------CCCCCCHHHHHHHHHHcCCChhh
Confidence            9996 99999887665544333211 000                0           00123467889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      ||++.++.+
T Consensus       242 Rp~~~~i~~  250 (257)
T cd05115         242 RPNFAKVEE  250 (257)
T ss_pred             CcCHHHHHH
Confidence            999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=4e-31  Score=261.95  Aligned_cols=211  Identities=27%  Similarity=0.433  Sum_probs=170.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT--------PVPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~--------~~~l~e~~i~~i~~qll~aL~   88 (562)
                      ...+.+|+++++.++|+||+++++++.....+++||||+. ++|.+++...        ...+++..+..++.|++.||+
T Consensus        40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~  119 (262)
T cd00192          40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME  119 (262)
T ss_pred             HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            3567799999999999999999999999999999999995 6999999876        357999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||++||+||||||+||+++.++.+||+|||.+........          +                            
T Consensus       120 ~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----------~----------------------------  161 (262)
T cd00192         120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY----------Y----------------------------  161 (262)
T ss_pred             HHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc----------c----------------------------
Confidence            99999999999999999999999999999998764421100          0                            


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         .......++..|+|||.+.+. .++.++|
T Consensus       162 ---------------------------------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~D  189 (262)
T cd00192         162 ---------------------------------------------------RKKTGGKLPIRWMAPESLKDG-IFTSKSD  189 (262)
T ss_pred             ---------------------------------------------------ccccCCCcCccccCHHHhccC-Ccchhhc
Confidence                                                               000123457889999998765 4899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|+|++ |..||.+....+....+...  ...               .           .....++.+.+++.
T Consensus       190 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~~---------------~-----------~~~~~~~~~~~li~  241 (262)
T cd00192         190 VWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--YRL---------------P-----------KPEYCPDELYELML  241 (262)
T ss_pred             cHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC---------------C-----------CCccCChHHHHHHH
Confidence            9999999999998 69999888766555544321  000               0           00112567899999


Q ss_pred             HccccCCCCCCCHHHHHcC
Q psy10954        328 KIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~H  346 (562)
                      +||+.||++|||+.|++++
T Consensus       242 ~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         242 SCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHccCCcccCcCHHHHHHh
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=5.3e-31  Score=260.48  Aligned_cols=212  Identities=33%  Similarity=0.566  Sum_probs=172.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+++++.++|||++++++.+......++|+||+++ +|.+++....   ..+++..+..++.|++.||.|||++
T Consensus        43 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~  122 (258)
T cd08215          43 REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR  122 (258)
T ss_pred             HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            34578999999999999999999999999999999999985 8999987652   5799999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |++|+||+|+||+++.++.++|+|||++........                                            
T Consensus       123 ~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------------------------------------------  158 (258)
T cd08215         123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--------------------------------------------  158 (258)
T ss_pred             CEecccCChHHeEEcCCCcEEECCccceeecccCcc--------------------------------------------
Confidence            999999999999999999999999998754321100                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                     ......|++.|+|||.+.+.. ++.++|+||+|
T Consensus       159 -----------------------------------------------~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG  190 (258)
T cd08215         159 -----------------------------------------------LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLG  190 (258)
T ss_pred             -----------------------------------------------eecceeeeecccChhHhccCC-CCccccHHHHH
Confidence                                                           001224678899999887654 78899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      +++++|++|..||...+..+...........                    .        +....+..+.+++.+||..|
T Consensus       191 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~~~~~~~~~i~~~l~~~  242 (258)
T cd08215         191 CVLYELCTLKHPFEGENLLELALKILKGQYP--------------------P--------IPSQYSSELRNLVSSLLQKD  242 (258)
T ss_pred             HHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC--------------------C--------CCCCCCHHHHHHHHHHcCCC
Confidence            9999999999999877654444433221100                    0        00123467899999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy10954        334 PKQRVSAKTILQHEYF  349 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f  349 (562)
                      |++|||+.|+|+||||
T Consensus       243 p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         243 PEERPSIAQILQSPFI  258 (258)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=2.5e-31  Score=273.28  Aligned_cols=207  Identities=26%  Similarity=0.351  Sum_probs=163.1

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|++++.++ +||||+++++++..++..|+||||++ ++|.+++....               ..+++..++.++.
T Consensus        52 ~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  131 (303)
T cd05088          52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA  131 (303)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHH
Confidence            3567899999999 89999999999999999999999997 59999986532               2478999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++||+||||||+|||++.++.+||+|||+++.....             .        .           
T Consensus       132 qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-------------~--------~-----------  179 (303)
T cd05088         132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------------V--------K-----------  179 (303)
T ss_pred             HHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh-------------h--------h-----------
Confidence            9999999999999999999999999999999999999986421100             0        0           


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                  .....++..|+|||++.+..
T Consensus       180 ------------------------------------------------------------~~~~~~~~~y~aPE~~~~~~  199 (303)
T cd05088         180 ------------------------------------------------------------KTMGRLPVRWMAIESLNYSV  199 (303)
T ss_pred             ------------------------------------------------------------cccCCCcccccCHHHHhccC
Confidence                                                                        00012355699999886544


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++||||+||++|||++ |.+||.+.+..+....+....  ..               ..           ....++
T Consensus       200 -~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~---------------~~-----------~~~~~~  250 (303)
T cd05088         200 -YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RL---------------EK-----------PLNCDD  250 (303)
T ss_pred             -CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--cC---------------CC-----------CCCCCH
Confidence             8899999999999999998 999998776654443331100  00               00           011245


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||+.||++|||+++++++
T Consensus       251 ~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         251 EVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=6.7e-31  Score=264.06  Aligned_cols=210  Identities=22%  Similarity=0.330  Sum_probs=167.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++||||+++++++..++..|+||||+++ +|.+++......+++..+..++.|++.||.|||++|++|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h  129 (267)
T cd05066          50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH  129 (267)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            4578899999999999999999999999999999999975 899999876667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.........                                              
T Consensus       130 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~----------------------------------------------  163 (267)
T cd05066         130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA----------------------------------------------  163 (267)
T ss_pred             hhhchhcEEECCCCeEEeCCCCccccccccccee----------------------------------------------
Confidence            9999999999999999999999876442110000                                              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......++..|+|||.+.+.. ++.++|+||+||++|
T Consensus       164 ------------------------------------------~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~  200 (267)
T cd05066         164 ------------------------------------------YTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMW  200 (267)
T ss_pred             ------------------------------------------eecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHH
Confidence                                                      0000112356799999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+++ |..||.+....+....+.+....+                            .....++.+.+++.+||+.+|.+
T Consensus       201 ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~  252 (267)
T cd05066         201 EVMSYGERPYWEMSNQDVIKAIEEGYRLP----------------------------APMDCPAALHQLMLDCWQKDRNE  252 (267)
T ss_pred             HHhcCCCCCcccCCHHHHHHHHhCCCcCC----------------------------CCCCCCHHHHHHHHHHcccCchh
Confidence            9886 999998776655544443221100                            00112467899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.++++
T Consensus       253 Rp~~~~i~~  261 (267)
T cd05066         253 RPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=4.7e-31  Score=266.90  Aligned_cols=212  Identities=26%  Similarity=0.445  Sum_probs=171.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.++++++||||+++++++..+...|+||||+++ +|.+++...  .+++..+..++.|++.|+.|||++|++|
T Consensus        47 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h  124 (277)
T cd06641          47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIH  124 (277)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence            4567899999999999999999999999999999999985 888888643  5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.++|+|||++.......                                                 
T Consensus       125 ~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-------------------------------------------------  155 (277)
T cd06641         125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-------------------------------------------------  155 (277)
T ss_pred             CCCCHHhEEECCCCCEEEeecccceecccch-------------------------------------------------
Confidence            9999999999999999999999865332100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                     +           ......++..|+|||.+.+.. ++.++|+||+||++|
T Consensus       156 -------------------------------~-----------~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~  192 (277)
T cd06641         156 -------------------------------I-----------KRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAI  192 (277)
T ss_pred             -------------------------------h-----------hhccccCCccccChhhhccCC-CCchhhHHHHHHHHH
Confidence                                           0           001234677899999887543 788999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|..||...+.......+... +.+                   .        .....+..+.+++.+||+.||.+|
T Consensus       193 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------------~--------~~~~~~~~~~~~i~~~l~~~p~~R  244 (277)
T cd06641         193 ELAKGEPPHSELHPMKVLFLIPKN-NPP-------------------T--------LEGNYSKPLKEFVEACLNKEPSFR  244 (277)
T ss_pred             HHHcCCCCCCccchHHHHHHHhcC-CCC-------------------C--------CCcccCHHHHHHHHHHccCChhhC
Confidence            999999999876654443333110 000                   0        112235678999999999999999


Q ss_pred             CCHHHHHcCccccCC
Q psy10954        338 VSAKTILQHEYFNQV  352 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~  352 (562)
                      |++.++++||||.+.
T Consensus       245 p~~~~~l~~~~~~~~  259 (277)
T cd06641         245 PTAKELLKHKFIVRF  259 (277)
T ss_pred             cCHHHHHhCHHHhhh
Confidence            999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=8.4e-31  Score=263.38  Aligned_cols=214  Identities=23%  Similarity=0.315  Sum_probs=160.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV----PVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~----~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+.+++.++||||+++++.+......|+||||+.+ +|.+++.....    ..++..+..++.|++.||+|||++
T Consensus        40 ~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  119 (269)
T cd05042          40 LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA  119 (269)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc
Confidence            3567999999999999999999999999999999999974 99999876432    246788899999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++....... .                     .                    
T Consensus       120 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~---------------------~--------------------  157 (269)
T cd05042         120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-Y---------------------I--------------------  157 (269)
T ss_pred             CEecccccHhheEecCCCcEEEeccccccccccchh-e---------------------e--------------------
Confidence            999999999999999999999999998753211000 0                     0                    


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC------CCCCCchh
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG------AKVYSTTV  247 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~------~~~y~~~~  247 (562)
                                                                     ......++..|+|||++..      ...++.++
T Consensus       158 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~  190 (269)
T cd05042         158 -----------------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS  190 (269)
T ss_pred             -----------------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhh
Confidence                                                           0011234566888888742      23468899


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        248 DIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       248 DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      ||||+||++|||++ |..||......+.+..+..........               +.        .....+....+++
T Consensus       191 DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~--------~~~~~~~~~~~~~  247 (269)
T cd05042         191 NIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK---------------PQ--------LDLKYSDRWYEVM  247 (269)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC---------------Cc--------ccccCCHHHHHHH
Confidence            99999999999999 788998777666555554322111000               00        0112235667888


Q ss_pred             HHccccCCCCCCCHHHHHc
Q psy10954        327 SKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~  345 (562)
                      ..|+ .||++|||++|+++
T Consensus       248 ~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         248 QFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHh-cCcccccCHHHHHH
Confidence            8887 59999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=5.9e-31  Score=265.16  Aligned_cols=206  Identities=26%  Similarity=0.357  Sum_probs=162.3

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|+++++++ +||||+++++++...+..|+||||+. ++|.+++....               ..+++..++.++.
T Consensus        40 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  119 (270)
T cd05047          40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA  119 (270)
T ss_pred             HHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHH
Confidence            4567899999999 89999999999999999999999997 59999987532               2478999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++|++||||||+|||++.++.+||+|||+++.....             ..                   
T Consensus       120 ~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~-------------~~-------------------  167 (270)
T cd05047         120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------------VK-------------------  167 (270)
T ss_pred             HHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh-------------hh-------------------
Confidence            9999999999999999999999999999999999999986421100             00                   


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                  ......+..|+|||++.+. 
T Consensus       168 ------------------------------------------------------------~~~~~~~~~y~apE~~~~~-  186 (270)
T cd05047         168 ------------------------------------------------------------KTMGRLPVRWMAIESLNYS-  186 (270)
T ss_pred             ------------------------------------------------------------ccCCCCccccCChHHHccC-
Confidence                                                                        0001224579999988654 


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                      .++.++||||+||++|||++ |..||.+.+..+....+......                 .           .....+.
T Consensus       187 ~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~  238 (270)
T cd05047         187 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-----------------E-----------KPLNCDD  238 (270)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC-----------------C-----------CCCcCCH
Confidence            48999999999999999997 99999887665544443211000                 0           0011345


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+.+++.+|+..||.+|||+.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         239 EVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHH
Confidence            7889999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=9.8e-31  Score=269.00  Aligned_cols=210  Identities=21%  Similarity=0.392  Sum_probs=166.5

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++++++ +||||+++++++...+.+|+||||+. ++|.+++..... .+++.++..++.|++.||+|||++||
T Consensus        83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i  162 (302)
T cd05055          83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC  162 (302)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3577899999999 89999999999999999999999997 599999876432 38999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+|||++.++.+||+|||+++........                                             
T Consensus       163 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~---------------------------------------------  197 (302)
T cd05055         163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY---------------------------------------------  197 (302)
T ss_pred             ehhhhccceEEEcCCCeEEECCCcccccccCCCce---------------------------------------------
Confidence            99999999999999999999999987543210000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......++..|+|||.+.+.. ++.++||||+||+
T Consensus       198 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvi  232 (302)
T cd05055         198 --------------------------------------------VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIL  232 (302)
T ss_pred             --------------------------------------------eecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHH
Confidence                                                        0000123467899999987655 7999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |..||.+.+..+.+...... +...               .           .....++.+.+|+.+||..||
T Consensus       233 l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~---------------~-----------~~~~~~~~~~~li~~cl~~~p  285 (302)
T cd05055         233 LWEIFSLGSNPYPGMPVDSKFYKLIKE-GYRM---------------A-----------QPEHAPAEIYDIMKTCWDADP  285 (302)
T ss_pred             HHHHHhCCCCCcCCCCchHHHHHHHHc-CCcC---------------C-----------CCCCCCHHHHHHHHHHcCCCc
Confidence            999998 99999887765544443321 0000               0           001224678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.|+++
T Consensus       286 ~~Rpt~~ell~  296 (302)
T cd05055         286 LKRPTFKQIVQ  296 (302)
T ss_pred             hhCcCHHHHHH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.8e-31  Score=261.73  Aligned_cols=209  Identities=24%  Similarity=0.417  Sum_probs=166.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.++++++||||+++++++...+..|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  124 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY  124 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3567899999999999999999999999999999999995 69999987644 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++......  ..                                           
T Consensus       125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~-------------------------------------------  159 (261)
T cd05068         125 IHRDLAARNVLVGENNICKVADFGLARVIKEDI--YE-------------------------------------------  159 (261)
T ss_pred             eeccCCcceEEEcCCCCEEECCcceEEEccCCc--cc-------------------------------------------
Confidence            999999999999999999999999876442100  00                                           


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||++.+.. ++.++|+||+||+
T Consensus       160 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  193 (261)
T cd05068         160 ---------------------------------------------AREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGIL  193 (261)
T ss_pred             ---------------------------------------------ccCCCcCceeccCccccccCC-CCchhhHHHHHHH
Confidence                                                         000011245799999887654 7899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+....+..+......+                            .....+..+.+++.+||+.||
T Consensus       194 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P  245 (261)
T cd05068         194 LTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP----------------------------CPPGCPKELYDIMLDCWKEDP  245 (261)
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHHHhhcCc
Confidence            999999 999998877665555443221100                            001124578999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      .+||++.++++
T Consensus       246 ~~Rp~~~~l~~  256 (261)
T cd05068         246 DDRPTFETLQW  256 (261)
T ss_pred             ccCCCHHHHHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=2.2e-31  Score=272.47  Aligned_cols=215  Identities=30%  Similarity=0.505  Sum_probs=171.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++.+......|+|+||+++ +|.+++.+.  .+++..+..++.|++.||.|||++|++|
T Consensus        61 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H  138 (293)
T cd06647          61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIH  138 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence            4578999999999999999999999999999999999975 999988754  4789999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++.......                                                 
T Consensus       139 ~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-------------------------------------------------  169 (293)
T cd06647         139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------------  169 (293)
T ss_pred             ccCCHHHEEEcCCCCEEEccCcceecccccc-------------------------------------------------
Confidence            9999999999999999999999865332100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......|++.|+|||.+.+. .++.++|+||+||++|
T Consensus       170 ------------------------------------------~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~  206 (293)
T cd06647         170 ------------------------------------------SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAI  206 (293)
T ss_pred             ------------------------------------------cccccccCChhhcCchhhccC-CCCchhhHHHHHHHHH
Confidence                                                      000123567889999998764 4789999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+..+.+..+.. .+.+.                   +.      .....+....+++.+||..||.+|
T Consensus       207 ~ll~g~~pf~~~~~~~~~~~~~~-~~~~~-------------------~~------~~~~~~~~l~~li~~~l~~~p~~R  260 (293)
T cd06647         207 EMVEGEPPYLNENPLRALYLIAT-NGTPE-------------------LQ------NPEKLSAIFRDFLNRCLEMDVEKR  260 (293)
T ss_pred             HHHhCCCCCCCCChhhheeehhc-CCCCC-------------------CC------CccccCHHHHHHHHHHccCChhhC
Confidence            99999999987665433222110 00000                   00      001124568899999999999999


Q ss_pred             CCHHHHHcCccccCCc
Q psy10954        338 VSAKTILQHEYFNQVE  353 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~  353 (562)
                      |++.++++|+||+...
T Consensus       261 p~~~~il~h~~~~~~~  276 (293)
T cd06647         261 GSAKELLQHPFLKIAK  276 (293)
T ss_pred             cCHHHHhcCHHHhcCc
Confidence            9999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=5.7e-31  Score=269.05  Aligned_cols=217  Identities=23%  Similarity=0.380  Sum_probs=167.6

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gIi   96 (562)
                      ....+|+.++... +||||+++++++......|+||||+++.|..++......+++..+..++.|++.||.|||+ .||+
T Consensus        58 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~  137 (296)
T cd06618          58 KRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI  137 (296)
T ss_pred             HHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEe
Confidence            4567788877766 4999999999999999999999999888888877655679999999999999999999997 5999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........                                               
T Consensus       138 H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-----------------------------------------------  170 (296)
T cd06618         138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-----------------------------------------------  170 (296)
T ss_pred             cCCCcHHHEEEcCCCCEEECccccchhccCCCc-----------------------------------------------
Confidence            999999999999999999999998654321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC---CCCCchhhHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA---KVYSTTVDIWSAG  253 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~---~~y~~~~DIWSlG  253 (562)
                                                                   .....++..|+|||.+.+.   ..++.++||||+|
T Consensus       171 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG  205 (296)
T cd06618         171 ---------------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG  205 (296)
T ss_pred             ---------------------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHH
Confidence                                                         0012356778888887644   2478899999999


Q ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++|+|++|+.||..... .+.+..+.....   .                 ...      .....+..+.+|+.+||..
T Consensus       206 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~-----------------~~~------~~~~~~~~l~~li~~~l~~  259 (296)
T cd06618         206 ISLVELATGQFPYKNCKTEFEVLTKILQEEP---P-----------------SLP------PNEGFSPDFCSFVDLCLTK  259 (296)
T ss_pred             HHHHHHHhCCCCCCcchhHHHHHHHHhcCCC---C-----------------CCC------CCCCCCHHHHHHHHHHccC
Confidence            999999999999976432 233333322100   0                 000      0001245789999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||++++++||||....
T Consensus       260 ~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         260 DHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ChhhCCCHHHHhcChhhhccc
Confidence            999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=5.1e-31  Score=268.23  Aligned_cols=210  Identities=24%  Similarity=0.389  Sum_probs=164.5

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC---------------CCCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---------------PVPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~---------------~~~l~e~~i~~i~~   81 (562)
                      ..+.+|+.+++.+ +||||+++++++..++.+|+||||+. ++|.+++...               ...+++..+..++.
T Consensus        60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  139 (293)
T cd05053          60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY  139 (293)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence            3477899999999 89999999999999999999999997 5999998642               23588999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++||+||||||+||+++.++.+||+|||+++.......                .      .        
T Consensus       140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----------------~------~--------  189 (293)
T cd05053         140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY----------------Y------R--------  189 (293)
T ss_pred             HHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccc----------------e------e--------
Confidence            999999999999999999999999999999999999998764421100                0      0        


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                 ......++..|+|||++.+..
T Consensus       190 -----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  210 (293)
T cd05053         190 -----------------------------------------------------------KTTNGRLPVKWMAPEALFDRV  210 (293)
T ss_pred             -----------------------------------------------------------ccCCCCCCccccCHHHhccCC
Confidence                                                                       000112356799999986644


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++||||+||++|||++ |..||.+.+..+....+......                 .           .....+.
T Consensus       211 -~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~  261 (293)
T cd05053         211 -YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM-----------------E-----------KPQNCTQ  261 (293)
T ss_pred             -cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-----------------C-----------CCCCCCH
Confidence             8999999999999999997 99999887655444433211000                 0           0011246


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||..||++|||+.|++++
T Consensus       262 ~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         262 ELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHH
Confidence            78999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1.1e-30  Score=264.77  Aligned_cols=209  Identities=26%  Similarity=0.389  Sum_probs=166.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC--------------CCCCHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP--------------VPVPPALAKSYLYQL   83 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~--------------~~l~e~~i~~i~~ql   83 (562)
                      ..+.+|+++++.++||||+++++++......|+||||+. ++|.+++....              ..+++..+..++.|+
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  131 (280)
T cd05092          52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI  131 (280)
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHH
Confidence            457899999999999999999999999999999999997 49999987643              247899999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         84 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        84 l~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      +.||+|||++||+||||||+|||++.++.+||+|||+++.......                      +           
T Consensus       132 ~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~----------------------~-----------  178 (280)
T cd05092         132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----------------------Y-----------  178 (280)
T ss_pred             HHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCce----------------------e-----------
Confidence            9999999999999999999999999999999999998753321000                      0           


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                              .......+++.|+|||.+.+.. +
T Consensus       179 --------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~  201 (280)
T cd05092         179 --------------------------------------------------------RVGGRTMLPIRWMPPESILYRK-F  201 (280)
T ss_pred             --------------------------------------------------------ecCCCccccccccCHHHhccCC-c
Confidence                                                                    0001123467899999987655 8


Q ss_pred             CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        244 STTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      +.++||||+||++|||++ |.+||......+.+..+....  +..                          .....++..
T Consensus       202 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~  253 (280)
T cd05092         202 TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR--ELE--------------------------RPRTCPPEV  253 (280)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc--cCC--------------------------CCCCCCHHH
Confidence            999999999999999998 999998776665554443211  000                          001124568


Q ss_pred             HHHHHHccccCCCCCCCHHHHHc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+++.+||+.||.+||+++|+++
T Consensus       254 ~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         254 YAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHHccCChhhCCCHHHHHH
Confidence            89999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.7e-30  Score=257.82  Aligned_cols=207  Identities=22%  Similarity=0.373  Sum_probs=164.9

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+++++.++||||+++++++...+..|+||||++ ++|.+++......+++..+..++.|++.||.|+|++|++||
T Consensus        38 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~  117 (250)
T cd05085          38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR  117 (250)
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            57789999999999999999999999999999999997 49999987665568999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||+++......                       +.                         
T Consensus       118 dl~p~nili~~~~~~~l~d~g~~~~~~~~~-----------------------~~-------------------------  149 (250)
T cd05085         118 DLAARNCLVGENNVLKISDFGMSRQEDDGI-----------------------YS-------------------------  149 (250)
T ss_pred             ccChheEEEcCCCeEEECCCccceeccccc-----------------------cc-------------------------
Confidence            999999999999999999999865321000                       00                         


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                                ......++..|+|||++.+.. ++.++||||+||++|+
T Consensus       150 ------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~  186 (250)
T cd05085         150 ------------------------------------------SSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWE  186 (250)
T ss_pred             ------------------------------------------cCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHH
Confidence                                                      000112356799999987544 7889999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        259 MIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       259 Llt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      |++ |..||.+.........+......                 .           .....+..+.+++.+||..||++|
T Consensus       187 ~~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         187 TFSLGVCPYPGMTNQQAREQVEKGYRM-----------------S-----------CPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             HhcCCCCCCCCCCHHHHHHHHHcCCCC-----------------C-----------CCCCCCHHHHHHHHHHcccCcccC
Confidence            998 99999887665544433221000                 0           001124678999999999999999


Q ss_pred             CCHHHHHc
Q psy10954        338 VSAKTILQ  345 (562)
Q Consensus       338 ~Ta~elL~  345 (562)
                      ||+.|+++
T Consensus       239 p~~~~l~~  246 (250)
T cd05085         239 PKFSELQK  246 (250)
T ss_pred             CCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=9.9e-31  Score=257.00  Aligned_cols=212  Identities=31%  Similarity=0.500  Sum_probs=171.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++||||+++++.+......++|+||++ ++|.+++......+++..+..++.|++.||.|||++|++
T Consensus        41 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~  120 (253)
T cd05122          41 KEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII  120 (253)
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEe
Confidence            3567899999999999999999999999999999999998 599999877655799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||+|+||+++.++.++|+|||.+........                                               
T Consensus       121 h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----------------------------------------------  153 (253)
T cd05122         121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-----------------------------------------------  153 (253)
T ss_pred             cCCCCHHHEEEccCCeEEEeecccccccccccc-----------------------------------------------
Confidence            999999999999999999999998654321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                   .....++..|+|||.+.+.. ++.++|+||+||++
T Consensus       154 ---------------------------------------------~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il  187 (253)
T cd05122         154 ---------------------------------------------RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITA  187 (253)
T ss_pred             ---------------------------------------------ccceecCCcccCHHHHcCCC-CCccccHHHHHHHH
Confidence                                                         01224577899999987654 78899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||...+....+..+... ..+                   ....      -...+..+.+++.+||+.||++
T Consensus       188 ~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------------~~~~------~~~~~~~~~~~i~~~l~~~p~~  241 (253)
T cd05122         188 IELAEGKPPYSELPPMKALFKIATN-GPP-------------------GLRN------PEKWSDEFKDFLKKCLQKNPEK  241 (253)
T ss_pred             HHHHhCCCCCCCCchHHHHHHHHhc-CCC-------------------CcCc------ccccCHHHHHHHHHHccCChhh
Confidence            9999999999877555444433221 000                   0000      0001457899999999999999


Q ss_pred             CCCHHHHHcCcc
Q psy10954        337 RVSAKTILQHEY  348 (562)
Q Consensus       337 R~Ta~elL~Hp~  348 (562)
                      |||+.|+++|||
T Consensus       242 R~t~~~~l~~~~  253 (253)
T cd05122         242 RPTAEQLLKHPF  253 (253)
T ss_pred             CCCHHHHhcCCC
Confidence            999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.2e-30  Score=260.39  Aligned_cols=219  Identities=30%  Similarity=0.491  Sum_probs=170.1

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+++++.++|+||+++++.+...+..++|+||+++ +|.+++.... .+++..++.++.|++.||.|||++||
T Consensus        42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i  120 (264)
T cd06626          42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGI  120 (264)
T ss_pred             HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678999999999999999999999999999999999985 8999887643 58899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.+||+|||++..........                                            
T Consensus       121 ~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--------------------------------------------  156 (264)
T cd06626         121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--------------------------------------------  156 (264)
T ss_pred             ccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc--------------------------------------------
Confidence            999999999999999999999999876542110000                                            


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC--CCCchhhHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAG  253 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~--~y~~~~DIWSlG  253 (562)
                                                                 ........++..|+|||++.+..  .++.++||||+|
T Consensus       157 -------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G  193 (264)
T cd06626         157 -------------------------------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG  193 (264)
T ss_pred             -------------------------------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHH
Confidence                                                       00001234677899999987543  378899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++++|++|..||.+.... .....+..  +..+.               ++.         ....++.+.+|+.+||+.
T Consensus       194 ~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~---------------~~~---------~~~~~~~~~~li~~~l~~  247 (264)
T cd06626         194 CVVLEMATGKRPWSELDNEFQIMFHVGA--GHKPP---------------IPD---------SLQLSPEGKDFLDRCLES  247 (264)
T ss_pred             HHHHHHHhCCCCccCCcchHHHHHHHhc--CCCCC---------------CCc---------ccccCHHHHHHHHHHccC
Confidence            9999999999999765332 22222211  11000               000         011246788999999999


Q ss_pred             CCCCCCCHHHHHcCccc
Q psy10954        333 DPKQRVSAKTILQHEYF  349 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f  349 (562)
                      ||.+|||+.|+++|||+
T Consensus       248 ~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         248 DPKKRPTASELLQHPFV  264 (264)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=4.1e-31  Score=264.71  Aligned_cols=210  Identities=31%  Similarity=0.478  Sum_probs=164.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+++++.++||||+++++++...+..|+||||+++ +|.+++..   ....+++..+..++.|++.||.|||++|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  126 (267)
T cd08228          47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR  126 (267)
T ss_pred             HHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            3567899999999999999999999999999999999985 89888753   2335899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.++|+|||++........                                             
T Consensus       127 i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---------------------------------------------  161 (267)
T cd08228         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---------------------------------------------  161 (267)
T ss_pred             eeCCCCCHHHEEEcCCCCEEECccccceeccchhH---------------------------------------------
Confidence            99999999999999999999999998654321000                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    ......|++.|+|||.+.+.. ++.++|+||+||
T Consensus       162 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~  194 (267)
T cd08228         162 ----------------------------------------------AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGC  194 (267)
T ss_pred             ----------------------------------------------HHhcCCCCccccChhhhccCC-CCchhhHHHHHH
Confidence                                                          001124678899999997654 789999999999


Q ss_pred             HHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|||++|+.||.+... ...+...+...+.++.                          .....+..+.+++.+||..|
T Consensus       195 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~cl~~~  248 (267)
T cd08228         195 LLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------------------------PTEHYSEKLRELVSMCIYPD  248 (267)
T ss_pred             HHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--------------------------ChhhcCHHHHHHHHHHCCCC
Confidence            99999999999976532 2222222222111110                          00112457899999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy10954        334 PKQRVSAKTILQH  346 (562)
Q Consensus       334 P~~R~Ta~elL~H  346 (562)
                      |++|||+.++++.
T Consensus       249 p~~Rp~~~~vl~~  261 (267)
T cd08228         249 PDQRPDIGYVHQI  261 (267)
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.5e-30  Score=259.15  Aligned_cols=211  Identities=28%  Similarity=0.383  Sum_probs=168.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.++++++||||+++++.+.. ...++||||+. ++|.+++.+.. ..+++..+..++.|++.||.|||++|+
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i  118 (257)
T cd05040          40 MDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF  118 (257)
T ss_pred             HHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4567899999999999999999999988 89999999997 59999997755 468999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++........         |            .                      
T Consensus       119 ~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---------~------------~----------------------  155 (257)
T cd05040         119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---------Y------------V----------------------  155 (257)
T ss_pred             cccccCcccEEEecCCEEEeccccccccccccccc---------e------------e----------------------
Confidence            99999999999999999999999987654211000         0            0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||.+.+.. ++.++||||+||+
T Consensus       156 ---------------------------------------------~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~  189 (257)
T cd05040         156 ---------------------------------------------MEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVT  189 (257)
T ss_pred             ---------------------------------------------cccCCCCCceecCHHHhcccC-cCchhhhHHHHHH
Confidence                                                         000124567899999987654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+.+..+... +..    ++                      .....+..+.+++.+||+.+|
T Consensus       190 l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~----~~----------------------~~~~~~~~~~~li~~~l~~~p  242 (257)
T cd05040         190 LWEMFTYGEEPWAGLSGSQILKKIDKE-GER----LE----------------------RPEACPQDIYNVMLQCWAHNP  242 (257)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhc-CCc----CC----------------------CCccCCHHHHHHHHHHCCCCc
Confidence            999998 99999877776655554321 000    00                      001124578899999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.++++
T Consensus       243 ~~Rps~~~~~~  253 (257)
T cd05040         243 ADRPTFAALRE  253 (257)
T ss_pred             ccCCCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4645|consensus

Probab=99.97  E-value=5.7e-33  Score=315.20  Aligned_cols=217  Identities=30%  Similarity=0.488  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|..+|..|+|||+|++|++-.+++.+||.||||. |+|.+.++. ++..+|...+-|..|++.|+.|||+.||||
T Consensus      1279 ~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVH 1357 (1509)
T KOG4645|consen 1279 KLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVH 1357 (1509)
T ss_pred             cchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCcee
Confidence            346799999999999999999999999999999999997 588888764 345788888999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.+|.+|++|||.|..+..+.+.          +++|                                 
T Consensus      1358 RDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~----------~~~e--------------------------------- 1394 (1509)
T KOG4645|consen 1358 RDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT----------MPGE--------------------------------- 1394 (1509)
T ss_pred             cCCCccceeeecCCcEEeecccceeEecCchhc----------CCHH---------------------------------
Confidence            999999999999999999999998765422100          0011                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC--CCCchhhHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCI  255 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~--~y~~~~DIWSlG~i  255 (562)
                                                                  .....||+.|||||+|.|.+  +.+-+.||||+||+
T Consensus      1395 --------------------------------------------l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1395 --------------------------------------------LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCV 1430 (1509)
T ss_pred             --------------------------------------------HHhhcCCchhcCchhhcccccCCCCcchhhhcccce
Confidence                                                        12457899999999998754  46778999999999


Q ss_pred             HHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ..||+||+.||..-+. -..++.+    |.-+.                |.        +-...++..+|||.+||+.||
T Consensus      1431 VlEM~tGkrPW~~~dne~aIMy~V----~~gh~----------------Pq--------~P~~ls~~g~dFle~Cl~~dP 1482 (1509)
T KOG4645|consen 1431 VLEMATGKRPWAELDNEWAIMYHV----AAGHK----------------PQ--------IPERLSSEGRDFLEHCLEQDP 1482 (1509)
T ss_pred             EEEeecCCCchhhccchhHHHhHH----hccCC----------------CC--------CchhhhHhHHHHHHHHHhcCc
Confidence            9999999999975433 2222222    21111                00        001135789999999999999


Q ss_pred             CCCCCHHHHHcCccccC
Q psy10954        335 KQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~  351 (562)
                      ++|.++.|+|.|.|-+.
T Consensus      1483 ~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1483 KMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hhhhHHHHHHHhhcccc
Confidence            99999999999998754

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=1.4e-30  Score=261.30  Aligned_cols=210  Identities=20%  Similarity=0.321  Sum_probs=166.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++++...+..|+||||+++ +|.+++......+++..+..++.|++.||+|||++|++|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  130 (268)
T cd05063          51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH  130 (268)
T ss_pred             HHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            3567899999999999999999999999999999999985 899998776667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++..........                                              
T Consensus       131 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~----------------------------------------------  164 (268)
T cd05063         131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT----------------------------------------------  164 (268)
T ss_pred             cccchhhEEEcCCCcEEECCCccceecccccccc----------------------------------------------
Confidence            9999999999999999999999875432100000                                              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                     +.           ......+..|+|||++.+.. ++.++||||+||++|
T Consensus       165 -------------------------------~~-----------~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~  201 (268)
T cd05063         165 -------------------------------YT-----------TSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMW  201 (268)
T ss_pred             -------------------------------ee-----------ccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHH
Confidence                                           00           00012245799999987654 789999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||...+..+....+......+.                            ....+..+.+++.+|++.||++
T Consensus       202 ell~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~~~~li~~c~~~~p~~  253 (268)
T cd05063         202 EVMSFGERPYWDMSNHEVMKAINDGFRLPA----------------------------PMDCPSAVYQLMLQCWQQDRAR  253 (268)
T ss_pred             HHHhCCCCCCCcCCHHHHHHHHhcCCCCCC----------------------------CCCCCHHHHHHHHHHcCCCccc
Confidence            9997 9999987776655555532211100                            0112456889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      ||++.++++
T Consensus       254 Rp~~~~i~~  262 (268)
T cd05063         254 RPRFVDIVN  262 (268)
T ss_pred             CcCHHHHHH
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=4.2e-31  Score=263.93  Aligned_cols=210  Identities=30%  Similarity=0.484  Sum_probs=166.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+.+++.++||||+++++++......|+||||+.+ +|.+++..   ....+++..++.++.|++.||.|||++|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (260)
T cd08222          47 VQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR  126 (260)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence            4567899999999999999999999988999999999985 88888754   2346899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ++|+||||+||+++. +.+||+|||+++......                                              
T Consensus       127 i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~----------------------------------------------  159 (260)
T cd08222         127 ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC----------------------------------------------  159 (260)
T ss_pred             ccccCCChhheEeec-CCEeecccCceeecCCCc----------------------------------------------
Confidence            999999999999974 679999999864331100                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......|++.|+|||.+.+.. ++.++|+||+||
T Consensus       160 ---------------------------------------------~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~  193 (260)
T cd08222         160 ---------------------------------------------DLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGC  193 (260)
T ss_pred             ---------------------------------------------ccccCCCCCcCccCHHHHccCC-CCchhhHHHHHH
Confidence                                                         0001224678899999986544 788999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|..||.+.........+..  +..+                  .        .....+..+.+++.+||..||
T Consensus       194 ~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~------------------~--------~~~~~~~~~~~li~~~l~~~p  245 (260)
T cd08222         194 ILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP------------------S--------LPETYSRQLNSIMQSMLNKDP  245 (260)
T ss_pred             HHHHHHhCCCCCCCccHHHHHHHHHc--CCCC------------------C--------CcchhcHHHHHHHHHHhcCCh
Confidence            99999999999987665544444322  1100                  0        001224578999999999999


Q ss_pred             CCCCCHHHHHcCccc
Q psy10954        335 KQRVSAKTILQHEYF  349 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f  349 (562)
                      ++||++.|+++||||
T Consensus       246 ~~Rp~~~~il~~~~~  260 (260)
T cd08222         246 SLRPSAAEILRNPFI  260 (260)
T ss_pred             hhCcCHHHHhhCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.3e-30  Score=260.10  Aligned_cols=205  Identities=25%  Similarity=0.405  Sum_probs=161.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEE-eCCEEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~-~~~~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+.++++++|+||+++++++. .++..|+||||+++ +|.+++..... .+++..+..++.|++.||+|||++|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  122 (256)
T cd05082          43 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456789999999999999999999754 55689999999975 99999876543 4889999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||+++......                                              
T Consensus       123 i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----------------------------------------------  156 (256)
T cd05082         123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------------------------------------------  156 (256)
T ss_pred             EeccccchheEEEcCCCcEEecCCccceeccccC----------------------------------------------
Confidence            9999999999999999999999999865321000                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                      ....++..|+|||++.+.. ++.++||||+||
T Consensus       157 ------------------------------------------------~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~  187 (256)
T cd05082         157 ------------------------------------------------DTGKLPVKWTAPEALREKK-FSTKSDVWSFGI  187 (256)
T ss_pred             ------------------------------------------------CCCccceeecCHHHHccCC-CCchhhhHHHHH
Confidence                                                            0011245699999886554 789999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|||++ |+.||...+..+....+....  +.               .           .....++.+.+++.+||+.|
T Consensus       188 i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~---------------~-----------~~~~~~~~~~~li~~~l~~~  239 (256)
T cd05082         188 LLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KM---------------D-----------APDGCPPVVYDVMKQCWHLD  239 (256)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC---------------C-----------CCCCCCHHHHHHHHHHhcCC
Confidence            9999997 999998766544433332110  00               0           01123567899999999999


Q ss_pred             CCCCCCHHHHHc
Q psy10954        334 PKQRVSAKTILQ  345 (562)
Q Consensus       334 P~~R~Ta~elL~  345 (562)
                      |++|||+.++++
T Consensus       240 p~~Rpt~~~l~~  251 (256)
T cd05082         240 AATRPSFLQLRE  251 (256)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=8.1e-31  Score=274.54  Aligned_cols=211  Identities=23%  Similarity=0.433  Sum_probs=162.9

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEe-CCEEEEEeecCcC-CHHHHHhhCC---------------------------
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTP---------------------------   68 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~-~~~i~lV~Ey~~~-~L~~~i~~~~---------------------------   68 (562)
                      ..+.+|+.+++++ +||||+++++++.. +..+|+||||+.+ +|.+++....                           
T Consensus        55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (337)
T cd05054          55 KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD  134 (337)
T ss_pred             HHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence            3567899999999 89999999998764 4679999999985 8998886422                           


Q ss_pred             ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeE
Q psy10954         69 ---------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL  115 (562)
Q Consensus        69 ---------------------------------~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL  115 (562)
                                                       ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL  214 (337)
T cd05054         135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI  214 (337)
T ss_pred             cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEE
Confidence                                             25788999999999999999999999999999999999999999999


Q ss_pred             eeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcc
Q psy10954        116 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN  195 (562)
Q Consensus       116 ~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeN  195 (562)
                      +|||+++.+....               +..                                                 
T Consensus       215 ~DfG~a~~~~~~~---------------~~~-------------------------------------------------  230 (337)
T cd05054         215 CDFGLARDIYKDP---------------DYV-------------------------------------------------  230 (337)
T ss_pred             eccccchhcccCc---------------chh-------------------------------------------------
Confidence            9999976442100               000                                                 


Q ss_pred             eeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy10954        196 ILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQ  274 (562)
Q Consensus       196 ILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~  274 (562)
                                               ......++..|+|||++.+.. ++.++||||+||++|||++ |..||.+....+.
T Consensus       231 -------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~  284 (337)
T cd05054         231 -------------------------RKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE  284 (337)
T ss_pred             -------------------------hccCCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence                                     001123467799999997754 8999999999999999997 9999987554444


Q ss_pred             HHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        275 LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       275 l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +...+.. +....                          ......+.+.+++.+||+.+|++|||+.|+++|
T Consensus       285 ~~~~~~~-~~~~~--------------------------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         285 FCRRLKE-GTRMR--------------------------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHhc-cCCCC--------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3333221 00000                          001124678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=8e-31  Score=270.94  Aligned_cols=210  Identities=20%  Similarity=0.334  Sum_probs=164.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++... ..++|+||+. ++|.+++......+++..+..++.|++.||+|||++||+
T Consensus        53 ~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ii  131 (316)
T cd05108          53 NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV  131 (316)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCee
Confidence            35678899999999999999999998764 5789999997 589999987666789999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.........                                             
T Consensus       132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~---------------------------------------------  166 (316)
T cd05108         132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY---------------------------------------------  166 (316)
T ss_pred             ccccchhheEecCCCcEEEccccccccccCCCcce---------------------------------------------
Confidence            99999999999999999999999986543110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......+|..|+|||.+.+.. ++.++||||+||++
T Consensus       167 --------------------------------------------~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l  201 (316)
T cd05108         167 --------------------------------------------HAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTV  201 (316)
T ss_pred             --------------------------------------------eccCCccceeecChHHhccCC-CCchhhhHHHHHHH
Confidence                                                        000112366799999997654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |..||.+....+ +..+......++.                           ....+..+.+++.+|++.||+
T Consensus       202 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~cl~~~p~  253 (316)
T cd05108         202 WELMTFGSKPYDGIPASE-ISSILEKGERLPQ---------------------------PPICTIDVYMIMVKCWMIDAD  253 (316)
T ss_pred             HHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCC---------------------------CCCCCHHHHHHHHHHccCChh
Confidence            99997 999998766543 3333321110000                           011235678999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||+.+++.+
T Consensus       254 ~Rps~~~l~~~  264 (316)
T cd05108         254 SRPKFRELIIE  264 (316)
T ss_pred             hCcCHHHHHHH
Confidence            99999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.4e-30  Score=260.39  Aligned_cols=207  Identities=23%  Similarity=0.387  Sum_probs=163.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+++.++||||+++++++. ....|+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++||
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            456789999999999999999999875 4568999999975 9999987643 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++........                       .                      
T Consensus       124 ~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-----------------------~----------------------  158 (260)
T cd05070         124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-----------------------T----------------------  158 (260)
T ss_pred             ccCCCccceEEEeCCceEEeCCceeeeeccCccc-----------------------c----------------------
Confidence            9999999999999999999999998754321000                       0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||++.+.. ++.++||||+||+
T Consensus       159 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  192 (260)
T cd05070         159 ---------------------------------------------ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGIL  192 (260)
T ss_pred             ---------------------------------------------cccCCCCCccccChHHHhcCC-CcchhhhHHHHHH
Confidence                                                         000112456799999887654 7899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++ |.+||.+.+..+.+..+......+                            .....+..+.+|+.+||..||
T Consensus       193 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p  244 (260)
T cd05070         193 LTELVTKGRVPYPGMNNREVLEQVERGYRMP----------------------------CPQDCPISLHELMLQCWKKDP  244 (260)
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHHHcccCc
Confidence            999999 899998877666555553211100                            001224678999999999999


Q ss_pred             CCCCCHHHHH
Q psy10954        335 KQRVSAKTIL  344 (562)
Q Consensus       335 ~~R~Ta~elL  344 (562)
                      ++|||++++.
T Consensus       245 ~~Rpt~~~l~  254 (260)
T cd05070         245 EERPTFEYLQ  254 (260)
T ss_pred             ccCcCHHHHH
Confidence            9999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=1.8e-30  Score=259.56  Aligned_cols=209  Identities=23%  Similarity=0.321  Sum_probs=162.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++. ....++||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+
T Consensus        40 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~  117 (257)
T cd05116          40 KDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFV  117 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            345789999999999999999999875 4577999999984 899998754 3689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||.||+++.++.+||+|||+++.........                                             
T Consensus       118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------  152 (257)
T cd05116         118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYY---------------------------------------------  152 (257)
T ss_pred             ecccchhhEEEcCCCeEEECCCccccccCCCCCee---------------------------------------------
Confidence            99999999999999999999999876442110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......++..|+|||.+.+. .++.++|+||+||++
T Consensus       153 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l  188 (257)
T cd05116         153 -------------------------------------------KAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLM  188 (257)
T ss_pred             -------------------------------------------eecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHH
Confidence                                                       000011346789999988654 488999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |..||.+.+..+....+.+.. .+                   .        .....++.+.|+|++|++.||+
T Consensus       189 ~el~t~g~~p~~~~~~~~~~~~i~~~~-~~-------------------~--------~~~~~~~~l~~li~~~~~~~p~  240 (257)
T cd05116         189 WEAFSYGQKPYKGMKGNEVTQMIESGE-RM-------------------E--------CPQRCPPEMYDLMKLCWTYGVD  240 (257)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHCCC-CC-------------------C--------CCCCCCHHHHHHHHHHhccCch
Confidence            99997 999998876655544442210 00                   0        0012346789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||++++.+
T Consensus       241 ~Rp~~~~i~~  250 (257)
T cd05116         241 ERPGFAVVEL  250 (257)
T ss_pred             hCcCHHHHHH
Confidence            9999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.6e-31  Score=264.93  Aligned_cols=199  Identities=25%  Similarity=0.365  Sum_probs=156.1

Q ss_pred             HHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy10954         22 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL  100 (562)
Q Consensus        22 ~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDL  100 (562)
                      .+|...+....||||+++++++......|+||||+.+ +|.+++.... .+++..+..++.|++.||+|||++||+||||
T Consensus        33 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl  111 (237)
T cd05576          33 SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDL  111 (237)
T ss_pred             hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            4565556666799999999999999999999999985 8999887643 5899999999999999999999999999999


Q ss_pred             CCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHh
Q psy10954        101 KPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY  180 (562)
Q Consensus       101 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~y  180 (562)
                      ||+||+++.++.++++|||.+......                                                     
T Consensus       112 kp~Nil~~~~~~~~l~df~~~~~~~~~-----------------------------------------------------  138 (237)
T cd05576         112 NPNNILLDDRGHIQLTYFSRWSEVEDS-----------------------------------------------------  138 (237)
T ss_pred             CHHHEEEcCCCCEEEecccchhccccc-----------------------------------------------------
Confidence            999999999999999999975432110                                                     


Q ss_pred             hhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHH
Q psy10954        181 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  260 (562)
Q Consensus       181 LHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLl  260 (562)
                                                               .....++..|+|||.+.+.. ++.++|+||+||++|||+
T Consensus       139 -----------------------------------------~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~  176 (237)
T cd05576         139 -----------------------------------------CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELL  176 (237)
T ss_pred             -----------------------------------------cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHH
Confidence                                                     00112355688999875543 788999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCH
Q psy10954        261 TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSA  340 (562)
Q Consensus       261 tG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta  340 (562)
                      +|+.||.......     .            ..     .....+           ...++.+.+++.+||+.||++|+|+
T Consensus       177 ~g~~~~~~~~~~~-----~------------~~-----~~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         177 TGKTLVECHPSGI-----N------------TH-----TTLNIP-----------EWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HCcchhhcCchhc-----c------------cc-----cccCCc-----------ccCCHHHHHHHHHHccCCHHHhcCC
Confidence            9998875432110     0            00     000011           1235678999999999999999996


Q ss_pred             -----HHHHcCccc
Q psy10954        341 -----KTILQHEYF  349 (562)
Q Consensus       341 -----~elL~Hp~f  349 (562)
                           +|+++||||
T Consensus       224 ~~~~~~~~~~h~~~  237 (237)
T cd05576         224 GVAGVEDIKSHPFF  237 (237)
T ss_pred             CccchHHHHcCCCC
Confidence                 899999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=257.43  Aligned_cols=211  Identities=32%  Similarity=0.582  Sum_probs=172.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|++++++++||||+++++++......|+||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~  121 (254)
T cd06627          43 LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVI  121 (254)
T ss_pred             HHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence            34578999999999999999999999999999999999975 899988765 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.++|+|||++........                                               
T Consensus       122 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----------------------------------------------  154 (254)
T cd06627         122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSK-----------------------------------------------  154 (254)
T ss_pred             cCCCCHHHEEECCCCCEEEeccccceecCCCcc-----------------------------------------------
Confidence            999999999999999999999998764421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||.+.+.. ++.++|+||+|+++
T Consensus       155 --------------------------------------------~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l  189 (254)
T cd06627         155 --------------------------------------------DDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTV  189 (254)
T ss_pred             --------------------------------------------cccccccchhhcCHhhhcCCC-CCcchhHHHHHHHH
Confidence                                                        001124577899999887655 78999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ++|++|..||...+.......+...   ..                 +.        .....+..+.+++.+||..||++
T Consensus       190 ~~l~~g~~p~~~~~~~~~~~~~~~~---~~-----------------~~--------~~~~~~~~~~~~i~~~l~~~p~~  241 (254)
T cd06627         190 IELLTGNPPYYDLNPMAALFRIVQD---DH-----------------PP--------LPEGISPELKDFLMQCFQKDPNL  241 (254)
T ss_pred             HHHHhCCCCCCCccHHHHHHHHhcc---CC-----------------CC--------CCCCCCHHHHHHHHHHHhCChhh
Confidence            9999999999876655444443210   00                 00        00122467889999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      |||+.++++||||
T Consensus       242 R~~~~~~l~~~~~  254 (254)
T cd06627         242 RPTAKQLLKHPWI  254 (254)
T ss_pred             CcCHHHHhcCCCC
Confidence            9999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=260.14  Aligned_cols=213  Identities=27%  Similarity=0.479  Sum_probs=167.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|++++++++||||+++++.+...  ..+++||||+++ +|.+++.... .+++..++.++.|++.||.|||++|+
T Consensus        49 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i  127 (264)
T cd06653          49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMI  127 (264)
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4567899999999999999999998764  568999999975 8999887644 58999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||+++.......            +                                 
T Consensus       128 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~------------~---------------------------------  162 (264)
T cd06653         128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICM------------S---------------------------------  162 (264)
T ss_pred             ecCCCCHHHEEEcCCCCEEECccccccccccccc------------c---------------------------------
Confidence            9999999999999999999999998764321000            0                                 


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 ........||..|+|||.+.+.. ++.++|+||+||+
T Consensus       163 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  198 (264)
T cd06653         163 -------------------------------------------GTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACT  198 (264)
T ss_pred             -------------------------------------------CccccccCCcccccCHhhhcCCC-CCccccHHHHHHH
Confidence                                                       00011235788899999997754 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|++||.+........++.   ..+....                        +-...++.+.+++.+||+ +|.
T Consensus       199 l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~------------------------~p~~~~~~~~~~i~~~l~-~~~  250 (264)
T cd06653         199 VVEMLTEKPPWAEYEAMAAIFKIA---TQPTKPM------------------------LPDGVSDACRDFLKQIFV-EEK  250 (264)
T ss_pred             HHHHHhCCCCCCccCHHHHHHHHH---cCCCCCC------------------------CCcccCHHHHHHHHHHhc-Ccc
Confidence            999999999998776555444332   1111100                        011234678999999999 579


Q ss_pred             CCCCHHHHHcCccc
Q psy10954        336 QRVSAKTILQHEYF  349 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f  349 (562)
                      +|||+.+++.|||.
T Consensus       251 ~r~~~~~~~~~~~~  264 (264)
T cd06653         251 RRPTAEFLLRHPFV  264 (264)
T ss_pred             cCccHHHHhcCCCC
Confidence            99999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=1.1e-30  Score=260.64  Aligned_cols=208  Identities=25%  Similarity=0.397  Sum_probs=167.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|+.++||||+++++++......|+||||+++ +|.+++.... ..+++..+..++.|++.||.|||++||
T Consensus        46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i  125 (261)
T cd05148          46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS  125 (261)
T ss_pred             HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34577899999999999999999999999999999999975 9999997643 458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++.......                       +                       
T Consensus       126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-----------------------~-----------------------  159 (261)
T cd05148         126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDV-----------------------Y-----------------------  159 (261)
T ss_pred             eccccCcceEEEcCCceEEEccccchhhcCCcc-----------------------c-----------------------
Confidence            999999999999999999999999875432100                       0                       


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||++.+. .++.++||||+||+
T Consensus       160 ---------------------------------------------~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~  193 (261)
T cd05148         160 ---------------------------------------------LSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGIL  193 (261)
T ss_pred             ---------------------------------------------cccCCCCceEecCHHHHccC-CCCchhhHHHHHHH
Confidence                                                         00011245679999998765 48899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++ |+.||.+.+..+.+..+......+                            .....++.+.+++.+||+.||
T Consensus       194 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p  245 (261)
T cd05148         194 LYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------------------------CPAKCPQEIYKIMLECWAAEP  245 (261)
T ss_pred             HHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC----------------------------CCCCCCHHHHHHHHHHcCCCc
Confidence            999998 899998877666555554211110                            001234678899999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      .+|||+.++++
T Consensus       246 ~~Rpt~~~l~~  256 (261)
T cd05148         246 EDRPSFKALRE  256 (261)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=261.40  Aligned_cols=210  Identities=23%  Similarity=0.343  Sum_probs=162.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCE------EEEEeecCcC-CHHHHHhhC-----CCCCCHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFK------LFLVFEFLRQ-DLKDFLQTT-----PVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~------i~lV~Ey~~~-~L~~~i~~~-----~~~l~e~~i~~i~~qll~a   86 (562)
                      ..+.+|+.+|+.++||||+++++++.....      .++||||+.+ +|..++...     ...+++..+..++.|++.|
T Consensus        46 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~a  125 (273)
T cd05035          46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG  125 (273)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHH
Confidence            357899999999999999999998865543      7999999974 898887442     1358999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++||+||||||+||+++.++.+||+|||+++.......          |.                         
T Consensus       126 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~----------~~-------------------------  170 (273)
T cd05035         126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY----------YR-------------------------  170 (273)
T ss_pred             HHHHHhCCeeccccchheEEECCCCeEEECCccceeecccccc----------cc-------------------------
Confidence            9999999999999999999999999999999998764421100          00                         


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                            ......++..|+|||++.+. .++.+
T Consensus       171 ------------------------------------------------------~~~~~~~~~~~~~pe~~~~~-~~~~~  195 (273)
T cd05035         171 ------------------------------------------------------QGRIAKMPVKWIAIESLADR-VYTSK  195 (273)
T ss_pred             ------------------------------------------------------ccccccCCccccCHhhcccC-CCCcc
Confidence                                                                  00011235679999998654 48999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        247 VDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       247 ~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      +||||+||++|||++ |.+||.+....+.+..+....  ..                  .        .....+..+.++
T Consensus       196 ~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~------------------~--------~~~~~~~~~~~l  247 (273)
T cd05035         196 SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--RL------------------K--------QPEDCLDELYDL  247 (273)
T ss_pred             cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CC------------------C--------CCcCCCHHHHHH
Confidence            999999999999999 899998877655544432210  00                  0        001234678999


Q ss_pred             HHHccccCCCCCCCHHHHHcC
Q psy10954        326 FSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+||+.||++|||+.|++++
T Consensus       248 i~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         248 MYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=2.2e-30  Score=257.90  Aligned_cols=209  Identities=25%  Similarity=0.429  Sum_probs=166.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|++++++++||||+++++++......|+||||+.+ +|.+++......++++.++.++.|++.||+|||++|++|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h  123 (256)
T cd05112          44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH  123 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4578999999999999999999999999999999999975 899998876667899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++......  .                     .                        
T Consensus       124 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~---------------------~------------------------  156 (256)
T cd05112         124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--Y---------------------T------------------------  156 (256)
T ss_pred             cccccceEEEcCCCeEEECCCcceeecccCc--c---------------------c------------------------
Confidence            9999999999999999999999865331100  0                     0                        


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+.. ++.++|+||+||++|
T Consensus       157 -------------------------------------------~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~  192 (256)
T cd05112         157 -------------------------------------------SSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMW  192 (256)
T ss_pred             -------------------------------------------ccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHH
Confidence                                                       000123456799999987644 889999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||......+.+..+......                     ..+       ...+..+.+|+.+||+.||++
T Consensus       193 el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~-------~~~~~~~~~l~~~~l~~~p~~  244 (256)
T cd05112         193 EVFSEGKTPYENRSNSEVVETINAGFRL---------------------YKP-------RLASQSVYELMQHCWKERPED  244 (256)
T ss_pred             HHHcCCCCCCCcCCHHHHHHHHhCCCCC---------------------CCC-------CCCCHHHHHHHHHHcccChhh
Confidence            9998 99999877765544443211000                     000       112467899999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.|++++
T Consensus       245 Rp~~~~~l~~  254 (256)
T cd05112         245 RPSFSLLLHQ  254 (256)
T ss_pred             CCCHHHHHHh
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=2.8e-30  Score=258.54  Aligned_cols=208  Identities=24%  Similarity=0.383  Sum_probs=164.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++++.++||||+++++++. ....|+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++||
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            356789999999999999999999875 4568999999985 9999997643 347899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||+++........                                             
T Consensus       124 ~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~---------------------------------------------  158 (260)
T cd05069         124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---------------------------------------------  158 (260)
T ss_pred             eecccCcceEEEcCCCeEEECCCccceEccCCccc---------------------------------------------
Confidence            99999999999999999999999987543210000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||.+.+.. ++.++||||+||+
T Consensus       159 ---------------------------------------------~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~  192 (260)
T cd05069         159 ---------------------------------------------ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGIL  192 (260)
T ss_pred             ---------------------------------------------ccCCCccchhhCCHHHhccCC-cChHHHHHHHHHH
Confidence                                                         000112466799999887654 7899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |..||.+....+....+......+                            .....+..+.+++++||..||
T Consensus       193 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p  244 (260)
T cd05069         193 LTELVTKGRVPYPGMVNREVLEQVERGYRMP----------------------------CPQGCPESLHELMKLCWKKDP  244 (260)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCcccCHHHHHHHHHHccCCc
Confidence            999999 899999877766555543211000                            001224578999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++||+++++++
T Consensus       245 ~~Rp~~~~i~~  255 (260)
T cd05069         245 DERPTFEYIQS  255 (260)
T ss_pred             ccCcCHHHHHH
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.7e-30  Score=261.65  Aligned_cols=209  Identities=23%  Similarity=0.392  Sum_probs=164.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------~~l~e~~i~~i~~qll~aL~   88 (562)
                      ..+.+|+.+|+.++||||+++++++......|+||||++ ++|.+++....         ..+++..+..++.|++.||.
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  133 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHH
Confidence            357799999999999999999999999999999999997 59999986532         23678889999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||++||+||||||+||+++.++.+||+|||+++.......                      +                
T Consensus       134 ~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~----------------------~----------------  175 (277)
T cd05032         134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY----------------------Y----------------  175 (277)
T ss_pred             HHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcc----------------------c----------------
Confidence            99999999999999999999999999999998754321000                      0                


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         .......+|..|+|||.+.+.. ++.++|
T Consensus       176 ---------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  203 (277)
T cd05032         176 ---------------------------------------------------RKGGKGLLPVRWMAPESLKDGV-FTTKSD  203 (277)
T ss_pred             ---------------------------------------------------ccCCCCCccccccCHHHHhcCC-CCcccc
Confidence                                                               0001224577899999987654 889999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|||++ |..||.+.+..+....+. ..+.+.                .+           ...+..+.+++.
T Consensus       204 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~----------------~~-----------~~~~~~~~~li~  255 (277)
T cd05032         204 VWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLD----------------LP-----------ENCPDKLLELMR  255 (277)
T ss_pred             hHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCC----------------CC-----------CCCCHHHHHHHH
Confidence            9999999999998 999998777655444332 111000                00           112467889999


Q ss_pred             HccccCCCCCCCHHHHHc
Q psy10954        328 KIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~  345 (562)
                      +||+.||++|||+.++++
T Consensus       256 ~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         256 MCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHcCCChhhCCCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=2.1e-30  Score=260.36  Aligned_cols=211  Identities=25%  Similarity=0.333  Sum_probs=160.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCc-CCHHHHHhh-----CCCCCCHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLR-QDLKDFLQT-----TPVPVPPALAKSYLYQLLE   85 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~-~~L~~~i~~-----~~~~l~e~~i~~i~~qll~   85 (562)
                      ...+.+|+++|+.++||||+++++.+...      ...++||||+. ++|.+++..     ....+++..+..++.|++.
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  123 (272)
T cd05075          44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS  123 (272)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHH
Confidence            34577899999999999999999976432      25799999997 589888742     1234899999999999999


Q ss_pred             HHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccc
Q psy10954         86 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  165 (562)
Q Consensus        86 aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il  165 (562)
                      ||+|||++||+||||||+|||++.++.+||+|||+++.......                ..                  
T Consensus       124 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------------~~------------------  169 (272)
T cd05075         124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY----------------YR------------------  169 (272)
T ss_pred             HHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccc----------------ee------------------
Confidence            99999999999999999999999999999999998764321000                00                  


Q ss_pred             hhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       166 ~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                                                                             ......+++.|+|||.+.+. .++.
T Consensus       170 -------------------------------------------------------~~~~~~~~~~~~~pe~~~~~-~~~~  193 (272)
T cd05075         170 -------------------------------------------------------QGRIAKMPVKWIAIESLADR-VYTT  193 (272)
T ss_pred             -------------------------------------------------------cCCcccCCcccCCHHHccCC-CcCh
Confidence                                                                   00011346779999998765 4899


Q ss_pred             hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        246 TVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       246 ~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      ++||||+||++|||++ |++||.+....+....+...  ....                          .....+..+.+
T Consensus       194 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------------~~~~~~~~~~~  245 (272)
T cd05075         194 KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NRLK--------------------------QPPDCLDGLYS  245 (272)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CCCC--------------------------CCCCCCHHHHH
Confidence            9999999999999999 89999887655444333211  0000                          00112356889


Q ss_pred             HHHHccccCCCCCCCHHHHHcC
Q psy10954        325 VFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ++.+||+.||++|||+.+++++
T Consensus       246 li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         246 LMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.1e-30  Score=265.44  Aligned_cols=220  Identities=28%  Similarity=0.432  Sum_probs=168.7

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|+++++++ +||||+++++.+..+..+|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++
T Consensus        49 ~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~  127 (288)
T cd05583          49 EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGII  127 (288)
T ss_pred             HHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4567899999999 699999999999999999999999975 899888654 3689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||.||+++.++.++|+|||+++........                                              
T Consensus       128 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------------------------------------  161 (288)
T cd05583         128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE----------------------------------------------  161 (288)
T ss_pred             ccCCCHHHeEECCCCCEEEEECcccccccccccc----------------------------------------------
Confidence            9999999999999999999999987543210000                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-CCCchhhHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCI  255 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-~y~~~~DIWSlG~i  255 (562)
                                                                  ......|+..|+|||.+.+.. ..+.++|+||+||+
T Consensus       162 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~i  197 (288)
T cd05583         162 --------------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL  197 (288)
T ss_pred             --------------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHH
Confidence                                                        001124678899999986543 36789999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|..||...........+.+..-..                 .+.        .....+..+.+++.+||+.||+
T Consensus       198 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~--------~~~~~~~~l~~li~~~l~~~p~  252 (288)
T cd05583         198 TFELLTGASPFTVDGEQNSQSEISRRILKS-----------------KPP--------FPKTMSAEARDFIQKLLEKDPK  252 (288)
T ss_pred             HHHHHhCCCCcccCcccchHHHHHHHHHcc-----------------CCC--------CCcccCHHHHHHHHHHhcCCHh
Confidence            999999999996543221111111110000                 000        0011245789999999999999


Q ss_pred             CCCC---HHHHHcCccccCCcc
Q psy10954        336 QRVS---AKTILQHEYFNQVEM  354 (562)
Q Consensus       336 ~R~T---a~elL~Hp~f~~~~~  354 (562)
                      +|||   +.++|+||||+++.+
T Consensus       253 ~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         253 KRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             hccCcchHHHHhcCcccccCCH
Confidence            9998   567899999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=2e-30  Score=264.01  Aligned_cols=216  Identities=23%  Similarity=0.348  Sum_probs=166.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC----------CCCCHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------VPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~----------~~l~e~~i~~i~~qll~aL   87 (562)
                      ..+.+|+++|++++||||+++++++..+...++||||+.+ +|.+++....          ..+++..+..++.|++.||
T Consensus        64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al  143 (296)
T cd05051          64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGM  143 (296)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999999999999999974 8999987643          2589999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      .|||++||+||||||+||+++.++.++|+|||+++.......                                      
T Consensus       144 ~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--------------------------------------  185 (296)
T cd05051         144 RYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY--------------------------------------  185 (296)
T ss_pred             HHHHHcCccccccchhceeecCCCceEEccccceeecccCcc--------------------------------------
Confidence            999999999999999999999999999999998754321000                                      


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                               +          .......+|+.|+|||.+.+.. ++.++
T Consensus       186 -----------------------------------------~----------~~~~~~~~~~~y~aPE~~~~~~-~~~~~  213 (296)
T cd05051         186 -----------------------------------------Y----------RVQGRAPLPIRWMAWESVLLGK-FTTKS  213 (296)
T ss_pred             -----------------------------------------e----------eecCcCCCCceecCHHHhhcCC-CCccc
Confidence                                                     0          0001224577899999987654 89999


Q ss_pred             hHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        248 DIWSAGCIFSEMIT--KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       248 DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      ||||+||++|||++  |..||...+..+.+..............         .   . .        .....+..+.++
T Consensus       214 Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~---~-~--------~~~~~~~~l~~l  272 (296)
T cd05051         214 DVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQI---------Y---L-P--------RPPNCPKDIYEL  272 (296)
T ss_pred             hhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccc---------c---C-C--------CccCCCHHHHHH
Confidence            99999999999998  7788877666555544433211100000         0   0 0        001224678999


Q ss_pred             HHHccccCCCCCCCHHHHHc
Q psy10954        326 FSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~  345 (562)
                      +.+||+.||.+|||+.|+++
T Consensus       273 i~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         273 MLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHhccChhcCCCHHHHHH
Confidence            99999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=2.8e-30  Score=262.01  Aligned_cols=208  Identities=20%  Similarity=0.306  Sum_probs=161.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+..|+.++++++||||+++++++. ....++|+||+. ++|.+++......+++..+..++.|++.||.|||++|++|
T Consensus        54 ~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH  132 (279)
T cd05111          54 QEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH  132 (279)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            34567888899999999999999875 456889999997 5999999876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++........                                               
T Consensus       133 ~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------  165 (279)
T cd05111         133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKK-----------------------------------------------  165 (279)
T ss_pred             cccCcceEEEcCCCcEEEcCCccceeccCCCcc-----------------------------------------------
Confidence            999999999999999999999987643210000                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......++..|+|||.+.+.. ++.++||||+||++|
T Consensus       166 ------------------------------------------~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~  202 (279)
T cd05111         166 ------------------------------------------YFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVW  202 (279)
T ss_pred             ------------------------------------------cccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHH
Confidence                                                      0001224567899999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+...... ..++.....+.                           .....+....+++.+|+..||++
T Consensus       203 el~t~g~~p~~~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~  254 (279)
T cd05111         203 EMMSYGAEPYAGMRPHEV-PDLLEKGERLA---------------------------QPQICTIDVYMVMVKCWMIDENV  254 (279)
T ss_pred             HHHcCCCCCCCCCCHHHH-HHHHHCCCcCC---------------------------CCCCCCHHHHHHHHHHcCCCccc
Confidence            9998 9999987765432 22222110000                           00112346788999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.|+++
T Consensus       255 Rps~~el~~  263 (279)
T cd05111         255 RPTFKELAN  263 (279)
T ss_pred             CcCHHHHHH
Confidence            999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=2.8e-30  Score=266.67  Aligned_cols=208  Identities=25%  Similarity=0.404  Sum_probs=163.0

Q ss_pred             hHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHHH
Q psy10954         20 TALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLYQ   82 (562)
Q Consensus        20 ~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~q   82 (562)
                      .+.+|+.+++++ +||||+++++++..++.+|+||||+. ++|.+++....               ..++...+..++.|
T Consensus        63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  142 (314)
T cd05099          63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ  142 (314)
T ss_pred             HHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHH
Confidence            467899999999 69999999999999999999999997 49999986532               24788899999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         83 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        83 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      ++.||.|||++||+||||||+|||++.++.+||+|||+++.......          +         .            
T Consensus       143 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~----------~---------~------------  191 (314)
T cd05099         143 VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY----------Y---------K------------  191 (314)
T ss_pred             HHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccccccccccc----------c---------c------------
Confidence            99999999999999999999999999999999999998764321000          0         0            


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                                ......++..|+|||++.+. .
T Consensus       192 ----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~-~  212 (314)
T cd05099         192 ----------------------------------------------------------KTSNGRLPVKWMAPEALFDR-V  212 (314)
T ss_pred             ----------------------------------------------------------ccccCCCCccccCHHHHccC-C
Confidence                                                                      00011234679999999764 4


Q ss_pred             CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHH
Q psy10954        243 YSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL  321 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  321 (562)
                      ++.++||||+||++|||++ |..||.+.+..+.+..+...  ...               .           .....+..
T Consensus       213 ~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~---------------~-----------~~~~~~~~  264 (314)
T cd05099         213 YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG--HRM---------------D-----------KPSNCTHE  264 (314)
T ss_pred             cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCC---------------C-----------CCCCCCHH
Confidence            8999999999999999998 89999887665544433211  000               0           00112457


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHc
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      +.+++.+||..||++|||+.|+++
T Consensus       265 l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         265 LYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=2.7e-30  Score=259.49  Aligned_cols=207  Identities=22%  Similarity=0.365  Sum_probs=163.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++++.++||||+++++.+. ....|+||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+
T Consensus        46 ~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~  124 (262)
T cd05071          46 EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV  124 (262)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45789999999999999999999875 4568999999985 9999997643 3588999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||.++........                                              
T Consensus       125 H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~----------------------------------------------  158 (262)
T cd05071         125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT----------------------------------------------  158 (262)
T ss_pred             ccccCcccEEEcCCCcEEeccCCceeeccccccc----------------------------------------------
Confidence            9999999999999999999999987543211000                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||++.+.. ++.++|+||+||++
T Consensus       159 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l  193 (262)
T cd05071         159 --------------------------------------------ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILL  193 (262)
T ss_pred             --------------------------------------------cccCCcccceecCHhHhccCC-CCchhhHHHHHHHH
Confidence                                                        000123467799999887655 79999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |..||.+....+.+..+......+                            .....+..+.+++.+||+.||+
T Consensus       194 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~  245 (262)
T cd05071         194 TELTTKGRVPYPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEPE  245 (262)
T ss_pred             HHHHcCCCCCCCCCChHHHHHHHhcCCCCC----------------------------CccccCHHHHHHHHHHccCCcc
Confidence            99999 888998877665554443211000                            0012245788999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.++++
T Consensus       246 ~Rp~~~~~~~  255 (262)
T cd05071         246 ERPTFEYLQA  255 (262)
T ss_pred             cCCCHHHHHH
Confidence            9999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.9e-30  Score=258.05  Aligned_cols=202  Identities=20%  Similarity=0.302  Sum_probs=155.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++.. ...|+||||+++ +|.+++......+++..+..++.|++.||+|||++||+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            4567899999999999999999999887 778999999985 89999887655789999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC-------CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         97 HRDLKPQNILINKSG-------ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        97 HRDLKP~NILl~~~~-------~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||||||+|||++.++       .+||+|||++.                                               
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~-----------------------------------------------  156 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----------------------------------------------  156 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccc-----------------------------------------------
Confidence            999999999998766       45666666543                                               


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhh
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVD  248 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~D  248 (562)
                                                                  ....    ....+++..|+|||++.+. ..++.++|
T Consensus       157 --------------------------------------------~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~D  188 (259)
T cd05037         157 --------------------------------------------TVLS----REERVERIPWIAPECIRNGQASLTIAAD  188 (259)
T ss_pred             --------------------------------------------cccc----ccccccCCCccChhhhcCCCCCcchhhH
Confidence                                                        2211    1123456679999998765 45899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||+++||++ |..||...+..+... .......                  .+           ......+.+++.
T Consensus       189 i~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~~~------------------~~-----------~~~~~~~~~li~  238 (259)
T cd05037         189 KWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHR------------------LP-----------MPDCAELANLIN  238 (259)
T ss_pred             HHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcCCC------------------CC-----------CCCchHHHHHHH
Confidence            9999999999999 577786654222111 1110000                  00           001257889999


Q ss_pred             HccccCCCCCCCHHHHHc
Q psy10954        328 KIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~  345 (562)
                      +||..||.+|||+.++++
T Consensus       239 ~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         239 QCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHhccChhhCCCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1989|consensus

Probab=99.97  E-value=1.9e-31  Score=295.98  Aligned_cols=217  Identities=26%  Similarity=0.471  Sum_probs=161.4

Q ss_pred             chhhHHHHHHHHHccC-CCCcceEEEE-EEe------CCEEEEEeecCc-CCHHHHHhhC-CCCCCHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELK-HPNVIRLHDV-IPV------DFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~-HpnIv~L~~~-~~~------~~~i~lV~Ey~~-~~L~~~i~~~-~~~l~e~~i~~i~~qll~a   86 (562)
                      ....+.+||++|+.|. |||||.++|. ...      ...+.|.||||. +.|.+++..+ ...|+|..|..|++|+++|
T Consensus        77 ~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~A  156 (738)
T KOG1989|consen   77 ALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEA  156 (738)
T ss_pred             HHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHH
Confidence            3456789999999995 9999999993 221      135789999998 5999998743 3459999999999999999


Q ss_pred             HHHHHHCC--ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         87 LRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        87 L~yLH~~g--IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      |.+||...  |||||||-|||||+.+|..||||||.|.....               .|+--                  
T Consensus       157 Va~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~---------------~~~~~------------------  203 (738)
T KOG1989|consen  157 VAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL---------------SPTSA------------------  203 (738)
T ss_pred             HHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC---------------CCccH------------------
Confidence            99999987  99999999999999999999999998754321               11100                  


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhh--cCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKV  242 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl--~~~~~  242 (562)
                       .|+.++.+                     ||                           ....|+.|||||+|  .....
T Consensus       204 -~e~~~ve~---------------------eI---------------------------~k~TTp~YRsPEMIDlysg~p  234 (738)
T KOG1989|consen  204 -QEVNYVEE---------------------EI---------------------------EKYTTPQYRSPEMIDLYSGLP  234 (738)
T ss_pred             -HHHHHHHH---------------------HH---------------------------HhhCCccccChHHHhhhcCCC
Confidence             01111110                     00                           12348999999988  23345


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      .+.|+|||+|||+||-|+...+||.+.....    |+..                  ...+|..         +..+..+
T Consensus       235 I~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng------------------~Y~~P~~---------p~ys~~l  283 (738)
T KOG1989|consen  235 IGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNG------------------NYSFPPF---------PNYSDRL  283 (738)
T ss_pred             CcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEec------------------cccCCCC---------ccHHHHH
Confidence            7999999999999999999999998764321    1110                  0112221         1124578


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcC
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ++||+.||+.||.+||++.|++.+
T Consensus       284 ~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  284 KDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HHHHHHHhccCcccCCCHHHHHHH
Confidence            999999999999999999988754

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=2.7e-30  Score=265.12  Aligned_cols=210  Identities=23%  Similarity=0.361  Sum_probs=165.0

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|+.+++.+ +||||+++++++.....+|+||||+.+ +|.+++.+..               ..++...+..++.
T Consensus        65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (304)
T cd05101          65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY  144 (304)
T ss_pred             HHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence            4577999999999 899999999999999999999999974 9999987632               2467888899999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++........                               
T Consensus       145 qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~-------------------------------  193 (304)
T cd05101         145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY-------------------------------  193 (304)
T ss_pred             HHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceeccccccc-------------------------------
Confidence            9999999999999999999999999999999999999987644211000                               


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                .......+++.|+|||++.+..
T Consensus       194 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~  215 (304)
T cd05101         194 ----------------------------------------------------------KKTTNGRLPVKWMAPEALFDRV  215 (304)
T ss_pred             ----------------------------------------------------------ccccCCCCCceeeCchhhccCC
Confidence                                                                      0001123466799999997654


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       |+.++||||+||++|+|++ |..||.+.+..+....+....  ..               .           .....+.
T Consensus       216 -~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~---------------~-----------~~~~~~~  266 (304)
T cd05101         216 -YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--RM---------------D-----------KPANCTN  266 (304)
T ss_pred             -CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cC---------------C-----------CCCCCCH
Confidence             8999999999999999998 889998876655444332110  00               0           0012346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||..+|++|||+.|+++.
T Consensus       267 ~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         267 ELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHH
Confidence            78999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=3.7e-30  Score=257.06  Aligned_cols=211  Identities=21%  Similarity=0.341  Sum_probs=160.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEE-eCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~-~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+++.++||||+++++++. .++..|+||||+. ++|.+++.+....+++..+..++.|++.||.|||++||+
T Consensus        41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  120 (262)
T cd05058          41 EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV  120 (262)
T ss_pred             HHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            45678999999999999999999765 4566899999997 599999987655677888889999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......           ..+                                 
T Consensus       121 H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~-----------~~~---------------------------------  156 (262)
T cd05058         121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEY-----------YSV---------------------------------  156 (262)
T ss_pred             ccccCcceEEEcCCCcEEECCccccccccCCcc-----------eee---------------------------------
Confidence            999999999999999999999998764321000           000                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......++..|+|||.+.+.. ++.++||||+||++
T Consensus       157 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  192 (262)
T cd05058         157 -------------------------------------------HNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLL  192 (262)
T ss_pred             -------------------------------------------cccccCcCCccccChhHhccCc-cchHHHHHHHHHHH
Confidence                                                       0001123467899999987654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |.+||...+..+....+...  .+..               .+           ...+..+.+++.+||..||+
T Consensus       193 ~el~~~~~~~~~~~~~~~~~~~~~~~--~~~~---------------~~-----------~~~~~~~~~li~~cl~~~p~  244 (262)
T cd05058         193 WELMTRGAPPYPDVDSFDITVYLLQG--RRLL---------------QP-----------EYCPDPLYEVMLSCWHPKPE  244 (262)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHhcC--CCCC---------------CC-----------CcCCHHHHHHHHHHcCCChh
Confidence            99999 46677766554433333211  0000               00           11235688999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +||++.|+++
T Consensus       245 ~Rp~~~~il~  254 (262)
T cd05058         245 MRPTFSELVS  254 (262)
T ss_pred             hCCCHHHHHH
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=2.6e-30  Score=265.83  Aligned_cols=210  Identities=23%  Similarity=0.382  Sum_probs=163.4

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|+++++.+ +||||+++++++...+.+|+||||+++ +|.+++....               ..++...+..++.
T Consensus        68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  147 (307)
T cd05098          68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY  147 (307)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            3577899999999 799999999999999999999999974 9999997542               2478889999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++|++||||||+||+++.++.+||+|||+++.......                .               
T Consensus       148 qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~----------------~---------------  196 (307)
T cd05098         148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY----------------Y---------------  196 (307)
T ss_pred             HHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccch----------------h---------------
Confidence            999999999999999999999999999999999999998753321000                0               


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                .......++..|+|||++.+..
T Consensus       197 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~  218 (307)
T cd05098         197 ----------------------------------------------------------KKTTNGRLPVKWMAPEALFDRI  218 (307)
T ss_pred             ----------------------------------------------------------hccccCCCccceeChHHhccCC
Confidence                                                                      0000112356799999997654


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++|+||+||++|||++ |..||.+.+..+....+ ... ...               .           .....+.
T Consensus       219 -~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~-~~~---------------~-----------~~~~~~~  269 (307)
T cd05098         219 -YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEG-HRM---------------D-----------KPSNCTN  269 (307)
T ss_pred             -CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-HcC-CCC---------------C-----------CCCcCCH
Confidence             8999999999999999998 88999876654333322 210 000               0           0012246


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||..+|++|||+.+++++
T Consensus       270 ~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         270 ELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHHHH
Confidence            78899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.9e-30  Score=256.23  Aligned_cols=209  Identities=25%  Similarity=0.386  Sum_probs=165.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|++++++++||||+++++++......|+||||+. ++|.+++......+++..+..++.|++.||.|||++|++|
T Consensus        37 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h  116 (251)
T cd05041          37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH  116 (251)
T ss_pred             HHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeh
Confidence            457889999999999999999999999999999999997 5899999776556899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||++.......  .                     ..                       
T Consensus       117 ~di~p~nili~~~~~~~l~d~g~~~~~~~~~--~---------------------~~-----------------------  150 (251)
T cd05041         117 RDLAARNCLVGENNVLKISDFGMSREEEGGI--Y---------------------TV-----------------------  150 (251)
T ss_pred             hhcCcceEEEcCCCcEEEeeccccccccCCc--c---------------------ee-----------------------
Confidence            9999999999999999999999875332100  0                     00                       


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+. .++.++|+||+||++|
T Consensus       151 -------------------------------------------~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~  186 (251)
T cd05041         151 -------------------------------------------SDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLW  186 (251)
T ss_pred             -------------------------------------------ccccCcceeccCChHhhccC-CCCcchhHHHHHHHHH
Confidence                                                       00001235569999998765 4899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+.........+....+.+                            .....+..+.+++.+||+.+|.+
T Consensus       187 ~l~t~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         187 ETFSLGDTPYPGMSNQQTRERIESGYRMP----------------------------APQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             HHHhccCCCCccCCHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHhccChhh
Confidence            9998 889998776544333332110000                            00112457899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.|+++
T Consensus       239 Rp~~~ell~  247 (251)
T cd05041         239 RPSFSEIYN  247 (251)
T ss_pred             CcCHHHHHH
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2.3e-30  Score=256.71  Aligned_cols=210  Identities=29%  Similarity=0.460  Sum_probs=169.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+++++.++||||+++++++......|+||||+++ +|.+++...   ...+++..+..++.|++.||.|||++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~  122 (256)
T cd08530          43 REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            34567899999999999999999999999999999999975 899988652   23589999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |++|+||||+||+++.++.+||+|||++......                                              
T Consensus       123 ~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----------------------------------------------  156 (256)
T cd08530         123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKN----------------------------------------------  156 (256)
T ss_pred             CcccCCCCcceEEEecCCcEEEeeccchhhhccC----------------------------------------------
Confidence            9999999999999999999999999986533210                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                     ......++..|+|||.+.+.. ++.++|+||+|
T Consensus       157 -----------------------------------------------~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG  188 (256)
T cd08530         157 -----------------------------------------------MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLG  188 (256)
T ss_pred             -----------------------------------------------CcccccCCccccCHHHHCCCC-CCchhhHHHHH
Confidence                                                           001124577899999987654 78899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      +++++|++|+.||...+..+....+....                    ++.        +....+.++.+++.+||..|
T Consensus       189 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------~~~--------~~~~~~~~~~~li~~~l~~~  240 (256)
T cd08530         189 CLLYEMATFAPPFEARSMQDLRYKVQRGK--------------------YPP--------IPPIYSQDLQNFIRSMLQVK  240 (256)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------CCC--------CchhhCHHHHHHHHHHcCCC
Confidence            99999999999998877544333332110                    000        00123467899999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy10954        334 PKQRVSAKTILQHEYF  349 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f  349 (562)
                      |++|||+.|+++||++
T Consensus       241 p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         241 PKLRPNCDKILASPAV  256 (256)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=4.1e-30  Score=258.67  Aligned_cols=213  Identities=22%  Similarity=0.263  Sum_probs=158.3

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP----VPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~----~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .+.+|+.++++++||||+++++++.....+|+||||++ ++|.+++....    ...++..++.++.|++.||+|||++|
T Consensus        41 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (269)
T cd05087          41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN  120 (269)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            57789999999999999999999998889999999998 59999987532    23567778899999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ++||||||+||+++.++.+||+|||+++.......          +.                                 
T Consensus       121 i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~----------~~---------------------------------  157 (269)
T cd05087         121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY----------YV---------------------------------  157 (269)
T ss_pred             EeccccCcceEEEcCCCcEEECCccccccccCcce----------ee---------------------------------
Confidence            99999999999999999999999998753210000          00                                 


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC------CCCchhh
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK------VYSTTVD  248 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~------~y~~~~D  248 (562)
                                                                    ......|+..|+|||++.+..      .++.++|
T Consensus       158 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D  191 (269)
T cd05087         158 ----------------------------------------------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN  191 (269)
T ss_pred             ----------------------------------------------cCCCcCCcccccCHhHhccccccccccCCCccch
Confidence                                                          001124567788888875321      3578999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|||++ |+.||......+.+............               .+.        .....+..+.+++.
T Consensus       192 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~--------~~~~~~~~~~~l~~  248 (269)
T cd05087         192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP---------------KPR--------LKLPLSDRWYEVMQ  248 (269)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC---------------CCc--------cCCCCChHHHHHHH
Confidence            9999999999996 99999876655443332211000000               000        01122456789999


Q ss_pred             HccccCCCCCCCHHHHHc
Q psy10954        328 KIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~  345 (562)
                      +|+ .||++|||++|+++
T Consensus       249 ~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         249 FCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHh-cCcccCCCHHHHHH
Confidence            998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.6e-30  Score=257.01  Aligned_cols=209  Identities=24%  Similarity=0.335  Sum_probs=162.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++. ....++||||+. ++|.+++.... .+++..+..++.|++.||+|||++|++
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~  117 (257)
T cd05060          40 KKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFV  117 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            346789999999999999999999876 456899999997 49999997654 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++........         +.                                   
T Consensus       118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---------~~-----------------------------------  153 (257)
T cd05060         118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---------YR-----------------------------------  153 (257)
T ss_pred             ccCcccceEEEcCCCcEEeccccccceeecCCcc---------cc-----------------------------------
Confidence            9999999999999999999999987643211000         00                                   


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||.+.+.. ++.++||||+||++
T Consensus       154 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  188 (257)
T cd05060         154 --------------------------------------------ATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTL  188 (257)
T ss_pred             --------------------------------------------cccCccccccccCHHHhcCCC-CCccchHHHHHHHH
Confidence                                                        000112356799999987654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |.+||...+..+....+... ...                .           .....+..+.+++.+||..||+
T Consensus       189 ~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~----------------~-----------~~~~~~~~l~~li~~cl~~~p~  240 (257)
T cd05060         189 WEAFSYGAKPYGEMKGAEVIAMLESG-ERL----------------P-----------RPEECPQEIYSIMLSCWKYRPE  240 (257)
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHcC-CcC----------------C-----------CCCCCCHHHHHHHHHHhcCChh
Confidence            99997 99999877655443333211 000                0           0012245788999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.++++
T Consensus       241 ~Rp~~~~l~~  250 (257)
T cd05060         241 DRPTFSELES  250 (257)
T ss_pred             hCcCHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=3.6e-30  Score=258.14  Aligned_cols=210  Identities=22%  Similarity=0.396  Sum_probs=163.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT------PVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~------~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ...+.+|+++|+.++||||+++++++......|+||||++ ++|.+++...      ...+++..+..++.|++.||+||
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  122 (269)
T cd05044          43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL  122 (269)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999999999999999997 4999998652      22478899999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCC-----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccc
Q psy10954         91 HSRRIIHRDLKPQNILINKSG-----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  165 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~-----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il  165 (562)
                      |+++++|+||||+||+++.++     .+||+|||+++......                ..                   
T Consensus       123 H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~----------------~~-------------------  167 (269)
T cd05044         123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----------------YY-------------------  167 (269)
T ss_pred             HhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccc----------------cc-------------------
Confidence            999999999999999999877     79999999875432100                00                   


Q ss_pred             hhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       166 ~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                                                                            .......++..|+|||++.+.. ++.
T Consensus       168 ------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~  192 (269)
T cd05044         168 ------------------------------------------------------RKEGEGLLPVRWMAPESLLDGK-FTT  192 (269)
T ss_pred             ------------------------------------------------------ccCcccCCCccccCHHHHccCC-ccc
Confidence                                                                  0000123466799999997654 799


Q ss_pred             hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        246 TVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       246 ~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      ++||||+||++|||++ |..||...+..+....+... +.+                .           .....+..+.+
T Consensus       193 ~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~----------------~-----------~~~~~~~~~~~  244 (269)
T cd05044         193 QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRL----------------Q-----------KPENCPDKIYQ  244 (269)
T ss_pred             chhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Ccc----------------C-----------CcccchHHHHH
Confidence            9999999999999998 99999877765544433211 000                0           00122457889


Q ss_pred             HHHHccccCCCCCCCHHHHHc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~  345 (562)
                      ++.+||+.+|.+|||++++++
T Consensus       245 li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         245 LMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHcCCCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4e-30  Score=262.71  Aligned_cols=216  Identities=25%  Similarity=0.355  Sum_probs=164.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-----------CCCCHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-----------VPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-----------~~l~e~~i~~i~~qll~a   86 (562)
                      ..+.+|+++|++++||||+++++++......|+||||+.+ +|.+++....           ..+++..+..++.|++.|
T Consensus        62 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  141 (295)
T cd05097          62 NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG  141 (295)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence            3467899999999999999999999999999999999985 9999886432           136788899999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++|++||||||+||+++.++.+||+|||+++.......                .                    
T Consensus       142 l~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~----------------~--------------------  185 (295)
T cd05097         142 MKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY----------------Y--------------------  185 (295)
T ss_pred             HHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcc----------------e--------------------
Confidence            9999999999999999999999999999999998754311000                0                    


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           .......++..|+|||++.+.. ++.+
T Consensus       186 -----------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~  211 (295)
T cd05097         186 -----------------------------------------------------RIQGRAVLPIRWMAWESILLGK-FTTA  211 (295)
T ss_pred             -----------------------------------------------------eccCcCcCceeecChhhhccCC-cCch
Confidence                                                                 0001123467899999987654 8999


Q ss_pred             hhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        247 VDIWSAGCIFSEMIT--KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       247 ~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      +|+||+||++|+|++  |..||...+..+.+..+...........         +.            ......++.+.+
T Consensus       212 ~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~------------~~~~~~~~~l~~  270 (295)
T cd05097         212 SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI---------YL------------SQTPLCPSPVFK  270 (295)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc---------cC------------CCCCCCCHHHHH
Confidence            999999999999988  6788887665554444332111000000         00            001123467899


Q ss_pred             HHHHccccCCCCCCCHHHHHc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~  345 (562)
                      |+.+|++.||++|||++++++
T Consensus       271 li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         271 LMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.3e-30  Score=256.46  Aligned_cols=209  Identities=24%  Similarity=0.411  Sum_probs=168.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.++++++||||+++++++......|+||||+++ +|.+++.... ..+++..+..++.|++.||.|||++||
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i  124 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY  124 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            35678999999999999999999999988899999999975 9999997654 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||||+||+++.++.+||+|||++.......           +.                                  
T Consensus       125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-----------~~----------------------------------  159 (261)
T cd05034         125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE-----------YT----------------------------------  159 (261)
T ss_pred             ccCCcchheEEEcCCCCEEECccccceeccchh-----------hh----------------------------------
Confidence            999999999999999999999999875432100           00                                  


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       160 ---------------------------------------------~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i  193 (261)
T cd05034         160 ---------------------------------------------AREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGIL  193 (261)
T ss_pred             ---------------------------------------------hhhccCCCccccCHHHhccCC-cCchhHHHHHHHH
Confidence                                                         000112356799999997654 7899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++ |+.||.+.+....+..+......+..                            ...+..+.+++.+||+.||
T Consensus       194 l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~i~~~l~~~p  245 (261)
T cd05034         194 LTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP----------------------------PNCPEELYDLMLQCWDKDP  245 (261)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------------------------CCCCHHHHHHHHHHcccCc
Confidence            999998 99999888776666665432111100                            1124578999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++++++
T Consensus       246 ~~Rp~~~~l~~  256 (261)
T cd05034         246 EERPTFEYLQS  256 (261)
T ss_pred             ccCCCHHHHHH
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=3.9e-30  Score=261.85  Aligned_cols=209  Identities=22%  Similarity=0.385  Sum_probs=162.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-----------------------CCCCHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-----------------------VPVPPA   74 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-----------------------~~l~e~   74 (562)
                      ..+.+|+.+|+.++||||+++++.+...+..|+||||+. ++|.+++....                       ..+++.
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  127 (290)
T cd05045          48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG  127 (290)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHH
Confidence            357789999999999999999999999999999999998 58998876421                       247888


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccc
Q psy10954         75 LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  154 (562)
Q Consensus        75 ~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~  154 (562)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......          |            . 
T Consensus       128 ~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~----------~------------~-  184 (290)
T cd05045         128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS----------Y------------V-  184 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccc----------h------------h-
Confidence            9999999999999999999999999999999999999999999998754321000          0            0 


Q ss_pred             ccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccch
Q psy10954        155 TVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP  234 (562)
Q Consensus       155 ~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~AP  234 (562)
                                                                                        ......++..|+||
T Consensus       185 ------------------------------------------------------------------~~~~~~~~~~y~ap  198 (290)
T cd05045         185 ------------------------------------------------------------------KRSKGRIPVKWMAI  198 (290)
T ss_pred             ------------------------------------------------------------------cccCCCCCccccCH
Confidence                                                                              00011235679999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhh
Q psy10954        235 EILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE  313 (562)
Q Consensus       235 Evl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (562)
                      |.+.+.. ++.++||||+||+++||++ |..||.+....+....+......                 ..          
T Consensus       199 E~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~----------  250 (290)
T cd05045         199 ESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-----------------ER----------  250 (290)
T ss_pred             HHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------CC----------
Confidence            9987654 8999999999999999998 99999877654433322111000                 00          


Q ss_pred             hcCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        314 ILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       314 ~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                       ....+..+.+|+.+||+.||++||++.|+++
T Consensus       251 -~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         251 -PENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence             0112457889999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=3.8e-30  Score=258.59  Aligned_cols=213  Identities=23%  Similarity=0.356  Sum_probs=166.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++..+...|+||||+++ +|.+++....+.+++..+..++.|++.||+|||++|++
T Consensus        49 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~  128 (269)
T cd05065          49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV  128 (269)
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            34678899999999999999999999999999999999975 89999887666789999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........            .|.       +.                       
T Consensus       129 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~------------~~~-------~~-----------------------  166 (269)
T cd05065         129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS------------DPT-------YT-----------------------  166 (269)
T ss_pred             ecccChheEEEcCCCcEEECCCccccccccCcc------------ccc-------cc-----------------------
Confidence            999999999999999999999998754321100            000       00                       


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||.+.+.. ++.++||||+||++
T Consensus       167 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l  201 (269)
T cd05065         167 --------------------------------------------SSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVM  201 (269)
T ss_pred             --------------------------------------------cccCCCcceeecCHhHhccCc-ccchhhhhhhHHHH
Confidence                                                        000011245799999987654 79999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |..||.+.+..+....+......+.                            ....+..+.+++.+||+.||+
T Consensus       202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~  253 (269)
T cd05065         202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPP----------------------------PMDCPTALHQLMLDCWQKDRN  253 (269)
T ss_pred             HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC----------------------------cccCCHHHHHHHHHHcCCChh
Confidence            99886 9999987776555444422111000                            011245688999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +||+++++++
T Consensus       254 ~Rp~~~~i~~  263 (269)
T cd05065         254 ARPKFGQIVS  263 (269)
T ss_pred             hCcCHHHHHH
Confidence            9999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-30  Score=257.20  Aligned_cols=209  Identities=33%  Similarity=0.556  Sum_probs=170.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++.+..+..+|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+++++|
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H  116 (250)
T cd05123          38 EHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIY  116 (250)
T ss_pred             HHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            367889999999999999999999999999999999995 69999987654 5899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      +||||+||+++.++.++|+|||++.......                                                 
T Consensus       117 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------------  147 (250)
T cd05123         117 RDLKPENILLDADGHIKLTDFGLAKELSSEG-------------------------------------------------  147 (250)
T ss_pred             cCCCcceEEEcCCCcEEEeecCcceecccCC-------------------------------------------------
Confidence            9999999999999999999999865432100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......++..|+|||.+.+.. ++.++|+||+||++|
T Consensus       148 ------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~  184 (250)
T cd05123         148 ------------------------------------------SRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLY  184 (250)
T ss_pred             ------------------------------------------CcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHH
Confidence                                                      0001234677899999987654 788999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|..||...+.......+..  +..                .+           -...+....+++.+||..||++|
T Consensus       185 ~l~~g~~p~~~~~~~~~~~~~~~--~~~----------------~~-----------~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         185 EMLTGKPPFYAEDRKEIYEKILK--DPL----------------RF-----------PEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             HHHHCCCCCCCCCHHHHHHHHhc--CCC----------------CC-----------CCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999999987766444444332  000                00           01124578899999999999999


Q ss_pred             CCH---HHHHcCccc
Q psy10954        338 VSA---KTILQHEYF  349 (562)
Q Consensus       338 ~Ta---~elL~Hp~f  349 (562)
                      ||+   +++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=2.5e-30  Score=259.00  Aligned_cols=209  Identities=30%  Similarity=0.496  Sum_probs=162.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+.+++.++||||+++++++..++..|+||||+.+ +|.+++..   ....+++..+..++.|++.||.|||++|
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  126 (267)
T cd08229          47 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR  126 (267)
T ss_pred             HHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4577899999999999999999999999999999999985 89988764   2335899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ++|+||||+||+++.++.++|+|||++........                                             
T Consensus       127 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---------------------------------------------  161 (267)
T cd08229         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---------------------------------------------  161 (267)
T ss_pred             eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc---------------------------------------------
Confidence            99999999999999999999999998654321000                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    ......|+..|+|||.+.+.. ++.++|+||+||
T Consensus       162 ----------------------------------------------~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~  194 (267)
T cd08229         162 ----------------------------------------------AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGC  194 (267)
T ss_pred             ----------------------------------------------ccccccCCcCccCHHHhcCCC-ccchhhHHHHHH
Confidence                                                          001134678899999987654 788999999999


Q ss_pred             HHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|+|++|..||.+.... ..+...+....                   .+...       ....++.+.+++.+||..|
T Consensus       195 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~-------~~~~~~~~~~li~~~l~~~  248 (267)
T cd08229         195 LLYEMAALQSPFYGDKMNLYSLCKKIEQCD-------------------YPPLP-------SDHYSEELRQLVNMCINPD  248 (267)
T ss_pred             HHHHHHhCCCCcccccchHHHHhhhhhcCC-------------------CCCCC-------cccccHHHHHHHHHhcCCC
Confidence            999999999999765432 11111111100                   00000       0123467899999999999


Q ss_pred             CCCCCCHHHHHc
Q psy10954        334 PKQRVSAKTILQ  345 (562)
Q Consensus       334 P~~R~Ta~elL~  345 (562)
                      |.+|||+.++++
T Consensus       249 p~~Rpt~~~i~~  260 (267)
T cd08229         249 PEKRPDITYVYD  260 (267)
T ss_pred             cccCCCHHHHHH
Confidence            999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=5.8e-31  Score=264.45  Aligned_cols=229  Identities=28%  Similarity=0.431  Sum_probs=176.7

Q ss_pred             hhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+|++++++++ ||||+++++++...+..|+||||+. ++|.+++.+.. .+++..+..++.|++.||.|||+.|++
T Consensus        46 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~  124 (280)
T cd05581          46 KYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGII  124 (280)
T ss_pred             HHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45788999999998 9999999999999999999999995 69999997754 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||||+||+++.++.++|+|||++...........   ....+.                                   
T Consensus       125 H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~-----------------------------------  166 (280)
T cd05581         125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES---NKGDAT-----------------------------------  166 (280)
T ss_pred             ecCCCHHHeEECCCCCEEecCCccccccCCcccccc---CCCCCc-----------------------------------
Confidence            999999999999999999999999865532110000   000000                                   


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                    .++...   ...........++..|+|||++.+.. ++.++|+||+||++
T Consensus       167 ------------------------------~~~~~~---~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l  212 (280)
T cd05581         167 ------------------------------NIDSQI---EKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCII  212 (280)
T ss_pred             ------------------------------cccccc---cccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHH
Confidence                                          000000   00111223456889999999987654 78899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ++|++|+.||...+....+..+......                             .....++.+.+|+.+||..||++
T Consensus       213 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~  263 (280)
T cd05581         213 YQMLTGKPPFRGSNEYLTFQKILKLEYS-----------------------------FPPNFPPDAKDLIEKLLVLDPQD  263 (280)
T ss_pred             HHHHhCCCCCCCccHHHHHHHHHhcCCC-----------------------------CCCccCHHHHHHHHHHhcCCHhh
Confidence            9999999999987765554444321100                             00112467899999999999999


Q ss_pred             CCCH----HHHHcCccc
Q psy10954        337 RVSA----KTILQHEYF  349 (562)
Q Consensus       337 R~Ta----~elL~Hp~f  349 (562)
                      |||+    +++|+||||
T Consensus       264 R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         264 RLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCcccCHHHHhcCCCC
Confidence            9999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=3.7e-30  Score=258.79  Aligned_cols=207  Identities=26%  Similarity=0.433  Sum_probs=164.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++.. ...|+||||+. ++|.+++......+++..+..++.|++.||+|||++|++|
T Consensus        52 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H  130 (270)
T cd05056          52 EKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH  130 (270)
T ss_pred             HHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            457789999999999999999998875 56789999997 5999999876556899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++...... .         |                                     
T Consensus       131 ~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~---------~-------------------------------------  163 (270)
T cd05056         131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDES-Y---------Y-------------------------------------  163 (270)
T ss_pred             cccChheEEEecCCCeEEccCceeeeccccc-c---------e-------------------------------------
Confidence            9999999999999999999999875432100 0         0                                     


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+. .++.++||||+||++|
T Consensus       164 -------------------------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~  199 (270)
T cd05056         164 -------------------------------------------KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMW  199 (270)
T ss_pred             -------------------------------------------ecCCCCccccccChhhhccC-CCCchhhhHHHHHHHH
Confidence                                                       00011235679999988654 4889999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+.+..+.+..+......+                            ..+..+..+.+++.+|+..+|++
T Consensus       200 el~~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~  251 (270)
T cd05056         200 EILMLGVKPFQGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTKCWAYDPSK  251 (270)
T ss_pred             HHHHcCCCCCCCCCHHHHHHHHHcCCcCC----------------------------CCCCCCHHHHHHHHHHcCCChhh
Confidence            9986 999998887766555443211000                            01123467899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.+++.
T Consensus       252 Rpt~~~~~~  260 (270)
T cd05056         252 RPRFTELKA  260 (270)
T ss_pred             CcCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=3.6e-30  Score=254.04  Aligned_cols=214  Identities=32%  Similarity=0.511  Sum_probs=170.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|++++++++||||+++++.+...  ...++|+||++ ++|.+++.+.. .+++..+..++.|++.||.|||++|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~  121 (260)
T cd06606          43 LEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG  121 (260)
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678999999999999999999999988  89999999995 59999987765 7999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ++|+||+|+||+++.++.+||+|||.+.........                                            
T Consensus       122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--------------------------------------------  157 (260)
T cd06606         122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--------------------------------------------  157 (260)
T ss_pred             ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--------------------------------------------
Confidence            999999999999999999999999987544211000                                            


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......++..|+|||.+.+.. ++.++|+||+||
T Consensus       158 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~  191 (260)
T cd06606         158 ---------------------------------------------EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGC  191 (260)
T ss_pred             ---------------------------------------------ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHH
Confidence                                                         0001235678899999987655 789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++++|++|..||...... .....+..  +..                 .+        .+....+....+|+.+||+.|
T Consensus       192 il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-----------------~~--------~~~~~~~~~l~~~i~~~l~~~  244 (260)
T cd06606         192 TVIEMATGKPPWSELGNPMAALYKIGS--SGE-----------------PP--------EIPEHLSEEAKDFLRKCLRRD  244 (260)
T ss_pred             HHHHHHhCCCCCCCCCchHHHHHhccc--cCC-----------------Cc--------CCCcccCHHHHHHHHHhCcCC
Confidence            999999999999876522 11111110  000                 00        011122567899999999999


Q ss_pred             CCCCCCHHHHHcCccc
Q psy10954        334 PKQRVSAKTILQHEYF  349 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f  349 (562)
                      |++||++.|+++||||
T Consensus       245 p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         245 PKKRPTADELLQHPFL  260 (260)
T ss_pred             hhhCCCHHHHhhCCCC
Confidence            9999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=2.9e-30  Score=276.99  Aligned_cols=211  Identities=20%  Similarity=0.361  Sum_probs=163.2

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------------------
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------------------   68 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------------------   68 (562)
                      .+.+.+|+++|++++ ||||+++++++.....+|||||||. ++|.+++....                           
T Consensus        84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (400)
T cd05105          84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST  163 (400)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence            356789999999996 9999999999999999999999997 49998875421                           


Q ss_pred             --------------------------------------------------------------------CCCCHHHHHHHH
Q psy10954         69 --------------------------------------------------------------------VPVPPALAKSYL   80 (562)
Q Consensus        69 --------------------------------------------------------------------~~l~e~~i~~i~   80 (562)
                                                                                          ..+++..+..++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~  243 (400)
T cd05105         164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT  243 (400)
T ss_pred             cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence                                                                                237788889999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .|++.||+|||++||+||||||+|||++.++.+||+|||+++.......          +                    
T Consensus       244 ~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~----------~--------------------  293 (400)
T cd05105         244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN----------Y--------------------  293 (400)
T ss_pred             HHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceecccccc----------c--------------------
Confidence            9999999999999999999999999999999999999998764321000          0                    


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                 .......+++.|+|||++.+.
T Consensus       294 -----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~  314 (400)
T cd05105         294 -----------------------------------------------------------VSKGSTFLPVKWMAPESIFDN  314 (400)
T ss_pred             -----------------------------------------------------------cccCCcCCCcceEChhhhcCC
Confidence                                                                       000122457789999999765


Q ss_pred             CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCC
Q psy10954        241 KVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD  319 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (562)
                      . ++.++||||+||++|||++ |..||.+......+...+.....+.                           .....+
T Consensus       315 ~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  366 (400)
T cd05105         315 L-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA---------------------------KPDHAT  366 (400)
T ss_pred             C-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCccCC
Confidence            4 8999999999999999997 9999987654433333322100000                           001224


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      ..+.+++.+||+.||++|||+.++.+
T Consensus       367 ~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         367 QEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            57899999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=5.8e-30  Score=258.91  Aligned_cols=208  Identities=19%  Similarity=0.296  Sum_probs=162.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++.. ...+++|||++ ++|.+++......+++..+..++.|++.||+|||++||+|
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH  132 (279)
T cd05109          54 KEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH  132 (279)
T ss_pred             HHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            456789999999999999999999875 45789999997 5999998876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++........                                               
T Consensus       133 ~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~-----------------------------------------------  165 (279)
T cd05109         133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETE-----------------------------------------------  165 (279)
T ss_pred             cccccceEEEcCCCcEEECCCCceeecccccce-----------------------------------------------
Confidence            999999999999999999999987644211000                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+++.|+|||.+.+.. ++.++||||+||++|
T Consensus       166 ------------------------------------------~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~  202 (279)
T cd05109         166 ------------------------------------------YHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVW  202 (279)
T ss_pred             ------------------------------------------eecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHH
Confidence                                                      0000112467799999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+...... ...+.....++.                           ....+..+.+++.+||..||++
T Consensus       203 el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~dp~~  254 (279)
T cd05109         203 ELMTFGAKPYDGIPAREI-PDLLEKGERLPQ---------------------------PPICTIDVYMIMVKCWMIDSEC  254 (279)
T ss_pred             HHHcCCCCCCCCCCHHHH-HHHHHCCCcCCC---------------------------CccCCHHHHHHHHHHcCCChhh
Confidence            9998 8999976654332 233322111000                           0112456889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.++++
T Consensus       255 Rp~~~~l~~  263 (279)
T cd05109         255 RPRFRELVD  263 (279)
T ss_pred             CcCHHHHHH
Confidence            999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.4e-30  Score=254.80  Aligned_cols=205  Identities=24%  Similarity=0.406  Sum_probs=163.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..++.+|+.+++.++|+||+++++++...+..|+||||++ ++|.+++..... .+++..++.++.|++.||.|||++||
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i  123 (256)
T cd05039          44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF  123 (256)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3567899999999999999999999998999999999998 599999876543 58999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||.++......                                               
T Consensus       124 ~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----------------------------------------------  156 (256)
T cd05039         124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----------------------------------------------  156 (256)
T ss_pred             cchhcccceEEEeCCCCEEEccccccccccccc-----------------------------------------------
Confidence            999999999999999999999999875431000                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                     ....++..|+|||.+.+.. ++.++|+||+||+
T Consensus       157 -----------------------------------------------~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~i  188 (256)
T cd05039         157 -----------------------------------------------DSGKLPVKWTAPEALREKK-FSTKSDVWSFGIL  188 (256)
T ss_pred             -----------------------------------------------ccCCCcccccCchhhcCCc-CCcHHHHHHHHHH
Confidence                                                           0011244689999886544 7889999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++||++ |..||...+..+....+....  ..               .           .....++.+.+++.+||..||
T Consensus       189 l~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~---------------~-----------~~~~~~~~~~~li~~~l~~~p  240 (256)
T cd05039         189 LWEIYSFGRVPYPRIPLKDVVPHVEKGY--RM---------------E-----------APEGCPPEVYKVMKDCWELDP  240 (256)
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhcCC--CC---------------C-----------CccCCCHHHHHHHHHHhccCh
Confidence            999997 999998776544333322110  00               0           001234678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.|+++
T Consensus       241 ~~Rp~~~~l~~  251 (256)
T cd05039         241 AKRPTFKQLRE  251 (256)
T ss_pred             hhCcCHHHHHH
Confidence            99999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=5.6e-30  Score=260.21  Aligned_cols=209  Identities=24%  Similarity=0.433  Sum_probs=163.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------------CCCCHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------------VPVPPALA   76 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------------~~l~e~~i   76 (562)
                      ..+.+|+.+++.++||||+++++++..+...|+||||+++ +|.+++....                     ..+++..+
T Consensus        53 ~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  132 (288)
T cd05050          53 ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ  132 (288)
T ss_pred             HHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHH
Confidence            4577899999999999999999999999999999999985 9999987432                     13788889


Q ss_pred             HHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccc
Q psy10954         77 KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  156 (562)
Q Consensus        77 ~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~  156 (562)
                      ..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......          +.               
T Consensus       133 ~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----------~~---------------  187 (288)
T cd05050         133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----------YK---------------  187 (288)
T ss_pred             HHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcc----------cc---------------
Confidence            99999999999999999999999999999999999999999998653321000          00               


Q ss_pred             ccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhh
Q psy10954        157 DIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI  236 (562)
Q Consensus       157 DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEv  236 (562)
                                                                                      ......++..|+|||+
T Consensus       188 ----------------------------------------------------------------~~~~~~~~~~y~aPE~  203 (288)
T cd05050         188 ----------------------------------------------------------------ASENDAIPIRWMPPES  203 (288)
T ss_pred             ----------------------------------------------------------------ccCCCccChhhcCHHH
Confidence                                                                            0001123556999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhc
Q psy10954        237 LLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL  315 (562)
Q Consensus       237 l~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (562)
                      +.+.. ++.++||||+||++|||++ |..||.+.+..+....+....      .+              .        ..
T Consensus       204 ~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~------~~--------------~--------~~  254 (288)
T cd05050         204 IFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN------VL--------------S--------CP  254 (288)
T ss_pred             HhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------CC--------------C--------CC
Confidence            87654 8999999999999999997 888998877655444432210      00              0        00


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        316 NLPDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       316 ~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         255 DNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            112457899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=2.1e-30  Score=296.91  Aligned_cols=229  Identities=24%  Similarity=0.347  Sum_probs=165.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC----------CCCCCHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT----------PVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~----------~~~l~e~~i~~i~~qll~a   86 (562)
                      ..++.+|+++++.++||||+++++++..++..|+||||+++ +|.+++.+.          ...++...+..++.|++.|
T Consensus        46 ~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~A  125 (932)
T PRK13184         46 KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT  125 (932)
T ss_pred             HHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHH
Confidence            45678999999999999999999999999999999999975 999988642          1234566778899999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |+|||++||+||||||+|||++.++.+||+|||+++..........    +.....                        
T Consensus       126 L~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~----~l~~~~------------------------  177 (932)
T PRK13184        126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL----DIDVDE------------------------  177 (932)
T ss_pred             HHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccccccccc----cccccc------------------------
Confidence            9999999999999999999999999999999999875521110000    000000                        


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                 .|..                  ..........+||+.|+|||++.+.. ++.+
T Consensus       178 ---------------------------~~s~------------------~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~k  211 (932)
T PRK13184        178 ---------------------------RNIC------------------YSSMTIPGKIVGTPDYMAPERLLGVP-ASES  211 (932)
T ss_pred             ---------------------------cccc------------------ccccccCCCCCCCCCCCCHHHhcCCC-CCcH
Confidence                                       0000                  00001112357999999999998765 7999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|||++|+.||.+.........  .....+..               ..         -....++.+.+++
T Consensus       212 SDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~~---------------~~---------p~~~iP~~L~~LI  265 (932)
T PRK13184        212 TDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPIE---------------VA---------PYREIPPFLSQIA  265 (932)
T ss_pred             hHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChhh---------------cc---------ccccCCHHHHHHH
Confidence            9999999999999999999987544322211  00000000               00         0012346788999


Q ss_pred             HHccccCCCCCCCHHHHHcC
Q psy10954        327 SKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+||+.||++|++..+.+.+
T Consensus       266 ~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        266 MKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999987766544

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=8.4e-30  Score=256.76  Aligned_cols=215  Identities=17%  Similarity=0.280  Sum_probs=160.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+.+++.++||||+++++.+......|+||||+.+ +|.+++.+..   ...++..++.++.|++.||+|||++
T Consensus        39 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~  118 (268)
T cd05086          39 QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH  118 (268)
T ss_pred             HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            45688999999999999999999999999999999999984 9999987542   2367778889999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      +|+||||||+|||++.++.+||+|||++.........                                           
T Consensus       119 ~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~-------------------------------------------  155 (268)
T cd05086         119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI-------------------------------------------  155 (268)
T ss_pred             CeeccCCccceEEEcCCccEEecccccccccCcchhh-------------------------------------------
Confidence            9999999999999999999999999986432100000                                           


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC------CCCCchh
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA------KVYSTTV  247 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~------~~y~~~~  247 (562)
                                                                    ......+|+..|+|||++.+.      ..++.++
T Consensus       156 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~  189 (268)
T cd05086         156 ----------------------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPS  189 (268)
T ss_pred             ----------------------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcc
Confidence                                                          000112456677777776421      1257789


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        248 DIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       248 DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      ||||+||++|||++ |..||...++.+.+..+.......   .+            .+.        +....++...+++
T Consensus       190 DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~------------~~~--------~~~~~~~~~~~l~  246 (268)
T cd05086         190 NVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---LF------------KPQ--------LELPYSERWYEVL  246 (268)
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---cC------------CCc--------cCCCCcHHHHHHH
Confidence            99999999999996 577888777666555544321110   00            000        1112345678899


Q ss_pred             HHccccCCCCCCCHHHHHc
Q psy10954        327 SKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~  345 (562)
                      ..|+ .||++|||++++++
T Consensus       247 ~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         247 QFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHh-hCcccCCCHHHHHH
Confidence            9998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=5.4e-30  Score=258.04  Aligned_cols=211  Identities=24%  Similarity=0.376  Sum_probs=165.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP--------VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~--------~~l~e~~i~~i~~qll~aL~   88 (562)
                      ...+.+|+++|++++||||+++++++...+..|+||||++ ++|.+++....        ..+++..+..++.|++.||+
T Consensus        52 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~  131 (275)
T cd05046          52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD  131 (275)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999998899999999998 59999987544        15899999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||++||+||||||+||+++.++.++++|||+++......                .                       
T Consensus       132 ~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~----------------~-----------------------  172 (275)
T cd05046         132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE----------------Y-----------------------  172 (275)
T ss_pred             HhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc----------------c-----------------------
Confidence            9999999999999999999999999999999865321000                0                       


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         .......++..|+|||.+.+.. ++.++|
T Consensus       173 ---------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~-~~~~~D  200 (275)
T cd05046         173 ---------------------------------------------------YKLRNALIPLRWLAPEAVQEDD-FSTKSD  200 (275)
T ss_pred             ---------------------------------------------------cccCCceeEEeecChhhhccCC-CCchhh
Confidence                                                               0001123466799999887654 788999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|+|++ |..||.+......+..+...  ...   |+                      .....+..+.+++.
T Consensus       201 i~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~---~~----------------------~~~~~~~~l~~~i~  253 (275)
T cd05046         201 VWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLE---LP----------------------VPEGCPSRLYKLMT  253 (275)
T ss_pred             HHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcC---CC----------------------CCCCCCHHHHHHHH
Confidence            9999999999998 88899776655444433211  000   00                      00123467899999


Q ss_pred             HccccCCCCCCCHHHHHcC
Q psy10954        328 KIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~H  346 (562)
                      +||+.||++|||+.|+++.
T Consensus       254 ~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         254 RCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHcCCCcccCCCHHHHHHH
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=9.4e-30  Score=252.28  Aligned_cols=209  Identities=25%  Similarity=0.417  Sum_probs=167.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~-l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|+.++||||+++++++...+..|+||||+.+ +|.+++...... +++..+..++.|++.||.|||++|+
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~  124 (258)
T smart00219       45 IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF  124 (258)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            44678899999999999999999999999999999999975 999998765544 8999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||++.......                .      +.                      
T Consensus       125 ~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----------------~------~~----------------------  160 (258)
T smart00219      125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----------------Y------YK----------------------  160 (258)
T ss_pred             eecccccceEEEccCCeEEEcccCCceeccccc----------------c------cc----------------------
Confidence            999999999999999999999999875432110                0      00                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                    .....+++.|+|||.+.+ ..++.++|+||+||+
T Consensus       161 ----------------------------------------------~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i  193 (258)
T smart00219      161 ----------------------------------------------KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVL  193 (258)
T ss_pred             ----------------------------------------------cccCCCcccccChHHhcc-CCCCcchhHHHHHHH
Confidence                                                          000125778999999854 458999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++ |.+||.+.+..+....+......                 .           .....+..+.+++.+||..||
T Consensus       194 ~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~~~~~~i~~~l~~~p  245 (258)
T smart00219      194 LWEIFTLGESPYPGMSNEEVLEYLKKGYRL-----------------P-----------KPENCPPEIYKLMLQCWAEDP  245 (258)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-----------------C-----------CCCcCCHHHHHHHHHHCcCCh
Confidence            999998 88999877665555444321100                 0           011135678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.|+++
T Consensus       246 ~~Rpt~~~ll~  256 (258)
T smart00219      246 EDRPTFSELVE  256 (258)
T ss_pred             hhCcCHHHHHh
Confidence            99999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=9.1e-30  Score=260.18  Aligned_cols=216  Identities=25%  Similarity=0.371  Sum_probs=162.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP----------VPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~----------~~l~e~~i~~i~~qll~aL   87 (562)
                      ..+.+|+++|+.++||||+++++++...+..|+||||+. ++|.+++....          ..+++..+..++.|++.||
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al  143 (296)
T cd05095          64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM  143 (296)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence            457799999999999999999999999999999999997 49999987532          1367788999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +|||++|++||||||+|||++.++.+||+|||+++.......                                      
T Consensus       144 ~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--------------------------------------  185 (296)
T cd05095         144 KYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY--------------------------------------  185 (296)
T ss_pred             HHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcc--------------------------------------
Confidence            999999999999999999999999999999998764321000                                      


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                               +          .......++..|+|||+..+.. ++.++
T Consensus       186 -----------------------------------------~----------~~~~~~~~~~~~~~pe~~~~~~-~~~~~  213 (296)
T cd05095         186 -----------------------------------------Y----------RIQGRAVLPIRWMSWESILLGK-FTTAS  213 (296)
T ss_pred             -----------------------------------------e----------eccCcCcCccccCCHHHHhcCC-ccchh
Confidence                                                     0          0001123457799999887654 89999


Q ss_pred             hHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        248 DIWSAGCIFSEMIT--KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       248 DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      |+||+||++|||++  |..||...+..+.+............         ..+   .+         .....++.+.+|
T Consensus       214 DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~---~~---------~~~~~~~~~~~l  272 (296)
T cd05095         214 DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR---------QVY---LP---------KPALCPDSLYKL  272 (296)
T ss_pred             hhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc---------ccc---CC---------CCCCCCHHHHHH
Confidence            99999999999998  77899776654443322211100000         000   00         001224678899


Q ss_pred             HHHccccCCCCCCCHHHHHc
Q psy10954        326 FSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~  345 (562)
                      +.+||+.||++|||+.|+++
T Consensus       273 i~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         273 MLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=6.3e-30  Score=266.48  Aligned_cols=210  Identities=24%  Similarity=0.381  Sum_probs=164.5

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|+++++++ +||||+++++++...+.+|+||||+++ +|.+++....               ..++...+..++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (334)
T cd05100          62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY  141 (334)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            4578999999999 899999999999999999999999975 9999986532               2367788889999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++.......          +                     
T Consensus       142 qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~----------~---------------------  190 (334)
T cd05100         142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY----------Y---------------------  190 (334)
T ss_pred             HHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccc----------c---------------------
Confidence            999999999999999999999999999999999999998764321000          0                     


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                .......++..|+|||++.+..
T Consensus       191 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~  212 (334)
T cd05100         191 ----------------------------------------------------------KKTTNGRLPVKWMAPEALFDRV  212 (334)
T ss_pred             ----------------------------------------------------------ccccCCCcCceEcCHHHhccCC
Confidence                                                                      0000112356799999997654


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++||||+||++|||++ |..||.+.+..+....+......                 .           .......
T Consensus       213 -~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~  263 (334)
T cd05100         213 -YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM-----------------D-----------KPANCTH  263 (334)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------C-----------CCCCCCH
Confidence             8899999999999999998 88999887765544443221000                 0           0011245


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+++.+||+.+|++|||+.|++++
T Consensus       264 ~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         264 ELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHHHH
Confidence            68899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-29  Score=256.22  Aligned_cols=208  Identities=20%  Similarity=0.353  Sum_probs=164.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++.. ...++||||+. ++|.+++......+++..+..++.|++.||+|||++||+|
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H  132 (279)
T cd05057          54 KEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH  132 (279)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence            456789999999999999999999887 78999999997 5999999876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++.........                                              
T Consensus       133 ~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~----------------------------------------------  166 (279)
T cd05057         133 RDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY----------------------------------------------  166 (279)
T ss_pred             cccCcceEEEcCCCeEEECCCcccccccCcccce----------------------------------------------
Confidence            9999999999999999999999876542110000                                              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......++..|+|||.+.+. .++.++|+||+||++|
T Consensus       167 -------------------------------------------~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~  202 (279)
T cd05057         167 -------------------------------------------HAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVW  202 (279)
T ss_pred             -------------------------------------------ecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHH
Confidence                                                       00001235679999988654 4789999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+++ |+.||.+....+....+... ...+                           .....+..+.+++.+||..||.+
T Consensus       203 el~~~g~~p~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~~~~~l~~~p~~  254 (279)
T cd05057         203 ELMTFGAKPYEGIPAVEIPDLLEKG-ERLP---------------------------QPPICTIDVYMVLVKCWMIDAES  254 (279)
T ss_pred             HHhcCCCCCCCCCCHHHHHHHHhCC-CCCC---------------------------CCCCCCHHHHHHHHHHcCCChhh
Confidence            9998 99999887654433333211 0000                           00112456889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.++++
T Consensus       255 Rp~~~~l~~  263 (279)
T cd05057         255 RPTFKELIN  263 (279)
T ss_pred             CCCHHHHHH
Confidence            999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=8.2e-30  Score=258.74  Aligned_cols=227  Identities=21%  Similarity=0.370  Sum_probs=161.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++|+.++||||+++++++...  ...|+||||++ ++|.+++.+....+++..+..++.|++.||+|||++|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g  129 (284)
T cd05079          50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ  129 (284)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34678999999999999999999998775  57899999997 4999998765556899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||+++.........                                           
T Consensus       130 i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-------------------------------------------  166 (284)
T cd05079         130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-------------------------------------------  166 (284)
T ss_pred             eeecccchheEEEcCCCCEEECCCccccccccCccce-------------------------------------------
Confidence            9999999999999999999999999876442110000                                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......++..|+|||++.+.. ++.++||||+||
T Consensus       167 ---------------------------------------------~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~  200 (284)
T cd05079         167 ---------------------------------------------TVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGV  200 (284)
T ss_pred             ---------------------------------------------eecCCCCCCccccCHHHhccCC-CCccccchhhhh
Confidence                                                         0001124567899999987654 889999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||+++..|+.....  .+   ....+....+...... .......  ..     .......+..+.+|+.+||+.||
T Consensus       201 il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~-~~~~~~~--~~-----~~~~~~~~~~~~~li~~~l~~~p  267 (284)
T cd05079         201 TLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTRL-VRVLEEG--KR-----LPRPPNCPEEVYQLMRKCWEFQP  267 (284)
T ss_pred             hhhhhhcCCCCCccccc--hh---hhhcccccccccHHHH-HHHHHcC--cc-----CCCCCCCCHHHHHHHHHHccCCc
Confidence            99999998776543211  00   1111111100000000 0000000  00     00011235678999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||+++++++
T Consensus       268 ~~Rpt~~~il~~  279 (284)
T cd05079         268 SKRTTFQNLIEG  279 (284)
T ss_pred             ccCcCHHHHHHH
Confidence            999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=8.4e-30  Score=254.84  Aligned_cols=208  Identities=22%  Similarity=0.401  Sum_probs=163.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|+.++||||+++++++. .+..|+||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i  123 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            356789999999999999999999874 457999999997 59999886543 458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.++|+|||++........                       .                      
T Consensus       124 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-----------------------~----------------------  158 (260)
T cd05067         124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEY-----------------------T----------------------  158 (260)
T ss_pred             ecccccHHhEEEcCCCCEEEccCcceeecCCCCc-----------------------c----------------------
Confidence            9999999999999999999999998754321000                       0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||++.+.. ++.++||||+||+
T Consensus       159 ---------------------------------------------~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~  192 (260)
T cd05067         159 ---------------------------------------------AREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGIL  192 (260)
T ss_pred             ---------------------------------------------cccCCcccccccCHHHhccCC-cCcccchHHHHHH
Confidence                                                         000113456799999887654 7899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |++||.+.+..+....+......+                            .....+..+.+++.+||..||
T Consensus       193 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p  244 (260)
T cd05067         193 LTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------------------------RPDNCPEELYELMRLCWKEKP  244 (260)
T ss_pred             HHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCCh
Confidence            999998 999998877655544442211100                            001224578999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+++++.
T Consensus       245 ~~Rp~~~~l~~  255 (260)
T cd05067         245 EERPTFEYLRS  255 (260)
T ss_pred             hhCCCHHHHHH
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=7.1e-30  Score=255.15  Aligned_cols=209  Identities=32%  Similarity=0.503  Sum_probs=163.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|++++++++|+||+++++++...+..++||||+++ +|.+++...   ...+++..+..++.|++.||.|||++
T Consensus        46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  125 (267)
T cd08224          46 RQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK  125 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            45678999999999999999999999999999999999985 999888642   34589999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+||+++.++.++|+|||+++.......                                            
T Consensus       126 ~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--------------------------------------------  161 (267)
T cd08224         126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--------------------------------------------  161 (267)
T ss_pred             CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc--------------------------------------------
Confidence            999999999999999999999999998653321000                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                     ......++..|+|||.+.+.. ++.++|+||+|
T Consensus       162 -----------------------------------------------~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG  193 (267)
T cd08224         162 -----------------------------------------------AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLG  193 (267)
T ss_pred             -----------------------------------------------ccceecCCccccCHHHhccCC-CCchhcHHHHH
Confidence                                                           001124677899999987654 88999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        254 CIFSEMITKKTLFAGDSEI--DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~--~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      |++|+|++|+.||.+....  +....+..  +.                  ++...       ....+..+.+++.+||.
T Consensus       194 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------------~~~~~-------~~~~~~~~~~~i~~cl~  246 (267)
T cd08224         194 CLLYEMAALQSPFYGDKMNLYSLCKKIEK--CD------------------YPPLP-------ADHYSEELRDLVSRCIN  246 (267)
T ss_pred             HHHHHHHHCCCCcccCCccHHHHHhhhhc--CC------------------CCCCC-------hhhcCHHHHHHHHHHcC
Confidence            9999999999999765421  11111111  00                  00000       01224578899999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy10954        332 LDPKQRVSAKTILQ  345 (562)
Q Consensus       332 ~DP~~R~Ta~elL~  345 (562)
                      .||++|||+.++++
T Consensus       247 ~~p~~Rp~~~~il~  260 (267)
T cd08224         247 PDPEKRPDISYVLQ  260 (267)
T ss_pred             CCcccCCCHHHHHH
Confidence            99999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=1.8e-29  Score=251.62  Aligned_cols=204  Identities=25%  Similarity=0.417  Sum_probs=160.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.++++++||||+++++++..+ ..|+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|+
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~  121 (254)
T cd05083          43 AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL  121 (254)
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            35678999999999999999999998654 57999999974 9999997654 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++......                                               
T Consensus       122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------------  154 (254)
T cd05083         122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----------------------------------------------  154 (254)
T ss_pred             eccccCcceEEEcCCCcEEECCCccceeccccC-----------------------------------------------
Confidence            999999999999999999999999864321000                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                     .....+..|+|||.+.+.. ++.++|+||+||+
T Consensus       155 -----------------------------------------------~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~  186 (254)
T cd05083         155 -----------------------------------------------DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVL  186 (254)
T ss_pred             -----------------------------------------------CCCCCCceecCHHHhccCC-cCchhhHHHHHHH
Confidence                                                           0011235699999886544 8899999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |++||.+.+..+....+......                    .        .....+..+.+++.+||+.+|
T Consensus       187 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~~~~~~~~li~~~l~~~p  238 (254)
T cd05083         187 LWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------------------E--------PPEGCPADVYVLMTSCWETEP  238 (254)
T ss_pred             HHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------------------C--------CCCcCCHHHHHHHHHHcCCCh
Confidence            999997 99999887665443333211000                    0        001224678899999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+++++.
T Consensus       239 ~~Rp~~~~l~~  249 (254)
T cd05083         239 KKRPSFHKLRE  249 (254)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1167|consensus

Probab=99.97  E-value=8.9e-31  Score=270.06  Aligned_cols=287  Identities=24%  Similarity=0.436  Sum_probs=192.8

Q ss_pred             cCCchhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ....+.++.+|+++|..+ .+.||+++.+++..++.+++||||++. +..++...    ++-..++.|++.++.||.++|
T Consensus        74 ~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h  149 (418)
T KOG1167|consen   74 RTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH  149 (418)
T ss_pred             cccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh
Confidence            345678899999999998 589999999999999999999999986 66666653    667889999999999999999


Q ss_pred             HCCceeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCcccee--ccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l--~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      .+|||||||||+|||.+. .+.-.|+|||+|.......    ....+..|+.|-..  .|.                   
T Consensus       150 ~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~----~~~~s~~~~~~~~~~~~g~-------------------  206 (418)
T KOG1167|consen  150 KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ----QTEHSRSYSGRHATPAMGK-------------------  206 (418)
T ss_pred             ccCccccCCCccccccccccCCceEEechhHHHHHhhh----hhhhhhhhhcccCCccccC-------------------
Confidence            999999999999999985 4678999999997532111    01112223333100  010                   


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                 ..|.+.+.- -=+|.       |..+-+       ...........+||++|||||++...+..++++|
T Consensus       207 -----------~~~~~~~~~-~~~p~-------g~~~~~-------~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  207 -----------DVHCQSVAT-ASKPA-------GYYRRC-------NDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             -----------ccccccccc-ccCCC-------Cceecc-------CCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence                       111111110 00111       111111       0111222345789999999999999888899999


Q ss_pred             HHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCC--------CC--CCCCC--CCCCCccCCCCCC-----Cc--
Q psy10954        249 IWSAGCIFSEMITKKTLFA-GDSEIDQLFRIFRTLGTPH--------ED--VWPGV--SKLPIYKTDFPEW-----RP--  308 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~-~~~~~~~l~~i~~~lg~~~--------~~--~~~~~--~~~~~~~~~~~~~-----~~--  308 (562)
                      |||.|||+..+++++.||. ..++.+.+.+|...+|...        ..  .|...  ...+.....+...     .+  
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999999975 4456677777776666321        11  22210  0000011111111     00  


Q ss_pred             ---cchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        309 ---KKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       309 ---~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                         ..........++.+.||+.+||..||.+|+||+++|+||||....
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence               001111223356899999999999999999999999999998654

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=9.3e-30  Score=257.95  Aligned_cols=222  Identities=22%  Similarity=0.299  Sum_probs=159.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++|+.++||||+++++++...  ..+|+||||+.+ +|.+++...  .+++..+..++.|++.||.|||++||
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i  128 (283)
T cd05080          51 SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHY  128 (283)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4567899999999999999999987653  468999999985 899988754  48999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++........         +.                                  
T Consensus       129 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---------~~----------------------------------  165 (283)
T cd05080         129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---------YR----------------------------------  165 (283)
T ss_pred             eccccChheEEEcCCCcEEEeecccccccCCcchh---------hc----------------------------------
Confidence            99999999999999999999999987643210000         00                                  


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......++..|+|||.+.+.. ++.++||||+||+
T Consensus       166 ---------------------------------------------~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~  199 (283)
T cd05080         166 ---------------------------------------------VREDGDSPVFWYAVECLKENK-FSYASDVWSFGVT  199 (283)
T ss_pred             ---------------------------------------------cCCCCCCCceeeCHhHhcccC-CCcccccHHHHHH
Confidence                                                         000113456799999987654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRT-LGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~-lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++|..||......  +..+... .+......+...      .......      ......+..+.+++.+||+.||
T Consensus       200 l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~~~~~------~~~~~~~~~~~~li~~cl~~~p  265 (283)
T cd05080         200 LYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL------LERGMRL------PCPKNCPQEVYILMKNCWETEA  265 (283)
T ss_pred             HHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh------hhcCCCC------CCCCCCCHHHHHHHHHHhccCh
Confidence            99999999998654321  1111100 000000000000      0000000      0011235678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++++++
T Consensus       266 ~~Rps~~~i~~  276 (283)
T cd05080         266 KFRPTFRSLIP  276 (283)
T ss_pred             hhCCCHHHHHH
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0600|consensus

Probab=99.97  E-value=3.4e-31  Score=277.69  Aligned_cols=101  Identities=29%  Similarity=0.451  Sum_probs=92.0

Q ss_pred             cccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhhc
Q psy10954        413 QRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHES  492 (562)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  492 (562)
                      |.|.|.||+|+|.++||                                               ..+|+||.||| ++|+
T Consensus       282 TLWYRpPELLLG~t~Yg-----------------------------------------------~aVDlWS~GCI-l~El  313 (560)
T KOG0600|consen  282 TLWYRPPELLLGATSYG-----------------------------------------------TAVDLWSVGCI-LAEL  313 (560)
T ss_pred             EeeccChHHhcCCcccc-----------------------------------------------cceeehhhhHH-HHHH
Confidence            57999999999999999                                               89999999999 9999


Q ss_pred             ccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCccc-CccccccCCCCChhHHHHHhcC
Q psy10954        493 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                      ++++|+|||..|++||-+||+..|+|+|+.|| +++||.+..--|+-+ +..+.|.+...++.|++|++.|
T Consensus       314 ~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~l  383 (560)
T KOG0600|consen  314 FLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKL  383 (560)
T ss_pred             HcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHH
Confidence            99999999999999999999999999999999 999997765545544 3458999999999999998764

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=1.8e-29  Score=252.79  Aligned_cols=207  Identities=24%  Similarity=0.389  Sum_probs=162.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++++.++|+||+++++.+.. ...|+||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.|++
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~  124 (260)
T cd05073          46 EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI  124 (260)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            467899999999999999999999887 78899999997 59999997643 3578888999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........           .                                   
T Consensus       125 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----------~-----------------------------------  158 (260)
T cd05073         125 HRDLRAANILVSASLVCKIADFGLARVIEDNEY-----------T-----------------------------------  158 (260)
T ss_pred             ccccCcceEEEcCCCcEEECCCcceeeccCCCc-----------c-----------------------------------
Confidence            999999999999999999999998754321000           0                                   


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||++.+. .++.++|+||+||++
T Consensus       159 --------------------------------------------~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l  193 (260)
T cd05073         159 --------------------------------------------AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILL  193 (260)
T ss_pred             --------------------------------------------cccCCcccccccCHhHhccC-CcCccccchHHHHHH
Confidence                                                        00011245679999998764 478899999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |..||.+.+..+....+......+                            .....+..+.+++.+||+.||+
T Consensus       194 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~  245 (260)
T cd05073         194 MEIVTYGRIPYPGMSNPEVIRALERGYRMP----------------------------RPENCPEELYNIMMRCWKNRPE  245 (260)
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHhCCCCCC----------------------------CcccCCHHHHHHHHHHcccCcc
Confidence            99998 999998876655444432211100                            0012345789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +||++.++++
T Consensus       246 ~Rp~~~~l~~  255 (260)
T cd05073         246 ERPTFEYIQS  255 (260)
T ss_pred             cCcCHHHHHH
Confidence            9999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0695|consensus

Probab=99.97  E-value=3.8e-30  Score=257.61  Aligned_cols=213  Identities=29%  Similarity=0.473  Sum_probs=168.0

Q ss_pred             HHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         22 LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        22 ~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      ..|-.+..+. +||.+|.|+.+|++++.+++|.||+++ +|.-.+++. ..+||+.+++|..+|..||.|||++|||.||
T Consensus       298 qtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrd  376 (593)
T KOG0695|consen  298 QTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRD  376 (593)
T ss_pred             HhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeee
Confidence            4455555544 899999999999999999999999975 876555543 3699999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHH
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALR  179 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~  179 (562)
                      ||.+|+|++.+|++||+|+|+++.--.                                                     
T Consensus       377 lkldnvlldaeghikltdygmcke~l~-----------------------------------------------------  403 (593)
T KOG0695|consen  377 LKLDNVLLDAEGHIKLTDYGMCKEGLG-----------------------------------------------------  403 (593)
T ss_pred             ccccceEEccCCceeecccchhhcCCC-----------------------------------------------------
Confidence            999999999999999999998652210                                                     


Q ss_pred             hhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHH
Q psy10954        180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       180 yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eL  259 (562)
                                                            +....+++||||+|+|||++.|.. |++++|+|++||+++||
T Consensus       404 --------------------------------------~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfem  444 (593)
T KOG0695|consen  404 --------------------------------------PGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEM  444 (593)
T ss_pred             --------------------------------------CCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHH
Confidence                                                  122346789999999999998876 99999999999999999


Q ss_pred             HhCCCCCC--C-----CCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        260 ITKKTLFA--G-----DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       260 ltG~~pF~--~-----~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      +.|+.||.  |     .+..+-+++++---.                 ..           +-...+-.+..+++..|..
T Consensus       445 magrspfdivgm~n~d~ntedylfqvilekq-----------------ir-----------iprslsvkas~vlkgflnk  496 (593)
T KOG0695|consen  445 MAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-----------------IR-----------IPRSLSVKASHVLKGFLNK  496 (593)
T ss_pred             HcCCCCcceecCCCcccchhHHHHHHHhhhc-----------------cc-----------ccceeehhhHHHHHHhhcC
Confidence            99999994  2     223344444431100                 00           0011233567889999999


Q ss_pred             CCCCCCC------HHHHHcCccccCCccc
Q psy10954        333 DPKQRVS------AKTILQHEYFNQVEMV  355 (562)
Q Consensus       333 DP~~R~T------a~elL~Hp~f~~~~~~  355 (562)
                      ||.+|+.      ..++..|+||+.++|.
T Consensus       497 dp~erlgc~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  497 DPKERLGCRPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             CcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence            9999986      4699999999999864

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=2.8e-29  Score=257.89  Aligned_cols=208  Identities=20%  Similarity=0.303  Sum_probs=162.0

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+.+|+.+++.++||||+++++++... ..++|+||++ ++|.+++......+++..+..++.|++.||.|||++||+||
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  133 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR  133 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            567899999999999999999998754 5789999997 58999988766678999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+||+++.++.+||+|||+++........                                                
T Consensus       134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------------  165 (303)
T cd05110         134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKE------------------------------------------------  165 (303)
T ss_pred             ccccceeeecCCCceEEccccccccccCcccc------------------------------------------------
Confidence            99999999999999999999987643210000                                                


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                               .......++..|+|||.+.+.. ++.++||||+||++||
T Consensus       166 -----------------------------------------~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~e  203 (303)
T cd05110         166 -----------------------------------------YNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWE  203 (303)
T ss_pred             -----------------------------------------cccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHH
Confidence                                                     0001123467899999987654 8999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        259 MIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       259 Llt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      |++ |..||.+....+. ..+......++                           .....+..+.+++.+|+..||++|
T Consensus       204 l~t~g~~p~~~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~R  255 (303)
T cd05110         204 LMTFGGKPYDGIPTREI-PDLLEKGERLP---------------------------QPPICTIDVYMVMVKCWMIDADSR  255 (303)
T ss_pred             HHhCCCCCCCCCCHHHH-HHHHHCCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhC
Confidence            997 8999987654332 22222111000                           001124568899999999999999


Q ss_pred             CCHHHHHcC
Q psy10954        338 VSAKTILQH  346 (562)
Q Consensus       338 ~Ta~elL~H  346 (562)
                      |+++++++.
T Consensus       256 p~~~~l~~~  264 (303)
T cd05110         256 PKFKELAAE  264 (303)
T ss_pred             cCHHHHHHH
Confidence            999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=3.4e-29  Score=253.14  Aligned_cols=209  Identities=22%  Similarity=0.295  Sum_probs=162.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCc-CCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLR-QDLKDFLQTTP-------VPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~-~~L~~~i~~~~-------~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ..+.+|+.+|+.++||||+++++++.. +...++++||+. ++|.+++....       ..+++..+..++.|++.||+|
T Consensus        53 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  132 (280)
T cd05043          53 TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY  132 (280)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            457799999999999999999998765 577899999997 59999886532       348999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||+++++||||||+||+++.++.+||+|||+++.+......                   .                   
T Consensus       133 LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~-------------------~-------------------  174 (280)
T cd05043         133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------------------C-------------------  174 (280)
T ss_pred             HHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE-------------------E-------------------
Confidence            99999999999999999999999999999998644211000                   0                   


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                  .                       .....++..|+|||++.+.. ++.++||
T Consensus       175 ----------------------------~-----------------------~~~~~~~~~y~apE~~~~~~-~~~~~Di  202 (280)
T cd05043         175 ----------------------------L-----------------------GDNENRPVKWMALESLVNKE-YSSASDV  202 (280)
T ss_pred             ----------------------------e-----------------------CCCCCcchhccCHHHHhcCC-CCchhhH
Confidence                                        0                       00112456799999997654 8999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+||++||+++ |++||.+.+..+....+....  ..                  .        .....++.+.+++.+
T Consensus       203 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~------------------~--------~~~~~~~~~~~li~~  254 (280)
T cd05043         203 WSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY--RL------------------A--------QPINCPDELFAVMAC  254 (280)
T ss_pred             HHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC--CC------------------C--------CCCcCCHHHHHHHHH
Confidence            999999999998 999998776544332222110  00                  0        001124568899999


Q ss_pred             ccccCCCCCCCHHHHHc
Q psy10954        329 IMALDPKQRVSAKTILQ  345 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~  345 (562)
                      |+..||++|||+.++++
T Consensus       255 ~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         255 CWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HcCCChhhCCCHHHHHH
Confidence            99999999999999884

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=4.5e-29  Score=252.77  Aligned_cols=226  Identities=25%  Similarity=0.358  Sum_probs=158.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++|+.++||||+++++++..  ...+|+||||++ ++|.+++......+++..+..++.|++.||.|||++||
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i  129 (284)
T cd05081          50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRY  129 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356789999999999999999998754  346899999997 59999997665568999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||+++........         +.                                  
T Consensus       130 ~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~---------~~----------------------------------  166 (284)
T cd05081         130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY---------YK----------------------------------  166 (284)
T ss_pred             eeccCCHhhEEECCCCeEEECCCcccccccCCCcc---------ee----------------------------------
Confidence            99999999999999999999999987644211000         00                                  


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                    .               .....++..|+|||++.+.. ++.++||||+||+
T Consensus       167 ------------------------------~---------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  200 (284)
T cd05081         167 ------------------------------V---------------REPGESPIFWYAPESLTESK-FSVASDVWSFGVV  200 (284)
T ss_pred             ------------------------------e---------------cCCCCCceEeeCHHHhccCC-cChHHHHHHHHHH
Confidence                                          0               00012345699999987654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|..++...... .    .+..+...... ................      ......+..+.+|+.+||..||+
T Consensus       201 l~el~~~~~~~~~~~~~-~----~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~  268 (284)
T cd05081         201 LYELFTYSDKSCSPPAE-F----MRMMGNDKQGQ-MIVYHLIELLKNNGRL------PAPPGCPAEIYAIMKECWNNDPS  268 (284)
T ss_pred             HHHHhhcCCcCCCcchh-h----hhhcccccccc-cchHHHHHHHhcCCcC------CCCCCCCHHHHHHHHHHccCChh
Confidence            99999987776543211 1    11111100000 0000000000000000      00112346789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||++|+++
T Consensus       269 ~Rpt~~ei~~  278 (284)
T cd05081         269 QRPSFSELAL  278 (284)
T ss_pred             hCCCHHHHHH
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=6.5e-29  Score=249.34  Aligned_cols=208  Identities=25%  Similarity=0.469  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHc-cCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy10954         19 STALREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHS-   92 (562)
Q Consensus        19 ~~~~rEi~iL~~-l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~-   92 (562)
                      ....+|+.+++. ++||||+++++++..++..|+||||+++ +|.+++..   ....+++..++.++.|++.||.|||+ 
T Consensus        53 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  132 (269)
T cd08528          53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE  132 (269)
T ss_pred             HHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC
Confidence            446789988864 7999999999999999999999999975 88887643   34468999999999999999999996 


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      .||+|+||||+||+++.++.+||+|||++.......                                            
T Consensus       133 ~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--------------------------------------------  168 (269)
T cd08528         133 KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--------------------------------------------  168 (269)
T ss_pred             CceeecCCCHHHEEECCCCcEEEecccceeeccccc--------------------------------------------
Confidence            789999999999999999999999999865321100                                            


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                      ......|+..|+|||.+.+.. ++.++|+||+
T Consensus       169 ------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~sl  199 (269)
T cd08528         169 ------------------------------------------------KLTSVVGTILYSCPEIVKNEP-YGEKADVWAF  199 (269)
T ss_pred             ------------------------------------------------ccccccCcccCcChhhhcCCC-CchHHHHHHH
Confidence                                                            001234678899999997654 7999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|++||...........+......+..                           ....++.+.+++.+||+.
T Consensus       200 G~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~cl~~  252 (269)
T cd08528         200 GCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP---------------------------EGMYSEDVTDVITSCLTP  252 (269)
T ss_pred             HHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC---------------------------cccCCHHHHHHHHHHCCC
Confidence            99999999999999876655444443321111000                           012346789999999999


Q ss_pred             CCCCCCCHHHHHcC
Q psy10954        333 DPKQRVSAKTILQH  346 (562)
Q Consensus       333 DP~~R~Ta~elL~H  346 (562)
                      ||++|||+.|+..+
T Consensus       253 ~p~~Rp~~~e~~~~  266 (269)
T cd08528         253 DAEARPDIIQVSAM  266 (269)
T ss_pred             CCccCCCHHHHHHH
Confidence            99999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=1.8e-29  Score=253.71  Aligned_cols=210  Identities=31%  Similarity=0.492  Sum_probs=161.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++++||||+++++++...+..++|||||. ++|.+++... ...+++..+..++.|++.||.|||+++|
T Consensus        45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i  124 (259)
T PF07714_consen   45 EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI  124 (259)
T ss_dssp             HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4578899999999999999999999998888999999998 5999999887 5579999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +|+||+|.||+++.++.+||+|||+++........               .                             
T Consensus       125 iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~---------------~-----------------------------  160 (259)
T PF07714_consen  125 IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY---------------K-----------------------------  160 (259)
T ss_dssp             EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE---------------E-----------------------------
T ss_pred             ccccccccccccccccccccccccccccccccccc---------------c-----------------------------
Confidence            99999999999999999999999987644210000               0                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+...|+|||.+.+.. ++.++||||+|++
T Consensus       161 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~  194 (259)
T PF07714_consen  161 ---------------------------------------------NDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGML  194 (259)
T ss_dssp             ---------------------------------------------ESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHH
T ss_pred             ---------------------------------------------ccccccccccccccccccccc-ccccccccccccc
Confidence                                                         000123456789999987665 7999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+....+.+..-.+                            .....+..+.+++.+|+..||
T Consensus       195 l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~C~~~~p  246 (259)
T PF07714_consen  195 LYEILTLGKFPFSDYDNEEIIEKLKQGQRLP----------------------------IPDNCPKDIYSLIQQCWSHDP  246 (259)
T ss_dssp             HHHHHTTSSGTTTTSCHHHHHHHHHTTEETT----------------------------SBTTSBHHHHHHHHHHT-SSG
T ss_pred             cccccccccccccccccccccccccccccce----------------------------eccchhHHHHHHHHHHcCCCh
Confidence            999999 789998887666555553211000                            001124568899999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++++++
T Consensus       247 ~~RPs~~~i~~  257 (259)
T PF07714_consen  247 EKRPSFQEILQ  257 (259)
T ss_dssp             GGS--HHHHHH
T ss_pred             hhCcCHHHHHh
Confidence            99999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1027|consensus

Probab=99.96  E-value=3.4e-30  Score=282.82  Aligned_cols=218  Identities=33%  Similarity=0.452  Sum_probs=165.0

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhC--CCC-CCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT--PVP-VPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~--~~~-l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.|||.+|+.- +|||||++|..-.+++.+||+.|.|..+|.+++...  ... ......+..+.|++.||++||+.
T Consensus       546 ~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl  625 (903)
T KOG1027|consen  546 FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL  625 (903)
T ss_pred             HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc
Confidence            34578999999988 699999999999999999999999999999999874  111 11134578899999999999999


Q ss_pred             CceeccCCCCcEEEcc---CC--CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         94 RIIHRDLKPQNILINK---SG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        94 gIiHRDLKP~NILl~~---~~--~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      +||||||||+||||+.   ++  .++|+|||+++.+.....                                       
T Consensus       626 ~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s---------------------------------------  666 (903)
T KOG1027|consen  626 KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS---------------------------------------  666 (903)
T ss_pred             ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc---------------------------------------
Confidence            9999999999999976   33  467888887766532100                                       


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                       ...+.++..||-.|+|||++.+.. -..++|
T Consensus       667 -------------------------------------------------S~~r~s~~sGt~GW~APE~L~~~~-~~~avD  696 (903)
T KOG1027|consen  667 -------------------------------------------------SFSRLSGGSGTSGWQAPEQLREDR-KTQAVD  696 (903)
T ss_pred             -------------------------------------------------hhhcccCCCCcccccCHHHHhccc-cCcccc
Confidence                                                             011234557899999999998766 467999


Q ss_pred             HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |+|+||++|..++| ..||-..-+.  -..|+..  ..                        .+..+-...+..|.|||.
T Consensus       697 iFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~--~~------------------------~L~~L~~~~d~eA~dLI~  748 (903)
T KOG1027|consen  697 IFSLGCVFYYVLTGGSHPFGDSLER--QANILTG--NY------------------------TLVHLEPLPDCEAKDLIS  748 (903)
T ss_pred             hhhcCceEEEEecCCccCCCchHHh--hhhhhcC--cc------------------------ceeeeccCchHHHHHHHH
Confidence            99999999998886 8899644222  2233221  00                        000111222338999999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCC
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +||.+||..||+|.++|.||+|-+.
T Consensus       749 ~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  749 RMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HhcCCCcccCCCHHHHhCCCccCCh
Confidence            9999999999999999999999654

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=4.7e-29  Score=261.40  Aligned_cols=211  Identities=23%  Similarity=0.438  Sum_probs=159.4

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEe-CCEEEEEeecCcC-CHHHHHhhCC---------------------------
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTP---------------------------   68 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~-~~~i~lV~Ey~~~-~L~~~i~~~~---------------------------   68 (562)
                      ..+.+|+.+|+++ +||||+++++++.. +..+|+|||||++ +|.+++....                           
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (343)
T cd05103          55 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL  134 (343)
T ss_pred             HHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhh
Confidence            3577999999999 68999999998764 4578999999984 9999886432                           


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q psy10954         69 ---------------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK  109 (562)
Q Consensus        69 ---------------------------------------~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~  109 (562)
                                                             ..++...+..++.|++.||+|||++||+||||||+|||++.
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  214 (343)
T cd05103         135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  214 (343)
T ss_pred             hhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC
Confidence                                                   13677788899999999999999999999999999999999


Q ss_pred             CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeec
Q psy10954        110 SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHR  189 (562)
Q Consensus       110 ~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHR  189 (562)
                      ++.+||+|||++.......               +..                                           
T Consensus       215 ~~~~kl~dfg~~~~~~~~~---------------~~~-------------------------------------------  236 (343)
T cd05103         215 NNVVKICDFGLARDIYKDP---------------DYV-------------------------------------------  236 (343)
T ss_pred             CCcEEEEecccccccccCc---------------chh-------------------------------------------
Confidence            9999999999875431100               000                                           


Q ss_pred             CCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q psy10954        190 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAG  268 (562)
Q Consensus       190 DLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~  268 (562)
                                                     ......++..|+|||++.+.. ++.++||||+||++|+|++ |..||.+
T Consensus       237 -------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~  284 (343)
T cd05103         237 -------------------------------RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG  284 (343)
T ss_pred             -------------------------------hcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                                           000113466799999987654 8999999999999999996 9999987


Q ss_pred             CCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        269 DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       269 ~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ......+...... +...               ..+           ...++.+.+++.+||+.||++|||+.|+++|
T Consensus       285 ~~~~~~~~~~~~~-~~~~---------------~~~-----------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         285 VKIDEEFCRRLKE-GTRM---------------RAP-----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ccccHHHHHHHhc-cCCC---------------CCC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5433333222211 1000               000           1124578899999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.1e-29  Score=283.35  Aligned_cols=232  Identities=25%  Similarity=0.384  Sum_probs=154.8

Q ss_pred             eCCEEEEEeecCcC-CHHHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q psy10954         45 VDFKLFLVFEFLRQ-DLKDFLQTTPVP-------------------VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQN  104 (562)
Q Consensus        45 ~~~~i~lV~Ey~~~-~L~~~i~~~~~~-------------------l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  104 (562)
                      .+..+++||||+++ +|.+++......                   ..+..++.++.|++.||.|||++||+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            45679999999985 899888654311                   1234567899999999999999999999999999


Q ss_pred             EEEcc-CCCeeEeeccccccccccCc-ccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhh
Q psy10954        105 ILINK-SGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH  182 (562)
Q Consensus       105 ILl~~-~~~vKL~DFGla~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLH  182 (562)
                      ||++. ++.+||+|||+|+....... ......+++.|+|||.+..... +.                            
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~-~~----------------------------  336 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ-TP----------------------------  336 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCC-CC----------------------------
Confidence            99986 57899999999986532211 2234577899999997543211 00                            


Q ss_pred             cCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhC
Q psy10954        183 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK  262 (562)
Q Consensus       183 s~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG  262 (562)
                                                             ......+..+.+|++...  .++.++||||+||++|||+++
T Consensus       337 ---------------------------------------~~~~~~~~~~~sp~l~~~--~~~~k~DVwSlGviL~el~~~  375 (566)
T PLN03225        337 ---------------------------------------SAPSAPVATALSPVLWQL--NLPDRFDIYSAGLIFLQMAFP  375 (566)
T ss_pred             ---------------------------------------CCccccccccccchhccc--cCCCCcccHHHHHHHHHHHhC
Confidence                                                   001122344567766532  378899999999999999986


Q ss_pred             CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHH
Q psy10954        263 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT  342 (562)
Q Consensus       263 ~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~e  342 (562)
                      ..+  .++...++..++...+.... .|...... ..   .++.  ....+++...+..+.|||.+||++||++|||++|
T Consensus       376 ~~~--~~~~~~~~~~~l~~~~~~~~-~~~~~~~~-~~---~~~~--~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        376 NLR--SDSNLIQFNRQLKRNDYDLV-AWRKLVEP-RA---SPDL--RRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             cCC--CchHHHHHHHHHHhcCCcHH-HHHHhhcc-cc---chhh--hhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            544  44555555555554443211 11100000 00   0000  0001122233456779999999999999999999


Q ss_pred             HHcCccccCCccc
Q psy10954        343 ILQHEYFNQVEMV  355 (562)
Q Consensus       343 lL~Hp~f~~~~~~  355 (562)
                      +|+||||++....
T Consensus       447 ~L~Hpff~~~~~~  459 (566)
T PLN03225        447 ALAHPYFDREGLL  459 (566)
T ss_pred             HhCCcCcCCCCcc
Confidence            9999999886643

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=7.5e-29  Score=266.18  Aligned_cols=211  Identities=21%  Similarity=0.352  Sum_probs=164.4

Q ss_pred             hhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC----------------------------
Q psy10954         19 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP----------------------------   68 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~----------------------------   68 (562)
                      ..+.+|+++|.+++ |||||++++++..+..+|+|||||. ++|.+++....                            
T Consensus        85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (401)
T cd05107          85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR  164 (401)
T ss_pred             HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence            46789999999997 9999999999999999999999998 59999986432                            


Q ss_pred             ---------------------------------------------------------------------CCCCHHHHHHH
Q psy10954         69 ---------------------------------------------------------------------VPVPPALAKSY   79 (562)
Q Consensus        69 ---------------------------------------------------------------------~~l~e~~i~~i   79 (562)
                                                                                           ..++...+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  244 (401)
T cd05107         165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF  244 (401)
T ss_pred             ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence                                                                                 12566778899


Q ss_pred             HHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccc
Q psy10954         80 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  159 (562)
Q Consensus        80 ~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~Dvw  159 (562)
                      +.|++.||+|||++||+||||||+|||++.++.+||+|||+++........                             
T Consensus       245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~-----------------------------  295 (401)
T cd05107         245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY-----------------------------  295 (401)
T ss_pred             HHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc-----------------------------
Confidence            999999999999999999999999999999999999999987543110000                             


Q ss_pred             cccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC
Q psy10954        160 SAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG  239 (562)
Q Consensus       160 SlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~  239 (562)
                                                                                  .......++..|+|||++.+
T Consensus       296 ------------------------------------------------------------~~~~~~~~~~~y~aPE~~~~  315 (401)
T cd05107         296 ------------------------------------------------------------ISKGSTFLPLKWMAPESIFN  315 (401)
T ss_pred             ------------------------------------------------------------ccCCCcCCCCceeChHHhcC
Confidence                                                                        00012246788999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCC
Q psy10954        240 AKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP  318 (562)
Q Consensus       240 ~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  318 (562)
                      .. ++.++||||+||++|||++ |..||......+.+...+.. +...               ..           ....
T Consensus       316 ~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~~---------------~~-----------p~~~  367 (401)
T cd05107         316 NL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYRM---------------AK-----------PAHA  367 (401)
T ss_pred             CC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCCC---------------CC-----------CCCC
Confidence            54 8999999999999999998 89999876655544443321 1000               00           0112


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +..+.+++.+|+..||.+||+++|+++.
T Consensus       368 ~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         368 SDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.2e-28  Score=252.65  Aligned_cols=214  Identities=18%  Similarity=0.243  Sum_probs=154.7

Q ss_pred             HHHHHHHccCCCCcceEEEEEEeCC----EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         23 REISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        23 rEi~iL~~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      .+...++.++|+||+++++......    ..+++||++..++.+.+... ...++..++.++.|++.||+|||+++|+||
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            3444566779999999998765442    45889999887777766543 246888899999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+|+.+.......       .|                                      
T Consensus       151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~-------~~--------------------------------------  185 (294)
T PHA02882        151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI-------EY--------------------------------------  185 (294)
T ss_pred             CCCHHHEEEcCCCcEEEEEcCCceeeccCCccc-------cc--------------------------------------
Confidence            999999999999999999999987553110000       00                                      


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                             .........||+.|+|||++.+.. |+.++||||+||++||
T Consensus       186 ---------------------------------------~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~e  225 (294)
T PHA02882        186 ---------------------------------------SKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLK  225 (294)
T ss_pred             ---------------------------------------ccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHH
Confidence                                                   000011236899999999998665 8999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHH--hcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFR--TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~--~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |++|++||.+.+....+.....  .......                +.       ...+..+..+.+++..|+..+|++
T Consensus       226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~----------------~~-------~~~~~~~~~~~~~~~~~~~~~~~~  282 (294)
T PHA02882        226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE----------------GK-------IKIKNANKFIYDFIECVTKLSYEE  282 (294)
T ss_pred             HHhCCCCCCccccchHHHHHhHHHHHHHhhh----------------hh-------hccCCCCHHHHHHHHHHHhCCCCC
Confidence            9999999987743222211110  0000000                00       001223467889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      ||+.+++++
T Consensus       283 rp~~~~l~~  291 (294)
T PHA02882        283 KPDYDALIK  291 (294)
T ss_pred             CCCHHHHHH
Confidence            999999875

>KOG0661|consensus

Probab=99.96  E-value=1.4e-30  Score=271.44  Aligned_cols=103  Identities=30%  Similarity=0.495  Sum_probs=93.6

Q ss_pred             ccccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhh
Q psy10954        412 SQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHE  491 (562)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (562)
                      +|||-|+||+|+++..|-                                               -..|.|+.||| ++|
T Consensus       171 STRWYRAPEvLLrs~~Ys-----------------------------------------------~pvD~wA~GcI-~aE  202 (538)
T KOG0661|consen  171 STRWYRAPEVLLRSGYYS-----------------------------------------------SPVDMWAVGCI-MAE  202 (538)
T ss_pred             hcccccchHHhhhccccC-----------------------------------------------CchHHHHHHHH-HHH
Confidence            579999999999999998                                               67899999999 999


Q ss_pred             cccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC-CCCCCCCcccCccccccCCCCChhHHHHHhcC
Q psy10954        492 SITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP-IYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                      +.+.+|||||.+|+|||++|..+||||.++.||--.+|- ..+-.||+..|..+..+++...+.+++++.+|
T Consensus       203 l~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~l  274 (538)
T KOG0661|consen  203 LYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERL  274 (538)
T ss_pred             HHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHH
Confidence            999999999999999999999999999999999744433 33568999999999999999999999998764

>KOG2345|consensus

Probab=99.96  E-value=6.8e-30  Score=247.82  Aligned_cols=222  Identities=26%  Similarity=0.405  Sum_probs=156.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCc-CCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLR-QDLKDFLQTTP---VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~-~~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~   88 (562)
                      .+.+++|++..+.++||||++++++...+     ..+||+++|.. ++|.+.++...   ..++|.++..|+.++++||+
T Consensus        62 ~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~  141 (302)
T KOG2345|consen   62 IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLE  141 (302)
T ss_pred             HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999875433     45999999996 68999886533   25899999999999999999


Q ss_pred             HHHHCC--ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         89 YCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        89 yLH~~g--IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      +||+..  ..||||||.|||++.++.++|.|||.+......                  +.+..                
T Consensus       142 ~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~------------------i~~~~----------------  187 (302)
T KOG2345|consen  142 ALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ------------------IEGSR----------------  187 (302)
T ss_pred             HHhccCCcccccCCCcceeEecCCCceEEEeccCccccceE------------------eechH----------------
Confidence            999998  999999999999999999999999987643211                  00000                


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCC
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYS  244 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~  244 (562)
                            |.++                             |             ......-.|..|||||.+.-.  ...+
T Consensus       188 ------~a~~-----------------------------l-------------Qe~a~e~Ct~pyRAPELf~vk~~~ti~  219 (302)
T KOG2345|consen  188 ------QALR-----------------------------L-------------QEWAEERCTIPYRAPELFNVKSHCTIT  219 (302)
T ss_pred             ------HHHH-----------------------------H-------------HHHHHHhCCCcccCchheecccCcccc
Confidence                  0000                             0             001112236667777766321  2257


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      .++||||+||++|+|+.|..||...         .+..|.-......       -...+|.-         +..++....
T Consensus       220 ertDIWSLGCtLYa~mf~~sPfe~~---------~~~GgSlaLAv~n-------~q~s~P~~---------~~yse~l~~  274 (302)
T KOG2345|consen  220 ERTDIWSLGCTLYAMMFGESPFERI---------YQQGGSLALAVQN-------AQISIPNS---------SRYSEALHQ  274 (302)
T ss_pred             cccchhhhhHHHHHHHHcCCcchHH---------hhcCCeEEEeeec-------cccccCCC---------CCccHHHHH
Confidence            8999999999999999999999532         1111111000000       00011111         112467889


Q ss_pred             HHHHccccCCCCCCCHHHHHcC
Q psy10954        325 VFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ||+.||+.||.+||++.+++.+
T Consensus       275 lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  275 LIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHHhcCCcccCCCHHHHHHH
Confidence            9999999999999999999864

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.4e-28  Score=247.91  Aligned_cols=215  Identities=25%  Similarity=0.373  Sum_probs=161.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++++.++||||+++++++..  +...|+||||++ ++|.+++......+++..+..++.|++.||+|||++|
T Consensus        50 ~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  129 (284)
T cd05038          50 RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR  129 (284)
T ss_pred             HHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567899999999999999999999887  568999999997 4999999876656999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ++||||||+||+++.++.+||+|||++...........                                          
T Consensus       130 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------------------------------------------  167 (284)
T cd05038         130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY------------------------------------------  167 (284)
T ss_pred             eecCCCCHHhEEEcCCCCEEEcccccccccccCCccee------------------------------------------
Confidence            99999999999999999999999998765431100000                                          


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    ......++..|+|||.+.+.. ++.++||||+||
T Consensus       168 ----------------------------------------------~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~  200 (284)
T cd05038         168 ----------------------------------------------VKEPGESPIFWYAPECLRTSK-FSSASDVWSFGV  200 (284)
T ss_pred             ----------------------------------------------ccCCCCCcccccCcHHHccCC-CCcccchHHHhh
Confidence                                                          000112345689999887654 789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHH-----------HHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        255 IFSEMITKKTLFAGDSEIDQ-----------LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~-----------l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      +++||++|..||........           ...+.+.+....               ..+         .....+..+.
T Consensus       201 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~---------~~~~~~~~~~  256 (284)
T cd05038         201 TLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---------------RLP---------RPPSCPDEVY  256 (284)
T ss_pred             hhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------------cCC---------CCccCCHHHH
Confidence            99999999999875432110           001111000000               000         0011235788


Q ss_pred             HHHHHccccCCCCCCCHHHHHc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      +++.+||+.||++|||+.|+++
T Consensus       257 ~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         257 DLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=2.3e-28  Score=245.58  Aligned_cols=210  Identities=24%  Similarity=0.381  Sum_probs=158.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCC------EEEEEeecCc-CCHHHHHhhC-----CCCCCHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLR-QDLKDFLQTT-----PVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~------~i~lV~Ey~~-~~L~~~i~~~-----~~~l~e~~i~~i~~qll~a   86 (562)
                      ..+.+|+++|+.++||||+++++++....      ..++++||+. ++|.+++...     ...+++..++.++.|++.|
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~  125 (273)
T cd05074          46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG  125 (273)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Confidence            35779999999999999999999886532      3478999997 5888776432     1247899999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |+|||++||+||||||+||+++.++.+||+|||+++.......                      +              
T Consensus       126 l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~----------------------~--------------  169 (273)
T cd05074         126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY----------------------Y--------------  169 (273)
T ss_pred             HHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcc----------------------e--------------
Confidence            9999999999999999999999999999999998764321000                      0              


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           .......+++.|++||.+.+.. ++.+
T Consensus       170 -----------------------------------------------------~~~~~~~~~~~~~~pe~~~~~~-~~~~  195 (273)
T cd05074         170 -----------------------------------------------------RQGCASKLPVKWLALESLADNV-YTTH  195 (273)
T ss_pred             -----------------------------------------------------ecCCCccCchhhcCHhHHhcCc-cchh
Confidence                                                                 0001123456799999987554 7899


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        247 VDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       247 ~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      +||||+||++|||++ |++||.+.+..+....+... ...                   .        .....+..+.++
T Consensus       196 sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-------------------~--------~~~~~~~~~~~l  247 (273)
T cd05074         196 SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRL-------------------K--------QPPDCLEDVYEL  247 (273)
T ss_pred             hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcC-------------------C--------CCCCCCHHHHHH
Confidence            999999999999998 89999877664433333211 000                   0        001123578999


Q ss_pred             HHHccccCCCCCCCHHHHHcC
Q psy10954        326 FSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+||..+|++|||+.+++++
T Consensus       248 ~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         248 MCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0660|consensus

Probab=99.96  E-value=1e-30  Score=265.51  Aligned_cols=103  Identities=29%  Similarity=0.439  Sum_probs=94.0

Q ss_pred             ccccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhh
Q psy10954        412 SQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHE  491 (562)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (562)
                      .|||-|+||++.+.-.|.                                               ..+|.||.||| |||
T Consensus       189 aTRWYRAPElll~~~~Yt-----------------------------------------------~aiDiWSvGCI-~AE  220 (359)
T KOG0660|consen  189 ATRWYRAPELLLNSSEYT-----------------------------------------------KAIDIWSVGCI-LAE  220 (359)
T ss_pred             eeeeecCHHHHhcccccc-----------------------------------------------chhhhhhhhHH-HHH
Confidence            579999999999998887                                               77999999999 999


Q ss_pred             cccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcc--cCCCCCCCCCcccCccccccCCCCChhHHHHHhcC
Q psy10954        492 SITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                      +++++|||||+..++||..|..++|||+++..-..+  +.-.|-+.+|+.+++.|+.+++..+|+|+|++++|
T Consensus       221 mL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekm  293 (359)
T KOG0660|consen  221 MLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKM  293 (359)
T ss_pred             HHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999987554  23337788999999999999999999999999886

>KOG1026|consensus

Probab=99.96  E-value=9.9e-29  Score=273.42  Aligned_cols=208  Identities=28%  Similarity=0.451  Sum_probs=170.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-------------CCCCHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-------------VPVPPALAKSYLYQL   83 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-------------~~l~e~~i~~i~~ql   83 (562)
                      .+.+.||+++|..++|||||+|++++..++.+|||+|||. |||.++++...             .+|+..+...++.||
T Consensus       533 ~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QI  612 (774)
T KOG1026|consen  533 RQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQI  612 (774)
T ss_pred             HHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHH
Confidence            4568899999999999999999999999999999999997 79999998642             127888899999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         84 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        84 l~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      +.|++||-++.+|||||-..|+||+..-.|||+||||+|.....          -+|..-                    
T Consensus       613 AaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss----------DYYk~~--------------------  662 (774)
T KOG1026|consen  613 AAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSS----------DYYKVR--------------------  662 (774)
T ss_pred             HHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhh----------hhhccc--------------------
Confidence            99999999999999999999999999999999999998855310          111100                    


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                                 ....-...|||||.|+-.+ |
T Consensus       663 -----------------------------------------------------------~~t~lPIRWMppEsIly~k-F  682 (774)
T KOG1026|consen  663 -----------------------------------------------------------GNTLLPIRWMPPESILYGK-F  682 (774)
T ss_pred             -----------------------------------------------------------CCceeeeecCCHHHhhcCc-c
Confidence                                                                       0012245699999998766 8


Q ss_pred             CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        244 STTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      ++++||||+||+|||+++ |+.||+|-++.+.+..|...--      ++           .|           ...+...
T Consensus       683 TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l------L~-----------~P-----------e~CP~~v  734 (774)
T KOG1026|consen  683 TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL------LS-----------CP-----------ENCPTEV  734 (774)
T ss_pred             cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc------cc-----------CC-----------CCCCHHH
Confidence            999999999999999987 9999999999888887754210      00           01           1234678


Q ss_pred             HHHHHHccccCCCCCCCHHHH
Q psy10954        323 VDVFSKIMALDPKQRVSAKTI  343 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~el  343 (562)
                      .+|+..|++.+|++||+..|+
T Consensus       735 Y~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  735 YSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHHHHhhcCcccCCCHHHH
Confidence            899999999999999999886

>KOG0194|consensus

Probab=99.96  E-value=3.3e-29  Score=268.76  Aligned_cols=209  Identities=28%  Similarity=0.468  Sum_probs=170.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+++|+++|++++|||||++|++......+|+|||+|.+ +|.+++++.+..++..+...++.+.+.||+|||++++|
T Consensus       205 ~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~I  284 (474)
T KOG0194|consen  205 IKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCI  284 (474)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCc
Confidence            45688999999999999999999999999999999999985 99999999877799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||-..|+|++.++.+||+|||+++....    +         .    .  ..                          
T Consensus       285 HRDIAARNcL~~~~~~vKISDFGLs~~~~~----~---------~----~--~~--------------------------  319 (474)
T KOG0194|consen  285 HRDIAARNCLYSKKGVVKISDFGLSRAGSQ----Y---------V----M--KK--------------------------  319 (474)
T ss_pred             chhHhHHHheecCCCeEEeCccccccCCcc----e---------e----e--cc--------------------------
Confidence            999999999999999999999999764320    0         0    0  00                          


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                    ...-...-|+|||++... .|++++||||+||++
T Consensus       320 ----------------------------------------------~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~  352 (474)
T KOG0194|consen  320 ----------------------------------------------FLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLL  352 (474)
T ss_pred             ----------------------------------------------ccccCcceecChhhhccC-ccccccchhheeeeE
Confidence                                                          000124568899998765 699999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ||+++ |..||.|....+...+|....- +.               ..+           ...+.....++.+|+..||+
T Consensus       353 ~Eif~~g~~Py~g~~~~~v~~kI~~~~~-r~---------------~~~-----------~~~p~~~~~~~~~c~~~~p~  405 (474)
T KOG0194|consen  353 WEIFENGAEPYPGMKNYEVKAKIVKNGY-RM---------------PIP-----------SKTPKELAKVMKQCWKKDPE  405 (474)
T ss_pred             EeeeccCCCCCCCCCHHHHHHHHHhcCc-cC---------------CCC-----------CCCHHHHHHHHHHhccCChh
Confidence            99988 8889999998887777743211 00               000           12345667888999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      .|+|+.++.+
T Consensus       406 ~R~tm~~i~~  415 (474)
T KOG0194|consen  406 DRPTMSTIKK  415 (474)
T ss_pred             hccCHHHHHH
Confidence            9999998764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=6.4e-28  Score=234.93  Aligned_cols=213  Identities=43%  Similarity=0.670  Sum_probs=169.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|++.+++++|+||+++++.+......++|+||+++ +|.+++.... .+++..+..++.|++.|+.|||+.||+
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~  109 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGII  109 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCee
Confidence            45778999999999999999999999999999999999987 9999987654 389999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||+|.||+++.++.++|+|||.+.......                                                
T Consensus       110 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------------------------------------------------  141 (244)
T smart00220      110 HRDLKPENILLDEDGHVKLADFGLARQLDPGG------------------------------------------------  141 (244)
T ss_pred             cCCcCHHHeEECCCCcEEEccccceeeecccc------------------------------------------------
Confidence            99999999999999999999999865432100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|+|||.+.+.. ++.++|+||+|+++
T Consensus       142 --------------------------------------------~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l  176 (244)
T smart00220      142 --------------------------------------------LLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVIL  176 (244)
T ss_pred             --------------------------------------------ccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHH
Confidence                                                        001224577899999987544 78899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ++|++|..||......+.+......   .......                      .....+..+.+++.+||..||++
T Consensus       177 ~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~----------------------~~~~~~~~~~~~i~~~l~~~p~~  231 (244)
T smart00220      177 YELLTGKPPFPGDDQLLELFKKIGK---PKPPFPP----------------------PEWKISPEAKDLIRKLLVKDPEK  231 (244)
T ss_pred             HHHHhCCCCCCCCCcHHHHHHHHhc---cCCCCcc----------------------ccccCCHHHHHHHHHHccCCchh
Confidence            9999999999874433333333221   0000000                      00003457889999999999999


Q ss_pred             CCCHHHHHcCccc
Q psy10954        337 RVSAKTILQHEYF  349 (562)
Q Consensus       337 R~Ta~elL~Hp~f  349 (562)
                      ||++.++++||||
T Consensus       232 Rp~~~~~~~~~~~  244 (244)
T smart00220      232 RLTAEEALQHPFF  244 (244)
T ss_pred             ccCHHHHhhCCCC
Confidence            9999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0193|consensus

Probab=99.96  E-value=4.3e-29  Score=266.62  Aligned_cols=215  Identities=20%  Similarity=0.316  Sum_probs=170.8

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+.+|+..|++-+|.||+-+.+++..... .||+-+|++ +|+.+++..+..|.....+.|++|++.|+.|||.++|
T Consensus       431 qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~I  509 (678)
T KOG0193|consen  431 QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNI  509 (678)
T ss_pred             HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhh
Confidence            45678899999999999999999999987766 999999997 8999998877789999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      ||||||..||++..++.|||+|||++....            .++.       .                          
T Consensus       510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~------------~w~g-------~--------------------------  544 (678)
T KOG0193|consen  510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKT------------RWSG-------E--------------------------  544 (678)
T ss_pred             hhhhccccceEEccCCcEEEecccceeeee------------eecc-------c--------------------------
Confidence            999999999999999999999999975321            1100       0                          


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc--CCCCCCchhhHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAG  253 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~--~~~~y~~~~DIWSlG  253 (562)
                                                                  .......|...|||||++.  ....|++.+||||+|
T Consensus       545 --------------------------------------------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG  580 (678)
T KOG0193|consen  545 --------------------------------------------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG  580 (678)
T ss_pred             --------------------------------------------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhh
Confidence                                                        0112335678899999985  344699999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|..||...+....++++-+..+.+.                        .+........+.++|+..|+.++
T Consensus       581 iV~YELltg~lPysi~~~dqIifmVGrG~l~pd------------------------~s~~~s~~pk~mk~Ll~~C~~~~  636 (678)
T KOG0193|consen  581 IVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------------------------LSKIRSNCPKAMKRLLSDCWKFD  636 (678)
T ss_pred             HHHHHHHhCcCCcCCCChhheEEEecccccCcc------------------------chhhhccCHHHHHHHHHHHHhcC
Confidence            999999999999996655444443322211111                        11122223457899999999999


Q ss_pred             CCCCCCHHHHHc
Q psy10954        334 PKQRVSAKTILQ  345 (562)
Q Consensus       334 P~~R~Ta~elL~  345 (562)
                      +++||+..++|.
T Consensus       637 ~~eRP~F~~il~  648 (678)
T KOG0193|consen  637 REERPLFPQLLS  648 (678)
T ss_pred             cccCccHHHHHH
Confidence            999999998874

>KOG1151|consensus

Probab=99.96  E-value=8.4e-29  Score=255.18  Aligned_cols=230  Identities=27%  Similarity=0.442  Sum_probs=171.1

Q ss_pred             cCCchhhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         14 VEGVPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        14 ~~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ++...+-+.||..|.+.|+||.||++||+|.- .+.+|-|+|||++ ||.-+++... .++|..++.|+-||+.||.||.
T Consensus       507 KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN  585 (775)
T KOG1151|consen  507 KENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN  585 (775)
T ss_pred             hhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh
Confidence            44556678999999999999999999999974 5679999999987 7887777654 6899999999999999999999


Q ss_pred             HC--CceeccCCCCcEEEc---cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         92 SR--RIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        92 ~~--gIiHRDLKP~NILl~---~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      ..  .|||=||||.|||+.   ..|.+||+|||++++.....-                       .             
T Consensus       586 EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy-----------------------~-------------  629 (775)
T KOG1151|consen  586 EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY-----------------------N-------------  629 (775)
T ss_pred             ccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc-----------------------C-------------
Confidence            76  699999999999874   236788888888776542100                       0             


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC---CCCC
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG---AKVY  243 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~---~~~y  243 (562)
                                     |                         |-|        +.-.+...||-||.+||.+.-   -+..
T Consensus       630 ---------------~-------------------------vdG--------meLTSQgAGTYWYLPPEcFvVgkePPKI  661 (775)
T KOG1151|consen  630 ---------------S-------------------------VDG--------MELTSQGAGTYWYLPPECFVVGKEPPKI  661 (775)
T ss_pred             ---------------c-------------------------ccc--------eeeecccCceeeecCcceeecCCCCCcc
Confidence                           0                         000        111234578999999997743   2447


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      +.++||||+|||+|..+.|+-||-..-...   .|++-....           .-....||..         +..++.++
T Consensus       662 snKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqeNTIl-----------kAtEVqFP~K---------PvVsseAk  718 (775)
T KOG1151|consen  662 SNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQENTIL-----------KATEVQFPPK---------PVVSSEAK  718 (775)
T ss_pred             ccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhhhchh-----------cceeccCCCC---------CccCHHHH
Confidence            889999999999999999999996443221   121110000           0000112111         23467899


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccC
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      +||++||++.-+.|+...++-.||||.-
T Consensus       719 aFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  719 AFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            9999999999999999999999999965

>KOG0593|consensus

Probab=99.96  E-value=1e-29  Score=252.44  Aligned_cols=102  Identities=25%  Similarity=0.371  Sum_probs=77.9

Q ss_pred             ccccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhh
Q psy10954        412 SQRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHE  491 (562)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (562)
                      +|||.|+||+|.+.++||                                               -++|.|++||+ |+|
T Consensus       163 ATRWYRaPELLvGDtqYG-----------------------------------------------~pVDiWAiGCv-~aE  194 (396)
T KOG0593|consen  163 ATRWYRAPELLVGDTQYG-----------------------------------------------KPVDIWAIGCV-FAE  194 (396)
T ss_pred             hhhhccChhhhcccCcCC-----------------------------------------------CcccchhhhHH-HHH
Confidence            579999999999999999                                               78999999999 999


Q ss_pred             cccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC-CCCCccc-CccccccCCCCChhHHHHHhc
Q psy10954        492 SITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWR-PKKFSEILNLPDPLAVDVFSR  561 (562)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  561 (562)
                      ++++.|||||.|||||||.|.++||+....-=--.++=|.+. -.+|+-. |+.+..-++...+.+.|++..
T Consensus       195 l~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~  266 (396)
T KOG0593|consen  195 LLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKK  266 (396)
T ss_pred             HhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHH
Confidence            999999999999999999999999987543211111112221 1344433 455666667777788887753

>KOG1187|consensus

Probab=99.95  E-value=4.8e-28  Score=255.95  Aligned_cols=159  Identities=27%  Similarity=0.393  Sum_probs=132.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC-EEEEEeecCc-CCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLR-QDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-~i~lV~Ey~~-~~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++|.+++|||+|+|+++|.+.+ ..+||+|||. |+|.+.+..... ++++....+|+.+++.||+|||...
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence            345999999999999999999999999888 5999999998 599999987666 8999999999999999999999854


Q ss_pred             ---ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         95 ---IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        95 ---IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                         ||||||||+|||+|.+...||+|||+|+..... ...                                        
T Consensus       195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~----------------------------------------  233 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTS----------------------------------------  233 (361)
T ss_pred             CCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccc----------------------------------------
Confidence               999999999999999999999999998533210 000                                        


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCccccc-ccCCCccchhhhcCCCCCCchhhHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~-vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                        ..+. .||..|+|||.+.. +..+.++|||
T Consensus       234 --------------------------------------------------~~~~~~gt~gY~~PEy~~~-g~lt~KsDVy  262 (361)
T KOG1187|consen  234 --------------------------------------------------VSTTVMGTFGYLAPEYAST-GKLTEKSDVY  262 (361)
T ss_pred             --------------------------------------------------eeeecCCCCccCChhhhcc-CCcCcccccc
Confidence                                                              0011 56777888888765 3368899999


Q ss_pred             HHHHHHHHHHhCCCCCCC
Q psy10954        251 SAGCIFSEMITKKTLFAG  268 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~  268 (562)
                      |+||++.||++|+.+...
T Consensus       263 SFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  263 SFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             cchHHHHHHHhCCcccCC
Confidence            999999999999977764

>KOG0587|consensus

Probab=99.95  E-value=7e-28  Score=265.86  Aligned_cols=217  Identities=28%  Similarity=0.440  Sum_probs=173.6

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEe-----CCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPV-----DFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~-----~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ...+-.|.+||+.. +|||++.+|++|..     ++.+|||||||+ |+..+++++.. ..+.|+.+..|++.++.||.+
T Consensus        59 deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~H  138 (953)
T KOG0587|consen   59 EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAH  138 (953)
T ss_pred             cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34566788889877 79999999999864     478999999997 48888887654 359999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||.+.+||||||-.|||++.+|.|||+|||++..++....+                                       
T Consensus       139 LH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~gr---------------------------------------  179 (953)
T KOG0587|consen  139 LHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGR---------------------------------------  179 (953)
T ss_pred             HhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccccc---------------------------------------
Confidence            99999999999999999999999999999998766432222                                       


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC----CCCc
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK----VYST  245 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~----~y~~  245 (562)
                                                                          ..+++|||+||||||+...+    .|+.
T Consensus       180 ----------------------------------------------------RnT~iGtP~WMAPEViac~e~~d~tyd~  207 (953)
T KOG0587|consen  180 ----------------------------------------------------RNTFIGTPYWMAPEVIACDESPDATYDY  207 (953)
T ss_pred             ----------------------------------------------------ccCcCCCcccccceeeecccCCCCCccc
Confidence                                                                23456677777777765432    3778


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       246 ~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      .+|+||||++..||..|.+|+.+......|+.|-+.   |+...                .+++.++       ..+.||
T Consensus       208 R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN---PPPkL----------------krp~kWs-------~~FndF  261 (953)
T KOG0587|consen  208 RSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PPPKL----------------KRPKKWS-------KKFNDF  261 (953)
T ss_pred             ccchhhccceeehhcCCCCCccCcchhhhhccCCCC---CCccc----------------cchhhHH-------HHHHHH
Confidence            899999999999999999999998887777665321   11100                1122232       467899


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccC
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      |+.||..|-.+||+..++|+|||+++
T Consensus       262 Is~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  262 ISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             HHHHHhhccccCcchhhhccCCcccc
Confidence            99999999999999999999999984

>KOG1035|consensus

Probab=99.95  E-value=1.1e-27  Score=271.35  Aligned_cols=202  Identities=25%  Similarity=0.416  Sum_probs=141.1

Q ss_pred             EEEEeecCcCCHHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeecccccccccc
Q psy10954         49 LFLVFEFLRQDLKDFLQTTPVPV-PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP  127 (562)
Q Consensus        49 i~lV~Ey~~~~L~~~i~~~~~~l-~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~  127 (562)
                      +||-||||+.++.+.+...+... ....++.+++||++||.|+|++|||||||||.||+++.++.|||+|||+|......
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~  750 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKEN  750 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhh
Confidence            69999999986555544433222 46678999999999999999999999999999999999999999999998643210


Q ss_pred             CcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEe
Q psy10954        128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLA  207 (562)
Q Consensus       128 ~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~  207 (562)
                      ...                                           +.             -|..+.|.           
T Consensus       751 ~~~-------------------------------------------~d-------------~~~~~~~~-----------  763 (1351)
T KOG1035|consen  751 LES-------------------------------------------ID-------------QDLSFSTN-----------  763 (1351)
T ss_pred             hhh-------------------------------------------Hh-------------hccCcccc-----------
Confidence            000                                           00             00000000           


Q ss_pred             ecccccccccCCCcccccccCCCccchhhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Q psy10954        208 DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP  285 (562)
Q Consensus       208 DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~--~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~  285 (562)
                            ....+....+..+||.-|+|||++.+..  .|+.|+|+||+|+|++||+.   ||...-+.-....-++ -|..
T Consensus       764 ------~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~i  833 (1351)
T KOG1035|consen  764 ------RAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSI  833 (1351)
T ss_pred             ------ccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCC
Confidence                  0011222456789999999999998776  69999999999999999994   5765433322211111 1111


Q ss_pred             CCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q psy10954        286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      +..                       ..++-...+..+.+|+.||+.||++||||.|+|++.||-
T Consensus       834 P~~-----------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  834 PEP-----------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             CCC-----------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            110                       001122345678999999999999999999999999997

>KOG4250|consensus

Probab=99.95  E-value=7.8e-28  Score=261.16  Aligned_cols=161  Identities=35%  Similarity=0.520  Sum_probs=131.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC------EEEEEeecCc-CCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLR-QDLKDFLQTTP--VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~------~i~lV~Ey~~-~~L~~~i~~~~--~~l~e~~i~~i~~qll~aL~   88 (562)
                      ..+..+|+++|++++|||||+++++-++..      .-.+|||||. |+|+.++++..  ..|||.....++..+..||.
T Consensus        55 ~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~  134 (732)
T KOG4250|consen   55 RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALR  134 (732)
T ss_pred             HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHH
Confidence            345679999999999999999999866543      4589999997 59999998644  35999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEc--cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         89 YCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~--~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |||++||+||||||+||++-  .+|..                                                     
T Consensus       135 ~LrEn~IvHRDlKP~NIvl~~Gedgq~-----------------------------------------------------  161 (732)
T KOG4250|consen  135 HLRENGIVHRDLKPGNIVLQIGEDGQS-----------------------------------------------------  161 (732)
T ss_pred             HHHHcCceeccCCCCcEEEeecCCCce-----------------------------------------------------
Confidence            99999999999999999863  22220                                                     


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                          --||+|||.||.+.... ...+.+||+.|.+||++...+.|+..
T Consensus       162 ------------------------------------IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~t  204 (732)
T KOG4250|consen  162 ------------------------------------IYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTAT  204 (732)
T ss_pred             ------------------------------------EEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCce
Confidence                                                12555555555544333 45677999999999999865679999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCC
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAG  268 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~  268 (562)
                      +|.||+||++|+.+||..||-.
T Consensus       205 VDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  205 VDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             eehhhhhhHHHHHhccCCCCCc
Confidence            9999999999999999999953

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.4e-27  Score=258.57  Aligned_cols=247  Identities=22%  Similarity=0.308  Sum_probs=159.4

Q ss_pred             hhHHHHHHHHHccCCCCc-----ceEEEEEEe--------CCEEEEEeecCcC-CHHHHHhhCCC---------------
Q psy10954         19 STALREISVLKELKHPNV-----IRLHDVIPV--------DFKLFLVFEFLRQ-DLKDFLQTTPV---------------   69 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnI-----v~L~~~~~~--------~~~i~lV~Ey~~~-~L~~~i~~~~~---------------   69 (562)
                      +....|+..+.+++|.++     ++++++|..        .+..||||||+++ +|.+++.....               
T Consensus       217 e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~  296 (507)
T PLN03224        217 ETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK  296 (507)
T ss_pred             chhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence            344567888888876554     667666643        3568999999985 89888764211               


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCccc-ceeeeeccC
Q psy10954         70 --------PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THEVVTLWY  140 (562)
Q Consensus        70 --------~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~-~~~~~t~~y  140 (562)
                              .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++......... ....+|+.|
T Consensus       297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y  376 (507)
T PLN03224        297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY  376 (507)
T ss_pred             hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence                    23566788999999999999999999999999999999999999999999987553221111 112347889


Q ss_pred             CccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCC
Q psy10954        141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN  220 (562)
Q Consensus       141 ~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~  220 (562)
                      +|||.+.... .+..++.++.+..+...                                                    
T Consensus       377 ~aPE~l~~~~-~~~~~~~~~~~~~l~~~----------------------------------------------------  403 (507)
T PLN03224        377 SPPEELVMPQ-SCPRAPAPAMAALLSPF----------------------------------------------------  403 (507)
T ss_pred             eChhhhcCCC-CCCccchhhhhhhhhhh----------------------------------------------------
Confidence            9999876432 23334444333322221                                                    


Q ss_pred             cccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q psy10954        221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY  299 (562)
Q Consensus       221 ~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~-pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~  299 (562)
                                     ... . ....++||||+||++|+|++|.. ||.+........+.   ... ....|......   
T Consensus       404 ---------------~~~-y-g~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~~~-~~~~~r~~~~~---  459 (507)
T PLN03224        404 ---------------AWL-Y-GRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---YDN-DLNRWRMYKGQ---  459 (507)
T ss_pred             ---------------HHh-c-CCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---ccc-hHHHHHhhccc---
Confidence                           000 0 02335799999999999999875 77543211110000   000 00001000000   


Q ss_pred             cCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC---CCCCCHHHHHcCccccC
Q psy10954        300 KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP---KQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP---~~R~Ta~elL~Hp~f~~  351 (562)
                      ..++        + .+...++.++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       460 ~~~~--------~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDF--------S-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCc--------c-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0001        1 123346789999999999876   78999999999999963

>KOG1006|consensus

Probab=99.95  E-value=2.4e-28  Score=238.95  Aligned_cols=223  Identities=20%  Similarity=0.319  Sum_probs=166.1

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL---QT-TPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i---~~-~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      .++++.|.+...+- +.||||++|+....++.-||.||+|.-+|..+.   .. .+..+||...-.+.-..+.||+||..
T Consensus       106 q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~  185 (361)
T KOG1006|consen  106 QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE  185 (361)
T ss_pred             HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH
Confidence            45677888765544 789999999999999999999999987665543   22 22358999888888899999999986


Q ss_pred             C-CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 R-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 ~-gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      . .|||||+||+|||++..|.+||||||++..+.....                                          
T Consensus       186 ~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA------------------------------------------  223 (361)
T KOG1006|consen  186 ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA------------------------------------------  223 (361)
T ss_pred             HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH------------------------------------------
Confidence            4 899999999999999999999999998654321100                                          


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-CCCchhhHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIW  250 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-~y~~~~DIW  250 (562)
                                                                        .+..+|-+.|||||.|-... +|+-++|+|
T Consensus       224 --------------------------------------------------kT~daGCrpYmAPERi~p~~~gyDiRSDvW  253 (361)
T KOG1006|consen  224 --------------------------------------------------KTVDAGCRPYMAPERIDPSDKGYDIRSDVW  253 (361)
T ss_pred             --------------------------------------------------hhhccCCccccChhccCCccCCcchhhhhh
Confidence                                                              01235667788888775433 499999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |||++|||++||..|+.+-+. .+|+.+++.  |.|+.-..+           .          ---..+..+++||.-|
T Consensus       254 SLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~~-----------~----------~~~~~s~~~~~fintC  310 (361)
T KOG1006|consen  254 SLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLFD-----------K----------ECVHYSFSMVRFINTC  310 (361)
T ss_pred             hhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecCc-----------c----------cccccCHHHHHHHHHH
Confidence            999999999999999987654 345554432  322211000           0          0001245689999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCccc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      |..|-+.||...+++++||++.....
T Consensus       311 l~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  311 LIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             hhcccccCcchhhhhcCchhhhhhhc
Confidence            99999999999999999999876543

>KOG1095|consensus

Probab=99.94  E-value=5.2e-27  Score=267.94  Aligned_cols=211  Identities=24%  Similarity=0.449  Sum_probs=169.7

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT------PVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~------~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ....+++|..+|+.++|||||+|++++.+....+|++|||+ +||..+|++.      ...++......++.||++|.+|
T Consensus       738 ~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~Y  817 (1025)
T KOG1095|consen  738 EVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNY  817 (1025)
T ss_pred             HHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHH
Confidence            34578999999999999999999999999999999999997 5999999986      4568899999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      |++++.|||||-..|+|++....|||+|||||+.+...          -+|+-                           
T Consensus       818 Le~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~----------~yyr~---------------------------  860 (1025)
T KOG1095|consen  818 LESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDK----------DYYRK---------------------------  860 (1025)
T ss_pred             HHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhc----------hheec---------------------------
Confidence            99999999999999999999999999999999844210          01110                           


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                     +|.                     .--..-|||||.+.. ..++.++||
T Consensus       861 -------------------------------~~~---------------------a~lPvkWm~PEsl~d-~iFtskSDv  887 (1025)
T KOG1095|consen  861 -------------------------------HGE---------------------AMLPVKWMPPESLKD-GIFTSKSDV  887 (1025)
T ss_pred             -------------------------------cCc---------------------cccceecCCHHHHhh-cccccccch
Confidence                                           000                     001345999999986 459999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        250 WSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       250 WSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      ||+||++||+++ |.+||.+.+..+.+....+.-..+                 .|.           ..+...-+++.+
T Consensus       888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~-----------------~P~-----------~CP~~ly~lM~~  939 (1025)
T KOG1095|consen  888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD-----------------PPS-----------YCPEKLYQLMLQ  939 (1025)
T ss_pred             hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC-----------------CCC-----------CCChHHHHHHHH
Confidence            999999999997 899999988877665444321100                 111           112345699999


Q ss_pred             ccccCCCCCCCHHHHHc
Q psy10954        329 IMALDPKQRVSAKTILQ  345 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~  345 (562)
                      |++-+|++||+...+++
T Consensus       940 CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  940 CWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HccCChhhCccHHHHHh
Confidence            99999999999999886

>KOG1094|consensus

Probab=99.93  E-value=3.7e-26  Score=242.56  Aligned_cols=218  Identities=24%  Similarity=0.367  Sum_probs=165.3

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~-l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.+||++|.+++|||||+|.++|..++.+|+|||||+ |+|.+++..+..+ +......+++.||+.|++||.+.+
T Consensus       578 ~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n  657 (807)
T KOG1094|consen  578 ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN  657 (807)
T ss_pred             HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc
Confidence            35678999999999999999999999999999999999998 6999999887533 345556679999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      +|||||-+.|+|++.++++||+|||++|.+...          .+|++                                
T Consensus       658 fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg----------~yy~v--------------------------------  695 (807)
T KOG1094|consen  658 FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG----------DYYRV--------------------------------  695 (807)
T ss_pred             hhhccccccceeecCcccEEecCcccccccccC----------Cceee--------------------------------
Confidence            999999999999999999999999999855311          01110                                


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                               +                                      ...|-...|||||.|+-.+ +++++|+|++||
T Consensus       696 ---------q--------------------------------------gr~vlpiRwmawEsillgk-FttaSDvWafgv  727 (807)
T KOG1094|consen  696 ---------Q--------------------------------------GRAVLPIRWMAWESILLGK-FTTASDVWAFGV  727 (807)
T ss_pred             ---------e--------------------------------------cceeeeeeehhHHHHHhcc-ccchhhhhhhHH
Confidence                     0                                      0123356789999887555 899999999999


Q ss_pred             HHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        255 IFSEMI--TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       255 il~eLl--tG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ++||++  +...||...++.+.....-..+..+.......          .|           ...+.....++.+|+.+
T Consensus       728 TlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~----------~P-----------~~cp~~lyelml~Cw~~  786 (807)
T KOG1094|consen  728 TLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS----------RP-----------PACPQGLYELMLRCWRR  786 (807)
T ss_pred             HHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc----------CC-----------CcCcHHHHHHHHHHhch
Confidence            999975  57889987766554444333332222211110          01           11123456889999999


Q ss_pred             CCCCCCCHHHHHc
Q psy10954        333 DPKQRVSAKTILQ  345 (562)
Q Consensus       333 DP~~R~Ta~elL~  345 (562)
                      |.++|||.+++-.
T Consensus       787 es~~RPsFe~lh~  799 (807)
T KOG1094|consen  787 ESEQRPSFEQLHL  799 (807)
T ss_pred             hhhcCCCHHHHHH
Confidence            9999999998743

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=7.2e-26  Score=213.58  Aligned_cols=169  Identities=23%  Similarity=0.247  Sum_probs=125.1

Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeee
Q psy10954         58 QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT  137 (562)
Q Consensus        58 ~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t  137 (562)
                      |+|.+++...+..+++..++.+++|++.||.|||+++      ||+|||++.++.+|+  ||+++....           
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-----------   61 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-----------   61 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence            5788999876667999999999999999999999998      999999999999888  887642210           


Q ss_pred             ccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccccc
Q psy10954        138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI  217 (562)
Q Consensus       138 ~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~  217 (562)
                                                                                                      
T Consensus        62 --------------------------------------------------------------------------------   61 (176)
T smart00750       62 --------------------------------------------------------------------------------   61 (176)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             CCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCCCCCCCCCCC
Q psy10954        218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTPHEDVWPGVSKL  296 (562)
Q Consensus       218 ~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-l~~i~~~lg~~~~~~~~~~~~~  296 (562)
                           ....||+.|||||++.+.. |+.++||||+||++|||++|+.||........ +..+........   ...    
T Consensus        62 -----~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----  128 (176)
T smart00750       62 -----EQSRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD---PRD----  128 (176)
T ss_pred             -----ccCCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---ccc----
Confidence                 0014688999999998765 89999999999999999999999976654332 222222111000   000    


Q ss_pred             CCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccC
Q psy10954        297 PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                            .  ..+..+.     ....+.+++.+||..||++|||+.|+++|+|+..
T Consensus       129 ------~--~~~~~~~-----~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 ------R--SNLESVS-----AARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ------c--ccHHHHH-----hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                  0  0000000     0025899999999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0984|consensus

Probab=99.93  E-value=3.4e-26  Score=216.98  Aligned_cols=170  Identities=25%  Similarity=0.449  Sum_probs=136.1

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEALRYCHSR-   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~---~~~~~l~e~~i~~i~~qll~aL~yLH~~-   93 (562)
                      .+.++|+.+..+. ..|.+|++|+.+.....+++.||.|..+|..+-+   ..++.+||..+-+++-.++.||.|||++ 
T Consensus        89 ~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL  168 (282)
T KOG0984|consen   89 KRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL  168 (282)
T ss_pred             HHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh
Confidence            4567888876544 7899999999999999999999999988877654   3556799999999999999999999987 


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      .|||||+||+||||+.+|++|+||||.+..+...... +.                                        
T Consensus       169 ~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-t~----------------------------------------  207 (282)
T KOG0984|consen  169 SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-TM----------------------------------------  207 (282)
T ss_pred             hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-HH----------------------------------------
Confidence            9999999999999999999999999987654321100 00                                        


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc---CCCCCCchhhHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL---GAKVYSTTVDIW  250 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~---~~~~y~~~~DIW  250 (562)
                                                                         ..|-..|||||.+.   +...|+-++|||
T Consensus       208 ---------------------------------------------------daGCkpYmaPEri~~e~n~~gY~vksDvW  236 (282)
T KOG0984|consen  208 ---------------------------------------------------DAGCKPYMAPERINPELNQKGYSVKSDVW  236 (282)
T ss_pred             ---------------------------------------------------hcCCCccCChhhcCcccCcccceeehhhh
Confidence                                                               12344566666653   233599999999


Q ss_pred             HHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q psy10954        251 SAGCIFSEMITKKTLFAG-DSEIDQLFRIFR  280 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~-~~~~~~l~~i~~  280 (562)
                      |||+++.||.+++.||.. .++.++|.++++
T Consensus       237 SLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  237 SLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            999999999999999964 467788887765

>KOG4257|consensus

Probab=99.93  E-value=6.2e-26  Score=241.95  Aligned_cols=207  Identities=27%  Similarity=0.447  Sum_probs=162.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.++.|.-+|++++|||||+|++++.+ ..++||||+++ |.|..+++.+...++......|.+||+.||.|||+...|
T Consensus       435 tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfV  513 (974)
T KOG4257|consen  435 TEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFV  513 (974)
T ss_pred             HHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchh
Confidence            5678999999999999999999999875 58999999998 799999998888899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||-..|||++...+|||+|||++|.+... .         +|-|                                  
T Consensus       514 HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~-~---------yYka----------------------------------  549 (974)
T KOG4257|consen  514 HRDIAARNILVSSPQCVKLADFGLSRYLEDD-A---------YYKA----------------------------------  549 (974)
T ss_pred             hhhhhhhheeecCcceeeecccchhhhcccc-c---------hhhc----------------------------------
Confidence            9999999999999999999999998865421 0         0110                                  


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                    +...-..-|||||-+.-.+ +++++|||-+||.+
T Consensus       550 ----------------------------------------------S~~kLPIKWmaPESINfRr-FTtASDVWMFgVCm  582 (974)
T KOG4257|consen  550 ----------------------------------------------SRGKLPIKWMAPESINFRR-FTTASDVWMFGVCM  582 (974)
T ss_pred             ----------------------------------------------cccccceeecCccccchhc-ccchhhHHHHHHHH
Confidence                                                          0001133488888875444 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ||++. |.-||.|-.+.+.+..+.+.-                    ..+.        -+..++..-.|.++|+.+||.
T Consensus       583 WEIl~lGvkPfqgvkNsDVI~~iEnGe--------------------RlP~--------P~nCPp~LYslmskcWayeP~  634 (974)
T KOG4257|consen  583 WEILSLGVKPFQGVKNSDVIGHIENGE--------------------RLPC--------PPNCPPALYSLMSKCWAYEPS  634 (974)
T ss_pred             HHHHHhcCCccccccccceEEEecCCC--------------------CCCC--------CCCCChHHHHHHHHHhccCcc
Confidence            99865 899999876554333322110                    0010        012345677899999999999


Q ss_pred             CCCCHHHHH
Q psy10954        336 QRVSAKTIL  344 (562)
Q Consensus       336 ~R~Ta~elL  344 (562)
                      +||+..|+.
T Consensus       635 kRPrftei~  643 (974)
T KOG4257|consen  635 KRPRFTEIK  643 (974)
T ss_pred             cCCcHHHHH
Confidence            999987654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.93  E-value=1.5e-25  Score=265.08  Aligned_cols=211  Identities=21%  Similarity=0.338  Sum_probs=148.9

Q ss_pred             HHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcee
Q psy10954         22 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH---SRRIIH   97 (562)
Q Consensus        22 ~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH---~~gIiH   97 (562)
                      ..|+++|++++|||||++++++......|+|||||+ ++|.++++.    +++..+..++.|++.||+|||   +.+|+|
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  806 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVV  806 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence            468999999999999999999999999999999997 599999853    788899999999999999999   669999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++..++. ||.+....                                                    
T Consensus       807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~----------------------------------------------------  833 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR-LSLPGLLC----------------------------------------------------  833 (968)
T ss_pred             CCCCHHhEEECCCCceEEE-eccccccc----------------------------------------------------
Confidence            9999999999887776654 44321100                                                    


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 .....+||+.|+|||++.+.. |+.++||||+||++|
T Consensus       834 -------------------------------------------~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~  869 (968)
T PLN00113        834 -------------------------------------------TDTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILI  869 (968)
T ss_pred             -------------------------------------------cCCCccccccccCcccccCCC-CCcccchhhHHHHHH
Confidence                                                       001125688899999987654 899999999999999


Q ss_pred             HHHhCCCCCCCCCH-HHHHHHHHHhc-CCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        258 EMITKKTLFAGDSE-IDQLFRIFRTL-GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       258 eLltG~~pF~~~~~-~~~l~~i~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ||++|+.||..... ...+....+.. .......|         ..  +......  .........+.+++.+|++.||+
T Consensus       870 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~  936 (968)
T PLN00113        870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW---------ID--PSIRGDV--SVNQNEIVEVMNLALHCTATDPT  936 (968)
T ss_pred             HHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe---------eC--ccccCCC--CccHHHHHHHHHHHHhhCcCCch
Confidence            99999999954321 01111111110 00000000         00  0000000  00000112467899999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||+.|+++.
T Consensus       937 ~RPt~~evl~~  947 (968)
T PLN00113        937 ARPCANDVLKT  947 (968)
T ss_pred             hCcCHHHHHHH
Confidence            99999999864

>KOG0666|consensus

Probab=99.93  E-value=5.6e-27  Score=233.46  Aligned_cols=101  Identities=32%  Similarity=0.538  Sum_probs=80.9

Q ss_pred             ccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhhcc
Q psy10954        414 RSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESI  493 (562)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  493 (562)
                      =|.|+||+|+|...|-                                               -.+|.|++||| |||+|
T Consensus       203 iWYRAPELLLGa~hYT-----------------------------------------------~AiDvWAiGCI-faElL  234 (438)
T KOG0666|consen  203 IWYRAPELLLGARHYT-----------------------------------------------KAIDVWAIGCI-FAELL  234 (438)
T ss_pred             EEecChHHhccccccc-----------------------------------------------chhhhHHHHHH-HHHHH
Confidence            4899999999999987                                               67899999998 99999


Q ss_pred             cCCcccCCCC---------chhhHHHHHHhcCCCCCCCCCCcccCCCCCC---CCC--cccCccccc---cCCCCChhHH
Q psy10954        494 TKKTLFAGDS---------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT---DFP--EWRPKKFSE---ILNLPDPLAV  556 (562)
Q Consensus       494 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~---~~~~~~~~~~  556 (562)
                      |.+|||-|.-         +.|||.|||.+||+|+++.||+..|+|.|..   +|+  .|.+-.+..   ....-||.|.
T Consensus       235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~  314 (438)
T KOG0666|consen  235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSAL  314 (438)
T ss_pred             ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHH
Confidence            9999999964         4699999999999999999999999999954   444  233322211   2233566688


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      ||+++|
T Consensus       315 ~LL~kl  320 (438)
T KOG0666|consen  315 DLLQKL  320 (438)
T ss_pred             HHHHHH
Confidence            888764

>KOG0196|consensus

Probab=99.93  E-value=2.4e-26  Score=250.64  Aligned_cols=214  Identities=23%  Similarity=0.351  Sum_probs=178.7

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      +.....++.|+.||-+++||||++|.++......+.||.|||+ +.|+.+++.+++.|+.-+....++.|+.|++||-++
T Consensus       671 ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm  750 (996)
T KOG0196|consen  671 EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM  750 (996)
T ss_pred             HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc
Confidence            4556778999999999999999999999999999999999998 599999999999999999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |.|||||-..||||+.+-.+|++|||++|.+.......                    |++.                  
T Consensus       751 ~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~--------------------ytt~------------------  792 (996)
T KOG0196|consen  751 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--------------------YTTL------------------  792 (996)
T ss_pred             CchhhhhhhhheeeccceEEEeccccceeecccCCCcc--------------------cccc------------------
Confidence            99999999999999999999999999998664321100                    1100                  


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                        ...-...|.|||.|.-.+ ++.++|+||+|
T Consensus       793 --------------------------------------------------GGKIPiRWTAPEAIa~RK-FTsASDVWSyG  821 (996)
T KOG0196|consen  793 --------------------------------------------------GGKIPIRWTAPEAIAYRK-FTSASDVWSYG  821 (996)
T ss_pred             --------------------------------------------------CCccceeecChhHhhhcc-cCchhhccccc
Confidence                                                              001145688999987655 89999999999


Q ss_pred             HHHHHHH-hCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMI-TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLl-tG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ++|||.+ .|..||...++.+.+..|.+....|+.-                            ..+.....|+..|+++
T Consensus       822 IVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm----------------------------DCP~aL~qLMldCWqk  873 (996)
T KOG0196|consen  822 IVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM----------------------------DCPAALYQLMLDCWQK  873 (996)
T ss_pred             eEEEEecccCCCcccccchHHHHHHHHhccCCCCCC----------------------------CCcHHHHHHHHHHHHH
Confidence            9999854 6999999999999999887766554431                            1234567889999999


Q ss_pred             CCCCCCCHHHHHc
Q psy10954        333 DPKQRVSAKTILQ  345 (562)
Q Consensus       333 DP~~R~Ta~elL~  345 (562)
                      |-.+||+..|+..
T Consensus       874 dR~~RP~F~qiV~  886 (996)
T KOG0196|consen  874 DRNRRPKFAQIVS  886 (996)
T ss_pred             HhhcCCCHHHHHH
Confidence            9999999999875

>KOG0658|consensus

Probab=99.93  E-value=2.3e-26  Score=234.27  Aligned_cols=99  Identities=29%  Similarity=0.467  Sum_probs=85.0

Q ss_pred             ccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhhcc
Q psy10954        414 RSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESI  493 (562)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  493 (562)
                      |=-|+||+++|.++|.                                               -.+|.||.||| .||++
T Consensus       189 RyYRaPELifga~~Yt-----------------------------------------------~~IDiWSaGCV-~aELl  220 (364)
T KOG0658|consen  189 RYYRAPELIFGATEYT-----------------------------------------------TSIDIWSAGCV-MAELL  220 (364)
T ss_pred             ccccCHHHHcCccccC-----------------------------------------------ceeEEhhhhHH-HHHHh
Confidence            5689999999999999                                               67999999999 99999


Q ss_pred             cCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCC-CCCCCcccCccccc-cCCCCChhHHHHHhcC
Q psy10954        494 TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSE-ILNLPDPLAVDVFSRV  562 (562)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  562 (562)
                      .+.|||||+|..|||..|+++||||+.+.=..+  -|.| ...||+..+-.+.+ +....+|.++|+++++
T Consensus       221 ~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m--n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~  289 (364)
T KOG0658|consen  221 KGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM--NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKL  289 (364)
T ss_pred             cCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc--CcccccccCcccccccceeecccCCCHHHHHHHHHH
Confidence            999999999999999999999999999986544  2443 33477777777767 5677999999999864

>KOG1152|consensus

Probab=99.92  E-value=5.1e-26  Score=241.34  Aligned_cols=154  Identities=29%  Similarity=0.480  Sum_probs=136.8

Q ss_pred             HHHHHHHHHccC---CCCcceEEEEEEeCCEEEEEeecCc-C-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         21 ALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLR-Q-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        21 ~~rEi~iL~~l~---HpnIv~L~~~~~~~~~i~lV~Ey~~-~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      +--||+||..|+   |+||++++++|+++++.||+||--+ + ||+++|.... .++|..++.|++|++.|+++||++||
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~i  691 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGI  691 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCc
Confidence            457999999998   9999999999999999999999875 4 9999998654 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      ||||||-||+.++.+|.+||+|||.|....                                                  
T Consensus       692 vhrdikdenvivd~~g~~klidfgsaa~~k--------------------------------------------------  721 (772)
T KOG1152|consen  692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTK--------------------------------------------------  721 (772)
T ss_pred             eecccccccEEEecCCeEEEeeccchhhhc--------------------------------------------------
Confidence            999999999999999999999999864221                                                  


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 ...+..++||..|.|||++-|.++-+.+-|||++|++
T Consensus       722 -------------------------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgil  758 (772)
T KOG1152|consen  722 -------------------------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGIL  758 (772)
T ss_pred             -------------------------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhhe
Confidence                                                       1123457889999999999988888999999999999


Q ss_pred             HHHHHhCCCCCCC
Q psy10954        256 FSEMITKKTLFAG  268 (562)
Q Consensus       256 l~eLltG~~pF~~  268 (562)
                      ||.++...-||+.
T Consensus       759 lytivykenpyyn  771 (772)
T KOG1152|consen  759 LYTIVYKENPYYN  771 (772)
T ss_pred             eeEEEeccCCCcC
Confidence            9999999888874

>KOG0576|consensus

Probab=99.92  E-value=3.1e-26  Score=246.40  Aligned_cols=299  Identities=24%  Similarity=0.319  Sum_probs=230.6

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ....||-+++..+|||||-+++.|..++.++++||||++ +|.+.-. .-++++|.++....++.+.||+|||++|-+||
T Consensus        58 ~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hR  136 (829)
T KOG0576|consen   58 GIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHR  136 (829)
T ss_pred             ccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccc
Confidence            356799999999999999999999999999999999986 6666543 34579999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceec--cccccccccccccccccchhhh-------
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMS-------  169 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~--~~~~~s~~~DvwSlG~il~Em~-------  169 (562)
                      |||-.|||++..|.+|++|||.+..++....+.+.+.||++|||||+..  ....|...+|+|++|+...|+.       
T Consensus       137 diKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf  216 (829)
T KOG0576|consen  137 DIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF  216 (829)
T ss_pred             cccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence            9999999999999999999999888776566677889999999999863  3456889999999998776640       


Q ss_pred             --------------------------------------------------------------------------------
Q psy10954        170 --------------------------------------------------------------------------------  169 (562)
Q Consensus       170 --------------------------------------------------------------------------------  169 (562)
                                                                                                      
T Consensus       217 dlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~  296 (829)
T KOG0576|consen  217 DLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPV  296 (829)
T ss_pred             ccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCc
Confidence                                                                                            


Q ss_pred             --------------------------------------------hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEE
Q psy10954        170 --------------------------------------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALK  205 (562)
Q Consensus       170 --------------------------------------------~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vK  205 (562)
                                                                  ..+.-.++++++|+.--+|||    ||+.++ +..|
T Consensus       297 v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~  371 (829)
T KOG0576|consen  297 VRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVK  371 (829)
T ss_pred             ccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccc
Confidence                                                        123334677888887778888    777665 7899


Q ss_pred             EeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Q psy10954        206 LADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP  285 (562)
Q Consensus       206 L~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~  285 (562)
                      ..|||....++... ..++..+|+.++|||+..+.. +....|.||+|+-..+|..|.+|-.....              
T Consensus       372 ~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--------------  435 (829)
T KOG0576|consen  372 LLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--------------  435 (829)
T ss_pred             cccccCCcccCccc-ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--------------
Confidence            99999988776554 456778999999999998765 78899999999987888888776544110              


Q ss_pred             CCCCCCCCCC-CCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        286 HEDVWPGVSK-LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       286 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                       .....+.+. .+..... ..|.+           ..-.|+...|+..-|..|.++.+++.|.+|+...
T Consensus       436 -~~~~~g~~p~s~~L~~~-~aw~~-----------~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  436 -VLPMIGNGPNSPMLTDK-SAWSP-----------VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             -ccCCCCCCCCccccchh-hhcCc-----------ccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence             000001110 0000000 00100           0011466789999999999999999999997654

>KOG0199|consensus

Probab=99.92  E-value=1.1e-24  Score=235.12  Aligned_cols=212  Identities=28%  Similarity=0.426  Sum_probs=170.8

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~-~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+++|+.+|.+|+|||+|+||++..+ ..+.||||++. |+|.+.+++ ....|.......|+.||+.|+.||-+++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            34578999999999999999999999987 78999999998 599999987 4456888889999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      .|||||-..|+|+.....|||+||||.|.+......+.        |+|                               
T Consensus       233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv--------m~p-------------------------------  273 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV--------MAP-------------------------------  273 (1039)
T ss_pred             hhhhhhhhhhheecccceeeeecccceeccCCCCcceE--------ecC-------------------------------
Confidence            99999999999999999999999999887764332210        110                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                       ..-....|.|||.|...+ ++.++|+|++||
T Consensus       274 -------------------------------------------------~rkvPfAWCaPEsLrh~k-FShaSDvWmyGV  303 (1039)
T KOG0199|consen  274 -------------------------------------------------QRKVPFAWCAPESLRHRK-FSHASDVWMYGV  303 (1039)
T ss_pred             -------------------------------------------------CCcCcccccCHhHhcccc-ccccchhhhhhh
Confidence                                                             012245689999997665 899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|||++ |+-||.|....+.|.+|-..-                   ..+.  +       +..+.+.-+++.+|+..+
T Consensus       304 TiWEMFtyGEePW~G~~g~qIL~~iD~~e-------------------rLpR--P-------k~csedIY~imk~cWah~  355 (1039)
T KOG0199|consen  304 TIWEMFTYGEEPWVGCRGIQILKNIDAGE-------------------RLPR--P-------KYCSEDIYQIMKNCWAHN  355 (1039)
T ss_pred             hHHhhhccCCCCCCCCCHHHHHHhccccc-------------------cCCC--C-------CCChHHHHHHHHHhccCC
Confidence            9999997 789999999887777663210                   0000  0       112456789999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy10954        334 PKQRVSAKTILQH  346 (562)
Q Consensus       334 P~~R~Ta~elL~H  346 (562)
                      |.+|+|...+-..
T Consensus       356 paDRptFsair~~  368 (1039)
T KOG0199|consen  356 PADRPTFSAIRED  368 (1039)
T ss_pred             ccccccHHHHHHh
Confidence            9999998877543

>KOG4278|consensus

Probab=99.91  E-value=2.3e-24  Score=229.57  Aligned_cols=209  Identities=29%  Similarity=0.461  Sum_probs=160.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~-l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...++.|..+|+.++|||+|+|+++|..+-.+|||+|||. ++|.++++..... ++.-.....+.||..|++||..++.
T Consensus       307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF  386 (1157)
T KOG4278|consen  307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF  386 (1157)
T ss_pred             HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh
Confidence            4568999999999999999999999999999999999997 6999999876643 5555556777899999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||-..|.||..+..||++|||++|.....  .++...|.                                      
T Consensus       387 IHRDLAARNCLVgEnhiVKvADFGLsRlMtgD--TYTAHAGA--------------------------------------  426 (1157)
T KOG4278|consen  387 IHRDLAARNCLVGENHIVKVADFGLSRLMTGD--TYTAHAGA--------------------------------------  426 (1157)
T ss_pred             hhhhhhhhhccccccceEEeeccchhhhhcCC--ceecccCc--------------------------------------
Confidence            99999999999999999999999999876421  12111110                                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                        .-..-|.|||-|.-. .++.++|||++||+
T Consensus       427 --------------------------------------------------KFPIKWTAPEsLAyN-tFSiKSDVWAFGVL  455 (1157)
T KOG4278|consen  427 --------------------------------------------------KFPIKWTAPESLAYN-TFSIKSDVWAFGVL  455 (1157)
T ss_pred             --------------------------------------------------cCcccccCccccccc-ccccchhhHHHHHH
Confidence                                                              002347777776433 37889999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |||+.| |-.||.|-+-. +.+..++.                .|.-+.|+           ..++..-.|++.|++++|
T Consensus       456 LWEIATYGMsPYPGidlS-qVY~LLEk----------------gyRM~~Pe-----------GCPpkVYeLMraCW~WsP  507 (1157)
T KOG4278|consen  456 LWEIATYGMSPYPGIDLS-QVYGLLEK----------------GYRMDGPE-----------GCPPKVYELMRACWNWSP  507 (1157)
T ss_pred             HHHHHhcCCCCCCCccHH-HHHHHHhc----------------cccccCCC-----------CCCHHHHHHHHHHhcCCc
Confidence            999987 88899887643 33333321                11111111           234567889999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      +.||+..|+-+
T Consensus       508 sDRPsFaeiHq  518 (1157)
T KOG4278|consen  508 SDRPSFAEIHQ  518 (1157)
T ss_pred             ccCccHHHHHH
Confidence            99999887643

>KOG0200|consensus

Probab=99.90  E-value=2.6e-23  Score=234.22  Aligned_cols=208  Identities=28%  Similarity=0.483  Sum_probs=162.3

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYL   80 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~   80 (562)
                      .+....|+++|+.+ .||||+.|.+++..++.+++|+|||. ++|.++++..+               ..++......++
T Consensus       345 ~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa  424 (609)
T KOG0200|consen  345 KKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFA  424 (609)
T ss_pred             HHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHH
Confidence            45678999999999 69999999999999999999999997 69999998766               248888999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      +||+.|++||++..+|||||-..|||+..+..+||+|||+|+......                      .|..      
T Consensus       425 ~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~----------------------~y~~------  476 (609)
T KOG0200|consen  425 YQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKD----------------------YYRT------  476 (609)
T ss_pred             HHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCC----------------------ceEe------
Confidence            999999999999999999999999999999999999999987543110                      0000      


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCccccccc--CCCccchhhhc
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEILL  238 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vg--T~~Y~APEvl~  238 (562)
                                                                                    ....|  ...|||||.+.
T Consensus       477 --------------------------------------------------------------~~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  477 --------------------------------------------------------------KSSAGTLPVKWMAPESLF  494 (609)
T ss_pred             --------------------------------------------------------------cCCCCccceeecCHHHhc
Confidence                                                                          00112  23399999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcC
Q psy10954        239 GAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDS-EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN  316 (562)
Q Consensus       239 ~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~-~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  316 (562)
                      . ..|+.++||||+||+|||+++ |.+||.+-. ..+. .+.++. |...               ..|.           
T Consensus       495 ~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~~-G~r~---------------~~P~-----------  545 (609)
T KOG0200|consen  495 D-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEFLKE-GNRM---------------EQPE-----------  545 (609)
T ss_pred             c-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHhc-CCCC---------------CCCC-----------
Confidence            7 569999999999999999987 789998854 3333 222211 1100               0011           


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHH
Q psy10954        317 LPDPLAVDVFSKIMALDPKQRVSAKTIL  344 (562)
Q Consensus       317 ~~~~~~~dLi~~mL~~DP~~R~Ta~elL  344 (562)
                      ....+.-++++.|+..+|++||+..|+.
T Consensus       546 ~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  546 HCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             CCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            1245677999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=9.5e-23  Score=192.79  Aligned_cols=178  Identities=44%  Similarity=0.681  Sum_probs=151.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.+.|++|+++++++......++|||+++ .+|.+++......++...+..++.+++.++++||++|++|
T Consensus        36 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H  115 (215)
T cd00180          36 EELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIH  115 (215)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            568899999999999999999999999999999999998 6999998775446899999999999999999999999999


Q ss_pred             ccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         98 RDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        98 RDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      +||+|.||+++. ++.++|+|||.+........                                               
T Consensus       116 ~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----------------------------------------------  148 (215)
T cd00180         116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----------------------------------------------  148 (215)
T ss_pred             cCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----------------------------------------------
Confidence            999999999998 89999999998754321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......++..|++||.+.....++.+.|+||+|+++
T Consensus       149 --------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~  184 (215)
T cd00180         149 --------------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL  184 (215)
T ss_pred             --------------------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHH
Confidence                                                        001123567789999887653578999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ++|                                                            ..+.+++.+|+..||++
T Consensus       185 ~~l------------------------------------------------------------~~~~~~l~~~l~~~p~~  204 (215)
T cd00180         185 YEL------------------------------------------------------------PELKDLIRKMLQKDPEK  204 (215)
T ss_pred             HHH------------------------------------------------------------HHHHHHHHHHhhCCccc
Confidence            999                                                            02568899999999999


Q ss_pred             CCCHHHHHcCc
Q psy10954        337 RVSAKTILQHE  347 (562)
Q Consensus       337 R~Ta~elL~Hp  347 (562)
                      |+++.++++|+
T Consensus       205 R~~~~~l~~~~  215 (215)
T cd00180         205 RPSAKEILEHL  215 (215)
T ss_pred             CcCHHHHhhCC
Confidence            99999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0603|consensus

Probab=99.88  E-value=2.2e-23  Score=224.90  Aligned_cols=142  Identities=32%  Similarity=0.572  Sum_probs=120.5

Q ss_pred             HHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         21 ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        21 ~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+|+.++... +||||+++++++.++.++|+|||.+.+ .+.+.+....  .....+..++.||+.|+.|||++|||||
T Consensus       362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhR  439 (612)
T KOG0603|consen  362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHR  439 (612)
T ss_pred             cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeec
Confidence            56788777655 899999999999999999999999986 6666665543  2336777899999999999999999999


Q ss_pred             cCCCCcEEE-ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         99 DLKPQNILI-NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        99 DLKP~NILl-~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ||||+|||+ +..|+++|+|||.++.....   ..+.+-|..|.|||++. ...|+.++|+||+|+++|+|
T Consensus       440 DLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~M  506 (612)
T KOG0603|consen  440 DLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEM  506 (612)
T ss_pred             CCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHH
Confidence            999999999 68899999999998866432   33446688999999998 55689999999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=1.5e-21  Score=188.97  Aligned_cols=165  Identities=42%  Similarity=0.651  Sum_probs=137.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|++.++.++|+|++++++.+......++++||+.+ +|.+++......+++..+..++.|++.++.+||+++++
T Consensus        41 ~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  120 (225)
T smart00221       41 REEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIV  120 (225)
T ss_pred             HHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45678899999999999999999999998999999999987 99999877543388999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      |+||+|.||+++.++.++|+|||++........                                               
T Consensus       121 h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-----------------------------------------------  153 (225)
T smart00221      121 HRDLKPENILLGMDGLVKLADFGLARFIHRDLA-----------------------------------------------  153 (225)
T ss_pred             cCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-----------------------------------------------
Confidence            999999999999999999999998654321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......++..|++||.+.+...++.++|+||+||++
T Consensus       154 -------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~  190 (225)
T smart00221      154 -------------------------------------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVIL  190 (225)
T ss_pred             -------------------------------------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHH
Confidence                                                       0001234567799999884444578899999999999


Q ss_pred             HHHHhCCCCCCC-CCHH
Q psy10954        257 SEMITKKTLFAG-DSEI  272 (562)
Q Consensus       257 ~eLltG~~pF~~-~~~~  272 (562)
                      ++|++|++||.+ .+..
T Consensus       191 ~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      191 YELLWGPEPFSGEGEFT  207 (225)
T ss_pred             HHHHHCCCCccccchhH
Confidence            999999999977 4443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG3653|consensus

Probab=99.87  E-value=3.6e-22  Score=208.65  Aligned_cols=165  Identities=25%  Similarity=0.336  Sum_probs=132.3

Q ss_pred             hhhHHHHHHHHH--ccCCCCcceEEEEEEeCC----EEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLK--ELKHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~--~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      .+++.+|-+|.+  .++|+||++++.+-+...    ..+||+||-+ ++|.+++..+  .++......++..+++||+||
T Consensus       246 kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~L  323 (534)
T KOG3653|consen  246 KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHL  323 (534)
T ss_pred             HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHh
Confidence            345677777766  458999999998876554    7899999997 6999999875  588999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |+-      +-                +|                             .                     
T Consensus       324 Hee------~p----------------~~-----------------------------d---------------------  331 (534)
T KOG3653|consen  324 HEE------LP----------------RG-----------------------------D---------------------  331 (534)
T ss_pred             ccc------CC----------------cC-----------------------------C---------------------
Confidence            962      10                00                             0                     


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccC--CCcccccccCCCccchhhhcCCCCCC----
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYS----  244 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~--~~~~~~~vgT~~Y~APEvl~~~~~y~----  244 (562)
                                =|+..|+|||||..||||.+++...|+|||+|..+...  ....-..|||..|||||+|.|.-...    
T Consensus       332 ----------~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~A  401 (534)
T KOG3653|consen  332 ----------HHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDA  401 (534)
T ss_pred             ----------CCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHH
Confidence                      04557999999999999999999999999999987632  33344579999999999998765444    


Q ss_pred             -chhhHHHHHHHHHHHHhCCCCC
Q psy10954        245 -TTVDIWSAGCIFSEMITKKTLF  266 (562)
Q Consensus       245 -~~~DIWSlG~il~eLltG~~pF  266 (562)
                       ..+||||+|.++|||++.-..+
T Consensus       402 fkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  402 FKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccc
Confidence             3599999999999999876544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=1.5e-20  Score=186.86  Aligned_cols=231  Identities=35%  Similarity=0.573  Sum_probs=174.4

Q ss_pred             chhhHHHHHHHHHccCCC-CcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHP-NVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~Hp-nIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~--~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ....+.+|+.+++.+.|+ +|+++++.+......+++++++.+ ++.+++....  ..+++..+..++.|++.++.|+|+
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            356788999999999988 799999999888889999999985 7887766544  268999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 RRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      .|++|||+||+||+++..+ .++++|||+++.........                       ...              
T Consensus       120 ~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~-----------------------~~~--------------  162 (384)
T COG0515         120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS-----------------------SIP--------------  162 (384)
T ss_pred             CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc-----------------------ccc--------------
Confidence            9999999999999999988 69999999876332110000                       000              


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDI  249 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DI  249 (562)
                                                                      ......+||..|+|||.+.+.  ..++..+|+
T Consensus       163 ------------------------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~  194 (384)
T COG0515         163 ------------------------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI  194 (384)
T ss_pred             ------------------------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhH
Confidence                                                            112356789999999999874  468999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC-CCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSE---IDQLFRIFRTLGTP-HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      ||+|++++++++|..||.....   .......+...+.+ ......         ....           ......+.++
T Consensus       195 ~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~-----------~~~~~~~~~~  254 (384)
T COG0515         195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS---------PSNP-----------ELISKAASDL  254 (384)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC---------cccc-----------chhhHHHHHH
Confidence            9999999999999999887764   34444444333322 000000         0000           1112467899


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +.+++..+|..|.++.+...+++....
T Consensus       255 ~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         255 LKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             HHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            999999999999999999988666543

>KOG0669|consensus

Probab=99.85  E-value=5.9e-22  Score=192.90  Aligned_cols=101  Identities=26%  Similarity=0.432  Sum_probs=83.9

Q ss_pred             ccchhhhhhhhhheeccccccccccccCCCCCccccCCccccccccccCccccccCCCCCCCCCCCCccccchhhhhhcc
Q psy10954        414 RSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSDDAVSIDVVTYHESI  493 (562)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  493 (562)
                      =|.|-||+++|..+||                                               -+.|.|.-+|| .+||.
T Consensus       192 LwYrppEllLG~r~yg-----------------------------------------------~~iDiWgAgCi-maeMw  223 (376)
T KOG0669|consen  192 LWYRPPELLLGDREYG-----------------------------------------------PPIDIWGAGCI-MAEMW  223 (376)
T ss_pred             eecCCHHHhhcccccC-----------------------------------------------CcchhHhHHHH-HHHHH
Confidence            4788899999999999                                               78999999999 99999


Q ss_pred             cCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCC----CCcccCccccccCC--CCChhHHHHHhcC
Q psy10954        494 TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD----FPEWRPKKFSEILN--LPDPLAVDVFSRV  562 (562)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~~~  562 (562)
                      |+.|+|.|+++-.||--|-..+|+-+.|+||+|.+||.|.+-    .|+=.-.+..+++.  .-|+.|.||+.++
T Consensus       224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l  298 (376)
T KOG0669|consen  224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL  298 (376)
T ss_pred             ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence            999999999999999999999999999999999999999763    33322223333332  2477899998753

>KOG1025|consensus

Probab=99.85  E-value=3.9e-21  Score=210.74  Aligned_cols=208  Identities=24%  Similarity=0.388  Sum_probs=161.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...++.|+-+|..|+|||+++|++++..+. +-||++|++ |.|.++++.++..+-......|.+||++|+.|||.+++|
T Consensus       742 s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlV  820 (1177)
T KOG1025|consen  742 SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLV  820 (1177)
T ss_pred             hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchh
Confidence            467899999999999999999999998765 889999998 699999999888899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||-..||||..-..+|+.|||+|+.+......         |.+|.                                
T Consensus       821 HrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e---------y~~~~--------------------------------  859 (1177)
T KOG1025|consen  821 HRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE---------YSAPG--------------------------------  859 (1177)
T ss_pred             hhhhhhhheeecCCCeEEEEecchhhccCccccc---------ccccc--------------------------------
Confidence            9999999999999999999999999876533221         11111                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                      ....+-|||-|.+... .|+.++||||+||++
T Consensus       860 ------------------------------------------------gK~pikwmale~i~~~-~~thqSDVWsfGVti  890 (1177)
T KOG1025|consen  860 ------------------------------------------------GKVPIKWMALESIRIR-KYTHQSDVWSFGVTI  890 (1177)
T ss_pred             ------------------------------------------------cccCcHHHHHHHhhcc-CCCchhhhhhhhhhH
Confidence                                                            0123457777877654 499999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ||++| |..|+.|.+..+. -..++. |.  .        ++     .|           +.-+-+.--++.+|+..|+.
T Consensus       891 WElmTFGa~Py~gi~~~eI-~dlle~-ge--R--------Ls-----qP-----------piCtiDVy~~mvkCwmid~~  942 (1177)
T KOG1025|consen  891 WELMTFGAKPYDGIPAEEI-PDLLEK-GE--R--------LS-----QP-----------PICTIDVYMVMVKCWMIDAD  942 (1177)
T ss_pred             HHHHhcCCCccCCCCHHHh-hHHHhc-cc--c--------CC-----CC-----------CCccHHHHHHHHHHhccCcc
Confidence            99987 8899988765432 112211 00  0        00     00           01123455678899999999


Q ss_pred             CCCCHHHHH
Q psy10954        336 QRVSAKTIL  344 (562)
Q Consensus       336 ~R~Ta~elL  344 (562)
                      .||+++++-
T Consensus       943 ~rp~fkel~  951 (1177)
T KOG1025|consen  943 SRPTFKELA  951 (1177)
T ss_pred             cCccHHHHH
Confidence            999998765

>KOG2052|consensus

Probab=99.84  E-value=1.4e-20  Score=195.51  Aligned_cols=104  Identities=29%  Similarity=0.445  Sum_probs=81.5

Q ss_pred             hhhHHHHHHHHHc--cCCCCcceEEEEEEeC----CEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKE--LKHPNVIRLHDVIPVD----FKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~--l~HpnIv~L~~~~~~~----~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ..+..||.+|.+.  |+|+||.+++..-..+    ..+|||.+|-+ |+|++++...  .++.+...+++..++.||++|
T Consensus       247 E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHL  324 (513)
T KOG2052|consen  247 ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHL  324 (513)
T ss_pred             hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHH
Confidence            4567899999875  4999999999876543    36899999997 6999999873  689999999999999999999


Q ss_pred             HHC--------CceeccCCCCcEEEccCCCeeEeecccccc
Q psy10954         91 HSR--------RIIHRDLKPQNILINKSGALKLADFGLSRA  123 (562)
Q Consensus        91 H~~--------gIiHRDLKP~NILl~~~~~vKL~DFGla~~  123 (562)
                      |..        .|.|||||..||||..+|..-|+|+|||-.
T Consensus       325 H~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  325 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             HHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            953        366666666666666666666666666543

>KOG1345|consensus

Probab=99.83  E-value=3.9e-21  Score=188.98  Aligned_cols=217  Identities=27%  Similarity=0.327  Sum_probs=146.1

Q ss_pred             hHHHHHHHHHcc-CCCCcceEEEE-EEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         20 TALREISVLKEL-KHPNVIRLHDV-IPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        20 ~~~rEi~iL~~l-~HpnIv~L~~~-~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.||...--.| .|-||+.-|++ |++.+..+++|||++ +||.+-+...  .+-|...+.++.|+++|+.|||++++|
T Consensus        66 dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlV  143 (378)
T KOG1345|consen   66 DFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLV  143 (378)
T ss_pred             HHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchh
Confidence            356676655555 47899998876 788889999999998 6998877653  488999999999999999999999999


Q ss_pred             eccCCCCcEEEcc-C-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILINK-S-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl~~-~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||.+||||-. | -.+||||||+.+..+.-...   ..-+..|.+||++....                        
T Consensus       144 HRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe~~~~~~------------------------  196 (378)
T KOG1345|consen  144 HRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPELCDTVV------------------------  196 (378)
T ss_pred             hcccccceEEEecCCccEEEeeecccccccCceehh---hhhhcccCCcHHHhhcc------------------------
Confidence            9999999999853 2 36899999986544311000   00123344444432110                        


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                                     .+.-...+..|+|.+|+
T Consensus       197 ---------------------------------------------------------------ne~~~~~ps~D~WqfGI  213 (378)
T KOG1345|consen  197 ---------------------------------------------------------------NEKLVVNPSTDIWQFGI  213 (378)
T ss_pred             ---------------------------------------------------------------ccceEecccccchheee
Confidence                                                                           00111356789999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQL-FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l-~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|..++|.+||+.+...+.- .+...-.+...                      ....+.++..++.+..+.++-|..+
T Consensus       214 i~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~----------------------~~~P~~F~~fs~~a~r~Fkk~lt~~  271 (378)
T KOG1345|consen  214 IFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN----------------------PALPKKFNPFSEKALRLFKKSLTPR  271 (378)
T ss_pred             eeeeeecCCCcchhhhccCchHHHHHHHhcccC----------------------ccCchhhcccCHHHHHHHHHhcCCc
Confidence            999999999999855433221 11111111100                      0122245556788999999999999


Q ss_pred             CCCC---CCHHHHHcCcccc
Q psy10954        334 PKQR---VSAKTILQHEYFN  350 (562)
Q Consensus       334 P~~R---~Ta~elL~Hp~f~  350 (562)
                      |++|   -++.......|..
T Consensus       272 ~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  272 FKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             ccccchhHHHHHHHHHHHHH
Confidence            9999   4444444444543

>KOG0606|consensus

Probab=99.82  E-value=1.3e-20  Score=212.15  Aligned_cols=155  Identities=31%  Similarity=0.478  Sum_probs=126.9

Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCC--Cc-------------ccccccCCCccchhhhc
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NR-------------YTHEVVTLWYRPPEILL  238 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~--~~-------------~~~~vgT~~Y~APEvl~  238 (562)
                      .+.+++|+|+-||+|||+||+|+||+.-|++|++|||+++..-...  ..             -...+|||.|+||||++
T Consensus       152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            3789999999999999999999999999999999999988653211  10             12348999999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCC
Q psy10954        239 GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP  318 (562)
Q Consensus       239 ~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  318 (562)
                      .. +|+.+||||++|+|+||.+.|..||.|++..+.+.+.+.-...-++..                          ...
T Consensus       232 rq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d--------------------------ea~  284 (1205)
T KOG0606|consen  232 RQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED--------------------------EAL  284 (1205)
T ss_pred             hh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC--------------------------cCC
Confidence            65 499999999999999999999999999998887777665432221111                          123


Q ss_pred             CHHHHHHHHHccccCCCCCCC---HHHHHcCccccCCccc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVS---AKTILQHEYFNQVEMV  355 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~T---a~elL~Hp~f~~~~~~  355 (562)
                      .++++|++.++|+.+|..|..   +-++.+|+||...++.
T Consensus       285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            478999999999999999985   6689999999998865

>KOG0601|consensus

Probab=99.80  E-value=5.5e-20  Score=198.55  Aligned_cols=298  Identities=29%  Similarity=0.289  Sum_probs=228.1

Q ss_pred             CchhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHH
Q psy10954         16 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLE----ALRYC   90 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~----aL~yL   90 (562)
                      -...+-++|+...+.+ .|+|.++.+..++.++..|+-+|+|+.+|.++.......+++..++.++.+...    ||.++
T Consensus       159 ~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~  238 (524)
T KOG0601|consen  159 LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL  238 (524)
T ss_pred             cccccccchhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhccccccccc
Confidence            3455677899888888 599999999999999999999999999999998877666999999999999999    99999


Q ss_pred             HHCCceeccCCCCcEEEccC-CCeeEeeccccccccccCccccee-----eeeccCCccceecccccccccccccccccc
Q psy10954         91 HSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~-----~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      |+.+++|-|+||+||....+ ...+++|||+...+....-.....     .+...|++||++.+.  ++...|++|+|-+
T Consensus       239 hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev  316 (524)
T KOG0601|consen  239 HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEV  316 (524)
T ss_pred             CCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhh
Confidence            99999999999999999999 789999999987765332111111     345679999998654  6788999999977


Q ss_pred             chhh-------------------------------------------------hhHHHHHHHHHhhhcCceeecCCCCcc
Q psy10954        165 FSEM-------------------------------------------------SYLYQLLEALRYCHSRRIIHRDLKPQN  195 (562)
Q Consensus       165 l~Em-------------------------------------------------~~l~QIl~gL~yLHs~~IIHRDLKPeN  195 (562)
                      ..+.                                                 ..+.|++.++.++|++.++|+|+||+|
T Consensus       317 ~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psn  396 (524)
T KOG0601|consen  317 ILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSN  396 (524)
T ss_pred             hHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccc
Confidence            6553                                                 246899999999999999999999999


Q ss_pred             eeecCC-CCEEEeecccccccccCCCcccccccCCCcc-chhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy10954        196 ILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYR-PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID  273 (562)
Q Consensus       196 ILl~~~-g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~-APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~  273 (562)
                      |++.++ +..++.|||.+..+...   .....++-.+. ..|++.....+..++|++|+|..+.+.++|.++-...... 
T Consensus       397 i~i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-  472 (524)
T KOG0601|consen  397 ILISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-  472 (524)
T ss_pred             eeeccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-
Confidence            999886 78899999987542211   11222333444 4777777777899999999999999999986543221110 


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q psy10954        274 QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       274 ~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                        ..|..           +         ..+         ..+.....+..+...|+..|+..|+.+.++..|.=|.
T Consensus       473 --~~i~~-----------~---------~~p---------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  473 --LTIRS-----------G---------DTP---------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             --eeeec-----------c---------ccc---------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence              00000           0         000         1111124567788899999999999999998887654

>KOG0576|consensus

Probab=99.79  E-value=9.9e-20  Score=196.57  Aligned_cols=172  Identities=28%  Similarity=0.434  Sum_probs=137.0

Q ss_pred             cccccccccchhhh--h-HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCcc
Q psy10954        156 VDIWSAGCIFSEMS--Y-LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR  232 (562)
Q Consensus       156 ~DvwSlG~il~Em~--~-l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~  232 (562)
                      -|+|-.-..+.|+.  | .++.+.||+|||++|-+|||||-.|||+++.|.+|++|||.+..++....+..+++||++||
T Consensus       100 Qdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywm  179 (829)
T KOG0576|consen  100 QDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWM  179 (829)
T ss_pred             cceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCcccc
Confidence            35665555666653  3 36789999999999999999999999999999999999999999988888888999999999


Q ss_pred             chhhhc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCC-cc
Q psy10954        233 PPEILL--GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PK  309 (562)
Q Consensus       233 APEvl~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~  309 (562)
                      |||+--  ....|+..+|||++|++..|+..-++|-..-.....++.+..-.-.|+                  ... +.
T Consensus       180 apEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------------------~lkDk~  241 (829)
T KOG0576|consen  180 APEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------------------TLKDKT  241 (829)
T ss_pred             chhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC------------------cccCCc
Confidence            999863  345699999999999999999888888666555555555433211111                  100 11


Q ss_pred             chhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        310 KFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       310 ~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .       -++.+.+|++.+|..+|++|||++.+|+|||..+.
T Consensus       242 k-------ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  242 K-------WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             c-------chHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            1       14568899999999999999999999999999764

>KOG1024|consensus

Probab=99.78  E-value=7.2e-18  Score=172.90  Aligned_cols=208  Identities=25%  Similarity=0.321  Sum_probs=157.8

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeC-CEEEEEeecCc-CCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHH
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFLR-QDLKDFLQTTP-------VPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~-~~i~lV~Ey~~-~~L~~~i~~~~-------~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ..+.|.-.|..+.|||+..+.++..+. ...++++.+++ ++|..+++..+       ..++..+....+.|+..|++||
T Consensus       333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl  412 (563)
T KOG1024|consen  333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL  412 (563)
T ss_pred             HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence            467888888999999999999987654 56677888887 69999987321       2377778888999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |+.||||.||-..|.+|++.-.+||+|-.++|.+...                             |--.+|        
T Consensus       413 h~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~-----------------------------DYhcLG--------  455 (563)
T KOG1024|consen  413 HNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPG-----------------------------DYHCLG--------  455 (563)
T ss_pred             HhcCcccchhhhhcceehhheeEEeccchhccccCcc-----------------------------cccccC--------
Confidence            9999999999999999999999999999888765321                             000000        


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                           |         ..      --..-|||||.+.+.. |+.++|+|
T Consensus       456 -------------------------------------D---------nE------nRPvkWMslEal~n~~-yssasDvW  482 (563)
T KOG1024|consen  456 -------------------------------------D---------NE------NRPVKWMSLEALQNSH-YSSASDVW  482 (563)
T ss_pred             -------------------------------------C---------CC------CCcccccCHHHHhhhh-hcchhhhH
Confidence                                                 0         00      1145699999998765 99999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |+||++|||++ |+.|+..-+..++...+.....                           +..=++.+ .+...++.-|
T Consensus       483 sfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR---------------------------laQP~NCP-DeLf~vMacC  534 (563)
T KOG1024|consen  483 SFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR---------------------------LAQPFNCP-DELFTVMACC  534 (563)
T ss_pred             HHHHHHHHHHhcCCCCccccCHHHHHHHHhccce---------------------------ecCCCCCc-HHHHHHHHHH
Confidence            99999999987 8999988877666554432110                           00012233 3456788899


Q ss_pred             cccCCCCCCCHHHHHc
Q psy10954        330 MALDPKQRVSAKTILQ  345 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~  345 (562)
                      +..+|++||+.+|+..
T Consensus       535 WallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  535 WALLPEERPSFSQLVI  550 (563)
T ss_pred             HhcCcccCCCHHHHHH
Confidence            9999999999998864

>KOG4158|consensus

Probab=99.77  E-value=1.3e-18  Score=178.70  Aligned_cols=205  Identities=28%  Similarity=0.390  Sum_probs=140.4

Q ss_pred             CCCCcceEEEEEEe---------------------------CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy10954         32 KHPNVIRLHDVIPV---------------------------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLL   84 (562)
Q Consensus        32 ~HpnIv~L~~~~~~---------------------------~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll   84 (562)
                      .|||||++..+|.+                           +..+|+||.-+..+|.+++..+  ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence            69999999887732                           1458999999999999999765  367888889999999


Q ss_pred             HHHHHHHHCCceeccCCCCcEEEc--cCC--CeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILIN--KSG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~--~~~--~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      +|+.|||.+||.|||+|.+|||+.  +|+  .+.++|||++-......-       -..|.+-|+               
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGl-------qlpy~S~~V---------------  409 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGL-------QLPYESDEV---------------  409 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccc-------ccccccccc---------------
Confidence            999999999999999999999986  333  378999998643221000       001111111               


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                     ..-|.-.-||||+....
T Consensus       410 ---------------------------------------------------------------d~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  410 ---------------------------------------------------------------DLGGNAKLMAPEIATAV  426 (598)
T ss_pred             ---------------------------------------------------------------cCCCcceecchhhhhcC
Confidence                                                                           01123345677776543


Q ss_pred             CC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhc
Q psy10954        241 KV-----YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL  315 (562)
Q Consensus       241 ~~-----y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (562)
                      +.     .-.++|.|+.|.+.||++...-||++..+...-.+..                   -....|.        +-
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-------------------qe~qLPa--------lp  479 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-------------------QESQLPA--------LP  479 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-------------------hhhhCCC--------Cc
Confidence            32     1136899999999999999999999865432100000                   0011111        11


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHH---HHHcCcccc
Q psy10954        316 NLPDPLAVDVFSKIMALDPKQRVSAK---TILQHEYFN  350 (562)
Q Consensus       316 ~~~~~~~~dLi~~mL~~DP~~R~Ta~---elL~Hp~f~  350 (562)
                      ...++.+++++..+|+.||+||+++.   .+|+-.-|.
T Consensus       480 ~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~  517 (598)
T KOG4158|consen  480 SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR  517 (598)
T ss_pred             ccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence            23467899999999999999999954   566544443

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.77  E-value=2.7e-19  Score=180.95  Aligned_cols=84  Identities=50%  Similarity=0.913  Sum_probs=78.4

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ +-|++|+++.|+|+++.++++++++.+|+|.+..||+...+|.+...||+|.++.+.++.+..++...|
T Consensus       181 ~~Dv~slG~i-l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (284)
T cd07860         181 AVDIWSLGCI-FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRD  259 (284)
T ss_pred             HHHHHHHHHH-HHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHH
Confidence            3699999998 778999999999999999999999999999999999999999999999999999999998888899999


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       260 li~~~  264 (284)
T cd07860         260 LLSQM  264 (284)
T ss_pred             HHHHh
Confidence            88764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0665|consensus

Probab=99.76  E-value=2e-19  Score=180.58  Aligned_cols=82  Identities=32%  Similarity=0.485  Sum_probs=61.6

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC----CCCCCCCcccCccccccCC---
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP----IYKTDFPEWRPKKFSEILN---  549 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~---  549 (562)
                      ..+|.||+||+ ++|+++++-||||...|||-.+|.+.||||.+.-.   .+|+    .|....|+|..-.|+++++   
T Consensus       196 e~vdiwSvGci-~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~---~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~  271 (369)
T KOG0665|consen  196 ENVDIWSVGCI-MGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM---KQLQPTVRNYVENRPQYQAISFSELFPDSL  271 (369)
T ss_pred             ccchhhhhhhH-HHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH---HHhhHHHHHHhhcChHhhccchhhhCCccc
Confidence            67899999999 99999999999999999999999999999987532   2222    2333455555555555554   


Q ss_pred             ---------CCChhHHHHHhcC
Q psy10954        550 ---------LPDPLAVDVFSRV  562 (562)
Q Consensus       550 ---------~~~~~~~~~~~~~  562 (562)
                               +-...|.|++++|
T Consensus       272 f~~~~e~~~~~~~~ardll~~M  293 (369)
T KOG0665|consen  272 FPVVLEGSKLDCSLARDLLSKM  293 (369)
T ss_pred             ccccccCCccchHHHHHHHHHh
Confidence                     2345678888775

>KOG0591|consensus

Probab=99.76  E-value=4.4e-20  Score=182.46  Aligned_cols=45  Identities=33%  Similarity=0.540  Sum_probs=36.9

Q ss_pred             ceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954        132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus       132 ~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      ...+|||+||+||++.+.+ |+.+|||||+||++|||.-+..-..|
T Consensus       186 ~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  186 HSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             HhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCccc
Confidence            4579999999999998765 89999999999999999654333333

>KOG0664|consensus

Probab=99.76  E-value=5e-19  Score=174.15  Aligned_cols=45  Identities=49%  Similarity=0.999  Sum_probs=43.6

Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      |++||++||.|||+.+|+||||||.|+|++++..+||||||+||.
T Consensus       161 FlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  161 FVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             hHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccc
Confidence            789999999999999999999999999999999999999999874

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.75  E-value=9.8e-19  Score=176.79  Aligned_cols=84  Identities=50%  Similarity=0.931  Sum_probs=77.1

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ +-|++++++.|++.++.++++++++.+|+|.++.||+...+|.+...+|.|.+.......+..++.+.|
T Consensus       180 ~~Di~slG~~-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (283)
T cd07835         180 PVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLD  258 (283)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHH
Confidence            3599999997 889999999999999999999999999999999999999999999999999988888888888888888


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       259 li~~~  263 (283)
T cd07835         259 LLSKM  263 (283)
T ss_pred             HHHHH
Confidence            88764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.74  E-value=1.4e-18  Score=177.15  Aligned_cols=84  Identities=27%  Similarity=0.546  Sum_probs=74.3

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCCChhHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ..|.||+||+ +.|++++++.|+|.+..+++..|++.+|+|.++.||++.....+.. .+|+|++++..+..+..++.++
T Consensus       184 ~~DiwslG~~-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (288)
T cd07871         184 PIDMWGVGCI-LYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGI  262 (288)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHH
Confidence            3699999998 8899999999999999999999999999999999999876665543 5888988888888888999999


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++++|
T Consensus       263 dll~~m  268 (288)
T cd07871         263 DLLSSL  268 (288)
T ss_pred             HHHHHh
Confidence            999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1240|consensus

Probab=99.74  E-value=1.2e-18  Score=196.68  Aligned_cols=100  Identities=34%  Similarity=0.495  Sum_probs=86.4

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL  100 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDL  100 (562)
                      -++|++ ...+++||++.+..+..+....|||=+|...+|++.+..++ -+..-+-+-|+.|++.||.-||..||+|+||
T Consensus        69 rL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDI  146 (1431)
T KOG1240|consen   69 RLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDI  146 (1431)
T ss_pred             HHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence            345666 56679999999988877778889999999999999987654 3667777889999999999999999999999


Q ss_pred             CCCcEEEccCCCeeEeeccccc
Q psy10954        101 KPQNILINKSGALKLADFGLSR  122 (562)
Q Consensus       101 KP~NILl~~~~~vKL~DFGla~  122 (562)
                      |.|||||..=..+.|+||..-+
T Consensus       147 KsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  147 KSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             ccceEEEeeechhhhhcccccC
Confidence            9999999999999999998654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=1.3e-17  Score=176.17  Aligned_cols=120  Identities=28%  Similarity=0.267  Sum_probs=94.1

Q ss_pred             hhhHHHHHHHHHccCCCCcce-EEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~-L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++++|+||+. +++.    +..|||||||++ +|.. +..    ..   ...++.|++.||.|||++||
T Consensus        65 ~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gI  132 (365)
T PRK09188         65 RHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGI  132 (365)
T ss_pred             HHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCC
Confidence            445789999999999999984 5542    468999999986 6752 211    11   14688999999999999999


Q ss_pred             eeccC-CCCcEEEccCCCeeEeeccccccccccCcc--------cceeeeeccCCccceeccc
Q psy10954         96 IHRDL-KPQNILINKSGALKLADFGLSRAFTIPMNR--------YTHEVVTLWYRPPEILLGA  149 (562)
Q Consensus        96 iHRDL-KP~NILl~~~~~vKL~DFGla~~~~~~~~~--------~~~~~~t~~y~aPE~l~~~  149 (562)
                      +|||| ||+|||++.++.+||+|||+|+.+......        .+...+++.|+|||.+...
T Consensus       133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999 999999999999999999999976543221        1234668889999998643

>KOG0615|consensus

Probab=99.71  E-value=3e-18  Score=176.95  Aligned_cols=46  Identities=50%  Similarity=0.865  Sum_probs=42.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCC---CCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---GALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~---g~vKL~DFGla~~  214 (562)
                      .|++|++.|+.|||++||+||||||||||++.+   ..+||+|||+|+.
T Consensus       280 ~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  280 LLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             HHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            489999999999999999999999999999876   7899999999863

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.70  E-value=1.9e-17  Score=170.02  Aligned_cols=84  Identities=38%  Similarity=0.616  Sum_probs=67.6

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCch-hhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCC--Ch
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLP--DP  553 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~  553 (562)
                      ..|.||+||+ +-|++++++.|+|..++ +++.+++..+|+|+++.||+...+|.+.. .+..+.|+.+.+..+..  .+
T Consensus       184 ~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (303)
T cd07869         184 CLDMWGVGCI-FVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN  262 (303)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCCh
Confidence            3599999998 77999999999998776 88999999999999999999998887754 36666777666655443  36


Q ss_pred             hHHHHHhcC
Q psy10954        554 LAVDVFSRV  562 (562)
Q Consensus       554 ~~~~~~~~~  562 (562)
                      .+.|++++|
T Consensus       263 ~~~dli~~m  271 (303)
T cd07869         263 HAEDLASKL  271 (303)
T ss_pred             HHHHHHHHH
Confidence            677887754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=2.1e-16  Score=154.11  Aligned_cols=93  Identities=25%  Similarity=0.258  Sum_probs=77.3

Q ss_pred             hHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      .+.+|+++|++|+ |++|++++++    +..|+||||+.+ +|.+.+..       . ...++.|++.+|+++|++||+|
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvH  114 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAH  114 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCcc
Confidence            4679999999995 5889999986    357999999987 67543211       1 1357889999999999999999


Q ss_pred             ccC-CCCcEEEccCCCeeEeeccccccc
Q psy10954         98 RDL-KPQNILINKSGALKLADFGLSRAF  124 (562)
Q Consensus        98 RDL-KP~NILl~~~~~vKL~DFGla~~~  124 (562)
                      ||| ||+|||++.+|.++|+|||+|...
T Consensus       115 rDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274        115 NDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             CCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999 799999999999999999998643

>KOG1164|consensus

Probab=99.69  E-value=3.1e-16  Score=163.66  Aligned_cols=170  Identities=27%  Similarity=0.301  Sum_probs=135.1

Q ss_pred             hHHHHHHHHHccCC----CCcceEEEEE-EeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         20 TALREISVLKELKH----PNVIRLHDVI-PVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        20 ~~~rEi~iL~~l~H----pnIv~L~~~~-~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      .+..|+.+|..+..    +++.++++.. ..+..-||||+.++.+|.++..... ..++...+..++.|++.||++||+.
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~  141 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK  141 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc
Confidence            57789999998873    6899999999 4778899999999999999886655 6799999999999999999999999


Q ss_pred             CceeccCCCCcEEEccC-----CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         94 RIIHRDLKPQNILINKS-----GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~-----~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |+|||||||+|++++..     ..+.|.|||+|+.........     .                               
T Consensus       142 G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~-----~-------------------------------  185 (322)
T KOG1164|consen  142 GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSG-----G-------------------------------  185 (322)
T ss_pred             CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCC-----c-------------------------------
Confidence            99999999999999865     358999999987432100000     0                               


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                        .||-                           +......+.||..|.++.+-.+.. .+.+-|
T Consensus       186 ------------------~~~~---------------------------~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DD  219 (322)
T KOG1164|consen  186 ------------------NLRP---------------------------PRPQKGLFRGTLRYASINVHLGIE-QGRRDD  219 (322)
T ss_pred             ------------------cccc---------------------------CCCCccCCCCccccccHHHhCCCc-cCCchh
Confidence                              0000                           000012346899999999888766 799999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSE  271 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~  271 (562)
                      +||++-++.|+..|..||.+...
T Consensus       220 les~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  220 LESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             hhhHHHHHHHHhcCCCCCccccc
Confidence            99999999999999999977654

>KOG0581|consensus

Probab=99.69  E-value=5.3e-18  Score=173.68  Aligned_cols=56  Identities=29%  Similarity=0.381  Sum_probs=42.3

Q ss_pred             CcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954        103 QNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus       103 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ..|=|++-|.-+...=.+|          .+++||..|||||.+.+.. |+.++||||||+.+.|+.
T Consensus       216 GeVKicDFGVS~~lvnS~a----------~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a  271 (364)
T KOG0581|consen  216 GEVKICDFGVSGILVNSIA----------NTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELA  271 (364)
T ss_pred             CCEEeccccccHHhhhhhc----------ccccccccccChhhhcCCc-CCcccceecccHHHHHHh
Confidence            4555666665543333343          2458999999999999875 899999999999999983

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.67  E-value=5.1e-17  Score=167.50  Aligned_cols=84  Identities=26%  Similarity=0.487  Sum_probs=62.9

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCc---------hhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCcccc---
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS---  545 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  545 (562)
                      ..|.||+||+ +.|+++++|.|.|..+         .+|+.+|++++|.|....|+...++|.....+..+......   
T Consensus       196 ~~DiwslG~i-l~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (317)
T cd07868         196 AIDIWAIGCI-FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCS  274 (317)
T ss_pred             hhhHHHHHHH-HHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCccc
Confidence            4699999998 8899999999988765         58999999999999999999998888665444433322211   


Q ss_pred             ------ccCCCCChhHHHHHhcC
Q psy10954        546 ------EILNLPDPLAVDVFSRV  562 (562)
Q Consensus       546 ------~~~~~~~~~~~~~~~~~  562 (562)
                            ..-..+++.++|++.+|
T Consensus       275 ~~~~~~~~~~~~~~~~~dli~~m  297 (317)
T cd07868         275 LIKYMEKHKVKPDSKAFHLLQKL  297 (317)
T ss_pred             ccchHHhcCCCCChHHHHHHHHH
Confidence                  11123567788888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG1033|consensus

Probab=99.67  E-value=3.5e-17  Score=174.24  Aligned_cols=183  Identities=28%  Similarity=0.463  Sum_probs=132.0

Q ss_pred             EEEEEeecCcC-CHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccc
Q psy10954         48 KLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  124 (562)
Q Consensus        48 ~i~lV~Ey~~~-~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~  124 (562)
                      .+||.|++|.. +|.+|++....  ..+....+.++.|+..|++|   +|.+|||+||.||....++.+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            58999999985 99999975432  35666778999999999999   99999999999999999999999999986543


Q ss_pred             cccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCE
Q psy10954        125 TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL  204 (562)
Q Consensus       125 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~v  204 (562)
                      ....+.           +|                                                             
T Consensus       407 ~~~~~~-----------~~-------------------------------------------------------------  414 (516)
T KOG1033|consen  407 DKDETV-----------AP-------------------------------------------------------------  414 (516)
T ss_pred             ccCCcc-----------cc-------------------------------------------------------------
Confidence            211100           00                                                             


Q ss_pred             EEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Q psy10954        205 KLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT  284 (562)
Q Consensus       205 KL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~  284 (562)
                                   .....+..+||++||+||.|.|.. |+.++||||||+|++|++.   +|....+.......++- | 
T Consensus       415 -------------~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~-g-  475 (516)
T KOG1033|consen  415 -------------AAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRD-G-  475 (516)
T ss_pred             -------------hhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhc-C-
Confidence                         011234568999999999998765 9999999999999999986   23222221111111110 0 


Q ss_pred             CCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q psy10954        285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                                               .+...+-..++...+|+.+||...|.+||++.+.--|+|.
T Consensus       476 -------------------------~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 -------------------------IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             -------------------------CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                     0111122235667899999999999999988887777764

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.67  E-value=4.1e-17  Score=177.37  Aligned_cols=82  Identities=32%  Similarity=0.542  Sum_probs=64.3

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC-CCCCcccCccccccCCC-CChhH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNL-PDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~  555 (562)
                      ..|.||+||+ +.|++++.|.|.|.+..+++.+|.+.+|+|+.+.+..+.  |.|. ..||...++.+...++. .++.+
T Consensus       251 ~~DiwSlGvi-l~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~p~~~~~~~  327 (440)
T PTZ00036        251 HIDLWSLGCI-IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDA  327 (440)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc--hhhhcccCCccCchhHHHHhccCCCHHH
Confidence            5799999998 899999999999999999999999999999998876542  4443 24666666666655543 45678


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      +|++++|
T Consensus       328 ~~li~~~  334 (440)
T PTZ00036        328 INFISQF  334 (440)
T ss_pred             HHHHHHH
Confidence            8888764

>KOG0590|consensus

Probab=99.67  E-value=2.3e-17  Score=184.78  Aligned_cols=147  Identities=31%  Similarity=0.523  Sum_probs=125.8

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL  100 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDL  100 (562)
                      +..|.-+-..+.|||++...+.+......+-+||||+.||+.++... +.+....+-.+++|++.||+|+|++||.||||
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            44566666778999998887777766666666999998999988764 35788889999999999999999999999999


Q ss_pred             CCCcEEEccCCCeeEeeccccccccccCcc----cceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954        101 KPQNILINKSGALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus       101 KP~NILl~~~~~vKL~DFGla~~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ||+|+++..+|.+||+|||.+..+..+...    ....+|+..|.|||++.+.......+||||.|+++..|
T Consensus       447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m  518 (601)
T KOG0590|consen  447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM  518 (601)
T ss_pred             ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence            999999999999999999998876544332    34668899999999999988888899999999999888

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.66  E-value=6.4e-17  Score=166.50  Aligned_cols=84  Identities=27%  Similarity=0.604  Sum_probs=71.4

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCC-CCCCCcccCccccccCCCCChhHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ..|.||+|++ ..|++++++.|+|....+.+..|++.+|.|.++.||+......+ ...+|.+.++.+....+..++.+.
T Consensus       185 ~~DiwslG~i-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T cd07872         185 QIDMWGVGCI-FFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGI  263 (309)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHH
Confidence            4699999998 88999999999999999999999999999999999987654433 245788888877777778889999


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++.+|
T Consensus       264 ~li~~~  269 (309)
T cd07872         264 ELLTKF  269 (309)
T ss_pred             HHHHHh
Confidence            998875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.65  E-value=1.9e-16  Score=161.09  Aligned_cols=84  Identities=33%  Similarity=0.565  Sum_probs=62.1

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCc-hhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCccc-CccccccCCC--CCh
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNL--PDP  553 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~  553 (562)
                      ..|.||+|++ +-|++++++.|.+.++ .+++..+...+|.|.++.||..+++|.|...+-... +..+.++...  .++
T Consensus       184 ~~Dv~slG~~-l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (291)
T cd07870         184 ALDIWGAGCI-FIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP  262 (291)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCCh
Confidence            3599999998 7799999999987765 588999999999999999999999998866543332 3333333322  245


Q ss_pred             hHHHHHhcC
Q psy10954        554 LAVDVFSRV  562 (562)
Q Consensus       554 ~~~~~~~~~  562 (562)
                      .+.|++.+|
T Consensus       263 ~~~~ll~~~  271 (291)
T cd07870         263 KAEDLASQM  271 (291)
T ss_pred             HHHHHHHHH
Confidence            566766653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.65  E-value=1e-16  Score=162.00  Aligned_cols=84  Identities=50%  Similarity=0.882  Sum_probs=77.5

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ +.|++++++.|.|+.+.+++.++++.+|.|.++.||+...+++|+..++.|....+.+.....++.+.|
T Consensus       182 ~~Dv~slG~i-l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (285)
T cd07861         182 PVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLD  260 (285)
T ss_pred             HHHHHHHHHH-HHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHH
Confidence            4699999998 889999999999999999999999999999999999999999999999999988888888888888889


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++++|
T Consensus       261 li~~~  265 (285)
T cd07861         261 LLEKM  265 (285)
T ss_pred             HHHHH
Confidence            88764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PRK10345 hypothetical protein; Provisional

Probab=99.65  E-value=7.3e-16  Score=151.38  Aligned_cols=100  Identities=25%  Similarity=0.321  Sum_probs=82.3

Q ss_pred             hhhHHHHHHHHHcc-----CCCCcceEEEEEEeCC---EEE-EEeecCc---CCHHHHHhhCCCCCCHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-----KHPNVIRLHDVIPVDF---KLF-LVFEFLR---QDLKDFLQTTPVPVPPALAKSYLYQLLE   85 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-----~HpnIv~L~~~~~~~~---~i~-lV~Ey~~---~~L~~~i~~~~~~l~e~~i~~i~~qll~   85 (562)
                      ...+.+|+.+++.+     +||||+++|++++++.   .++ +||||++   ++|.+++.+.  .+++.  ..++.|++.
T Consensus        40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~  115 (210)
T PRK10345         40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLK  115 (210)
T ss_pred             HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHH
Confidence            45689999999999     6799999999999873   444 7899954   5999999663  46666  356889898


Q ss_pred             HH-HHHHHCCceeccCCCCcEEEccC----CCeeEeecccc
Q psy10954         86 AL-RYCHSRRIIHRDLKPQNILINKS----GALKLADFGLS  121 (562)
Q Consensus        86 aL-~yLH~~gIiHRDLKP~NILl~~~----~~vKL~DFGla  121 (562)
                      ++ +|||+++||||||||+|||++..    +.++|+||+.+
T Consensus       116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            88 99999999999999999999743    37999995544

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.64  E-value=3.5e-16  Score=158.91  Aligned_cols=82  Identities=28%  Similarity=0.498  Sum_probs=70.1

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ +-|+++++|.|.|..+.+++..|++.+|.|..+.||....+|.  ..|....+..+.++.+..++.+.|
T Consensus       189 ~~DiwslG~i-l~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  265 (290)
T cd07862         189 PVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKD  265 (290)
T ss_pred             ccchHHHHHH-HHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc--hhccCCCCCCHHHHccCCCHHHHH
Confidence            4699999998 7799999999999999999999999999999999999877774  345555566677788888899999


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++++|
T Consensus       266 li~~~  270 (290)
T cd07862         266 LLLKC  270 (290)
T ss_pred             HHHHH
Confidence            98765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0667|consensus

Probab=99.64  E-value=1.2e-16  Score=173.59  Aligned_cols=50  Identities=34%  Similarity=0.446  Sum_probs=45.1

Q ss_pred             CCCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCC---CCCCc
Q psy10954        476 SLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHED---VWPGV  526 (562)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  526 (562)
                      ...+|.||+||| .|||+++.|||||++|.|||.||..++|-|++.   +|+..
T Consensus       366 ~~~IDmWSLGCI-lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  366 DTAIDMWSLGCI-LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             CCccceeehhhh-HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            368999999999 999999999999999999999999999999874   45544

>KOG0668|consensus

Probab=99.64  E-value=5e-17  Score=156.85  Aligned_cols=83  Identities=27%  Similarity=0.418  Sum_probs=58.4

Q ss_pred             CCCccccchhhhhhc-ccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCccc--C-CCCCCCCCcccCccccccCC----
Q psy10954        478 SDDAVSIDVVTYHES-ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--L-PIYKTDFPEWRPKKFSEILN----  549 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~----  549 (562)
                      +-|.||+||. +|+| +.++|.|-|.+..|||-||-++|||-.-..+=+--+  | |.|..-+-+++.|.++.+++    
T Consensus       213 SLD~WS~Gcm-lA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~  291 (338)
T KOG0668|consen  213 SLDMWSLGCM-LASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQ  291 (338)
T ss_pred             cHHHHHHHHH-HHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccc
Confidence            4599999999 6665 567899999999999999999999865443321111  1 33333344566666666664    


Q ss_pred             -CCChhHHHHHhc
Q psy10954        550 -LPDPLAVDVFSR  561 (562)
Q Consensus       550 -~~~~~~~~~~~~  561 (562)
                       +.+|.|+|++.+
T Consensus       292 hl~~peaiDlldk  304 (338)
T KOG0668|consen  292 HLVSPEAIDLLDK  304 (338)
T ss_pred             ccCChHHHHHHHH
Confidence             457999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.63  E-value=4.1e-16  Score=154.53  Aligned_cols=124  Identities=14%  Similarity=0.233  Sum_probs=96.1

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeC--------CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~--------~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+|+..+.+++||+|..+.+++...        ...+|||||++| +|.++.     .+++.    .+.+++.+|..||
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH  152 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLH  152 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHH
Confidence            46899999999999999999987643        358999999997 887763     23332    4569999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +.|++|||+||+||+++.+| ++|+|||..+.......             -..+.-...|..++|+||+|+.+.-
T Consensus       153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehH
Confidence            99999999999999999988 99999998765532111             1112222335678999999998754

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.63  E-value=6.1e-16  Score=156.74  Aligned_cols=82  Identities=29%  Similarity=0.540  Sum_probs=72.7

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ +-|+++++|.|.|..+.+++.+|+..+|.|..+.||....+|  ...|+...+....++.+..+..+.|
T Consensus       187 ~~DiwslG~~-l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  263 (288)
T cd07863         187 PVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP--RGAFSPRGPRPVQSVVPEIEESGAQ  263 (288)
T ss_pred             cchhhhHHHH-HHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc--ccccCCCCCCchHHhCcCcCHHHHH
Confidence            4699999998 778999999999999999999999999999999999887777  4567888888888888888888999


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       264 li~~~  268 (288)
T cd07863         264 LLLEM  268 (288)
T ss_pred             HHHHH
Confidence            98764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.63  E-value=6.7e-16  Score=149.38  Aligned_cols=100  Identities=22%  Similarity=0.337  Sum_probs=79.1

Q ss_pred             HHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecc
Q psy10954         22 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC-HSRRIIHRD   99 (562)
Q Consensus        22 ~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL-H~~gIiHRD   99 (562)
                      .+|+++|.++.+++|...+... ... .+|||||+++ ++...... ...+++..+..++.|++.+|.|+ |+.||+|||
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrD  143 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPIL-LKS-HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHAD  143 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEE-ecC-CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            4699999999888764433322 222 3899999986 44443322 34689999999999999999999 799999999


Q ss_pred             CCCCcEEEccCCCeeEeecccccccc
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFT  125 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~  125 (562)
                      |||+|||++ ++.++|+|||+|....
T Consensus       144 lkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         144 LSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCHHHEEEE-CCcEEEEEccccccCC
Confidence            999999998 5789999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0599|consensus

Probab=99.62  E-value=1.3e-16  Score=157.22  Aligned_cols=71  Identities=35%  Similarity=0.620  Sum_probs=64.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                      .+|+|+++|++|||.++|+||||||||||++++.++||+|||+|+.+. +..+....||||.|.|||++...
T Consensus       127 ~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~-~GekLrelCGTPgYLAPEtikC~  197 (411)
T KOG0599|consen  127 RIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE-PGEKLRELCGTPGYLAPETIKCS  197 (411)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC-CchhHHHhcCCCcccChhheeee
Confidence            589999999999999999999999999999999999999999999875 45566788999999999999654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.62  E-value=7.8e-16  Score=156.54  Aligned_cols=83  Identities=41%  Similarity=0.809  Sum_probs=74.6

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ .-|++++++.|+|.++..++.++++.+|+|+.+.||...+++.+.. +|+|.+..+.+..+..++.+.+
T Consensus       192 ~~Di~slG~~-l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  269 (295)
T cd07837         192 PVDIWSVGCI-FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE-FPQWKPQDLSRAVPDLSPEGLD  269 (295)
T ss_pred             hHHHHHHHHH-HHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhh-cCcccchhHHHhccccCHHHHH
Confidence            4699999998 7789999999999999999999999999999999999999998765 8999999888888888888888


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       270 ~i~~~  274 (295)
T cd07837         270 LLQKM  274 (295)
T ss_pred             HHHHH
Confidence            87764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.60  E-value=1e-15  Score=154.79  Aligned_cols=83  Identities=36%  Similarity=0.635  Sum_probs=69.3

Q ss_pred             CCCccccchhhhhhccc-CCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCcc-ccccCCCCChhH
Q psy10954        478 SDDAVSIDVVTYHESIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  555 (562)
                      ..|.||+||+ +-|+++ +.|.|+|.+..+++.+|++.+|.|.++.||..+.+|.+ ..++.+.... +.+..+..++.+
T Consensus       180 ~~DiwslG~i-l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  257 (284)
T cd07839         180 SIDMWSAGCI-FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY-KPYPMYPATTSLVNVVPKLNSTG  257 (284)
T ss_pred             HHHHHHHHHH-HHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc-cccCCCCCcchhhhhcccCCHHH
Confidence            4699999998 778886 57889999999999999999999999999999999987 4567666543 456677788888


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       258 ~~li~~~  264 (284)
T cd07839         258 RDLLQNL  264 (284)
T ss_pred             HHHHHHH
Confidence            8988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.60  E-value=2.8e-15  Score=144.65  Aligned_cols=100  Identities=27%  Similarity=0.329  Sum_probs=81.3

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCC-HHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcee
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKD-FLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRIIH   97 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~-L~~-~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gIiH   97 (562)
                      ..+|.+.+.++.|++|.....+...  ..||||||+++. +.. .+.  ...+++..+..++.|++.++.++|+ +||+|
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givH  141 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVH  141 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            3589999999999988554444332  248999999863 433 333  2357888999999999999999999 99999


Q ss_pred             ccCCCCcEEEccCCCeeEeecccccccc
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFT  125 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~  125 (562)
                      |||||+|||++ ++.++|+|||+|....
T Consensus       142 rDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         142 GDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999999 8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.60  E-value=1.8e-15  Score=157.21  Aligned_cols=45  Identities=47%  Similarity=0.797  Sum_probs=42.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       100 ~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~  144 (325)
T cd05602         100 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK  144 (325)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence            478999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0589|consensus

Probab=99.59  E-value=1.1e-15  Score=162.20  Aligned_cols=48  Identities=42%  Similarity=0.791  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..|+.|++.|++|||+++|+|||||+.||+++.++.|||+|||+|+..
T Consensus       109 ~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen  109 LKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            368999999999999999999999999999999999999999999864

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.58  E-value=1.9e-15  Score=156.97  Aligned_cols=46  Identities=37%  Similarity=0.692  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       104 ~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616         104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             HHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence            4578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.58  E-value=2.5e-15  Score=153.23  Aligned_cols=137  Identities=22%  Similarity=0.332  Sum_probs=93.7

Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC----
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----  240 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~----  240 (562)
                      ...+....|+++.+++||+.|++|+||||+|++++.+|.+.|+||+.........   .....+..|.+||+....    
T Consensus       145 ~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~  221 (288)
T PF14531_consen  145 AARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFG  221 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCH
T ss_pred             HHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccC
Confidence            3456677999999999999999999999999999999999999998766543221   113456889999987442    


Q ss_pred             ---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC
Q psy10954        241 ---KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL  317 (562)
Q Consensus       241 ---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  317 (562)
                         -.++.+.|.|++|+++|.|++|..||.......          .                   .+   ..+...- .
T Consensus       222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~----------~-------------------~~---~~f~~C~-~  268 (288)
T PF14531_consen  222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEA----------D-------------------PE---WDFSRCR-D  268 (288)
T ss_dssp             HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGS----------T-------------------SG---GGGTTSS--
T ss_pred             cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccc----------c-------------------cc---ccchhcC-C
Confidence               237889999999999999999999997553210          0                   00   0111122 3


Q ss_pred             CCHHHHHHHHHccccCCCCC
Q psy10954        318 PDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R  337 (562)
                      .++..++||.+||++||.+|
T Consensus       269 ~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  269 MPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             --HHHHHHHHHHT-SSGGGS
T ss_pred             cCHHHHHHHHHHccCCcccC
Confidence            45678999999999999988

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.58  E-value=4.8e-15  Score=154.92  Aligned_cols=48  Identities=48%  Similarity=0.801  Sum_probs=45.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       105 ~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573         105 FYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            478999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.58  E-value=1.5e-15  Score=158.76  Aligned_cols=84  Identities=30%  Similarity=0.517  Sum_probs=65.7

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccC--CCCCCCCCcccCccccccCCCCChhH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (562)
                      ..|.||+||+ +.|++++++.|+|....+++.++....|+|..+.++..+.-  ..|...+|...+..+.+++...++.+
T Consensus       196 ~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (343)
T cd07878         196 TVDIWSVGCI-MAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLA  274 (343)
T ss_pred             hhhhHhHHHH-HHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHH
Confidence            4699999999 88999999999999999999999999999988776544221  12233456666666777777788888


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       275 ~~li~~m  281 (343)
T cd07878         275 IDLLEKM  281 (343)
T ss_pred             HHHHHHH
Confidence            9988765

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG1165|consensus

Probab=99.57  E-value=8.9e-15  Score=147.95  Aligned_cols=178  Identities=21%  Similarity=0.305  Sum_probs=137.3

Q ss_pred             CCCCCCCccccccCCchhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHH
Q psy10954          2 VSDESRPRSRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL   80 (562)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~   80 (562)
                      ||-|.+||..     .......|....+.|. -++|..+|.+-..+.+-.||||+++.+|.++..-.+..|+...+..++
T Consensus        56 VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA  130 (449)
T KOG1165|consen   56 VAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIA  130 (449)
T ss_pred             EEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHH
Confidence            3445566652     2344667888888775 589999998888888889999999877777666566679999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCC-----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSG-----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  155 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~-----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~  155 (562)
                      .|++.-++|+|++.+|.|||||+|+||..-+     .+.++|||+|+.+..                |+.-.        
T Consensus       131 ~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD----------------p~Tkq--------  186 (449)
T KOG1165|consen  131 KQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD----------------PKTKQ--------  186 (449)
T ss_pred             HHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC----------------ccccc--------
Confidence            9999999999999999999999999997543     377888888765432                22110        


Q ss_pred             cccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchh
Q psy10954        156 VDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPE  235 (562)
Q Consensus       156 ~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APE  235 (562)
                                                   .                               .+.....+..||..||+--
T Consensus       187 -----------------------------H-------------------------------IPYrE~KSLsGTARYMSIN  206 (449)
T KOG1165|consen  187 -----------------------------H-------------------------------IPYREHKSLSGTARYMSIN  206 (449)
T ss_pred             -----------------------------c-------------------------------CccccccccccceeeeEee
Confidence                                         0                               0112234456788888888


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy10954        236 ILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD  269 (562)
Q Consensus       236 vl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~  269 (562)
                      .-+|.+ .+..-|+=|+|=+++..+.|..||.|-
T Consensus       207 THlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  207 THLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             ccccch-hhhhhhHHHhhhhhhhhccCCCccccc
Confidence            777766 688899999999999999999999874

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.57  E-value=3.7e-15  Score=154.84  Aligned_cols=46  Identities=37%  Similarity=0.689  Sum_probs=43.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       104 ~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587         104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            3578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.57  E-value=3.2e-15  Score=155.02  Aligned_cols=45  Identities=40%  Similarity=0.776  Sum_probs=42.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+
T Consensus       100 ~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~  144 (316)
T cd05592         100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK  144 (316)
T ss_pred             HHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence            578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.57  E-value=3.6e-15  Score=154.68  Aligned_cols=46  Identities=41%  Similarity=0.634  Sum_probs=43.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        99 ~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccce
Confidence            3578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.56  E-value=1.8e-15  Score=169.33  Aligned_cols=71  Identities=32%  Similarity=0.504  Sum_probs=60.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecC-CCCEEEeecccccccccCC-CcccccccCCCccchhhhcC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLG  239 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~-~g~vKL~DFGla~~~~~~~-~~~~~~vgT~~Y~APEvl~~  239 (562)
                      .++.|++.||+|||+++|+||||||+|||++. ++.+||+|||+|+...... ......+||+.|+|||.+..
T Consensus       259 ~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~  331 (566)
T PLN03225        259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM  331 (566)
T ss_pred             HHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhc
Confidence            47899999999999999999999999999986 6899999999998664332 23345689999999997743

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.56  E-value=5.7e-15  Score=148.63  Aligned_cols=84  Identities=50%  Similarity=0.923  Sum_probs=77.2

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ .-|++++++.|.|+...+++.+|++.+|+|.++.|+....++.+...||.|......+.++..++.+.|
T Consensus       179 ~~Dv~slG~~-l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (282)
T cd07829         179 AVDIWSVGCI-FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID  257 (282)
T ss_pred             cccHHHHHHH-HHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHH
Confidence            4699999998 778999999999999999999999999999999999999999889999999999998888888888898


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       258 ~i~~~  262 (282)
T cd07829         258 LLSKM  262 (282)
T ss_pred             HHHHh
Confidence            88764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.56  E-value=1.7e-15  Score=157.19  Aligned_cols=84  Identities=31%  Similarity=0.449  Sum_probs=59.6

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC--CCCCCCCcccCccccccCCCCChhH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  555 (562)
                      ..|.||+||+ +-|++++++.|+|....+|+..+...+|+|..+.++.+..-.  .+-..+..-.|..+++.++..++.+
T Consensus       188 ~~DvwSlGvv-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (338)
T cd07859         188 AIDIWSIGCI-FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLA  266 (338)
T ss_pred             hhHHHHHHHH-HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHH
Confidence            4699999998 888999999999999999999999999999988776543211  0111122223344555555566677


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       267 ~~li~~~  273 (338)
T cd07859         267 LRLLERL  273 (338)
T ss_pred             HHHHHHH
Confidence            7776653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.56  E-value=5.2e-15  Score=151.58  Aligned_cols=84  Identities=27%  Similarity=0.530  Sum_probs=67.0

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCC-CCCCCcccCccccccCCCCChhHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ..|.||+|++ +-|++++++.|++....+|+.+|.+.+|.|.++.||.......+ ...+|.+.+..+...-+..++.+.
T Consensus       185 ~~Dv~slG~~-l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (301)
T cd07873         185 QIDMWGVGCI-FYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA  263 (301)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHH
Confidence            4699999998 78999999999999999999999999999999999976443332 335666666555555566777888


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++.+|
T Consensus       264 ~li~~m  269 (301)
T cd07873         264 ELLSKL  269 (301)
T ss_pred             HHHHHH
Confidence            888764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.56  E-value=5.5e-15  Score=153.56  Aligned_cols=45  Identities=49%  Similarity=0.780  Sum_probs=42.6

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       104 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (323)
T cd05584         104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK  148 (323)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence            468899999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.55  E-value=6.4e-15  Score=153.23  Aligned_cols=46  Identities=37%  Similarity=0.689  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       104 ~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615         104 VFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence            4678999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.55  E-value=4.8e-15  Score=149.70  Aligned_cols=84  Identities=37%  Similarity=0.751  Sum_probs=72.9

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCCChhHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ..|.||+|++ +.|++++.|.|+|+.+..++.++.+.+|.|+.+.||....++++.. .|+.-.+..+.++++..+....
T Consensus       181 ~~Di~slG~~-l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (286)
T cd07832         181 GVDLWAVGCI-FAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL  259 (286)
T ss_pred             hhHHHHHHHH-HHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHH
Confidence            4799999998 8899999999999999999999999999999999999999988854 4666666667778878888888


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++++|
T Consensus       260 ~li~~~  265 (286)
T cd07832         260 DLLKGL  265 (286)
T ss_pred             HHHHHH
Confidence            888764

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.55  E-value=2.9e-15  Score=158.71  Aligned_cols=46  Identities=52%  Similarity=0.974  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       106 ~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853         106 KVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccccee
Confidence            3578999999999999999999999999999999999999999865

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.55  E-value=6.3e-15  Score=151.59  Aligned_cols=56  Identities=32%  Similarity=0.579  Sum_probs=48.2

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCc---------hhhHHHHHHhcCCCCCCCCCCcccCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYK  533 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (562)
                      ...|.||+||+ +.|++|++|.|.+..+         .+|+.++++.+|.|..+.|+...+.|.|.
T Consensus       195 ~~~DiwSlG~i-l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (317)
T cd07867         195 KAIDIWAIGCI-FAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYP  259 (317)
T ss_pred             cHHHHHhHHHH-HHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccch
Confidence            34699999998 8899999999987653         58999999999999999999988777653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG1163|consensus

Probab=99.52  E-value=2.4e-14  Score=139.39  Aligned_cols=106  Identities=26%  Similarity=0.385  Sum_probs=91.1

Q ss_pred             hHHHHHHHHHccCC-CCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l~H-pnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ....|..+.+.|++ ..|..+..+..+..+-.+|||..+.+|.++..-....++...+..++-|++.-++|+|.++.|||
T Consensus        56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHR  135 (341)
T KOG1163|consen   56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHR  135 (341)
T ss_pred             chhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccc
Confidence            46789999999976 67888888888888999999999987777766555579999999999999999999999999999


Q ss_pred             cCCCCcEEEccC---CCeeEeecccccccc
Q psy10954         99 DLKPQNILINKS---GALKLADFGLSRAFT  125 (562)
Q Consensus        99 DLKP~NILl~~~---~~vKL~DFGla~~~~  125 (562)
                      ||||+|+|..-.   ..+.|+|||+|+.+.
T Consensus       136 DIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen  136 DIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cCCccceeeccccccceEEEEeccchhhhc
Confidence            999999998744   348899999998764

>KOG1023|consensus

Probab=99.52  E-value=3.7e-14  Score=153.37  Aligned_cols=206  Identities=24%  Similarity=0.331  Sum_probs=147.9

Q ss_pred             HHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCcE
Q psy10954         28 LKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI-IHRDLKPQNI  105 (562)
Q Consensus        28 L~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI-iHRDLKP~NI  105 (562)
                      |+.+.|.|+.++++.+..+..+++|-+||. ++|.+.+......++..-...+++.++.||+|+|.-.| .|..|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            567899999999999999999999999997 69999998877778888888999999999999998766 9999999999


Q ss_pred             EEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCc
Q psy10954        106 LINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR  185 (562)
Q Consensus       106 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~  185 (562)
                      +++..-.+||+|||+......          +..+.+     ..                                    
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~----------~~~~~~-----~~------------------------------------  109 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEE----------TAEPEA-----HH------------------------------------  109 (484)
T ss_pred             eeeeeEEEEechhhhcccccc----------cccccc-----cc------------------------------------
Confidence            999999999999998654421          000000     00                                    


Q ss_pred             eeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC------CCchhhHHHHHHHHHHH
Q psy10954        186 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV------YSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       186 IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~------y~~~~DIWSlG~il~eL  259 (562)
                                                            ...-..-|.|||++.+...      -+.+.||||+|++++|+
T Consensus       110 --------------------------------------~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen  110 --------------------------------------PIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             --------------------------------------hhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence                                                  0001223566666654311      35578999999999999


Q ss_pred             HhCCCCCCCCCH----HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        260 ITKKTLFAGDSE----IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       260 ltG~~pF~~~~~----~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      ++...||.....    .+.+..+.. .|..+                   .+|....  .....+....++.+|+.-+|.
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~-------------------~rP~i~~--~~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKK-GGSNP-------------------FRPSIEL--LNELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHh-cCCCC-------------------cCcchhh--hhhcchHHHHHHHHhcccChh
Confidence            999999976432    223333322 11110                   0111100  012233678899999999999


Q ss_pred             CCCCHHHHH
Q psy10954        336 QRVSAKTIL  344 (562)
Q Consensus       336 ~R~Ta~elL  344 (562)
                      +||+++++-
T Consensus       210 ~rPs~~~i~  218 (484)
T KOG1023|consen  210 KRPSIEQIR  218 (484)
T ss_pred             hCccHHHHH
Confidence            999998775

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.52  E-value=1.8e-14  Score=146.84  Aligned_cols=82  Identities=37%  Similarity=0.691  Sum_probs=65.0

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ ..|++++.|.|+|..+.+.+.++++.+|.|.++.||....++.+.. +....+....++.........+
T Consensus       183 ~~Dv~slG~i-l~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T cd07841         183 GVDMWSVGCI-FAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE-FKPFPPTPLKQIFPAASDDALD  260 (298)
T ss_pred             HHHHHHHHHH-HHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc-ccccCCcchhhhcccccHHHHH
Confidence            4699999988 8889999999999999999999999999999999999988887754 3333444455555555566666


Q ss_pred             HHhc
Q psy10954        558 VFSR  561 (562)
Q Consensus       558 ~~~~  561 (562)
                      ++.+
T Consensus       261 li~~  264 (298)
T cd07841         261 LLQR  264 (298)
T ss_pred             HHHH
Confidence            6654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.52  E-value=2.4e-14  Score=147.22  Aligned_cols=84  Identities=27%  Similarity=0.501  Sum_probs=65.5

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCCChhHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ..|.||+|++ +-|++++++.|++.+..+++..|...+|.|....||....+|.+.+ .++......++..+...++.+.
T Consensus       189 ~~DvwslG~i-l~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T cd07845         189 AIDMWAVGCI-LAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGL  267 (309)
T ss_pred             hHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHH
Confidence            4699999998 8889999999999999999999999999999999999988886543 1232222333444444577788


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++++|
T Consensus       268 ~li~~m  273 (309)
T cd07845         268 RLLNFL  273 (309)
T ss_pred             HHHHHH
Confidence            887664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.50  E-value=2.7e-14  Score=144.38  Aligned_cols=46  Identities=54%  Similarity=1.123  Sum_probs=43.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.|++.||.|||+++|+||||||+||++++++.+||+|||++.
T Consensus       103 ~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846         103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            4578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.50  E-value=2.3e-14  Score=148.41  Aligned_cols=46  Identities=54%  Similarity=0.782  Sum_probs=43.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       101 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  146 (318)
T cd05582         101 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK  146 (318)
T ss_pred             HHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence            3578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.50  E-value=2.5e-14  Score=151.02  Aligned_cols=45  Identities=51%  Similarity=0.839  Sum_probs=42.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       130 ~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             HHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            578999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.49  E-value=3.7e-14  Score=147.61  Aligned_cols=83  Identities=41%  Similarity=0.727  Sum_probs=72.3

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ +-|++++++.|+|..+.+++.+|+..+|+|....||....+|.|.. +....|..+.++.+..+..+.|
T Consensus       214 ~~Dv~slG~~-l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  291 (335)
T PTZ00024        214 AVDMWSVGCI-FAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE-FTPRKPKDLKTIFPNASDDAID  291 (335)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc-cCcCCcccHHHhCcCCChHHHH
Confidence            4699999998 8899999999999999999999999999999999999999998754 5666677788888777788888


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       292 li~~~  296 (335)
T PTZ00024        292 LLQSL  296 (335)
T ss_pred             HHHHH
Confidence            87764

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.49  E-value=3.3e-14  Score=144.71  Aligned_cols=84  Identities=38%  Similarity=0.661  Sum_probs=64.2

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCC--Chh
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLP--DPL  554 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~  554 (562)
                      ..|.||+|++ +-|++++++.|.+.+..+.+.++++.+|.|..+.||+...+|.... .++.-......+.++..  ++.
T Consensus       187 ~~Di~slG~~-l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (293)
T cd07843         187 AIDMWSVGCI-FAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDN  265 (293)
T ss_pred             hhhHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChH
Confidence            4799999997 8899999999999999999999999999999999999988887763 22222233333444443  666


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       266 ~~~li~~~  273 (293)
T cd07843         266 GFDLLNRL  273 (293)
T ss_pred             HHHHHHHH
Confidence            66766553

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PTZ00284 protein kinase; Provisional

Probab=99.49  E-value=1.7e-14  Score=157.80  Aligned_cols=45  Identities=24%  Similarity=0.310  Sum_probs=40.9

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDV  522 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (562)
                      ...|.||+||+ +.|+++++++|.|..+.+++..|.+++|+++++-
T Consensus       324 ~~~DiwSlGvi-l~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~  368 (467)
T PTZ00284        324 YSTDMWSMGCI-IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEW  368 (467)
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH
Confidence            34799999998 8899999999999999999999999999997653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.49  E-value=4e-14  Score=143.80  Aligned_cols=84  Identities=36%  Similarity=0.632  Sum_probs=66.7

Q ss_pred             CCCccccchhhhhhcccCCcccCCCC-chhhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCCC--h
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDS-EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPD--P  553 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~  553 (562)
                      ..|.||+|++ +-|++++++.|++.. ..+|+..+++.+|.|.++.||.....+.+.. .++.+.+..+.+.+...+  +
T Consensus       184 ~~Dv~slG~i-l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (291)
T cd07844         184 SLDMWGVGCI-FYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIP  262 (291)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCch
Confidence            4699999998 888999999999877 5689999999999999999999988876644 456666666655555555  6


Q ss_pred             hHHHHHhcC
Q psy10954        554 LAVDVFSRV  562 (562)
Q Consensus       554 ~~~~~~~~~  562 (562)
                      .+.|++.+|
T Consensus       263 ~~~~li~~~  271 (291)
T cd07844         263 HGEELALKF  271 (291)
T ss_pred             hHHHHHHHH
Confidence            777776653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.49  E-value=6.3e-14  Score=143.26  Aligned_cols=83  Identities=34%  Similarity=0.665  Sum_probs=64.5

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCC--CCCcccCccccccCCCCChhH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT--DFPEWRPKKFSEILNLPDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  555 (562)
                      ..|.||+|++ +.|+++++|.|.|.++.+++..+++..|.|.++.||....+|....  .++.. |..+.+.+....+..
T Consensus       207 ~~Dv~slG~i-l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  284 (311)
T cd07866         207 AVDIWGIGCV-FAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERFGKLGPEG  284 (311)
T ss_pred             hhHhHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCC-CccHHHHcccCChhH
Confidence            4699999998 8889999999999999999999999999999999999988887543  22222 223444455555667


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       285 ~~~i~~~  291 (311)
T cd07866         285 LDLLSKL  291 (311)
T ss_pred             HHHHHHH
Confidence            7776653

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.49  E-value=4.6e-14  Score=148.72  Aligned_cols=45  Identities=51%  Similarity=0.839  Sum_probs=42.6

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       127 ~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            478899999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.48  E-value=2.3e-14  Score=148.93  Aligned_cols=45  Identities=40%  Similarity=0.746  Sum_probs=42.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        99 ~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~  143 (323)
T cd05571          99 FYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK  143 (323)
T ss_pred             HHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            467899999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0579|consensus

Probab=99.47  E-value=1.7e-14  Score=155.18  Aligned_cols=44  Identities=55%  Similarity=0.901  Sum_probs=42.0

Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..+|+|.||+|||+++|||||||..|||++-+|.|+|+|||.+.
T Consensus       135 vc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  135 VCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             HHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccc
Confidence            57899999999999999999999999999999999999999864

>KOG0597|consensus

Probab=99.47  E-value=2.6e-14  Score=152.64  Aligned_cols=46  Identities=63%  Similarity=1.050  Sum_probs=43.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .+.+|++.||.|||+++|+|||+||+|||+...|.+|+||||+||.
T Consensus       104 ~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen  104 AIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             HHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhh
Confidence            4678999999999999999999999999999999999999999985

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.46  E-value=8.1e-14  Score=141.31  Aligned_cols=47  Identities=51%  Similarity=1.060  Sum_probs=43.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||+++|+||||||+||+++.+|.+||+|||+++.
T Consensus       103 ~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848         103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            35789999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.46  E-value=4.3e-14  Score=147.39  Aligned_cols=45  Identities=42%  Similarity=0.789  Sum_probs=43.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        99 ~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~  143 (328)
T cd05593          99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK  143 (328)
T ss_pred             HHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence            578899999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.46  E-value=6e-14  Score=141.70  Aligned_cols=84  Identities=42%  Similarity=0.845  Sum_probs=75.4

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ +-|++++++.|.|.+..+++.++++..++|.++.|+....+|.+...+|...+.....+.+..++.+++
T Consensus       181 ~~Dv~slG~~-l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (284)
T cd07836         181 SIDIWSVGCI-MAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID  259 (284)
T ss_pred             HHHHHHHHHH-HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHH
Confidence            3699999998 778999999999999999999999999999999999999999999999988887777777777888888


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       260 ~i~~~  264 (284)
T cd07836         260 LLHRL  264 (284)
T ss_pred             HHHHH
Confidence            88764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.45  E-value=6.3e-14  Score=144.84  Aligned_cols=46  Identities=46%  Similarity=0.704  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        96 ~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~  141 (312)
T cd05585          96 RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK  141 (312)
T ss_pred             HHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence            3578899999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.45  E-value=8e-14  Score=144.89  Aligned_cols=45  Identities=40%  Similarity=0.792  Sum_probs=42.4

Q ss_pred             hhHHHHHHHHHhhhc-CceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs-~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++
T Consensus        99 ~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          99 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             HHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            567899999999997 799999999999999999999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.44  E-value=6.6e-14  Score=145.13  Aligned_cols=45  Identities=47%  Similarity=0.780  Sum_probs=42.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++
T Consensus       100 ~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  144 (321)
T cd05603         100 FYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (321)
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence            478899999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.44  E-value=6.6e-14  Score=145.52  Aligned_cols=45  Identities=47%  Similarity=0.788  Sum_probs=43.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       100 ~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~  144 (325)
T cd05604         100 FYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK  144 (325)
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence            478999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.44  E-value=7.4e-14  Score=145.44  Aligned_cols=84  Identities=29%  Similarity=0.520  Sum_probs=63.2

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC--CCCCCCCcccCccccccCCCCChhH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  555 (562)
                      ..|.||+|++ +.|++++++.|.+....+++..+++.+|+|+++.|.-+..-.  .+...+..+.+..+..+.+..++..
T Consensus       190 ~~Di~slGv~-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (332)
T cd07857         190 AIDVWSVGCI-LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA  268 (332)
T ss_pred             HHHHHHHHHH-HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHH
Confidence            4699999997 779999999999999999999999999999987765432211  1223455566666666666677778


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .+++.++
T Consensus       269 ~~li~~~  275 (332)
T cd07857         269 LDLLEKL  275 (332)
T ss_pred             HHHHHHH
Confidence            8887654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.44  E-value=1.2e-13  Score=145.30  Aligned_cols=45  Identities=51%  Similarity=0.839  Sum_probs=42.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|+++||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       123 ~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874         123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            578999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0606|consensus

Probab=99.44  E-value=5.1e-14  Score=159.60  Aligned_cols=240  Identities=26%  Similarity=0.360  Sum_probs=166.3

Q ss_pred             cCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q psy10954         31 LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK  109 (562)
Q Consensus        31 l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~  109 (562)
                      ..+|-+++....|......+||++|.++ +|...+++.+ ..+++-++.++..+..+++|||+..++|||+||.|+|+..
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~  939 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY  939 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcc
Confidence            3456666665556667889999999974 8998887754 5778888999999999999999999999999999999999


Q ss_pred             CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeec
Q psy10954        110 SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHR  189 (562)
Q Consensus       110 ~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHR  189 (562)
                      +|+.++.|||..+........ ...      ..|+-......                                   .++
T Consensus       940 ~gh~~l~~~~t~~~vg~~~p~-~~~------sg~~~~~~~~~-----------------------------------~~~  977 (1205)
T KOG0606|consen  940 DGHRPLTDFGTLSKVGLIPPT-TDL------SGPSSSGTPRR-----------------------------------LSR  977 (1205)
T ss_pred             cCCcccCccccccccccccCc-CCc------ccccccCcccc-----------------------------------ccc
Confidence            999999999965443211000 000      00000000000                                   000


Q ss_pred             CCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q psy10954        190 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD  269 (562)
Q Consensus       190 DLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~  269 (562)
                      +-...             .+.     ..........+||+.|.|||.+++.. .+..+|+|+.|++++|.++|.+||...
T Consensus       978 ~~~~~-------------~l~-----~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  978 SERRP-------------QLS-----ADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             ccccc-------------ccc-----cchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence            00000             000     00011223457899999999999887 789999999999999999999999988


Q ss_pred             CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHH---HHHcC
Q psy10954        270 SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK---TILQH  346 (562)
Q Consensus       270 ~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~---elL~H  346 (562)
                      .....+..|...     ...|+...                     ...+..+.+++.++|..+|.+|.++.   ++-.|
T Consensus      1039 tpq~~f~ni~~~-----~~~~p~g~---------------------~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNR-----DIPWPEGP---------------------EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred             chhhhhhccccC-----CCCCCCCc---------------------cccChhhhhhhhhhhccCchhccCcccccccccC
Confidence            776544444321     11122111                     12356789999999999999999987   99999


Q ss_pred             ccccCCcccCCc
Q psy10954        347 EYFNQVEMVKPT  358 (562)
Q Consensus       347 p~f~~~~~~~~~  358 (562)
                      +||+.+++....
T Consensus      1093 ~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1093 PFFQDVDWENLA 1104 (1205)
T ss_pred             CccCCCCccccc
Confidence            999999876533

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.44  E-value=7.5e-14  Score=144.73  Aligned_cols=45  Identities=38%  Similarity=0.772  Sum_probs=42.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       100 ~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05620         100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK  144 (316)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence            578999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	562
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-67
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-67
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-67
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-67
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-67
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-67
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-67
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-67
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-67
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-67
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-67
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-67
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-67
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-66
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-66
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-66
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-66
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-66
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-66
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-66
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-66
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-66
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-66
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-66
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-66
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-66
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-66
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-66
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-66
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-66
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-66
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-66
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-66
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-66
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-66
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-61
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-61
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-61
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-57
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-52
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-56
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-52
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-55
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-54
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-54
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-52
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-51
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-49
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-48
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-41
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-40
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-39
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-39
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-39
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-39
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-39
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-39
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-38
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-38
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-38
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-37
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-37
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-37
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-37
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-37
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-37
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-37
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-37
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-37
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-37
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-37
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-37
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-37
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-37
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-37
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-37
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-37
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-37
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-37
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-37
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-37
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-37
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-37
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-37
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-37
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-37
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-37
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-37
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-37
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-37
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-37
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-37
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-37
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-37
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-37
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-37
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-37
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-37
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-37
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-36
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-36
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-36
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-36
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-36
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-36
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-36
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-36
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-36
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-36
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-36
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-36
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-36
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-36
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-36
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-36
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-36
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-36
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-36
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-36
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-36
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-35
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-35
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-34
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-34
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-33
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-32
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-32
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-32
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-32
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-32
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-32
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-31
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-32
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-32
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-32
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-32
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-32
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-32
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-31
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-31
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-31
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-31
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-31
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-31
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-31
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-31
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-31
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-31
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-31
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-31
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-31
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-31
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-31
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-31
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-31
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-31
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-31
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-30
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-30
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-29
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-29
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-29
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-29
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-29
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-29
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-29
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-29
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-29
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-29
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-29
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-29
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-28
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-28
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-28
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-28
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-28
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-28
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-28
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-28
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-27
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-27
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-27
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-27
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-27
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-27
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-27
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-27
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-27
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-27
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-27
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-27
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-27
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-27
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-27
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-27
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-26
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-26
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-26
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-26
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-26
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-26
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-26
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-26
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-26
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-26
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-26
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-26
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-26
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-26
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-26
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-26
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-26
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-26
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-26
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-26
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-20
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-26
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-26
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-26
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-26
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-25
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-24
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-25
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-25
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-22
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-22
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-21
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-21
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-21
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-21
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-21
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-21
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-21
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-21
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-17
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-20
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-18
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-17
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-17
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-17
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-17
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
3soa_A	444	Full-Length Human Camkii Length = 444		1e-15
3soa_A	444	Full-Length Human Camkii Length = 444		3e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-15
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-14
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-12
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-13
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-13
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-13
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-13
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-13
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-13
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-13
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-13
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-05
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		6e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		5e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		8e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		4e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 107 SYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  252 bits (644), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 108 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 167
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 228 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 288 FQDVTKPVPHL 298

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 195 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 254

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  252 bits (644), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 114 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 233
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 234 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 294 FQDVTKPVPHL 304

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 201 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 260

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  252 bits (643), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  252 bits (643), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 111 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 230
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 231 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 291 FQDVTKPVPHL 301

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 198 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 257

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  252 bits (643), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 116/191 (60%), Positives = 144/191 (75%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVVT
Sbjct: 114 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 233
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 234 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 294 FQDVTKPVPHL 304

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 201 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 260

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 290 FQDVTKPVPHL 300

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 197 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 256

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 109 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 229 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 289 FQDVTKPVPHL 299

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 196 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 255

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 109 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 229 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 289 FQDVTKPVPHL 299

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 196 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 255

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 108 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 228 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 288 FQDVTKPVPHL 298

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 195 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 254

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 290 FQDVTKPVPHL 300

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 197 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 256

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 290 FQDVTKPVPHL 300

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 197 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 256

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 108 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 228 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 288 FQDVTKPVPHL 298

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 195 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 254

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 290 FQDVTKPVPHL 300

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 197 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 256

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 109 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 229 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 289 FQDVTKPVPHL 299

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 196 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 255

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 286 FQDVTKPVPHL 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  250 bits (639), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 111 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 230
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 231 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 291 FQDVTKPVPHL 301

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 198 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 257

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  250 bits (638), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 115/191 (60%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 290 FQDVTKPVPHL 300

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 197 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 256

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  249 bits (635), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 114/191 (59%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 108 SYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 228 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 288 FQDVTKPVPHL 298

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 195 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 254

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  249 bits (635), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 114/191 (59%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 109 SYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 229 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 289 FQDVTKPVPHL 299

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 196 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 255

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  249 bits (635), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 114/191 (59%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 290 FQDVTKPVPHL 300

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 197 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 256

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  249 bits (635), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 114/191 (59%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 108 SYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 228 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 288 FQDVTKPVPHL 298

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 195 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 254

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  249 bits (635), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 114/191 (59%), Positives = 143/191 (74%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FNQVEMVKPTL 359
           F  V    P L
Sbjct: 287 FQDVTKPVPHL 297

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  249 bits (635), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 112/182 (61%), Positives = 140/182 (76%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y HEVVT
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H +
Sbjct: 227 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286
Query: 349 FN 350
           F 
Sbjct: 287 FQ 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 36/60 (60%), Positives = 47/60 (78%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++
Sbjct: 194 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 253

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  233 bits (594), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 103/183 (56%), Positives = 134/183 (73%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHEVVT
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVT 163
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++L+G+K YSTT+DIWS GCIF+EM+    LF G SE DQL RIFR LGTP+  
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP V++LP Y  +F  + P  +   L   D   +D+ SK++ LDP QR++AK  L+H Y
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 349 FNQ 351
           F +
Sbjct: 284 FKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 41/74 (55%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +    LF G SE DQL RIFR LGTP+   WP V++LP Y  +F  + P  +   L
Sbjct: 191 FAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 549 NLPDPLAVDVFSRV 562
              D   +D+ S++
Sbjct: 251 KGLDESGIDLLSKM 264

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  233 bits (594), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 103/183 (56%), Positives = 134/183 (73%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHEVVT
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVT 163
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++L+G+K YSTT+DIWS GCIF+EM+    LF G SE DQL RIFR LGTP+  
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP V++LP Y  +F  + P  +   L   D   +D+ SK++ LDP QR++AK  L+H Y
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 349 FNQ 351
           F +
Sbjct: 284 FKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 41/74 (55%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +    LF G SE DQL RIFR LGTP+   WP V++LP Y  +F  + P  +   L
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 549 NLPDPLAVDVFSRV 562
              D   +D+ S++
Sbjct: 251 KGLDESGIDLLSKM 264

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 102/183 (55%), Positives = 134/183 (73%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE+VT
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++L+G+K YSTT+DIWS GCIF+EM+    LF G SE DQL RIFR LGTP+  
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP V++LP Y  +F  + P  +   L   D   +D+ SK++ LDP QR++AK  L+H Y
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 349 FNQ 351
           F +
Sbjct: 284 FKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 41/74 (55%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E +    LF G SE DQL RIFR LGTP+   WP V++LP Y  +F  + P  +   L
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 549 NLPDPLAVDVFSRV 562
              D   +D+ S++
Sbjct: 251 KGLDESGIDLLSKM 264

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  218 bits (556), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 98/155 (63%), Positives = 128/155 (82%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLADFGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E++
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  204 bits (519), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 99/185 (53%), Positives = 136/185 (73%), Gaps = 5/185 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLADFGL+RAF IP+  Y+ EVVT
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVT 164
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHE 287
           LWYRPP++L GAK+YST++D+WSAGCIF+E+    + LF G+   DQL RIFR LGTP E
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLP--DPLAVDVFSKIMALDPKQRVSAKTILQ 345
           + WP ++KLP YK  +P + P   S +  +P  +    D+   ++  +P QR+SA+  LQ
Sbjct: 225 EQWPSMTKLPDYKP-YPMY-PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 346 HEYFN 350
           H YF+
Sbjct: 283 HPYFS 287

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/38 (57%), Positives = 27/38 (71%)
Query: 496 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK 533
           + LF G+   DQL RIFR LGTP E+ WP ++KLP YK
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  217 bits (552), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 97/155 (62%), Positives = 128/155 (82%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E++
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  202 bits (515), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 98/185 (52%), Positives = 136/185 (73%), Gaps = 5/185 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ EVVT
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHE 287
           LWYRPP++L GAK+YST++D+WSAGCIF+E+    + LF G+   DQL RIFR LGTP E
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLP--DPLAVDVFSKIMALDPKQRVSAKTILQ 345
           + WP ++KLP YK  +P + P   S +  +P  +    D+   ++  +P QR+SA+  LQ
Sbjct: 225 EQWPSMTKLPDYKP-YPMY-PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 346 HEYFN 350
           H YF+
Sbjct: 283 HPYFS 287

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/38 (57%), Positives = 27/38 (71%)
Query: 496 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK 533
           + LF G+   DQL RIFR LGTP E+ WP ++KLP YK
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 101/189 (53%), Positives = 139/189 (73%), Gaps = 6/189 (3%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYT 223
           S+LYQL+  + +CHSRR +HRDLKPQN+L++ S A     LK+ DFGL+RAF IP+ ++T
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
           HE++TLWYRPPEILLG++ YST+VDIWS  CI++EM+ K  LF GDSEIDQLF+IF  LG
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKT 342
            P +  WPGV+ LP +K  FP++R K    +L  L D   +D+ + ++ +DP +R+SAK 
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 343 ILQHEYFNQ 351
            L+H YF+ 
Sbjct: 316 ALEHPYFSH 324

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 32/73 (43%), Positives = 44/73 (60%), Gaps = 4/73 (5%)
Query: 481 AVSIDV----VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDF 536
           + S+D+      + E + K  LF GDSEIDQLF+IF  LG P +  WPGV+ LP +K  F
Sbjct: 216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275
Query: 537 PEWRPKKFSEILN 549
           P++R K    +L 
Sbjct: 276 PKFRGKTLKRVLG 288

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  211 bits (536), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 100/185 (54%), Positives = 132/185 (71%), Gaps = 1/185 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHEVVTL
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR P++L+G+K YST+VDIWS GCIF+EMIT K LF G ++ DQL +IF  LGTP+   
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 290 WPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           WP V +LP++K   F  +  K +S I+       +D+ S ++  DP +R+SA+  + H Y
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
Query: 349 FNQVE 353
           F  ++
Sbjct: 304 FKDLD 308

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 42/73 (57%), Gaps = 5/73 (6%)
Query: 481 AVSIDV----VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-D 535
           + S+D+      + E IT K LF G ++ DQL +IF  LGTP+   WP V +LP++K   
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 536 FPEWRPKKFSEIL 548
           F  +  K +S I+
Sbjct: 258 FQVFEKKPWSSII 270

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  210 bits (535), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 100/185 (54%), Positives = 132/185 (71%), Gaps = 1/185 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHEVVTL
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR P++L+G+K YST+VDIWS GCIF+EMIT K LF G ++ DQL +IF  LGTP+   
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 290 WPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           WP V +LP++K   F  +  K +S I+       +D+ S ++  DP +R+SA+  + H Y
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
Query: 349 FNQVE 353
           F  ++
Sbjct: 304 FKDLD 308

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 42/73 (57%), Gaps = 5/73 (6%)
Query: 481 AVSIDV----VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-D 535
           + S+D+      + E IT K LF G ++ DQL +IF  LGTP+   WP V +LP++K   
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 536 FPEWRPKKFSEIL 548
           F  +  K +S I+
Sbjct: 258 FQVFEKKPWSSII 270

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  201 bits (511), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 91/159 (57%), Positives = 122/159 (76%), Gaps = 5/159 (3%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-----TPV 69
           EG PSTA+REIS++KELKH N++RL+DVI  + KL LVFEF+  DLK ++ +     TP 
Sbjct: 44  EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR 103
Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
            +   L K + +QLL+ L +CH  +I+HRDLKPQN+LINK G LKL DFGL+RAF IP+N
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163
Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            ++ EVVTLWYR P++L+G++ YST++DIWS GCI +EM
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  198 bits (504), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 93/194 (47%), Positives = 133/194 (68%), Gaps = 9/194 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           + +QLL+ L +CH  +I+HRDLKPQN+LINK G LKL DFGL+RAF IP+N ++ EVVTL
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR P++L+G++ YST++DIWS GCI +EMIT K LF G ++ +QL  IF  +GTP+E +
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEIL--NLPDPL---AVDVFSKIMALDPKQRVSAKTIL 344
           WP V+KLP Y  +  +  P+   ++L  +  +PL    +D    ++ L+P  R+SAK  L
Sbjct: 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292
Query: 345 QH----EYFNQVEM 354
            H    EY++   M
Sbjct: 293 HHPWFAEYYHHASM 306

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 41/72 (56%), Gaps = 4/72 (5%)
Query: 481 AVSIDV----VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDF 536
           + SID+        E IT K LF G ++ +QL  IF  +GTP+E +WP V+KLP Y  + 
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246
Query: 537 PEWRPKKFSEIL 548
            +  P+   ++L
Sbjct: 247 QQRPPRDLRQVL 258

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  192 bits (487), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 87/155 (56%), Positives = 115/155 (74%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE+S+LK+LKH N++ LHD+I  +  L LVFE+L +DLK +L      +   
Sbjct: 41  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMH 100
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K +L+QLL  L YCH ++++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y +E
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           VVTLWYRPP+ILLG+  YST +D+W  GCIF EM+
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA 195

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 87/181 (48%), Positives = 124/181 (68%), Gaps = 1/181 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +L+QLL  L YCH ++++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y +EVVTL
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL 164
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYRPP+ILLG+  YST +D+W  GCIF EM T + LF G +  +QL  IFR LGTP E+ 
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 290 WPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           WPG+     +KT ++P++R +         D    D+ +K++  + + R+SA+  ++H +
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 349 F 349
           F
Sbjct: 285 F 285

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 22/55 (40%), Positives = 35/55 (63%), Gaps = 1/55 (1%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPK 542
           ++E  T + LF G +  +QL  IFR LGTP E+ WPG+     +KT ++P++R +
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE 245

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 84/189 (44%), Positives = 116/189 (61%), Gaps = 4/189 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++  M   T  VVTLW
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G S++DQL +I   +G P E+ W
Sbjct: 185 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  F     +   + +   D L  D+  K +  +P +R+SA + L H YF 
Sbjct: 244 PRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 351 QVEMVKPTL 359
            +E  K  L
Sbjct: 302 DLERCKENL 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 76/183 (41%), Positives = 113/183 (61%), Gaps = 1/183 (0%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   Y H+VVT
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVT 175
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PE+L GA++Y   VD+W+ GCI +E++ +     GDS++DQL RIF TLGTP E+
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP +  LP Y T F  +       I +      +D+   +   +P  R++A   L+ +Y
Sbjct: 236 QWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 349 FNQ 351
           F+ 
Sbjct: 295 FSN 297

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/34 (61%), Positives = 25/34 (73%)
Query: 501 GDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT 534
           GDS++DQL RIF TLGTP E+ WP +  LP Y T
Sbjct: 215 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 83/186 (44%), Positives = 115/186 (61%), Gaps = 4/186 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++  M   T  VVTLW
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G S++DQL +I   +G P E+ W
Sbjct: 185 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  F     +   + +   D L  D+  K +  +P +R+SA + L H YF 
Sbjct: 244 PRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 351 QVEMVK 356
            +E  K
Sbjct: 302 DLERCK 307

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 81/180 (45%), Positives = 112/180 (62%), Gaps = 4/180 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++  M   T  VVTLW
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G S++DQL +I   +G P E+ W
Sbjct: 185 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  F     +   + +   D L  D+  K +  +P +R+SA + L H YF 
Sbjct: 244 PRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 119/193 (61%), Gaps = 8/193 (4%)
Query: 165 FSEMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--- 220
            SE+  + Q LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++  N   
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 221 -RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
            RY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 280 RTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQ 336
           +  G+   +VWP V    +Y K +  + + +K  + L   + DP A+D+  K++ LDP Q
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 303
Query: 337 RVSAKTILQHEYF 349
           R+ +   L H++F
Sbjct: 304 RIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 119/193 (61%), Gaps = 8/193 (4%)
Query: 165 FSEMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--- 220
            SE+  + Q LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++  N   
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 221 -RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
            RY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 280 RTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQ 336
           +  G+   +VWP V    +Y K +  + + +K  + L   + DP A+D+  K++ LDP Q
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 303
Query: 337 RVSAKTILQHEYF 349
           R+ +   L H++F
Sbjct: 304 RIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 119/193 (61%), Gaps = 8/193 (4%)
Query: 165 FSEMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--- 220
            SE+  + Q LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++  N   
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 221 -RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
            RY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 280 RTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQ 336
           +  G+   +VWP V    +Y K +  + + +K  + L   + DP A+D+  K++ LDP Q
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 303
Query: 337 RVSAKTILQHEYF 349
           R+ +   L H++F
Sbjct: 304 RIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 119/193 (61%), Gaps = 8/193 (4%)
Query: 165 FSEMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--- 220
            SE+  + Q LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++  N   
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 221 -RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
            RY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I 
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 280 RTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQ 336
           +  G+   +VWP V    +Y K +  + + +K  + L   + DP A+D+  K++ LDP Q
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 337 RVSAKTILQHEYF 349
           R+ +   L H++F
Sbjct: 303 RIDSDDALNHDFF 315

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 82/183 (44%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y   V T W
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---VATRW 193
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++  K LF G   IDQL RI   +GTP  +V 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 253
Query: 291 PGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y    P    K  S I    +PLA+D+  +++ LD  QRVSA   L H Y
Sbjct: 254 AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 313
Query: 349 FNQ 351
           F+Q
Sbjct: 314 FSQ 316

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 34/74 (45%), Gaps = 2/74 (2%)
Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEIL 548
           E +  K LF G   IDQL RI   +GTP  +V   +S      Y    P    K  S I 
Sbjct: 221 ELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIF 280
Query: 549 NLPDPLAVDVFSRV 562
              +PLA+D+  R+
Sbjct: 281 RGANPLAIDLLGRM 294

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/183 (44%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y   V T W
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---VATRW 193
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++  K LF G   IDQL RI   +GTP  +V 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 253
Query: 291 PGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y    P    K  S I    +PLA+D+  +++ LD  QRVSA   L H Y
Sbjct: 254 AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 313
Query: 349 FNQ 351
           F+Q
Sbjct: 314 FSQ 316

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 34/74 (45%), Gaps = 2/74 (2%)
Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEIL 548
           E +  K LF G   IDQL RI   +GTP  +V   +S      Y    P    K  S I 
Sbjct: 221 ELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIF 280
Query: 549 NLPDPLAVDVFSRV 562
              +PLA+D+  R+
Sbjct: 281 RGANPLAIDLLGRM 294

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  158 bits (399), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 82/183 (44%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y   V T W
Sbjct: 129 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY---VATRW 185
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++  K LF G   IDQL RI   +GTP  +V 
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVL 245
Query: 291 PGVSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y    P    K  S I    +PLA+D+  +++ LD  QRVSA   L H Y
Sbjct: 246 AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 305
Query: 349 FNQ 351
           F+Q
Sbjct: 306 FSQ 308

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 34/74 (45%), Gaps = 2/74 (2%)
Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEIL 548
           E +  K LF G   IDQL RI   +GTP  +V   +S      Y    P    K  S I 
Sbjct: 213 ELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIF 272
Query: 549 NLPDPLAVDVFSRV 562
              +PLA+D+  R+
Sbjct: 273 RGANPLAIDLLGRM 286

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 82/184 (44%), Positives = 108/184 (58%), Gaps = 5/184 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R     M      VVT W
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---XGXVVTRW 190
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE++L    Y+ TVDIWS GCI +EMIT KTLF G   +DQL  I +  GTP  +  
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 291 PGV--SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +   +   Y    PE   K F+ IL    PLAV++  K++ LD +QRV+A   L H Y
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 349 FNQV 352
           F  +
Sbjct: 311 FESL 314

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 36/74 (48%), Gaps = 2/74 (2%)
Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV--SKLPIYKTDFPEWRPKKFSEIL 548
           E IT KTLF G   +DQL  I +  GTP  +    +   +   Y    PE   K F+ IL
Sbjct: 218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 277
Query: 549 NLPDPLAVDVFSRV 562
               PLAV++  ++
Sbjct: 278 TNASPLAVNLLEKM 291

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  155 bits (392), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 112/186 (60%), Gaps = 11/186 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 160 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 216
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   I+QL +I R  GTP   V 
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASV- 275
Query: 291 PGVSKLPI-----YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
             +S++P      Y    P+   + F+++    +PLAVD+  K++ LD  +R++A   L 
Sbjct: 276 --ISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALA 333
Query: 346 HEYFNQ 351
           H YF+Q
Sbjct: 334 HPYFSQ 339

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 41/77 (53%), Gaps = 8/77 (10%)
Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI-----YKTDFPEWRPKKFS 545
           E +T +TLF G   I+QL +I R  GTP   V   +S++P      Y    P+   + F+
Sbjct: 244 ELLTGRTLFPGTDHINQLQQIMRLTGTPPASV---ISRMPSHEARNYINSLPQMPKRNFA 300
Query: 546 EILNLPDPLAVDVFSRV 562
           ++    +PLAVD+  ++
Sbjct: 301 DVFIGANPLAVDLLEKM 317

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 79/183 (43%), Positives = 107/183 (58%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L A  Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 79/183 (43%), Positives = 112/183 (61%), Gaps = 4/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  M   T  VVTLW
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G+SE DQL +IF  +G P ED W
Sbjct: 185 YRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  FP   P+    ++   +     +  +++  +P +R+SA   LQH Y +
Sbjct: 244 PRDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 351 QVE 353
           + E
Sbjct: 302 KDE 304

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E   +K LF G+SE DQL +IF  +G P ED WP    LP  +  FP   P+    ++
Sbjct: 209 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP--RGAFPPRGPRPVQSVV 266

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 112/183 (61%), Gaps = 4/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  M  +   VVTLW
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP-VVVTLW 176
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G+SE DQL +IF  +G P ED W
Sbjct: 177 YRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  FP   P+    ++   +     +  +++  +P +R+SA   LQH Y +
Sbjct: 236 PRDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293
Query: 351 QVE 353
           + E
Sbjct: 294 KDE 296

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E   +K LF G+SE DQL +IF  +G P ED WP    LP  +  FP   P+    ++
Sbjct: 201 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP--RGAFPPRGPRPVQSVV 258

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 111/183 (60%), Gaps = 4/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  M      VVTLW
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVVTLW 176
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G+SE DQL +IF  +G P ED W
Sbjct: 177 YRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  FP   P+    ++   +     +  +++  +P +R+SA   LQH Y +
Sbjct: 236 PRDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293
Query: 351 QVE 353
           + E
Sbjct: 294 KDE 296

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E   +K LF G+SE DQL +IF  +G P ED WP    LP  +  FP   P+    ++
Sbjct: 201 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP--RGAFPPRGPRPVQSVV 258

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRW 193
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 254 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313
Query: 349 FNQ 351
           F Q
Sbjct: 314 FAQ 316

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 111/183 (60%), Gaps = 4/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  M      VVTLW
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLW 176
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G+SE DQL +IF  +G P ED W
Sbjct: 177 YRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P    LP  +  FP   P+    ++   +     +  +++  +P +R+SA   LQH Y +
Sbjct: 236 PRDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293
Query: 351 QVE 353
           + E
Sbjct: 294 KDE 296

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 489 YHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 548
           + E   +K LF G+SE DQL +IF  +G P ED WP    LP  +  FP   P+    ++
Sbjct: 201 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP--RGAFPPRGPRPVQSVV 258

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRW 189
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 250 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309
Query: 349 FNQ 351
           F Q
Sbjct: 310 FAQ 312

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRW 194
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 349 FNQ 351
           F Q
Sbjct: 315 FAQ 317

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRW 194
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 349 FNQ 351
           F Q
Sbjct: 315 FAQ 317

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRW 194
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 349 FNQ 351
           F Q
Sbjct: 315 FAQ 317

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 193
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 254 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313
Query: 349 FNQ 351
           F Q
Sbjct: 314 FAQ 316

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRW 192
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 253 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312
Query: 349 FNQ 351
           F Q
Sbjct: 313 FAQ 315

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 207
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 267
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 268 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 327
Query: 349 FNQ 351
           F Q
Sbjct: 328 FAQ 330

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRW 192
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 253 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312
Query: 349 FNQ 351
           F Q
Sbjct: 313 FAQ 315

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 192
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 253 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312
Query: 349 FNQ 351
           F Q
Sbjct: 313 FAQ 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 141 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 197
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 257
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 258 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 317
Query: 349 FNQ 351
           F Q
Sbjct: 318 FAQ 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 130 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 186
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 246
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 247 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 306
Query: 349 FNQ 351
           F Q
Sbjct: 307 FAQ 309

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 154 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 210
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 270
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 271 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 330
Query: 349 FNQ 351
           F Q
Sbjct: 331 FAQ 333

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 189
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 250 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309
Query: 349 FNQ 351
           F Q
Sbjct: 310 FAQ 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 189
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 250 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309
Query: 349 FNQ 351
           F Q
Sbjct: 310 FAQ 312

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 150 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 206
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 266
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 267 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 326
Query: 349 FNQ 351
           F Q
Sbjct: 327 FAQ 329

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 193
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 254 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313
Query: 349 FNQ 351
           F Q
Sbjct: 314 FAQ 316

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 142 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRW 198
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 258
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 259 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 318
Query: 349 FNQ 351
           F Q
Sbjct: 319 FAQ 321

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 194
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 349 FNQ 351
           F Q
Sbjct: 315 FAQ 317

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 192
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 252
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 253 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312
Query: 349 FNQ 351
           F Q
Sbjct: 313 FAQ 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 189
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 249
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 250 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309
Query: 349 FNQ 351
           F Q
Sbjct: 310 FAQ 312

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 150 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 206
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 266
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 267 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 326
Query: 349 FNQ 351
           F Q
Sbjct: 327 FAQ 329

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 199
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 259
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 260 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319
Query: 349 FNQ 351
           F Q
Sbjct: 320 FAQ 322

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 193
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 253
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 254 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313
Query: 349 FNQ 351
           F Q
Sbjct: 314 FAQ 316

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 183
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 244 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 349 FNQ 351
           F Q
Sbjct: 304 FAQ 306

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 199
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 259
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 260 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319
Query: 349 FNQ 351
           F Q
Sbjct: 320 FAQ 322

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 207
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 267
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 268 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 327
Query: 349 FNQ 351
           F Q
Sbjct: 328 FAQ 330

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 199
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 259
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 260 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319
Query: 349 FNQ 351
           F Q
Sbjct: 320 FAQ 322

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 183
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 244 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 349 FNQ 351
           F Q
Sbjct: 304 FAQ 306

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 129 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 185
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 245
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 246 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 305
Query: 349 FNQ 351
           F Q
Sbjct: 306 FAQ 308

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 142 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 198
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 258
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 259 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 318
Query: 349 FNQ 351
           F Q
Sbjct: 319 FAQ 321

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 128 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 244
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 245 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 304
Query: 349 FNQ 351
           F Q
Sbjct: 305 FAQ 307

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 154 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VATRW 210
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 270
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 271 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 330
Query: 349 FNQ 351
           F Q
Sbjct: 331 FAQ 333

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 128 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 244
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 245 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 304
Query: 349 FNQ 351
           F Q
Sbjct: 305 FAQ 307

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V T W
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRW 183
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 349 FNQ 351
           F Q
Sbjct: 304 FAQ 306

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D+GL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 78/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  +   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  +   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 106/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  +   V T W
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VATRW 183
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 244 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 349 FNQ 351
           F Q
Sbjct: 304 FAQ 306

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+  FGL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 77/191 (40%), Positives = 112/191 (58%), Gaps = 18/191 (9%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL+Q++  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   Y  EV T 
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR 188
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT---PH 286
           WYR PE+L+G   Y   VD+W+ GC+ +EM   + LF GDS+IDQL+ I   LG     H
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 287 ED------VWPGVSKLPIYKTDFP-EWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
           ++      V+ GV +LP  K   P E R  K SE++       +D+  K + +DP +R  
Sbjct: 249 QELFNKNPVFAGV-RLPEIKEREPLERRYPKLSEVV-------IDLAKKCLHIDPDKRPF 300
Query: 340 AKTILQHEYFN 350
              +L H++F 
Sbjct: 301 CAELLHHDFFQ 311

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  148 bits (374), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M      V T W
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVATRW 207
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 267
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 268 KKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 327
Query: 349 FNQ 351
           F Q
Sbjct: 328 FAQ 330

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D GL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D GL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D GL+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 77/183 (42%), Positives = 105/183 (57%), Gaps = 5/183 (2%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DF L+R     M  Y   V T W
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VATRW 187
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H Y
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307
Query: 349 FNQ 351
           F Q
Sbjct: 308 FAQ 310

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 112/197 (56%), Gaps = 14/197 (7%)
Query: 162 GCIFSE--MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G  FSE  + YL YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R     
Sbjct: 138 GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197
Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+T KTLF G   +DQL +I
Sbjct: 198 MTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254
Query: 279 FRTLGTPHEDVWPGVSKL-----PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
            +  G P  +    V KL       Y    P+   K F+++     P A D+  K++ LD
Sbjct: 255 LKVTGVPGTEF---VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD 311
Query: 334 PKQRVSAKTILQHEYFN 350
             +R++A   L H +F 
Sbjct: 312 VDKRLTAAQALTHPFFE 328

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 112/197 (56%), Gaps = 14/197 (7%)
Query: 162 GCIFSE--MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G  FSE  + YL YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R     
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+T KTLF G   +DQL +I
Sbjct: 180 MTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
Query: 279 FRTLGTPHEDVWPGVSKL-----PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
            +  G P  +    V KL       Y    P+   K F+++     P A D+  K++ LD
Sbjct: 237 LKVTGVPGTEF---VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD 293
Query: 334 PKQRVSAKTILQHEYFN 350
             +R++A   L H +F 
Sbjct: 294 VDKRLTAAQALTHPFFE 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           +   ALREI +LK+LKHPN++ L +V     +L LVFE+    +   L      VP  L 
Sbjct: 45  IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLV 104
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           KS  +Q L+A+ +CH    IHRD+KP+NILI K   +KL DFG +R  T P + Y  EV 
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T WYR PE+L+G   Y   VD+W+ GC+F+E+
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 4/191 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S  +Q L+A+ +CH    IHRD+KP+NILI K   +KL DFG +R  T P + Y  EV T
Sbjct: 106 SITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT---P 285
            WYR PE+L+G   Y   VD+W+ GC+F+E+++   L+ G S++DQL+ I +TLG     
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           H+ V+         K   PE       +  N+  P A+ +    + +DP +R++ + +L 
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYP-ALGLLKGCLHMDPTERLTCEQLLH 284
Query: 346 HEYFNQVEMVK 356
           H YF  +  ++
Sbjct: 285 HPYFENIREIE 295

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 70/187 (37%), Positives = 107/187 (57%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 286 HEDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
            ED+  G++ K   Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 251 QEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 311 AHPYLAQ 317

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 69/188 (36%), Positives = 105/188 (55%), Gaps = 6/188 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNR---YTHE 225
           +LYQLL  L+Y HS ++IHRDLKP N+L+N++  LK+ DFG++R   T P       T  
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PE++L    Y+  +D+WS GCIF EM+ ++ LF G + + QL  I   LGTP
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 283
Query: 286 HEDVWP--GVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
              V    G  ++  Y    P  +P  +  +    D  A+ +  +++  +P  R+SA   
Sbjct: 284 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 343
Query: 344 LQHEYFNQ 351
           L+H +  +
Sbjct: 344 LRHPFLAK 351

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 69/188 (36%), Positives = 105/188 (55%), Gaps = 6/188 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNR---YTHE 225
           +LYQLL  L+Y HS ++IHRDLKP N+L+N++  LK+ DFG++R   T P       T  
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PE++L    Y+  +D+WS GCIF EM+ ++ LF G + + QL  I   LGTP
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282
Query: 286 HEDVWP--GVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
              V    G  ++  Y    P  +P  +  +    D  A+ +  +++  +P  R+SA   
Sbjct: 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342
Query: 344 LQHEYFNQ 351
           L+H +  +
Sbjct: 343 LRHPFLAK 350

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 74/186 (39%), Positives = 112/186 (60%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQLL +L Y HS  I HRD+KPQN+L++  SG LKL DFG S    I        + +
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIAGEPNVSXICS 204
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y+T +DIWS GC+ +E++  + LF G+S IDQL  I + LGTP  +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ RP  FS++      P A+D+ S+++   P  R++A   L H
Sbjct: 265 QIKTMN--PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
Query: 347 EYFNQV 352
            +F+++
Sbjct: 323 PFFDEL 328

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/175 (40%), Positives = 107/175 (61%), Gaps = 17/175 (9%)
Query: 11  RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQ--- 65
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   ++   
Sbjct: 55  QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114
Query: 66  -----TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN----KSGALKLA 116
                  PV +P  + KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 117 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E+
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 119/219 (54%), Gaps = 27/219 (12%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN----KSGALKLADFGLSRAFTIPMNRYTH 224
           S LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+AD G +R F  P+     
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI--------- 272
               VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++T + +F    E          
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL---------PDPLAV 323
           DQL RIF  +G P +  W  + K+P + T   ++R   ++    +         PD  A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 324 DVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVF 362
            +  K++ +DP +R++++  +Q  YF  +E   PT  VF
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYF--LEDPLPTSDVF 348

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 67/188 (35%), Positives = 108/188 (57%), Gaps = 7/188 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HE 225
           +LYQ+L  L+Y HS  ++HRDLKP N+LIN +  LK+ DFGL+R    P + +T      
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEX 207
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267
Query: 286 HEDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            ++    +  +    Y    P      ++++    D  A+D+  +++  +P +R++ +  
Sbjct: 268 SQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEA 327
Query: 344 LQHEYFNQ 351
           L H Y  Q
Sbjct: 328 LAHPYLEQ 335

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 87/245 (35%), Positives = 132/245 (53%), Gaps = 24/245 (9%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  A+ + HS  I HRD+KPQN+L+N K   LKL DFG ++   IP       + +
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAXICS 204
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++LGA  Y+ ++D+WS GC+F E+I  K LF+G++ IDQL RI + +GTP ++
Sbjct: 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE 264
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDP-LAVDVFSKIMALDPKQRVSAKTILQH 346
               +   P Y +  FP  + K + +IL    P LA+D+  +I+  +P  R++    + H
Sbjct: 265 QM--IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322
Query: 347 EYF----NQVEMVKPTLAVFPELGYGGNGCK--DFKPWIAKLIKTQWQRSWDDIPNNKLK 400
            +F    N  E      + FP  G   N  +  +F P+   +           IP N L 
Sbjct: 323 PFFDHLRNSYESEVKNNSNFPH-GVNQNIPQLFNFSPYELSI-----------IPGNVLN 370
Query: 401 RIKPK 405
           RI PK
Sbjct: 371 RILPK 375

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPE 246
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 307 AHPYLEQ 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 311 AHPYLEQ 317

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 249 QEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 309 AHPYLEQ 315

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 329 AHPYLEQ 335

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 309 AHPYLEQ 315

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 246
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 247 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 306
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 307 AHPYLEQ 313

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 309 AHPYLEQ 315

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 313 AHPYLEQ 319

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 269 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 328
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 329 AHPYLEQ 335

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 313 AHPYLEQ 319

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 137 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 256
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 257 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 316
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 317 AHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 249 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 309 AHPYLEQ 315

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 254 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 313
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 314 AHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 254
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 255 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 314
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 315 AHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 245
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 246 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 305
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 306 AHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 313 AHPYLEQ 319

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 313 AHPYLEQ 319

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 313 AHPYLEQ 319

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 68/188 (36%), Positives = 106/188 (56%), Gaps = 7/188 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HE 225
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +T      
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEX 191
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 286 HEDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 344 LQHEYFNQ 351
           L H Y  Q
Sbjct: 312 LAHPYLEQ 319

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 249 QEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 308
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 309 AHPYLEQ 315

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 68/188 (36%), Positives = 106/188 (56%), Gaps = 7/188 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HE 225
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +T      
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEX 192
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           V T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 252
Query: 286 HEDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  
Sbjct: 253 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 312
Query: 344 LQHEYFNQ 351
           L H Y  Q
Sbjct: 313 LAHPYLEQ 320

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250
Query: 287 EDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L    Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 251 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 311 AHPYLAQ 317

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 76/206 (36%), Positives = 116/206 (56%), Gaps = 15/206 (7%)
Query: 156 VDIWSAGCIFSEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLS 212
            ++   G +  E +  ++YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+
Sbjct: 109 ANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 213 RAFTIPMNRYTHE------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           R        Y+H+      +VT WYR P +LL    Y+  +D+W+AGCIF+EM+T KTLF
Sbjct: 169 RIMD---PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
Query: 267 AGDSEIDQLFRIFRTLGTPH-EDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAVD 324
           AG  E++Q+  I  ++   H ED    +S +P+Y + D  E   K  +++L      AVD
Sbjct: 226 AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH-KPLTQLLPGISREAVD 284
Query: 325 VFSKIMALDPKQRVSAKTILQHEYFN 350
              +I+   P  R++A+  L H Y +
Sbjct: 285 FLEQILTFSPMDRLTAEEALSHPYMS 310

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 306 PAKRISVDDALQHPYIN 322

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 306 PAKRISVDDALQHPYIN 322

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 121 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYV 179
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 299 PAKRISVDDALQHPYIN 315

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----------TIPM 219
           ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R            T   
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
           +  T  V T WYR PE++L +  YS  +D+WS GCI +E+  ++ +F G     QL  IF
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236
Query: 280 RTLGTPHEDVWPGVSKLP---IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
             +GTPH D      + P    Y    P +      ++    +P  +D+  +++  DP +
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 337 RVSAKTILQHEYF 349
           R++AK  L+H Y 
Sbjct: 297 RITAKEALEHPYL 309

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 224
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 225 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 344 PAKRISVDDALQHPYIN 360

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 224
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 225 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 344 PAKRISVDDALQHPYIN 360

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----------TIPM 219
           ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R            T   
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
           +  T  V T WYR PE++L +  YS  +D+WS GCI +E+  ++ +F G     QL  IF
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236
Query: 280 RTLGTPHEDVWPGVSKLP---IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
             +GTPH D      + P    Y    P +      ++    +P  +D+  +++  DP +
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 337 RVSAKTILQHEYF 349
           R++AK  L+H Y 
Sbjct: 297 RITAKEALEHPYL 309

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 306 PAKRISVDDALQHPYIN 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 187
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 188 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 247 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 307 PAKRISVDDALQHPYIN 323

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 127 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 185
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 186 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 244
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 245 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 304
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 305 PAKRISVDDALQHPYIN 321

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 306 PAKRISVDDALQHPYIN 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 306 PAKRISVDDALQHPYIN 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 187
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 188 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 247 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 307 PAKRISVDDALQHPYIN 323

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 306 PAKRISVDDALQHPYIN 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 122 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 180
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 181 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 240 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 299
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 300 PAKRISVDDALQHPYIN 316

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 179
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 299 PAKRISVDDALQHPYIN 315

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/197 (41%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 122 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 180
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP- 285
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 181 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 286 -------HEDVWPGVSKLPIYKT-DFPEWRPKKF----SEILNLPDPLAVDVFSKIMALD 333
                     V   V   P Y    FP+  P       SE   L    A D+ SK++ +D
Sbjct: 240 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 299
Query: 334 PKQRVSAKTILQHEYFN 350
           P +R+S    LQH Y N
Sbjct: 300 PAKRISVDDALQHPYIN 316

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 24/200 (12%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R  +      T  V
Sbjct: 126 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF-MMTPYV 184
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  E++    +F G   IDQ  ++   LGTP 
Sbjct: 185 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 243
Query: 287 ED-----------------VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI 329
            +                  +PG++    ++  FP+W     SE   +    A D+ SK+
Sbjct: 244 AEFMAALQPTVRNYVENRPAYPGIA----FEELFPDWIFPSESERDKIKTSQARDLLSKM 299
Query: 330 MALDPKQRVSAKTILQHEYF 349
           + +DP +R+S    L+H Y 
Sbjct: 300 LVIDPDKRISVDEALRHPYI 319

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/199 (38%), Positives = 104/199 (52%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T EV
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPEV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNALKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 106/186 (56%), Gaps = 4/186 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T   N+ TH V   
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHR 197
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH-ED 288
           WYR PE+++  K ++  VD+WSAGC+ +EM  +K LF G +  +QL +I   +GTP  ED
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 289 V--WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           V  +   S     +        + ++ ++   DP+A+D+ +K++  +P++R+S +  L+H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 347 EYFNQV 352
            YF  +
Sbjct: 318 PYFESL 323

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 106/186 (56%), Gaps = 4/186 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T   N+ TH V   
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHR 197
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH-ED 288
           WYR PE+++  K ++  VD+WSAGC+ +EM  +K LF G +  +QL +I   +GTP  ED
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 289 V--WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           V  +   S     +        + ++ ++   DP+A+D+ +K++  +P++R+S +  L+H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 347 EYFNQV 352
            YF  +
Sbjct: 318 PYFESL 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----------TIPM 219
           ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R            T   
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
           +     V T WYR PE++L +  YS  +D+WS GCI +E+  ++ +F G     QL  IF
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236
Query: 280 RTLGTPHEDVWPGVSKLP---IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
             +GTPH D      + P    Y    P +      ++    +P  +D+  +++  DP +
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 337 RVSAKTILQHEYFN 350
           R++AK  L+H Y  
Sbjct: 297 RITAKEALEHPYLQ 310

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 24/200 (12%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y+  VDIWS GCI  E++    +F G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDV-----------------WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI 329
            +                  +PG+     ++  FP+W     SE   +    A D+ SK+
Sbjct: 246 AEFMAALQPTVRNYVENRPKYPGIK----FEELFPDWIFPSESERDKIKTSQARDLLSKM 301
Query: 330 MALDPKQRVSAKTILQHEYF 349
           + +DP +R+S    L+H Y 
Sbjct: 302 LVIDPDKRISVDEALRHPYI 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 105/201 (52%), Gaps = 24/201 (11%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R           EV
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP- 244
Query: 287 EDVWPG-VSKLPIYKTDFPEWRPKK--------FSEIL--------NLPDPLAVDVFSKI 329
               P  + KL     ++ E RPK         F ++L         L    A D+ SK+
Sbjct: 245 ---CPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 330 MALDPKQRVSAKTILQHEYFN 350
           + +D  +R+S    LQH Y N
Sbjct: 302 LVIDASKRISVDEALQHPYIN 322

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 104/199 (52%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R           EV
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VD+WS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 187
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 188 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 304
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 305 IDASKRISVDEALQHPYIN 323

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 111/191 (58%), Gaps = 13/191 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 137 YMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVAS 195
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTP-- 285
            +++ PE+L+  ++Y  ++D+WS GC+ + MI ++   F G    DQL RI + LGT   
Sbjct: 196 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEEL 255
Query: 286 -------HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                  H D+ P  + + + +     W     SE  +L  P A+D+  K++  D +QR+
Sbjct: 256 YGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRL 314
Query: 339 SAKTILQHEYF 349
           +AK  ++H YF
Sbjct: 315 TAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 111/191 (58%), Gaps = 13/191 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 142 YMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVAS 200
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTP-- 285
            +++ PE+L+  ++Y  ++D+WS GC+ + MI ++   F G    DQL RI + LGT   
Sbjct: 201 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEEL 260
Query: 286 -------HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                  H D+ P  + + + +     W     SE  +L  P A+D+  K++  D +QR+
Sbjct: 261 YGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRL 319
Query: 339 SAKTILQHEYF 349
           +AK  ++H YF
Sbjct: 320 TAKEAMEHPYF 330

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 104/199 (52%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 133 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 191
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VD+WS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 192 VTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 250
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 251 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 308
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 309 IDASKRISVDEALQHPYIN 327

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 104/199 (52%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 122 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 180
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VD+WS GCI  EM+  K LF G   IDQ  ++   LGTP 
Sbjct: 181 VTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 240 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 297
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 298 IDASKRISVDEALQHPYIN 316

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/204 (37%), Positives = 104/204 (50%), Gaps = 30/204 (14%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-----FTIPMNR 221
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R        +P   
Sbjct: 130 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPF-- 187
Query: 222 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
               VVT +YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   
Sbjct: 188 ----VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 242
Query: 282 LGTPHEDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVF 326
           LGTP  +    +   +  Y  + P++    F ++   PD L              A D+ 
Sbjct: 243 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLL 300
Query: 327 SKIMALDPKQRVSAKTILQHEYFN 350
           SK++ +D  +R+S    LQH Y N
Sbjct: 301 SKMLVIDASKRISVDEALQHPYIN 324

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS G I  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 168 MSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
           MSYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  V
Sbjct: 128 MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYV 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT +YR PE++LG   Y   VDIWS G I  EMI    LF G   IDQ  ++   LGTP 
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 287 EDVWPGVS-KLPIYKTDFPEWRPKKFSEILNLPDPL--------------AVDVFSKIMA 331
            +    +   +  Y  + P++    F ++   PD L              A D+ SK++ 
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 332 LDPKQRVSAKTILQHEYFN 350
           +D  +R+S    LQH Y N
Sbjct: 304 IDASKRISVDEALQHPYIN 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N+LI+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 192
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 250
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 311 LTAREAMEHPYFYTV 325

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 193
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 251
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 312 LTAREAMEHPYFYTV 326

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 313 LTAREAMEHPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 193
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 251
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 312 LTAREAMEHPYFYTV 326

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 15/195 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 141 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVAS 199
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 200 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 257
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 258 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 317
Query: 338 VSAKTILQHEYFNQV 352
           ++A+  ++H YF  V
Sbjct: 318 LTAREAMEHPYFYTV 332

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 108/192 (56%), Gaps = 15/192 (7%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVAS 194
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  E
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--E 252
Query: 288 DVWPGVSKLPIY----------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           D++  + K  I           +     W     SE  +L  P A+D   K++  D + R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 338 VSAKTILQHEYF 349
           ++A+  ++H YF
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 113/219 (51%), Gaps = 43/219 (19%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--------TIPM--N 220
           +YQL++ ++Y HS  ++HRD+KP NIL+N    +K+ADFGLSR+F         IP+  N
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 221 RYTHE-----------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
             T             V T WYR PEILLG+  Y+  +D+WS GCI  E++  K +F G 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 270 SEIDQLFRIFRTLGTP-HEDVWPGVSKLPIYKTDFPEWRPK-------------KFSEIL 315
           S ++QL RI   +  P +EDV    S  P  KT     + K             K+  +L
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQS--PFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 316 NLPDPL------AVDVFSKIMALDPKQRVSAKTILQHEY 348
              +P       A+D+  K++  +P +R+SA   L+H +
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         ++ + +
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 219
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 280 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337
Query: 347 EYFNQV 352
            +F+++
Sbjct: 338 SFFDEL 343

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +        + +
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 219
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 280 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337
Query: 347 EYFNQV 352
            +F+++
Sbjct: 338 SFFDEL 343

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         ++ + +
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 213
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 273
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 274 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 331
Query: 347 EYFNQV 352
            +F+++
Sbjct: 332 SFFDEL 337

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         ++ + +
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 221
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 281
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 282 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 339
Query: 347 EYFNQV 352
            +F+++
Sbjct: 340 SFFDEL 345

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         ++ + +
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 223
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 283
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 284 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 341
Query: 347 EYFNQV 352
            +F+++
Sbjct: 342 SFFDEL 347

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         ++ + +
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 264
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 324
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 325 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 382
Query: 347 EYFNQV 352
            +F+++
Sbjct: 383 SFFDEL 388

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++         ++ + +
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 190
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 250
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 251 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 308
Query: 347 EYFNQV 352
            +F+++
Sbjct: 309 SFFDEL 314

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++         ++ + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +        + +
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 197
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 257
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 258 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 315
Query: 347 EYFNQV 352
            +F+++
Sbjct: 316 SFFDEL 321

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         ++ + +
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 198
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 258
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 259 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 316
Query: 347 EYFNQV 352
            +F+++
Sbjct: 317 SFFDEL 322

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +        + +
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 193
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 253
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 254 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 311
Query: 347 EYFNQV 352
            +F+++
Sbjct: 312 SFFDEL 317

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++         ++ + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +        + +
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 204
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 264
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 265 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 322
Query: 347 EYFNQV 352
            +F+++
Sbjct: 323 SFFDEL 328

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++         ++ + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + +
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 197
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 257
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 258 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 315
Query: 347 EYFNQV 352
            +F+++
Sbjct: 316 SFFDEL 321

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + +
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 186
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 246
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 247 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 304
Query: 347 EYFNQV 352
            +F+++
Sbjct: 305 SFFDEL 310

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +        + +
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 189
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 249
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 250 QIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 307
Query: 347 EYFNQV 352
            +F+++
Sbjct: 308 SFFDEL 313

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 109/186 (58%), Gaps = 6/186 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 185
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 289 VWPGVSKLPIY-KTDFPEWRPKKFSEILN-LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               ++  P Y +  FP+ +   ++++      P A+ + S+++   P  R++      H
Sbjct: 246 QIREMN--PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 347 EYFNQV 352
            +F+++
Sbjct: 304 SFFDEL 309

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 68/177 (38%), Positives = 96/177 (54%), Gaps = 31/177 (17%)
Query: 22  LREISVLKELKHPNVIRLHD-VIPVDF----KLFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           LREI++L  LK   +IRLHD +IP D     +L++V E    DLK   +T P+ +     
Sbjct: 75  LREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEQHV 133
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI---------- 126
           K+ LY LL   ++ H   IIHRDLKP N L+N+  ++K+ DFGL+R              
Sbjct: 134 KTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 127 ----------PMNR-----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                     P N+      T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E+
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 102/237 (43%), Gaps = 55/237 (23%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI------------- 217
           LY LL   ++ H   IIHRDLKP N L+N+  ++K+ DFGL+R                 
Sbjct: 137 LYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 218 -------PMNR-----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT- 264
                  P N+      T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E++     
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256
Query: 265 ----------LFAGD-----------------SEIDQLFRIFRTLGTPHEDVWPGVSKLP 297
                     LF G                  S  DQL  IF  +GTP E+    ++K  
Sbjct: 257 HINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQE 316
Query: 298 I--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
           +  Y   FP       S+  +      +D+   ++  + ++R++    L H Y   V
Sbjct: 317 VIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDV 373

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 131 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 189
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 190 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 249
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 250 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 309 TALEAMTHPYFQQVRAAENS 328

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 132 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 190
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 191 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 250
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 251 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 309
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 310 TALEAMTHPYFQQVRAAENS 329

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 131 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 189
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 190 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 249
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 250 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 309 TALEAMTHPYFQQVRAAENS 328

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 188
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 189 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 248
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 249 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 308 TALEAMTHPYFQQVRAAENS 327

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 188
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 189 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 248
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 249 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 308 TALEAMTHPYFQQVRAAENS 327

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 188
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 189 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 248
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 249 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 308 TALEAMTHPYFQQVRAAENS 327

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 109/194 (56%), Gaps = 13/194 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 188
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 189 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 248
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 249 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 339 SAKTILQHEYFNQV 352
           +A   + H YF QV
Sbjct: 308 TALEAMTHPYFQQV 321

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 109/194 (56%), Gaps = 13/194 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 188
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 189 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 248
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 249 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 339 SAKTILQHEYFNQV 352
           +A   + H YF QV
Sbjct: 308 TALEAMTHPYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 109/194 (56%), Gaps = 13/194 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 188
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 189 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 248
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           +V+         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 249 NVYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 339 SAKTILQHEYFNQV 352
           +A   + H YF QV
Sbjct: 308 TALEAMTHPYFQQV 321

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 105/190 (55%), Gaps = 9/190 (4%)
Query: 170 YLYQLLEALRYCH--SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEV 226
           +L+QL+ ++   H  S  + HRD+KP N+L+N++ G LKL DFG ++  + P       +
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYI 192
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            + +YR PE++ G + Y+T VDIWS GCIF+EM+  + +F GD+   QL  I R LG P 
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 287 EDVW----PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
            +V     P  + + +Y +    W    FS+        A D+ S ++   P++R+    
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWS-NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311
Query: 343 ILQHEYFNQV 352
            L H YF+++
Sbjct: 312 ALCHPYFDEL 321

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/179 (36%), Positives = 96/179 (53%), Gaps = 33/179 (18%)
Query: 22  LREISVLKELKHPNVIRLHD-VIPVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           LREI++L  L H +V+++ D VIP D +    L++V E    D K   +T PV +     
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHI 158
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------- 129
           K+ LY LL  ++Y HS  I+HRDLKP N L+N+  ++K+ DFGL+R    P N       
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 130 --------------------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                               + T  VVT WYR PE++L  + Y+  +D+WS GCIF+E+
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 108/248 (43%), Gaps = 60/248 (24%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-------- 220
           + LY LL  ++Y HS  I+HRDLKP N L+N+  ++K+ DFGL+R    P N        
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 221 -------------------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                              + T  VVT WYR PE++L  + Y+  +D+WS GCIF+E++ 
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 262 -----------KKTLFAGDS--------------------EIDQLFRIFRTLGTPHEDVW 290
                      +  LF G S                      DQL  IF  LGTP E+  
Sbjct: 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339
Query: 291 PGVSKLPI--YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             + K     Y   FP+      +E        A+ +  +++  +P +R++    L H +
Sbjct: 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399
Query: 349 FNQVEMVK 356
           F +V + +
Sbjct: 400 FKEVRIAE 407

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 13/200 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y+LL+AL YCHS+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V +
Sbjct: 151 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVAS 209
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  + Y  ++D+WS GC+F+ MI +K   F G    DQL +I + LGT   
Sbjct: 210 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGL 269
Query: 288 DVW---------PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           + +         P +  L    +  P W     ++  +L  P A+D   K++  D ++R+
Sbjct: 270 NAYLNKYRIELDPQLEALVGRHSRKP-WLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 328
Query: 339 SAKTILQHEYFNQVEMVKPT 358
           +A   + H YF QV   + +
Sbjct: 329 TALEAMTHPYFQQVRAAENS 348

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/179 (37%), Positives = 97/179 (54%), Gaps = 28/179 (15%)
Query: 22  LREISVLKELKHPNVIRLHD-VIPVDF----KLFLVFEFLRQDLKDFLQTTPVPVPPALA 76
           LREI++L  LK   +IRL+D +IP D     +L++V E    DLK   +T P+ +     
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHI 131
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI---------- 126
           K+ LY LL    + H   IIHRDLKP N L+N+  ++K+ DFGL+R              
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 127 -------PMNR-----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ 173
                  P N+      T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E+  + Q
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 103/238 (43%), Gaps = 52/238 (21%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI------------- 217
           LY LL    + H   IIHRDLKP N L+N+  ++K+ DFGL+R                 
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 218 ----PMNR-----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI-------- 260
               P N+      T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E++        
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 261 ---TKKTLFAGD-----------------SEIDQLFRIFRTLGTPHEDVWPGVSKLPI-- 298
               +  LF G                  S  DQL  IF  +GTP ED    ++K  +  
Sbjct: 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314
Query: 299 YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVK 356
           Y   FP  +P    +         +++   ++  +P +R++    L H Y   V   K
Sbjct: 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 104/186 (55%), Gaps = 6/186 (3%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT 67
           +S+++ EGV     REI +   L+HPN++R+++      +++L+ EF  R +L   LQ  
Sbjct: 50  KSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH 109
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                   + +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S     P
Sbjct: 110 GR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAP 166
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS-RRI 186
             R      TL Y PPE++ G K +   VD+W AG +  E        ++  +  + RRI
Sbjct: 167 SLRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 225
Query: 187 IHRDLK 192
           ++ DLK
Sbjct: 226 VNVDLK 231

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 85/178 (47%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S     P  R      T
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGT 176
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G K +   VD+W AG +  E +     F   S  +   RI         D
Sbjct: 177 LDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------D 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           +     K P + +D                   + D+ SK++   P QR+  K +++H
Sbjct: 230 L-----KFPPFLSDG------------------SKDLISKLLRYHPPQRLPLKGVMEH 264

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 104/186 (55%), Gaps = 6/186 (3%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT 67
           +S+++ EGV     REI +   L+HPN++R+++      +++L+ EF  R +L   LQ  
Sbjct: 49  KSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH 108
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                   + +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S     P
Sbjct: 109 GR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAP 165
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS-RRI 186
             R      TL Y PPE++ G K +   VD+W AG +  E        ++  +  + RRI
Sbjct: 166 SLRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224
Query: 187 IHRDLK 192
           ++ DLK
Sbjct: 225 VNVDLK 230

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 85/178 (47%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S     P  R      T
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGT 175
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G K +   VD+W AG +  E +     F   S  +   RI         D
Sbjct: 176 LDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------D 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           +     K P + +D                   + D+ SK++   P QR+  K +++H
Sbjct: 229 L-----KFPPFLSDG------------------SKDLISKLLRYHPPQRLPLKGVMEH 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 93/161 (57%), Gaps = 5/161 (3%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT 67
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+  R ++   LQ  
Sbjct: 48  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL 107
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                     +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P
Sbjct: 108 S-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAP 164
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 204

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 175 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 230 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 19/189 (10%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 69  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 129 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY 180
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E        EA  Y
Sbjct: 181 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 237
Query: 181 CHSRRIIHR 189
             + + I R
Sbjct: 238 QETYKRISR 246

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 138 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 195
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 196 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 250
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 251 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 283

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 92/161 (57%), Gaps = 5/161 (3%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT 67
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+  R ++   LQ  
Sbjct: 48  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL 107
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                     +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P
Sbjct: 108 S-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAP 164
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 165 SSRRXXLXGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 204

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGT 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 175 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 230 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRTELCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 60  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 119
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 120 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 171
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 172 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 129 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 186
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 187 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 241
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 242 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 274

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 48  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 107
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 108 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 160 S--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGT 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 175 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 230 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 44  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 103
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 104 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 156 S--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 200

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGT 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 171 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 226 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 99/189 (52%), Gaps = 19/189 (10%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 47  KTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 106
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 107 SRFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW 158
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY 180
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E        EA  Y
Sbjct: 159 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY 215
Query: 181 CHSRRIIHR 189
             + R I R
Sbjct: 216 QETYRRISR 224

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 89/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGT 173
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +     F   +  +   RI R   T    
Sbjct: 174 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT---- 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +  QR++   +L+H
Sbjct: 229 --------------FPDFVTEG-----------ARDLISRLLKHNASQRLTLAEVLEH 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 48  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 107
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 108 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 160 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 175 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 230 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 46  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 106 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 158 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 202

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 228 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRTXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 47  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 106
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 107 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 158
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 159 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 173
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 174 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 229 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 46  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 106 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 158 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 228 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 42  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 101
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 102 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 153
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 154 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 198

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 111 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 168
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 169 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 223
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 224 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 40  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 99
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 100 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 151
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 152 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 196

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 109 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 166
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 167 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 221
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 222 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 254

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 44  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 103
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 104 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 156 S--CHAPSSRRTTLSGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGT 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 171 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 226 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 98/189 (51%), Gaps = 19/189 (10%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 69  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 129 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY 180
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E        EA  Y
Sbjct: 181 S--VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 237
Query: 181 CHSRRIIHR 189
             + + I R
Sbjct: 238 QETYKRISR 246

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 138 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGT 195
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 196 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 250
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 251 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 283

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 46  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 106 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 158 S--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGT 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 228 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 48  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 107
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 108 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE + G + +   VD+WS G +  E 
Sbjct: 160 S--VHAPSSRRTTLCGTLDYLPPEXIEG-RXHDEKVDLWSLGVLCYEF 204

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    T
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGT 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE + G + +   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 175 LDYLPPEXIEG-RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 229
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 230 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPXLREVLEH 262

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 45  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 104
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 105 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 156
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 157 S--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 201

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 114 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGT 171
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 172 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 227 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 84/146 (57%), Gaps = 2/146 (1%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 121
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 122 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 180
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE++ G       VD+WS G I   M
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVILYVM 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 30/180 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +  Q++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       + 
Sbjct: 118 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSP 176
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE++ G       VD+WS G I   M+ ++  F  D  I  LF+          ++
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-DDESIPVLFK----------NI 225
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             GV  LP + +                  P A  +  +++ ++P  R+S   I+Q ++F
Sbjct: 226 SNGVYTLPKFLS------------------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 84/146 (57%), Gaps = 2/146 (1%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 120
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 121 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 179
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE++ G       VD+WS G I   M
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVILYVM 205

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 30/180 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +  Q++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       + 
Sbjct: 117 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSP 175
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE++ G       VD+WS G I   M+ ++  F  D  I  LF+          ++
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-DDESIPVLFK----------NI 224
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             GV  LP + +                  P A  +  +++ ++P  R+S   I+Q ++F
Sbjct: 225 SNGVYTLPKFLS------------------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 45  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 104
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+A+FG 
Sbjct: 105 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW 156
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 157 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 201

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+A+FG S     P +R T    T
Sbjct: 114 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGT 171
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 172 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 226
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 227 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 98/189 (51%), Gaps = 19/189 (10%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 47  KTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 106
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 107 SRFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW 158
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY 180
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E        EA  Y
Sbjct: 159 S--VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTY 215
Query: 181 CHSRRIIHR 189
             + R I R
Sbjct: 216 QETYRRISR 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGT 173
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +     F   +  +   RI R   T    
Sbjct: 174 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT---- 228
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +  QR++   +L+H
Sbjct: 229 --------------FPDFVTEG-----------ARDLISRLLKHNASQRLTLAEVLEH 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 46  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+A+FG 
Sbjct: 106 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW 157
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 158 S--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 202

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+A+FG S     P +R T    T
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGT 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 228 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 46  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 106 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 158 S--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 202

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGT 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 228 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 44  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 103
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 104 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 156 S--VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 200

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGT 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 171 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 226 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 84/146 (57%), Gaps = 2/146 (1%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 115
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 116 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 174
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE++ G       VD+WS G I   M
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVILYVM 200

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 30/180 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +  Q++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       + 
Sbjct: 112 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSP 170
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE++ G       VD+WS G I   M+ ++  F  D  I  LF+          ++
Sbjct: 171 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-DDESIPVLFK----------NI 219
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             GV  LP + +                  P A  +  +++ ++P  R+S   I+Q ++F
Sbjct: 220 SNGVYTLPKFLS------------------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 84/146 (57%), Gaps = 2/146 (1%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 111
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 112 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 170
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE++ G       VD+WS G I   M
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVILYVM 196

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 30/180 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +  Q++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       + 
Sbjct: 108 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSP 166
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE++ G       VD+WS G I   M+ ++  F  D  I  LF+          ++
Sbjct: 167 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-DDESIPVLFK----------NI 215
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             GV  LP + +                  P A  +  +++ ++P  R+S   I+Q ++F
Sbjct: 216 SNGVYTLPKFLS------------------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 98/189 (51%), Gaps = 19/189 (10%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 46  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 106 SKFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY 180
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E        EA  Y
Sbjct: 158 S--VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 214
Query: 181 CHSRRIIHR 189
             + + I R
Sbjct: 215 QETYKRISR 223

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGT 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R   T    
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---- 227
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 228 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 7/158 (4%)
Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPP 73
           +  ++EI +LK+L HPNVI+ +     D +L +V E      L + +K F +   + +P 
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPE 135
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
                Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+        
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
            V T +Y  PE  +    Y+   DIWS GC+  EM+ L
Sbjct: 196 LVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAAL 232

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V T 
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
           +Y  PE  +    Y+   DIWS GC+  EM   ++ F GD
Sbjct: 201 YYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDL 60
           +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L
Sbjct: 43  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL 102
Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             F +            +Y+ +L  AL YCHS+++IHRD+KP+N+L+  +G LK+ADFG 
Sbjct: 103 SKFDEQRTA--------TYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           S     P +R      TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 155 S--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 199

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 32/178 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+ +L  AL YCHS+++IHRD+KP+N+L+  +G LK+ADFG S     P +R      T
Sbjct: 112 TYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGT 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           L Y PPE++ G +++   VD+WS G +  E +  K  F  ++  D   RI R   T    
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT---- 224
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                         FP++  +            A D+ S+++  +P QR   + +L+H
Sbjct: 225 --------------FPDFVTEG-----------ARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 83/145 (57%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+L+ E+    ++ D+L      +    A+S  
Sbjct: 59  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKF 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+     T    +  Y
Sbjct: 118 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGSPPY 176
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVIL 201

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S   Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+     T    +
Sbjct: 115 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGS 173
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+  G K     VD+WS G I   +++    F G           + L    E 
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRER 222
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM 330
           V  G  ++P Y +   E   K+F  +LN   P+      +IM
Sbjct: 223 VLRGKYRIPFYMSTDCENLLKRFL-VLN---PIKRGTLEQIM 260

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+L+ E+    ++ D+L      +    A+S  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKF 120
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+   +         Y
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPY 179
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVIL 204

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S   Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+   +       
Sbjct: 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGA 176
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+  G K     VD+WS G I   +++    F G           + L    E 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRER 225
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM 330
           V  G  ++P Y +   E   K+F  +LN   P+      +IM
Sbjct: 226 VLRGKYRIPFYMSTDCENLLKRFL-VLN---PIKRGTLEQIM 263

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 83/145 (57%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 120
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT+  N+      +  Y
Sbjct: 121 RQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDTFCGSPPY 179
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVIL 204

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 1/108 (0%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT+  N+      +  Y 
Sbjct: 122 QIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDTFCGSPPYA 180
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            PE+  G K     VD+WS G I   +++    F G +  +   R+ R
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 2/146 (1%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REIS LK L+HP++I+L+DVI     + +V E+   +L D++      +     + +  Q
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTEDEGRRFFQQ 116
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           ++ A+ YCH  +I+HRDLKP+N+L++ +  +K+ADFGLS   T   N       +  Y  
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 175
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE++ G       VD+WS G +   M
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVM 201

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 36/184 (19%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +  Q++ A+ YCH  +I+HRDLKP+N+L++ +  +K+ADFGLS   T   N       + 
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSP 171
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE++ G       VD+WS G +   M+                             
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVML----------------------------- 202
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPD---PLAVDVFSKIMALDPKQRVSAKTILQH 346
              V +LP      P    K  S +  +PD   P A  +  +++  DP QR++ + I + 
Sbjct: 203 ---VGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259
Query: 347 EYFN 350
            +FN
Sbjct: 260 PWFN 263

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDEFCGSPPY 178
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 33/195 (16%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y 
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDEFCGSPPYA 179
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 228
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN-- 350
             ++P Y +   E   KKF                  + L+P +R + + I++  + N  
Sbjct: 229 KYRIPFYMSTDCENLLKKF------------------LILNPSKRGTLEQIMKDRWMNVG 270
Query: 351 -QVEMVKPTLAVFPE 364
            + + +KP +   P+
Sbjct: 271 HEDDELKPYVEPLPD 285

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 178
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 33/195 (16%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y 
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYA 179
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 228
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN-- 350
             ++P Y +   E   KKF                  + L+P +R + + I++  + N  
Sbjct: 229 KYRIPFYMSTDCENLLKKF------------------LILNPSKRGTLEQIMKDRWMNVG 270
Query: 351 -QVEMVKPTLAVFPE 364
            + + +KP +   P+
Sbjct: 271 HEDDELKPYVEPLPD 285

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 178
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 33/195 (16%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y 
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYA 179
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 228
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN-- 350
             ++P Y +   E   KKF                  + L+P +R + + I++  + N  
Sbjct: 229 KYRIPFYMSTDCENLLKKF------------------LILNPSKRGTLEQIMKDRWMNVG 270
Query: 351 -QVEMVKPTLAVFPE 364
            + + +KP +   P+
Sbjct: 271 HEDDELKPYVEPLPD 285

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 178
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 33/195 (16%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y 
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYA 179
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 228
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN-- 350
             ++P Y +   E   KKF                  + L+P +R + + I++  + N  
Sbjct: 229 KYRIPFYMSTDCENLLKKF------------------LILNPSKRGTLEQIMKDRWMNVG 270
Query: 351 -QVEMVKPTLAVFPE 364
            + + +KP +A  P+
Sbjct: 271 HEDDELKPYVAPLPD 285

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 81/145 (55%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+         Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDAFCGAPPY 178
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 33/195 (16%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+         Y 
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDAFCGAPPYA 179
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 228
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN-- 350
             ++P Y +   E   KKF                  + L+P +R + + I++  + N  
Sbjct: 229 KYRIPFYMSTDCENLLKKF------------------LILNPSKRGTLEQIMKDRWMNVG 270
Query: 351 -QVEMVKPTLAVFPE 364
            + + +KP +   P+
Sbjct: 271 HEDDELKPYVEPLPD 285

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 54  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGWMKEKEARAKF 112
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 113 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 171
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVIL 196

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 33/195 (16%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y 
Sbjct: 114 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYA 172
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 221
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN-- 350
             ++P Y +   E   KKF                  + L+P +R + + I++  + N  
Sbjct: 222 KYRIPFYMSTDCENLLKKF------------------LILNPSKRGTLEQIMKDRWMNVG 263
Query: 351 -QVEMVKPTLAVFPE 364
            + + +KP +   P+
Sbjct: 264 HEDDELKPYVEPLPD 278

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 79/145 (54%), Gaps = 3/145 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ + K L HPN+++L +VI  +  L+LV E+    ++ D+L           A++  
Sbjct: 61  FREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKF 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+         Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFG-NKLDAFCGAPPY 178
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIF 165
             PE+  G K     VD+WS G I 
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 12/139 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+         Y 
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFG-NKLDAFCGAPPYA 179
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G           + L    E V  G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------QNLKELRERVLRG 228
Query: 293 VSKLPIYKTDFPEWRPKKF 311
             ++P Y +   E   KKF
Sbjct: 229 KYRIPFYXSTDCENLLKKF 247

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 3/157 (1%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE++VL  +KHPN+++  +    +  L++V ++       K       V         + 
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q+  AL++ H R+I+HRD+K QNI + K G ++L DFG++R     +      + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
             PEI    K Y+   DIW+ GC+  E+  L    EA
Sbjct: 192 LSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEA 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 65/120 (54%), Gaps = 4/120 (3%)
Query: 162 GCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G +F E   + +  Q+  AL++ H R+I+HRD+K QNI + K G ++L DFG++R     
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178
Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           +      + T +Y  PEI    K Y+   DIW+ GC+  E+ T K  F   S  + + +I
Sbjct: 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 89/155 (57%), Gaps = 5/155 (3%)
Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPV 69
           +Q  G      +EI++LK+L HPNV++L +V+  P +  L++VFE + Q     + T   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK- 132
Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
           P+    A+ Y   L++ + Y H ++IIHRD+KP N+L+ + G +K+ADFG+S  F     
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 130 RYTHEVVTLWYRPPEILLGA-KVYST-TVDIWSAG 162
             ++ V T  +  PE L    K++S   +D+W+ G
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG 227

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 51/86 (59%), Gaps = 2/86 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y   L++ + Y H ++IIHRD+KP N+L+ + G +K+ADFG+S  F       ++ V T 
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 230 WYRPPEILLGA-KVYST-TVDIWSAG 253
            +  PE L    K++S   +D+W+ G
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMG 227

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 86/149 (57%), Gaps = 6/149 (4%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKSYL 80
           RE+    +L H N++ + DV   D   +LV E++    L +++++  P+ V  A+  ++ 
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFT 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTLW 139
            Q+L+ +++ H  RI+HRD+KPQNILI+ +  LK+ DFG+++A +   + +  H + T+ 
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           Y  PE   G      T DI+S G +  EM
Sbjct: 178 YFSPEQAKGEATDECT-DIYSIGIVLYEM 205

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 66/111 (59%), Gaps = 2/111 (1%)
Query: 163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNR 221
            + + +++  Q+L+ +++ H  RI+HRD+KPQNILI+ +  LK+ DFG+++A +   + +
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168
Query: 222 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
             H + T+ Y  PE   G      T DI+S G +  EM+  +  F G++ +
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 103/186 (55%), Gaps = 6/186 (3%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT 67
           +S+++ EGV     REI +   L HPN++RL++      +++L+ E+  R +L   LQ +
Sbjct: 58  KSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS 117
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                     + + +L +AL YCH +++IHRD+KP+N+L+   G LK+ADFG S     P
Sbjct: 118 -CTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAP 174
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS-RRI 186
             R      TL Y PPE++ G ++++  VD+W  G +  E+       E+  +  + RRI
Sbjct: 175 SLRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 233
Query: 187 IHRDLK 192
           +  DLK
Sbjct: 234 VKVDLK 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 163 CIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           C F E    + + +L +AL YCH +++IHRD+KP+N+L+   G LK+ADFG S     P 
Sbjct: 118 CTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPS 175
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
            R      TL Y PPE++ G ++++  VD+W  G +  E++     F   S  +   RI 
Sbjct: 176 LRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIV 234
Query: 280 RT 281
           + 
Sbjct: 235 KV 236

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 43/249 (17%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDL 191
           EIL  +  +    ++++ G +F E+              + Q+   + Y H   I+HRDL
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 192 KPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD 248
           KP+NIL+    K   +K+ DFGLS  F     +    + T +Y  PE+L G   Y    D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG--TYDEKCD 204
Query: 249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP 308
           +WSAG I   +++    F G +E D L R+                +   Y  D P+WR 
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRV----------------ETGKYAFDLPQWRT 248
Query: 309 KKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYG 368
                   + D  A D+  K++   P  R++A   L+H +  +     PT++  P L   
Sbjct: 249 --------ISDD-AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESA 299
Query: 369 GNGCKDFKP 377
               + F+ 
Sbjct: 300 MTNIRQFQA 308

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/122 (37%), Positives = 70/122 (57%), Gaps = 6/122 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVV 227
           + + +L+ L   H  RIIH DLKP+NIL+ + G   +K+ DFG S        R    + 
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYXXIQ 261
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + +YR PE++LGA+ Y   +D+WS GCI +E++T   L  G+ E DQL  +   LG P +
Sbjct: 262 SRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ 320
Query: 288 DV 289
            +
Sbjct: 321 KL 322

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 84/147 (57%), Gaps = 8/147 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVP-VPPALAKSY 79
           +EI +L+ L+H NVI+L DV+  +   K+++V E+    +++ L + P    P   A  Y
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY 114
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVV 136
             QL++ L Y HS+ I+H+D+KP N+L+   G LK++  G++ A   F       T +  
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-G 173
Query: 137 TLWYRPPEILLGAKVYST-TVDIWSAG 162
           +  ++PPEI  G   +S   VDIWSAG
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAG 200

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 34/187 (18%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHE 225
            Y  QL++ L Y HS+ I+H+D+KP N+L+   G LK++  G++ A   F       T +
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 226 VVTLWYRPPEILLGAKVYST-TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
             +  ++PPEI  G   +S   VDIWSAG     + T    F GD+    ++++F  +G 
Sbjct: 173 -GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYKLFENIGK 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
               + PG    P+                         D+   ++  +P +R S + I 
Sbjct: 228 GSYAI-PGDCGPPL------------------------SDLLKGMLEYEPAKRFSIRQIR 262
Query: 345 QHEYFNQ 351
           QH +F +
Sbjct: 263 QHSWFRK 269

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/122 (37%), Positives = 70/122 (57%), Gaps = 6/122 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVV 227
           + + +L+ L   H  RIIH DLKP+NIL+ + G   +K+ DFG S        R    + 
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQ 261
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + +YR PE++LGA+ Y   +D+WS GCI +E++T   L  G+ E DQL  +   LG P +
Sbjct: 262 SRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320
Query: 288 DV 289
            +
Sbjct: 321 KL 322

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/122 (37%), Positives = 70/122 (57%), Gaps = 6/122 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVV 227
           + + +L+ L   H  RIIH DLKP+NIL+ + G   +K+ DFG S        R    + 
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQ 261
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + +YR PE++LGA+ Y   +D+WS GCI +E++T   L  G+ E DQL  +   LG P +
Sbjct: 262 SRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320
Query: 288 DV 289
            +
Sbjct: 321 KL 322

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL------QTTPVPVPPALA 76
           RE S+   LKHP+++ L +    D  L++VFEF+  D  D                 A+A
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFM--DGADLCFEIVKRADAGFVYSEAVA 132
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 133
             Y+ Q+LEALRYCH   IIHRD+KP+N+L+     S  +KL DFG++            
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            V T  +  PE+ +  + Y   VD+W  G I 
Sbjct: 193 RVGTPHFMAPEV-VKREPYGKPVDVWGCGVIL 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIH 188
           T+    + Y   E + GA +    V    AG ++SE     Y+ Q+LEALRYCH   IIH
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153
Query: 189 RDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
           RD+KP+N+L+     S  +KL DFG++             V T  +  PE+ +  + Y  
Sbjct: 154 RDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGK 212
Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
            VD+W  G I   +++    F G  E     R+F       E +  G  K+         
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTKE-----RLF-------EGIIKGKYKM--------- 251
Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             P+++S I       A D+  +++ LDP +R++    L H +  +
Sbjct: 252 -NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 75
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-------EAD 129
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 187
Query: 133 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 188 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   H   
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 191
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE+ L    YS  VDIW+ G I   ++     F  + +     R++  +    
Sbjct: 192 GTPGYLSPEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQI---- 242
Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   K   Y    PEW         +   P A  +   ++ ++PK+R++A   L+
Sbjct: 243 --------KAGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 284

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-D 59
           KV+ +   R +++   V     REI  LK  +HP++I+L+ VI      F+V E++   +
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           L D++      V    A+    Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFG
Sbjct: 98  LFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           LS   +      T    +  Y  PE++ G       VDIWS G I      LY LL
Sbjct: 157 LSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYAGPEVDIWSCGVI------LYALL 205

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 140 YRPPEILLGAKVYSTTVDIW------SAGCIFS---------EMS---YLYQLLEALRYC 181
           +R P I+   +V ST  D +      S G +F          EM       Q+L A+ YC
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 182 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 241
           H   ++HRDLKP+N+L++     K+ADFGLS   +      T    +  Y  PE++ G  
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRL 186
Query: 242 VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT 301
                VDIWS G I   ++   TL   D  +  LF+  R           GV  +     
Sbjct: 187 YAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRG----------GVFYI----- 230
Query: 302 DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             PE+  +  + +L             ++ +DP +R + K I +HE+F Q
Sbjct: 231 --PEYLNRSVATLL-----------MHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 9/176 (5%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-D 59
           KV+ +   R +++   V     REI  LK  +HP++I+L+ VI      F+V E++   +
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           L D++      V    A+    Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFG
Sbjct: 98  LFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           LS   +           +  Y  PE++ G       VDIWS G I      LY LL
Sbjct: 157 LSNMMS-DGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI------LYALL 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 140 YRPPEILLGAKVYSTTVDIW------SAGCIFS---------EMS---YLYQLLEALRYC 181
           +R P I+   +V ST  D +      S G +F          EM       Q+L A+ YC
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 182 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 241
           H   ++HRDLKP+N+L++     K+ADFGLS   +           +  Y  PE++ G  
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYAAPEVISGRL 186
Query: 242 VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT 301
                VDIWS G I   ++   TL   D  +  LF+  R           GV  +     
Sbjct: 187 YAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRG----------GVFYI----- 230
Query: 302 DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             PE+  +  + +L             ++ +DP +R + K I +HE+F Q
Sbjct: 231 --PEYLNRSVATLL-----------MHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 75
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 164
Query: 133 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 165 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 197

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   H   
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 168
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE+ L    YS  VDIW+ G I   ++     F  + +     R++  +    
Sbjct: 169 GTPGYLSPEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQI---- 219
Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   K   Y    PEW         +   P A  +   ++ ++PK+R++A   L+
Sbjct: 220 --------KAGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 75
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 106 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 163
Query: 133 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 164 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 196

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   H   
Sbjct: 110 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 167
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE+ L    YS  VDIW+ G I   ++     F  + +     R++  +    
Sbjct: 168 GTPGYLSPEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQI---- 218
Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   K   Y    PEW         +   P A  +   ++ ++PK+R++A   L+
Sbjct: 219 --------KAGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 260

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 75
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 164
Query: 133 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 165 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   H   
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFA 168
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE+ L    YS  VDIW+ G I   ++     F  + +     R++  +    
Sbjct: 169 GTPGYLSPEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQI---- 219
Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   K   Y    PEW         +   P A  +   ++ ++PK+R++A   L+
Sbjct: 220 --------KAGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 30/202 (14%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWM 183
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ +  T GTP       
Sbjct: 184 APEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ---- 237
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S I         D  ++ + +D ++R SAK +LQH++    
Sbjct: 238 --------------NPEKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL--- 273
Query: 353 EMVKPTLAVFPELGYGGNGCKD 374
           ++ KP  ++ P +       K+
Sbjct: 274 KIAKPLSSLTPLIAAAKEATKN 295

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 41/204 (20%)
Query: 186 IIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 243
           IIH DLKP+NIL+   K  A+K+ DFG S        R    + + +YR PE+LLG   Y
Sbjct: 161 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-Y 216
Query: 244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP--------------HEDV 289
              +D+WS GCI  EM T + LF+G +E+DQ+ +I   LG P               E +
Sbjct: 217 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 276
Query: 290 WPGVSKLPIYKTDFPEWRP---KKFSEILN-----------------LPDPLAV-DVFSK 328
             G   L   K    E++P   +K   IL                  + D L   D+  +
Sbjct: 277 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 336
Query: 329 IMALDPKQRVSAKTILQHEYFNQV 352
           ++  DPK R+     LQH +F + 
Sbjct: 337 MLDYDPKTRIQPYYALQHSFFKKT 360

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 41/204 (20%)
Query: 186 IIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 243
           IIH DLKP+NIL+   K  A+K+ DFG S        R    + + +YR PE+LLG   Y
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-Y 235
Query: 244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP--------------HEDV 289
              +D+WS GCI  EM T + LF+G +E+DQ+ +I   LG P               E +
Sbjct: 236 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 295
Query: 290 WPGVSKLPIYKTDFPEWRP---KKFSEILN-----------------LPDPLAV-DVFSK 328
             G   L   K    E++P   +K   IL                  + D L   D+  +
Sbjct: 296 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355
Query: 329 IMALDPKQRVSAKTILQHEYFNQV 352
           ++  DPK R+     LQH +F + 
Sbjct: 356 MLDYDPKTRIQPYYALQHSFFKKT 379

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 30/202 (14%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWM 183
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ +  T GTP       
Sbjct: 184 APEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ---- 237
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S I         D  ++ + +D ++R SAK +LQH++    
Sbjct: 238 --------------NPEKLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHQFL--- 273
Query: 353 EMVKPTLAVFPELGYGGNGCKD 374
           ++ KP  ++ P +       K+
Sbjct: 274 KIAKPLSSLTPLIAAAKEATKN 295

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 41/204 (20%)
Query: 186 IIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 243
           IIH DLKP+NIL+   K  A+K+ DFG S        R    + + +YR PE+LLG   Y
Sbjct: 180 IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-Y 235
Query: 244 STTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP--------------HEDV 289
              +D+WS GCI  EM T + LF+G +E+DQ+ +I   LG P               E +
Sbjct: 236 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 295
Query: 290 WPGVSKLPIYKTDFPEWRP---KKFSEILN-----------------LPDPLAV-DVFSK 328
             G   L   K    E++P   +K   IL                  + D L   D+  +
Sbjct: 296 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355
Query: 329 IMALDPKQRVSAKTILQHEYFNQV 352
           ++  DPK R+     LQH +F + 
Sbjct: 356 MLDYDPKTRIQPYYALQHSFFKKT 379

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 9/160 (5%)
Query: 13  QVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 70
           Q+E V     RE  +L+++  HP++I L D       +FLVF+ +R+ +L D+L T  V 
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVA 196
Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
           +     +S +  LLEA+ + H+  I+HRDLKP+NIL++ +  ++L+DFG S     P  +
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEK 255
Query: 131 YTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCIF 165
                 T  Y  PEIL  +       Y   VD+W+ G I 
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 31/188 (16%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S +  LLEA+ + H+  I+HRDLKP+NIL++ +  ++L+DFG S     P  +      T
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRELCGT 262
Query: 229 LWYRPPEILLGAK-----VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
             Y  PEIL  +       Y   VD+W+ G I   ++     F    +I  L  I     
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ- 321
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                          Y+   PEW  +  +           D+ S+++ +DP+ R++A+  
Sbjct: 322 ---------------YQFSSPEWDDRSST---------VKDLISRLLQVDPEARLTAEQA 357
Query: 344 LQHEYFNQ 351
           LQH +F +
Sbjct: 358 LQHPFFER 365

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 30/202 (14%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ +  T GTP       
Sbjct: 184 APEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ---- 237
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S I         D  ++ + +D ++R SAK +LQH++    
Sbjct: 238 --------------NPEKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL--- 273
Query: 353 EMVKPTLAVFPELGYGGNGCKD 374
           ++ KP  ++ P +       K+
Sbjct: 274 KIAKPLSSLTPLIAAAKEATKN 295

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 30/202 (14%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 125 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWM 184
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ +  T GTP       
Sbjct: 185 APEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ---- 238
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S I         D  ++ + +D ++R SAK ++QH++    
Sbjct: 239 --------------NPEKLSAIFR-------DFLNRCLEMDVEKRGSAKELIQHQFL--- 274
Query: 353 EMVKPTLAVFPELGYGGNGCKD 374
           ++ KP  ++ P +       K+
Sbjct: 275 KIAKPLSSLTPLIAAAKEATKN 296

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 135
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +  + ++ + D WS G +  EM
Sbjct: 196 PEV-VNRRGHTQSADWWSFGVLMFEM 220

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 14/144 (9%)
Query: 156 VDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA 203
           +D    G +F+ +S            YL +L  AL + HS  II+RDLKP+NIL+++ G 
Sbjct: 106 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 165
Query: 204 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
           +KL DFGLS+       +      T+ Y  PE+ +  + ++ + D WS G +  EM+T  
Sbjct: 166 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGT 224
Query: 264 TLFAGDSEIDQLFRIFRT-LGTPH 286
             F G    + +  I +  LG P 
Sbjct: 225 LPFQGKDRKETMTMILKAKLGMPQ 248

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 5/151 (3%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 82
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+  +  +    Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
            L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 203
Query: 143 PEILLGA----KVYSTTVDIWSAGCIFSEMS 169
           PE+++      + Y    D+WS G    EM+
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++ 
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 233 PPEILLGA----KVYSTTVDIWSAGCIFSEM 259
            PE+++      + Y    D+WS G    EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 134
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +  + ++ + D WS G +  EM
Sbjct: 195 PEV-VNRRGHTQSADWWSFGVLMFEM 219

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 14/144 (9%)
Query: 156 VDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA 203
           +D    G +F+ +S            YL +L  AL + HS  II+RDLKP+NIL+++ G 
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 164
Query: 204 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
           +KL DFGLS+       +      T+ Y  PE+ +  + ++ + D WS G +  EM+T  
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGT 223
Query: 264 TLFAGDSEIDQLFRIFRT-LGTPH 286
             F G    + +  I +  LG P 
Sbjct: 224 LPFQGKDRKETMTMILKAKLGMPQ 247

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 134
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +  + ++ + D WS G +  EM
Sbjct: 195 PEV-VNRRGHTQSADWWSFGVLMFEM 219

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 14/144 (9%)
Query: 156 VDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA 203
           +D    G +F+ +S            YL +L  AL + HS  II+RDLKP+NIL+++ G 
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 164
Query: 204 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
           +KL DFGLS+       +      T+ Y  PE+ +  + ++ + D WS G +  EM+T  
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGT 223
Query: 264 TLFAGDSEIDQLFRIFRT-LGTPH 286
             F G    + +  I +  LG P 
Sbjct: 224 LPFQGKDRKETMTMILKAKLGMPQ 247

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 5/151 (3%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 82
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+  +  +    Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
            L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMA 203
Query: 143 PEILLGA----KVYSTTVDIWSAGCIFSEMS 169
           PE+++      + Y    D+WS G    EM+
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++ 
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 233 PPEILLGA----KVYSTTVDIWSAGCIFSEM 259
            PE+++      + Y    D+WS G    EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 13  QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-TPVPV 71
            +E        EIS+LK L HPN+I+L DV       +LV EF  +  + F Q       
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY-EGGELFEQIINRHKF 143
Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPM 128
               A + + Q+L  + Y H   I+HRD+KP+NIL+    +L   K+ DFGLS  F+   
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            +    + T +Y  PE+L   K Y+   D+WS G I
Sbjct: 204 -KLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVI 236

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 31/176 (17%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPMNRYTHEVVTL 229
           Q+L  + Y H   I+HRD+KP+NIL+    +L   K+ DFGLS  F+    +    + T 
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTA 212
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           +Y  PE+L   K Y+   D+WS G I   ++     F G ++               +D+
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND---------------QDI 255
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
              V K   Y  DF +W+        N+ D  A ++   ++  D  +R +A+  L 
Sbjct: 256 IKKVEKGKYY-FDFNDWK--------NISDE-AKELIKLMLTYDYNKRCTAEEALN 301

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 5/151 (3%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 82
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+  +  +    Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
            L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMA 203
Query: 143 PEILLGA----KVYSTTVDIWSAGCIFSEMS 169
           PE+++      + Y    D+WS G    EM+
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++ 
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 233 PPEILLGA----KVYSTTVDIWSAGCIFSEM 259
            PE+++      + Y    D+WS G    EM
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 80/146 (54%), Gaps = 3/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  +L ++ HP V++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 138
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           L   L + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +  + +S + D WS G +  EM
Sbjct: 199 PEV-VNRQGHSHSADWWSYGVLMFEM 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 156 VDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA 203
           +D    G +F+ +S            YL +L   L + HS  II+RDLKP+NIL+++ G 
Sbjct: 109 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGH 168
Query: 204 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
           +KL DFGLS+       +      T+ Y  PE+ +  + +S + D WS G +  EM+T  
Sbjct: 169 IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV-VNRQGHSHSADWWSYGVLMFEMLTGS 227
Query: 264 TLFAGDSEIDQLFRIFRT-LGTPH 286
             F G    + +  I +  LG P 
Sbjct: 228 LPFQGKDRKETMTLILKAKLGMPQ 251

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE  + + LKHPN++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 109
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+LE++ +CH   I+HRDLKP+N+L+   +K  A+KLADFGL+         +     T
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 170 PGYLSPEVLR-KDPYGKPVDMWACGVIL 196

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LE++ +CH   I+HRDLKP+N+L+   +K  A+KLADFGL+         +     
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L     Y   VD+W+ G I   ++     F  + +     R+++ +     
Sbjct: 169 TPGYLSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPFWDEDQ----HRLYQQI----- 218
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                  K   Y    PEW         +   P A D+ +K++ ++P +R++A   L+H 
Sbjct: 219 -------KAGAYDFPSPEW---------DTVTPEAKDLINKMLTINPAKRITASEALKHP 262
Query: 348 YFNQVEMVKPTL 359
           +  Q   V   +
Sbjct: 263 WICQRSTVASMM 274

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE  + + LKHPN++RLHD I  +   +L+F+ +      +D +         A A   +
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCI 127
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+LEA+ +CH   ++HRDLKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 188 PGYLSPEVLR-KDPYGKPVDLWACGVIL 214

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 29/192 (15%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LEA+ +CH   ++HRDLKP+N+L+    K  A+KLADFGL+         +     
Sbjct: 127 IQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 186
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L     Y   VD+W+ G I   ++     F  + +     R+++ +     
Sbjct: 187 TPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----HRLYQQI----- 236
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                  K   Y    PEW         +   P A D+ +K++ ++P +R++A   L+H 
Sbjct: 237 -------KAGAYDFPSPEW---------DTVTPEAKDLINKMLTINPSKRITAAEALKHP 280
Query: 348 YFNQVEMVKPTL 359
           + +    V   +
Sbjct: 281 WISHRSTVASCM 292

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 9/168 (5%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           R +++   V     REI  LK  +HP++I+L+ VI     +F+V E++   +L D++   
Sbjct: 51  RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN 110
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
              +    ++    Q+L  + YCH   ++HRDLKP+N+L++     K+ADFGLS   +  
Sbjct: 111 G-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-D 168
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                    +  Y  PE++ G       VDIWS+G I      LY LL
Sbjct: 169 GEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI------LYALL 210

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 140 YRPPEILLGAKVYSTTVDIW------SAGCIFS-----------EMSYLYQ-LLEALRYC 181
           +R P I+   +V ST  DI+      S G +F            E   L+Q +L  + YC
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 182 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 241
           H   ++HRDLKP+N+L++     K+ADFGLS   +           +  Y  PE++ G  
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCGSPNYAAPEVISGRL 191
Query: 242 VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT 301
                VDIWS+G I   ++   TL   D  +  LF+           +  G+   P Y  
Sbjct: 192 YAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFK----------KICDGIFYTPQY-- 238
Query: 302 DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                        LN   P  + +   ++ +DP +R + K I +HE+F Q
Sbjct: 239 -------------LN---PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE  + + LKHPN++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 109
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+LE++ +CH   I+HRDLKP+N+L+   +K  A+KLADFGL+         +     T
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 170 PGYLSPEVLR-KDPYGKPVDMWACGVIL 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LE++ +CH   I+HRDLKP+N+L+   +K  A+KLADFGL+         +     
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L     Y   VD+W+ G I   ++     F  + +     R+++ +     
Sbjct: 169 TPGYLSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPFWDEDQ----HRLYQQI----- 218
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                  K   Y    PEW         +   P A D+ +K++ ++P +R++A   L+H 
Sbjct: 219 -------KAGAYDFPSPEW---------DTVTPEAKDLINKMLTINPAKRITASEALKHP 262
Query: 348 YFNQVEMVKPTL 359
           +  Q   V   +
Sbjct: 263 WICQRSTVASMM 274

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE  + + LKH N++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 109
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+LEA+ +CH   ++HRDLKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 110 QQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             Y  PE+L   + Y   VDIW+ G I 
Sbjct: 170 PGYLSPEVLR-KEAYGKPVDIWACGVIL 196

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LEA+ +CH   ++HRDLKP+N+L+    K  A+KLADFGL+         +     
Sbjct: 109 IQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L   + Y   VDIW+ G I   ++     F  D +  +L++  +       
Sbjct: 169 TPGYLSPEVLR-KEAYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKA------ 220
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
               G    P      PEW         +   P A ++ ++++ ++P +R++A   L+H 
Sbjct: 221 ----GAYDFP-----SPEW---------DTVTPEAKNLINQMLTINPAKRITAHEALKHP 262
Query: 348 YFNQVEMVKPTL 359
           +  Q   V   +
Sbjct: 263 WVCQRSTVASMM 274

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKD--FL 64
            +S V         L E++VLK+L HPN+++L++        +LV E  R  +L D   L
Sbjct: 38  KKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL 97
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLS 121
           +     V  A+    + Q+L    Y H   I+HRDLKP+N+L+   ++   +K+ DFGLS
Sbjct: 98  RQKFSEVDAAVI---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS 154
Query: 122 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             F +   +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 155 AHFEVG-GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVIL 195

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 43/210 (20%)
Query: 152 YSTTVDIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI- 198
           Y   ++++  G +F E+              + Q+L    Y H   I+HRDLKP+N+L+ 
Sbjct: 79  YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 138
Query: 199 --NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
             ++   +K+ DFGLS  F +   +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 139 SKSRDALIKIVDFGLSAHFEVG-GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVIL 195
Query: 257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN 316
             ++     F G ++ + L R+ +                  +  D P+W          
Sbjct: 196 YILLCGYPPFGGQTDQEILKRVEK----------------GKFSFDPPDW--------TQ 231
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           + D  A  +   ++  +P +R+SA+  L H
Sbjct: 232 VSDE-AKQLVKLMLTYEPSKRISAEEALNH 260

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAK 77
           ST LRE+ +LK+L HPN+++L +++      ++V E +   +L D +           A 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA 124
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 134
             + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           + T +Y  PE+L G   Y    D+WSAG I 
Sbjct: 184 IGTAYYIAPEVLRG--TYDEKCDVWSAGVIL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 43/218 (19%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDL 191
           EIL  +  +    ++++ G +F E+              + Q+   + Y H   I+HRDL
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 192 KPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD 248
           KP+NIL+    K   +K+ DFGLS  F     +    + T +Y  PE+L G   Y    D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG--TYDEKCD 204
Query: 249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP 308
           +WSAG I   +++    F G +E D L R+                +   Y  D P+WR 
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRV----------------ETGKYAFDLPQWR- 247
Query: 309 KKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                   + D  A D+  K++   P  R++A   L+H
Sbjct: 248 -------TISDD-AKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAK 77
           ST LRE+ +LK+L HPN+++L +++      ++V E +   +L D +           A 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA 124
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 134
             + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           + T +Y  PE+L G   Y    D+WSAG I 
Sbjct: 184 IGTAYYIAPEVLRG--TYDEKCDVWSAGVIL 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 43/218 (19%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDL 191
           EIL  +  +    ++++ G +F E+              + Q+   + Y H   I+HRDL
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 192 KPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD 248
           KP+NIL+    K   +K+ DFGLS  F     +    + T +Y  PE+L G   Y    D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG--TYDEKCD 204
Query: 249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP 308
           +WSAG I   +++    F G +E D L R+                +   Y  D P+WR 
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRV----------------ETGKYAFDLPQWR- 247
Query: 309 KKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                   + D  A D+  K++   P  R++A   L+H
Sbjct: 248 -------TISDD-AKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 30/202 (14%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           + L+AL + HS ++IHR++K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 125 ECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 184
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ +  T GTP       
Sbjct: 185 APEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ---- 238
Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                          P+K S I         D  ++ + +D ++R SAK ++QH++    
Sbjct: 239 --------------NPEKLSAIFR-------DFLNRCLEMDVEKRGSAKELIQHQFL--- 274
Query: 353 EMVKPTLAVFPELGYGGNGCKD 374
           ++ KP  ++ P +       K+
Sbjct: 275 KIAKPLSSLTPLIAAAKEATKN 296

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 80
           LRE+ +LK+L HPN+++L++        +LV E +   +L D +  +        A   +
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII 156
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGT 215
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 216 AYYIAPEVLHG--TYDEKCDVWSTGVIL 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 43/207 (20%)
Query: 157 DIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKS 201
           ++++ G +F E+              + Q+L  + Y H  +I+HRDLKP+N+L+   +K 
Sbjct: 130 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD 189
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +++ DFGLS  F     +   ++ T +Y  PE+L G   Y    D+WS G I   +++
Sbjct: 190 ANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLS 246
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
               F G +E D L ++ +                  Y  + P+W  KK SE        
Sbjct: 247 GCPPFNGANEYDILKKVEK----------------GKYTFELPQW--KKVSES------- 281
Query: 322 AVDVFSKIMALDPKQRVSAKTILQHEY 348
           A D+  K++   P  R+SA+  L HE+
Sbjct: 282 AKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 80
           LRE+ +LK+L HPN+++L++        +LV E +   +L D +  +        A   +
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII 155
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGT 214
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 215 AYYIAPEVLHG--TYDEKCDVWSTGVIL 240

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 43/207 (20%)
Query: 157 DIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKS 201
           ++++ G +F E+              + Q+L  + Y H  +I+HRDLKP+N+L+   +K 
Sbjct: 129 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD 188
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +++ DFGLS  F     +   ++ T +Y  PE+L G   Y    D+WS G I   +++
Sbjct: 189 ANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLS 245
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
               F G +E D L ++ +                  Y  + P+W  KK SE        
Sbjct: 246 GCPPFNGANEYDILKKVEK----------------GKYTFELPQW--KKVSES------- 280
Query: 322 AVDVFSKIMALDPKQRVSAKTILQHEY 348
           A D+  K++   P  R+SA+  L HE+
Sbjct: 281 AKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 8/162 (4%)
Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQT 66
            + +V+ +    + LRE+ +LK+L HPN+++L++        +LV E +   +L D +  
Sbjct: 60  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-I 118
Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRA 123
           +        A   + Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  
Sbjct: 119 SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 124 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           F     +   ++ T +Y  PE+L G   Y    D+WS G I 
Sbjct: 179 FEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVIL 217

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 43/207 (20%)
Query: 157 DIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKS 201
           ++++ G +F E+              + Q+L  + Y H  +I+HRDLKP+N+L+   +K 
Sbjct: 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD 165
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +++ DFGLS  F     +   ++ T +Y  PE+L G   Y    D+WS G I   +++
Sbjct: 166 ANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLS 222
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
               F G +E D L ++ +                  Y  + P+W  KK SE        
Sbjct: 223 GCPPFNGANEYDILKKVEK----------------GKYTFELPQW--KKVSES------- 257
Query: 322 AVDVFSKIMALDPKQRVSAKTILQHEY 348
           A D+  K++   P  R+SA+  L HE+
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
             L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWM 178
Query: 142 PPEILLGAK--VYSTTVDIWSAGCIFSEMS 169
            PE++L      Y   VD+WS G    E++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 234
           L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++  P
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWMAP 180
Query: 235 EILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           E++L      Y   VD+WS G    E+  +K      + +  L+ I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  +
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
             L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++ 
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWM 217
Query: 142 PPEILLGAK--VYSTTVDIWSAGCIFSEMS 169
            PE++L      Y   VD+WS G    E++
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 234
           L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++  P
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWMAP 219
Query: 235 EILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
           E++L      Y   VD+WS G    E+  +K      + +  L+ I + 
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 2/151 (1%)
Query: 16  GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPA 74
           G+      E+ +  +LKHP+++ L++       ++LV E     ++  +L+    P    
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN 112
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
            A+ +++Q++  + Y HS  I+HRDL   N+L+ ++  +K+ADFGL+    +P  ++   
Sbjct: 113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             T  Y  PEI   +  +    D+WS GC+F
Sbjct: 173 CGTPNYISPEIATRS-AHGLESDVWSLGCMF 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 60/109 (55%), Gaps = 1/109 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +++Q++  + Y HS  I+HRDL   N+L+ ++  +K+ADFGL+    +P  ++     T 
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            Y  PEI   +  +    D+WS GC+F  ++  +  F  D+  + L ++
Sbjct: 177 NYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPV 71
            E      + E+++L+ELKHPN++R +D I    +  L++V E+        + T     
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 72  PPALAKSY----LYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSR 122
              L + +    + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY---------Q 173
                 +     V T +Y  PE  +    Y+   DIWS GC+  E+  L          +
Sbjct: 165 ILNHDEDFAKEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 209
           L   +R    RRI +R     N +I +   L L D+
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITR--MLNLKDY 257

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +     V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           T +Y  PE  +    Y+   DIWS GC+  E+
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKD--FLQ 65
           +S V         L E++VLK+L HPN+++L++        +LV E  R  +L D   L+
Sbjct: 56  KSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR 115
Query: 66  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSR 122
                V  A+    + Q+L    Y H   I+HRDLKP+N+L+   ++   +K+ DFGLS 
Sbjct: 116 QKFSEVDAAVI---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA 172
Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            F +   +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 173 HFEVG-GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVIL 212

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 43/210 (20%)
Query: 152 YSTTVDIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI- 198
           Y   ++++  G +F E+              + Q+L    Y H   I+HRDLKP+N+L+ 
Sbjct: 96  YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 155
Query: 199 --NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
             ++   +K+ DFGLS  F +   +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 156 SKSRDALIKIVDFGLSAHFEVG-GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVIL 212
Query: 257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN 316
             ++     F G ++ + L R+ +                  +  D P+W          
Sbjct: 213 YILLCGYPPFGGQTDQEILKRVEKGK----------------FSFDPPDWT--------Q 248
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           + D  A  +   ++  +P +R+SA+  L H
Sbjct: 249 VSDE-AKQLVKLMLTYEPSKRISAEEALNH 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE  + + LKHPN++RLHD I  +   +L+F+ +      +D +         A A   +
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCI 116
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+LEA+ +CH   ++HR+LKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 177 PGYLSPEVLR-KDPYGKPVDLWACGVIL 203

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 29/192 (15%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Q+LEA+ +CH   ++HR+LKP+N+L+    K  A+KLADFGL+         +     
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L     Y   VD+W+ G I   ++     F  + +     R+++ +     
Sbjct: 176 TPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----HRLYQQI----- 225
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                  K   Y    PEW         +   P A D+ +K++ ++P +R++A   L+H 
Sbjct: 226 -------KAGAYDFPSPEW---------DTVTPEAKDLINKMLTINPSKRITAAEALKHP 269
Query: 348 YFNQVEMVKPTL 359
           + +    V   +
Sbjct: 270 WISHRSTVASCM 281

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 80
           RE  + + LKHPN++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 136
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 137
           +Q+LE++ + H   I+HRDLKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGT 196
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
             Y  PE+L     Y   VDIW+ G I 
Sbjct: 197 PGYLSPEVLR-KDPYGKPVDIWACGVIL 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 29/192 (15%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++Q+LE++ + H   I+HRDLKP+N+L+    K  A+KLADFGL+         +     
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAG 195
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L     Y   VDIW+ G I   ++     F  D +  +L+          +
Sbjct: 196 TPGYLSPEVLR-KDPYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLY----------Q 243
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
            +  G    P      PEW         +   P A ++ ++++ ++P +R++A   L+H 
Sbjct: 244 QIKAGAYDFPS-----PEW---------DTVTPEAKNLINQMLTINPAKRITADQALKHP 289
Query: 348 YFNQVEMVKPTL 359
           +  Q   V   +
Sbjct: 290 WVCQRSTVASMM 301

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 125
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+    P +  +    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACG 180
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+ L  K YS  VD WS G I   ++     F  +++     +I +       
Sbjct: 181 TPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----- 234
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                      Y+ D P W         ++ D  A D    +M  DP++R + +  LQH
Sbjct: 235 -----------YEFDSPYWD--------DISDS-AKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 125
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+    P +  +    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACG 180
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+ L  K YS  VD WS G I   ++     F  +++     +I +       
Sbjct: 181 TPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----- 234
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                      Y+ D P W         ++ D  A D    +M  DP++R + +  LQH
Sbjct: 235 -----------YEFDSPYWD--------DISDS-AKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 125
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+    P +  +    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACG 180
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+ L  K YS  VD WS G I   ++     F  +++     +I +       
Sbjct: 181 TPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----- 234
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                      Y+ D P W         ++ D  A D    +M  DP++R + +  LQH
Sbjct: 235 -----------YEFDSPYWD--------DISDS-AKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 125
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+    P +  +    
Sbjct: 122 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACG 180
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+ L  K YS  VD WS G I   ++     F  +++     +I +       
Sbjct: 181 TPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----- 234
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                      Y+ D P W         ++ D  A D    +M  DP++R + +  LQH
Sbjct: 235 -----------YEFDSPYWD--------DISDS-AKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPV 71
            E      + E+++L+ELKHPN++R +D I    +  L++V E+        + T     
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 72  PPALAKSY----LYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSR 122
              L + +    + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY---------Q 173
                 +     V T +Y  PE  +    Y+   DIWS GC+  E+  L          +
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 209
           L   +R    RRI +R     N +I +   L L D+
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITR--MLNLKDY 257

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +     V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           T +Y  PE  +    Y+   DIWS GC+  E+
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 8/162 (4%)
Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQT 66
            + +V+ +    + LRE+ +LK+L HPN+++L++        +LV E +   +L D +  
Sbjct: 66  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-I 124
Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRA 123
           +        A   + Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  
Sbjct: 125 SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 184
Query: 124 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           F     +   ++ T +Y  PE+L G   Y    D+WS G I 
Sbjct: 185 FEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 223

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 43/207 (20%)
Query: 157 DIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKS 201
           ++++ G +F E+              + Q+L  + Y H  +I+HRDLKP+N+L+   +K 
Sbjct: 112 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD 171
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +++ DFGLS  F     +   ++ T +Y  PE+L G   Y    D+WS G I   +++
Sbjct: 172 ANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 228
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
               F G +E D L ++ +                  Y  + P+W  KK SE        
Sbjct: 229 GCPPFNGANEYDILKKVEKGK----------------YTFELPQW--KKVSES------- 263
Query: 322 AVDVFSKIMALDPKQRVSAKTILQHEY 348
           A D+  K++   P  R+SA+  L HE+
Sbjct: 264 AKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPV 71
            E      + E+++L+ELKHPN++R +D I    +  L++V E+        + T     
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 72  PPALAKSY----LYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSR 122
              L + +    + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY---------Q 173
                 +     V T +Y  PE  +    Y+   DIWS GC+  E+  L          +
Sbjct: 165 ILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 209
           L   +R    RRI +R     N +I +   L L D+
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITR--MLNLKDY 257

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +     V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           T +Y  PE  +    Y+   DIWS GC+  E+
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL------QTTPVPVPPALA 76
           RE S+   LKHP+++ L +    D  L++VFEF+  D  D                 A+A
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEFM--DGADLCFEIVKRADAGFVYSEAVA 134
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 133
             Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++            
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            V T  +  PE+ +  + Y   VD+W  G I 
Sbjct: 195 RVGTPHFMAPEV-VKREPYGKPVDVWGCGVIL 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIH 188
           T+    + Y   E + GA +    V    AG ++SE     Y+ Q+LEALRYCH   IIH
Sbjct: 96  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 155
Query: 189 RDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
           RD+KP  +L+     S  +KL  FG++             V T  +  PE+ +  + Y  
Sbjct: 156 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGK 214
Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
            VD+W  G I   +++    F G  E     R+F       E +  G  K+         
Sbjct: 215 PVDVWGCGVILFILLSGCLPFYGTKE-----RLF-------EGIIKGKYKM--------- 253
Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             P+++S I       A D+  +++ LDP +R++    L H +  +
Sbjct: 254 -NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 80
           LRE+ +LK+L HPN+ +L++        +LV E +   +L D +  +        A   +
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII 132
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 133 RQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKXKDKIGT 191
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 192 AYYIAPEVLHG--TYDEKCDVWSTGVIL 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 43/207 (20%)
Query: 157 DIWSAGCIFSEM------------SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKS 201
           ++++ G +F E+              + Q+L  + Y H  +I+HRDLKP+N+L+   +K 
Sbjct: 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKD 165
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +++ DFGLS  F     +   ++ T +Y  PE+L G   Y    D+WS G I   +++
Sbjct: 166 ANIRIIDFGLSTHFE-ASKKXKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLS 222
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
               F G +E D L ++ +                  Y  + P+W  KK SE        
Sbjct: 223 GCPPFNGANEYDILKKVEK----------------GKYTFELPQW--KKVSES------- 257
Query: 322 AVDVFSKIMALDPKQRVSAKTILQHEY 348
           A D+  K +   P  R+SA+  L HE+
Sbjct: 258 AKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL------QTTPVPVPPALA 76
           RE S+   LKHP+++ L +    D  L++VFEF+  D  D                 A+A
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFM--DGADLCFEIVKRADAGFVYSEAVA 132
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 133
             Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++            
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            V T  +  PE+ +  + Y   VD+W  G I 
Sbjct: 193 RVGTPHFMAPEV-VKREPYGKPVDVWGCGVIL 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIH 188
           T+    + Y   E + GA +    V    AG ++SE     Y+ Q+LEALRYCH   IIH
Sbjct: 94  TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153
Query: 189 RDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST 245
           RD+KP  +L+     S  +KL  FG++             V T  +  PE+ +  + Y  
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGK 212
Query: 246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE 305
            VD+W  G I   +++    F G  E     R+F       E +  G  K+         
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTKE-----RLF-------EGIIKGKYKM--------- 251
Query: 306 WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             P+++S I       A D+  +++ LDP +R++    L H +  +
Sbjct: 252 -NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 10  SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 46  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 104
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 105 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 163
Query: 128 MNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCIF 165
             +      T  Y  PEI+  +       Y   VD+WS G I 
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 31/183 (16%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P  +      T  Y  
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLA 178
Query: 234 PEILLGAK-----VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           PEI+  +       Y   VD+WS G I   ++     F    ++  L  I          
Sbjct: 179 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------- 231
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                     Y+   PEW    +S+ +        D+ S+ + + P++R +A+  L H +
Sbjct: 232 ---------NYQFGSPEW--DDYSDTVK-------DLVSRFLVVQPQKRYTAEEALAHPF 273
Query: 349 FNQ 351
           F Q
Sbjct: 274 FQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 10  SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 117
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 176
Query: 128 MNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCIF 165
             +      T  Y  PEI+  +       Y   VD+WS G I 
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 31/183 (16%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P  +      T  Y  
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLA 191
Query: 234 PEILLGAK-----VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           PEI+  +       Y   VD+WS G I   ++     F    ++  L  I          
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------- 244
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                     Y+   PEW    +S+ +        D+ S+ + + P++R +A+  L H +
Sbjct: 245 ---------NYQFGSPEW--DDYSDTVK-------DLVSRFLVVQPQKRYTAEEALAHPF 286
Query: 349 FNQ 351
           F Q
Sbjct: 287 FQQ 289

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 15/169 (8%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-D 59
           ++S   R  SR ++E       RE+++L+E++HPN+I LHD+      + L+ E +   +
Sbjct: 49  RLSSSRRGVSREEIE-------REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGE 101
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKL 115
           L DFL      +    A  +L Q+L+ + Y HS+RI H DLKP+NI++         +KL
Sbjct: 102 LFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 160
Query: 116 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            DFG++       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 161 IDFGIAHKIE-AGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++       N + + 
Sbjct: 120 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNI 178
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI +  +      D+WS G I   +++  + F G+++ + L          
Sbjct: 179 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---------- 227
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   + +     DF E       E  +    LA D   +++  DPK+R+     L+
Sbjct: 228 --------TNISAVNYDFDE-------EYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272
Query: 346 H 346
           H
Sbjct: 273 H 273

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 15/169 (8%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-D 59
           ++S   R  SR ++E       RE+++L+E++HPN+I LHD+      + L+ E +   +
Sbjct: 42  RLSSSRRGVSREEIE-------REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGE 94
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKL 115
           L DFL      +    A  +L Q+L+ + Y HS+RI H DLKP+NI++         +KL
Sbjct: 95  LFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153
Query: 116 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            DFG++       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 154 IDFGIAHKIE-AGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 200

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++       N + + 
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNI 171
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI +  +      D+WS G I   +++  + F G+++ + L          
Sbjct: 172 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---------- 220
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   + +     DF E       E  +    LA D   +++  DPK+R++    L+
Sbjct: 221 --------TNISAVNYDFDE-------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 346 HEYFNQV 352
           H +   +
Sbjct: 266 HSWIKAI 272

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 10  SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 117
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 176
Query: 128 MNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCIF 165
             +      T  Y  PEI+  +       Y   VD+WS G I 
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 31/183 (16%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P  +      T  Y  
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLRSVCGTPSYLA 191
Query: 234 PEILLGAK-----VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           PEI+  +       Y   VD+WS G I   ++     F    ++  L  I          
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------- 244
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                     Y+   PEW    +S+ +        D+ S+ + + P++R +A+  L H +
Sbjct: 245 ---------NYQFGSPEW--DDYSDTVK-------DLVSRFLVVQPQKRYTAEEALAHPF 286
Query: 349 FNQ 351
           F Q
Sbjct: 287 FQQ 289

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 76  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 135
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 136 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           E+L   K +S  VDIWS GCI      LY LL
Sbjct: 196 EVLC-KKGHSFEVDIWSLGCI------LYTLL 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 1/109 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++ Q ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T 
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            Y  PE+L   K +S  VDIWS GCI   ++  K  F      +   RI
Sbjct: 191 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 238

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 11  RVQVEGVPSTALR-------EISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKD 62
           R+ ++ +P    R       EI++ K LKH N+++ L       F    + +     L  
Sbjct: 49  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108
Query: 63  FLQT--TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFG 119
            L++   P+         Y  Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 120 LSRAFTIPMNRYTHEVV-TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMS 169
            S+     +N  T     TL Y  PEI+  G + Y    DIWS GC   EM+
Sbjct: 169 TSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 45/100 (45%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV- 227
           Y  Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG S+     +N  T     
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTG 185
Query: 228 TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           TL Y  PEI+  G + Y    DIWS GC   EM T K  F
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           E+L   K +S  VDIWS GCI      LY LL
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCI------LYTLL 236

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 1/109 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++ Q ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            Y  PE+L   K +S  VDIWS GCI   ++  K  F      +   RI
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAK 77
           S  L E++VLK L HPN+++L+D        +LV E +   +L D +    +      A 
Sbjct: 81  SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAA 139
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 134
             + Q+L  + Y H   I+HRDLKP+N+L+    K   +K+ DFGLS  F     +    
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKER 198
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
           + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 199 LGTAYYIAPEVL--RKKYDEKCDVWSIGVIL 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 43/230 (18%)
Query: 152 YSTTVDIWSAGCIFSEMSY------------LYQLLEALRYCHSRRIIHRDLKPQNILIN 199
           Y   ++ +  G +F E+ +            + Q+L  + Y H   I+HRDLKP+N+L+ 
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170
Query: 200 ---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
              K   +K+ DFGLS  F     +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 171 SKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVIL 227
Query: 257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN 316
             ++     F G ++ + L ++ +                  Y  D PEW+        N
Sbjct: 228 FILLAGYPPFGGQTDQEILRKVEK----------------GKYTFDSPEWK--------N 263
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELG 366
           + +  A D+  +++  D ++R+SA+  L+H +  ++   K +    P L 
Sbjct: 264 VSEG-AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLA 312

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           E+L   K +S  VDIWS GCI      LY LL
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCI------LYTLL 236

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 1/109 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++ Q ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            Y  PE+L   K +S  VDIWS GCI   ++  K  F      +   RI
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           E+L   K +S  VDIWS GCI      LY LL
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCI------LYTLL 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 1/109 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++ Q ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            Y  PE+L   K +S  VDIWS GCI   ++  K  F      +   RI
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 90/184 (48%), Gaps = 31/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +   +      T 
Sbjct: 124 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEILLG K Y+ +VD WS G +  EM+  ++ F G  E ++LF   R         
Sbjct: 184 DYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDN------ 235
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK-TILQHEY 348
                  P Y    P W  K+           A D+  K+   +P++R+  +  I QH  
Sbjct: 236 -------PFY----PRWLEKE-----------AKDLLVKLFVREPEKRLGVRGDIRQHPL 273
Query: 349 FNQV 352
           F ++
Sbjct: 274 FREI 277

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 23  REISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKDFLQT--TPVPVPPALAKSY 79
            EI++ K LKH N+++ L       F    + +     L   L++   P+         Y
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV-T 137
             Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG S+     +N  T     T
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGT 172
Query: 138 LWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMS 169
           L Y  PEI+  G + Y    DIWS GC   EM+
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/100 (45%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV- 227
           Y  Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG S+     +N  T     
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTG 171
Query: 228 TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           TL Y  PEI+  G + Y    DIWS GC   EM T K  F
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 82/147 (55%), Gaps = 5/147 (3%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPV-PPALAKSYLYQ 82
           E ++L+E+KHP ++ L        KL+L+ E+L    + F+Q     +     A  YL +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAE 129
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 141
           +  AL + H + II+RDLKP+NI++N  G +KL DFGL +  +I     TH    T+ Y 
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHXFCGTIEYM 188
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PEIL+ +  ++  VD WS G +  +M
Sbjct: 189 APEILMRSG-HNRAVDWWSLGALMYDM 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 77/146 (52%), Gaps = 16/146 (10%)
Query: 148 GAKVYSTTVDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQN 195
           G K+Y   ++  S G +F ++             YL ++  AL + H + II+RDLKP+N
Sbjct: 93  GGKLY-LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 196 ILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGC 254
           I++N  G +KL DFGL +  +I     TH    T+ Y  PEIL+ +  ++  VD WS G 
Sbjct: 152 IMLNHQGHVKLTDFGLCKE-SIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGA 209
Query: 255 IFSEMITKKTLFAGDSEIDQLFRIFR 280
           +  +M+T    F G++    + +I +
Sbjct: 210 LMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 90/184 (48%), Gaps = 31/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +   +      T 
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTP 182
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEILLG K Y+ +VD WS G +  EM+  ++ F G  E ++LF   R         
Sbjct: 183 DYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDN------ 234
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK-TILQHEY 348
                  P Y    P W  K+           A D+  K+   +P++R+  +  I QH  
Sbjct: 235 -------PFY----PRWLEKE-----------AKDLLVKLFVREPEKRLGVRGDIRQHPL 272
Query: 349 FNQV 352
           F ++
Sbjct: 273 FREI 276

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 82/147 (55%), Gaps = 5/147 (3%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPV-PPALAKSYLYQ 82
           E ++L+E+KHP ++ L        KL+L+ E+L    + F+Q     +     A  YL +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAE 129
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 141
           +  AL + H + II+RDLKP+NI++N  G +KL DFGL +  +I     TH    T+ Y 
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYM 188
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PEIL+ +  ++  VD WS G +  +M
Sbjct: 189 APEILMRSG-HNRAVDWWSLGALMYDM 214

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 77/146 (52%), Gaps = 16/146 (10%)
Query: 148 GAKVYSTTVDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQN 195
           G K+Y   ++  S G +F ++             YL ++  AL + H + II+RDLKP+N
Sbjct: 93  GGKLY-LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 196 ILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGC 254
           I++N  G +KL DFGL +  +I     TH    T+ Y  PEIL+ +  ++  VD WS G 
Sbjct: 152 IMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGA 209
Query: 255 IFSEMITKKTLFAGDSEIDQLFRIFR 280
           +  +M+T    F G++    + +I +
Sbjct: 210 LMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 7   RPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ 65
           R  SR ++E       RE+++L+E++HPN+I LHD+      + L+ E +   +L DFL 
Sbjct: 69  RGVSREEIE-------REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 121
Query: 66  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLS 121
                +    A  +L Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++
Sbjct: 122 EKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180
Query: 122 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
                  N + +   T  +  PEI +  +      D+WS G I
Sbjct: 181 HKIE-AGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 31/187 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++       N + + 
Sbjct: 134 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNI 192
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI +  +      D+WS G I   +++  + F G+++ + L          
Sbjct: 193 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---------- 241
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                   + +     DF E       E  +    LA D   +++  DPK+R+     L+
Sbjct: 242 --------TNISAVNYDFDE-------EYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286
Query: 346 HEYFNQV 352
           H +   +
Sbjct: 287 HSWIKAI 293

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD--FLQTTPVPVPPALAKSYLY 81
           EI +L    HP +++L      D KL+++ EF      D   L+       P + +    
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVVCR 124
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++ 
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 142 PPEILLGAKV----YSTTVDIWSAGCIFSEMSYL 171
            PE+++   +    Y    DIWS G    EM+ +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 36/187 (19%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++ 
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 233 PPEILLGAKV----YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            PE+++   +    Y    DIWS G    EM                      +  PH +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMA--------------------QIEPPHHE 224
Query: 289 VWPGVSKLPIYKTDFPE-WRPKKFSEILNLPDPLAVDVFSKIMALD--PKQRVSAKTILQ 345
           + P    L I K+D P    P K+S  +   D      F KI ALD  P+ R SA  +L+
Sbjct: 225 LNPMRVLLKIAKSDPPTLLTPSKWS--VEFRD------FLKI-ALDKNPETRPSAAQLLE 275
Query: 346 HEYFNQV 352
           H + + +
Sbjct: 276 HPFVSSI 282

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD--FLQTTPVPVPPALAKSYLY 81
           EI +L    HP +++L      D KL+++ EF      D   L+       P + +    
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVVCR 116
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++ 
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 176
Query: 142 PPEILLGAKV----YSTTVDIWSAGCIFSEMSYL 171
            PE+++   +    Y    DIWS G    EM+ +
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 210

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 36/187 (19%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++ 
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 176
Query: 233 PPEILLGAKV----YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            PE+++   +    Y    DIWS G    EM                      +  PH +
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEM--------------------AQIEPPHHE 216
Query: 289 VWPGVSKLPIYKTDFPE-WRPKKFSEILNLPDPLAVDVFSKIMALD--PKQRVSAKTILQ 345
           + P    L I K+D P    P K+S  +   D      F KI ALD  P+ R SA  +L+
Sbjct: 217 LNPMRVLLKIAKSDPPTLLTPSKWS--VEFRD------FLKI-ALDKNPETRPSAAQLLE 267
Query: 346 HEYFNQV 352
           H + + +
Sbjct: 268 HPFVSSI 274

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK 200
           E   G ++    V   + G   SE      + Q++ AL Y HS+ ++H+DLKP+NIL   
Sbjct: 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159
Query: 201 SGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS 257
           +     +K+ DFGL+  F       T+   T  Y  PE+    +  +   DIWSAG +  
Sbjct: 160 TSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMY 216
Query: 258 EMITKKTLFAGDS--EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL 315
            ++T    F G S  E+ Q                    K P Y     E RP       
Sbjct: 217 FLLTGCLPFTGTSLEEVQQ----------------KATYKEPNYAV---ECRPLT----- 252
Query: 316 NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
               P AVD+  +++  DP++R SA  +L HE+F Q 
Sbjct: 253 ----PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 126
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 186
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y +  DIWS G    E++
Sbjct: 187 APEV-IKQSAYDSKADIWSLGITAIELA 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           +  PE+ +    Y +  DIWS G    E+
Sbjct: 185 WMAPEV-IKQSAYDSKADIWSLGITAIEL 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 111
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 171
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y +  DIWS G    E++
Sbjct: 172 APEV-IKQSAYDSKADIWSLGITAIELA 198

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 110 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF 169
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           +  PE+ +    Y +  DIWS G    E+
Sbjct: 170 WMAPEV-IKQSAYDSKADIWSLGITAIEL 197

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 23  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 137 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  Y  PE   G  V + + D++S GC+  E+
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEV 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYR 232
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T       T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
            PE   G  V + + D++S GC+  E++T +  F GDS
Sbjct: 187 SPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 23  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 137 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  Y  PE   G  V + + D++S GC+  E+
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEV 212

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYR 232
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T       T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            PE   G  V + + D++S GC+  E++T +  F GDS +   ++  R
Sbjct: 187 SPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 131
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y +  DIWS G    E++
Sbjct: 192 APEV-IKQSAYDSKADIWSLGITAIELA 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 130 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 189
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           +  PE+ +    Y +  DIWS G    E+
Sbjct: 190 WMAPEV-IKQSAYDSKADIWSLGITAIEL 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 23  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 137 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  Y  PE   G  V + + D++S GC+  E+
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEV 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYR 232
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T       T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            PE   G  V + + D++S GC+  E++T +  F GDS +   ++  R
Sbjct: 187 SPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 4/148 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 111
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 171
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y +  DIWS G    E++
Sbjct: 172 APEV-IKQSAYDSKADIWSLGITAIELA 198

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 110 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 169
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           +  PE+ +    Y +  DIWS G    E+
Sbjct: 170 WMAPEV-IKQSAYDSKADIWSLGITAIEL 197

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 23  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 78  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 136
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 137 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  Y  PE   G  V + + D++S GC+  E+
Sbjct: 197 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEV 229

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYR 232
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T       T  Y 
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            PE   G  V + + D++S GC+  E++T +  F GDS +   ++  R
Sbjct: 204 SPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 250

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 1/137 (0%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 197
Query: 152 YSTTVDIWSAGCIFSEM 168
           Y  +VD W+ G +  EM
Sbjct: 198 YGFSVDWWALGVLMFEM 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 1/97 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 126 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP 185
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PEIL G   Y  +VD W+ G +  EM+  ++ F
Sbjct: 186 NYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 1/137 (0%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED- 229
Query: 152 YSTTVDIWSAGCIFSEM 168
           Y  +VD W+ G +  EM
Sbjct: 230 YGFSVDWWALGVLMFEM 246

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 1/97 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 217
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PEIL G   Y  +VD W+ G +  EM+  ++ F
Sbjct: 218 NYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 1/137 (0%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 182
Query: 152 YSTTVDIWSAGCIFSEM 168
           Y  +VD W+ G +  EM
Sbjct: 183 YGFSVDWWALGVLMFEM 199

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 1/97 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 111 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP 170
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PEIL G   Y  +VD W+ G +  EM+  ++ F
Sbjct: 171 NYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 1/137 (0%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 186
Query: 152 YSTTVDIWSAGCIFSEM 168
           Y  +VD W+ G +  EM
Sbjct: 187 YGFSVDWWALGVLMFEM 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 1/97 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T 
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP 174
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PEIL G   Y  +VD W+ G +  EM+  ++ F
Sbjct: 175 NYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 23  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
             +    +AL + H   IIHRD+KP NILI+ + A+K+ DFG++RA     N        
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 137 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  Y  PE   G  V + + D++S GC+  E+
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEV 212

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYR 232
           +AL + H   IIHRD+KP NILI+ + A+K+ DFG++RA     N          T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            PE   G  V + + D++S GC+  E++T +  F GDS +   ++  R
Sbjct: 187 SPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 81/180 (45%), Gaps = 28/180 (15%)
Query: 19  STALREISVLKELKHPNVIRLH-------------DVIPVDFKLFLVFEFLRQD-LKDFL 64
           ST L E+ +L  L H  V+R +               +     LF+  E+     L D +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--- 121
            +  +            Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL+   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 122 -RAFTI----------PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            R+  I            +  T  + T  Y   E+L G   Y+  +D++S G IF EM Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/102 (41%), Positives = 57/102 (55%), Gaps = 14/102 (13%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----RAFTI----------P 218
           Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL+    R+  I           
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            +  T  + T  Y   E+L G   Y+  +D++S G IF EMI
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +   L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG-SFDETCTRFYTA 139
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K  S + D+W+ GCI      +YQL+  L
Sbjct: 200 YVSPE-LLTEKSASKSSDLWALGCI------IYQLVAGL 231

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K  S + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 197 TAQYVSPE-LLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 244
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 245 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 282

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 82/180 (45%), Gaps = 28/180 (15%)
Query: 19  STALREISVLKELKHPNVIRLH-------------DVIPVDFKLFLVFEFL-RQDLKDFL 64
           ST L E+ +L  L H  V+R +               +     LF+  E+   + L D +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--- 121
            +  +            Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL+   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 122 -RAFTI----------PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            R+  I            +  T  + T  Y   E+L G   Y+  +D++S G IF EM Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/102 (41%), Positives = 57/102 (55%), Gaps = 14/102 (13%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----RAFTI----------P 218
           Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL+    R+  I           
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            +  T  + T  Y   E+L G   Y+  +D++S G IF EMI
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYR 232
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T       T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            PE   G  V + + D++S GC+  E++T +  F GDS +   ++  R
Sbjct: 187 SPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 1/142 (0%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 144 EILLGAKVYSTTVDIWSAGCIF 165
           E+ L  K +S  VD+WS GCI 
Sbjct: 187 EV-LSKKGHSFEVDVWSIGCIM 207

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T 
Sbjct: 122 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+ L  K +S  VD+WS GCI   ++  K  F      +   RI +         
Sbjct: 182 NYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 232
Query: 290 WPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                          E+  PK         +P+A  +  K++  DP  R +   +L  E+
Sbjct: 233 ---------------EYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 349 F 349
           F
Sbjct: 271 F 271

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 8/185 (4%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E + +   REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 132
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+ DFG S++ ++  ++  
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 174
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHR 189
             V T  Y  PE+LL  +      D+WS G     M   +Y ++  E  +  + R+ IHR
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK--NFRKTIHR 232
Query: 190 DLKPQ 194
            L  Q
Sbjct: 233 ILNVQ 237

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 30/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVV 227
           +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+ DFG S++ ++  ++    V 
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR--IFRTLGTP 285
           T  Y  PE+LL  +      D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILNVQ 237
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +         +P Y    PE R                 + S+I   DP +R+S   I  
Sbjct: 238 Y--------AIPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRN 273
Query: 346 HEYF 349
           HE+F
Sbjct: 274 HEWF 277

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 1/142 (0%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 144 EILLGAKVYSTTVDIWSAGCIF 165
           E+ L  K +S  VD+WS GCI 
Sbjct: 187 EV-LSKKGHSFEVDVWSIGCIM 207

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T 
Sbjct: 122 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+ L  K +S  VD+WS GCI   ++  K  F      +   RI +         
Sbjct: 182 NYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 232
Query: 290 WPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                          E+  PK         +P+A  +  K++  DP  R +   +L  E+
Sbjct: 233 ---------------EYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 349 F 349
           F
Sbjct: 271 F 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 11  RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 69
           +V VE      ++EIS++++   P+V++ +     +  L++V E+     + D ++    
Sbjct: 61  QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
            +      + L   L+ L Y H  R IHRD+K  NIL+N  G  KLADFG++   T  M 
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA 180
Query: 130 RYTHEVVTLWYRPPEIL--LGAKVYSTTVDIWSAGCIFSEMS 169
           +    + T ++  PE++  +G   Y+   DIWS G    EM+
Sbjct: 181 KRNXVIGTPFWMAPEVIQEIG---YNCVADIWSLGITAIEMA 219

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 148 GAKVYSTTVDIWSAGCIFSEMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           GA   S  + + +      E++ + Q  L+ L Y H  R IHRD+K  NIL+N  G  KL
Sbjct: 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKL 166
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIWSAGCIFSEMITKKT 264
           ADFG++   T  M +    + T ++  PE++  +G   Y+   DIWS G    EM   K 
Sbjct: 167 ADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIG---YNCVADIWSLGITAIEMAEGKP 223
Query: 265 LFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD 324
            +A   +I  +  IF     P     P   K  ++  +F                    D
Sbjct: 224 PYA---DIHPMRAIFMIPTNPP----PTFRKPELWSDNF-------------------TD 257
Query: 325 VFSKIMALDPKQRVSAKTILQHEYFNQVEMV 355
              + +   P+QR +A  +LQH +    + V
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 1/142 (0%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 131 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190
Query: 144 EILLGAKVYSTTVDIWSAGCIF 165
           E+ L  K +S  VD+WS GCI 
Sbjct: 191 EV-LSKKGHSFEVDVWSIGCIM 211

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T 
Sbjct: 126 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+ L  K +S  VD+WS GCI   ++  K  F      +   RI +         
Sbjct: 186 NYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 236
Query: 290 WPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                          E+  PK         +P+A  +  K++  DP  R +   +L  E+
Sbjct: 237 ---------------EYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELLNDEF 274
Query: 349 F 349
           F
Sbjct: 275 F 275

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 229

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 195 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 242
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 243 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 280

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 140
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 201 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 198 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 245
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 246 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 1/142 (0%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 144 EILLGAKVYSTTVDIWSAGCIF 165
           E+ L  K +S  VD+WS GCI 
Sbjct: 185 EV-LSKKGHSFEVDVWSIGCIM 205

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 32/183 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T 
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+ L  K +S  VD+WS GCI   ++  K  F      +   RI +         
Sbjct: 180 NYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 230
Query: 290 WPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                          E+  PK         +P+A  +  K++  DP  R +   +L  E+
Sbjct: 231 ---------------EYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 349 FNQ 351
           F  
Sbjct: 269 FTS 271

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 140
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 201 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 198 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 245
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 246 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 283

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 195 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 242
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 243 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 280

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 195 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 242
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 243 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 280

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 34/177 (19%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF-AGDSEIDQLFRIFRTLGTPH 286
           T  Y  PE LL  K    + D+W+ GCI  +++     F AG+  +              
Sbjct: 197 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------------- 241
Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
             ++  + KL   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 242 --IFAKIIKL---EYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 282

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 197 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 244
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 245 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 282

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 200 YVSPE-LLTEKSAXKSSDLWALGCI------IYQLVAGL 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 34/177 (19%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF-AGDSEIDQLFRIFRTLGTPH 286
           T  Y  PE LL  K    + D+W+ GCI  +++     F AG+  +              
Sbjct: 197 TAQYVSPE-LLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------------- 241
Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
             ++  + KL   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 242 --IFAKIIKL---EYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 282

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 76/146 (52%), Gaps = 5/146 (3%)
Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 85
           +LK +KHP ++ LH       KL+ V +++   +L   LQ     + P  A+ Y  ++  
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS 150
Query: 86  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPE 144
           AL Y HS  I++RDLKP+NIL++  G + L DFGL +   I  N  T     T  Y  PE
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPE 209
Query: 145 ILLGAKVYSTTVDIWSAGCIFSEMSY 170
           + L  + Y  TVD W  G +  EM Y
Sbjct: 210 V-LHKQPYDRTVDWWCLGAVLYEMLY 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  ++  AL Y HS  I++RDLKP+NIL++  G + L DFGL +   I  N  T     T
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGT 202
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
             Y  PE+ L  + Y  TVD W  G +  EM+
Sbjct: 203 PEYLAPEV-LHKQPYDRTVDWWCLGAVLYEML 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 46  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 104
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 159
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 108 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 162
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 208
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 209 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 255
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 256 DIKKDRWYNK 265

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 197 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 244
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 245 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 282

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 229

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 195 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 242
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 243 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 280

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 142
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 143 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 203 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 140 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E
Sbjct: 200 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 75
           +EI ++K L HPN+IRL++    +  ++LV E       F R   K   + +        
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD------- 107
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   +  +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P     
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMR 166
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            +V T +Y  P++L G  +Y    D WSAG + 
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMM 197

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 112/269 (41%), Gaps = 50/269 (18%)
Query: 105 ILINKSGALKLADFGLSRAFTIPMNRYTHEV-VTLWYRPPEILLGAKVYSTTVDIW---- 159
           I + K   ++ A   + + F   ++R+  E+ +      P I+   + +    DI+    
Sbjct: 27  IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86
Query: 160 --SAGCIFSEMSY------------LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSG 202
             + G +F  + +            +  +L A+ YCH   + HRDLKP+N L    +   
Sbjct: 87  LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS 146
Query: 203 ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            LKL DFGL+  F  P      +V T +Y  P++L G  +Y    D WSAG +   ++  
Sbjct: 147 PLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCG 203
Query: 263 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA 322
              F+  ++ + + +I     T  E  W  VS                         P A
Sbjct: 204 YPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS-------------------------PQA 238
Query: 323 VDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             +  +++   PKQR+++   L+HE+F +
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 86  RERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 144
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 145 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 205 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 236

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 142 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 202 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 249
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 250 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 287

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 197 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 244
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 245 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 282

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 75
           +EI ++K L HPN+IRL++    +  ++LV E       F R   K   + +        
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD------- 124
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   +  +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P     
Sbjct: 125 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMR 183
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 165
            +V T +Y  P++L G  +Y    D WSAG + 
Sbjct: 184 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMM 214

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 112/269 (41%), Gaps = 50/269 (18%)
Query: 105 ILINKSGALKLADFGLSRAFTIPMNRYTHEV-VTLWYRPPEILLGAKVYSTTVDIW---- 159
           I + K   ++ A   + + F   ++R+  E+ +      P I+   + +    DI+    
Sbjct: 44  IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 103
Query: 160 --SAGCIFSEMSY------------LYQLLEALRYCHSRRIIHRDLKPQNILI---NKSG 202
             + G +F  + +            +  +L A+ YCH   + HRDLKP+N L    +   
Sbjct: 104 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS 163
Query: 203 ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
            LKL DFGL+  F  P      +V T +Y  P++L G  +Y    D WSAG +   ++  
Sbjct: 164 PLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCG 220
Query: 263 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA 322
              F+  ++ + + +I     T  E  W  VS                         P A
Sbjct: 221 YPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS-------------------------PQA 255
Query: 323 VDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             +  +++   PKQR+++   L+HE+F +
Sbjct: 256 ESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 136
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 197 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 194 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 241
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 242 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 279

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 121
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 122 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 182 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 213

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 119 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 179 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 226
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 227 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 264

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 1/142 (0%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 149 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208
Query: 144 EILLGAKVYSTTVDIWSAGCIF 165
           E+ L  K +S  VD+WS GCI 
Sbjct: 209 EV-LSKKGHSFEVDVWSIGCIM 229

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T 
Sbjct: 144 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+ L  K +S  VD+WS GCI   ++  K  F      +   RI +         
Sbjct: 204 NYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 254
Query: 290 WPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                          E+  PK         +P+A  +  K++  DP  R +   +L  E+
Sbjct: 255 ---------------EYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELLNDEF 292
Query: 349 F 349
           F
Sbjct: 293 F 293

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D         L+ E +   QDL DF+ T    +   LA+S+
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI-TERGALQEELARSF 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 207

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 1/142 (0%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 143
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 144 EILLGAKVYSTTVDIWSAGCIF 165
           E+ L  K +S  VD+WS GCI 
Sbjct: 211 EV-LSKKGHSFEVDVWSIGCIM 231

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 32/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T 
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+ L  K +S  VD+WS GCI   ++  K  F      +   RI +         
Sbjct: 206 NYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 256
Query: 290 WPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                          E+  PK         +P+A  +  K++  DP  R +   +L  E+
Sbjct: 257 ---------------EYSIPKHI-------NPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 349 F 349
           F
Sbjct: 295 F 295

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 4/148 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 81
           +EI+VL +   P + R         KL+++ E+L      D L+  P P+      + L 
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR 123
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS R IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 124 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE+ +    Y    DIWS G    E++
Sbjct: 184 APEV-IKQSAYDFKADIWSLGITAIELA 210

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 1/89 (1%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS R IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 122 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF 181
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           +  PE+ +    Y    DIWS G    E+
Sbjct: 182 WMAPEV-IKQSAYDFKADIWSLGITAIEL 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 136
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 197 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 194 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 241
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 242 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 279

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 15/155 (9%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 77
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  +  
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-- 287
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----H 133
            +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT     
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGA 345
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    W  P  I  G+  ++   D+WS G +  E+
Sbjct: 346 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 378

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT     +   
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPI 349
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G+  ++   D+WS G +  E++T
Sbjct: 350 KWTAPEAINFGS--FTIKSDVWSFGILLMEIVT 380

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 134
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 135 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 114
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 115 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 175 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 112 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 172 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 219
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 220 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 257

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 115
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 176 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 173 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 220
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 221 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 258

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 116
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 117 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 177 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 114 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 174 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 221
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 222 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 259

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 15/155 (9%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 77
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  +  
Sbjct: 58  LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-- 114
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----H 133
            +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT     
Sbjct: 115 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGA 172
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    W  P  I  G+  ++   D+WS G +  E+
Sbjct: 173 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---- 223
           + +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT    
Sbjct: 114 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREG 171
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +    W  P  I  G+  ++   D+WS G +  E++T
Sbjct: 172 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVT 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 117
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 139
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 118 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           Y  PE LL  K    + D+W+ GCI      +YQL+  L
Sbjct: 178 YVSPE-LLTEKSACKSSDLWALGCI------IYQLVAGL 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 115 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE LL  K    + D+W+ GCI  +++     F   +E    + IF+       
Sbjct: 175 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ------- 222
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                  K+   + DFPE    KF        P A D+  K++ LD  +R+  + +
Sbjct: 223 -------KIIKLEYDFPE----KFF-------PKARDLVEKLLVLDATKRLGCEEM 260

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 134
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 135 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++              
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 222
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ++    VS +        E+  + FS        LA D   +++  DPK+R++ +  LQ
Sbjct: 223 -QETLANVSAVNY------EFEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++              
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 222
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ++    VS +        E+  + FS        LA D   +++  DPK+R++ +  LQ
Sbjct: 223 -QETLANVSAVNY------EFEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 105 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 164 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 205

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 176
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 177 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 234
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 235 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 346 H 346
           H
Sbjct: 271 H 271

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++              
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------------- 222
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ++    VS +        E+  + FS        LA D   +++  DPK+R++ +  LQ
Sbjct: 223 -QETLANVSAVNY------EFEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 134
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 135 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
                   P  S       ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --------PSDS-----XQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 105 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 164 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 176
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 177 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 234
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 235 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 346 H 346
           H
Sbjct: 271 H 271

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPAFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPAFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 134
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 135 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 134
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 135 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 209
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 210 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 257 DIKKDRWYNK 266

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 40/208 (19%)
Query: 4   DESRPRSRVQVE-----GVPSTALR-EISVLKELKHPN------VIRLHDVIPVDFKLFL 51
           D +R +S+V ++     G    A R EI+VLK++K  +       + + D       + +
Sbjct: 49  DHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 108
Query: 52  VFEFLRQDLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-I 107
            FE L ++  +FL+     P P+P    +   YQL  ALR+ H  ++ H DLKP+NIL +
Sbjct: 109 AFELLGKNTFEFLKENNFQPYPLPHV--RHMAYQLCHALRFLHENQLTHTDLKPENILFV 166
Query: 108 N------------------KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 149
           N                  K+ ++++ADFG   + T     +T  V T  YRPPE++L  
Sbjct: 167 NSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILEL 223
Query: 150 KVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
             ++   D+WS GCI  E    + L + 
Sbjct: 224 G-WAQPCDVWSIGCILFEYYRGFTLFQT 250

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKLADFGLS 212
           YQL  ALR+ H  ++ H DLKP+NIL +N                  K+ ++++ADFG  
Sbjct: 139 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-- 196
Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            + T     +T  V T  YRPPE++L    ++   D+WS GCI  E     TLF      
Sbjct: 197 -SATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENR 254
Query: 273 DQLFRIFRTLG-TPHEDVWPGVSKLPIYKTDF-------------PEWRP-KKFSEILNL 317
           + L  + + LG  P   +     +   YK                   +P K +    +L
Sbjct: 255 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 314
Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
                 D+  +++  DP QR++    L H +F
Sbjct: 315 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 49  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 107
Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 134
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 162
Query: 135 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 163 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 44  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 101
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 102 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 161
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 162 NCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 220
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 221 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 258

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 200 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 229

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 20  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKS 78
           T   EIS++ +L HP +I LHD     +++ L+ EFL   +L D +      +  A   +
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVV 136
           Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTA 212
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           T  +  PEI+    V   T D+W+ G +
Sbjct: 213 TAEFAAPEIVDREPVGFYT-DMWAIGVL 239

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHE 225
           ++Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P       
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVT 210
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+    V   T D+W+ G +   +++  + FAG+ +++ L  + R     
Sbjct: 211 TATAEFAAPEIVDREPVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED +  VS                         P A D    ++  +P++R++    L+
Sbjct: 270 DEDAFSSVS-------------------------PEAKDFIKNLLQKEPRKRLTVHDALE 304
Query: 346 H 346
           H
Sbjct: 305 H 305

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 8/185 (4%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 55  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 114
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 132
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+ DFG S++ ++  ++  
Sbjct: 115 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 173
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHR 189
             V T  Y  PE+LL  +      D+WS G     M   +Y ++  E  +  + R+ IHR
Sbjct: 174 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK--NFRKTIHR 231
Query: 190 DLKPQ 194
            L  Q
Sbjct: 232 ILNVQ 236

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 30/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVV 227
           +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+ DFG S++ ++  ++    V 
Sbjct: 119 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 177
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR--IFRTLGTP 285
           T  Y  PE+LL  +      D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 178 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILNVQ 236
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +         +P Y    PE R                 + S+I   DP +R+S   I  
Sbjct: 237 Y--------AIPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRN 272
Query: 346 HEYF 349
           HE+F
Sbjct: 273 HEWF 276

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 40/208 (19%)
Query: 4   DESRPRSRVQVE-----GVPSTALR-EISVLKELKHPN------VIRLHDVIPVDFKLFL 51
           D +R +S+V ++     G    A R EI+VLK++K  +       + + D       + +
Sbjct: 72  DHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 131
Query: 52  VFEFLRQDLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-I 107
            FE L ++  +FL+     P P+P    +   YQL  ALR+ H  ++ H DLKP+NIL +
Sbjct: 132 AFELLGKNTFEFLKENNFQPYPLPHV--RHMAYQLCHALRFLHENQLTHTDLKPENILFV 189
Query: 108 N------------------KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 149
           N                  K+ ++++ADFG   + T     +T  V T  YRPPE++L  
Sbjct: 190 NSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILEL 246
Query: 150 KVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
             ++   D+WS GCI  E    + L + 
Sbjct: 247 G-WAQPCDVWSIGCILFEYYRGFTLFQT 273

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKLADFGLS 212
           YQL  ALR+ H  ++ H DLKP+NIL +N                  K+ ++++ADFG  
Sbjct: 162 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-- 219
Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            + T     +T  V T  YRPPE++L    ++   D+WS GCI  E     TLF      
Sbjct: 220 -SATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENR 277
Query: 273 DQLFRIFRTLG-TPHEDVWPGVSKLPIYKTDF-------------PEWRP-KKFSEILNL 317
           + L  + + LG  P   +     +   YK                   +P K +    +L
Sbjct: 278 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 337
Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
                 D+  +++  DP QR++    L H +F
Sbjct: 338 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 36/206 (17%)
Query: 4   DESRPRSRVQVE-----GVPSTALR-EISVLKELKHPN------VIRLHDVIPVDFKLFL 51
           D +R +S+V ++     G    A R EI+VLK++K  +       + + D       + +
Sbjct: 40  DHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99
Query: 52  VFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-IN- 108
            FE L ++  +FL+     P P    +   YQL  ALR+ H  ++ H DLKP+NIL +N 
Sbjct: 100 AFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159
Query: 109 -----------------KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
                            K+ ++++ADFG   + T     +T  V T  YRPPE++L    
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 152 YSTTVDIWSAGCIFSEMSYLYQLLEA 177
           ++   D+WS GCI  E    + L + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQT 241

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKLADFGLS 212
           YQL  ALR+ H  ++ H DLKP+NIL +N                  K+ ++++ADFG  
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-- 187
Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            + T     +T  V T  YRPPE++L    ++   D+WS GCI  E     TLF      
Sbjct: 188 -SATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 273 DQLFRIFRTLG-TPHEDVWPGVSKLPIYKTDF-------------PEWRP-KKFSEILNL 317
           + L  + + LG  P   +     +   YK                   +P K +    +L
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
                 D+  +++  DP QR++    L H +F
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQY 122
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVKEPG 180
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 181 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVK 177
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 178 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 115
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 116 FWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 173
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 114 SFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 171
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V  ++   ++V E++   +L D+L+        A+   Y+
Sbjct: 76  LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYM 135
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT       
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTYTAHAGAKF 193
Query: 138 --LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              W  P    L    +S   D+W+ G +  E++
Sbjct: 194 PIKWTAPES--LAYNTFSIKSDVWAFGVLLWEIA 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---- 228
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT         
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTYTAHAGAKFPI 195
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P    L    +S   D+W+ G +  E+ T
Sbjct: 196 KWTAPES--LAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 82/146 (56%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ ++    V  +L+++ EFL+   L D +  + V +      +    
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEA 149
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMA 209
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +   +Y+T VDIWS G +  EM
Sbjct: 210 PEV-ISRSLYATEVDIWSLGIMVIEM 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 27/178 (15%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMA 209
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE+ +   +Y+T VDIWS G +  EM+  +  +  DS +  + R+               
Sbjct: 210 PEV-ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------------- 253
Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                   D P  + K   ++     P+  D   +++  DP++R +A+ +L H +  Q
Sbjct: 254 -------RDSPPPKLKNSHKV----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 35  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 92
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 93  ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 152
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 153 NCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 211
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 212 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 249

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 191 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 3/142 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           REI   + L+HPN++R  +VI     L ++ E+                    A+ +  Q
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           LL  + YCHS +I HRDLK +N L++ S A  LK+ DFG S++ ++  ++    V T  Y
Sbjct: 125 LLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 183
Query: 141 RPPEILLGAKVYSTTVDIWSAG 162
             PE+LL  +      D+WS G
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCG 205

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 48/228 (21%)
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS---YLYQLLEALRYCHSRRIIH 188
           TH  + + Y       G ++Y     I +AG  FSE     +  QLL  + YCHS +I H
Sbjct: 89  THLAIIMEYAS-----GGELYER---ICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 189 RDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT 246
           RDLK +N L++ S A  LK+ DFG S++ ++  ++    V T  Y  PE+LL  +     
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198
Query: 247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW 306
            D+WS G      +T   +  G                P ED        P    D+ + 
Sbjct: 199 ADVWSCG------VTLYVMLVG--------------AYPFED--------PEEPRDYRKT 230
Query: 307 RPKKFSEILNLPD-----PLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             +  S   ++PD     P    + S+I   DP  R+S   I  H +F
Sbjct: 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 67  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 126
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 127 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVKEPG 184
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 185 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 124 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVK 181
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 182 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 122
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 180
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 181 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 177
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 178 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT       
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 138 -LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            + +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT        +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 176
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 208
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 209 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 241

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 205
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 206 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 195
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 196 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 135 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 192
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 193 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 66  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 125
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 126 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVKEPG 183
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 184 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 123 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVK 180
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 181 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 65  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 124
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 125 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVKEPG 182
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 183 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 122 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVK 179
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 180 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 177
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 174
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 175 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 195
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 196 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 135 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 192
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 193 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 206

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 176
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 177
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 174
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 175 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 58  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 117
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 118 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 175
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 176 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 208

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 115 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 172
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 173 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 120
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 178
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 208

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 176
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 120
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 178
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 208

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 176
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 118
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 119 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 176
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 117 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 174
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 59  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 118
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 119 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 176
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 177 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 116 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 173
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 174 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 211

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 84/157 (53%), Gaps = 6/157 (3%)
Query: 12  VQVEGVPSTALR-EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 69
           V+V+G     ++ EIS+L   +H N++ LH+      +L ++FEF+   D+ + + T+  
Sbjct: 38  VKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF 97
Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIP 127
            +      SY++Q+ EAL++ HS  I H D++P+NI+    +S  +K+ +FG +R    P
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-P 156
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
            + +        Y  PE+     V ST  D+WS G +
Sbjct: 157 GDNFRLLFTAPEYYAPEV-HQHDVVSTATDMWSLGTL 192

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 81/186 (43%), Gaps = 29/186 (15%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHE 225
           +SY++Q+ EAL++ HS  I H D++P+NI+    +S  +K+ +FG +R    P + +   
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLL 163
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
                Y  PE+     V ST  D+WS G +   +++    F  ++    +  I     T 
Sbjct: 164 FTAPEYYAPEV-HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            E+ +  +S                           A+D   +++  + K R++A   LQ
Sbjct: 223 DEEAFKEIS-------------------------IEAMDFVDRLLVKERKSRMTASEALQ 257
Query: 346 HEYFNQ 351
           H +  Q
Sbjct: 258 HPWLKQ 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           + R++    GV    + RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL
Sbjct: 106 AEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +       N + +   T  +  PEI +  +      D+WS G I
Sbjct: 165 AHKIDFG-NEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHE 225
           +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + + 
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNI 177
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +   +   
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYE 235
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            ED                        E  +    LA D   +++  DPK+R++ +  LQ
Sbjct: 236 FED------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 346 H 346
           H
Sbjct: 272 H 272

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 207

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 115
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 173
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 171
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 64  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 123
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 124 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 181
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 182 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 214

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 121 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 178
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 179 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 216

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 115
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 173
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 171
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 135
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 193
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 223

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 191
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 120
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 178
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 208

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 176
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 134
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 192
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 222

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 190
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 142
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 143 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 200
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 230

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 141 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 198
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 135
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 193
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 223

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 191
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 79
           REI +LK L    +++   V   P    L LV E+L    L+DFLQ     +  +    Y
Sbjct: 60  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      + 
Sbjct: 120 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              WY P    L   ++S   D+WS G +  E+
Sbjct: 180 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYEL 210

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HE 225
           Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      +
Sbjct: 119 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 178
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
               WY P    L   ++S   D+WS G +  E+ T
Sbjct: 179 SPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 211

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 181
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 182 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 212

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 89/185 (48%), Gaps = 8/185 (4%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 132
            A+ +  QL+  + Y H+ ++ HRDLK +N L++ S A  LK+ADFG S+A ++  ++  
Sbjct: 116 EARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPK 174
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHR 189
             V T  Y  PE+LL  +      D+WS G     M   +Y ++  E  +  + R+ IHR
Sbjct: 175 SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK--NFRKTIHR 232
Query: 190 DLKPQ 194
            L  Q
Sbjct: 233 ILNVQ 237

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 83/184 (45%), Gaps = 30/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVV 227
           +  QL+  + Y H+ ++ HRDLK +N L++ S A  LK+ADFG S+A ++  ++    V 
Sbjct: 120 FFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPKSAVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR--IFRTLGTP 285
           T  Y  PE+LL  +      D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILNVQ 237
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +         +P Y    PE R                 + S+I   DP +R+S   I  
Sbjct: 238 Y--------AIPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRN 273
Query: 346 HEYF 349
           HE+F
Sbjct: 274 HEWF 277

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 162
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 220
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 218
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ EFL    L+++LQ     +       Y
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQY 122
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 180
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 181 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 120 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVK 177
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 178 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 204
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 203
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 204
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 203
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 79
           REI +LK L    +++   V   P    L LV E+L    L+DFLQ     +  +    Y
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      + 
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              WY P    L   ++S   D+WS G +  E+
Sbjct: 193 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HE 225
           Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      +
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
               WY P    L   ++S   D+WS G +  E+ T
Sbjct: 192 SPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 134
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 192
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 222

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 190
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 204
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 203
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           +EI +L+ L H N+++   +   D    + L+ EFL    LK++L      +       Y
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A        T     + 
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS 183
              WY  PE L+ +K Y  + D+WS G    E+         L YC S
Sbjct: 192 PVFWY-APECLMQSKFYIAS-DVWSFGVTLHEL---------LTYCDS 228

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--- 223
           ++ Y  Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A        T   
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 224 -HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +    WY  PE L+ +K Y  + D+WS G    E++T
Sbjct: 188 DRDSPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELLT 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 79
           REI +LK L    +++   V   P    L LV E+L    L+DFLQ     +  +    Y
Sbjct: 61  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 120
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      + 
Sbjct: 121 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              WY P    L   ++S   D+WS G +  E+
Sbjct: 181 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HE 225
           Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      +
Sbjct: 120 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 179
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
               WY P    L   ++S   D+WS G +  E+ T
Sbjct: 180 SPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 176
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 147 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 204
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 154
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 212
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 210
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 135
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 193
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 223

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 191
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 146 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 203
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 37  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 94
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 95  ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 154
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 155 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 213
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 214 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 251

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 193 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 222

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSE-------------MSYLYQLLE 176
              +  PE L   K +S   D+W+ G +  E             +S +Y+LLE
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 231

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 181
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 182 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 212

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 162
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 220
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 218
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI VL  L HPN+I+L ++     ++ LV E +   +L D +           A + + Q
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQ 156
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVV--- 136
           +LEA+ Y H   I+HRDLKP+N+L         LK+ADFGLS+          H+V+   
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-------EHQVLMKT 209
Query: 137 ---TLWYRPPEILLGAKVYSTTVDIWSAGCI 164
              T  Y  PEIL G   Y   VD+WS G I
Sbjct: 210 VCGTPGYCAPEILRGC-AYGPEVDMWSVGII 239

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 84/184 (45%), Gaps = 43/184 (23%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVV-- 227
           Q+LEA+ Y H   I+HRDLKP+N+L         LK+ADFGLS+          H+V+  
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-------EHQVLMK 208
Query: 228 ----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
               T  Y  PEIL G   Y   VD+WS G I   ++     F  D   DQ F   R L 
Sbjct: 209 TVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFY-DERGDQ-FMFRRILN 265
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEI-LNLPDPLAVDVFSKIMALDPKQRVSAKT 342
             +  + P              W    + E+ LN     A D+  K++ LDPK+R++   
Sbjct: 266 CEYYFISP--------------W----WDEVSLN-----AKDLVRKLIVLDPKKRLTTFQ 302
Query: 343 ILQH 346
            LQH
Sbjct: 303 ALQH 306

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 167
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 225
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 226 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 255

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 166 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 223
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 44  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 101
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 102 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 161
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 162 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 220
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 221 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 258

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 200 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 229

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 24  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 162
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 220
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y PPE +   + +  +  +WS G +  +M
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDG 218
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
           T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    FR
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 176
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPG 177
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVK 174
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 175 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 4/151 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 138
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 204

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWY 231
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      + +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 TAPESLAYNK-FSIKSDVWAFGVLLWEIAT 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 77/142 (54%), Gaps = 4/142 (2%)
Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 86
           +L  + HP +IR+        ++F++ +++       L       P  +AK Y  ++  A
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 87  LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL 146
           L Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++   +P   Y     T  Y  PE+ 
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYXL-CGTPDYIAPEV- 174
Query: 147 LGAKVYSTTVDIWSAGCIFSEM 168
           +  K Y+ ++D WS G +  EM
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEM 196

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++   +P   Y     T 
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYXL-CGTP 167
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
            Y  PE+ +  K Y+ ++D WS G +  EM+   T F
Sbjct: 168 DYIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSE-------------MSYLYQLLE 176
              +  PE L   K +S   D+W+ G +  E             +S +Y+LLE
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 231

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 181
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 182 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 212

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 41  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 98
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 99  ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 158
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 159 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 217
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 218 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 255

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 197 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 43  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 100
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 101 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 160
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 161 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 219
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 220 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 257

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 199 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 228

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           +EI +L+ L H N+++   +   D    + L+ EFL    LK++L      +       Y
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 119
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 135
             Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A        T     + 
Sbjct: 120 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS 183
              WY  PE L+ +K Y  + D+WS G    E+         L YC S
Sbjct: 180 PVFWY-APECLMQSKFYIAS-DVWSFGVTLHEL---------LTYCDS 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--- 223
           ++ Y  Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A        T   
Sbjct: 116 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 224 -HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +    WY  PE L+ +K Y  + D+WS G    E++T
Sbjct: 176 DRDSPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELLT 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 17  VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 75
            P    +EI +   L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 134
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 135 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 40/190 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---- 225
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +     
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 226 ---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
                TL Y  PE+L   + ++  VD+WS G + + M+      AG+   DQ        
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML------AGELPWDQ-------- 210
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P +              ++ +W+ KK +       D   + +  KI+  +P  R++  
Sbjct: 211 --PSDSC-----------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 342 TILQHEYFNQ 351
            I +  ++N+
Sbjct: 258 DIKKDRWYNK 267

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 72/139 (51%), Gaps = 6/139 (4%)
Query: 33  HPNVIRLHDVIPVDFKLFLVFE--FLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 90
           HP VIRL D         LV E     QDL D++ T   P+    ++ +  Q++ A+++C
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 91  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 149
           HSR ++HRD+K +NILI+ + G  KL DFG      +    YT    T  Y PPE +   
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEWISRH 213
Query: 150 KVYSTTVDIWSAGCIFSEM 168
           + ++    +WS G +  +M
Sbjct: 214 QYHALPATVWSLGILLYDM 232

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 3/105 (2%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
            +  Q++ A+++CHSR ++HRD+K +NILI+ + G  KL DFG      +    YT    
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDG 200
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           T  Y PPE +   + ++    +WS G +  +M+     F  D EI
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 176
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 177 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 178
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 179 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 209

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 43  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 100
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 101 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 160
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 161 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 219
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 220 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 257

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 199 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 61  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 120
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+ + + Y  ++R IHR+L  +NIL+     +K+ DFGL++   +P ++  ++V    
Sbjct: 121 TSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPG 178
Query: 138 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 179 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 211

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHR+L  +NIL+     +K+ DFGL++   +P ++  ++V 
Sbjct: 118 LQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVK 175
Query: 228 T------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                   WY  PE L  +K +S   D+WS G +  E+ T
Sbjct: 176 EPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 7/155 (4%)
Query: 14  VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVP 72
           ++G  S+   EI+VL+++KH N++ L D+      L+LV + +   +L D +        
Sbjct: 60  LKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE 119
Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMN 129
              A + + Q+L+A+ Y H   I+HRDLKP+N+L    ++   + ++DFGLS+      +
Sbjct: 120 KD-ASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGD 177
Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
             +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 178 VMSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 211

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Q+L+A+ Y H   I+HRDLKP+N+L    ++   + ++DFGLS+      +  +    T 
Sbjct: 128 QVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTP 186
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCI 255
            Y  PE+ L  K YS  VD WS G I
Sbjct: 187 GYVAPEV-LAQKPYSKAVDCWSIGVI 211

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 40  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 97
Query: 54  EFL-RQDLKDFLQT-------TPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L++        PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 98  ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 157
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 158 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 216
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 217 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 254

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 196 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 225

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 85/164 (51%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
           + +SR    GV    + RE+S+L+++ HPN+I LHDV      + L+ E +   +L DFL
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL
Sbjct: 107 AQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +      +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 166 AHEIEDGVE-FKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 31/182 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTH 224
           S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+      +  + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  +  PEI +  +      D+WS G I   +++  + F GD++ + L         
Sbjct: 178 IFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------- 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                    + +     DF E       E  +    LA D   K++  + ++R++ +  L
Sbjct: 228 ---------ANITAVSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 345 QH 346
           +H
Sbjct: 272 RH 273

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 50  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 108 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 167
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 226
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 264

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 206 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 235

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 61  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 113
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 114 LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 173
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 174 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 216

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 188
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
             PE L G   YS   DIWS G    EM   +      S    +F + 
Sbjct: 189 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 176
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 177 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 178
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 179 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 181
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 182 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 178
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 179 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 210

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 180
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 181 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 176
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 129
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 130 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 187
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 188 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 219

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 189
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 190 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 206

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 176
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 207

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 50  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107
Query: 54  EFL-RQDLKDFLQT-------TPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L++        PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 167
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 226
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 264

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 206 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 235

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 33/188 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMNRYTHEV 226
           L+ + + + Y HS+ ++HRDLKP NIL +++SG    L++ DFG ++             
Sbjct: 127 LHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG---DSEIDQLFRIFRTLG 283
            T  +  PE+ L  + Y    DIWS G +   M+   T FA    D+  + L RI     
Sbjct: 187 YTANFVAPEV-LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKF 245
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
           T     W  VS+                          A D+ SK++ +DP QR++AK +
Sbjct: 246 TLSGGNWNTVSE-------------------------TAKDLVSKMLHVDPHQRLTAKQV 280
Query: 344 LQHEYFNQ 351
           LQH +  Q
Sbjct: 281 LQHPWVTQ 288

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 4/151 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 138
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            +  PE L   K +S   D+W+ G +  E++
Sbjct: 178 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWY 231
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      + +
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             PE L   K +S   D+W+ G +  E+ T
Sbjct: 180 TAPESLAYNK-FSIKSDVWAFGVLLWEIAT 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 4/151 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 138
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 204

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWY 231
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      + +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKW 176
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 TAPESLAYNK-FSIKSDVWAFGVLLWEIAT 205

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 72  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 129
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 130 ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 189
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N ++ +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 190 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 248
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 249 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 286

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    +    ++ + 
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 228 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 257

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 45  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 97
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 98  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 157
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 158 LIDEMANEF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 200

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF---VGTRSY 172
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 173 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 69  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 122 LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 182 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 224

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 196
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 197 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 33/188 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMNRYTHEV 226
           L+ + + + Y HS+ ++HRDLKP NIL +++SG    L++ DFG ++             
Sbjct: 127 LHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG---DSEIDQLFRIFRTLG 283
            T  +  PE+ L  + Y    DIWS G +   M+   T FA    D+  + L RI     
Sbjct: 187 YTANFVAPEV-LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKF 245
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
           T     W  VS+                          A D+ SK++ +DP QR++AK +
Sbjct: 246 TLSGGNWNTVSE-------------------------TAKDLVSKMLHVDPHQRLTAKQV 280
Query: 344 LQHEYFNQ 351
           LQH +  Q
Sbjct: 281 LQHPWVTQ 288

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 4/151 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 138
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            +  PE L   K +S   D+W+ G +  E++
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 204

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWY 231
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      + +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             PE L   K +S   D+W+ G +  E+ T
Sbjct: 177 TAPESLAYNK-FSIKSDVWAFGVLLWEIAT 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 42  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 94
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 95  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 155 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 197

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 169
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 170 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 42  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 94
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 95  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 155 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 169
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 170 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 42  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 94
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 95  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 155 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 197

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 169
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 170 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 104 EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 156
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 157 LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 216
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 217 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 259

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 231
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 232 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 262

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 79
           REI +LK L    +++   V   P   +L LV E+L    L+DFLQ     +  +    Y
Sbjct: 57  REIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 116
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEV 135
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  +    R   + 
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              WY P    L   ++S   D+WS G +  E+
Sbjct: 177 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYEL 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHE 225
           Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  +    R   +
Sbjct: 116 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQ 175
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
               WY P    L   ++S   D+WS G +  E+ T
Sbjct: 176 SPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 42  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 94
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 95  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 155 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 197

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 169
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 170 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 42  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 94
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 95  LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    EM+
Sbjct: 155 LIDSMANSF---VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA 197

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 169
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    EM   +
Sbjct: 170 MSPERLQGTH-YSVQSDIWSMGLSLVEMAVGR 200

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGAKF 175
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 176 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGAKFPI 177
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 178 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGAKF 176
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +  PE L   K +S   D+W+ G +  E++
Sbjct: 177 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGAKFPI 178
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 179 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 44/216 (20%)
Query: 156 VDIWSAGCIFSEMS------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA 203
           +D  + G +F+ +S            Y+ +++ AL + H   II+RD+K +NIL++ +G 
Sbjct: 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 197
Query: 204 LKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMIT 261
           + L DFGLS+ F        ++   T+ Y  P+I+ G    +   VD WS G +  E++T
Sbjct: 198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
             + F  D E +    I R                 I K++ P   P++ S        L
Sbjct: 258 GASPFTVDGEKNSQAEISRR----------------ILKSEPP--YPQEMS-------AL 292
Query: 322 AVDVFSKIMALDPKQRVS-----AKTILQHEYFNQV 352
           A D+  +++  DPK+R+      A  I +H +F ++
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 110
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 168
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 169 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 204

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 86  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 145
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  + YT  V + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 146 SDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 200

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 175
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 176 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 211

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 93  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 152
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  + YT  V + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 153 SDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 207

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 2   VSDESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVF 53
           V DE  P +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ 
Sbjct: 37  VKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 94
Query: 54  EFL-RQDLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQ 103
           E + R DLK +L       +  PV  PP+L+K      ++ + + Y ++ + +HRDL  +
Sbjct: 95  ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 154
Query: 104 NILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA 161
           N  + +   +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS 
Sbjct: 155 NCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSF 213
Query: 162 GCIFSEMSYL----YQLL---EALRYCHSRRIIHRDLKPQN 195
           G +  E++ L    YQ L   + LR+     ++    KP N
Sbjct: 214 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDN 251

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/91 (25%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++ + +HRDL  +N  + +   +K+ DFG++R    T    +    ++ + 
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T  D+WS G +  E+ T
Sbjct: 193 WMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 222

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 184
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 185 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  + YT  V + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 162 SDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 14/155 (9%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 77
           L E +++K L+H  ++RL+ V+  +  ++++ E++ +  L DFL++     V +P  +  
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-- 113
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----H 133
            +  Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     
Sbjct: 114 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGA 171
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    W  P  I  G   ++   D+WS G +  E+
Sbjct: 172 KFPIKWTAPEAINFGC--FTIKSDVWSFGILLYEI 204

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 15/126 (11%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     +   
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPI 175
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEID------QLFRIFRT 281
            W  P  I  G   ++   D+WS G +  E++T  K  + G +  D      Q +R+ R 
Sbjct: 176 KWTAPEAINFGC--FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV 233
Query: 282 LGTPHE 287
              P E
Sbjct: 234 ENCPDE 239

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 115
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 173
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 174 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT     +   
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPI 180
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 181 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 4/151 (2%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 138
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 181
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            +  PE L   K +S   D+W+ G +  E++
Sbjct: 182 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIA 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWY 231
           Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      + +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             PE L   K +S   D+W+ G +  E+ T
Sbjct: 184 TAPESLAYNK-FSIKSDVWAFGVLLWEIAT 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 169
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 170 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 146
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  + YT  V + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 147 SDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 201

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 47  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 104
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 105 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 162
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 163 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 198

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT     +   
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPI 169
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 170 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 200

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 57  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 114
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 172
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 173 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 180 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 210

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   D+   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 19/152 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 77
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  +  
Sbjct: 225 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-- 281
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRYTHEVV 136
            +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R     P+        
Sbjct: 282 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK------- 334
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             W  P  I  G+  ++   D+WS G +  E+
Sbjct: 335 --WTAPEAINFGS--FTIKSDVWSFGILLMEI 362

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 12/90 (13%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRYTHEVVTLWY 231
           Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R     P+          W 
Sbjct: 286 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK---------WT 336
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            P  I  G+  ++   D+WS G +  E++T
Sbjct: 337 APEAINFGS--FTIKSDVWSFGILLMEIVT 364

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALK--LADFGLSRAFTIPMNRY 222
           ++ L Q    L + HS  I+HRDLKP NILI   N  G +K  ++DFGL +   +  + +
Sbjct: 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 223 THEV----VTLWYRPPEILLGAKVYST-TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
           +          W  P  +    K   T TVDI+SAGC+F  +I++ +   G S   Q   
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--- 237
Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
                     ++  G   L           P+K  ++      +A ++  K++A+DP++R
Sbjct: 238 ---------ANILLGACSLDC-------LHPEKHEDV------IARELIEKMIAMDPQKR 275
Query: 338 VSAKTILQHEYFNQVE 353
            SAK +L+H +F  +E
Sbjct: 276 PSAKHVLKHPFFWSLE 291

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 13/167 (7%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           +S  Q    P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T 
Sbjct: 43  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT- 100
Query: 68  PVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
           P  +   + K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--L 158
Query: 126 IPMNRYT----HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           I  N YT     +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 159 IEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 203

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT     +   
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPI 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 205

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 5/153 (3%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 73
           E    T  +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +  
Sbjct: 89  ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 148
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRY 131
             A  Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+ A   P    
Sbjct: 149 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSV 207
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
                T  +  PE+  G  V   T D+WS G +
Sbjct: 208 KVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVL 239

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KS 201
           E + G +++    D  +       + Y+ Q+ + L + H    +H DLKP+NI+    +S
Sbjct: 128 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 187
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             LKL DFGL+ A   P         T  +  PE+  G  V   T D+WS G +   +++
Sbjct: 188 NELKLIDFGLT-AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVLSYILLS 245
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK 295
             + F G+++ + L  +        +  + G+S+
Sbjct: 246 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 279

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   D+   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 164
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 165 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 141
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  + YT  V + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 142 SDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 196

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 137
             Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR  T   + YT       
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 381
Query: 138 -LWYRPPEILLGAKVYSTTVDIWSAGCIFSE-------------MSYLYQLLE 176
            + +  PE L   K +S   D+W+ G +  E             +S +Y+LLE
Sbjct: 382 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR  T   + YT        +
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 383
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 384 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 414

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 14/155 (9%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 77
           L E +++K L+H  ++RL+ V+  +  ++++ EF+ +  L DFL++     V +P  +  
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI-- 112
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----H 133
            +  Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     
Sbjct: 113 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGA 170
Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    W  P  I  G   ++   ++WS G +  E+
Sbjct: 171 KFPIKWTAPEAINFGC--FTIKSNVWSFGILLYEI 203

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 15/126 (11%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     +   
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPI 174
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEID------QLFRIFRT 281
            W  P  I  G   ++   ++WS G +  E++T  K  + G +  D      Q +R+ R 
Sbjct: 175 KWTAPEAINFGC--FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM 232
Query: 282 LGTPHE 287
              P E
Sbjct: 233 ENCPDE 238

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 8/185 (4%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 132
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+  FG S++ ++  ++  
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPK 174
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHR 189
             V T  Y  PE+LL  +      D+WS G     M   +Y ++  E  +  + R+ IHR
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK--NFRKTIHR 232
Query: 190 DLKPQ 194
            L  Q
Sbjct: 233 ILNVQ 237

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 30/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVV 227
           +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+  FG S++ ++  ++    V 
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKSTVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR--IFRTLGTP 285
           T  Y  PE+LL  +      D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILNVQ 237
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +         +P Y    PE R                 + S+I   DP +R+S   I  
Sbjct: 238 Y--------AIPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRN 273
Query: 346 HEYF 349
           HE+F
Sbjct: 274 HEWF 277

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 119
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 177
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 178 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT     +   
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPI 184
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 185 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 215

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 8/185 (4%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 132
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+  FG S++ ++  ++  
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPK 174
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHR 189
             V T  Y  PE+LL  +      D+WS G     M   +Y ++  E  +  + R+ IHR
Sbjct: 175 DTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK--NFRKTIHR 232
Query: 190 DLKPQ 194
            L  Q
Sbjct: 233 ILNVQ 237

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 30/184 (16%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVV 227
           +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+  FG S++ ++  ++    V 
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKDTVG 178
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR--IFRTLGTP 285
           T  Y  PE+LL  +      D+WS G     M+     F  D E  + FR  I R L   
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILNVQ 237
Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +         +P Y    PE R                 + S+I   DP +R+S   I  
Sbjct: 238 Y--------AIPDYVHISPECR----------------HLISRIFVADPAKRISIPEIRN 273
Query: 346 HEYF 349
           HE+F
Sbjct: 274 HEWF 277

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 121
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 180
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 88  YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 143
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 202
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 203 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 242
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 243 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 282

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 181
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 89  YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 203
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 204 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 243
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 244 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 181
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 89  YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 203
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 204 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 243
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 244 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 181
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 89  YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 203
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 204 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 243
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 244 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 128
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 187
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 95  YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 150
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 209
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 210 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 249
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 250 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 289

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 20  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKS 78
           T  +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +    A  
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVV 136
           Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+ A   P         
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTG 318
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           T  +  PE+  G  V   T D+WS G +
Sbjct: 319 TAEFAAPEVAEGKPVGYYT-DMWSVGVL 345

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 29/205 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KS 201
           E + G +++    D  +       + Y+ Q+ + L + H    +H DLKP+NI+    +S
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 293
Query: 202 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             LKL DFGL+ A   P         T  +  PE+  G  V   T D+WS G +   +++
Sbjct: 294 NELKLIDFGLT-AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVLSYILLS 351
Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
             + F G+++ + L  +        +  + G+S+                          
Sbjct: 352 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-------------------------D 386
Query: 322 AVDVFSKIMALDPKQRVSAKTILQH 346
             D   K++  DP  R++    L+H
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALEH 411

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++  H NV+ ++    V  +L++V EFL    L D +  T   +      +    
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLS 149
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 150 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE+ +    Y T VDIWS G +  EM
Sbjct: 210 PEV-ISRLPYGTEVDIWSLGIMVIEM 234

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 1/109 (0%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 150 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
           PE+ +    Y T VDIWS G +  EMI  +  +  +  +  + RI  +L
Sbjct: 210 PEV-ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSL 257

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 261
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 320
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 348

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 228 YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 283
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 342
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 343 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 382
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 383 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 422

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQ 82
           E  ++     P V++L      D  L++V E++   DL + +      VP   A+ Y  +
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 181
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYR 141
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T  Y 
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 142 PPEILL---GAKVYSTTVDIWSAGCIFSEM 168
            PE+L    G   Y    D WS G    EM
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVT 228
           Y  +++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             Y  PE+L    G   Y    D WS G    EM+   T F  DS +    +I
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 28/177 (15%)
Query: 21  ALREISVLKELKHPNVIRLHD----------VIPVDFKLFLVFEFL---RQDLKDFL--Q 65
            +RE+  L +L+HP ++R  +          + P   K++L  +     +++LKD++  +
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109
Query: 66  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T      ++      Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A  
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 126 ---------IPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
                     PM    R+T +V T  Y  PE + G   YS  VDI+S G I  E+ Y
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 25/189 (13%)
Query: 94  RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY- 152
           R+ +R+L  + ++       KL   G+ R F   + + T E   L    P++ L  ++  
Sbjct: 39  RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE--KLQPSSPKVYLYIQMQL 96
Query: 153 --STTVDIWSAG-CIFSE------MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA 203
                +  W  G C   E      +    Q+ EA+ + HS+ ++HRDLKP NI       
Sbjct: 97  CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 156
Query: 204 LKLADFGLSRAFT---------IPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS 251
           +K+ DFGL  A            PM    R+T +V T  Y  PE + G   YS  VDI+S
Sbjct: 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFS 215
Query: 252 AGCIFSEMI 260
            G I  E++
Sbjct: 216 LGLILFELL 224

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQ 82
           E  ++     P V++L      D  L++V E++   DL + +      VP   A+ Y  +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 176
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYR 141
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T  Y 
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 142 PPEILL---GAKVYSTTVDIWSAGCIFSEM 168
            PE+L    G   Y    D WS G    EM
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVT 228
           Y  +++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             Y  PE+L    G   Y    D WS G    EM+   T F  DS +    +I
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 362
Query: 81  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 363 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 420
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSE-------------MSYLYQLLE 176
              +  PE L   K +S   D+W+ G +  E             +S +Y+LLE
Sbjct: 421 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 472

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 230
           Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR  T   + YT      +  
Sbjct: 365 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPI 422
Query: 231 -YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +  PE L   K +S   D+W+ G +  E+ T
Sbjct: 423 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 453

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQ 82
           E  ++     P V++L      D  L++V E++   DL + +      VP   A+ Y  +
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 181
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYR 141
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T  Y 
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 142 PPEILL---GAKVYSTTVDIWSAGCIFSEM 168
            PE+L    G   Y    D WS G    EM
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 55/113 (48%), Gaps = 4/113 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVT 228
           Y  +++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             Y  PE+L    G   Y    D WS G    EM+   T F  DS +    +I
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
           + +SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL
Sbjct: 107 AQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +      +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 166 AHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTH 224
           S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+      +  + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKN 177
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  +  PEI +  +      D+WS G I   +++  + F GD++ + L         
Sbjct: 178 IFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------- 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                    + +     DF E       E  +    LA D   K++  + ++R++ +  L
Sbjct: 228 ---------ANITSVSYDFDE-------EFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 345 QHEYF----NQVEMVK 356
           +H +     NQ  MV+
Sbjct: 272 RHPWITPVDNQQAMVR 287

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 247
Query: 83  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 306
Query: 140 YRPPEIL--LGAKVYSTTVDIWSAGCIF 165
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 139 WYRPPEILLGAKVYSTTVD---IWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
           +Y   E++ G +++   V    +  A C      Y YQ+L A++Y H   IIHRDLKP+N
Sbjct: 214 YYIVLELMEGGELFDKVVGNKRLKEATCKL----YFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 196 ILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL--LGAKVYSTTVDIW 250
           +L++   +   +K+ DFG S+         T    T  Y  PE+L  +G   Y+  VD W
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKK 310
           S G I    ++    F+            RT  +  + +  G       K +F    P+ 
Sbjct: 329 SLGVILFICLSGYPPFSE----------HRTQVSLKDQITSG-------KYNFI---PEV 368
Query: 311 FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           ++E+       A+D+  K++ +DPK R + +  L+H +    +M
Sbjct: 369 WAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
           + +SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL
Sbjct: 107 AQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +      +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 166 AHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTH 224
           S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+      +  + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKN 177
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  +  PEI +  +      D+WS G I   +++  + F GD++ + L         
Sbjct: 178 IFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------- 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                    + +     DF E       E  +    LA D   K++  + ++R++ +  L
Sbjct: 228 ---------ANITAVSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 345 QHEYF----NQVEMVK 356
           +H +     NQ  MV+
Sbjct: 272 RHPWITPVDNQQAMVR 287

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 141
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 142 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 202 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 234

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 138 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 197
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 198 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 185 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 217

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 121 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 181 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
           + +SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL
Sbjct: 107 AQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +      +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 166 AHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTH 224
           S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+      +  + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKN 177
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  +  PEI +  +      D+WS G I   +++  + F GD++ + L         
Sbjct: 178 IFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------- 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                    + +     DF E       E  +    LA D   K++  + ++R++ +  L
Sbjct: 228 ---------ANITSVSYDFDE-------EFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 345 QHEYF----NQVEMVK 356
           +H +     NQ  MV+
Sbjct: 272 RHPWITPVDNQQAMVR 287

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL 64
           E +P  R Q+       +RE+ VL E   P ++  +     D ++ +  E +     D +
Sbjct: 52  EIKPAIRNQI-------IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 104
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 123
                 +P  +       +L  L Y   + +I+HRD+KP NIL+N  G +KL DFG+S  
Sbjct: 105 LKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 164
Query: 124 FTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               M N +   V T  Y  PE L G   YS   DIWS G    E++
Sbjct: 165 LIDSMANSF---VGTRSYMAPERLQGTH-YSVQSDIWSMGLSLVELA 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWY 231
           +L  L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y
Sbjct: 123 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 179
Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKK 263
             PE L G   YS   DIWS G    E+   +
Sbjct: 180 MAPERLQGTH-YSVQSDIWSMGLSLVELAVGR 210

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
           + +SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL
Sbjct: 107 AQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +      +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 166 AHEIEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTH 224
           S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+      +  + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKN 177
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  +  PEI +  +      D+WS G I   +++  + F GD++ + L         
Sbjct: 178 IFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------- 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                    + +     DF E       E  +    LA D   K++  + ++R++ +  L
Sbjct: 228 ---------ANITSVSYDFDE-------EFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 345 QHEYF----NQVEMVK 356
           +H +     NQ  MV+
Sbjct: 272 RHPWITPVDNQQAMVR 287

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 7   RPRSRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
           + +SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGL 120
                 +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL
Sbjct: 107 AQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +      +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 166 AHEIEDGVE-FKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTH 224
           S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+      +  + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  +  PEI +  +      D+WS G I   +++  + F GD++ + L         
Sbjct: 178 IFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------- 227
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                    + +     DF E       E  +    LA D   K++  + ++R++ +  L
Sbjct: 228 ---------ANITAVSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 345 QHEYF----NQVEMVK 356
           +H +     NQ  MV+
Sbjct: 272 RHPWITPVDNQQAMVR 287

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 19  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           S+   EI+VLK++KH N++ L D+       +LV + +   +L D +    V      A 
Sbjct: 51  SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD-AS 109
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 134
             + Q+L A++Y H   I+HRDLKP+N+L     ++  + + DFGLS+   +  N     
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMST 166
Query: 135 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 164
              T  Y  PE+ L  K YS  VD WS G I
Sbjct: 167 ACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 196

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Q+L A++Y H   I+HRDLKP+N+L     ++  + + DFGLS+   +  N        T
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGT 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCI 255
             Y  PE+ L  K YS  VD WS G I
Sbjct: 171 PGYVAPEV-LAQKPYSKAVDCWSIGVI 196

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 24  EISVLKELKHPNVIR-------LHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPV 71
           EI ++K+L HPNV+        L  + P D  L L  E+     LR+ L  F     +  
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPM 128
            P   ++ L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++      
Sbjct: 121 GPI--RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QG 177
Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
              T  V TL Y  PE LL  K Y+ TVD WS G +  E
Sbjct: 178 ELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFE 215

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPMNRYTHE 225
           + L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++         T  
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF 183
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V TL Y  PE LL  K Y+ TVD WS G +  E IT
Sbjct: 184 VGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 24  EISVLKELKHPNVIR-------LHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPV 71
           EI ++K+L HPNV+        L  + P D  L L  E+     LR+ L  F     +  
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKE 121
Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPM 128
            P   ++ L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++      
Sbjct: 122 GPI--RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QG 178
Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
              T  V TL Y  PE LL  K Y+ TVD WS G +  E
Sbjct: 179 ELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFE 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPMNRYTHE 225
           + L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++         T  
Sbjct: 126 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF 184
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V TL Y  PE LL  K Y+ TVD WS G +  E IT
Sbjct: 185 VGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 275
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 276 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 311
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 312 RISIPELLAHPY 323

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 133
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 247
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 248 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 283
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 284 RISIPELLAHPY 295

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 275
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 276 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 311
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 312 RISIPELLAHPY 323

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 114
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 228
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 229 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 264
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 265 RISIPELLAHPY 276

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 55  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 113
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 114 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 214

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 111 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 169
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 170 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 227
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 228 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 263
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 264 RISIPELLAHPY 275

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 218

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 115 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 173
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 174 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 231
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 232 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 267
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 268 RISIPELLAHPY 279

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 151
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 152 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 212 IRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSY 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 148 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 208 GKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMS 243

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 28/180 (15%)
Query: 19  STALREISVLKELKHPNVIRLH-------------DVIPVDFKLFLVFEFL-RQDLKDFL 64
           ST L E+ +L  L H  V+R +               +     LF+  E+   + L D +
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI 106
Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--- 121
            +  +            Q+LEAL Y HS+ IIHR+LKP NI I++S  +K+ DFGL+   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 122 -RAFTI----------PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            R+  I            +  T  + T  Y   E+L G   Y+  +D +S G IF E  Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY 226

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 14/102 (13%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----RAFTI----------P 218
           Q+LEAL Y HS+ IIHR+LKP NI I++S  +K+ DFGL+    R+  I           
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            +  T  + T  Y   E+L G   Y+  +D +S G IF E I
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 21  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 78
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 79  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 120
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 121 SRAFTIPMNRYTHEV----VTLWYRPPEILLGA--KVYSTTVDIWSAGCIF 165
            +        +   +     T  +R PE+L  +  +  + ++DI+S GC+F
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 19/124 (15%)
Query: 165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 211
           ++ +S L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 212 SRAFTIPMNRYTHEV----VTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMITKKTL 265
            +        +   +     T  +R PE+L  +  +  + ++DI+S GC+F  +++K   
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 266 FAGD 269
             GD
Sbjct: 253 PFGD 256

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPP 73
           E    T L+E+ V++ L+HPNV++   V+  D +L  + E+++   L+  +++     P 
Sbjct: 48  EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----TIPMN 129
           +   S+   +   + Y HS  IIHRDL   N L+ ++  + +ADFGL+R      T P  
Sbjct: 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167
Query: 130 -----------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                      RYT      W  P   ++  + Y   VD++S G +  E+
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMAPE--MINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 50/110 (45%), Gaps = 17/110 (15%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----TIPMN--- 220
           +S+   +   + Y HS  IIHRDL   N L+ ++  + +ADFGL+R      T P     
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 221 --------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                   RYT      W  P   ++  + Y   VD++S G +  E+I +
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPE--MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 110 LDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 167
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 168 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEV 197

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 230
           + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 169
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
           +  PE+   ++ YS+  D+WS G +  E+ ++  +
Sbjct: 170 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 21  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 78
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 79  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 120
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 121 SRAFTIPMNRYTHEV----VTLWYRPPEILLGA--KVYSTTVDIWSAGCIF 165
            +        +   +     T  +R PE+L  +  +  + ++DI+S GC+F
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 64/124 (51%), Gaps = 19/124 (15%)
Query: 165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 211
           ++ +S L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 212 SRAFTIPMNRYTHEV----VTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMITKKTL 265
            +        +   +     T  +R PE+L  +  +  + ++DI+S GC+F  +++K   
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 266 FAGD 269
             GD
Sbjct: 253 PFGD 256

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 133
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V T+
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTV 192
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQV 189
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            T+ Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 247
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 248 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 283
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 284 RISIPELLAHPY 295

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 84/175 (48%), Gaps = 30/175 (17%)
Query: 21  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 78
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 79  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 120
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 121 SRAFTIPMNRYTHEVV----TLWYRPPEILLGAKVYST------TVDIWSAGCIF 165
            +      + +   +     T  +R PE+L  +    T      ++DI+S GC+F
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 23/128 (17%)
Query: 165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 211
           ++ +S L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 212 SRAFTIPMNRYTHEVV----TLWYRPPEILLGAKVYST------TVDIWSAGCIFSEMIT 261
            +      + +   +     T  +R PE+L  +    T      ++DI+S GC+F  +++
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 262 KKTLFAGD 269
           K     GD
Sbjct: 235 KGKHPFGD 242

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 124
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 125 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 184
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEM 209

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 27/176 (15%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 125 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 184
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE L+    Y   VDIWS G +  EM+                      G P     P +
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPL 222
Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             + + + + P  R K   ++     P       +++  DP QR +A  +L+H + 
Sbjct: 223 KAMKMIRDNLPP-RLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 128
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 129 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 188
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 189 PE-LISRLPYGPEVDIWSLGIMVIEM 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 27/176 (15%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 129 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 188
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE L+    Y   VDIWS G +  EM+                      G P     P +
Sbjct: 189 PE-LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPL 226
Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             + + + + P  R K   ++     P       +++  DP QR +A  +L+H + 
Sbjct: 227 KAMKMIRDNLPP-RLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 135
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 136 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 195
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 196 PE-LISRLPYGPEVDIWSLGIMVIEM 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 27/176 (15%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 136 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 195
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE L+    Y   VDIWS G +  EM+                      G P     P +
Sbjct: 196 PE-LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPL 233
Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             + + + + P  R K   ++     P       +++  DP QR +A  +L+H + 
Sbjct: 234 KAMKMIRDNLPP-RLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 133
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 134 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 193
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 194 PE-LISRLPYGPEVDIWSLGIMVIEM 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 27/176 (15%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 134 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 193
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE L+    Y   VDIWS G +  EM+                      G P     P +
Sbjct: 194 PE-LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPL 231
Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             + + + + P  R K   ++     P       +++  DP QR +A  +L+H + 
Sbjct: 232 KAMKMIRDNLPP-RLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 39/178 (21%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT--------------- 66
           RE +++ E  +PN+++L  V  V   + L+FE++   DL +FL++               
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 67  ------TPVPVPPALAKSYLY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
                 +P P P + A+      Q+   + Y   R+ +HRDL  +N L+ ++  +K+ADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 119 GLSRAFTIPMNRYT--------HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GLSR      N Y+        ++ + + + PPE +   + Y+T  D+W+ G +  E+
Sbjct: 219 GLSR------NIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 269

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 15/97 (15%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--------H 224
           Q+   + Y   R+ +HRDL  +N L+ ++  +K+ADFGLSR      N Y+        +
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSADYYKADGN 235
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + + + + PPE +   + Y+T  D+W+ G +  E+ +
Sbjct: 236 DAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 271

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 48  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 105
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           K      Q+ E + +   R  IHR+L+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 106 KLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 163
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 164 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 199

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+ E + +   R  IHR+L+  NIL++ + + K+ADFGL+R   I  N YT     +   
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPI 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            W  P  I  G   ++   D+WS G + +E++T
Sbjct: 171 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVT 201

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 XSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTI--PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI--PMNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 255
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 256 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 315
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 316 PE-LISRLPYGPEVDIWSLGIMVIEM 340

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 41/236 (17%)
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY-----------LYQLLE 176
           M  Y HE V   Y     L+G +++   ++    G +   +++              +L+
Sbjct: 202 MRDYQHENVVEMYN--SYLVGDELW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQ 258
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
           AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  PE 
Sbjct: 259 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE- 317
Query: 237 LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL 296
           L+    Y   VDIWS G +  EM+                      G P     P +  +
Sbjct: 318 LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPLKAM 356
Query: 297 PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
            + + + P  R K   ++     P       +++  DP QR +A  +L+H +  + 
Sbjct: 357 KMIRDNLPP-RLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 53  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 112
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 113 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 170
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 171 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEV 200

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 230
           + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 172
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
           +  PE+   ++ YS+  D+WS G +  E+ ++  +
Sbjct: 173 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 82
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 178
Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 179 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 238
Query: 143 PEILLGAKVYSTTVDIWSAGCIFSEM 168
           PE L+    Y   VDIWS G +  EM
Sbjct: 239 PE-LISRLPYGPEVDIWSLGIMVIEM 263

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 27/176 (15%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 179 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 238
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE L+    Y   VDIWS G +  EM+                      G P     P +
Sbjct: 239 PE-LISRLPYGPEVDIWSLGIMVIEMVD---------------------GEPPYFNEPPL 276
Query: 294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             + + + + P  R K   ++     P       +++  DP QR +A  +L+H + 
Sbjct: 277 KAMKMIRDNLPP-RLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 32/188 (17%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMN----RYTH 224
           + Q+  AL Y H++ I HRD+KP+N L   NKS  +KL DFGLS+ F    N      T 
Sbjct: 174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 225 EVVTLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
           +  T ++  PE+L    + Y    D WSAG +   ++     F G ++ D + ++     
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN--- 290
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                      KL     ++            N+  PLA D+ S ++  +  +R  A   
Sbjct: 291 ----------KKLCFENPNY------------NVLSPLARDLLSNLLNRNVDERFDAMRA 328
Query: 344 LQHEYFNQ 351
           LQH + +Q
Sbjct: 329 LQHPWISQ 336

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 110 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 167
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 168 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEV 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 230
           + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 169
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
           +  PE+   ++ YS+  D+WS G +  E+ ++  +
Sbjct: 170 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGL+R     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGL+R     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 83/175 (47%), Gaps = 30/175 (17%)
Query: 21  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 78
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 79  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 120
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 121 SRAFTIPMNRYTHEVV----TLWYRPPEILLGAKVYST------TVDIWSAGCIF 165
            +        +   +     T  +R PE+L  +    T      ++DI+S GC+F
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 63/128 (49%), Gaps = 23/128 (17%)
Query: 165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 211
           ++ +S L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 212 SRAFTIPMNRYTHEVV----TLWYRPPEILLGAKVYST------TVDIWSAGCIFSEMIT 261
            +        +   +     T  +R PE+L  +    T      ++DI+S GC+F  +++
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 262 KKTLFAGD 269
           K     GD
Sbjct: 235 KGKHPFGD 242

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 165
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 166 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEV 195

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 230
           + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 167
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
           +  PE+   ++ YS+  D+WS G +  E+ ++  +
Sbjct: 168 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 201

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 70  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 129
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 130 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 187
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 188 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEV 217

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 230
           + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 189
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
           +  PE+   ++ YS+  D+WS G +  E+ ++  +
Sbjct: 190 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGL R     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGL R     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTI--PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI--PMNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT    + + 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSRGSKFP 169
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 170 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 66/118 (55%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 146
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  + YT    + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 147 SDFGLSR--YVLDDEYTSSRGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 201

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E +    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARE---PPGLE 134
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 195 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 213 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E +    L  FL+              L
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 185 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 217

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 121 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 181 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 17  VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTT 67
           + +   +EI+ LK  + HPN+++LH+V       FLV E L         +  K F +T 
Sbjct: 48  MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE 107
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAF 124
                   A   + +L+ A+ + H   ++HRDLKP+N+L    N +  +K+ DFG +R  
Sbjct: 108 --------ASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-L 158
Query: 125 TIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             P N+       TL Y  PE LL    Y  + D+WS G I   M
Sbjct: 159 KPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTM 202

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 57/106 (53%), Gaps = 7/106 (6%)
Query: 166 SEMSYLY-QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 221
           +E SY+  +L+ A+ + H   ++HRDLKP+N+L    N +  +K+ DFG +R    P N+
Sbjct: 106 TEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-LKPPDNQ 164
Query: 222 -YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
                  TL Y  PE LL    Y  + D+WS G I   M++ +  F
Sbjct: 165 PLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 117
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 178 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 185 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 213

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 20  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKS 78
              +E+ +++ L+HP ++ L      +  +F+V + L   DL+  LQ   V       K 
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKL 119
Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           ++ +L+ AL Y  ++RIIHRD+KP NIL+++ G + + DF ++ A      + T    T 
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITTMAGTK 178
Query: 139 WYRPPEILLGAK--VYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH------SRRIIH 188
            Y  PE+    K   YS  VD WS G         Y+LL   R  H      S+ I+H
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVT------AYELLRGRRPYHIRSSTSSKEIVH 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 7/155 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++ +L+ AL Y  ++RIIHRD+KP NIL+++ G + + DF ++ A      + T    T 
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITTMAGTK 178
Query: 230 WYRPPEILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFA--GDSEIDQLFRIFRTLGTP 285
            Y  PE+    K   YS  VD WS G    E++  +  +     +   ++   F T    
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238
Query: 286 HEDVWPG--VSKLPIYKTDFPEWRPKKFSEILNLP 318
           +   W    VS L       P+ R  + S++ N P
Sbjct: 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 53  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 110
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 171 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 178 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E +    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSY 246

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 4/148 (2%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 81
           +EI+VL +     V + +       KL+++ E+L      D L+  P         + L 
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLK 127
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 128 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 187
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            PE++  +  Y +  DIWS G    E++
Sbjct: 188 APEVIQQS-AYDSKADIWSLGITAIELA 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 3/109 (2%)
Query: 153 STTVDIWSAGCI--FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 210
            + +D+  AG    F   + L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG
Sbjct: 106 GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFG 165
Query: 211 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
           ++   T    +    V T ++  PE++  +  Y +  DIWS G    E+
Sbjct: 166 VAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIEL 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 203

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR---PPGLE 126
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 127 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 186
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 187 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 237

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 205 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 258

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 9/165 (5%)
Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           +S  Q    P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T 
Sbjct: 45  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT- 102
Query: 68  PVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF- 124
           P  +   + K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   
Sbjct: 103 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 162
Query: 125 -TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 R   +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 163 DNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 179 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 115
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 176 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 209

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 183 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 203

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 61  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 118
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 179 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 186 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 214

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 23  REISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVTL 138
             +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V  +
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 139 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSY 170
            Y PPE +                S   D+WS GCI   M+Y
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 77/192 (40%), Gaps = 39/192 (20%)
Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEV 226
           SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++              +V
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 227 VTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
             + Y PPE +                S   D+WS GCI   M   KT F     I+Q+ 
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 275
Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
           ++   +   HE              +FP+           +P+    DV    +  DPKQ
Sbjct: 276 KLHAIIDPNHE-------------IEFPD-----------IPEKDLQDVLKCCLKRDPKQ 311
Query: 337 RVSAKTILQHEY 348
           R+S   +L H Y
Sbjct: 312 RISIPELLAHPY 323

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +    W  P  I  G   ++   D+WS G + +E+
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEI 203

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R   +    W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             P  I  G   ++   D+WS G + +E++T
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVT 205

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 70/151 (46%), Gaps = 7/151 (4%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLY 81
            E  ++     P V++L      D  L++V E++   DL + +      VP   AK Y  
Sbjct: 124 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTA 181
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTLWY 140
           +++ AL   HS  +IHRD+KP N+L++K G LKLADFG         M      V T  Y
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 141 RPPEILL---GAKVYSTTVDIWSAGCIFSEM 168
             PE+L    G   Y    D WS G    EM
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 272

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVT 228
           Y  +++ AL   HS  +IHRD+KP N+L++K G LKLADFG         M      V T
Sbjct: 179 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGT 238
Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             Y  PE+L    G   Y    D WS G    EM+   T F  DS +    +I
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 291

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR---PPGLE 134
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 195 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 213 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV--PVPPALAKS 78
           LRE++++K L+HPN++     +     L +V E+L R  L   L  +     +      S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 79  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
             Y + + + Y H+R   I+HRDLK  N+L++K   +K+ DFGLSR              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAG 201
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY---------QLLEALRYCHSRRII 187
           T  +  PE+L        + D++S G I  E++ L          Q++ A+ +   R  I
Sbjct: 202 TPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 188 HRDLKPQ 194
            R+L PQ
Sbjct: 261 PRNLNPQ 267

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 225
           +S  Y + + + Y H+R   I+HRDLK  N+L++K   +K+ DFGLSR            
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA 199
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             T  +  PE+L        + D++S G I  E+ T
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 123
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 124 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 183
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 184 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 234

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 202 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 255

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 130
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 131 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 190
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 191 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 209 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 262

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR---PPGLE 127
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 128 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 187
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 188 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 238

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 206 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 259

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 133
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 134 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 193
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 194 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 244

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 212 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 265

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  +  T  V + + 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEETSSVGSKFP 184
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
             + PPE+L+ +K +S+  DIW+ G +  E+  L ++
Sbjct: 185 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM 220

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 66/118 (55%), Gaps = 19/118 (16%)
Query: 160 SAGCIFS---EMSYLYQ----------LLEALRYCHSRRIIHRDLKPQNILINKSGALKL 206
           + GC+ +   EM + +Q          + EA+ Y  S++ +HRDL  +N L+N  G +K+
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161
Query: 207 ADFGLSRAFTIPMNRYTHEVVTLW---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +DFGLSR   +  +  T  V + +   + PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 162 SDFGLSR--YVLDDEETSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 175
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 235
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 236 GLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEI 286

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 254 RLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 28/173 (16%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R     ++ Y   T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDIN-NIDYYKNTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 5/116 (4%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R     ++ Y   T+
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKNTTN 218
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
             + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 219 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTL 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           W  P  I    + +++  D+W  G    E+
Sbjct: 178 WMAPESI--NFRRFTSASDVWMFGVCMWEI 205

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 227
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++ 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
             W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 128
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 129 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADF 188
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 189 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 239

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 207 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 187
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 298

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 266 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 36/192 (18%)
Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTI 217
           FSE    + L+ + + + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++    
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG---DSEIDQ 274
                     T  +  PE+ L  + Y    DIWS G +   M+T  T FA    D+  + 
Sbjct: 173 ENGLLMTPCYTANFVAPEV-LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 275 LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
           L RI     +     W  VS                           A D+ SK++ +DP
Sbjct: 232 LARIGSGKFSLSGGYWNSVSD-------------------------TAKDLVSKMLHVDP 266
Query: 335 KQRVSAKTILQH 346
            QR++A  +L+H
Sbjct: 267 HQRLTAALVLRH 278

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP-------VPP 73
           L+EI  + +  HPN++  +    V  +L+LV + L    + D ++            +  
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           +   + L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S AF       T 
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITR 179
Query: 134 E------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
                  V T  +  PE++   + Y    DIWS G    E++
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 26/189 (13%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE----- 225
           L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S AF       T       
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKT 185
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            V T  +  PE++   + Y    DIWS G    E+ T    +    +   +  +  TL  
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
               +  GV    + K        K F ++++L            +  DP++R +A  +L
Sbjct: 243 DPPSLETGVQDKEMLKK-----YGKSFRKMISL-----------CLQKDPEKRPTAAELL 286
Query: 345 QHEYFNQVE 353
           +H++F + +
Sbjct: 287 RHKFFQKAK 295

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 120
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 121 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 179
Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  I    + +++  D+W  G    E+
Sbjct: 180 KWMAPESI--NFRRFTSASDVWMFGVCMWEI 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKL 177
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
              W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 178 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTL 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           W  P  I    + +++  D+W  G    E+
Sbjct: 178 WMAPESI--NFRRFTSASDVWMFGVCMWEI 205

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 227
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++ 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
             W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 7/152 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+       +V E++    L  FL+T             L
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   +RY      +HRDL  +N+L++ +   K++DFGLSR     P   YT    ++ 
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             W  P  I    + +S+  D+WS G +  E+
Sbjct: 218 IRWTAPEAIAF--RTFSSASDVWSFGVVMWEV 247

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 63/137 (45%), Gaps = 19/137 (13%)
Query: 164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRY 222
           I   +  L  +   +RY      +HRDL  +N+L++ +   K++DFGLSR     P   Y
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 223 T---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI----------TKKTLFAGD 269
           T    ++   W  P  I    + +S+  D+WS G +  E++          T + +    
Sbjct: 210 TTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI--- 264
Query: 270 SEIDQLFRIFRTLGTPH 286
           S +++ +R+   +G PH
Sbjct: 265 SSVEEGYRLPAPMGCPH 281

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTL 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++   
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           W  P  I    + +++  D+W  G    E+
Sbjct: 206 WMAPESI--NFRRFTSASDVWMFGVCMWEI 233

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 227
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++ 
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
             W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 204 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP-------VPP 73
           L+EI  + +  HPN++  +    V  +L+LV + L    + D ++            +  
Sbjct: 56  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           +   + L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S AF       T 
Sbjct: 116 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITR 174
Query: 134 E------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
                  V T  +  PE++   + Y    DIWS G    E++
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 26/189 (13%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE----- 225
           L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S AF       T       
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKT 180
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            V T  +  PE++   + Y    DIWS G    E+ T    +    +   +  +  TL  
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 237
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
               +  GV    + K        K F ++++L            +  DP++R +A  +L
Sbjct: 238 DPPSLETGVQDKEMLKK-----YGKSFRKMISL-----------CLQKDPEKRPTAAELL 281
Query: 345 QHEYFNQVE 353
           +H++F + +
Sbjct: 282 RHKFFQKAK 290

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 181
Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  I    + +++  D+W  G    E+
Sbjct: 182 KWMAPESI--NFRRFTSASDVWMFGVCMWEI 210

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKL 179
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
              W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 180 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAK--- 77
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 78  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                               S+ +Q+ + ++Y    +++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 118 FGLSRAF---TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL--- 171
           FGLSR        + R    +   W     +     +Y+T  D+WS G +  E+  L   
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 172 -YQLLEALRYCHSRRIIHRDLKPQN 195
            Y  +   R  +  +  HR  +P N
Sbjct: 252 PYPGIPPERLFNLLKTGHRMERPDN 276

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF---TIPMNRYTH 224
           +S+ +Q+ + ++Y    +++HRDL  +NIL+ +   +K++DFGLSR        + R   
Sbjct: 153 ISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W     +     +Y+T  D+WS G +  E++T
Sbjct: 213 RIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 61  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 119
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 178
Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  I    + +++  D+W  G    E+
Sbjct: 179 KWMAPESI--NFRRFTSASDVWMFGVCMWEI 207

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKL 176
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
              W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 177 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +++ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADF 201
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +++ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E S++ + +HPN+IRL  V+     + ++ EF+    L  FL+              L
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 122
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 134
             +   +RY      +HRDL  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
           +   W  P  I    + +++  D WS G +  E MS+
Sbjct: 183 IPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMSF 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--- 224
           +  L  +   +RY      +HRDL  +NIL+N +   K++DFGLSR      +  T+   
Sbjct: 119 VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              ++   W  P  I    + +++  D WS G +  E+++
Sbjct: 179 LGGKIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMS 216

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTL 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           W  P  I    + +++  D+W  G    E+
Sbjct: 178 WMAPESI--NFRRFTSASDVWMFGVCMWEI 205

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 227
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++ 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
             W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 173
Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  I    + +++  D+W  G    E+
Sbjct: 174 KWMAPESI--NFRRFTSASDVWMFGVCMWEI 202

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKL 171
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
              W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 172 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFGL++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFGL++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTL 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           W  P  I    + +++  D+W  G    E+
Sbjct: 178 WMAPESI--NFRRFTSASDVWMFGVCMWEI 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 227
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++ 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
             W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 176 IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 556
Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  I    + +++  D+W  G    E+
Sbjct: 557 KWMAPESI--NFRRFTSASDVWMFGVCMWEI 585

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKL 554
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
              W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 555 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR---PPGLE 134
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            S+                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 FSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 195 GLARDIHHIDXXKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 213 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 556
Query: 139 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  I    + +++  D+W  G    E+
Sbjct: 557 KWMAPESI--NFRRFTSASDVWMFGVCMWEI 585

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKL 554
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAG-CIFSEMITKKTLFAGDSEIDQLFRI 278
              W  P  I    + +++  D+W  G C++  ++     F G    D + RI
Sbjct: 555 PIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 81/151 (53%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
            +E   + +L HP +++ + V   ++ +++V E++    L ++L++    + P+      
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           Y + E + +  S + IHRDL  +N L+++   +K++DFG++R   +  ++Y   V T + 
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSSVGTKFP 168
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+    K YS+  D+W+ G +  E+
Sbjct: 169 VKWSAPEVFHYFK-YSSKSDVWAFGILMWEV 198

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 30/166 (18%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 230
           Y + E + +  S + IHRDL  +N L+++   +K++DFG++R   +  ++Y   V T + 
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSSVGTKFP 168
Query: 231 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL---FAGDSE----IDQLFRIFRT 281
             +  PE+    K YS+  D+W+ G +  E+ +   +      +SE    + Q  R++R 
Sbjct: 169 VKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR- 226
Query: 282 LGTPHEDVWPGVSKLPIYKT------DFPEWRPKKFSEILNLPDPL 321
                    P ++   IY+       + PE RP  F ++L+  +PL
Sbjct: 227 ---------PHLASDTIYQIMYSCWHELPEKRP-TFQQLLSSIEPL 262

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYL 80
           L E S++ +  HPNV+ L  V+     + +V EF+     D FL+              L
Sbjct: 92  LCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGML 151
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   +RY      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 152 RGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 212 VRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSY 244

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT--- 223
           +  L  +   +RY      +HRDL  +NIL+N +   K++DFGLSR     P   YT   
Sbjct: 148 VGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTG 207
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 208 GKIPVRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMS 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 16/161 (9%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPV-------PP 73
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+   P  V       P 
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPT 123
Query: 74  ALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPM 128
            L +S +     Q+   + Y  S+  +HRDL  +N L+ ++  +K+ DFG+SR  ++   
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183
Query: 129 NRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            R   H ++ + + PPE ++  K ++T  D+WS G +  E+
Sbjct: 184 YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEI 223

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 58/99 (58%), Gaps = 4/99 (4%)
Query: 166 SEMSYLYQLLEA-LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRY- 222
           S+M ++ Q + A + Y  S+  +HRDL  +N L+ ++  +K+ DFG+SR  ++    R  
Sbjct: 128 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 187
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            H ++ + + PPE ++  K ++T  D+WS G +  E+ T
Sbjct: 188 GHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFT 225

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV--PVPPALAKS 78
           LRE++++K L+HPN++     +     L +V E+L R  L   L  +     +      S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 79  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
             Y + + + Y H+R   I+HR+LK  N+L++K   +K+ DFGLSR              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY---------QLLEALRYCHSRRII 187
           T  +  PE+L        + D++S G I  E++ L          Q++ A+ +   R  I
Sbjct: 202 TPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 188 HRDLKPQ 194
            R+L PQ
Sbjct: 261 PRNLNPQ 267

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 225
           +S  Y + + + Y H+R   I+HR+LK  N+L++K   +K+ DFGLSR            
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             T  +  PE+L        + D++S G I  E+ T
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T    +        +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVVT 137
                 + Y  S+  IHRDL  +N L+ +   LK++DFG+SR         +    +V  
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
            W  P  +  G   YS+  D+WS G +  E
Sbjct: 280 KWTAPEALNYGR--YSSESDVWSFGILLWE 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVVTLWYRP 233
            + Y  S+  IHRDL  +N L+ +   LK++DFG+SR         +    +V   W  P
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +  G   YS+  D+WS G +  E  +
Sbjct: 285 EALNYGR--YSSESDVWSFGILLWETFS 310

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E S++ + +HPN+IRL  V+     + ++ EF+    L  FL+              L
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 124
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
             +   +RY      +HRDL  +NIL+N +   K++DFGLSR F    +    E  +L  
Sbjct: 125 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSDPTETSSLGG 183
Query: 139 -----WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
                W  P  I    + +++  D WS G +  E MS+
Sbjct: 184 KIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMSF 219

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  L  +   +RY      +HRDL  +NIL+N +   K++DFGLSR F    +    E  
Sbjct: 121 VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSDPTETS 179
Query: 228 TL-------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +L       W  P  I    + +++  D WS G +  E+++
Sbjct: 180 SLGGKIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMS 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T    +        +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVVT 137
                 + Y  S+  IHRDL  +N L+ +   LK++DFG+SR         +    +V  
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV 279
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSE 167
            W  P  +  G   YS+  D+WS G +  E
Sbjct: 280 KWTAPEALNYGR--YSSESDVWSFGILLWE 307

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVVTLWYRP 233
            + Y  S+  IHRDL  +N L+ +   LK++DFG+SR         +    +V   W  P
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAP 284
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +  G   YS+  D+WS G +  E  +
Sbjct: 285 EALNYGR--YSSESDVWSFGILLWETFS 310

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAK--- 77
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 78  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                               S+ +Q+ + ++Y    +++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 118 FGLSRAFTIP---MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL--- 171
           FGLSR        + R    +   W     +     +Y+T  D+WS G +  E+  L   
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 172 -YQLLEALRYCHSRRIIHRDLKPQN 195
            Y  +   R  +  +  HR  +P N
Sbjct: 252 PYPGIPPERLFNLLKTGHRMERPDN 276

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP---MNRYTH 224
           +S+ +Q+ + ++Y    +++HRDL  +NIL+ +   +K++DFGLSR        + R   
Sbjct: 153 ISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W     +     +Y+T  D+WS G +  E++T
Sbjct: 213 RIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 38/213 (17%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSG-------------------ALKLADFGLS 212
           YQ+ +++ + HS ++ H DLKP+NIL  +S                     +K+ DFG  
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-- 182
Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            + T     ++  V T  YR PE++L A  +S   D+WS GCI  E     T+F      
Sbjct: 183 -SATYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW--------------RP-KKFSEILNL 317
           + L  + R LG   + +     K   +  D  +W              +P K+F    ++
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
                 D+  K++  DP +R++ +  L+H +F+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR---PPGLE 119
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
             Y                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 120 YCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 230

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 198 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 45/218 (20%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVT 228
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGT 348
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PE++   + Y+ + D W+ GC+  EMI      AG S   Q     R      E+
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQ-----RKKKIKREE 396
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
           V   V ++       PE   ++FS       P A  + S+++  DP +R+     SA+ +
Sbjct: 397 VERLVKEV-------PEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREV 442
Query: 344 LQHEYFNQVE-------MVKPTLAVFPELGYGGNGCKD 374
            +H  F ++        M++P     P+  Y    CKD
Sbjct: 443 KEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY----CKD 476

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 36/203 (17%)
Query: 173 QLLEALRYCHSR-RIIHRDLKPQNILINKSGA------LKLADFGLSRAFTIPMNRYTHE 225
           QLL  L Y H R  IIH D+KP+N+L+    +      +K+AD G +  +      YT+ 
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNS 195
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIF 279
           + T  YR PE+LLGA  +    DIWS  C+  E+IT   LF  D       + D + +I 
Sbjct: 196 IQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 280 RTLGT----------------PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV 323
             LG                     +   +SKL  +  +       KFS+  +    ++ 
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKEIS- 311
Query: 324 DVFSKIMALDPKQRVSAKTILQH 346
           D  S ++ LDP++R  A  ++ H
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNH 334

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 36/203 (17%)
Query: 173 QLLEALRYCHSR-RIIHRDLKPQNILINKSGA------LKLADFGLSRAFTIPMNRYTHE 225
           QLL  L Y H R  IIH D+KP+N+L+    +      +K+AD G +  +      YT+ 
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNS 195
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIF 279
           + T  YR PE+LLGA  +    DIWS  C+  E+IT   LF  D       + D + +I 
Sbjct: 196 IQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 280 RTLGT----------------PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV 323
             LG                     +   +SKL  +  +       KFS+  +    ++ 
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKEIS- 311
Query: 324 DVFSKIMALDPKQRVSAKTILQH 346
           D  S ++ LDP++R  A  ++ H
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNH 334

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 45/218 (20%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVT 228
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGT 348
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PE++   + Y+ + D W+ GC+  EMI      AG S   Q     R      E+
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQ-----RKKKIKREE 396
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
           V   V ++       PE   ++FS       P A  + S+++  DP +R+     SA+ +
Sbjct: 397 VERLVKEV-------PEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREV 442
Query: 344 LQHEYFNQVE-------MVKPTLAVFPELGYGGNGCKD 374
            +H  F ++        M++P     P+  Y    CKD
Sbjct: 443 KEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY----CKD 476

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 36/206 (17%)
Query: 4   DESRPRSRV------QVEGVPSTALREISVLKELKHPN------VIRLHDVIPVDFKLFL 51
           D  R  +RV       VE     A  EI+VL+++   +       +++ D       + +
Sbjct: 54  DHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCI 113
Query: 52  VFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-IN- 108
            FE L     DFL+    +P P    +   +QL +A+++ H  ++ H DLKP+NIL +N 
Sbjct: 114 SFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNS 173
Query: 109 -----------------KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
                            KS A+++ DFG   + T     ++  V T  YR PE++L    
Sbjct: 174 DYELTYNLEKKRDERSVKSTAVRVVDFG---SATFDHEHHSTIVSTRHYRAPEVILELG- 229
Query: 152 YSTTVDIWSAGCIFSEMSYLYQLLEA 177
           +S   D+WS GCI  E    + L + 
Sbjct: 230 WSQPCDVWSIGCIIFEYYVGFTLFQT 255

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 23/131 (17%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKLADFGLS 212
           +QL +A+++ H  ++ H DLKP+NIL +N                  KS A+++ DFG  
Sbjct: 144 FQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG-- 201
Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            + T     ++  V T  YR PE++L    +S   D+WS GCI  E     TLF      
Sbjct: 202 -SATFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNR 259
Query: 273 DQLFRIFRTLG 283
           + L  + R LG
Sbjct: 260 EHLAMMERILG 270

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 26/165 (15%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDL------------KDFLQTTPVP 70
            E+ ++ ++K+   +    +I    ++++++E++  D             K++    P+ 
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 71  VPPALAKSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFT---I 126
           V   + KS    +L +  Y H+ + I HRD+KP NIL++K+G +KL+DFG S       I
Sbjct: 152 VIKCIIKS----VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMSY 170
             +R T+E     + PPE       Y+   VDIWS G     M Y
Sbjct: 208 KGSRGTYE-----FMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 150 KVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLAD 208
           K Y+  + I    CI         +L +  Y H+ + I HRD+KP NIL++K+G +KL+D
Sbjct: 142 KNYTCFIPIQVIKCIIK------SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 209 FGLSRAFT---IPMNRYTHEVVTLWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMITKKT 264
           FG S       I  +R T+E     + PPE       Y+   VDIWS G     M     
Sbjct: 196 FGESEYMVDKKIKGSRGTYE-----FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 265 LFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPE-WRPKKFSEILNLPDPLAV 323
            F+    + +LF   RT    +          P+ +  F      KK +   N      +
Sbjct: 251 PFSLKISLVELFNNIRTKNIEY----------PLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
Query: 324 DVFSKIMALDPKQRVSAKTILQHE 347
           D     +  +P +R++++  L+HE
Sbjct: 301 DFLKLFLRKNPAERITSEDALKHE 324

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 168
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 225
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 256

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 223
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
            EISV+ +L H N+I+L+D       + LV E++   +L D +      +       ++ 
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194
Query: 82  QLLEALRYCHSRRIIHRDLKPQNIL-INKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           Q+ E +R+ H   I+H DLKP+NIL +N+    +K+ DFGL+R +  P  +      T  
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPE 253
Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL 178
           +  PE+ +     S   D+WS G I       Y LL  L
Sbjct: 254 FLAPEV-VNYDFVSFPTDMWSVGVI------AYMLLSGL 285

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 4/138 (2%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG 202
           E + G +++   +D          + ++ Q+ E +R+ H   I+H DLKP+NIL +N+  
Sbjct: 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225
Query: 203 -ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +K+ DFGL+R +  P  +      T  +  PE+ +     S   D+WS G I   +++
Sbjct: 226 KQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEV-VNYDFVSFPTDMWSVGVIAYMLLS 283
Query: 262 KKTLFAGDSEIDQLFRIF 279
             + F GD++ + L  I 
Sbjct: 284 GLSPFLGDNDAETLNNIL 301

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLAGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLAGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR---PPGLE 134
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
             Y                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 YCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 119 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 195 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 61/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +
Sbjct: 213 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 32/183 (17%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Q+LE + Y H   I+H DLKPQNIL++     G +K+ DFG+SR   I       E++ T
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIMGT 196
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PEIL    + +T  D+W+ G I   ++T  + F G+                +++
Sbjct: 197 PEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGED---------------NQE 240
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            +  +S++ +      ++  + FS +      LA D    ++  +P++R +A+  L H +
Sbjct: 241 TYLNISQVNV------DYSEETFSSV----SQLATDFIQSLLVKNPEKRPTAEICLSHSW 290
Query: 349 FNQ 351
             Q
Sbjct: 291 LQQ 293

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAK--- 77
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 78  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                               S+ +Q+ + ++Y     ++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 118 FGLSRAF---TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL--- 171
           FGLSR        + R    +   W     +     +Y+T  D+WS G +  E+  L   
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 172 -YQLLEALRYCHSRRIIHRDLKPQN 195
            Y  +   R  +  +  HR  +P N
Sbjct: 252 PYPGIPPERLFNLLKTGHRMERPDN 276

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF---TIPMNRYTH 224
           +S+ +Q+ + ++Y     ++HRDL  +NIL+ +   +K++DFGLSR        + R   
Sbjct: 153 ISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W     +     +Y+T  D+WS G +  E++T
Sbjct: 213 RIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 142
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 143 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 199
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 200 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 230

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 141 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 197
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 198 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LV EF+    L D+L+T              
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 168
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 169 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEV 198

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 230
           + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 170
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL 265
           +  PE+   ++ YS+  D+WS G +  E+ ++  +
Sbjct: 171 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++  +  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPI 244

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 1/102 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
            +  PE+LLG + Y  +VD ++ G    EMI  +  F    E
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 1/102 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
            +  PE+LLG + Y  +VD ++ G    EMI  +  F    E
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 168
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 225
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 256

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 223
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 265

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 10/173 (5%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQD 59
           K+ D+ +     Q+E      L E  +L+ +  P +++L      +  L++V E++   +
Sbjct: 65  KILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE 120
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           +   L+       P  A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG
Sbjct: 121 MFSHLRRIGRFXEPH-ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
            ++       R      T  Y  PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 180 FAKRVK---GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 228

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 195
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  + + +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 1/102 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
            +  PE+LLG + Y  +VD ++ G    EMI  +  F    E
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLXGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLXGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 19/164 (11%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------VPVPPAL 75
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+         V   P  
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 76  AKSYL---------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFT 125
           AK  L          Q+   + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR  ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 126 IPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               R   H ++ + + PPE ++  K ++T  D+WS G I  E+
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEI 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRY-THEVVTLW 230
           Q+   + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR  ++    R   H ++ + 
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + PPE ++  K ++T  D+WS G I  E+ T
Sbjct: 201 WMPPESIMYRK-FTTESDVWSFGVILWEIFT 230

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 1/102 (0%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
            +  PE+LLG + Y  +VD ++ G    EMI  +  F    E
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +++ DFGL++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +++ DFGL++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT      W 
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGC-IFSEMSY 170
             +  PE  +  + +S+  D+WS G  ++  +SY
Sbjct: 177 LKWYAPEC-INFRKFSSRSDVWSYGVTMWEALSY 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L+Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT      W
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              +  PE  +  + +S+  D+WS G    E ++
Sbjct: 176 PLKWYAPEC-INFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           S  + E+ ++K + KH N+I L      D  L+++  +  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARR---PPGME 141
Query: 77  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 118
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 119 GLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 3/115 (2%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R         + T+ 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            + + +  PE L   +VY+   D+WS G +  E+ T          +++LF++ +
Sbjct: 220 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPNVI L  V+     + ++ EF+    L  FL+              L
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 141
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 134
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 142 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
           +   W  P  I    + +++  D+WS G +  E MSY
Sbjct: 202 IPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSY 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/100 (26%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--- 224
           +  L  +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+   
Sbjct: 138 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 198 LGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMS 235

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 10/173 (5%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-D 59
           K+ D+ +     Q+E      L E  +L+ +  P +++L      +  L++V E++   +
Sbjct: 59  KILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 114
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           +   L+       P  A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG
Sbjct: 115 MFSHLRRIGRFSEPH-ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
            ++       R      T  Y  PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 174 FAKRVK---GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 222

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 133 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK---GRTWXLCGTP 189
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 190 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 10/173 (5%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQD 59
           K+ D+ +     Q+E      L E  +L+ +  P +++L      +  L++V E++   +
Sbjct: 65  KILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE 120
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           +   L+       P  A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG
Sbjct: 121 MFSHLRRIGRFSEPH-ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
            ++       R      T  Y  PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 180 FAKRVK---GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 228

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 195
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 237

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+       +V E++    L  FL+T             L
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT----IPMNRYTHEVV 136
             +   +RY      +HRDL  +N+L++ +   K++DFGLSR               ++ 
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             W  P  I    + +S+  D+WS G +  E+
Sbjct: 218 IRWTAPEAIAF--RTFSSASDVWSFGVVMWEV 247

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 19/137 (13%)
Query: 164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT----IPM 219
           I   +  L  +   +RY      +HRDL  +N+L++ +   K++DFGLSR          
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI----------TKKTLFAGD 269
                ++   W  P  I    + +S+  D+WS G +  E++          T + +    
Sbjct: 210 TTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI--- 264
Query: 270 SEIDQLFRIFRTLGTPH 286
           S +++ +R+   +G PH
Sbjct: 265 SSVEEGYRLPAPMGCPH 281

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 282 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 338
Query: 135 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
                   W  P   L G   ++   D+WS G + +E++
Sbjct: 339 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 375

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---- 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT         
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 345
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 346 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+I L  V+     + +V E++    L  FL+              L
Sbjct: 71  LGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGML 130
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 131 RGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             W  P  I    + +++  D+WS G +  E+
Sbjct: 191 IRWTAPEAIAF--RKFTSASDVWSYGIVMWEV 220

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT   
Sbjct: 127 VGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 186
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 187 GKIPIRWTAPEAIAF--RKFTSASDVWSYGIVMWEVVS 222

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 282 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 338
Query: 135 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
                   W  P   L G   ++   D+WS G + +E++
Sbjct: 339 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 375

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---- 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT         
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 345
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 346 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 10/173 (5%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQD 59
           K+ D+ +     Q+E      L E  +L+ +  P +++L      +  L++V E++   +
Sbjct: 58  KILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE 113
Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           +   L+       P  A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG
Sbjct: 114 MFSHLRRIGRFSEPH-ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 172
Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
            ++       R      T  Y  PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 173 FAKRVK---GRTWTLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 132 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTP 188
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 189 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 282 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 338
Query: 135 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
                   W  P   L G   ++   D+WS G + +E++
Sbjct: 339 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 375

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---- 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT         
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 345
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 346 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 168
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      TL  
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGATWTLCG 221
Query: 140 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
              Y  PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 222 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 256

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      TL
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGATWTL 219
Query: 230 W----YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
                Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 220 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 265

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPV 69
           ++ +      L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++   
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283
Query: 70  PV--PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V     L K  L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +  
Sbjct: 284 SVLGGDCLLKFSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  T ++   W  P    L  K +ST  D+WS G +  E+
Sbjct: 343 QD--TGKLPVKWTAPEA--LREKKFSTKSDVWSFGILLWEI 379

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 31/170 (18%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +  T ++ 
Sbjct: 292 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP 349
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
             W  P    L  K +ST  D+WS G +  E+ +              F        P +
Sbjct: 350 VKWTAPEA--LREKKFSTKSDVWSFGILLWEIYS--------------FGRVPYPRIPLK 393
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           DV P V K   YK D P+  P           P   DV      LD   R
Sbjct: 394 DVVPRVEK--GYKMDAPDGCP-----------PAVYDVMKNCWHLDAATR 430

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 115 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP 174
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 175 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 204
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 205 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 261
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 262 EVMEHRFF 269

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPV 69
           ++ +      L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++   
Sbjct: 52  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 70  PV--PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V     L K  L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +  
Sbjct: 112 SVLGGDCLLKFSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  T ++   W  P    L  K +ST  D+WS G +  E+
Sbjct: 171 QD--TGKLPVKWTAPEA--LREKKFSTKSDVWSFGILLWEI 207

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 20/148 (13%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +  T ++ 
Sbjct: 120 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP 177
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
             W  P    L  K +ST  D+WS G +  E+ +              F        P +
Sbjct: 178 VKWTAPEA--LREKKFSTKSDVWSFGILLWEIYS--------------FGRVPYPRIPLK 221
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEIL 315
           DV P V K   YK D P+  P    E++
Sbjct: 222 DVVPRVEK--GYKMDAPDGCPPAVYEVM 247

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 364
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 365 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 421
Query: 135 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
                   W  P   L G   ++   D+WS G + +E++
Sbjct: 422 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 458

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---- 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT         
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 428
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 429 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP 169
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 170 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 199
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 200 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 257 EVMEHRFF 264

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPV 69
           ++ +      L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++   
Sbjct: 37  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 96
Query: 70  PV--PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V     L K  L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +  
Sbjct: 97  SVLGGDCLLKFSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155
Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  T ++   W  P    L  K +ST  D+WS G +  E+
Sbjct: 156 QD--TGKLPVKWTAPEA--LREKKFSTKSDVWSFGILLWEI 192

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 20/148 (13%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +  T ++ 
Sbjct: 105 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP 162
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
             W  P    L  K +ST  D+WS G +  E+ +              F        P +
Sbjct: 163 VKWTAPEA--LREKKFSTKSDVWSFGILLWEIYS--------------FGRVPYPRIPLK 206
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEIL 315
           DV P V K   YK D P+  P    E++
Sbjct: 207 DVVPRVEK--GYKMDAPDGCPPAVYEVM 232

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 50  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 108
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 132
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 109 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 165
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
              +    W  P   L G   ++   D+WS G + +E++
Sbjct: 166 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 202

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 172
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 173 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 226

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP 169
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 170 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 199
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 200 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 257 EVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTP 169
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 170 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 199
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 200 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 257 EVMEHRFF 264

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSG-------------------ALKLADFGLS 212
           YQ+ +++ + HS ++ H DLKP+NIL  +S                     +K+ DFG  
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-- 182
Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            + T     ++  V    YR PE++L A  +S   D+WS GCI  E     T+F      
Sbjct: 183 -SATYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW--------------RP-KKFSEILNL 317
           + L  + R LG   + +     K   +  D  +W              +P K+F    ++
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
                 D+  K++  DP +R++ +  L+H +F+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 11/173 (6%)
Query: 24  EISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           EI++L  ++H N+I++ D+      F+L +       DL  F+   P    P LA     
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP-LASYIFR 137
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           QL+ A+ Y   + IIHRD+K +NI+I +   +KL DFG S A+      +     T+ Y 
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKLFYTFCGTIEYC 196
Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKP 193
            PE+L+G       +++WS G        LY L+ E   +C     +   + P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVT------LYTLVFEENPFCELEETVEAAIHP 243

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 2/100 (2%)
Query: 169 SYLY-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           SY++ QL+ A+ Y   + IIHRD+K +NI+I +   +KL DFG S A+      +     
Sbjct: 133 SYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKLFYTFCG 191
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFA 267
           T+ Y  PE+L+G       +++WS G     ++ ++  F 
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 170 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 199
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 200 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 257 EVMEHRFF 264

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  S   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 113 LVDMSA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 168
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 169 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 206

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 176
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 177 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 230

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 113 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 172
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 173 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 202
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 203 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 259
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 260 EVMEHRFF 267

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  +M+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYQMAAGY 235

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  +M      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPI 244

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE+L     Y   VD W  G +  EM+                             
Sbjct: 170 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM----------------------------- 199
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQRVS-----AK 341
                +LP Y  D          E +  P    P A  + + ++  DPKQR+      AK
Sbjct: 200 ---CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
Query: 342 TILQHEYF 349
            +++H +F
Sbjct: 257 EVMEHRFF 264

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P + +L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P + +L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 36/192 (18%)
Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTI 217
           FSE    + L+ + + + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++    
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG---DSEIDQ 274
                     T  +  PE+ L  + Y    DIWS G +    +T  T FA    D+  + 
Sbjct: 173 ENGLLXTPCYTANFVAPEV-LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEI 231
Query: 275 LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
           L RI     +     W  VS                           A D+ SK + +DP
Sbjct: 232 LARIGSGKFSLSGGYWNSVSD-------------------------TAKDLVSKXLHVDP 266
Query: 335 KQRVSAKTILQH 346
            QR++A  +L+H
Sbjct: 267 HQRLTAALVLRH 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 81/151 (53%), Gaps = 9/151 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPVPV--PPALAK 77
           L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++    V     L K
Sbjct: 53  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 112
Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
             L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +  T ++  
Sbjct: 113 FSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPV 169
Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            W  P  +   A  +ST  D+WS G +  E+
Sbjct: 170 KWTAPEALREAA--FSTKSDVWSFGILLWEI 198

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 20/148 (13%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +  T ++ 
Sbjct: 111 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP 168
Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
             W  P  +   A  +ST  D+WS G +  E+ +              F        P +
Sbjct: 169 VKWTAPEALREAA--FSTKSDVWSFGILLWEIYS--------------FGRVPYPRIPLK 212
Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEIL 315
           DV P V K   YK D P+  P    E++
Sbjct: 213 DVVPRVEK--GYKMDAPDGCPPAVYEVM 238

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 35/200 (17%)
Query: 167 EMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR- 221
           E S + Q +  AL + H++ I HRDLKP+NIL    N+   +K+ DFGL     +  +  
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCS 171
Query: 222 --YTHEVVT----LWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
              T E++T      Y  PE++      A +Y    D+WS G I   +++    F G   
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG--- 228
Query: 272 IDQLFRIFRTLGTPHEDVWPGVSKLPIY-----KTDFPEWRPKKFSEILNLPDPLAVDVF 326
                R     G    +  P    +        K +FP+   K ++ I       A D+ 
Sbjct: 229 -----RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD---KDWAHI----SCAAKDLI 276
Query: 327 SKIMALDPKQRVSAKTILQH 346
           SK++  D KQR+SA  +LQH
Sbjct: 277 SKLLVRDAKQRLSAAQVLQH 296

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P + +L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T 
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTP 203
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 245

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N++I++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             PEI++ +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPEIII-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N++I++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  PEI++ +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+I L  V+     + ++ E++    L  FL+              L
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT    ++ 
Sbjct: 138 RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 198 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSY 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT   
Sbjct: 134 VGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 194 GKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+I L  V+     + ++ E++    L  FL+              L
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT    ++ 
Sbjct: 123 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 183 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSY 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT   
Sbjct: 119 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 179 GKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 214

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           +  LH     D  L+LV ++ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 95  IIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYRPPEILL----GA 149
            +HRD+KP NIL++ +G ++LADFG   +       + +  V T  Y  PEIL     G 
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 150 KVYSTTVDIWSAGCIFSEMSY 170
             Y    D WS G    EM Y
Sbjct: 256 GRYGPECDWWSLGVCMYEMLY 276

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 5/116 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVT 228
           YL +++ A+   H    +HRD+KP NIL++ +G ++LADFG   +       + +  V T
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 229 LWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
             Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++   +I  
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 45/201 (22%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           +FSE     Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +      
Sbjct: 106 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 165
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  Y  PE+L     Y   VD W  G +  EM+                   
Sbjct: 166 ATMKXFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM------------------- 205
Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQ 336
                          +LP Y  D  +       E +  P    P A  + S ++  DPKQ
Sbjct: 206 -------------CGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 252
Query: 337 RVS-----AKTILQHEYFNQV 352
           R+      AK I+QH +F  +
Sbjct: 253 RLGGGSEDAKEIMQHRFFAGI 273

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 45/201 (22%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           +FSE     Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +      
Sbjct: 104 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 163
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  Y  PE+L     Y   VD W  G +  EM+                   
Sbjct: 164 ATMKXFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM------------------- 203
Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQ 336
                          +LP Y  D  +       E +  P    P A  + S ++  DPKQ
Sbjct: 204 -------------CGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 250
Query: 337 RVS-----AKTILQHEYFNQV 352
           R+      AK I+QH +F  +
Sbjct: 251 RLGGGSEDAKEIMQHRFFAGI 271

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 45/201 (22%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           +FSE     Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +      
Sbjct: 105 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 164
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  Y  PE+L     Y   VD W  G +  EM+                   
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM------------------- 204
Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQ 336
                          +LP Y  D  +       E +  P    P A  + S ++  DPKQ
Sbjct: 205 -------------CGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 251
Query: 337 RVS-----AKTILQHEYFNQV 352
           R+      AK I+QH +F  +
Sbjct: 252 RLGGGSEDAKEIMQHRFFAGI 272

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
             P I+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 205 LAPAIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T 
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTP 202
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
            Y  P I+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 203 EYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+I L  V+     + ++ E++    L  FL+              L
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 116
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT    ++ 
Sbjct: 117 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E MSY
Sbjct: 177 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSY 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT--- 223
           +  L  +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT   
Sbjct: 113 VGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 173 GKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 45/201 (22%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           +FSE     Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +      
Sbjct: 244 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  Y  PE+L     Y   VD W  G +  EM+                   
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM------------------- 343
Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQ 336
                          +LP Y  D  +       E +  P    P A  + S ++  DPKQ
Sbjct: 344 -------------CGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 337 RVS-----AKTILQHEYFNQV 352
           R+      AK I+QH +F  +
Sbjct: 391 RLGGGSEDAKEIMQHRFFAGI 411

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 45/201 (22%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 219
           +FSE     Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +      
Sbjct: 247 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 306
Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  Y  PE+L     Y   VD W  G +  EM+                   
Sbjct: 307 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM------------------- 346
Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP---DPLAVDVFSKIMALDPKQ 336
                          +LP Y  D  +       E +  P    P A  + S ++  DPKQ
Sbjct: 347 -------------CGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 393
Query: 337 RVS-----AKTILQHEYFNQV 352
           R+      AK I+QH +F  +
Sbjct: 394 RLGGGSEDAKEIMQHRFFAGI 414

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------------T 67
           RE  +L  L+H +++R   V      L +VFE++R  DL  FL++               
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTI 126
           P P+      +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++ 
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 127 PMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              R     ++ + + PPE +L  K ++T  D+WS G +  E+
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEI 253

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRYTHE-VVTLW 230
           Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++    R     ++ + 
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + PPE +L  K ++T  D+WS G +  E+ T
Sbjct: 226 WMPPESILYRK-FTTESDVWSFGVVLWEIFT 255

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 65/146 (44%), Gaps = 1/146 (0%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
            HP + +L        +LF V EF+      F          A A+ Y  +++ AL + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
            + II+RDLK  N+L++  G  KLADFG+ +              T  Y  PEIL    +
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ-EML 200
Query: 152 YSTTVDIWSAGCIFSEMSYLYQLLEA 177
           Y   VD W+ G +  EM   +   EA
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 2/108 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  +++ AL + H + II+RDLK  N+L++  G  KLADFG+ +              T 
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            Y  PEIL    +Y   VD W+ G +  EM+     F  ++E D LF 
Sbjct: 189 DYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFE 234

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 116
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 117 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 175 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 211

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEV 226
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V   +  PE  L  + +S   D W  G    EM T
Sbjct: 180 VPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 122
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 123 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 181 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEV 226
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V   +  PE  L  + +S   D W  G    EM T
Sbjct: 186 VPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 112
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 113 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 171 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEV 226
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V   +  PE  L  + +S   D W  G    EM T
Sbjct: 176 VPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 116
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 117 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 175 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 211

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEV 226
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V   +  PE  L  + +S   D W  G    EM T
Sbjct: 180 VPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 48  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 106
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 107 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 162
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 163 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 200

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 170
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 171 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 224

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------------T 67
           RE  +L  L+H +++R   V      L +VFE++R  DL  FL++               
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 122
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTI 126
           P P+      +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++ 
Sbjct: 123 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 127 PMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              R     ++ + + PPE +L  K ++T  D+WS G +  E+
Sbjct: 183 DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEI 224

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRYTHE-VVTLW 230
           Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++    R     ++ + 
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + PPE +L  K ++T  D+WS G +  E+ T
Sbjct: 197 WMPPESILYRK-FTTESDVWSFGVVLWEIFT 226

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 46  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 104
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 105 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 160
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 161 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 198

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 168
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 169 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 222

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 71
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 282
Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL R   I  N Y
Sbjct: 283 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGR--LIEDNEY 336
Query: 132 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           T          W  P   L G   ++   D+WS G + +E++
Sbjct: 337 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 376

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---- 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL R   I  N YT         
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPI 346
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 347 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 400

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------------T 67
           RE  +L  L+H +++R   V      L +VFE++R  DL  FL++               
Sbjct: 69  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 128
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTI 126
           P P+      +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++ 
Sbjct: 129 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 127 PMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              R     ++ + + PPE +L  K ++T  D+WS G +  E+
Sbjct: 189 DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEI 230

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRYTHE-VVTLW 230
           Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++    R     ++ + 
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           + PPE +L  K ++T  D+WS G +  E+ T
Sbjct: 203 WMPPESILYRK-FTTESDVWSFGVVLWEIFT 232

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 112
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 113 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 133 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 171 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 207

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEV 226
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           V   +  PE  L  + +S   D W  G    EM T
Sbjct: 176 VPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  S   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N +T 
Sbjct: 113 LVDMSA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEWTA 168
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 169 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 206

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N +T     +   
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPI 176
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 177 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPNVI L  V+     + ++ EF+    L  FL+              L
Sbjct: 56  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 115
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 134
             +   ++Y      +HR L  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 116 RGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
           +   W  P  I    + +++  D+WS G +  E MSY
Sbjct: 176 IPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSY 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--- 224
           +  L  +   ++Y      +HR L  +NIL+N +   K++DFGLSR      +  T+   
Sbjct: 112 VGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              ++   W  P  I    + +++  D+WS G +  E+++
Sbjct: 172 LGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMS 209

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R       L  
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCG 200
Query: 141 RP----PEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
            P    PEI+L +K Y+  VD W+ G +  EM+  Y
Sbjct: 201 TPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R       L
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXL 198
Query: 230 WYRP----PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
              P    PEI+L +K Y+  VD W+ G +  EM      F  D  I
Sbjct: 199 CGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLY 81
           +E  +   LKHPN+I L  V   +  L LV EF R   L   L      +PP +  ++  
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAV 112
Query: 82  QLLEALRYCHSRR---IIHRDLKPQNILINK--------SGALKLADFGLSRAFTIPMNR 130
           Q+   + Y H      IIHRDLK  NILI +        +  LK+ DFGL+R +     +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTK 171
Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +      W  P   ++ A ++S   D+WS G +  E+
Sbjct: 172 MSAAGAYAWMAPE--VIRASMFSKGSDVWSYGVLLWEL 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 14/112 (12%)
Query: 168 MSYLYQLLEALRYCHSRRI---IHRDLKPQNILINK--------SGALKLADFGLSRAFT 216
           +++  Q+   + Y H   I   IHRDLK  NILI +        +  LK+ DFGL+R + 
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167
Query: 217 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG 268
               + +      W  P   ++ A ++S   D+WS G +  E++T +  F G
Sbjct: 168 -RTTKMSAAGAYAWMAPE--VIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y   +  +HR+L  +N+L+      K++DFGLS+A     + YT      W 
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGC-IFSEMSY 170
             +  PE  +  + +S+  D+WS G  ++  +SY
Sbjct: 503 LKWYAPEC-INFRKFSSRSDVWSYGVTMWEALSY 535

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L+Q+   ++Y   +  +HR+L  +N+L+      K++DFGLS+A     + YT      W
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              +  PE  +  + +S+  D+WS G    E ++
Sbjct: 502 PLKWYAPEC-INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKS-- 78
           E+ VL +L H PN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134
Query: 79  ------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                       +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            + +    +   W       L   VY+T  D+WS G +  E+
Sbjct: 195 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEI 234

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   + + +    +   W      
Sbjct: 154 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES- 212
Query: 237 LLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   VY+T  D+WS G +  E+++
Sbjct: 213 -LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 20/167 (11%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           E+     L  P ++ L+  +     + +  E L       L      +P   A  YL Q 
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 175
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           LE L Y HSRRI+H D+K  N+L++  G+   L DFG   A  +  +    +++T  Y P
Sbjct: 176 LEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKDLLTGDYIP 233
Query: 143 -------PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH 182
                  PE++LG +     VD+WS+ C+         +L  L  CH
Sbjct: 234 GTETHMAPEVVLG-RSCDAKVDVWSSCCM---------MLHMLNGCH 270

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 13/110 (11%)
Query: 162 GCIFSEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIP 218
           GC+  + +  YL Q LE L Y HSRRI+H D+K  N+L++  G+   L DFG   A  + 
Sbjct: 161 GCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQ 218
Query: 219 MNRYTHEVVTLWYRP-------PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +    +++T  Y P       PE++LG +     VD+WS+ C+   M+ 
Sbjct: 219 PDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDAKVDVWSSCCMMLHMLN 267

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 3/138 (2%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 91
           +HP  +RL         L+L  E     L+   +     +P A    YL   L AL + H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 92  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 151
           S+ ++H D+KP NI +   G  KL DFGL             E     Y  PE+L G+  
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQGS-- 231
Query: 152 YSTTVDIWSAGCIFSEMS 169
           Y T  D++S G    E++
Sbjct: 232 YGTAADVFSLGLTILEVA 249

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 53/121 (43%), Gaps = 4/121 (3%)
Query: 156 VDIWSAGCIFSEM-SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 214
            + W A    +++  YL   L AL + HS+ ++H D+KP NI +   G  KL DFGL   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 215 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ 274
                     E     Y  PE+L G+  Y T  D++S G    E+     L  G     Q
Sbjct: 207 LGTAGAGEVQEGDPR-YMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 275 L 275
           L
Sbjct: 264 L 264

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 93  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 152
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I   +
Sbjct: 153 PNAILKLTDFGFAKE-TTSHNSLTEPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 210
Query: 260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS---KLPIYKTDFPEWRPKKFSEILN 316
           +     F  +  +                + PG+    ++  Y+   PEW   + SE + 
Sbjct: 211 LCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW--SEVSEEVK 253
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPT 358
           +       +   ++  +P QR++    + H +  Q   V  T
Sbjct: 254 M-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKS-- 78
           E+ VL +L H PN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 65  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 124
Query: 79  ------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                       +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 184
Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            + +    +   W       L   VY+T  D+WS G +  E+
Sbjct: 185 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEI 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   + + +    +   W      
Sbjct: 144 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES- 202
Query: 237 LLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   VY+T  D+WS G +  E+++
Sbjct: 203 -LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+++H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKIRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 82/160 (51%), Gaps = 15/160 (9%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 132
            +  +   Q+   + Y      +HRDL   NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLAR--LIEDNEYTA 171
Query: 133 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVT 228
           Q+   + Y      +HRDL   NIL+ ++   K+ADFGL+R   I  N YT     +   
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPI 179
Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
            W  P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 180 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 199 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 253

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 101 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 160
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I   +
Sbjct: 161 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 218
Query: 260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS---KLPIYKTDFPEWRPKKFSEILN 316
           +     F  +  +                + PG+    ++  Y+   PEW   + SE + 
Sbjct: 219 LCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW--SEVSEEVK 261
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPT 358
           +       +   ++  +P QR++    + H +  Q   V  T
Sbjct: 262 M-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 296

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E  ++ +  H N+IRL  VI     + ++ E++    L  FL+              L
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT---HEVV 136
             +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W  P  I    + +++  D+WS G +  E M+Y
Sbjct: 214 IRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTY 246

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 6/98 (6%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYT--- 223
           +  L  +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            ++   W  P  I    + +++  D+WS G +  E++T
Sbjct: 210 GKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 145 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 204
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 205 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 259

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 100 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 159
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I   +
Sbjct: 160 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 217
Query: 260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS---KLPIYKTDFPEWRPKKFSEILN 316
           +     F  +  +                + PG+    ++  Y+   PEW   + SE + 
Sbjct: 218 LCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW--SEVSEEVK 260
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPT 358
           +       +   ++  +P QR++    + H +  Q   V  T
Sbjct: 261 M-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 295

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 95  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 155 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 24/160 (15%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 122
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---- 129
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA  +P N    
Sbjct: 123 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHX 178
Query: 130 -RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 179 VMQEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTH 224
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA  +P N        H
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHXVMQEH 183
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             V   +  PE  L  + +S   D W  G    EM T
Sbjct: 184 RKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 99  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 158
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I   +
Sbjct: 159 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 216
Query: 260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS---KLPIYKTDFPEWRPKKFSEILN 316
           +     F  +  +                + PG+    ++  Y+   PEW   + SE + 
Sbjct: 217 LCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW--SEVSEEVK 259
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPT 358
           +       +   ++  +P QR++    + H +  Q   V  T
Sbjct: 260 M-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 294

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 40  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 99
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N +
Sbjct: 100 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 159
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 160 VAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 218
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 219 LWEITSLAE 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 195 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 83
           E+     L  P ++ L+  +     + +  E L       L      +P   A  YL Q 
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 194
Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRP 142
           LE L Y HSRRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y P
Sbjct: 195 LEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKSLLTGDYIP 252
Query: 143 -------PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH 182
                  PE++LG +     VD+WS+ C+         +L  L  CH
Sbjct: 253 GTETHMAPEVVLG-RSCDAKVDVWSSCCM---------MLHMLNGCH 289

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 13/110 (11%)
Query: 162 GCIFSEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIP 218
           GC+  + +  YL Q LE L Y HSRRI+H D+K  N+L++  G+   L DFG   A  + 
Sbjct: 180 GCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQ 237
Query: 219 MNRYTHEVVTLWYRP-------PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +     ++T  Y P       PE++LG +     VD+WS+ C+   M+ 
Sbjct: 238 PDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCDAKVDVWSSCCMMLHMLN 286

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 95  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 155 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 24/160 (15%)
Query: 22  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 73
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 112
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---- 129
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA  +P N    
Sbjct: 113 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHX 168
Query: 130 -RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 169 VMQEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 207

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTH 224
           Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA  +P N        H
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHXVMQEH 173
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             V   +  PE  L  + +S   D W  G    EM T
Sbjct: 174 RKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 43  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 102
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N +
Sbjct: 103 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 162
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 163 VAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 221
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 222 LWEITSLAE 230

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 227

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 93  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 152
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I   +
Sbjct: 153 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 210
Query: 260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS---KLPIYKTDFPEWRPKKFSEILN 316
           +     F  +  +                + PG+    ++  Y+   PEW   + SE + 
Sbjct: 211 LCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW--SEVSEEVK 253
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPT 358
           +       +   ++  +P QR++    + H +  Q   V  T
Sbjct: 254 M-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 109 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 168
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I   +
Sbjct: 169 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 226
Query: 260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS---KLPIYKTDFPEWRPKKFSEILN 316
           +     F  +  +                + PG+    ++  Y+   PEW   + SE + 
Sbjct: 227 LCGYPPFYSNHGL---------------AISPGMKTRIRMGQYEFPNPEW--SEVSEEVK 269
Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPT 358
           +       +   ++  +P QR++    + H +  Q   V  T
Sbjct: 270 M-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 304

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 2/108 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L + H R II+RDLK  N++++  G +K+ADFG+ +   +          T 
Sbjct: 125 YAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTP 184
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            Y  PEI +  + Y  +VD W+ G +  EM+  +  F G+ E D+LF+
Sbjct: 185 DYIAPEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 230

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 94  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 153
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 256
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 154 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 43  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 102
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N +
Sbjct: 103 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 162
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 163 VAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 221
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 222 LWEITSLAE 230

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 227

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 73
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRY 131
            +  +   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R         R 
Sbjct: 116 LVDMAA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 173
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
             +    W  P   L G   ++   D+WS G + +E++
Sbjct: 174 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 209

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R         R   +    W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
             P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 182 TAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E+     L  P ++ L+  +     + +  E L       L      +P   A  YL 
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 171
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y
Sbjct: 172 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDY 229
Query: 141 RP-------PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH 182
            P       PE+++G K     VDIWS+ C+         +L  L  CH
Sbjct: 230 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCM---------MLHMLNGCH 268

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 13/110 (11%)
Query: 162 GCIFSEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIP 218
           GC+  + +  YL Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  + 
Sbjct: 159 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQ 216
Query: 219 MNRYTHEVVTLWYRP-------PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +     ++T  Y P       PE+++G K     VDIWS+ C+   M+ 
Sbjct: 217 PDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E+     L  P ++ L+  +     + +  E L       L      +P   A  YL 
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 157
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDY 215
Query: 141 RP-------PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH 182
            P       PE+++G K     VDIWS+ C+         +L  L  CH
Sbjct: 216 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCM---------MLHMLNGCH 254

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 13/110 (11%)
Query: 162 GCIFSEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIP 218
           GC+  + +  YL Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  + 
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQ 202
Query: 219 MNRYTHEVVTLWYRP-------PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +     ++T  Y P       PE+++G K     VDIWS+ C+   M+ 
Sbjct: 203 PDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 251

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 33/200 (16%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           +++AL + HS+  +IHRD+KP N+LIN  G +K+ DFG+S  + +     T +     Y 
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTIDAGCKPYM 220
Query: 233 PPEIL---LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI-FRTLGTPHED 288
            PE +   L  K YS   DIWS G    E+               + R  + + GTP + 
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIEL--------------AILRFPYDSWGTPFQQ 266
Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
           +        + +   P+    KFS          VD  S+ +  + K+R +   ++QH +
Sbjct: 267 LK------QVVEEPSPQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPF 313
Query: 349 FNQVEMVKPTLAVFPELGYG 368
           F   E     +A F +L  G
Sbjct: 314 FTLHESKGTDVASFVKLILG 333

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E+     L  P ++ L+  +     + +  E L       L      +P   A  YL 
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 173
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y
Sbjct: 174 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDY 231
Query: 141 RP-------PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH 182
            P       PE+++G K     VDIWS+ C+         +L  L  CH
Sbjct: 232 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCM---------MLHMLNGCH 270

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 13/110 (11%)
Query: 162 GCIFSEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIP 218
           GC+  + +  YL Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  + 
Sbjct: 161 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQ 218
Query: 219 MNRYTHEVVTLWYRP-------PEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +     ++T  Y P       PE+++G K     VDIWS+ C+   M+ 
Sbjct: 219 PDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 267

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    
Sbjct: 287 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KK 344
Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           +    V T  Y  PE+L     Y ++ D +S GC+  +++   + F
Sbjct: 345 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KK 345
Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           +    V T  Y  PE+L     Y ++ D +S GC+  +++   + F
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KK 345
Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           +    V T  Y  PE+L     Y ++ D +S GC+  +++   + F
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 164 IFSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 220
           +FSE     Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KK 345
Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLF 266
           +    V T  Y  PE+L     Y ++ D +S GC+  +++   + F
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL---QTTPVPVPP 73
           P + L E  ++K+LKH  +++L+ V+  +  +++V E++ +  L DFL   +   + +P 
Sbjct: 48  PESFLEEAQIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPN 106
Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRY 131
            +  +   Q+   + Y      IHRDL+  NIL+      K+ADFGL+R         R 
Sbjct: 107 LVDMAA--QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQ 164
Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +    W  P   L G   ++   D+WS G + +E+
Sbjct: 165 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 199

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+   + Y      IHRDL+  NIL+      K+ADFGL+R         R   +    W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
             P   L G   ++   D+WS G + +E++TK
Sbjct: 173 TAPEAALYGR--FTIKSDVWSFGILLTELVTK 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
           +   LA     Q+ + + Y HS+++IHRDLKP NI +  +  +K+ DFGL  +      R
Sbjct: 133 LDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 192
Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T    TL Y  PE  + ++ Y   VD+++ G I +E+
Sbjct: 193 -TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAEL 228

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+ + + Y HS+++IHRDLKP NI +  +  +K+ DFGL  +      R T    TL Y 
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTLRYM 202
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            PE  + ++ Y   VD+++ G I +E++
Sbjct: 203 SPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 43  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 102
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N +
Sbjct: 103 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 162
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 221
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 222 LWEITSLAE 230

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 35/200 (17%)
Query: 167 EMSYLYQ-LLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR- 221
           E S + Q +  AL + H++ I HRDLKP+NIL    N+   +K+ DF L     +  +  
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 222 --YTHEVVT----LWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
              T E++T      Y  PE++      A +Y    D+WS G I   +++    F G   
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG--- 228
Query: 272 IDQLFRIFRTLGTPHEDVWPGVSKLPIY-----KTDFPEWRPKKFSEILNLPDPLAVDVF 326
                R     G    +  P    +        K +FP+   K ++ I       A D+ 
Sbjct: 229 -----RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD---KDWAHI----SCAAKDLI 276
Query: 327 SKIMALDPKQRVSAKTILQH 346
           SK++  D KQR+SA  +LQH
Sbjct: 277 SKLLVRDAKQRLSAAQVLQH 296

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 144 EILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKPQNILINK-- 200
           E L G +++S   D         E S + + + EA++Y HS  I HRD+KP+N+L     
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198
Query: 201 -SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 255
            +  LKL DFG ++  T   N  T    T +Y  PE+ LG + Y  + D WS G I
Sbjct: 199 PNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDXWSLGVI 252

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 53/103 (51%), Gaps = 13/103 (12%)
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT---------IPMNRY- 131
           Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A            PM  Y 
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 132 TH--EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
           TH  +V T  Y  PE + G   YS  VDI+S G I  E+ Y +
Sbjct: 232 THXGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSF 273

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT---------IPMNRY- 222
           Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A            PM  Y 
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 223 TH--EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
           TH  +V T  Y  PE + G   YS  VDI+S G I  E++
Sbjct: 232 THXGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELL 270

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 23  REISVLKELKHP-NVIRLHDVI------PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPA 74
           +EI++LK+  H  N+   +          +D +L+LV EF     + D ++ T       
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 75  LAKSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
              +Y+  ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R   
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 134 EVVTLWYRPPEILLGAK----VYSTTVDIWSAGCIFSEMS 169
            + T ++  PE++   +     Y    D+WS G    EM+
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R    + T ++ 
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 233 PPEILLGAK----VYSTTVDIWSAGCIFSEM 259
            PE++   +     Y    D+WS G    EM
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKS-- 78
           E+ VL +L H PN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 72  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 131
Query: 79  ------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                       +   +   + Y   ++ IHR+L  +NIL+ ++   K+ADFGLSR   +
Sbjct: 132 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV 191
Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            + +    +   W       L   VY+T  D+WS G +  E+
Sbjct: 192 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEI 231

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 236
            + Y   ++ IHR+L  +NIL+ ++   K+ADFGLSR   + + +    +   W      
Sbjct: 151 GMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES- 209
Query: 237 LLGAKVYSTTVDIWSAGCIFSEMIT 261
            L   VY+T  D+WS G +  E+++
Sbjct: 210 -LNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 74
           P   L+E  V+K+L+H  +++L+ V+  +  + +V E++ +  L DFL  +T      P 
Sbjct: 47  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQ 105
Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 132
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R         R  
Sbjct: 106 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
            +    W  P   L G   ++   D+WS G + +E++
Sbjct: 165 AKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 199

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R         R   +    W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL----FAGDSEIDQLFRIFR 280
             P   L G   ++   D+WS G + +E+ TK  +          +DQ+ R +R
Sbjct: 172 TAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 223

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 42  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 101
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N +
Sbjct: 102 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 161
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 162 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 220
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 221 LWEITSLAE 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 197 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 226

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 24  EISVLKELKHPNVIRLHDVIPVDFK----LFLVFEFLRQD-LKDFLQTTPVPVPPALAKS 78
           E   LK L+HPN++R +D      K    + LV E      LK +L+   V     L +S
Sbjct: 75  EAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVL-RS 133
Query: 79  YLYQLLEALRYCHSRR--IIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEV 135
           +  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+   T+    +   V
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAV 190
Query: 136 V-TLWYRPPEILLGAKVYSTTVDIWSAG-CIFSEMSYLYQLLEALRYCHSRRIIHRDLKP 193
           + T  +  PE     + Y  +VD+++ G C     +  Y   E        R +   +KP
Sbjct: 191 IGTPEFXAPEXY--EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKP 248

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 35/187 (18%)
Query: 169 SYLYQLLEALRYCHSRR--IIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHE 225
           S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+   T+    +   
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKA 189
Query: 226 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           V+ T  +  PE     + Y  +VD+++ G    E  T +  +   SE     +I+R    
Sbjct: 190 VIGTPEFXAPEXY--EEKYDESVDVYAFGXCXLEXATSEYPY---SECQNAAQIYRR--- 241
Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
               V  GV      K   PE +                ++    +  +  +R S K +L
Sbjct: 242 ----VTSGVKPASFDKVAIPEVK----------------EIIEGCIRQNKDERYSIKDLL 281
Query: 345 QHEYFNQ 351
            H +F +
Sbjct: 282 NHAFFQE 288

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 43  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 102
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N +
Sbjct: 103 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 162
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 221
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 222 LWEITSLAE 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HRDL  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 227

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           +EI +L+ L H ++I+            L LV E++    L+D+L    +     LA+  
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI----GLAQLL 137
Query: 80  LY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
           L+  Q+ E + Y H++  IHRDL  +N+L++    +K+ DFGL++A  +P     + V  
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEXYRVRE 195
Query: 137 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  WY  PE L   K Y  + D+WS G    E+
Sbjct: 196 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYEL 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV----- 227
           Q+ E + Y H++  IHRDL  +N+L++    +K+ DFGL++A  +P     + V      
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEXYRVREDGDS 199
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              WY  PE L   K Y  + D+WS G    E++T
Sbjct: 200 PVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 24/175 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +L+ L H ++++         +  + LV E++    L+D+L    V +   L   +
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 116
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--- 136
             Q+ E + Y H++  IHR L  +N+L++    +K+ DFGL++A  +P     + V    
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 174
Query: 137 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIH 188
                WY  PE L   K Y  + D+WS G           L E L YC S +  H
Sbjct: 175 DSPVFWY-APECLKECKFYYAS-DVWSFGVT---------LYELLTYCDSNQSPH 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV----- 227
           Q+ E + Y H++  IHR L  +N+L++    +K+ DFGL++A  +P     + V      
Sbjct: 119 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDGDS 176
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              WY  PE L   K Y  + D+WS G    E++T
Sbjct: 177 PVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ Y+ +++ A+   H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 95  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILL-- 147
            +HRD+KP N+L++ +G ++LADFG      + MN     + +  V T  Y  PEIL   
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFG----SCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 148 --GAKVYSTTVDIWSAGCIFSEMSY 170
             G   Y    D WS G    EM Y
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLY 276

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 22/145 (15%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTH 224
           Y+ +++ A+   H    +HRD+KP N+L++ +G ++LADFG      + MN     + + 
Sbjct: 180 YIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG----SCLKMNDDGTVQSSV 235
Query: 225 EVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            V T  Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++   +I  
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPE 305
                HE+ +    + P + TD  E
Sbjct: 296 -----HEERF----QFPSHVTDVSE 311

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ Y+ +++ A+   H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 95  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILL-- 147
            +HRD+KP N+L++ +G ++LADFG      + MN     + +  V T  Y  PEIL   
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGS----CLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 148 --GAKVYSTTVDIWSAGCIFSEMSY 170
             G   Y    D WS G    EM Y
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLY 292

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 22/145 (15%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTH 224
           Y+ +++ A+   H    +HRD+KP N+L++ +G ++LADFG      + MN     + + 
Sbjct: 196 YIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGS----CLKMNDDGTVQSSV 251
Query: 225 EVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
            V T  Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++   +I  
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311
Query: 281 TLGTPHEDVWPGVSKLPIYKTDFPE 305
                HE+ +    + P + TD  E
Sbjct: 312 -----HEERF----QFPSHVTDVSE 327

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 24/175 (13%)
Query: 23  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           REI +L+ L H ++++         +  + LV E++    L+D+L    V +   L   +
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 117
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--- 136
             Q+ E + Y H++  IHR L  +N+L++    +K+ DFGL++A  +P     + V    
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 175
Query: 137 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIH 188
                WY  PE L   K Y  + D+WS G           L E L YC S +  H
Sbjct: 176 DSPVFWY-APECLKECKFYYAS-DVWSFGVT---------LYELLTYCDSNQSPH 219

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV----- 227
           Q+ E + Y H++  IHR L  +N+L++    +K+ DFGL++A  +P     + V      
Sbjct: 120 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDGDS 177
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              WY  PE L   K Y  + D+WS G    E++T
Sbjct: 178 PVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 23  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           +EI +L+ L H ++I+         +  L LV E++    L+D+L    + +   L   +
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--F 122
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--- 136
             Q+ E + Y HS+  IHR+L  +N+L++    +K+ DFGL++A  +P     + V    
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 180
Query: 137 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L   K Y  + D+WS G    E+
Sbjct: 181 DSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYEL 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV----- 227
           Q+ E + Y HS+  IHR+L  +N+L++    +K+ DFGL++A  +P     + V      
Sbjct: 125 QICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDGDS 182
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              WY  PE L   K Y  + D+WS G    E++T
Sbjct: 183 PVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 177 ALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T   N       T +Y  
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVA 178
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE+ LG + Y  + D+WS G I   ++     F  ++                + + PG+
Sbjct: 179 PEV-LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT---------------GQAISPGM 222
Query: 294 S---KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
               +L  Y    PEW     SE+       A  +   ++  DP +R++    + H + N
Sbjct: 223 KRRIRLGQYGFPNPEW-----SEV----SEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 273
Query: 351 QVEMVKPT 358
           Q  +V  T
Sbjct: 274 QSMVVPQT 281

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 177 ALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 233
           A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T   N       T +Y  
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVA 197
Query: 234 PEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV 293
           PE+ LG + Y  + D+WS G I   ++     F  ++                + + PG+
Sbjct: 198 PEV-LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT---------------GQAISPGM 241
Query: 294 S---KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
               +L  Y    PEW     SE+       A  +   ++  DP +R++    + H + N
Sbjct: 242 KRRIRLGQYGFPNPEW-----SEV----SEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292
Query: 351 QVEMVKPT 358
           Q  +V  T
Sbjct: 293 QSMVVPQT 300

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTIP--MNRYTH 224
           +SY +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + +   
Sbjct: 202 ISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W  P  I    K+YST  D+WS G +  E+ +
Sbjct: 262 RLPLKWMAPESIF--DKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           +++AL + HS+  +IHRD+KP N+LIN  G +K+ DFG+S      + +        +  
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 233 PPEI--LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           P  I   L  K YS   DIWS G    E+   +  F  DS            GTP + + 
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQLK 224
Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
                  + +   P+    KFS          VD  S+ +  + K+R +   ++QH +F 
Sbjct: 225 ------QVVEEPSPQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFFT 271
Query: 351 QVEMVKPTLAVFPELGYG 368
             E     +A F +L  G
Sbjct: 272 LHESKGTDVASFVKLILG 289

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 23  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 79
           +EI +L+ L H ++I+         +  L LV E++    L+D+L    + +   L   +
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--F 122
Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--- 136
             Q+ E + Y H++  IHR+L  +N+L++    +K+ DFGL++A  +P     + V    
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 180
Query: 137 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                WY  PE L   K Y  + D+WS G    E+
Sbjct: 181 DSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYEL 213

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV----- 227
           Q+ E + Y H++  IHR+L  +N+L++    +K+ DFGL++A  +P     + V      
Sbjct: 125 QICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDGDS 182
Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              WY  PE L   K Y  + D+WS G    E++T
Sbjct: 183 PVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 44  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 103
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HR+L  +N +
Sbjct: 104 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCM 163
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 164 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 222
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 223 LWEITSLAE 231

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/91 (23%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HR+L  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 199 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 5   ESRPRSRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL 56
           +    +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +
Sbjct: 43  KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 102
Query: 57  RQ-DLKDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNIL 106
              DLK +L       +  P   PP L +      ++ + + Y ++++ +HR+L  +N +
Sbjct: 103 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCM 162
Query: 107 INKSGALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 164
           +     +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVV 221
Query: 165 FSEMSYLYQ 173
             E++ L +
Sbjct: 222 LWEITSLAE 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/91 (23%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTLW 230
           ++ + + Y ++++ +HR+L  +N ++     +K+ DFG++R    T    +    ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L    V++T+ D+WS G +  E+ +
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITS 227

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 76/222 (34%)
Query: 20  TALREISVLKELKH-----PN---VIRLHDVIPVDFKL--------FLVFEFLRQDL-KD 62
           TAL EI +LK ++      PN   V++L D    DFK+         +VFE L   L K 
Sbjct: 73  TALDEIKLLKCVRESDPSDPNKDMVVQLID----DFKISGMNGIHVCMVFEVLGHHLLKW 128
Query: 63  FLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILI-------------- 107
            +++    +P    KS + Q+L+ L Y HS+ +IIH D+KP+NIL+              
Sbjct: 129 IIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEA 188
Query: 108 ---NKSGA------------------------------LKLADFGLSRAFTIPMNRYTHE 134
               K+GA                              +K+AD G +         +T +
Sbjct: 189 TEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNA---CWVHKHFTED 245
Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS---YLYQ 173
           + T  YR  E+L+GA  YST  DIWS  C+  E++   YL++
Sbjct: 246 IQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFE 286

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 70/170 (41%), Gaps = 58/170 (34%)
Query: 169 SYLYQLLEALRYCHSR-RIIHRDLKPQNILI-----------------NKSGA------- 203
           S + Q+L+ L Y HS+ +IIH D+KP+NIL+                  K+GA       
Sbjct: 144 SIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSA 203
Query: 204 -----------------------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 240
                                  +K+AD G +         +T ++ T  YR  E+L+GA
Sbjct: 204 VSTAPAADLLVNPLDPRNADKIRVKIADLGNA---CWVHKHFTEDIQTRQYRSIEVLIGA 260
Query: 241 KVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIFRTLGT 284
             YST  DIWS  C+  E+ T   LF   S      + D +  I   LG+
Sbjct: 261 G-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGS 309

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 34/182 (18%)
Query: 168 MSYLYQLLEALRYCHS---RRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYT 223
           MS+  Q  + + Y HS   + +IHRDLKP N+L+   G  LK+ DFG +      M   T
Sbjct: 106 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---T 162
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
           +   +  +  PE+  G+  YS   D++S G I  E+IT++  F    EI      FR + 
Sbjct: 163 NNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPF---DEIGG--PAFRIMW 216
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
             H    P     P+ K               NLP P+   + ++  + DP QR S + I
Sbjct: 217 AVHNGTRP-----PLIK---------------NLPKPIE-SLMTRCWSKDPSQRPSMEEI 255
Query: 344 LQ 345
           ++
Sbjct: 256 VK 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 34/182 (18%)
Query: 168 MSYLYQLLEALRYCHS---RRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYT 223
           MS+  Q  + + Y HS   + +IHRDLKP N+L+   G  LK+ DFG +      M   T
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---T 161
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
           +   +  +  PE+  G+  YS   D++S G I  E+IT++  F    EI      FR + 
Sbjct: 162 NNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPF---DEIGG--PAFRIMW 215
Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
             H    P     P+ K               NLP P+   + ++  + DP QR S + I
Sbjct: 216 AVHNGTRP-----PLIK---------------NLPKPIE-SLMTRCWSKDPSQRPSMEEI 254
Query: 344 LQ 345
           ++
Sbjct: 255 VK 256

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 24/184 (13%)
Query: 177 ALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMN-------RYTHEV 226
           AL + H++ I HRDLKP+NIL     K   +K+ DF L     +  +         T   
Sbjct: 123 ALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 227 VTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
            +  Y  PE++      A  Y    D+WS G +   M++    F G    D  +      
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVC 242
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
                 ++  + +    K +FP+   K ++ I       A D+ SK++  D KQR+SA  
Sbjct: 243 RVCQNKLFESIQE---GKYEFPD---KDWAHI----SSEAKDLISKLLVRDAKQRLSAAQ 292
Query: 343 ILQH 346
           +LQH
Sbjct: 293 VLQH 296

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 21  ALREISVLKELKHPNVIRLH---DVIPVDFK-------------LFLVFEFL-RQDLKDF 63
           A RE+  L +L H N++  +   D    D +             LF+  EF  +  L+ +
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110
Query: 64  LQTT-PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
           ++      +   LA     Q+ + + Y HS+++I+RDLKP NI +  +  +K+ DFGL  
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +      R   +  TL Y  PE  + ++ Y   VD+++ G I +E+
Sbjct: 171 SLKNDGKRXRSK-GTLRYMSPE-QISSQDYGKEVDLYALGLILAEL 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q+ + + Y HS+++I+RDLKP NI +  +  +K+ DFGL  +      R   +  TL Y 
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK-GTLRYM 188
Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMI 260
            PE  + ++ Y   VD+++ G I +E++
Sbjct: 189 SPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 57  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 116
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 117 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 176 FGLAR------DMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 135 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEXX 188
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 189 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 245
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 246 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 8/143 (5%)
Query: 36  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 94
           + +LH     +  L+LV E+ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 95  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYS 153
            +HRD+KP NIL+++ G ++LADFG           R    V T  Y  PEIL       
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 154 TT------VDIWSAGCIFSEMSY 170
            T       D W+ G    EM Y
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFY 265

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 9/122 (7%)
Query: 166 SEMS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RY 222
           +EM+  YL +++ A+   H    +HRD+KP NIL+++ G ++LADFG           R 
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 223 THEVVTLWYRPPEILLGAKVYSTT------VDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
              V T  Y  PEIL        T       D W+ G    EM   +T F  DS  +   
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
Query: 277 RI 278
           +I
Sbjct: 281 KI 282

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 2/108 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T 
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP 185
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            Y  PEI +  + Y  +VD W+ G +  EM+  +  F G+ E D+LF+
Sbjct: 186 DYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 231

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E  ++K L HP++++L  +I  +    ++  +   +L  +L+     +       Y  
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 138
           Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L   
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 139 WYRPPEILLGAKVYSTTVDIWS-AGCIFSEMSYLYQ 173
           W  P  I    + ++T  D+W  A C++  +S+  Q
Sbjct: 180 WMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQ 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRL 176
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              W  P  I    + ++T  D+W       E+++
Sbjct: 177 PIKWMSPESI--NFRRFTTASDVWMFAVCMWEILS 209

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E  ++K L HP++++L  +I  +    ++  +   +L  +L+     +       Y  
Sbjct: 73  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 132
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 138
           Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L   
Sbjct: 133 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 191
Query: 139 WYRPPEILLGAKVYSTTVDIWS-AGCIFSEMSYLYQ 173
           W  P  I    + ++T  D+W  A C++  +S+  Q
Sbjct: 192 WMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQ 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L
Sbjct: 130 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRL 188
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              W  P  I    + ++T  D+W       E+++
Sbjct: 189 PIKWMSPESI--NFRRFTTASDVWMFAVCMWEILS 221

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 62/230 (26%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-------------------------KSGAL 204
           Y  ++L+AL Y     + H DLKP+NIL++                         KS  +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 205 KLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT 264
           KL DFG +   T   + +   + T  YR PE++L    +  + D+WS GC+ +E+ T   
Sbjct: 202 KLIDFGCA---TFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSL 257
Query: 265 LFAGDSEIDQL---------------FRIFRTLGTPHED------VWP----GVSKLPIY 299
           LF     ++ L               +   +T G+ + +       WP     ++ +   
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 300 KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
           K   P ++  K          L  D    I+ +DP  R S   +L+H++ 
Sbjct: 318 KKCLPLYKIIKHE--------LFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 2/108 (1%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T 
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP 506
Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            Y  PEI +  + Y  +VD W+ G +  EM+  +  F G+ E D+LF+
Sbjct: 507 DYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 552

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 59  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 118
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 119 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 178 FGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 137 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT 196
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 197 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 251
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 252 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + E  ++K L HP++++L  +I  +    ++  +   +L  +L+     +       Y  
Sbjct: 57  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 116
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 138
           Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L   
Sbjct: 117 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 175
Query: 139 WYRPPEILLGAKVYSTTVDIWS-AGCIFSEMSYLYQ 173
           W  P  I    + ++T  D+W  A C++  +S+  Q
Sbjct: 176 WMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQ 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L
Sbjct: 114 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRL 172
Query: 230 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              W  P  I    + ++T  D+W       E+++
Sbjct: 173 PIKWMSPESI--NFRRFTTASDVWMFAVCMWEILS 205

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 59  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 118
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 119 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 178 FGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 231

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 137 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 196
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 197 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 251
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 252 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 58  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 117
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 118 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      +    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      +    N+ 
Sbjct: 136 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 196 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 250
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 56  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 115
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 116 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 175 FGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 134 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 193
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 194 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 248
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 249 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 57  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 116
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 117 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 176 FGLAR------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 135 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEYY 188
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 189 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 245
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 246 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 22  LREISVLKELK-HPNVIRLHDVIPV--------DFKLFLVFEFLRQDLKDFLQT--TPVP 70
           ++E+  +K+L  HPN+++      +          +  L+ E  +  L +FL+   +  P
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 71  VPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSR------ 122
           +         YQ   A+++ H ++  IIHRDLK +N+L++  G +KL DFG +       
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 123 --AFTIPMNRYTHEVVTL----WYRPPEILLGAKVYST-----TVDIWSAGCIF 165
             +++        E +T      YR PEI+    +YS        DIW+ GCI 
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEII---DLYSNFPIGEKQDIWALGCIL 243

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 22/108 (20%)
Query: 168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSR--------AFTI 217
           +   YQ   A+++ H ++  IIHRDLK +N+L++  G +KL DFG +         +++ 
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 218 PMNRYTHEVVTL----WYRPPEILLGAKVYST-----TVDIWSAGCIF 256
                  E +T      YR PEI+    +YS        DIW+ GCI 
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEII---DLYSNFPIGEKQDIWALGCIL 243

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 53  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 112
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 113 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      +    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 225

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      +    N+ 
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 191 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 245
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 246 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 58  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 117
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 118 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 136 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 196 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 250
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 56  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 115
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 116 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 175 FGLAR------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 134 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEYY 187
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 188 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 244
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 245 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 55  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 115 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 174 FGLAR------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 133 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEYY 186
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 243
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 244 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 58  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 117
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 118 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 136 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 196 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 250
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 76  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 135
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 136 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 194
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 195 FGLAR------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 248

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 154 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEYY 207
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 208 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 264
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 265 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 307

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 63  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 122
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 123 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 181
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 182 FGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 235

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 141 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 200
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 201 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 255
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 256 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 294

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 58  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 117
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 118 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 177 FGLAR------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 136 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEYY 189
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 190 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 246
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 247 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 50  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 109
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 110 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 168
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      +    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 169 FGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 222

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      +    N+ 
Sbjct: 128 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 187
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 188 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 242
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 243 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 281

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 77  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 136
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+AD
Sbjct: 137 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 195
Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      + Y  E  ++  +    L         L  + ++T  D+WS G +  E+
Sbjct: 196 FGLAR------DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R      + Y  E  
Sbjct: 155 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR------DMYDKEYY 208
Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           ++  +    L         L  + ++T  D+WS G +  E++T+      D      F I
Sbjct: 209 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI 265
Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
              L      + P     P+Y+     W PK      FSE+++
Sbjct: 266 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 308

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ- 58
           K+    +  +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  
Sbjct: 117 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 176
Query: 59  DLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
           DL++F++  T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+AD
Sbjct: 177 DLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 118 FGLSR-----AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R      F    N+   ++   W       L  + ++T  D+WS G +  E+
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWEL 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRY 222
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R      F    N+ 
Sbjct: 195 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
             ++   W       L  + ++T  D+WS G +  E++T+      D      F I   L
Sbjct: 255 GAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL 309
Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPK-----KFSEILN 316
                 + P     P+Y+     W PK      FSE+++
Sbjct: 310 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 56/113 (49%), Gaps = 7/113 (6%)
Query: 62  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGL 120
           D  QT P  +   +A S    +++AL + HS+  +IHRD+KP N+LIN  G +K  DFG+
Sbjct: 128 DKGQTIPEDILGKIAVS----IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGI 183
Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEI--LLGAKVYSTTVDIWSAGCIFSEMSYL 171
           S      + +        +  P  I   L  K YS   DIWS G    E++ L
Sbjct: 184 SGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAIL 236

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 31/196 (15%)
Query: 174 LLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           +++AL + HS+  +IHRD+KP N+LIN  G +K  DFG+S      + +        +  
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXA 204
Query: 233 PPEI--LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI-FRTLGTPHEDV 289
           P  I   L  K YS   DIWS G    E+               + R  + + GTP + +
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIEL--------------AILRFPYDSWGTPFQQL 250
Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
              V +        P+    KFS          VD  S+ +  + K+R +   + QH +F
Sbjct: 251 KQVVEEPS------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFF 297
Query: 350 NQVEMVKPTLAVFPEL 365
              E     +A F +L
Sbjct: 298 TLHESKGTDVASFVKL 313

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 24  EISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFL-RQDLKDFLQTTPVP------VP 72
           E+  L  +KH N+++          VD  L+L+  F  +  L DFL+   V       + 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 73  PALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
             +A+  +YL++ +  L+  H   I HRD+K +N+L+  +    +ADFGL+  F    + 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 131 Y-TH-EVVTLWYRPPEILLGAKVYSTT----VDIWSAGCIFSEMS 169
             TH +V T  Y  PE+L GA  +       +D+++ G +  E++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 13/127 (10%)
Query: 159 WSAGCIFSE-----MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
           W+  C  +E     ++YL++ +  L+  H   I HRD+K +N+L+  +    +ADFGL+ 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 214 AFTIPMNRY-TH-EVVTLWYRPPEILLGAKVYSTT----VDIWSAGCIFSEMITKKTLFA 267
            F    +   TH +V T  Y  PE+L GA  +       +D+++ G +  E+ ++ T  A
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT--A 237
Query: 268 GDSEIDQ 274
            D  +D+
Sbjct: 238 ADGPVDE 244

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE      L+ P+V+ +HD   +D +L++    +   DL   L+    P+ P  A + + 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQG-PLAPPRAVAIVR 141
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWY 140
           Q+  AL   H+    HRD+KP+NIL++      L DFG++ A T   + +  + V TL+Y
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 141 RPPEILLGAKVYST-TVDIWSAGCIFSE 167
             PE    ++ ++T   DI++  C+  E
Sbjct: 202 XAPERF--SESHATYRADIYALTCVLYE 227

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 188 HRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILLGAKVYST- 245
           HRD+KP+NIL++      L DFG++ A T   + +  + V TL+Y  PE    ++ ++T 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERF--SESHATY 214
Query: 246 TVDIWSAGCIFSEMITKKTLFAGD 269
             DI++  C+  E +T    + GD
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGD 238

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 78/230 (33%)
Query: 14  VEGVPSTALREISVLKELKH-----PN---VIRLHDVIPVDFKL--------FLVFEFLR 57
            E    TAL EI +LK +++     PN   V++L D    DFK+         +VFE L 
Sbjct: 73  AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD----DFKISGVNGTHICMVFEVLG 128
Query: 58  QDL-KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------- 108
             L K  +++    +P    K  + Q+L+ L Y H++ RIIH D+KP+NIL++       
Sbjct: 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188
Query: 109 ----------KSGA--------------------------------LKLADFGLSRAFTI 126
                     +SGA                                +K+AD G +     
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CW 245
Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS---YLYQ 173
               +T ++ T  YR  E+L+G+  Y+T  DIWS  C+  E++   YL++
Sbjct: 246 VHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFE 294

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 62/146 (42%), Gaps = 54/146 (36%)
Query: 171 LYQLLEALRYCHSR-RIIHRDLKPQNILIN-----------------KSGA--------- 203
           + Q+L+ L Y H++ RIIH D+KP+NIL++                 +SGA         
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 204 -----------------------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 240
                                  +K+AD G +         +T ++ T  YR  E+L+G+
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 241 KVYSTTVDIWSAGCIFSEMITKKTLF 266
             Y+T  DIWS  C+  E+ T   LF
Sbjct: 269 G-YNTPADIWSTACMAFELATGDYLF 293

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 78/230 (33%)
Query: 14  VEGVPSTALREISVLKELKH-----PN---VIRLHDVIPVDFKL--------FLVFEFLR 57
            E    TAL EI +LK +++     PN   V++L D    DFK+         +VFE L 
Sbjct: 57  AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD----DFKISGVNGTHICMVFEVLG 112
Query: 58  QDL-KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------- 108
             L K  +++    +P    K  + Q+L+ L Y H++ RIIH D+KP+NIL++       
Sbjct: 113 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 172
Query: 109 ----------KSGA--------------------------------LKLADFGLSRAFTI 126
                     +SGA                                +K+AD G +     
Sbjct: 173 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CW 229
Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS---YLYQ 173
               +T ++ T  YR  E+L+G+  Y+T  DIWS  C+  E++   YL++
Sbjct: 230 VHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFE 278

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 62/146 (42%), Gaps = 54/146 (36%)
Query: 171 LYQLLEALRYCHSR-RIIHRDLKPQNILIN-----------------KSGA--------- 203
           + Q+L+ L Y H++ RIIH D+KP+NIL++                 +SGA         
Sbjct: 136 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 195
Query: 204 -----------------------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 240
                                  +K+AD G +         +T ++ T  YR  E+L+G+
Sbjct: 196 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGS 252
Query: 241 KVYSTTVDIWSAGCIFSEMITKKTLF 266
             Y+T  DIWS  C+  E+ T   LF
Sbjct: 253 G-YNTPADIWSTACMAFELATGDYLF 277

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 178 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 206

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 177 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 235
Query: 285 P 285
           P
Sbjct: 236 P 236

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 54  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 111
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 112 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 172 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 200

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 111 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 171 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 229
Query: 285 P 285
           P
Sbjct: 230 P 230

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALR-- 88
           +HP+++ L        ++ L+++++   +LK  L  + +P      +  L   + A R  
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 89  -YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEI 145
            Y H+R IIHRD+K  NIL++++   K+ DFG+S+  T     +   VV  TL Y  PE 
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEY 212
Query: 146 LLGAKVYSTTVDIWSAGCIFSEM 168
            +  ++   + D++S G +  E+
Sbjct: 213 FIKGRLTEKS-DVYSFGVVLFEV 234

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPP 234
            L Y H+R IIHRD+K  NIL++++   K+ DFG+S+  T     +   VV  TL Y  P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 235 EILLGAKVYSTTVDIWSAGCIFSEMITKKT 264
           E  +  ++   + D++S G +  E++  ++
Sbjct: 211 EYFIKGRLTEKS-DVYSFGVVLFEVLCARS 239

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 38/173 (21%)
Query: 22  LREISVLKELKHPNVIRLHDV--------IPVDFKLFLVFEFLR-QDLKDFL-----QTT 67
           L E + +K+  HPNVIRL  V        IP   K  ++  F++  DL  +L     +T 
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIP---KPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
           P  +P      ++  +   + Y  +R  +HRDL  +N ++     + +ADFGLS+     
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--- 197
Query: 128 MNRYTHEVVTLWYRPPEIL-----------LGAKVYSTTVDIWSAGCIFSEMS 169
              Y+ +    +YR   I            L  +VY++  D+W+ G    E++
Sbjct: 198 ---YSGD----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 117
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 178 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 177 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 235
Query: 285 P 285
           P
Sbjct: 236 P 236

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 113
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 174 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 202

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 173 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 285 P 285
           P
Sbjct: 232 P 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 133
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 194 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 222

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 193 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 251
Query: 285 P 285
           P
Sbjct: 252 P 252

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 133
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 194 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 193 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 251
Query: 285 P 285
           P
Sbjct: 252 P 252

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 123
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 184 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 183 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241
Query: 285 P 285
           P
Sbjct: 242 P 242

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 74  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 131
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 132 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 192 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 191 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 249
Query: 285 P 285
           P
Sbjct: 250 P 250

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 211 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 231

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALR-- 88
           +HP+++ L        ++ L+++++   +LK  L  + +P      +  L   + A R  
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 89  -YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEI 145
            Y H+R IIHRD+K  NIL++++   K+ DFG+S+  T     +   VV  TL Y  PE 
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEY 212
Query: 146 LLGAKVYSTTVDIWSAGCIFSEM 168
            +  ++   + D++S G +  E+
Sbjct: 213 FIKGRLTEKS-DVYSFGVVLFEV 234

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPP 234
            L Y H+R IIHRD+K  NIL++++   K+ DFG+S+  T     +   VV  TL Y  P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 235 EILLGAKVYSTTVDIWSAGCIFSEMITKKT 264
           E  +  ++   + D++S G +  E++  ++
Sbjct: 211 EYFIKGRLTEKS-DVYSFGVVLFEVLCARS 239

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 211 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 256

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 57/110 (51%), Gaps = 4/110 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q    + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 230 WYRPPEI-LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           W  P  I +  +  YS   D+++ G +  E++T +  ++  +  DQ+  +
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 202 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 257

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 201 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 261 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 295

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 202 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ E + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 117 LNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 177 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 185 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL---LGAK 241
           +IIHRD+KP NIL+++SG +KL DFG+S      + + T +     Y  PE +      +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSASRQ 204
Query: 242 VYSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFR 280
            Y    D+WS G    E+ T +  +   +S  DQL ++ +
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 151 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 211 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 203 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 263 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 249

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 230 WYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTP 285
           W  P  I +  K  YS   D+++ G +  E++T +  ++  +  DQ +F + R   +P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 257

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 57/110 (51%), Gaps = 4/110 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q    + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 230 WYRPPEI-LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           W  P  I +  +  YS   D+++ G +  E++T +  ++  +  DQ+  +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 81/149 (54%), Gaps = 18/149 (12%)
Query: 28  LKELKHPNVIRLHDVIP-----VDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
           L E+ HP+++++ + +       D   ++V E++  Q LK   ++    +P A A +YL 
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYLL 189
Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG-LSRAFTIPMNRYTHEVVTLWY 140
           ++L AL Y HS  +++ DLKP+NI++ +   LKL D G +SR     +N + +   T  +
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGYLYGTPGF 243
Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           + PEI+      +T  DI++ G   + ++
Sbjct: 244 QAPEIVRTGPTVAT--DIYTVGRTLAALT 270

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG-LSRAFTIPMNRY 222
           +   ++YL ++L AL Y HS  +++ DLKP+NI++ +   LKL D G +SR     +N +
Sbjct: 181 VAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSF 234
Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 259
            +   T  ++ PEI+      +T  DI++ G   + +
Sbjct: 235 GYLYGTPGFQAPEIVRTGPTVAT--DIYTVGRTLAAL 269

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 256 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 290

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 57/110 (51%), Gaps = 4/110 (3%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT---L 229
           Q    + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E ++   L
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 230 WYRPPEI-LLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           W  P  I +  +  YS   D+++ G +  E++T +  ++  +  DQ+  +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 419 LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELV 476
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 477 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 537 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 565

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 476 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 536 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 594
Query: 285 P 285
           P
Sbjct: 595 P 595

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 211 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 194 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 254 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 288

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 418 LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELV 475
Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 139
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 476 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 140 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 167
             +  PE +   K +S+  D+WS G +  E
Sbjct: 536 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 564

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 7/121 (5%)
Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W
Sbjct: 475 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 231 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT---KKTLFAGDSEIDQLFRIFRTLGT 284
              +  PE +   K +S+  D+WS G +  E  +   K       SE+  +      +G 
Sbjct: 535 PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 593
Query: 285 P 285
           P
Sbjct: 594 P 594

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 211 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 213 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 202 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 202 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 248 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 282

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 4/147 (2%)
Query: 27  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 86
           VLK    P +++       +  +F+  E +    +   +    P+P  +       +++A
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 87  LRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 145
           L Y   +  +IHRD+KP NIL+++ G +KL DFG+S        +        +  P  I
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
Query: 146 LLGAKV---YSTTVDIWSAGCIFSEMS 169
                    Y    D+WS G    E++
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELA 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 4/94 (4%)
Query: 174 LLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           +++AL Y   +  +IHRD+KP NIL+++ G +KL DFG+S        +        +  
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 233 PPEILLGAKV---YSTTVDIWSAGCIFSEMITKK 263
           P  I         Y    D+WS G    E+ T +
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 24/177 (13%)
Query: 13  QVEGVPSTALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL------ 64
           + EG      R  ++L+  L+HPNV+ L  V+  D  L ++F +    DL +FL      
Sbjct: 50  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 65  ---------QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 115
                    +T    + P      + Q+   + Y  S  ++H+DL  +N+L+     +K+
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 169
Query: 116 ADFGLSRAFTIPMNRYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +D GL R      + Y     +L    W  P  I+ G   +S   DIWS G +  E+
Sbjct: 170 SDLGLFRE-VYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEV 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 12/145 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 229
           Q+   + Y  S  ++H+DL  +N+L+     +K++D GL R      + Y     +L   
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYKLLGNSLLPI 194
Query: 230 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL-FAGDSEID--QLFRIFRTLGTP 285
            W  P  I+ G   +S   DIWS G +  E+ +     + G S  D  ++ R  + L  P
Sbjct: 195 RWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP 252
Query: 286 HEDVWPGVSKLPIYK-TDFPEWRPK 309
            +D    V  L I    +FP  RP+
Sbjct: 253 -DDCPAWVYALMIECWNEFPSRRPR 276

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 207 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 24/177 (13%)
Query: 13  QVEGVPSTALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL------ 64
           + EG      R  ++L+  L+HPNV+ L  V+  D  L ++F +    DL +FL      
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 65  ---------QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 115
                    +T    + P      + Q+   + Y  S  ++H+DL  +N+L+     +K+
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 186
Query: 116 ADFGLSRAFTIPMNRYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +D GL R      + Y     +L    W  P  I+ G   +S   DIWS G +  E+
Sbjct: 187 SDLGLFRE-VYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEV 240

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 12/145 (8%)
Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 229
           Q+   + Y  S  ++H+DL  +N+L+     +K++D GL R      + Y     +L   
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYKLLGNSLLPI 211
Query: 230 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL-FAGDSEID--QLFRIFRTLGTP 285
            W  P  I+ G   +S   DIWS G +  E+ +     + G S  D  ++ R  + L  P
Sbjct: 212 RWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP 269
Query: 286 HEDVWPGVSKLPIYK-TDFPEWRPK 309
            +D    V  L I    +FP  RP+
Sbjct: 270 -DDCPAWVYALMIECWNEFPSRRPR 293

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            + L +  PE +   +VY+   D+WS G +  E+ +
Sbjct: 207 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 6   SRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDF 63
           SR     QVE      LRE  +++ L HPNV+ L  ++  P      L+      DL  F
Sbjct: 58  SRITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113
Query: 64  LQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 123
           +++           S+  Q+   + Y   ++ +HRDL  +N ++++S  +K+ADFGL+R 
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
Query: 124 FT----IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                   + ++ H  + + +   E L   + ++T  D+WS G +  E+
Sbjct: 174 ILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWEL 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT----IPMNRYT 223
           +S+  Q+   + Y   ++ +HRDL  +N ++++S  +K+ADFGL+R         + ++ 
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT 264
           H  + + +   E L   + ++T  D+WS G +  E++T+  
Sbjct: 187 HARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGA 226

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 130 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 190 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 224

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 145 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 205 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 239

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 122 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 182 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 124 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 184 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 121 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 181 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 121 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 181 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 122 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 182 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 123 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 183 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 123 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 226 -VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            V   W     IL   ++Y+   D+WS G    E++T
Sbjct: 183 KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	562
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-113
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-101
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-112
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-99
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-110
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-100
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-110
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-110
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-99
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-109
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-108
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-106
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-106
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-101
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-106
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-98
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-105
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-98
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-105
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-89
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-101
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-83
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-85
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-68
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-80
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-65
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-79
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-65
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-77
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-62
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-74
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-56
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-68
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-62
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-65
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-49
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-64
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-50
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-64
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-50
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-07
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-64
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-51
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-63
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-50
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-07
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-63
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-53
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-62
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-50
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-06
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-59
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-47
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-06
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-59
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-47
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-57
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-48
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-54
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-49
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-44
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-44
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-38
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-43
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-43
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-42
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-40
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-40
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-39
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-32
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-39
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-38
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-38
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-32
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-38
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-38
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-38
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-26
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-36
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-33
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-35
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-35
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-35
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-35
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-35
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-29
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-34
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-34
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-34
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-34
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-34
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-34
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-34
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-27
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-34
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-34
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-34
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-34
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-34
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-34
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-34
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-27
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-34
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-31
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-33
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-33
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-32
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-33
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-33
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-31
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-33
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-33
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-33
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-33
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-33
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-32
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-32
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-30
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-31
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-31
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-31
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-31
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-30
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-23
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-28
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-27
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-27
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-19
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-18
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-16
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-25
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-21
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-24
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-12
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-13
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-11
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-11
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-22
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-10
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-11
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-13
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-11
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-10
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-10
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-09
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-08
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-08
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-07
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-08

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  336 bits (865), Expect = e-113
 Identities = 102/184 (55%), Positives = 134/184 (72%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE+VT
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++L+G+K YSTT+DIWS GCIF+EM+    LF G SE DQL RIFR LGTP+  
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP V++LP Y  +F  + P  +   L   D   +D+ SK++ LDP QR++AK  L+H Y
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

Query: 349 FNQV 352
           F + 
Sbjct: 284 FKEN 287

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  307 bits (789), Expect = e-101
 Identities = 95/154 (61%), Positives = 121/154 (78%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L      +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
            AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +VTLWYR P++L+G+K YSTT+DIWS GCIF+EM
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  102 bits (258), Expect = 1e-24
 Identities = 29/71 (40%), Positives = 39/71 (54%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E +    LF G SE DQL RIFR LGTP+   WP V++LP Y  +F  + P  +   L  
Sbjct: 193 EMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG 252

Query: 551 PDPLAVDVFSR 561
            D   +D+ S+
Sbjct: 253 LDESGIDLLSK 263

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  102 bits (256), Expect = 3e-24
 Identities = 38/71 (53%), Positives = 50/71 (70%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+++  
Sbjct: 196 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

Query: 551 PDPLAVDVFSR 561
            D     + S+
Sbjct: 256 LDEDGRSLLSQ 266

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  330 bits (849), Expect = e-110
 Identities = 100/186 (53%), Positives = 132/186 (70%), Gaps = 1/186 (0%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHEVVT
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++L+G+K YST+VDIWS GCIF+EMIT K LF G ++ DQL +IF  LGTP+  
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 289 VWPGVSKLPIYKTD-FPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
            WP V +LP++K   F  +  K +S I+       +D+ S ++  DP +R+SA+  + H 
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302

Query: 348 YFNQVE 353
           YF  ++
Sbjct: 303 YFKDLD 308

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  304 bits (782), Expect = e-100
 Identities = 97/154 (62%), Positives = 119/154 (77%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG+PSTA+REIS+LKEL HPN++ L DVI  +  L LVFEF+ +DLK  L      +  +
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHE
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYR P++L+G+K YST+VDIWS GCIF+EM
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEM 213

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 28/72 (38%), Positives = 40/72 (55%), Gaps = 1/72 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWRPKKFSEILN 549
           E IT K LF G ++ DQL +IF  LGTP+   WP V +LP++K   F  +  K +S I+ 
Sbjct: 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP 271

Query: 550 LPDPLAVDVFSR 561
                 +D+ S 
Sbjct: 272 GFCQEGIDLLSN 283

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  330 bits (848), Expect = e-110
 Identities = 90/194 (46%), Positives = 128/194 (65%), Gaps = 5/194 (2%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            + +QLL+ L +CH  +I+HRDLKPQN+LINK G LKL DFGL+RAF IP+N ++ EVVT
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR P++L+G++ YST++DIWS GCI +EMIT K LF G ++ +QL  IF  +GTP+E 
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLP-----DPLAVDVFSKIMALDPKQRVSAKTI 343
           +WP V+KLP Y  +  +  P+   ++L        D   +D    ++ L+P  R+SAK  
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 344 LQHEYFNQVEMVKP 357
           L H +F +      
Sbjct: 292 LHHPWFAEYYHHAS 305

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  298 bits (765), Expect = 1e-97
 Identities = 91/159 (57%), Positives = 122/159 (76%), Gaps = 5/159 (3%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-----TPV 69
           EG PSTA+REIS++KELKH N++RL+DVI  + KL LVFEF+  DLK ++ +     TP 
Sbjct: 44  EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR 103

Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
            +   L K + +QLL+ L +CH  +I+HRDLKPQN+LINK G LKL DFGL+RAF IP+N
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            ++ EVVTLWYR P++L+G++ YST++DIWS GCI +EM
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 5/76 (6%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E IT K LF G ++ +QL  IF  +GTP+E +WP V+KLP Y  +  +  P+   ++L  
Sbjct: 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQP 260

Query: 551 P-----DPLAVDVFSR 561
                 D   +D    
Sbjct: 261 HTKEPLDGNLMDFLHG 276

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  330 bits (848), Expect = e-110
 Identities = 88/198 (44%), Positives = 127/198 (64%), Gaps = 1/198 (0%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            +L+QLL  L YCH ++++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y +EVVT
Sbjct: 104 LFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT 163

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYRPP+ILLG+  YST +D+W  GCIF EM T + LF G +  +QL  IFR LGTP E+
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223

Query: 289 VWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
            WPG+     +KT ++P++R +         D    D+ +K++  + + R+SA+  ++H 
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283

Query: 348 YFNQVEMVKPTLAVFPEL 365
           +F  +      L     +
Sbjct: 284 FFLSLGERIHKLPDTTSI 301

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  302 bits (776), Expect = 4e-99
 Identities = 87/154 (56%), Positives = 114/154 (74%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EG P TA+RE+S+LK+LKH N++ LHD+I  +  L LVFE+L +DLK +L      +   
Sbjct: 41  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMH 100

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K +L+QLL  L YCH ++++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y +E
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYRPP+ILLG+  YST +D+W  GCIF EM
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 194

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 1/72 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILN 549
           E  T + LF G +  +QL  IFR LGTP E+ WPG+     +KT ++P++R +       
Sbjct: 193 EMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAP 252

Query: 550 LPDPLAVDVFSR 561
             D    D+ ++
Sbjct: 253 RLDSDGADLLTK 264

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  327 bits (841), Expect = e-109
 Identities = 100/192 (52%), Positives = 139/192 (72%), Gaps = 6/192 (3%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-----GALKLADFGLSRAFTIPMNRYT 223
           S+LYQL+  + +CHSRR +HRDLKPQN+L++ S       LK+ DFGL+RAF IP+ ++T
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
           HE++TLWYRPPEILLG++ YST+VDIWS  CI++EM+ K  LF GDSEIDQLF+IF  LG
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL-NLPDPLAVDVFSKIMALDPKQRVSAKT 342
            P +  WPGV+ LP +K  FP++R K    +L  L D   +D+ + ++ +DP +R+SAK 
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315

Query: 343 ILQHEYFNQVEM 354
            L+H YF+  + 
Sbjct: 316 ALEHPYFSHNDF 327

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  291 bits (748), Expect = 8e-95
 Identities = 87/159 (54%), Positives = 119/159 (74%), Gaps = 6/159 (3%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVP TA+RE+S+LKEL+H N+I L  VI  + +L L+FE+   DLK ++   P  V   
Sbjct: 74  EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMR 132

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-----GALKLADFGLSRAFTIPMN 129
           + KS+LYQL+  + +CHSRR +HRDLKPQN+L++ S       LK+ DFGL+RAF IP+ 
Sbjct: 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           ++THE++TLWYRPPEILLG++ YST+VDIWS  CI++EM
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (255), Expect = 6e-24
 Identities = 33/72 (45%), Positives = 44/72 (61%), Gaps = 1/72 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL-N 549
           E + K  LF GDSEIDQLF+IF  LG P +  WPGV+ LP +K  FP++R K    +L  
Sbjct: 230 EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA 289

Query: 550 LPDPLAVDVFSR 561
           L D   +D+ + 
Sbjct: 290 LLDDEGLDLLTA 301

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  326 bits (838), Expect = e-108
 Identities = 77/182 (42%), Positives = 114/182 (62%), Gaps = 1/182 (0%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   YTH+VVT
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PE+L GA++Y   VD+W+ GCI +E++ +     GDS++DQL RIF TLGTP E+
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP +  LP Y T F  +       I +      +D+   +   +P  R++A   L+ +Y
Sbjct: 236 QWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

Query: 349 FN 350
           F+
Sbjct: 295 FS 296

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  300 bits (771), Expect = 5e-98
 Identities = 71/154 (46%), Positives = 105/154 (68%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           +G+  TALREI +L+EL HPN+I L D       + LVF+F+  DL+  ++   + + P+
Sbjct: 53  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 112

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K+Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   YTH+
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT WYR PE+L GA++Y   VD+W+ GCI +E+
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 25/71 (35%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E + +     GDS++DQL RIF TLGTP E+ WP +  LP Y T F  +       I + 
Sbjct: 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSA 263

Query: 551 PDPLAVDVFSR 561
                +D+   
Sbjct: 264 AGDDLLDLIQG 274

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  322 bits (827), Expect = e-106
 Identities = 84/191 (43%), Positives = 115/191 (60%), Gaps = 4/191 (2%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++  M   T  VVT
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVT 182

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G S++DQL +I   +G P E+
Sbjct: 183 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP    LP     F     +   + +   D L  D+  K +  +P +R+SA + L H Y
Sbjct: 242 DWPRDVALPRQA--FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

Query: 349 FNQVEMVKPTL 359
           F  +E  K  L
Sbjct: 300 FQDLERCKENL 310

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  281 bits (721), Expect = 7e-91
 Identities = 84/163 (51%), Positives = 110/163 (67%), Gaps = 11/163 (6%)

Query: 15  EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 66
           EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL  +L  
Sbjct: 52  EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 111

Query: 67  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM
Sbjct: 172 FQM-ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEM 212

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 21/71 (29%), Positives = 32/71 (45%), Gaps = 2/71 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E   +K LF G S++DQL +I   +G P E+ WP    LP     F     +   + +  
Sbjct: 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA--FHSKSAQPIEKFVTD 268

Query: 551 PDPLAVDVFSR 561
            D L  D+  +
Sbjct: 269 IDELGKDLLLK 279

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  320 bits (823), Expect = e-106
 Identities = 95/186 (51%), Positives = 132/186 (70%), Gaps = 3/186 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ EVVT
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
           LWYRPP++L GAK+YST++D+WSAGCIF+E+      LF G+   DQL RIFR LGTP E
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 288 DVWPGVSKLPIYKTDFPEW-RPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           + WP ++KLP YK  +P +        ++   +    D+   ++  +P QR+SA+  LQH
Sbjct: 225 EQWPSMTKLPDYKP-YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

Query: 347 EYFNQV 352
            YF+  
Sbjct: 284 PYFSDF 289

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  305 bits (784), Expect = e-101
 Identities = 97/154 (62%), Positives = 127/154 (82%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.3 bits (220), Expect = 2e-19
 Identities = 24/68 (35%), Positives = 35/68 (51%), Gaps = 2/68 (2%)

Query: 495 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW-RPKKFSEILNLPDP 553
            + LF G+   DQL RIFR LGTP E+ WP ++KLP YK  +P +        ++   + 
Sbjct: 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP-YPMYPATTSLVNVVPKLNA 257

Query: 554 LAVDVFSR 561
              D+   
Sbjct: 258 TGRDLLQN 265

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  320 bits (822), Expect = e-106
 Identities = 68/191 (35%), Positives = 105/191 (54%), Gaps = 2/191 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            YL+Q++  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   Y  EV T
Sbjct: 128 KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PE+L+G   Y   VD+W+ GC+ +EM   + LF GDS+IDQL+ I   LG     
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247

Query: 289 VWPGVSKLPIYK-TDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                +K P++     PE + ++           + +D+  K + +DP +R     +L H
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307

Query: 347 EYFNQVEMVKP 357
           ++F      + 
Sbjct: 308 DFFQMDGFAER 318

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  299 bits (769), Expect = 5e-98
 Identities = 64/154 (41%), Positives = 98/154 (63%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           + V   A+REI +LK+L+H N++ L +V     + +LVFEF+   + D L+  P  +   
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ 124

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           + + YL+Q++  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   Y  E
Sbjct: 125 VVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           V T WYR PE+L+G   Y   VD+W+ GC+ +EM
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 18/73 (24%), Positives = 31/73 (42%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKK-FSEIL 548
           E    + LF GDS+IDQL+ I   LG          +K P++     PE + ++      
Sbjct: 217 EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY 276

Query: 549 NLPDPLAVDVFSR 561
                + +D+  +
Sbjct: 277 PKLSEVVIDLAKK 289

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  319 bits (819), Expect = e-105
 Identities = 64/191 (33%), Positives = 102/191 (53%), Gaps = 2/191 (1%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           S  +Q L+A+ +CH    IHRD+KP+NILI K   +KL DFG +R  T P + Y  EV T
Sbjct: 106 SITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PE+L+G   Y   VD+W+ GC+F+E+++   L+ G S++DQL+ I +TLG     
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225

Query: 289 VWPGVSKLPIYK-TDFPEWRPKK-FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                S    +     P+    +            A+ +    + +DP +R++ + +L H
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285

Query: 347 EYFNQVEMVKP 357
            YF  +  ++ 
Sbjct: 286 PYFENIREIED 296

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  299 bits (769), Expect = 3e-98
 Identities = 68/154 (44%), Positives = 93/154 (60%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
             +   ALREI +LK+LKHPN++ L +V     +L LVFE+    +   L      VP  
Sbjct: 43  PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEH 102

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           L KS  +Q L+A+ +CH    IHRD+KP+NILI K   +KL DFG +R  T P + Y  E
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           V T WYR PE+L+G   Y   VD+W+ GC+F+E+
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.5 bits (223), Expect = 8e-20
 Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKK-FSEIL 548
           E ++   L+ G S++DQL+ I +TLG          S    +     P+    +      
Sbjct: 195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF 254

Query: 549 NLPDPLAVDVFSR 561
                 A+ +   
Sbjct: 255 PNISYPALGLLKG 267

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  318 bits (818), Expect = e-105
 Identities = 79/185 (42%), Positives = 111/185 (60%), Gaps = 4/185 (2%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  M   T  VVT
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVT 182

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           LWYR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G+SE DQL +IF  +G P ED
Sbjct: 183 LWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
            WP    LP     FP   P+    ++   +     +  +++  +P +R+SA   LQH Y
Sbjct: 242 DWPRDVSLPRGA--FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

Query: 349 FNQVE 353
            ++ E
Sbjct: 300 LHKDE 304

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  276 bits (708), Expect = 4e-89
 Identities = 75/163 (46%), Positives = 105/163 (64%), Gaps = 11/163 (6%)

Query: 15  EGVPSTALREISVLKELK---HPNVIRLHDVI-----PVDFKLFLVFEFLRQDLKDFLQT 66
            G+P + +RE+++L+ L+   HPNV+RL DV        + K+ LVFE + QDL+ +L  
Sbjct: 52  GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK 111

Query: 67  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM
Sbjct: 172 YQM-ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEM 212

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 23/71 (32%), Positives = 32/71 (45%), Gaps = 2/71 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E   +K LF G+SE DQL +IF  +G P ED WP    LP     FP   P+    ++  
Sbjct: 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA--FPPRGPRPVQSVVPE 268

Query: 551 PDPLAVDVFSR 561
            +     +   
Sbjct: 269 MEESGAQLLLE 279

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  309 bits (793), Expect = e-101
 Identities = 78/190 (41%), Positives = 116/190 (61%), Gaps = 7/190 (3%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTH 224
             +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++  N    RYT+
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            VVTLWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I +  G+
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247

Query: 285 PHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQRVSAK 341
              +VWP V    +Y+  +  + + +K  + L   + DP A+D+  K++ LDP QR+ + 
Sbjct: 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 307

Query: 342 TILQHEYFNQ 351
             L H++F  
Sbjct: 308 DALNHDFFWS 317

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  273 bits (701), Expect = 1e-87
 Identities = 76/166 (45%), Positives = 100/166 (60%), Gaps = 12/166 (7%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVI--------PVDFKLFLVFEFLRQDLKDFLQT 66
           EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L  
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 127 PMN----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             N    RYT+ VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 19/74 (25%), Positives = 37/74 (50%), Gaps = 3/74 (4%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILN 549
           E  T+  +  G++E  QL  I +  G+   +VWP V    +Y+  +  + + +K  + L 
Sbjct: 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 280

Query: 550 --LPDPLAVDVFSR 561
             + DP A+D+  +
Sbjct: 281 AYVRDPYALDLIDK 294

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  295 bits (757), Expect = 3e-95
 Identities = 76/219 (34%), Positives = 118/219 (53%), Gaps = 27/219 (12%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTH 224
           S LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+AD G +R F  P+     
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 225 ---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI--------- 272
               VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++T + +F    E          
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS---------EILNLPDPLAV 323
           DQL RIF  +G P +  W  + K+P + T   ++R   ++         +    PD  A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311

Query: 324 DVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVF 362
            +  K++ +DP +R++++  +Q  YF   E   PT  VF
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFL--EDPLPTSDVF 348

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  263 bits (673), Expect = 8e-83
 Identities = 71/175 (40%), Positives = 106/175 (60%), Gaps = 17/175 (9%)

Query: 11  RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFL---- 64
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   +    
Sbjct: 55  QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114

Query: 65  ----QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLA 116
                  PV +P  + KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 117 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E+
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 18/89 (20%)

Query: 491 ESITKKTLFAGDSEI---------DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP 541
           E +T + +F    E          DQL RIF  +G P +  W  + K+P + T   ++R 
Sbjct: 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 287

Query: 542 KKFS---------EILNLPDPLAVDVFSR 561
             ++         +    PD  A  +  +
Sbjct: 288 NTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  269 bits (691), Expect = 1e-85
 Identities = 75/202 (37%), Positives = 115/202 (56%), Gaps = 7/202 (3%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV 227
            Y+YQLL +L Y HS  I HRD+KPQN+L++  SG LKL DFG ++   I        + 
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYIC 203

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + +YR PE++ GA  Y+T +DIWS GC+ +E++  + LF G+S IDQL  I + LGTP  
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           +    ++     +  FP+ RP  FS++      P A+D+ S+++   P  R++A   L H
Sbjct: 264 EQIKTMNPN-YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322

Query: 347 EYFNQV---EMVKPTLAVFPEL 365
            +F+++   E   P     P L
Sbjct: 323 PFFDELRTGEARMPNGRELPPL 344

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  224 bits (574), Expect = 3e-68
 Identities = 61/175 (34%), Positives = 94/175 (53%), Gaps = 21/175 (12%)

Query: 22  LREISVLKELKHPNVIRLHDVI------PVDFKLFLVFEFLRQDLKDFLQTTPV---PVP 72
            RE+ +++ +KHPNV+ L            +  L LV E++ + +    +        +P
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRY 131
             L K Y+YQLL +L Y HS  I HRD+KPQN+L++  SG LKL DFG ++   I     
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPN 198

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQLLE 176
              + + +YR PE++ GA  Y+T +DIWS GC+ +E+          S + QL+E
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 2/72 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL 550
           E +  + LF G+S IDQL  I + LGTP  +    ++     +  FP+ RP  FS++   
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN-YMEHKFPQIRPHPFSKVFRP 292

Query: 551 -PDPLAVDVFSR 561
              P A+D+ SR
Sbjct: 293 RTPPDAIDLISR 304

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  254 bits (651), Expect = 2e-80
 Identities = 62/194 (31%), Positives = 106/194 (54%), Gaps = 11/194 (5%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
            Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V 
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVA 192

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPH 286
           + +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT  
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252

Query: 287 EDVWPGVSKL---PIYKTDFPEWRPKKFSEILN-----LPDPLAVDVFSKIMALDPKQRV 338
              +     +   P +         K++   ++     L  P A+D   K++  D + R+
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312

Query: 339 SAKTILQHEYFNQV 352
           +A+  ++H YF  V
Sbjct: 313 TAREAMEHPYFYTV 326

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  214 bits (548), Expect = 3e-65
 Identities = 55/153 (35%), Positives = 90/153 (58%), Gaps = 10/153 (6%)

Query: 21  ALREISVLKELK-HPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
             REI +L+ L+  PN+I L D++  PV     LVFE +   D K   Q     +     
Sbjct: 77  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDI 132

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEV 135
           + Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRV 191

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            + +++ PE+L+  ++Y  ++D+WS GC+ + M
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 9/76 (11%)

Query: 491 ESITKKT-LFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL---PIYKTDFPEWRPKKFSE 546
             I +K   F G    DQL RI + LGT     +     +   P +         K++  
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282

Query: 547 ILN-----LPDPLAVD 557
            ++     L  P A+D
Sbjct: 283 FVHSENQHLVSPEALD 298

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  255 bits (654), Expect = 1e-79
 Identities = 61/187 (32%), Positives = 108/187 (57%), Gaps = 8/187 (4%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV 227
            Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +        + 
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYIC 218

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP  
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

Query: 288 DVWPGVSKLPIYK-TDFPEWRPKKFSEILNLP--DPLAVDVFSKIMALDPKQRVSAKTIL 344
           +    ++  P Y    FP+ +   ++++   P   P A+ + S+++   P  R++     
Sbjct: 279 EQIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLEAC 335

Query: 345 QHEYFNQ 351
            H +F++
Sbjct: 336 AHSFFDE 342

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  216 bits (552), Expect = 9e-65
 Identities = 53/175 (30%), Positives = 93/175 (53%), Gaps = 21/175 (12%)

Query: 22  LREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQTTPV---PVP 72
            RE+ ++++L H N++RL            +  L LV +++ + +    +        +P
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 154

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRY 131
               K Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +     
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 213

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQLLE 176
              + + +YR PE++ GA  Y++++D+WSAGC+ +E+          S + QL+E
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 22/74 (29%), Positives = 38/74 (51%), Gaps = 6/74 (8%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILN 549
           E +  + +F GDS +DQL  I + LGTP  +    ++  P Y    FP+ +   ++++  
Sbjct: 249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF- 305

Query: 550 LP--DPLAVDVFSR 561
            P   P A+ + SR
Sbjct: 306 RPRTPPEAIALCSR 319

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  246 bits (631), Expect = 4e-77
 Identities = 64/190 (33%), Positives = 103/190 (54%), Gaps = 9/190 (4%)

Query: 169 SYLYQLLEALRYCH--SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHE 225
            +L+QL+ ++   H  S  + HRD+KP N+L+N++ G LKL DFG ++    P       
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAY 191

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           + + +YR PE++ G + Y+T VDIWS GCIF+EM+  + +F GD+   QL  I R LG P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251

Query: 286 HEDVW----PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             +V     P  + + +Y +    W    FS+        A D+ S ++   P++R+   
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWS-NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310

Query: 342 TILQHEYFNQ 351
             L H YF++
Sbjct: 311 EALCHPYFDE 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  206 bits (527), Expect = 9e-62
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 27/185 (14%)

Query: 18  PSTALREISVLKELK---HPNVIRLHDVI-------PVDFKLFLVFEFLRQDLKDFLQTT 67
           P    RE+ ++++L    HPN+++L             D  L +V E++   L    +  
Sbjct: 60  PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119

Query: 68  PV---PVPPALAKSYLYQLLEALRYCH--SRRIIHRDLKPQNILINKS-GALKLADFGLS 121
                  PP L K +L+QL+ ++   H  S  + HRD+KP N+L+N++ G LKL DFG +
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

Query: 122 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYL 171
           +    P       + + +YR PE++ G + Y+T VDIWS GCIF+EM          +  
Sbjct: 180 KKL-SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

Query: 172 YQLLE 176
            QL E
Sbjct: 239 GQLHE 243

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 20/75 (26%), Positives = 31/75 (41%), Gaps = 5/75 (6%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW----PGVSKLPIYKTDFPEWRPKKFSE 546
           E +  + +F GD+   QL  I R LG P  +V     P  + + +Y +    W    FS+
Sbjct: 224 EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWS-NVFSD 282

Query: 547 ILNLPDPLAVDVFSR 561
                   A D+ S 
Sbjct: 283 HSLKDAKEAYDLLSA 297

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  240 bits (614), Expect = 2e-74
 Identities = 70/186 (37%), Positives = 112/186 (60%), Gaps = 6/186 (3%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV 227
            Y+YQL  A+ + HS  I HRD+KPQN+L+N K   LKL DFG ++   IP       + 
Sbjct: 145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAYIC 203

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + +YR PE++LGA  Y+ ++D+WS GC+F E+I  K LF+G++ IDQL RI + +GTP +
Sbjct: 204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTK 263

Query: 288 DVWPGVSKLPIY-KTDFPEWRPKKFSEIL-NLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           +    ++  P Y +  FP  + K + +IL      LA+D+  +I+  +P  R++    + 
Sbjct: 264 EQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321

Query: 346 HEYFNQ 351
           H +F+ 
Sbjct: 322 HPFFDH 327

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  192 bits (490), Expect = 4e-56
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 53/211 (25%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVI---------------------------------- 43
           P    RE+ ++K L H N+I+L D                                    
Sbjct: 44  PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSV 103

Query: 44  ---PVDFK-LFLVFEFLRQDLKDFLQTTPV---PVPPALAKSYLYQLLEALRYCHSRRII 96
              P   K L ++ E++   L   L++       +P  L   Y+YQL  A+ + HS  I 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163

Query: 97  HRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT 155
           HRD+KPQN+L+N K   LKL DFG ++   IP       + + +YR PE++LGA  Y+ +
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 156 VDIWSAGCIFSEM----------SYLYQLLE 176
           +D+WS GC+F E+          + + QL+ 
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVR 253

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 25/73 (34%), Positives = 41/73 (56%), Gaps = 4/73 (5%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEIL- 548
           E I  K LF+G++ IDQL RI + +GTP ++    ++  P Y +  FP  + K + +IL 
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILP 291

Query: 549 NLPDPLAVDVFSR 561
                LA+D+  +
Sbjct: 292 EGTPSLAIDLLEQ 304

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  227 bits (581), Expect = 1e-68
 Identities = 69/244 (28%), Positives = 104/244 (42%), Gaps = 60/244 (24%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR------- 221
           + LY LL  ++Y HS  I+HRDLKP N L+N+  ++K+ DFGL+R    P N        
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 222 --------------------YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                                T  VVT WYR PE++L  + Y+  +D+WS GCIF+E++ 
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

Query: 262 -----------KKTLFAGDS--------------------EIDQLFRIFRTLGTPHEDVW 290
                      +  LF G S                      DQL  IF  LGTP E+  
Sbjct: 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339

Query: 291 PGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
             +       Y   FP+      +E        A+ +  +++  +P +R++    L H +
Sbjct: 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399

Query: 349 FNQV 352
           F +V
Sbjct: 400 FKEV 403

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  210 bits (535), Expect = 6e-62
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 35/205 (17%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPV 69
                  LREI++L  L H +V+++ D++       F  L++V E    D K   +T PV
Sbjct: 93  LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PV 151

Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
            +     K+ LY LL  ++Y HS  I+HRDLKP N L+N+  ++K+ DFGL+R    P N
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 130 R---------------------------YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG 162
                                        T  VVT WYR PE++L  + Y+  +D+WS G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

Query: 163 CIFSEMSYLYQLLEALRYCHSRRII 187
           CIF+E+  L  + E + Y   R  +
Sbjct: 272 CIFAEL--LNMIKENVAYHADRGPL 294

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 18/81 (22%), Positives = 27/81 (33%), Gaps = 2/81 (2%)

Query: 483 SIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPIYKTDFPEWR 540
           S   ++  +       F      DQL  IF  LGTP E+    +       Y   FP+  
Sbjct: 299 SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358

Query: 541 PKKFSEILNLPDPLAVDVFSR 561
               +E        A+ +  R
Sbjct: 359 GTDLAERFPASSADAIHLLKR 379

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  214 bits (547), Expect = 3e-65
 Identities = 69/186 (37%), Positives = 105/186 (56%), Gaps = 5/186 (2%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRY---THEV 226
           +YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+R      +     +  +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           VT WYR P +LL    Y+  +D+W+AGCIF+EM+T KTLFAG  E++Q+  I  ++   H
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245

Query: 287 EDVWPGV-SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
           E+    + S +P+Y  +      K  +++L      AVD   +I+   P  R++A+  L 
Sbjct: 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305

Query: 346 HEYFNQ 351
           H Y + 
Sbjct: 306 HPYMSI 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  172 bits (437), Expect = 3e-49
 Identities = 59/182 (32%), Positives = 97/182 (53%), Gaps = 30/182 (16%)

Query: 21  ALREISVLKELKHPNVIRLHDVIP-------------VDFK-LFLVFEFLRQDLKDFLQT 66
           ALREI +++ L H N++++ +++               +   +++V E++  DL + L+ 
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT 125
            P+      A+ ++YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+R   
Sbjct: 115 GPLL--EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 126 IPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLY 172
              +     +  +VT WYR P +LL    Y+  +D+W+AGCIF+EM            L 
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232

Query: 173 QL 174
           Q+
Sbjct: 233 QM 234

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 21/72 (29%), Positives = 36/72 (50%), Gaps = 1/72 (1%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV-SKLPIYKTDFPEWRPKKFSEILN 549
           E +T KTLFAG  E++Q+  I  ++   HE+    + S +P+Y  +      K  +++L 
Sbjct: 217 EMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP 276

Query: 550 LPDPLAVDVFSR 561
                AVD   +
Sbjct: 277 GISREAVDFLEQ 288

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  213 bits (545), Expect = 3e-64
 Identities = 78/184 (42%), Positives = 106/184 (57%), Gaps = 5/184 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
            +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  V T 
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGYVATR 193

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 290 WPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
              +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H 
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 348 YFNQ 351
           YF Q
Sbjct: 314 YFAQ 317

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  177 bits (451), Expect = 1e-50
 Identities = 65/170 (38%), Positives = 91/170 (53%), Gaps = 21/170 (12%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 74
             RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +     
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DD 132

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGY 189

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
           V T WYR PEI+L    Y+ TVDIWS GCI +E+           ++ QL
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPIYKTDFPEWRPKKFSEIL 548
           E +T +TLF G   IDQL  I R +GTP  ++   +S      Y     +     F+ + 
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 281

Query: 549 NLPDPLAVDVFSR 561
              +PLAVD+  +
Sbjct: 282 IGANPLAVDLLEK 294

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  213 bits (544), Expect = 3e-64
 Identities = 83/184 (45%), Positives = 108/184 (58%), Gaps = 5/184 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
            +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  VVT 
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTR 189

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PE++L    Y+ TVDIWS GCI +EMIT KTLF G   +DQL  I +  GTP  + 
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 290 WPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
              +   +   Y    PE   K F+ IL    PLAV++  K++ LD +QRV+A   L H 
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

Query: 348 YFNQ 351
           YF  
Sbjct: 310 YFES 313

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  177 bits (450), Expect = 1e-50
 Identities = 66/154 (42%), Positives = 89/154 (57%), Gaps = 11/154 (7%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ +LK ++H NVI L DV        DF   +LV  F+  DL   ++   +     
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG--ED 128

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             +  +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGY 185

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT WYR PE++L    Y+ TVDIWS GCI +EM
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 26/73 (35%), Positives = 35/73 (47%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPIYKTDFPEWRPKKFSEIL 548
           E IT KTLF G   +DQL  I +  GTP  +    +   +   Y    PE   K F+ IL
Sbjct: 218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 277

Query: 549 NLPDPLAVDVFSR 561
               PLAV++  +
Sbjct: 278 TNASPLAVNLLEK 290

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  212 bits (542), Expect = 4e-64
 Identities = 72/184 (39%), Positives = 105/184 (57%), Gaps = 5/184 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
            +YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R     M   T  VVT 
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTR 187

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PE++L    Y+ TVDIWS GCI +EM+T KTLF G   +DQL +I +  G P  + 
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 290 WPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
              ++      Y    P+   K F+++     P A D+  K++ LD  +R++A   L H 
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307

Query: 348 YFNQ 351
           +F  
Sbjct: 308 FFEP 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  177 bits (451), Expect = 8e-51
 Identities = 67/170 (39%), Positives = 93/170 (54%), Gaps = 22/170 (12%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ +LK ++H NVI L DV        +F   +LV  F++ DL+  +          
Sbjct: 70  AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---KFSEE 126

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             +  +YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R     M   T  
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGY 183

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
           VVT WYR PE++L    Y+ TVDIWS GCI +EM           YL QL
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 233

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPIYKTDFPEWRPKKFSEIL 548
           E +T KTLF G   +DQL +I +  G P  +    ++      Y    P+   K F+++ 
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275

Query: 549 NLPDPLAVDVFSR 561
               P A D+  +
Sbjct: 276 PRASPQAADLLEK 288

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  211 bits (540), Expect = 1e-63
 Identities = 67/187 (35%), Positives = 104/187 (55%), Gaps = 5/187 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 287 EDVWPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +   K   Y    P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 313 AHPYLEQ 319

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  177 bits (450), Expect = 1e-50
 Identities = 65/172 (37%), Positives = 95/172 (55%), Gaps = 20/172 (11%)

Query: 21  ALREISVLKELKHPNVIRLHDVIP----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 75
            LREI +L   +H N+I ++D+I        K +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS--NDH 129

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---T 132
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM           YL QL
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 16/73 (21%), Positives = 31/73 (42%), Gaps = 2/73 (2%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPIYKTDFPEWRPKKFSEIL 548
           E ++ + +F G   +DQL  I   LG+P ++    +   K   Y    P      ++ + 
Sbjct: 224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 283

Query: 549 NLPDPLAVDVFSR 561
              D  A+D+  +
Sbjct: 284 PNADSKALDLLDK 296

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  210 bits (537), Expect = 3e-63
 Identities = 58/185 (31%), Positives = 99/185 (53%), Gaps = 4/185 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T      TH V   
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYVTHR 197

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PE+++  K ++  VD+WSAGC+ +EM  +K LF G +  +QL +I   +GTP  + 
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257

Query: 290 WPGVSKLPIYK---TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               S                 + ++ ++   DP+A+D+ +K++  +P++R+S +  L+H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317

Query: 347 EYFNQ 351
            YF  
Sbjct: 318 PYFES 322

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  183 bits (467), Expect = 5e-53
 Identities = 55/169 (32%), Positives = 85/169 (50%), Gaps = 16/169 (9%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 75
            LREI +L    HPN++ L D+           L+LV E +R DL   +    + + P  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
            + ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T      TH V
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYV 194

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
              WYR PE+++  K ++  VD+WSAGC+ +EM          ++  QL
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 16/74 (21%), Positives = 32/74 (43%), Gaps = 3/74 (4%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK---TDFPEWRPKKFSEI 547
           E   +K LF G +  +QL +I   +GTP  +     S                 + ++ +
Sbjct: 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285

Query: 548 LNLPDPLAVDVFSR 561
           +   DP+A+D+ ++
Sbjct: 286 VPTADPVALDLIAK 299

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  206 bits (527), Expect = 8e-62
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 13/194 (6%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-------- 222
           +YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R                 
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 223 --THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR 280
                V T WYR PE++L +  YS  +D+WS GCI +E+  ++ +F G     QL  IF 
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237

Query: 281 TLGTPH--EDVWPGVSKLPI-YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
            +GTPH   D+    S     Y    P +      ++    +P  +D+  +++  DP +R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297

Query: 338 VSAKTILQHEYFNQ 351
           ++AK  L+H Y   
Sbjct: 298 ITAKEALEHPYLQT 311

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  174 bits (443), Expect = 9e-50
 Identities = 58/179 (32%), Positives = 90/179 (50%), Gaps = 27/179 (15%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 75
            LREI +LK  KH N+I + ++       +F  ++++ E ++ DL   + T  +      
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS--DDH 113

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 131
            + ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R             
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 132 ------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
                    V T WYR PE++L +  YS  +D+WS GCI +E+           Y +QL
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 18/74 (24%), Positives = 29/74 (39%), Gaps = 3/74 (4%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPH--EDVWPGVSKLPI-YKTDFPEWRPKKFSEI 547
           E   ++ +F G     QL  IF  +GTPH   D+    S     Y    P +      ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274

Query: 548 LNLPDPLAVDVFSR 561
               +P  +D+  R
Sbjct: 275 FPRVNPKGIDLLQR 288

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  202 bits (515), Expect = 5e-59
 Identities = 75/194 (38%), Positives = 98/194 (50%), Gaps = 15/194 (7%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  VVT +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRY 228

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP  +  
Sbjct: 229 YRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287

Query: 291 PGVS--------KLPIYK-----TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
             +           P Y        FP+      SE   L    A D+ SK++ +DP +R
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347

Query: 338 VSAKTILQHEYFNQ 351
           +S    LQH Y N 
Sbjct: 348 ISVDDALQHPYINV 361

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  171 bits (435), Expect = 2e-47
 Identities = 61/170 (35%), Positives = 87/170 (51%), Gaps = 21/170 (12%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q     +   
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHE 164

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPY 223

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM----------SYLYQL 174
           VVT +YR PE++LG   Y   VDIWS GCI  EM           Y+ Q 
Sbjct: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 22/84 (26%), Positives = 30/84 (35%), Gaps = 13/84 (15%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--------KLPIYK-----TDFP 537
           E +  K LF G   IDQ  ++   LGTP  +    +           P Y        FP
Sbjct: 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314

Query: 538 EWRPKKFSEILNLPDPLAVDVFSR 561
           +      SE   L    A D+ S+
Sbjct: 315 DSLFPADSEHNKLKASQARDLLSK 338

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  199 bits (507), Expect = 8e-59
 Identities = 74/194 (38%), Positives = 96/194 (49%), Gaps = 15/194 (7%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  VVT +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRY 191

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           YR PE++LG   Y   VDIWS GCI  EMI    LF G   IDQ  ++   LGTP  +  
Sbjct: 192 YRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250

Query: 291 PGVS--------KLPIYK-----TDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
             +           P Y        FP+      SE   L    A D+ SK++ +D  +R
Sbjct: 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310

Query: 338 VSAKTILQHEYFNQ 351
           +S    LQH Y N 
Sbjct: 311 ISVDEALQHPYINV 324

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  167 bits (426), Expect = 4e-47
 Identities = 58/154 (37%), Positives = 84/154 (54%), Gaps = 11/154 (7%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 74
           A RE+ ++K + H N+I L +V        +F+ +++V E +  +L   +Q     +   
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHE 127

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPY 186

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT +YR PE++LG   Y   VDIWS GCI  EM
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEM 219

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 22/84 (26%), Positives = 29/84 (34%), Gaps = 13/84 (15%)

Query: 491 ESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--------KLPIYK-----TDFP 537
           E I    LF G   IDQ  ++   LGTP  +    +           P Y        FP
Sbjct: 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 277

Query: 538 EWRPKKFSEILNLPDPLAVDVFSR 561
           +      SE   L    A D+ S+
Sbjct: 278 DVLFPADSEHNKLKASQARDLLSK 301

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  196 bits (500), Expect = 1e-57
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 39/220 (17%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-------- 222
           +YQL++ ++Y HS  ++HRD+KP NIL+N    +K+ADFGLSR+F               
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 223 -------------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
                        T  V T WYR PEILLG+  Y+  +D+WS GCI  E++  K +F G 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

Query: 270 SEIDQLFRIFRTLGTPHED---------VWPGVSKLPIY-KTDFPEWRPKKFSEILNLP- 318
           S ++QL RI   +  P  +             +  L    +      R         L  
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294

Query: 319 -------DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                  +  A+D+  K++  +P +R+SA   L+H + + 
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  172 bits (437), Expect = 2e-48
 Identities = 63/188 (33%), Positives = 97/188 (51%), Gaps = 36/188 (19%)

Query: 21  ALREISVLKELK-HPNVIRLHDVI-PVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALAK 77
             REI +L EL  H N++ L +V+   + + ++LVF+++  DL   ++   +   P   +
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--PVHKQ 112

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY------ 131
             +YQL++ ++Y HS  ++HRD+KP NIL+N    +K+ADFGLSR+F             
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 132 ---------------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM-------- 168
                          T  V T WYR PEILLG+  Y+  +D+WS GCI  E+        
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232

Query: 169 --SYLYQL 174
             S + QL
Sbjct: 233 GSSTMNQL 240

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  188 bits (480), Expect = 3e-54
 Identities = 67/234 (28%), Positives = 100/234 (42%), Gaps = 52/234 (22%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-------- 222
           LY LL    + H   IIHRDLKP N L+N+  ++K+ DFGL+R      +          
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 223 --------------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT------- 261
                         T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E++        
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254

Query: 262 ----KKTLFAGDSE-----------------IDQLFRIFRTLGTPHEDVWPGVSKLPI-- 298
               +  LF G S                   DQL  IF  +GTP ED    ++K  +  
Sbjct: 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314

Query: 299 YKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
           Y   FP  +P    +         +++   ++  +P +R++    L H Y   V
Sbjct: 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  176 bits (448), Expect = 1e-49
 Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 30/194 (15%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 75
            LREI++L  LK   +IRL+D+I       F  L++V E    DLK   +T P+ +    
Sbjct: 72  ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEH 130

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 131
            K+ LY LL    + H   IIHRDLKP N L+N+  ++K+ DFGL+R      +      
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 132 ------------------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ 173
                             T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E+  L  
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL--LNM 248

Query: 174 LLEALRYCHSRRII 187
           L   +    +R  +
Sbjct: 249 LQSHINDPTNRFPL 262

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  159 bits (404), Expect = 1e-44
 Identities = 52/168 (30%), Positives = 74/168 (44%), Gaps = 22/168 (13%)

Query: 22  LREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
             EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSY 132

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--T 137
              +LEA+   H   I+H DLKP N LI   G LKL DFG++            +    T
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 138 LWYRPPEILLGA----------KVYSTTVDIWSAGCIFSEMSYLYQLL 175
           + Y PPE +                S   D+WS GCI      LY + 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI------LYYMT 233

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  145 bits (369), Expect = 1e-39
 Identities = 56/203 (27%), Positives = 76/203 (37%), Gaps = 44/203 (21%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
                  SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++         
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182

Query: 222 YTHEVV--TLWYRPPEILLGA----------KVYSTTVDIWSAGCIFSEMITKKTLFAG- 268
              +    T+ Y PPE +                S   D+WS GCI   M   KT F   
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

Query: 269 DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK 328
            ++I +L  I                  P ++ +FP+            P+    DV   
Sbjct: 243 INQISKLHAIID----------------PNHEIEFPDI-----------PEKDLQDVLKC 275

Query: 329 IMALDPKQRVSAKTILQHEYFNQ 351
            +  DPKQR+S   +L H Y   
Sbjct: 276 CLKRDPKQRISIPELLAHPYVQI 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  157 bits (398), Expect = 8e-44
 Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 28/180 (15%)

Query: 19  STALREISVLKELKHPNVIRLHDV-------------IPVDFKLFLVFEFLR-QDLKDFL 64
           ST L E+ +L  L H  V+R +               +     LF+  E+     L D +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
            +  +            Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL++  
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

Query: 125 TIPMNRYTHEVV--------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
              ++    +                T  Y   E+L G   Y+  +D++S G IF EM Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  141 bits (358), Expect = 3e-38
 Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 44/211 (20%)

Query: 158 IWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 214
           I S               Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL++ 
Sbjct: 106 IHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165

Query: 215 FTIPMNRYTHEVV--------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 260
               ++    +                T  Y   E+L G   Y+  +D++S G IF EMI
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

Query: 261 TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP 320
                F+   E   + +                 KL     +FP                
Sbjct: 226 ---YPFSTGMERVNILK-----------------KLRSVSIEFPPDFDDNKM-------K 258

Query: 321 LAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
           +   +   ++  DP +R  A+T+L   +   
Sbjct: 259 VEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  155 bits (394), Expect = 2e-43
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 8/169 (4%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT 66
            +  +   G+      E+ +  +LKHP+++ L++       ++LV E     ++  +L+ 
Sbjct: 45  DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN 104

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
              P     A+ +++Q++  + Y HS  I+HRDL   N+L+ ++  +K+ADFGL+    +
Sbjct: 105 RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           P  ++     T  Y  PEI      +    D+WS GC+       Y LL
Sbjct: 165 PHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCM------FYTLL 206

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (319), Expect = 6e-33
 Identities = 42/182 (23%), Positives = 82/182 (45%), Gaps = 30/182 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +++Q++  + Y HS  I+HRDL   N+L+ ++  +K+ADFGL+    +P  ++     T 
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP 176

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEI      +    D+WS GC+F  ++  +  F  D+  + L ++           
Sbjct: 177 NYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-------- 227

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
                    Y+   P +     S         A D+  +++  +P  R+S  ++L H + 
Sbjct: 228 --------DYE--MPSF----LS-------IEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

Query: 350 NQ 351
           ++
Sbjct: 267 SR 268

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  153 bits (390), Expect = 7e-43
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 20/169 (11%)

Query: 21  ALREISVLKELKHPNVIRLHD----------------VIPVDFKLFLVFEFL-RQDLKDF 63
           A RE+  L +L H N++  +                        LF+  EF  +  L+ +
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110

Query: 64  L-QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
           + +     +   LA     Q+ + + Y HS+++I+RDLKP NI +  +  +K+ DFGL  
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170

Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
           +      R      TL Y  PE +   + Y   VD+++ G I +E+ ++
Sbjct: 171 SLKNDGKRTRS-KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHV 217

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (349), Expect = 4e-37
 Identities = 38/190 (20%), Positives = 70/190 (36%), Gaps = 42/190 (22%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
             +   +    Q+ + + Y HS+++I+RDLKP NI +  +  +K+ DFGL  +      R
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 222 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
                 TL Y  PE +   + Y   VD+++ G I +E++                     
Sbjct: 179 TRS-KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD----------------- 219

Query: 282 LGTPHE--DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
             T  E    +  +    I            F +           +  K+++  P+ R +
Sbjct: 220 --TAFETSKFFTDLRDGII---------SDIFDKKEK-------TLLQKLLSKKPEDRPN 261

Query: 340 AKTILQHEYF 349
              IL+    
Sbjct: 262 TSEILRTLTV 271

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  154 bits (392), Expect = 1e-42
 Identities = 52/168 (30%), Positives = 74/168 (44%), Gaps = 22/168 (13%)

Query: 22  LREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
             EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSY 113

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--T 137
              +LEA+   H   I+H DLKP N LI   G LKL DFG++            +    T
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 138 LWYRPPEILLG----------AKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           + Y PPE +                S   D+WS GCI      LY + 
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI------LYYMT 214

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  142 bits (361), Expect = 3e-38
 Identities = 56/203 (27%), Positives = 76/203 (37%), Gaps = 44/203 (21%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
                  SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++         
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 163

Query: 222 YTHEVV--TLWYRPPEILLG----------AKVYSTTVDIWSAGCIFSEMITKKTLFAG- 268
              +    T+ Y PPE +                S   D+WS GCI   M   KT F   
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223

Query: 269 DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK 328
            ++I +L  I                  P ++ +FP+            P+    DV   
Sbjct: 224 INQISKLHAIID----------------PNHEIEFPDI-----------PEKDLQDVLKC 256

Query: 329 IMALDPKQRVSAKTILQHEYFNQ 351
            +  DPKQR+S   +L H Y   
Sbjct: 257 CLKRDPKQRISIPELLAHPYVQI 279

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  151 bits (384), Expect = 8e-42
 Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 4/149 (2%)

Query: 21  ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
            L E+   +++ +HP  +RL         L+L  E     L+   +     +P A    Y
Sbjct: 103 KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGY 162

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           L   L AL + HS+ ++H D+KP NI +   G  KL DFGL             +     
Sbjct: 163 LRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPR 221

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           Y  PE+L G+  Y T  D++S G    E+
Sbjct: 222 YMAPELLQGS--YGTAADVFSLGLTILEV 248

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  137 bits (348), Expect = 1e-36
 Identities = 48/198 (24%), Positives = 68/198 (34%), Gaps = 36/198 (18%)

Query: 157 DIWSAGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
              + G    E     YL   L AL + HS+ ++H D+KP NI +   G  KL DFGL  
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID 273
                      +     Y  PE+L G+  Y T  D++S G    E+     L  G     
Sbjct: 206 ELGTAGAGEV-QEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQ 262

Query: 274 QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
           QL + +                        P       S  L         V   ++  D
Sbjct: 263 QLRQGY-----------------------LPPEFTAGLSSELR-------SVLVMMLEPD 292

Query: 334 PKQRVSAKTILQHEYFNQ 351
           PK R +A+ +L      Q
Sbjct: 293 PKLRATAEALLALPVLRQ 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  152 bits (386), Expect = 2e-41
 Identities = 51/168 (30%), Positives = 73/168 (43%), Gaps = 22/168 (13%)

Query: 22  LREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 79
             EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSY 160

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--T 137
              +LEA+   H   I+H DLKP N LI   G LKL DFG++            +     
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 138 LWYRPPEILLGAKV----------YSTTVDIWSAGCIFSEMSYLYQLL 175
           + Y PPE +                S   D+WS GCI      LY + 
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI------LYYMT 261

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  141 bits (357), Expect = 2e-37
 Identities = 55/203 (27%), Positives = 75/203 (36%), Gaps = 44/203 (21%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
                  SY   +LEA+   H   I+H DLKP N LI   G LKL DFG++         
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 210

Query: 222 YTHEVV--TLWYRPPEILLGAKV----------YSTTVDIWSAGCIFSEMITKKTLFAG- 268
              +     + Y PPE +                S   D+WS GCI   M   KT F   
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

Query: 269 DSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK 328
            ++I +L  I                  P ++ +FP+            P+    DV   
Sbjct: 271 INQISKLHAIID----------------PNHEIEFPDI-----------PEKDLQDVLKC 303

Query: 329 IMALDPKQRVSAKTILQHEYFNQ 351
            +  DPKQR+S   +L H Y   
Sbjct: 304 CLKRDPKQRISIPELLAHPYVQI 326

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  150 bits (380), Expect = 3e-41
 Identities = 57/156 (36%), Positives = 82/156 (52%), Gaps = 7/156 (4%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 75
            ++EI +LK+L HPNVI+ +     D +L +V E      L + +K F +     +P   
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF-KKQKRLIPERT 137

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
              Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
            T +Y  PE +     Y+   DIWS GC+  EM+ L
Sbjct: 198 GTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAAL 232

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  139 bits (352), Expect = 3e-37
 Identities = 52/191 (27%), Positives = 78/191 (40%), Gaps = 31/191 (16%)

Query: 160 SAGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 216
               +  E     Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 217 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS-EIDQL 275
                    V T +Y  PE +     Y+   DIWS GC+  EM   ++ F GD   +  L
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246

Query: 276 FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK 335
            +                    I + D+P      +SE L         + +  +  DP+
Sbjct: 247 CKK-------------------IEQCDYPPLPSDHYSEELR-------QLVNMCINPDPE 280

Query: 336 QRVSAKTILQH 346
           +R     +   
Sbjct: 281 KRPDVTYVYDV 291

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  150 bits (380), Expect = 7e-41
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 3/153 (1%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-TTPVPVPPALAKS 78
           + RE++VL  +KHPN+++  +    +  L++V ++    DL   +     V         
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           +  Q+  AL++ H R+I+HRD+K QNI + K G ++L DFG++R     +      + T 
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL 171
           +Y  PEI    K Y+   DIW+ GC+  E+  L
Sbjct: 190 YYLSPEICEN-KPYNNKSDIWALGCVLYELCTL 221

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (355), Expect = 2e-37
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 32/188 (17%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           F E   + +  Q+  AL++ H R+I+HRD+K QNI + K G ++L DFG++R     +  
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181

Query: 222 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
               + T +Y  PEI    K Y+   DIW+ GC+  E+ T K  F   S +  L      
Sbjct: 182 ARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLK--- 236

Query: 282 LGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
                           I    FP      +S  L         + S++   +P+ R S  
Sbjct: 237 ----------------IISGSFPPV-SLHYSYDLR-------SLVSQLFKRNPRDRPSVN 272

Query: 342 TILQHEYF 349
           +IL+  + 
Sbjct: 273 SILEKGFI 280

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  149 bits (379), Expect = 5e-40
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 19  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAK 77
           S A RE+ +L+E  +HPNVIR           ++  E     L+++++            
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYT 132
           + L Q    L + HS  I+HRDLKP NILI+   A       ++DFGL +   +  + ++
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 133 H---EVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEM 168
                  T  +  PE+L     +  + TVDI+SAGC+F  +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (332), Expect = 1e-33
 Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 35/195 (17%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYT 223
           + L Q    L + HS  I+HRDLKP NILI+   A       ++DFGL +   +  + ++
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 224 H---EVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
                  T  +  PE+L     +  + TVDI+SAGC+F  +I++ +   G S   Q   +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                                                     +A ++  K++A+DP++R 
Sbjct: 242 LGACSLDCLHPEKHED-------------------------VIARELIEKMIAMDPQKRP 276

Query: 339 SAKTILQHEYFNQVE 353
           SAK +L+H +F  +E
Sbjct: 277 SAKHVLKHPFFWSLE 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  145 bits (369), Expect = 8e-40
 Identities = 53/171 (30%), Positives = 83/171 (48%), Gaps = 13/171 (7%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQT 66
           P+S +           EIS+ + L H +V+  H     +  +F+V E   R+ L +  + 
Sbjct: 49  PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 108

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               +    A+ YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+     
Sbjct: 109 RK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167

Query: 127 PMNRYTHEVV--TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
              R   +V+  T  Y  PE+L   K +S  VD+WS GCI      +Y LL
Sbjct: 168 DGER--KKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCI------MYTLL 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  124 bits (313), Expect = 4e-32
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 34/184 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 227
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R   +V+  
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCG 177

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L   K +S  VD+WS GCI   ++  K  F   S + + +           
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL---------- 225

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                     I K ++    PK  +       P+A  +  K++  DP  R +   +L  E
Sbjct: 226 ---------RIKKNEYSI--PKHIN-------PVAASLIQKMLQTDPTARPTINELLNDE 267

Query: 348 YFNQ 351
           +F  
Sbjct: 268 FFTS 271

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  145 bits (367), Expect = 9e-40
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 12/163 (7%)

Query: 21  ALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPA 74
            + E+++L+ELKHPN++R +D I    +  L++V E+    DL   +         +   
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111

Query: 75  LAKSYLYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
                + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY 172
                V T +Y  PE +     Y+   DIWS GC+  E+  L 
Sbjct: 172 FAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALM 213

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  133 bits (338), Expect = 1e-35
 Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 37/193 (19%)

Query: 165 FSE---MSYLYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFT 216
             E   +  + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R   
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167

Query: 217 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
              +     V T +Y  PE +     Y+   DIWS GC+  E+      F   S   +L 
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELA 225

Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
                                I +  F    P ++S+ LN       ++ ++++ L    
Sbjct: 226 GK-------------------IREGKFRRI-PYRYSDELN-------EIITRMLNLKDYH 258

Query: 337 RVSAKTILQHEYF 349
           R S + IL++   
Sbjct: 259 RPSVEEILENPLI 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (369), Expect = 9e-40
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 28/175 (16%)

Query: 21  ALREISVLKELKHPNVIRLHDVI------------PVDFKLFLVFEFL-RQDLKDFL--Q 65
            +RE+  L +L+HP ++R  +                   L++  +   +++LKD++  +
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109

Query: 66  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            T      ++      Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A  
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169

Query: 126 IPMN------------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                           R+T +V T  Y  PE + G   YS  VDI+S G I  E+
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFEL 223

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (345), Expect = 2e-36
 Identities = 46/199 (23%), Positives = 76/199 (38%), Gaps = 43/199 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------- 220
           +    Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A             
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 221 -----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQL 275
                R+T +V T  Y  PE + G   YS  VDI+S G I  E++     F+   E  + 
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLYP---FSTQMERVRT 236

Query: 276 FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK 335
                                 +    FP    +K+     +           +++  P 
Sbjct: 237 LTD-------------------VRNLKFPPLFTQKYPCEYVM--------VQDMLSPSPM 269

Query: 336 QRVSAKTILQHEYFNQVEM 354
           +R  A  I+++  F  ++ 
Sbjct: 270 ERPEAINIIENAVFEDLDF 288

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  145 bits (368), Expect = 2e-39
 Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 23/170 (13%)

Query: 22  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQ--TTPVPVPPALA 76
           +RE  VLK+L H N+++L  +          L+ EF     L   L+  +    +P +  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYT 132
              L  ++  + +     I+HR++KP NI+     +     KL DFG +R         +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 133 HEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMSYLYQLL 175
               T  Y  P++   A       K Y  TVD+WS G         Y   
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT------FYHAA 217

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 3e-31
 Identities = 39/203 (19%), Positives = 65/203 (32%), Gaps = 25/203 (12%)

Query: 163 CIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAF 215
               E   +  L  ++  + +     I+HR++KP NI+     +     KL DFG +R  
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

Query: 216 TIPMNRYTHEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMITKKTLF-- 266
                  +    T  Y  P++   A       K Y  TVD+WS G  F    T    F  
Sbjct: 167 EDDEQFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

Query: 267 --AGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI-YKTDFPEWRPKKFSEILNLPDPLAV 323
                   + +++I     +            PI +  D P         +      L  
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS-----CSLSRGLQVLLT 280

Query: 324 DVFSKIMALDPKQRVSAKTILQH 346
            V + I+  D ++          
Sbjct: 281 PVLANILEADQEKCWGFDQFFAE 303

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  145 bits (369), Expect = 2e-39
 Identities = 53/171 (30%), Positives = 83/171 (48%), Gaps = 13/171 (7%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT 66
           P+S +           EIS+ + L H +V+  H     +  +F+V E   R+ L +  + 
Sbjct: 75  PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               +    A+ YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+     
Sbjct: 135 RK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193

Query: 127 PMNRYTHEVV--TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
              R   +V+  T  Y  PE+L   K +S  VD+WS GCI      +Y LL
Sbjct: 194 DGER--KKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCI------MYTLL 235

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  124 bits (314), Expect = 9e-32
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 34/184 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 227
           YL Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R   +V+  
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCG 203

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L   K +S  VD+WS GCI   ++  K  F   S + + +           
Sbjct: 204 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYL---------- 251

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                     I K ++    PK  +       P+A  +  K++  DP  R +   +L  E
Sbjct: 252 ---------RIKKNEYSI--PKHIN-------PVAASLIQKMLQTDPTARPTINELLNDE 293

Query: 348 YFNQ 351
           +F  
Sbjct: 294 FFTS 297

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  144 bits (366), Expect = 2e-39
 Identities = 55/179 (30%), Positives = 92/179 (51%), Gaps = 15/179 (8%)

Query: 3   SDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-D 59
                P   +Q  G      +EI++LK+L HPNV++L +V+  P +  L++VFE + Q  
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124

Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
           + +     P+      A+ Y   L++ + Y H ++IIHRD+KP N+L+ + G +K+ADFG
Sbjct: 125 VMEVPTLKPLS--EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 120 LSRAFTIPMNRYTHEVV-TLWYRPPEILLGA-KVYS-TTVDIWSAGCIFSEMSYLYQLL 175
           +S  F    +      V T  +  PE L    K++S   +D+W+ G        LY  +
Sbjct: 183 VSNEFK-GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT------LYCFV 234

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  109 bits (275), Expect = 8e-27
 Identities = 41/187 (21%), Positives = 75/187 (40%), Gaps = 35/187 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y   L++ + Y H ++IIHRD+KP N+L+ + G +K+ADFG+S  F    +      V T
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLSNTVGT 200

Query: 229 LWYRPPEILLGA-KVYS-TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
             +  PE L    K++S   +D+W+ G      +  +  F  +  I  L           
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSK-------- 251

Query: 287 EDVWPGVSKLPIYKTDF--PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                      I       P+      +           D+ ++++  +P+ R+    I 
Sbjct: 252 -----------IKSQALEFPDQPD--IA-------EDLKDLITRMLDKNPESRIVVPEIK 291

Query: 345 QHEYFNQ 351
            H +  +
Sbjct: 292 LHPWVTR 298

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (365), Expect = 4e-39
 Identities = 41/170 (24%), Positives = 65/170 (38%), Gaps = 19/170 (11%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVD----FKLFLVFEF-LRQDLKDFLQTTPV---PVP 72
           A RE  + +   HPN++RL      +     + +L+  F  R  L + ++        + 
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-- 130
                  L  +   L   H++   HRDLKP NIL+   G   L D G      I +    
Sbjct: 133 EDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 131 -------YTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMSYL 171
                  +  +  T+ YR PE+       V     D+WS GC+   M + 
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  117 bits (294), Expect = 3e-29
 Identities = 40/196 (20%), Positives = 65/196 (33%), Gaps = 40/196 (20%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
            +E   +  L  +   L   H++   HRDLKP NIL+   G   L D G      I +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 222 ---------YTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
                    +  +  T+ YR PE+       V     D+WS GC+   M+  +  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 271 EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM 330
           +                    G S     +      +  + S  L         + + +M
Sbjct: 251 Q-------------------KGDSVALAVQNQLSIPQSPRHSSALW-------QLLNSMM 284

Query: 331 ALDPKQRVSAKTILQH 346
            +DP QR     +L  
Sbjct: 285 TVDPHQRPHIPLLLSQ 300

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  143 bits (362), Expect = 6e-39
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 5/147 (3%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE+ +   L+HPN++RL+       +++L+ E+     +   LQ            +Y+ 
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYIT 116

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S        R      TL Y 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL-CGTLDYL 174

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
           PPE++ G +++   VD+WS G +  E 
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEF 200

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (316), Expect = 1e-32
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 32/182 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S        R      TL
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL-CGTL 171

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R         
Sbjct: 172 DYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------- 222

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
                     +  FP++     +         A D+ S+++  +P QR   + +L+H + 
Sbjct: 223 ----------EFTFPDF----VT-------EGARDLISRLLKHNPSQRPMLREVLEHPWI 261

Query: 350 NQ 351
             
Sbjct: 262 TA 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  141 bits (358), Expect = 2e-38
 Identities = 57/161 (35%), Positives = 93/161 (57%), Gaps = 5/161 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           +S+++ EGV     REI +   L+HPN++R+++      +++L+ EF  + +L   LQ  
Sbjct: 49  KSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH 108

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                   + +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S      
Sbjct: 109 G-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPS 166

Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + R T    TL Y PPE++ G K +   VD+W AG +  E 
Sbjct: 167 LRRRTM-CGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEF 205

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  121 bits (305), Expect = 5e-31
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 34/195 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           ++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S      + R T    TL
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM-CGTL 176

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y PPE++ G K +   VD+W AG +  E +     F   S  +   RI           
Sbjct: 177 DYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------- 227

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
                        FP +     S         + D+ SK++   P QR+  K +++H + 
Sbjct: 228 ----------DLKFPPF----LS-------DGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

Query: 350 NQVEMVKPTLAVFPE 364
                 +  L    +
Sbjct: 267 --KANSRRVLPPVYQ 279

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  143 bits (362), Expect = 2e-38
 Identities = 40/181 (22%), Positives = 80/181 (44%), Gaps = 18/181 (9%)

Query: 5   ESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDF 63
                 ++ ++        E+ ++ ++K+   +    +I    ++++++E++    +  F
Sbjct: 74  TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133

Query: 64  LQ-------TTPVPVPPALAKSYLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKL 115
            +            +P  + K  +  +L +  Y H+ + I HRD+KP NIL++K+G +KL
Sbjct: 134 DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKL 193

Query: 116 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMSYLYQL 174
           +DFG S  + +          T  + PPE       Y+   VDIWS G        LY +
Sbjct: 194 SDFGES-EYMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC------LYVM 245

Query: 175 L 175
            
Sbjct: 246 F 246

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 4e-32
 Identities = 45/188 (23%), Positives = 76/188 (40%), Gaps = 17/188 (9%)

Query: 170 YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
            +  +L +  Y H+ + I HRD+KP NIL++K+G +KL+DFG S  + +          T
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKG-SRGT 213

Query: 229 LWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF-RIFR-TLGTP 285
             + PPE       Y+   VDIWS G     M      F+    + +LF  I    +  P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            +             T    +     S          +D     +  +P +R++++  L+
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNF----LS-------NEDIDFLKLFLRKNPAERITSEDALK 322

Query: 346 HEYFNQVE 353
           HE+     
Sbjct: 323 HEWLADTN 330

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  142 bits (360), Expect = 5e-38
 Identities = 54/160 (33%), Positives = 78/160 (48%), Gaps = 14/160 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP---ALAKS 78
           RE S+   LKHP+++ L +    D  L++VFEF+   DL   +            A+A  
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEV 135
           Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++             V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            T  +  PE++   + Y   VD+W  G I      L+ LL
Sbjct: 195 GTPHFMAPEVVKR-EPYGKPVDVWGCGVI------LFILL 227

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  116 bits (293), Expect = 8e-29
 Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 43/198 (21%)

Query: 160 SAGCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSR 213
            AG ++SE     Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++ 
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG----D 269
                       V T  +  PE++   + Y   VD+W  G I         L +G     
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILF------ILLSGCLPFY 234

Query: 270 SEIDQLFR-IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK 328
              ++LF  I +     +   W  +S                           A D+  +
Sbjct: 235 GTKERLFEGIIKGKYKMNPRQWSHIS-------------------------ESAKDLVRR 269

Query: 329 IMALDPKQRVSAKTILQH 346
           ++ LDP +R++    L H
Sbjct: 270 MLMLDPAERITVYEALNH 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  144 bits (365), Expect = 5e-38
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 36/187 (19%)

Query: 19  STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ------TTPVPV 71
             AL EI +L E   HPNVIR +     D  L++  E    +L+D ++            
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 112

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-------------LKLADF 118
                 S L Q+   + + HS +IIHRDLKPQNIL++ S               + ++DF
Sbjct: 113 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 119 GLSRAFTIPMNRYTHEVV----TLWYRPPEILLGA------KVYSTTVDIWSAGCIFSEM 168
           GL +      + +   +     T  +R PE+L  +      +  + ++DI+S GC+F   
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF--- 229

Query: 169 SYLYQLL 175
              Y +L
Sbjct: 230 ---YYIL 233

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  128 bits (323), Expect = 2e-32
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 50/211 (23%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-------------LKLADFGLSRAF 215
           S L Q+   + + HS +IIHRDLKPQNIL++ S               + ++DFGL +  
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 216 TIPMNRYTHEVV----TLWYRPPEILLGA------KVYSTTVDIWSAGCIFSEMITKKTL 265
               + +   +     T  +R PE+L  +      +  + ++DI+S GC+F  +++K   
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 266 -FAGDSEID-QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV 323
            F      +  + R   +L          +                            A 
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLI-------------------------AEAT 273

Query: 324 DVFSKIMALDPKQRVSAKTILQHEYFNQVEM 354
           D+ S+++  DP +R +A  +L+H  F     
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  142 bits (360), Expect = 6e-38
 Identities = 32/187 (17%), Positives = 57/187 (30%), Gaps = 24/187 (12%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
                QL+       S+ ++H    P N+ I   G L L D            R     V
Sbjct: 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK---VGTRGPASSV 253

Query: 228 TLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            + Y P E L  +   ++  ++ W  G     +      F   +   +      +L  P 
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
            D              F    P        LPD     +  + +  D ++R+     ++ 
Sbjct: 314 TDSL-----------AFGSCTP--------LPDF-VKTLIGRFLNFDRRRRLLPLEAMET 353

Query: 347 EYFNQVE 353
             F Q++
Sbjct: 354 PEFLQLQ 360

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  131 bits (330), Expect = 8e-34
 Identities = 31/208 (14%), Positives = 53/208 (25%), Gaps = 46/208 (22%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRL----HDVIPVD---------- 46
           KV       SR ++E +             L   +          ++P D          
Sbjct: 93  KVFTMGAENSRSELERL----HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 47  ------------FKLFLVFEFLRQDLKDFLQ------TTPVPVPPALAKSYLYQLLEALR 88
                           L+      DL+                          QL+    
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208

Query: 89  YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG 148
              S+ ++H    P N+ I   G L L D            R     V + Y P E L  
Sbjct: 209 NLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK---VGTRGPASSVPVTYAPREFLNA 265

Query: 149 AKV-YSTTVDIWSAGCIFSEMSYLYQLL 175
           +   ++  ++ W  G        +Y++ 
Sbjct: 266 STATFTHALNAWQLGLS------IYRVW 287

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  143 bits (362), Expect = 6e-38
 Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 23/170 (13%)

Query: 22  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQ--TTPVPVPPALA 76
           +RE  VLK+L H N+++L  +          L+ EF     L   L+  +    +P +  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYT 132
              L  ++  + +     I+HR++KP NI+     +     KL DFG +R         +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 133 HEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMSYLYQLL 175
               T  Y  P++   A       K Y  TVD+WS G         Y   
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT------FYHAA 217

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 1e-28
 Identities = 39/203 (19%), Positives = 64/203 (31%), Gaps = 25/203 (12%)

Query: 163 CIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAF 215
               E      L  ++  + +     I+HR++KP NI+     +     KL DFG +R  
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

Query: 216 TIPMNRYTHEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMITKKTLF-- 266
                  +    T  Y  P++   A       K Y  TVD+WS G  F    T    F  
Sbjct: 167 EDDEQFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

Query: 267 --AGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI-YKTDFPEWRPKKFSEILNLPDPLAV 323
                   + +++I     +            PI +  D P         +      L  
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS-----CSLSRGLQVLLT 280

Query: 324 DVFSKIMALDPKQRVSAKTILQH 346
            V + I+  D ++          
Sbjct: 281 PVLANILEADQEKCWGFDQFFAE 303

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  140 bits (354), Expect = 3e-37
 Identities = 70/340 (20%), Positives = 115/340 (33%), Gaps = 91/340 (26%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
            E+ ++K+L HPN+ RL++V   +  + LV E      L D                   
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD------------------- 117

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
                       ++                  +                           
Sbjct: 118 ------------KLNVFIDDSTGKCAMDVVKTQ------------------------ICP 141

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI 198
            PE    A   S      S   +  E    + + Q+  AL Y H++ I HRD+KP+N L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 199 --NKSGALKLADFGLSRAFTIPMNRYTHEVVTL----WYRPPEILLGA-KVYSTTVDIWS 251
             NKS  +KL DFGLS+ F    N   + + T     ++  PE+L    + Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKF 311
           AG +   ++     F G ++ D + ++           +  +S                 
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLS----------------- 304

Query: 312 SEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                   PLA D+ S ++  +  +R  A   LQH + +Q
Sbjct: 305 --------PLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  135 bits (342), Expect = 6e-36
 Identities = 54/161 (33%), Positives = 84/161 (52%), Gaps = 16/161 (9%)

Query: 23  REISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLR---QDLKDFLQTTPVPVPPALAK 77
           +EI +L+ L+H NVI+L DV+      K+++V E+     Q++ D +     PV    A 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC--QAH 112

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 136
            Y  QL++ L Y HS+ I+H+D+KP N+L+   G LK++  G++ A        T     
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 137 -TLWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMSYLYQLL 175
            +  ++PPEI  G   +S   VDIWSAG        LY + 
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVT------LYNIT 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  109 bits (274), Expect = 1e-26
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 36/187 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 227
           Y  QL++ L Y HS+ I+H+D+KP N+L+   G LK++  G++ A        T      
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 228 TLWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
           +  ++PPEI  G   +S   VDIWSAG     + T    F GD+ I +LF          
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFE--------- 223

Query: 287 EDVWPGVSKLPIYKTDF--PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                      I K  +  P               P   D+   ++  +P +R S + I 
Sbjct: 224 ----------NIGKGSYAIPGD----CG-------PPLSDLLKGMLEYEPAKRFSIRQIR 262

Query: 345 QHEYFNQ 351
           QH +F +
Sbjct: 263 QHSWFRK 269

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  138 bits (349), Expect = 7e-36
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEV 226
            + + +L+ L   H  RIIH DLKP+NIL+       +K+ DFG S      +  Y   +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY---I 260

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            + +YR PE++LGA+ Y   +D+WS GCI +E++T   L  G+ E DQL  +   LG P 
Sbjct: 261 QSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319

Query: 287 EDV------------------WPGVSKLPIYKTDFPEWRPKK------------FSEILN 316
           + +                  +  V+ L          R ++             + +  
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379

Query: 317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
             DPL +D   + +  DP  R++    L+H +  +
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  129 bits (327), Expect = 6e-33
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 21  ALREISVLKELKH------PNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPV 71
           A  EI +L+ L+        NVI + +     F+  + + FE L  +L + ++       
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLEN--FTFRNHICMTFELLSMNLYELIKKNKFQGF 197

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMN 129
              L + + + +L+ L   H  RIIH DLKP+NIL+       +K+ DFG S      + 
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y   + + +YR PE++LGA+ Y   +D+WS GCI +E+
Sbjct: 258 TY---IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAEL 292

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  137 bits (346), Expect = 1e-35
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 15/159 (9%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
            EI +LK+L HP +I++ +        ++V E +   +L D +      +  A  K Y Y
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFY 246

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Q+L A++Y H   IIHRDLKP+N+L+    +   +K+ DFG S+      +       T 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 305

Query: 139 WYRPPEILLGAKV--YSTTVDIWSAGCIFSEMSYLYQLL 175
            Y  PE+L+      Y+  VD WS G I      L+  L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVI------LFICL 338

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  118 bits (298), Expect = 4e-29
 Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 35/201 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
             E     Y YQ+L A++Y H   IIHRDLKP+N+L+    +   +K+ DFG S+     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 294

Query: 219 MNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            +       T  Y  PE+L+      Y+  VD WS G I    ++    F+       L 
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354

Query: 277 -RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK 335
            +I         +VW  VS                           A+D+  K++ +DPK
Sbjct: 355 DQITSGKYNFIPEVWAEVS-------------------------EKALDLVKKLLVVDPK 389

Query: 336 QRVSAKTILQHEYFNQVEMVK 356
            R + +  L+H +    +M +
Sbjct: 390 ARFTTEEALRHPWLQDEDMKR 410

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  133 bits (336), Expect = 3e-35
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 15/176 (8%)

Query: 7   RPRSRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL 64
              S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L
Sbjct: 56  GSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL 115

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
            T  V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S   
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 125 TIPMNRYTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMSYLYQLL 175
             P  +      T  Y  PEI+  +       Y   VD+WS G I      +Y LL
Sbjct: 175 D-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI------MYTLL 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  114 bits (287), Expect = 2e-28
 Identities = 49/195 (25%), Positives = 73/195 (37%), Gaps = 34/195 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
            SE      +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P  +
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEK 179

Query: 222 YTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
                 T  Y  PEI+  +       Y   VD+WS G I   ++     F    ++  L 
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239

Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
            I           W   S                             D+ S+ + + P++
Sbjct: 240 MIMSGNYQFGSPEWDDYS-------------------------DTVKDLVSRFLVVQPQK 274

Query: 337 RVSAKTILQHEYFNQ 351
           R +A+  L H +F Q
Sbjct: 275 RYTAEEALAHPFFQQ 289

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  134 bits (338), Expect = 4e-35
 Identities = 46/194 (23%), Positives = 75/194 (38%), Gaps = 43/194 (22%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR------ 221
           +    Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A             
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226

Query: 222 ------YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQL 275
                 +T +V T  Y  PE + G   YS  VDI+S G I  E++     F+   E  ++
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRI 282

Query: 276 FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK 335
               R                      FP    +K+ +   +           +++  P 
Sbjct: 283 ITDVR-------------------NLKFPLLFTQKYPQEHMM--------VQDMLSPSPT 315

Query: 336 QRVSAKTILQHEYF 349
           +R  A  I+++  F
Sbjct: 316 ERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  133 bits (335), Expect = 8e-35
 Identities = 43/199 (21%), Positives = 81/199 (40%), Gaps = 23/199 (11%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPALAKSYL 80
           +I  +      N +           L++  +   +++LKD++  + +       +     
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---------- 130
            Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A                 
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 131 --YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY-------LYQLLEALRYC 181
             +T +V T  Y  PE + G   YS  VDI+S G I  E+ Y         +++  +R  
Sbjct: 231 ATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNL 289

Query: 182 HSRRIIHRDLKPQNILINK 200
               +  +    +++++  
Sbjct: 290 KFPLLFTQKYPQEHMMVQD 308

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  133 bits (337), Expect = 7e-35
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR------- 221
              YQ+ +++ + HS ++ H DLKP+NIL  +S   +  +  + R     +N        
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 222 ----YTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
               Y  E     V T  YR PE++L    +S   D+WS GCI  E     T+F      
Sbjct: 182 GSATYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW------------RPKKFSEIL---NL 317
           + L  + R LG   + +     K   +  D  +W              K   E +   ++
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
                 D+  K++  DP +R++ +  L+H +F+ +
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  117 bits (296), Expect = 2e-29
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 28/173 (16%)

Query: 21  ALREISVLKELKHP------NVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPV 71
           A  EI VL+ L           +++ +    +    + +VFE L     DF++    +P 
Sbjct: 58  ARSEIQVLEHLNTTDPNSTFRCVQMLEW--FEHHGHICIVFELLGLSTYDFIKENGFLPF 115

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR- 130
                +   YQ+ +++ + HS ++ H DLKP+NIL  +S   +  +  + R     +N  
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 131 ----------YTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                     Y  E     V T  YR PE++L    +S   D+WS GCI  E 
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEY 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  134 bits (339), Expect = 7e-35
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
             EIS++ +L HP +I LHD     +++ L+ EFL   +L D +      +  A   +Y+
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         T 
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATA 214

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            +  PEI+   +      D+W+ G +       Y LL
Sbjct: 215 EFAAPEIVDR-EPVGFYTDMWAIGVL------GYVLL 244

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  118 bits (297), Expect = 3e-29
 Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 62/265 (23%)

Query: 158 IWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLS 212
           I +     SE    +Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198

Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
                P         T  +  PEI+   +      D+W+ G +   +++  + FAG+ ++
Sbjct: 199 TKLN-PDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL 332
           + L  + R      ED +  VS                         P A D    ++  
Sbjct: 257 ETLQNVKRCDWEFDEDAFSSVS-------------------------PEAKDFIKNLLQK 291

Query: 333 DPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRSWD 392
           +P++R++    L+H                              PW+         R   
Sbjct: 292 EPRKRLTVHDALEH------------------------------PWLKGDHSNLTSRIPS 321

Query: 393 DIPNNKLKRIKPKIEEWPSSQRSTR 417
              N   ++IK K  +WP+ Q +  
Sbjct: 322 SRYNKIRQKIKEKYADWPAPQPAIG 346

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  132 bits (334), Expect = 1e-34
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 21/180 (11%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLR- 57
           ++SD     +  +V         E+ +LK++      VIRL D         L+ E    
Sbjct: 80  RISDWGELPNGTRVP-------MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 132

Query: 58  -QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKL 115
            QDL DF+      +   LA+S+ +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL
Sbjct: 133 VQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191

Query: 116 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            DFG      +    YT    T  Y PPE +   + +  +  +WS G +      LY ++
Sbjct: 192 IDFGSGA--LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL------LYDMV 243

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  101 bits (254), Expect = 6e-24
 Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 38/186 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           + +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFDGT 211

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y PPE +   + +  +  +WS G +  +M+     F  D EI                
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 255

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                      +     +  ++ S            +    +AL P  R + + I  H +
Sbjct: 256 ----------IRGQV--FFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPW 296

Query: 349 FNQVEM 354
              V +
Sbjct: 297 MQDVLL 302

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  132 bits (334), Expect = 1e-34
 Identities = 46/156 (29%), Positives = 82/156 (52%), Gaps = 11/156 (7%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
           +EIS+L   +H N++ LH+      +L ++FEF+   D+ + + T+   +      SY++
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109

Query: 82  QLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLW 139
           Q+ EAL++ HS  I H D++P+NI+   +  + +K+ +FG +R    P + +        
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPE 168

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           Y  PE+     V ST  D+WS G +      +Y LL
Sbjct: 169 YYAPEVHQH-DVVSTATDMWSLGTL------VYVLL 197

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  112 bits (283), Expect = 1e-27
 Identities = 43/196 (21%), Positives = 82/196 (41%), Gaps = 36/196 (18%)

Query: 158 IWSAGCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLS 212
           I ++    +E    SY++Q+ EAL++ HS  I H D++P+NI+   +  + +K+ +FG +
Sbjct: 92  INTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
           R    P + +        Y  PE+     V ST  D+WS G +   +++    F  ++  
Sbjct: 152 RQLK-PGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209

Query: 273 DQLFRIFRTLGTP--HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM 330
             +  I          E+ +  +S                           A+D   +++
Sbjct: 210 QIIENIMN--AEYTFDEEAFKEIS-------------------------IEAMDFVDRLL 242

Query: 331 ALDPKQRVSAKTILQH 346
             + K R++A   LQH
Sbjct: 243 VKERKSRMTASEALQH 258

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  131 bits (331), Expect = 1e-34
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 33/186 (17%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE------ 54
           ++S   R  SR ++E       RE+++L+E++HPN+I LHD+      + L+ E      
Sbjct: 42  RLSSSRRGVSREEIE-------REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGE 94

Query: 55  -FLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NK 109
            F     K+ L           A  +L Q+L+ + Y HS+RI H DLKP+NI++      
Sbjct: 95  LFDFLAEKESL-------TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVP 147

Query: 110 SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS 169
           +  +KL DFG++       N + +   T  +  PEI+   +      D+WS G I     
Sbjct: 148 NPRIKLIDFGIAHKIE-AGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI----- 200

Query: 170 YLYQLL 175
             Y LL
Sbjct: 201 -TYILL 205

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  112 bits (282), Expect = 7e-28
 Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 34/194 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTI 217
            +E     +L Q+L+ + Y HS+RI H DLKP+NI++      +  +KL DFG++     
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE- 163

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
             N + +   T  +  PEI+   +      D+WS G I   +++  + F G+++ + L  
Sbjct: 164 AGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN 222

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           I        E+ +   S                          LA D   +++  DPK+R
Sbjct: 223 ISAVNYDFDEEYFSNTS-------------------------ELAKDFIRRLLVKDPKRR 257

Query: 338 VSAKTILQHEYFNQ 351
           ++    L+H +   
Sbjct: 258 MTIAQSLEHSWIKA 271

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  132 bits (333), Expect = 1e-34
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 15/159 (9%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
            EI +LK+L HP +I++ +        ++V E +   +L D +      +  A  K Y Y
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFY 121

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Q+L A++Y H   IIHRDLKP+N+L+    +   +K+ DFG S+      +       T 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 180

Query: 139 WYRPPEILLGA--KVYSTTVDIWSAGCIFSEMSYLYQLL 175
            Y  PE+L+      Y+  VD WS G I      L+  L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVI------LFICL 213

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  114 bits (288), Expect = 2e-28
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 53/218 (24%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
             E     Y YQ+L A++Y H   IIHRDLKP+N+L+    +   +K+ DFG S+     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169

Query: 219 MNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCI----------FSEMITKKTLF 266
            +       T  Y  PE+L+      Y+  VD WS G I          FSE  T+ +L 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229

Query: 267 AGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF 326
                     +I         +VW  VS                           A+D+ 
Sbjct: 230 D---------QITSGKYNFIPEVWAEVS-------------------------EKALDLV 255

Query: 327 SKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPE 364
            K++ +DPK R + +  L+H +    +M +    +  E
Sbjct: 256 KKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  137 bits (346), Expect = 1e-34
 Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 22/166 (13%)

Query: 23  REISVLKELKHPNVIRLHDVI------PVDFKLFLVFEFLRQ-DLKDFLQT--TPVPVPP 73
            EI ++K+L HPNV+   +V         +    L  E+    DL+ +L        +  
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNR 130
              ++ L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++        
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGE 178

Query: 131 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
              E V TL Y  PE+L   K Y+ TVD WS G +       ++ +
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTL------AFECI 217

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (316), Expect = 1e-30
 Identities = 54/198 (27%), Positives = 78/198 (39%), Gaps = 15/198 (7%)

Query: 163 CIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFT 216
           C   E    + L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++   
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL- 174

Query: 217 IPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQL 275
                   E V TL Y  PE+L   K Y+ TVD WS G +  E IT    F  + +  Q 
Sbjct: 175 -DQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

Query: 276 FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK 335
               R     H  V+  ++    + +  P   P   S IL             ++    +
Sbjct: 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPT--PNHLSGIL---AGKLERWLQCMLMWHQR 287

Query: 336 QRVSAKTILQHEYFNQVE 353
           QR +         F  ++
Sbjct: 288 QRGTDPQNPNVGCFQALD 305

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  132 bits (333), Expect = 2e-34
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 11/174 (6%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYL 80
            EI++L  ++H N+I++ D+        LV E      DL  F+   P  +   LA    
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIF 136

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            QL+ A+ Y   + IIHRD+K +NI+I +   +KL DFG +         YT    T+ Y
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEY 195

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL-EALRYCHSRRIIHRDLKP 193
             PE+L+G       +++WS G        LY L+ E   +C     +   + P
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVT------LYTLVFEENPFCELEETVEAAIHP 243

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 37/183 (20%), Positives = 68/183 (37%), Gaps = 38/183 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              QL+ A+ Y   + IIHRD+K +NI+I +   +KL DFG +         YT    T+
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTI 193

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ-LFRIFRTLGTPHED 288
            Y  PE+L+G       +++WS G     ++ ++  F    E  +               
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP---------- 243

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                              P   S          + + S ++   P++R + + ++   +
Sbjct: 244 -------------------PYLVS-------KELMSLVSGLLQPVPERRTTLEKLVTDPW 277

Query: 349 FNQ 351
             Q
Sbjct: 278 VTQ 280

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  133 bits (336), Expect = 2e-34
 Identities = 78/370 (21%), Positives = 126/370 (34%), Gaps = 89/370 (24%)

Query: 19  STALREISVLKELK-----HPN---VIRLHDVIPVDFKLF--------LVFEFLRQDLKD 62
            TAL EI +LK ++      PN   V++L D    DFK+         +VFE L   L  
Sbjct: 78  ETALDEIRLLKSVRNSDPNDPNREMVVQLLD----DFKISGVNGTHICMVFEVLGHHLLK 133

Query: 63  FLQTTPV-PVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGL 120
           ++  +    +P    K  + Q+L+ L Y H++ RIIH D+KP+NIL      L + +  +
Sbjct: 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL------LSVNEQYI 187

Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRY 180
            R                                                          
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAV------------------------------------S 211

Query: 181 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 240
                  +  + P      +   +K+AD G +         +T ++ T  YR  E+L+G+
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGS 268

Query: 241 KVYSTTVDIWSAGCIFSEMITKKTLFAG------DSEIDQLFRIFRTLGTPHEDVWPGVS 294
             Y+T  DIWS  C+  E+ T   LF          + D +  I   LG     +     
Sbjct: 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA-G 326

Query: 295 KL----------PIYKTDFPEWR-PKKFSEILNLPD---PLAVDVFSKIMALDPKQRVSA 340
           K             + T    W   +   E             D    ++ L P++R +A
Sbjct: 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386

Query: 341 KTILQHEYFN 350
              L+H + N
Sbjct: 387 AECLRHPWLN 396

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  130 bits (329), Expect = 3e-34
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 20/177 (11%)

Query: 6   SRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFL 64
           ++ RS+V +E +      EI VLK L HPN+I++ +V      +++V E     +L + +
Sbjct: 56  NKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI 111

Query: 65  QTTPVPVPP---ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADF 118
            +                + Q++ AL Y HS+ ++H+DLKP+NIL    +    +K+ DF
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171

Query: 119 GLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           GL+  F       T+   T  Y  PE+       +   DIWSAG +      +Y LL
Sbjct: 172 GLAELFK-SDEHSTNAAGTALYMAPEVFKRD--VTFKCDIWSAGVV------MYFLL 219

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 6e-27
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 35/193 (18%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
            SE      + Q++ AL Y HS+ ++H+DLKP+NIL    +    +K+ DFGL+  F   
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-S 179

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
               T+   T  Y  PE+       +   DIWSAG +   ++T    F G S  +++   
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQ-- 234

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                   +            + ++     +  +         AVD+  +++  DP++R 
Sbjct: 235 --------QKATYK-------EPNYAV-ECRPLTP-------QAVDLLKQMLTKDPERRP 271

Query: 339 SAKTILQHEYFNQ 351
           SA  +L HE+F Q
Sbjct: 272 SAAQVLHHEWFKQ 284

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  132 bits (333), Expect = 3e-34
 Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 38/218 (17%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-------------------KSGALKLADF 209
              YQL  ALR+ H  ++ H DLKP+NIL                     K+ ++++ADF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 210 GLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD 269
           G S A     +  T  V T  YRPPE++L    ++   D+WS GCI  E     TLF   
Sbjct: 187 G-S-ATFDHEHHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTH 242

Query: 270 SEIDQLFRIFRTLGTP----------HEDVWPGVSKLPIYKTDFPEWRP--KKFSEIL-- 315
              + L  + + LG             +  + G        +D    +   K     +  
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302

Query: 316 -NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV 352
            +L      D+  +++  DP QR++    L H +F  +
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  118 bits (297), Expect = 2e-29
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 34/176 (19%)

Query: 21  ALREISVLKELKHP------NVIRLHDVIPVDFK--LFLVFEFLRQDLKDFL-QTTPVPV 71
           A  EI+VLK++K          + + D    +F   + + FE L ++  +FL +    P 
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSDW--FNFHGHMCIAFELLGKNTFEFLKENNFQPY 120

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-------------------KSGA 112
           P    +   YQL  ALR+ H  ++ H DLKP+NIL                     K+ +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 113 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +++ADFG S A     +  T  V T  YRPPE++L    ++   D+WS GCI  E 
Sbjct: 181 IRVADFG-S-ATFDHEHHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY 232

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  129 bits (328), Expect = 3e-34
 Identities = 58/157 (36%), Positives = 85/157 (54%), Gaps = 13/157 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  + ++L+HPN++RLHD I  +   +LVF+ +   +L + +         A A   + 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQ 112

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL+         +     T 
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTP 171

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            Y  PE+L     YS  VDIW+ G I      LY LL
Sbjct: 172 GYLSPEVLKK-DPYSKPVDIWACGVI------LYILL 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (272), Expect = 2e-26
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 33/201 (16%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           +SE      + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL+      
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 160

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
              +     T  Y  PE+L     YS  VDIW+ G I   ++     F  + +     +I
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                      W  V+                         P A  +   ++ ++PK+R+
Sbjct: 220 KAGAYDYPSPEWDTVT-------------------------PEAKSLIDSMLTVNPKKRI 254

Query: 339 SAKTILQHEYFNQVEMVKPTL 359
           +A   L+  +    E V   +
Sbjct: 255 TADQALKVPWICNRERVASAI 275

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  130 bits (330), Expect = 4e-34
 Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 9/154 (5%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
           RE+ ++K L HPN+++L +VI  +  L+L+ E+    ++ D+L      +    A+S   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFR 121

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+             Y 
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYA 180

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            PE+  G K     VD+WS G I      LY L+
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVI------LYTLV 208

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (261), Expect = 8e-25
 Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 30/179 (16%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
           Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+             Y 
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYA 180

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG 292
            PE+  G K     VD+WS G I   +++    F G + + +L                 
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRE--------------- 224

Query: 293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                + +  +    P   S           ++  + + L+P +R + + I++  + N 
Sbjct: 225 ----RVLRGKYRI--PFYMS-------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  134 bits (338), Expect = 5e-34
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 18/179 (10%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QD 59
           KV  + + + +   E +    LRE+ +LK+L HPN+++L++        +LV E     +
Sbjct: 57  KVISKRQVKQKTDKESL----LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112

Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLA 116
           L D + +         A   + Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ 
Sbjct: 113 LFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171

Query: 117 DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           DFGLS  F     +   ++ T +Y  PE+L G   Y    D+WS G I      LY LL
Sbjct: 172 DFGLSTHFE-ASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVI------LYILL 221

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  125 bits (316), Expect = 4e-31
 Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 34/193 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           FSE+     + Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F   
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-A 181

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             +   ++ T +Y  PE+L G   Y    D+WS G I   +++    F G +E D L ++
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
            +   T     W  VS                           A D+  K++   P  R+
Sbjct: 240 EKGKYTFELPQWKKVS-------------------------ESAKDLIRKMLTYVPSMRI 274

Query: 339 SAKTILQHEYFNQ 351
           SA+  L HE+   
Sbjct: 275 SARDALDHEWIQT 287

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  131 bits (331), Expect = 6e-34
 Identities = 58/157 (36%), Positives = 85/157 (54%), Gaps = 13/157 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           RE  + ++L+HPN++RLHD I  +   +LVF+ +   +L + +         A A   + 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQ 135

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL+         +     T 
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTP 194

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            Y  PE+L     YS  VDIW+ G I      LY LL
Sbjct: 195 GYLSPEVLKK-DPYSKPVDIWACGVI------LYILL 224

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (273), Expect = 4e-26
 Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 45/194 (23%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           +SE      + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL+      
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 183

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL------FAGDSEI 272
              +     T  Y  PE+L     YS  VDIW+ G I         L      F  + + 
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVIL------YILLVGYPPFWDEDQH 236

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL 332
               +I           W  V+                         P A  +   ++ +
Sbjct: 237 RLYAQIKAGAYDYPSPEWDTVT-------------------------PEAKSLIDSMLTV 271

Query: 333 DPKQRVSAKTILQH 346
           +PK+R++A   L+ 
Sbjct: 272 NPKKRITADQALKV 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  130 bits (328), Expect = 6e-34
 Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 17/182 (9%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKEL----KHPNVIRLHDVIPVDFKLFLVFEFL 56
           KV   +R      +    +    E+++L ++     HP VIRL D         LV E  
Sbjct: 62  KVIPRNRVLGWSPLSDSVTCP-LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120

Query: 57  R--QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGAL 113
              QDL D++ T   P+    ++ +  Q++ A+++CHSR ++HRD+K +NILI+ + G  
Sbjct: 121 LPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179

Query: 114 KLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ 173
           KL DFG      +    YT    T  Y PPE +   + ++    +WS G +      LY 
Sbjct: 180 KLIDFGSGA--LLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGIL------LYD 231

Query: 174 LL 175
           ++
Sbjct: 232 MV 233

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  101 bits (253), Expect = 8e-24
 Identities = 44/183 (24%), Positives = 72/183 (39%), Gaps = 38/183 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +  Q++ A+++CHSR ++HRD+K +NILI+ + G  KL DFG      +    YT    T
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFDGT 201

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y PPE +   + ++    +WS G +  +M+     F  D EI                
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---------------- 245

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                      + +     P   S       P    +  + +A  P  R S + IL   +
Sbjct: 246 ----------LEAEL--HFPAHVS-------PDCCALIRRCLAPKPSSRPSLEEILLDPW 286

Query: 349 FNQ 351
              
Sbjct: 287 MQT 289

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  132 bits (335), Expect = 7e-34
 Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 36/169 (21%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL------------KDFLQTTPV 69
           RE  + + LKHPN++RLHD I  +   +L+F+ +   +L             D       
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD------- 111

Query: 70  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTI 126
                 A   + Q+LEA+ +CH   ++HR+LKP+N+L+    K  A+KLADFGL+     
Sbjct: 112 ------ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165

Query: 127 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
               +     T  Y  PE+L     Y   VD+W+ G I      LY LL
Sbjct: 166 EQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVI------LYILL 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (284), Expect = 4e-27
 Identities = 49/194 (25%), Positives = 80/194 (41%), Gaps = 44/194 (22%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           +SE      + Q+LEA+ +CH   ++HR+LKP+N+L+    K  A+KLADFGL+      
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTL------FAGDSEI 272
              +     T  Y  PE+L     Y   VD+W+ G I         L      F  + + 
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVIL------YILLVGYPPFWDEDQH 219

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL 332
               +I           W  V+                         P A D+ +K++ +
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTVT-------------------------PEAKDLINKMLTI 254

Query: 333 DPKQRVSAKTILQH 346
           +P +R++A   L+H
Sbjct: 255 NPSKRITAAEALKH 268

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  134 bits (339), Expect = 7e-34
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
            +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +    A  Y+
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+     P         T 
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTA 320

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            +  PE+  G K      D+WS G +       Y LL
Sbjct: 321 EFAAPEVAEG-KPVGYYTDMWSVGVL------SYILL 350

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (289), Expect = 2e-27
 Identities = 43/187 (22%), Positives = 74/187 (39%), Gaps = 32/187 (17%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPM 219
            SE   + Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+     P 
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PK 310

Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIF 279
                   T  +  PE+  G K      D+WS G +   +++  + F G+++ + L  + 
Sbjct: 311 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369

Query: 280 RTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
                  +  + G+S                             D   K++  DP  R++
Sbjct: 370 SCDWNMDDSAFSGIS-------------------------EDGKDFIRKLLLADPNTRMT 404

Query: 340 AKTILQH 346
               L+H
Sbjct: 405 IHQALEH 411

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  130 bits (328), Expect = 9e-34
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 18/173 (10%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT 67
            R  ++   +     REIS LK L+HP++I+L+DVI     + +V E+   +L D++   
Sbjct: 43  SRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VE 101

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
              +     + +  Q++ A+ YCH  +I+HRDLKP+N+L++ +  +K+ADFGLS   T  
Sbjct: 102 KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-- 159

Query: 128 MNRYTHEVVTLW-----YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                   +        Y  PE++ G       VD+WS G +      LY +L
Sbjct: 160 ----DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV------LYVML 202

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 40/187 (21%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           +  Q++ A+ YCH  +I+HRDLKP+N+L++ +  +K+ADFGLS   T          +  
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT------DGNFLKT 166

Query: 230 W-----YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
                 Y  PE++ G       VD+WS G +   M+  +  F  +  I  LF+       
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKK------ 219

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                        +    +    P   S       P A  +  +++  DP QR++ + I 
Sbjct: 220 -------------VNSCVYVM--PDFLS-------PGAQSLIRRMIVADPMQRITIQEIR 257

Query: 345 QHEYFNQ 351
           +  +FN 
Sbjct: 258 RDPWFNV 264

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  133 bits (336), Expect = 1e-33
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 14/179 (7%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QD 59
           +            +E        EIS+LK L HPN+I+L DV       +LV EF    +
Sbjct: 73  QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE 132

Query: 60  LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLA 116
           L + +           A + + Q+L  + Y H   I+HRD+KP+NIL+   N    +K+ 
Sbjct: 133 LFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191

Query: 117 DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           DFGLS  F+    +    + T +Y  PE+L     Y+   D+WS G I      +Y LL
Sbjct: 192 DFGLSSFFS-KDYKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVI------MYILL 241

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  126 bits (318), Expect = 3e-31
 Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 34/193 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F E    + + Q+L  + Y H   I+HRD+KP+NIL+   N    +K+ DFGLS  F+  
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-K 201

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             +    + T +Y  PE+L     Y+   D+WS G I   ++     F G ++ D + ++
Sbjct: 202 DYKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
            +       + W  +S                           A ++   ++  D  +R 
Sbjct: 260 EKGKYYFDFNDWKNIS-------------------------DEAKELIKLMLTYDYNKRC 294

Query: 339 SAKTILQHEYFNQ 351
           +A+  L   +  +
Sbjct: 295 TAEEALNSRWIKK 307

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  132 bits (335), Expect = 1e-33
 Identities = 53/158 (33%), Positives = 79/158 (50%), Gaps = 14/158 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           LRE+ +LK+L HPN+++L +++      ++V E     +L D +           A   +
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARII 127

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    + T
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGT 186

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            +Y  PE+L G   Y    D+WSAG I      LY LL
Sbjct: 187 AYYIAPEVLRGT--YDEKCDVWSAGVI------LYILL 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  126 bits (318), Expect = 2e-31
 Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 34/207 (16%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           FSE      + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-Q 176

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             +    + T +Y  PE+L G   Y    D+WSAG I   +++    F G +E D L R+
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                      W  +S                           A D+  K++   P  R+
Sbjct: 235 ETGKYAFDLPQWRTIS-------------------------DDAKDLIRKMLTFHPSLRI 269

Query: 339 SAKTILQHEYFNQVEMVKPTLAVFPEL 365
           +A   L+H +  +     PT++  P L
Sbjct: 270 TATQCLEHPWIQKYSSETPTISDLPSL 296

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  132 bits (335), Expect = 1e-33
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 14/158 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           L E++VLK L HPN+++L+D        +LV E  +  +L D +    +      A   +
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVII 142

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Q+L  + Y H   I+HRDLKP+N+L+    K   +K+ DFGLS  F     +    + T
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGT 201

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            +Y  PE+L     Y    D+WS G I      L+ LL
Sbjct: 202 AYYIAPEVLRKK--YDEKCDVWSIGVI------LFILL 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  128 bits (323), Expect = 5e-32
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 34/193 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F+E+     + Q+L  + Y H   I+HRDLKP+N+L+    K   +K+ DFGLS  F   
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-N 191

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             +    + T +Y  PE+L     Y    D+WS G I   ++     F G ++ + L ++
Sbjct: 192 QKKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
            +   T     W  VS                           A D+  +++  D ++R+
Sbjct: 250 EKGKYTFDSPEWKNVS-------------------------EGAKDLIKQMLQFDSQRRI 284

Query: 339 SAKTILQHEYFNQ 351
           SA+  L+H +  +
Sbjct: 285 SAQQALEHPWIKE 297

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  129 bits (326), Expect = 1e-33
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 26/165 (15%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPA 74
            RE+S+L+++ H NVI LHDV      + L+ E       F     K+ L          
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-------SEE 115

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNR 130
            A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+         
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE 174

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           + +   T  +  PEI+   +      D+WS G I       Y LL
Sbjct: 175 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI------TYILL 212

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (283), Expect = 9e-28
 Identities = 45/196 (22%), Positives = 84/196 (42%), Gaps = 34/196 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTI 217
            SE    S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
               + +   T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           I        E+ +   S                          LA D   K++  + ++R
Sbjct: 230 ITSVSYDFDEEFFSHTS-------------------------ELAKDFIRKLLVKETRKR 264

Query: 338 VSAKTILQHEYFNQVE 353
           ++ +  L+H +   V+
Sbjct: 265 LTIQEALRHPWITPVD 280

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  130 bits (329), Expect = 1e-33
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 43/222 (19%)

Query: 169 SYLYQLLEALRYCHSRR--IIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTH 224
            +  Q+  AL +  +    IIH DLKP+NIL+   K  A+K+ DFG S      + +Y  
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY-- 218

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            + + +YR PE+LLG   Y   +D+WS GCI  EM T + LF+G +E+DQ+ +I   LG 
Sbjct: 219 -IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276

Query: 285 P-----------------HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA----- 322
           P                   D    + K    K ++     +K   IL +          
Sbjct: 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336

Query: 323 -------------VDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                         D+  +++  DPK R+     LQH +F +
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  122 bits (308), Expect = 1e-30
 Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 19/161 (11%)

Query: 21  ALREISVLKELKHP------NVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPV 71
           A  E+ +L+ +          ++ L       F+  L LVFE L  +L D L+ T    V
Sbjct: 97  AQIEVRLLELMNKHDTEMKYYIVHLKRH--FMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154

Query: 72  PPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILI--NKSGALKLADFGLSRAFTIP 127
              L + +  Q+  AL +  +    IIH DLKP+NIL+   K  A+K+ DFG S      
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + +Y   + + +YR PE+LLG   Y   +D+WS GCI  EM
Sbjct: 215 IYQY---IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEM 251

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (326), Expect = 1e-33
 Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 26/165 (15%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPA 74
            RE+S+LKE++HPNVI LH+V      + L+ E       F     K+ L          
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL-------TEE 114

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNR 130
            A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N 
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNE 173

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           + +   T  +  PEI+   +      D+WS G I       Y LL
Sbjct: 174 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI------TYILL 211

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (285), Expect = 6e-28
 Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 34/194 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTI 217
            +E     +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
             N + +   T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           +        ++ +   S                          LA D   +++  DPK+R
Sbjct: 229 VSAVNYEFEDEYFSNTS-------------------------ALAKDFIRRLLVKDPKKR 263

Query: 338 VSAKTILQHEYFNQ 351
           ++ +  LQH +   
Sbjct: 264 MTIQDSLQHPWIKP 277

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  128 bits (323), Expect = 1e-33
 Identities = 36/172 (20%), Positives = 59/172 (34%), Gaps = 28/172 (16%)

Query: 21  ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ---TTPVPVPPAL 75
           ALRE+     L +H +V+R       D  + +  E+     L D +            A 
Sbjct: 57  ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-------------------KLA 116
            K  L Q+   LRY HS  ++H D+KP NI I+++                      K+ 
Sbjct: 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 117 DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           D G     +   +    E     +   E+L     +    DI++        
Sbjct: 177 DLGHVTRIS---SPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (307), Expect = 3e-31
 Identities = 37/206 (17%), Positives = 65/206 (31%), Gaps = 57/206 (27%)

Query: 165 FSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL----------------- 204
           F E      L Q+   LRY HS  ++H D+KP NI I+++                    
Sbjct: 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171

Query: 205 --KLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
             K+ D G     +   +    E     +   E+L     +    DI++           
Sbjct: 172 MFKIGDLGHVTRIS---SPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227

Query: 263 KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA 322
           + L       DQ   I                     +   P   P+  S+         
Sbjct: 228 EPLP---RNGDQWHEIR--------------------QGRLPRI-PQVLSQEFT------ 257

Query: 323 VDVFSKIMALDPKQRVSAKTILQHEY 348
            ++   ++  DP++R SA  +++H  
Sbjct: 258 -ELLKVMIHPDPERRPSAMALVKHSV 282

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  129 bits (327), Expect = 2e-33
 Identities = 50/224 (22%), Positives = 83/224 (37%), Gaps = 48/224 (21%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-------------------------KSGA 203
            Y  ++L+AL Y     + H DLKP+NIL++                         KS  
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 204 LKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
           +KL DFG    F    + Y   ++ T  YR PE++L    +  + D+WS GC+ +E+ T 
Sbjct: 201 IKLIDFG-CATFK---SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTG 255

Query: 263 KTLFAGDSEIDQLFRIFRTLGTP---------------HEDVWPGVSKLPIYKTDFPEWR 307
             LF     ++ L  +   +                  + +        P   +     +
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315

Query: 308 PKKFSEILNLP--DPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
             K    L       L  D    I+ +DP  R S   +L+H++ 
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  118 bits (299), Expect = 1e-29
 Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 41/182 (22%)

Query: 21  ALREISVLKELKH-----PNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPVP 72
           A  E  +LK++++      N+++ H      +   + L+FE L   L + +         
Sbjct: 78  AKIEADILKKIQNDDINNNNIVKYHGK--FMYYDHMCLIFEPLGPSLYEIITRNNYNGFH 135

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN------------------------ 108
               K Y  ++L+AL Y     + H DLKP+NIL++                        
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195

Query: 109 -KSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFS 166
            KS  +KL DFG    F    + Y   ++ T  YR PE++L    +  + D+WS GC+ +
Sbjct: 196 TKSTGIKLIDFG-CATFK---SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLA 250

Query: 167 EM 168
           E+
Sbjct: 251 EL 252

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  129 bits (326), Expect = 3e-33
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 26/164 (15%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 75
           RE+S+L+++ HPN+I LHDV      + L+ E       F     K+ L           
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-------SEEE 116

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRY 131
           A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+         +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            +   T  +  PEI+   +      D+WS G I       Y LL
Sbjct: 176 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI------TYILL 212

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  113 bits (284), Expect = 1e-27
 Identities = 45/196 (22%), Positives = 84/196 (42%), Gaps = 34/196 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTI 217
            SE    S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
               + +   T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           I        E+ +   S                          LA D   K++  + ++R
Sbjct: 230 ITAVSYDFDEEFFSQTS-------------------------ELAKDFIRKLLVKETRKR 264

Query: 338 VSAKTILQHEYFNQVE 353
           ++ +  L+H +   V+
Sbjct: 265 LTIQEALRHPWITPVD 280

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  127 bits (321), Expect = 3e-33
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT 66
            R +++   V     REI  LK  +HP++I+L+ VI      F+V E++   +L D++  
Sbjct: 45  NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-C 103

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               V    A+    Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFGLS   + 
Sbjct: 104 KHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS- 162

Query: 127 PMNRYTHEVVTLW-----YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                  E +        Y  PE++ G       VDIWS G I      LY LL
Sbjct: 163 -----DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI------LYALL 205

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 40/187 (21%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFGLS   +        E +  
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS------DGEFLRT 169

Query: 230 W-----YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
                 Y  PE++ G       VDIWS G I   ++     F  +  +  LF+       
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFK------- 221

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                     K  I    F    P+  +            +   ++ +DP +R + K I 
Sbjct: 222 ----------K--IRGGVFYI--PEYLN-------RSVATLLMHMLQVDPLKRATIKDIR 260

Query: 345 QHEYFNQ 351
           +HE+F Q
Sbjct: 261 EHEWFKQ 267

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  126 bits (319), Expect = 5e-33
 Identities = 52/157 (33%), Positives = 78/157 (49%), Gaps = 14/157 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           +EI ++K L HPN+IRL++    +  ++LV E     +L + +         + A   + 
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMK 113

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
            +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P      +V T 
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTP 172

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
           +Y  P++L G   Y    D WSAG +      +Y LL
Sbjct: 173 YYVSPQVLEGL--YGPECDEWSAGVM------MYVLL 201

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (280), Expect = 1e-27
 Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 38/193 (19%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F E      +  +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P
Sbjct: 103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-P 161

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
                 +V T +Y  P++L G   Y    D WSAG +   ++     F+  ++  ++   
Sbjct: 162 GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTD-SEVMLK 218

Query: 279 FRTLGTP--HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
            R  GT    E  W  VS                         P A  +  +++   PKQ
Sbjct: 219 IRE-GTFTFPEKDWLNVS-------------------------PQAESLIRRLLTKSPKQ 252

Query: 337 RVSAKTILQHEYF 349
           R+++   L+HE+F
Sbjct: 253 RITSLQALEHEWF 265

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  128 bits (323), Expect = 7e-33
 Identities = 59/173 (34%), Positives = 91/173 (52%), Gaps = 15/173 (8%)

Query: 10  SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 67
           S  Q+E V     RE  +L+++  HP++I L D       +FLVF+ +R+ +L D+L T 
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TE 193

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
            V +     +S +  LLEA+ + H+  I+HRDLKP+NIL++ +  ++L+DFG S     P
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-P 252

Query: 128 MNRYTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMSYLYQLL 175
             +      T  Y  PEIL  +       Y   VD+W+ G I      L+ LL
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI------LFTLL 299

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  110 bits (277), Expect = 1e-26
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
            SE    S +  LLEA+ + H+  I+HRDLKP+NIL++ +  ++L+DFG S     P  +
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEK 255

Query: 222 YTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
                 T  Y  PEIL  +       Y   VD+W+ G I   ++     F    +   + 
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILML 314

Query: 277 RIFRTLGTP--HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
           R+    G        W   S                             D+ S+++ +DP
Sbjct: 315 RMIME-GQYQFSSPEWDDRS-------------------------STVKDLISRLLQVDP 348

Query: 335 KQRVSAKTILQHEYFNQ 351
           + R++A+  LQH +F +
Sbjct: 349 EARLTAEQALQHPFFER 365

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  128 bits (323), Expect = 9e-33
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 11/157 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
             EISV+ +L H N+I+L+D       + LV E++   +L D +      +       ++
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLSRAFTIPMNRYTHEVVTL 138
            Q+ E +R+ H   I+H DLKP+NIL +N+    +K+ DFGL+R +  P  +      T 
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTP 252

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            +  PE++      S   D+WS G I       Y LL
Sbjct: 253 EFLAPEVVNY-DFVSFPTDMWSVGVI------AYMLL 282

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (286), Expect = 8e-28
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 32/195 (16%)

Query: 162 GCIFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLSRAFT 216
               +E+    ++ Q+ E +R+ H   I+H DLKP+NIL +N+    +K+ DFGL+R + 
Sbjct: 181 SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240

Query: 217 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
            P  +      T  +  PE++      S   D+WS G I   +++  + F GD++ + L 
Sbjct: 241 -PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298

Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
            I        ++ +  +S                           A +  SK++  +   
Sbjct: 299 NILACRWDLEDEEFQDIS-------------------------EEAKEFISKLLIKEKSW 333

Query: 337 RVSAKTILQHEYFNQ 351
           R+SA   L+H + + 
Sbjct: 334 RISASEALKHPWLSD 348

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  126 bits (318), Expect = 9e-33
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 28/164 (17%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPA 74
           RE+ +LK+L HPN+++L +++      ++V E              K F +         
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------H 121

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRY 131
            A   + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     + 
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM 180

Query: 132 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
              + T +Y  PE+L G   Y    D+WSAG I      LY LL
Sbjct: 181 KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVI------LYILL 216

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  111 bits (279), Expect = 2e-27
 Identities = 53/188 (28%), Positives = 78/188 (41%), Gaps = 34/188 (18%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           FSE      + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-Q 176

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             +    + T +Y  PE+L G   Y    D+WSAG I   +++    F G +E D L R+
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
                      W  +S                           A D+  K++   P  R+
Sbjct: 235 ETGKYAFDLPQWRTIS-------------------------DDAKDLIRKMLTFHPSLRI 269

Query: 339 SAKTILQH 346
           +A   L+H
Sbjct: 270 TATQCLEH 277

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  125 bits (317), Expect = 1e-32
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 10/169 (5%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
              +    P    +EI + K L H NV++ +         +L  E+    +L D +    
Sbjct: 41  DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPD 99

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IP 127
           + +P   A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F    
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 128 MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
             R  +++  TL Y  PE+L   + ++  VD+WS G +      L  +L
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV------LTAML 202

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  100 bits (251), Expect = 8e-24
 Identities = 42/184 (22%), Positives = 81/184 (44%), Gaps = 28/184 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVV- 227
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F      R  +++  
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TL Y  PE+L   + ++  VD+WS G + + M+  +  +   S+  Q +           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------- 219

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                       +        KK            + +  KI+  +P  R++   I +  
Sbjct: 220 ---------DWKEKKTYLNPWKKID-------SAPLALLHKILVENPSARITIPDIKKDR 263

Query: 348 YFNQ 351
           ++N+
Sbjct: 264 WYNK 267

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  127 bits (320), Expect = 1e-32
 Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 35/183 (19%)

Query: 21  ALREISVLKELK-HPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQTTPV-- 69
            ++E+  +K+L  HPN+++      +          +  L+ E  +  L +FL+      
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131

Query: 70  PVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
           P+         YQ   A+++ H ++  IIHRDLK +N+L++  G +KL DFG +   +  
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 128 ----------------MNRYTHEVVTLWYRPPEI--LLGAKVYSTTVDIWSAGCIFSEMS 169
                           + R T    T  YR PEI  L          DIW+ GCI   + 
Sbjct: 192 PDYSWSAQRRALVEEEITRNT----TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247

Query: 170 YLY 172
           +  
Sbjct: 248 FRQ 250

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (273), Expect = 2e-26
 Identities = 42/205 (20%), Positives = 74/205 (36%), Gaps = 58/205 (28%)

Query: 165 FSE---MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIP- 218
            S    +   YQ   A+++ H ++  IIHRDLK +N+L++  G +KL DFG +   +   
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192

Query: 219 ---------------MNRYTHEVVTLWYRPPEI--LLGAKVYSTTVDIWSAGCIFSEMIT 261
                          + R T    T  YR PEI  L          DIW+ GCI   +  
Sbjct: 193 DYSWSAQRRALVEEEITRNT----TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248

Query: 262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL 321
           ++  F                           +KL I    +          + +     
Sbjct: 249 RQHPFEDG------------------------AKLRIVNGKYSIPPHDTQYTVFH----- 279

Query: 322 AVDVFSKIMALDPKQRVSAKTILQH 346
              +   ++ ++P++R+S   ++  
Sbjct: 280 --SLIRAMLQVNPEERLSIAEVVHQ 302

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  125 bits (316), Expect = 3e-32
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 10/169 (5%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 68
              +    P    +EI + K L H NV++ +         +L  E+    +L D +    
Sbjct: 41  DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPD 99

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IP 127
           + +P   A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F    
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 128 MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
             R  +++  TL Y  PE+L   + ++  VD+WS G +      L  +L
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV------LTAML 202

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 43/186 (23%), Positives = 82/186 (44%), Gaps = 32/186 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVV- 227
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F      R  +++  
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TL Y  PE+L   + ++  VD+WS G + + M+  +  +   S+  Q +           
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------- 219

Query: 288 DVWPGVSKLPIYKTDF--PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                       +       W  KK            + +  KI+  +P  R++   I +
Sbjct: 220 ---------DWKEKKTYLNPW--KKID-------SAPLALLHKILVENPSARITIPDIKK 261

Query: 346 HEYFNQ 351
             ++N+
Sbjct: 262 DRWYNK 267

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  124 bits (313), Expect = 4e-32
 Identities = 53/152 (34%), Positives = 76/152 (50%), Gaps = 7/152 (4%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTT--PVPVPPALAKSY 79
            EI++ K LKH N+++       +  + +  E +    L   L++   P+         Y
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV-T 137
             Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG S+     +N  T     T
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGT 186

Query: 138 LWYRPPE-ILLGAKVYSTTVDIWSAGCIFSEM 168
           L Y  PE I  G + Y    DIWS GC   EM
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (285), Expect = 3e-28
 Identities = 60/202 (29%), Positives = 82/202 (40%), Gaps = 35/202 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEV 226
             Y  Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG S+     +N  T   
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETF 183

Query: 227 V-TLWYRPPE-ILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFRTLG 283
             TL Y  PE I  G + Y    DIWS GC   EM T K  F         +F++     
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
            P            I         P+  S         A     K    DP +R  A  +
Sbjct: 244 HP-----------EI---------PESMS-------AEAKAFILKCFEPDPDKRACANDL 276

Query: 344 LQHEYFNQVEMVKPTLAVFPEL 365
           L  E+   +++        P+L
Sbjct: 277 LVDEF---LKVSSKKKKTQPKL 295

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  124 bits (314), Expect = 5e-32
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 24/162 (14%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT----TPVPVPPALAK 77
            EI+VLK++KH N++ L D+       +LV + +   +L D +      T        A 
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE-----KDAS 109

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 134
             + Q+L A++Y H   I+HRDLKP+N+L     ++  + + DFGLS+      N     
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMST 166

Query: 135 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
              T  Y  PE+L   K YS  VD WS G I       Y LL
Sbjct: 167 ACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVI------TYILL 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  107 bits (270), Expect = 3e-26
 Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 36/189 (19%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           ++E      + Q+L A++Y H   I+HRDLKP+N+L     ++  + + DFGLS+     
Sbjct: 103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-- 160

Query: 219 MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
            N        T  Y  PE+L   K YS  VD WS G I   ++     F  ++E     +
Sbjct: 161 -NGIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           I           W  +S                           A D    ++  DP +R
Sbjct: 219 IKEGYYEFESPFWDDIS-------------------------ESAKDFICHLLEKDPNER 253

Query: 338 VSAKTILQH 346
            + +  L H
Sbjct: 254 YTCEKALSH 262

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  125 bits (316), Expect = 8e-32
 Identities = 25/206 (12%), Positives = 62/206 (30%), Gaps = 48/206 (23%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q++  L   H   ++H  L+P +I++++ G + L  F                 V
Sbjct: 209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSSV 264

Query: 228 TLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
           +  + PPE+               + + + D W+ G +   +         D+ +     
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           IFR+                    + P+                   +    +    + R
Sbjct: 325 IFRS------------------CKNIPQP---------------VRALLEGFLRYPKEDR 351

Query: 338 VSAKTILQHEYFNQV-EMVKPTLAVF 362
           +     ++   + Q+   +   L ++
Sbjct: 352 LLPLQAMETPEYEQLRTELSAALPLY 377

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (307), Expect = 1e-30
 Identities = 25/172 (14%), Positives = 63/172 (36%), Gaps = 28/172 (16%)

Query: 22  LREISVLKELKHPNVIRL--HDVIPVDFKLFLVFEFLRQDLKDFLQ------TTPVPVPP 73
           +    ++K+ +   +IR+   +        F ++  ++ +L+ F +      +T   +  
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
                   Q++  L   H   ++H  L+P +I++++ G + L  F               
Sbjct: 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVV 261

Query: 134 EVVTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
             V+  + PPE+               + + + D W+ G +      +Y + 
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV------IYWIW 307

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  125 bits (315), Expect = 1e-31
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 42/215 (19%)

Query: 169 SYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------KSGALKLADFGLSRAFTIPMNR 221
               QLL  L Y H R  IIH D+KP+N+L+           +K+AD G +  +      
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWY--DEH 191

Query: 222 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQL 275
           YT+ + T  YR PE+LLGA  +    DIWS  C+  E+IT   LF  D       + D +
Sbjct: 192 YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250

Query: 276 FRIFRTLGTP----------------HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD 319
            +I   LG                     +   +SKL  +            +E      
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP------LEDVLTEKYKFSK 304

Query: 320 PLAVDVF---SKIMALDPKQRVSAKTILQHEYFNQ 351
             A ++    S ++ LDP++R  A  ++ H +   
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  120 bits (304), Expect = 3e-30
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 35/176 (19%)

Query: 20  TALREISVLKELK-----------HPNVIRLHDVIPVDFK--------LFLVFEFLRQDL 60
            A  EI +L+ +              ++++L D     F         + +VFE L ++L
Sbjct: 61  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLD----HFNHKGPNGVHVVMVFEVLGENL 116

Query: 61  KDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------KSGA 112
              ++      +P    K    QLL  L Y H R  IIH D+KP+N+L+           
Sbjct: 117 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176

Query: 113 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +K+AD G +  +      YT+ + T  YR PE+LLGA  +    DIWS  C+  E+
Sbjct: 177 IKIADLG-NACWY--DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFEL 228

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  123 bits (311), Expect = 2e-31
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 14/160 (8%)

Query: 22  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP-ALAKS 78
           L EI+VL+  K  P VI LH+V     ++ L+ E+    ++          +        
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEV 135
            + Q+LE + Y H   I+H DLKPQNIL+      G +K+ DFG+SR            +
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM 194

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            T  Y  PEIL      +T  D+W+ G I       Y LL
Sbjct: 195 GTPEYLAPEILNY-DPITTATDMWNIGII------AYMLL 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  109 bits (275), Expect = 1e-26
 Identities = 51/193 (26%), Positives = 79/193 (40%), Gaps = 33/193 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
            SE      + Q+LE + Y H   I+H DLKPQNIL+      G +K+ DFG+SR     
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-H 186

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
                  + T  Y  PEIL      +T  D+W+ G I   ++T  + F G+   +    I
Sbjct: 187 ACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
            +      E+ +  VS                          LA D    ++  +P++R 
Sbjct: 246 SQVNVDYSEETFSSVS-------------------------QLATDFIQSLLVKNPEKRP 280

Query: 339 SAKTILQHEYFNQ 351
           +A+  L H +  Q
Sbjct: 281 TAEICLSHSWLQQ 293

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  126 bits (317), Expect = 2e-31
 Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 19/174 (10%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT 66
            R +++   V     REI  LK  +HP++I+L+ VI     +F+V E++   +L D++  
Sbjct: 50  NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK 109

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               +    ++    Q+L  + YCH   ++HRDLKP+N+L++     K+ADFGLS   + 
Sbjct: 110 NG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS- 167

Query: 127 PMNRYTHEVVTLW-----YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                  E +        Y  PE++ G       VDIWS+G I      LY LL
Sbjct: 168 -----DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI------LYALL 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 95.2 bits (237), Expect = 5e-21
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 40/187 (21%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              Q+L  + YCH   ++HRDLKP+N+L++     K+ADFGLS   +        E +  
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS------DGEFLRT 174

Query: 230 W-----YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
                 Y  PE++ G       VDIWS+G I   ++     F  D  +  LF+       
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKK------ 227

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                        I    F    P+  +       P  + +   ++ +DP +R + K I 
Sbjct: 228 -------------ICDGIFYT--PQYLN-------PSVISLLKHMLQVDPMKRATIKDIR 265

Query: 345 QHEYFNQ 351
           +HE+F Q
Sbjct: 266 EHEWFKQ 272

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  123 bits (311), Expect = 3e-31
 Identities = 55/172 (31%), Positives = 72/172 (41%), Gaps = 43/172 (25%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE----------------FLRQDLKDFLQT 66
            EI VL  L HPN+I+L ++     ++ LV E                +  +D       
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD------- 149

Query: 67  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRA 123
                    A   + Q+LEA+ Y H   I+HRDLKP+N+L         LK+ADFGLS+ 
Sbjct: 150 ---------AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200

Query: 124 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                        T  Y  PEIL G   Y   VD+WS G I       Y LL
Sbjct: 201 VE-HQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGII------TYILL 244

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (269), Expect = 1e-25
 Identities = 57/189 (30%), Positives = 77/189 (40%), Gaps = 34/189 (17%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           +SE      + Q+LEA+ Y H   I+HRDLKP+N+L         LK+ADFGLS+     
Sbjct: 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-H 203

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR- 277
                    T  Y  PEIL G   Y   VD+WS G I   ++     F  +     +FR 
Sbjct: 204 QVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
           I           W  VS                           A D+  K++ LDPK+R
Sbjct: 263 ILNCEYYFISPWWDEVS-------------------------LNAKDLVRKLIVLDPKKR 297

Query: 338 VSAKTILQH 346
           ++    LQH
Sbjct: 298 LTTFQALQH 306

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (308), Expect = 5e-31
 Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 18/167 (10%)

Query: 13  QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTT 67
           +V  +    + E+     L  P ++ L+  +     + +  E      L Q +K      
Sbjct: 90  KVR-LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--- 145

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTI 126
              +P   A  YL Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG +     
Sbjct: 146 --CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203

Query: 127 PMNRYTHEVV-----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                +         T  +  PE+++G K     VDIWS+ C+   M
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHM 249

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  111 bits (279), Expect = 4e-27
 Identities = 43/192 (22%), Positives = 70/192 (36%), Gaps = 36/192 (18%)

Query: 164 IFSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTIPM 219
              E     YL Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG +       
Sbjct: 146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205

Query: 220 NRYTHEVV-----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ 274
              +         T  +  PE+++G K     VDIWS+ C+   M+     +        
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264

Query: 275 LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
             +I  +   P  ++                  P   +       PL      + +  +P
Sbjct: 265 CLKI-ASEPPPIREI------------------PPSCA-------PLTAQAIQEGLRKEP 298

Query: 335 KQRVSAKTILQH 346
             R SA  + + 
Sbjct: 299 VHRASAMELRRK 310

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  122 bits (307), Expect = 6e-31
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 27/165 (16%)

Query: 23  REISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPP 73
           +EI+ LK  + HPN+++LH+V       FLV E L         +  K F +        
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE-------- 105

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 130
             A   + +L+ A+ + H   ++HRDLKP+N+L    N +  +K+ DFG +R        
Sbjct: 106 TEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                 TL Y  PE+ L    Y  + D+WS G I      LY +L
Sbjct: 166 LKTPCFTLHYAAPEL-LNQNGYDESCDLWSLGVI------LYTML 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  111 bits (280), Expect = 3e-27
 Identities = 44/200 (22%), Positives = 75/200 (37%), Gaps = 39/200 (19%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           FSE      + +L+ A+ + H   ++HRDLKP+N+L    N +  +K+ DFG +R     
Sbjct: 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE---IDQL 275
                    TL Y  PE+ L    Y  + D+WS G I   M++ +  F            
Sbjct: 163 NQPLKTPCFTLHYAAPEL-LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221

Query: 276 FRIFRTLGTPH----EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA 331
             I + +         + W  VS                           A D+   ++ 
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVS-------------------------QEAKDLIQGLLT 256

Query: 332 LDPKQRVSAKTILQHEYFNQ 351
           +DP +R+    +  +E+   
Sbjct: 257 VDPNKRLKMSGLRYNEWLQD 276

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (304), Expect = 1e-30
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 4/148 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
           RE      L+ P+V+ +HD   +D +L++    +   DL   L+    P+ P  A + + 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVR 141

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 140
           Q+  AL   H+    HRD+KP+NIL++      L DFG++ A T          V TL+Y
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE    +   +   DI++  C+  E 
Sbjct: 202 MAPERFSESHA-TYRADIYALTCVLYEC 228

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 2/99 (2%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 231
           Q+  AL   H+    HRD+KP+NIL++      L DFG++ A T          V TL+Y
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 232 RPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
             PE    +   +   DI++  C+  E +T    + GD 
Sbjct: 202 MAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQ 239

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  120 bits (304), Expect = 2e-30
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 30/167 (17%)

Query: 23  REISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPP 73
            EI +L +  +HPN+I L DV      +++V E ++           K F +        
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-------- 115

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMN 129
             A + L+ + + + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++      N
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174

Query: 130 RYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                   T  +  PE+L   + Y    DIWS G +      LY +L
Sbjct: 175 GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVL------LYTML 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (280), Expect = 4e-27
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 40/199 (20%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTI 217
           FSE    + L+ + + + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++    
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR- 171

Query: 218 PMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
             N        T  +  PE+L   + Y    DIWS G +   M+T  T FA   +     
Sbjct: 172 AENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-E 229

Query: 277 RIFRTLGTPH----EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL 332
            I   +G+         W  VS                           A D+ SK++ +
Sbjct: 230 EILARIGSGKFSLSGGYWNSVS-------------------------DTAKDLVSKMLHV 264

Query: 333 DPKQRVSAKTILQHEYFNQ 351
           DP QR++A  +L+H +   
Sbjct: 265 DPHQRLTAALVLRHPWIVH 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (299), Expect = 3e-30
 Identities = 48/148 (32%), Positives = 83/148 (56%), Gaps = 4/148 (2%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 81
           RE+    +L H N++ + DV   D   +LV E++    L +++++   P+    A ++  
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTN 118

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 140
           Q+L+ +++ H  RI+HRD+KPQNILI+ +  LK+ DFG+++A +      T+ V+ T+ Y
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE   G        DI+S G +  EM
Sbjct: 179 FSPEQAKGEAT-DECTDIYSIGIVLYEM 205

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (256), Expect = 2e-24
 Identities = 36/104 (34%), Positives = 62/104 (59%), Gaps = 2/104 (1%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +++  Q+L+ +++ H  RI+HRD+KPQNILI+ +  LK+ DFG+++A +      T+ V+
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
            T+ Y  PE   G        DI+S G +  EM+  +  F G++
Sbjct: 174 GTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGET 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  120 bits (302), Expect = 5e-30
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           REI   + L+HPN++R  +VI     L ++ E+    +L + +           A+ +  
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQ 123

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 138
           QLL  + YCHS +I HRDLK +N L+  + +  LK+ DFG S++    ++      V T 
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTP 181

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
            Y  PE+LL  +      D+WS G        LY +L
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVT------LYVML 212

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 49/185 (26%), Positives = 74/185 (40%), Gaps = 28/185 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  QLL  + YCHS +I HRDLK +N L+  + +  LK+ DFG S++    ++      V
Sbjct: 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTV 178

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE+LL  +      D+WS G     M+     F  D E  + +R         
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQ----- 232

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                      I    +      + S       P    + S+I   DP  R+S   I  H
Sbjct: 233 ----------RILSVKYSIPDDIRIS-------PECCHLISRIFVADPATRISIPEIKTH 275

Query: 347 EYFNQ 351
            +F +
Sbjct: 276 SWFLK 280

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (298), Expect = 1e-29
 Identities = 32/165 (19%), Positives = 57/165 (34%), Gaps = 19/165 (11%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ----TTPVPVPPALA 76
            + +  LK       ++ +          LV E      L + +     T    +P  L 
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-----------KSGALKLADFGLSRAFT 125
            S+  ++L  +   H   IIH D+KP N ++             S  L L D G S    
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 126 IPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +      +T +  T  ++  E+L   K ++  +D +        M
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCM 278

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (251), Expect = 2e-23
 Identities = 38/202 (18%), Positives = 73/202 (36%), Gaps = 38/202 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-----------KSGALKLADFGLSRAFT 216
           +S+  ++L  +   H   IIH D+KP N ++             S  L L D G S    
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 217 IPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ 274
           +      +T +  T  ++  E+L   K ++  +D +        M+    +   +   + 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 275 LFR-IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL---AVDVFSKIM 330
               +FR    PH D+W                    F  +LN+PD     ++D+  + +
Sbjct: 294 KPEGLFR--RLPHLDMWNEF-----------------FHVMLNIPDCHHLPSLDLLRQKL 334

Query: 331 ALDPKQRVSAKTI-LQHEYFNQ 351
               +Q  + K   L++     
Sbjct: 335 KKVFQQHYTNKIRALRNRLIVL 356

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  115 bits (290), Expect = 6e-29
 Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 19/170 (11%)

Query: 12  VQVEGVPSTALR----EISVLKELKHPNVIRLH----DVIPVDFKLFLVFEFLRQ-DLKD 62
           +Q   +  +  +    E  +LK L+HPN++R +      +     + LV E +    LK 
Sbjct: 59  LQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 118

Query: 63  FLQTTPVPVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILIN-KSGALKLADFG 119
           +L+     +   + +S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D G
Sbjct: 119 YLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 120 LSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L+   T+    +   V+ T  +  PE  +  + Y  +VD+++ G    EM
Sbjct: 178 LA---TLKRASFAKAVIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEM 222

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  103 bits (260), Expect = 6e-25
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 35/185 (18%)

Query: 169 SYLYQLLEALRYCHSRR--IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHE 225
           S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+   T+    +   
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKA 189

Query: 226 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           V+ T  +  PE  +  + Y  +VD+++ G    EM T +  ++      Q++R   T G 
Sbjct: 190 VIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGV 246

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                                  P  F ++     P   ++    +  +  +R S K +L
Sbjct: 247 K----------------------PASFDKVA---IPEVKEIIEGCIRQNKDERYSIKDLL 281

Query: 345 QHEYF 349
            H +F
Sbjct: 282 NHAFF 286

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (290), Expect = 4e-28
 Identities = 28/190 (14%), Positives = 62/190 (32%), Gaps = 30/190 (15%)

Query: 7   RPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLK 61
           R    ++ +      LR I     +K P   ++  V   +        F ++  ++ +L+
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192

Query: 62  DFLQ------TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 115
            F +      +T   +          Q++  L   H   ++H  L+P +I++++ G + L
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252

Query: 116 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFS 166
             F                 +   + PPE               + +   D W+ G    
Sbjct: 253 TGFEHLV----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA-- 306

Query: 167 EMSYLYQLLE 176
               +Y +  
Sbjct: 307 ----IYWIWC 312

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (285), Expect = 2e-27
 Identities = 25/195 (12%), Positives = 55/195 (28%), Gaps = 46/195 (23%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q++  L   H   ++H  L+P +I++++ G + L  F                 +
Sbjct: 214 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGASAVSPI 269

Query: 228 TLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
              + PPE               + +   D W+ G     +         D+ +     I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           FR                                   N+P P+   +    +    + R+
Sbjct: 330 FR--------------------------------SCKNIPQPVR-ALLEGFLRYPKEDRL 356

Query: 339 SAKTILQHEYFNQVE 353
                ++   + Q+ 
Sbjct: 357 LPLQAMETPEYEQLR 371

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  113 bits (285), Expect = 4e-28
 Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 37/176 (21%)

Query: 23  REISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPP 73
           RE+ +L + + H NV+ L +    + + +LVFE +R           + F +        
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-------- 110

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 130
             A   +  +  AL + H++ I HRDLKP+NIL    N+   +K+ DF L     +  + 
Sbjct: 111 LEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170

Query: 131 YTHEVV-------TLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                        +  Y  PE++      A +Y    D+WS G I      LY LL
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI------LYILL 220

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (256), Expect = 4e-24
 Identities = 47/219 (21%), Positives = 79/219 (36%), Gaps = 57/219 (26%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F+E+     +  +  AL + H++ I HRDLKP+NIL    N+   +K+ DF L     + 
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167

Query: 219 MNRYTHEVV-------TLWYRPPEILLG----AKVYSTTVDIWSAGCI-----------F 256
            +              +  Y  PE++      A +Y    D+WS G I            
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

Query: 257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPH----EDVWPGVSKLPIYKTDFPEWRPKKFS 312
               +      G++       +F ++        +  W  +S                  
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHIS------------------ 269

Query: 313 EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ 351
                    A D+ SK++  D KQR+SA  +LQH +   
Sbjct: 270 -------CAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (295), Expect = 5e-28
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)

Query: 21  ALREISVLKELKHPNVIRLHDV-----IPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPA 74
           A+ E   L E+ HP+++++ +         D   ++V E++  Q LK         +P A
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVA 182

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
            A +YL ++L AL Y HS  +++ DLKP+NI++ +   LKL D G        +N + + 
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR----INSFGYL 237

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
             T  ++ PEI+      +T  DI++ G        L  L 
Sbjct: 238 YGTPGFQAPEIVRTGPTVAT--DIYTVGRT------LAALT 270

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 96.1 bits (239), Expect = 6e-21
 Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++YL ++L AL Y HS  +++ DLKP+NI++ +   LKL D G        +N + +   
Sbjct: 185 IAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR----INSFGYLYG 239

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
           T  ++ PEI+      +T  DI++ G   + +        G  
Sbjct: 240 TPGFQAPEIVRTGPTVAT--DIYTVGRTLAALTLDLPTRNGRY 280

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  114 bits (288), Expect = 6e-28
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 18/163 (11%)

Query: 23  REISVLKEL-KHPNVIRLHDV----IPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPAL 75
           RE+ +     + P+++R+ DV          L +V E L   +                 
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 163 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLT 221

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
               T +Y  PE+ LG + Y  + D+WS G I      +Y LL
Sbjct: 222 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVI------MYILL 257

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  106 bits (267), Expect = 3e-25
 Identities = 45/197 (22%), Positives = 75/197 (38%), Gaps = 37/197 (18%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F+E      +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T  
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-S 216

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
            N  T    T +Y  PE+ LG + Y  + D+WS G I   ++     F  +  +     +
Sbjct: 217 HNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275

Query: 279 FRTLGTPH----EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
              +           W  VS                              +   ++  +P
Sbjct: 276 KTRIRMGQYEFPNPEWSEVS-------------------------EEVKMLIRNLLKTEP 310

Query: 335 KQRVSAKTILQHEYFNQ 351
            QR++    + H +  Q
Sbjct: 311 TQRMTITEFMNHPWIMQ 327

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  112 bits (283), Expect = 8e-28
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 18/163 (11%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E+ V++ L+HPNV++   V+  D +L  + E+++   L+  +++     P +   S+ 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---------------AFT 125
             +   + Y HS  IIHRDL   N L+ ++  + +ADFGL+R                  
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               RYT  V   ++  PE++ G + Y   VD++S G +  E+
Sbjct: 175 DRKKRYT-VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEI 215

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 36/193 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-------------- 213
           M+YL          HS  IIHRDL   N L+ ++  + +ADFGL+R              
Sbjct: 121 MAYL----------HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170

Query: 214 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
                   RYT  V   ++  PE++ G + Y   VD++S G +  E+I +          
Sbjct: 171 LKKPDRKKRYT-VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228

Query: 273 DQLFRI----FRTLGTPHEDVWPGVSKLPIY--KTDFPEWRPKKFSEILNLPDPLAVDVF 326
              F +    F     P  +  P    + +     D PE RP  F ++ +  + L + + 
Sbjct: 229 TMDFGLNVRGFLDRYCP-PNCPPSFFPITVRCCDLD-PEKRP-SFVKLEHWLETLRMHLA 285

Query: 327 SKIMALDPKQRVS 339
             +      +++ 
Sbjct: 286 GHLPLGPQLEQLD 298

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  112 bits (282), Expect = 1e-27
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 10/147 (6%)

Query: 30  ELKHPNVIRLHDV----IPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLL 84
            L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A   +    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADAC 126

Query: 85  EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EVV-TLWYR 141
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T    V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE   G  V     D++S GC+  E+
Sbjct: 187 SPEQARGDSV-DARSDVYSLGCVLYEV 212

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 39/106 (36%), Positives = 58/106 (54%), Gaps = 4/106 (3%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--E 225
           +  +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T    
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178

Query: 226 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
           V+ T  Y  PE   G  V     D++S GC+  E++T +  F GDS
Sbjct: 179 VIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDS 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  112 bits (281), Expect = 2e-27
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 21/164 (12%)

Query: 23  REISVLKEL-KHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKD-FLQTTPVPVPPAL 75
           +E+    +    P+++ + DV          L ++ E +   +L     +          
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   +  +  A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T       
Sbjct: 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNAL 186

Query: 133 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                T +Y  PE+ LG + Y  + D+WS G I      +Y LL
Sbjct: 187 QTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVI------MYILL 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  108 bits (273), Expect = 2e-26
 Identities = 45/198 (22%), Positives = 75/198 (37%), Gaps = 40/198 (20%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F+E      +  +  A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T  
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-- 182

Query: 219 MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
                     T +Y  PE+ LG + Y  + D+WS G I   ++     F  ++       
Sbjct: 183 -QNALQTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240

Query: 278 IFRTLGTPH----EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
           + R +           W  VS                           A  +   ++  D
Sbjct: 241 MKRRIRLGQYGFPNPEWSEVS-------------------------EDAKQLIRLLLKTD 275

Query: 334 PKQRVSAKTILQHEYFNQ 351
           P +R++    + H + NQ
Sbjct: 276 PTERLTITQFMNHPWINQ 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  110 bits (277), Expect = 3e-27
 Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 14/156 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+ ++  L HPN+++L+ +  +     +V EF+   DL   L     P+  ++    +
Sbjct: 71  QREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 81  YQLLEALRYCHSRR--IIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYTH 133
             +   + Y  ++   I+HRDL+  NI +           K+ADFGLS+     +   + 
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SG 185

Query: 134 EVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEM 168
            +    +  PE +    + Y+   D +S   I   +
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 23/109 (21%), Positives = 43/109 (39%), Gaps = 21/109 (19%)

Query: 168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMN 220
           + Y+           ++   I+HRDL+  NI +           K+ADFGLS+     + 
Sbjct: 135 IEYM----------QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV- 183

Query: 221 RYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMITKKTLFAG 268
             +  +    +  PE +    + Y+   D +S   I   ++T +  F  
Sbjct: 184 --SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (274), Expect = 1e-26
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR----QDLKDFLQTTPVPVPPALAK 77
           L+EI  + +  HPN++  +    V  +L+LV + L      D+   +          L +
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 78  SY----LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           S     L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S       +   +
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 134 E-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +     V T  +  PE++   + Y    DIWS G    E+
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 32/190 (16%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE----- 225
           L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S       +   ++     
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR----T 281
           V T  +  PE++   + Y    DIWS G    E+ T    +     +  L    +    +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246

Query: 282 LGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
           L T  +D                +   KK+ +           + S  +  DP++R +A 
Sbjct: 247 LETGVQD----------------KEMLKKYGKSFR-------KMISLCLQKDPEKRPTAA 283

Query: 342 TILQHEYFNQ 351
            +L+H++F +
Sbjct: 284 ELLRHKFFQK 293

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (273), Expect = 2e-26
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 6/160 (3%)

Query: 12  VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVP 70
           V VE      ++EIS++++   P+V++ +     +  L++V E+     + D ++     
Sbjct: 62  VPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121

Query: 71  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
           +      + L   L+ L Y H  R IHRD+K  NIL+N  G  KLADFG++   T  M +
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG--CIFSEM 168
               + T ++  PE++     Y+   DIWS G   I  EM
Sbjct: 182 RNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAI--EM 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 31/185 (16%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L   L+ L Y H  R IHRD+K  NIL+N  G  KLADFG++   T  M +    + T +
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190

Query: 231 YRPPEILLGAKVYSTTVDIWSAG--CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           +  PE++     Y+   DIWS G   I  EM   K  +A    +  +F I  T   P   
Sbjct: 191 WMAPEVIQEIG-YNCVADIWSLGITAI--EMAEGKPPYADIHPMRAIFMI-PTNPPP--- 243

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                             +P+ +S+          D   + +   P+QR +A  +LQH +
Sbjct: 244 ------TFR---------KPELWSDNFT-------DFVKQCLVKSPEQRATATQLLQHPF 281

Query: 349 FNQVE 353
               +
Sbjct: 282 VRSAK 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  108 bits (272), Expect = 2e-26
 Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 13/154 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKS 78
           + E+  L  + HPN+++L+        + LV E+     L + L           A A S
Sbjct: 49  IVELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 79  YLYQLLEALRYCHSRR---IIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHE 134
           +  Q  + + Y HS +   +IHRDLKP N+L+   G  LK+ DFG +      M   T+ 
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNN 163

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  +  PE+  G   YS   D++S G I  E+
Sbjct: 164 KGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEV 196

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 19/160 (11%)

Query: 168 MSYLYQLLEALRYCHSRR---IIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYT 223
           MS+  Q  + + Y HS +   +IHRDLKP N+L+   G  LK+ DFG +      M   T
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---T 161

Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ--LFRIFRT 281
           +   +  +  PE+  G   YS   D++S G I  E+IT++  F          ++ +   
Sbjct: 162 NNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220

Query: 282 LGTPH--EDVWPGVSKLPIYK---TDFPEWRPKKFSEILN 316
              P   +++   +  L + +    D P  RP    EI+ 
Sbjct: 221 T-RPPLIKNLPKPIESL-MTRCWSKD-PSQRP-SMEEIVK 256

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 2e-26
 Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 10/157 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 79
             E+ V K   HPN++        D +L++V  F+     KD + T     +        
Sbjct: 74  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-------YT 132
           L  +L+AL Y H    +HR +K  +ILI+  G + L+    + +      R         
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 133 HEVVTLWYRPPEILL-GAKVYSTTVDIWSAGCIFSEM 168
           + V  L +  PE+L    + Y    DI+S G    E+
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.4 bits (232), Expect = 8e-21
 Identities = 48/264 (18%), Positives = 81/264 (30%), Gaps = 35/264 (13%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-------YT 223
           L  +L+AL Y H    +HR +K  +ILI+  G + L+    + +      R         
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 224 HEVVTLWYRPPEILL-GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFR-- 280
           + V  L +  PE+L    + Y    DI+S G    E+      F        L       
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253

Query: 281 -------TLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI---- 329
                  +     E        +                   + P       FS      
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313

Query: 330 --MAL--DPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKT 385
               L  +P  R SA T+L H +F Q++  +      PEL       +   P      + 
Sbjct: 314 VEQCLQRNPDARPSASTLLNHSFFKQIK--RRASEALPEL------LRPVTPITNF--EG 363

Query: 386 QWQRSWDDIPNNKLKRIKPKIEEW 409
              +    I        + ++++W
Sbjct: 364 SQSQDHSGIFGLVTNLEELEVDDW 387

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  107 bits (270), Expect = 3e-26
 Identities = 33/152 (21%), Positives = 68/152 (44%), Gaps = 6/152 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
             E+ VL++ +H N++          +L +V ++     L   L  +             
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYTHEVVTL 138
            Q    + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +++     ++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 139 WYRPPEILLG--AKVYSTTVDIWSAGCIFSEM 168
            +  PE++    +  YS   D+++ G +  E+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 28/111 (25%), Positives = 56/111 (50%), Gaps = 14/111 (12%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYTHE 225
           M YL          H++ IIHRDLK  NI +++   +K+ DFGL+   +     +++   
Sbjct: 133 MDYL----------HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182

Query: 226 VVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQ 274
             ++ +  PE++    +  YS   D+++ G +  E++T +  ++  +  DQ
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  107 bits (269), Expect = 6e-26
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 6/152 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL--QTTPVPVPPALAKS 78
           LRE++++K L+HPN++     +     L +V E+L +  L   L        +      S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141

Query: 79  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
             Y + + + Y H+R   I+HR+LK  N+L++K   +K+ DFGLSR              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T  +  PE+L   +  +   D++S G I  E+
Sbjct: 202 TPEWMAPEVLRD-EPSNEKSDVYSFGVILWEL 232

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 21/169 (12%)

Query: 168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 225
           M+YL          H+R   I+HR+LK  N+L++K   +K+ DFGLSR            
Sbjct: 150 MNYL----------HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
             T  +  PE+L   +  +   D++S G I  E+ T +  +   +    +  +       
Sbjct: 200 AGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258

Query: 286 H--EDVWPGVSKLPIYK---TDFPEWRPKKFSEILNLPDPLAVDVFSKI 329
               ++ P V+ + I      + P  RP  F+ I++L  PL        
Sbjct: 259 EIPRNLNPQVAAI-IEGCWTNE-PWKRP-SFATIMDLLRPLIKSAVPPP 304

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (269), Expect = 9e-26
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 18/154 (11%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 82
           +E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  + 
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEVVTL 138
            L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG    ++ A +         V T 
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF--------VGTP 214

Query: 139 WYRPPEILLGAK--VYSTTVDIWSAG--CIFSEM 168
           ++  PE++L      Y   VD+WS G  CI  E+
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCI--EL 246

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 44/189 (23%), Positives = 79/189 (41%), Gaps = 45/189 (23%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEV 226
            +  L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG    ++ A +         V
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF--------V 211

Query: 227 VTLWYRPPEILLGAK--VYSTTVDIWSAG--CIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
            T ++  PE++L      Y   VD+WS G  CI  E+  +K                   
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERK------------------- 250

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
             P  ++    +   I + + P  +   +SE          +     +   P+ R +++ 
Sbjct: 251 -PPLFNMNAMSALYHIAQNESPALQSGHWSEYFR-------NFVDSCLQKIPQDRPTSEV 302

Query: 343 ILQHEYFNQ 351
           +L+H +  +
Sbjct: 303 LLKHRFVLR 311

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 1e-25
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 9/154 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           + EI +L    HP +++L      D KL+++ EF     +   +      +     +   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183

Query: 141 RPPEILLGAKV----YSTTVDIWSAG--CIFSEM 168
             PE+++   +    Y    DIWS G   I  EM
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLI--EM 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 34/193 (17%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
             Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T +
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182

Query: 231 YRPPEILLGAKV----YSTTVDIWSAG--CIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           +  PE+++   +    Y    DIWS G   I  EM   +      + +  L +I      
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLI--EMAQIEPPHHELNPMRVLLKI-AKSDP 239

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           P          L           P K+S           D     +  +P+ R SA  +L
Sbjct: 240 P---------TLL---------TPSKWSVEFR-------DFLKIALDKNPETRPSAAQLL 274

Query: 345 QHEYFNQVEMVKP 357
           +H + + +   K 
Sbjct: 275 EHPFVSSITSNKA 287

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (265), Expect = 2e-25
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 12/151 (7%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY-- 79
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P      L ++   
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIA 122

Query: 80  --LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
             L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 182

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            ++  PE++  +  Y +  DIWS G    E+
Sbjct: 183 PFWMAPEVIKQSA-YDSKADIWSLGITAIEL 212

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 29/181 (16%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
           L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T +
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 184

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           +  PE++  +  Y +  DIWS G    E+   +                     PH ++ 
Sbjct: 185 WMAPEVIKQSA-YDSKADIWSLGITAIELARGE--------------------PPHSELH 223

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
           P      I K + P      +S+ L        +     +  +P  R +AK +L+H++  
Sbjct: 224 PMKVLFLIPKNNPPTLE-GNYSKPLK-------EFVEACLNKEPSFRPTAKELLKHKFIL 275

Query: 351 Q 351
           +
Sbjct: 276 R 276

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  105 bits (264), Expect = 3e-25
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 5/150 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYT 136

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV-TL 138
            +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG +            +  V T 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y  PE+L   K    + D+W+ GCI  ++
Sbjct: 197 QYVSPELLTE-KSACKSSDLWALGCIIYQL 225

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (251), Expect = 2e-23
 Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 40/192 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV- 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG +            +  V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF-RIFRTLGTPH 286
           T  Y  PE+L   K    + D+W+ GCI  +++     F   +E   +F +I +      
Sbjct: 195 TAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKL----- 247

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV------SA 340
                        + DFPE     F        P A D+  K++ LD  +R+        
Sbjct: 248 -------------EYDFPEK----FF-------PKARDLVEKLLVLDATKRLGCEEMEGY 283

Query: 341 KTILQHEYFNQV 352
             +  H +F  V
Sbjct: 284 GPLKAHPFFESV 295

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 6e-25
 Identities = 29/161 (18%), Positives = 67/161 (41%), Gaps = 15/161 (9%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            RE+   ++ +H NV+           L ++    +   L   ++   + +     +   
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            ++++ + Y H++ I+H+DLK +N+  +  G + + DFGL     +       + + +  
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 139 -WYRP--PEIL--------LGAKVYSTTVDIWSAGCIFSEM 168
            W     PEI+             +S   D+++ G I+ E+
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 24/114 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           M YL          H++ I+H+DLK +N+  +  G + + DFGL     +       + +
Sbjct: 143 MGYL----------HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKL 191

Query: 228 TL---WYRP--PEIL--------LGAKVYSTTVDIWSAGCIFSEMITKKTLFAG 268
            +   W     PEI+             +S   D+++ G I+ E+  ++  F  
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  103 bits (258), Expect = 7e-25
 Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 17/159 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            +E  +   LKHPN+I L  V   +  L LV EF R   L   L    +P  P +  ++ 
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP--PDILVNWA 111

Query: 81  YQLLEALRYCHSRR---IIHRDLKPQNILINKSGA--------LKLADFGLSRAFTIPMN 129
            Q+   + Y H      IIHRDLK  NILI +           LK+ DFGL+R       
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRT 169

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                     +  PE++    ++S   D+WS G +  E+
Sbjct: 170 TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWEL 207

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 42/165 (25%), Positives = 63/165 (38%), Gaps = 32/165 (19%)

Query: 168 MSYLYQLLEALRYCHSRR---IIHRDLKPQNILINKSGA--------LKLADFGLSRAFT 216
           M+YL          H      IIHRDLK  NILI +           LK+ DFGL+R   
Sbjct: 118 MNYL----------HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--E 165

Query: 217 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF 276
                         +  PE++    ++S   D+WS G +  E++T +  F G   +   +
Sbjct: 166 WHRTTKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224

Query: 277 RIFRTLGTPH--EDVWPGVSKLPIYK---TDFPEWRPKKFSEILN 316
            +                 +KL +      D P  RP  F+ IL+
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKL-MEDCWNPD-PHSRP-SFTNILD 266

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (260), Expect = 8e-25
 Identities = 52/150 (34%), Positives = 82/150 (54%), Gaps = 8/150 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T +     +A +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-EGQIA-AVC 122

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 141 RPPEILLGAKVYSTTVDIWSAG--CIFSEM 168
             PE++   K Y   VDIWS G   I  EM
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAI--EM 209

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 31/183 (16%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
             + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T +
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 231 YRPPEILLGAKVYSTTVDIWSAG--CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           +  PE++   K Y   VDIWS G   I  EMI  +  +  ++ +  L+ I  T GTP   
Sbjct: 182 WMAPEVVTR-KAYGPKVDIWSLGIMAI--EMIEGEPPYLNENPLRALYLI-ATNGTP--- 234

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
                 +L           P+K S I         D  ++ + +D ++R SAK +LQH++
Sbjct: 235 ------ELQ---------NPEKLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHQF 272

Query: 349 FNQ 351
              
Sbjct: 273 LKI 275

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  102 bits (257), Expect = 1e-24
 Identities = 27/154 (17%), Positives = 56/154 (36%), Gaps = 13/154 (8%)

Query: 23  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQ-TTPVPVPPALAKS 78
            E   L+   HPNV+ +      P      L+  ++    L + L   T   V  + A  
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115

Query: 79  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           +   +   + + H+    I    L  ++++I++    +++   +  +F  P   Y     
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA-- 173

Query: 137 TLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEM 168
              +  PE L          + D+WS   +  E+
Sbjct: 174 ---WVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 27/158 (17%)

Query: 168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 225
           M++L          H+    I    L  ++++I++    +++   +  +F  P   Y   
Sbjct: 124 MAFL----------HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA 173

Query: 226 VVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
                +  PE L          + D+WS   +  E++T++  FA  S ++   ++     
Sbjct: 174 -----WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228

Query: 284 TPH--EDVWPGVSKLPIYK---TDFPEWRPKKFSEILN 316
            P     + P VSKL +      D P  RP KF  I+ 
Sbjct: 229 RPTIPPGISPHVSKL-MKICMNED-PAKRP-KFDMIVP 263

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (259), Expect = 1e-24
 Identities = 44/148 (29%), Positives = 82/148 (55%), Gaps = 4/148 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
             E+ ++++ +H NV+ ++    V  +L+++ EFL+   L D +    +     +A +  
Sbjct: 90  FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN-EEQIA-TVC 147

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
             +L+AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE++  +  Y+T VDIWS G +  EM
Sbjct: 208 MAPEVISRSL-YATEVDIWSLGIMVIEM 234

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 27/181 (14%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
              +L+AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T +
Sbjct: 147 CEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 206

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW 290
           +  PE++  +  Y+T VDIWS G +  EM+  +  +  DS +  + R+ R    P     
Sbjct: 207 WMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPP----- 259

Query: 291 PGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN 350
               KL             K S +L        D   +++  DP++R +A+ +L H +  
Sbjct: 260 ----KLK---------NSHKVSPVLR-------DFLERMLVRDPQERATAQELLDHPFLL 299

Query: 351 Q 351
           Q
Sbjct: 300 Q 300

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  104 bits (261), Expect = 3e-24
 Identities = 47/151 (31%), Positives = 66/151 (43%), Gaps = 6/151 (3%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  VL       +  LH     D  L+LV ++    DL   L      +P  +A+ YL +
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 141
           ++ A+   H    +HRD+KP NIL++ +G ++LADFG            +   V T  Y 
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 142 PPEILL----GAKVYSTTVDIWSAGCIFSEM 168
            PEIL     G   Y    D WS G    EM
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.3 bits (232), Expect = 2e-20
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           YL +++ A+   H    +HRD+KP NIL++ +G ++LADFG            +   V T
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239

Query: 229 LWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID 273
             Y  PEIL     G   Y    D WS G    EM+  +T F  +S ++
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (255), Expect = 4e-24
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 10/157 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
            REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++        +  +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
               WY  PE L     +S   D+WS G +  E  +Y
Sbjct: 179 SPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFTY 213

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++        +  +  
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 WY  PE L     +S   D+WS G +  E+ T
Sbjct: 177 GESPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFT 212

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  101 bits (254), Expect = 4e-24
 Identities = 41/163 (25%), Positives = 63/163 (38%), Gaps = 39/163 (23%)

Query: 23  REISVLKEL-KHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKD-FLQTTPVPVPPAL 75
           RE+ +     + P+++R+ DV          L +V E L   +L                
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 132
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG +           
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------- 167

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL 175
                      E     + Y  + D+WS G I      +Y LL
Sbjct: 168 ----------KETT--GEKYDKSCDMWSLGVI------MYILL 192

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 37/192 (19%), Positives = 63/192 (32%), Gaps = 58/192 (30%)

Query: 165 FSEM---SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIP 218
           F+E      +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG +      
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------ 167

Query: 219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
                           E     + Y  + D+WS G I   ++     F  +  +     +
Sbjct: 168 ---------------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210

Query: 279 FR--TLGTP--HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP 334
                +G        W  VS                              +   ++  +P
Sbjct: 211 KTRIRMGQYEFPNPEWSEVS-------------------------EEVKMLIRNLLKTEP 245

Query: 335 KQRVSAKTILQH 346
            QR++    + H
Sbjct: 246 TQRMTITEFMNH 257

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (255), Expect = 5e-24
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 10/157 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
            REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++        Y  +    
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
               WY  PE L     +S   D+WS G +  E  +Y
Sbjct: 210 SPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFTY 244

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++        Y  +  
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 WY  PE L     +S   D+WS G +  E+ T
Sbjct: 208 GESPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFT 243

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  101 bits (254), Expect = 8e-24
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 10/157 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
            REI +LK L    +++   V     +  L LV E+L    L+DFLQ     +  +    
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y       
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
               WY  PE L    ++S   D+WS G +  E  +Y
Sbjct: 192 SPIFWY-APESLS-DNIFSRQSDVWSFGVVLYELFTY 226

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y     
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 WY  PE L    ++S   D+WS G +  E+ T
Sbjct: 190 GQSPIFWY-APESLS-DNIFSRQSDVWSFGVVLYELFT 225

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (253), Expect = 1e-23
 Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 22  LREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEF----LRQDLKDFLQTTPVPVP-PAL 75
           L ++ V ++    P +++ +  +  +   ++  E       +  K         +P   L
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127

Query: 76  AKSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
            K      ++AL +     +IIHRD+KP NIL+++SG +KL DFG+S      + + T +
Sbjct: 128 GK-ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRD 185

Query: 135 VVTLWYRPPEILLGAKV---YSTTVDIWSAG 162
                Y  PE +  +     Y    D+WS G
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 30/197 (15%)

Query: 171 LYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
               ++AL +     +IIHRD+KP NIL+++SG +KL DFG+S      + + T +    
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCR 189

Query: 230 WYRPPEILLGAKV---YSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFRTLGTP 285
            Y  PE +  +     Y    D+WS G    E+ T +  +   +S  DQL ++       
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------V 243

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
             D        P           ++FS           +  +  +  D  +R   K +L+
Sbjct: 244 KGDP-------PQ----LSNSEEREFSPSFI-------NFVNLCLTKDESKRPKYKELLK 285

Query: 346 HEYFNQVEMVKPTLAVF 362
           H +    E     +A +
Sbjct: 286 HPFILMYEERAVEVACY 302

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (251), Expect = 1e-23
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 9/148 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
            +EI +L+ L H N+++   +        + L+ EFL    LK++L      +       
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A       YT +    
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAG 162
               WY  PE L+ +K +    D+WS G
Sbjct: 191 SPVFWY-APECLMQSK-FYIASDVWSFG 216

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 11/126 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A       YT +  
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
                 WY  PE L+ +K +    D+WS G    E++T       DS+   +    + +G
Sbjct: 189 RDSPVFWY-APECLMQSK-FYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG 241

Query: 284 TPHEDV 289
             H  +
Sbjct: 242 PTHGQM 247

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 38/155 (24%), Positives = 79/155 (50%), Gaps = 10/155 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            +E   + +L HP +++ + V   ++ +++V E++    L ++L++    + P+      
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           Y + E + +  S + IHRDL  +N L+++   +K++DFG++R   +  ++Y   V T   
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP 168

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W   PE+      YS+  D+W+ G +  E  S 
Sbjct: 169 VKWS-APEVFH-YFKYSSKSDVWAFGILMWEVFSL 201

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 27/98 (27%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +   Y + E + +  S + IHRDL  +N L+++   +K++DFG++R   +  ++Y   V 
Sbjct: 107 LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVG 164

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           T     W   PE+      YS+  D+W+ G +  E+ +
Sbjct: 165 TKFPVKWS-APEVFH-YFKYSSKSDVWAFGILMWEVFS 200

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  103 bits (258), Expect = 1e-23
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 10/153 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 79
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+      V   +    
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 138
             Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR   +  + YT       
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKF 381

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              W  P  +      +S   D+W+ G +  E+
Sbjct: 382 PIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 412

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR   +  + YT    
Sbjct: 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAG 378

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W  P  +      +S   D+W+ G +  E+ T 
Sbjct: 379 AKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATY 415

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  101 bits (252), Expect = 2e-23
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 10/151 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD---LKDFLQTTPVPVPPALAKS 78
           +RE+ VL E   P ++  +     D ++ +  E +  D   L   L+     +P  +   
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM--DGGSLDQVLKKAG-RIPEQILGK 135

Query: 79  YLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
               +++ L Y     +I+HRD+KP NIL+N  G +KL DFG+S      M   +  V T
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF-VGT 193

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  PE L G   YS   DIWS G    EM
Sbjct: 194 RSYMSPERLQGTH-YSVQSDIWSMGLSLVEM 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 97.6 bits (243), Expect = 3e-22
 Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 19/208 (9%)

Query: 171 LYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              +++ L Y     +I+HRD+KP NIL+N  G +KL DFG+S      M   +  V T 
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF-VGTR 194

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGD--SEIDQLFRIFRTLGTPHE 287
            Y  PE L G   YS   DIWS G    EM   +         E++ +F           
Sbjct: 195 SYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNL-----PDPLAVDVFSKI--------MALDP 334
              P     P+ K       P    E+L+      P  L   VFS          +  +P
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313

Query: 335 KQRVSAKTILQHEYFNQVEMVKPTLAVF 362
            +R   K ++ H +  + +  +   A +
Sbjct: 314 AERADLKQLMVHAFIKRSDAEEVDFAGW 341

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  101 bits (253), Expect = 2e-23
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 8/153 (5%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  VL       + +LH     +  L+LV E+    DL   L      +P  +A+ YL +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 141
           ++ A+   H    +HRD+KP NIL+++ G ++LADFG            +   V T  Y 
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230

Query: 142 PPEILLG------AKVYSTTVDIWSAGCIFSEM 168
            PEIL           Y    D W+ G    EM
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 37/126 (29%), Positives = 54/126 (42%), Gaps = 11/126 (8%)

Query: 162 GCIFSE-MS--YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 218
           G      M+  YL +++ A+   H    +HRD+KP NIL+++ G ++LADFG        
Sbjct: 156 GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215

Query: 219 MNRYTHEVV-TLWYRPPEILLG------AKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE 271
               +   V T  Y  PEIL           Y    D W+ G    EM   +T F  DS 
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275

Query: 272 IDQLFR 277
             + + 
Sbjct: 276 -AETYG 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  101 bits (253), Expect = 3e-23
 Identities = 50/150 (33%), Positives = 69/150 (46%), Gaps = 7/150 (4%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQ 82
           E  ++     P V++L      D  L++V E++   DL + +    VP     A+ Y  +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTAE 176

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 141
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG                V T  Y 
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 142 PPEILL---GAKVYSTTVDIWSAGCIFSEM 168
            PE+L    G   Y    D WS G    EM
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 41/108 (37%), Positives = 51/108 (47%), Gaps = 4/108 (3%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  +++ AL   HS   IHRD+KP N+L++KSG LKLADFG                V T
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232

Query: 229 LWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID 273
             Y  PE+L    G   Y    D WS G    EM+   T F  DS + 
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (252), Expect = 3e-23
 Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 10/147 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T    +        +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
                 + Y  S+  IHRDL  +N L+ +   LK++DFG+SR        Y         
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQV 277

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAG 162
              W   PE L     YS+  D+WS G
Sbjct: 278 PVKWT-APEALN-YGRYSSESDVWSFG 302

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 28/99 (28%), Positives = 42/99 (42%), Gaps = 9/99 (9%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  +      + Y  S+  IHRDL  +N L+ +   LK++DFG+SR        Y     
Sbjct: 216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGG 273

Query: 228 TL-----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                  W   PE L     YS+  D+WS G +  E  +
Sbjct: 274 LRQVPVKWT-APEALN-YGRYSSESDVWSFGILLWETFS 310

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LV EF+    L D+L+T              
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R   +  ++YT    T   
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP 168

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W   PE+   ++ YS+  D+WS G +  E  S 
Sbjct: 169 VKWA-SPEVFSFSR-YSSKSDVWSFGVLMWEVFSE 201

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 62.2 bits (152), Expect = 5e-11
 Identities = 27/98 (27%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +     + E + Y     +IHRDL  +N L+ ++  +K++DFG++R   +  ++YT    
Sbjct: 107 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTG 164

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           T     W   PE+   ++ YS+  D+WS G +  E+ +
Sbjct: 165 TKFPVKWA-SPEVFSFSR-YSSKSDVWSFGVLMWEVFS 200

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 98.7 bits (246), Expect = 8e-23
 Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 24/168 (14%)

Query: 23  REISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK 77
            EI     ++H N++              +L+L+ ++     L D+L++T +     L  
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML-- 137

Query: 78  SYLYQLLEALRYCHSRR--------IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
              Y  +  L + H+          I HRDLK +NIL+ K+G   +AD GL+  F    N
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 130 RY----THEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEM 168
                    V T  Y PPE+L  +            D++S G I  E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 35/161 (21%), Positives = 58/161 (36%), Gaps = 15/161 (9%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----T 223
           + +L+   E         I HRDLK +NIL+ K+G   +AD GL+  F    N       
Sbjct: 147 LCHLHT--EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 224 HEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             V T  Y PPE+L  +            D++S G I  E+  +        E    +  
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264

Query: 279 FRTLGTPHEDVWPGVSK----LPIYKTDFPEWRPKKFSEIL 315
                  +ED+   V               +   ++  +++
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLM 305

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 11/148 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
            +EI +L+ L H ++I+            L LV E++    L+D+L    + +   L   
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL--L 138

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           +  Q+ E + Y H++  IHRDL  +N+L++    +K+ DFGL++A       Y       
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAG 162
               WY  PE L   K +    D+WS G
Sbjct: 199 SPVFWY-APECLKEYK-FYYASDVWSFG 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 11/126 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ E + Y H++  IHRDL  +N+L++    +K+ DFGL++A       Y     
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
                 WY  PE L   K +    D+WS G    E++T       DS      +    +G
Sbjct: 197 GDSPVFWY-APECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIG 249

Query: 284 TPHEDV 289
                +
Sbjct: 250 IAQGQM 255

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 7/151 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
            +E+ +++ L+HP ++ L      +  +F+V + L   DL+  LQ   V       K ++
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFI 121

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 139
            +L+ AL Y  ++RIIHRD+KP NIL+++ G + + DF ++    +P       +  T  
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKP 179

Query: 140 YRPPEILL--GAKVYSTTVDIWSAGCIFSEM 168
           Y  PE+        YS  VD WS G    E+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 39/197 (19%)

Query: 165 FSEMS---YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 221
           F E +   ++ +L+ AL Y  ++RIIHRD+KP NIL+++ G + + DF ++    +P   
Sbjct: 112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRET 169

Query: 222 YTHEVV-TLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMITKKTLFAG--DSEIDQLF 276
               +  T  Y  PE+        YS  VD WS G    E++  +  +     +   ++ 
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

Query: 277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ 336
             F T                     +P      +S          V +  K++  +P Q
Sbjct: 230 HTFET-----------------TVVTYPSA----WS-------QEMVSLLKKLLEPNPDQ 261

Query: 337 RV-SAKTILQHEYFNQV 352
           R      +    Y N +
Sbjct: 262 RFSQLSDVQNFPYMNDI 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 9/154 (5%)

Query: 22  LREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP-PALAKSY 79
           L ++ V+ K    P +++       +  +F+  E +    +   +    P+P   L K  
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-M 129

Query: 80  LYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
              +++AL Y   +  +IHRD+KP NIL+++ G +KL DFG+S        +        
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCA 188

Query: 139 WYRPPEILLGAKV----YSTTVDIWSAGCIFSEM 168
            Y  PE +         Y    D+WS G    E+
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 33/198 (16%)

Query: 171 LYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              +++AL Y   +  +IHRD+KP NIL+++ G +KL DFG+S        +        
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCA 188

Query: 230 WYRPPEILLGAKV----YSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFRTLGT 284
            Y  PE +         Y    D+WS G    E+ T +  +    ++ + L ++      
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV------ 242

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
             E+  P    LP             FS                 +  D ++R     +L
Sbjct: 243 LQEEP-P---LLP---------GHMGFS-------GDFQSFVKDCLTKDHRKRPKYNKLL 282

Query: 345 QHEYFNQVEMVKPTLAVF 362
           +H +  + E ++  +A +
Sbjct: 283 EHSFIKRYETLEVDVASW 300

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 8/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+       +V E++    L  FL+T             L
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
             +   +RY      +HRDL  +N+L++ +   K++DFGLSR      +           
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W   PE +     +S+  D+WS G +  E ++Y
Sbjct: 218 IRWT-APEAIAFRT-FSSASDVWSFGVVMWEVLAY 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 25/99 (25%), Positives = 44/99 (44%), Gaps = 6/99 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  L  +   +RY      +HRDL  +N+L++ +   K++DFGLSR      +       
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W   PE +     +S+  D+WS G +  E++  
Sbjct: 214 GKIPIRWT-APEAIAFRT-FSSASDVWSFGVVMWEVLAY 250

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 79
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+      V   +    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 138
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR   +  + YT       
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF 174

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAG 162
              W   PE L     +S   D+W+ G
Sbjct: 175 PIKWT-APESLA-YNKFSIKSDVWAFG 199

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 8/98 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR   +  + YT    
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAG 171

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 W   PE L     +S   D+W+ G +  E+ T
Sbjct: 172 AKFPIKWT-APESLA-YNKFSIKSDVWAFGVLLWEIAT 207

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 24/168 (14%)

Query: 23  REISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK 77
            E+     L+H N++              +L+L+  +     L D+LQ T +     L  
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-- 108

Query: 78  SYLYQLLEALRYCHSRR--------IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
             +  +   L + H           I HRDLK +NIL+ K+G   +AD GL+   +   N
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 130 RY----THEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEM 168
           +        V T  Y  PE+L              VDIW+ G +  E+
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 15/161 (9%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----T 223
           +++L+   E         I HRDLK +NIL+ K+G   +AD GL+   +   N+      
Sbjct: 118 LAHLHI--EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 224 HEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
             V T  Y  PE+L              VDIW+ G +  E+  +        +    F  
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235

Query: 279 FRTLGTPHEDVWPGVSK----LPIYKTDFPEWRPKKFSEIL 315
                   ED+   V        I    F +      ++++
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 9/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           +RE++ +  L H N+IRL+ V+     + +V E      L D L+             Y 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  +      
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W   PE L     +S   D W  G    E  +Y
Sbjct: 188 FAWC-APESLKTRT-FSHASDTWMFGVTLWEMFTY 220

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
             Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  +  
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 W   PE L     +S   D W  G    EM T
Sbjct: 184 RKVPFAWC-APESLKTRT-FSHASDTWMFGVTLWEMFT 219

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 8/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
             +   ++Y      +HRDL  +NILIN +   K++DFGL R                  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W   PE +   K +++  D+WS G +  E MSY
Sbjct: 214 IRWT-SPEAIAYRK-FTSASDVWSYGIVLWEVMSY 246

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 6/99 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  L  +   ++Y      +HRDL  +NILIN +   K++DFGL R              
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W   PE +   K +++  D+WS G +  E+++ 
Sbjct: 210 GKIPIRWT-SPEAIAYRK-FTSASDVWSYGIVLWEVMSY 246

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.1 bits (247), Expect = 4e-22
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 6/151 (3%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPV-PPALAKS 78
           AL E  +L+++    V+ L         L LV   +   DLK  +        P A A  
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 137
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL+    +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH--VPEGQTIKGRVGT 348

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + Y  PE++   + Y+ + D W+ GC+  EM
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEM 378

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.0 bits (239), Expect = 4e-21
 Identities = 47/189 (24%), Positives = 88/189 (46%), Gaps = 34/189 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL+    +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH--VPEGQTIKGRVGT 348

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
           + Y  PE++   + Y+ + D W+ GC+  EMI  ++ F    +  +   + R        
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL------- 400

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
                        + PE   ++FS       P A  + S+++  DP +R+     SA+ +
Sbjct: 401 -----------VKEVPEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREV 442

Query: 344 LQHEYFNQV 352
            +H  F ++
Sbjct: 443 KEHPLFKKL 451

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 9/146 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V +   
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 184

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAG 162
             W  PPE+L+ +K +S+  DIW+ G
Sbjct: 185 VRWS-PPEVLMYSK-FSSKSDIWAFG 208

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 8/98 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +     + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V 
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVG 180

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +     W  PPE+L+ +K +S+  DIW+ G +  E+ +
Sbjct: 181 SKFPVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 19/165 (11%)

Query: 23  REISVLKELKHPNVIRL--HDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPAL-- 75
            E+  L  +KH N+++    +         L+L+  F  +  L DFL+   V        
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI 126

Query: 76  ----AK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
               A+  +YL++ +  L+  H   I HRD+K +N+L+  +    +ADFGL+  F    +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 130 RY--THEVVTLWYRPPEILLGA----KVYSTTVDIWSAGCIFSEM 168
                 +V T  Y  PE+L GA    +     +D+++ G +  E+
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 40/190 (21%), Positives = 79/190 (41%), Gaps = 24/190 (12%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--THE 225
           ++YL++ +  L+  H   I HRD+K +N+L+  +    +ADFGL+  F    +      +
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 226 VVTLWYRPPEILLGA----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRT 281
           V T  Y  PE+L GA    +     +D+++ G +  E+ ++ T   G  +   L      
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML------ 247

Query: 282 LGTPHED-VWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMAL----DPK 335
              P E+ +    S   + +     + RP              + +  + +      D +
Sbjct: 248 ---PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA---GMAMLCETIEECWDHDAE 301

Query: 336 QRVSAKTILQ 345
            R+SA  + +
Sbjct: 302 ARLSAGCVGE 311

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 28/166 (16%)

Query: 13  QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFL 64
           Q+E      L E  +L+ +  P +++L      +  L++V E++         + +  F 
Sbjct: 84  QIEHT----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF- 138

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
                      A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++  
Sbjct: 139 -------SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

Query: 125 TIPMNRY--THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                    T E        PEI+L  K Y+  VD W+ G +  EM
Sbjct: 192 KGRTWTLCGTPE-----ALAPEIILS-KGYNKAVDWWALGVLIYEM 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 56/242 (23%), Positives = 81/242 (33%), Gaps = 74/242 (30%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--THEVV 227
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++           T E  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-- 203

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
                 PEI+L  K Y+  VD W+ G +  EM      F  D  I    +I         
Sbjct: 204 ---ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------ 253

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                       K  FP      FS           D+   ++ +D  +R          
Sbjct: 254 ------------KVRFPSH----FS-------SDLKDLLRNLLQVDLTKR---------- 280

Query: 348 YFNQVEMVKPTLAVFPELGYGGNGCKDFK--PWIAKLIKTQWQRSWDDIPNNKLK-RIKP 404
                             G   NG  D K   W A          W  I   K++    P
Sbjct: 281 -----------------FGNLKNGVNDIKNHKWFATT-------DWIAIYQRKVEAPFIP 316

Query: 405 KI 406
           K 
Sbjct: 317 KF 318

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 35/145 (24%), Positives = 68/145 (46%), Gaps = 7/145 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  V+  + +P+V RL  +      + L+ + +    L D+++     +      ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   +  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 139 -WYRPPEILLGAKVYSTTVDIWSAG 162
            W    E +L  ++Y+   D+WS G
Sbjct: 184 KWM-ALESIL-HRIYTHQSDVWSYG 206

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W    E +L  ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWM-ALESIL-HRIYTHQSDVWSYGVTVWELMT 214

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 34/150 (22%), Positives = 61/150 (40%), Gaps = 13/150 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
               S++ +L H +++  + V     +  LV EF++   L  +L+     +         
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGAL--------KLADFGLSRAFTIPMNRYT 132
            QL  A+ +     +IH ++  +NIL+ +            KL+D G+S   T+      
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDIL 177

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAG 162
            E +  W  PPE +   K  +   D WS G
Sbjct: 178 QERIP-WV-PPECIENPKNLNLATDKWSFG 205

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 25/102 (24%), Positives = 42/102 (41%), Gaps = 12/102 (11%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL--------KLADFGLSRAFTIPM 219
           +    QL  A+ +     +IH ++  +NIL+ +            KL+D G+S   T+  
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLP 173

Query: 220 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                E +  W  PPE +   K  +   D WS G    E+ +
Sbjct: 174 KDILQERIP-WV-PPECIENPKNLNLATDKWSFGTTLWEICS 213

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 96.4 bits (240), Expect = 6e-22
 Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 24/168 (14%)

Query: 23  REISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK 77
            EI     L+H N++      +       +L+LV ++     L D+L    V V   +  
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-- 142

Query: 78  SYLYQLLEALRYCHSRR--------IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
                    L + H           I HRDLK +NIL+ K+G   +AD GL+       +
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 130 RY----THEVVTLWYRPPEILLGAKV-----YSTTVDIWSAGCIFSEM 168
                  H V T  Y  PE+L  +            DI++ G +F E+
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 41/191 (21%), Positives = 75/191 (39%), Gaps = 26/191 (13%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----T 223
           +++L+   E +       I HRDLK +NIL+ K+G   +AD GL+       +       
Sbjct: 152 LAHLHM--EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 224 HEVVTLWYRPPEILLGAKV-----YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRI 278
           H V T  Y  PE+L  +            DI++ G +F E+  + ++     +    +  
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 279 FRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM----ALDP 334
                   E++   V +  +        RP   +   +     A+ V +KIM      + 
Sbjct: 270 LVPSDPSVEEMRKVVCEQKL--------RPNIPNRWQSCE---ALRVMAKIMRECWYANG 318

Query: 335 KQRVSAKTILQ 345
             R++A  I +
Sbjct: 319 AARLTALRIKK 329

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           L+E   +++  HP++++L  VI   PV    +++ E     +L+ FLQ     +  A   
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITENPV----WIIMELCTLGELRSFLQVRKYSLDLASLI 119

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR   +  + Y      
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKG 177

Query: 138 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
                W   PE +   + +++  D+W  G    E + +
Sbjct: 178 KLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILMH 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR   +  + Y     
Sbjct: 119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK 176

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W   PE +   + +++  D+W  G    E++  
Sbjct: 177 GKLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILMH 213

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.5 bits (243), Expect = 7e-22
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 11/153 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKSY 79
           L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+  T   +        
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 138
             Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT       
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF 343

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              W  P   L G   ++   D+WS G + +E+
Sbjct: 344 PIKWTAPEAALYG--RFTIKSDVWSFGILLTEL 374

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT    
Sbjct: 283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQG 340

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W  P   L G   ++   D+WS G + +E+ TK
Sbjct: 341 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 377

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  ++ +  H N+IRL  VI     + ++ E++    L  FL+              L
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL- 138
             +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR     P   YT     + 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             W   PE +   + +++  D+WS G +  E M+Y
Sbjct: 214 IRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMTY 246

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 6/99 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEV 226
           +  L  +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR     P   YT   
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209

Query: 227 VTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
             +   W   PE +   + +++  D+WS G +  E++T 
Sbjct: 210 GKIPIRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMTY 246

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 30/157 (19%), Positives = 46/157 (29%), Gaps = 38/157 (24%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 79
            L     L  +  P V R+ DV+       +V E++R   L++   T+P    P  A   
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP---SPVGAIRA 134

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
           +  L  A    H   +      P  + ++  G + LA                       
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE 176
             P          +   DI   G        LY LL 
Sbjct: 175 TMPDA--------NPQDDIRGIGAS------LYALLV 197

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 13/113 (11%), Positives = 22/113 (19%), Gaps = 28/113 (24%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 232
            L  A    H   +      P  + ++  G + LA                         
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TM 176

Query: 233 PPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           P          +   DI   G     ++  +           L    R     
Sbjct: 177 PDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 7/153 (4%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 75
           A+ E  +L ++    ++ L         L LV        +R  + +  +  P       
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPR 290

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
           A  Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +     
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T  +  PE+LLG + Y  +VD ++ G    EM
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEM 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 37/191 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSE---IDQLFRIFRTLGTPH 286
            +  PE+LLG + Y  +VD ++ G    EMI  +  F    E     +L +  R L    
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--RVLEQA- 409

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAK 341
                       Y        P KFS       P + D    ++  DP++R+     S  
Sbjct: 410 ----------VTY--------PDKFS-------PASKDFCEALLQKDPEKRLGFRDGSCD 444

Query: 342 TILQHEYFNQV 352
            +  H  F  +
Sbjct: 445 GLRTHPLFRDI 455

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 24/155 (15%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPAL 75
           E  +L  + HP +IR+        ++F++ +++         +  + F        P  +
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--------PNPV 107

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--TH 133
           AK Y  ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++           T 
Sbjct: 108 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP 167

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +     Y  PE++   K Y+ ++D WS G +  EM
Sbjct: 168 D-----YIAPEVVST-KPYNKSIDWWSFGILIYEM 196

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 74/246 (30%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--THEVV 227
           Y  ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++           T +  
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD-- 168

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
              Y  PE++   K Y+ ++D WS G +  EM+   T F   +   + +           
Sbjct: 169 ---YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYE---------- 213

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                  K+   +  FP +    F+           D+ S+++  D  QR          
Sbjct: 214 -------KILNAELRFPPF----FN-------EDVKDLLSRLITRDLSQR---------- 245

Query: 348 YFNQVEMVKPTLAVFPELGYGGNGCKDFK--PWIAKLIKTQWQRSWDDIPNNKLK-RIKP 404
                            LG   NG +D K  PW  ++        W+ + +  ++   +P
Sbjct: 246 -----------------LGNLQNGTEDVKNHPWFKEV-------VWEKLLSRNIETPYEP 281

Query: 405 KIEEWP 410
            I++  
Sbjct: 282 PIQQGQ 287

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 9/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT        
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             WY P  I      +S+  D+WS G    E +SY
Sbjct: 177 LKWYAPECINFR--KFSSRSDVWSYGVTMWEALSY 209

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
              L+Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT    
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 WY P  I      +S+  D+WS G    E ++
Sbjct: 173 GKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALS 208

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 17/150 (11%)

Query: 22  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALA 76
           L E +++K+L+H  ++RL+ V+   P+    +++ E++    L DFL+T   + +     
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQEPI----YIITEYMENGSLVDFLKTPSGIKLTINKL 111

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
                Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT    
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREG 169

Query: 137 TL----WYRPPEILLGAKVYSTTVDIWSAG 162
                 W   PE +     ++   D+WS G
Sbjct: 170 AKFPIKWT-APEAIN-YGTFTIKSDVWSFG 197

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT    
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREG 169

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W   PE +     ++   D+WS G + +E++T 
Sbjct: 170 AKFPIKWT-APEAIN-YGTFTIKSDVWSFGILLTEIVTH 206

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 43/226 (19%), Positives = 84/226 (37%), Gaps = 41/226 (18%)

Query: 171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 230
             ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R    + T +
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 231 YRPPEILLGAKV----YSTTVDIWSAG--CIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           +  PE++   +     Y    D+WS G   I  EM                         
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAI--EMAEGA--------------------P 232

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           P  D+ P  +   I +   P  + KK+S+                +  +  QR + + ++
Sbjct: 233 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ-------SFIESCLVKNHSQRPATEQLM 285

Query: 345 QHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPWIAKLIKTQWQRS 390
           +H +       +       +           K    +  +T+++ S
Sbjct: 286 KHPFIRDQPNERQVRIQLKDH------IDRTKKKRGEKDETEYEYS 325

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 13/153 (8%)

Query: 23  REISVLKEL-KHPNVIRLHD------VIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPA 74
           +EI++LK+   H N+   +          +D +L+LV EF     + D ++ T       
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128

Query: 75  LAKSY-LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
              +Y   ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R   
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 134 EVVTLWYRPPEILLGAKV----YSTTVDIWSAG 162
            + T ++  PE++   +     Y    D+WS G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 22  LREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT---PVPVP-PALA 76
           L ++ + ++ +  P  +  +  +  +  +++  E +   L  F +        +P   L 
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG 112

Query: 77  KSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
           K     +++AL + HS   +IHRD+KP N+LIN  G +K+ DFG+S      + +   + 
Sbjct: 113 KI-AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DA 170

Query: 136 VTLWYRPPEILLGAKV---YSTTVDIWSAG 162
               Y  PE +        YS   DIWS G
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLG 200

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 33/197 (16%)

Query: 171 LYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
              +++AL + HS   +IHRD+KP N+LIN  G +K+ DFG+S      + +   +    
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCK 173

Query: 230 WYRPPEILLGAKV---YSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFRTLGTP 285
            Y  PE +        YS   DIWS G    E+   +  +    +   QL ++       
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------V 227

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            E                P+    KFS          VD  S+ +  + K+R +   ++Q
Sbjct: 228 EEPS--------------PQLPADKFS-------AEFVDFTSQCLKKNSKERPTYPELMQ 266

Query: 346 HEYFNQVEMVKPTLAVF 362
           H +F   E     +A F
Sbjct: 267 HPFFTLHESKGTDVASF 283

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.9 bits (241), Expect = 2e-21
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 11/153 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKSY 79
           L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+  T   +        
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 138
             Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT       
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF 426

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              W  P   L G   ++   D+WS G + +E+
Sbjct: 427 PIKWTAPEAALYG--RFTIKSDVWSFGILLTEL 457

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT    
Sbjct: 366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQG 423

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W  P   L G   ++   D+WS G + +E+ TK
Sbjct: 424 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 460

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 2e-21
 Identities = 43/191 (22%), Positives = 83/191 (43%), Gaps = 39/191 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F     +  H  V T
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGT 353

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID--QLFRIFRTLGTPH 286
             Y  PE+L     Y ++ D +S GC+  +++   + F      D  ++ R   TL    
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTL---T 408

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAK 341
             V            + P+     FS       P    +   ++  D  +R+      A+
Sbjct: 409 MAV------------ELPDS----FS-------PELRSLLEGLLQRDVNRRLGCLGRGAQ 445

Query: 342 TILQHEYFNQV 352
            + +  +F  +
Sbjct: 446 EVKESPFFRSL 456

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.9 bits (241), Expect = 3e-21
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)

Query: 21  ALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
           AL E  +L  +     P ++ +        KL  + + +   DL   L    V    A  
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADM 294

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           + Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F     +  H  V
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASV 351

Query: 137 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T  Y  PE+L     Y ++ D +S GC+  ++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.2 bits (242), Expect = 2e-21
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 17/158 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           L+E   +++  HP++++L  VI   PV    +++ E     +L+ FLQ     +  A   
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENPV----WIIMELCTLGELRSFLQVRKFSLDLASLI 494

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR   +  + Y      
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKG 552

Query: 138 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
                W  P  I      +++  D+W  G    E + +
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMH 588

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 8/98 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR   +  + Y     
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK 551

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 W  P  I      +++  D+W  G    E++ 
Sbjct: 552 GKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILM 587

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 19/154 (12%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPAL 75
           E  +L E+ HP +++LH     + KL+L+ +FLR             F            
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--------TEED 127

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
            K YL +L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+   I   +  +  
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSF 186

Query: 136 V-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T+ Y  PE++     ++ + D WS G +  EM
Sbjct: 187 CGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEM 219

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 89.1 bits (222), Expect = 1e-19
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 39/190 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           YL +L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+   I   +  +    T
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGT 189

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR-IFRTLGTPHE 287
           + Y  PE++     ++ + D WS G +  EM+T    F G     +    I +       
Sbjct: 190 VEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILK------- 240

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKT 342
                 +KL +         P+  S       P A  +   +   +P  R+       + 
Sbjct: 241 ------AKLGM---------PQFLS-------PEAQSLLRMLFKRNPANRLGAGPDGVEE 278

Query: 343 ILQHEYFNQV 352
           I +H +F+ +
Sbjct: 279 IKRHSFFSTI 288

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 9/146 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ         + +  +
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 123

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +      
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAG 162
             WY  PE +   K +S+  D+WS G
Sbjct: 184 VKWY-APECINYYK-FSSKSDVWSFG 207

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 6/99 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +  
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 WY  PE +   K +S+  D+WS G +  E  + 
Sbjct: 180 GKWPVKWY-APECINYYK-FSSKSDVWSFGVLMWEAFSY 216

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 35/164 (21%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------TTPVPVPP 73
           L E SV+KE    +V+RL  V+       ++ E + + DLK +L+         PV  PP
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135

Query: 74  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R      + Y
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIY 189

Query: 132 THEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 162
             +     YR             PE +  G  V++T  D+WS G
Sbjct: 190 ETDY----YRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 25/107 (23%), Positives = 50/107 (46%), Gaps = 25/107 (23%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R      + Y  +  
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDY- 193

Query: 228 TLWYR------------PPE-ILLGAKVYSTTVDIWSAGCIFSEMIT 261
              YR             PE +  G  V++T  D+WS G +  E+ T
Sbjct: 194 ---YRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIAT 235

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 19/154 (12%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPAL 75
           E ++L+E+KHP ++ L        KL+L+ E+L         +    F            
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--------MEDT 122

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
           A  YL ++  AL + H + II+RDLKP+NI++N  G +KL DFGL +   I     TH  
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHTF 181

Query: 136 V-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T+ Y  PEIL+ +  ++  VD WS G +  +M
Sbjct: 182 CGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDM 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 89.9 bits (224), Expect = 6e-20
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 39/190 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           YL ++  AL + H + II+RDLKP+NI++N  G +KL DFGL +   I     TH    T
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHTFCGT 184

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR-IFRTLGTPHE 287
           + Y  PEIL+ +  ++  VD WS G +  +M+T    F G++   +    I +       
Sbjct: 185 IEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILK------- 235

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKT 342
                  KL +         P   +         A D+  K++  +   R+      A  
Sbjct: 236 ------CKLNL---------PPYLT-------QEARDLLKKLLKRNAASRLGAGPGDAGE 273

Query: 343 ILQHEYFNQV 352
           +  H +F  +
Sbjct: 274 VQAHPFFRHI 283

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.9 bits (234), Expect = 5e-21
 Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 32/190 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y+ +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        ++   T
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223

Query: 229 LWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           + Y  P+I+ G    +   VD WS G +  E++T  + F  D E +    I R +     
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----- 278

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKT 342
                +   P Y        P++ S        LA D+  +++  DPK+R+      A  
Sbjct: 279 -----LKSEPPY--------PQEMS-------ALAKDLIQRLLMKDPKKRLGCGPRDADE 318

Query: 343 ILQHEYFNQV 352
           I +H +F ++
Sbjct: 319 IKEHLFFQKI 328

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 19/156 (12%)

Query: 24  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPA 74
           E  VL+ ++  P ++ LH     + KL L+ +++            + F           
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--------TEH 159

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             + Y+ +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        ++
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219

Query: 135 VV-TLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEM 168
              T+ Y  P+I+ G    +   VD WS G +  E+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 16/149 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 77
           + E  ++K L HP++++L  +I   P     +++ E     +L  +L+     +      
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPT----WIIMELYPYGELGHYLERNKNSLKVLTLV 116

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
            Y  Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR   I    Y    VT
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVT 174

Query: 138 L----WYRPPEILLGAKVYSTTVDIWSAG 162
                W   PE +   + ++T  D+W   
Sbjct: 175 RLPIKWM-SPESIN-FRRFTTASDVWMFA 201

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y  Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR   I    Y    V
Sbjct: 116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASV 173

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
           T     W   PE +   + ++T  D+W       E+++ 
Sbjct: 174 TRLPIKWM-SPESIN-FRRFTTASDVWMFAVCMWEILSF 210

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 92.8 bits (231), Expect = 7e-21
 Identities = 35/145 (24%), Positives = 68/145 (46%), Gaps = 7/145 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E  V+  + +P+V RL  +      + L+ + +    L D+++     +      ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   +  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 139 -WYRPPEILLGAKVYSTTVDIWSAG 162
            W    E +L  ++Y+   D+WS G
Sbjct: 184 KWM-ALESIL-HRIYTHQSDVWSYG 206

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
            +   W    E +L  ++Y+   D+WS G    E++T
Sbjct: 180 KVPIKWM-ALESIL-HRIYTHQSDVWSYGVTVWELMT 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.8 bits (231), Expect = 7e-21
 Identities = 31/145 (21%), Positives = 63/145 (43%), Gaps = 7/145 (4%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
              +  +  L H +++RL  + P    L LV ++L    L D ++     + P L  ++ 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
            Q+ + + Y     ++HR+L  +N+L+     +++ADFG++        +  +       
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181

Query: 139 -WYRPPEILLGAKVYSTTVDIWSAG 162
            W    E +     Y+   D+WS G
Sbjct: 182 KWM-ALESIH-FGKYTHQSDVWSYG 204

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 20/97 (20%), Positives = 44/97 (45%), Gaps = 5/97 (5%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +++  Q+ + + Y     ++HR+L  +N+L+     +++ADFG++        +  +   
Sbjct: 118 LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177

Query: 228 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                W    E +     Y+   D+WS G    E++T
Sbjct: 178 KTPIKWM-ALESIH-FGKYTHQSDVWSYGVTVWELMT 212

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 15/148 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKS 78
           L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++     +       
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++         + +    
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGK 347

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAG 162
               W   PE L   K +ST  D+WS G
Sbjct: 348 LPVKWT-APEALR-EKKFSTKSDVWSFG 373

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 12/99 (12%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++         + +  
Sbjct: 292 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDT 345

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W   PE L   K +ST  D+WS G +  E+ + 
Sbjct: 346 GKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYSF 382

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 15/148 (10%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKS 78
           L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++     +       
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++         + +    
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGK 175

Query: 139 ----WYRPPEILLGAKVYSTTVDIWSAG 162
               W   PE L   K +ST  D+WS G
Sbjct: 176 LPVKWT-APEALR-EKKFSTKSDVWSFG 201

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 12/98 (12%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++         + +  
Sbjct: 120 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDT 173

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 W   PE L   K +ST  D+WS G +  E+ +
Sbjct: 174 GKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYS 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 11/147 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 79
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++      P      +
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 138
             Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT       
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKF 347

Query: 139 ---WYRPPEILLGAKVYSTTVDIWSAG 162
              W  P  I  G   ++   D+WS G
Sbjct: 348 PIKWTAPEAINFG--SFTIKSDVWSFG 372

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 8/99 (8%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT    
Sbjct: 287 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREG 344

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK 262
                 W  P  I  G   ++   D+WS G +  E++T 
Sbjct: 345 AKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTY 381

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.5 bits (232), Expect = 3e-20
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 9/155 (5%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 138
           +Q+   ++Y   +  +HR+L  +N+L+      K++DFGLS+A     + YT        
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 139 --WYRPPEILLGAKVYSTTVDIWSAGCIFSE-MSY 170
             WY P  I      +S+  D+WS G    E +SY
Sbjct: 503 LKWYAPECINFR--KFSSRSDVWSYGVTMWEALSY 535

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
              L+Q+   ++Y   +  +HR+L  +N+L+      K++DFGLS+A     + YT    
Sbjct: 439 AELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 WY P  I      +S+  D+WS G    E ++
Sbjct: 499 GKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALS 534

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 13/151 (8%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  VL+  +HP +  L        +L  V E+    +L   L    V      A+ Y  +
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAE 113

Query: 83  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----THEVVT 137
           ++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T E   
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--- 170

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             Y  PE+L     Y   VD W  G +  EM
Sbjct: 171 --YLAPEVLEDND-YGRAVDWWGLGVVMYEM 198

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 45/193 (23%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----TH 224
           Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           E     Y  PE+L     Y   VD W  G +  EM+  +  F      ++LF +      
Sbjct: 170 E-----YLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL---- 218

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----S 339
             E++             FP     +           A  + + ++  DPKQR+      
Sbjct: 219 -MEEI------------RFPRTLSPE-----------AKSLLAGLLKKDPKQRLGGGPSD 254

Query: 340 AKTILQHEYFNQV 352
           AK +++H +F  +
Sbjct: 255 AKEVMEHRFFLSI 267

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.7 bits (226), Expect = 5e-20
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 33/185 (17%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +  +  T+    T
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKTNTFCGT 181

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PEILLG + Y+ +VD WS G +  EM+  ++ F G  E ++LF   R      ++
Sbjct: 182 PDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIR-----MDN 234

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-SAKTILQHE 347
                         +P W  K+           A D+  K+   +P++R+     I QH 
Sbjct: 235 P------------FYPRWLEKE-----------AKDLLVKLFVREPEKRLGVRGDIRQHP 271

Query: 348 YFNQV 352
            F ++
Sbjct: 272 LFREI 276

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 6/148 (4%)

Query: 24  EISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 81
           E  VL    +HP +  +         LF V E+L   DL   +Q+       + A  Y  
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAA 125

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 140
           +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +  +  T+    T  Y
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKTNTFCGTPDY 184

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PEILLG + Y+ +VD WS G +  EM
Sbjct: 185 IAPEILLG-QKYNHSVDWWSFGVLLYEM 211

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           L E  ++K+  HPNV+ L  +    +    +V  +++  DL++F++             +
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVT 137
             Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R        + +      
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 138 L---WYRPPEILLGAKVYSTTVDIWSAG 162
           L   W    E L   + ++T  D+WS G
Sbjct: 194 LPVKWM-ALESLQ-TQKFTTKSDVWSFG 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 7/99 (7%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           + +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R        + +   
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190

Query: 226 VVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              L   W    E L   + ++T  D+WS G +  E++T
Sbjct: 191 GAKLPVKWM-ALESLQ-TQKFTTKSDVWSFGVLLWELMT 227

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 40/175 (22%), Positives = 65/175 (37%), Gaps = 31/175 (17%)

Query: 23  REISVLKELKHPNVIRL-----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 76
           + I  +  ++H N+ R              +  LV E+     L  +L         +  
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC- 114

Query: 77  KSYLYQLLEALRYCHS---------RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
               + +   L Y H+           I HRDL  +N+L+   G   ++DFGLS   T  
Sbjct: 115 -RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 128 MNRY--------THEVVTLWYRPPEILLGA------KVYSTTVDIWSAGCIFSEM 168
                         EV T+ Y  PE+L GA      +     VD+++ G I+ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 42/204 (20%)

Query: 168 MSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 222
           ++YL+   E  R  H +  I HRDL  +N+L+   G   ++DFGLS   T          
Sbjct: 124 LAYLHT--ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 223 ----THEVVTLWYRPPEILLGA------KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
                 EV T+ Y  PE+L GA      +     VD+++ G I+ E+  + T       +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

Query: 273 DQLFRIFRTLGTPH---EDVWPGVSK----LPIYKTDFPEWRPKKFSEILNLPDPLAVDV 325
            +    F+T    H   ED+   VS+              W+           + LAV  
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP----EAWK----------ENSLAVRS 287

Query: 326 FSKIMAL----DPKQRVSAKTILQ 345
             + +      D + R++A+   +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEE 311

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 41/170 (24%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ--------TTPVPVP 72
            RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+               
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 73  PALAKSYLYQLL-------EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
            A  +  L Q+L         + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR   
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--- 181

Query: 126 IPMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 162
              + Y+ +     YR            PPE I+     ++T  D+WS G
Sbjct: 182 ---DVYSTDY----YRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFG 222

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 35/107 (32%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           M YL           S+  +HRDL  +N L+  +  +K+ DFG+SR      + Y+ +  
Sbjct: 146 MVYL----------ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDY- 188

Query: 228 TLWYR------------PPE-ILLGAKVYSTTVDIWSAGCIFSEMIT 261
              YR            PPE I+     ++T  D+WS G I  E+ T
Sbjct: 189 ---YRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 35/165 (21%)

Query: 22  LREISVLKELKHPNVIRLHDV------IPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPP 73
           LRE + +KE  HP+V +L  V              ++  F++  DL  FL  +     P 
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 74  ALAK----SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 129
            L       ++  +   + Y  SR  IHRDL  +N ++ +   + +ADFGLSR       
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR------K 186

Query: 130 RYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
            Y+ +     YR              E L    +Y+   D+W+ G
Sbjct: 187 IYSGDY----YRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFG 226

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 23/106 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + ++  +   + Y  SR  IHRDL  +N ++ +   + +ADFGLSR        Y+ +  
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR------KIYSGDY- 192

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              YR              E L    +Y+   D+W+ G    E++T
Sbjct: 193 ---YRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMT 234

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 45/193 (23%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----TH 224
           Y  ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T 
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 185

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           +     Y  PEI+     Y  +VD W+ G +  EM+  +  F G+ E D+LF+       
Sbjct: 186 D-----YIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIM---- 234

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----S 339
              +V             +P+   K+           AV +   +M   P +R+      
Sbjct: 235 -EHNV------------AYPKSMSKE-----------AVAICKGLMTKHPGKRLGCGPEG 270

Query: 340 AKTILQHEYFNQV 352
            + I +H +F  +
Sbjct: 271 ERDIKEHAFFRYI 283

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 27/150 (18%)

Query: 32  KHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPALAKSYLYQL 83
           K P + +LH       +L+ V E++         Q +  F            A  Y  ++
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF--------KEPHAVFYAAEI 130

Query: 84  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----THEVVTL 138
              L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T +    
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD---- 186

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y  PEI+     Y  +VD W+ G +  EM
Sbjct: 187 -YIAPEIIAYQP-YGKSVDWWAFGVLLYEM 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 41/170 (24%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------TPVPVP 72
             E  +   L+HPNV+ L  V+  D  L ++F +    DL +FL          +     
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 73  PALAKSYLYQLLEALR-------YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
              +       +  +        Y  S  ++H+DL  +N+L+     +K++D GL R   
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--- 176

Query: 126 IPMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 162
                Y  +     Y+             PE I+ G   +S   DIWS G
Sbjct: 177 ---EVYAADY----YKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYG 217

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 26/107 (24%), Positives = 46/107 (42%), Gaps = 25/107 (23%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  + Q+   + Y  S  ++H+DL  +N+L+     +K++D GL R        Y  +  
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR------EVYAADY- 183

Query: 228 TLWYR------------PPE-ILLGAKVYSTTVDIWSAGCIFSEMIT 261
              Y+             PE I+ G   +S   DIWS G +  E+ +
Sbjct: 184 ---YKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFS 225

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 35/148 (23%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 22  LREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           L E  ++K+  HPNV+ L  +    +    +V  +++  DL++F++             +
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVT 137
             Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R        + +      
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 138 L---WYRPPEILLGAKVYSTTVDIWSAG 162
           L   W    E L   + ++T  D+WS G
Sbjct: 258 LPVKWM-ALESLQ-TQKFTTKSDVWSFG 283

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 25/99 (25%), Positives = 52/99 (52%), Gaps = 7/99 (7%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R        + +   
Sbjct: 195 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254

Query: 226 VVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              L   W    E L   + ++T  D+WS G +  E++T
Sbjct: 255 GAKLPVKWM-ALESLQ-TQKFTTKSDVWSFGVLLWELMT 291

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 52/155 (33%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 24  EISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPA 74
           E +VL K +KHP ++ LH       KL+ V +++         Q  + F           
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF--------LEP 139

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
            A+ Y  ++  AL Y HS  I++RDLKP+NIL++  G + L DFGL +   I  N  T  
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNSTTST 198

Query: 135 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              T  Y  PE+L   + Y  TVD W  G +  EM
Sbjct: 199 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEM 232

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 47/189 (24%), Positives = 75/189 (39%), Gaps = 38/189 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  ++  AL Y HS  I++RDLKP+NIL++  G + L DFGL +   I  N  T     T
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNSTTSTFCGT 202

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR-IFRTLGTPHE 287
             Y  PE+L   + Y  TVD W  G +  EM+     F   +   +++  I       ++
Sbjct: 203 PEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNIL------NK 254

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT----I 343
            +                                A  +   ++  D  +R+ AK     I
Sbjct: 255 PL------------QLKPNITNS-----------ARHLLEGLLQKDRTKRLGAKDDFMEI 291

Query: 344 LQHEYFNQV 352
             H +F+ +
Sbjct: 292 KSHVFFSLI 300

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 48/194 (24%), Positives = 77/194 (39%), Gaps = 46/194 (23%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----TH 224
           Y  +++ AL + H + II+RDLK  N+L++  G  KLADFG+ +              T 
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
           +     Y  PEIL     Y   VD W+ G +  EM+     F  ++E D LF        
Sbjct: 189 D-----YIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAIL---- 237

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV------ 338
            +++V             +P W  +            A  +    M  +P  R+      
Sbjct: 238 -NDEV------------VYPTWLHED-----------ATGILKSFMTKNPTMRLGSLTQG 273

Query: 339 SAKTILQHEYFNQV 352
               IL+H +F ++
Sbjct: 274 GEHAILRHPFFKEI 287

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 28/161 (17%)

Query: 22  LREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVP 72
           + E  +L     HP + +L        +LF V EF+         Q  + F         
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF--------D 122

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY- 131
            A A+ Y  +++ AL + H + II+RDLK  N+L++  G  KLADFG+ +          
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182

Query: 132 ----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               T +     Y  PEIL     Y   VD W+ G +  EM
Sbjct: 183 TFCGTPD-----YIAPEILQEML-YGPAVDWWAMGVLLYEM 217

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 4/147 (2%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 82
           E  VL+  +HP +  L        +L  V E+    +L   L    V      A+ Y  +
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAE 256

Query: 83  LLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  Y 
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE+L     Y   VD W  G +  EM
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEM 342

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 36/189 (19%)

Query: 170 YLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y  +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PE+L     Y   VD W  G +  EM+  +  F      ++LF +        E+
Sbjct: 313 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL-----MEE 365

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTI 343
           +             FP     +           A  + S ++  DPKQR+      AK I
Sbjct: 366 I------------RFPRTLGPE-----------AKSLLSGLLKKDPKQRLGGGSEDAKEI 402

Query: 344 LQHEYFNQV 352
           +QH +F  +
Sbjct: 403 MQHRFFAGI 411

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 40/169 (23%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ------------TTP 68
            RE  +L  L+H +++R   V      L +VFE++R  DL  FL+               
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 69  VPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
            P P  L +  +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR   I
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DI 208

Query: 127 PMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 162
               Y        YR            PPE IL     ++T  D+WS G
Sbjct: 209 YSTDY--------YRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFG 247

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 25/107 (23%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           ++   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR   I    Y     
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDY----- 213

Query: 228 TLWYR------------PPE-ILLGAKVYSTTVDIWSAGCIFSEMIT 261
              YR            PPE IL     ++T  D+WS G +  E+ T
Sbjct: 214 ---YRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFT 255

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 34/164 (20%)

Query: 22  LREISVLKELKHPNVIRLHDVI-----PVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPA 74
           L E + +K+  HPNVIRL  V          K  ++  F++  DL  +L  +     P  
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 75  LAK----SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 130
           +       ++  +   + Y  +R  +HRDL  +N ++     + +ADFGLS+        
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK------KI 197

Query: 131 YTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
           Y+ +     YR              E L   +VY++  D+W+ G
Sbjct: 198 YSGDY----YRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFG 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 25/106 (23%), Positives = 46/106 (43%), Gaps = 23/106 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + ++  +   + Y  +R  +HRDL  +N ++     + +ADFGLS+        Y+ +  
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK------KIYSGDY- 202

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              YR              E L   +VY++  D+W+ G    E+ T
Sbjct: 203 ---YRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIAT 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 22  LREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKS 78
           LRE  +++ L HPNV+ L  + +P +    ++  ++   DL  F+++    P    L  S
Sbjct: 70  LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-S 128

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 136
           +  Q+   + Y   ++ +HRDL  +N ++++S  +K+ADFGL+R        +   H   
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 137 TL---WYRPPEILLGAKVYSTTVDIWSAG 162
            L   W    E L     ++T  D+WS G
Sbjct: 189 RLPVKWT-ALESLQ-TYRFTTKSDVWSFG 215

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 7/99 (7%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S+  Q+   + Y   ++ +HRDL  +N ++++S  +K+ADFGL+R        +   H 
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186

Query: 226 VVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              L   W    E L     ++T  D+WS G +  E++T
Sbjct: 187 HARLPVKWT-ALESLQ-TYRFTTKSDVWSFGVLLWELLT 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.8 bits (217), Expect = 2e-18
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 35/188 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T 
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PEI+     Y  +VD W+ G +  EM+  +  F G+ E D+LF+          +V
Sbjct: 507 DYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIM-----EHNV 559

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTIL 344
                        +P+   K+           AV +   +M   P +R+       + I 
Sbjct: 560 ------------AYPKSMSKE-----------AVAICKGLMTKHPGKRLGCGPEGERDIK 596

Query: 345 QHEYFNQV 352
           +H +F  +
Sbjct: 597 EHAFFRYI 604

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.2 bits (213), Expect = 6e-18
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 4/149 (2%)

Query: 22  LREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           + E  VL    K P + +LH       +L+ V E++   DL   +Q          A  Y
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFY 447

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T  
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           Y  PEI+     Y  +VD W+ G +  EM
Sbjct: 508 YIAPEIIAYQP-YGKSVDWWAFGVLLYEM 535

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 48/157 (30%), Positives = 71/157 (45%), Gaps = 20/157 (12%)

Query: 22  LREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVP 72
             E  V  +   HP ++ LH     + +LF V E++         Q  +          P
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL--------P 108

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 132
              A+ Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  T
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-T 167

Query: 133 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                T  Y  PEIL G   Y  +VD W+ G +  EM
Sbjct: 168 STFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEM 203

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 29/190 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  T     T
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGT 173

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PEIL G   Y  +VD W+ G +  EM+  ++ F      D             + 
Sbjct: 174 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDY 226

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV------SAKT 342
           ++  + +  I     P     K           A  V    +  DPK+R+          
Sbjct: 227 LFQVILEKQIR---IPRSLSVK-----------AASVLKSFLNKDPKERLGCHPQTGFAD 272

Query: 343 ILQHEYFNQV 352
           I  H +F  V
Sbjct: 273 IQGHPFFRNV 282

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 35/164 (21%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKS 78
           L E  ++ +  H N++R   V       F++ E +   DLK FL+ T      P +LA  
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140

Query: 79  YL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRY 131
            L      +    +Y      IHRD+  +N L+   G     K+ DFG++R      + Y
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIY 194

Query: 132 THEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 162
                  +YR            PPE  + G  ++++  D WS G
Sbjct: 195 RAS----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFG 232

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 38/110 (34%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTH 224
             YL               IHRD+  +N L+   G     K+ DFG++R      + Y  
Sbjct: 153 CQYL----------EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRA 196

Query: 225 EVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAGCIFSEMIT 261
                +YR            PPE  + G  ++++  D WS G +  E+ +
Sbjct: 197 S----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFS 240

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.1 bits (211), Expect = 6e-18
 Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 6/150 (4%)

Query: 22  LREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 79
             E  V  +   HP ++ LH     + +LF V E++   DL   +Q     +P   A+ Y
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFY 158

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 138
             ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  T     T 
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTP 217

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            Y  PEIL G   Y  +VD W+ G +  EM
Sbjct: 218 NYIAPEILRGED-YGFSVDWWALGVLMFEM 246

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 29/190 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 228
           Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  T     T
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGT 216

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
             Y  PEIL G   Y  +VD W+ G +  EM+  ++ F      D             + 
Sbjct: 217 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDY 269

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV------SAKT 342
           ++  + +  I     P     K           A  V    +  DPK+R+          
Sbjct: 270 LFQVILEKQIR---IPRSLSVK-----------AASVLKSFLNKDPKERLGCHPQTGFAD 315

Query: 343 ILQHEYFNQV 352
           I  H +F  V
Sbjct: 316 IQGHPFFRNV 325

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 33/163 (20%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ----TTPVPVPPALA 76
           L E  ++ +  H N++R   V       F++ E +   DLK FL+        P   A+ 
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181

Query: 77  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRY 131
                   +    +Y      IHRD+  +N L+   G     K+ DFG++R   I    Y
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGY 239

Query: 132 THEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
                   YR            PPE  +   ++++  D WS G
Sbjct: 240 --------YRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFG 273

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 26/109 (23%), Positives = 40/109 (36%), Gaps = 36/109 (33%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTH 224
             YL               IHRD+  +N L+   G     K+ DFG++R   I    Y  
Sbjct: 194 CQYL----------EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGY-- 239

Query: 225 EVVTLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 YR            PPE  +   ++++  D WS G +  E+ +
Sbjct: 240 ------YRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 40/170 (23%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-----------TP 68
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+              
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147

Query: 69  VPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
                 +    L    YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-- 205

Query: 125 TIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
               +    +    +Y+             PE L   +VY+   D+WS G
Sbjct: 206 ----DINNID----YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 246

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 33/106 (31%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           M YL           S++ IHRDL  +N+L+ ++  +K+ADFGL+R      +    +  
Sbjct: 170 MEYL----------ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNID-- 211

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
             +Y+             PE L   +VY+   D+WS G +  E+ T
Sbjct: 212 --YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 47/177 (26%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133

Query: 81  -----------------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                                  +Q+ + ++Y    +++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193

Query: 118 FGLSRAFTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
           FGLSR      + Y  +     Y               E L    +Y+T  D+WS G
Sbjct: 194 FGLSR------DVYEEDS----YVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFG 239

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 49/178 (27%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ--------------- 65
            RE +++ E  +PN+++L  V  V   + L+FE++   DL +FL+               
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 66  ----TTPVPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                   P PP L+ +       Q+   + Y   R+ +HRDL  +N L+ ++  +K+AD
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217

Query: 118 FGLSRAFTIPMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 162
           FGLSR      N Y+ +     Y+            PPE I      Y+T  D+W+ G
Sbjct: 218 FGLSR------NIYSADY----YKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYG 263

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 40/170 (23%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+    P         
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193

Query: 80  L---------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
                           YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R  
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-- 251

Query: 125 TIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
               +    +     Y+             PE L   +VY+   D+WS G
Sbjct: 252 ----DINNIDY----YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 292

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 23/106 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +S  YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R      +    +  
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY- 258

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              Y+             PE L   +VY+   D+WS G +  E+ T
Sbjct: 259 ---YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 40/170 (23%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ    P         
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181

Query: 80  L---------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
                           YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R  
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-- 239

Query: 125 TIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
               + +  +    +Y+             PE L   ++Y+   D+WS G
Sbjct: 240 ----DIHHID----YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFG 280

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 23/102 (22%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 231
           YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R      + +  +    +Y
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHID----YY 247

Query: 232 R------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +             PE L   ++Y+   D+WS G +  E+ T
Sbjct: 248 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 288

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 82.6 bits (203), Expect = 2e-17
 Identities = 34/191 (17%), Positives = 62/191 (32%), Gaps = 31/191 (16%)

Query: 169 SYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           S L+QL  +L    +  R  HRDL   N+L+ K+   KL      ++ TIP       ++
Sbjct: 165 SILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
                          Y+ +        +F ++   + LF GD   D  F I+R +   + 
Sbjct: 225 D--------------YTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENN 268

Query: 288 DVWPGVSK---------LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV 338
           + W              L         ++ K  +  +        +    ++        
Sbjct: 269 NRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323

Query: 339 SAKTILQHEYF 349
           SA  +L     
Sbjct: 324 SATDLLCQHSL 334

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.5 bits (169), Expect = 4e-13
 Identities = 43/210 (20%), Positives = 66/210 (31%), Gaps = 55/210 (26%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKEL---------KHPNVIRLHDVIPV------ 45
            ++ E         +      L EI + KEL         +    I L+ V  V      
Sbjct: 50  IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109

Query: 46  ------------------------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
                                   D +LF+V EF      D  Q        A AKS L+
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF-GGIDLEQMRTKLSSLATAKSILH 168

Query: 82  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
           QL  +L    +  R  HRDL   N+L+ K+   KL      ++ TIP       ++    
Sbjct: 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID--- 225

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
                      Y+ +        +F ++S 
Sbjct: 226 -----------YTLSRLERDGIVVFCDVSM 244

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 38/172 (22%), Positives = 63/172 (36%), Gaps = 42/172 (24%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
           + E+ VL  L  H N++ L     +     ++ E+    DL +FL+        +     
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 80  L-----------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
           +                 YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 123 AFTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
                 +          Y              PE +    VY+   D+WS G
Sbjct: 194 ------DIKNDSN----YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 48/162 (29%), Positives = 67/162 (41%), Gaps = 27/162 (16%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 79
             E+ VL +L  HPN+I L         L+L  E+    +L DFL+ + V          
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132

Query: 80  --------LYQLLEALR-------YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
                     QLL           Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR  
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG- 191

Query: 125 TIPMNRYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAG 162
                 Y  + +      W    E L    VY+T  D+WS G
Sbjct: 192 ---QEVYVKKTMGRLPVRWM-AIESLN-YSVYTTNSDVWSYG 228

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 10/98 (10%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR        Y  + +
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTM 200

Query: 228 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
                 W    E L    VY+T  D+WS G +  E+++
Sbjct: 201 GRLPVRWM-AIESLN-YSVYTTNSDVWSYGVLLWEIVS 236

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 40/171 (23%), Positives = 71/171 (41%), Gaps = 41/171 (23%)

Query: 22  LREISVLKEL-KHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT-----------T 67
           + E+ +L  +  H NV+ L          L ++ EF +  +L  +L++            
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137

Query: 68  PVPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 123
                  L   +L    +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR- 196

Query: 124 FTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
                + Y        Y              PE +   +VY+   D+WS G
Sbjct: 197 -----DIYKDPD----YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 23/106 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      + Y     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------DIYKDPD- 203

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              Y              PE +   +VY+   D+WS G +  E+ +
Sbjct: 204 ---YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 36/177 (20%), Positives = 69/177 (38%), Gaps = 47/177 (26%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT------------- 66
           + E+ ++ +L  H N++ L     +   ++L+FE+    DL ++L++             
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155

Query: 67  -----TPVPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                        L    L    YQ+ + + +   +  +HRDL  +N+L+     +K+ D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215

Query: 118 FGLSRAFTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
           FGL+R      +  +       Y              PE L    +Y+   D+WS G
Sbjct: 216 FGLAR------DIMSDSN----YVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYG 261

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 24/106 (22%), Positives = 46/106 (43%), Gaps = 23/106 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + + YQ+ + + +   +  +HRDL  +N+L+     +K+ DFGL+R      +  +    
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR------DIMSDSN- 227

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              Y              PE L    +Y+   D+WS G +  E+ +
Sbjct: 228 ---YVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFS 269

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 38/168 (22%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ----------TTPV 69
           + E+ ++  L +H N++ L         + ++ E+    DL +FL+             +
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 70  PVPPALAKSYL---YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
               A  +  L    Q+ + + +  S+  IHRD+  +N+L+      K+ DFGL+R    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---- 212

Query: 127 PMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 162
             +          Y              PE +    VY+   D+WS G
Sbjct: 213 --DIMNDS----NYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYG 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 24/106 (22%), Positives = 44/106 (41%), Gaps = 23/106 (21%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +  Q+ + + +  S+  IHRD+  +N+L+      K+ DFGL+R      +       
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDS-- 218

Query: 228 TLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
              Y              PE +    VY+   D+WS G +  E+ +
Sbjct: 219 --NYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFS 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 51/245 (20%), Positives = 96/245 (39%), Gaps = 32/245 (13%)

Query: 22  LREISVLKEL-KHPNVIRLH-DVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKS 78
           + E+ +L  +  H NV+ L          L ++ EF +  +L  +L++      P     
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----- 127

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           Y  +     +       I  DLK +   I  S +   + F   ++ +        E +  
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILI 198
            +   E L+                      Y +Q+ + + +  SR+ IHRDL  +NIL+
Sbjct: 188 DFLTLEHLI---------------------CYSFQVAKGMEFLASRKCIHRDLAARNILL 226

Query: 199 NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR--PPEILLGAKVYSTTVDIWSAGCIF 256
           ++   +K+ DFGL+R      +        L  +   PE +   +VY+   D+WS G + 
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLL 285

Query: 257 SEMIT 261
            E+ +
Sbjct: 286 WEIFS 290

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 22/122 (18%)

Query: 24  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPP--------- 73
           EI  L   +HP+++ L        ++ L+++++   +LK  L  + +P            
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 74  AL--AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
            +  A+         L Y H+R IIHRD+K  NIL++++   K+ DFG+S+         
Sbjct: 145 CIGAAR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG--TELDQ 194

Query: 132 TH 133
           TH
Sbjct: 195 TH 196

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 56.8 bits (138), Expect = 6e-09
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 19/94 (20%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVV-TLWYRP 233
           L Y H+R IIHRD+K  NIL++++   K+ DFG+S+         TH    V  TL Y  
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG--TELDQTHLSTVVKGTLGYID 209

Query: 234 PEILLGAKVYSTT------VDIWSAGCIFSEMIT 261
           PE       Y          D++S G +  E++ 
Sbjct: 210 PE-------YFIKGRLTEKSDVYSFGVVLFEVLC 236

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 18/93 (19%)

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVV-TLWYRP 233
           + + H    IHRD+K  NIL++++   K++DFGL+RA        T     +V T  Y  
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQTVMTSRIVGTTAYMA 203

Query: 234 PEILLGAKVYST---TV--DIWSAGCIFSEMIT 261
           PE             T   DI+S G +  E+IT
Sbjct: 204 PE-------ALRGEITPKSDIYSFGVVLLEIIT 229

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 59.5 bits (145), Expect = 8e-10
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 38/156 (24%)

Query: 22  LREISVLKELKHPNVIRLH----DVIPVDFKLFLVFEFL-RQDLKDFL----QTTPVPVP 72
            +EI V+ + +H N++ L     D       L LV+ ++    L D L     T P+   
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 73  P----AL--AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
                A   A          + + H    IHRD+K  NIL++++   K++DFGL+RA   
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS-- 183

Query: 127 PMNRYTH---EVV-TLWYRPPEILLG---AK--VYS 153
                T     +V T  Y  PE L G    K  +YS
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYS 219

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 3/86 (3%)

Query: 50  FLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK 109
           F++ +    DL+   +                ++L+ L Y H    +H D+K  N+L+N 
Sbjct: 128 FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187

Query: 110 SGALK--LADFGLSRAFTIPMNRYTH 133
               +  L D+GL+  +  P   +  
Sbjct: 188 KNPDQVYLVDYGLAYRY-CPEGVHKA 212

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 3/54 (5%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALK--LADFGLSRAFTIPMNRYTH 224
           ++L+ L Y H    +H D+K  N+L+N     +  L D+GL+  +  P   +  
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-CPEGVHKA 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 4/113 (3%)

Query: 22  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
             E  + K ++    +  +           +V E L   L+D                  
Sbjct: 52  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 111

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 130
            Q++  + Y HS+  IHRD+KP N L+    K   + + DFGL++ +      
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 17/53 (32%), Positives = 28/53 (52%), Gaps = 3/53 (5%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 221
            Q++  + Y HS+  IHRD+KP N L+    K   + + DFGL++ +      
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 11/82 (13%)

Query: 50  FLVFEFLRQDLKDFLQTTPVPVPPA-----LAKSYLYQLLEALRYCHSRRIIHRDLKPQN 104
           FLV   L + L+  L  +P  V        +A     +LL+AL + H    +H ++  +N
Sbjct: 134 FLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC----RLLDALEFLHENEYVHGNVTAEN 189

Query: 105 ILINKSGALK--LADFGLSRAF 124
           I ++     +  LA +G +  +
Sbjct: 190 IFVDPEDQSQVTLAGYGFAFRY 211

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 11/45 (24%), Positives = 24/45 (53%), Gaps = 2/45 (4%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALK--LADFGLSRAF 215
           +LL+AL + H    +H ++  +NI ++     +  LA +G +  +
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 19/88 (21%)

Query: 50  FLVFEFLRQDLKDF--------LQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLK 101
           F+V E L  DL+            T        L      ++L+ L Y H    +H D+K
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQ-----LGI----RMLDVLEYIHENEYVHGDIK 178

Query: 102 PQNILINKSGALK--LADFGLSRAFTIP 127
             N+L+      +  LAD+GLS  +   
Sbjct: 179 AANLLLGYKNPDQVYLADYGLSYRYCPN 206

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 2/48 (4%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALK--LADFGLSRAFTIP 218
           ++L+ L Y H    +H D+K  N+L+      +  LAD+GLS  +   
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.6 bits (138), Expect = 8e-09
 Identities = 72/627 (11%), Positives = 168/627 (26%), Gaps = 206/627 (32%)

Query: 30  ELKHPNVIRLHDVIPV-------DFKLFLVFEFLRQ-----DLKDFLQTTPVPVPPALAK 77
           E ++       D++ V       +F    V +  +      ++   +         A++ 
Sbjct: 13  EHQYQY----KDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIM-----SKDAVSG 63

Query: 78  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
           +    L   L             K + +        K  +  L   +   M+    E   
Sbjct: 64  TLR--LFWTLL-----------SKQEEM------VQKFVEEVLRINYKFLMSPIKTE--- 101

Query: 138 LWYRPPEILLGAKVYSTTVD-IWSAGCIFSEMS-YLYQLLEALRYCHSRRIIHRDLKP-Q 194
              R P   +  ++Y    D +++   +F++ +    Q    LR           L+P +
Sbjct: 102 --QRQPS--MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE------LRPAK 151

Query: 195 NILIN------KS--GALKLADFGLSRAFTIPM------NRYTHEVV-----TLWYR--- 232
           N+LI+      K+         + +       +      N  + E V      L Y+   
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 233 ------------PPEI---------LLGAKVYSTTV----DIWSAGCI--FSEMITKKTL 265
                          I         LL +K Y   +    ++ +A     F+  ++ K L
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN--LSCKIL 269

Query: 266 F-AGDSEIDQLFRIFRTLGTPHEDVWPGVSK---LPIYKTDFPEWRPKKFSEILNLP--- 318
                 ++        T     +     ++      +      ++   +  +   LP   
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL----LLKYLDCRPQD---LPREV 322

Query: 319 ---DPLAVDVFSKIM-------------ALDPKQRVSAKTI------LQHEYFNQVEMVK 356
              +P  + + ++ +               D    +   ++         + F++     
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR----- 377

Query: 357 PTLAVFPELGYGGNGCKDFK-PWIAKLIKTQWQRSWDDIPN---NKLKRIKPKIEEWPSS 412
             L+VFP              P    L+   W            NKL +    +E+ P  
Sbjct: 378 --LSVFPP---------SAHIP--TILLSLIWFDVIKSDVMVVVNKLHK-YSLVEKQPKE 423

Query: 413 QRSTRMEEVVLTRLRIGHTRLTHKYLFTREPQPVCQCGETLSI--------QHI---LVC 461
              +     +  ++++ +    H+ +      P     + L           HI   L  
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483

Query: 462 PTHAH------------------IR---SSLPSPPSLSDDAVSIDVVTYHESITKKTLFA 500
             H                    IR   ++  +  S+ +      +  Y   I       
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL--QQLKFYKPYICDNDP-K 540

Query: 501 GDSEIDQLFRIFRTLGT-----PHEDV 522
            +  ++ +      +        + D+
Sbjct: 541 YERLVNAILDFLPKIEENLICSKYTDL 567

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 22/108 (20%), Positives = 45/108 (41%), Gaps = 4/108 (3%)

Query: 22  LREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
           L E  + + L+    +  +           LV + L   L+D        +         
Sbjct: 50  LYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFT 125
            Q++  + + HS+  +HRD+KP N L+    ++  + + DFGL++ + 
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 14/47 (29%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFT 216
           Q++  + + HS+  +HRD+KP N L+    ++  + + DFGL++ + 
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 36/157 (22%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPP------- 73
             E+ ++    H N++RL        +  LV+ ++    +   L+  P   PP       
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 74  --AL--AKSYLYQLLEALRYCH---SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 126
             AL  A+         L Y H     +IIHRD+K  NIL+++     + DFGL++    
Sbjct: 135 RIALGSAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD- 185

Query: 127 PMNRYTH---EVV-TLWYRPPEILLGAK------VYS 153
              + TH    V  T+ +  PE L   K      V+ 
Sbjct: 186 --YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 220

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 11/91 (12%)

Query: 178 LRYCH---SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVV-TLW 230
           L Y H     +IIHRD+K  NIL+++     + DFGL++       + TH    V  T+ 
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAVRGTIG 200

Query: 231 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIT 261
           +  PE L   K  S   D++  G +  E+IT
Sbjct: 201 HIAPEYLSTGKS-SEKTDVFGYGVMLLELIT 230

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 16/48 (33%), Positives = 28/48 (58%), Gaps = 5/48 (10%)

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILI-----NKSGALKLADFGLSRAF 124
           QL+  + Y HS+ +I+RD+KP+N LI          + + DF L++ +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 16/48 (33%), Positives = 28/48 (58%), Gaps = 5/48 (10%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILI-----NKSGALKLADFGLSRAF 215
           QL+  + Y HS+ +I+RD+KP+N LI          + + DF L++ +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 23/115 (20%), Positives = 43/115 (37%), Gaps = 12/115 (10%)

Query: 19  STALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAK 77
                E    K L     +  ++          LV + L   L+D L            K
Sbjct: 50  PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV---K 106

Query: 78  SYL---YQLLEALRYCHSRRIIHRDLKPQNILINKSGALK-----LADFGLSRAF 124
           +      Q+L  ++  H + +++RD+KP N LI +  +       + DFG+ + +
Sbjct: 107 TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 13/48 (27%), Positives = 27/48 (56%), Gaps = 5/48 (10%)

Query: 173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALK-----LADFGLSRAF 215
           Q+L  ++  H + +++RD+KP N LI +  +       + DFG+ + +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	562
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.9
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.86
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.86
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.84
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.84
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.83
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.8
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.79
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.77
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.77
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.76
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.76
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.76
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.75
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.75
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.75
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.74
3niz_A	311	Rhodanese family protein; structural genomics, str	99.74
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.73
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.72
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.72
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.72
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.72
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.72
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.7
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.7
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.69
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.68
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.68
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.68
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.67
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.66
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.65
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.63
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.63
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.58
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.58
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.57
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.57
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.56
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.56
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.55
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.55
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.55
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.54
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.54
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.54
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.54
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.54
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.54
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.54
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.51
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.51
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.51
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.5
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.5
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.5
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.5
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.49
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.48
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.47
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.47
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.46
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.45
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.43
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.42
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.41
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.4
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.4
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.39
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.39
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.39
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.39
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.38
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.36
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.36
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.36
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.35
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.32
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.3
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.3
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.3
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.3
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.3
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.3
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.3
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.29
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.29
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.29
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.28
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.27
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.2
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.2
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.16
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.13
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.09
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.08
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.08
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.06
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.03
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.02
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.02
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	98.99
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	98.99
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	98.98
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	98.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	98.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	98.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	98.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	98.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	98.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	98.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	98.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	98.95
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	98.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	98.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	98.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	98.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	98.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	98.94
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	98.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	98.93
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	98.92
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	98.92
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	98.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	98.92
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	98.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	98.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	98.91
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	98.91
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	98.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	98.91
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	98.91
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	98.91
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	98.91
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	98.9
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	98.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.9
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	98.9
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	98.89
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	98.89
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	98.89
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	98.89
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	98.89
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	98.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.88
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	98.88
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	98.88
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.88
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	98.88
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	98.88
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	98.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	98.87
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	98.87
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	98.87
3fme_A	290	Dual specificity mitogen-activated protein kinase;	98.87
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	98.86
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	98.86
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	98.86
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	98.86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	98.86
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	98.86
2a19_B	284	Interferon-induced, double-stranded RNA-activated	98.86
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	98.86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	98.85
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	98.85
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	98.85
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	98.85
3an0_A	340	Dual specificity mitogen-activated protein kinase;	98.85
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	98.85
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	98.84
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	98.84
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	98.84
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	98.83
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	98.83
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	98.83
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	98.83
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	98.82
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	98.82
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	98.82
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	98.82
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	98.81
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	98.81
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	98.81
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	98.81
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	98.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.8
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	98.78
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.78
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	98.78
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.77
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	98.77
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	98.77
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	98.77
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	98.77
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	98.76
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	98.76
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	98.76
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	98.75
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	98.75
3bhy_A	283	Death-associated protein kinase 3; death associate	98.74
3aln_A	327	Dual specificity mitogen-activated protein kinase;	98.74
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	98.74
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	98.74

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-52  Score=441.83  Aligned_cols=249  Identities=33%  Similarity=0.665  Sum_probs=210.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+++|+++|+.++|||||++++++...      +.+|||||||+++|.+++.+. +.+++..++.|++||+.||+|||
T Consensus        97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH  175 (398)
T 4b99_A           97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH  175 (398)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999998643      679999999999999999764 47999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++|||||||||+|||++.+|.+||+|||+|+.+......                                         
T Consensus       176 ~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~-----------------------------------------  214 (398)
T 4b99_A          176 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE-----------------------------------------  214 (398)
T ss_dssp             HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----------------------------------------------
T ss_pred             HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccc-----------------------------------------
Confidence            999999999999999999999999999998755311000                                         


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                    ......+.+||++|||||++.+...|+.++||||
T Consensus       215 ----------------------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWS  248 (398)
T 4b99_A          215 ----------------------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS  248 (398)
T ss_dssp             -----------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred             ----------------------------------------------cccccccceeChHhcCHHHhcCCCCCCChhheeh
Confidence                                                          0011235689999999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +|||+|||++|++||.+.+..+++..|+...|.++...+.......  .+...++...+..+..+++..++.++|||.+|
T Consensus       249 lG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m  328 (398)
T 4b99_A          249 VGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRM  328 (398)
T ss_dssp             HHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999999988776654322  22334556666677777888899999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++||++|+||+|+|+||||++...
T Consensus       329 L~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          329 LRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             SCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             CcCChhHCcCHHHHhcCHhhCcCCC
Confidence            9999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-51  Score=425.36  Aligned_cols=222  Identities=27%  Similarity=0.460  Sum_probs=189.3

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+.+|+++|+.++|||||+++++|++++.+|||||||++ +|.+++++.+ .++|..++.|+.||+.||+|||++|
T Consensus        74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~  152 (311)
T 4aw0_A           74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG  152 (311)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999985 9999997653 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.+|.+||+|||+|+.+.....                                             
T Consensus       153 IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~---------------------------------------------  187 (311)
T 4aw0_A          153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---------------------------------------------  187 (311)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT---------------------------------------------
T ss_pred             CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC---------------------------------------------
Confidence            99999999999999999999999999875431100                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .....+.+||+.|||||++.+.. |+.++||||+||
T Consensus       188 --------------------------------------------~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGv  222 (311)
T 4aw0_A          188 --------------------------------------------QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGC  222 (311)
T ss_dssp             --------------------------------------------CCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHH
T ss_pred             --------------------------------------------cccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHH
Confidence                                                        01123568999999999998755 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+.+|.+.--                  .+|           ...++.++|||.+||+.||
T Consensus       223 ilyeml~G~~PF~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~dli~~lL~~dp  273 (311)
T 4aw0_A          223 IIYQLVAGLPPFRAGNEGLIFAKIIKLEY------------------DFP-----------EKFFPKARDLVEKLLVLDA  273 (311)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHTCC------------------CCC-----------TTCCHHHHHHHHHHSCSSG
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------CCC-----------cccCHHHHHHHHHHccCCH
Confidence            99999999999999998888888865311                  011           1235789999999999999


Q ss_pred             CCCCCHHH------HHcCccccCCcccCC
Q psy10954        335 KQRVSAKT------ILQHEYFNQVEMVKP  357 (562)
Q Consensus       335 ~~R~Ta~e------lL~Hp~f~~~~~~~~  357 (562)
                      ++|+|++|      +++||||++++|...
T Consensus       274 ~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          274 TKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             GGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             hHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            99999987      689999999887553

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-50  Score=423.79  Aligned_cols=217  Identities=25%  Similarity=0.456  Sum_probs=184.7

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+++|+.++|||||+++++|.+++.+|||||||++ +|.+++.+.  .+++..++.|+.||+.||+|||++||
T Consensus       114 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~I  191 (346)
T 4fih_A          114 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGV  191 (346)
T ss_dssp             SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345688999999999999999999999999999999999985 999998763  59999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.+|.+||+|||+|+.+...                                                
T Consensus       192 iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------------------------------------------------  223 (346)
T 4fih_A          192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------------------------------------------------  223 (346)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECCSS------------------------------------------------
T ss_pred             ccccCCHHHEEECCCCCEEEecCcCceecCCC------------------------------------------------
Confidence            99999999999999999999999988654211                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .....+.+||++|||||++.+.. |+.++||||+||+
T Consensus       224 -------------------------------------------~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvi  259 (346)
T 4fih_A          224 -------------------------------------------VPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIM  259 (346)
T ss_dssp             -------------------------------------------SCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             -------------------------------------------CCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHH
Confidence                                                       01123468999999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+..|....... ..                         .....++.++|||.+||+.||+
T Consensus       260 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~-------------------------~~~~~s~~~~dli~~~L~~dP~  313 (346)
T 4fih_A          260 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LK-------------------------NLHKVSPSLKGFLDRLLVRDPA  313 (346)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CS-------------------------CGGGSCHHHHHHHHHHSCSSTT
T ss_pred             HHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-CC-------------------------ccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999888887776532110 00                         0112357899999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +|+|++|+|+||||++..
T Consensus       314 ~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          314 QRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             TSCCHHHHTTCGGGGGCC
T ss_pred             HCcCHHHHhcCHhhcCCC
Confidence            999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.5e-51  Score=413.14  Aligned_cols=214  Identities=30%  Similarity=0.553  Sum_probs=177.7

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+.+|+++|+.++|||||+++++|++++.+|||||||+++|.+++.+.+ .+++..++.+++||+.||+|||++||
T Consensus        55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~I  133 (275)
T 3hyh_A           55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKI  133 (275)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567889999999999999999999999999999999999999999998754 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+|+.....                                                
T Consensus       134 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~------------------------------------------------  165 (275)
T 3hyh_A          134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDG------------------------------------------------  165 (275)
T ss_dssp             CCCCCCTTTEEECTTCCEEECCSSCC------------------------------------------------------
T ss_pred             ccccCChHHeEECCCCCEEEeecCCCeecCCC------------------------------------------------
Confidence            99999999999999999999999998643210                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ....+.+||+.|||||++.+...++.++||||+||+
T Consensus       166 --------------------------------------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvi  201 (275)
T 3hyh_A          166 --------------------------------------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI  201 (275)
T ss_dssp             -----------------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHH
T ss_pred             --------------------------------------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHH
Confidence                                                        001235799999999999988767899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+..+.+..-.                  ++           ...++.++|||.+||+.||+
T Consensus       202 ly~lltg~~PF~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~~L~~dP~  252 (275)
T 3hyh_A          202 LYVMLCRRLPFDDESIPVLFKNISNGVYT------------------LP-----------KFLSPGAAGLIKRMLIVNPL  252 (275)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHTCCC------------------CC-----------TTSCHHHHHHHHHHSCSSGG
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHcCCCC------------------CC-----------CCCCHHHHHHHHHHccCChh
Confidence            99999999999998887777666542110                  01           12357899999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy10954        336 QRVSAKTILQHEYFNQ  351 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~  351 (562)
                      +|+|++|+|+||||+.
T Consensus       253 ~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          253 NRISIHEIMQDDWFKV  268 (275)
T ss_dssp             GSCCHHHHHHCHHHHT
T ss_pred             HCcCHHHHHcCccccc
Confidence            9999999999999973

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.6e-50  Score=419.28  Aligned_cols=214  Identities=27%  Similarity=0.484  Sum_probs=183.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++|+|||||+++++|++++.+|||||||+ ++|.++|...+ ..++|..++.|+.||+.||+|||++||
T Consensus        67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~I  146 (350)
T 4b9d_A           67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI  146 (350)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4568899999999999999999999999999999999997 49999997654 458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.+|.+||+|||+|+......                                               
T Consensus       147 iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-----------------------------------------------  179 (350)
T 4b9d_A          147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-----------------------------------------------  179 (350)
T ss_dssp             EETTCCGGGEEECTTCCEEECSTTEESCCCHHH-----------------------------------------------
T ss_pred             eeccCCHHHEEECCCCCEEEcccccceeecCCc-----------------------------------------------
Confidence            999999999999999999999999987542100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ....+.+||+.|||||++.+.. |+.++||||+||+
T Consensus       180 --------------------------------------------~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvi  214 (350)
T 4b9d_A          180 --------------------------------------------ELARACIGTPYYLSPEICENKP-YNNKSDIWALGCV  214 (350)
T ss_dssp             --------------------------------------------HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHH
Confidence                                                        0012357999999999998755 9999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+.+|.+.--.+                            .....++.++|||.+||+.||+
T Consensus       215 lyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~dP~  266 (350)
T 4b9d_A          215 LYELCTLKHAFEAGSMKNLVLKIISGSFPP----------------------------VSLHYSYDLRSLVSQLFKRNPR  266 (350)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHccCChh
Confidence            999999999999999988888887531110                            0012356899999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy10954        336 QRVSAKTILQHEYFNQ  351 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~  351 (562)
                      +|||++|+|+||||++
T Consensus       267 ~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          267 DRPSVNSILEKGFIAK  282 (350)
T ss_dssp             GSCCHHHHHTSHHHHT
T ss_pred             HCcCHHHHhcCHHhhc
Confidence            9999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.3e-49  Score=421.73  Aligned_cols=217  Identities=26%  Similarity=0.470  Sum_probs=185.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|+.++|||||+++++|.+++.+|||||||++ +|.+++...  .+++..++.|++||+.||+|||++||
T Consensus       191 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~I  268 (423)
T 4fie_A          191 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGV  268 (423)
T ss_dssp             SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345688999999999999999999999999999999999985 999998764  59999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.+|.+||+|||+|+.+....                                               
T Consensus       269 iHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-----------------------------------------------  301 (423)
T 4fie_A          269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-----------------------------------------------  301 (423)
T ss_dssp             ECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----------------------------------------------
T ss_pred             ecccCCHHHEEEcCCCCEEEecCccceECCCCC-----------------------------------------------
Confidence            999999999999999999999999986543110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ....+.+||++|||||++.+.. |+.++||||+||+
T Consensus       302 --------------------------------------------~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvi  336 (423)
T 4fie_A          302 --------------------------------------------PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIM  336 (423)
T ss_dssp             --------------------------------------------CCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHH
Confidence                                                        1123468999999999997655 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+..|..... +...                         .....++.++|||.+||+.||+
T Consensus       337 lyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~-------------------------~~~~~s~~~~dli~~~L~~dP~  390 (423)
T 4fie_A          337 VIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLK-------------------------NLHKVSPSLKGFLDRLLVRDPA  390 (423)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCS-------------------------CTTSSCHHHHHHHHHHSCSSTT
T ss_pred             HHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCc-------------------------ccccCCHHHHHHHHHHcCCChh
Confidence            9999999999999998888877765321 1100                         0122357899999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +|+||+|+|+||||++..
T Consensus       391 ~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          391 QRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             TSCCHHHHTTCGGGGGCC
T ss_pred             HCcCHHHHhcCHHhcCCC
Confidence            999999999999998643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-49  Score=418.11  Aligned_cols=271  Identities=22%  Similarity=0.344  Sum_probs=189.6

Q ss_pred             CchhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         16 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ....++.+|+++|+.+ +|||||+++++|++++++|||||||+ ++|.+++.    .+++..++.+++||+.||+|||++
T Consensus        61 ~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~  136 (361)
T 4f9c_A           61 SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF  136 (361)
T ss_dssp             SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456788999999998 69999999999999999999999997 59999884    489999999999999999999999


Q ss_pred             CceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         94 RIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      |||||||||+|||++.+ +.+||+|||+|+..........      .+...+.....                       
T Consensus       137 gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~------~~~~~~~~~~~-----------------------  187 (361)
T 4f9c_A          137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL------KFVQSEAQQER-----------------------  187 (361)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG------GGC-------------------------------
T ss_pred             CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc------ccccccccccc-----------------------
Confidence            99999999999999877 7999999999986542211100      00000000000                       


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                   ..-.-+.+..     .......+.+||++|||||++.+.+.|+.++||||+
T Consensus       188 -----------------------------~~~~~~~~~~-----~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl  233 (361)
T 4f9c_A          188 -----------------------------CSQNKCSICL-----SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA  233 (361)
T ss_dssp             ----------------------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             -----------------------------cccccccccc-----cccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence                                         0000000000     012234567999999999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCCCCCCCC-----------C---------CCCCccCCCCCCCcc--
Q psy10954        253 GCIFSEMITKKTLFA-GDSEIDQLFRIFRTLGTPHEDVWPGV-----------S---------KLPIYKTDFPEWRPK--  309 (562)
Q Consensus       253 G~il~eLltG~~pF~-~~~~~~~l~~i~~~lg~~~~~~~~~~-----------~---------~~~~~~~~~~~~~~~--  309 (562)
                      ||++|||++|++||. +.++.+++.+|...+|++....+...           .         .........+.....  
T Consensus       234 G~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~  313 (361)
T 4f9c_A          234 GVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQ  313 (361)
T ss_dssp             HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------
T ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccc
Confidence            999999999999984 56788999999998885432111000           0         000000001110000  


Q ss_pred             ---chhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        310 ---KFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       310 ---~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                         ...+.....++.++|||++||++||++|+||+|+|+||||++++
T Consensus       314 ~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          314 GHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence               00111234578899999999999999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.8e-49  Score=401.31  Aligned_cols=212  Identities=26%  Similarity=0.412  Sum_probs=173.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+++|++++|||||+++++|+.    +..+|||||||++ +|.+++.+. ..+++..++.++.||+.||+|||+
T Consensus        69 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~  147 (290)
T 3fpq_A           69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT  147 (290)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999975    3568999999985 999999764 369999999999999999999999


Q ss_pred             CC--ceeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         93 RR--IIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        93 ~g--IiHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      +|  ||||||||+|||++. +|.+||+|||+|+....                                           
T Consensus       148 ~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-------------------------------------------  184 (290)
T 3fpq_A          148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------------------------------------------  184 (290)
T ss_dssp             SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-------------------------------------------
T ss_pred             CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-------------------------------------------
Confidence            98  999999999999974 78899999998753210                                           


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                        ....+.+||+.|||||++.+  .|+.++||
T Consensus       185 --------------------------------------------------~~~~~~~GTp~YmAPE~~~~--~y~~~~Di  212 (290)
T 3fpq_A          185 --------------------------------------------------SFAKAVIGTPEFMAPEMYEE--KYDESVDV  212 (290)
T ss_dssp             --------------------------------------------------TSBEESCSSCCCCCGGGGGT--CCCTHHHH
T ss_pred             --------------------------------------------------CccCCcccCccccCHHHcCC--CCCcHHHH
Confidence                                                              01124579999999999865  49999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      ||+||++|||++|++||.+.+....+.+.+... ..+                      ..   .-...++.+.+||.+|
T Consensus       213 wSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~----------------------~~---~~~~~~~~~~~li~~~  266 (290)
T 3fpq_A          213 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP----------------------AS---FDKVAIPEVKEIIEGC  266 (290)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC----------------------GG---GGGCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCC----------------------CC---CCccCCHHHHHHHHHH
Confidence            999999999999999998876665555443211 000                      00   1122357899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccC
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      |+.||++|||++|+|+||||++
T Consensus       267 L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          267 IRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-49  Score=409.09  Aligned_cols=215  Identities=30%  Similarity=0.460  Sum_probs=179.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|++++|||||+++++|++++.+|||||||++ +|.+++.+.+ .+++..++.++.||+.||+|||++||||
T Consensus        71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiH  149 (304)
T 3ubd_A           71 VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIY  149 (304)
T ss_dssp             C------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence            3578999999999999999999999999999999999984 9999997654 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.+|.+||+|||+|+......                                                 
T Consensus       150 RDlKp~NILl~~~g~vKl~DFGla~~~~~~~-------------------------------------------------  180 (304)
T 3ubd_A          150 RDLKPENILLDEEGHIKLTDFGLSKESIDHE-------------------------------------------------  180 (304)
T ss_dssp             SSCCGGGEEECTTSCEEEESSEEEEC------------------------------------------------------
T ss_pred             CCCCHHHeEEcCCCCEEecccccceeccCCC-------------------------------------------------
Confidence            9999999999999999999999986432100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ....+.+||+.|||||++.+.. |+.++||||+||++|
T Consensus       181 ------------------------------------------~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvily  217 (304)
T 3ubd_A          181 ------------------------------------------KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMF  217 (304)
T ss_dssp             ------------------------------------------CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHH
T ss_pred             ------------------------------------------ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHH
Confidence                                                      0113458999999999998765 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|++||.+.+..+.+.+|.+..-.                  +|           ...++.++|||.+||+.||++|
T Consensus       218 emltG~~PF~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~~L~~dP~~R  268 (304)
T 3ubd_A          218 EMLTGTLPFQGKDRKETMTMILKAKLG------------------MP-----------QFLSPEAQSLLRMLFKRNPANR  268 (304)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred             HHHhCCCCCCCcCHHHHHHHHHcCCCC------------------CC-----------CcCCHHHHHHHHHHcccCHHHC
Confidence            999999999999998888888653110                  11           1235789999999999999999


Q ss_pred             CC-----HHHHHcCccccCCccc
Q psy10954        338 VS-----AKTILQHEYFNQVEMV  355 (562)
Q Consensus       338 ~T-----a~elL~Hp~f~~~~~~  355 (562)
                      +|     ++|+++||||+++++.
T Consensus       269 ~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          269 LGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             TTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCCcCCHHHHHcCccccCCCHH
Confidence            98     4799999999988653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.9e-48  Score=404.91  Aligned_cols=218  Identities=24%  Similarity=0.341  Sum_probs=178.6

Q ss_pred             HHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy10954         22 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL  100 (562)
Q Consensus        22 ~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDL  100 (562)
                      .+|+.+|+.++|||||+++++|++++.+|||||||++ +|.+++++.+ .+++..++.|+.||+.||+|||++|||||||
T Consensus        98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl  176 (336)
T 4g3f_A           98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDV  176 (336)
T ss_dssp             THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence            5899999999999999999999999999999999985 9999997653 6999999999999999999999999999999


Q ss_pred             CCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHH
Q psy10954        101 KPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALR  179 (562)
Q Consensus       101 KP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~  179 (562)
                      ||+|||++.+| .+||+|||+|+.+.......                                                
T Consensus       177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~~~------------------------------------------------  208 (336)
T 4g3f_A          177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGK------------------------------------------------  208 (336)
T ss_dssp             CGGGEEECTTSCCEEECCCTTCEEC-------------------------------------------------------
T ss_pred             CHHHEEEeCCCCEEEEeeCCCCeEccCCCccc------------------------------------------------
Confidence            99999999988 59999999987653210000                                                


Q ss_pred             hhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHH
Q psy10954        180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       180 yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eL  259 (562)
                                                            ........+||+.|||||++.+.. |+.++||||+||++|||
T Consensus       209 --------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyem  249 (336)
T 4g3f_A          209 --------------------------------------SLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHM  249 (336)
T ss_dssp             -------------------------------------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHH
T ss_pred             --------------------------------------ceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHH
Confidence                                                  000112357999999999998765 99999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCC
Q psy10954        260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS  339 (562)
Q Consensus       260 ltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~T  339 (562)
                      ++|++||.+.+..+.+.+|....  ++                        +.++.+..++.+.+||.+||+.||++|||
T Consensus       250 ltG~~Pf~~~~~~~~~~~i~~~~--~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s  303 (336)
T 4g3f_A          250 LNGCHPWTQYFRGPLCLKIASEP--PP------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRAS  303 (336)
T ss_dssp             HHSSCSSTTTCCSCCHHHHHHSC--CG------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHCcCCCCCCCHHHHHHHHHcCC--CC------------------------chhcCccCCHHHHHHHHHHccCCHhHCcC
Confidence            99999999887766666665421  10                        00111234678999999999999999999


Q ss_pred             HHHH-------------HcCccccCCc
Q psy10954        340 AKTI-------------LQHEYFNQVE  353 (562)
Q Consensus       340 a~el-------------L~Hp~f~~~~  353 (562)
                      +.|+             |+|||+.+..
T Consensus       304 a~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          304 AMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            9997             5799998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-46  Score=387.36  Aligned_cols=228  Identities=26%  Similarity=0.455  Sum_probs=163.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC------------EEEEEeecCcC-CHHHHHhhCCC--CCCHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF------------KLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQ   82 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~------------~i~lV~Ey~~~-~L~~~i~~~~~--~l~e~~i~~i~~q   82 (562)
                      ...+.+|+++|++++|||||+++++|...+            .+|||||||.+ +|.+++.....  ..++..++.++.|
T Consensus        47 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~q  126 (299)
T 4g31_A           47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ  126 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHH
Confidence            356889999999999999999999997543            47999999975 99999986542  2456678999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         83 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        83 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      |+.||+|||++|||||||||+|||++.+|.+||+|||+|+.........+..       .+                   
T Consensus       127 i~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~-------~~-------------------  180 (299)
T 4g31_A          127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL-------TP-------------------  180 (299)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-----------------------------------------
T ss_pred             HHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccc-------cc-------------------
Confidence            9999999999999999999999999999999999999998664221100000       00                   


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                           .......++.+||+.|||||++.+.. 
T Consensus       181 -----------------------------------------------------~~~~~~~~~~~GT~~YmAPE~~~~~~-  206 (299)
T 4g31_A          181 -----------------------------------------------------MPAYARHTGQVGTKLYMSPEQIHGNS-  206 (299)
T ss_dssp             ----------------------------------------------------------------CCCTTSCHHHHTTCC-
T ss_pred             -----------------------------------------------------cccccccCCcccCccccCHHHHcCCC-
Confidence                                                                 00011234568999999999998754 


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      |+.++||||+||++|||++   ||.+..+  ....+......                 .+|.        .+....+.+
T Consensus       207 y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~~~~~~~~-----------------~~p~--------~~~~~~~~~  256 (299)
T 4g31_A          207 YSHKVDIFSLGLILFELLY---PFSTQME--RVRTLTDVRNL-----------------KFPP--------LFTQKYPCE  256 (299)
T ss_dssp             CCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHHHHHHHTT-----------------CCCH--------HHHHHCHHH
T ss_pred             CCCHHHHHHHHHHHHHHcc---CCCCccH--HHHHHHHHhcC-----------------CCCC--------CCcccCHHH
Confidence            9999999999999999995   7865432  22222221110                 0110        111224567


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      .+||.+||+.||++|||+.|+|+||||+++++.
T Consensus       257 ~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          257 YVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            899999999999999999999999999987643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.5e-46  Score=413.03  Aligned_cols=220  Identities=23%  Similarity=0.385  Sum_probs=187.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++|||||+|+++|+++..+|||||||.+ +|.+++....+.+++..++.|++||+.||+|||++||+
T Consensus       198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  277 (573)
T 3uto_A          198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV  277 (573)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35678999999999999999999999999999999999975 99999977666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccC--CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILINKS--GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl~~~--~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||+|||++.+  +.+||+|||+|+.+...                                               
T Consensus       278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-----------------------------------------------  310 (573)
T 3uto_A          278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-----------------------------------------------  310 (573)
T ss_dssp             CCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-----------------------------------------------
T ss_pred             eccCChhhccccCCCCCCEEEeeccceeEccCC-----------------------------------------------
Confidence            99999999999854  78888888887644210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ....+.+||+.|||||++.+.. |+.++||||+||
T Consensus       311 ---------------------------------------------~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGv  344 (573)
T 3uto_A          311 ---------------------------------------------QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGV  344 (573)
T ss_dssp             ---------------------------------------------SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHH
T ss_pred             ---------------------------------------------CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHH
Confidence                                                         0112457999999999998765 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..|......++..                         .....++.++|||.+||+.||
T Consensus       345 ilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~dli~~~L~~dp  399 (573)
T 3uto_A          345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------------------------AFSGISEDGKDFIRKLLLADP  399 (573)
T ss_dssp             HHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG-------------------------GGTTSCHHHHHHHHTTSCSSG
T ss_pred             HHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHccCCh
Confidence            9999999999999999988888886543222211                         122345789999999999999


Q ss_pred             CCCCCHHHHHcCccccCCccc
Q psy10954        335 KQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ++|+|++|+|+||||+.....
T Consensus       400 ~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          400 NTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             GGSCCHHHHHHSTTTSCCCCT
T ss_pred             hHCcCHHHHhcCcCcCCCCCC
Confidence            999999999999999976543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-44  Score=363.92  Aligned_cols=246  Identities=54%  Similarity=0.990  Sum_probs=211.4

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+.+|+++|+.++||||+++++++...+.+|+||||++++|.+++......+++..++.++.|++.||.|||++||
T Consensus        42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (288)
T 1ob3_A           42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV  121 (288)
T ss_dssp             CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999998776789999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++....+.                                               
T Consensus       122 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------------  154 (288)
T 1ob3_A          122 LHRDLKPQNLLINREGELKIADFGLARAFGIPV-----------------------------------------------  154 (288)
T ss_dssp             CCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------------------------------------------------
T ss_pred             ecCCCCHHHEEEcCCCCEEEeECccccccCccc-----------------------------------------------
Confidence            999999999999999999999999875432110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+...|+.++||||+||+
T Consensus       155 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  190 (288)
T 1ob3_A          155 --------------------------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI  190 (288)
T ss_dssp             ---------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             --------------------------------------------cccccccccccccCchheeCCCCCCcHHHHHHHHHH
Confidence                                                        001223679999999999877779999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+..+.+.++.+....|+.....+.+...+....+..+.......++.+.+||.+||+.||+
T Consensus       191 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  270 (288)
T 1ob3_A          191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN  270 (288)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcc
Confidence            99999999999999999999999999999998888877766666555555555555556666788999999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy10954        336 QRVSAKTILQHEYFNQV  352 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~  352 (562)
                      +|||++|+|+||||++.
T Consensus       271 ~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          271 QRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TSCCHHHHHTSGGGGC-
T ss_pred             cCCCHHHHhcCcchhhc
Confidence            99999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.4e-45  Score=410.07  Aligned_cols=209  Identities=21%  Similarity=0.370  Sum_probs=173.5

Q ss_pred             HHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy10954         24 EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKP  102 (562)
Q Consensus        24 Ei~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP  102 (562)
                      ++.+++.++|||||+++++|++.+.+|||||||.+ +|.++|.+. +.++|..++.|+.||+.||+|||++|||||||||
T Consensus       242 ~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP  320 (689)
T 3v5w_A          242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  320 (689)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred             HHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence            36677788999999999999999999999999974 999999765 3699999999999999999999999999999999


Q ss_pred             CcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhh
Q psy10954        103 QNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH  182 (562)
Q Consensus       103 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLH  182 (562)
                      +|||++.+|++||+|||+|+.+...                                                       
T Consensus       321 eNILld~~G~vKL~DFGlA~~~~~~-------------------------------------------------------  345 (689)
T 3v5w_A          321 ANILLDEHGHVRISDLGLACDFSKK-------------------------------------------------------  345 (689)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSC-------------------------------------------------------
T ss_pred             HHeEEeCCCCEEecccceeeecCCC-------------------------------------------------------
Confidence            9999999999999999998643210                                                       


Q ss_pred             cCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhC
Q psy10954        183 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK  262 (562)
Q Consensus       183 s~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG  262 (562)
                                                            ...+.|||+.|||||++.+...|+.++||||+||++|||++|
T Consensus       346 --------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG  387 (689)
T 3v5w_A          346 --------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG  387 (689)
T ss_dssp             --------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             --------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence                                                  012458999999999998666799999999999999999999


Q ss_pred             CCCCCCCCH---HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCC
Q psy10954        263 KTLFAGDSE---IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS  339 (562)
Q Consensus       263 ~~pF~~~~~---~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~T  339 (562)
                      ++||.+.+.   .+....+...  .  .              .+|           ...++.++|||.+||+.||++|+|
T Consensus       388 ~~PF~~~~~~~~~~i~~~i~~~--~--~--------------~~p-----------~~~S~~a~dLI~~lL~~dP~~Rl~  438 (689)
T 3v5w_A          388 HSPFRQHKTKDKHEIDRMTLTM--A--V--------------ELP-----------DSFSPELRSLLEGLLQRDVNRRLG  438 (689)
T ss_dssp             SCTTCGGGCCCHHHHHHHHHHC--C--C--------------CCC-----------TTSCHHHHHHHHHHTCSCGGGCTT
T ss_pred             CCCCCCCChHHHHHHHHhhcCC--C--C--------------CCC-----------ccCCHHHHHHHHHHccCCHhHCCC
Confidence            999986532   2222223221  0  0              000           123578999999999999999998


Q ss_pred             -----HHHHHcCccccCCccc
Q psy10954        340 -----AKTILQHEYFNQVEMV  355 (562)
Q Consensus       340 -----a~elL~Hp~f~~~~~~  355 (562)
                           |+|+++||||++++|.
T Consensus       439 ~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          439 CLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             CSSSTHHHHTTSGGGTTCCHH
T ss_pred             CCCCCHHHHhcCccccCCCHH
Confidence                 7999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=372.75  Aligned_cols=215  Identities=18%  Similarity=0.260  Sum_probs=171.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+.+|+++|++++|||||++++++. ++.+|||||||+ ++|.+++......+++..+..++.|++.||+|||+++||
T Consensus        76 ~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~Ii  154 (307)
T 3omv_A           76 FQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNII  154 (307)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            356789999999999999999999875 457899999998 599999988777899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.......                                               
T Consensus       155 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-----------------------------------------------  187 (307)
T 3omv_A          155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-----------------------------------------------  187 (307)
T ss_dssp             CSCCCSSSEEEETTEEEEECCCSSCBC-----------------------------------------------------
T ss_pred             CCccCHHHEEECCCCcEEEeeccCceecccCCc-----------------------------------------------
Confidence            999999999999999999999999875421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGC  254 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIWSlG~  254 (562)
                                                                .....+.+||+.|||||++.+.  ..|+.++||||+||
T Consensus       188 ------------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv  225 (307)
T 3omv_A          188 ------------------------------------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI  225 (307)
T ss_dssp             ------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred             ------------------------------------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence                                                      0011245799999999999753  35899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.+....+..++.....++.                       ........++.+.+|+.+||+.||
T Consensus       226 vl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li~~cl~~dP  282 (307)
T 3omv_A          226 VLYELMTGELPYSHINNRDQIIFMVGRGYASPD-----------------------LSKLYKNCPKAMKRLVADCVKKVK  282 (307)
T ss_dssp             HHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----------------------STTSCTTSCHHHHHHHHHHTCSSS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----------------------cccccccchHHHHHHHHHHcCCCH
Confidence            999999999999988776666655442111100                       000112235678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.|+++
T Consensus       283 ~~RPs~~ei~~  293 (307)
T 3omv_A          283 EERPLFPQILS  293 (307)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.2e-44  Score=367.77  Aligned_cols=247  Identities=53%  Similarity=0.936  Sum_probs=209.3

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+.+|+++|+.++||||+++++++..+..+|+|||||+++|.+++......+++..++.++.|++.||.|||++||
T Consensus        61 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  140 (311)
T 3niz_A           61 GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI  140 (311)
T ss_dssp             CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34467889999999999999999999999999999999999999999998877779999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++....+.                                               
T Consensus       141 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------------  173 (311)
T 3niz_A          141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPV-----------------------------------------------  173 (311)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-----------------------------------------------
T ss_pred             ccCCCchHhEEECCCCCEEEccCcCceecCCCc-----------------------------------------------
Confidence            999999999999999999999999876432110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+...|+.++||||+||+
T Consensus       174 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  209 (311)
T 3niz_A          174 --------------------------------------------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCI  209 (311)
T ss_dssp             --------------------------------------------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHH
Confidence                                                        011234679999999999887779999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++|++||.+.+..+.+..+...+|.+....|+.....+.+.. .+.......+....+..++.+.|||.+||++||
T Consensus       210 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  289 (311)
T 3niz_A          210 FAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP  289 (311)
T ss_dssp             HHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCT
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999999998888876655443322 122223334445556667899999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++|||++|+|+||||++++
T Consensus       290 ~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          290 NKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSCCHHHHHTSGGGTTSC
T ss_pred             hHCCCHHHHhcCcccccCC
Confidence            9999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-43  Score=358.63  Aligned_cols=245  Identities=52%  Similarity=0.914  Sum_probs=205.0

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+.+|+.+|++++||||+++++++..++.+|+|||||+++|.+.+......+++..++.++.|++.||+|||++||+
T Consensus        44 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~iv  123 (292)
T 3o0g_A           44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL  123 (292)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             cchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34678899999999999999999999999999999999999999988887677899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++....+                                                 
T Consensus       124 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------------  154 (292)
T 3o0g_A          124 HRDLKPQNLLINRNGELKLANFGLARAFGIP-------------------------------------------------  154 (292)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCSC-------------------------------------------------
T ss_pred             cCCCCHHHEEEcCCCCEEEeecccceecCCc-------------------------------------------------
Confidence            9999999999999999999999987643211                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .......+||+.|+|||++.+...|+.++||||+||++
T Consensus       155 ------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  192 (292)
T 3o0g_A          155 ------------------------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF  192 (292)
T ss_dssp             ------------------------------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             ------------------------------------------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHH
Confidence                                                      00112346799999999998877789999999999999


Q ss_pred             HHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMITKKTL-FAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLltG~~p-F~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++|..| |.+.+..+.+..+.+..+.+....|+.....+.+................+..++.+.+||.+||+.||+
T Consensus       193 ~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  272 (292)
T 3o0g_A          193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV  272 (292)
T ss_dssp             HHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChh
Confidence            999987666 6777888899999999999999988877665544322111112222333445678899999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy10954        336 QRVSAKTILQHEYFNQV  352 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~  352 (562)
                      +|||++|+|+||||+++
T Consensus       273 ~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          273 QRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GSCCHHHHHTSGGGTTC
T ss_pred             hCCCHHHHhcCcccccC
Confidence            99999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-43  Score=364.19  Aligned_cols=248  Identities=49%  Similarity=0.899  Sum_probs=208.4

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-----VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-----~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ....+.+|+++|+.++||||+++++++..++.+|+|||||+++|.+++....     ..+++..++.++.|++.||.|||
T Consensus        46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH  125 (317)
T 2pmi_A           46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH  125 (317)
T ss_dssp             SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4467889999999999999999999999999999999999999999886532     35899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++....+.                                           
T Consensus       126 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------  162 (317)
T 2pmi_A          126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-------------------------------------------  162 (317)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-------------------------------------------
T ss_pred             HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-------------------------------------------
Confidence            9999999999999999999999999999876432110                                           


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+...|+.++||||
T Consensus       163 ------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  194 (317)
T 2pmi_A          163 ------------------------------------------------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWS  194 (317)
T ss_dssp             ------------------------------------------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred             ------------------------------------------------ccCCCCcccccccCchHhhCCCCCCcHHHHHH
Confidence                                                            01123467999999999987767999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhc-----CCCCHHHHHHH
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL-----NLPDPLAVDVF  326 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~~~~~~~~dLi  326 (562)
                      +||++|||++|++||.+.+..+.+..+.+..|.+....|+.....+.+....+...+..+...+     ...++.+.|||
T Consensus       195 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  274 (317)
T 2pmi_A          195 CGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFL  274 (317)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHH
Confidence            9999999999999999999999999999999999999998877666555444333333222222     23577899999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      .+||+.||++|||++|+|+||||++....
T Consensus       275 ~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          275 HGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             HHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            99999999999999999999999986543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-44  Score=370.78  Aligned_cols=216  Identities=23%  Similarity=0.363  Sum_probs=178.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC------------CCCCHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP------------VPVPPALAKSYLYQLL   84 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~------------~~l~e~~i~~i~~qll   84 (562)
                      .+.+.+|+++|++++|||||++++++.+++.+|||||||+ ++|.++++..+            ..+++..+..++.|++
T Consensus        59 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia  138 (299)
T 4asz_A           59 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA  138 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHH
Confidence            4568899999999999999999999999999999999997 59999997642            3699999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      .||+|||+++||||||||+|||++.++.+||+|||+|+........                                  
T Consensus       139 ~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~----------------------------------  184 (299)
T 4asz_A          139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY----------------------------------  184 (299)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCE----------------------------------
T ss_pred             HHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCce----------------------------------
Confidence            9999999999999999999999999999999999998754211000                                  


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                                             ......+||+.|||||++.+.. |+
T Consensus       185 -------------------------------------------------------~~~~~~~gt~~ymAPE~~~~~~-~~  208 (299)
T 4asz_A          185 -------------------------------------------------------RVGGHTMLPIRWMPPESIMYRK-FT  208 (299)
T ss_dssp             -------------------------------------------------------EETTTEEECGGGCCHHHHHHCC-CC
T ss_pred             -------------------------------------------------------eecCceecChhhcCHHHHcCCC-CC
Confidence                                                                   0011246899999999998765 99


Q ss_pred             chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        245 TTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       245 ~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      .++||||+||++|||++ |+.||.+.+..+.+..+.+..-.+                 .|           ...++.+.
T Consensus       209 ~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------~p-----------~~~~~~~~  260 (299)
T 4asz_A          209 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ-----------------RP-----------RTCPQEVY  260 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC-----------------CC-----------TTCCHHHH
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-----------------CC-----------ccchHHHH
Confidence            99999999999999998 899999998887777765421100                 00           12346789


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +|+.+||+.||++|||++|+  |+|++++.
T Consensus       261 ~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          261 ELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            99999999999999999999  56776543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-43  Score=382.80  Aligned_cols=274  Identities=33%  Similarity=0.630  Sum_probs=200.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..++.+|+++|++++|||||++++++...     ..+|+||||++++|.+++... ..+++..++.+++||+.||+|||+
T Consensus        96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~  174 (458)
T 3rp9_A           96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS  174 (458)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            35678999999999999999999998543     579999999999999999764 469999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|||||||||+|||++.++.+||+|||+|+....+......     ....|                             
T Consensus       175 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-----~~~~~-----------------------------  220 (458)
T 3rp9_A          175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ-----LPISP-----------------------------  220 (458)
T ss_dssp             TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCC-----CC--------------------------------
T ss_pred             CCcCCCCCChhhEEECCCCCEeecccccchhccCccccccc-----cccCc-----------------------------
Confidence            99999999999999999999999999999866432111000     00000                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                 ......+.+|+.....   .......+||++|+|||++.+...|+.++||||+
T Consensus       221 ---------------------------~~~~~~~~~~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          221 ---------------------------REDDMNLVTFPHTKNL---KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             ------------------------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             ---------------------------cccccccccccccccc---cccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence                                       0111233344332211   1234567899999999998777779999999999


Q ss_pred             HHHHHHHHh-----------CCCCCCCCC--------------------HHHHHHHHHHhcCCCCCCCCCCCCCC--CCc
Q psy10954        253 GCIFSEMIT-----------KKTLFAGDS--------------------EIDQLFRIFRTLGTPHEDVWPGVSKL--PIY  299 (562)
Q Consensus       253 G~il~eLlt-----------G~~pF~~~~--------------------~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~  299 (562)
                      ||++|||++           |+++|.|.+                    ..+++..|++.+|.+..+.+......  ..+
T Consensus       271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  350 (458)
T 3rp9_A          271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY  350 (458)
T ss_dssp             HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHH
T ss_pred             HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHH
Confidence            999999998           788887765                    36788899999999887655443321  112


Q ss_pred             cCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcccC
Q psy10954        300 KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       300 ~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      ...++......+...++..++.+.|||.+||++||++|+|++|+|+||||+++.+..
T Consensus       351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            222333334445556666789999999999999999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-43  Score=365.76  Aligned_cols=246  Identities=51%  Similarity=0.995  Sum_probs=204.0

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+.+|+++|+.++||||+++++++..+..+|+|||||+++|.+++.... .+++..++.++.||+.||+|||++||+
T Consensus        76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~iv  154 (329)
T 3gbz_A           76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCL  154 (329)
T ss_dssp             ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3455679999999999999999999999999999999999999999998754 599999999999999999999999999


Q ss_pred             eccCCCCcEEEccC-----CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         97 HRDLKPQNILINKS-----GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        97 HRDLKP~NILl~~~-----~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ||||||+|||++.+     +.+||+|||+++...                                              
T Consensus       155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~----------------------------------------------  188 (329)
T 3gbz_A          155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----------------------------------------------  188 (329)
T ss_dssp             CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----------------------------------------------
T ss_pred             CCCCCHHHEEEecCCCCccceEEECcCCCccccC----------------------------------------------
Confidence            99999999999543     347777777664332                                              


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                   .........+||+.|+|||++.+...|+.++||||
T Consensus       189 ---------------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  223 (329)
T 3gbz_A          189 ---------------------------------------------IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWS  223 (329)
T ss_dssp             --------------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred             ---------------------------------------------CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHH
Confidence                                                         11112233467999999999988777999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC-CCHHHHHHHHHcc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLAVDVFSKIM  330 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~dLi~~mL  330 (562)
                      +||++|||++|++||.+.+..+.+..+.+.++.+....|+.....+.+...++......+...+.. .++.+.+||.+||
T Consensus       224 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  303 (329)
T 3gbz_A          224 IACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML  303 (329)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHc
Confidence            999999999999999999999999999999999999999888777777766766665555444433 5788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCcc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      +.||++|||++|+|+||||++.++
T Consensus       304 ~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          304 EMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             cCChhhCCCHHHHhCCcccCCCCC
Confidence            999999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=367.21  Aligned_cols=211  Identities=25%  Similarity=0.382  Sum_probs=171.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC--------------CCCCHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP--------------VPVPPALAKSYLYQ   82 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~--------------~~l~e~~i~~i~~q   82 (562)
                      .+.+.+|+++|++++|||||++++++.++..+|||||||+ ++|.++++...              .++++.++..++.|
T Consensus        87 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  166 (329)
T 4aoj_A           87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ  166 (329)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHH
Confidence            3568899999999999999999999999999999999998 59999997642              35899999999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         83 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        83 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      ++.||+|||+++||||||||+|||++.++.+||+|||+|+.......                                 
T Consensus       167 ia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~---------------------------------  213 (329)
T 4aoj_A          167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---------------------------------  213 (329)
T ss_dssp             HHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------------------------------------
T ss_pred             HHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCc---------------------------------
Confidence            99999999999999999999999999999999999999875421100                                 


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                              .......+||+.|||||++.+.. 
T Consensus       214 --------------------------------------------------------~~~~~~~~gt~~ymAPE~~~~~~-  236 (329)
T 4aoj_A          214 --------------------------------------------------------YRVGGRTMLPIRWMPPESILYRK-  236 (329)
T ss_dssp             --------------------------------------------------------------CCCCGGGCCHHHHTTCC-
T ss_pred             --------------------------------------------------------ceecCcccccccccChhhhcCCC-
Confidence                                                                    00012347899999999998765 


Q ss_pred             CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHH
Q psy10954        243 YSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPL  321 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  321 (562)
                      |+.++||||+||++|||++ |+.||.+.+..+.+..+.+....+                 .|           ...++.
T Consensus       237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~-----------------~p-----------~~~~~~  288 (329)
T 4aoj_A          237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE-----------------RP-----------RACPPE  288 (329)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCC-----------------CC-----------TTCCHH
T ss_pred             CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-----------------Cc-----------ccccHH
Confidence            8999999999999999998 899999998887777765431110                 00           123467


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+|+.+||+.||++|||++|++++
T Consensus       289 ~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          289 VYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.8e-43  Score=361.19  Aligned_cols=212  Identities=23%  Similarity=0.340  Sum_probs=175.7

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHH
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYL   80 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~   80 (562)
                      ..+.+.+|+.+|++++|||||++++++..++.+|||||||+ |+|.+++....               ..+++..+..++
T Consensus        72 ~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  151 (308)
T 4gt4_A           72 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV  151 (308)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHH
Confidence            34678899999999999999999999999999999999997 59999996532               358999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .||+.||+|||+++||||||||+||||+.++.+||+|||+|+.......                               
T Consensus       152 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~-------------------------------  200 (308)
T 4gt4_A          152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-------------------------------  200 (308)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGC-------------------------------
T ss_pred             HHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCc-------------------------------
Confidence            9999999999999999999999999999999999999999875431100                               


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                .......+||+.|||||++.+.
T Consensus       201 ----------------------------------------------------------~~~~~~~~gt~~ymAPE~l~~~  222 (308)
T 4gt4_A          201 ----------------------------------------------------------YKLLGNSLLPIRWMAPEAIMYG  222 (308)
T ss_dssp             ----------------------------------------------------------BCSSSSSCBCGGGCCHHHHHHC
T ss_pred             ----------------------------------------------------------eeEecccccCCcccCHHHHhCC
Confidence                                                                      0011234789999999999876


Q ss_pred             CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCC
Q psy10954        241 KVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD  319 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (562)
                      . |+.++||||+||++|||++ |+.||.+.+..+.+..+.+....+.                            ....+
T Consensus       223 ~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------p~~~~  273 (308)
T 4gt4_A          223 K-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC----------------------------PDDCP  273 (308)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTCC
T ss_pred             C-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------cccch
Confidence            5 9999999999999999998 8999999988777666643211100                            01234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+.+|+.+||+.||++|||+.|++++
T Consensus       274 ~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          274 AWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            678999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=360.45  Aligned_cols=244  Identities=45%  Similarity=0.854  Sum_probs=203.4

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      .+.+|+++|+.++||||+++++++..+...|+||||++++|.+++......+++..++.++.|++.||.|||++||+|||
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D  125 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD  125 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence            45589999999999999999999999999999999999999999988777799999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHH
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALR  179 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~  179 (562)
                      |||+|||++.++.+||+|||+++....+.                                                   
T Consensus       126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---------------------------------------------------  154 (324)
T 3mtl_A          126 LKPQNLLINERGELKLADFGLARAKSIPT---------------------------------------------------  154 (324)
T ss_dssp             CCGGGEEECTTCCEEECSSSEEECC-------------------------------------------------------
T ss_pred             cCHHHEEECCCCCEEEccCcccccccCCc---------------------------------------------------
Confidence            99999999999999999999875432110                                                   


Q ss_pred             hhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHH
Q psy10954        180 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  259 (562)
Q Consensus       180 yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eL  259 (562)
                                                              ......+||+.|+|||++.+...|+.++||||+||++|+|
T Consensus       155 ----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  194 (324)
T 3mtl_A          155 ----------------------------------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM  194 (324)
T ss_dssp             ------------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHH
Confidence                                                    0012246799999999998877799999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCc-cCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        260 ITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       260 ltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      ++|++||.+.+..+++..+.+.+|.+....|+.......+ ...++..............++.+.+||.+||++||++||
T Consensus       195 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  274 (324)
T 3mtl_A          195 ATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI  274 (324)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence            9999999999999999999999999999888765433211 122333333333344455678999999999999999999


Q ss_pred             CHHHHHcCccccCCcc
Q psy10954        339 SAKTILQHEYFNQVEM  354 (562)
Q Consensus       339 Ta~elL~Hp~f~~~~~  354 (562)
                      |++|+|+||||.++..
T Consensus       275 t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          275 SAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CHHHHTTSGGGGGGCS
T ss_pred             CHHHHhcChhhhhccc
Confidence            9999999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-42  Score=357.70  Aligned_cols=249  Identities=41%  Similarity=0.789  Sum_probs=210.6

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ....+.+|+++|+.++||||+++++++.....+|+||||++++|.+++......+++..++.++.|++.||+|||++||+
T Consensus        55 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  134 (346)
T 1ua2_A           55 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL  134 (346)
T ss_dssp             -CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            34567899999999999999999999999999999999999999999987766799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------------------------------------------------  166 (346)
T 1ua2_A          135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------------------------------------------------  166 (346)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------------------------------------------------
T ss_pred             CCCCCHHHEEEcCCCCEEEEecccceeccCCc------------------------------------------------
Confidence            99999999999999999999999876442110                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+...|+.++||||+||++
T Consensus       167 -------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  203 (346)
T 1ua2_A          167 -------------------------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL  203 (346)
T ss_dssp             -------------------------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHH
Confidence                                                       0112346799999999998777799999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+..+.+.++++..|.+....|+.....+.+.. +...............++.+.+||.+||+.||++
T Consensus       204 ~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  282 (346)
T 1ua2_A          204 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA  282 (346)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC-CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTT
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc-ccccCCCChHHhhccCCHHHHHHHHHHhccChhh
Confidence            999999999999999999999999999999988887766544321 1222222344455666789999999999999999


Q ss_pred             CCCHHHHHcCccccCCcccCC
Q psy10954        337 RVSAKTILQHEYFNQVEMVKP  357 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~~~~~  357 (562)
                      |||++|+|+||||++.....+
T Consensus       283 Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          283 RITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             SCCHHHHHTSGGGTSSSCCCC
T ss_pred             CCCHHHHhcChhhhcCCCCCC
Confidence            999999999999998664443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=347.24  Aligned_cols=242  Identities=43%  Similarity=0.794  Sum_probs=201.1

Q ss_pred             chhhHHHHHHHHHccC---CCCcceEEEEEEeCC-----EEEEEeecCcCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELK---HPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~---HpnIv~L~~~~~~~~-----~i~lV~Ey~~~~L~~~i~~~~~-~l~e~~i~~i~~qll~aL   87 (562)
                      ......+|+++++.++   ||||+++++++....     .+|+||||++++|.+++..... .+++..++.++.|++.||
T Consensus        54 ~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al  133 (308)
T 3g33_A           54 LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL  133 (308)
T ss_dssp             CCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHH
Confidence            3457789999988775   999999999998765     5899999999999999987553 399999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      +|||++||+||||||+|||++.++.+||+|||+++.....                                        
T Consensus       134 ~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----------------------------------------  173 (308)
T 3g33_A          134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----------------------------------------  173 (308)
T ss_dssp             HHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC----------------------------------------
T ss_pred             HHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC----------------------------------------
Confidence            9999999999999999999999999999999987543210                                        


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                          ......+||+.|+|||++.+.. |+.++
T Consensus       174 ----------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~  200 (308)
T 3g33_A          174 ----------------------------------------------------MALTPVVVTLWYRAPEVLLQST-YATPV  200 (308)
T ss_dssp             ----------------------------------------------------CCSGGGGCCCSSCCHHHHHTSC-CCSTH
T ss_pred             ----------------------------------------------------cccCCccccccccCchHHcCCC-CCchH
Confidence                                                                0012346899999999998765 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      ||||+||++|+|++|++||.+.+..+.+.++.+.++.++...|+.....+.  ..++...+.......+..++.+.+||.
T Consensus       201 DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~  278 (308)
T 3g33_A          201 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR--GAFPPRGPRPVQSVVPEMEESGAQLLL  278 (308)
T ss_dssp             HHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG--GGSCCCCCCCHHHHSCSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc--cccCCCCCCcHHHhCccccHHHHHHHH
Confidence            999999999999999999999999999999999999999888876544332  223333344455566667889999999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCCc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||++||++|||+.|+|+||||++.+
T Consensus       279 ~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          279 EMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             HHhcCCCccCCCHHHHhcCccccCCC
Confidence            99999999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5e-42  Score=368.90  Aligned_cols=269  Identities=35%  Similarity=0.594  Sum_probs=202.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..++.+|+++|++++||||+++++++...     ..+|+||||++++|.+++... ..+++..++.+++||+.||+|||+
T Consensus        69 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~  147 (432)
T 3n9x_A           69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHE  147 (432)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999766     579999999999999999764 469999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+|||++.++.+||+|||+|+..........  ..     ..+   ...                      
T Consensus       148 ~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~~-----~~~---~~~----------------------  195 (432)
T 3n9x_A          148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI--VN-----DLE---ENE----------------------  195 (432)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------------------------------------------
T ss_pred             CCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccc--cc-----ccc---ccc----------------------
Confidence            9999999999999999999999999999986542211000  00     000   000                      


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                         .+                |-  ............+||++|+|||++.+...|+.++||||+
T Consensus       196 -------------------~~----------------~~--~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl  238 (432)
T 3n9x_A          196 -------------------EP----------------GP--HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST  238 (432)
T ss_dssp             ----------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred             -------------------cc----------------cc--cccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence                               00                00  000001123467899999999998777779999999999


Q ss_pred             HHHHHHHHh-----------CCCCCCCCC-----------------HHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCC
Q psy10954        253 GCIFSEMIT-----------KKTLFAGDS-----------------EIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTD  302 (562)
Q Consensus       253 G~il~eLlt-----------G~~pF~~~~-----------------~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~  302 (562)
                      ||++|||++           |.++|.|.+                 ..+++..|++.+|.|..+.+..+...  ..+...
T Consensus       239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~  318 (432)
T 3n9x_A          239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL  318 (432)
T ss_dssp             HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred             HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence            999999997           566676654                 46889999999999887655443321  111122


Q ss_pred             CCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcccC
Q psy10954        303 FPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       303 ~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      .+...+..+...++..++.+.|||.+||++||++|||++|+|+||||+++....
T Consensus       319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            333334445556666789999999999999999999999999999999987543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.7e-42  Score=362.85  Aligned_cols=265  Identities=31%  Similarity=0.575  Sum_probs=196.1

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCC--EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDF--KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~--~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+|+.+|+++. ||||+++++++...+  .+|+|||||+++|.++++..  .+++..++.+++|++.||+|||++|
T Consensus        52 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~  129 (388)
T 3oz6_A           52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG  129 (388)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456789999999997 999999999998654  79999999999999999864  6899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.++.+||+|||+|+..........        ..|-...                           
T Consensus       130 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~--------~~~~~~~---------------------------  174 (388)
T 3oz6_A          130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN--------NIPLSIN---------------------------  174 (388)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCC--------CGGGCCC---------------------------
T ss_pred             EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccc--------ccccccc---------------------------
Confidence            99999999999999999999999999986542111000        0000000                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                               ..          ..............+||++|+|||++.+...|+.++||||+||
T Consensus       175 -------------------------~~----------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~  219 (388)
T 3oz6_A          175 -------------------------EN----------TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC  219 (388)
T ss_dssp             --------------------------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             -------------------------cc----------ccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHH
Confidence                                     00          0000001122345689999999999988777999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--Cc-----------cCCCCCCCcc---chhhh--cC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IY-----------KTDFPEWRPK---KFSEI--LN  316 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~-----------~~~~~~~~~~---~~~~~--l~  316 (562)
                      ++|||++|++||.+.+..+++..|+..+|.|..+.+.......  .+           ........+.   .....  ..
T Consensus       220 il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (388)
T 3oz6_A          220 ILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA  299 (388)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTC
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccc
Confidence            9999999999999999999999999999988765443221100  00           0000000000   00000  01


Q ss_pred             CCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        317 LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       317 ~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      ..++.+.|||.+||++||++|+|++|+|+||||+....
T Consensus       300 ~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN  337 (388)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred             cCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence            34678999999999999999999999999999987653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=363.92  Aligned_cols=242  Identities=41%  Similarity=0.699  Sum_probs=201.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+++|++++||||+++++++...      ..+|+||||++++|.+++...  .+++..++.+++|++.||+|||
T Consensus        68 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH  145 (367)
T 1cm8_A           68 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH  145 (367)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999865      356999999988999999863  5999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++....                                             
T Consensus       146 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---------------------------------------------  180 (367)
T 1cm8_A          146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------------------------------------------  180 (367)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---------------------------------------------
T ss_pred             HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc---------------------------------------------
Confidence            99999999999999999999999999998753210                                             


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                       .....+||++|+|||++.+...|+.++||||
T Consensus       181 -------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  211 (367)
T 1cm8_A          181 -------------------------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWS  211 (367)
T ss_dssp             -------------------------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred             -------------------------------------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHH
Confidence                                                             0112467999999999988667999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|||++|++||.+.+..+++..|....|.++.+.+..+...  ..+....+......+...+...++.+.|||.+|
T Consensus       212 lG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~m  291 (367)
T 1cm8_A          212 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM  291 (367)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999887655443221  111222334444455556667789999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCccc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      |+.||++|+|++|+|+||||++....
T Consensus       292 L~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          292 LVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             SCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             ccCChhHCCCHHHHhcChHHHhhcCC
Confidence            99999999999999999999987643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-42  Score=376.86  Aligned_cols=240  Identities=35%  Similarity=0.602  Sum_probs=190.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|+.++|||||+++++|...      ..+|||||||+++|.+.+..   .+++..++.+++|++.||+|||
T Consensus       105 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH  181 (464)
T 3ttj_A          105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  181 (464)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999654      46899999999999888854   4899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+|+.....                                            
T Consensus       182 ~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--------------------------------------------  217 (464)
T 3ttj_A          182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------------------------------------  217 (464)
T ss_dssp             HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C--------------------------------------------
T ss_pred             HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--------------------------------------------
Confidence            999999999999999999999999999987543210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||++|+|||++.+.. |+.++||||
T Consensus       218 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  248 (464)
T 3ttj_A          218 ------------------------------------------------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWS  248 (464)
T ss_dssp             ------------------------------------------------CCC----CCCTTCCHHHHTTCC-CCTTHHHHH
T ss_pred             ------------------------------------------------cccCCCcccccccCHHHHcCCC-CCHHHHHHH
Confidence                                                            0012357899999999998864 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchhhhcCC------------C
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFSEILNL------------P  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~------------~  318 (562)
                      +||++|||++|++||.+.+..+++..|++.+|.|..+.+..... ...+....+......+...++.            .
T Consensus       249 lG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
T 3ttj_A          249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK  328 (464)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccccc
Confidence            99999999999999999999999999999999987765544321 0111112222222222222211            1


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++.++|||.+||++||++|+|++|+|+||||+...
T Consensus       329 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence            45789999999999999999999999999998653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-41  Score=350.22  Aligned_cols=251  Identities=41%  Similarity=0.754  Sum_probs=203.5

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEe--------CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPV--------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~--------~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL   87 (562)
                      .....+.+|+++|+.++||||+++++++..        .+.+|+|||||+++|.+.+......+++..++.++.|++.||
T Consensus        58 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l  137 (351)
T 3mi9_A           58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL  137 (351)
T ss_dssp             SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999987        457899999999999999887767799999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      .|||++||+||||||+|||++.++.+||+|||+|+........                                     
T Consensus       138 ~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-------------------------------------  180 (351)
T 3mi9_A          138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS-------------------------------------  180 (351)
T ss_dssp             HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSS-------------------------------------
T ss_pred             HHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccc-------------------------------------
Confidence            9999999999999999999999999999999998654311000                                     


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                        ........+||+.|+|||++.+...|+.++
T Consensus       181 --------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  210 (351)
T 3mi9_A          181 --------------------------------------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPI  210 (351)
T ss_dssp             --------------------------------------------------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHH
T ss_pred             --------------------------------------------------cccccCCcccccCccCchhhcCCCCCCcHh
Confidence                                                              001123457899999999998877799999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCC-CCCCCccchhhhcC--CCCHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWRPKKFSEILN--LPDPLAVD  324 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~--~~~~~~~d  324 (562)
                      ||||+||++|||++|.+||.+.+..+.+..+....+.++...|+.......+... ............+.  ..++.+.+
T Consensus       211 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (351)
T 3mi9_A          211 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD  290 (351)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHH
Confidence            9999999999999999999999999999999999999988888776543322211 11111111111111  13677999


Q ss_pred             HHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||.+||+.||++|||++|+|+||||.+..
T Consensus       291 li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          291 LIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             HHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            99999999999999999999999998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-41  Score=361.19  Aligned_cols=242  Identities=35%  Similarity=0.661  Sum_probs=196.7

Q ss_pred             HHHHHHHHccCCCCcceEEEEEEeCC------EEEEEeecCcCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         22 LREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        22 ~rEi~iL~~l~HpnIv~L~~~~~~~~------~i~lV~Ey~~~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      .+|+++|+.++||||++++++|....      .+|+|||||++++.+.+..   ....+++..++.+++|++.||+|||+
T Consensus        80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~  159 (394)
T 4e7w_A           80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS  159 (394)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48999999999999999999996543      3899999999877765542   34569999999999999999999999


Q ss_pred             CCceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 RRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +||+||||||+|||++ .++.+||+|||+|+.....                                            
T Consensus       160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~--------------------------------------------  195 (394)
T 4e7w_A          160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--------------------------------------------  195 (394)
T ss_dssp             TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--------------------------------------------
T ss_pred             CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC--------------------------------------------
Confidence            9999999999999998 7889999999987643210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+...|+.++||||
T Consensus       196 ------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  227 (394)
T 4e7w_A          196 ------------------------------------------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWS  227 (394)
T ss_dssp             ------------------------------------------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred             ------------------------------------------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHH
Confidence                                                            00123467999999999988777999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC-CCHHHHHHHHHcc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLAVDVFSKIM  330 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~dLi~~mL  330 (562)
                      +||++|||++|++||.+.+..+++..++..+|.+..+.+..... ......++...+..+...+.. .++.+.|||.+||
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (394)
T 4e7w_A          228 TGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLL  306 (394)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999887654332211 111223444444555555543 5789999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCcccC
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      ++||++|||+.|+|+||||+++....
T Consensus       307 ~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          307 EYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             CCChhhCCCHHHHhcChhhhhhcccc
Confidence            99999999999999999999876543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.2e-42  Score=359.84  Aligned_cols=211  Identities=22%  Similarity=0.400  Sum_probs=170.5

Q ss_pred             hhHHHHHHHHHccCC-CCcceEEEEEEe-CCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHH
Q psy10954         19 STALREISVLKELKH-PNVIRLHDVIPV-DFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYL   80 (562)
Q Consensus        19 ~~~~rEi~iL~~l~H-pnIv~L~~~~~~-~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~   80 (562)
                      ..+.+|+++|++++| ||||+++++|.. ++.+|||||||+ ++|.++|+...               ..+++..+..++
T Consensus       112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  191 (353)
T 4ase_A          112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  191 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHH
Confidence            457899999999966 899999999865 467999999998 49999997532               348999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .||+.||+|||+++||||||||+|||++.++.+||+|||+|+........                              
T Consensus       192 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~------------------------------  241 (353)
T 4ase_A          192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------------------------------  241 (353)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------------------------------
T ss_pred             HHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCc------------------------------
Confidence            99999999999999999999999999999999999999998755311000                              


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                 ....+.+||+.|||||++.+.
T Consensus       242 -----------------------------------------------------------~~~~~~~gt~~ymAPE~l~~~  262 (353)
T 4ase_A          242 -----------------------------------------------------------VRKGDARLPLKWMAPETIFDR  262 (353)
T ss_dssp             -----------------------------------------------------------EEETTEEECGGGCCHHHHHHC
T ss_pred             -----------------------------------------------------------eeeccccccccccCHHHHhcC
Confidence                                                                       001234689999999999875


Q ss_pred             CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCC
Q psy10954        241 KVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD  319 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (562)
                      . |+.++||||+||++|||++ |++||.+.+..+.+.+++.....+.                .|           ...+
T Consensus       263 ~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~----------------~p-----------~~~~  314 (353)
T 4ase_A          263 V-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----------------AP-----------DYTT  314 (353)
T ss_dssp             C-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC----------------CC-----------TTCC
T ss_pred             C-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC----------------CC-----------ccCC
Confidence            5 9999999999999999998 9999998765555554443211100                00           1235


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+.+|+.+||+.||++|||+.|+++|
T Consensus       315 ~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          315 PEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            678999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=362.48  Aligned_cols=251  Identities=39%  Similarity=0.778  Sum_probs=193.0

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcCCHHHHHhhC--------CCCCCHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQDLKDFLQTT--------PVPVPPALAKSYLYQLLE   85 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~~L~~~i~~~--------~~~l~e~~i~~i~~qll~   85 (562)
                      +....+.+|+.+|+.++|||||+++++|..  ...+|+||||++++|.+++...        ...+++..++.++.||+.
T Consensus        60 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  139 (405)
T 3rgf_A           60 GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD  139 (405)
T ss_dssp             SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            445678899999999999999999999965  6789999999999999887532        124999999999999999


Q ss_pred             HHHHHHHCCceeccCCCCcEEE----ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         86 ALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        86 aL~yLH~~gIiHRDLKP~NILl----~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      ||.|||++||+||||||+|||+    +.++.+||+|||+|+.......                                
T Consensus       140 al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~--------------------------------  187 (405)
T 3rgf_A          140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK--------------------------------  187 (405)
T ss_dssp             HHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---------------------------------------
T ss_pred             HHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc--------------------------------
Confidence            9999999999999999999999    5667899999998764421100                                


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                              ........+||+.|+|||++.+..
T Consensus       188 --------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~  211 (405)
T 3rgf_A          188 --------------------------------------------------------PLADLDPVVVTFWYRAPELLLGAR  211 (405)
T ss_dssp             -----------------------------------------------------------------CCCTTCCHHHHTTCC
T ss_pred             --------------------------------------------------------ccccCCCceecCcccCchhhcCCC
Confidence                                                                    000112357899999999998877


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCc----
Q psy10954        242 VYSTTVDIWSAGCIFSEMITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP----  308 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~----  308 (562)
                      .|+.++||||+||++|||++|++||.+..+         .+++..++..+|.+....|..+...+.+.........    
T Consensus       212 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (405)
T 3rgf_A          212 HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT  291 (405)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT
T ss_pred             cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC
Confidence            799999999999999999999999987665         4789999999999999888876554432211000000    


Q ss_pred             -cc----hhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        309 -KK----FSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       309 -~~----~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                       ..    +.......++.+.+||.+||++||++|||++|+|+||||.+...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          292 NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred             cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence             00    01111223678999999999999999999999999999987653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.7e-41  Score=347.34  Aligned_cols=214  Identities=28%  Similarity=0.536  Sum_probs=182.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++...+.+|+|||||+ ++|.+++...+ .+++..++.++.|++.||+|||++||+|
T Consensus        59 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivH  137 (328)
T 3fe3_A           59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVH  137 (328)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            457899999999999999999999999999999999997 59999987653 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.....                                                  
T Consensus       138 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~--------------------------------------------------  167 (328)
T 3fe3_A          138 RDLKAENLLLDADMNIKIADFGFSNEFTVG--------------------------------------------------  167 (328)
T ss_dssp             SCCCGGGEEECTTSCEEECSTTCCGGGSSS--------------------------------------------------
T ss_pred             cCCCHHHEEEcCCCCEEEeeccCceecCCC--------------------------------------------------
Confidence            999999999999999999999987543210                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+...++.++||||+||++|
T Consensus       168 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~  205 (328)
T 3fe3_A          168 ------------------------------------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY  205 (328)
T ss_dssp             ------------------------------------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHH
T ss_pred             ------------------------------------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHH
Confidence                                                      01123478999999999998876678999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+..+....+......                  .|           ...++.+.+|+.+||+.||++|
T Consensus       206 ell~g~~pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~~L~~dP~~R  256 (328)
T 3fe3_A          206 TLVSGSLPFDGQNLKELRERVLRGKYR------------------IP-----------FYMSTDCENLLKRFLVLNPIKR  256 (328)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHCCSSTTTS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------CCCCHHHHHHHHHHCCCChhHC
Confidence            999999999999887776666542110                  00           1135689999999999999999


Q ss_pred             CCHHHHHcCccccCCcc
Q psy10954        338 VSAKTILQHEYFNQVEM  354 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~~~  354 (562)
                      ||++|+++||||+....
T Consensus       257 ~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          257 GTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             CCHHHHTTCTTTTTTCT
T ss_pred             cCHHHHhcCHhhcCCCc
Confidence            99999999999987643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-41  Score=358.35  Aligned_cols=242  Identities=38%  Similarity=0.655  Sum_probs=192.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|+.++||||+++++++...      ..+|+||||++++|.+++..  ..+++..++.+++||+.||+|||
T Consensus        72 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH  149 (367)
T 2fst_X           72 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH  149 (367)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999754      56899999998899998865  36999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++....                                             
T Consensus       150 ~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------------------  184 (367)
T 2fst_X          150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---------------------------------------------  184 (367)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECC------------------------------------------------------
T ss_pred             HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc---------------------------------------------
Confidence            99999999999999999999999999998753210                                             


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                       .....+||++|+|||++.+...|+.++||||
T Consensus       185 -------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  215 (367)
T 2fst_X          185 -------------------------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWS  215 (367)
T ss_dssp             -------------------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHH
T ss_pred             -------------------------------------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHH
Confidence                                                             0112468999999999988667999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|||++|++||.+.+..+++..+.+.+|.|..+.+..+...  ..+....+...+..+...+...++.+.|||.+|
T Consensus       216 lG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~m  295 (367)
T 2fst_X          216 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM  295 (367)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHh
Confidence            999999999999999999999999999999999887666554321  111122333334455556667788999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCccc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      |++||++|+|+.|+|+||||++....
T Consensus       296 L~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          296 LVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             CCCCcccCcCHHHHhcChhhhhccCC
Confidence            99999999999999999999987543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-41  Score=360.51  Aligned_cols=241  Identities=29%  Similarity=0.614  Sum_probs=192.8

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+|+++|+.++|||||+++++|...      ..+++||||++++|.+.+..   ....+++..++.+++||+.||.|||
T Consensus        94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  173 (420)
T 1j1b_A           94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH  173 (420)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34899999999999999999998642      24789999999888776643   3457999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         92 SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      ++||+||||||+|||++.+ +.+||+|||+++.....                                           
T Consensus       174 ~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~-------------------------------------------  210 (420)
T 1j1b_A          174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-------------------------------------------  210 (420)
T ss_dssp             TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-------------------------------------------
T ss_pred             HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC-------------------------------------------
Confidence            9999999999999999965 56899999987643210                                           


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                       ......+||++|+|||++.+...|+.++|||
T Consensus       211 -------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  241 (420)
T 1j1b_A          211 -------------------------------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVW  241 (420)
T ss_dssp             -------------------------------------------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHH
T ss_pred             -------------------------------------------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhH
Confidence                                                             0012346899999999998876799999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcC-CCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN-LPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~dLi~~m  329 (562)
                      |+||++|||++|++||.+.+..+++.+++..+|.+..+.+..... ......++......+...+. ..++.+.|||.+|
T Consensus       242 SlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~  320 (420)
T 1j1b_A          242 SAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL  320 (420)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS-CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh-hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHh
Confidence            999999999999999999999999999999999887654432211 01111233333344444443 3478899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++||++|+|+.|+|+||||+++..
T Consensus       321 L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          321 LEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccCChhHCCCHHHHhCCHhhccccc
Confidence            9999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-40  Score=350.96  Aligned_cols=217  Identities=29%  Similarity=0.490  Sum_probs=181.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||++++++|.....+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giv  137 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIA  137 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567899999999999999999999999999999999996 5999999764 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         97 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        97 HRDLKP~NILl~~~~----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ||||||+|||++.++    .+||+|||+++.....                                             
T Consensus       138 HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~---------------------------------------------  172 (361)
T 2yab_A          138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---------------------------------------------  172 (361)
T ss_dssp             CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT---------------------------------------------
T ss_pred             cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC---------------------------------------------
Confidence            999999999998766    6888888876533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+.. |+.++||||+
T Consensus       173 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diwsl  204 (361)
T 2yab_A          173 -----------------------------------------------VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSI  204 (361)
T ss_dssp             -----------------------------------------------CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHH
T ss_pred             -----------------------------------------------CccccCCCCccEECchHHcCCC-CCccccHHHH
Confidence                                                           0112347899999999997654 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|.+||.+.+..+.+..+.......+.                         ......++.+++||.+||..
T Consensus       205 Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~  259 (361)
T 2yab_A          205 GVITYILLSGASPFLGDTKQETLANITAVSYDFDE-------------------------EFFSQTSELAKDFIRKLLVK  259 (361)
T ss_dssp             HHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-------------------------hhccCCCHHHHHHHHHHCCC
Confidence            99999999999999999888877777543211110                         12233467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+|+||||+.++
T Consensus       260 dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          260 ETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             STTTSCCHHHHHTSTTTSCSS
T ss_pred             ChhHCcCHHHHhcCcCcCCCc
Confidence            999999999999999998765

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-41  Score=353.97  Aligned_cols=240  Identities=34%  Similarity=0.668  Sum_probs=194.2

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeC--------------------------------------CEEEEEeecCcCCHHH
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVD--------------------------------------FKLFLVFEFLRQDLKD   62 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~--------------------------------------~~i~lV~Ey~~~~L~~   62 (562)
                      ..+|+++|+.++||||++++++|...                                      ..+|+|||||+++|.+
T Consensus        47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~  126 (383)
T 3eb0_A           47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK  126 (383)
T ss_dssp             CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHH
T ss_pred             HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHH
Confidence            34899999999999999999999543                                      3489999999998887


Q ss_pred             HHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeec
Q psy10954         63 FLQT---TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL  138 (562)
Q Consensus        63 ~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~  138 (562)
                      .+..   ....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.....           
T Consensus       127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-----------  195 (383)
T 3eb0_A          127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-----------  195 (383)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----------
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----------
Confidence            7653   345799999999999999999999999999999999999998 5788999999987643211           


Q ss_pred             cCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccC
Q psy10954        139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP  218 (562)
Q Consensus       139 ~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~  218 (562)
                                                                                                      
T Consensus       196 --------------------------------------------------------------------------------  195 (383)
T 3eb0_A          196 --------------------------------------------------------------------------------  195 (383)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             CCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q psy10954        219 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI  298 (562)
Q Consensus       219 ~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~  298 (562)
                       ......+||+.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+++.+++..+|.+..+.+..... ..
T Consensus       196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-~~  273 (383)
T 3eb0_A          196 -EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP-HY  273 (383)
T ss_dssp             -SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT-TC
T ss_pred             -CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCc-cc
Confidence             0012346799999999998877799999999999999999999999999999999999999999887643322111 01


Q ss_pred             ccCCCCCCCccchhhhcCC-CCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        299 YKTDFPEWRPKKFSEILNL-PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       299 ~~~~~~~~~~~~~~~~l~~-~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ....++......+...++. .++.+.+||.+||++||++|+|+.|+|+||||+++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          274 TEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             --CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             ccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence            1123344444444444443 578899999999999999999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-40  Score=347.84  Aligned_cols=245  Identities=33%  Similarity=0.653  Sum_probs=200.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+++|+.++||||+++++++...     ..+|+||||++++|.+++...  .+++..++.++.|++.||.|||++
T Consensus        70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~  147 (364)
T 3qyz_A           70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA  147 (364)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            5678999999999999999999999765     479999999999999999764  599999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++.......                                            
T Consensus       148 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--------------------------------------------  183 (364)
T 3qyz_A          148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD--------------------------------------------  183 (364)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC--------------------------------------------
T ss_pred             CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC--------------------------------------------
Confidence            999999999999999999999999999864421100                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                  ........+||+.|+|||++.+...|+.++||||+|
T Consensus       184 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG  219 (364)
T 3qyz_A          184 --------------------------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG  219 (364)
T ss_dssp             --------------------------------------------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHH
T ss_pred             --------------------------------------------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHH
Confidence                                                        000112347899999999988777799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      |++|+|++|++||.+.+..+.+..+...+|.+..+.+.......  .+....+......+.......++.+.+||.+||+
T Consensus       220 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  299 (364)
T 3qyz_A          220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT  299 (364)
T ss_dssp             HHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcC
Confidence            99999999999999999999999999999988765443322211  1111222222333445556678899999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCc
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||++|||+.|+|+||||++..
T Consensus       300 ~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          300 FNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             SSTTTSCCHHHHHTSGGGTTTC
T ss_pred             CChhhCCCHHHHhcCcchhhcc
Confidence            9999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=355.80  Aligned_cols=216  Identities=28%  Similarity=0.469  Sum_probs=180.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++..++.+|+|||||.+ +|.+.+.... .+++..++.++.|++.||.|||++||+|
T Consensus        55 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givH  133 (444)
T 3soa_A           55 QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVH  133 (444)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4578999999999999999999999999999999999975 9999987754 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+|||++.   ++.+||+|||+|+....                                                
T Consensus       134 rDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~------------------------------------------------  165 (444)
T 3soa_A          134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEG------------------------------------------------  165 (444)
T ss_dssp             CCCSSTTEEESBSSTTCCEEECCCSSCBCCCT------------------------------------------------
T ss_pred             cCCCHHHEEEeccCCCCcEEEccCceeEEecC------------------------------------------------
Confidence            999999999984   46688888887643321                                                


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                 ........+||+.|+|||++.+.. |+.++||||+||
T Consensus       166 -------------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGv  201 (444)
T 3soa_A          166 -------------------------------------------EQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGV  201 (444)
T ss_dssp             -------------------------------------------TCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             -------------------------------------------CCceeecccCCcccCCHHHhcCCC-CCCccccHHHHH
Confidence                                                       111122357899999999997654 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|.+||.+.+..+.+..+.......+...|                         ...++.+.+||.+||+.||
T Consensus       202 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~dP  256 (444)
T 3soa_A          202 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW-------------------------DTVTPEAKDLINKMLTINP  256 (444)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT-------------------------TTSCHHHHHHHHHHSCSST
T ss_pred             HHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc-------------------------ccCCHHHHHHHHHHcCCCh
Confidence            999999999999999888777777654322221111                         2235789999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++|||+.|+|+||||+..
T Consensus       257 ~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          257 SKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TTSCCHHHHHHSCTTHHH
T ss_pred             hHCCCHHHHhcCccccCC
Confidence            999999999999999764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=344.31  Aligned_cols=216  Identities=26%  Similarity=0.417  Sum_probs=182.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++...+.+|+|||||++ +|.+++......+++..++.++.|++.||.|||++||+|
T Consensus        46 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH  125 (321)
T 1tki_A           46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH  125 (321)
T ss_dssp             HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence            4567999999999999999999999999999999999985 999999876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEcc--CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         98 RDLKPQNILINK--SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        98 RDLKP~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||+|||++.  ++.+||+|||+++.....                                                
T Consensus       126 ~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~------------------------------------------------  157 (321)
T 1tki_A          126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------------------------------------------------  157 (321)
T ss_dssp             CCCCGGGEEESSSSCCCEEECCCTTCEECCTT------------------------------------------------
T ss_pred             CCCCHHHEEEccCCCCCEEEEECCCCeECCCC------------------------------------------------
Confidence            999999999987  678999999987543210                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. ++.++||||+||+
T Consensus       158 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  192 (321)
T 1tki_A          158 --------------------------------------------DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTL  192 (321)
T ss_dssp             --------------------------------------------CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHH
T ss_pred             --------------------------------------------CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHH
Confidence                                                        0011236789999999997654 7999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|.+||.+.+..+.+..+.......+.                         ......++.+.+|+.+||..||+
T Consensus       193 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~  247 (321)
T 1tki_A          193 VYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------------------------EAFKEISIEAMDFVDRLLVKERK  247 (321)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHHHHTTSCSSGG
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-------------------------hhhccCCHHHHHHHHHHcCCChh
Confidence            99999999999999888777777653221111                         11233467899999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy10954        336 QRVSAKTILQHEYFNQV  352 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~  352 (562)
                      +|||+.|+|+||||++.
T Consensus       248 ~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          248 SRMTASEALQHPWLKQK  264 (321)
T ss_dssp             GSCCHHHHHHSHHHHSC
T ss_pred             HCcCHHHHhcChhhccC
Confidence            99999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-40  Score=358.20  Aligned_cols=226  Identities=25%  Similarity=0.377  Sum_probs=188.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||++++++|.++..+|||||||. ++|.+++......+++..++.++.|++.||+|||++|||
T Consensus       118 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gii  197 (437)
T 4aw2_A          118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV  197 (437)
T ss_dssp             TCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            3447899999999999999999999999999999999996 599999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.+|.+||+|||+|+.......                                               
T Consensus       198 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-----------------------------------------------  230 (437)
T 4aw2_A          198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-----------------------------------------------  230 (437)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-----------------------------------------------
T ss_pred             ecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-----------------------------------------------
Confidence            999999999999999999999999864421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc----CCCCCCchhhHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSA  252 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~----~~~~y~~~~DIWSl  252 (562)
                                                                 ......+||+.|+|||++.    +...|+.++||||+
T Consensus       231 -------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl  267 (437)
T 4aw2_A          231 -------------------------------------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL  267 (437)
T ss_dssp             -------------------------------------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred             -------------------------------------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence                                                       0012347899999999987    24458999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|||++|++||.+.+..+.+.+|.......                .+|.        .....++.++|||++||..
T Consensus       268 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~--------~~~~~s~~~~dLi~~lL~~  323 (437)
T 4aw2_A          268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------------QFPT--------QVTDVSENAKDLIRRLICS  323 (437)
T ss_dssp             HHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----------------CCCS--------SCCCSCHHHHHHHHTTSSC
T ss_pred             HHHHHHHHhCCCCCCCCChhHHHHhhhhccccc----------------cCCc--------ccccCCHHHHHHHHHHhcc
Confidence            999999999999999999888888776432110                0111        1122467899999999999


Q ss_pred             CCCC--CCCHHHHHcCccccCCcccCC
Q psy10954        333 DPKQ--RVSAKTILQHEYFNQVEMVKP  357 (562)
Q Consensus       333 DP~~--R~Ta~elL~Hp~f~~~~~~~~  357 (562)
                      +|++  |++++|+++||||+++++...
T Consensus       324 ~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          324 REHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             GGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             cccccCCCCHHHHhCCCccCCCCHHHH
Confidence            9988  999999999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=347.22  Aligned_cols=216  Identities=28%  Similarity=0.438  Sum_probs=181.0

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+|+.+|+.+ +||||++++++|.+.+.+|+|||||.+ +|.+++.... .+++..++.++.||+.||+|||++||
T Consensus        67 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gi  145 (353)
T 3txo_A           67 VECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGI  145 (353)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            44578999999988 799999999999999999999999985 9999987643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.+|.+||+|||+|+......                                               
T Consensus       146 vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-----------------------------------------------  178 (353)
T 3txo_A          146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-----------------------------------------------  178 (353)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCSCC-------------------------------------------------
T ss_pred             cccCCCHHHEEECCCCCEEEccccceeecccCC-----------------------------------------------
Confidence            999999999999999999999999976321100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ....+.+||+.|+|||++.+.. |+.++||||+||+
T Consensus       179 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  213 (353)
T 3txo_A          179 --------------------------------------------VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVL  213 (353)
T ss_dssp             ---------------------------------------------------CCGGGCCHHHHHHHH-CTTHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHH
Confidence                                                        0112347899999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+..|......                  ++           ...++.+.+||++||+.||+
T Consensus       214 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~lL~~dP~  264 (353)
T 3txo_A          214 LYEMLCGHAPFEAENEDDLFEAILNDEVV------------------YP-----------TWLHEDATGILKSFMTKNPT  264 (353)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------------CC-----------CCCCHHHHHHHHHHhhhCHH
Confidence            99999999999999988888887653110                  11           11356799999999999999


Q ss_pred             CCCCH------HHHHcCccccCCccc
Q psy10954        336 QRVSA------KTILQHEYFNQVEMV  355 (562)
Q Consensus       336 ~R~Ta------~elL~Hp~f~~~~~~  355 (562)
                      +|+++      +|+++||||+++++.
T Consensus       265 ~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          265 MRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             GSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             HccCCcccCCHHHHhhCCcccCCCHH
Confidence            99998      899999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-39  Score=340.24  Aligned_cols=217  Identities=26%  Similarity=0.416  Sum_probs=182.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ......+|+.+|+.++||||++++++|...+.+|+|||||++ +|..++.... .+++..++.++.||+.||+|||++||
T Consensus        48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i  126 (337)
T 1o6l_A           48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDV  126 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678999999999999999999999999999999999975 9999887643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.+|.+||+|||+++......                                               
T Consensus       127 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-----------------------------------------------  159 (337)
T 1o6l_A          127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-----------------------------------------------  159 (337)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-----------------------------------------------
T ss_pred             ecCcCCHHHEEECCCCCEEEeeccchhhcccCC-----------------------------------------------
Confidence            999999999999999999999999876321100                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ....+.+||+.|+|||++.+.. |+.++||||+||+
T Consensus       160 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  194 (337)
T 1o6l_A          160 --------------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVV  194 (337)
T ss_dssp             --------------------------------------------CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHH
T ss_pred             --------------------------------------------CcccccccChhhCChhhhcCCC-CCchhhcccchhH
Confidence                                                        0112357899999999987654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+....+....-                  .++           ...++.+.+||.+||+.||+
T Consensus       195 l~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~~li~~lL~~dP~  245 (337)
T 1o6l_A          195 MYEMMCGRLPFYNQDHERLFELILMEEI------------------RFP-----------RTLSPEAKSLLAGLLKKDPK  245 (337)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------CCC-----------TTSCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------CCC-----------CCCCHHHHHHHHHHhhcCHH
Confidence            9999999999999887776666654210                  001           12357899999999999999


Q ss_pred             CCC-----CHHHHHcCccccCCccc
Q psy10954        336 QRV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       336 ~R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      +|+     +++|+++||||.++++.
T Consensus       246 ~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          246 QRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             TSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            999     89999999999988753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.4e-40  Score=342.65  Aligned_cols=245  Identities=31%  Similarity=0.625  Sum_probs=192.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe-----CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~-----~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+++|++++||||+++++++..     ...+|+||||++++|.+++......+++..++.++.|++.||.|||++
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  153 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA  153 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            568899999999999999999999854     247899999999999999987766799999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++.....                                              
T Consensus       154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----------------------------------------------  187 (362)
T 3pg1_A          154 GVVHRDLHPGNILLADNNDITICDFNLAREDTAD----------------------------------------------  187 (362)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCTTC-----------------------------------------------------
T ss_pred             cCEecCCChHHEEEcCCCCEEEEecCcccccccc----------------------------------------------
Confidence            9999999999999999999999999987532110                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ......+||+.|+|||++.+...++.++||||+|
T Consensus       188 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  221 (362)
T 3pg1_A          188 ----------------------------------------------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG  221 (362)
T ss_dssp             ------------------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHH
T ss_pred             ----------------------------------------------cccceecccceecCcHHhcCCCCCCcHhHHHhHH
Confidence                                                          0011236788999999998866799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC---CCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK---LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|+|++|+.||.+.+..+.+..+....|.+....+.....   ...............+....+..++.+.+||.+||
T Consensus       222 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  301 (362)
T 3pg1_A          222 CVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML  301 (362)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999888765432211100   00000111112222333444556788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +.||++|||+.|+|+||||+++...
T Consensus       302 ~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          302 EFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             cCChhhCCCHHHHHcCchhhhccCc
Confidence            9999999999999999999987543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=336.50  Aligned_cols=213  Identities=27%  Similarity=0.466  Sum_probs=182.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||++++++|.+...+|+|||||.+ +|.+++.... .+++..++.++.|++.||+|||++||+
T Consensus        50 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  128 (318)
T 1fot_A           50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDII  128 (318)
T ss_dssp             HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45577899999999999999999999999999999999975 9999998754 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.+|.+||+|||+++....                                                  
T Consensus       129 HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--------------------------------------------------  158 (318)
T 1fot_A          129 YRDLKPENILLDKNGHIKITDFGFAKYVPD--------------------------------------------------  158 (318)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSCEECSS--------------------------------------------------
T ss_pred             ccCCChheEEEcCCCCEEEeecCcceecCC--------------------------------------------------
Confidence            999999999999999999999998753210                                                  


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ...+.+||+.|+|||++.+.. |+.++||||+||++
T Consensus       159 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  193 (318)
T 1fot_A          159 --------------------------------------------VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILI  193 (318)
T ss_dssp             --------------------------------------------CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccCCccccCHhHhcCCC-CCcccchhhhHHHH
Confidence                                                        001246899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|++||.+.+..+.+.++....-.                  ++           ...++.+.+||++||+.||++
T Consensus       194 ~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~lL~~dp~~  244 (318)
T 1fot_A          194 YEMLAGYTPFYDSNTMKTYEKILNAELR------------------FP-----------PFFNEDVKDLLSRLITRDLSQ  244 (318)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSCTTT
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------CCCCHHHHHHHHHHhccCHHH
Confidence            9999999999999888777777652100                  00           123568999999999999999


Q ss_pred             CC-----CHHHHHcCccccCCccc
Q psy10954        337 RV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      |+     +++|+++||||+++.+.
T Consensus       245 R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          245 RLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             CTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             cCCCcCCCHHHHhcCccccCCCHH
Confidence            99     89999999999988754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=333.53  Aligned_cols=245  Identities=36%  Similarity=0.655  Sum_probs=186.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++...+..|+|||||++ +|.+++.. ...+++..++.++.|++.||.|||++||+
T Consensus        46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iv  124 (311)
T 4agu_A           46 KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCI  124 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            34567999999999999999999999999999999999987 56565544 45699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       125 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------  156 (311)
T 4agu_A          125 HRDVKPENILITKHSVIKLCDFGFARLLTGPS------------------------------------------------  156 (311)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECC---------------------------------------------------
T ss_pred             CCCCChhhEEEcCCCCEEEeeCCCchhccCcc------------------------------------------------
Confidence            99999999999999999999999875432110                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+...++.++||||+||++
T Consensus       157 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  193 (311)
T 4agu_A          157 -------------------------------------------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVF  193 (311)
T ss_dssp             ----------------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHH
T ss_pred             -------------------------------------------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHH
Confidence                                                       0012236789999999998877799999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCCC-CccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEW-RPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      |+|++|++||.+.+..+.+..+...++...............+. ...+.. ........++..++.+.+|+.+||+.||
T Consensus       194 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  273 (311)
T 4agu_A          194 AELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP  273 (311)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSST
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCCh
Confidence            99999999999999988888888777654321110000000000 000000 0111222334567789999999999999


Q ss_pred             CCCCCHHHHHcCccccCCcc
Q psy10954        335 KQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      ++|||++|+|+||||+++..
T Consensus       274 ~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          274 TERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TTSCCHHHHHTSGGGTTCC-
T ss_pred             hhcCCHHHHhcChHHHhccC
Confidence            99999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-39  Score=331.82  Aligned_cols=216  Identities=28%  Similarity=0.461  Sum_probs=181.1

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|+.++||||++++++|..++.+|+|||||. ++|.+++...  .+++..++.++.|++.||.|||++||
T Consensus        60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i  137 (297)
T 3fxz_A           60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQV  137 (297)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567899999999999999999999999999999999996 5999999765  58999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||++.......                                               
T Consensus       138 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------------  170 (297)
T 3fxz_A          138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----------------------------------------------  170 (297)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----------------------------------------------
T ss_pred             eeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-----------------------------------------------
Confidence            999999999999999999999999875432110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       171 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  205 (297)
T 3fxz_A          171 --------------------------------------------SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  205 (297)
T ss_dssp             --------------------------------------------CCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHH
T ss_pred             --------------------------------------------cccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHH
Confidence                                                        0012346899999999998765 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+....+..+...... ...                         .....++.+.+|+.+||+.||+
T Consensus       206 l~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~l~~dp~  259 (297)
T 3fxz_A          206 AIEMIEGEPPYLNENPLRALYLIATNGTP-ELQ-------------------------NPEKLSAIFRDFLNRCLEMDVE  259 (297)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCS-------------------------CGGGSCHHHHHHHHHHSCSSTT
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC-------------------------CccccCHHHHHHHHHHccCChh
Confidence            99999999999998887776666543211 000                         0012346789999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy10954        336 QRVSAKTILQHEYFNQV  352 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~  352 (562)
                      +|||++|+|+||||+..
T Consensus       260 ~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          260 KRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             TSCCHHHHTTCGGGGGC
T ss_pred             HCcCHHHHhhChhhccc
Confidence            99999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.2e-40  Score=350.77  Aligned_cols=221  Identities=29%  Similarity=0.404  Sum_probs=184.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++|||||+++++|.++..+|||||||++ +|.+++...  .+++..++.++.|++.||+|||++|||
T Consensus       113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~giv  190 (410)
T 3v8s_A          113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFI  190 (410)
T ss_dssp             CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34578999999999999999999999999999999999964 999998764  589999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.+|.+||+|||+|+.......                                               
T Consensus       191 HrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-----------------------------------------------  223 (410)
T 3v8s_A          191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-----------------------------------------------  223 (410)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-----------------------------------------------
T ss_pred             eccCCHHHeeECCCCCEEEeccceeEeeccCCc-----------------------------------------------
Confidence            999999999999999999999999864421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC---CCchhhHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV---YSTTVDIWSAG  253 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~---y~~~~DIWSlG  253 (562)
                                                                 ....+.+||+.|+|||++.+...   |+.++||||+|
T Consensus       224 -------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlG  260 (410)
T 3v8s_A          224 -------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  260 (410)
T ss_dssp             -------------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHH
T ss_pred             -------------------------------------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecch
Confidence                                                       00123578999999999976542   78999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|++||.+.+..+.+.+|.......                .++.+         ...++.+++||.+||+.+
T Consensus       261 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~~---------~~~s~~~~~li~~lL~~~  315 (410)
T 3v8s_A          261 VFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL----------------TFPDD---------NDISKEAKNLICAFLTDR  315 (410)
T ss_dssp             HHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----------------CCCTT---------CCCCHHHHHHHHHHSSCG
T ss_pred             HHHHHHHhCCCCCCCCChhhHHHHHHhccccc----------------cCCCc---------ccccHHHHHHHHHHccCh
Confidence            99999999999999999888888776532110                01110         123578999999999999


Q ss_pred             CCC--CCCHHHHHcCccccCCccc
Q psy10954        334 PKQ--RVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       334 P~~--R~Ta~elL~Hp~f~~~~~~  355 (562)
                      |.+  |+|++|+++||||+++++.
T Consensus       316 ~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          316 EVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             GGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             hhhCCCCCHHHHhcCccccCCCHH
Confidence            998  9999999999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-40  Score=349.55  Aligned_cols=240  Identities=35%  Similarity=0.590  Sum_probs=183.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC------EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~------~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|+.++||||+++++++....      .+|+|||||+++|.+.+..   .+++..++.++.|++.||.|||
T Consensus        68 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH  144 (371)
T 2xrw_A           68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  144 (371)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH
Confidence            345789999999999999999999997654      8999999999999998863   4899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++.....                                            
T Consensus       145 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------  180 (371)
T 2xrw_A          145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------------------------------------  180 (371)
T ss_dssp             HTTCCCSCCCGGGEEECTTSCEEECCCCC---------------------------------------------------
T ss_pred             HCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--------------------------------------------
Confidence            999999999999999999999999999987533100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+.. |+.++||||
T Consensus       181 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws  211 (371)
T 2xrw_A          181 ------------------------------------------------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWS  211 (371)
T ss_dssp             ---------------------------------------------------------CTTCCHHHHTTCC-CCTTHHHHH
T ss_pred             ------------------------------------------------cccCCceecCCccCHHHhcCCC-CCchHhHHH
Confidence                                                            0011246799999999998754 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCCccchhhhcC-----C-------C
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWRPKKFSEILN-----L-------P  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~-----~-------~  318 (562)
                      +||++|+|++|+.||.+.+..+++..+++.+|.+..+.+...... ..+....+.+....+...++     .       .
T Consensus       212 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (371)
T 2xrw_A          212 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK  291 (371)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccc
Confidence            999999999999999999999999999998888765544332110 00011111111111111111     0       1


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++.++|||.+||+.||++|||++|+|+||||+...
T Consensus       292 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          292 ASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             cHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            35789999999999999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=335.01  Aligned_cols=217  Identities=30%  Similarity=0.493  Sum_probs=180.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++.....+|+|||||. ++|.+++... ..+++..++.++.|++.||.|||++||+
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iv  136 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIA  136 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4567899999999999999999999999999999999997 5999998754 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         97 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        97 HRDLKP~NILl~~~~----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ||||||+|||++.++    .+||+|||+++.....                                             
T Consensus       137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~---------------------------------------------  171 (326)
T 2y0a_A          137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---------------------------------------------  171 (326)
T ss_dssp             CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT---------------------------------------------
T ss_pred             cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC---------------------------------------------
Confidence            999999999998776    6888888876533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+.. |+.++||||+
T Consensus       172 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diwsl  203 (326)
T 2y0a_A          172 -----------------------------------------------NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSI  203 (326)
T ss_dssp             -----------------------------------------------SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHH
T ss_pred             -----------------------------------------------CccccccCCcCcCCceeecCCC-CCcHHHHHHH
Confidence                                                           0112346899999999997654 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|..||.+.+..+.+..+.......+                         .......++.+.+||.+||+.
T Consensus       204 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~  258 (326)
T 2y0a_A          204 GVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------------------DEYFSNTSALAKDFIRRLLVK  258 (326)
T ss_dssp             HHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-------------------------HHHHTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-------------------------ccccccCCHHHHHHHHHHccC
Confidence            9999999999999999888777776654321110                         012234467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+|+||||+...
T Consensus       259 dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          259 DPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             SGGGSCCHHHHHHSTTTSCCS
T ss_pred             ChhhCCCHHHHhcCCCccCCc
Confidence            999999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-39  Score=341.26  Aligned_cols=215  Identities=29%  Similarity=0.460  Sum_probs=177.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++..++..|+|||||.+ +|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus        73 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH  151 (362)
T 2bdw_A           73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVH  151 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            4577999999999999999999999999999999999985 999988764 36999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+|||++.++   .+||+|||++......                                               
T Consensus       152 ~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-----------------------------------------------  184 (362)
T 2bdw_A          152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------------------------------------------  184 (362)
T ss_dssp             CCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-----------------------------------------------
T ss_pred             ccCchHHEEEecCCCCCCEEEeecCcceEecCC-----------------------------------------------
Confidence            99999999997653   4888888876433210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+.. |+.++||||+||
T Consensus       185 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  218 (362)
T 2bdw_A          185 ---------------------------------------------EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGV  218 (362)
T ss_dssp             ---------------------------------------------CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHH
T ss_pred             ---------------------------------------------cccccCCCCccccCHHHHccCC-CCchhhHHHHHH
Confidence                                                         0112346899999999997654 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|.+||.+.+..+.+..+.......+..                         .....++.+.+||.+||+.||
T Consensus       219 il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP  273 (362)
T 2bdw_A          219 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLIDSMLTVNP  273 (362)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------GGGGSCHHHHHHHHHHSCSSG
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHcCCCh
Confidence            9999999999999988877776665432111111                         111235689999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++|||+.|+|+||||...
T Consensus       274 ~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          274 KKRITADQALKVPWICNR  291 (362)
T ss_dssp             GGSCCHHHHTTSHHHHTH
T ss_pred             hhCcCHHHHhcCcccCCC
Confidence            999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7e-40  Score=352.17  Aligned_cols=239  Identities=29%  Similarity=0.560  Sum_probs=189.8

Q ss_pred             hhHHHHHHHHHcc------CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL------KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l------~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|+.+|+.+      +|+||+++++++.....+|+||||++++|.+++.... ..+++..++.++.||+.||+|||
T Consensus       138 ~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH  217 (429)
T 3kvw_A          138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH  217 (429)
T ss_dssp             HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567899998887      5789999999999999999999999999999997754 35999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCC--eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         92 SRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~--vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ++|||||||||+|||++.++.  +||+|||+|.....                                           
T Consensus       218 ~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-------------------------------------------  254 (429)
T 3kvw_A          218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-------------------------------------------  254 (429)
T ss_dssp             HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-------------------------------------------
T ss_pred             HCCeecCCCCHHHeEEccCCCcceEEeecccceecCC-------------------------------------------
Confidence            999999999999999998876  89999987642210                                           


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                         ...+.+||+.|+|||++.+.. |+.++||
T Consensus       255 ---------------------------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  282 (429)
T 3kvw_A          255 ---------------------------------------------------RVYTYIQSRFYRAPEVILGAR-YGMPIDM  282 (429)
T ss_dssp             ---------------------------------------------------CCCSSCSCGGGCCHHHHHTBC-CCTHHHH
T ss_pred             ---------------------------------------------------cccccCCCCCccChHHHhCCC-CCchHHH
Confidence                                                               012346899999999998765 8999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC--CCCC----------------------
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT--DFPE----------------------  305 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~--~~~~----------------------  305 (562)
                      ||+||++|||++|.+||.+.++.+++..+.+.+|.++...+........+..  .++.                      
T Consensus       283 wSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (429)
T 3kvw_A          283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRG  362 (429)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTC
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchh
Confidence            9999999999999999999999999999999999887654322211110000  0000                      


Q ss_pred             -----CCccchhhhc-CCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        306 -----WRPKKFSEIL-NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       306 -----~~~~~~~~~l-~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                           .....+...+ ...++.+.|||.+||++||++|||++|+|+||||++.
T Consensus       363 ~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          363 KLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             CEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             hccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence                 0011122222 2347889999999999999999999999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-39  Score=343.11  Aligned_cols=240  Identities=37%  Similarity=0.659  Sum_probs=195.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEE------EEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i------~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|+.++||||+++++++...+..      |+||||+.++|.+++..   .+++..++.++.|++.||+|||
T Consensus        85 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH  161 (371)
T 4exu_A           85 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH  161 (371)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999877654      99999999999887743   4999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++.....                                            
T Consensus       162 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------------------------------------------  197 (371)
T 4exu_A          162 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--------------------------------------------  197 (371)
T ss_dssp             HTTCCCSCCCGGGEEECTTCCEEECSTTCC--------------------------------------------------
T ss_pred             HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--------------------------------------------
Confidence            999999999999999999999999999987532100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        ....+||+.|+|||++.+...++.++||||
T Consensus       198 --------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (371)
T 4exu_A          198 --------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWS  227 (371)
T ss_dssp             ----------------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred             --------------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence                                                              112367999999999988667999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|+|++|+.||.+.+..+.+..+....|.+..+.+......  ..+....+......+.......++.+.+||.+|
T Consensus       228 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  307 (371)
T 4exu_A          228 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM  307 (371)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHH
Confidence            999999999999999999999999999999988776544433210  001111222222334445556688999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |+.||++|||++|+|+||||+....
T Consensus       308 L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          308 LELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             SCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CCCChhhcCCHHHHhcCcccccCCC
Confidence            9999999999999999999998654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.9e-39  Score=338.57  Aligned_cols=213  Identities=25%  Similarity=0.421  Sum_probs=182.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++.+...+|+||||++ ++|.+++.... .+++..++.++.|++.||+|||++||+
T Consensus        85 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  163 (350)
T 1rdq_E           85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLI  163 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567899999999999999999999999999999999997 59999997643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.+|.+||+|||+++....                                                  
T Consensus       164 HrDlkp~NIll~~~g~~kL~DFg~a~~~~~--------------------------------------------------  193 (350)
T 1rdq_E          164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKG--------------------------------------------------  193 (350)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECSS--------------------------------------------------
T ss_pred             cccCccceEEECCCCCEEEcccccceeccC--------------------------------------------------
Confidence            999999999999999999999998753310                                                  


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ...+.+||+.|+|||++.+.. |+.++||||+||++
T Consensus       194 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  228 (350)
T 1rdq_E          194 --------------------------------------------RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLI  228 (350)
T ss_dssp             --------------------------------------------CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHH
T ss_pred             --------------------------------------------CcccccCCccccCHHHhcCCC-CCCcCCEecccHhH
Confidence                                                        001246899999999998754 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+..+.+..+....-.                  ++           ...++.+.+||.+||+.||++
T Consensus       229 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~lL~~dp~~  279 (350)
T 1rdq_E          229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------------------FP-----------SHFSSDLKDLLRNLLQVDLTK  279 (350)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTCCHHHHHHHHHHSCSCTTT
T ss_pred             hHHhhCCCCCCCCCHHHHHHHHHcCCCC------------------CC-----------CCCCHHHHHHHHHHhhcCHHh
Confidence            9999999999999887777777652100                  00           123568999999999999999


Q ss_pred             CCC-----HHHHHcCccccCCccc
Q psy10954        337 RVS-----AKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~T-----a~elL~Hp~f~~~~~~  355 (562)
                      |++     ++|+++||||+++++.
T Consensus       280 R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          280 RFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             CTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             ccCCccCCHHHHHhCcCcCCCCHH
Confidence            998     9999999999988753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8e-39  Score=327.95  Aligned_cols=244  Identities=45%  Similarity=0.818  Sum_probs=198.9

Q ss_pred             chhhHHHHHHHHHcc---CCCCcceEEEEEE-----eCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKEL---KHPNVIRLHDVIP-----VDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l---~HpnIv~L~~~~~-----~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL   87 (562)
                      ......+|+.+++.+   +||||+++++++.     ....+|+||||++++|.+++.... ..+++..++.++.|++.||
T Consensus        54 ~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l  133 (326)
T 1blx_A           54 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  133 (326)
T ss_dssp             CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred             CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence            345677899888877   8999999999987     456799999999999999997754 3499999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      .|||++||+||||||+|||++.++.+||+|||+++......                                       
T Consensus       134 ~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------------------------------------  174 (326)
T 1blx_A          134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---------------------------------------  174 (326)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---------------------------------------
T ss_pred             HHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC---------------------------------------
Confidence            99999999999999999999999999999999875432100                                       


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                           ......||+.|+|||++.+.. ++.++
T Consensus       175 -----------------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~  200 (326)
T 1blx_A          175 -----------------------------------------------------ALTSVVVTLWYRAPEVLLQSS-YATPV  200 (326)
T ss_dssp             -----------------------------------------------------GGCCCCCCCTTCCHHHHTTCC-CCTHH
T ss_pred             -----------------------------------------------------CccccccccceeCHHHHhcCC-CCcch
Confidence                                                                 011236789999999998765 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      ||||+||++|+|++|++||.+.+..+.+..+...++.+....|+.....+...  +...............++.+.+||.
T Consensus       201 Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~  278 (326)
T 1blx_A          201 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA--FHSKSAQPIEKFVTDIDELGKDLLL  278 (326)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG--SCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhh--hcccCcchhhhccccCCHHHHHHHH
Confidence            99999999999999999999999999999999999988877776543322111  1111122233344556788999999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +||..||++|||+.|+|+||||++++..
T Consensus       279 ~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          279 KCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             HHcCCCcccCCCHHHHhcCccccccchh
Confidence            9999999999999999999999987643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-39  Score=340.39  Aligned_cols=218  Identities=28%  Similarity=0.454  Sum_probs=174.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+.+|+.++||||+++++++..++.+|+|||||+ ++|.+.+...   ...+++..++.++.|++.||+|||++
T Consensus        70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~  149 (351)
T 3c0i_A           70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN  149 (351)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567899999999999999999999999999999999998 5998877542   33589999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCC---eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         94 RIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~---vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      ||+||||||+|||++.++.   +||+|||+++....                                            
T Consensus       150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~--------------------------------------------  185 (351)
T 3c0i_A          150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--------------------------------------------  185 (351)
T ss_dssp             TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT--------------------------------------------
T ss_pred             CceeccCChHHeEEecCCCCCcEEEecCcceeEecC--------------------------------------------
Confidence            9999999999999986554   88888887654321                                            


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                     ........+||+.|+|||++.+.. |+.++|||
T Consensus       186 -----------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw  217 (351)
T 3c0i_A          186 -----------------------------------------------SGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVW  217 (351)
T ss_dssp             -----------------------------------------------TSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHH
T ss_pred             -----------------------------------------------CCeeecCCcCCcCccCHHHHcCCC-CCchHhhH
Confidence                                                           001112347899999999998754 89999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|+|++|..||.+.. .+.+..+........                         .......++.+.+||.+||
T Consensus       218 slG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L  271 (351)
T 3c0i_A          218 GCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN-------------------------PRQWSHISESAKDLVRRML  271 (351)
T ss_dssp             HHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC-------------------------HHHHTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC-------------------------ccccccCCHHHHHHHHHHC
Confidence            99999999999999998854 334444433211000                         0011234578999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +.||++|||+.|+|+||||++..
T Consensus       272 ~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          272 MLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             CCChhHCcCHHHHhcChhhcCCc
Confidence            99999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=343.22  Aligned_cols=218  Identities=26%  Similarity=0.395  Sum_probs=182.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++||||+++++++...+.+|||||||++ +|.+++......+++..++.++.|++.||+|||++||+
T Consensus       130 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  209 (373)
T 2x4f_A          130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL  209 (373)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34678999999999999999999999999999999999975 99999877666799999999999999999999999999


Q ss_pred             eccCCCCcEEE--ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl--~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||+|||+  +.++.+||+|||+++.....                                               
T Consensus       210 H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-----------------------------------------------  242 (373)
T 2x4f_A          210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-----------------------------------------------  242 (373)
T ss_dssp             CCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-----------------------------------------------
T ss_pred             cccCCHHHEEEecCCCCcEEEEeCCCceecCCc-----------------------------------------------
Confidence            99999999999  45567999999987543210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+. .++.++||||+||
T Consensus       243 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~  276 (373)
T 2x4f_A          243 ---------------------------------------------EKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGV  276 (373)
T ss_dssp             ---------------------------------------------CBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHH
T ss_pred             ---------------------------------------------cccccccCCCcEeChhhccCC-CCCcHHhHHHHHH
Confidence                                                         001123689999999998765 4899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.+..+.+..+..........                         .....++.+.+||.+||+.||
T Consensus       277 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dp  331 (373)
T 2x4f_A          277 IAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE-------------------------EFQDISEEAKEFISKLLIKEK  331 (373)
T ss_dssp             HHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-------------------------GGTTSCHHHHHHHHTTSCSSG
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-------------------------hhccCCHHHHHHHHHHcCCCh
Confidence            9999999999999999888888877642221111                         122345789999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+|||+.|+|+||||++..
T Consensus       332 ~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          332 SWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             GGSCCHHHHHHSHHHHCHH
T ss_pred             hhCCCHHHHhcCcCcCCCc
Confidence            9999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-39  Score=342.91  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=179.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|+.++|||||+++++|..++.+|+|||||. ++|.+++.... ..+++..++.++.||+.||+|||++||
T Consensus        70 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  149 (389)
T 3gni_B           70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY  149 (389)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3456789999999999999999999999999999999997 59999987652 469999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||++.........                                             
T Consensus       150 vHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------------  184 (389)
T 3gni_B          150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR---------------------------------------------  184 (389)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE---------------------------------------------
T ss_pred             ecCCCCHHHEEEcCCCCEEEcccccceeecccccc---------------------------------------------
Confidence            99999999999999999999999987543211000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGC  254 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~  254 (562)
                                                           ...  ........+||+.|+|||++.+. ..|+.++||||+||
T Consensus       185 -------------------------------------~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  225 (389)
T 3gni_B          185 -------------------------------------QRV--VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI  225 (389)
T ss_dssp             -------------------------------------CSC--BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHH
T ss_pred             -------------------------------------ccc--cccccccccccccccCHHHHhccCCCCCcHhHHHHHHH
Confidence                                                 000  00011234789999999999874 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcC--------CCCCCCCCCCCCCC-------Cc--cCCCCCCCccchhhhcCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLG--------TPHEDVWPGVSKLP-------IY--KTDFPEWRPKKFSEILNL  317 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg--------~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~~~~~l~~  317 (562)
                      ++|||++|++||.+.+..+.+..+....-        .+............       ..  ....+.............
T Consensus       226 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (389)
T 3gni_B          226 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT  305 (389)
T ss_dssp             HHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccc
Confidence            99999999999998776655544332110        00000000000000       00  000000000000112233


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      .++.+.+||.+||+.||++|||++|+|+||||+++..
T Consensus       306 ~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            4678999999999999999999999999999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-39  Score=334.15  Aligned_cols=254  Identities=31%  Similarity=0.597  Sum_probs=197.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+++|+.++||||+++++++...     ...|+||||++++|.+++...  .+++..++.++.|++.||.|||++
T Consensus        54 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~  131 (353)
T 2b9h_A           54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGS  131 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567999999999999999999988654     679999999999999998763  599999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++..........                ..                       
T Consensus       132 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~----------------~~-----------------------  172 (353)
T 2b9h_A          132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS----------------EP-----------------------  172 (353)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECC------------------------------------------------
T ss_pred             CeecCCCCHHHeEEcCCCcEEEEeccccccccccccccc----------------Cc-----------------------
Confidence            999999999999999999999999999875532110000                00                       


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                ..........+||+.|+|||++.+...++.++||||+|
T Consensus       173 ------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG  210 (353)
T 2b9h_A          173 ------------------------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG  210 (353)
T ss_dssp             -------------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHH
T ss_pred             ------------------------------------------cccccchhhccccccccCCeeeccCCCccchhhHHHHH
Confidence                                                      00000122457899999999998766799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC---CCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL---PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|+|++|++||.+.+..+++..+....|.+...........   ..+....+......+.......++.+.+||.+||
T Consensus       211 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  290 (353)
T 2b9h_A          211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML  290 (353)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhc
Confidence            9999999999999999999999999988887764322111100   0011112222222334444566788999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +.||++|||++|+|+||||+.....
T Consensus       291 ~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          291 VFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             CSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             CcCcccCCCHHHHhcCccccccCCc
Confidence            9999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=348.12  Aligned_cols=224  Identities=27%  Similarity=0.370  Sum_probs=184.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|..++||||++++++|.+.+.+|||||||. ++|.+++.+.+..+++..++.++.|++.||+|||++||||
T Consensus       106 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiH  185 (412)
T 2vd5_A          106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH  185 (412)
T ss_dssp             CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            457889999999999999999999999999999999996 5999999876557999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.+|.+||+|||+|+.......                                                
T Consensus       186 rDLKp~NILld~~g~vkL~DFGla~~~~~~~~------------------------------------------------  217 (412)
T 2vd5_A          186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGT------------------------------------------------  217 (412)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECCTTSC------------------------------------------------
T ss_pred             cccCHHHeeecCCCCEEEeechhheeccCCCc------------------------------------------------
Confidence            99999999999999999999999864421100                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC------CCCCCchhhHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG------AKVYSTTVDIWS  251 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~------~~~y~~~~DIWS  251 (562)
                                                                ......+||+.|+|||++.+      ...|+.++||||
T Consensus       218 ------------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwS  255 (412)
T 2vd5_A          218 ------------------------------------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA  255 (412)
T ss_dssp             ------------------------------------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHH
T ss_pred             ------------------------------------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhH
Confidence                                                      00113478999999999873      345899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +||++|||++|++||.+.+..+.+.+|.......                .++.        .....++.++|||++||.
T Consensus       256 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~p~--------~~~~~s~~~~dli~~lL~  311 (412)
T 2vd5_A          256 LGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL----------------SLPL--------VDEGVPEEARDFIQRLLC  311 (412)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----------------CCC------------CCCHHHHHHHHTTSS
T ss_pred             HhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc----------------CCCc--------cccCCCHHHHHHHHHHcC
Confidence            9999999999999999999888777776421100                0000        012245789999999999


Q ss_pred             cCCCCCC---CHHHHHcCccccCCcccCC
Q psy10954        332 LDPKQRV---SAKTILQHEYFNQVEMVKP  357 (562)
Q Consensus       332 ~DP~~R~---Ta~elL~Hp~f~~~~~~~~  357 (562)
                       ||.+|+   |++|+++||||+++++...
T Consensus       312 -~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          312 -PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             -ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence             999985   8999999999999987653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.3e-40  Score=343.24  Aligned_cols=213  Identities=29%  Similarity=0.515  Sum_probs=174.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+.+|+.+|+.++||||+++++++.....+|+||||++++|.+++.... .+++..++.++.|++.||.|||++||+|
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH  131 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVH  131 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            456789999999999999999999999999999999999889999887643 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.....                                                  
T Consensus       132 ~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--------------------------------------------------  161 (336)
T 3h4j_B          132 RDLKPENLLLDDNLNVKIADFGLSNIMTDG--------------------------------------------------  161 (336)
T ss_dssp             CCCSTTTEEECTTCCEEECCSSCTBTTTTS--------------------------------------------------
T ss_pred             cCCchhhEEEcCCCCEEEEEeccceeccCC--------------------------------------------------
Confidence            999999999999999999999987543210                                                  


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+...++.++||||+||++|
T Consensus       162 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~  199 (336)
T 3h4j_B          162 ------------------------------------------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLY  199 (336)
T ss_dssp             ------------------------------------------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHH
Confidence                                                      00123468999999999987765689999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.....               ....+..   ....           .....++.+.+||++||+.||.+|
T Consensus       200 ~ll~g~~Pf~~~~~~~---------------~~~~i~~---~~~~-----------~p~~~s~~~~~li~~~L~~dP~~R  250 (336)
T 3h4j_B          200 VMLVGRLPFDDEFIPN---------------LFKKVNS---CVYV-----------MPDFLSPGAQSLIRRMIVADPMQR  250 (336)
T ss_dssp             HHHHSSCSSBCSSSTT---------------CBCCCCS---SCCC-----------CCTTSCHHHHHHHHTTSCSSGGGS
T ss_pred             HHHhCCCCCCCccHHH---------------HHHHHHc---CCCC-----------CcccCCHHHHHHHHHHcCCChhHC
Confidence            9999999997653211               0000000   0000           111236789999999999999999


Q ss_pred             CCHHHHHcCccccCC
Q psy10954        338 VSAKTILQHEYFNQV  352 (562)
Q Consensus       338 ~Ta~elL~Hp~f~~~  352 (562)
                      ||++|+++||||+..
T Consensus       251 pt~~eil~hp~~~~~  265 (336)
T 3h4j_B          251 ITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CCHHHHTTCHHHHTT
T ss_pred             cCHHHHHhChhhccC
Confidence            999999999999853

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-39  Score=336.79  Aligned_cols=246  Identities=31%  Similarity=0.575  Sum_probs=191.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC-------EEEEEeecCcCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF-------KLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-------~i~lV~Ey~~~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL   87 (562)
                      .....+|++.++.++||||++++++|....       .+|+||||++++|...+..   ....+++..++.++.|++.||
T Consensus        63 ~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  142 (360)
T 3e3p_A           63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI  142 (360)
T ss_dssp             CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence            446778888889999999999999997643       2899999999988766543   445689999999999999999


Q ss_pred             HHHH--HCCceeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         88 RYCH--SRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        88 ~yLH--~~gIiHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      .|||  ++||+||||||+|||++. ++.+||+|||+++.....                                     
T Consensus       143 ~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~-------------------------------------  185 (360)
T 3e3p_A          143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-------------------------------------  185 (360)
T ss_dssp             HHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT-------------------------------------
T ss_pred             HHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC-------------------------------------
Confidence            9999  999999999999999996 889999999987643210                                     


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                                             ......+||+.|+|||++.+...++
T Consensus       186 -------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  210 (360)
T 3e3p_A          186 -------------------------------------------------------EPNVAYICSRYYRAPELIFGNQHYT  210 (360)
T ss_dssp             -------------------------------------------------------SCCCSTTSCGGGCCHHHHTTCSSCC
T ss_pred             -------------------------------------------------------CCcccccCCcceeCHHHHcCCCCCC
Confidence                                                                   0011246799999999998877799


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcC----CCCH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN----LPDP  320 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----~~~~  320 (562)
                      .++||||+||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+........ ...+.......+...+.    ..++
T Consensus       211 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  289 (360)
T 3e3p_A          211 TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHT-DVDLYNSKGIPWSNVFSDHSLKDAK  289 (360)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCC-CGGGGCCCCCCHHHHTTTCCCTTHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchh-hccccccccCCcccccchhhccccH
Confidence            999999999999999999999999999999999999988876654432211100 00001111111222222    1356


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcCccccCCcccC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      .+.+||.+||+.||++|||+.|+|+||||+++....
T Consensus       290 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          290 EAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             HHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence            799999999999999999999999999999886543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-39  Score=341.89  Aligned_cols=217  Identities=26%  Similarity=0.460  Sum_probs=180.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++.....+|+|||||.+ +|.+++......+++..++.++.|++.||+|||++||+|
T Consensus        93 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  172 (387)
T 1kob_A           93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH  172 (387)
T ss_dssp             HHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            3578999999999999999999999999999999999975 999999876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEcc--CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         98 RDLKPQNILINK--SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        98 RDLKP~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||+|||++.  ++.+||+|||+++.....                                                
T Consensus       173 rDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~------------------------------------------------  204 (387)
T 1kob_A          173 LDIKPENIMCETKKASSVKIIDFGLATKLNPD------------------------------------------------  204 (387)
T ss_dssp             CCCCGGGEEESSTTCCCEEECCCTTCEECCTT------------------------------------------------
T ss_pred             cccchHHeEEecCCCCceEEEecccceecCCC------------------------------------------------
Confidence            999999999974  467899999987543210                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. ++.++||||+||+
T Consensus       205 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~i  239 (387)
T 1kob_A          205 --------------------------------------------EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVL  239 (387)
T ss_dssp             --------------------------------------------SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHH
T ss_pred             --------------------------------------------cceeeeccCCCccCchhccCCC-CCCcccEeeHhHH
Confidence                                                        0011236799999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|..||.+.+..+.+..+..........                         .....++.+.+||.+||+.||+
T Consensus       240 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~  294 (387)
T 1kob_A          240 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-------------------------AFSSVSPEAKDFIKNLLQKEPR  294 (387)
T ss_dssp             HHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS-------------------------TTTTSCHHHHHHHHTTSCSSGG
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------------------ccccCCHHHHHHHHHHcCCChh
Confidence            999999999999998887777765532111111                         1123457899999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +|||+.|+|+||||++..
T Consensus       295 ~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          295 KRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             GSCCHHHHHTSTTTSSCC
T ss_pred             HCcCHHHHhhCccccCCc
Confidence            999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-39  Score=338.76  Aligned_cols=262  Identities=25%  Similarity=0.376  Sum_probs=195.1

Q ss_pred             hhHHHHHHHHHccC-----CCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELK-----HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-----HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ....+|+.+|+.+.     ||||+++++++...+.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||+
T Consensus        76 ~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  155 (360)
T 3llt_A           76 RSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK  155 (360)
T ss_dssp             HHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45678999999996     999999999999999999999999889999997654 359999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+|||++.....+-. .+... .                                                
T Consensus       156 ~~ivHrDlkp~NIll~~~~~~~~~-~~~~~-~------------------------------------------------  185 (360)
T 3llt_A          156 MSLTHTDLKPENILLDDPYFEKSL-ITVRR-V------------------------------------------------  185 (360)
T ss_dssp             TTEECSCCSGGGEEESCTTCCEEE-EEEEC-T------------------------------------------------
T ss_pred             CCeeeCCCCcccEEEccccccccc-cchhc-c------------------------------------------------
Confidence            999999999999999865322100 00000 0                                                


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                      .|-+...+..+.++.+||+|||+|+....   .....+||+.|+|||++.+.. |+.++||||+
T Consensus       186 ----------------~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Diwsl  245 (360)
T 3llt_A          186 ----------------TDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLG-WDVSSDMWSF  245 (360)
T ss_dssp             ----------------TTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHH
T ss_pred             ----------------cccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCC-CCCccchHHH
Confidence                            00011122334678999999999986443   234568999999999998765 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC--------CCCccCCCCCCCccc---------hhhhc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--------LPIYKTDFPEWRPKK---------FSEIL  315 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---------~~~~l  315 (562)
                      ||++|+|++|+.||.+.+..+.+..+....+..+...+.....        .......++......         ....-
T Consensus       246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  325 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK  325 (360)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred             HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence            9999999999999999999998888888877665432211100        000011111111000         00011


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q psy10954        316 NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       316 ~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      ...++.+.+||.+||+.||++|||++|+|+||||+
T Consensus       326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            12346788999999999999999999999999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.2e-39  Score=333.08  Aligned_cols=215  Identities=28%  Similarity=0.435  Sum_probs=176.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++...+.+|+|||||.+ +|.+++.... .+++..++.++.|++.||.|||++||+|
T Consensus        66 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH  144 (327)
T 3a62_A           66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIY  144 (327)
T ss_dssp             -----HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            4567899999999999999999999999999999999974 9999987643 6899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       145 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  175 (327)
T 3a62_A          145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDG-------------------------------------------------  175 (327)
T ss_dssp             CCCCTTTEEECTTSCEEECCCSCC--------------------------------------------------------
T ss_pred             ccCCHHHeEECCCCcEEEEeCCcccccccCC-------------------------------------------------
Confidence            9999999999999999999999875321000                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                ......+||+.|+|||++.+.. ++.++||||+||++|
T Consensus       176 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~  212 (327)
T 3a62_A          176 ------------------------------------------TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMY  212 (327)
T ss_dssp             ---------------------------------------------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHH
T ss_pred             ------------------------------------------ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHH
Confidence                                                      0012346899999999997654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||.+.+..+.+..+......                  ++           ...++.+.+||.+||+.||++|
T Consensus       213 el~~g~~pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~~L~~dp~~R  263 (327)
T 3a62_A          213 DMLTGAPPFTGENRKKTIDKILKCKLN------------------LP-----------PYLTQEARDLLKKLLKRNAASR  263 (327)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHTCCC------------------CC-----------TTSCHHHHHHHHHHSCSCGGGS
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------CCCCHHHHHHHHHHHhcCHhhc
Confidence            999999999999888777777653110                  00           1235678999999999999999


Q ss_pred             C-----CHHHHHcCccccCCccc
Q psy10954        338 V-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       338 ~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      +     ++.|+++||||+++.+.
T Consensus       264 ~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          264 LGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             TTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             cCCCCCCHHHHHcCCcccCCCHH
Confidence            9     89999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.8e-40  Score=336.75  Aligned_cols=216  Identities=22%  Similarity=0.273  Sum_probs=151.6

Q ss_pred             HHHHHHHccCCCCcceEEEEEEeCC----EEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         23 REISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        23 rEi~iL~~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      +|+..+.+++|||||++++++..++    .+|||||||+ ++|.++++..  .++++.+..++.|++.||+|||+++   
T Consensus        46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~---  120 (303)
T 3hmm_A           46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEI---  120 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCB---
T ss_pred             HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhh---
Confidence            3555556889999999999998653    6899999998 5999999865  5899999999999999999999652   


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                                                                                                      
T Consensus       121 --------------------------------------------------------------------------------  120 (303)
T 3hmm_A          121 --------------------------------------------------------------------------------  120 (303)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCC----cccccccCCCccchhhhcCCC-----CCCchhh
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAK-----VYSTTVD  248 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~----~~~~~vgT~~Y~APEvl~~~~-----~y~~~~D  248 (562)
                      +.++|+.+||||||||+|||++.+|.+||+|||+|+.......    ...+.+||+.|||||++.+..     .|+.++|
T Consensus       121 ~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D  200 (303)
T 3hmm_A          121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD  200 (303)
T ss_dssp             CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred             hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence            1134556777777777777777777788888887776543322    223468999999999997642     3677999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhh
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSE--------------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEI  314 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~--------------~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (562)
                      |||+||++|||++|.+||.....              .+.+...+..-+.                  .|.. +..   .
T Consensus       201 VwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------------------rp~~-p~~---~  258 (303)
T 3hmm_A          201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL------------------RPNI-PNR---W  258 (303)
T ss_dssp             HHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC------------------CCCC-CGG---G
T ss_pred             hhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccC------------------CCCC-Ccc---c
Confidence            99999999999999887754321              1111111100000                  0000 000   0


Q ss_pred             cCC-CCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        315 LNL-PDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       315 l~~-~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      ... ....+.+|+.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          259 QSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            000 1135679999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-39  Score=339.74  Aligned_cols=217  Identities=29%  Similarity=0.465  Sum_probs=182.9

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ......+|..+|+.+ +||||++++++|.+...+|+|||||. ++|.+++.... .+++..++.++.|++.||+|||++|
T Consensus        60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~  138 (345)
T 1xjd_A           60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG  138 (345)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678999999877 99999999999999999999999997 49999987643 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.+|.+||+|||+|+......                                              
T Consensus       139 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----------------------------------------------  172 (345)
T 1xjd_A          139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----------------------------------------------  172 (345)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----------------------------------------------
T ss_pred             eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC----------------------------------------------
Confidence            9999999999999999999999999875321100                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+.. |+.++||||+||
T Consensus       173 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  206 (345)
T 1xjd_A          173 ---------------------------------------------AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGV  206 (345)
T ss_dssp             ---------------------------------------------CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             ---------------------------------------------CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHH
Confidence                                                         0112457899999999998765 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..+.....                  .++           ...++.+.+||.+||+.||
T Consensus       207 il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~~li~~lL~~dp  257 (345)
T 1xjd_A          207 LLYEMLIGQSPFHGQDEEELFHSIRMDNP------------------FYP-----------RWLEKEAKDLLVKLFVREP  257 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------CCC-----------TTSCHHHHHHHHHHSCSSG
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHhCCC------------------CCC-----------cccCHHHHHHHHHHhcCCH
Confidence            99999999999999888777776654210                  011           1135689999999999999


Q ss_pred             CCCCCHH-HHHcCccccCCccc
Q psy10954        335 KQRVSAK-TILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~Ta~-elL~Hp~f~~~~~~  355 (562)
                      ++|+|+. |+++||||+++++.
T Consensus       258 ~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          258 EKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             GGSBTTBSCGGGSGGGTTCCHH
T ss_pred             hHcCCChHHHHcCccccCCCHH
Confidence            9999998 99999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-39  Score=344.74  Aligned_cols=216  Identities=29%  Similarity=0.461  Sum_probs=175.8

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|..+|+++ +|||||+++++|.+...+|+|||||.+ +|..++.... .+++..++.++.||+.||+|||++||
T Consensus        96 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~gi  174 (396)
T 4dc2_A           96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGI  174 (396)
T ss_dssp             CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34578999999887 899999999999999999999999975 9999887643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.+|.+||+|||+|+.....                                                
T Consensus       175 vHrDLKp~NILl~~~g~ikL~DFGla~~~~~~------------------------------------------------  206 (396)
T 4dc2_A          175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------------------------------------------------  206 (396)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCT------------------------------------------------
T ss_pred             EeccCCHHHEEECCCCCEEEeecceeeecccC------------------------------------------------
Confidence            99999999999999999999999997632110                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .....+.+||+.|+|||++.+.. |+.++||||+||+
T Consensus       207 -------------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvl  242 (396)
T 4dc2_A          207 -------------------------------------------GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVL  242 (396)
T ss_dssp             -------------------------------------------TCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             -------------------------------------------CCccccccCCcccCCchhhcCCC-CChHHHHHHHHHH
Confidence                                                       00123457899999999998765 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCH--------HH-HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        256 FSEMITKKTLFAGDSE--------ID-QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       256 l~eLltG~~pF~~~~~--------~~-~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +|||++|++||.+...        .+ ....+... ..                 .+|           ...++.+.+||
T Consensus       243 lyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~-----------------~~p-----------~~~s~~~~~li  293 (396)
T 4dc2_A          243 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI-----------------RIP-----------RSLSVKAASVL  293 (396)
T ss_dssp             HHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CC-----------------CCC-----------TTSCHHHHHHH
T ss_pred             HHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-cc-----------------CCC-----------CcCCHHHHHHH
Confidence            9999999999974321        12 22222221 00                 000           12357899999


Q ss_pred             HHccccCCCCCCCH------HHHHcCccccCCccc
Q psy10954        327 SKIMALDPKQRVSA------KTILQHEYFNQVEMV  355 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta------~elL~Hp~f~~~~~~  355 (562)
                      ++||+.||++|+|+      +|+++||||+++++.
T Consensus       294 ~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          294 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             HHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             HHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            99999999999995      799999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7e-39  Score=336.29  Aligned_cols=217  Identities=25%  Similarity=0.389  Sum_probs=183.2

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ......+|..+|+.+ +||||++++++|...+.+|+|||||.+ +|.+++...+ .+++..++.++.|++.||+|||++|
T Consensus        63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g  141 (353)
T 2i0e_A           63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG  141 (353)
T ss_dssp             CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678999999988 899999999999999999999999975 9999987643 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.+|.+||+|||+|+......                                              
T Consensus       142 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----------------------------------------------  175 (353)
T 2i0e_A          142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----------------------------------------------  175 (353)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----------------------------------------------
T ss_pred             EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC----------------------------------------------
Confidence            9999999999999999999999999875321000                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+.. |+.++||||+||
T Consensus       176 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  209 (353)
T 2i0e_A          176 ---------------------------------------------VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV  209 (353)
T ss_dssp             ---------------------------------------------CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHH
T ss_pred             ---------------------------------------------cccccccCCccccChhhhcCCC-cCCcccccchHH
Confidence                                                         0112357899999999997654 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..|....-.                  ++           ...++.+.+||.+||+.||
T Consensus       210 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~lL~~dP  260 (353)
T 2i0e_A          210 LLYEMLAGQAPFEGEDEDELFQSIMEHNVA------------------YP-----------KSMSKEAVAICKGLMTKHP  260 (353)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSCT
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------CCCCHHHHHHHHHHhhcCH
Confidence            999999999999999888777777652110                  11           1235789999999999999


Q ss_pred             CCCCC-----HHHHHcCccccCCccc
Q psy10954        335 KQRVS-----AKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~T-----a~elL~Hp~f~~~~~~  355 (562)
                      ++|++     ++|+++||||+.+++.
T Consensus       261 ~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          261 GKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             TSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             HHcCCCCCCCHHHHhcCccccCCCHH
Confidence            99994     6999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=337.81  Aligned_cols=217  Identities=26%  Similarity=0.432  Sum_probs=176.8

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|+.++|||||+++++|.+...+|+|||||.+ +|..++... ..+++..++.++.|++.||.|||++||
T Consensus        58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~gi  136 (384)
T 4fr4_A           58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRI  136 (384)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678999999999999999999999999999999999975 999998764 469999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.+|.+||+|||+|+.....                                                
T Consensus       137 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~------------------------------------------------  168 (384)
T 4fr4_A          137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRE------------------------------------------------  168 (384)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECCTT------------------------------------------------
T ss_pred             eeccCcHHHeEECCCCCEEEeccceeeeccCC------------------------------------------------
Confidence            99999999999999999999999987643210                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAG  253 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIWSlG  253 (562)
                                                                  ....+.+||+.|+|||++.+.  ..|+.++||||+|
T Consensus       169 --------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG  204 (384)
T 4fr4_A          169 --------------------------------------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG  204 (384)
T ss_dssp             --------------------------------------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHH
T ss_pred             --------------------------------------------CceeccCCCccccCCeeeccCCCCCCCccceeechH
Confidence                                                        011234688999999998643  3489999999999


Q ss_pred             HHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSE---IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|||++|+.||.+.+.   .+....+......                  +           ....++.+.+||.+||
T Consensus       205 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------------~-----------p~~~s~~~~~li~~lL  255 (384)
T 4fr4_A          205 VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT------------------Y-----------PSAWSQEMVSLLKKLL  255 (384)
T ss_dssp             HHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC------------------C-----------CTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC------------------C-----------CCcCCHHHHHHHHHHh
Confidence            999999999999975432   2222222221000                  0           0123568999999999


Q ss_pred             ccCCCCCCC-HHHHHcCccccCCccc
Q psy10954        331 ALDPKQRVS-AKTILQHEYFNQVEMV  355 (562)
Q Consensus       331 ~~DP~~R~T-a~elL~Hp~f~~~~~~  355 (562)
                      +.||++|++ ++++++||||+++++.
T Consensus       256 ~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          256 EPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             CSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             cCCHhHhcccHHHHHcChhhhcCCHH
Confidence            999999998 8999999999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.3e-39  Score=334.26  Aligned_cols=215  Identities=29%  Similarity=0.457  Sum_probs=174.8

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|+++ +||||++++++|.+...+|+|||||.+ +|.+++.... .+++..++.++.|++.||+|||++||+
T Consensus        54 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iv  132 (345)
T 3a8x_A           54 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGII  132 (345)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            4567899999988 899999999999999999999999975 9999987643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.+|.+||+|||+++......                                                
T Consensus       133 HrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~------------------------------------------------  164 (345)
T 3a8x_A          133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG------------------------------------------------  164 (345)
T ss_dssp             CCCCCGGGEEECTTSCEEECCGGGCBCSCCTT------------------------------------------------
T ss_pred             ecCCCHHHEEECCCCCEEEEeccccccccCCC------------------------------------------------
Confidence            99999999999999999999999875321100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ....+.+||+.|+|||++.+.. |+.++||||+||++
T Consensus       165 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  200 (345)
T 3a8x_A          165 -------------------------------------------DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLM  200 (345)
T ss_dssp             -------------------------------------------CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHH
T ss_pred             -------------------------------------------CcccccCCCccccCccccCCCC-CChHHhHHHHHHHH
Confidence                                                       0112357899999999998754 89999999999999


Q ss_pred             HHHHhCCCCCCCC---------CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        257 SEMITKKTLFAGD---------SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       257 ~eLltG~~pF~~~---------~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||++|++||.+.         ........+....  .                .++           ...++.+.+||.
T Consensus       201 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~----------------~~p-----------~~~s~~~~~li~  251 (345)
T 3a8x_A          201 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--I----------------RIP-----------RSLSVKAASVLK  251 (345)
T ss_dssp             HHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--C----------------CCC-----------TTSCHHHHHHHH
T ss_pred             HHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--C----------------CCC-----------CCCCHHHHHHHH
Confidence            9999999999752         1122222232210  0                000           123568999999


Q ss_pred             HccccCCCCCCCH------HHHHcCccccCCccc
Q psy10954        328 KIMALDPKQRVSA------KTILQHEYFNQVEMV  355 (562)
Q Consensus       328 ~mL~~DP~~R~Ta------~elL~Hp~f~~~~~~  355 (562)
                      +||+.||++|+|+      +|+++||||+++++.
T Consensus       252 ~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             HHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             HHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            9999999999995      899999999988753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.3e-39  Score=335.37  Aligned_cols=216  Identities=28%  Similarity=0.462  Sum_probs=170.3

Q ss_pred             hHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         20 TALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        20 ~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ...+|+++|.++ +||||++++++|.++..+|+|||||.+ +|.+++.... .+++..++.++.|++.||+|||++||+|
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH  139 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVH  139 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            346899999888 799999999999999999999999975 9999987653 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEccC-C---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         98 RDLKPQNILINKS-G---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        98 RDLKP~NILl~~~-~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |||||+|||+..+ +   .+||+|||+++...                                                
T Consensus       140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~------------------------------------------------  171 (342)
T 2qr7_A          140 RDLKPSNILYVDESGNPESIRICDFGFAKQLR------------------------------------------------  171 (342)
T ss_dssp             SCCCGGGEEESSSSCSGGGEEECCCTTCEECB------------------------------------------------
T ss_pred             ccCCHHHEEEecCCCCcCeEEEEECCCcccCc------------------------------------------------
Confidence            9999999998533 2   37777777664321                                                


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                 .......+.+||+.|+|||++.+.. |+.++||||+|
T Consensus       172 -------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  207 (342)
T 2qr7_A          172 -------------------------------------------AENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLG  207 (342)
T ss_dssp             -------------------------------------------CTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHH
T ss_pred             -------------------------------------------CCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHh
Confidence                                                       1111223457899999999997644 89999999999


Q ss_pred             HHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGD---SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~---~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|||++|.+||.+.   +..+.+..+....-.....                         .....++.+.+||.+||
T Consensus       208 ~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L  262 (342)
T 2qr7_A          208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG-------------------------YWNSVSDTAKDLVSKML  262 (342)
T ss_dssp             HHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST-------------------------TTTTSCHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc-------------------------ccccCCHHHHHHHHHHC
Confidence            9999999999999863   3334444443321111100                         11223578999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ..||++|||+.|+|+||||.+..
T Consensus       263 ~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          263 HVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             CSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             CCChhHCcCHHHHhcCCeecCcc
Confidence            99999999999999999997643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-39  Score=333.16  Aligned_cols=243  Identities=36%  Similarity=0.706  Sum_probs=186.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+.+|+.++||||+++++++......|+||||+++++...+......+++..++.++.|++.||.|||++||+||
T Consensus        69 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  148 (331)
T 4aaa_A           69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR  148 (331)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEcc
Confidence            44679999999999999999999999999999999999975444444444579999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++......                                                  
T Consensus       149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------------  178 (331)
T 4aaa_A          149 DIKPENILVSQSGVVKLCDFGFARTLAAPG--------------------------------------------------  178 (331)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTC---------------------------------------------------------
T ss_pred             CcChheEEEcCCCcEEEEeCCCceeecCCc--------------------------------------------------
Confidence            999999999999999999999875432110                                                  


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                               ......+||+.|+|||++.+...++.++||||+||++|+
T Consensus       179 -----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~  217 (331)
T 4aaa_A          179 -----------------------------------------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTE  217 (331)
T ss_dssp             ----------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred             -----------------------------------------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHH
Confidence                                                     001223678999999999877678999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc-CCCCCCC-ccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWR-PKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |++|++||.+.+..+.+..+....|......+......+.+. ...+... ........+..++.+.+|+.+||+.||++
T Consensus       218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  297 (331)
T 4aaa_A          218 MFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK  297 (331)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCccc
Confidence            999999999999999888888877754332111000000000 0111111 11122233445788999999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++|+|+||||+..
T Consensus       298 Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          298 RPFCAELLHHDFFQMD  313 (331)
T ss_dssp             SCCGGGGGGSHHHHGG
T ss_pred             CCCHHHHhcCchhccC
Confidence            9999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-39  Score=326.12  Aligned_cols=213  Identities=26%  Similarity=0.473  Sum_probs=171.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++|+.++||||+++++++..  ...+|+||||+++ +|.+++.  ...+++..++.++.|++.||.|||++|
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~  157 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK  157 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4568899999999999999999999987  5789999999975 7766543  236999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.++.+||+|||+++.......                                             
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---------------------------------------------  192 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---------------------------------------------  192 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC---------------------------------------------
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCccccccccc---------------------------------------------
Confidence            99999999999999999999999999764421100                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC--CCchhhHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSA  252 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~--y~~~~DIWSl  252 (562)
                                                                    .....+||+.|+|||++.+...  ++.++||||+
T Consensus       193 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  226 (298)
T 2zv2_A          193 ----------------------------------------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM  226 (298)
T ss_dssp             ----------------------------------------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred             ----------------------------------------------cccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence                                                          0112367888999998876542  4788999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|+.||.+.........+......                  ++.         ....++.+.+||.+||+.
T Consensus       227 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~---------~~~~~~~l~~li~~~l~~  279 (298)
T 2zv2_A          227 GVTLYCFVFGQCPFMDERIMCLHSKIKSQALE------------------FPD---------QPDIAEDLKDLITRMLDK  279 (298)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CCS---------SSCCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHCCCCCCCccHHHHHHHHhcccCC------------------CCC---------ccccCHHHHHHHHHHhhc
Confidence            99999999999999988766555444332110                  000         012356789999999999


Q ss_pred             CCCCCCCHHHHHcCcccc
Q psy10954        333 DPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~  350 (562)
                      ||++|||+.|+|+||||+
T Consensus       280 dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          280 NPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CTTTSCCHHHHTTCHHHH
T ss_pred             ChhhCCCHHHHhcCcccc
Confidence            999999999999999996

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=334.03  Aligned_cols=240  Identities=37%  Similarity=0.656  Sum_probs=192.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCE------EEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFK------LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~------i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|+.++||||+++++++.....      .|+||||+.++|.+++..   .+++..++.++.|++.||.|||
T Consensus        67 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH  143 (353)
T 3coi_A           67 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH  143 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999987643      599999999988877643   5999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+||+|||+++.....                                            
T Consensus       144 ~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------  179 (353)
T 3coi_A          144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--------------------------------------------  179 (353)
T ss_dssp             HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------------------------------------------
T ss_pred             HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--------------------------------------------
Confidence            999999999999999999999999999987532100                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                        ....+||+.|+|||++.+...++.++||||
T Consensus       180 --------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s  209 (353)
T 3coi_A          180 --------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWS  209 (353)
T ss_dssp             ------------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHH
T ss_pred             --------------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHH
Confidence                                                              012357899999999987667899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|+|++|+.||.+.+..+.+..+....|.+..+.+.......  .+....+......+.......++.+.+||.+|
T Consensus       210 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (353)
T 3coi_A          210 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM  289 (353)
T ss_dssp             HHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHH
Confidence            9999999999999999999999999999988887665443332110  01111122222223334445678899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |+.||++|||++|+|+||||+....
T Consensus       290 L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          290 LELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             SCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             cCCCcccCCCHHHHhcCcchhhccC
Confidence            9999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.9e-39  Score=331.64  Aligned_cols=220  Identities=25%  Similarity=0.427  Sum_probs=176.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++..++..|+|||||.+ +|.+++... ..+++..++.++.|++.||+|||++||+
T Consensus        49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~giv  127 (323)
T 3tki_A           49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (323)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678999999999999999999999999999999999975 899888654 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.+.....                                               
T Consensus       128 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------------------------------------------  160 (323)
T 3tki_A          128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNR-----------------------------------------------  160 (323)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECEETTE-----------------------------------------------
T ss_pred             ccccchHHEEEeCCCCEEEEEeeccceeccCCc-----------------------------------------------
Confidence            999999999999999999999999864421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .......+||+.|+|||++.+...++.++||||+||++
T Consensus       161 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  198 (323)
T 3tki_A          161 ------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL  198 (323)
T ss_dssp             ------------------------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHH
Confidence                                                      00012347899999999998877668899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.................                 .+         .....++.+.+|+.+||+.||++
T Consensus       199 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------------~~---------~~~~~~~~~~~li~~~L~~dP~~  252 (323)
T 3tki_A          199 TAMLAGELPWDQPSDSCQEYSDWKEKKTY-----------------LN---------PWKKIDSAPLALLHKILVENPSA  252 (323)
T ss_dssp             HHHHHSSCSCSSSCTTSHHHHHHHTTCTT-----------------ST---------TGGGSCHHHHHHHHHHSCSSTTT
T ss_pred             HHHHhCCCCCCCCchHHHHHHHHhccccc-----------------CC---------ccccCCHHHHHHHHHHccCChhh
Confidence            99999999998766543222222111000                 00         01123567899999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||++|+++||||++..
T Consensus       253 R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          253 RITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             SCCHHHHTTCTTTTCCC
T ss_pred             CcCHHHHhhChhhcccc
Confidence            99999999999998653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.1e-39  Score=339.27  Aligned_cols=215  Identities=27%  Similarity=0.388  Sum_probs=174.8

Q ss_pred             hhHHHHHHH-HHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~i-L~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|..+ ++.++||||++++++|.+.+.+|+|||||.+ +|.+++.+.. .+++..++.++.||+.||+|||++||+
T Consensus        83 ~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~giv  161 (373)
T 2r5t_A           83 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIV  161 (373)
T ss_dssp             --------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            446677777 5778999999999999999999999999975 9999987643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.+|.+||+|||+++.....                                                 
T Consensus       162 HrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-------------------------------------------------  192 (373)
T 2r5t_A          162 YRDLKPENILLDSQGHIVLTDFGLCKENIEH-------------------------------------------------  192 (373)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCCBCGGGBCC-------------------------------------------------
T ss_pred             ecCCCHHHEEECCCCCEEEeeCccccccccC-------------------------------------------------
Confidence            9999999999999999999999987532110                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .....+.+||+.|+|||++.+.. |+.++||||+||++
T Consensus       193 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  229 (373)
T 2r5t_A          193 ------------------------------------------NSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVL  229 (373)
T ss_dssp             ------------------------------------------CCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHH
T ss_pred             ------------------------------------------CCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHH
Confidence                                                      00112457899999999998754 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|.+||.+.+..+....|....-.                  +           ....++.+.+||.+||+.||.+
T Consensus       230 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------------~-----------~~~~~~~~~~li~~lL~~dp~~  280 (373)
T 2r5t_A          230 YEMLYGLPPFYSRNTAEMYDNILNKPLQ------------------L-----------KPNITNSARHLLEGLLQKDRTK  280 (373)
T ss_dssp             HHHHHSSCTTCCSBHHHHHHHHHHSCCC------------------C-----------CSSSCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHcCCCCCCCCCHHHHHHHHHhcccC------------------C-----------CCCCCHHHHHHHHHHcccCHHh
Confidence            9999999999999888877777652100                  0           0123568999999999999999


Q ss_pred             CCCH----HHHHcCccccCCccc
Q psy10954        337 RVSA----KTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~Ta----~elL~Hp~f~~~~~~  355 (562)
                      |+++    .|+++||||+.+++.
T Consensus       281 R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          281 RLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             STTTTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCCCCCHHHHhCCccccCCCHH
Confidence            9996    699999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-38  Score=345.99  Aligned_cols=218  Identities=30%  Similarity=0.523  Sum_probs=179.4

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+++|++++||||+++++++.....+|+|||||.+ +|.+.+.... .+++..++.++.|++.||.|||++||
T Consensus        64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i  142 (486)
T 3mwu_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNI  142 (486)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            355688999999999999999999999999999999999975 9998886643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEc---cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         96 IHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        96 iHRDLKP~NILl~---~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||||||+|||++   .++.+||+|||+|+.....                                             
T Consensus       143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---------------------------------------------  177 (486)
T 3mwu_A          143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---------------------------------------------  177 (486)
T ss_dssp             CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---------------------------------------------
T ss_pred             EeccCchHHEEEecCCCCCCEEEEECCcCeECCCC---------------------------------------------
Confidence            9999999999995   3456888888876533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+  .|+.++||||+
T Consensus       178 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Diwsl  208 (486)
T 3mwu_A          178 -----------------------------------------------TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSA  208 (486)
T ss_dssp             ---------------------------------------------------CCTTGGGGCCGGGGGS--CCCHHHHHHHH
T ss_pred             -----------------------------------------------CccCCCcCCCCCCCHHHhCC--CCCchhhHHHH
Confidence                                                           01123468999999999976  38999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|.+||.+.+..+.+..+.........                +.         ....++.+++||.+||+.
T Consensus       209 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------~~---------~~~~s~~~~~li~~~L~~  263 (486)
T 3mwu_A          209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------------PQ---------WRTISDDAKDLIRKMLTF  263 (486)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----------------GG---------GGGSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----------------cc---------cCCCCHHHHHHHHHHcCC
Confidence            99999999999999999988887777653211111                11         112356899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCcc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      ||++|||+.|+|+||||+....
T Consensus       264 dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          264 HPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             STTTSCCHHHHHHCHHHHHTCC
T ss_pred             ChhhCcCHHHHhcCHhhccCcc
Confidence            9999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.7e-39  Score=336.19  Aligned_cols=219  Identities=28%  Similarity=0.453  Sum_probs=165.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++.....+|+|||||. ++|.+++...+ .+++..++.++.|++.||+|||++||+
T Consensus        60 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~iv  138 (361)
T 3uc3_A           60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQIC  138 (361)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567899999999999999999999999999999999997 49999987643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCC--eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl~~~~~--vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||+|||++.++.  +||+|||+|+.....                                               
T Consensus       139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-----------------------------------------------  171 (361)
T 3uc3_A          139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----------------------------------------------  171 (361)
T ss_dssp             SCCCCGGGEEECSSSSCCEEECCCCCC-----------------------------------------------------
T ss_pred             cCCCCHHHEEEcCCCCceEEEeecCcccccccc-----------------------------------------------
Confidence            9999999999987665  899999986522100                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+...++.++||||+||
T Consensus       172 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  206 (361)
T 3uc3_A          172 ---------------------------------------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV  206 (361)
T ss_dssp             ------------------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHH
T ss_pred             ---------------------------------------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHH
Confidence                                                         00123468999999999988765555699999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|+.||.+.........+.........              .++.         ....++.+.+||.+||+.||
T Consensus       207 il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~s~~~~~li~~~L~~dP  263 (361)
T 3uc3_A          207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY--------------SIPD---------DIRISPECCHLISRIFVADP  263 (361)
T ss_dssp             HHHHHHHSSCSCC----CCCHHHHHHHHHTTCC--------------CCCT---------TSCCCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC--------------CCCC---------cCCCCHHHHHHHHHHccCCh
Confidence            999999999999876543222222221110000              0000         01235788999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++|||+.|+++||||...
T Consensus       264 ~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          264 ATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             TTSCCHHHHHTSHHHHTT
T ss_pred             hHCcCHHHHHhCcchhcC
Confidence            999999999999999653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.5e-39  Score=327.52  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=195.0

Q ss_pred             hhhHHHHHHHHHccCCC------CcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHP------NVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~Hp------nIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ...+.+|+++++.++|+      +|+++++++...+.+|+||||++++|.+++.... ..+++..++.++.|++.||+||
T Consensus        55 ~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l  134 (339)
T 1z57_A           55 CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL  134 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH
Confidence            35678999999998765      4999999999999999999999889999997754 3589999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |++||+||||||+|||++.++..+..+.+....                                               
T Consensus       135 H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~-----------------------------------------------  167 (339)
T 1z57_A          135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD-----------------------------------------------  167 (339)
T ss_dssp             HHTTEECCCCCGGGEEESCCCEEEEEC----CE-----------------------------------------------
T ss_pred             HHCCCcCCCCCHHHEEEeccccccccCCccccc-----------------------------------------------
Confidence            999999999999999998765444322211000                                               


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                               ---..++.+||+|||+++....   .....+||+.|+|||++.+.. |+.++|||
T Consensus       168 -------------------------~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~  218 (339)
T 1z57_A          168 -------------------------ERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALG-WSQPCDVW  218 (339)
T ss_dssp             -------------------------EEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSC-CCTHHHHH
T ss_pred             -------------------------cccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCC-CCcchhhH
Confidence                                     0001356899999999876432   234568999999999998755 89999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCcc------------chhhhcC--
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK------------KFSEILN--  316 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~l~--  316 (562)
                      |+||++|||++|..||.+.+..+.+..+....+..+...+........+......|...            .+.....  
T Consensus       219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
T 1z57_A          219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ  298 (339)
T ss_dssp             HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence            99999999999999999999888888888887766554332222111111111111100            0000011  


Q ss_pred             -CCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        317 -LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       317 -~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                       ..++.+.+||.+||+.||++|||++|+|+||||+.+.
T Consensus       299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             hhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence             1135688999999999999999999999999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-38  Score=345.35  Aligned_cols=213  Identities=29%  Similarity=0.521  Sum_probs=180.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++...+.+|+|||||+ ++|.+++... +.+++..++.++.|++.||+|||++||+
T Consensus        60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giv  138 (476)
T 2y94_A           60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVV  138 (476)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            4567899999999999999999999999999999999996 4999998754 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.....                                                 
T Consensus       139 HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-------------------------------------------------  169 (476)
T 2y94_A          139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDG-------------------------------------------------  169 (476)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCSSCEECCTT-------------------------------------------------
T ss_pred             cccccHHHEEEecCCCeEEEeccchhhcccc-------------------------------------------------
Confidence            9999999999999999999999987543210                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ....+.+||+.|+|||++.+...++.++||||+||++
T Consensus       170 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  206 (476)
T 2y94_A          170 -------------------------------------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL  206 (476)
T ss_dssp             -------------------------------------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHH
Confidence                                                       0012347899999999998877668999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+....+..+.......                  +           ...++.+.+||.+||+.||++
T Consensus       207 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------p-----------~~~s~~~~~Li~~~L~~dP~~  257 (476)
T 2y94_A          207 YALLCGTLPFDDDHVPTLFKKICDGIFYT------------------P-----------QYLNPSVISLLKHMLQVDPMK  257 (476)
T ss_dssp             HHHHHSSCSSCCSSSHHHHHHHHTTCCCC------------------C-----------TTCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHhhCCCCCCCCCHHHHHHHHhcCCcCC------------------C-----------ccCCHHHHHHHHHHcCCCchh
Confidence            99999999999888777666665421100                  0           113567899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++|+++||||++.
T Consensus       258 Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          258 RATIKDIREHEWFKQD  273 (476)
T ss_dssp             SCCHHHHHTCHHHHTT
T ss_pred             CcCHHHHHhCHHhhhc
Confidence            9999999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-38  Score=331.15  Aligned_cols=212  Identities=24%  Similarity=0.415  Sum_probs=179.0

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ..+.+|+++|+.++||||+++++++..++..|+|||||.++|.+++......+++..++.++.|++.||.|||++||+||
T Consensus        99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  178 (348)
T 1u5q_A           99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  178 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            45789999999999999999999999999999999999999999887656679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||+++....                                                    
T Consensus       179 Dlkp~NIll~~~~~~kL~DfG~a~~~~~----------------------------------------------------  206 (348)
T 1u5q_A          179 DVKAGNILLSEPGLVKLGDFGSASIMAP----------------------------------------------------  206 (348)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCBSSSS----------------------------------------------------
T ss_pred             CCCHHHEEECCCCCEEEeeccCceecCC----------------------------------------------------
Confidence            9999999999999999999998753210                                                    


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~il  256 (562)
                                                                 ....+||+.|+|||++.+  ...|+.++||||+||++
T Consensus       207 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il  243 (348)
T 1u5q_A          207 -------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  243 (348)
T ss_dssp             -------------------------------------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred             -------------------------------------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence                                                       012357888999998863  34589999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|++||.+.+..+.+..+.......                    .       .....++.+.+||.+||+.||++
T Consensus       244 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~-------~~~~~~~~l~~li~~~l~~dP~~  296 (348)
T 1u5q_A          244 IELAERKPPLFNMNAMSALYHIAQNESPA--------------------L-------QSGHWSEYFRNFVDSCLQKIPQD  296 (348)
T ss_dssp             HHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------------C-------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------------C-------CCCCCCHHHHHHHHHHcccChhh
Confidence            99999999999988877776665421100                    0       00123567899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++++++||||...
T Consensus       297 Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          297 RPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             SCCHHHHTTCHHHHSC
T ss_pred             CcCHHHHhhChhhhcc
Confidence            9999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.1e-38  Score=314.29  Aligned_cols=218  Identities=29%  Similarity=0.459  Sum_probs=178.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..+...|+||||+.+ +|.+.+.... .+++..+..++.|++.||.|||++||+|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H  128 (284)
T 3kk8_A           50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVH  128 (284)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCc
Confidence            4567999999999999999999999999999999999975 8988886643 6999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCC---eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~~~~---vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+||+++.++.   +||+|||++......                                               
T Consensus       129 ~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------------  161 (284)
T 3kk8_A          129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------------------------------------------  161 (284)
T ss_dssp             SCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-----------------------------------------------
T ss_pred             CCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-----------------------------------------------
Confidence            999999999986654   888888876433210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......||+.|+|||++.+.. ++.++||||+||
T Consensus       162 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  195 (284)
T 3kk8_A          162 ---------------------------------------------EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGV  195 (284)
T ss_dssp             ---------------------------------------------CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             ---------------------------------------------ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHH
Confidence                                                         0012246799999999997755 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|+.||.+.+..+....+.......+..                         .....++.+.+|+.+||+.||
T Consensus       196 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp  250 (284)
T 3kk8_A          196 ILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLIDSMLTVNP  250 (284)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSST
T ss_pred             HHHHHHHCCCCCCCCchhHHHHHHHhccccCCch-------------------------hhcccCHHHHHHHHHHcccCh
Confidence            9999999999999988877766665432211111                         112235678999999999999


Q ss_pred             CCCCCHHHHHcCccccCCccc
Q psy10954        335 KQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ++|||++|+|+||||.+....
T Consensus       251 ~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          251 KKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             TTSCCHHHHTTSHHHHSCCCG
T ss_pred             hhCCCHHHHhcCccccCChhH
Confidence            999999999999999876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.3e-39  Score=348.28  Aligned_cols=217  Identities=30%  Similarity=0.521  Sum_probs=180.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|++++||||+++++++.....+|+|||||.+ +|.+++.... .+++..++.++.|++.||.|||++||
T Consensus        69 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i  147 (484)
T 3nyv_A           69 DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKI  147 (484)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456788999999999999999999999999999999999974 9999887654 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEc---cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         96 IHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        96 iHRDLKP~NILl~---~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||||||+|||++   .++.+||+|||+|+.....                                             
T Consensus       148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---------------------------------------------  182 (484)
T 3nyv_A          148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---------------------------------------------  182 (484)
T ss_dssp             CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC---------------------------------------------
T ss_pred             eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc---------------------------------------------
Confidence            9999999999994   5677888888876543210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+  .|+.++||||+
T Consensus       183 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Diwsl  213 (484)
T 3nyv_A          183 -----------------------------------------------KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWST  213 (484)
T ss_dssp             -----------------------------------------------CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHH
T ss_pred             -----------------------------------------------cccccCCCCccccCceeecC--CCCCcceeHHH
Confidence                                                           01123468999999999976  48999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|.+||.+.+..+.+..+.........                +.         ....++.+++||.+||+.
T Consensus       214 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------~~---------~~~~s~~~~~li~~~L~~  268 (484)
T 3nyv_A          214 GVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----------------PQ---------WKKVSESAKDLIRKMLTY  268 (484)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----------------GG---------GGGSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----------------cc---------cccCCHHHHHHHHHHCCC
Confidence            99999999999999999988887777653211111                11         112357899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+|+||||+...
T Consensus       269 dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          269 VPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             SGGGSCCHHHHHTSHHHHHHT
T ss_pred             ChhHCcCHHHHhhChhhcccc
Confidence            999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-38  Score=316.67  Aligned_cols=215  Identities=29%  Similarity=0.488  Sum_probs=178.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++..+...|+||||+++ +|.+++.... .+++..++.++.|++.||+|||++||+
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~  128 (277)
T 3f3z_A           50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVA  128 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45688999999999999999999999999999999999975 9999887643 599999999999999999999999999


Q ss_pred             eccCCCCcEEE---ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl---~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||+|||+   +.++.+||+|||++......                                              
T Consensus       129 H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~----------------------------------------------  162 (277)
T 3f3z_A          129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG----------------------------------------------  162 (277)
T ss_dssp             CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT----------------------------------------------
T ss_pred             CCCCCHHHEEEecCCCCCcEEEEecccceeccCc----------------------------------------------
Confidence            99999999999   67778899999886533210                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    .......||+.|+|||++.+.  ++.++||||+|
T Consensus       163 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG  194 (277)
T 3f3z_A          163 ----------------------------------------------KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAG  194 (277)
T ss_dssp             ----------------------------------------------SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHH
T ss_pred             ----------------------------------------------cchhccCCCCCccChHHhccc--CCchhhehhHH
Confidence                                                          011234689999999998653  89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|+|++|+.||.+.+..+....+.......+..                         .....++.+.+|+.+||+.|
T Consensus       195 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~d  249 (277)
T 3f3z_A          195 VMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK-------------------------DWLNVSPQAESLIRRLLTKS  249 (277)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-------------------------HHTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-------------------------hhhcCCHHHHHHHHHHccCC
Confidence            99999999999999988877777665532211110                         11234578899999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy10954        334 PKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~  352 (562)
                      |++|||+.|+|+||||++.
T Consensus       250 p~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          250 PKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             TTTSCCHHHHTTSHHHHHH
T ss_pred             hhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4e-38  Score=323.79  Aligned_cols=217  Identities=28%  Similarity=0.472  Sum_probs=180.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++......|+||||+. ++|.+++... ..+++..++.++.|++.||.|||++||+
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~iv  137 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIA  137 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4567899999999999999999999999999999999996 5999999764 4689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         97 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        97 HRDLKP~NILl~~~~----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ||||||+|||++.++    .+||+|||+++.....                                             
T Consensus       138 H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------  172 (321)
T 2a2a_A          138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---------------------------------------------  172 (321)
T ss_dssp             CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT---------------------------------------------
T ss_pred             cCCCChHHEEEecCCCCcCCEEEccCccceecCcc---------------------------------------------
Confidence            999999999998877    6888888876533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+.. ++.++||||+
T Consensus       173 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~sl  204 (321)
T 2a2a_A          173 -----------------------------------------------VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSI  204 (321)
T ss_dssp             -----------------------------------------------CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHH
T ss_pred             -----------------------------------------------ccccccCCCCCccCcccccCCC-CCCccccHHH
Confidence                                                           0012236799999999997654 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|..||.+.+..+.+..+.......+                         .......++.+.+||.+||+.
T Consensus       205 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~  259 (321)
T 2a2a_A          205 GVITYILLSGASPFLGDTKQETLANITSVSYDFD-------------------------EEFFSHTSELAKDFIRKLLVK  259 (321)
T ss_dssp             HHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHHHHHTTSCS
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-------------------------hhhhcccCHHHHHHHHHHcCC
Confidence            9999999999999999888777766654211100                         012234467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+|+||||+.+.
T Consensus       260 dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          260 ETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             STTTSCCHHHHHHSTTTSCSS
T ss_pred             ChhhCcCHHHHhcCccccCCC
Confidence            999999999999999998765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.4e-38  Score=325.39  Aligned_cols=216  Identities=25%  Similarity=0.479  Sum_probs=179.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++...+..|+||||+++ +|.+++...  .+++..+..++.|++.||.|||++||+
T Consensus        86 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iv  163 (321)
T 2c30_A           86 RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVI  163 (321)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678999999999999999999999999999999999975 899988653  599999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------  195 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------------------------------  195 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSS------------------------------------------------
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCc------------------------------------------------
Confidence            99999999999999999999999876432110                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       196 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il  231 (321)
T 2c30_A          196 -------------------------------------------PKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMV  231 (321)
T ss_dssp             -------------------------------------------CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccccCCccccCHhhhcCCC-CCchhhHHHHHHHH
Confidence                                                       0011346899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+.+..+...... .                   ..      .....++.+.+|+.+||+.||++
T Consensus       232 ~el~~g~~pf~~~~~~~~~~~~~~~~~~-~-------------------~~------~~~~~~~~l~~li~~~l~~dp~~  285 (321)
T 2c30_A          232 IEMVDGEPPYFSDSPVQAMKRLRDSPPP-K-------------------LK------NSHKVSPVLRDFLERMLVRDPQE  285 (321)
T ss_dssp             HHHHHSSCTTTTSCHHHHHHHHHHSSCC-C-------------------CT------TGGGSCHHHHHHHHHHSCSSTTT
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhcCCCC-C-------------------cC------ccccCCHHHHHHHHHHccCChhh
Confidence            9999999999998877766655432110 0                   00      00123567899999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||++|+++||||.+..
T Consensus       286 Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          286 RATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCCHHHHHTSGGGGGCC
T ss_pred             CcCHHHHhcChhhccCC
Confidence            99999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-38  Score=344.11  Aligned_cols=215  Identities=28%  Similarity=0.426  Sum_probs=174.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~gIi   96 (562)
                      ..+.+|+.+|+.++||||++++++|...+.+|+|||||++ +|.+++.... .+++..++.++.|++.||+|||+ +|||
T Consensus       193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~gii  271 (446)
T 4ejn_A          193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVV  271 (446)
T ss_dssp             --------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEE
Confidence            4567899999999999999999999999999999999975 8998887643 69999999999999999999998 9999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+......                                                
T Consensus       272 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~------------------------------------------------  303 (446)
T 4ejn_A          272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG------------------------------------------------  303 (446)
T ss_dssp             CCCCCGGGEEECSSSCEEECCCCCCCTTCC--------------------------------------------------
T ss_pred             ECCCCHHHEEECCCCCEEEccCCCceeccCCC------------------------------------------------
Confidence            99999999999999999999999976321100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. |+.++||||+||++
T Consensus       304 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  339 (446)
T 4ejn_A          304 -------------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVM  339 (446)
T ss_dssp             ----------------------------------------------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccccCCccccCHhhcCCCC-CCCccchhhhHHHH
Confidence                                                       0012357899999999998755 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|+.||.+.+..+....+......                  ++           ...++.+.+||.+||+.||++
T Consensus       340 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~~~~~~~li~~~L~~dP~~  390 (446)
T 4ejn_A          340 YEMMCGRLPFYNQDHEKLFELILMEEIR------------------FP-----------RTLGPEAKSLLSGLLKKDPKQ  390 (446)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSSTTT
T ss_pred             HHHhhCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------ccCCHHHHHHHHHHcccCHHH
Confidence            9999999999998887776666542110                  00           123578999999999999999


Q ss_pred             CC-----CHHHHHcCccccCCccc
Q psy10954        337 RV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       337 R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      |+     |++|+++||||+++.+.
T Consensus       391 R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          391 RLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             STTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             hCCCCCCCHHHHHhCccccCCCHH
Confidence            99     99999999999988643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.7e-39  Score=325.26  Aligned_cols=247  Identities=34%  Similarity=0.645  Sum_probs=188.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEE--------------eCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIP--------------VDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL   83 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~--------------~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~ql   83 (562)
                      ...+.+|+++++.++||||+++++++.              .....|+||||++++|.+++..  ..+++..++.++.|+
T Consensus        52 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi  129 (320)
T 2i6l_A           52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQL  129 (320)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHH
Confidence            356789999999999999999999873              3468999999999999999865  368999999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         84 LEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        84 l~aL~yLH~~gIiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      +.||+|||++||+||||||+|||++ .++.+||+|||+++.......                                 
T Consensus       130 ~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---------------------------------  176 (320)
T 2i6l_A          130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS---------------------------------  176 (320)
T ss_dssp             HHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------------------------------------
T ss_pred             HHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc---------------------------------
Confidence            9999999999999999999999997 456899999998764421000                                 


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                             .........||+.|+|||++.+...
T Consensus       177 -------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~  201 (320)
T 2i6l_A          177 -------------------------------------------------------HKGHLSEGLVTKWYRSPRLLLSPNN  201 (320)
T ss_dssp             ----------------------------------------------------------CCCGGGSCCTTCCHHHHHCTTC
T ss_pred             -------------------------------------------------------cccccccccccccccCcHHhcCccc
Confidence                                                                   0001123467999999999987667


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC-CCCccCCCCCCCccchhhhcCCCCHH
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFSEILNLPDPL  321 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~  321 (562)
                      ++.++||||+||++|||++|+.||.+.+..+.+..+....+......+..... .+.+...........+....+..++.
T Consensus       202 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (320)
T 2i6l_A          202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE  281 (320)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHH
T ss_pred             CCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHH
Confidence            99999999999999999999999999998888888877655443221111000 00000000000111223334456788


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        322 AVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       322 ~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      +.+||.+||+.||++|||++|+|+||||+...+
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          282 AVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            999999999999999999999999999997653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-38  Score=335.30  Aligned_cols=239  Identities=33%  Similarity=0.547  Sum_probs=184.5

Q ss_pred             hhHHHHHHHHHccC-CC-----CcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELK-HP-----NVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-Hp-----nIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|+.+++.++ |+     +|+++++++.....+|+||||++++|.+++.... ..+++..++.++.|++.||.|||
T Consensus        95 ~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH  174 (382)
T 2vx3_A           95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA  174 (382)
T ss_dssp             HHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc
Confidence            45678999998885 54     4999999999999999999999999999998754 45999999999999999999999


Q ss_pred             --HCCceeccCCCCcEEEc--cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         92 --SRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        92 --~~gIiHRDLKP~NILl~--~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                        ++|||||||||+|||++  .++.+||+|||+|+....                                         
T Consensus       175 ~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-----------------------------------------  213 (382)
T 2vx3_A          175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----------------------------------------  213 (382)
T ss_dssp             STTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-----------------------------------------
T ss_pred             cCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-----------------------------------------
Confidence              57999999999999995  356788888887643210                                         


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                           .....+||+.|+|||++.+.. |+.++
T Consensus       214 -----------------------------------------------------~~~~~~~t~~y~aPE~~~~~~-~~~~~  239 (382)
T 2vx3_A          214 -----------------------------------------------------RIYQYIQSRFYRSPEVLLGMP-YDLAI  239 (382)
T ss_dssp             -----------------------------------------------------CCCSSCSCGGGCCHHHHTTCC-CCTHH
T ss_pred             -----------------------------------------------------ccccccCCccccChHHHcCCC-CCcHH
Confidence                                                                 012346789999999998765 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCC-----------------CCCCCccc
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-----------------FPEWRPKK  310 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~  310 (562)
                      ||||+||++|||++|++||.+.+..+++..+.+.+|.++...++.......+...                 +.......
T Consensus       240 DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (382)
T 2vx3_A          240 DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRK  319 (382)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhh
Confidence            9999999999999999999999999999999999988775443322111000000                 00000111


Q ss_pred             hhhhcCCC------------------CHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        311 FSEILNLP------------------DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       311 ~~~~l~~~------------------~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +...+...                  ++.+.|||.+||++||++|||++|+|+||||++.
T Consensus       320 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          320 LHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            11111110                  1368999999999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.3e-38  Score=344.56  Aligned_cols=215  Identities=28%  Similarity=0.490  Sum_probs=178.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||++++++|.....+|+|||||.+ +|.+.+... ..+++..++.++.|++.||.|||++||+
T Consensus        80 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iv  158 (494)
T 3lij_A           80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIV  158 (494)
T ss_dssp             THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            45678999999999999999999999999999999999975 898888654 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||+|||++..   +.+||+|||+|+.....                                              
T Consensus       159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~----------------------------------------------  192 (494)
T 3lij_A          159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ----------------------------------------------  192 (494)
T ss_dssp             CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT----------------------------------------------
T ss_pred             eccCChhhEEEeCCCCCCcEEEEECCCCeECCCC----------------------------------------------
Confidence            99999999999754   44888888876533210                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ......+||+.|+|||++.+  .|+.++||||+|
T Consensus       193 ----------------------------------------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG  224 (494)
T 3lij_A          193 ----------------------------------------------KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIG  224 (494)
T ss_dssp             ----------------------------------------------BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCCCcCeeCHHHHcc--cCCCchhHHHHH
Confidence                                                          01123468999999999853  489999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|+|++|.+||.+.+..+.+..+...........                         ....++.+.+||.+||+.|
T Consensus       225 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~d  279 (494)
T 3lij_A          225 VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-------------------------WKNVSEGAKDLIKQMLQFD  279 (494)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG-------------------------GTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------------------cccCCHHHHHHHHHHCCCC
Confidence            999999999999999998887777765422211111                         1234578999999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy10954        334 PKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~  352 (562)
                      |++|||+.|+|+||||++.
T Consensus       280 p~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          280 SQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             TTTSCCHHHHHTCHHHHHH
T ss_pred             hhhCccHHHHhcCcccccC
Confidence            9999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-38  Score=327.53  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=196.3

Q ss_pred             hhhHHHHHHHHHccCCCC------cceEEEEEEeCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPN------VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~Hpn------Iv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ...+.+|+.+|+.++|++      ++.+++++...+.+|+||||++++|.+++.... ..+++..++.++.||+.||.||
T Consensus        60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l  139 (355)
T 2eu9_A           60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL  139 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            345778999999997765      999999999999999999999989888887654 4699999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         91 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        91 H~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      |++||+||||||+|||++..+...+.+.+...                                                
T Consensus       140 H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~------------------------------------------------  171 (355)
T 2eu9_A          140 HENQLTHTDLKPENILFVNSEFETLYNEHKSC------------------------------------------------  171 (355)
T ss_dssp             HTTTEECCCCCGGGEEESCCCEEEEECCC-CC------------------------------------------------
T ss_pred             HHCCcccCCCCHHHEEEecccccccccccccc------------------------------------------------
Confidence            99999999999999999876655443322100                                                


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                              .-.-+.++.+||+|||+++....   .....+||+.|+|||++.+.. |+.++|||
T Consensus       172 ------------------------~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~  223 (355)
T 2eu9_A          172 ------------------------EEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELG-WAQPCDVW  223 (355)
T ss_dssp             ------------------------CEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCC-CCTHHHHH
T ss_pred             ------------------------cccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCC-CCCccchH
Confidence                                    00113467899999999876432   234568999999999998765 89999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCcc------------chhhhc---
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPK------------KFSEIL---  315 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~l---  315 (562)
                      |+||++|||++|+.||.+.+..+.+..+....+..+...+........+......|...            .+....   
T Consensus       224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (355)
T 2eu9_A          224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD  303 (355)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence            99999999999999999999888888888888876654332221111110000001000            000000   


Q ss_pred             CCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        316 NLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       316 ~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ...++.+.+||.+||+.||++|||+.|+|+||||+++.
T Consensus       304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             chhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            01134688999999999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-38  Score=332.97  Aligned_cols=288  Identities=25%  Similarity=0.349  Sum_probs=193.6

Q ss_pred             hhhHHHHHHHHHccC--------CCCcceEEEEEE----eCCEEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELK--------HPNVIRLHDVIP----VDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLL   84 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~--------HpnIv~L~~~~~----~~~~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~qll   84 (562)
                      ...+.+|+.+|+.++        ||||++++++|.    ....+|+||||++++|.+.+.... ..+++..++.++.||+
T Consensus        77 ~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~  156 (397)
T 1wak_A           77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL  156 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence            356789999999985        788999999998    456899999999988888776543 5699999999999999


Q ss_pred             HHHHHHHHC-CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         85 EALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        85 ~aL~yLH~~-gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      .||+|||++ ||+||||||+|||++.++.....+++.+.........  ...++....+|.....            +. 
T Consensus       157 ~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~------------~~-  221 (397)
T 1wak_A          157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP--PPSGSAVSTAPATAGN------------FL-  221 (397)
T ss_dssp             HHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------------------CCT------------TS-
T ss_pred             HHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCC--CCCCCccccCCccccc------------cc-
Confidence            999999998 9999999999999998875444444433222110000  0000111111110000            00 


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                 ..|....-.....+||+|||+|+.....   ....+||+.|+|||++.+.. |
T Consensus       222 ---------------------------~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~  270 (397)
T 1wak_A          222 ---------------------------VNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSG-Y  270 (397)
T ss_dssp             ---------------------------CCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSC-C
T ss_pred             ---------------------------ccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCC-C
Confidence                                       0000001123468999999999876432   34568999999999998765 8


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCCCCCCCCCCCCCccC------CCCCCCccch
Q psy10954        244 STTVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT------DFPEWRPKKF  311 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~------~~~~~~~~~~  311 (562)
                      +.++||||+||++|||++|+.||.+.+      ..+++..+...+|.++...+........+..      ......+...
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            999999999999999999999998765      5677888888888765433211100000000      0111111111


Q ss_pred             hh----hcCC---CCHHHHHHHHHccccCCCCCCCHHHHHcCccccC
Q psy10954        312 SE----ILNL---PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       312 ~~----~l~~---~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      .+    ....   .++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            10    1111   1346789999999999999999999999999974

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8e-38  Score=326.78  Aligned_cols=216  Identities=31%  Similarity=0.419  Sum_probs=165.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|++++||||+++++++.....+|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+|
T Consensus        93 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  171 (349)
T 2w4o_A           93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVH  171 (349)
T ss_dssp             ------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            4567899999999999999999999999999999999974 999998764 36999999999999999999999999999


Q ss_pred             ccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+|||++.   ++.+||+|||+++.....                                               
T Consensus       172 ~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-----------------------------------------------  204 (349)
T 2w4o_A          172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-----------------------------------------------  204 (349)
T ss_dssp             CCCCGGGEEESSSSTTCCEEECCCC-------------------------------------------------------
T ss_pred             cCCCcccEEEecCCCCCCEEEccCccccccCcc-----------------------------------------------
Confidence            999999999975   778889999886533100                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+.. |+.++||||+||
T Consensus       205 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  238 (349)
T 2w4o_A          205 ---------------------------------------------VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGI  238 (349)
T ss_dssp             -----------------------------------------------------CGGGSCHHHHTTCC-CCTHHHHHHHHH
T ss_pred             ---------------------------------------------cccccccCCCCccCHHHhcCCC-CCcccchHHHHH
Confidence                                                         0011246899999999998754 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGDSEID-QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~-~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|||++|..||.+....+ .+..+..........                         .....+..+.+||.+||+.|
T Consensus       239 il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~d  293 (349)
T 2w4o_A          239 ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP-------------------------WWDEVSLNAKDLVRKLIVLD  293 (349)
T ss_dssp             HHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT-------------------------TTTTSCHHHHHHHHTTSCSS
T ss_pred             HHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc-------------------------hhhhCCHHHHHHHHHHccCC
Confidence            9999999999998776554 333443321110000                         11223568899999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|||+.|+|+||||.+..
T Consensus       294 P~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          294 PKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             GGGSCCHHHHHHSTTTTSTT
T ss_pred             hhhCcCHHHHhcCcccCCCc
Confidence            99999999999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-38  Score=325.17  Aligned_cols=241  Identities=32%  Similarity=0.615  Sum_probs=180.5

Q ss_pred             chhhHHHHHHHHHccC-CCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         17 VPSTALREISVLKELK-HPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~-HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ....+.+|+++|++++ ||||+++++++..  ....|+||||+.+ +|.+++.    .+++..++.++.|++.||+|||+
T Consensus        73 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~  148 (330)
T 3nsz_A           73 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS  148 (330)
T ss_dssp             CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh
Confidence            3467889999999997 9999999999987  6789999999985 8888775    38999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 RRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +||+||||||+|||++.++ .+||+|||+|+.....                                            
T Consensus       149 ~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------  184 (330)
T 3nsz_A          149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--------------------------------------------  184 (330)
T ss_dssp             TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT--------------------------------------------
T ss_pred             CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC--------------------------------------------
Confidence            9999999999999999777 7999999987543210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+...++.++||||
T Consensus       185 ------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  216 (330)
T 3nsz_A          185 ------------------------------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWS  216 (330)
T ss_dssp             ------------------------------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred             ------------------------------------------------CccccccccccccChhhhcCCCcCCchhhHHH
Confidence                                                            00123467889999999988677999999999


Q ss_pred             HHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCCCCC-C--CCCCCCCccCCCCCCCccchhhh-----cCCCCHHH
Q psy10954        252 AGCIFSEMITKKTLFA-GDSEIDQLFRIFRTLGTPHEDVW-P--GVSKLPIYKTDFPEWRPKKFSEI-----LNLPDPLA  322 (562)
Q Consensus       252 lG~il~eLltG~~pF~-~~~~~~~l~~i~~~lg~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~-----l~~~~~~~  322 (562)
                      +||++|+|++|+.||. +.+..+++..+...++.+....+ .  .....+.+...........+...     ....++.+
T Consensus       217 lG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (330)
T 3nsz_A          217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA  296 (330)
T ss_dssp             HHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHH
T ss_pred             HHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHH
Confidence            9999999999999984 55666777777666553221000 0  00000000000000000011111     11246789


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+||.+||++||++|||++|+|+||||+++.
T Consensus       297 ~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          297 LDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            9999999999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-38  Score=326.82  Aligned_cols=224  Identities=29%  Similarity=0.454  Sum_probs=178.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC-----------------------------
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-----------------------------   67 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~-----------------------------   67 (562)
                      ...+.+|+++|+.++||||+++++++......|+|||||+ ++|.+++...                             
T Consensus        72 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (345)
T 3hko_A           72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN  151 (345)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccc
Confidence            4567899999999999999999999999999999999997 5999988420                             


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC--CeeEeeccccccccccCcccceee
Q psy10954         68 ----------PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEV  135 (562)
Q Consensus        68 ----------~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~--~vKL~DFGla~~~~~~~~~~~~~~  135 (562)
                                ...+++..++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++........     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~-----  226 (345)
T 3hko_A          152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-----  226 (345)
T ss_dssp             SCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----
T ss_pred             cccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc-----
Confidence                      11246788899999999999999999999999999999998776  7999999988654311000     


Q ss_pred             eeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       136 ~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                                                                                                      
T Consensus       227 --------------------------------------------------------------------------------  226 (345)
T 3hko_A          227 --------------------------------------------------------------------------------  226 (345)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             ccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCC
Q psy10954        216 TIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS  294 (562)
Q Consensus       216 ~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~  294 (562)
                        .........||+.|+|||++.+. ..|+.++||||+||++|||++|+.||.+.+..+.+..+..........      
T Consensus       227 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  298 (345)
T 3hko_A          227 --EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP------  298 (345)
T ss_dssp             ----------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG------
T ss_pred             --ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc------
Confidence              00001234689999999999753 558999999999999999999999999998888777776532111100      


Q ss_pred             CCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        295 KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                                         .....++.+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       299 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          299 -------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             -------------------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             -------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence                               1122357899999999999999999999999999999865

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.6e-38  Score=356.62  Aligned_cols=217  Identities=25%  Similarity=0.390  Sum_probs=184.3

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ......+|..+|..+ +||||++++++|.+.+.+||||||+.+ +|.+++.... .+++..++.|+.||+.||+|||++|
T Consensus       384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g  462 (674)
T 3pfq_A          384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG  462 (674)
T ss_dssp             TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345678999999988 799999999999999999999999975 9999997653 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.+|.+||+|||+|+.....                                               
T Consensus       463 IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-----------------------------------------------  495 (674)
T 3pfq_A          463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-----------------------------------------------  495 (674)
T ss_dssp             EECCCCCSTTEEECSSSCEEECCCTTCEECCCT-----------------------------------------------
T ss_pred             eEeccCChhhEEEcCCCcEEEeecceeeccccC-----------------------------------------------
Confidence            999999999999999999999999987632110                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .....+.+||+.|+|||++.+.. |+.++||||+||
T Consensus       496 --------------------------------------------~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGv  530 (674)
T 3pfq_A          496 --------------------------------------------GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV  530 (674)
T ss_dssp             --------------------------------------------TCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHH
T ss_pred             --------------------------------------------CcccccccCCCcccCHhhhcCCC-CCccceEechHH
Confidence                                                        00112457999999999997655 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..|......                  ++           ...++.+.+||++||+.||
T Consensus       531 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~lL~~dP  581 (674)
T 3pfq_A          531 LLYEMLAGQAPFEGEDEDELFQSIMEHNVA------------------YP-----------KSMSKEAVAICKGLMTKHP  581 (674)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHSSCCC------------------CC-----------TTSCHHHHHHHHHHSCSSS
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhCCCC------------------CC-----------ccCCHHHHHHHHHHccCCH
Confidence            999999999999999988888877642110                  11           1235789999999999999


Q ss_pred             CCCCCH-----HHHHcCccccCCccc
Q psy10954        335 KQRVSA-----KTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~Ta-----~elL~Hp~f~~~~~~  355 (562)
                      ++|+++     +|+++||||+++++.
T Consensus       582 ~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          582 GKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             TTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             HHCCCCCCCcHHHHhcCccccCCCHH
Confidence            999997     999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-37  Score=315.42  Aligned_cols=214  Identities=29%  Similarity=0.476  Sum_probs=171.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+++|+.++||||+++++++......|+||||+++ +|.+++...   ...+++..++.++.|++.||+|||++
T Consensus        64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  143 (285)
T 3is5_A           64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ  143 (285)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45678999999999999999999999999999999999975 999888542   34699999999999999999999999


Q ss_pred             CceeccCCCCcEEEc---cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         94 RIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        94 gIiHRDLKP~NILl~---~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      ||+||||||+|||++   .++.+||+|||+++.....                                           
T Consensus       144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-------------------------------------------  180 (285)
T 3is5_A          144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-------------------------------------------  180 (285)
T ss_dssp             TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------------------------------------------
T ss_pred             CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-------------------------------------------
Confidence            999999999999994   4567888888886533210                                           


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                       ......+||+.|+|||++.+  .++.++|||
T Consensus       181 -------------------------------------------------~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~  209 (285)
T 3is5_A          181 -------------------------------------------------EHSTNAAGTALYMAPEVFKR--DVTFKCDIW  209 (285)
T ss_dssp             -------------------------------------------------------CTTGGGCCHHHHTT--CCCHHHHHH
T ss_pred             -------------------------------------------------ccCcCcccccCcCChHHhcc--CCCcccCee
Confidence                                                             00112367999999999853  489999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|+|++|+.||.+.+..+....+.........                          .....++.+.+|+.+||
T Consensus       210 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L  263 (285)
T 3is5_A          210 SAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV--------------------------ECRPLTPQAVDLLKQML  263 (285)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC----------------------------CCCCHHHHHHHHHHT
T ss_pred             hHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc--------------------------ccCcCCHHHHHHHHHHc
Confidence            9999999999999999988766655444321110000                          01123578899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      +.||++|||+.|+|+||||++
T Consensus       264 ~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          264 TKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.4e-38  Score=344.45  Aligned_cols=218  Identities=27%  Similarity=0.440  Sum_probs=180.8

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+.+|+.+|+.++||||+++++++..+..+|+|||||.+ +|.+++.... .+++..++.++.|++.||.|||++|
T Consensus        88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~  166 (504)
T 3q5i_A           88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHN  166 (504)
T ss_dssp             CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999975 9999887643 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         95 IIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      |+||||||+|||++.++   .+||+|||+|+.....                                            
T Consensus       167 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------  202 (504)
T 3q5i_A          167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--------------------------------------------  202 (504)
T ss_dssp             EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT--------------------------------------------
T ss_pred             eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC--------------------------------------------
Confidence            99999999999998765   5888888876533210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+  .|+.++||||
T Consensus       203 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Diws  232 (504)
T 3q5i_A          203 ------------------------------------------------YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWS  232 (504)
T ss_dssp             ------------------------------------------------SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHH
T ss_pred             ------------------------------------------------CccccccCCcCCCCHHHhcc--CCCchHHHHH
Confidence                                                            01123468999999999864  4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +||++|+|++|.+||.+.+..+.+..+.......+.                         ......++.+.+||.+||+
T Consensus       233 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~  287 (504)
T 3q5i_A          233 CGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF-------------------------NDWKNISDEAKELIKLMLT  287 (504)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-------------------------cccCCCCHHHHHHHHHHcC
Confidence            999999999999999999888877777553111100                         0112345789999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCc
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||.+|||++|+|+||||++..
T Consensus       288 ~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          288 YDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             SSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CChhHCCCHHHHhcCHhhhhch
Confidence            9999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-38  Score=352.10  Aligned_cols=217  Identities=27%  Similarity=0.460  Sum_probs=177.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+.++|||||+++++|.+.+.+|+|||||. ++|.+++.... ..+++..++.++.||+.||+|||++||
T Consensus       228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI  307 (576)
T 2acx_A          228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI  307 (576)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4557899999999999999999999999999999999997 59999987654 349999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.+|.+||+|||+|+.....                                                
T Consensus       308 vHrDLKPeNILld~~g~vKL~DFGla~~~~~~------------------------------------------------  339 (576)
T 2acx_A          308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEG------------------------------------------------  339 (576)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECCTT------------------------------------------------
T ss_pred             eccCCchheEEEeCCCCeEEEecccceecccC------------------------------------------------
Confidence            99999999999999999999999987543210                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       340 --------------------------------------------~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvi  374 (576)
T 2acx_A          340 --------------------------------------------QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCL  374 (576)
T ss_dssp             --------------------------------------------CCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccCCCccccCHHHHcCCC-CCccchHHHHHHH
Confidence                                                        0012347899999999998754 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        256 FSEMITKKTLFAGDSE---IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       256 l~eLltG~~pF~~~~~---~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      +|||++|++||.+...   ...+...+....   .              .+           ....++.+.+||.+||+.
T Consensus       375 lyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---~--------------~~-----------p~~~s~~~~dLI~~lL~~  426 (576)
T 2acx_A          375 LYEMIAGQSPFQQRKKKIKREEVERLVKEVP---E--------------EY-----------SERFSPQARSLCSQLLCK  426 (576)
T ss_dssp             HHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---C--------------CC-----------CTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCcccccchhHHHHHHHhhccc---c--------------cC-----------CccCCHHHHHHHHHhccC
Confidence            9999999999987642   222322222110   0              00           012357899999999999


Q ss_pred             CCCCCC-----CHHHHHcCccccCCccc
Q psy10954        333 DPKQRV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       333 DP~~R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      ||++|+     |++|+++||||+++++.
T Consensus       427 dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          427 DPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             SGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             CHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            999999     79999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-38  Score=321.74  Aligned_cols=208  Identities=28%  Similarity=0.372  Sum_probs=168.5

Q ss_pred             hHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy10954         20 TALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   98 (562)
Q Consensus        20 ~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHR   98 (562)
                      ...+|+..+..+ +||||+++++++..++.+|+|||||+++|.+++...+..+++..++.++.|++.||+|||++||+||
T Consensus       102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (311)
T 3p1a_A          102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL  181 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            455666666555 9999999999999999999999999999999988776679999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHH
Q psy10954         99 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEAL  178 (562)
Q Consensus        99 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL  178 (562)
                      ||||+|||++.++.+||+|||++.......                                                  
T Consensus       182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--------------------------------------------------  211 (311)
T 3p1a_A          182 DVKPANIFLGPRGRCKLGDFGLLVELGTAG--------------------------------------------------  211 (311)
T ss_dssp             CCSGGGEEECGGGCEEECCCTTCEECC-----------------------------------------------------
T ss_pred             CCCHHHEEECCCCCEEEccceeeeecccCC--------------------------------------------------
Confidence            999999999999999999999875432100                                                  


Q ss_pred             HhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHH
Q psy10954        179 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  258 (562)
Q Consensus       179 ~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~e  258 (562)
                                                                ......||+.|+|||++.+  .|+.++||||+||++||
T Consensus       212 ------------------------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~e  247 (311)
T 3p1a_A          212 ------------------------------------------AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILE  247 (311)
T ss_dssp             ---------------------------------------------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHH
T ss_pred             ------------------------------------------CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHH
Confidence                                                      0112357999999999876  48999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCC
Q psy10954        259 MITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV  338 (562)
Q Consensus       259 LltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~  338 (562)
                      |++|..||.+......+   ..  +..                      +   .......++.+.+|+.+||+.||++||
T Consensus       248 l~~g~~~~~~~~~~~~~---~~--~~~----------------------~---~~~~~~~~~~l~~li~~~L~~dP~~Rp  297 (311)
T 3p1a_A          248 VACNMELPHGGEGWQQL---RQ--GYL----------------------P---PEFTAGLSSELRSVLVMMLEPDPKLRA  297 (311)
T ss_dssp             HHHTCCCCSSHHHHHHH---TT--TCC----------------------C---HHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             HHhCCCCCCCccHHHHH---hc--cCC----------------------C---cccccCCCHHHHHHHHHHcCCChhhCc
Confidence            99998877664332221   11  000                      0   012233467899999999999999999


Q ss_pred             CHHHHHcCccccC
Q psy10954        339 SAKTILQHEYFNQ  351 (562)
Q Consensus       339 Ta~elL~Hp~f~~  351 (562)
                      |++|+|+||||++
T Consensus       298 t~~ell~hp~~~~  310 (311)
T 3p1a_A          298 TAEALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHTSGGGSC
T ss_pred             CHHHHHhCccccC
Confidence            9999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.1e-38  Score=321.69  Aligned_cols=227  Identities=26%  Similarity=0.405  Sum_probs=170.0

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.+|+++|+++ +||||+++++++..++.+|+|||||. ++|.+++.... .+++..++.++.|++.||+|||++|
T Consensus        53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~  131 (316)
T 2ac3_A           53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKG  131 (316)
T ss_dssp             CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356788999999885 79999999999999999999999997 59999987643 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCC---eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         95 IIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~---vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      |+||||||+|||++.++.   +||+|||+++.........                  .                     
T Consensus       132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~------------------~---------------------  172 (316)
T 2ac3_A          132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS------------------P---------------------  172 (316)
T ss_dssp             CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------------------------------------
T ss_pred             ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc------------------c---------------------
Confidence            999999999999988765   9999999876442110000                  0                     


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC----CCCCchh
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----KVYSTTV  247 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~----~~y~~~~  247 (562)
                                                                   .........+||+.|+|||++.+.    ..|+.++
T Consensus       173 ---------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  207 (316)
T 2ac3_A          173 ---------------------------------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC  207 (316)
T ss_dssp             ------------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTH
T ss_pred             ---------------------------------------------ccccccccccCCcCccChHHhhcccccccCCCccc
Confidence                                                         000011234689999999999642    3478999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchh
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEI---------------DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS  312 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~---------------~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (562)
                      ||||+||++|||++|+.||.+....               .....+.....                  .++       .
T Consensus       208 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------------------~~~-------~  262 (316)
T 2ac3_A          208 DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY------------------EFP-------D  262 (316)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC------------------CCC-------H
T ss_pred             ccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc------------------ccC-------c
Confidence            9999999999999999999876421               11222221100                  000       0


Q ss_pred             hhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        313 EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       313 ~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ......++.+.+||.+||+.||++|||++|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            01123457899999999999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.3e-38  Score=327.53  Aligned_cols=218  Identities=25%  Similarity=0.457  Sum_probs=157.5

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+|+.+|+.+. ||||+++++++.++...|+|||||++ +|.+++... ..+++..++.++.|++.||+|||++||
T Consensus        49 ~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i  127 (325)
T 3kn6_A           49 EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGV  127 (325)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            456789999999997 99999999999999999999999975 999999875 469999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         96 IHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        96 iHRDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||||||+|||++.++   .+||+|||+++......                                            
T Consensus       128 vH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------  163 (325)
T 3kn6_A          128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--------------------------------------------  163 (325)
T ss_dssp             ECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------------------------------
T ss_pred             eecCCCHHHEEEecCCCcccEEEeccccceecCCCC--------------------------------------------
Confidence            9999999999998765   78999999875432110                                            


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+.. |+.++||||+
T Consensus       164 -----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Diwsl  195 (325)
T 3kn6_A          164 -----------------------------------------------QPLKTPCFTLHYAAPELLNQNG-YDESCDLWSL  195 (325)
T ss_dssp             -------------------------------------------------------------------CC-CCHHHHHHHH
T ss_pred             -----------------------------------------------CcccccCCCcCccCHHHhcCCC-CCCccchHHH
Confidence                                                           0112346789999999987654 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        253 GCIFSEMITKKTLFAGDSE-------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~-------~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      ||++|+|++|+.||.+.+.       .+.+..+......                     ...    ......++.+.+|
T Consensus       196 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---------------------~~~----~~~~~~s~~~~~l  250 (325)
T 3kn6_A          196 GVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---------------------FEG----EAWKNVSQEAKDL  250 (325)
T ss_dssp             HHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---------------------CCS----HHHHTSCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---------------------CCc----ccccCCCHHHHHH
Confidence            9999999999999987543       2223332211000                     000    0112345789999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |.+||+.||++|||++|+++||||++..
T Consensus       251 i~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          251 IQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             HHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            9999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6e-38  Score=334.15  Aligned_cols=216  Identities=26%  Similarity=0.369  Sum_probs=164.7

Q ss_pred             hhHHHHHHHHH-ccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLK-ELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~-~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ....+|+.++. ..+||||++++++|..    ...+|||||||.+ +|.+++.... ..+++..++.++.||+.||.|||
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  178 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  178 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45779999985 4589999999999876    5679999999975 9999998654 35999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ++||+||||||+|||++.   ++.+||+|||+++.....                                         
T Consensus       179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-----------------------------------------  217 (400)
T 1nxk_A          179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----------------------------------------  217 (400)
T ss_dssp             HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------------------------------------
T ss_pred             HCCccccCcCcceEEEecCCCCccEEEEecccccccCCC-----------------------------------------
Confidence            999999999999999987   678899999887532100                                         


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         ....+.+||+.|+|||++.+. .|+.++|
T Consensus       218 ---------------------------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~D  245 (400)
T 1nxk_A          218 ---------------------------------------------------NSLTTPCYTPYYVAPEVLGPE-KYDKSCD  245 (400)
T ss_dssp             ------------------------------------------------------------CTTCCGGGSCCC-CSSSHHH
T ss_pred             ---------------------------------------------------CccccCCCCCCccCHhhcCCC-CCCCccc
Confidence                                                               001234689999999998665 4899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEID----QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~----~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      |||+||++|||++|+.||.+.+...    ....+....-..+                .+         .....++.+.+
T Consensus       246 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~----------------~~---------~~~~~s~~~~~  300 (400)
T 1nxk_A          246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP----------------NP---------EWSEVSEEVKM  300 (400)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC----------------TT---------TTTTSCHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC----------------Cc---------ccccCCHHHHH
Confidence            9999999999999999998765321    1222221100000                00         01223578999


Q ss_pred             HHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        325 VFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||.+||+.||++|||+.|+|+||||.+.
T Consensus       301 li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          301 LIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-37  Score=311.85  Aligned_cols=213  Identities=32%  Similarity=0.532  Sum_probs=177.6

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.++++++||||+++++++......|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++||
T Consensus        52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i  130 (279)
T 3fdn_A           52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRV  130 (279)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345678999999999999999999999999999999999985 8999887643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||++......                                                
T Consensus       131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~------------------------------------------------  162 (279)
T 3fdn_A          131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS------------------------------------------------  162 (279)
T ss_dssp             EECCCCGGGEEECTTSCEEECSCCEESCC---------------------------------------------------
T ss_pred             ecccCChHhEEEcCCCCEEEEeccccccCCcc------------------------------------------------
Confidence            99999999999999999999999986422100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......||+.|+|||++.+.. ++.++||||+||+
T Consensus       163 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  196 (279)
T 3fdn_A          163 ---------------------------------------------RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVL  196 (279)
T ss_dssp             --------------------------------------------------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHH
T ss_pred             ---------------------------------------------cccccCCCCCccCHhHhccCC-CCccchhHhHHHH
Confidence                                                         001235789999999997654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|..||.+.+..+....+.......                  +           ...++.+.+||.+||+.||+
T Consensus       197 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~-----------~~~~~~~~~li~~~l~~~p~  247 (279)
T 3fdn_A          197 CYEFLVGKPPFEANTYQETYKRISRVEFTF------------------P-----------DFVTEGARDLISRLLKHNPS  247 (279)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------------------C-----------TTSCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHhCCCCC------------------C-----------CcCCHHHHHHHHHHhccChh
Confidence            999999999999988777666665421110                  0           11346789999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +|||++|+++||||++..
T Consensus       248 ~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          248 QRPMLREVLEHPWITANS  265 (279)
T ss_dssp             GSCCHHHHHHCHHHHHHC
T ss_pred             hCCCHHHHhhCccccCCc
Confidence            999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-37  Score=320.63  Aligned_cols=221  Identities=28%  Similarity=0.437  Sum_probs=180.7

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+.+|+.+ +||||+++++++.....+|+|||||.+ +|.+++... ...+++..++.++.|++.||+|||++|
T Consensus        72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g  151 (327)
T 3lm5_A           72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN  151 (327)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45688999999999 569999999999999999999999986 898887543 346999999999999999999999999


Q ss_pred             ceeccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         95 IIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        95 IiHRDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      |+||||||+|||++.   ++.+||+|||+++.....                                            
T Consensus       152 ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~--------------------------------------------  187 (327)
T 3lm5_A          152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--------------------------------------------  187 (327)
T ss_dssp             EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------------------------------------------
T ss_pred             eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc--------------------------------------------
Confidence            999999999999987   678888888887543210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+.. ++.++||||
T Consensus       188 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws  218 (327)
T 3lm5_A          188 ------------------------------------------------CELREIMGTPEYLAPEILNYDP-ITTATDMWN  218 (327)
T ss_dssp             ------------------------------------------------------CCCGGGCCHHHHTTCC-CCTHHHHHH
T ss_pred             ------------------------------------------------cccccccCCcCccCCeeecCCC-CCchhhHHH
Confidence                                                            0011246899999999997654 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +||++|+|++|+.||.+.+..+....+..........                         .....++.+.+||.+||+
T Consensus       219 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~  273 (327)
T 3lm5_A          219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE-------------------------TFSSVSQLATDFIQSLLV  273 (327)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSC
T ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch-------------------------hhcccCHHHHHHHHHHcC
Confidence            9999999999999999998887777776543322211                         112335678999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCcccC
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVEMVK  356 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~~~~  356 (562)
                      .||++|||++|+|+||||++.++..
T Consensus       274 ~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          274 KNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             SSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             CChhhCcCHHHHhCCHhhccccccc
Confidence            9999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-37  Score=342.94  Aligned_cols=217  Identities=24%  Similarity=0.400  Sum_probs=178.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+++|+.++||||++++++|.....+|+|||||. ++|.+++....   ..+++..++.++.||+.||+|||++
T Consensus       229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~  308 (543)
T 3c4z_A          229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR  308 (543)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence            4567899999999999999999999999999999999997 49999987643   3599999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.+|.+||+|||+++......                                             
T Consensus       309 gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~---------------------------------------------  343 (543)
T 3c4z_A          309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---------------------------------------------  343 (543)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---------------------------------------------
T ss_pred             CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC---------------------------------------------
Confidence            99999999999999999999999999876432100                                             


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ......+||+.|+|||++.+.. |+.++||||+|
T Consensus       344 ----------------------------------------------~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlG  376 (543)
T 3c4z_A          344 ----------------------------------------------TKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALG  376 (543)
T ss_dssp             ----------------------------------------------CCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHH
T ss_pred             ----------------------------------------------cccccccCCccccChhhhcCCC-CChHHhcCcch
Confidence                                                          0012347899999999998754 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        254 CIFSEMITKKTLFAGDSE----IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~----~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |++|||++|++||.+.+.    .+....+.....                  .++           ...++.+.+||.+|
T Consensus       377 vilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~~li~~l  427 (543)
T 3c4z_A          377 VTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------------------TYP-----------DKFSPASKDFCEAL  427 (543)
T ss_dssp             HHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC------------------CCC-----------TTSCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc------------------CCC-----------cccCHHHHHHHHHh
Confidence            999999999999987642    333333332110                  000           12357899999999


Q ss_pred             cccCCCCCCC-----HHHHHcCccccCCccc
Q psy10954        330 MALDPKQRVS-----AKTILQHEYFNQVEMV  355 (562)
Q Consensus       330 L~~DP~~R~T-----a~elL~Hp~f~~~~~~  355 (562)
                      |+.||++|++     ++++++||||+++++.
T Consensus       428 L~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             SCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             ccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            9999999996     5899999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-37  Score=325.80  Aligned_cols=216  Identities=30%  Similarity=0.498  Sum_probs=177.1

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+++ +||||+++++++......|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||
T Consensus       143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi  221 (365)
T 2y7j_A          143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNI  221 (365)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34678999999999 899999999999999999999999985 999998764 369999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||++.......                                               
T Consensus       222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-----------------------------------------------  254 (365)
T 2y7j_A          222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-----------------------------------------------  254 (365)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-----------------------------------------------
T ss_pred             ecCCCCHHHEEECCCCCEEEEecCcccccCCCc-----------------------------------------------
Confidence            999999999999999999999999875442110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC-----CCCCCchhhHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-----AKVYSTTVDIW  250 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~-----~~~y~~~~DIW  250 (562)
                                                                   .....+||+.|+|||++.+     ...|+.++|||
T Consensus       255 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~  289 (365)
T 2y7j_A          255 ---------------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW  289 (365)
T ss_dssp             ---------------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHH
T ss_pred             ---------------------------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHH
Confidence                                                         0112357888888888753     23488999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|+|++|..||.+.+....+..+.........                         ......++.+.+||.+||
T Consensus       290 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L  344 (365)
T 2y7j_A          290 ACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS-------------------------PEWDDRSSTVKDLISRLL  344 (365)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH-------------------------HHHSSSCHHHHHHHHHHS
T ss_pred             hHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------------cccccCCHHHHHHHHHHc
Confidence            9999999999999999988877766666542111000                         011234567899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      +.||++|||+.|+|+||||+.
T Consensus       345 ~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          345 QVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999963

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-37  Score=310.30  Aligned_cols=228  Identities=21%  Similarity=0.267  Sum_probs=171.6

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+.++..+ +||||+++++++..++..|+||||+++ +|.+++....   ..+++..++.++.|++.||.|||+
T Consensus        54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  133 (289)
T 1x8b_A           54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS  133 (289)
T ss_dssp             HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45678999999999 999999999999999999999999975 9999987532   468999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||+||||||+|||++.++..++.+......                                                 
T Consensus       134 ~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~-------------------------------------------------  164 (289)
T 1x8b_A          134 MSLVHMDIKPSNIFISRTSIPNAASEEGDED-------------------------------------------------  164 (289)
T ss_dssp             TTEECSCCSGGGEEEC----------------------------------------------------------------
T ss_pred             CCEeecCCCHHHEEEcCCCCCcccccccccc-------------------------------------------------
Confidence            9999999999999999877655443321000                                                 


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                             ..-+..+.+||+|||++......    ....||+.|+|||++.+...++.++||||+
T Consensus       165 -----------------------~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  217 (289)
T 1x8b_A          165 -----------------------DWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFAL  217 (289)
T ss_dssp             ----------------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred             -----------------------cccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHH
Confidence                                   00123467999999998876533    234699999999999877667889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|.+++......   ..+...  .                  .+.        .....++.+.+|+.+||+.
T Consensus       218 G~il~~l~~~~~~~~~~~~~---~~~~~~--~------------------~~~--------~~~~~~~~~~~li~~~l~~  266 (289)
T 1x8b_A          218 ALTVVCAAGAEPLPRNGDQW---HEIRQG--R------------------LPR--------IPQVLSQEFTELLKVMIHP  266 (289)
T ss_dssp             HHHHHHHTTCCCCCSSSHHH---HHHHTT--C------------------CCC--------CSSCCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhcCCCCCcchhHH---HHHHcC--C------------------CCC--------CCcccCHHHHHHHHHHhCC
Confidence            99999999999887655332   222211  0                  000        1112357889999999999


Q ss_pred             CCCCCCCHHHHHcCccccCC
Q psy10954        333 DPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||++|||+.|+++||||.+.
T Consensus       267 dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          267 DPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             SGGGSCCHHHHHTCTTC---
T ss_pred             CcccCCCHHHHhhChHhhhh
Confidence            99999999999999999863

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=322.10  Aligned_cols=216  Identities=34%  Similarity=0.504  Sum_probs=167.9

Q ss_pred             hhHHHHHHHHHccCC--CCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~H--pnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|+.++|  |||+++++++..+..+|+|||+++++|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ii  130 (343)
T 3dbq_A           52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV  130 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456799999999987  99999999999999999999987889999998754 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++ ++.+||+|||+++........                                              
T Consensus       131 HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~----------------------------------------------  163 (343)
T 3dbq_A          131 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS----------------------------------------------  163 (343)
T ss_dssp             CCCCCGGGEEEE-TTEEEECCCSSSCCC----------------------------------------------------
T ss_pred             cCCCCcceEEEE-CCcEEEeecccccccCccccc----------------------------------------------
Confidence            999999999996 688999999998654311000                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----------CCCCCch
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----------AKVYSTT  246 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----------~~~y~~~  246 (562)
                                                                 ......+||+.|+|||++.+          ...|+.+
T Consensus       164 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~  200 (343)
T 3dbq_A          164 -------------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK  200 (343)
T ss_dssp             -------------------------------------------------CCCCSSCCHHHHHHCC-----------CCHH
T ss_pred             -------------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCch
Confidence                                                       00112357888888888753          2458999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      +||||+||++|||++|+.||.+... ...+..+...   ....             .+           ....+..+.+|
T Consensus       201 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~-------------~~-----------~~~~~~~l~~l  253 (343)
T 3dbq_A          201 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEI-------------EF-----------PDIPEKDLQDV  253 (343)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---TSCC-------------CC-----------CCCSCHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC---Cccc-------------CC-----------cccCCHHHHHH
Confidence            9999999999999999999987543 2333333221   0000             00           11234678999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +.+||+.||++|||+.|+|+||||+..
T Consensus       254 i~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          254 LKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHcCCChhHCCCHHHHHhCcccccc
Confidence            999999999999999999999999853

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-37  Score=317.98  Aligned_cols=226  Identities=26%  Similarity=0.435  Sum_probs=167.9

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCC-------------------------------------------------
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDF-------------------------------------------------   47 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-------------------------------------------------   47 (562)
                      ....+.+|+++|++++||||++++++|....                                                 
T Consensus        47 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (332)
T 3qd2_B           47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ  126 (332)
T ss_dssp             HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------------------------
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccc
Confidence            4567889999999999999999999986543                                                 


Q ss_pred             --------EEEEEeecCcC-CHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEe
Q psy10954         48 --------KLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLA  116 (562)
Q Consensus        48 --------~i~lV~Ey~~~-~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~  116 (562)
                              .+|+|||||++ +|.+++.....  ..++..++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus       127 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~  206 (332)
T 3qd2_B          127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG  206 (332)
T ss_dssp             -----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEe
Confidence                    38999999985 99999987542  25666789999999999999999999999999999999999999999


Q ss_pred             eccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcce
Q psy10954        117 DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNI  196 (562)
Q Consensus       117 DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNI  196 (562)
                      |||+++...........       ..|                                                     
T Consensus       207 DfG~a~~~~~~~~~~~~-------~~~-----------------------------------------------------  226 (332)
T 3qd2_B          207 DFGLVTAMDQDEEEQTV-------LTP-----------------------------------------------------  226 (332)
T ss_dssp             CCTTCEECSCC---------------------------------------------------------------------
T ss_pred             ecCcccccccchhhccc-------ccc-----------------------------------------------------
Confidence            99998765422110000       000                                                     


Q ss_pred             eecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy10954        197 LINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLF  276 (562)
Q Consensus       197 Ll~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~  276 (562)
                                         ..........+||+.|+|||++.+.. |+.++||||+||++|||++|..|+...  .....
T Consensus       227 -------------------~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~  284 (332)
T 3qd2_B          227 -------------------MPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMER--VRIIT  284 (332)
T ss_dssp             ------------------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHH
T ss_pred             -------------------ccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhHH--HHHHH
Confidence                               00001123457899999999998765 899999999999999999987665321  11111


Q ss_pred             HHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        277 RIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       277 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      .+.. . .                  ++        ......++.+.+|+.+||+.||++|||++|+|+||||+++
T Consensus       285 ~~~~-~-~------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          285 DVRN-L-K------------------FP--------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHT-T-C------------------CC--------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             Hhhc-c-C------------------CC--------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            1111 0 0                  00        0111124567899999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=312.28  Aligned_cols=214  Identities=25%  Similarity=0.495  Sum_probs=156.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.++++++||||+++++++......|+||||+++ +|.+++......+++..++.++.|++.||.|||++||+
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  134 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL  134 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678999999999999999999999999999999999975 99999987766799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++.....+..                                               
T Consensus       135 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------------  167 (278)
T 3cok_A          135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-----------------------------------------------  167 (278)
T ss_dssp             CSSCCGGGEEECTTCCEEECCCTTCEECC---------------------------------------------------
T ss_pred             cCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-----------------------------------------------
Confidence            999999999999999999999998754321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  .....+||+.|+|||++.+.. ++.++||||+||++
T Consensus       168 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  202 (278)
T 3cok_A          168 --------------------------------------------KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMF  202 (278)
T ss_dssp             ---------------------------------------------------------------------CTHHHHHHHHH
T ss_pred             --------------------------------------------cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHH
Confidence                                                        001235788899999887654 78999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+..+.+..+..                    ... .        .....+..+.+|+.+||+.||++
T Consensus       203 ~~l~~g~~p~~~~~~~~~~~~~~~--------------------~~~-~--------~~~~~~~~~~~li~~~l~~dp~~  253 (278)
T 3cok_A          203 YTLLIGRPPFDTDTVKNTLNKVVL--------------------ADY-E--------MPSFLSIEAKDLIHQLLRRNPAD  253 (278)
T ss_dssp             HHHHHSSCSSCCCSCC-----CCS--------------------SCC-C--------CCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             HHHHhCCCCCCChhHHHHHHHHhh--------------------ccc-C--------CccccCHHHHHHHHHHcccCHhh
Confidence            999999999987653322211100                    000 0        01123567899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++++++||||.+.
T Consensus       254 Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          254 RLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             SCCHHHHTTSTTTC--
T ss_pred             CCCHHHHhcCccccCC
Confidence            9999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.6e-37  Score=309.74  Aligned_cols=218  Identities=28%  Similarity=0.467  Sum_probs=178.3

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+++. ||||+++++++..+...|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  145 (298)
T 1phk_A           67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNI  145 (298)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356789999999995 9999999999999999999999997 5999998764 369999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++.......                                               
T Consensus       146 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-----------------------------------------------  178 (298)
T 1phk_A          146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-----------------------------------------------  178 (298)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-----------------------------------------------
T ss_pred             ccCCCCcceEEEcCCCcEEEecccchhhcCCCc-----------------------------------------------
Confidence            999999999999999999999999875432110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc-----CCCCCCchhhHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL-----GAKVYSTTVDIW  250 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~-----~~~~y~~~~DIW  250 (562)
                                                                   ......||+.|+|||++.     ....++.++|||
T Consensus       179 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~  213 (298)
T 1phk_A          179 ---------------------------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW  213 (298)
T ss_dssp             ---------------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred             ---------------------------------------------ccccccCCccccCHHHhccccccccccCCcccccH
Confidence                                                         001235677888888875     234578999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|+|++|..||.+.+..+....+..........                         .....+..+.+|+.+||
T Consensus       214 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l  268 (298)
T 1phk_A          214 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP-------------------------EWDDYSDTVKDLVSRFL  268 (298)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------TGGGSCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc-------------------------cccccCHHHHHHHHHHc
Confidence            99999999999999999888777666665432111100                         01123567899999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +.||++|||+.|+|+||||++..
T Consensus       269 ~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          269 VVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cCCcccCCCHHHHHhChHhhhcc
Confidence            99999999999999999998765

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-37  Score=313.26  Aligned_cols=214  Identities=27%  Similarity=0.403  Sum_probs=176.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++......|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++||+|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H  129 (304)
T 2jam_A           51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVH  129 (304)
T ss_dssp             -HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4577999999999999999999999999999999999975 9999887643 6899999999999999999999999999


Q ss_pred             ccCCCCcEEE---ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl---~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+||++   +.++.+||+|||+++.....                                               
T Consensus       130 ~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------------  162 (304)
T 2jam_A          130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----------------------------------------------  162 (304)
T ss_dssp             CSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----------------------------------------------
T ss_pred             cCCCHHHEEEecCCCCCCEEEccCCcceecCCC-----------------------------------------------
Confidence            9999999999   66778888888876422100                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    .....+||+.|+|||++.+.. |+.++||||+||
T Consensus       163 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  195 (304)
T 2jam_A          163 ----------------------------------------------IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGV  195 (304)
T ss_dssp             ----------------------------------------------TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCCCCccChHHhccCC-CCchhhHHHHHH
Confidence                                                          011235788999999987654 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|..||.+.+..+.+..+.+........                         .....++.+.+||.+||+.||
T Consensus       196 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp  250 (304)
T 2jam_A          196 ITYILLCGYPPFYEETESKLFEKIKEGYYEFESP-------------------------FWDDISESAKDFICHLLEKDP  250 (304)
T ss_dssp             HHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT-------------------------TTTTSCHHHHHHHHHHHCSST
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc-------------------------ccccCCHHHHHHHHHHcCCCh
Confidence            9999999999999988877776665532111110                         112235688999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      ++|||++|+|+||||++.
T Consensus       251 ~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          251 NERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTSCCHHHHHTSHHHHSS
T ss_pred             hHCcCHHHHhcCccccCC
Confidence            999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4e-37  Score=326.59  Aligned_cols=216  Identities=33%  Similarity=0.504  Sum_probs=169.8

Q ss_pred             hhHHHHHHHHHccC--CCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~--HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|+.++  ||||+++++++...+.+|||||+++++|.+++.... .+++..++.++.||+.||.|||++||+
T Consensus        99 ~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~iv  177 (390)
T 2zmd_A           99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV  177 (390)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45789999999996  599999999999999999999977789999998754 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++ ++.+||+|||+++........                                              
T Consensus       178 HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~----------------------------------------------  210 (390)
T 2zmd_A          178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS----------------------------------------------  210 (390)
T ss_dssp             CCCCCGGGEEES-SSCEEECCCSSSCCC----------------------------------------------------
T ss_pred             ecCCCHHHEEEE-CCeEEEEecCccccccCCCcc----------------------------------------------
Confidence            999999999995 688999999998654311000                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC----------CCCCch
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----------KVYSTT  246 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~----------~~y~~~  246 (562)
                                                                 ......+||+.|+|||++.+.          ..|+.+
T Consensus       211 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~  247 (390)
T 2zmd_A          211 -------------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK  247 (390)
T ss_dssp             ----------------------------------------------CCSCCCGGGCCHHHHHCC------------CCHH
T ss_pred             -------------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCCh
Confidence                                                       001234678888888888652          358999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      +||||+||++|||++|++||.+... ...+..+.....   .             ..++           ...+..+.+|
T Consensus       248 ~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~---~-------------~~~~-----------~~~~~~~~~l  300 (390)
T 2zmd_A          248 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH---E-------------IEFP-----------DIPEKDLQDV  300 (390)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS---C-------------CCCC-----------CCSCHHHHHH
T ss_pred             hhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc---c-------------CCCC-----------ccchHHHHHH
Confidence            9999999999999999999987643 334444332100   0             0011           1124678999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      |.+||+.||++|||+.|+|+||||+..
T Consensus       301 i~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          301 LKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHcccChhhCCCHHHHhhCcCcccc
Confidence            999999999999999999999999854

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.8e-37  Score=309.19  Aligned_cols=217  Identities=29%  Similarity=0.509  Sum_probs=177.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++......|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~  130 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIA  130 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4567899999999999999999999999999999999997 5999998764 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         97 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        97 HRDLKP~NILl~~~~----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ||||||+||+++.++    .+||+|||++......                                             
T Consensus       131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~---------------------------------------------  165 (283)
T 3bhy_A          131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---------------------------------------------  165 (283)
T ss_dssp             CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------------------------------------------
T ss_pred             CCCCChHHEEEecCCCCCCceEEEecccceeccCC---------------------------------------------
Confidence            999999999998776    6888888876433110                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     .......||+.|+|||++.+.. ++.++||||+
T Consensus       166 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~sl  197 (283)
T 3bhy_A          166 -----------------------------------------------NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSI  197 (283)
T ss_dssp             -----------------------------------------------------CCCGGGCCHHHHTTCC-CCTHHHHHHH
T ss_pred             -----------------------------------------------CcccccCCCcCccCcceecCCC-CCcchhhhhH
Confidence                                                           0011235789999999997654 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|..||.+.+..+.+..+........                         .......++.+.+|+.+||..
T Consensus       198 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~  252 (283)
T 3bhy_A          198 GVITYILLSGASPFLGETKQETLTNISAVNYDFD-------------------------EEYFSNTSELAKDFIRRLLVK  252 (283)
T ss_dssp             HHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHHHHHTTSCS
T ss_pred             HHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------------------------chhcccCCHHHHHHHHHHccC
Confidence            9999999999999999887776665543211000                         112234467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+++||||+.+.
T Consensus       253 dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          253 DPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             SGGGSCCHHHHHHCHHHHHHH
T ss_pred             CHhHCcCHHHHHhCHHHHHHH
Confidence            999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.9e-37  Score=308.73  Aligned_cols=212  Identities=26%  Similarity=0.421  Sum_probs=170.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+.+|+.++||||+++++++..    ...+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||+
T Consensus        69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~  147 (290)
T 1t4h_A           69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT  147 (290)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHc
Confidence            3457899999999999999999999875    3568999999975 999999764 368999999999999999999999


Q ss_pred             CC--ceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         93 RR--IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        93 ~g--IiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      +|  |+||||||+|||++ .++.+||+|||++......                                          
T Consensus       148 ~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~------------------------------------------  185 (290)
T 1t4h_A          148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------------------------------------  185 (290)
T ss_dssp             SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT------------------------------------------
T ss_pred             CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc------------------------------------------
Confidence            99  99999999999997 7789999999987432100                                          


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                         ......||+.|+|||++.+  .++.++||
T Consensus       186 ---------------------------------------------------~~~~~~~t~~y~aPE~~~~--~~~~~~Di  212 (290)
T 1t4h_A          186 ---------------------------------------------------FAKAVIGTPEFMAPEMYEE--KYDESVDV  212 (290)
T ss_dssp             ---------------------------------------------------SBEESCSSCCCCCGGGGGT--CCCTHHHH
T ss_pred             ---------------------------------------------------ccccccCCcCcCCHHHHhc--cCCCcchH
Confidence                                                               0112357899999998864  38999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      ||+||++|+|++|+.||.+......+.........+                       .   ......++.+.+|+.+|
T Consensus       213 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------~---~~~~~~~~~l~~li~~~  266 (290)
T 1t4h_A          213 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-----------------------A---SFDKVAIPEVKEIIEGC  266 (290)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------------------G---GGGGCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----------------------c---ccCCCCCHHHHHHHHHH
Confidence            999999999999999998866655544433211000                       0   01122356789999999


Q ss_pred             cccCCCCCCCHHHHHcCccccC
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      |+.||++|||++|+|+||||++
T Consensus       267 l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          267 IRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ccCChhhCCCHHHHhhCccccc
Confidence            9999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.7e-37  Score=308.30  Aligned_cols=214  Identities=31%  Similarity=0.543  Sum_probs=178.8

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+.+|+++++.++||||+++++++..++..|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++|
T Consensus        56 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~  134 (284)
T 2vgo_A           56 GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK  134 (284)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3345678999999999999999999999999999999999975 9999987643 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+||+++.++.+||+|||++......                                               
T Consensus       135 i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------------  167 (284)
T 2vgo_A          135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----------------------------------------------  167 (284)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-----------------------------------------------
T ss_pred             ceecCCCHHHEEEcCCCCEEEecccccccCccc-----------------------------------------------
Confidence            999999999999999999999999986432100                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                    ......||+.|+|||++.+.. ++.++||||+||
T Consensus       168 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  200 (284)
T 2vgo_A          168 ----------------------------------------------RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGV  200 (284)
T ss_dssp             ----------------------------------------------CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCCCCcCCHHHhccCC-CCcccchhhHHH
Confidence                                                          001235788999999998654 799999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|..||.+.+..+....+.....                  .++           ...+..+.+||.+||+.||
T Consensus       201 il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------~~~-----------~~~~~~~~~li~~~l~~~p  251 (284)
T 2vgo_A          201 LCYEFLVGMPPFDSPSHTETHRRIVNVDL------------------KFP-----------PFLSDGSKDLISKLLRYHP  251 (284)
T ss_dssp             HHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------------CCC-----------TTSCHHHHHHHHHHSCSSG
T ss_pred             HHHHHHHCCCCCCCCCHhHHHHHHhcccc------------------CCC-----------CcCCHHHHHHHHHHhhcCH
Confidence            99999999999998887766665543210                  000           1234678999999999999


Q ss_pred             CCCCCHHHHHcCccccCCc
Q psy10954        335 KQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+|||++|+++||||+...
T Consensus       252 ~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          252 PQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             GGSCCHHHHHTCHHHHHHC
T ss_pred             hhCCCHHHHhhCHHHHhhc
Confidence            9999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.6e-37  Score=310.07  Aligned_cols=213  Identities=23%  Similarity=0.368  Sum_probs=163.1

Q ss_pred             HHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Q psy10954         22 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR-RIIH   97 (562)
Q Consensus        22 ~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~-gIiH   97 (562)
                      .+|...++.++||||+++++++..++..|+||||++++|.+++..   ....+++..++.++.|++.||.|||++ ||+|
T Consensus        54 ~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H  133 (290)
T 3fme_A           54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH  133 (290)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCC
T ss_pred             HHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence            344455788899999999999999999999999999988777653   445799999999999999999999998 9999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......                                                 
T Consensus       134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------  164 (290)
T 3fme_A          134 RDVKPSNVLINALGQVKMCDFGISGYLVDDV-------------------------------------------------  164 (290)
T ss_dssp             CCCSGGGCEECTTCCEEBCCC-----------------------------------------------------------
T ss_pred             CCCCHHHEEECCCCCEEEeecCCcccccccc-------------------------------------------------
Confidence            9999999999999999999999875432100                                                 


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhh---cCCCCCCchhhHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL---LGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl---~~~~~y~~~~DIWSlG~  254 (562)
                                                                 ......||+.|+|||++   .....++.++||||+||
T Consensus       165 -------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~  201 (290)
T 3fme_A          165 -------------------------------------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI  201 (290)
T ss_dssp             ------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHH
T ss_pred             -------------------------------------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHH
Confidence                                                       00112578889999997   34456899999999999


Q ss_pred             HHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTLFAGD-SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~pF~~~-~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|+|++|+.||.+. .....+..........                    ..       ....++.+.+|+.+||+.|
T Consensus       202 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~~-------~~~~~~~~~~li~~~l~~~  254 (290)
T 3fme_A          202 TMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--------------------LP-------ADKFSAEFVDFTSQCLKKN  254 (290)
T ss_dssp             HHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--------------------CC-------TTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHCCCCccccCchHHHHHHHhccCCCC--------------------cc-------cccCCHHHHHHHHHHhhcC
Confidence            999999999999863 4444444444321100                    00       0123567899999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|||++|+++||||+...
T Consensus       255 p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          255 SKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             GGGSCCHHHHTTSHHHHHHH
T ss_pred             hhhCcCHHHHHhCcccccCc
Confidence            99999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=319.48  Aligned_cols=206  Identities=24%  Similarity=0.384  Sum_probs=171.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-C-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-Q-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|+.++||||++++++|...+.+|+||||+. + +|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        74 ~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iv  152 (335)
T 3dls_A           74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDII  152 (335)
T ss_dssp             EEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            456789999999999999999999999999999999985 4 8999987654 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.....                                                 
T Consensus       153 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-------------------------------------------------  183 (335)
T 3dls_A          153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERG-------------------------------------------------  183 (335)
T ss_dssp             CSCCSGGGEEECTTSCEEECCCTTCEECCTT-------------------------------------------------
T ss_pred             EeccCHHHEEEcCCCcEEEeecccceECCCC-------------------------------------------------
Confidence            9999999999999999999999987543210                                                 


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+...++.++||||+||++
T Consensus       184 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  220 (335)
T 3dls_A          184 -------------------------------------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL  220 (335)
T ss_dssp             -------------------------------------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred             -------------------------------------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHH
Confidence                                                       0012246899999999998877668999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|..||.+....      ...           .       ..           .-...++.+.+||.+||+.||++
T Consensus       221 ~el~~g~~pf~~~~~~------~~~-----------~-------~~-----------~~~~~~~~l~~li~~~L~~dP~~  265 (335)
T 3dls_A          221 YTLVFEENPFCELEET------VEA-----------A-------IH-----------PPYLVSKELMSLVSGLLQPVPER  265 (335)
T ss_dssp             HHHHHSSCSCSSGGGG------TTT-----------C-------CC-----------CSSCCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHhCCCchhhHHHH------Hhh-----------c-------cC-----------CCcccCHHHHHHHHHHccCChhh
Confidence            9999999999753221      000           0       00           00113568999999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||++|+++||||++.
T Consensus       266 Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          266 RTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             SCCHHHHHHCTTTTCC
T ss_pred             CcCHHHHhcCccccCC
Confidence            9999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.5e-37  Score=307.20  Aligned_cols=220  Identities=25%  Similarity=0.427  Sum_probs=175.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++..++..|+||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~  127 (276)
T 2yex_A           49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45678999999999999999999999999999999999985 899888653 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++........                                               
T Consensus       128 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------------  160 (276)
T 2yex_A          128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNR-----------------------------------------------  160 (276)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECEETTE-----------------------------------------------
T ss_pred             ccCCChHHEEEccCCCEEEeeCCCccccCCCcc-----------------------------------------------
Confidence            999999999999999999999998764321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .......+||+.|+|||++.+...++.++||||+||++
T Consensus       161 ------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  198 (276)
T 2yex_A          161 ------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL  198 (276)
T ss_dssp             ------------------------------------------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHH
Confidence                                                      00012346789999999998776568899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+................                 ..+         .....++.+.+||.+||+.||++
T Consensus       199 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~p~~  252 (276)
T 2yex_A          199 TAMLAGELPWDQPSDSCQEYSDWKEKKT-----------------YLN---------PWKKIDSAPLALLHKILVENPSA  252 (276)
T ss_dssp             HHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------------TST---------TGGGSCHHHHHHHHHHSCSSTTT
T ss_pred             HHHHhCCCCCCCCchHHHHHHHhhhccc-----------------ccC---------chhhcCHHHHHHHHHHCCCCchh
Confidence            9999999999876543222221111000                 000         01123567899999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||++|+++||||++..
T Consensus       253 Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          253 RITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             SCCHHHHTTCTTTTCCC
T ss_pred             CCCHHHHhcCccccChh
Confidence            99999999999998653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-38  Score=327.00  Aligned_cols=217  Identities=28%  Similarity=0.462  Sum_probs=173.5

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+++ +||||+++++++.....+|+|||||.+ +|.+++.... .+++..++.++.|++.||.|||++||
T Consensus       102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i  180 (355)
T 1vzo_A          102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGI  180 (355)
T ss_dssp             GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            45567899999999 799999999999999999999999975 9999987643 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.......                                              
T Consensus       181 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----------------------------------------------  214 (355)
T 1vzo_A          181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADET----------------------------------------------  214 (355)
T ss_dssp             CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG----------------------------------------------
T ss_pred             ccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC----------------------------------------------
Confidence            9999999999999999999999998764421100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGC  254 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSlG~  254 (562)
                                                                  ......+||+.|+|||++.+. ..++.++||||+||
T Consensus       215 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~  250 (355)
T 1vzo_A          215 --------------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV  250 (355)
T ss_dssp             --------------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred             --------------------------------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHH
Confidence                                                        001234689999999999863 34789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        255 IFSEMITKKTLFAGDSEI----DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~----~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ++|||++|+.||......    .....+....  +                   .        .....++.+.+||.+||
T Consensus       251 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~-------------------~--------~~~~~~~~~~~li~~~L  301 (355)
T 1vzo_A          251 LMYELLTGASPFTVDGEKNSQAEISRRILKSE--P-------------------P--------YPQEMSALAKDLIQRLL  301 (355)
T ss_dssp             HHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--C-------------------C--------CCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHCCCCCccCCccchHHHHHHHHhccC--C-------------------C--------CCcccCHHHHHHHHHHh
Confidence            999999999999754322    2222222110  0                   0        00123467899999999


Q ss_pred             ccCCCCCC-----CHHHHHcCccccCCcc
Q psy10954        331 ALDPKQRV-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~-----Ta~elL~Hp~f~~~~~  354 (562)
                      +.||++||     |++|+++||||+.+++
T Consensus       302 ~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          302 MKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             CSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             hhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence            99999999     9999999999998764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-37  Score=314.53  Aligned_cols=231  Identities=25%  Similarity=0.387  Sum_probs=168.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT-------TPVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~-------~~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ...+.+|+.+|+.++||||+++++++...+..|+||||++ ++|.+++..       ....+++..+..++.|++.||.|
T Consensus        57 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  136 (303)
T 2vwi_A           57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY  136 (303)
T ss_dssp             ---------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHH
Confidence            3457799999999999999999999999999999999996 599998864       23459999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+||||||+||+++.++.+||+|||++..........                                      
T Consensus       137 lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--------------------------------------  178 (303)
T 2vwi_A          137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT--------------------------------------  178 (303)
T ss_dssp             HHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--------------------------------------------
T ss_pred             HHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCcc--------------------------------------
Confidence            999999999999999999999999999999876442110000                                      


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                      .........||+.|+|||++.+...++.++||
T Consensus       179 ------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  210 (303)
T 2vwi_A          179 ------------------------------------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADI  210 (303)
T ss_dssp             ---------------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHH
T ss_pred             ------------------------------------------------chhhhcccCCCccccCHHHhccccCCCchhhH
Confidence                                                            00001234689999999999764558999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      ||+||++|+|++|+.||.+.+....+............   ...                .........++.+.+|+.+|
T Consensus       211 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~----------------~~~~~~~~~~~~~~~li~~~  271 (303)
T 2vwi_A          211 WSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---TGV----------------QDKEMLKKYGKSFRKMISLC  271 (303)
T ss_dssp             HHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT---C---------------------CCCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc---ccc----------------ccchhhhhhhHHHHHHHHHH
Confidence            99999999999999999887765554443321110000   000                00012233457889999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |+.||++|||+.|+++||||++..
T Consensus       272 l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          272 LQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccCChhhCcCHHHHhhChhhhcCC
Confidence            999999999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.9e-37  Score=305.81  Aligned_cols=213  Identities=29%  Similarity=0.494  Sum_probs=171.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++...+..|+||||+.+ +|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  133 (276)
T 2h6d_A           55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVV  133 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            44678999999999999999999999999999999999975 9999987643 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++.......                                                
T Consensus       134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~------------------------------------------------  165 (276)
T 2h6d_A          134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------------------------------------------------  165 (276)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------------------------------------------
T ss_pred             cCCCChhhEEECCCCCEEEeecccccccCCCc------------------------------------------------
Confidence            99999999999999999999999875432100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                  ......||+.|+|||++.+...++.++||||+||++
T Consensus       166 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l  201 (276)
T 2h6d_A          166 --------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL  201 (276)
T ss_dssp             -------------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHH
T ss_pred             --------------------------------------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHH
Confidence                                                        001235788999999998766557899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+..+....+......                  .+           ...+..+.+++.+||+.||++
T Consensus       202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~-----------~~~~~~l~~li~~~l~~~p~~  252 (276)
T 2h6d_A          202 YALLCGTLPFDDEHVPTLFKKIRGGVFY------------------IP-----------EYLNRSVATLLMHMLQVDPLK  252 (276)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHhCCCCCCCCcHHHHHHHhhcCccc------------------Cc-----------hhcCHHHHHHHHHHccCChhh
Confidence            9999999999988776655555432100                  00           112467899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||+.|+++||||++.
T Consensus       253 Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          253 RATIKDIREHEWFKQD  268 (276)
T ss_dssp             SCCHHHHHHSHHHHTT
T ss_pred             CCCHHHHHhChhhccC
Confidence            9999999999999753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.5e-37  Score=310.94  Aligned_cols=219  Identities=25%  Similarity=0.383  Sum_probs=176.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++...+..|+||||+++ +|.+++......+++..++.++.|++.||.|||++||+
T Consensus        60 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  139 (302)
T 2j7t_A           60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII  139 (302)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence            45678999999999999999999999999999999999975 89988876566799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++........                                               
T Consensus       140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  172 (302)
T 2j7t_A          140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-----------------------------------------------  172 (302)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-----------------------------------------------
T ss_pred             cCCCCHHHEEECCCCCEEEEECCCCcccccccc-----------------------------------------------
Confidence            999999999999999999999998643210000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc----CCCCCCchhhHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSA  252 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~----~~~~y~~~~DIWSl  252 (562)
                                                                  ......||+.|+|||++.    +...++.++||||+
T Consensus       173 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  208 (302)
T 2j7t_A          173 --------------------------------------------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  208 (302)
T ss_dssp             --------------------------------------------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred             --------------------------------------------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence                                                        001235788899999884    34458999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|..||.+.+....+..+........                   .       .....+..+.+|+.+||..
T Consensus       209 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~-------~~~~~~~~l~~li~~~l~~  262 (302)
T 2j7t_A          209 GITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-------------------L-------TPSKWSVEFRDFLKIALDK  262 (302)
T ss_dssp             HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------------S-------SGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-------------------C-------CccccCHHHHHHHHHHccc
Confidence            9999999999999998887766665544211000                   0       0011246789999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+++||||+++.
T Consensus       263 dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          263 NPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             CTTTSCCHHHHTTSTTTTTCC
T ss_pred             ChhhCCCHHHHhcChHHhhhc
Confidence            999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-37  Score=332.41  Aligned_cols=217  Identities=28%  Similarity=0.470  Sum_probs=164.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++||||+++++++. ....|+|||||.+ +|.+++... ..+++..++.++.|++.||+|||++||+|
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH  262 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIH  262 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            35789999999999999999999985 4568999999975 898887654 46999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+|||++.++   .+||+|||+|+.....                                               
T Consensus       263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-----------------------------------------------  295 (419)
T 3i6u_A          263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----------------------------------------------  295 (419)
T ss_dssp             SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------------------------------------------
T ss_pred             cCCChHhEEEecCCCcceEEEeecccceecCCC-----------------------------------------------
Confidence            99999999997544   4888888887543210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSA  252 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSl  252 (562)
                                                                   ......+||+.|+|||++.+  ...|+.++||||+
T Consensus       296 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  330 (419)
T 3i6u_A          296 ---------------------------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  330 (419)
T ss_dssp             ------------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred             ---------------------------------------------ccccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence                                                         00123467889999998853  3458899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|.+||.+......+...+.....                    ..    ........++.+.+||.+||+.
T Consensus       331 G~il~~lltg~~pf~~~~~~~~~~~~i~~~~~--------------------~~----~~~~~~~~~~~~~~li~~~L~~  386 (419)
T 3i6u_A          331 GVILFICLSGYPPFSEHRTQVSLKDQITSGKY--------------------NF----IPEVWAEVSEKALDLVKKLLVV  386 (419)
T ss_dssp             HHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC--------------------CC----CHHHHTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC--------------------CC----CchhhcccCHHHHHHHHHHccC
Confidence            99999999999999876443222222221000                    00    0112233467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||++|+|+||||++..
T Consensus       387 dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          387 DPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             STTTSCCHHHHHHSGGGCCHH
T ss_pred             ChhHCcCHHHHhCCcccCChh
Confidence            999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=307.03  Aligned_cols=219  Identities=29%  Similarity=0.484  Sum_probs=175.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEE--eCCEEEEEeecCcCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~--~~~~i~lV~Ey~~~~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++|+.++||||+++++++.  .....|+|||||.++|.+++... ...+++..+..++.|++.||.|||++|
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~  129 (305)
T 2wtk_C           50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG  129 (305)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456789999999999999999999984  44679999999998888887654 346999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.++.+||+|||++........                                             
T Consensus       130 i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~---------------------------------------------  164 (305)
T 2wtk_C          130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA---------------------------------------------  164 (305)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS---------------------------------------------
T ss_pred             eeecCCCcccEEEcCCCcEEeeccccccccCcccc---------------------------------------------
Confidence            99999999999999999999999998764421000                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-CCCchhhHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAG  253 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-~y~~~~DIWSlG  253 (562)
                                                                  ........||+.|+|||++.+.. .++.++||||+|
T Consensus       165 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG  200 (305)
T 2wtk_C          165 --------------------------------------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAG  200 (305)
T ss_dssp             --------------------------------------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHH
T ss_pred             --------------------------------------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHH
Confidence                                                        00011235789999999997643 347899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.+..+....+....-.                             .....++.+.+|+.+||..|
T Consensus       201 ~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~d  251 (305)
T 2wtk_C          201 VTLYNITTGLYPFEGDNIYKLFENIGKGSYA-----------------------------IPGDCGPPLSDLLKGMLEYE  251 (305)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-----------------------------CCSSSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCCCCCchHHHHHHHHhcCCCC-----------------------------CCCccCHHHHHHHHHHccCC
Confidence            9999999999999988876665555432100                             01123567899999999999


Q ss_pred             CCCCCCHHHHHcCccccCCcc
Q psy10954        334 PKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++|||++|+++||||++...
T Consensus       252 p~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          252 PAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             TTTSCCHHHHHHSHHHHSCCC
T ss_pred             hhhCCCHHHHhcCcccccCCC
Confidence            999999999999999987653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=308.50  Aligned_cols=219  Identities=27%  Similarity=0.429  Sum_probs=180.4

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|+.++||||+++++++.....+|+||||+++ +|.+++......+++..+..++.|++.||.|||++||
T Consensus        67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  146 (314)
T 3com_A           67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK  146 (314)
T ss_dssp             CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            346788999999999999999999999999999999999986 9999987655679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++.......                                               
T Consensus       147 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-----------------------------------------------  179 (314)
T 3com_A          147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-----------------------------------------------  179 (314)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-----------------------------------------------
T ss_pred             cCCCcCHHHEEECCCCCEEEeecccchhhhhhc-----------------------------------------------
Confidence            999999999999999999999999875432110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. ++.++||||+||+
T Consensus       180 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  214 (314)
T 3com_A          180 --------------------------------------------AKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGIT  214 (314)
T ss_dssp             --------------------------------------------SCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHH
T ss_pred             --------------------------------------------cccCccCCCCCccChhhcCCCC-CCccccHHHHHHH
Confidence                                                        0011235789999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+.+.......+..... +.                   ..      .....+..+.+|+.+||..||.
T Consensus       215 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-------------------~~------~~~~~~~~l~~li~~~l~~dp~  268 (314)
T 3com_A          215 AIEMAEGKPPYADIHPMRAIFMIPTNPP-PT-------------------FR------KPELWSDNFTDFVKQCLVKSPE  268 (314)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-------------------CS------SGGGSCHHHHHHHHHHTCSCTT
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHhcCCC-cc-------------------cC------CcccCCHHHHHHHHHHccCChh
Confidence            9999999999998877665554433210 00                   00      0011246789999999999999


Q ss_pred             CCCCHHHHHcCccccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~  353 (562)
                      +|||+.++++||||++..
T Consensus       269 ~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          269 QRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             TSCCHHHHTTSHHHHTCC
T ss_pred             hCcCHHHHHhCHHHhcCC
Confidence            999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-38  Score=335.22  Aligned_cols=208  Identities=15%  Similarity=0.252  Sum_probs=159.1

Q ss_pred             chhhHHHHH---HHHHccCCCCcceEE-------EEEEeCCE-----------------EEEEeecCcCCHHHHHhhCCC
Q psy10954         17 VPSTALREI---SVLKELKHPNVIRLH-------DVIPVDFK-----------------LFLVFEFLRQDLKDFLQTTPV   69 (562)
Q Consensus        17 ~~~~~~rEi---~iL~~l~HpnIv~L~-------~~~~~~~~-----------------i~lV~Ey~~~~L~~~i~~~~~   69 (562)
                      ....+.+|+   ++|+.++|||||+++       ++++..+.                 .|||||||+++|.+++.... 
T Consensus       116 ~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-  194 (377)
T 3byv_A          116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-  194 (377)
T ss_dssp             HHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-
Confidence            346678999   455566899999998       77776542                 89999999889999997642 


Q ss_pred             CCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCc
Q psy10954         70 PVP-------PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP  142 (562)
Q Consensus        70 ~l~-------e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~a  142 (562)
                      .++       +..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....   ..           
T Consensus       195 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~-----------  260 (377)
T 3byv_A          195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RV-----------  260 (377)
T ss_dssp             HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EE-----------
T ss_pred             ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cc-----------
Confidence            244       477888999999999999999999999999999999999999999998763211   00           


Q ss_pred             cceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcc
Q psy10954        143 PEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY  222 (562)
Q Consensus       143 PE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~  222 (562)
                                                                                                      
T Consensus       261 --------------------------------------------------------------------------------  260 (377)
T 3byv_A          261 --------------------------------------------------------------------------------  260 (377)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             cccccCCCccchhhhcCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCC
Q psy10954        223 THEVVTLWYRPPEILLGA----------KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPG  292 (562)
Q Consensus       223 ~~~vgT~~Y~APEvl~~~----------~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~  292 (562)
                      ...+| +.|+|||++.+.          ..|+.++||||+||++|||++|+.||.+.+..+....+.             
T Consensus       261 ~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------------  326 (377)
T 3byv_A          261 VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-------------  326 (377)
T ss_dssp             ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-------------
T ss_pred             cCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-------------
Confidence            12245 677777777654          248999999999999999999999997654321111000             


Q ss_pred             CCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        293 VSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                                          ......++.+.+|+.+||+.||++|||+.|+++||||+++.
T Consensus       327 --------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          327 --------------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             --------------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             --------------------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence                                01123457899999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-37  Score=320.04  Aligned_cols=241  Identities=23%  Similarity=0.358  Sum_probs=174.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~-gI   95 (562)
                      ...+.+|+.+|+.++||||+++++++..++..|+||||+++ +|.+++.... .+++..+..++.|++.||.|||++ ||
T Consensus        75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i  153 (360)
T 3eqc_A           75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKI  153 (360)
T ss_dssp             HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence            35678999999999999999999999999999999999975 9999997643 699999999999999999999996 99


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||++......                                                
T Consensus       154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------------------------------------------------  185 (360)
T 3eqc_A          154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------------------------------------------  185 (360)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH------------------------------------------------
T ss_pred             EcCCccHHHEEECCCCCEEEEECCCCcccccc------------------------------------------------
Confidence            99999999999999999999999986432100                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   .....+||+.|+|||++.+.. |+.++||||+||+
T Consensus       186 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~i  219 (360)
T 3eqc_A          186 ---------------------------------------------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLS  219 (360)
T ss_dssp             ---------------------------------------------C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHH
T ss_pred             ---------------------------------------------cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHH
Confidence                                                         001236799999999998754 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhc-CCCCCCCCCCC---CCCCCccC-CCCCCCc-cchhh--------h-cCCCCH
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTL-GTPHEDVWPGV---SKLPIYKT-DFPEWRP-KKFSE--------I-LNLPDP  320 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~l-g~~~~~~~~~~---~~~~~~~~-~~~~~~~-~~~~~--------~-l~~~~~  320 (562)
                      +|+|++|+.||.+.+..+....+.... +......+...   .....+.. ..+.... .....        . ....+.
T Consensus       220 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (360)
T 3eqc_A          220 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL  299 (360)
T ss_dssp             HHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccH
Confidence            999999999999877654332221111 11111000000   00000000 0000000 00000        0 012356


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+.+||.+||+.||++|||++|+|+||||++..
T Consensus       300 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          300 EFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence            899999999999999999999999999998764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-37  Score=322.92  Aligned_cols=217  Identities=16%  Similarity=0.188  Sum_probs=151.8

Q ss_pred             hHHHHH---HHHHccCCCCcceEE-------EEEEeC-----------------CEEEEEeecCcCCHHHHHhhCCCCCC
Q psy10954         20 TALREI---SVLKELKHPNVIRLH-------DVIPVD-----------------FKLFLVFEFLRQDLKDFLQTTPVPVP   72 (562)
Q Consensus        20 ~~~rEi---~iL~~l~HpnIv~L~-------~~~~~~-----------------~~i~lV~Ey~~~~L~~~i~~~~~~l~   72 (562)
                      .+.+|+   .+|+. +||||++++       +++...                 ..+|||||||+++|.+++...+..++
T Consensus       108 ~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~  186 (371)
T 3q60_A          108 RLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV  186 (371)
T ss_dssp             HHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccc
Confidence            455774   55555 799988765       565543                 34899999999999999986543455


Q ss_pred             HHHH------HHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCcccee
Q psy10954         73 PALA------KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL  146 (562)
Q Consensus        73 e~~i------~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l  146 (562)
                      +...      ..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....                   
T Consensus       187 ~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------------------  247 (371)
T 3q60_A          187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------------------  247 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------------------
T ss_pred             hhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-------------------
Confidence            4444      566699999999999999999999999999999999999999987643210                   


Q ss_pred             ccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccc
Q psy10954        147 LGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV  226 (562)
Q Consensus       147 ~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~v  226 (562)
                                                                                                 .....
T Consensus       248 ---------------------------------------------------------------------------~~~~~  252 (371)
T 3q60_A          248 ---------------------------------------------------------------------------GPASS  252 (371)
T ss_dssp             ---------------------------------------------------------------------------EEGGG
T ss_pred             ---------------------------------------------------------------------------ccCcc
Confidence                                                                                       00124


Q ss_pred             cCCCccchhhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCC--CccCCC
Q psy10954        227 VTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDF  303 (562)
Q Consensus       227 gT~~Y~APEvl~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~--~~~~~~  303 (562)
                      +|+.|+|||++.+. ..|+.++||||+||++|||++|+.||.+.....             ...+.......  .....+
T Consensus       253 ~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~~~~~~~~~~~~  319 (371)
T 3q60_A          253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------KGSWKRPSLRVPGTDSLAF  319 (371)
T ss_dssp             SCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------TTCCCBCCTTSCCCCSCCC
T ss_pred             CCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------ccchhhhhhhhccccccch
Confidence            56889999999752 358999999999999999999999998764310             00010000000  000000


Q ss_pred             CCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        304 PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       304 ~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +         .....++.+.+||.+||+.||++|||+.|+|+||||+++.
T Consensus       320 ~---------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          320 G---------SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             T---------TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             h---------hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            0         1123467899999999999999999999999999998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4e-37  Score=321.15  Aligned_cols=241  Identities=28%  Similarity=0.475  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHccC-----------CCCcceEEEEEEeCC----EEEEEeecCcCCHHHHHhhCC-CCCCHHHHHHHHHH
Q psy10954         19 STALREISVLKELK-----------HPNVIRLHDVIPVDF----KLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQ   82 (562)
Q Consensus        19 ~~~~rEi~iL~~l~-----------HpnIv~L~~~~~~~~----~i~lV~Ey~~~~L~~~i~~~~-~~l~e~~i~~i~~q   82 (562)
                      ..+.+|++++++++           ||||+++++++...+    .+++||||++++|.+++.... ..+++..++.++.|
T Consensus        60 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~q  139 (373)
T 1q8y_A           60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ  139 (373)
T ss_dssp             HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred             hhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHH
Confidence            45679999999886           899999999998654    799999999889999997643 45999999999999


Q ss_pred             HHHHHHHHHHC-CceeccCCCCcEEEccCC------CeeEeeccccccccccCcccceeeeeccCCccceeccccccccc
Q psy10954         83 LLEALRYCHSR-RIIHRDLKPQNILINKSG------ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  155 (562)
Q Consensus        83 ll~aL~yLH~~-gIiHRDLKP~NILl~~~~------~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~  155 (562)
                      |+.||+|||++ ||+||||||+|||++.++      .+||+|||+++                                 
T Consensus       140 i~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~---------------------------------  186 (373)
T 1q8y_A          140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---------------------------------  186 (373)
T ss_dssp             HHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE---------------------------------
T ss_pred             HHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEccccccc---------------------------------
Confidence            99999999998 999999999999996432      45666666543                                 


Q ss_pred             cccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchh
Q psy10954        156 VDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPE  235 (562)
Q Consensus       156 ~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APE  235 (562)
                                                                                ....   .....+||+.|+|||
T Consensus       187 ----------------------------------------------------------~~~~---~~~~~~~t~~y~aPE  205 (373)
T 1q8y_A          187 ----------------------------------------------------------WYDE---HYTNSIQTREYRSPE  205 (373)
T ss_dssp             ----------------------------------------------------------ETTB---CCCSCCSCGGGCCHH
T ss_pred             ----------------------------------------------------------ccCC---CCCCCCCCccccCcH
Confidence                                                                      2211   112346899999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCCCCCCCCCCCCCcc------C--
Q psy10954        236 ILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVWPGVSKLPIYK------T--  301 (562)
Q Consensus       236 vl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~------~--  301 (562)
                      ++.+.. |+.++||||+||++|||++|+.||.+.+      ..+.+..+...+|.++...+........+.      .  
T Consensus       206 ~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  284 (373)
T 1q8y_A          206 VLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI  284 (373)
T ss_dssp             HHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSC
T ss_pred             HHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccc
Confidence            998765 8999999999999999999999998764      556778888888876543221110000000      0  


Q ss_pred             -CCCCCCcc-chhhhcCC---CCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        302 -DFPEWRPK-KFSEILNL---PDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       302 -~~~~~~~~-~~~~~l~~---~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                       ....+... ........   .++.+.+||.+||+.||++|||++|+|+||||++...
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          285 SKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             CCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             ccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence             00011000 00111111   1356889999999999999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-36  Score=308.50  Aligned_cols=215  Identities=27%  Similarity=0.443  Sum_probs=178.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++..++..|+||||++ ++|.+++... ..+++..++.++.|++.||+|||++||+
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~  137 (294)
T 2rku_A           59 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVI  137 (294)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3457789999999999999999999999999999999998 5899888664 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++.......                                                
T Consensus       138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------------------  169 (294)
T 2rku_A          138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------------------------------------------------  169 (294)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEECCSTT------------------------------------------------
T ss_pred             ccCCChHhEEEcCCCCEEEEeccCceecccCc------------------------------------------------
Confidence            99999999999999999999999875432100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       170 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  205 (294)
T 2rku_A          170 -------------------------------------------ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIM  205 (294)
T ss_dssp             -------------------------------------------CCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccccCCCCcCCcchhccCC-CCchhhHHHHHHHH
Confidence                                                       0011236789999999997654 79999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+....+....+......                  .           ....++.+.+++.+||+.||++
T Consensus       206 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~-----------~~~~~~~~~~li~~~l~~~p~~  256 (294)
T 2rku_A          206 YTLLVGKPPFETSCLKETYLRIKKNEYS------------------I-----------PKHINPVAASLIQKMLQTDPTA  256 (294)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHTTCCC------------------C-----------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhhccCC------------------C-----------ccccCHHHHHHHHHHcccChhh
Confidence            9999999999988876665554321000                  0           0123467899999999999999


Q ss_pred             CCCHHHHHcCccccCCcc
Q psy10954        337 RVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~~  354 (562)
                      |||++|+++||||.+...
T Consensus       257 Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          257 RPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             SCCGGGGGGSHHHHTSCC
T ss_pred             CcCHHHHhhChheecCCc
Confidence            999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.8e-37  Score=316.19  Aligned_cols=214  Identities=28%  Similarity=0.441  Sum_probs=178.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++...+.+|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+
T Consensus        85 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~iv  163 (335)
T 2owb_A           85 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVI  163 (335)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCE
Confidence            34578999999999999999999999999999999999984 899988764 3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++......                                                
T Consensus       164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------  195 (335)
T 2owb_A          164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------------------------------------------------  195 (335)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCTTCEECCSTT------------------------------------------------
T ss_pred             ecCCCchhEEEcCCCCEEEeeccCceecccCc------------------------------------------------
Confidence            99999999999999999999999876432100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       196 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il  231 (335)
T 2owb_A          196 -------------------------------------------ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIM  231 (335)
T ss_dssp             -------------------------------------------CCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccccCCCccccCHHHhccCC-CCchhhHHHHHHHH
Confidence                                                       0011236799999999998754 79999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+....+....+......                  .           -...++.+.+||.+||+.||++
T Consensus       232 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~-----------~~~~~~~~~~li~~~l~~dp~~  282 (335)
T 2owb_A          232 YTLLVGKPPFETSCLKETYLRIKKNEYS------------------I-----------PKHINPVAASLIQKMLQTDPTA  282 (335)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHHTCCC------------------C-----------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHHCcCCCCCCCHHHHHHHHhcCCCC------------------C-----------CccCCHHHHHHHHHHccCChhH
Confidence            9999999999988876666555432100                  0           0123467899999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||++|+|+||||.+..
T Consensus       283 Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          283 RPTINELLNDEFFTSGY  299 (335)
T ss_dssp             SCCGGGGGGSHHHHTSC
T ss_pred             CcCHHHHhcCccccCCC
Confidence            99999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-36  Score=311.79  Aligned_cols=216  Identities=29%  Similarity=0.500  Sum_probs=168.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++..+. .|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+|
T Consensus        60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  137 (322)
T 2ycf_A           60 LNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIH  137 (322)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            35789999999999999999999997665 8999999975 999988654 46999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCC---eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~~~~~---vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+|||++.++.   +||+|||+++.....                                               
T Consensus       138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------------  170 (322)
T 2ycf_A          138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----------------------------------------------  170 (322)
T ss_dssp             CCCSGGGEEESSSSSSCCEEECCCTTCEECCCC-----------------------------------------------
T ss_pred             cCCCHHHEEEecCCCCCeEEEccCccceecccc-----------------------------------------------
Confidence            999999999987654   889999886543210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc--CCCCCCchhhHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSA  252 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~--~~~~y~~~~DIWSl  252 (562)
                                                                   ......+||+.|+|||++.  +...|+.++||||+
T Consensus       171 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  205 (322)
T 2ycf_A          171 ---------------------------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  205 (322)
T ss_dssp             ---------------------------------------------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHH
T ss_pred             ---------------------------------------------cccccccCCcCccCchhhccCCCCCCCchhhHHHH
Confidence                                                         0001235789999999984  34558999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|..||.+......+...+.. +..                   ..    ........++.+.+|+.+||+.
T Consensus       206 G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~-------------------~~----~~~~~~~~~~~~~~li~~~l~~  261 (322)
T 2ycf_A          206 GVILFICLSGYPPFSEHRTQVSLKDQITS-GKY-------------------NF----IPEVWAEVSEKALDLVKKLLVV  261 (322)
T ss_dssp             HHHHHHHHHSSCSSCSTTCSSCHHHHHHH-TCC-------------------CC----CHHHHTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHhCCCCCcccchHHHHHHHHHh-Ccc-------------------cc----CchhhhhcCHHHHHHHHHHccc
Confidence            99999999999999865433222222211 000                   00    0112233467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCC
Q psy10954        333 DPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||++|||+.|+|+||||++.
T Consensus       262 dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          262 DPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             STTTSCCHHHHHTSGGGCCH
T ss_pred             CHhhCCCHHHHhhCcCcCCH
Confidence            99999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-37  Score=315.92  Aligned_cols=221  Identities=26%  Similarity=0.406  Sum_probs=174.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCC----EEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+|+.+++.++||||+++++++....    ..|+||||++ ++|.+++.... .+++..++.++.|++.||.|||++
T Consensus        57 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~  135 (311)
T 3ork_A           57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN  135 (311)
T ss_dssp             HHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45789999999999999999999987643    4599999997 59999987643 699999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++........                                           
T Consensus       136 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-------------------------------------------  172 (311)
T 3ork_A          136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS-------------------------------------------  172 (311)
T ss_dssp             TCCCCCCCGGGEEEETTSCEEECCCSCC----------------------------------------------------
T ss_pred             CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc-------------------------------------------
Confidence            9999999999999999999999999997644211000                                           


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                   .......+||+.|+|||++.+.. ++.++||||+|
T Consensus       173 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  206 (311)
T 3ork_A          173 ---------------------------------------------VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLG  206 (311)
T ss_dssp             ------------------------------------------------------CCTTCCHHHHHTCC-CCHHHHHHHHH
T ss_pred             ---------------------------------------------cccccccCcCcccCCHHHhcCCC-CCchHhHHHHH
Confidence                                                         00012346899999999998764 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.+..+....+......++                         .......++.+.+|+.+||+.|
T Consensus       207 ~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~d  261 (311)
T 3ork_A          207 CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVLKALAKN  261 (311)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH-------------------------HHHSTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc-------------------------ccccCCCCHHHHHHHHHHHhcC
Confidence            999999999999999888776666654321110                         0112234678899999999999


Q ss_pred             CCCCCCHHHHHcCccccCCcc
Q psy10954        334 PKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++|+++.++++|+|++....
T Consensus       262 P~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          262 PENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             GGGSCSSHHHHHHHHHHHHTT
T ss_pred             HhhChhhHHHHHHHHHHHhcC
Confidence            999999999999999986543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=315.51  Aligned_cols=235  Identities=23%  Similarity=0.324  Sum_probs=168.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC--EEEEEeecCc-CCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLR-QDLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~--~i~lV~Ey~~-~~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+++|++++||||+++++++....  .+|+|||||. ++|.+++.....  .+++..++.++.|++.||+|||+
T Consensus        51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  130 (319)
T 4euu_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (319)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999998765  8899999997 599999976432  39999999999999999999999


Q ss_pred             CCceeccCCCCcEEE----ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         93 RRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        93 ~gIiHRDLKP~NILl----~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      +||+||||||+|||+    +.++.+||+|||+++......                                        
T Consensus       131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----------------------------------------  170 (319)
T 4euu_A          131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----------------------------------------  170 (319)
T ss_dssp             TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC----------------------------------------
T ss_pred             CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC----------------------------------------
Confidence            999999999999998    566678888888875432110                                        


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC-------CC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-------AK  241 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~-------~~  241 (562)
                                                                          .....+||+.|+|||++.+       ..
T Consensus       171 ----------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~  198 (319)
T 4euu_A          171 ----------------------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQK  198 (319)
T ss_dssp             ----------------------------------------------------CBCCCCSCGGGCCHHHHHHHTSCCCCCC
T ss_pred             ----------------------------------------------------ceeecccCCCccCHHHhhhccccccccC
Confidence                                                                0112357788888887752       34


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC
Q psy10954        242 VYSTTVDIWSAGCIFSEMITKKTLFAGDS----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL  317 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLltG~~pF~~~~----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  317 (562)
                      .|+.++||||+||++|||++|+.||.+..    ..+.+..+...   .+...+............+....+.. ..+...
T Consensus       199 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  274 (319)
T 4euu_A          199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---KPSGAISGVQKAENGPIDWSGDMPVS-CSLSRG  274 (319)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH---CCTTCCEEEECSTTCCEEEESSCCTT-CSSCHH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC---CCcccchhhhcccCCccccCccCCcc-cccchh
Confidence            58999999999999999999999997533    23444444432   22222222211110000000000000 000011


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q psy10954        318 PDPLAVDVFSKIMALDPKQRVSAKTILQHEY  348 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~  348 (562)
                      .+..+.+||.+||+.||++|+|++|+|+||=
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          275 LQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             HHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2356889999999999999999999999973

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.3e-36  Score=302.29  Aligned_cols=219  Identities=29%  Similarity=0.375  Sum_probs=171.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+.+++.++||||+++++++...+..|+||||++ ++|.+++.....  .+++..++.++.|++.||.|||++|
T Consensus        63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  142 (295)
T 2clq_A           63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ  142 (295)
T ss_dssp             -HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567899999999999999999999999999999999997 599999987543  4678999999999999999999999


Q ss_pred             ceeccCCCCcEEEcc-CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 IIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 IiHRDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |+||||||+||+++. ++.+||+|||++........                                            
T Consensus       143 i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------  178 (295)
T 2clq_A          143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--------------------------------------------  178 (295)
T ss_dssp             EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----------------------------------------------
T ss_pred             EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--------------------------------------------
Confidence            999999999999987 88999999998754321000                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-CCCCchhhHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSA  252 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-~~y~~~~DIWSl  252 (562)
                                                                     ......||+.|+|||++.+. ..++.++||||+
T Consensus       179 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  211 (295)
T 2clq_A          179 -----------------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL  211 (295)
T ss_dssp             -------------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHH
T ss_pred             -----------------------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHH
Confidence                                                           00123578899999998653 247899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|+.||.+.................+                  .        .....++.+.+|+.+||+.
T Consensus       212 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~~~li~~~l~~  265 (295)
T 2clq_A          212 GCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP------------------E--------IPESMSAEAKAFILKCFEP  265 (295)
T ss_dssp             HHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC------------------C--------CCTTSCHHHHHHHHHTTCS
T ss_pred             HHHHHHHHHCCCCccCCCchhHHHHhhccccccc------------------c--------ccccCCHHHHHHHHHHccC
Confidence            9999999999999976543322211111111100                  0        1112356789999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+|+||||+...
T Consensus       266 dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          266 DPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             STTTSCCHHHHHTSGGGCC--
T ss_pred             ChhhCCCHHHHhcChhhhhcc
Confidence            999999999999999998654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-37  Score=328.81  Aligned_cols=221  Identities=31%  Similarity=0.455  Sum_probs=166.4

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.+ +|||||++++++.....+|||||||+++|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        62 ~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  141 (432)
T 3p23_A           62 SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH  141 (432)
T ss_dssp             EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEe
Confidence            3467999999999 899999999999999999999999999999999887666777778899999999999999999999


Q ss_pred             ccCCCCcEEEcc---CC--CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         98 RDLKPQNILINK---SG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        98 RDLKP~NILl~~---~~--~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      |||||+|||++.   ++  .+||+|||+|+.......                                           
T Consensus       142 rDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~-------------------------------------------  178 (432)
T 3p23_A          142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH-------------------------------------------  178 (432)
T ss_dssp             CCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------------------------------------------
T ss_pred             CCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc-------------------------------------------
Confidence            999999999953   22  466888888764421100                                           


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIW  250 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIW  250 (562)
                                                                   ........+||+.|+|||++.+  ...++.++|||
T Consensus       179 ---------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Diw  213 (432)
T 3p23_A          179 ---------------------------------------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIF  213 (432)
T ss_dssp             ----------------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHH
T ss_pred             ---------------------------------------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHH
Confidence                                                         0001123468999999999975  34477899999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |+||++|||++ |..||.+..... ...+   .+.....                ...+.      ...+..+.+||.+|
T Consensus       214 SlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~~~~~----------------~~~~~------~~~~~~~~~li~~~  267 (432)
T 3p23_A          214 SAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGACSLD----------------CLHPE------KHEDVIARELIEKM  267 (432)
T ss_dssp             HHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTCCCCT----------------TSCTT------CHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcchhhHHH-HHHH---hccCCcc----------------ccCcc------ccccHHHHHHHHHH
Confidence            99999999999 899996654332 2211   1111100                00000      01134578999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |+.||++|||++|+++||||.++.
T Consensus       268 L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          268 IAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             SCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             HhCCHhhCCCHHHHHhCccccChH
Confidence            999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.5e-36  Score=303.02  Aligned_cols=217  Identities=30%  Similarity=0.525  Sum_probs=175.8

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|++++++++||||+++++++......|+||||+.+ +|.+++.... .+++..++.++.|++.||.|||++||
T Consensus        64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i  142 (287)
T 2wei_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNI  142 (287)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345688999999999999999999999999999999999974 8988886543 69999999999999999999999999


Q ss_pred             eeccCCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         96 IHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        96 iHRDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +||||||+||+++.+   +.+||+|||++......                                             
T Consensus       143 ~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~---------------------------------------------  177 (287)
T 2wei_A          143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---------------------------------------------  177 (287)
T ss_dssp             CCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC---------------------------------------------
T ss_pred             eccCCChhhEEEecCCCcccEEEeccCcceeecCC---------------------------------------------
Confidence            999999999999754   35888888876533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     .......||+.|+|||++.+.  ++.++||||+
T Consensus       178 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~sl  208 (287)
T 2wei_A          178 -----------------------------------------------TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSA  208 (287)
T ss_dssp             -----------------------------------------------SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHH
T ss_pred             -----------------------------------------------CccccccCcccccChHHhcCC--CCCchhhHhH
Confidence                                                           001123578899999998653  8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|..||.+.+..+.+..+........                .+         .....++.+.+||.+||..
T Consensus       209 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~~---------~~~~~~~~~~~li~~~l~~  263 (287)
T 2wei_A          209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----------------LP---------QWRTISDDAKDLIRKMLTF  263 (287)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------SG---------GGTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------------ch---------hhhhcCHHHHHHHHHHccc
Confidence            9999999999999999887776666554211100                00         1122356789999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||++|||+.|+|+||||++..
T Consensus       264 dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          264 HPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             SGGGSCCHHHHHHSHHHHHHC
T ss_pred             ChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999998653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.2e-36  Score=301.73  Aligned_cols=229  Identities=29%  Similarity=0.422  Sum_probs=166.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe-------------CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV-------------DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLL   84 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~-------------~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll   84 (562)
                      ..+.+|+.+|+.++||||+++++++..             ...+|+||||+++ +|.+++......+++..+..++.|++
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~  126 (303)
T 1zy4_A           47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL  126 (303)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHH
Confidence            457899999999999999999999865             3578999999975 99999987666788999999999999


Q ss_pred             HHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      .||+|||++||+||||||+|||++.++.+||+|||++...........          ..    .               
T Consensus       127 ~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~----------~~----~---------------  177 (303)
T 1zy4_A          127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK----------LD----S---------------  177 (303)
T ss_dssp             HHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--------------------------------------
T ss_pred             HHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhc----------cc----c---------------
Confidence            999999999999999999999999999999999999865432110000          00    0               


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  244 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~  244 (562)
                                                   .                   ............+||+.|+|||++.+...++
T Consensus       178 -----------------------------~-------------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  209 (303)
T 1zy4_A          178 -----------------------------Q-------------------NLPGSSDNLTSAIGTAMYVATEVLDGTGHYN  209 (303)
T ss_dssp             ----------------------------------------------------------------CTTSCHHHHTSCSCCC
T ss_pred             -----------------------------c-------------------cccccccccccCCCcccccCcccccCCCCCc
Confidence                                         0                   0000011123457899999999998776799


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  323 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  323 (562)
                      .++||||+||++|+|++   ||...... +.+..+......                  ++..       .....++.+.
T Consensus       210 ~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~------------------~~~~-------~~~~~~~~~~  261 (303)
T 1zy4_A          210 EKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIE------------------FPPD-------FDDNKMKVEK  261 (303)
T ss_dssp             THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCC------------------CCTT-------CCTTTSHHHH
T ss_pred             chhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccc------------------cCcc-------ccccchHHHH
Confidence            99999999999999998   55533222 222222211000                  0000       1112345689


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +|+.+||+.||++|||+.|+++||||...
T Consensus       262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          262 KIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            99999999999999999999999999754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-36  Score=312.86  Aligned_cols=232  Identities=22%  Similarity=0.399  Sum_probs=177.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDF------LQTT-PVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~------i~~~-~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      ..+.+|+++|+.++||||+++++++...+.+|+||||+++ +|.++      +... ...+++..++.++.|++.||.||
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            6788999999999999999999999999999999999986 89887      5442 35699999999999999999999


Q ss_pred             HH-CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         91 HS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        91 H~-~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      |+ +||+||||||+|||++.++.+||+|||++......                                          
T Consensus       168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------------------------------------------  205 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK------------------------------------------  205 (348)
T ss_dssp             HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT------------------------------------------
T ss_pred             hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc------------------------------------------
Confidence            99 99999999999999999999999999987543210                                          


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc-hhh
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST-TVD  248 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~-~~D  248 (562)
                                                                         ......||+.|+|||++.+...++. ++|
T Consensus       206 ---------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  234 (348)
T 2pml_X          206 ---------------------------------------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVD  234 (348)
T ss_dssp             ---------------------------------------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHH
T ss_pred             ---------------------------------------------------cccCCCCCcCccCchhhcCCCCCCcchhh
Confidence                                                               0012357889999999987645666 999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|||++|..||.+.+. .+....+.......+.. ..      .+   ................++.+.+|+.
T Consensus       235 i~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~-~~------~~---~~~~~~~~~~~~~~~~~~~l~~li~  304 (348)
T 2pml_X          235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD-RN------HF---LYPLTNKKSTCSNNFLSNEDIDFLK  304 (348)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCS-SS------SS---TTTTCC--------CCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccc-hh------hh---hccccccccccchhhcCHHHHHHHH
Confidence            99999999999999999998776 44444443211111000 00      00   0001111111122345678999999


Q ss_pred             HccccCCCCCCCHHHHHcCccccCCc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +||+.||.+|||+.|+++||||++..
T Consensus       305 ~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          305 LFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHccCChhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.4e-36  Score=299.95  Aligned_cols=210  Identities=22%  Similarity=0.370  Sum_probs=174.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++||||+++++++..+...|+||||+++ +|.+++......+++..+..++.|++.||.|||++||+
T Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  128 (269)
T 4hcu_A           49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  128 (269)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35678999999999999999999999999999999999975 89999987777799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||+++.......                                               
T Consensus       129 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  161 (269)
T 4hcu_A          129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----------------------------------------------  161 (269)
T ss_dssp             CSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-----------------------------------------------
T ss_pred             cCCcchheEEEcCCCCEEecccccccccccccc-----------------------------------------------
Confidence            999999999999999999999998764321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       162 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  197 (269)
T 4hcu_A          162 -------------------------------------------TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLM  197 (269)
T ss_dssp             -------------------------------------------HSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHH
Confidence                                                       0001234678899999997655 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |+.||.+.+..+....+........                            ....++.+.+++.+||+.||+
T Consensus       198 ~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~~l~~~p~  249 (269)
T 4hcu_A          198 WEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------------------------PRLASTHVYQIMNHCWRERPE  249 (269)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHhcCCCCCCCCCCHHHHHHHHhcCccCCC----------------------------CCcCCHHHHHHHHHHccCCcc
Confidence            99999 9999999888776666643211100                            012356789999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||+.|+++|
T Consensus       250 ~Rps~~~ll~~  260 (269)
T 4hcu_A          250 DRPAFSRLLRQ  260 (269)
T ss_dssp             GSCCHHHHHHH
T ss_pred             cCcCHHHHHHH
Confidence            99999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8e-36  Score=303.42  Aligned_cols=219  Identities=24%  Similarity=0.407  Sum_probs=173.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.++++++||||+++++++..++..|+||||+++ +|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        55 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  133 (294)
T 4eqm_A           55 LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIV  133 (294)
T ss_dssp             HHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34678999999999999999999999999999999999975 9999987653 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......                                               
T Consensus       134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  166 (294)
T 4eqm_A          134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----------------------------------------------  166 (294)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSSTTC----------------------------------------------------
T ss_pred             cCCCCHHHEEECCCCCEEEEeCCCccccccccc-----------------------------------------------
Confidence            999999999999999999999998764421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       167 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l  202 (294)
T 4eqm_A          167 -------------------------------------------TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVL  202 (294)
T ss_dssp             ---------------------------------------------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHH
T ss_pred             -------------------------------------------cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHH
Confidence                                                       0011246899999999998765 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.+..+.........-                    +    ..........++.+.+++.+||..||++
T Consensus       203 ~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~  258 (294)
T 4eqm_A          203 YEMLVGEPPFNGETAVSIAIKHIQDSV--------------------P----NVTTDVRKDIPQSLSNVILRATEKDKAN  258 (294)
T ss_dssp             HHHHHSSCSSCSSCHHHHHHHHHSSCC--------------------C----CHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHhhccC--------------------C----CcchhcccCCCHHHHHHHHHHhcCCHhH
Confidence            999999999999887665554432100                    0    0001112234577899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |++..+.+.+.|..-.
T Consensus       259 R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          259 RYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             SCSSHHHHHHHHHTSS
T ss_pred             ccccHHHHHHHHHHHH
Confidence            9977777777766543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-36  Score=305.97  Aligned_cols=218  Identities=22%  Similarity=0.354  Sum_probs=173.0

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEe------CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPV------DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~------~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~   88 (562)
                      ...+.+|+.+++++ +||||+++++++..      ...+|+||||+++ +|.+++.... ..+++..++.++.|++.||.
T Consensus        64 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~  143 (326)
T 2x7f_A           64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS  143 (326)
T ss_dssp             THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence            45678999999999 89999999999987      4689999999986 9999997653 46999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||++||+||||||+|||++.++.+||+|||++........                                       
T Consensus       144 ~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---------------------------------------  184 (326)
T 2x7f_A          144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---------------------------------------  184 (326)
T ss_dssp             HHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----------------------------------------------
T ss_pred             HHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc---------------------------------------
Confidence            99999999999999999999999999999998754321100                                       


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYS  244 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~  244 (562)
                                                                          .....+||+.|+|||++.+    ...++
T Consensus       185 ----------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~  212 (326)
T 2x7f_A          185 ----------------------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYD  212 (326)
T ss_dssp             ----------------------------------------------------------CCGGGCCHHHHC--------CC
T ss_pred             ----------------------------------------------------ccccccCCccccChhhhccccccCcCCC
Confidence                                                                0012357888889998863    33488


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        245 TTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       245 ~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      .++||||+||++|+|++|..||.+.+....+..+......                    ..       .....+..+.+
T Consensus       213 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~-------~~~~~~~~l~~  265 (326)
T 2x7f_A          213 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--------------------RL-------KSKKWSKKFQS  265 (326)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------------------CC-------SCSCSCHHHHH
T ss_pred             ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--------------------cC-------CccccCHHHHH
Confidence            9999999999999999999999988877666555432110                    00       00123567899


Q ss_pred             HHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||.+||..||.+|||+.|+++||||++..
T Consensus       266 li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          266 FIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             HHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            99999999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-35  Score=301.02  Aligned_cols=213  Identities=26%  Similarity=0.417  Sum_probs=177.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++......|+||||+++ +|.+++..  ..+++..+..++.|++.||.|||++||+
T Consensus        64 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~  141 (303)
T 3a7i_A           64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKI  141 (303)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            46688999999999999999999999999999999999986 99998865  3699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||++.......                                                
T Consensus       142 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------  173 (303)
T 3a7i_A          142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------------------------------------------------  173 (303)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECBTTB------------------------------------------------
T ss_pred             cCCCChheEEECCCCCEEEeecccceecCccc------------------------------------------------
Confidence            99999999999999999999999875432100                                                


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       174 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  209 (303)
T 3a7i_A          174 -------------------------------------------IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITA  209 (303)
T ss_dssp             -------------------------------------------CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHH
T ss_pred             -------------------------------------------cccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHH
Confidence                                                       0011246789999999997654 88999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |+|++|+.||.+.........+....  ++                  .        .....+..+.+|+.+||..||++
T Consensus       210 ~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------------~--------~~~~~~~~l~~li~~~l~~dp~~  261 (303)
T 3a7i_A          210 IELARGEPPHSELHPMKVLFLIPKNN--PP------------------T--------LEGNYSKPLKEFVEACLNKEPSF  261 (303)
T ss_dssp             HHHHHSSCTTTTSCHHHHHHHHHHSC--CC------------------C--------CCSSCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHccCCCCCCCcCHHHHHHHhhcCC--CC------------------C--------CccccCHHHHHHHHHHcCCChhh
Confidence            99999999999887766555443311  00                  0        11123567899999999999999


Q ss_pred             CCCHHHHHcCccccCC
Q psy10954        337 RVSAKTILQHEYFNQV  352 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~  352 (562)
                      |||+.|+++||||...
T Consensus       262 Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          262 RPTAKELLKHKFILRN  277 (303)
T ss_dssp             SCCHHHHTTCHHHHHH
T ss_pred             CcCHHHHhhChhhhcC
Confidence            9999999999999753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.4e-36  Score=304.24  Aligned_cols=213  Identities=18%  Similarity=0.235  Sum_probs=164.3

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|+.++||||+++++++..++..|+||||+. ++|.+++......+++..+..++.|++.||.|||++||
T Consensus        55 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i  134 (289)
T 4fvq_A           55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL  134 (289)
T ss_dssp             GHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            34568899999999999999999999999999999999998 59999998876569999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++..++.|+                                                         
T Consensus       135 vH~Dlkp~NIll~~~~~~~~~~~---------------------------------------------------------  157 (289)
T 4fvq_A          135 IHGNVCAKNILLIREEDRKTGNP---------------------------------------------------------  157 (289)
T ss_dssp             CCCCCCGGGEEEEECCBGGGTBC---------------------------------------------------------
T ss_pred             ECCCcCcceEEEecCCccccccc---------------------------------------------------------
Confidence            99999999999987765221111                                                         


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                +.+||+|||+++....    .....||+.|+|||++.+...++.++||||+||+
T Consensus       158 --------------------------~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  207 (289)
T 4fvq_A          158 --------------------------PFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTT  207 (289)
T ss_dssp             --------------------------CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHH
T ss_pred             --------------------------ceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHH
Confidence                                      2245555555443211    1233578899999999875669999999999999


Q ss_pred             HHHHHhCC-CCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKK-TLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~-~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++|. +||.+..... ...+.......+                             ...++.+.+|+.+||+.||
T Consensus       208 l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~-----------------------------~~~~~~l~~li~~~l~~dp  257 (289)
T 4fvq_A          208 LWEICSGGDKPLSALDSQR-KLQFYEDRHQLP-----------------------------APKAAELANLINNCMDYEP  257 (289)
T ss_dssp             HHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCC-----------------------------CCSSCTTHHHHHHHSCSSG
T ss_pred             HHHHHcCCCCCccccchHH-HHHHhhccCCCC-----------------------------CCCCHHHHHHHHHHcCCCh
Confidence            99999965 4555444433 333322111000                             0113457899999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||+.|+++|
T Consensus       258 ~~Rps~~~ll~~  269 (289)
T 4fvq_A          258 DHRPSFRAIIRD  269 (289)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8e-36  Score=308.18  Aligned_cols=210  Identities=22%  Similarity=0.318  Sum_probs=172.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++..+...|+||||+++ +|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        95 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  174 (325)
T 3kul_A           95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH  174 (325)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence            4578999999999999999999999999999999999975 999999877678999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.........                                              
T Consensus       175 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----------------------------------------------  208 (325)
T 3kul_A          175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA----------------------------------------------  208 (325)
T ss_dssp             SCCSGGGEEECTTCCEEECCCSSCEECC----CC----------------------------------------------
T ss_pred             CCCCcceEEECCCCCEEECCCCcccccccCccce----------------------------------------------
Confidence            9999999999999999999999986543110000                                              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+|+.|+|||++.+.. |+.++||||+||++|
T Consensus       209 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~  245 (325)
T 3kul_A          209 ------------------------------------------YTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMW  245 (325)
T ss_dssp             ------------------------------------------EECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHH
T ss_pred             ------------------------------------------eeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHH
Confidence                                                      0001224578899999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+.+..+....+......+.                            ....++.+.+|+.+||..||++
T Consensus       246 ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~  297 (325)
T 3kul_A          246 EVLAYGERPYWNMTNRDVISSVEEGYRLPA----------------------------PMGCPHALHQLMLDCWHKDRAQ  297 (325)
T ss_dssp             HHHTTSCCTTTTSCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHcCCCCCcccCCHHHHHHHHHcCCCCCC----------------------------CCCcCHHHHHHHHHHccCChhh
Confidence            9999 9999999888776666654311110                            0123467899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.|+++
T Consensus       298 Rps~~eil~  306 (325)
T 3kul_A          298 RPRFSQIVS  306 (325)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999885

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-35  Score=312.97  Aligned_cols=210  Identities=23%  Similarity=0.365  Sum_probs=170.5

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|+++|+.+ +||||+++++++...+.+|+||||+.+ +|.+++....               ..+++..+..++.
T Consensus       131 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  210 (370)
T 2psq_A          131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY  210 (370)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHH
Confidence            4578999999999 899999999999999999999999975 9999997643               2488999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      ||+.||+|||++||+||||||+|||++.++.+||+|||+++.......                                
T Consensus       211 qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--------------------------------  258 (370)
T 2psq_A          211 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY--------------------------------  258 (370)
T ss_dssp             HHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCT--------------------------------
T ss_pred             HHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccc--------------------------------
Confidence            999999999999999999999999999999999999999864421100                                


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                               ........+|+.|+|||++.+..
T Consensus       259 ---------------------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~  281 (370)
T 2psq_A          259 ---------------------------------------------------------YKKTTNGRLPVKWMAPEALFDRV  281 (370)
T ss_dssp             ---------------------------------------------------------TCTTTTTTSCGGGCCHHHHHTCC
T ss_pred             ---------------------------------------------------------eecccCCCcccceECHhHhcCCC
Confidence                                                                     00011235688999999998755


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       |+.++||||+||++|||++ |..||.+.+..+.+..+.......                            .....++
T Consensus       282 -~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  332 (370)
T 2psq_A          282 -YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD----------------------------KPANCTN  332 (370)
T ss_dssp             -CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----------------------------CCTTSCH
T ss_pred             -CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC----------------------------CCCCCCH
Confidence             8999999999999999999 999999877655544443211000                            0012346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||+.||++|||+.|++++
T Consensus       333 ~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          333 ELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=300.75  Aligned_cols=213  Identities=21%  Similarity=0.350  Sum_probs=163.3

Q ss_pred             HHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCC
Q psy10954         23 REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLK  101 (562)
Q Consensus        23 rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~-gIiHRDLK  101 (562)
                      ++..+++.++||||+++++++..++.+|+||||+++.+..+.......+++..+..++.|++.||.|||++ ||+|||||
T Consensus        73 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlk  152 (318)
T 2dyl_A           73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK  152 (318)
T ss_dssp             HHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             HHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCC
Confidence            44456788899999999999999999999999997667666665456799999999999999999999996 99999999


Q ss_pred             CCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhh
Q psy10954        102 PQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYC  181 (562)
Q Consensus       102 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yL  181 (562)
                      |+|||++.++.+||+|||++.......                                                     
T Consensus       153 p~Nil~~~~~~~kl~dfg~~~~~~~~~-----------------------------------------------------  179 (318)
T 2dyl_A          153 PSNILLDERGQIKLCDFGISGRLVDDK-----------------------------------------------------  179 (318)
T ss_dssp             GGGEEECTTSCEEECCCTTC------------------------------------------------------------
T ss_pred             HHHEEECCCCCEEEEECCCchhccCCc-----------------------------------------------------
Confidence            999999999999999999875432100                                                     


Q ss_pred             hcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHHHHHHH
Q psy10954        182 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       182 Hs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSlG~il~  257 (562)
                                                             ......||+.|+|||++.+    ...++.++||||+||++|
T Consensus       180 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~  220 (318)
T 2dyl_A          180 ---------------------------------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV  220 (318)
T ss_dssp             ----------------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHH
T ss_pred             ---------------------------------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHH
Confidence                                                   0012246888999998852    345889999999999999


Q ss_pred             HHHhCCCCCCCC-CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTLFAGD-SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~pF~~~-~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++|+.||.+. ...+.+..+.......                 .+.         ....++.+.+|+.+||..||.+
T Consensus       221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------~~~---------~~~~~~~l~~li~~~l~~dp~~  274 (318)
T 2dyl_A          221 ELATGQFPYKNCKTDFEVLTKVLQEEPPL-----------------LPG---------HMGFSGDFQSFVKDCLTKDHRK  274 (318)
T ss_dssp             HHHHSSCTTTTCCSHHHHHHHHHHSCCCC-----------------CCS---------SSCCCHHHHHHHHHHTCSCTTT
T ss_pred             HHHhCCCCCCCCCccHHHHHHHhccCCCC-----------------CCc---------cCCCCHHHHHHHHHHccCChhH
Confidence            999999999874 4445555554321100                 000         0123567899999999999999


Q ss_pred             CCCHHHHHcCccccCCc
Q psy10954        337 RVSAKTILQHEYFNQVE  353 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~~~  353 (562)
                      |||++|+++||||++..
T Consensus       275 Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          275 RPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             SCCHHHHTTSHHHHHHH
T ss_pred             CcCHHHHhhCHHHHhcc
Confidence            99999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-35  Score=303.78  Aligned_cols=218  Identities=21%  Similarity=0.260  Sum_probs=171.5

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.+ +||||+++++++..+...|+||||++++|.+++......+++..+..++.|++.||+|||++||+
T Consensus        48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ii  127 (330)
T 2izr_A           48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI  127 (330)
T ss_dssp             SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34688999999999 99999999999999999999999997799999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCC-----eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         97 HRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        97 HRDLKP~NILl~~~~~-----vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ||||||+|||++.++.     +||+|||+|+..........                                       
T Consensus       128 HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~---------------------------------------  168 (330)
T 2izr_A          128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH---------------------------------------  168 (330)
T ss_dssp             CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCB---------------------------------------
T ss_pred             ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcc---------------------------------------
Confidence            9999999999998876     99999998865432110000                                       


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                   .+.......+||+.|+|||++.+.. ++.++||||
T Consensus       169 ---------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s  202 (330)
T 2izr_A          169 ---------------------------------------------IPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEA  202 (330)
T ss_dssp             ---------------------------------------------CCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHH
T ss_pred             ---------------------------------------------ccccccCCcCCCccccChHHHcCCC-CCchhHHHH
Confidence                                                         0001123457899999999998755 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        252 AGCIFSEMITKKTLFAGDS---EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~---~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      +||++|||++|+.||.+.+   ..+.+..+.......+                        . ..+....+.+.+++.+
T Consensus       203 lG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------~-~~~~~~~p~~~~li~~  257 (330)
T 2izr_A          203 LGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP------------------------I-EVLCENFPEMATYLRY  257 (330)
T ss_dssp             HHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC------------------------H-HHHTTTCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC------------------------H-HHHhccChHHHHHHHH
Confidence            9999999999999998743   2333333322110000                        0 0111122478999999


Q ss_pred             ccccCCCCCCCHHHHHc
Q psy10954        329 IMALDPKQRVSAKTILQ  345 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~  345 (562)
                      ||..||.+||+++++++
T Consensus       258 ~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          258 VRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHCCTTCCCCHHHHHH
T ss_pred             HHhCCCCCCCCHHHHHH
Confidence            99999999999998775

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.2e-36  Score=320.80  Aligned_cols=231  Identities=28%  Similarity=0.400  Sum_probs=160.7

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP------VPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~------l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|+++|+++ +|||||++++++..+..+|+|||||+++|.+++......      .++..+..++.|++.||+|||
T Consensus        53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  132 (434)
T 2rio_A           53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH  132 (434)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH
Confidence            4578999999886 899999999999999999999999999999999765421      133346789999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++..+...                                                      
T Consensus       133 ~~~ivHrDLkp~NILl~~~~~~~~~~------------------------------------------------------  158 (434)
T 2rio_A          133 SLKIIHRDLKPQNILVSTSSRFTADQ------------------------------------------------------  158 (434)
T ss_dssp             HTTEECCCCSGGGEEEECCHHHHSCC------------------------------------------------------
T ss_pred             HCCccccCCChHhEEEecCccccccc------------------------------------------------------
Confidence            99999999999999997653110000                                                      


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCC----cccccccCCCccchhhhcC------CC
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLG------AK  241 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~----~~~~~vgT~~Y~APEvl~~------~~  241 (562)
                                              -.-+.++.+||+|||+|+.......    .....+||+.|+|||++.+      ..
T Consensus       159 ------------------------~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  214 (434)
T 2rio_A          159 ------------------------QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKR  214 (434)
T ss_dssp             ------------------------TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCC
T ss_pred             ------------------------ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccccc
Confidence                                    0001223455566665554432211    1234578999999999976      24


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                      .++.++||||+||++|||++ |..||.+....+  ..+........  .             .......       ..++
T Consensus       215 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~--~-------------~~~~~~~-------~~~~  270 (434)
T 2rio_A          215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLD--E-------------MKCLHDR-------SLIA  270 (434)
T ss_dssp             CCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCC--C-------------CTTCCCH-------HHHH
T ss_pred             CcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcc--c-------------ccccccc-------cchH
Confidence            58999999999999999999 999997665432  22322111000  0             0000000       0125


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcCccccC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      .+.+|+.+||+.||++|||+.|+++||||..
T Consensus       271 ~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          271 EATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            7899999999999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-35  Score=296.57  Aligned_cols=210  Identities=19%  Similarity=0.360  Sum_probs=172.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++||||+++++++..+...|+||||++ ++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  126 (268)
T 3sxs_A           47 EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI  126 (268)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3567899999999999999999999999999999999997 489999987665699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++........                                               
T Consensus       127 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-----------------------------------------------  159 (268)
T 3sxs_A          127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-----------------------------------------------  159 (268)
T ss_dssp             ESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-----------------------------------------------
T ss_pred             cCCcCcceEEECCCCCEEEccCccceecchhhh-----------------------------------------------
Confidence            999999999999999999999998764321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       160 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  195 (268)
T 3sxs_A          160 -------------------------------------------VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILM  195 (268)
T ss_dssp             -------------------------------------------EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHH
T ss_pred             -------------------------------------------hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHH
Confidence                                                       0001124577899999997654 88999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |+.||.+.+..+....+........                            ....++.+.+++.+||+.||+
T Consensus       196 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~  247 (268)
T 3sxs_A          196 WEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR----------------------------PHLASDTIYQIMYSCWHELPE  247 (268)
T ss_dssp             HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHHTTCSSGG
T ss_pred             HHHHcCCCCCccccChHHHHHHHHcCCCCCC----------------------------CCcChHHHHHHHHHHcCCChh
Confidence            99998 9999998887766665543211000                            011246789999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||+.|+++|
T Consensus       248 ~Rps~~~ll~~  258 (268)
T 3sxs_A          248 KRPTFQQLLSS  258 (268)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCcCHHHHHHH
Confidence            99999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-35  Score=298.37  Aligned_cols=210  Identities=22%  Similarity=0.363  Sum_probs=174.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++.....+|+||||+. ++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        63 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  142 (283)
T 3gen_A           63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL  142 (283)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567899999999999999999999999999999999996 599999987556799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......                                               
T Consensus       143 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  175 (283)
T 3gen_A          143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-----------------------------------------------  175 (283)
T ss_dssp             CSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-----------------------------------------------
T ss_pred             CCCCccceEEEcCCCCEEEcccccccccccccc-----------------------------------------------
Confidence            999999999999999999999998764321000                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       176 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l  211 (283)
T 3gen_A          176 -------------------------------------------TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLM  211 (283)
T ss_dssp             -------------------------------------------HSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHH
Confidence                                                       0001224578899999998665 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |+.||.+.+..+....+........                            ....++.+.+++.+||+.||+
T Consensus       212 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~  263 (283)
T 3gen_A          212 WEIYSLGKMPYERFTNSETAEHIAQGLRLYR----------------------------PHLASEKVYTIMYSCWHEKAD  263 (283)
T ss_dssp             HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHTTCSSGG
T ss_pred             HHHHhCCCCCccccChhHHHHHHhcccCCCC----------------------------CCcCCHHHHHHHHHHccCChh
Confidence            99998 9999999887776666654321110                            012346789999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||++|+++|
T Consensus       264 ~Rps~~~ll~~  274 (283)
T 3gen_A          264 ERPTFKILLSN  274 (283)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-35  Score=299.23  Aligned_cols=208  Identities=25%  Similarity=0.430  Sum_probs=162.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++. ++..|+||||+.+ +|.+++......+++..+..++.|++.||.|||++||+
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  138 (281)
T 1mp8_A           60 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV  138 (281)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            345789999999999999999999984 5678999999985 99999987766799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......                                               
T Consensus       139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  171 (281)
T 1mp8_A          139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----------------------------------------------  171 (281)
T ss_dssp             CSCCSGGGEEEEETTEEEECC-----------------------------------------------------------
T ss_pred             cccccHHHEEECCCCCEEECccccccccCcccc-----------------------------------------------
Confidence            999999999999999999999998764421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       172 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  207 (281)
T 1mp8_A          172 -------------------------------------------YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCM  207 (281)
T ss_dssp             --------------------------------------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccCCCcccccChhhcccCC-CCCccCchHHHHHH
Confidence                                                       0001124578899999997654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |..||.+....+.+..+......+                            .....++.+.+++.+||..||+
T Consensus       208 ~ell~~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~  259 (281)
T 1mp8_A          208 WEILMHGVKPFQGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTKCWAYDPS  259 (281)
T ss_dssp             HHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhcCCCCCCcCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChh
Confidence            99996 999999887766665554321000                            0112356789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.|+++
T Consensus       260 ~Rps~~~l~~  269 (281)
T 1mp8_A          260 RRPRFTELKA  269 (281)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-36  Score=314.07  Aligned_cols=214  Identities=19%  Similarity=0.300  Sum_probs=173.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~------~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|+.+|+.++||||+++++++......|+|||||.+ +|.+++....      ..+++..+..++.|++.||.|||
T Consensus       119 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  198 (367)
T 3l9p_A          119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE  198 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999999999999999975 9999997643      34899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCC---CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ++||+||||||+|||++.++   .+||+|||+|+.......                                       
T Consensus       199 ~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---------------------------------------  239 (367)
T 3l9p_A          199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---------------------------------------  239 (367)
T ss_dssp             HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS---------------------------------------
T ss_pred             hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc---------------------------------------
Confidence            99999999999999998555   489999998764321000                                       


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                        ........||+.|+|||++.+.. |+.++|
T Consensus       240 --------------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~-~~~~~D  268 (367)
T 3l9p_A          240 --------------------------------------------------YRKGGCAMLPVKWMPPEAFMEGI-FTSKTD  268 (367)
T ss_dssp             --------------------------------------------------CTTCCGGGSCGGGCCHHHHHHCC-CCHHHH
T ss_pred             --------------------------------------------------cccCCCcCCcccEECHHHhcCCC-CCcHHH
Confidence                                                              00112346789999999997655 899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|||++ |..||.+.+..+.+..+........                            ....++.+.+|+.
T Consensus       269 vwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~  320 (367)
T 3l9p_A          269 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP----------------------------PKNCPGPVYRIMT  320 (367)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccCCHHHHHHHH
Confidence            9999999999998 9999999887776666543211100                            0123467899999


Q ss_pred             HccccCCCCCCCHHHHHcCcccc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      +||+.||++|||+.|+++|.++-
T Consensus       321 ~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          321 QCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHH
Confidence            99999999999999999987663

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=300.21  Aligned_cols=228  Identities=24%  Similarity=0.348  Sum_probs=170.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++..+...|+||||+.+ +|.+++......+++..+..++.|++.||+|||++||+
T Consensus        51 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  130 (310)
T 3s95_A           51 QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII  130 (310)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34678999999999999999999999999999999999975 99999988777899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.........            +...                             
T Consensus       131 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------------~~~~-----------------------------  169 (310)
T 3s95_A          131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP------------EGLR-----------------------------  169 (310)
T ss_dssp             CSCCSTTSEEECTTSCEEECCCTTCEECC---------------------------------------------------
T ss_pred             CCCCCcCeEEECCCCCEEEeecccceecccccccc------------cccc-----------------------------
Confidence            99999999999999999999999987653211000            0000                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                          .............+||+.|+|||++.+.. ++.++||||+||++
T Consensus       170 ------------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l  212 (310)
T 3s95_A          170 ------------------------------------SLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVL  212 (310)
T ss_dssp             ----------------------------------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHH
T ss_pred             ------------------------------------cccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHH
Confidence                                                00000011123457999999999998754 89999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhh-hcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE-ILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++|..||........                           ............ .....++.+.+++.+||+.||+
T Consensus       213 ~el~~g~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  265 (310)
T 3s95_A          213 CEIIGRVNADPDYLPRTM---------------------------DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPE  265 (310)
T ss_dssp             HHHHHTCCSSTTTSCBCT---------------------------TSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGG
T ss_pred             HHHhcCCCCCcchhhhHH---------------------------HHhhhhhccccccCCCCCCHHHHHHHHHHccCChh
Confidence            999999999865321100                           000000000000 0122345789999999999999


Q ss_pred             CCCCHHHHHcCccccCC
Q psy10954        336 QRVSAKTILQHEYFNQV  352 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~  352 (562)
                      +|||+.|+++  +++.+
T Consensus       266 ~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          266 KRPSFVKLEH--WLETL  280 (310)
T ss_dssp             GSCCHHHHHH--HHHHH
T ss_pred             hCcCHHHHHH--HHHHH
Confidence            9999999986  55443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-35  Score=304.51  Aligned_cols=214  Identities=24%  Similarity=0.358  Sum_probs=168.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHSRR-   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yLH~~g-   94 (562)
                      ..+.+|+++|++++||||+++++++.....+|+|||||.+ +|.+++.....  .+++..+..++.|++.||+|||++| 
T Consensus        79 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~  158 (309)
T 3p86_A           79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP  158 (309)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence            4578999999999999999999999999999999999975 99999976542  3899999999999999999999999 


Q ss_pred             -ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 -IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 -IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                       |+||||||+|||++.++.+||+|||+++......                                             
T Consensus       159 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---------------------------------------------  193 (309)
T 3p86_A          159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF---------------------------------------------  193 (309)
T ss_dssp             CCCCTTCCGGGEEECTTCCEEECCCC------------------------------------------------------
T ss_pred             CEECCCCChhhEEEeCCCcEEECCCCCCccccccc---------------------------------------------
Confidence             9999999999999999999999999875321100                                             


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ......+||+.|+|||++.+.. ++.++||||+|
T Consensus       194 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  226 (309)
T 3p86_A          194 ----------------------------------------------LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFG  226 (309)
T ss_dssp             ------------------------------------------------------CCTTSCHHHHTTCC-CCTTHHHHHHH
T ss_pred             ----------------------------------------------cccccCCCCccccChhhhcCCC-CCchhhHHHHH
Confidence                                                          0011246899999999998765 79999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.+..+....+........                           .....++.+.+||.+||+.|
T Consensus       227 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~d  279 (309)
T 3p86_A          227 VILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---------------------------IPRNLNPQVAAIIEGCWTNE  279 (309)
T ss_dssp             HHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC---------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHccCC
Confidence            999999999999998887766555432211100                           11123567899999999999


Q ss_pred             CCCCCCHHHHHc--CccccC
Q psy10954        334 PKQRVSAKTILQ--HEYFNQ  351 (562)
Q Consensus       334 P~~R~Ta~elL~--Hp~f~~  351 (562)
                      |++|||++|+++  .++++.
T Consensus       280 P~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          280 PWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             GGGSCCHHHHHHHHHHHHC-
T ss_pred             hhhCcCHHHHHHHHHHHHHh
Confidence            999999999987  455543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.7e-35  Score=294.64  Aligned_cols=220  Identities=17%  Similarity=0.185  Sum_probs=173.7

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+++.+ +|+||+++++++......|+||||++++|.+++......+++..+..++.|++.||.|||++||
T Consensus        48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  127 (298)
T 1csn_A           48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL  127 (298)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345678999999999 8999999999999999999999999889999998776679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCC-----eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         96 IHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~-----vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      +||||||+|||++.++.     +||+|||+++..........                                      
T Consensus       128 vH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~--------------------------------------  169 (298)
T 1csn_A          128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH--------------------------------------  169 (298)
T ss_dssp             ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB--------------------------------------
T ss_pred             ecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccc--------------------------------------
Confidence            99999999999987765     99999998865432110000                                      


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                    .+.......+||+.|+|||++.+.. ++.++|||
T Consensus       170 ----------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~  202 (298)
T 1csn_A          170 ----------------------------------------------IPYREKKNLSGTARYMSINTHLGRE-QSRRDDLE  202 (298)
T ss_dssp             ----------------------------------------------CCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHH
T ss_pred             ----------------------------------------------ccccCccCCCCCcccCCchhhcCCC-CChHHHHH
Confidence                                                          0001123457899999999997755 89999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        251 SAGCIFSEMITKKTLFAGDS---EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~---~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |+||++|||++|+.||.+.+   ..+.+..+......+                        .........++.+.+++.
T Consensus       203 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~  258 (298)
T 1csn_A          203 ALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST------------------------PLRELCAGFPEEFYKYMH  258 (298)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS------------------------CHHHHTTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc------------------------cHHHHHhhCcHHHHHHHH
Confidence            99999999999999998743   333333333221100                        011122334678999999


Q ss_pred             HccccCCCCCCCHHHHHc
Q psy10954        328 KIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~  345 (562)
                      +||+.||++|||++++++
T Consensus       259 ~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          259 YARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCcccCCCHHHHHH
Confidence            999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-35  Score=303.06  Aligned_cols=218  Identities=24%  Similarity=0.332  Sum_probs=163.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEE------EEEeecCcC-CHHHHHhhCC-----CCCCHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQ-DLKDFLQTTP-----VPVPPALAKSYLYQLLE   85 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i------~lV~Ey~~~-~L~~~i~~~~-----~~l~e~~i~~i~~qll~   85 (562)
                      ...+.+|+++|++++||||+++++++......      |+||||+.+ +|.+++....     ..+++..+..++.|++.
T Consensus        69 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~  148 (323)
T 3qup_A           69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC  148 (323)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHH
Confidence            35678999999999999999999999877655      999999985 9999885422     25899999999999999


Q ss_pred             HHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccc
Q psy10954         86 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  165 (562)
Q Consensus        86 aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il  165 (562)
                      ||.|||++||+||||||+|||++.++.+||+|||+++........                                   
T Consensus       149 al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~-----------------------------------  193 (323)
T 3qup_A          149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----------------------------------  193 (323)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------------------------------------
T ss_pred             HHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccc-----------------------------------
Confidence            999999999999999999999999999999999998644211000                                   


Q ss_pred             hhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       166 ~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                                                                            .......+|+.|+|||++.+.. |+.
T Consensus       194 ------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~  218 (323)
T 3qup_A          194 ------------------------------------------------------RQGCASKLPVKWLALESLADNL-YTV  218 (323)
T ss_dssp             -------------------------------------------------------------CCGGGCCHHHHHHCC-CCH
T ss_pred             ------------------------------------------------------cccccccCcccccCchhhcCCC-CCC
Confidence                                                                  0001224578899999997754 899


Q ss_pred             hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        246 TVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       246 ~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      ++||||+||++|||++ |..||.+.+..+....+......+                            .....++.+.+
T Consensus       219 ~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~  270 (323)
T 3qup_A          219 HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK----------------------------QPPECMEEVYD  270 (323)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHH
T ss_pred             ccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC----------------------------CCCccCHHHHH
Confidence            9999999999999999 999999888766665554321100                            01123467899


Q ss_pred             HHHHccccCCCCCCC-------HHHHHcCccccCCc
Q psy10954        325 VFSKIMALDPKQRVS-------AKTILQHEYFNQVE  353 (562)
Q Consensus       325 Li~~mL~~DP~~R~T-------a~elL~Hp~f~~~~  353 (562)
                      |+.+||+.||++|||       .+++++|+|+....
T Consensus       271 li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          271 LMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            999999999999999       66788999997643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-35  Score=307.77  Aligned_cols=211  Identities=22%  Similarity=0.387  Sum_probs=168.7

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCC-EEEEEeecCcC-CHHHHHhhCCC--------------------------
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPV--------------------------   69 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~-~i~lV~Ey~~~-~L~~~i~~~~~--------------------------   69 (562)
                      ..+.+|+++|+++ +||||+++++++...+ .+|+|||||.+ +|.+++.....                          
T Consensus        70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (359)
T 3vhe_A           70 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL  149 (359)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------
T ss_pred             HHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhh
Confidence            4578999999999 7899999999998754 59999999985 99999976532                          


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q psy10954         70 ---------------------------------------PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS  110 (562)
Q Consensus        70 ---------------------------------------~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~  110 (562)
                                                             .+++..++.++.|++.||.|||++||+||||||+|||++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~  229 (359)
T 3vhe_A          150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  229 (359)
T ss_dssp             ----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             hccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence                                                   18999999999999999999999999999999999999999


Q ss_pred             CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecC
Q psy10954        111 GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRD  190 (562)
Q Consensus       111 ~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRD  190 (562)
                      +.+||+|||+++........                                                            
T Consensus       230 ~~~kl~Dfg~a~~~~~~~~~------------------------------------------------------------  249 (359)
T 3vhe_A          230 NVVKICDFGLARDIYKDPDY------------------------------------------------------------  249 (359)
T ss_dssp             GCEEECCCGGGSCTTSCTTC------------------------------------------------------------
T ss_pred             CcEEEEeccceeeecccccc------------------------------------------------------------
Confidence            99999999998644211000                                                            


Q ss_pred             CCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q psy10954        191 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGD  269 (562)
Q Consensus       191 LKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~  269 (562)
                                                   .......||+.|+|||++.+.. |+.++||||+||++|||++ |..||.+.
T Consensus       250 -----------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~  299 (359)
T 3vhe_A          250 -----------------------------VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV  299 (359)
T ss_dssp             -----------------------------EEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             -----------------------------hhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence                                         0011235788999999998654 8999999999999999998 99999987


Q ss_pred             CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        270 SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       270 ~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ...+.+.........+.                           .....++.+.+++.+||+.||++|||+.|+++|
T Consensus       300 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          300 KIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            75554444443211110                           001235678999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-35  Score=303.43  Aligned_cols=211  Identities=19%  Similarity=0.304  Sum_probs=169.4

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|++++||||+++++++..+. .++|+||+. ++|.+++......+++..+..++.|++.||.|||++||
T Consensus        60 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  138 (327)
T 3poz_A           60 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL  138 (327)
T ss_dssp             CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            3456889999999999999999999998764 788899987 59999998877789999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+|+........                                             
T Consensus       139 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------  173 (327)
T 3poz_A          139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE---------------------------------------------  173 (327)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC----------------------------------------------
T ss_pred             eCCCCChheEEECCCCCEEEccCcceeEccCCccc---------------------------------------------
Confidence            99999999999999999999999998654321000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. |+.++||||+||+
T Consensus       174 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i  208 (327)
T 3poz_A          174 --------------------------------------------YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  208 (327)
T ss_dssp             --------------------------------------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCCccccccChHHhccCC-CCchhhhhhhHHH
Confidence                                                        0001234688999999998754 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+....+......+                            .....+..+.+++.+||+.||
T Consensus       209 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p  260 (327)
T 3poz_A          209 VWELMTFGSKPYDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMVKCWMIDA  260 (327)
T ss_dssp             HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHHHHTCSCG
T ss_pred             HHHHHhcCCCCccCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCCh
Confidence            999999 999998877654433332211000                            001234678999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||+.|++++
T Consensus       261 ~~Rps~~ell~~  272 (327)
T 3poz_A          261 DSRPKFRELIIE  272 (327)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCCCHHHHHHH
Confidence            999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.3e-35  Score=298.31  Aligned_cols=216  Identities=33%  Similarity=0.488  Sum_probs=166.9

Q ss_pred             hhHHHHHHHHHccC--CCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~--HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++|+.++  ||||+++++++.....+|+|||+++++|.+++.... .+++..++.++.|++.||.|||++||+
T Consensus        71 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iv  149 (313)
T 3cek_A           71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV  149 (313)
T ss_dssp             HHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            45789999999997  599999999999999999999977789999998754 689999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++ ++.+||+|||+++.........                                             
T Consensus       150 H~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------------  183 (313)
T 3cek_A          150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV---------------------------------------------  183 (313)
T ss_dssp             CCCCCGGGEEEE-TTEEEECCCSSSCC-----------------------------------------------------
T ss_pred             ecCCCcccEEEE-CCeEEEeeccccccccCccccc---------------------------------------------
Confidence            999999999996 5889999999986543110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC----------CCCCch
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----------KVYSTT  246 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~----------~~y~~~  246 (562)
                                                                  .....+||+.|+|||++.+.          ..++.+
T Consensus       184 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~  219 (313)
T 3cek_A          184 --------------------------------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK  219 (313)
T ss_dssp             --------------------------------------------------CCGGGCCHHHHTTCC----------CCCHH
T ss_pred             --------------------------------------------cccCCCCCCCcCCHHHHhhcccccccccccccCCch
Confidence                                                        00123567788888887642          358899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      +||||+||++|+|++|+.||.+... ...+..+......                ..+           ....+..+.+|
T Consensus       220 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------~~~-----------~~~~~~~l~~l  272 (313)
T 3cek_A          220 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE----------------IEF-----------PDIPEKDLQDV  272 (313)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC----------------CCC-----------CCCSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc----------------cCC-----------cccchHHHHHH
Confidence            9999999999999999999987643 2333333211000                000           11224678999


Q ss_pred             HHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        326 FSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      +.+||+.||++|||+.|+|+||||+..
T Consensus       273 i~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          273 LKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             HHHHccCCcccCcCHHHHhcCccccCC
Confidence            999999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-35  Score=296.10  Aligned_cols=214  Identities=28%  Similarity=0.436  Sum_probs=173.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~~---~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ...+.+|+.+|++++||||+++++++..  +..+|+||||+++ +|.+++...   ...+++..+..++.|++.||+|||
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  128 (279)
T 2w5a_A           49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH  128 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            3457899999999999999999998854  5789999999975 999998653   234999999999999999999999


Q ss_pred             HCC-----ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         92 SRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        92 ~~g-----IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      ++|     |+||||||+|||++.++.+||+|||+++.......                                     
T Consensus       129 ~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-------------------------------------  171 (279)
T 2w5a_A          129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-------------------------------------  171 (279)
T ss_dssp             HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-------------------------------------
T ss_pred             cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc-------------------------------------
Confidence            999     99999999999999999999999998764321000                                     


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                            ......||+.|+|||++.+.. ++.+
T Consensus       172 ------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~  196 (279)
T 2w5a_A          172 ------------------------------------------------------FAKTFVGTPYYMSPEQMNRMS-YNEK  196 (279)
T ss_dssp             ------------------------------------------------------HHHHHHSCCTTCCHHHHHCC--CCHH
T ss_pred             ------------------------------------------------------cccccCCCccccChHHhccCC-CCch
Confidence                                                                  001235789999999998764 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|+|++|+.||.+.+..+....+......                    .        +....++.+.+++
T Consensus       197 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------------------~--------~~~~~~~~l~~li  248 (279)
T 2w5a_A          197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--------------------R--------IPYRYSDELNEII  248 (279)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------------C--------CCTTSCHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--------------------c--------CCcccCHHHHHHH
Confidence            99999999999999999999988776655555432100                    0        0012356789999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccC
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      .+||+.||++|||+.|+++|+|+.+
T Consensus       249 ~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          249 TRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             HHHcCCCcccCCCHHHHHhChhhhh
Confidence            9999999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-36  Score=311.45  Aligned_cols=235  Identities=23%  Similarity=0.264  Sum_probs=167.7

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCC----EEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+|+.+|++++||||+++++++....    .+|+|||||++ +|.+++...  .+++..++.++.|++.||.|||++-
T Consensus        64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~  141 (322)
T 3soc_A           64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDI  141 (322)
T ss_dssp             HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCE
T ss_pred             HHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhc
Confidence            4557899999999999999999998743    58999999975 999999774  4899999999999999999999630


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                                                                                                      
T Consensus       142 --------------------------------------------------------------------------------  141 (322)
T 3soc_A          142 --------------------------------------------------------------------------------  141 (322)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCC--cccccccCCCccchhhhcCC----CCCCchhh
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGA----KVYSTTVD  248 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~--~~~~~vgT~~Y~APEvl~~~----~~y~~~~D  248 (562)
                       .|+.++|+.+|+||||||+|||++.++.+||+|||+|+.......  .....+||+.|+|||++.+.    ..++.++|
T Consensus       142 -~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D  220 (322)
T 3soc_A          142 -PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID  220 (322)
T ss_dssp             -EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred             -cccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccch
Confidence             134567889999999999999999999999999999987654322  23446899999999999874    33567889


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC--CCHHHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL--PDPLAVDVF  326 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~dLi  326 (562)
                      |||+||++|||++|+.||.+......+.......+.+....+.....   .....+..     ......  .++.+.+|+
T Consensus       221 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~~l~~li  292 (322)
T 3soc_A          221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV---HKKKRPVL-----RDYWQKHAGMAMLCETI  292 (322)
T ss_dssp             HHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT---TSCCCCCC-----CGGGGSSHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhh---cccCCCCc-----cccccccchHHHHHHHH
Confidence            99999999999999999986542110000000000000000000000   00000000     000000  124588999


Q ss_pred             HHccccCCCCCCCHHHHHc
Q psy10954        327 SKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+||+.||++|||+.|+++
T Consensus       293 ~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          293 EECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.4e-35  Score=298.99  Aligned_cols=210  Identities=23%  Similarity=0.362  Sum_probs=169.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCC-----------------------CCCHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV-----------------------PVPPA   74 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~-----------------------~l~e~   74 (562)
                      ..+.+|+++|+.++||||+++++++...+..|+||||+. ++|.+++.....                       .+++.
T Consensus        71 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (314)
T 2ivs_A           71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG  150 (314)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHH
T ss_pred             HHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHH
Confidence            457899999999999999999999999999999999997 599999976432                       38999


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccc
Q psy10954         75 LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  154 (562)
Q Consensus        75 ~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~  154 (562)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........                        
T Consensus       151 ~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------------------  206 (314)
T 2ivs_A          151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY------------------------  206 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccc------------------------
Confidence            99999999999999999999999999999999999999999999987644311000                        


Q ss_pred             ccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccch
Q psy10954        155 TVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP  234 (562)
Q Consensus       155 ~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~AP  234 (562)
                                                                                       .......+|+.|+||
T Consensus       207 -----------------------------------------------------------------~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          207 -----------------------------------------------------------------VKRSQGRIPVKWMAI  221 (314)
T ss_dssp             -----------------------------------------------------------------ECSSCCCSCGGGCCH
T ss_pred             -----------------------------------------------------------------eeccCCCCcccccCh
Confidence                                                                             000123467889999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhh
Q psy10954        235 EILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE  313 (562)
Q Consensus       235 Evl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (562)
                      |++.+.. ++.++||||+||++|||++ |..||.+.+.......+.......                            
T Consensus       222 E~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------  272 (314)
T 2ivs_A          222 ESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRME----------------------------  272 (314)
T ss_dssp             HHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----------------------------
T ss_pred             hhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCC----------------------------
Confidence            9997654 8999999999999999999 999999877654444332211000                            


Q ss_pred             hcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        314 ILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       314 ~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .....++.+.+++.+||+.||++|||+.|++++
T Consensus       273 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          273 RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            011235678999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-35  Score=307.43  Aligned_cols=210  Identities=23%  Similarity=0.377  Sum_probs=172.4

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|+++|+.+ +||||+++++++..++.+|+||||+.+ +|.+++....               ..+++..++.++.
T Consensus       119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  198 (382)
T 3tt0_A          119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY  198 (382)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHH
Confidence            4578999999999 999999999999999999999999975 9999997654               3499999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++||+||||||+|||++.++.+||+|||+|+.......                                
T Consensus       199 qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~--------------------------------  246 (382)
T 3tt0_A          199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY--------------------------------  246 (382)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCT--------------------------------
T ss_pred             HHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccc--------------------------------
Confidence            999999999999999999999999999999999999999864421100                                


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                               ........||+.|+|||++.+..
T Consensus       247 ---------------------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~  269 (382)
T 3tt0_A          247 ---------------------------------------------------------YKKTTNGRLPVKWMAPEALFDRI  269 (382)
T ss_dssp             ---------------------------------------------------------TCCCTTCCCGGGGSCHHHHHSCC
T ss_pred             ---------------------------------------------------------cccccCCCCCcceeCHHHhcCCC
Confidence                                                                     00011235688999999998754


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++||||+||++|||++ |..||.+.+..+....+.......                            .....++
T Consensus       270 -~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  320 (382)
T 3tt0_A          270 -YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD----------------------------KPSNCTN  320 (382)
T ss_dssp             -CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCSSCCH
T ss_pred             -CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCH
Confidence             8999999999999999999 999999887766555543321100                            0012356


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+|+.+||+.||++|||++|++++
T Consensus       321 ~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          321 ELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-35  Score=302.41  Aligned_cols=213  Identities=19%  Similarity=0.343  Sum_probs=172.0

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC----------------------CCCH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV----------------------PVPP   73 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~----------------------~l~e   73 (562)
                      ...+.+|+.+|+++ +||||+++++++...+.+|+||||+++ +|.+++.....                      .+++
T Consensus        92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  171 (344)
T 1rjb_A           92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF  171 (344)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence            45688999999999 999999999999999999999999975 99999976543                      3789


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccc
Q psy10954         74 ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  153 (562)
Q Consensus        74 ~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s  153 (562)
                      ..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........                       
T Consensus       172 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----------------------  228 (344)
T 1rjb_A          172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-----------------------  228 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccc-----------------------
Confidence            999999999999999999999999999999999999999999999998644311000                       


Q ss_pred             cccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccc
Q psy10954        154 TTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP  233 (562)
Q Consensus       154 ~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~A  233 (562)
                                                                                        .......||+.|+|
T Consensus       229 ------------------------------------------------------------------~~~~~~~~t~~y~a  242 (344)
T 1rjb_A          229 ------------------------------------------------------------------VVRGNARLPVKWMA  242 (344)
T ss_dssp             ------------------------------------------------------------------EEETTEEECGGGCC
T ss_pred             ------------------------------------------------------------------eeccCccCccCccC
Confidence                                                                              00012356888999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchh
Q psy10954        234 PEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS  312 (562)
Q Consensus       234 PEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (562)
                      ||++.+.. ++.++||||+||++|+|++ |..||.+.+....+..++.....+.                          
T Consensus       243 PE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------  295 (344)
T 1rjb_A          243 PESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD--------------------------  295 (344)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC--------------------------
T ss_pred             HHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC--------------------------
Confidence            99997654 8999999999999999998 9999988775555554443210000                          


Q ss_pred             hhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q psy10954        313 EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE  347 (562)
Q Consensus       313 ~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp  347 (562)
                       .....++.+.+|+.+||..||.+|||+.|+++|-
T Consensus       296 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          296 -QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence             0012356789999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.7e-35  Score=306.61  Aligned_cols=219  Identities=14%  Similarity=0.156  Sum_probs=164.7

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeC----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVD----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+|+..++.++||||+++++++...    ...|||||||+++|.+++......+++..++.++.||+.||+|||++||+
T Consensus        95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ii  174 (364)
T 3op5_A           95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYV  174 (364)
T ss_dssp             HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            44555666777899999999998764    46899999997799999988767899999999999999999999999999


Q ss_pred             eccCCCCcEEEc--cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl~--~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||+|||++  .++.+||+|||+|+.+.......                                           
T Consensus       175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~-------------------------------------------  211 (364)
T 3op5_A          175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK-------------------------------------------  211 (364)
T ss_dssp             CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCC-------------------------------------------
T ss_pred             EecCCHHHEEEecCCCCeEEEEECCcceecccCCccc-------------------------------------------
Confidence            999999999999  78999999999987553210000                                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                               ..........+||+.|+|||++.+.. |+.++||||+||
T Consensus       212 -----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~  249 (364)
T 3op5_A          212 -----------------------------------------AYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGY  249 (364)
T ss_dssp             -----------------------------------------CSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred             -----------------------------------------ccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHH
Confidence                                                     00001112457899999999998765 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCCCCCCCCCCCCCccCCCCCCCccchhhhc--CCCCHHHHHHHHHccc
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRT-LGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL--NLPDPLAVDVFSKIMA  331 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~-lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~dLi~~mL~  331 (562)
                      ++|||++|+.||.+............. ....                     .+......+  ...++.+.+++.+||.
T Consensus       250 ~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~cl~  308 (364)
T 3op5_A          250 CMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN---------------------IASLMDKCFPAANAPGEIAKYMETVKL  308 (364)
T ss_dssp             HHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC---------------------HHHHHHHHSCTTCCCHHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCccccccCHHHHHHHHHHhhhh---------------------HHHHHHHhcccccCHHHHHHHHHHHhc
Confidence            999999999999864332222211110 0000                     000000011  2335788999999999


Q ss_pred             cCCCCCCCHHHHHc
Q psy10954        332 LDPKQRVSAKTILQ  345 (562)
Q Consensus       332 ~DP~~R~Ta~elL~  345 (562)
                      .||.+|||+.++++
T Consensus       309 ~~p~~RP~~~~l~~  322 (364)
T 3op5_A          309 LDYTEKPLYENLRD  322 (364)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence            99999999998875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.9e-35  Score=304.17  Aligned_cols=206  Identities=31%  Similarity=0.468  Sum_probs=169.9

Q ss_pred             hhHHHHHHHHHccC--CCCcceEEEEEEeCCEEEEEeecCc--CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~--HpnIv~L~~~~~~~~~i~lV~Ey~~--~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+.+|+.++  ||||+++++++...+..|+|||++.  ++|.+++... ..+++..++.++.|++.||+|||++|
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~  169 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG  169 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45668999999996  5999999999999999999999996  5899998764 36999999999999999999999999


Q ss_pred             ceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 IiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |+||||||+|||++ .++.+||+|||+++.....                                              
T Consensus       170 ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----------------------------------------------  203 (320)
T 3a99_A          170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------------------------------------------  203 (320)
T ss_dssp             EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----------------------------------------------
T ss_pred             cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----------------------------------------------
Confidence            99999999999998 6789999999987543210                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                     ......||+.|+|||++.+...++.++||||+|
T Consensus       204 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG  236 (320)
T 3a99_A          204 -----------------------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG  236 (320)
T ss_dssp             -----------------------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH
T ss_pred             -----------------------------------------------cccCCCCCccCCChHHhccCCCCCccchHHhHH
Confidence                                                           011235789999999998776668899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+...      +...  ...                           .....++.+.+|+.+||+.|
T Consensus       237 ~il~el~~g~~pf~~~~~------~~~~--~~~---------------------------~~~~~~~~~~~li~~~l~~d  281 (320)
T 3a99_A          237 ILLYDMVCGDIPFEHDEE------IIRG--QVF---------------------------FRQRVSSECQHLIRWCLALR  281 (320)
T ss_dssp             HHHHHHHHSSCSCCSHHH------HHHC--CCC---------------------------CSSCCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCCCChhh------hhcc--ccc---------------------------ccccCCHHHHHHHHHHccCC
Confidence            999999999999976432      1110  000                           00123567899999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|||++|+++||||++..
T Consensus       282 p~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          282 PSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             GGGSCCHHHHHTSGGGSSCC
T ss_pred             hhhCcCHHHHhcCHhhcCcc
Confidence            99999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-35  Score=300.80  Aligned_cols=211  Identities=23%  Similarity=0.379  Sum_probs=171.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-----------------------CCCCH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-----------------------VPVPP   73 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-----------------------~~l~e   73 (562)
                      ...+.+|+.+|+.++||||+++++++..++..|+||||+++ +|.+++....                       ..+++
T Consensus        94 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  173 (343)
T 1luf_A           94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC  173 (343)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH
Confidence            34578999999999999999999999999999999999975 9999997642                       46899


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccc
Q psy10954         74 ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  153 (562)
Q Consensus        74 ~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s  153 (562)
                      ..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......                        
T Consensus       174 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------------------------  229 (343)
T 1luf_A          174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY------------------------  229 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc------------------------
Confidence            99999999999999999999999999999999999999999999999764421100                        


Q ss_pred             cccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccc
Q psy10954        154 TTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP  233 (562)
Q Consensus       154 ~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~A  233 (562)
                                                                                       ........||+.|+|
T Consensus       230 -----------------------------------------------------------------~~~~~~~~~t~~y~a  244 (343)
T 1luf_A          230 -----------------------------------------------------------------YKADGNDAIPIRWMP  244 (343)
T ss_dssp             -----------------------------------------------------------------BC----CCBCGGGCC
T ss_pred             -----------------------------------------------------------------ccccCCCcccceecC
Confidence                                                                             000112356889999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchh
Q psy10954        234 PEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS  312 (562)
Q Consensus       234 PEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (562)
                      ||++.+.. ++.++||||+||++|||++ |..||.+.+..+....+....-.                    .       
T Consensus       245 PE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------~-------  296 (343)
T 1luf_A          245 PESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--------------------A-------  296 (343)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------------------C-------
T ss_pred             hhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC--------------------C-------
Confidence            99998655 8999999999999999999 99999998877666555432100                    0       


Q ss_pred             hhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        313 EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       313 ~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                       .....++.+.+++.+||..||++|||+.+++++
T Consensus       297 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          297 -CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence             001234678999999999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-34  Score=293.58  Aligned_cols=214  Identities=19%  Similarity=0.306  Sum_probs=162.9

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||++++++. .....++|||||. ++|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        65 ~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H  143 (289)
T 3og7_A           65 QAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH  143 (289)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4578999999999999999999954 5667899999998 4999999777777999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.......                                                
T Consensus       144 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------  175 (289)
T 3og7_A          144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG------------------------------------------------  175 (289)
T ss_dssp             SCCCGGGEEEETTTEEEECCCC----------------------------------------------------------
T ss_pred             ccCccceEEECCCCCEEEccceeccccccccc------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--CCCCCchhhHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCI  255 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--~~~y~~~~DIWSlG~i  255 (562)
                                                               ........||+.|+|||++..  ...++.++||||+||+
T Consensus       176 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  214 (289)
T 3og7_A          176 -----------------------------------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV  214 (289)
T ss_dssp             -------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHH
T ss_pred             -----------------------------------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHH
Confidence                                                     000122357999999999862  3458889999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+....+.+..+.......+.                       +.......++.+.+|+.+||+.||+
T Consensus       215 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~  271 (289)
T 3og7_A          215 LYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-----------------------LSKVRSNCPKRMKRLMAECLKKKRD  271 (289)
T ss_dssp             HHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-----------------------TTSSCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHCCCCccccchHHHHHHHhcccccCcc-----------------------hhhccccCCHHHHHHHHHHccCChh
Confidence            99999999999987776666655543211110                       0001123356789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.|+++
T Consensus       272 ~Rps~~ell~  281 (289)
T 3og7_A          272 ERPSFPRILA  281 (289)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCCCHHHHHH
Confidence            9999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.3e-35  Score=289.75  Aligned_cols=209  Identities=22%  Similarity=0.350  Sum_probs=172.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++++.++||||+++++++...+..|+||||++ ++|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  127 (267)
T 3t9t_A           48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH  127 (267)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            567899999999999999999999999999999999997 4999999887667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||+++.++.+||+|||+++.......                                                
T Consensus       128 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~------------------------------------------------  159 (267)
T 3t9t_A          128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY------------------------------------------------  159 (267)
T ss_dssp             SSCCGGGEEECGGGCEEECCTTGGGGBCCHHH------------------------------------------------
T ss_pred             CCCchheEEECCCCCEEEcccccccccccccc------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+|+.|+|||++.+.. ++.++||||+||++|
T Consensus       160 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  196 (267)
T 3t9t_A          160 ------------------------------------------TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMW  196 (267)
T ss_dssp             ------------------------------------------HSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------cccccccccccccChhhhcCCC-ccchhchhhhHHHHH
Confidence                                                      0001234678899999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++ |+.||.+.+..+....+.......                            .....++.+.+++.+||+.||++
T Consensus       197 ~l~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~  248 (267)
T 3t9t_A          197 EVFSEGKIPYENRSNSEVVEDISTGFRLY----------------------------KPRLASTHVYQIMNHCWRERPED  248 (267)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHhccCCCCCCCCCHHHHHHHHhcCCcCC----------------------------CCccCcHHHHHHHHHHccCChhh
Confidence            9999 899999888776665554321100                            00123567899999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.|++++
T Consensus       249 Rps~~~ll~~  258 (267)
T 3t9t_A          249 RPAFSRLLRQ  258 (267)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=292.87  Aligned_cols=212  Identities=23%  Similarity=0.312  Sum_probs=171.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++||||+++++++ .....|+||||+++ +|.+++......+++..+..++.|++.||.|||++||+
T Consensus        54 ~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  132 (287)
T 1u59_A           54 TEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV  132 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            34578999999999999999999999 45679999999986 99999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||+++.........                                             
T Consensus       133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------  167 (287)
T 1u59_A          133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---------------------------------------------  167 (287)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE---------------------------------------------
T ss_pred             eCCCchheEEEcCCCCEEECcccceeeeccCccee---------------------------------------------
Confidence            99999999999999999999999986543110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||+.|+|||++.+.. ++.++||||+||++
T Consensus       168 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  203 (287)
T 1u59_A          168 -------------------------------------------TARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTM  203 (287)
T ss_dssp             -------------------------------------------CCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred             -------------------------------------------eccccccccccccCHHHhccCC-CCchhhHHHHHHHH
Confidence                                                       0001234688999999997654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |+.||.+.+..+....+......                    .        .....++.+.+++.+||..||+
T Consensus       204 ~ellt~g~~p~~~~~~~~~~~~i~~~~~~--------------------~--------~~~~~~~~l~~li~~~l~~~p~  255 (287)
T 1u59_A          204 WEALSYGQKPYKKMKGPEVMAFIEQGKRM--------------------E--------CPPECPPELYALMSDCWIYKWE  255 (287)
T ss_dssp             HHHHTTSCCTTTTCCTHHHHHHHHTTCCC--------------------C--------CCTTCCHHHHHHHHHTTCSSGG
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHhcCCcC--------------------C--------CCCCcCHHHHHHHHHHcCCChh
Confidence            99998 99999988776655554331100                    0        0112356889999999999999


Q ss_pred             CCCCHHHHHcCc
Q psy10954        336 QRVSAKTILQHE  347 (562)
Q Consensus       336 ~R~Ta~elL~Hp  347 (562)
                      +|||+.|+++|.
T Consensus       256 ~Rps~~~l~~~l  267 (287)
T 1u59_A          256 DRPDFLTVEQRM  267 (287)
T ss_dssp             GSCCHHHHHHHH
T ss_pred             hCcCHHHHHHHH
Confidence            999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.4e-35  Score=289.95  Aligned_cols=206  Identities=28%  Similarity=0.432  Sum_probs=158.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR--   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g--   94 (562)
                      ...+.+|+++++.++||||+++++++..+...|+||||+++ +|.+++..  ..+++..+..++.|++.||.|||++|  
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~  127 (271)
T 3dtc_A           50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIV  127 (271)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            45678999999999999999999999999999999999975 89888854  36999999999999999999999999  


Q ss_pred             -ceeccCCCCcEEEcc--------CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccc
Q psy10954         95 -IIHRDLKPQNILINK--------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  165 (562)
Q Consensus        95 -IiHRDLKP~NILl~~--------~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il  165 (562)
                       |+||||||+|||++.        ++.+||+|||+                                             
T Consensus       128 ~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~---------------------------------------------  162 (271)
T 3dtc_A          128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGL---------------------------------------------  162 (271)
T ss_dssp             CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------------------------------------
T ss_pred             ceeecCCchHHEEEecccccccccCcceEEccCCc---------------------------------------------
Confidence             899999999999975        34455555554                                             


Q ss_pred             hhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCc
Q psy10954        166 SEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  245 (562)
Q Consensus       166 ~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~  245 (562)
                                                                    ++......  .....||+.|+|||++.+.. ++.
T Consensus       163 ----------------------------------------------~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~  193 (271)
T 3dtc_A          163 ----------------------------------------------AREWHRTT--KMSAAGAYAWMAPEVIRASM-FSK  193 (271)
T ss_dssp             -------------------------------------------------------------CCGGGSCHHHHHHCC-CSH
T ss_pred             ----------------------------------------------cccccccc--ccCCCCccceeCHHHhccCC-CCc
Confidence                                                          43322111  12346899999999997654 899


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHH
Q psy10954        246 TVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDV  325 (562)
Q Consensus       246 ~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dL  325 (562)
                      ++||||+||++|+|++|+.||.+.+.......+........                           .....++.+.++
T Consensus       194 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l  246 (271)
T 3dtc_A          194 GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP---------------------------IPSTCPEPFAKL  246 (271)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC---------------------------CCcccCHHHHHH
Confidence            99999999999999999999998887665555432110000                           011235678999


Q ss_pred             HHHccccCCCCCCCHHHHHcC
Q psy10954        326 FSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       326 i~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+||+.||++|||+.|+++|
T Consensus       247 i~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          247 MEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCcccCcCHHHHHHH
Confidence            999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.9e-35  Score=295.80  Aligned_cols=211  Identities=22%  Similarity=0.349  Sum_probs=171.1

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC-----------------CCCHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-----------------PVPPALAKSY   79 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~-----------------~l~e~~i~~i   79 (562)
                      ..+.+|+.+|+++ +||||+++++++..++..|+||||+++ +|.+++.....                 .+++..+..+
T Consensus        71 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (313)
T 1t46_A           71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF  150 (313)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred             HHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence            5678999999999 999999999999999999999999975 99999976542                 4899999999


Q ss_pred             HHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccc
Q psy10954         80 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  159 (562)
Q Consensus        80 ~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~Dvw  159 (562)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++........                             
T Consensus       151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------  201 (313)
T 1t46_A          151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-----------------------------  201 (313)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS-----------------------------
T ss_pred             HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccc-----------------------------
Confidence            999999999999999999999999999999999999999997654311000                             


Q ss_pred             cccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC
Q psy10954        160 SAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG  239 (562)
Q Consensus       160 SlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~  239 (562)
                                                                                  .......||+.|+|||++.+
T Consensus       202 ------------------------------------------------------------~~~~~~~~~~~y~aPE~~~~  221 (313)
T 1t46_A          202 ------------------------------------------------------------VVKGNARLPVKWMAPESIFN  221 (313)
T ss_dssp             ------------------------------------------------------------EECSSSEECGGGCCHHHHHH
T ss_pred             ------------------------------------------------------------eeccCCCCcceeeChHHhcC
Confidence                                                                        00012356888999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCC
Q psy10954        240 AKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP  318 (562)
Q Consensus       240 ~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  318 (562)
                      .. ++.++||||+||++|+|++ |..||.+......+..+......+.                           .....
T Consensus       222 ~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~  273 (313)
T 1t46_A          222 CV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEHA  273 (313)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTS
T ss_pred             CC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC---------------------------CcccC
Confidence            54 8999999999999999998 9999988775555554443211100                           00123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ++.+.+++.+||+.||.+|||+.|++++
T Consensus       274 ~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          274 PAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            5678999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.5e-35  Score=301.81  Aligned_cols=209  Identities=20%  Similarity=0.307  Sum_probs=166.7

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++. +...|+||||+. ++|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  138 (325)
T 3kex_A           60 QAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH  138 (325)
T ss_dssp             CSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            45678999999999999999999886 457999999997 5999999876667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++........                                               
T Consensus       139 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-----------------------------------------------  171 (325)
T 3kex_A          139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----------------------------------------------  171 (325)
T ss_dssp             SCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC-----------------------------------------------
T ss_pred             CccchheEEECCCCeEEECCCCcccccCccccc-----------------------------------------------
Confidence            999999999999999999999998654311000                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......||+.|+|||++.+.. |+.++||||+||++|
T Consensus       172 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~  208 (325)
T 3kex_A          172 ------------------------------------------LLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVW  208 (325)
T ss_dssp             ------------------------------------------CC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------ccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHH
Confidence                                                      0012235688999999997655 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      +|++ |..||.+....+....+......+                 .+           ...++.+.+++.+||+.||++
T Consensus       209 el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~-----------~~~~~~~~~li~~~l~~dp~~  260 (325)
T 3kex_A          209 ELMTFGAEPYAGLRLAEVPDLLEKGERLA-----------------QP-----------QICTIDVYMVMVKCWMIDENI  260 (325)
T ss_dssp             HHHTTSCCTTTTSCTTHHHHHHHTTCBCC-----------------CC-----------TTBCTTTTHHHHHHTCSCTTT
T ss_pred             HHHhCCCCCccccCHHHHHHHHHcCCCCC-----------------CC-----------CcCcHHHHHHHHHHcCCChhh
Confidence            9999 999999877655444443211000                 00           012345679999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.|+++|
T Consensus       261 Rps~~el~~~  270 (325)
T 3kex_A          261 RPTFKELANE  270 (325)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-34  Score=298.86  Aligned_cols=208  Identities=25%  Similarity=0.358  Sum_probs=168.7

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------------CCCCHHHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYL   80 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------------~~l~e~~i~~i~   80 (562)
                      ...+.+|+++|+++ +||||+++++++...+.+|+||||+++ +|.+++....               ..+++..++.++
T Consensus        69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  148 (327)
T 1fvr_A           69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA  148 (327)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHH
Confidence            45678999999999 999999999999999999999999975 9999997653               369999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++......                                
T Consensus       149 ~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--------------------------------  196 (327)
T 1fvr_A          149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--------------------------------  196 (327)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--------------------------------
T ss_pred             HHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccc--------------------------------
Confidence            999999999999999999999999999999999999999875321000                                


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                  ......+|+.|+|||++.+.
T Consensus       197 ------------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  216 (327)
T 1fvr_A          197 ------------------------------------------------------------KKTMGRLPVRWMAIESLNYS  216 (327)
T ss_dssp             ------------------------------------------------------------CC----CCTTTCCHHHHHHC
T ss_pred             ------------------------------------------------------------cccCCCCCccccChhhhccc
Confidence                                                                        00112457889999999765


Q ss_pred             CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCC
Q psy10954        241 KVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD  319 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (562)
                      . ++.++||||+||++|||++ |+.||.+.+..+....+......                 .           .....+
T Consensus       217 ~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~  267 (327)
T 1fvr_A          217 V-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-----------------E-----------KPLNCD  267 (327)
T ss_dssp             E-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-----------------C-----------CCTTBC
T ss_pred             c-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC-----------------C-----------CCCCCC
Confidence            4 8999999999999999998 99999988876655444221100                 0           001234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+.+|+.+||..||++|||++|++++
T Consensus       268 ~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          268 DEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            678999999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.9e-35  Score=298.07  Aligned_cols=210  Identities=21%  Similarity=0.348  Sum_probs=170.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---------~~l~e~~i~~i~~qll~aL~   88 (562)
                      ..+.+|+.+|+.++||||+++++++..+...|+||||+.+ +|.+++....         ..+++..+..++.|++.||.
T Consensus        73 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  152 (322)
T 1p4o_A           73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA  152 (322)
T ss_dssp             HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH
Confidence            3577999999999999999999999999999999999975 9999986522         35789999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||++||+||||||+|||++.++.+||+|||+++........                                      
T Consensus       153 ~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~--------------------------------------  194 (322)
T 1p4o_A          153 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------------------------------------  194 (322)
T ss_dssp             HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE--------------------------------------
T ss_pred             HHHHCCCccCCCccceEEEcCCCeEEECcCcccccccccccc--------------------------------------
Confidence            999999999999999999999999999999987644211000                                      


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         .......||+.|+|||++.+.. ++.++|
T Consensus       195 ---------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  222 (322)
T 1p4o_A          195 ---------------------------------------------------RKGGKGLLPVRWMSPESLKDGV-FTTYSD  222 (322)
T ss_dssp             ---------------------------------------------------EGGGSSEECGGGCCHHHHHHCC-CCHHHH
T ss_pred             ---------------------------------------------------ccccCCCCCCCccChhhhccCC-CCchhh
Confidence                                                               0001235688999999997654 899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|+|++ |..||.+.+..+....+....-.                    .        .....++.+.+|+.
T Consensus       223 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~~~~~l~~li~  274 (322)
T 1p4o_A          223 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL--------------------D--------KPDNCPDMLFELMR  274 (322)
T ss_dssp             HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC--------------------C--------CCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC--------------------C--------CCCCCCHHHHHHHH
Confidence            9999999999999 89999988776655554431100                    0        01123567899999


Q ss_pred             HccccCCCCCCCHHHHHcC
Q psy10954        328 KIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~H  346 (562)
                      +||+.||.+|||+.|+++|
T Consensus       275 ~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          275 MCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHHH
Confidence            9999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.8e-35  Score=298.68  Aligned_cols=218  Identities=23%  Similarity=0.388  Sum_probs=153.3

Q ss_pred             hHHHHHH-HHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy10954         20 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT----TPVPVPPALAKSYLYQLLEALRYCHSR-   93 (562)
Q Consensus        20 ~~~rEi~-iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~----~~~~l~e~~i~~i~~qll~aL~yLH~~-   93 (562)
                      ...+|+. +++.++||||+++++++..++..|+||||++++|.+++..    ....+++..+..++.|++.||.|||++ 
T Consensus        66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  145 (327)
T 3aln_A           66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL  145 (327)
T ss_dssp             HHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC
Confidence            4566666 6778899999999999999999999999999988887753    245699999999999999999999999 


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++...... .                                           
T Consensus       146 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~-------------------------------------------  181 (327)
T 3aln_A          146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-A-------------------------------------------  181 (327)
T ss_dssp             SCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------------------------
T ss_pred             CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-c-------------------------------------------
Confidence            99999999999999999999999999875432110 0                                           


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc---CCCCCCchhhHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL---GAKVYSTTVDIW  250 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~---~~~~y~~~~DIW  250 (562)
                                                                      .....||+.|+|||++.   ....++.++|||
T Consensus       182 ------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~  213 (327)
T 3aln_A          182 ------------------------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVW  213 (327)
T ss_dssp             ------------------------------------------------------------------------CCSHHHHH
T ss_pred             ------------------------------------------------cccCCCCccccCceeeccccCcCCCCchhhHH
Confidence                                                            01124677888888873   233488999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      |+||++|+|++|+.||.+.+.. +.+..+.                    ....+....    ......++.+.+|+.+|
T Consensus       214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------------------~~~~~~~~~----~~~~~~~~~l~~li~~~  269 (327)
T 3aln_A          214 SLGITLYELATGRFPYPKWNSVFDQLTQVV--------------------KGDPPQLSN----SEEREFSPSFINFVNLC  269 (327)
T ss_dssp             HHHHHHHHHHHSCCCSSCC-------CCCC--------------------CSCCCCCCC----CSSCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchHHHHHHHHh--------------------cCCCCCCCC----cccccCCHHHHHHHHHH
Confidence            9999999999999999875432 1110000                    000000000    01123467899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |+.||++|||+.|+++||||.+..
T Consensus       270 l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          270 LTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             TCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             hhCChhhCcCHHHHHhChHHHHhH
Confidence            999999999999999999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=299.62  Aligned_cols=210  Identities=19%  Similarity=0.306  Sum_probs=166.2

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+.+|+.++||||+++++++..+. .++|+||+. ++|.+++......+++..++.++.|++.||.|||++||
T Consensus        60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  138 (327)
T 3lzb_A           60 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL  138 (327)
T ss_dssp             CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Confidence            4567889999999999999999999998765 788889887 59999998877789999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++........                                             
T Consensus       139 vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~---------------------------------------------  173 (327)
T 3lzb_A          139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE---------------------------------------------  173 (327)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCTTC-------------------------------------------------------
T ss_pred             cCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc---------------------------------------------
Confidence            99999999999999999999999998654311000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. |+.++||||+||+
T Consensus       174 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i  208 (327)
T 3lzb_A          174 --------------------------------------------YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  208 (327)
T ss_dssp             --------------------------------------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCCccccccCHHHHcCCC-CChHHHHHHHHHH
Confidence                                                        0001234688899999998755 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |..||.+.+..+....+......+                            .....+..+.+++.+||+.||
T Consensus       209 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp  260 (327)
T 3lzb_A          209 VWELMTFGSKPYDGIPASEISSILEKGERLP----------------------------QPPICTIDVYMIMRKCWMIDA  260 (327)
T ss_dssp             HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTBCHHHHHHHHHHTCSSG
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCCCh
Confidence            999999 999999877655444333211000                            001234678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      .+|||+.|+++
T Consensus       261 ~~Rps~~ell~  271 (327)
T 3lzb_A          261 DSRPKFRELII  271 (327)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-34  Score=305.74  Aligned_cols=210  Identities=22%  Similarity=0.335  Sum_probs=163.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|++++||||+++++++.....+|+|||||+ ++|.+++......+++..+..++.|++.||+|||++||+|
T Consensus        91 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  170 (373)
T 2qol_A           91 RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH  170 (373)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence            457899999999999999999999999999999999996 5999999887667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.........                                              
T Consensus       171 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----------------------------------------------  204 (373)
T 2qol_A          171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA----------------------------------------------  204 (373)
T ss_dssp             SCCCGGGEEECTTCCEEECCC-----------------------------------------------------------
T ss_pred             CCCCcceEEEcCCCCEEECcCccccccccCCccc----------------------------------------------
Confidence            9999999999999999999999986543110000                                              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+|+.|+|||++.+.. |+.++||||+||++|
T Consensus       205 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~  241 (373)
T 2qol_A          205 ------------------------------------------YTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLW  241 (373)
T ss_dssp             ---------------------------------------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------eeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHH
Confidence                                                      0001123578899999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |+.||.+.+..+....+......+.                            ....+..+.+++.+||+.||++
T Consensus       242 ellt~g~~P~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~dp~~  293 (373)
T 2qol_A          242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPP----------------------------PMDCPAALYQLMLDCWQKDRNN  293 (373)
T ss_dssp             HHHTTC-CTTTTCCHHHHHHHHHTTEECCC----------------------------CTTCBHHHHHHHHHHTCSSGGG
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccccHHHHHHHHHHhCcChhh
Confidence            9997 9999998887666655543211110                            0112457889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.|+++
T Consensus       294 RPs~~~i~~  302 (373)
T 2qol_A          294 RPKFEQIVS  302 (373)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999885

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-34  Score=299.38  Aligned_cols=218  Identities=16%  Similarity=0.141  Sum_probs=167.5

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .+.+|+.+++.++||||+++++++..    ...+|+|||||+++|.+++.... .+++..++.++.|++.||+|||++||
T Consensus        94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i  172 (345)
T 2v62_A           94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEY  172 (345)
T ss_dssp             HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            46688899999999999999999988    77899999999779999987654 79999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCC--CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         96 IHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        96 iHRDLKP~NILl~~~~--~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      +||||||+|||++.++  .+||+|||+|+.+.......                                          
T Consensus       173 vH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~------------------------------------------  210 (345)
T 2v62_A          173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK------------------------------------------  210 (345)
T ss_dssp             ECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCC------------------------------------------
T ss_pred             eCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccc------------------------------------------
Confidence            9999999999999877  99999999987653210000                                          


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                ..........+||+.|+|||++.+.. ++.++||||+|
T Consensus       211 ------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  247 (345)
T 2v62_A          211 ------------------------------------------QYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILG  247 (345)
T ss_dssp             ------------------------------------------CCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHH
T ss_pred             ------------------------------------------cchhccccccCCCccccCHHHhcCCC-CCchhhHHHHH
Confidence                                                      00001113457899999999998764 89999999999


Q ss_pred             HHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcC--CCCHHHHHHHHHc
Q psy10954        254 CIFSEMITKKTLFAGD--SEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN--LPDPLAVDVFSKI  329 (562)
Q Consensus       254 ~il~eLltG~~pF~~~--~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~dLi~~m  329 (562)
                      |++|||++|+.||.+.  +...............                      +..+.....  ..++.+.+++.+|
T Consensus       248 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~li~~~  305 (345)
T 2v62_A          248 YCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL----------------------PQSVLKWAPSGSSCCEIAQFLVCA  305 (345)
T ss_dssp             HHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT----------------------THHHHHHSCTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCccccccccHHHHHHHHhhcccc----------------------cHHHHhhccccccHHHHHHHHHHH
Confidence            9999999999999653  2222211111111100                      001111111  3457899999999


Q ss_pred             cccCCCCCCCHHHHHc
Q psy10954        330 MALDPKQRVSAKTILQ  345 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~  345 (562)
                      |..||++|||++++++
T Consensus       306 l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          306 HSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HTCCTTCCCCHHHHHH
T ss_pred             hhcCcccCCCHHHHHH
Confidence            9999999999999886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.2e-35  Score=302.90  Aligned_cols=218  Identities=24%  Similarity=0.383  Sum_probs=144.8

Q ss_pred             HHHHHH-HHHccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         21 ALREIS-VLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        21 ~~rEi~-iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+|+. .++.++||||+++++++..    +..+|+|||||.+ +|.+++.... ..+++..++.++.|++.||.|||++
T Consensus        68 ~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~  147 (336)
T 3fhr_A           68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH  147 (336)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            344544 4567799999999999976    4568999999986 9999998754 3699999999999999999999999


Q ss_pred             CceeccCCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         94 RIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      ||+||||||+|||++.+   +.+||+|||+++.....                                           
T Consensus       148 ~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------  184 (336)
T 3fhr_A          148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-------------------------------------------  184 (336)
T ss_dssp             TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------------------------------
T ss_pred             CeecCCCCHHHEEEEecCCCceEEEeccccceecccc-------------------------------------------
Confidence            99999999999999763   45888888876432100                                           


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                        .....+||+.|+|||++.+.. |+.++|||
T Consensus       185 --------------------------------------------------~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~  213 (336)
T 3fhr_A          185 --------------------------------------------------ALQTPCYTPYYVAPEVLGPEK-YDKSCDMW  213 (336)
T ss_dssp             ---------------------------------------------------------------------CH-HHHHHHHH
T ss_pred             --------------------------------------------------ccccCCCCcCccChhhhCCCC-CCchhhHH
Confidence                                                              011235688899999886544 78999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|+|++|..||.+.................            .+  .++.       ......++.+.+||.+||
T Consensus       214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~~--~~~~-------~~~~~~~~~~~~li~~~L  272 (336)
T 3fhr_A          214 SLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------------QY--GFPN-------PEWSEVSEDAKQLIRLLL  272 (336)
T ss_dssp             HHHHHHHHHHHSSCCC-----------------------------------CCCT-------TTSTTCCHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc------------cc--ccCc-------hhhccCCHHHHHHHHHHC
Confidence            99999999999999998765432211111100000            00  0000       011234678999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +.||++|||++|+|+||||++..
T Consensus       273 ~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          273 KTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             CCChhHCcCHHHHhcCccccccc
Confidence            99999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5e-35  Score=308.51  Aligned_cols=209  Identities=27%  Similarity=0.402  Sum_probs=168.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++||||+++++++..++.+|+|||||+ ++|.++++..+..+++..+..++.|++.||+|||++||+|
T Consensus       157 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH  236 (377)
T 3cbl_A          157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH  236 (377)
T ss_dssp             TTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence            356799999999999999999999999899999999997 5999999876556999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++......  .                     ..                       
T Consensus       237 rDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~--~---------------------~~-----------------------  270 (377)
T 3cbl_A          237 RDLAARNCLVTEKNVLKISDFGMSREEADGV--Y---------------------AA-----------------------  270 (377)
T ss_dssp             SCCSGGGEEECTTCCEEECCGGGCEECTTSE--E---------------------EC-----------------------
T ss_pred             cccCHHHEEEcCCCcEEECcCCCceecCCCc--e---------------------ee-----------------------
Confidence            9999999999999999999999976432100  0                     00                       


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                 ......+|+.|+|||++.+.. |+.++||||+||++|
T Consensus       271 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~  306 (377)
T 3cbl_A          271 -------------------------------------------SGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLW  306 (377)
T ss_dssp             -------------------------------------------CSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHH
T ss_pred             -------------------------------------------cCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHH
Confidence                                                       000123467799999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+.+..+....+......+                 .+           ...++.+.+|+.+||+.||++
T Consensus       307 el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~-----------~~~~~~l~~li~~cl~~dP~~  358 (377)
T 3cbl_A          307 ETFSLGASPYPNLSNQQTREFVEKGGRLP-----------------CP-----------ELCPDAVFRLMEQCWAYEPGQ  358 (377)
T ss_dssp             HHHTTSCCSSTTSCHHHHHHHHHTTCCCC-----------------CC-----------TTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------CC-----------CCCCHHHHHHHHHHcCCCchh
Confidence            9998 999999887765544443211000                 00           113467889999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||++++++
T Consensus       359 Rps~~~i~~  367 (377)
T 3cbl_A          359 RPSFSTIYQ  367 (377)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-34  Score=290.69  Aligned_cols=209  Identities=21%  Similarity=0.338  Sum_probs=167.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|+.++||||+++++++.. ...|+||||+. ++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  135 (281)
T 3cc6_A           57 KEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV  135 (281)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567899999999999999999999865 45799999998 499999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||++........                                               
T Consensus       136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------  168 (281)
T 3cc6_A          136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----------------------------------------------  168 (281)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCCGGGCC----------------------------------------------------
T ss_pred             cCCCccceEEECCCCcEEeCccCCCcccccccc-----------------------------------------------
Confidence            999999999999999999999998764421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       169 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  204 (281)
T 3cc6_A          169 -------------------------------------------YKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCM  204 (281)
T ss_dssp             -----------------------------------------------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccCCCCcceeCchhhccCC-CCchhccHHHHHHH
Confidence                                                       0001124578899999997654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |+.||.+....+....+......+                            .....++.+.+++.+||..||+
T Consensus       205 ~~llt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~  256 (281)
T 3cc6_A          205 WEILSFGKQPFFWLENKDVIGVLEKGDRLP----------------------------KPDLCPPVLYTLMTRCWDYDPS  256 (281)
T ss_dssp             HHHHTTTCCTTTTSCGGGHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhCCCCCcccCChHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHccCCch
Confidence            99998 999998776655544443321110                            0012356789999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||+.|++++
T Consensus       257 ~Rps~~ell~~  267 (281)
T 3cc6_A          257 DRPRFTELVCS  267 (281)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCcCHHHHHHH
Confidence            99999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-34  Score=296.47  Aligned_cols=211  Identities=21%  Similarity=0.310  Sum_probs=168.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++...+..|+||||+++ +|.+++......+++..+..++.|++.||.|||++||+|
T Consensus        91 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  170 (333)
T 1mqb_A           91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH  170 (333)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            3577999999999999999999999999999999999986 999999877667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.........                                              
T Consensus       171 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------------------  204 (333)
T 1mqb_A          171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT----------------------------------------------  204 (333)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC---------------------------------------------------------
T ss_pred             CCCChheEEECCCCcEEECCCCcchhhccccccc----------------------------------------------
Confidence            9999999999999999999999976542110000                                              


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+|+.|+|||++.+.. ++.++||||+||++|
T Consensus       205 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  241 (333)
T 1mqb_A          205 ------------------------------------------YTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMW  241 (333)
T ss_dssp             ------------------------------------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------cccCCCCccccccCchhcccCC-CCchhhhHHHHHHHH
Confidence                                                      0001124578899999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |+.||.+.+..+.+..+......+.                            ....++.+.+++.+||+.||++
T Consensus       242 ellt~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~  293 (333)
T 1mqb_A          242 EVMTYGERPYWELSNHEVMKAINDGFRLPT----------------------------PMDCPSAIYQLMMQCWQQERAR  293 (333)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTCBHHHHHHHHHHTCSSTTT
T ss_pred             HHHcCCCCCcccCCHHHHHHHHHCCCcCCC----------------------------cccCCHHHHHHHHHHcCCChhh
Confidence            9998 9999998887666655543211100                            0122467899999999999999


Q ss_pred             CCCHHHHHcC
Q psy10954        337 RVSAKTILQH  346 (562)
Q Consensus       337 R~Ta~elL~H  346 (562)
                      |||+.+++++
T Consensus       294 Rps~~~l~~~  303 (333)
T 1mqb_A          294 RPKFADIVSI  303 (333)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999998864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-34  Score=292.18  Aligned_cols=211  Identities=21%  Similarity=0.332  Sum_probs=167.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEE-eCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~-~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|++++||||+++++++. .++..|+||||+++ +|.+++......+++..+..++.|++.||+|||++||+
T Consensus        71 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~  150 (298)
T 3f66_A           71 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV  150 (298)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            45789999999999999999999864 55688999999986 99999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++........                                              
T Consensus       151 H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~----------------------------------------------  184 (298)
T 3f66_A          151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY----------------------------------------------  184 (298)
T ss_dssp             CSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC----------------------------------------------
T ss_pred             CCCCchheEEECCCCCEEECcccccccccccchh----------------------------------------------
Confidence            9999999999999999999999998654311000                                              


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                               .........||+.|+|||++.+.. ++.++||||+||++
T Consensus       185 -----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  222 (298)
T 3f66_A          185 -----------------------------------------SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLL  222 (298)
T ss_dssp             -----------------------------------------BC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             -----------------------------------------ccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHH
Confidence                                                     000012235788999999997655 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |.+||.+.+..+....+........                            ....++.+.+++.+||..||+
T Consensus       223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~  274 (298)
T 3f66_A          223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----------------------------PEYCPDPLYEVMLKCWHPKAE  274 (298)
T ss_dssp             HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhCCCCCCccCCHHHHHHHHhcCCCCCC----------------------------CccCCHHHHHHHHHHcCCChh
Confidence            99999 6777877666555444433211000                            011246789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.|+++
T Consensus       275 ~Rps~~ell~  284 (298)
T 3f66_A          275 MRPSFSELVS  284 (298)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.1e-34  Score=288.94  Aligned_cols=204  Identities=24%  Similarity=0.326  Sum_probs=161.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR--I   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g--I   95 (562)
                      ..+.+|++++++++||||+++++++....  ++||||+. ++|.+.+......+++..+..++.|++.||+|||++|  |
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence            56789999999999999999999987655  79999998 5999998877778999999999999999999999999  9


Q ss_pred             eeccCCCCcEEEccCCC-----eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         96 IHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~-----vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      +||||||+|||++.++.     +||+|||+++....                                            
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--------------------------------------------  181 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--------------------------------------------  181 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--------------------------------------------
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--------------------------------------------
Confidence            99999999999987665     78888887642210                                            


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC-CCCCCchhhH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDI  249 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~-~~~y~~~~DI  249 (562)
                                                                        ......||+.|+|||++.+ ...++.++||
T Consensus       182 --------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di  211 (287)
T 4f0f_A          182 --------------------------------------------------SVSGLLGNFQWMAPETIGAEEESYTEKADT  211 (287)
T ss_dssp             --------------------------------------------------CEECCCCCCTTSCGGGSSCSSCEECHHHHH
T ss_pred             --------------------------------------------------cccccCCCccccCchhhccCCCCcCchhhH
Confidence                                                              1122467888999998843 3347899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQ--LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~--l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      ||+||++|+|++|+.||.+.+....  ...+.. .+..+.                          .....++.+.+|+.
T Consensus       212 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~--------------------------~~~~~~~~l~~li~  264 (287)
T 4f0f_A          212 YSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRPT--------------------------IPEDCPPRLRNVIE  264 (287)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCCCC--------------------------CCTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCCCC--------------------------CCcccCHHHHHHHH
Confidence            9999999999999999987653322  222222 111100                          11123567899999


Q ss_pred             HccccCCCCCCCHHHHHc
Q psy10954        328 KIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~  345 (562)
                      +||+.||++|||++|+++
T Consensus       265 ~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          265 LCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-35  Score=298.41  Aligned_cols=207  Identities=29%  Similarity=0.463  Sum_probs=163.1

Q ss_pred             hhHHHHHHHHHcc----CCCCcceEEEEEEeCCEEEEEeec-Cc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL----KHPNVIRLHDVIPVDFKLFLVFEF-LR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l----~HpnIv~L~~~~~~~~~i~lV~Ey-~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ....+|+.+++++    +||||+++++++...+..|+|||| +. ++|.+++.... .+++..++.++.|++.||+|||+
T Consensus        79 ~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  157 (312)
T 2iwi_A           79 VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHS  157 (312)
T ss_dssp             CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            3456899999999    899999999999999999999999 55 59999997643 69999999999999999999999


Q ss_pred             CCceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         93 RRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +||+||||||+||+++ .++.+||+|||+++.....                                            
T Consensus       158 ~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--------------------------------------------  193 (312)
T 2iwi_A          158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--------------------------------------------  193 (312)
T ss_dssp             HTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--------------------------------------------
T ss_pred             CCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--------------------------------------------
Confidence            9999999999999998 7888999999987543210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                       ......||+.|+|||++.+...++.++||||
T Consensus       194 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  224 (312)
T 2iwi_A          194 -------------------------------------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWS  224 (312)
T ss_dssp             -------------------------------------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHH
T ss_pred             -------------------------------------------------cccccCCcccccCceeeecCCCCCccchHHH
Confidence                                                             0112357889999999987665567999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      +||++|+|++|+.||.+...      +....-                  .           .....++.+.+|+.+||+
T Consensus       225 lG~il~~l~~g~~pf~~~~~------~~~~~~------------------~-----------~~~~~~~~~~~li~~~l~  269 (312)
T 2iwi_A          225 LGILLYDMVCGDIPFERDQE------ILEAEL------------------H-----------FPAHVSPDCCALIRRCLA  269 (312)
T ss_dssp             HHHHHHHHHHSSCSCCSHHH------HHHTCC------------------C-----------CCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHCCCCCCChHH------Hhhhcc------------------C-----------CcccCCHHHHHHHHHHcc
Confidence            99999999999999976422      111100                  0           011235678999999999


Q ss_pred             cCCCCCCCHHHHHcCccccCCcc
Q psy10954        332 LDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       332 ~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      .||++|||++|+++||||+....
T Consensus       270 ~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          270 PKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             SSTTTSCCHHHHHHSTTTCC---
T ss_pred             CChhhCcCHHHHhcChhhcCchh
Confidence            99999999999999999987653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-34  Score=288.81  Aligned_cols=211  Identities=22%  Similarity=0.357  Sum_probs=166.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEE-EEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKL-FLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i-~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+.+|+.++||||+++++++...+.. |+||||+. ++|.+++......+++..+..++.|++.||+|||++||+
T Consensus        67 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  146 (298)
T 3pls_A           67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV  146 (298)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4577999999999999999999999876655 99999996 599999988667799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.......                      +                        
T Consensus       147 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~----------------------~------------------------  180 (298)
T 3pls_A          147 HRDLAARNCMLDESFTVKVADFGLARDILDREY----------------------Y------------------------  180 (298)
T ss_dssp             CSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG----------------------G------------------------
T ss_pred             cCCCCcceEEEcCCCcEEeCcCCCcccccCCcc----------------------c------------------------
Confidence            999999999999999999999999864421100                      0                        


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                               .........+|+.|+|||++.+.. ++.++||||+||++
T Consensus       181 -----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  218 (298)
T 3pls_A          181 -----------------------------------------SVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLL  218 (298)
T ss_dssp             -----------------------------------------CSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred             -----------------------------------------ccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHH
Confidence                                                     000112345788999999997655 89999999999999


Q ss_pred             HHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMITK-KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLltG-~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++| .+||.+.+..+....+......+.                            ....++.+.+++.+||+.||.
T Consensus       219 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~  270 (298)
T 3pls_A          219 WELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ----------------------------PEYCPDSLYQVMQQCWEADPA  270 (298)
T ss_dssp             HHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHhhCCCCCCccCCHHHHHHHhhcCCCCCC----------------------------CccchHHHHHHHHHHccCChh
Confidence            999995 555655555444433332111000                            012346789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||++++++
T Consensus       271 ~Rps~~~ll~  280 (298)
T 3pls_A          271 VRPTFRVLVG  280 (298)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.4e-34  Score=285.91  Aligned_cols=204  Identities=17%  Similarity=0.242  Sum_probs=166.8

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ..+.+|+.+|++++||||+++++++...  ...|+||||+++ +|.+++..... .+++..+..++.|++.||.|||++|
T Consensus        52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  131 (271)
T 3kmu_A           52 RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE  131 (271)
T ss_dssp             HHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS
T ss_pred             HHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            4578999999999999999999999877  789999999985 99999987553 4899999999999999999999999


Q ss_pred             --ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         95 --IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        95 --IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                        |+||||||+|||++.++.++|+|||++....                                               
T Consensus       132 ~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-----------------------------------------------  164 (271)
T 3kmu_A          132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----------------------------------------------  164 (271)
T ss_dssp             SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-----------------------------------------------
T ss_pred             CceecCCCccceEEEcCCcceeEEeccceeeec-----------------------------------------------
Confidence              9999999999999999999999888643211                                               


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC--CCchhhHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIW  250 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~--y~~~~DIW  250 (562)
                                                                       ....+||+.|+|||++.+...  ++.++|||
T Consensus       165 -------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~  195 (271)
T 3kmu_A          165 -------------------------------------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMW  195 (271)
T ss_dssp             -------------------------------------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred             -------------------------------------------------ccCccCCccccChhhhccCCCCCCCchhhHH
Confidence                                                             011256788999998876532  33489999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|||++|+.||.+.+..+....+......+.                           .....++.+.+++.+||
T Consensus       196 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l  248 (271)
T 3kmu_A          196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT---------------------------IPPGISPHVSKLMKICM  248 (271)
T ss_dssp             HHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC---------------------------CCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHc
Confidence            999999999999999999887776665543211110                           01123567899999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy10954        331 ALDPKQRVSAKTILQ  345 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~  345 (562)
                      +.||++|||++|+++
T Consensus       249 ~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          249 NEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.7e-34  Score=289.18  Aligned_cols=209  Identities=25%  Similarity=0.362  Sum_probs=169.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++++||||+++++++.....+|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||
T Consensus        53 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  132 (288)
T 3kfa_A           53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF  132 (288)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCc
Confidence            3567899999999999999999999999999999999998 59999997643 459999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||+++.++.+||+|||++........                                              
T Consensus       133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----------------------------------------------  166 (288)
T 3kfa_A          133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----------------------------------------------  166 (288)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS----------------------------------------------
T ss_pred             cCCCCCcceEEEcCCCCEEEccCccceeccCCcc----------------------------------------------
Confidence            9999999999999999999999998764431100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......+|+.|+|||++.+.. ++.++||||+||+
T Consensus       167 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  201 (288)
T 3kfa_A          167 --------------------------------------------TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVL  201 (288)
T ss_dssp             --------------------------------------------EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCccccCcCChhhhccCC-CCchhhHHHHHHH
Confidence                                                        0001224578899999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|+|++ |..||.+.+.......+.......                            .....++.+.+|+.+||..||
T Consensus       202 l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp  253 (288)
T 3kfa_A          202 LWEIATYGMSPYPGIDLSQVYELLEKDYRME----------------------------RPEGCPEKVYELMRACWQWNP  253 (288)
T ss_dssp             HHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHhccCCCC----------------------------CCCCCCHHHHHHHHHHhCCCh
Confidence            999999 999998877654444433211100                            001235678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++|+++
T Consensus       254 ~~Rps~~~~~~  264 (288)
T 3kfa_A          254 SDRPSFAEIHQ  264 (288)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hhCcCHHHHHH
Confidence            99999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-34  Score=297.61  Aligned_cols=210  Identities=19%  Similarity=0.333  Sum_probs=169.2

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC-------------CCCCCHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-------------PVPVPPALAKSYLYQL   83 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~-------------~~~l~e~~i~~i~~ql   83 (562)
                      ..+.+|+.+|+.+ +||||+++++++..++.+|+||||+++ +|.+++...             ...+++..+..++.|+
T Consensus        94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi  173 (333)
T 2i1m_A           94 EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV  173 (333)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence            4578999999999 899999999999999999999999975 999998653             2358999999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         84 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        84 l~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      +.||.|||++||+||||||+|||++.++.+||+|||+++........                                 
T Consensus       174 ~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------  220 (333)
T 2i1m_A          174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---------------------------------  220 (333)
T ss_dssp             HHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTS---------------------------------
T ss_pred             HHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccce---------------------------------
Confidence            99999999999999999999999999999999999998644211000                                 


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                              .......||+.|+|||++.+.. +
T Consensus       221 --------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~  243 (333)
T 2i1m_A          221 --------------------------------------------------------IVKGNARLPVKWMAPESIFDCV-Y  243 (333)
T ss_dssp             --------------------------------------------------------EECSSCEECGGGSCHHHHHHCC-C
T ss_pred             --------------------------------------------------------eecCCCCCCccccCHHHhccCC-C
Confidence                                                                    0001234688899999997654 8


Q ss_pred             CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        244 STTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       244 ~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      +.++||||+||++|||++ |..||.+......+..+......+.                           .....++.+
T Consensus       244 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l  296 (333)
T 2i1m_A          244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------------QPAFAPKNI  296 (333)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTCCHHH
T ss_pred             ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCCCCCHHH
Confidence            999999999999999998 9999988765555555443211100                           001124678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+++.+||+.||.+|||+.|+++
T Consensus       297 ~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          297 YSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccChhhCcCHHHHHH
Confidence            99999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-34  Score=293.09  Aligned_cols=211  Identities=22%  Similarity=0.392  Sum_probs=167.8

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCC-EEEEEeecCcC-CHHHHHhhCCCC---------------CCHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPVP---------------VPPALAKSYL   80 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~-~i~lV~Ey~~~-~L~~~i~~~~~~---------------l~e~~i~~i~   80 (562)
                      ..+.+|+.+|+.+ +||||+++++++...+ .+|+|||||.+ +|.+++......               +++..+..++
T Consensus        75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (316)
T 2xir_A           75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  154 (316)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHH
Confidence            3578999999999 7999999999987654 59999999985 999999875432               8899999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++........                              
T Consensus       155 ~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------  204 (316)
T 2xir_A          155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------------------------------  204 (316)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------------------------------
T ss_pred             HHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccc------------------------------
Confidence            99999999999999999999999999999999999999998644211000                              


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                 .......||+.|+|||++.+.
T Consensus       205 -----------------------------------------------------------~~~~~~~~t~~y~aPE~~~~~  225 (316)
T 2xir_A          205 -----------------------------------------------------------VRKGDARLPLKWMAPETIFDR  225 (316)
T ss_dssp             -----------------------------------------------------------EEETTEEECGGGCCHHHHHHC
T ss_pred             -----------------------------------------------------------eeccCCCcceeecCchhhccc
Confidence                                                                       001123568899999999765


Q ss_pred             CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCC
Q psy10954        241 KVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD  319 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (562)
                      . ++.++||||+||++|+|++ |..||.+....+.+...+.....+.                           .....+
T Consensus       226 ~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  277 (316)
T 2xir_A          226 V-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTT  277 (316)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCC
T ss_pred             c-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC---------------------------CCCCCC
Confidence            4 8999999999999999998 9999988765444443333211100                           001235


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+.+++.+||+.||.+|||+.|+++|
T Consensus       278 ~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          278 PEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678999999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-34  Score=299.90  Aligned_cols=223  Identities=13%  Similarity=0.145  Sum_probs=169.6

Q ss_pred             hhHHHHHHHHHccCCCCcce---------------EEEEEEe-CCEEEEEeecCcCCHHHHHhhC-CCCCCHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIR---------------LHDVIPV-DFKLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~---------------L~~~~~~-~~~i~lV~Ey~~~~L~~~i~~~-~~~l~e~~i~~i~~   81 (562)
                      ..+.+|+++|++++||||++               +++++.. +...|+|||||+++|.+++... ...+++..+..++.
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~  166 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC  166 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHH
Confidence            45889999999999999988               6777776 6889999999977999999875 34699999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCC--CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  159 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~--~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~Dvw  159 (562)
                      |++.||.|||++||+||||||+|||++.++  .+||+|||+++..........                           
T Consensus       167 qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~---------------------------  219 (352)
T 2jii_A          167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA---------------------------  219 (352)
T ss_dssp             HHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC---------------------------
T ss_pred             HHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc---------------------------
Confidence            999999999999999999999999999988  899999999875532110000                           


Q ss_pred             cccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC
Q psy10954        160 SAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG  239 (562)
Q Consensus       160 SlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~  239 (562)
                                                                               ..........||+.|+|||++.+
T Consensus       220 ---------------------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          220 ---------------------------------------------------------YVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             ---------------------------------------------------------CCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             ---------------------------------------------------------ccccccccccCCccccCHHHHcc
Confidence                                                                     00011123478999999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCC
Q psy10954        240 AKVYSTTVDIWSAGCIFSEMITKKTLFAGDS-EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP  318 (562)
Q Consensus       240 ~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  318 (562)
                      .. ++.++||||+||++|||++|+.||.+.. ..+.+.................          ..         .....
T Consensus       243 ~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---------~~~~~  302 (352)
T 2jii_A          243 CG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP----------CG---------HWIRP  302 (352)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECT----------TS---------CEECC
T ss_pred             CC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhh----------cc---------ccCCC
Confidence            54 8999999999999999999999998764 3333333322111111000000          00         01123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      ++.+.+|+.+||..||++|||++++++
T Consensus       303 ~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          303 SETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            578999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.9e-34  Score=295.51  Aligned_cols=214  Identities=19%  Similarity=0.288  Sum_probs=172.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP------VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~------~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|+.+|+.++||||+++++++......|+||||++ ++|.+++....      ..+++..+..++.|++.||.|||
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH  157 (327)
T 2yfx_A           78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE  157 (327)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence            457899999999999999999999999999999999996 59999998654      34899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccC---CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~---~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ++||+||||||+|||++.+   ..+||+|||+++.......                                       
T Consensus       158 ~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~---------------------------------------  198 (327)
T 2yfx_A          158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---------------------------------------  198 (327)
T ss_dssp             HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------------------------------------------
T ss_pred             hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc---------------------------------------
Confidence            9999999999999999844   4589999998754321000                                       


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                        ........||+.|+|||++.+.. ++.++|
T Consensus       199 --------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  227 (327)
T 2yfx_A          199 --------------------------------------------------YRKGGCAMLPVKWMPPEAFMEGI-FTSKTD  227 (327)
T ss_dssp             -----------------------------------------------------CCGGGSCGGGCCHHHHHHCC-CCHHHH
T ss_pred             --------------------------------------------------cccCCCcCCCcceeCHhHhcCCC-CCchhh
Confidence                                                              00011235788999999997654 899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|+|++ |..||.+.+..+.+..+.......                            .....++.+.+++.
T Consensus       228 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~  279 (327)
T 2yfx_A          228 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD----------------------------PPKNCPGPVYRIMT  279 (327)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHH
Confidence            9999999999998 999999887766555554321100                            00123567899999


Q ss_pred             HccccCCCCCCCHHHHHcCcccc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      +||+.||++|||+.|+++|.|+-
T Consensus       280 ~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          280 QCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-34  Score=289.85  Aligned_cols=211  Identities=26%  Similarity=0.330  Sum_probs=169.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++||||+++++++..+. .++||||+. ++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  143 (291)
T 1u46_A           65 MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI  143 (291)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            356789999999999999999999998764 899999997 599999987656799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+||+++.++.+||+|||+++.........                                             
T Consensus       144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------  178 (291)
T 1u46_A          144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY---------------------------------------------  178 (291)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE---------------------------------------------
T ss_pred             cCCCchheEEEcCCCCEEEccccccccccccccch---------------------------------------------
Confidence            99999999999999999999999976543110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       179 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  214 (291)
T 1u46_A          179 -------------------------------------------VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTL  214 (291)
T ss_dssp             -------------------------------------------EC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             -------------------------------------------hhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHH
Confidence                                                       0001234678899999997654 78999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |+.||.+.+..+.+..+......++                           .....++.+.+++.+||..||+
T Consensus       215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~  267 (291)
T 1u46_A          215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVMVQCWAHKPE  267 (291)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhCCCCCcccCCHHHHHHHHHccCCCCC---------------------------CCcCcCHHHHHHHHHHccCCcc
Confidence            99999 9999999887766665543211000                           0012356789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.++++
T Consensus       268 ~Rps~~~l~~  277 (291)
T 1u46_A          268 DRPTFVALRD  277 (291)
T ss_dssp             GSCCHHHHHH
T ss_pred             cCcCHHHHHH
Confidence            9999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-34  Score=291.20  Aligned_cols=226  Identities=23%  Similarity=0.337  Sum_probs=162.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++|+.++||||+++++++...  ..+|+|||||++ +|.+++......+++..+..++.|++.||.|||++||
T Consensus        56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  135 (295)
T 3ugc_A           56 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY  135 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            4578999999999999999999998653  568999999964 9999998876679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++........                                             
T Consensus       136 vH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------------  170 (295)
T 3ugc_A          136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF---------------------------------------------  170 (295)
T ss_dssp             CCSCCSGGGEEEEETTEEEECCCCSCC-----------------------------------------------------
T ss_pred             ccCCCCHhhEEEcCCCeEEEccCcccccccCCcce---------------------------------------------
Confidence            99999999999999999999999998654211000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 ........+|..|+|||++.+.. ++.++||||+||+
T Consensus       171 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  206 (295)
T 3ugc_A          171 -------------------------------------------FKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVV  206 (295)
T ss_dssp             ------------------------------------------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             -------------------------------------------eeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHH
Confidence                                                       00001234678899999998765 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|..||......  ...   ..+......................       ......++.+.+|+.+||+.||+
T Consensus       207 l~~l~~g~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~  274 (295)
T 3ugc_A          207 LYELFTYIEKSKSPPAE--FMR---MIGNDKQGQMIVFHLIELLKNNGRL-------PRPDGCPDEIYMIMTECWNNNVN  274 (295)
T ss_dssp             HHHHHHTTCTTCSHHHH--HHH---HHCTTCCTHHHHHHHHHHHHTTCCC-------CCCTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHHHhcccccCCChHH--HHh---hhcCccccchhHHHHHHHHhccCcC-------CCCcCcCHHHHHHHHHHcCCChh
Confidence            99999999998654221  111   0110000000000000000000000       00112356789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.|+++
T Consensus       275 ~Rps~~el~~  284 (295)
T 3ugc_A          275 QRPSFRDLAL  284 (295)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCCCHHHHHH
Confidence            9999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.8e-34  Score=287.35  Aligned_cols=226  Identities=22%  Similarity=0.377  Sum_probs=164.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ...+.+|+++|+.++||||+++++++...  ..+|+||||+++ +|.+++......+++..+..++.|++.||+|||++|
T Consensus        67 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  146 (302)
T 4e5w_A           67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ  146 (302)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC
Confidence            35678999999999999999999999876  679999999975 999999766667999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |+||||||+|||++.++.+||+|||++..........                                           
T Consensus       147 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-------------------------------------------  183 (302)
T 4e5w_A          147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-------------------------------------------  183 (302)
T ss_dssp             EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEE-------------------------------------------
T ss_pred             cccCCCchheEEEcCCCCEEECcccccccccCCCcce-------------------------------------------
Confidence            9999999999999999999999999986543210000                                           


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......||..|+|||++.+.. ++.++||||+||
T Consensus       184 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  217 (302)
T 4e5w_A          184 ---------------------------------------------TVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGV  217 (302)
T ss_dssp             ---------------------------------------------ECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHH
T ss_pred             ---------------------------------------------eccCCCCCCccccCCeeecCCC-CCcchhHHHHHH
Confidence                                                         0011235788899999997765 789999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|+|++|..||....  ....   ...+......... ............       ......++.+.+|+.+||+.||
T Consensus       218 il~~l~~g~~p~~~~~--~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp  284 (302)
T 4e5w_A          218 TLHELLTYCDSDSSPM--ALFL---KMIGPTHGQMTVT-RLVNTLKEGKRL-------PCPPNCPDEVYQLMRKCWEFQP  284 (302)
T ss_dssp             HHHHHHTTTCGGGSHH--HHHH---HHHCSCCGGGHHH-HHHHHHHTTCCC-------CCCTTCCHHHHHHHHHTTCSSG
T ss_pred             HHHHHHHccCCCcchh--hHHh---hccCCcccccCHH-HHHHHHhccCCC-------CCCCCCCHHHHHHHHHHcCCCC
Confidence            9999999998864321  1111   1111100000000 000000000000       0011235788999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      .+|||+.|+++
T Consensus       285 ~~Rps~~~ll~  295 (302)
T 4e5w_A          285 SNRTSFQNLIE  295 (302)
T ss_dssp             GGSCCHHHHHH
T ss_pred             CCCCCHHHHHH
Confidence            99999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-33  Score=284.16  Aligned_cols=219  Identities=18%  Similarity=0.170  Sum_probs=167.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEE-EEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~-~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++|+|++..+.. +......|+||||++++|.+++......+++..++.++.|++.||.|||++||+
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv  127 (296)
T 4hgt_A           48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI  127 (296)
T ss_dssp             CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3467899999999998876665554 467789999999998899999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEE---ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl---~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||+|||+   +.++.+||+|||+++..........                                         
T Consensus       128 H~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~-----------------------------------------  166 (296)
T 4hgt_A          128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH-----------------------------------------  166 (296)
T ss_dssp             CSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB-----------------------------------------
T ss_pred             cCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc-----------------------------------------
Confidence            99999999999   7888999999999875532110000                                         


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                 .+........||+.|+|||++.+.. ++.++||||+|
T Consensus       167 -------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  202 (296)
T 4hgt_A          167 -------------------------------------------IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLG  202 (296)
T ss_dssp             -------------------------------------------CCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             -------------------------------------------CCCCcccccCCCccccchHHhcCCC-CCchhHHHHHH
Confidence                                                       0001123457899999999998765 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSEI---DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~---~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|+|++|+.||.+.+..   ..+..+....-.                        ..........++.+.+|+.+||
T Consensus       203 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~~l  258 (296)
T 4hgt_A          203 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------------------------TPIEVLCKGYPSEFATYLNFCR  258 (296)
T ss_dssp             HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH------------------------SCHHHHTTTSCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCcccchhhhhhhhhhhhccccc------------------------chhhhhhccCCHHHHHHHHHHH
Confidence            9999999999999865321   112222111000                        0001111234578999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy10954        331 ALDPKQRVSAKTILQ  345 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~  345 (562)
                      +.||++|||++++++
T Consensus       259 ~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          259 SLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TSCTTCCCCHHHHHH
T ss_pred             hcCCCCCCCHHHHHH
Confidence            999999999999885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.9e-34  Score=293.35  Aligned_cols=210  Identities=23%  Similarity=0.362  Sum_probs=170.7

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC---------------CCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV---------------PVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~---------------~l~e~~i~~i~~   81 (562)
                      ..+.+|+++|+.+ +||||+++++++...+.+|+||||+.+ +|.+++.....               .+++..+..++.
T Consensus        85 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  164 (334)
T 2pvf_A           85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY  164 (334)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence            4578999999999 999999999999999999999999975 99999976532               389999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++........                               
T Consensus       165 qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-------------------------------  213 (334)
T 2pvf_A          165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-------------------------------  213 (334)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSE-------------------------------
T ss_pred             HHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccc-------------------------------
Confidence            9999999999999999999999999999999999999997644211000                               


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                                .......+|+.|+|||++.+..
T Consensus       214 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~  235 (334)
T 2pvf_A          214 ----------------------------------------------------------KKTTNGRLPVKWMAPEALFDRV  235 (334)
T ss_dssp             ----------------------------------------------------------ECCSCCCCCGGGCCHHHHHHCE
T ss_pred             ----------------------------------------------------------cccCCCCcccceeChHHhcCCC
Confidence                                                                      0001224678899999997654


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                       ++.++||||+||++|||++ |..||.+.+..+....+......+                            .....++
T Consensus       236 -~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  286 (334)
T 2pvf_A          236 -YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD----------------------------KPANCTN  286 (334)
T ss_dssp             -ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC----------------------------CCTTCCH
T ss_pred             -cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC----------------------------CCccCCH
Confidence             8999999999999999999 999999887766555544321100                            0012346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+.+++.+||..||.+|||+.|++++
T Consensus       287 ~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          287 ELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-33  Score=285.18  Aligned_cols=219  Identities=18%  Similarity=0.167  Sum_probs=166.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEE-EEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~-~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++|++++..+.. +..+...|+||||++++|.+++......+++..+..++.|++.||.|||++||+
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  127 (296)
T 3uzp_A           48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI  127 (296)
T ss_dssp             CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3568899999999998876655554 467788999999998899999986666799999999999999999999999999


Q ss_pred             eccCCCCcEEE---ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl---~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||+|||+   +.++.+||+|||+++..........                                         
T Consensus       128 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~-----------------------------------------  166 (296)
T 3uzp_A          128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH-----------------------------------------  166 (296)
T ss_dssp             CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB-----------------------------------------
T ss_pred             eCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc-----------------------------------------
Confidence            99999999999   4788999999999865432110000                                         


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                 .+........||+.|+|||++.+.. ++.++||||+|
T Consensus       167 -------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  202 (296)
T 3uzp_A          167 -------------------------------------------IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLG  202 (296)
T ss_dssp             -------------------------------------------CCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             -------------------------------------------cccccccccccccccCChhhhcCCC-CCcchhhHHHH
Confidence                                                       0001123457899999999998765 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSE---IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|||++|+.||.+.+.   .+.+..+.......                        .........++.+.+|+.+||
T Consensus       203 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l  258 (296)
T 3uzp_A          203 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST------------------------PIEVLCKGYPSEFATYLNFCR  258 (296)
T ss_dssp             HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS------------------------CHHHHTTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC------------------------chHHHHhhCCHHHHHHHHHHH
Confidence            999999999999986432   12222222110000                        001111234578999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy10954        331 ALDPKQRVSAKTILQ  345 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~  345 (562)
                      +.||++|||+.++++
T Consensus       259 ~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          259 SLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TSCTTCCCCHHHHHH
T ss_pred             hcCcCcCCCHHHHHH
Confidence            999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-33  Score=285.78  Aligned_cols=209  Identities=22%  Similarity=0.300  Sum_probs=167.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++||||+++++++ .....|+||||+. ++|.+++.... .+++..+..++.|++.||.|||++||+
T Consensus        62 ~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~  139 (291)
T 1xbb_A           62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV  139 (291)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            45678999999999999999999999 5678999999998 49999998753 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.........                                             
T Consensus       140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------  174 (291)
T 1xbb_A          140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---------------------------------------------  174 (291)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE---------------------------------------------
T ss_pred             cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc---------------------------------------------
Confidence            99999999999999999999999976543110000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. ++.++||||+||++
T Consensus       175 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  210 (291)
T 1xbb_A          175 -------------------------------------------KAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLM  210 (291)
T ss_dssp             -------------------------------------------EC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccCCCCceeeChHHhccCC-CChhhhHHHHHHHH
Confidence                                                       0001124578899999997654 78999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |+|++ |+.||.+.+..+....+..... +                   .        .....++.+.+++.+||..||+
T Consensus       211 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~-------------------~--------~~~~~~~~l~~li~~~l~~dp~  262 (291)
T 1xbb_A          211 WEAFSYGQKPYRGMKGSEVTAMLEKGER-M-------------------G--------CPAGCPREMYDLMNLCWTYDVE  262 (291)
T ss_dssp             HHHHTTTCCSSTTCCHHHHHHHHHTTCC-C-------------------C--------CCTTCCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHcCCC-C-------------------C--------CCCCCCHHHHHHHHHHcCCChh
Confidence            99999 9999998877655544432110 0                   0        0112356789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.++++
T Consensus       263 ~Rps~~~l~~  272 (291)
T 1xbb_A          263 NRPGFAAVEL  272 (291)
T ss_dssp             TSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999885

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.8e-35  Score=300.56  Aligned_cols=225  Identities=21%  Similarity=0.260  Sum_probs=166.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+.+|+.++||||+++++++...+..|+||||+++ +|.+++....   ..+++..+..++.|++.||.|||++
T Consensus        79 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  158 (321)
T 2qkw_B           79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR  158 (321)
T ss_dssp             HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC
Confidence            35678999999999999999999999999999999999974 9998886543   2489999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++.......                                            
T Consensus       159 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------  194 (321)
T 2qkw_B          159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ--------------------------------------------  194 (321)
T ss_dssp             TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC--------------------------------------------
T ss_pred             CeecCCCCHHHEEECCCCCEEEeecccccccccccc--------------------------------------------
Confidence            999999999999999999999999998764321100                                            


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                   ........||+.|+|||++.+.. ++.++||||+|
T Consensus       195 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  228 (321)
T 2qkw_B          195 ---------------------------------------------THLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFG  228 (321)
T ss_dssp             ---------------------------------------------CCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHH
T ss_pred             ---------------------------------------------cccccccCCCccccCHHHhcCCC-CCcccchHhHH
Confidence                                                         00011235789999999997654 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQL---FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l---~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|||++|+.||.+....+..   ..........   .....     ........       ........+.+++.+||
T Consensus       229 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~~~~~~-------~~~~~~~~l~~li~~~l  293 (321)
T 2qkw_B          229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG---QLEQI-----VDPNLADK-------IRPESLRKFGDTAVKCL  293 (321)
T ss_dssp             HHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT---CCCSS-----SSSSCTTC-------SCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc---cHHHh-----cChhhccc-------cCHHHHHHHHHHHHHHc
Confidence            9999999999999765432110   0000000000   00000     00000000       00111346789999999


Q ss_pred             ccCCCCCCCHHHHHcCc
Q psy10954        331 ALDPKQRVSAKTILQHE  347 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp  347 (562)
                      +.||++|||+.|+++|-
T Consensus       294 ~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          294 ALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CSSGGGSCCHHHHHHHH
T ss_pred             CCCcccCcCHHHHHHHH
Confidence            99999999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-33  Score=305.07  Aligned_cols=206  Identities=24%  Similarity=0.389  Sum_probs=167.3

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCC-EEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+.+|+.+|++++||||+++++++.... .+|+|||||.+ +|.++++..+. .+++..+..++.|++.||+|||++
T Consensus       229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  308 (450)
T 1k9a_A          229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN  308 (450)
T ss_dssp             TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567899999999999999999999987664 79999999975 99999986543 379999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+|||++.++.+||+|||+++.....                                              
T Consensus       309 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----------------------------------------------  342 (450)
T 1k9a_A          309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------------------------------------------  342 (450)
T ss_dssp             TEECSCCCGGGEEECTTSCEEECCCTTCEECC------------------------------------------------
T ss_pred             CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----------------------------------------------
Confidence            9999999999999999999999999987532100                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                      .....+|+.|+|||++.+.. |+.++||||+|
T Consensus       343 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG  373 (450)
T 1k9a_A          343 ------------------------------------------------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFG  373 (450)
T ss_dssp             ----------------------------------------------------CCCTTTSCHHHHHSSC-CCHHHHHHHHH
T ss_pred             ------------------------------------------------ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHH
Confidence                                                            00113577899999998654 89999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++|||++ |+.||.+.+..+....+......+                 .           ....++.+.+|+.+||+.
T Consensus       374 ~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----------------~-----------p~~~~~~l~~li~~cl~~  425 (450)
T 1k9a_A          374 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-----------------A-----------PDGCPPAVYDVMKNCWHL  425 (450)
T ss_dssp             HHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-----------------C-----------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------C-----------CCcCCHHHHHHHHHHcCC
Confidence            99999998 999998877655554443211000                 0           012356789999999999


Q ss_pred             CCCCCCCHHHHHc
Q psy10954        333 DPKQRVSAKTILQ  345 (562)
Q Consensus       333 DP~~R~Ta~elL~  345 (562)
                      ||++|||+.++++
T Consensus       426 dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          426 DAATRPTFLQLRE  438 (450)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.6e-35  Score=295.80  Aligned_cols=225  Identities=23%  Similarity=0.274  Sum_probs=167.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT--PVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~--~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ....+.+|+.+|+.++||||+++++++...+..|+||||++ ++|.+++...  ...+++..+..++.|++.||.|||++
T Consensus        73 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  152 (307)
T 2nru_A           73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN  152 (307)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            35668899999999999999999999999999999999996 5999998643  23589999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+||+++.++.+||+|||+++........                                           
T Consensus       153 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-------------------------------------------  189 (307)
T 2nru_A          153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT-------------------------------------------  189 (307)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-------------------------------------------
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-------------------------------------------
Confidence            9999999999999999999999999987643211000                                           


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ......+||+.|+|||++.+  .++.++||||+|
T Consensus       190 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG  221 (307)
T 2nru_A          190 ----------------------------------------------VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFG  221 (307)
T ss_dssp             ----------------------------------------------EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCCCcCcCChHHhcC--CCCccchhHHHH
Confidence                                                          00112368999999999865  378999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|+|++|.+||.+......+..+........... ...     .....+.        .....+..+.+++.+||..|
T Consensus       222 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~--------~~~~~~~~l~~li~~cl~~~  287 (307)
T 2nru_A          222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI-EDY-----IDKKMND--------ADSTSVEAMYSVASQCLHEK  287 (307)
T ss_dssp             HHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH-HHH-----SCSSCSC--------CCHHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh-hhh-----ccccccc--------cchHHHHHHHHHHHHHcCCC
Confidence            999999999999987654332222222111100000 000     0000000        00011246789999999999


Q ss_pred             CCCCCCHHHHHcC
Q psy10954        334 PKQRVSAKTILQH  346 (562)
Q Consensus       334 P~~R~Ta~elL~H  346 (562)
                      |++|||+.+++++
T Consensus       288 p~~Rps~~~l~~~  300 (307)
T 2nru_A          288 KNKRPDIKKVQQL  300 (307)
T ss_dssp             TTTSCCHHHHHHH
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.9e-34  Score=292.18  Aligned_cols=214  Identities=15%  Similarity=0.247  Sum_probs=167.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+++.++||||+++++++.....+|+||||+.+ +|.+++...+..+++..+..++.|++.||+|||++||+
T Consensus        73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~  152 (319)
T 2y4i_B           73 LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL  152 (319)
T ss_dssp             CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34567899999999999999999999999999999999974 99999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++ ++.+||+|||+++.........                                             
T Consensus       153 H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~---------------------------------------------  186 (319)
T 2y4i_B          153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR---------------------------------------------  186 (319)
T ss_dssp             CCCCCSTTEEEC---CCEECCCSCCC------------------------------------------------------
T ss_pred             ccCCChhhEEEe-CCCEEEeecCCccccccccccc---------------------------------------------
Confidence            999999999998 7899999999876432100000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC--------CCCCCchhh
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--------AKVYSTTVD  248 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~--------~~~y~~~~D  248 (562)
                                                               .........||+.|+|||++.+        ...|+.++|
T Consensus       187 -----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~D  225 (319)
T 2y4i_B          187 -----------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD  225 (319)
T ss_dssp             ------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHH
T ss_pred             -----------------------------------------cccccccCCCcccccChHHhhhccccccccccCCCchhh
Confidence                                                     0001122357888999998865        335899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |||+||++|||++|+.||.+.+.......+........                    .       ....+..+.+++.+
T Consensus       226 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~-------~~~~~~~l~~li~~  278 (319)
T 2y4i_B          226 VFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL--------------------S-------QIGMGKEISDILLF  278 (319)
T ss_dssp             HHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC--------------------C-------CSSCCTTHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC--------------------C-------cCCCCHHHHHHHHH
Confidence            99999999999999999998887666555533211000                    0       00123568899999


Q ss_pred             ccccCCCCCCCHHHHHc
Q psy10954        329 IMALDPKQRVSAKTILQ  345 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~  345 (562)
                      ||..||++|||+.++++
T Consensus       279 ~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          279 CWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHCSSTTTSCCHHHHHH
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-34  Score=296.10  Aligned_cols=226  Identities=20%  Similarity=0.247  Sum_probs=166.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC-
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR-   93 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~---~~l~e~~i~~i~~qll~aL~yLH~~-   93 (562)
                      ..+.+|+++++.++||||+++++++......|+|||||.+ +|.+++....   ..+++..+..++.|++.||+|||++ 
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  151 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC  151 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3578999999999999999999999999999999999975 9999997643   2489999999999999999999999 


Q ss_pred             --CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         94 --RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        94 --gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                        ||+||||||+|||++.++.+||+|||+++.......                                          
T Consensus       152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------  189 (326)
T 3uim_A          152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------------------------------------------  189 (326)
T ss_dssp             SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS------------------------------------------
T ss_pred             CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc------------------------------------------
Confidence              999999999999999999999999998764421100                                          


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      .......||+.|+|||++.+.. ++.++||||
T Consensus       190 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s  220 (326)
T 3uim_A          190 ------------------------------------------------HVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFG  220 (326)
T ss_dssp             ------------------------------------------------CEECCCCSCGGGCCHHHHHHSE-ECHHHHHHH
T ss_pred             ------------------------------------------------cccccccCCcCccCHHHhccCC-CCccccchh
Confidence                                                            0011235899999999997655 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        252 AGCIFSEMITKKTLFAGDS----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      +||++|+|++|+.||....    ....+......  ............     .....   .    ........+.+++.
T Consensus       221 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~~---~----~~~~~~~~l~~li~  286 (326)
T 3uim_A          221 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKG--LLKEKKLEALVD-----VDLQG---N----YKDEEVEQLIQVAL  286 (326)
T ss_dssp             HHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT--TTSSCCSTTSSC-----TTCTT---S----CCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCcccccccccccchhHHHHHHH--HhhchhhhhhcC-----hhhcc---c----cCHHHHHHHHHHHH
Confidence            9999999999999995211    00001111110  000000000000     00000   0    00011256889999


Q ss_pred             HccccCCCCCCCHHHHHcCccc
Q psy10954        328 KIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      +||+.||++|||+.|+++|-.-
T Consensus       287 ~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          287 LCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhCcCCccCCCHHHHHHHhcC
Confidence            9999999999999999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.9e-34  Score=289.73  Aligned_cols=209  Identities=25%  Similarity=0.347  Sum_probs=160.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..++.+|+||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+|
T Consensus        79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  157 (309)
T 2h34_A           79 TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATH  157 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCc
Confidence            5678999999999999999999999999999999999986 999998764 36999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||++........                                                
T Consensus       158 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------  189 (309)
T 2h34_A          158 RDVKPENILVSADDFAYLVDFGIASATTDEKL------------------------------------------------  189 (309)
T ss_dssp             SCCCGGGEEECTTSCEEECSCCC---------------------------------------------------------
T ss_pred             CCCChHHEEEcCCCCEEEecCccCcccccccc------------------------------------------------
Confidence            99999999999999999999998754321000                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......||+.|+|||++.+.. ++.++||||+||++|
T Consensus       190 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  226 (309)
T 2h34_A          190 ------------------------------------------TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLY  226 (309)
T ss_dssp             -------------------------------------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHH
T ss_pred             ------------------------------------------ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHH
Confidence                                                      0011235789999999987654 899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      +|++|+.||.+.+.. .+...+.......                         .......++.+.++|.+||..||++|
T Consensus       227 ~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~R  280 (309)
T 2h34_A          227 ECLTGSPPYQGDQLS-VMGAHINQAIPRP-------------------------STVRPGIPVAFDAVIARGMAKNPEDR  280 (309)
T ss_dssp             HHHHSSCSSCSCHHH-HHHHHHHSCCCCG-------------------------GGTSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred             HHHHCCCCCCCchHH-HHHHHhccCCCCc-------------------------cccCCCCCHHHHHHHHHhccCCHHHH
Confidence            999999999887654 3333322111000                         00112335678999999999999999


Q ss_pred             C-CHHHHHc
Q psy10954        338 V-SAKTILQ  345 (562)
Q Consensus       338 ~-Ta~elL~  345 (562)
                      | |++++++
T Consensus       281 p~s~~~l~~  289 (309)
T 2h34_A          281 YVTCGDLSA  289 (309)
T ss_dssp             CSSHHHHHH
T ss_pred             HHhHHHHHH
Confidence            9 7777764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-35  Score=309.47  Aligned_cols=229  Identities=24%  Similarity=0.353  Sum_probs=165.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC--EEEEEeecCcC-CHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~--~i~lV~Ey~~~-~L~~~i~~~~--~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+++|++++||||+++++++....  ..|+|||||.+ +|.+++....  ..+++..++.++.|++.||+|||+
T Consensus        51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  130 (396)
T 4eut_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (396)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456779999999999999999999998764  78999999975 9999987543  239999999999999999999999


Q ss_pred             CCceeccCCCCcEEE----ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         93 RRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        93 ~gIiHRDLKP~NILl----~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      +||+||||||+|||+    +.++.+||+|||+++.....                                         
T Consensus       131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~-----------------------------------------  169 (396)
T 4eut_A          131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-----------------------------------------  169 (396)
T ss_dssp             TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG-----------------------------------------
T ss_pred             CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC-----------------------------------------
Confidence            999999999999998    55666888888887543210                                         


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-------C
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-------K  241 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-------~  241 (562)
                                                                         ......+||+.|+|||++.+.       .
T Consensus       170 ---------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  198 (396)
T 4eut_A          170 ---------------------------------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQK  198 (396)
T ss_dssp             ---------------------------------------------------GGSSCSSSCCTTCCHHHHHHHCC--CHHH
T ss_pred             ---------------------------------------------------CccccccCCccccCHHHhhcccccccccc
Confidence                                                               001223578888888887541       3


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCCCCCCCCCCCCCC----ccCCCCCCCccchhh
Q psy10954        242 VYSTTVDIWSAGCIFSEMITKKTLFAGD----SEIDQLFRIFRTLGTPHEDVWPGVSKLPI----YKTDFPEWRPKKFSE  313 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLltG~~pF~~~----~~~~~l~~i~~~lg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  313 (562)
                      .|+.++||||+||++|||++|+.||.+.    ...+.+..+..   ..+...+........    +....+...  .   
T Consensus       199 ~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~---  270 (396)
T 4eut_A          199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GKPSGAISGVQKAENGPIDWSGDMPVSC--S---  270 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---SCCTTCCEEEECSTTCCEEEESSCCTTC--S---
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---CCCcccchhheeccCCCcccCccCCccc--c---
Confidence            4788999999999999999999999743    23344444443   222222222211100    000111000  0   


Q ss_pred             hcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        314 ILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       314 ~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +....+..+.+++.+||+.||++|+|++|++++
T Consensus       271 l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             SCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            001123567899999999999999999988653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.3e-34  Score=286.34  Aligned_cols=206  Identities=25%  Similarity=0.407  Sum_probs=165.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe----------------CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV----------------DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYL   80 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~----------------~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~   80 (562)
                      ..+.+|+++|+.++||||+++++++..                ...+|+||||+++ +|.+++.... ..+++..+..++
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~  128 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF  128 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence            467899999999999999999999864                3458999999986 9999997543 469999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||++.......                                
T Consensus       129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------------------------------  176 (284)
T 2a19_B          129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--------------------------------  176 (284)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--------------------------------
T ss_pred             HHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc--------------------------------
Confidence            999999999999999999999999999999999999999875432100                                


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                  ......||+.|+|||++.+.
T Consensus       177 ------------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  196 (284)
T 2a19_B          177 ------------------------------------------------------------KRTRSKGTLRYMSPEQISSQ  196 (284)
T ss_dssp             ------------------------------------------------------------CCCCCCSCCTTSCHHHHHCS
T ss_pred             ------------------------------------------------------------cccccCCcccccChhhhccC
Confidence                                                                        00123578999999999875


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        241 KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                      . ++.++||||+||++|+|++|..||....  .....+..  +.                             .....++
T Consensus       197 ~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~--~~-----------------------------~~~~~~~  242 (284)
T 2a19_B          197 D-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD--GI-----------------------------ISDIFDK  242 (284)
T ss_dssp             C-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--TC-----------------------------CCTTSCH
T ss_pred             C-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--cc-----------------------------ccccCCH
Confidence            4 8999999999999999999998875321  11111110  00                             0012346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHcCcccc
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      .+.+++.+||..||++|||+.|+++|.+.-
T Consensus       243 ~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            789999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.8e-34  Score=307.96  Aligned_cols=208  Identities=25%  Similarity=0.415  Sum_probs=169.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|+.++|||||++++++. ...+|+|||||. ++|.++++... ..+++..+..++.|++.||+|||++||
T Consensus       227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  305 (454)
T 1qcf_A          227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY  305 (454)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            457889999999999999999999986 667999999997 59999997543 258899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++......  .                     .                      
T Consensus       306 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~---------------------~----------------------  340 (454)
T 1qcf_A          306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE--Y---------------------T----------------------  340 (454)
T ss_dssp             CCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--H---------------------H----------------------
T ss_pred             cCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--e---------------------e----------------------
Confidence            999999999999999999999999986542100  0                     0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+|..|+|||++.+.. |+.++||||+||+
T Consensus       341 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~  374 (454)
T 1qcf_A          341 ---------------------------------------------AREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGIL  374 (454)
T ss_dssp             ---------------------------------------------TTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             ---------------------------------------------ccCCCcccccccCHHHhccCC-CCcHHHHHhHHHH
Confidence                                                         001123577899999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+.+..+......+..                            ...++.+.+|+.+||..||
T Consensus       375 l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~----------------------------~~~~~~l~~li~~cl~~dp  426 (454)
T 1qcf_A          375 LMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP----------------------------ENCPEELYNIMMRCWKNRP  426 (454)
T ss_dssp             HHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC----------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------------------------CCCCHHHHHHHHHHccCCh
Confidence            999999 99999998887776666543211100                            1124678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++++++
T Consensus       427 ~~RPt~~~i~~  437 (454)
T 1qcf_A          427 EERPTFEYIQS  437 (454)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-33  Score=287.74  Aligned_cols=210  Identities=21%  Similarity=0.316  Sum_probs=163.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCC-----EEEEEeecCcC-CHHHHHhh-----CCCCCCHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQ-DLKDFLQT-----TPVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~-----~i~lV~Ey~~~-~L~~~i~~-----~~~~l~e~~i~~i~~qll~aL   87 (562)
                      ..+.+|+.+|+.++||||+++++++....     ..|+||||+.+ +|.+++..     ....+++..++.++.|++.||
T Consensus        81 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL  160 (313)
T 3brb_A           81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM  160 (313)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHH
Confidence            45789999999999999999999998654     35999999985 99999853     234699999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchh
Q psy10954         88 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  167 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~E  167 (562)
                      .|||++||+||||||+|||++.++.+||+|||+++.......          +                           
T Consensus       161 ~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----------~---------------------------  203 (313)
T 3brb_A          161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY----------Y---------------------------  203 (313)
T ss_dssp             HHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------------------------------------
T ss_pred             HHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccc----------c---------------------------
Confidence            999999999999999999999999999999998764421100          0                           


Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                                                                          .......+|+.|+|||++.+.. ++.++
T Consensus       204 ----------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~  230 (313)
T 3brb_A          204 ----------------------------------------------------RQGRIAKMPVKWIAIESLADRV-YTSKS  230 (313)
T ss_dssp             -----------------------------------------------------------CCGGGSCHHHHHSSC-CCHHH
T ss_pred             ----------------------------------------------------CcccccCCCccccCchhhcCCC-ccchh
Confidence                                                                0001224678899999998654 89999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        248 DIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       248 DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      ||||+||++|+|++ |.+||.+....+....+.......                            .....++.+.+++
T Consensus       231 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li  282 (313)
T 3brb_A          231 DVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK----------------------------QPEDCLDELYEIM  282 (313)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----------------------------CBTTCCHHHHHHH
T ss_pred             hhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC----------------------------CCccccHHHHHHH
Confidence            99999999999999 899998887665555544321100                            0112346789999


Q ss_pred             HHccccCCCCCCCHHHHHcC
Q psy10954        327 SKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+||..||++|||+.+++++
T Consensus       283 ~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          283 YSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-34  Score=303.43  Aligned_cols=213  Identities=21%  Similarity=0.319  Sum_probs=161.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEE-eCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~-~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|++++||||+++++++. .++..|+||||+.+ +|.+++......+++..+..++.|++.||+|||++||
T Consensus       134 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  213 (373)
T 3c1x_A          134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF  213 (373)
T ss_dssp             HHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            356789999999999999999999865 45688999999985 9999998776678999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++........                      .                      
T Consensus       214 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~----------------------~----------------------  249 (373)
T 3c1x_A          214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD----------------------S----------------------  249 (373)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCC---------------------------------------------------------
T ss_pred             ecCccchheEEECCCCCEEEeeccccccccccccc----------------------c----------------------
Confidence            99999999999999999999999998644211000                      0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 ........+|+.|+|||++.+.. |+.++||||+||+
T Consensus       250 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~i  285 (373)
T 3c1x_A          250 -------------------------------------------VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVL  285 (373)
T ss_dssp             ---------------------------------------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHH
Confidence                                                       00011235688999999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |.+||.+.+..+....+.......                 .           ....++.+.+++.+||+.||
T Consensus       286 l~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-----------------~-----------p~~~~~~l~~li~~cl~~dp  337 (373)
T 3c1x_A          286 LWELMTRGAPPYPDVNTFDITVYLLQGRRLL-----------------Q-----------PEYCPDPLYEVMLKCWHPKA  337 (373)
T ss_dssp             HHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-----------------C-----------CTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-----------------C-----------CCCCCHHHHHHHHHHcCCCh
Confidence            999999 788888766544444333211000                 0           01234678999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||+.|++++
T Consensus       338 ~~RPs~~ell~~  349 (373)
T 3c1x_A          338 EMRPSFSELVSR  349 (373)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.7e-34  Score=292.29  Aligned_cols=215  Identities=25%  Similarity=0.327  Sum_probs=165.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEE--eCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~--~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++|++++||||+++++++.  ....+|+||||++ ++|.+++......+++..+..++.|++.||.|||++||
T Consensus        69 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  148 (327)
T 3lxl_A           69 RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC  148 (327)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45789999999999999999999987  4567999999996 59999998755579999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.........                                            
T Consensus       149 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--------------------------------------------  184 (327)
T 3lxl_A          149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY--------------------------------------------  184 (327)
T ss_dssp             ECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEE--------------------------------------------
T ss_pred             cCCCCChhhEEECCCCCEEEcccccceecccCCccc--------------------------------------------
Confidence            999999999999999999999999986543110000                                            


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. ++.++||||+||+
T Consensus       185 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  219 (327)
T 3lxl_A          185 --------------------------------------------VVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVV  219 (327)
T ss_dssp             --------------------------------------------ECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHH
T ss_pred             --------------------------------------------eeeccCCccccccCHHHhccCC-CChHHhHHHHHHH
Confidence                                                        0011235788899999997654 7999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHH-----------HHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        256 FSEMITKKTLFAGDSEIDQL-----------FRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l-----------~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      +|+|++|..||.+.......           ..+.......                 ...       ......++.+.+
T Consensus       220 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~-------~~~~~~~~~l~~  275 (327)
T 3lxl_A          220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG-----------------QRL-------PAPPACPAEVHE  275 (327)
T ss_dssp             HHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT-----------------CCC-------CCCTTCCHHHHH
T ss_pred             HHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc-----------------cCC-------CCCCcccHHHHH
Confidence            99999999999754322100           0000000000                 000       001223577899


Q ss_pred             HHHHccccCCCCCCCHHHHHcC
Q psy10954        325 VFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~H  346 (562)
                      |+.+||+.||++|||+.|++++
T Consensus       276 li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          276 LMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=315.52  Aligned_cols=211  Identities=22%  Similarity=0.305  Sum_probs=169.2

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+++|+.++|||||++++++.. +.+|+|||||.+ +|.+++......+++..+..++.|++.||+|||++||
T Consensus       379 ~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  457 (613)
T 2ozo_A          379 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF  457 (613)
T ss_dssp             THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            35678899999999999999999999976 569999999975 9999998766679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+++.........                     .                      
T Consensus       458 iHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~---------------------~----------------------  494 (613)
T 2ozo_A          458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY---------------------T----------------------  494 (613)
T ss_dssp             CCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------------------------------------------
T ss_pred             EcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee---------------------e----------------------
Confidence            999999999999999999999999987543110000                     0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+|+.|+|||++.+.. |+.++||||+||+
T Consensus       495 ---------------------------------------------~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~  528 (613)
T 2ozo_A          495 ---------------------------------------------ARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVT  528 (613)
T ss_dssp             ----------------------------------------------------CCTTSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             ---------------------------------------------eccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHH
Confidence                                                         001124578899999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+.+..+......+                            .....++.+.+|+.+||..||
T Consensus       529 l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~dP  580 (613)
T 2ozo_A          529 MWEALSYGQKPYKKMKGPEVMAFIEQGKRME----------------------------CPPECPPELYALMSDCWIYKW  580 (613)
T ss_dssp             HHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHTTCSST
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCcCCHHHHHHHHHHcCCCh
Confidence            999998 999999988777666554321000                            001235678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.++++
T Consensus       581 ~~RPs~~~l~~  591 (613)
T 2ozo_A          581 EDRPDFLTVEQ  591 (613)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.4e-34  Score=310.36  Aligned_cols=209  Identities=25%  Similarity=0.374  Sum_probs=169.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|++++|||||++++++.....+|||||||. ++|.++++... ..+++..+..++.|++.||+|||++||
T Consensus       260 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i  339 (495)
T 1opk_A          260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF  339 (495)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4568899999999999999999999999999999999998 59999998643 458999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++......  .                     .                      
T Consensus       340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~---------------------~----------------------  374 (495)
T 1opk_A          340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--Y---------------------T----------------------  374 (495)
T ss_dssp             ECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--E---------------------E----------------------
T ss_pred             ccCCCChhhEEECCCCcEEEeecccceeccCCc--e---------------------e----------------------
Confidence            999999999999999999999999986542100  0                     0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+|..|+|||++.+.. |+.++||||+||+
T Consensus       375 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~  408 (495)
T 1opk_A          375 ---------------------------------------------AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVL  408 (495)
T ss_dssp             ---------------------------------------------CCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHH
T ss_pred             ---------------------------------------------ecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHH
Confidence                                                         001124577899999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |..||.+.+..+....+......+                            .....++.+.+|+.+||+.||
T Consensus       409 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP  460 (495)
T 1opk_A          409 LWEIATYGMSPYPGIDLSQVYELLEKDYRME----------------------------RPEGCPEKVYELMRACWQWNP  460 (495)
T ss_dssp             HHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCcCh
Confidence            999999 999999877655444332211000                            001234678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||+.++++
T Consensus       461 ~~RPs~~el~~  471 (495)
T 1opk_A          461 SDRPSFAEIHQ  471 (495)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=293.50  Aligned_cols=220  Identities=22%  Similarity=0.412  Sum_probs=148.2

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEE--------eCCEEEEEeecCcCCHHHHHhh--CCCCCCHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIP--------VDFKLFLVFEFLRQDLKDFLQT--TPVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~--------~~~~i~lV~Ey~~~~L~~~i~~--~~~~l~e~~i~~i~~qll~a   86 (562)
                      ...+.+|+.+|+++. ||||+++++++.        ....+|+||||+.++|.+++..  ....+++..++.++.|++.|
T Consensus        69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~  148 (337)
T 3ll6_A           69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA  148 (337)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHH
Confidence            345789999999995 999999999994        3346899999999999998865  34569999999999999999


Q ss_pred             HHHHHHCC--ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccccc
Q psy10954         87 LRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  164 (562)
Q Consensus        87 L~yLH~~g--IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~i  164 (562)
                      |.|||++|  |+||||||+|||++.++.+||+|||+++.........        +.+       .              
T Consensus       149 l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~-------~--------------  199 (337)
T 3ll6_A          149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS--------WSA-------Q--------------  199 (337)
T ss_dssp             HHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------------------------
T ss_pred             HHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccc--------ccc-------c--------------
Confidence            99999999  9999999999999999999999999987653211000        000       0              


Q ss_pred             chhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc--CCCC
Q psy10954        165 FSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKV  242 (562)
Q Consensus       165 l~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~--~~~~  242 (562)
                                                                        ...........+||+.|+|||++.  ....
T Consensus       200 --------------------------------------------------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  229 (337)
T 3ll6_A          200 --------------------------------------------------RRALVEEEITRNTTPMYRTPEIIDLYSNFP  229 (337)
T ss_dssp             --------------------------------------------------------------------------CCTTSC
T ss_pred             --------------------------------------------------ccccchhhccccCCCCcCChhhhhccccCC
Confidence                                                              000000112346899999999984  3345


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHH
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLA  322 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  322 (562)
                      ++.++||||+||++|+|++|+.||.+......+...   ..                   .+         .....+..+
T Consensus       230 ~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~-------------------~~---------~~~~~~~~~  278 (337)
T 3ll6_A          230 IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---YS-------------------IP---------PHDTQYTVF  278 (337)
T ss_dssp             SSHHHHHHHHHHHHHHHHHSSCCC---------------CC-------------------CC---------TTCCSSGGG
T ss_pred             CChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---cc-------------------CC---------cccccchHH
Confidence            889999999999999999999999765443211110   00                   00         001123457


Q ss_pred             HHHHHHccccCCCCCCCHHHHHcCc
Q psy10954        323 VDVFSKIMALDPKQRVSAKTILQHE  347 (562)
Q Consensus       323 ~dLi~~mL~~DP~~R~Ta~elL~Hp  347 (562)
                      .+|+.+||+.||++|||+.|+++|-
T Consensus       279 ~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          279 HSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHH
Confidence            8999999999999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-33  Score=282.58  Aligned_cols=208  Identities=22%  Similarity=0.371  Sum_probs=167.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|+.++||||+++++++. .+..|+||||+. ++|.+++.... ..+++..+..++.|++.||+|||++||
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  130 (279)
T 1qpc_A           52 PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY  130 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456789999999999999999999986 456899999996 59999986532 258999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||++........                                              
T Consensus       131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------  164 (279)
T 1qpc_A          131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----------------------------------------------  164 (279)
T ss_dssp             ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE----------------------------------------------
T ss_pred             eccCCCHhhEEEcCCCCEEECCCcccccccCccc----------------------------------------------
Confidence            9999999999999999999999998764421100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......+|+.|+|||++.+.. ++.++||||+||+
T Consensus       165 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  199 (279)
T 1qpc_A          165 --------------------------------------------TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGIL  199 (279)
T ss_dssp             --------------------------------------------ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCCCccCccChhhhccCC-CCchhhhHHHHHH
Confidence                                                        0001224578899999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+.+..+.......                            .....++.+.+++.+||..||
T Consensus       200 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p  251 (279)
T 1qpc_A          200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMV----------------------------RPDNCPEELYQLMRLCWKERP  251 (279)
T ss_dssp             HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCcccCHHHHHHHHhcccCCC----------------------------CcccccHHHHHHHHHHhccCh
Confidence            999999 999999888776665554321100                            001234678999999999999


Q ss_pred             CCCCCHHHHHc
Q psy10954        335 KQRVSAKTILQ  345 (562)
Q Consensus       335 ~~R~Ta~elL~  345 (562)
                      ++|||++++++
T Consensus       252 ~~Rps~~~l~~  262 (279)
T 1qpc_A          252 EDRPTFDYLRS  262 (279)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hhCCCHHHHHH
Confidence            99999999885

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=287.77  Aligned_cols=205  Identities=27%  Similarity=0.426  Sum_probs=157.9

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHH-
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHS-   92 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~yLH~-   92 (562)
                      ....+.+|+++|++++||||+++++++.  +..|+||||+++ +|.+++.....  .+++..+..++.|++.||.|||+ 
T Consensus        44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  121 (307)
T 2eva_A           44 ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM  121 (307)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456789999999999999999999876  458999999975 99999976542  37889999999999999999999 


Q ss_pred             --CCceeccCCCCcEEEccCCC-eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         93 --RRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        93 --~gIiHRDLKP~NILl~~~~~-vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                        +||+||||||+|||++.++. +||+|||++......                                          
T Consensus       122 ~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------------------------------------------  159 (307)
T 2eva_A          122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------------------------------------------  159 (307)
T ss_dssp             SSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------------------------------------------
T ss_pred             CCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------------------------------------------
Confidence              89999999999999988886 799999986432100                                          


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                          .....||+.|+|||++.+.. ++.++||
T Consensus       160 ----------------------------------------------------~~~~~gt~~y~aPE~~~~~~-~~~~~Di  186 (307)
T 2eva_A          160 ----------------------------------------------------MTNNKGSAAWMAPEVFEGSN-YSEKCDV  186 (307)
T ss_dssp             ---------------------------------------------------------CCTTSSCHHHHTCCC-CCTHHHH
T ss_pred             ----------------------------------------------------cccCCCCCceEChhhhCCCC-CCcHHHH
Confidence                                                                01124789999999997654 8999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSE--IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      ||+||++|||++|+.||.....  ......+..  +..+                  .        .....++.+.+++.
T Consensus       187 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~------------------~--------~~~~~~~~l~~li~  238 (307)
T 2eva_A          187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRP------------------P--------LIKNLPKPIESLMT  238 (307)
T ss_dssp             HHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCCC------------------C--------CBTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCCC------------------C--------cccccCHHHHHHHH
Confidence            9999999999999999975432  222222211  1100                  0        11223567899999


Q ss_pred             HccccCCCCCCCHHHHHcC
Q psy10954        328 KIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~H  346 (562)
                      +||+.||++|||++|++++
T Consensus       239 ~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          239 RCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCChhhCcCHHHHHHH
Confidence            9999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-33  Score=315.51  Aligned_cols=209  Identities=22%  Similarity=0.303  Sum_probs=167.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||++++++.. ...|+|||||.+ +|.+++.... .+++..++.++.||+.||+|||++|||
T Consensus       414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~ii  491 (635)
T 4fl3_A          414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV  491 (635)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            4578899999999999999999999964 568999999985 9999997643 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.+.......                                             
T Consensus       492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~---------------------------------------------  526 (635)
T 4fl3_A          492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---------------------------------------------  526 (635)
T ss_dssp             CSCCSGGGEEEEETTEEEECCTTHHHHTTC--------------------------------------------------
T ss_pred             CCCCChHhEEEeCCCCEEEEEcCCccccccCcccc---------------------------------------------
Confidence            99999999999999999999999987543210000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......+|+.|+|||++.+.. |+.++||||+||++
T Consensus       527 -------------------------------------------~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l  562 (635)
T 4fl3_A          527 -------------------------------------------KAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLM  562 (635)
T ss_dssp             ---------------------------------------------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHH
Confidence                                                       0001224678899999997654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |+.||.+.+..+....+......+                            .....++.+.+|+.+||+.||+
T Consensus       563 ~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~dP~  614 (635)
T 4fl3_A          563 WEAFSYGQKPYRGMKGSEVTAMLEKGERMG----------------------------CPAGCPREMYDLMNLCWTYDVE  614 (635)
T ss_dssp             HHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCHh
Confidence            99998 999999988876666554321100                            0012346789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||++++++
T Consensus       615 ~RPs~~~l~~  624 (635)
T 4fl3_A          615 NRPGFAAVEL  624 (635)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.6e-33  Score=283.14  Aligned_cols=210  Identities=30%  Similarity=0.487  Sum_probs=159.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+.+|+.++||||+++++++...+..|+||||+.+ +|.+++..   ....+++..+..++.|++.||.|||++
T Consensus        76 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  155 (310)
T 2wqm_A           76 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR  155 (310)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            34578999999999999999999999999999999999986 99998864   345699999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+||+++.++.+||+|||+++......                                             
T Consensus       156 ~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~---------------------------------------------  190 (310)
T 2wqm_A          156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---------------------------------------------  190 (310)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCC-------------------------------------------------------
T ss_pred             CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC---------------------------------------------
Confidence            99999999999999999999999999875432100                                             


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    .......||+.|+|||++.+.. ++.++||||+|
T Consensus       191 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG  223 (310)
T 2wqm_A          191 ----------------------------------------------TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLG  223 (310)
T ss_dssp             ------------------------------------------------------CCSSCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCCCeeEeChHHhCCCC-CCchhhHHHHH
Confidence                                                          0001235789999999997654 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++|+|++|..||.+... ...+...+.....+.                   .       .....++.+.+|+.+||..
T Consensus       224 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~-------~~~~~~~~l~~li~~~l~~  277 (310)
T 2wqm_A          224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-------------------L-------PSDHYSEELRQLVNMCINP  277 (310)
T ss_dssp             HHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-------------------C-------CTTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-------------------C-------cccccCHHHHHHHHHHcCC
Confidence            999999999999986532 222222222111110                   0       0012356789999999999


Q ss_pred             CCCCCCCHHHHHc
Q psy10954        333 DPKQRVSAKTILQ  345 (562)
Q Consensus       333 DP~~R~Ta~elL~  345 (562)
                      ||++|||+.++++
T Consensus       278 dp~~Rps~~~il~  290 (310)
T 2wqm_A          278 DPEKRPDVTYVYD  290 (310)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-33  Score=304.82  Aligned_cols=214  Identities=23%  Similarity=0.407  Sum_probs=169.1

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++++||||+++++++.. ..+|+|||||.+ +|.+++.... ..+++..+..++.|++.||+|||++||
T Consensus       223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  301 (452)
T 1fmk_A          223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  301 (452)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4568899999999999999999999865 679999999975 9999997532 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++......  .                     .                      
T Consensus       302 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~---------------------~----------------------  336 (452)
T 1fmk_A          302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE--Y---------------------T----------------------  336 (452)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCCTTC-----------------------------------------------------
T ss_pred             eCCCCChhhEEECCCCCEEECCCccceecCCCc--e---------------------e----------------------
Confidence            999999999999999999999999986442100  0                     0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+|..|+|||++.+.. |+.++||||+||+
T Consensus       337 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~  370 (452)
T 1fmk_A          337 ---------------------------------------------ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGIL  370 (452)
T ss_dssp             ---------------------------------------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             ---------------------------------------------cccCCcccccccCHhHHhcCC-CCccccHHhHHHH
Confidence                                                         001124577899999997654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+....+.+..+......+.                            ....++.+.+|+.+||+.||
T Consensus       371 l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~dP  422 (452)
T 1fmk_A          371 LTELTTKGRVPYPGMVNREVLDQVERGYRMPC----------------------------PPECPESLHDLMCQCWRKEP  422 (452)
T ss_dssp             HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CCCCCHHHHHHHHHHccCCh
Confidence            999999 9999999887776666543211100                            01234678999999999999


Q ss_pred             CCCCCHHHHHc--CccccC
Q psy10954        335 KQRVSAKTILQ--HEYFNQ  351 (562)
Q Consensus       335 ~~R~Ta~elL~--Hp~f~~  351 (562)
                      ++|||++++++  ..++..
T Consensus       423 ~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          423 EERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             GGSCCHHHHHHHHHTTTSC
T ss_pred             hhCcCHHHHHHHHHHHhcc
Confidence            99999999986  244443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.6e-33  Score=283.22  Aligned_cols=200  Identities=24%  Similarity=0.374  Sum_probs=152.2

Q ss_pred             hhHHHHHHHH-HccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVL-KELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL-~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ....+|+.++ +.++||||+++++++..    ...+|+|||||++ +|.+++.... ..+++..++.++.|++.||.|||
T Consensus        55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  134 (299)
T 3m2w_A           55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  134 (299)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4678999998 66699999999999987    6789999999975 9999998754 36999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ++||+||||||+|||++.   ++.+||+|||+++...                                           
T Consensus       135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------------------------------  171 (299)
T 3m2w_A          135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------------------------------  171 (299)
T ss_dssp             HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------------------------------------
T ss_pred             hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------------------------------------
Confidence            999999999999999987   5677888877653210                                           


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                                             ...|+.++|
T Consensus       172 -----------------------------------------------------------------------~~~~~~~~D  180 (299)
T 3m2w_A          172 -----------------------------------------------------------------------GEKYDKSCD  180 (299)
T ss_dssp             -----------------------------------------------------------------------TCGGGGHHH
T ss_pred             -----------------------------------------------------------------------cccCCchhh
Confidence                                                                                   112678999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |||+||++|||++|+.||.+.+.......+           .....      .......    .......++.+.+|+.+
T Consensus       181 iwslG~il~el~tg~~pf~~~~~~~~~~~~-----------~~~~~------~~~~~~~----~~~~~~~~~~~~~li~~  239 (299)
T 3m2w_A          181 MWSLGVIMYILLCGYPPFYSNHGLAISPGM-----------KTRIR------MGQYEFP----NPEWSEVSEEVKMLIRN  239 (299)
T ss_dssp             HHHHHHHHHHHHHSSCSCCC-------CCS-----------CCSSC------TTCCSSC----HHHHTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCcchhhhHHH-----------HHHHh------hccccCC----chhcccCCHHHHHHHHH
Confidence            999999999999999999876543211000           00000      0000000    00112346789999999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCCc
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ||+.||++|||+.|+|+||||.+..
T Consensus       240 ~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          240 LLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HcccChhhCCCHHHHhcChhhcccc
Confidence            9999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-33  Score=294.12  Aligned_cols=207  Identities=16%  Similarity=0.220  Sum_probs=158.2

Q ss_pred             CchhhHHHHHHHHHccC---CCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhh----CCCCCCHHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT----TPVPVPPALAKSYLYQLLEAL   87 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~---HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~----~~~~l~e~~i~~i~~qll~aL   87 (562)
                      .....+.+|+++++.++   |+||+++++++...+..|+|||||+ ++|.+++..    ....+++..++.++.|++.||
T Consensus       106 ~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L  185 (365)
T 3e7e_A          106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI  185 (365)
T ss_dssp             CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHH
T ss_pred             CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence            34556789999999887   8999999999999999999999997 599999974    344699999999999999999


Q ss_pred             HHHHHCCceeccCCCCcEEEcc-----------CCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccc
Q psy10954         88 RYCHSRRIIHRDLKPQNILINK-----------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  156 (562)
Q Consensus        88 ~yLH~~gIiHRDLKP~NILl~~-----------~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~  156 (562)
                      +|||++|||||||||+|||++.           ++.+||+|||+|                                   
T Consensus       186 ~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a-----------------------------------  230 (365)
T 3e7e_A          186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS-----------------------------------  230 (365)
T ss_dssp             HHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTC-----------------------------------
T ss_pred             HHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchh-----------------------------------
Confidence            9999999999999999999986           445555555554                                   


Q ss_pred             ccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccccc--CCCcccccccCCCccch
Q psy10954        157 DIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI--PMNRYTHEVVTLWYRPP  234 (562)
Q Consensus       157 DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~--~~~~~~~~vgT~~Y~AP  234 (562)
                                                                              +....  ........+||+.|+||
T Consensus       231 --------------------------------------------------------~~~~~~~~~~~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          231 --------------------------------------------------------IDMKLFPKGTIFTAKCETSGFQCV  254 (365)
T ss_dssp             --------------------------------------------------------EEGGGSCTTEEECCSSCTTSCCCH
T ss_pred             --------------------------------------------------------hhhhccCCCceeeeecCCCCCCCh
Confidence                                                                    33221  11123445799999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhh
Q psy10954        235 EILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEI  314 (562)
Q Consensus       235 Evl~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (562)
                      |++.+.. |+.++||||+||++|||++|+.||.......                +.       ....+...        
T Consensus       255 E~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~-------~~~~~~~~--------  302 (365)
T 3e7e_A          255 EMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----------------CK-------PEGLFRRL--------  302 (365)
T ss_dssp             HHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----------------EE-------ECSCCTTC--------
T ss_pred             HHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc----------------ee-------echhcccc--------
Confidence            9998766 8999999999999999999999996542200                00       00000000        


Q ss_pred             cCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q psy10954        315 LNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE  347 (562)
Q Consensus       315 l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp  347 (562)
                        ...+...+++.+||..+|.+|++..+.+.+.
T Consensus       303 --~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          303 --PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             --SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             --CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence              1134678999999999999997765555443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-33  Score=282.80  Aligned_cols=206  Identities=24%  Similarity=0.393  Sum_probs=160.8

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeC-CEEEEEeecCcC-CHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-~~i~lV~Ey~~~-~L~~~i~~~~~-~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ..+.+.+|+++++.++||||+++++++... +.+|+||||+++ +|.+++..... .+++..+..++.|++.||.|||++
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  136 (278)
T 1byg_A           57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN  136 (278)
T ss_dssp             --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            356688999999999999999999997554 578999999986 99999876432 389999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||+||||||+||+++.++.+||+|||+++.....                                              
T Consensus       137 ~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----------------------------------------------  170 (278)
T 1byg_A          137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------------------------------------------  170 (278)
T ss_dssp             TCCCSCCSGGGEEECTTSCEEECCCCC-----------------------------------------------------
T ss_pred             CccccCCCcceEEEeCCCcEEEeecccccccccc----------------------------------------------
Confidence            9999999999999999999999999986532100                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                      .....+|+.|+|||++.+.. ++.++||||+|
T Consensus       171 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG  201 (278)
T 1byg_A          171 ------------------------------------------------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFG  201 (278)
T ss_dssp             -----------------------------------------------------CCTTTSCHHHHHHCC-CCHHHHHHHHH
T ss_pred             ------------------------------------------------ccCCCccccccCHHHhCCCC-CCchhcHHHHH
Confidence                                                            00123577899999987654 89999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        254 CIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       254 ~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      |++|+|++ |+.||.+.+..+....+......                 .           .....++.+.+++.+||..
T Consensus       202 ~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~~l~~li~~~l~~  253 (278)
T 1byg_A          202 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-----------------D-----------APDGCPPAVYEVMKNCWHL  253 (278)
T ss_dssp             HHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-----------------C-----------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-----------------C-----------CcccCCHHHHHHHHHHhcC
Confidence            99999998 99999887665444433221000                 0           0112356789999999999


Q ss_pred             CCCCCCCHHHHHc
Q psy10954        333 DPKQRVSAKTILQ  345 (562)
Q Consensus       333 DP~~R~Ta~elL~  345 (562)
                      ||++|||+.|+++
T Consensus       254 ~p~~Rps~~~l~~  266 (278)
T 1byg_A          254 DAAMRPSFLQLRE  266 (278)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.1e-33  Score=280.67  Aligned_cols=218  Identities=23%  Similarity=0.320  Sum_probs=160.0

Q ss_pred             hhhHHHHHHHHHc--cCCCCcceEEEEEEeC----CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKE--LKHPNVIRLHDVIPVD----FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~--l~HpnIv~L~~~~~~~----~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      .....+|.+++..  ++||||+++++++...    ..+|+||||+++ +|.++++..  .+++..+..++.|++.||+||
T Consensus        44 ~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~l  121 (301)
T 3q4u_A           44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHL  121 (301)
T ss_dssp             HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHH
Confidence            3456678888776  7999999999987542    468999999985 999999643  699999999999999999999


Q ss_pred             H--------HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         91 H--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        91 H--------~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      |        ++||+||||||+|||++.++.+||+|||+|+.........                               
T Consensus       122 H~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-------------------------------  170 (301)
T 3q4u_A          122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-------------------------------  170 (301)
T ss_dssp             HSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE-------------------------------
T ss_pred             HHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc-------------------------------
Confidence            9        9999999999999999999999999999986543211000                               


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                              .......+||+.|+|||++.+...
T Consensus       171 --------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  194 (301)
T 3q4u_A          171 --------------------------------------------------------DVGNNPRVGTKRYMAPEVLDETIQ  194 (301)
T ss_dssp             --------------------------------------------------------ECCCCCCCCCGGGCCHHHHTTCCC
T ss_pred             --------------------------------------------------------cccccccccccceeChhhhcCcCC
Confidence                                                                    000123468999999999976532


Q ss_pred             -----CCchhhHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCC
Q psy10954        243 -----YSTTVDIWSAGCIFSEMITK----------KTLFAGDS----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDF  303 (562)
Q Consensus       243 -----y~~~~DIWSlG~il~eLltG----------~~pF~~~~----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~  303 (562)
                           ++.++||||+||++|||++|          ..||.+..    ....+.......+..                  
T Consensus       195 ~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------  256 (301)
T 3q4u_A          195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR------------------  256 (301)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC------------------
T ss_pred             CCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCC------------------
Confidence                 44789999999999999999          88886532    222333322111100                  


Q ss_pred             CCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        304 PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       304 ~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      +.......   ....++.+.+|+.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          257 PNIPNRWF---SDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCCCGGGG---GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCChhhc---cCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            00000000   0111356889999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.6e-34  Score=320.75  Aligned_cols=237  Identities=27%  Similarity=0.372  Sum_probs=168.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEe------CCEEEEEeecCc-CCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLR-QDLKDFLQTTPV--PVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~------~~~i~lV~Ey~~-~~L~~~i~~~~~--~l~e~~i~~i~~qll~aL~y   89 (562)
                      ..+.+|+++|+.++||||+++++++..      ++..|+|||||. ++|.+++.....  .+++..++.++.|++.||.|
T Consensus        57 ~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~y  136 (676)
T 3qa8_A           57 ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY  136 (676)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence            457889999999999999999998765      677899999996 599999986442  58999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCC---eeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~---vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      ||++||+||||||+|||++.++.   +||+|||++......                                       
T Consensus       137 LHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~---------------------------------------  177 (676)
T 3qa8_A          137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---------------------------------------  177 (676)
T ss_dssp             HHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC---------------------------------------
T ss_pred             HHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc---------------------------------------
Confidence            99999999999999999987664   788888876533210                                       


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           ......+||+.|+|||++.+.. |+.+
T Consensus       178 -----------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~-~s~k  203 (676)
T 3qa8_A          178 -----------------------------------------------------ELCTEFVGTLQYLAPELLEQKK-YTVT  203 (676)
T ss_dssp             -----------------------------------------------------CCCCCCCSCCTTCSSCSSCCSC-CSTT
T ss_pred             -----------------------------------------------------cccccccCCcccCChHHhccCC-CCch
Confidence                                                                 0012346789999999987654 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|+|++|..||.+..............+...............+....+.  +.   .+....++.+.+||
T Consensus       204 sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~--p~---~l~~~ls~~L~dLI  278 (676)
T 3qa8_A          204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPT--PN---HLSGILAGKLERWL  278 (676)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCC--SC---CCCGGGHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCC--ch---hhchhhhHHHHHHH
Confidence            99999999999999999999876544322111100000000000000000000000000  00   01112346789999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      .+||.+||++|||+.|+|+||||+.+.
T Consensus       279 ~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          279 QCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             HHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             HHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            999999999999999999999998865

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.5e-33  Score=284.80  Aligned_cols=212  Identities=22%  Similarity=0.329  Sum_probs=163.4

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++|+.++||||+++++++...  ..+|+||||+.+ +|.+++...  .+++..+..++.|++.||.|||++||
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~i  155 (318)
T 3lxp_A           78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHY  155 (318)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4578999999999999999999999874  689999999975 999998765  48999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.........                                            
T Consensus       156 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--------------------------------------------  191 (318)
T 3lxp_A          156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY--------------------------------------------  191 (318)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE--------------------------------------------
T ss_pred             cCCCCchheEEEcCCCCEEECCcccccccccccccc--------------------------------------------
Confidence            999999999999999999999999986543110000                                            


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. ++.++||||+||+
T Consensus       192 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  226 (318)
T 3lxp_A          192 --------------------------------------------RVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVT  226 (318)
T ss_dssp             --------------------------------------------EC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHH
Confidence                                                        0011235688899999998655 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHH-----------HHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHH
Q psy10954        256 FSEMITKKTLFAGDSEID-----------QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  324 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~-----------~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~d  324 (562)
                      +|+|++|..||.......           ....+...+....                ...        .....++.+.+
T Consensus       227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~--------~~~~~~~~l~~  282 (318)
T 3lxp_A          227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE----------------RLP--------RPDKCPAEVYH  282 (318)
T ss_dssp             HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC----------------CCC--------CCTTCCHHHHH
T ss_pred             HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc----------------CCC--------CCccccHHHHH
Confidence            999999999997543210           0011111100000                000        01223568899


Q ss_pred             HHHHccccCCCCCCCHHHHHc
Q psy10954        325 VFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       325 Li~~mL~~DP~~R~Ta~elL~  345 (562)
                      |+.+||+.||++|||+.|+++
T Consensus       283 li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          283 LMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8e-33  Score=312.75  Aligned_cols=207  Identities=26%  Similarity=0.437  Sum_probs=169.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+|+.++||||+++++++. ++.+|+|||||. ++|.+++......+++..+..++.|++.||.|||++||+|
T Consensus       436 ~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  514 (656)
T 2j0j_A          436 EKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH  514 (656)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            56789999999999999999999984 567899999998 5999999877667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+++.......                                                
T Consensus       515 rDikp~NILl~~~~~vkL~DFG~a~~~~~~~~------------------------------------------------  546 (656)
T 2j0j_A          515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------------------------------------------------  546 (656)
T ss_dssp             SCCSGGGEEEEETTEEEECCCCCCCSCCC---------------------------------------------------
T ss_pred             cccchHhEEEeCCCCEEEEecCCCeecCCCcc------------------------------------------------
Confidence            99999999999999999999999865421100                                                


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                .......+|+.|+|||++.+.. |+.++||||+||++|
T Consensus       547 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~  583 (656)
T 2j0j_A          547 ------------------------------------------YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMW  583 (656)
T ss_dssp             -------------------------------------------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------eeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHH
Confidence                                                      0001124578899999997654 899999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++ |..||.+.+..+.+..+......+                            .....++.+.+|+.+||..||++
T Consensus       584 ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~  635 (656)
T 2j0j_A          584 EILMHGVKPFQGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTKCWAYDPSR  635 (656)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccccHHHHHHHHHHcCCChhH
Confidence            9997 999999988877776665421110                            00123467899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.|+++
T Consensus       636 RPs~~el~~  644 (656)
T 2j0j_A          636 RPRFTELKA  644 (656)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.4e-33  Score=306.87  Aligned_cols=214  Identities=23%  Similarity=0.407  Sum_probs=171.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+++|++++||||+++++++.. ..+|||||||.+ +|.+++.... ..+++..+..++.||+.||+|||++||
T Consensus       306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  384 (535)
T 2h8h_A          306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  384 (535)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4568899999999999999999999865 679999999975 9999997532 358999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+++......  .                     .                      
T Consensus       385 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~---------------------~----------------------  419 (535)
T 2h8h_A          385 VHRDLRAANILVGENLVCKVADFGLARLIEDNE--Y---------------------T----------------------  419 (535)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--H---------------------H----------------------
T ss_pred             eCCCCCHhhEEEcCCCcEEEcccccceecCCCc--e---------------------e----------------------
Confidence            999999999999999999999999986442100  0                     0                      


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ......+|..|+|||++.+.. |+.++||||+||+
T Consensus       420 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~  453 (535)
T 2h8h_A          420 ---------------------------------------------ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGIL  453 (535)
T ss_dssp             ---------------------------------------------TTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             ---------------------------------------------cccCCcCcccccCHHHhccCC-CCchhhHHHHHHH
Confidence                                                         001124577899999998654 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+....+.+..+......+                            .....++.+.+|+.+||+.||
T Consensus       454 l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP  505 (535)
T 2h8h_A          454 LTELTTKGRVPYPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEP  505 (535)
T ss_dssp             HHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCh
Confidence            999999 999999988777666654321110                            001234678999999999999


Q ss_pred             CCCCCHHHHHcC--ccccC
Q psy10954        335 KQRVSAKTILQH--EYFNQ  351 (562)
Q Consensus       335 ~~R~Ta~elL~H--p~f~~  351 (562)
                      ++|||++++++.  .+|..
T Consensus       506 ~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          506 EERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             GGSCCHHHHHHHHHTSSCC
T ss_pred             hHCcCHHHHHHHHHHHhhc
Confidence            999999998863  44443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-32  Score=283.43  Aligned_cols=218  Identities=23%  Similarity=0.338  Sum_probs=157.9

Q ss_pred             hhHHHHHHHHHcc--CCCCcceEEEEEEeC----CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL--KHPNVIRLHDVIPVD----FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l--~HpnIv~L~~~~~~~----~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ....+|.+++..+  +||||+++++++...    ..+|+|||||.+ +|.+++...  .+++..+..++.|++.||.|||
T Consensus        74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH  151 (337)
T 3mdy_A           74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH  151 (337)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH
Confidence            4456777777665  999999999999887    789999999975 999999765  5899999999999999999999


Q ss_pred             HC--------CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccc
Q psy10954         92 SR--------RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  163 (562)
Q Consensus        92 ~~--------gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~  163 (562)
                      ++        ||+||||||+|||++.++.+||+|||+++.........                                
T Consensus       152 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------------------------------  199 (337)
T 3mdy_A          152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV--------------------------------  199 (337)
T ss_dssp             SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC--------------------------------------
T ss_pred             HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccc--------------------------------
Confidence            98        99999999999999999999999999876442110000                                


Q ss_pred             cchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCC
Q psy10954        164 IFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  243 (562)
Q Consensus       164 il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y  243 (562)
                                                                             .......+||+.|+|||++.+....
T Consensus       200 -------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~  224 (337)
T 3mdy_A          200 -------------------------------------------------------DIPPNTRVGTKRYMPPEVLDESLNR  224 (337)
T ss_dssp             ----------------------------------------------------------CCSSCSCGGGCCHHHHTTCCCT
T ss_pred             -------------------------------------------------------cCCCCCCccCcceeChhhcccccCC
Confidence                                                                   0001234789999999999765432


Q ss_pred             Cc-----hhhHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCC
Q psy10954        244 ST-----TVDIWSAGCIFSEMITK----------KTLFAGDS----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFP  304 (562)
Q Consensus       244 ~~-----~~DIWSlG~il~eLltG----------~~pF~~~~----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  304 (562)
                      ..     ++||||+||++|||++|          ..||.+..    ....+.......+..               ..++
T Consensus       225 ~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~  289 (337)
T 3mdy_A          225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR---------------PSFP  289 (337)
T ss_dssp             TCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC---------------CCCC
T ss_pred             ccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC---------------cccc
Confidence            22     49999999999999999          66665421    122222222110000               0000


Q ss_pred             CCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        305 EWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       305 ~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                          ..+.  ....++.+.+|+.+||+.||++|||+.|+++|
T Consensus       290 ----~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          290 ----NRWS--SDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             ----GGGG--GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----ccch--hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                0000  00113468899999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.5e-33  Score=285.22  Aligned_cols=220  Identities=23%  Similarity=0.373  Sum_probs=164.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRY   89 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~y   89 (562)
                      ...+.+|+++++.++||||+++++++..    ....|+||||+.+ +|.+++..   ....+++..++.++.|++.||.|
T Consensus        70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~  149 (317)
T 2buj_A           70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA  149 (317)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999873    3478999999986 99998875   34569999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         90 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        90 LH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      ||++||+||||||+|||++.++.+||+|||++.........                  ..                   
T Consensus       150 LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~------------------~~-------------------  192 (317)
T 2buj_A          150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG------------------SR-------------------  192 (317)
T ss_dssp             HHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES------------------HH-------------------
T ss_pred             HHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccc------------------cc-------------------
Confidence            99999999999999999999999999999987644211000                  00                   


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC--CCCchh
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK--VYSTTV  247 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~--~y~~~~  247 (562)
                         +...                                          ........||+.|+|||++.+..  .++.++
T Consensus       193 ---~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  227 (317)
T 2buj_A          193 ---QALT------------------------------------------LQDWAAQRCTISYRAPELFSVQSHCVIDERT  227 (317)
T ss_dssp             ---HHHH------------------------------------------HHHHHHHHSCGGGCCGGGSSCCSEEEECTHH
T ss_pred             ---cccc------------------------------------------ccccccccCCcccCCHhHhccCCCcCCCchh
Confidence               0000                                          00011235789999999987543  268899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        248 DIWSAGCIFSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       248 DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      ||||+||++|+|++|+.||.+.... +.+...... ..                 ..+         .....++.+.++|
T Consensus       228 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-----------------~~~---------~~~~~~~~l~~li  280 (317)
T 2buj_A          228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QL-----------------SIP---------QSPRHSSALWQLL  280 (317)
T ss_dssp             HHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C-------------------CC---------CCTTSCHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cC-----------------CCC---------ccccCCHHHHHHH
Confidence            9999999999999999999532110 001111110 00                 000         0012356789999


Q ss_pred             HHccccCCCCCCCHHHHHcC
Q psy10954        327 SKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~H  346 (562)
                      .+||+.||.+|||+.|++++
T Consensus       281 ~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          281 NSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcChhhCCCHHHHHHH
Confidence            99999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-32  Score=281.86  Aligned_cols=226  Identities=23%  Similarity=0.340  Sum_probs=163.1

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCC--EEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~--~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+|+++|+.++||||+++++++...+  .+|+||||+++ +|.+++......+++..+..++.|++.||.|||++||
T Consensus        87 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  166 (326)
T 2w1i_A           87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY  166 (326)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            46789999999999999999999987543  78999999975 9999998876679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++.........                                            
T Consensus       167 vH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~--------------------------------------------  202 (326)
T 2w1i_A          167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY--------------------------------------------  202 (326)
T ss_dssp             ECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEE--------------------------------------------
T ss_pred             eccCCCcceEEEcCCCcEEEecCcchhhcccccccc--------------------------------------------
Confidence            999999999999999999999999986543110000                                            


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......+|..|+|||++.+.. ++.++||||+||+
T Consensus       203 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  237 (326)
T 2w1i_A          203 --------------------------------------------KVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVV  237 (326)
T ss_dssp             --------------------------------------------ECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCCCceeEECchhhcCCC-CCchhhHHHHHHH
Confidence                                                        0001224677899999997654 7899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|..||.....  .+..   ..+......+.. .............      ......++.+.+++.+||..||+
T Consensus       238 l~el~tg~~~~~~~~~--~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~  305 (326)
T 2w1i_A          238 LYELFTYIEKSKSPPA--EFMR---MIGNDKQGQMIV-FHLIELLKNNGRL------PRPDGCPDEIYMIMTECWNNNVN  305 (326)
T ss_dssp             HHHHHHTTCGGGSHHH--HHHH---HHCTTCCTHHHH-HHHHHHHHTTCCC------CCCTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHHHhcCCCCCCCHH--HHHH---hhccccchhhhH-HHHHHHhhcCCCC------CCCCcccHHHHHHHHHHcCCChh
Confidence            9999999999864321  1111   011000000000 0000000000000      00112356789999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||+.|+++
T Consensus       306 ~Rps~~el~~  315 (326)
T 2w1i_A          306 QRPSFRDLAL  315 (326)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-34  Score=297.67  Aligned_cols=225  Identities=22%  Similarity=0.183  Sum_probs=160.1

Q ss_pred             hhhHHHHHHHHHccC---------CCCcceEEEEEE------------------------------eCCEEEEEeecCcC
Q psy10954         18 PSTALREISVLKELK---------HPNVIRLHDVIP------------------------------VDFKLFLVFEFLRQ   58 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~---------HpnIv~L~~~~~------------------------------~~~~i~lV~Ey~~~   58 (562)
                      ...+.+|+.+|+.++         |||||++++++.                              ....+|||||||.+
T Consensus        67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~  146 (336)
T 2vuw_A           67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG  146 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred             HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence            367889999999886         777777777643                              26789999999964


Q ss_pred             -CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeee
Q psy10954         59 -DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV  136 (562)
Q Consensus        59 -~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH-~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~  136 (562)
                       ++.+.+.+  ..+++..++.+++||+.||+||| ++|||||||||+|||++.++.-. .++++....            
T Consensus       147 g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~~~------------  211 (336)
T 2vuw_A          147 GIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNGKS------------  211 (336)
T ss_dssp             CEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEETTEE------------
T ss_pred             CccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcc-eeeeccCcc------------
Confidence             45555543  35899999999999999999999 99999999999999999776422 233321100            


Q ss_pred             eccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceee-cCCCCEEEeeccccccc
Q psy10954        137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILI-NKSGALKLADFGLSRAF  215 (562)
Q Consensus       137 t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl-~~~g~vKL~DFGla~~~  215 (562)
                                                                                 ... .....+||+|||+|+..
T Consensus       212 -----------------------------------------------------------~~~~~~~~~vkL~DFG~a~~~  232 (336)
T 2vuw_A          212 -----------------------------------------------------------STIPSCGLQVSIIDYTLSRLE  232 (336)
T ss_dssp             -----------------------------------------------------------EEEECTTEEEEECCCTTCBEE
T ss_pred             -----------------------------------------------------------ccccCCCceEEEeeccccEec
Confidence                                                                       001 12347899999999876


Q ss_pred             ccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCCCCCCCC
Q psy10954        216 TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI-FSEMITKKTLFAGDSEID-QLFRIFRTLGTPHEDVWPGV  293 (562)
Q Consensus       216 ~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i-l~eLltG~~pF~~~~~~~-~l~~i~~~lg~~~~~~~~~~  293 (562)
                      ..     ...+||+.|+|||++.+..  +.++||||+|++ .++++.|..||.+..... ....+.......        
T Consensus       233 ~~-----~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  297 (336)
T 2vuw_A          233 RD-----GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK--------  297 (336)
T ss_dssp             ET-----TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS--------
T ss_pred             CC-----CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC--------
Confidence            53     2458999999999998764  889999998777 778899999995432111 122222211100        


Q ss_pred             CCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHH-cCcccc
Q psy10954        294 SKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL-QHEYFN  350 (562)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL-~Hp~f~  350 (562)
                                 .....   ......++.+.|||++||++|     ||+|+| +||||+
T Consensus       298 -----------~~~~~---~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          298 -----------TKCNT---PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             -----------SCCCS---HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             -----------cccch---hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence                       00000   011123467999999999988     999999 999995

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-31  Score=292.92  Aligned_cols=219  Identities=16%  Similarity=0.206  Sum_probs=169.0

Q ss_pred             hhhHHHHHHHHHccCC-CCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~H-pnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++| ++|..+..++......||||||++++|.+++......+++..++.++.||+.||+|||++|||
T Consensus        46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv  125 (483)
T 3sv0_A           46 HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL  125 (483)
T ss_dssp             SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3468899999999987 566677777778889999999998899999987666799999999999999999999999999


Q ss_pred             eccCCCCcEEE---ccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl---~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||+||||   +.++.+||+|||+++.+........                                         
T Consensus       126 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~-----------------------------------------  164 (483)
T 3sv0_A          126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH-----------------------------------------  164 (483)
T ss_dssp             CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB-----------------------------------------
T ss_pred             ecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc-----------------------------------------
Confidence            99999999999   5788999999999875532110000                                         


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                 .+.......+||+.|+|||++.+.. |+.++||||+|
T Consensus       165 -------------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlG  200 (483)
T 3sv0_A          165 -------------------------------------------IPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLG  200 (483)
T ss_dssp             -------------------------------------------CCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             -------------------------------------------cccccccccCCCccccCHHHhcCCC-CChHHHHHHHH
Confidence                                                       0001122457899999999998765 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        254 CIFSEMITKKTLFAGDSE---IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |++|||++|+.||.+...   .+.+..+....-                        ......+....+..+.+|+.+||
T Consensus       201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~~l~~li~~cl  256 (483)
T 3sv0_A          201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------ATSIEALCRGYPTEFASYFHYCR  256 (483)
T ss_dssp             HHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH------------------------HSCHHHHHTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCccccchhHHHHHHHHhhccc------------------------cccHHHHhcCCcHHHHHHHHHHh
Confidence            999999999999987543   233333322100                        00011122344678999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q psy10954        331 ALDPKQRVSAKTILQ  345 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~  345 (562)
                      ..||++||++.++++
T Consensus       257 ~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          257 SLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TCCTTCCCCHHHHHH
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999987653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=1.9e-33  Score=300.41  Aligned_cols=208  Identities=15%  Similarity=0.201  Sum_probs=153.5

Q ss_pred             hhhHHHHHHHHHccCC-CCc---------c------------eEEEEEEe-----CCEEEEEeecCcCCHHHHHh-----
Q psy10954         18 PSTALREISVLKELKH-PNV---------I------------RLHDVIPV-----DFKLFLVFEFLRQDLKDFLQ-----   65 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~H-pnI---------v------------~L~~~~~~-----~~~i~lV~Ey~~~~L~~~i~-----   65 (562)
                      ...+.+|+.+++.++| +|+         +            .+.+++..     ....+++|+++.++|.+++.     
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~  201 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH  201 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcc
Confidence            4567899999999987 221         1            11111111     23478999999999998884     


Q ss_pred             -hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccc
Q psy10954         66 -TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPE  144 (562)
Q Consensus        66 -~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE  144 (562)
                       ..+..+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||+++.....   .             
T Consensus       202 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~-------------  265 (413)
T 3dzo_A          202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---A-------------  265 (413)
T ss_dssp             TTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---E-------------
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---c-------------
Confidence             22334788888999999999999999999999999999999999999999999987643211   0             


Q ss_pred             eeccccccccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccc
Q psy10954        145 ILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH  224 (562)
Q Consensus       145 ~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~  224 (562)
                                                                                                    ..
T Consensus       266 ------------------------------------------------------------------------------~~  267 (413)
T 3dzo_A          266 ------------------------------------------------------------------------------VS  267 (413)
T ss_dssp             ------------------------------------------------------------------------------CC
T ss_pred             ------------------------------------------------------------------------------cc
Confidence                                                                                          12


Q ss_pred             cccCCCccchhhhc---------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCC
Q psy10954        225 EVVTLWYRPPEILL---------GAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK  295 (562)
Q Consensus       225 ~vgT~~Y~APEvl~---------~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~  295 (562)
                      .+| +.|+|||++.         ....|+.++||||+||++|||++|+.||.+.+..+....+                 
T Consensus       268 ~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~-----------------  329 (413)
T 3dzo_A          268 PIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI-----------------  329 (413)
T ss_dssp             CCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-----------------
T ss_pred             CCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-----------------
Confidence            245 6677777773         3334888999999999999999999999876432110000                 


Q ss_pred             CCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        296 LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                             +..         ....++.+.+|+.+||+.||++|||+.|+++||||+++.
T Consensus       330 -------~~~---------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          330 -------FRS---------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             -------GSS---------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------Hhh---------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence                   000         012357899999999999999999999999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.98  E-value=8.1e-32  Score=277.31  Aligned_cols=243  Identities=21%  Similarity=0.247  Sum_probs=155.9

Q ss_pred             hhHHHHHHHH--HccCCCCcceEEEEEEe-----CCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVL--KELKHPNVIRLHDVIPV-----DFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        19 ~~~~rEi~iL--~~l~HpnIv~L~~~~~~-----~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      .....|.+++  +.++||||+++++.+..     ...+|+|||||+ ++|.+++....  .++..+..++.|++.||.||
T Consensus        50 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~L  127 (336)
T 3g2f_A           50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYL  127 (336)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHH
Confidence            3445555554  45899999999986643     236799999996 49999997654  58889999999999999999


Q ss_pred             HHC---------CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         91 HSR---------RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        91 H~~---------gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++         ||+||||||+|||++.++.+||+|||+++.........           +.                 
T Consensus       128 H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~-----------~~-----------------  179 (336)
T 3g2f_A          128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR-----------PG-----------------  179 (336)
T ss_dssp             HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-------------------------------
T ss_pred             HhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccC-----------cc-----------------
Confidence            999         99999999999999999999999999987553210000           00                 


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC-
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-  240 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~-  240 (562)
                                                                             .........+||+.|+|||++.+. 
T Consensus       180 -------------------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~  204 (336)
T 3g2f_A          180 -------------------------------------------------------EEDNAAISEVGTIRYMAPEVLEGAV  204 (336)
T ss_dssp             -------------------------------------------------------------CCTTSCGGGCCHHHHTTCC
T ss_pred             -------------------------------------------------------ccccccccCCCccceeCchhhcCCc
Confidence                                                                   000111235789999999999763 


Q ss_pred             -----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCC-CCCCCCCCCCCCccCCCCCCCccchhh
Q psy10954        241 -----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSE-IDQLFRIFRTLGTPH-EDVWPGVSKLPIYKTDFPEWRPKKFSE  313 (562)
Q Consensus       241 -----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (562)
                           ..++.++||||+||++|||++|..||..... .+....+....+..+ .+.+............++...+.    
T Consensus       205 ~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  280 (336)
T 3g2f_A          205 NLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE----  280 (336)
T ss_dssp             CGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC----
T ss_pred             ccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc----
Confidence                 3466789999999999999999766543221 000000000000000 00000000000000000000000    


Q ss_pred             hcCCCCHHHHHHHHHccccCCCCCCCHHHHH------cCccccC
Q psy10954        314 ILNLPDPLAVDVFSKIMALDPKQRVSAKTIL------QHEYFNQ  351 (562)
Q Consensus       314 ~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL------~Hp~f~~  351 (562)
                       ....++.+.+||.+||+.||++|||++|++      .++|-++
T Consensus       281 -~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          281 -NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             -CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             -ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence             000124689999999999999999999985      4566554

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=1.8e-31  Score=275.00  Aligned_cols=219  Identities=21%  Similarity=0.295  Sum_probs=162.0

Q ss_pred             hhhHHHHHHHHHc--cCCCCcceEEEEEEeCC----EEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKE--LKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   90 (562)
Q Consensus        18 ~~~~~rEi~iL~~--l~HpnIv~L~~~~~~~~----~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yL   90 (562)
                      .....+|+++++.  ++||||+++++++....    .+|+||||+++ +|.+++.+.  .+++..+..++.|++.||.||
T Consensus        78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~l  155 (342)
T 1b6c_B           78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHL  155 (342)
T ss_dssp             HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHH
Confidence            3457889999987  79999999999998775    89999999986 999999764  589999999999999999999


Q ss_pred             H--------HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccccc
Q psy10954         91 H--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus        91 H--------~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG  162 (562)
                      |        ++||+||||||+|||++.++.+||+|||++..........                               
T Consensus       156 H~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-------------------------------  204 (342)
T 1b6c_B          156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-------------------------------  204 (342)
T ss_dssp             HCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEE-------------------------------
T ss_pred             HHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccccc-------------------------------
Confidence            9        8999999999999999999999999999876443110000                               


Q ss_pred             ccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCC
Q psy10954        163 CIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  242 (562)
Q Consensus       163 ~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~  242 (562)
                                                                              .......+||+.|+|||++.+...
T Consensus       205 --------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  228 (342)
T 1b6c_B          205 --------------------------------------------------------DIAPNHRVGTKRYMAPEVLDDSIN  228 (342)
T ss_dssp             --------------------------------------------------------EECCCSCCCCGGGCCHHHHTSCCC
T ss_pred             --------------------------------------------------------ccccccCCcCcccCCHhhhccccc
Confidence                                                                    000123468999999999976532


Q ss_pred             -----CCchhhHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCC
Q psy10954        243 -----YSTTVDIWSAGCIFSEMITK----------KTLFAGDS----EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDF  303 (562)
Q Consensus       243 -----y~~~~DIWSlG~il~eLltG----------~~pF~~~~----~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~  303 (562)
                           ++.++||||+||++|||++|          ..||.+..    ..+.+...+..-+..               ...
T Consensus       229 ~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~  293 (342)
T 1b6c_B          229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR---------------PNI  293 (342)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC---------------CCC
T ss_pred             ccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC---------------CCC
Confidence                 23689999999999999999          77886542    222222222110000               000


Q ss_pred             CCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        304 PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       304 ~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +    ..+.  .......+.+|+.+||+.||++|||+.|+++|
T Consensus       294 ~----~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          294 P----NRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             C----GGGG--TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             c----cccc--chhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            0    0000  00012457899999999999999999999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2.9e-31  Score=300.92  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=156.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCE-----EEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFK-----LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~-----i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ..+.+|+.+|++++||||+++++++...+.     .||||||+++ +|.+++..   .+++..++.++.||+.||.|||+
T Consensus       124 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~  200 (681)
T 2pzi_A          124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS  200 (681)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH
Confidence            356799999999999999999999987654     7999999985 88877654   69999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|||||||||+|||++.+ .+||+|||+++....                                              
T Consensus       201 ~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~----------------------------------------------  233 (681)
T 2pzi_A          201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS----------------------------------------------  233 (681)
T ss_dssp             TTEECCCCSGGGEEECSS-CEEECCCTTCEETTC----------------------------------------------
T ss_pred             CCCeecccChHHeEEeCC-cEEEEecccchhccc----------------------------------------------
Confidence            999999999999999874 889999998653210                                              


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                       ....+||+.|+|||++.+.  ++.++||||+
T Consensus       234 -------------------------------------------------~~~~~gt~~y~aPE~~~~~--~~~~sDi~sl  262 (681)
T 2pzi_A          234 -------------------------------------------------FGYLYGTPGFQAPEIVRTG--PTVATDIYTV  262 (681)
T ss_dssp             -------------------------------------------------CSCCCCCTTTSCTTHHHHC--SCHHHHHHHH
T ss_pred             -------------------------------------------------CCccCCCccccCHHHHcCC--CCCceehhhh
Confidence                                                             0123679999999998654  5889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|+|++|.+||.+....                             ..+...  ..    ...++.+.+||.+||+.
T Consensus       263 G~~l~~l~~g~~~~~~~~~~-----------------------------~~~~~~--~~----~~~~~~l~~li~~~l~~  307 (681)
T 2pzi_A          263 GRTLAALTLDLPTRNGRYVD-----------------------------GLPEDD--PV----LKTYDSYGRLLRRAIDP  307 (681)
T ss_dssp             HHHHHHHHSCCCEETTEECS-----------------------------SCCTTC--HH----HHHCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhCCCCCcccccc-----------------------------cccccc--cc----cccCHHHHHHHhhhccC
Confidence            99999999999888753110                             000000  00    01135788999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy10954        333 DPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~  351 (562)
                      ||++|+++.+++.|+|+.-
T Consensus       308 dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          308 DPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             SGGGSCSSHHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHHH
Confidence            9999999999999998864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=3.7e-29  Score=254.21  Aligned_cols=182  Identities=20%  Similarity=0.172  Sum_probs=142.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+.+++.++||||+++++++..++..|+||||+++ +|.++++..   ..+..+..++.|++.||+|||++||+|
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH  152 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL  152 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            5688999999999999999999999999999999999975 999998542   455678889999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.+|.+||+++|.                                                         
T Consensus       153 ~Dikp~NIll~~~g~~kl~~~~~---------------------------------------------------------  175 (286)
T 3uqc_A          153 SIDHPSRVRVSIDGDVVLAYPAT---------------------------------------------------------  175 (286)
T ss_dssp             CCCSGGGEEEETTSCEEECSCCC---------------------------------------------------------
T ss_pred             CCCCcccEEEcCCCCEEEEeccc---------------------------------------------------------
Confidence            99999999999888888764321                                                         


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                                            ++        .++.++||||+||++|
T Consensus       176 ------------------------------------------------------~~--------~~~~~~Di~slG~il~  193 (286)
T 3uqc_A          176 ------------------------------------------------------MP--------DANPQDDIRGIGASLY  193 (286)
T ss_dssp             ------------------------------------------------------CT--------TCCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------------------cC--------CCCchhHHHHHHHHHH
Confidence                                                                  11        1688999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCC
Q psy10954        258 EMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR  337 (562)
Q Consensus       258 eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R  337 (562)
                      ||++|+.||.+.+..+.+..           ...          .. ..............++.+.+||.+||+.||++|
T Consensus       194 elltg~~Pf~~~~~~~~~~~-----------~~~----------~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  251 (286)
T 3uqc_A          194 ALLVNRWPLPEAGVRSGLAP-----------AER----------DT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR  251 (286)
T ss_dssp             HHHHSEECSCCCSBCCCSEE-----------CCB----------CT-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC
T ss_pred             HHHHCCCCCCcCCcchhhHH-----------HHH----------Hh-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC
Confidence            99999999987653210000           000          00 000111122334456789999999999999999


Q ss_pred             CCHHHHHc
Q psy10954        338 VSAKTILQ  345 (562)
Q Consensus       338 ~Ta~elL~  345 (562)
                       |+.|+++
T Consensus       252 -s~~el~~  258 (286)
T 3uqc_A          252 -SASTLLN  258 (286)
T ss_dssp             -CHHHHHH
T ss_pred             -CHHHHHH
Confidence             9999986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=3.7e-29  Score=278.39  Aligned_cols=146  Identities=19%  Similarity=0.112  Sum_probs=113.5

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ..+.+|+++|+++ +|+||+++++++++++.+|||||||+| +|.++|+.. +++++.   .|+.||+.||+|||++|||
T Consensus       286 ~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GII  361 (569)
T 4azs_A          286 YELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFW  361 (569)
T ss_dssp             HHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCE
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCce
Confidence            4578999999999 799999999999999999999999986 999999865 467764   5889999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      ||||||+|||++.+|.+||+|||+|+.........+..+||+.|+|||++.+.  +..++|+||+|++.+++..
T Consensus       362 HRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~  433 (569)
T 4azs_A          362 HDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQ  433 (569)
T ss_dssp             ESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCT
T ss_pred             eccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcc
Confidence            99999999999999999999999999876555555667899999999999875  4667999999999988743

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.90  E-value=6.2e-25  Score=234.09  Aligned_cols=85  Identities=25%  Similarity=0.416  Sum_probs=72.6

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC--CCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.||++++|+|+|.++.+|+.+|++.+|+|+.+.|+.+....  .+...+|.+.|..+.++++..++.
T Consensus       242 ~~~DiWSlG~i-l~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  320 (398)
T 4b99_A          242 QAIDLWSVGCI-FGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQ  320 (398)
T ss_dssp             THHHHHHHHHH-HHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHH
T ss_pred             ChhheehhHHH-HHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHH
Confidence            56799999998 999999999999999999999999999999999998765443  234568899999999999999999


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      ++|++++|
T Consensus       321 ~~dLl~~m  328 (398)
T 4b99_A          321 ALSLLGRM  328 (398)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.86  E-value=7.4e-23  Score=215.34  Aligned_cols=48  Identities=40%  Similarity=0.706  Sum_probs=44.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCC-CCEEEeecccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFT  216 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~-g~vKL~DFGla~~~~  216 (562)
                      .|++||+.||+|||++|||||||||+|||++.+ |.+||+|||+|+...
T Consensus       121 ~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          121 EYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             HHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            689999999999999999999999999999876 899999999998654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.86  E-value=2.8e-22  Score=214.64  Aligned_cols=46  Identities=37%  Similarity=0.694  Sum_probs=44.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .+++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus       251 ~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          251 AVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceE
Confidence            6899999999999999999999999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.84  E-value=4.1e-22  Score=204.89  Aligned_cols=46  Identities=54%  Similarity=0.793  Sum_probs=44.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .+++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       130 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            6899999999999999999999999999999999999999999863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.84  E-value=4.1e-23  Score=229.72  Aligned_cols=95  Identities=19%  Similarity=0.126  Sum_probs=68.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTV  247 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~  247 (562)
                      -.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..........+.+||+.|||||++.+.  +..++
T Consensus       342 ~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~  419 (569)
T 4azs_A          342 EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNG  419 (569)
T ss_dssp             HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC----------
T ss_pred             HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcc
Confidence            4589999999999999999999999999999999999999999999887666666778999999999999764  67789


Q ss_pred             hHHHHHHHHHHHHhCCC
Q psy10954        248 DIWSAGCIFSEMITKKT  264 (562)
Q Consensus       248 DIWSlG~il~eLltG~~  264 (562)
                      |+||+|+++++|.++..
T Consensus       420 d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          420 FWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ---------CCCCTTHH
T ss_pred             cccccccchhhhccccc
Confidence            99999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.83  E-value=2.9e-22  Score=221.51  Aligned_cols=135  Identities=20%  Similarity=0.216  Sum_probs=111.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      +++.+|+++|++++||||+++..++...+..|||||||+ ++|.+++..         +..++.|++.||+|||++||+|
T Consensus       384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiH  454 (540)
T 3en9_A          384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIH  454 (540)
T ss_dssp             HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCcc
Confidence            447899999999999999955444446677899999997 599998865         5689999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcc-------cceeeeeccCCccceeccc-ccccccccccccccc
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNR-------YTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCI  164 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~-------~~~~~~t~~y~aPE~l~~~-~~~s~~~DvwSlG~i  164 (562)
                      |||||+|||++.  .+||+|||+|+........       ....++|+.|+|||++.+. ..|+..+|+||...-
T Consensus       455 rDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~  527 (540)
T 3en9_A          455 NDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILE  527 (540)
T ss_dssp             TTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHH
T ss_pred             CCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHH
Confidence            999999999998  9999999999877543221       1345789999999998752 447788899987643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.80  E-value=1.3e-20  Score=202.98  Aligned_cols=85  Identities=29%  Similarity=0.428  Sum_probs=68.4

Q ss_pred             CCCCccccchhhhhhccc-----------CCcccCCCC--------------------chhhHHHHHHhcCCCCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESIT-----------KKTLFAGDS--------------------EIDQLFRIFRTLGTPHEDVWPG  525 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~  525 (562)
                      ...|.||+||+ +.|+++           ++|+|||.+                    +.+|+.+|+..+|+|+++.|..
T Consensus       263 ~~~DiwSlG~i-l~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~  341 (458)
T 3rp9_A          263 EAIDVWSIGCI-FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA  341 (458)
T ss_dssp             THHHHHHHHHH-HHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cHhHHHHHHHH-HHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh
Confidence            46799999998 999998           999999987                    4899999999999999998876


Q ss_pred             ccc--CCCCCCCCCcccCccccccCCCCChhHHHHHhcC
Q psy10954        526 VSK--LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       526 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                      ..+  ...|...+|......+.+.++..++.+.|++++|
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m  380 (458)
T 3rp9_A          342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRM  380 (458)
T ss_dssp             SSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence            543  1223445777777888899999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.79  E-value=1e-19  Score=183.43  Aligned_cols=85  Identities=36%  Similarity=0.688  Sum_probs=79.4

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ...|.||+||+ +.|++++++.|+|.++.+++.+|++.+|+|....||....+|.|...++.+.|....++.+..++.+.
T Consensus       180 ~~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (288)
T 1ob3_A          180 TTIDIWSVGCI-FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI  258 (288)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHH
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHH
Confidence            34699999998 88999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++.+|
T Consensus       259 ~li~~~  264 (288)
T 1ob3_A          259 DLLSKM  264 (288)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.77  E-value=7.2e-20  Score=192.90  Aligned_cols=48  Identities=50%  Similarity=0.917  Sum_probs=45.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      .+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus       113 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A          113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             HHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            578899999999999999999999999999999999999999987653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.77  E-value=3.7e-19  Score=182.33  Aligned_cols=85  Identities=34%  Similarity=0.582  Sum_probs=72.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCC-----CC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILN-----LP  551 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  551 (562)
                      ...|.||+||+ +.|++++++.|+|..+.+++.+|++.+|+|+++.||.+.++|.|...+++..+..+.+.+.     ..
T Consensus       188 ~~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (317)
T 2pmi_A          188 TSIDIWSCGCI-LAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL  266 (317)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccC
Confidence            34699999998 8899999999999999999999999999999999999999999998888877776655442     45


Q ss_pred             ChhHHHHHhcC
Q psy10954        552 DPLAVDVFSRV  562 (562)
Q Consensus       552 ~~~~~~~~~~~  562 (562)
                      ++.+.|++.+|
T Consensus       267 ~~~l~~li~~~  277 (317)
T 2pmi_A          267 DGNLMDFLHGL  277 (317)
T ss_dssp             CHHHHHHHHHH
T ss_pred             CHHHHHHHHHH
Confidence            67777777653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.76  E-value=1.5e-19  Score=189.70  Aligned_cols=85  Identities=33%  Similarity=0.523  Sum_probs=70.6

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCccc--CCCCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPIYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|+++++++|+|....+|+.+|++.+|+|+++.|+.+..  ...|-..+|...+..+.++++..++.
T Consensus       205 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (367)
T 1cm8_A          205 QTVDIWSVGCI-MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL  283 (367)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred             hhhhHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence            45799999998 9999999999999999999999999999999988876532  11222346677777888888899999


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       284 ~~~ll~~m  291 (367)
T 1cm8_A          284 AVNLLEKM  291 (367)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.76  E-value=1.4e-18  Score=175.30  Aligned_cols=84  Identities=33%  Similarity=0.601  Sum_probs=70.4

Q ss_pred             CCCCccccchhhhhhcc-cCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCccc-CccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESI-TKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|++ .+.|.|+|....+++.+|++.+|+|.++.||...++|++.. +|.+. .....++.+..++.
T Consensus       181 ~~~DiwslG~i-l~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  258 (292)
T 3o0g_A          181 TSIDMWSAGCI-FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP-YPMYPATTSLVNVVPKLNAT  258 (292)
T ss_dssp             THHHHHHHHHH-HHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC-CCCCCTTCCCTTTSTTCCHH
T ss_pred             chHHHHHHHHH-HHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc-cccccCCcchhhcccccChH
Confidence            45799999998 66777 67889999999999999999999999999999999999875 55554 33466677778888


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++.+|
T Consensus       259 ~~~li~~~  266 (292)
T 3o0g_A          259 GRDLLQNL  266 (292)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88888764

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.76  E-value=5.3e-19  Score=178.27  Aligned_cols=85  Identities=47%  Similarity=0.876  Sum_probs=79.2

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ...|.||+|++ +-|++++++.|+|.++.+++.+|++.+|+|.+..||+...+|.|...+|.|....++...+..++...
T Consensus       183 ~~~Di~slG~~-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (299)
T 2r3i_A          183 TAVDIWSLGCI-FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR  261 (299)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHH
T ss_pred             hHHHHHHHHHH-HHHHHhCCCCCCCccHHHHHHHHHHHhCCCchhhhhHhhcCcccchhhhcccchhhHhhCCCCCHHHH
Confidence            34699999998 78999999999999999999999999999999999999999999999999999999999888899889


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      +++.+|
T Consensus       262 ~li~~~  267 (299)
T 2r3i_A          262 SLLSQM  267 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            988764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.75  E-value=1.4e-19  Score=194.17  Aligned_cols=85  Identities=27%  Similarity=0.401  Sum_probs=69.6

Q ss_pred             CCCCccccchhhhhhccc-----------CCcccCCCC-----------------chhhHHHHHHhcCCCCCCCCCCccc
Q psy10954        477 LSDDAVSIDVVTYHESIT-----------KKTLFAGDS-----------------EIDQLFRIFRTLGTPHEDVWPGVSK  528 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~  528 (562)
                      ...|.||+||+ +.|+++           ++|+|||.+                 ..+|+.+|+.++|+|+++.|....+
T Consensus       231 ~~~DiwSlG~i-l~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~  309 (432)
T 3n9x_A          231 KSIDIWSTGCI-FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK  309 (432)
T ss_dssp             THHHHHHHHHH-HHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             cccccchHHHH-HHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccC
Confidence            46799999999 899997           999999987                 5899999999999999998876532


Q ss_pred             --CCCCCCCCCcccCccccccCCCCChhHHHHHhcC
Q psy10954        529 --LPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSRV  562 (562)
Q Consensus       529 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  562 (562)
                        .-.|...+|...+..+.+..+..++.+.|++++|
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m  345 (432)
T 3n9x_A          310 PEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESM  345 (432)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence              1222345677777788888889999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.75  E-value=1e-18  Score=181.15  Aligned_cols=84  Identities=31%  Similarity=0.578  Sum_probs=70.5

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ...|.||+||+ +.|++++.|.|+|.++.+++.+|+..+|+|+++.||....+|+|.. +....+....++.+..++.+.
T Consensus       192 ~~~DiwslG~i-l~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  269 (346)
T 1ua2_A          192 VGVDMWAVGCI-LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLL  269 (346)
T ss_dssp             HHHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC-CCCCCCCCHHHHCTTCCHHHH
T ss_pred             chhhhHhHHHH-HHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc-ccccCCCChHHhhccCCHHHH
Confidence            34699999998 8899999999999999999999999999999999999999998753 444445556666777778888


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++.+|
T Consensus       270 ~li~~~  275 (346)
T 1ua2_A          270 DLIQGL  275 (346)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.75  E-value=1.6e-19  Score=189.80  Aligned_cols=85  Identities=29%  Similarity=0.470  Sum_probs=70.6

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccC--CCCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|+++++++|+|....+|+.+|++.+|+|+++.|+.+..-  ..|...+++..+..+.++++..++.
T Consensus       209 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (367)
T 2fst_X          209 QTVDIWSVGCI-MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL  287 (367)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHH
T ss_pred             chhhHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHH
Confidence            45799999998 99999999999999999999999999999999998877431  1122345666677788888889999


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       288 ~~dLl~~m  295 (367)
T 2fst_X          288 AVDLLEKM  295 (367)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99998864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.74  E-value=6e-20  Score=188.47  Aligned_cols=84  Identities=33%  Similarity=0.455  Sum_probs=67.6

Q ss_pred             HHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCc----ccceeeeeccCCccceecccc-----ccccc
Q psy10954         85 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAK-----VYSTT  155 (562)
Q Consensus        85 ~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~-----~~s~~  155 (562)
                      .++.++|+.+||||||||+|||++.++.+||+|||+|+.......    .....+||+.|||||++.+..     .|+.+
T Consensus       119 ~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k  198 (303)
T 3hmm_A          119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR  198 (303)
T ss_dssp             CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred             hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChh
Confidence            445678999999999999999999999999999999987653322    123457999999999997642     46889


Q ss_pred             cccccccccchhh
Q psy10954        156 VDIWSAGCIFSEM  168 (562)
Q Consensus       156 ~DvwSlG~il~Em  168 (562)
                      +|||||||++|||
T Consensus       199 ~DVwS~Gvvl~El  211 (303)
T 3hmm_A          199 ADIYAMGLVFWEI  211 (303)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HhhhhHHHHHHHH
Confidence            9999999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.74  E-value=1.1e-18  Score=178.36  Aligned_cols=85  Identities=38%  Similarity=0.592  Sum_probs=73.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCC-CCCcccCccccccCCCCChhH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILNLPDPLA  555 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  555 (562)
                      ...|.||+||+ +.|++++++.|+|..+.+++.+|++.+|+|....||....+|.+.. .+..+..+....+.+..++.+
T Consensus       199 ~~~DiwslG~i-l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (311)
T 3niz_A          199 TSVDIWSIGCI-FAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEG  277 (311)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHH
T ss_pred             chHHhHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHH
Confidence            34799999998 8899999999999999999999999999999999999988887643 466666677788888888889


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++++|
T Consensus       278 ~~li~~~  284 (311)
T 3niz_A          278 IDLLSNM  284 (311)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9988764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.73  E-value=1.1e-18  Score=186.65  Aligned_cols=83  Identities=30%  Similarity=0.501  Sum_probs=65.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC-CCCCcccCccccccC-CCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEIL-NLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|+|.++.+|+.+|++.+|+|+.+.|...  -|.|. ..||+.....+..++ +..++.
T Consensus       236 ~~~DiwSlG~i-l~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~  312 (420)
T 1j1b_A          236 SSIDVWSAGCV-LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKAHPWTKVFRPRTPPE  312 (420)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH--CSCCCCCCCCCCCCCCHHHHSCTTSCHH
T ss_pred             chhhhHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh--ChhhhhhccCccCCCCHHHhcCCCCCHH
Confidence            35799999998 89999999999999999999999999999999988654  23332 246666666665555 356788


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       313 ~~~Li~~~  320 (420)
T 1j1b_A          313 AIALCSRL  320 (420)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.72  E-value=7.6e-18  Score=171.14  Aligned_cols=82  Identities=30%  Similarity=0.570  Sum_probs=74.5

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ +.|++++++.|.|.++.+++.+|++.+|.|.++.||....+|  ...|+...+.....+.+..++.+.+
T Consensus       199 ~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  275 (308)
T 3g33_A          199 PVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQ  275 (308)
T ss_dssp             THHHHHHHHH-HHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSC--GGGSCCCCCCCHHHHSCSCCHHHHH
T ss_pred             hHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcc--ccccCCCCCCcHHHhCccccHHHHH
Confidence            4799999998 889999999999999999999999999999999999998888  4568888888888899999999999


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       276 li~~~  280 (308)
T 3g33_A          276 LLLEM  280 (308)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.72  E-value=1.9e-18  Score=177.54  Aligned_cols=85  Identities=28%  Similarity=0.542  Sum_probs=72.6

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC-CCCCcccCccccccCCCCChhH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNLPDPLA  555 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  555 (562)
                      ...|.||+|++ +.|++++++.|+|.+..+++..|++.+|+|.++.||+......+. ..+|.+.........+..++.+
T Consensus       180 ~~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (324)
T 3mtl_A          180 TQIDMWGVGCI-FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDG  258 (324)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHH
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHH
Confidence            35799999998 889999999999999999999999999999999999986665442 3577777777777778888999


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       259 ~~li~~~  265 (324)
T 3mtl_A          259 ADLLTKL  265 (324)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9988764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.72  E-value=1.2e-18  Score=184.57  Aligned_cols=83  Identities=36%  Similarity=0.608  Sum_probs=68.9

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCC-CCCCCcccCccccccCCC-CChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILNL-PDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|+|.+..+|+.+|++.+|+|+.+.|....  |.| ...||+..+..++..++. .++.
T Consensus       221 ~~~DiwSlG~i-l~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (394)
T 4e7w_A          221 TNIDIWSTGCV-MAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN--PNYMEHKFPQIRPHPFSKVFRPRTPPD  297 (394)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC--GGGSSSCCCCCCCCCHHHHSCTTCCHH
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC--hhhhhhccccccCCcHHHhccccCCHH
Confidence            45799999998 899999999999999999999999999999998876442  333 235888888888877764 7888


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       298 ~~~li~~~  305 (394)
T 4e7w_A          298 AIDLISRL  305 (394)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.72  E-value=3.6e-18  Score=178.39  Aligned_cols=46  Identities=37%  Similarity=0.691  Sum_probs=43.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       173 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          173 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCce
Confidence            3689999999999999999999999999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.72  E-value=9.4e-19  Score=189.73  Aligned_cols=49  Identities=29%  Similarity=0.428  Sum_probs=44.9

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCc
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV  526 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (562)
                      ...|.||+||+ +.|+++++++|+|....+|+.+|++.+|+|..+.|...
T Consensus       242 ~~~DiwSlG~i-l~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          242 ENVDIWSVGCI-MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             HHHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            35799999999 89999999999999999999999999999998877654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.70  E-value=8.9e-18  Score=175.68  Aligned_cols=45  Identities=42%  Similarity=0.749  Sum_probs=43.2

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       128 ~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          128 FYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             HHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            588999999999999999999999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.70  E-value=3.6e-18  Score=181.00  Aligned_cols=57  Identities=32%  Similarity=0.533  Sum_probs=50.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCc---------hhhHHHHHHhcCCCCCCCCCCcccCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSE---------IDQLFRIFRTLGTPHEDVWPGVSKLPIYKT  534 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (562)
                      ...|.||+||+ +.|++++++.|.|..+         .+|+.+|++.+|+|+++.|+...++|.+..
T Consensus       215 ~~~DiwSlG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  280 (405)
T 3rgf_A          215 KAIDIWAIGCI-FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST  280 (405)
T ss_dssp             HHHHHHHHHHH-HHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHH
T ss_pred             chhhhHHHHHH-HHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhh
Confidence            35799999998 8899999999998876         599999999999999999999999987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.69  E-value=1.9e-17  Score=172.34  Aligned_cols=48  Identities=44%  Similarity=0.767  Sum_probs=44.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC-CEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g-~vKL~DFGla~~~  215 (562)
                      ..|+.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+..
T Consensus       153 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            36899999999999999999999999999999998 6999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.68  E-value=1.8e-17  Score=173.48  Aligned_cols=47  Identities=43%  Similarity=0.853  Sum_probs=44.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       128 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          128 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             HHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence            36899999999999999999999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.68  E-value=1.7e-17  Score=168.16  Aligned_cols=46  Identities=46%  Similarity=0.948  Sum_probs=43.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..+++||+.||+|||++||+||||||+|||++++|.+||+|||+|+
T Consensus       115 ~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A          115 RRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCe
Confidence            3689999999999999999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.68  E-value=1.3e-17  Score=171.71  Aligned_cols=46  Identities=43%  Similarity=0.822  Sum_probs=44.2

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       136 ~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          136 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            6899999999999999999999999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.67  E-value=2.2e-17  Score=173.72  Aligned_cols=83  Identities=36%  Similarity=0.605  Sum_probs=66.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC-CCCCcccCccccccCCC-CChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK-TDFPEWRPKKFSEILNL-PDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|+|.++.+|+.+|++.+|+|+.+.|....  |.|. ..||.+..+.+..+++. .++.
T Consensus       221 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (383)
T 3eb0_A          221 PSIDLWSIGCV-FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSL  297 (383)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC--TTC--CCCCCCCCCCHHHHSCTTCCHH
T ss_pred             cchhhhhHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhC--cccccccCCccCcccHHhhCCCCCCHH
Confidence            35799999998 899999999999999999999999999999998775432  3343 35777777777777655 6777


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       298 ~~~li~~~  305 (383)
T 3eb0_A          298 AIDLLEQI  305 (383)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88888763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.66  E-value=3.4e-17  Score=166.13  Aligned_cols=104  Identities=23%  Similarity=0.243  Sum_probs=84.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|+.++  | +++++++.. +..|+|||||++ +|.+ +.     .  ..+..++.|++.||.|||++||+
T Consensus       148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~gii  215 (282)
T 1zar_A          148 IRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIV  215 (282)
T ss_dssp             HHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCE
Confidence            345789999999999  4 555555544 456999999976 8887 32     1  23567999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceec
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL  147 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~  147 (562)
                      ||||||+|||++ ++.+||+|||+|+..             ..+.|||++.
T Consensus       216 HrDlkp~NILl~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          216 HGDLSQYNVLVS-EEGIWIIDFPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             CSCCSTTSEEEE-TTEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred             eCCCCHHHEEEE-CCcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence            999999999999 999999999998633             3467888774

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.65  E-value=9.2e-17  Score=166.30  Aligned_cols=56  Identities=25%  Similarity=0.421  Sum_probs=51.0

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYK  533 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (562)
                      ...|.||+||+ +.|++++++.|.|..+.+++..|.+..|.++.+.||.....+.+.
T Consensus       208 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  263 (351)
T 3mi9_A          208 PPIDLWGAGCI-MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE  263 (351)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGT
T ss_pred             cHhHHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhc
Confidence            35799999998 889999999999999999999999999999999999987776554

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.63  E-value=7.2e-17  Score=168.44  Aligned_cols=85  Identities=22%  Similarity=0.398  Sum_probs=65.4

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC--CCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|+|....+++.+|...+|+|..+.|....++.  .+...+|...+..+.++.+..++.
T Consensus       211 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (364)
T 3qyz_A          211 KSIDIWSVGCI-LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK  289 (364)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHH
T ss_pred             cchhHHHHHHH-HHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHH
Confidence            45799999998 889999999999999999999999999999998887654322  112234444445566677777888


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++.+|
T Consensus       290 ~~~li~~~  297 (364)
T 3qyz_A          290 ALDLLDKM  297 (364)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88887653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.63  E-value=1.8e-16  Score=176.44  Aligned_cols=49  Identities=16%  Similarity=0.211  Sum_probs=44.2

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcc
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS  527 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (562)
                      ..|.||+||+ +.||+++++.|+|..+.+++.+|.+.-.++++..|++++
T Consensus       336 ~~DiWSlGvi-lyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  384 (573)
T 3uto_A          336 YTDMWSVGVL-SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS  384 (573)
T ss_dssp             HHHHHHHHHH-HHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred             HHHHHHHHHH-HHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCC
Confidence            4699999998 779999999999999999999999988888888888764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.58  E-value=6.8e-16  Score=159.35  Aligned_cols=85  Identities=24%  Similarity=0.409  Sum_probs=63.6

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC---CCCCCCCcccCccccccCCCCCh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP---IYKTDFPEWRPKKFSEILNLPDP  553 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  553 (562)
                      ...|.||+||+ +.|++++++.|+|.+..+++..|+..+|+|..+....+..-+   .+...+|.+....+.+..+..++
T Consensus       202 ~~~Di~slG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (353)
T 2b9h_A          202 RAMDVWSCGCI-LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNP  280 (353)
T ss_dssp             HHHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             chhhHHHHHHH-HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCH
Confidence            35799999998 889999999999999999999999999999866544332211   11223555555666677777788


Q ss_pred             hHHHHHhcC
Q psy10954        554 LAVDVFSRV  562 (562)
Q Consensus       554 ~~~~~~~~~  562 (562)
                      .+.+++.+|
T Consensus       281 ~~~~li~~~  289 (353)
T 2b9h_A          281 KGIDLLQRM  289 (353)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHh
Confidence            888887653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.58  E-value=8e-16  Score=157.01  Aligned_cols=46  Identities=46%  Similarity=0.803  Sum_probs=42.5

Q ss_pred             hhhHHHHHHHHHhhhcCc--eeecCCCCcceeecC-CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINK-SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~--IIHRDLKPeNILl~~-~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||+++  ||||||||+|||+++ +|.+||+|||+|+
T Consensus       132 ~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             HHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            368999999999999999  999999999999985 7999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.57  E-value=4.3e-15  Score=151.42  Aligned_cols=82  Identities=28%  Similarity=0.498  Sum_probs=67.4

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+|++ +.|++++++.|.|..+.+++.+|.+.+|.|.++.||....+|.  ..|.......+.++.+..++.+.+
T Consensus       199 ~~Di~slG~i-l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 1blx_A          199 PVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKD  275 (326)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG--GGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred             chhHHHHHHH-HHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch--hhhcccCcchhhhccccCCHHHHH
Confidence            4699999998 8899999999999999999999999999999999998877774  334444555566677777777888


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       276 li~~~  280 (326)
T 1blx_A          276 LLLKC  280 (326)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.57  E-value=4.4e-17  Score=167.21  Aligned_cols=94  Identities=30%  Similarity=0.450  Sum_probs=77.3

Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCc--ccceeeeeccCCccceeccc---
Q psy10954         75 LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGA---  149 (562)
Q Consensus        75 ~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~~t~~y~aPE~l~~~---  149 (562)
                      .+..++.+.+.|+.++|+.||+||||||+|||++.++.+||+|||+|+.......  ......+|+.|+|||++.+.   
T Consensus       132 ~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  211 (322)
T 3soc_A          132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF  211 (322)
T ss_dssp             HHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhccccccc
Confidence            3456666666788999999999999999999999999999999999987643222  23345789999999999763   


Q ss_pred             -cccccccccccccccchhh
Q psy10954        150 -KVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus       150 -~~~s~~~DvwSlG~il~Em  168 (562)
                       ..++.++||||+||+++||
T Consensus       212 ~~~~~~~~DiwslG~il~el  231 (322)
T 3soc_A          212 QRDAFLRIDMYAMGLVLWEL  231 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH
T ss_pred             CcCCCccchhHHHHHHHHHH
Confidence             4567789999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.56  E-value=1.1e-15  Score=171.48  Aligned_cols=45  Identities=36%  Similarity=0.685  Sum_probs=43.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus       296 ~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence            689999999999999999999999999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.56  E-value=2e-15  Score=160.45  Aligned_cols=45  Identities=42%  Similarity=0.732  Sum_probs=43.4

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       157 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          157 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             HHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            588999999999999999999999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.55  E-value=1.2e-15  Score=163.58  Aligned_cols=45  Identities=44%  Similarity=0.755  Sum_probs=42.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC--EEEeecccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLS  212 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~--vKL~DFGla  212 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.  +||+|||+|
T Consensus       203 ~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            357899999999999999999999999999999987  999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.55  E-value=1.9e-15  Score=155.47  Aligned_cols=47  Identities=34%  Similarity=0.669  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++||||||||+|||+++++.+||+|||+|+.
T Consensus       135 ~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          135 IDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             HHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            46899999999999999999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.55  E-value=2.9e-15  Score=155.60  Aligned_cols=46  Identities=39%  Similarity=0.781  Sum_probs=43.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       109 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A          109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            5789999999999999999999999999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.54  E-value=1e-15  Score=160.38  Aligned_cols=85  Identities=26%  Similarity=0.451  Sum_probs=63.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccC--CCCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|.|....+++.+|++.+|.|..+.++....-  ..+...+++.....+..+.+..++.
T Consensus       221 ~~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
T 4exu_A          221 QTVDIWSVGCI-MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ  299 (371)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHH
T ss_pred             cHHhHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChH
Confidence            35699999998 88999999999999999999999999999988776654210  1111234455555666667777788


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++.+|
T Consensus       300 ~~~li~~~  307 (371)
T 4exu_A          300 AADLLEKM  307 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88887653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.54  E-value=6.3e-16  Score=170.80  Aligned_cols=97  Identities=21%  Similarity=0.345  Sum_probs=81.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCc-------ccccccCCCccchhhhcC-
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-------YTHEVVTLWYRPPEILLG-  239 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~-------~~~~vgT~~Y~APEvl~~-  239 (562)
                      +.++.|++.||+|||++||+||||||+|||++.  .+||+|||+|+........       ..+.+||++|||||++.+ 
T Consensus       434 ~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~  511 (540)
T 3en9_A          434 LDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF  511 (540)
T ss_dssp             THHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHH
Confidence            368999999999999999999999999999999  9999999999987543221       246689999999999965 


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCC
Q psy10954        240 AKVYSTTVDIWSAGCIFSEMITKKTLF  266 (562)
Q Consensus       240 ~~~y~~~~DIWSlG~il~eLltG~~pF  266 (562)
                      ...|+..+|+||...-..+...++.+|
T Consensus       512 ~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          512 LEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            134788899999998888887776665

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.54  E-value=6.6e-16  Score=161.84  Aligned_cols=45  Identities=51%  Similarity=0.839  Sum_probs=41.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       131 ~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             HHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            578999999999999999999999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.54  E-value=3.5e-15  Score=156.05  Aligned_cols=47  Identities=34%  Similarity=0.644  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       124 ~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A          124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            35889999999999999999999999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.54  E-value=1.5e-15  Score=157.40  Aligned_cols=85  Identities=26%  Similarity=0.454  Sum_probs=61.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCC--CCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+|++ +.|++++++.|.|....+++..|.+.+|.|..+.|.....-.  .+...+|......+.++.+..++.
T Consensus       203 ~~~Di~slG~i-l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (353)
T 3coi_A          203 QTVDIWSVGCI-MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ  281 (353)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHH
T ss_pred             chhhHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHH
Confidence            34699999998 889999999999999999999999999999887766542110  011123444444555666666777


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++.+|
T Consensus       282 ~~~li~~~  289 (353)
T 3coi_A          282 AADLLEKM  289 (353)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            77777653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.54  E-value=3.7e-15  Score=155.32  Aligned_cols=46  Identities=41%  Similarity=0.776  Sum_probs=43.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       122 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A          122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            5789999999999999999999999999999999999999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.54  E-value=4e-15  Score=154.89  Aligned_cols=47  Identities=40%  Similarity=0.689  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       113 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A          113 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             HHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            35789999999999999999999999999999999999999999863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.51  E-value=8.4e-15  Score=146.25  Aligned_cols=96  Identities=18%  Similarity=0.261  Sum_probs=78.0

Q ss_pred             hHHHHHHHHHccCCCCc--ceEEEEEEeCCEEEEEeecCcC------CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         20 TALREISVLKELKHPNV--IRLHDVIPVDFKLFLVFEFLRQ------DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnI--v~L~~~~~~~~~i~lV~Ey~~~------~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      .+.+|+.+|+++.|++|  ..+++.    ...||||||+++      .|.++...    .++..+..++.|++.||.|||
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH  187 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLY  187 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHH
Confidence            57899999999988754  444442    256899999953      67665432    345568899999999999999


Q ss_pred             -HCCceeccCCCCcEEEccCCCeeEeecccccccc
Q psy10954         92 -SRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  125 (562)
Q Consensus        92 -~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~  125 (562)
                       ++|||||||||+|||++.  .++|+|||+|....
T Consensus       188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HTSCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HHCCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence             999999999999999988  99999999987553

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.51  E-value=9.9e-15  Score=148.05  Aligned_cols=47  Identities=40%  Similarity=0.731  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       119 ~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A          119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence            35789999999999999999999999999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.51  E-value=9.6e-15  Score=147.44  Aligned_cols=48  Identities=44%  Similarity=0.905  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       140 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  187 (298)
T 2zv2_A          140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF  187 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccc
Confidence            357899999999999999999999999999999999999999998653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.50  E-value=1.1e-14  Score=152.90  Aligned_cols=49  Identities=31%  Similarity=0.474  Sum_probs=44.3

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCc
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV  526 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (562)
                      ...|.||+||+ +.|++++++.|+|..+.+++.+|.+.+|.|+++.|+..
T Consensus       237 ~~~DiwSlG~i-l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          237 LAIDMWSLGCI-LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            35799999998 88999999999999999999999999999998777653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.50  E-value=4.5e-15  Score=152.48  Aligned_cols=45  Identities=53%  Similarity=1.144  Sum_probs=42.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       128 ~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A          128 KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             HHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence            578999999999999999999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.50  E-value=9.8e-15  Score=150.15  Aligned_cols=47  Identities=28%  Similarity=0.567  Sum_probs=44.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++||||||||+|||+++++.+||+|||+|+.
T Consensus       148 ~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~  194 (308)
T 4gt4_A          148 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE  194 (308)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCG
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCccccee
Confidence            46899999999999999999999999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.50  E-value=7.2e-15  Score=152.06  Aligned_cols=49  Identities=29%  Similarity=0.507  Sum_probs=44.5

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCc
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV  526 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (562)
                      ...|.||+|++ +.|++++++.|.|....+++..|.+.+|.|..+.|+..
T Consensus       211 ~~~Di~slG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          211 TAVDIWSVGCI-FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cHHHHHHHHHH-HHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            35799999998 88999999999999999999999999999998887544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.49  E-value=1.1e-14  Score=156.28  Aligned_cols=45  Identities=40%  Similarity=0.792  Sum_probs=42.9

Q ss_pred             hhHHHHHHHHHhhhc-CceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs-~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+
T Consensus       252 ~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          252 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             HHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             HHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            578999999999998 999999999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.48  E-value=8e-15  Score=152.17  Aligned_cols=85  Identities=22%  Similarity=0.339  Sum_probs=61.4

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCccc--CCC-CCCCCCcccCccccccCCCCCh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK--LPI-YKTDFPEWRPKKFSEILNLPDP  553 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~  553 (562)
                      ...|.||+||+ +.|++++++.|.|....+++.+|+..+|+|..+.|...+.  ..+ +...+....+..+..+.+..++
T Consensus       213 ~~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (362)
T 3pg1_A          213 KLVDMWSAGCV-MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP  291 (362)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCH
T ss_pred             cHhHHHhHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCH
Confidence            34699999998 8899999999999999999999999999998776543211  000 1122333444556666677777


Q ss_pred             hHHHHHhcC
Q psy10954        554 LAVDVFSRV  562 (562)
Q Consensus       554 ~~~~~~~~~  562 (562)
                      ...+++.+|
T Consensus       292 ~~~~li~~~  300 (362)
T 3pg1_A          292 VALDLIAKM  300 (362)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            788877653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.47  E-value=1.7e-14  Score=148.30  Aligned_cols=85  Identities=42%  Similarity=0.783  Sum_probs=76.1

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCC-CChhH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL-PDPLA  555 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  555 (562)
                      ...|.||+||+ +.|++++++.|+|.++.+++.+|++.+|.|....||++..+|.+...+|.+..+.+...++. .++.+
T Consensus       217 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (329)
T 3gbz_A          217 TSVDIWSIACI-WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEG  295 (329)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHH
T ss_pred             cHHHHHHHHHH-HHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHH
Confidence            45799999998 89999999999999999999999999999999999999999999999999998887766654 67778


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       296 ~~li~~~  302 (329)
T 3gbz_A          296 LDLLTAM  302 (329)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8887653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.47  E-value=1.6e-14  Score=146.40  Aligned_cols=47  Identities=49%  Similarity=0.892  Sum_probs=43.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       105 ~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A          105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            35788999999999999999999999999999999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.46  E-value=9.6e-15  Score=147.82  Aligned_cols=84  Identities=25%  Similarity=0.361  Sum_probs=57.0

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCccc-CCCCCCCCCcccCccccccCCCCChhHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSK-LPIYKTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ..|.||+|++ +.|++++++.|.|..+.+++.+|.+..+.+.++.|+.... +|.|...-.......+.+..+..++...
T Consensus       205 ~~Di~slG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (320)
T 2i6l_A          205 AIDMWAAGCI-FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV  283 (320)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHH
T ss_pred             hhhhHhHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHH
Confidence            4699999998 8899999999999999999999999999988877764321 2211110001112233444555666666


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      +++.+|
T Consensus       284 ~li~~~  289 (320)
T 2i6l_A          284 DFLEQI  289 (320)
T ss_dssp             HHHHTT
T ss_pred             HHHHHH
Confidence            666553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.46  E-value=2.7e-14  Score=146.16  Aligned_cols=50  Identities=38%  Similarity=0.711  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~  217 (562)
                      +.++.||++||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus       121 ~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~  170 (299)
T 4g31_A          121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ  170 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-----
T ss_pred             HHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCC
Confidence            46889999999999999999999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.45  E-value=4.6e-14  Score=144.84  Aligned_cols=47  Identities=38%  Similarity=0.699  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       144 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  190 (321)
T 2c30_A          144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  190 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence            35789999999999999999999999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.45  E-value=6.3e-14  Score=150.86  Aligned_cols=46  Identities=39%  Similarity=0.708  Sum_probs=43.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       179 ~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            5889999999999999999999999999999999999999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.43  E-value=5.6e-14  Score=143.53  Aligned_cols=46  Identities=43%  Similarity=0.837  Sum_probs=41.3

Q ss_pred             hhhHHHHHHHHHhhhcCc--eeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~--IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.|++.||+|||++|  |+||||||+|||++.+|.+||+|||+++
T Consensus       140 ~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             HHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            357899999999999999  9999999999999999999999999976

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.42  E-value=3.4e-14  Score=145.21  Aligned_cols=45  Identities=49%  Similarity=1.015  Sum_probs=42.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCC-CEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g-~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus       134 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            5789999999999999999999999999999777 89999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.41  E-value=6e-14  Score=144.31  Aligned_cols=46  Identities=35%  Similarity=0.685  Sum_probs=41.2

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCC---CEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g---~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       110 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A          110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            5789999999999999999999999999998766   799999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.40  E-value=1.3e-13  Score=144.76  Aligned_cols=48  Identities=29%  Similarity=0.447  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||.+...
T Consensus       131 ~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            357899999999999999999999999999999999999999987543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.40  E-value=6.9e-14  Score=146.04  Aligned_cols=46  Identities=24%  Similarity=0.222  Sum_probs=40.3

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCC------chhhHHHHHHhcCCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVW  523 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  523 (562)
                      ...|.||+||+ +.|++++++.|.|.+      +.+++.++++.+|.++.+.|
T Consensus       272 ~~~DiwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  323 (397)
T 1wak_A          272 TPADIWSTACM-AFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI  323 (397)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred             cHHHHHHHHHH-HHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence            35799999998 889999999999877      78999999999999876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.39  E-value=2.4e-13  Score=140.02  Aligned_cols=47  Identities=40%  Similarity=0.699  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       144 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          144 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            35789999999999999999999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.39  E-value=1.5e-13  Score=146.60  Aligned_cols=46  Identities=50%  Similarity=0.734  Sum_probs=43.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       172 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            5789999999999999999999999999999999999999999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.39  E-value=2.8e-13  Score=136.21  Aligned_cols=47  Identities=40%  Similarity=0.699  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       118 ~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A          118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence            35789999999999999999999999999999999999999999764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.39  E-value=1.5e-13  Score=136.93  Aligned_cols=47  Identities=36%  Similarity=0.704  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       115 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A          115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            35789999999999999999999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.39  E-value=1.7e-13  Score=141.99  Aligned_cols=46  Identities=20%  Similarity=0.218  Sum_probs=41.2

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW  523 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (562)
                      ...|.||+||+ +.|++++++.|.|..+.+++..+...+|.++.+.+
T Consensus       238 ~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~  283 (360)
T 3llt_A          238 VSSDMWSFGCV-LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNML  283 (360)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHH
T ss_pred             CccchHHHHHH-HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHH
Confidence            45799999998 88999999999999999999999999998886543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.38  E-value=1.4e-13  Score=142.24  Aligned_cols=45  Identities=47%  Similarity=0.918  Sum_probs=42.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       118 ~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A          118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             HHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            578999999999999999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.37  E-value=2.4e-13  Score=138.57  Aligned_cols=46  Identities=37%  Similarity=0.653  Sum_probs=43.1

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       133 ~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  178 (326)
T 2x7f_A          133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  178 (326)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred             HHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence            5789999999999999999999999999999999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.36  E-value=4.3e-13  Score=135.47  Aligned_cols=47  Identities=43%  Similarity=0.786  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       122 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A          122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  168 (303)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeeccccee
Confidence            35789999999999999999999999999999999999999999764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.36  E-value=4.1e-13  Score=143.38  Aligned_cols=46  Identities=39%  Similarity=0.725  Sum_probs=43.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus       166 ~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            5789999999999999999999999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.36  E-value=7.2e-13  Score=139.26  Aligned_cols=46  Identities=41%  Similarity=0.729  Sum_probs=41.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee--cCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl--~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||+  +.++.+||+|||+++
T Consensus       190 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            3578999999999999999999999999999  567889999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.35  E-value=3.7e-13  Score=152.46  Aligned_cols=45  Identities=36%  Similarity=0.660  Sum_probs=43.3

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       446 ~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             HHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            588999999999999999999999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.35  E-value=4.5e-13  Score=134.27  Aligned_cols=46  Identities=52%  Similarity=0.901  Sum_probs=43.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecC-CCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~-~g~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++||+||||||+||+++. +|.+||+|||+++.
T Consensus       126 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A          126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             HHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence            46889999999999999999999999999987 89999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.35  E-value=5.7e-13  Score=135.07  Aligned_cols=47  Identities=47%  Similarity=0.705  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       128 ~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          128 ATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            35789999999999999999999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.32  E-value=6.8e-13  Score=134.41  Aligned_cols=46  Identities=50%  Similarity=0.874  Sum_probs=39.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       140 ~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             HHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            5789999999999999999999999999999999999999998754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.30  E-value=7.1e-13  Score=138.81  Aligned_cols=48  Identities=38%  Similarity=0.778  Sum_probs=45.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++||||||||+|||+++++.+||+|||+|+..
T Consensus       188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~  235 (353)
T 4ase_A          188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI  235 (353)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             HHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhc
Confidence            468899999999999999999999999999999999999999999854

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.30  E-value=1.3e-12  Score=137.56  Aligned_cols=45  Identities=47%  Similarity=0.797  Sum_probs=43.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       143 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            578999999999999999999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.30  E-value=5.4e-13  Score=136.56  Aligned_cols=48  Identities=31%  Similarity=0.569  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++||||||||+|||+++++.+||+|||+|+..
T Consensus       131 ~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~  178 (299)
T 4asz_A          131 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV  178 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceec
Confidence            468999999999999999999999999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.30  E-value=1.3e-12  Score=137.00  Aligned_cols=46  Identities=41%  Similarity=0.814  Sum_probs=42.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC----CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g----~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.++    .+||+|||+++
T Consensus       118 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A          118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            36889999999999999999999999999998877    79999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.30  E-value=6.4e-13  Score=135.14  Aligned_cols=47  Identities=43%  Similarity=0.781  Sum_probs=43.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       119 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A          119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             HHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            36789999999999999999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.30  E-value=8.9e-13  Score=135.41  Aligned_cols=46  Identities=41%  Similarity=0.743  Sum_probs=42.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC--CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK--SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~--~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.  ++.+||+|||+++
T Consensus       105 ~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A          105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            357899999999999999999999999999987  7899999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.30  E-value=1.7e-12  Score=133.37  Aligned_cols=47  Identities=45%  Similarity=0.837  Sum_probs=43.1

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCC--CEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g--~vKL~DFGla~~~  215 (562)
                      .++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++..
T Consensus       172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~  220 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF  220 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence            4789999999999999999999999999998776  8999999997643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.29  E-value=5.4e-13  Score=132.74  Aligned_cols=47  Identities=45%  Similarity=0.833  Sum_probs=43.1

Q ss_pred             hhhHHHHHHHHHhhhcCc-----eeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~-----IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||+++     |+||||||+||+++.+|.+||+|||+++.
T Consensus       114 ~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A          114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             HHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            467899999999999999     99999999999999999999999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.29  E-value=2.9e-12  Score=135.56  Aligned_cols=45  Identities=40%  Similarity=0.846  Sum_probs=43.1

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       119 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A          119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence            578999999999999999999999999999999999999999874

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.29  E-value=6.5e-13  Score=134.57  Aligned_cols=56  Identities=29%  Similarity=0.250  Sum_probs=51.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL  238 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~  238 (562)
                      .++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|+             .+..|+|||++.
T Consensus       197 ~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~-------------~~~~~~a~e~l~  252 (282)
T 1zar_A          197 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGEEGWREILE  252 (282)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE-------------ETTSTTHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe-------------ECCCCCHHHHHH
Confidence            5889999999999999999999999999999 9999999999985             356789999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.28  E-value=2.5e-12  Score=132.22  Aligned_cols=45  Identities=49%  Similarity=0.862  Sum_probs=42.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       110 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A          110 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcce
Confidence            578999999999999999999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.28  E-value=1e-12  Score=136.33  Aligned_cols=48  Identities=29%  Similarity=0.543  Sum_probs=41.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++||||||||+|||+++++.+||+|||+|+..
T Consensus       161 ~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~  208 (329)
T 4aoj_A          161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  208 (329)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             HHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceec
Confidence            468999999999999999999999999999999999999999998753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.28  E-value=1.1e-12  Score=133.05  Aligned_cols=48  Identities=33%  Similarity=0.503  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       137 ~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            357899999999999999999999999999999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.27  E-value=1.6e-12  Score=141.30  Aligned_cols=46  Identities=43%  Similarity=0.838  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       119 ~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A          119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             HHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence            3588999999999999999999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.27  E-value=2.8e-12  Score=135.69  Aligned_cols=46  Identities=37%  Similarity=0.730  Sum_probs=41.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC--CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK--SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~--~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.  .+.+||+|||+|+
T Consensus       152 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccce
Confidence            367899999999999999999999999999974  5789999999865

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.27  E-value=2.7e-12  Score=131.78  Aligned_cols=47  Identities=38%  Similarity=0.764  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       108 ~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A          108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (323)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence            36789999999999999999999999999999999999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.27  E-value=3.9e-12  Score=133.00  Aligned_cols=46  Identities=50%  Similarity=0.922  Sum_probs=41.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCC---CCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---GALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~---g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+++
T Consensus       131 ~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             HHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            3578999999999999999999999999999865   459999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.27  E-value=8.8e-13  Score=134.44  Aligned_cols=47  Identities=30%  Similarity=0.562  Sum_probs=43.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee----cCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl----~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||+    +.++.+||+|||+|+.
T Consensus       115 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A          115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            3578999999999999999999999999999    7788899999998753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.26  E-value=2e-12  Score=134.18  Aligned_cols=43  Identities=44%  Similarity=0.690  Sum_probs=38.7

Q ss_pred             hhhHHHHHHHHHhhhcC-ceeecCCCCcceeec------CCCCEEEeecc
Q psy10954        168 MSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------KSGALKLADFG  210 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~-~IIHRDLKPeNILl~------~~g~vKL~DFG  210 (562)
                      ..++.||+.||+|||++ ||+||||||+|||++      ..+.+||+|||
T Consensus       134 ~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg  183 (373)
T 1q8y_A          134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG  183 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred             HHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccc
Confidence            35789999999999998 999999999999995      34479999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.25  E-value=3.4e-12  Score=131.11  Aligned_cols=46  Identities=41%  Similarity=0.732  Sum_probs=42.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC----CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g----~vKL~DFGla~  213 (562)
                      ..++.|++.||.|||++||+||||||+|||++.++    .+||+|||+++
T Consensus       117 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A          117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            35789999999999999999999999999999887    89999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.25  E-value=3.2e-12  Score=138.58  Aligned_cols=46  Identities=43%  Similarity=0.804  Sum_probs=41.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeec---CCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~---~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+
T Consensus       124 ~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             HHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            35789999999999999999999999999995   45679999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.25  E-value=4e-12  Score=138.22  Aligned_cols=49  Identities=22%  Similarity=0.257  Sum_probs=42.1

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcc
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS  527 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (562)
                      ..|.||+||+ +.|++++++.|+|.++.+.+.+|.+....+....|+.++
T Consensus       217 ~~DiwslG~i-l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  265 (494)
T 3lij_A          217 KCDVWSIGVI-LFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS  265 (494)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred             chhHHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence            4699999998 669999999999999999999998877777777777653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.24  E-value=3.7e-12  Score=140.65  Aligned_cols=46  Identities=39%  Similarity=0.733  Sum_probs=43.6

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       293 ~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            5789999999999999999999999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.24  E-value=4.9e-12  Score=129.73  Aligned_cols=46  Identities=48%  Similarity=0.865  Sum_probs=42.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.   +|.+||+|||+++
T Consensus       134 ~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          134 IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             HHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            367899999999999999999999999999987   7999999999865

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.24  E-value=2.7e-12  Score=138.92  Aligned_cols=45  Identities=42%  Similarity=0.865  Sum_probs=41.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceee---cCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl---~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+
T Consensus       130 ~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            578999999999999999999999999999   467899999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.24  E-value=6.1e-12  Score=129.14  Aligned_cols=48  Identities=33%  Similarity=0.582  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       154 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            467899999999999999999999999999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.23  E-value=4e-12  Score=132.23  Aligned_cols=45  Identities=42%  Similarity=0.697  Sum_probs=42.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS  212 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla  212 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus       157 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          157 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence            357899999999999999999999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.23  E-value=1.1e-12  Score=136.24  Aligned_cols=46  Identities=46%  Similarity=0.935  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       111 ~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B          111 RRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            3678999999999999999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.23  E-value=4.4e-12  Score=140.90  Aligned_cols=46  Identities=37%  Similarity=0.683  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       289 ~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence            3578999999999999999999999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.22  E-value=4.5e-12  Score=131.86  Aligned_cols=46  Identities=41%  Similarity=0.648  Sum_probs=43.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       163 ~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            5788999999999999999999999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.22  E-value=4.3e-12  Score=128.70  Aligned_cols=46  Identities=37%  Similarity=0.658  Sum_probs=42.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC---EEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~---vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus       115 ~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A          115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             HHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            57899999999999999999999999999998776   99999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.21  E-value=7.6e-12  Score=124.40  Aligned_cols=46  Identities=43%  Similarity=0.810  Sum_probs=42.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee---cCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl---~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       109 ~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A          109 ARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            3578999999999999999999999999999   778999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.21  E-value=1.1e-11  Score=124.66  Aligned_cols=48  Identities=31%  Similarity=0.680  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       131 ~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            357889999999999999999999999999999999999999997643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.21  E-value=8.3e-12  Score=131.81  Aligned_cols=46  Identities=48%  Similarity=0.771  Sum_probs=42.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.
T Consensus       158 ~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            35789999999999999999999999999995 58999999999764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.20  E-value=1.1e-11  Score=129.43  Aligned_cols=46  Identities=46%  Similarity=0.813  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       203 ~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          203 RSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            3688999999999999999999999999999999999999999865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.20  E-value=6.5e-12  Score=131.39  Aligned_cols=46  Identities=28%  Similarity=0.561  Sum_probs=41.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC---CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g---~vKL~DFGla~  213 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|   .+||+|||+|+
T Consensus       184 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~  232 (367)
T 3l9p_A          184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  232 (367)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence            35789999999999999999999999999999665   49999999865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.19  E-value=4.4e-12  Score=132.46  Aligned_cols=46  Identities=50%  Similarity=0.825  Sum_probs=41.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC--EEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~--vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.++.  +||+|||+|+
T Consensus       119 ~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A          119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            357899999999999999999999999999987765  9999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.19  E-value=2.4e-11  Score=124.85  Aligned_cols=46  Identities=43%  Similarity=0.804  Sum_probs=43.2

Q ss_pred             hhhHHHHHHHHHhhhc-CceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs-~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||+++
T Consensus       154 ~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  200 (348)
T 2pml_X          154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE  200 (348)
T ss_dssp             HHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEecccccc
Confidence            3578999999999999 999999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.17  E-value=3.4e-12  Score=134.80  Aligned_cols=46  Identities=30%  Similarity=0.574  Sum_probs=42.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee----cCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl----~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||+    +.++.+||+|||+|+
T Consensus       115 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A          115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             HHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            3578999999999999999999999999999    777889999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.17  E-value=1.3e-11  Score=134.54  Aligned_cols=46  Identities=41%  Similarity=0.810  Sum_probs=42.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC---CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g---~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|   .+||+|||+|+
T Consensus       149 ~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  197 (504)
T 3q5i_A          149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS  197 (504)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCE
Confidence            35789999999999999999999999999999876   69999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.16  E-value=1.8e-11  Score=124.97  Aligned_cols=46  Identities=41%  Similarity=0.814  Sum_probs=42.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC----CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g----~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+||+++.++    .+||+|||+++
T Consensus       118 ~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A          118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            35789999999999999999999999999999888    79999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.16  E-value=1.9e-11  Score=122.57  Aligned_cols=47  Identities=43%  Similarity=0.738  Sum_probs=43.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       124 ~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A          124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            35789999999999999999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.16  E-value=4.2e-11  Score=119.33  Aligned_cols=45  Identities=49%  Similarity=0.932  Sum_probs=41.1

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC---EEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~---vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+||+++.++.   +||+|||++.
T Consensus       109 ~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A          109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            57899999999999999999999999999987655   9999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.14  E-value=2.9e-11  Score=127.84  Aligned_cols=93  Identities=16%  Similarity=0.207  Sum_probs=67.6

Q ss_pred             HHHHHHHHHccCCCCc--ceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         21 ALREISVLKELKHPNV--IRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnI--v~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      +.+|...|.++.+.++  ...++.  .  ..+|||||+++ +|.++.       ..+.++.++.|++.||.|||++||||
T Consensus       160 A~kE~~nL~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVH  228 (397)
T 4gyi_A          160 AIKEFAFMKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIH  228 (397)
T ss_dssp             HHHHHHHHHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcC
Confidence            3467777777755443  222322  2  23799999986 664331       12245678899999999999999999


Q ss_pred             ccCCCCcEEEccCCC----------eeEeeccccccc
Q psy10954         98 RDLKPQNILINKSGA----------LKLADFGLSRAF  124 (562)
Q Consensus        98 RDLKP~NILl~~~~~----------vKL~DFGla~~~  124 (562)
                      |||||.|||++.+|.          +.|+||+-+-..
T Consensus       229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999999988763          789999976443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.13  E-value=5.5e-11  Score=119.30  Aligned_cols=46  Identities=43%  Similarity=0.690  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++
T Consensus       127 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A          127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            3578999999999999999999999999999999999999999865

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.12  E-value=2e-11  Score=137.31  Aligned_cols=47  Identities=32%  Similarity=0.595  Sum_probs=44.3

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus       473 ~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          473 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            57899999999999999999999999999999999999999998653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.11  E-value=1.8e-11  Score=125.82  Aligned_cols=43  Identities=35%  Similarity=0.389  Sum_probs=36.0

Q ss_pred             hhhHHHHHHHHHhhh-cCceeecCCCCcceeecCCCCEEEeeccc
Q psy10954        168 MSYLYQLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGL  211 (562)
Q Consensus       168 m~~l~QIl~gL~yLH-s~~IIHRDLKPeNILl~~~g~vKL~DFGl  211 (562)
                      ..++.||+.||+||| ++||+||||||+|||++.+|.- ..+|+.
T Consensus       164 ~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~-~~~~~~  207 (336)
T 2vuw_A          164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLHYTL  207 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCS-EEEEEE
T ss_pred             HHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCc-ceeeec
Confidence            468999999999999 9999999999999999987642 234544

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.09  E-value=4.3e-11  Score=124.47  Aligned_cols=42  Identities=33%  Similarity=0.635  Sum_probs=40.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC-----------CCCEEEeec
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-----------SGALKLADF  209 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~-----------~g~vKL~DF  209 (562)
                      +.++.||+.||+|||++||+||||||+|||++.           ++.+||+||
T Consensus       175 ~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DF  227 (365)
T 3e7e_A          175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL  227 (365)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCC
T ss_pred             HHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeC
Confidence            468999999999999999999999999999998           899999999

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.08  E-value=4.4e-11  Score=124.80  Aligned_cols=45  Identities=24%  Similarity=0.367  Sum_probs=42.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~  242 (371)
T 3q60_A          198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW  242 (371)
T ss_dssp             HHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEE
T ss_pred             HHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceee
Confidence            445999999999999999999999999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.08  E-value=5.4e-11  Score=120.73  Aligned_cols=51  Identities=37%  Similarity=0.688  Sum_probs=47.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccC
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP  218 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~  218 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            468899999999999999999999999999999999999999999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.08  E-value=5.1e-11  Score=124.67  Aligned_cols=45  Identities=22%  Similarity=0.408  Sum_probs=43.4

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       210 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~  254 (377)
T 3byv_A          210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV  254 (377)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCE
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhhe
Confidence            589999999999999999999999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.08  E-value=8e-11  Score=118.89  Aligned_cols=45  Identities=42%  Similarity=0.809  Sum_probs=41.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceee---cCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl---~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++
T Consensus       110 ~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A          110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            578999999999999999999999999999   778999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.07  E-value=5.4e-11  Score=126.55  Aligned_cols=47  Identities=21%  Similarity=0.406  Sum_probs=43.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       214 ~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~  260 (413)
T 3dzo_A          214 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR  260 (413)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceee
Confidence            34669999999999999999999999999999999999999999764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.06  E-value=7.8e-11  Score=132.96  Aligned_cols=46  Identities=48%  Similarity=0.837  Sum_probs=43.6

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       495 ~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             HHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            5789999999999999999999999999999999999999999754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.03  E-value=1.2e-10  Score=119.11  Aligned_cols=48  Identities=23%  Similarity=0.585  Sum_probs=45.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       118 ~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A          118 LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            467899999999999999999999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.02  E-value=1.2e-10  Score=121.20  Aligned_cols=49  Identities=29%  Similarity=0.638  Sum_probs=45.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeec--CCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~--~~g~vKL~DFGla~~~~  216 (562)
                      +.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+...
T Consensus       155 ~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~  205 (364)
T 3op5_A          155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC  205 (364)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESS
T ss_pred             HHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecc
Confidence            46899999999999999999999999999999  88999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.02  E-value=1.3e-10  Score=121.67  Aligned_cols=47  Identities=43%  Similarity=0.788  Sum_probs=44.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       206 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  252 (370)
T 2psq_A          206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD  252 (370)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             HHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcc
Confidence            35789999999999999999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.00  E-value=1.6e-10  Score=120.32  Aligned_cols=46  Identities=39%  Similarity=0.751  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       144 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence            3588999999999999999999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.00  E-value=2e-10  Score=115.25  Aligned_cols=50  Identities=34%  Similarity=0.537  Sum_probs=46.1

Q ss_pred             hhhHHHHHHHHHhhh--------cCceeecCCCCcceeecCCCCEEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCH--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLH--------s~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~  217 (562)
                      +.++.|++.||+|||        +++|+||||||+|||++.++.+||+|||+|+....
T Consensus       108 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  165 (301)
T 3q4u_A          108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ  165 (301)
T ss_dssp             HHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             HHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence            468899999999999        99999999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=98.99  E-value=1.4e-10  Score=117.92  Aligned_cols=46  Identities=43%  Similarity=0.663  Sum_probs=43.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||+++|+||||||+|||++.+|.+||+|||+++.
T Consensus       161 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            5789999999999999999999999999999999999999999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=98.99  E-value=1.1e-10  Score=119.75  Aligned_cols=48  Identities=31%  Similarity=0.739  Sum_probs=45.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       120 ~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A          120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             HHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            467899999999999999999999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=98.98  E-value=1.9e-10  Score=117.01  Aligned_cols=48  Identities=33%  Similarity=0.627  Sum_probs=42.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       140 ~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~  187 (323)
T 3qup_A          140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI  187 (323)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             HHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccc
Confidence            367899999999999999999999999999999999999999998643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=98.97  E-value=2.4e-10  Score=117.04  Aligned_cols=50  Identities=34%  Similarity=0.714  Sum_probs=45.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC-----EEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~-----vKL~DFGla~~~~~  217 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.     +||+|||+|+....
T Consensus       108 ~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A          108 LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             HHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            468899999999999999999999999999998887     99999999987643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=98.97  E-value=2.4e-10  Score=117.37  Aligned_cols=45  Identities=49%  Similarity=0.792  Sum_probs=42.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       125 ~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A          125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             HHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            578999999999999999999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=98.97  E-value=2.7e-10  Score=114.98  Aligned_cols=47  Identities=45%  Similarity=0.880  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       114 ~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A          114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            36789999999999999999999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=98.96  E-value=3e-10  Score=114.99  Aligned_cols=49  Identities=37%  Similarity=0.664  Sum_probs=45.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       111 ~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A          111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            3678999999999999999999999999999999999999999987654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=98.96  E-value=3.3e-10  Score=113.17  Aligned_cols=50  Identities=34%  Similarity=0.687  Sum_probs=45.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee---cCCCCEEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl---~~~g~vKL~DFGla~~~~~  217 (562)
                      ..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       108 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A          108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            3678999999999999999999999999999   7889999999999987643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=98.96  E-value=3.1e-10  Score=115.94  Aligned_cols=49  Identities=35%  Similarity=0.606  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHHHhhhcC---------ceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSR---------RIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~---------~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++         ||+||||||+|||++.+|.+||+|||+|+...
T Consensus       114 ~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~  171 (336)
T 3g2f_A          114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT  171 (336)
T ss_dssp             HHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             HHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecc
Confidence            35789999999999999         99999999999999999999999999987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=98.96  E-value=2e-10  Score=117.97  Aligned_cols=48  Identities=31%  Similarity=0.739  Sum_probs=42.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       120 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A          120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             HHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            467899999999999999999999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=98.95  E-value=4.1e-10  Score=112.69  Aligned_cols=50  Identities=26%  Similarity=0.533  Sum_probs=45.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC-----EEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~-----vKL~DFGla~~~~~  217 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.     +||+|||+++....
T Consensus       109 ~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A          109 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             HHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            368899999999999999999999999999987776     99999999986643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=98.95  E-value=3.2e-10  Score=120.13  Aligned_cols=46  Identities=41%  Similarity=0.725  Sum_probs=43.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.   +|.+||+|||+++
T Consensus       164 ~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            368999999999999999999999999999997   7899999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=98.95  E-value=2.9e-10  Score=117.21  Aligned_cols=48  Identities=38%  Similarity=0.778  Sum_probs=44.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       196 ~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence            468899999999999999999999999999999999999999998643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=98.95  E-value=3.5e-10  Score=114.09  Aligned_cols=48  Identities=35%  Similarity=0.762  Sum_probs=44.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       153 ~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~  200 (314)
T 2ivs_A          153 ISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV  200 (314)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccc
Confidence            367899999999999999999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=98.95  E-value=2.2e-10  Score=114.37  Aligned_cols=47  Identities=47%  Similarity=0.837  Sum_probs=39.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       119 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A          119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             HHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence            35789999999999999999999999999999999999999999764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=98.95  E-value=2.5e-10  Score=114.62  Aligned_cols=49  Identities=35%  Similarity=0.733  Sum_probs=43.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       117 ~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A          117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             HHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            3578999999999999999999999999999999999999999987653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=98.95  E-value=3.6e-10  Score=113.18  Aligned_cols=48  Identities=33%  Similarity=0.659  Sum_probs=44.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       127 ~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            367899999999999999999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=98.94  E-value=4e-10  Score=118.07  Aligned_cols=46  Identities=35%  Similarity=0.611  Sum_probs=43.8

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       217 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             HHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            5789999999999999999999999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=98.94  E-value=7.1e-10  Score=110.88  Aligned_cols=50  Identities=34%  Similarity=0.684  Sum_probs=45.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeec---CCCCEEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~---~~g~vKL~DFGla~~~~~  217 (562)
                      ..++.|++.||+|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       108 ~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A          108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             HHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            35789999999999999999999999999994   789999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=98.93  E-value=3.9e-10  Score=118.22  Aligned_cols=48  Identities=40%  Similarity=0.769  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       194 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~  241 (382)
T 3tt0_A          194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI  241 (382)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCS
T ss_pred             HHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCccccc
Confidence            367899999999999999999999999999999999999999998643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=98.92  E-value=5e-10  Score=114.89  Aligned_cols=48  Identities=29%  Similarity=0.701  Sum_probs=44.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       175 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~  222 (344)
T 1rjb_A          175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI  222 (344)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCG
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCccc
Confidence            357899999999999999999999999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=98.92  E-value=5.2e-10  Score=114.00  Aligned_cols=49  Identities=39%  Similarity=0.636  Sum_probs=45.4

Q ss_pred             hhhHHHHHHHHHhhhcC--------ceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSR--------RIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~--------~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||++        ||+||||||+|||++.+|.+||+|||+|+...
T Consensus       137 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~  193 (337)
T 3mdy_A          137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI  193 (337)
T ss_dssp             HHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeec
Confidence            36789999999999999        99999999999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=98.92  E-value=3.7e-10  Score=116.51  Aligned_cols=47  Identities=47%  Similarity=0.766  Sum_probs=43.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+|||++ +|.+||+|||+|+..
T Consensus       111 ~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A          111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            36789999999999999999999999999997 688999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=98.92  E-value=4.6e-10  Score=120.69  Aligned_cols=47  Identities=40%  Similarity=0.684  Sum_probs=44.3

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus       288 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            57899999999999999999999999999999999999999998753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=98.92  E-value=4.7e-10  Score=113.54  Aligned_cols=47  Identities=28%  Similarity=0.613  Sum_probs=43.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       150 ~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~  196 (313)
T 3brb_A          150 LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK  196 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC--
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCccee
Confidence            46789999999999999999999999999999999999999999764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=98.92  E-value=5e-10  Score=115.52  Aligned_cols=46  Identities=39%  Similarity=0.589  Sum_probs=43.5

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       134 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            5789999999999999999999999999999999999999998753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=98.91  E-value=4.5e-10  Score=117.93  Aligned_cols=48  Identities=29%  Similarity=0.661  Sum_probs=40.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       195 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          195 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             HHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            357889999999999999999999999999999999999999998754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=98.91  E-value=5e-10  Score=112.46  Aligned_cols=49  Identities=35%  Similarity=0.713  Sum_probs=45.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       129 ~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            3578999999999999999999999999999999999999999987654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=98.91  E-value=5.6e-10  Score=113.29  Aligned_cols=48  Identities=23%  Similarity=0.585  Sum_probs=44.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       141 ~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~  188 (322)
T 1p4o_A          141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI  188 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccc
Confidence            357899999999999999999999999999999999999999998643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=98.91  E-value=8.4e-10  Score=120.11  Aligned_cols=50  Identities=28%  Similarity=0.679  Sum_probs=45.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee---cCCCCEEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl---~~~g~vKL~DFGla~~~~~  217 (562)
                      +.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       106 ~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A          106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             HHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            4678999999999999999999999999999   5889999999999987653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=98.91  E-value=5.7e-10  Score=111.12  Aligned_cols=47  Identities=40%  Similarity=0.732  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       123 ~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A          123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             HHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            36789999999999999999999999999999999999999999764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=98.91  E-value=6.4e-10  Score=109.85  Aligned_cols=47  Identities=32%  Similarity=0.674  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       107 ~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A          107 LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            35789999999999999999999999999999999999999999764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=98.91  E-value=5.7e-10  Score=115.16  Aligned_cols=49  Identities=31%  Similarity=0.600  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC--CEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g--~vKL~DFGla~~~~  216 (562)
                      ..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+...
T Consensus       154 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~  204 (345)
T 2v62_A          154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC  204 (345)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESS
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecc
Confidence            46889999999999999999999999999999877  99999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=98.90  E-value=3.8e-10  Score=115.42  Aligned_cols=47  Identities=36%  Similarity=0.650  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       177 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  223 (343)
T 1luf_A          177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN  223 (343)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcc
Confidence            35789999999999999999999999999999999999999999764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=98.90  E-value=7.2e-10  Score=112.86  Aligned_cols=47  Identities=38%  Similarity=0.644  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       142 ~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          142 LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            46789999999999999999999999999999999999999999764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.90  E-value=8.4e-10  Score=109.83  Aligned_cols=46  Identities=17%  Similarity=0.321  Sum_probs=42.4

Q ss_pred             hhhHHHHHHHHHhhh-cCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLH-s~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||.||| ++||+||||||+|||++.  .++|+|||+|...
T Consensus       173 ~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          173 EGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            357899999999999 999999999999999998  9999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=98.90  E-value=5.6e-10  Score=117.02  Aligned_cols=49  Identities=35%  Similarity=0.600  Sum_probs=40.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       150 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             HHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            4578999999999999999999999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=98.89  E-value=6.8e-10  Score=111.92  Aligned_cols=48  Identities=38%  Similarity=0.715  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  195 (313)
T 1t46_A          148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI  195 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCT
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccc
Confidence            357899999999999999999999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.89  E-value=5.8e-10  Score=110.37  Aligned_cols=47  Identities=30%  Similarity=0.612  Sum_probs=44.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       109 ~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A          109 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccc
Confidence            35789999999999999999999999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=98.89  E-value=5.4e-10  Score=112.03  Aligned_cols=47  Identities=36%  Similarity=0.699  Sum_probs=41.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       123 ~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A          123 IDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             HHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence            35789999999999999999999999999999999999999998753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=98.89  E-value=5.1e-10  Score=114.31  Aligned_cols=48  Identities=29%  Similarity=0.619  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       167 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  214 (333)
T 2i1m_A          167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI  214 (333)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCG
T ss_pred             HHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccccccc
Confidence            357899999999999999999999999999999999999999998754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=98.89  E-value=8.2e-10  Score=109.71  Aligned_cols=48  Identities=38%  Similarity=0.658  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       112 ~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A          112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            467899999999999999999999999999999999999999998653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=98.89  E-value=6.9e-10  Score=112.04  Aligned_cols=48  Identities=38%  Similarity=0.778  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       151 ~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  198 (316)
T 2xir_A          151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI  198 (316)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             HHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcccccc
Confidence            357899999999999999999999999999999999999999998653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.88  E-value=8.6e-10  Score=111.25  Aligned_cols=45  Identities=42%  Similarity=0.721  Sum_probs=42.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeecccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLS  212 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla  212 (562)
                      ..++.|++.||+|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       120 ~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A          120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            357899999999999999999999999999998   789999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=98.88  E-value=7.9e-10  Score=118.81  Aligned_cols=46  Identities=30%  Similarity=0.706  Sum_probs=43.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.|++.||+|||+++|+||||||+|||++.+|.+||+|||+++
T Consensus       292 ~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          292 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            3588999999999999999999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=98.88  E-value=8.7e-10  Score=113.00  Aligned_cols=48  Identities=42%  Similarity=0.778  Sum_probs=44.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       160 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  207 (334)
T 2pvf_A          160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI  207 (334)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccc
Confidence            467899999999999999999999999999999999999999998753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=98.88  E-value=8.1e-10  Score=112.24  Aligned_cols=49  Identities=39%  Similarity=0.739  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHHHhhhcCc--eeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~--IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++...
T Consensus       139 ~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  189 (337)
T 3ll6_A          139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS  189 (337)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred             HHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence            357899999999999999  9999999999999999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=98.88  E-value=8.7e-10  Score=109.67  Aligned_cols=46  Identities=54%  Similarity=1.054  Sum_probs=43.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++.
T Consensus       112 ~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A          112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             HHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             HHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            3578999999999999999999999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=98.87  E-value=7.1e-10  Score=113.21  Aligned_cols=46  Identities=37%  Similarity=0.691  Sum_probs=43.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus       145 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~  190 (327)
T 1fvr_A          145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  190 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCc
Confidence            3688999999999999999999999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=98.87  E-value=1e-09  Score=123.64  Aligned_cols=46  Identities=43%  Similarity=0.751  Sum_probs=42.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC---EEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~---vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.   +||+|||+++
T Consensus       124 ~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A          124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             HHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            357899999999999999999999999999997775   9999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=98.87  E-value=7.1e-10  Score=110.46  Aligned_cols=47  Identities=40%  Similarity=0.657  Sum_probs=44.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       116 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A          116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            35789999999999999999999999999999999999999999764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=98.87  E-value=8.6e-10  Score=112.58  Aligned_cols=49  Identities=39%  Similarity=0.719  Sum_probs=45.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       130 ~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            3578999999999999999999999999999999999999999987654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=98.87  E-value=5.9e-10  Score=111.13  Aligned_cols=46  Identities=43%  Similarity=0.748  Sum_probs=39.9

Q ss_pred             hhHHHHHHHHHhhhcC-ceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~-~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus       113 ~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A          113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             HHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             HHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            5789999999999998 999999999999999999999999998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=98.86  E-value=1e-09  Score=109.53  Aligned_cols=47  Identities=53%  Similarity=0.880  Sum_probs=44.4

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus       120 ~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  166 (303)
T 1zy4_A          120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV  166 (303)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred             HHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence            57899999999999999999999999999999999999999998754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=98.86  E-value=7.8e-10  Score=114.34  Aligned_cols=49  Identities=22%  Similarity=0.557  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC--CEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g--~vKL~DFGla~~~~  216 (562)
                      ..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       162 ~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~  212 (352)
T 2jii_A          162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC  212 (352)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSS
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeecc
Confidence            46789999999999999999999999999999998  99999999998654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=98.86  E-value=9.8e-10  Score=110.14  Aligned_cols=49  Identities=31%  Similarity=0.586  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A          120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            4678999999999999999999999999999999999999999987653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=98.86  E-value=7.9e-10  Score=120.39  Aligned_cols=47  Identities=36%  Similarity=0.608  Sum_probs=44.3

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       322 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            57889999999999999999999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=98.86  E-value=1.2e-09  Score=110.08  Aligned_cols=47  Identities=34%  Similarity=0.580  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       136 ~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            35789999999999999999999999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=98.86  E-value=9.9e-10  Score=109.54  Aligned_cols=49  Identities=41%  Similarity=0.718  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus       124 ~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A          124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            3578999999999999999999999999999999999999999987653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=98.86  E-value=8.7e-10  Score=109.36  Aligned_cols=47  Identities=36%  Similarity=0.738  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       125 ~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  171 (284)
T 2a19_B          125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS  171 (284)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhee
Confidence            35789999999999999999999999999999999999999998764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=98.86  E-value=1.4e-09  Score=110.74  Aligned_cols=49  Identities=35%  Similarity=0.713  Sum_probs=45.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       137 ~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            3578999999999999999999999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=98.85  E-value=1.3e-09  Score=111.00  Aligned_cols=48  Identities=33%  Similarity=0.559  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcC---ceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSR---RIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~---~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+++..
T Consensus       134 ~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             HHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            36789999999999999   9999999999999999999999999998653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.85  E-value=1.1e-09  Score=112.60  Aligned_cols=49  Identities=35%  Similarity=0.613  Sum_probs=42.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       150 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            4678999999999999999999999999999999999999999987543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=98.85  E-value=1e-09  Score=111.96  Aligned_cols=46  Identities=50%  Similarity=0.913  Sum_probs=42.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeec-CCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~-~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||+|||++||+||||||+|||++ ++|.+||+|||+++.
T Consensus       153 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            5789999999999999999999999999999 789999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=98.85  E-value=1.3e-09  Score=109.47  Aligned_cols=48  Identities=40%  Similarity=0.849  Sum_probs=44.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       112 ~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C          112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            357899999999999999999999999999999999999999998643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=98.85  E-value=1.2e-09  Score=108.62  Aligned_cols=46  Identities=30%  Similarity=0.706  Sum_probs=42.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++
T Consensus       120 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A          120 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             HHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence            3578999999999999999999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=98.84  E-value=9e-10  Score=109.80  Aligned_cols=48  Identities=38%  Similarity=0.632  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++..
T Consensus       114 ~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A          114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             HHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            357899999999999999999999999999999999999999998643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.84  E-value=1.3e-09  Score=108.99  Aligned_cols=49  Identities=33%  Similarity=0.595  Sum_probs=45.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus       113 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A          113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             HHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            3678999999999999999999999999999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=98.84  E-value=1e-09  Score=118.02  Aligned_cols=47  Identities=34%  Similarity=0.583  Sum_probs=43.3

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       284 ~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            57899999999999999999999999999999999999999998653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.83  E-value=1.2e-09  Score=107.43  Aligned_cols=47  Identities=30%  Similarity=0.612  Sum_probs=44.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       107 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A          107 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence            35789999999999999999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=98.83  E-value=1.7e-09  Score=107.01  Aligned_cols=47  Identities=38%  Similarity=0.764  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       108 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A          108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            36789999999999999999999999999999999999999999764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=98.83  E-value=1.8e-09  Score=107.75  Aligned_cols=46  Identities=50%  Similarity=1.008  Sum_probs=43.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++.
T Consensus       117 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A          117 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            3578999999999999999999999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=98.83  E-value=1.5e-09  Score=110.88  Aligned_cols=49  Identities=35%  Similarity=0.733  Sum_probs=45.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus       148 ~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            3578999999999999999999999999999999999999999987654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=98.82  E-value=1.9e-09  Score=110.21  Aligned_cols=49  Identities=35%  Similarity=0.514  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHHHhhh--------cCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCH--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLH--------s~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||        +++|+||||||+|||++.+|.+||+|||+++...
T Consensus       142 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  198 (342)
T 1b6c_B          142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  198 (342)
T ss_dssp             HHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             HHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecc
Confidence            367899999999999        8999999999999999999999999999987654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=98.82  E-value=1.2e-09  Score=116.86  Aligned_cols=35  Identities=51%  Similarity=0.738  Sum_probs=32.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG  202 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g  202 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|
T Consensus       118 ~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~  152 (434)
T 2rio_A          118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSS  152 (434)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCH
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCChHhEEEecCc
Confidence            45899999999999999999999999999998765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=98.82  E-value=1.3e-09  Score=119.97  Aligned_cols=47  Identities=34%  Similarity=0.583  Sum_probs=44.2

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus       367 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          367 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             HHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            57899999999999999999999999999999999999999998653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=98.82  E-value=1.9e-09  Score=107.47  Aligned_cols=46  Identities=33%  Similarity=0.671  Sum_probs=42.4

Q ss_pred             hhhHHHHHHHHHhhhcCc--eeecCCCCcceeecCCCC-----EEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGA-----LKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~--IIHRDLKPeNILl~~~g~-----vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++|  |+||||||+|||++.++.     +||+|||+++
T Consensus       125 ~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A          125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             HHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            367899999999999999  999999999999988876     9999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=98.81  E-value=1.3e-09  Score=121.94  Aligned_cols=47  Identities=32%  Similarity=0.615  Sum_probs=44.6

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      .++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       440 ~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             HHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            57899999999999999999999999999999999999999998754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=98.81  E-value=1.9e-09  Score=107.86  Aligned_cols=46  Identities=41%  Similarity=0.826  Sum_probs=41.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceee---cCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl---~~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       127 ~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A          127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             HHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            3578999999999999999999999999999   456889999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=98.81  E-value=2.1e-09  Score=109.50  Aligned_cols=45  Identities=49%  Similarity=0.921  Sum_probs=41.6

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCC---EEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~---vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       118 ~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A          118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            57899999999999999999999999999987665   9999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=98.81  E-value=1.8e-09  Score=111.88  Aligned_cols=46  Identities=50%  Similarity=0.836  Sum_probs=40.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       151 ~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            357899999999999999999999999999976   8999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=98.80  E-value=1.9e-09  Score=114.73  Aligned_cols=45  Identities=49%  Similarity=0.912  Sum_probs=41.1

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCC---CEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g---~vKL~DFGla~  213 (562)
                      .++.|++.||+|||++||+||||||+|||++.++   .+||+|||+|+
T Consensus       243 ~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            5789999999999999999999999999997654   59999999975

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.80  E-value=1.2e-08  Score=100.65  Aligned_cols=99  Identities=18%  Similarity=0.113  Sum_probs=80.4

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS---   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~---   92 (562)
                      ...+.+|+++|+.+. +.++.++++++...+..|+||||++| +|.+.+.      +......++.++..+|..||+   
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~  126 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDI  126 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCc
Confidence            345889999999984 67888999999999999999999987 7776521      122345678899999999998   


Q ss_pred             --------------------------------------------------------CCceeccCCCCcEEEccCCCeeEe
Q psy10954         93 --------------------------------------------------------RRIIHRDLKPQNILINKSGALKLA  116 (562)
Q Consensus        93 --------------------------------------------------------~gIiHRDLKP~NILl~~~~~vKL~  116 (562)
                                                                              .+++|+|++|.|||++.++.+.|+
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lI  206 (263)
T 3tm0_A          127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI  206 (263)
T ss_dssp             TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEEC
T ss_pred             ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEE
Confidence                                                                    458999999999999865556799


Q ss_pred             eccccc
Q psy10954        117 DFGLSR  122 (562)
Q Consensus       117 DFGla~  122 (562)
                      ||+.+.
T Consensus       207 Dwe~a~  212 (263)
T 3tm0_A          207 DLGRSG  212 (263)
T ss_dssp             CCTTCE
T ss_pred             Echhcc
Confidence            999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=98.78  E-value=2.3e-09  Score=106.17  Aligned_cols=47  Identities=45%  Similarity=0.829  Sum_probs=43.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus       114 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A          114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            35789999999999999999999999999999999999999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.78  E-value=2.1e-09  Score=108.61  Aligned_cols=47  Identities=43%  Similarity=0.793  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeec-CCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~-~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++ .+|.+||+|||+++.
T Consensus       142 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL  189 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence            35789999999999999999999999999999 789999999998753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=98.78  E-value=2.7e-09  Score=108.31  Aligned_cols=47  Identities=21%  Similarity=0.179  Sum_probs=41.4

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWP  524 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (562)
                      ...|.||+||+ +.|++++++.|++..+.+++..+.+.+|.++.+.|.
T Consensus       213 ~~~Di~slG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~  259 (339)
T 1z57_A          213 QPCDVWSIGCI-LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ  259 (339)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cchhhHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence            35799999998 889999999999999999999999999988765443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.77  E-value=2e-09  Score=108.03  Aligned_cols=45  Identities=53%  Similarity=0.854  Sum_probs=42.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus       121 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A          121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             HHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            578999999999999999999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=98.77  E-value=2.8e-09  Score=108.05  Aligned_cols=47  Identities=36%  Similarity=0.571  Sum_probs=42.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus       137 ~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             HHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            36789999999999999999999999999999999999999998753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=98.77  E-value=3.1e-09  Score=106.24  Aligned_cols=46  Identities=46%  Similarity=0.807  Sum_probs=42.6

Q ss_pred             hhhHHHHHHHHHhhhcCc--eeecCCCCcceeec-CCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILIN-KSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~--IIHRDLKPeNILl~-~~g~vKL~DFGla~  213 (562)
                      ..++.|++.||.|||+++  |+||||||+|||++ .+|.+||+|||++.
T Consensus       132 ~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             HHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            357899999999999999  99999999999998 78999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=98.77  E-value=5.9e-09  Score=106.65  Aligned_cols=46  Identities=22%  Similarity=0.213  Sum_probs=41.0

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVW  523 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (562)
                      ...|.||+|++ +.|++++++.|.|..+.+++..+.+.+|.++++.|
T Consensus       218 ~~~Di~slG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~  263 (355)
T 2eu9_A          218 QPCDVWSIGCI-LFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI  263 (355)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CccchHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHh
Confidence            35799999998 88999999999999999999999999998876543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=98.77  E-value=2.7e-09  Score=107.95  Aligned_cols=47  Identities=28%  Similarity=0.609  Sum_probs=40.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||+|||++||+||||||+||+++ +|.+||+|||+++..
T Consensus       133 ~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             HHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            35789999999999999999999999999998 689999999997643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=98.76  E-value=3.7e-09  Score=108.86  Aligned_cols=46  Identities=37%  Similarity=0.716  Sum_probs=41.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla~  213 (562)
                      ..++.|++.||+|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       131 ~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            468899999999999999999999999999986   4559999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=98.76  E-value=3e-09  Score=113.93  Aligned_cols=49  Identities=41%  Similarity=0.615  Sum_probs=42.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---C--CCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---S--GALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~--g~vKL~DFGla~~~~  216 (562)
                      ..++.||+.||+|||++||+||||||+|||++.   +  ..+||+|||+|+...
T Consensus       121 ~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             HHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            367899999999999999999999999999953   2  358899999987653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=98.76  E-value=3.4e-09  Score=107.45  Aligned_cols=46  Identities=46%  Similarity=0.795  Sum_probs=41.0

Q ss_pred             hhhHHHHHHHHHhhhc---CceeecCCCCcceeecCCCC-EEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHS---RRIIHRDLKPQNILINKSGA-LKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs---~~IIHRDLKPeNILl~~~g~-vKL~DFGla~  213 (562)
                      +.++.|+++||+|||+   +||+||||||+|||++.+|. +||+|||+++
T Consensus       105 ~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A          105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             HHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            4678999999999999   89999999999999998887 7999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=98.75  E-value=3.2e-09  Score=107.55  Aligned_cols=47  Identities=47%  Similarity=0.766  Sum_probs=42.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+++..
T Consensus       130 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  176 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred             HHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence            35789999999999999999999999999996 489999999998643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=98.75  E-value=4.1e-09  Score=104.00  Aligned_cols=41  Identities=41%  Similarity=0.691  Sum_probs=37.1

Q ss_pred             hhhHHHHHHHHHhhhcCc---eeecCCCCcceeecC--------CCCEEEee
Q psy10954        168 MSYLYQLLEALRYCHSRR---IIHRDLKPQNILINK--------SGALKLAD  208 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~---IIHRDLKPeNILl~~--------~g~vKL~D  208 (562)
                      ..++.|++.||+|||++|   |+||||||+|||++.        ++.+||+|
T Consensus       108 ~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A          108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             HHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             HHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            357899999999999999   999999999999986        67789887

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=98.74  E-value=4.6e-09  Score=104.32  Aligned_cols=46  Identities=43%  Similarity=0.823  Sum_probs=42.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC----CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g----~vKL~DFGla~  213 (562)
                      ..++.|++.||.|||++||+||||||+||+++.++    .+||+|||+++
T Consensus       111 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A          111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            35789999999999999999999999999998877    89999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=98.74  E-value=3e-09  Score=108.39  Aligned_cols=46  Identities=43%  Similarity=0.755  Sum_probs=43.5

Q ss_pred             hhHHHHHHHHHhhhcC-ceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        169 SYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~-~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      .++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++.
T Consensus       129 ~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             HHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            5789999999999999 999999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=98.74  E-value=3.6e-09  Score=109.46  Aligned_cols=45  Identities=42%  Similarity=0.817  Sum_probs=42.3

Q ss_pred             hhHHHHHHHHHhhhcC-ceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~-~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++
T Consensus       135 ~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            5789999999999996 99999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=98.74  E-value=1.9e-09  Score=107.43  Aligned_cols=47  Identities=19%  Similarity=0.294  Sum_probs=42.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||.|||++||+||||||+|||++.++..++.|||..+.
T Consensus       116 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A          116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             HHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            35789999999999999999999999999999999888888876554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	562
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-11
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-10
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-51
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-07
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-48
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-05
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-47
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-06
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-06
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-06
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-05
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-37
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-39
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-06
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-29
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-24
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-30
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-26
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-24
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-31
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-32
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-25
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-31
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-24
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-31
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-30
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-30
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-30
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-22
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-22
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-30
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-25
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-26
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-28
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-23
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-17
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-20
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-22
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-26
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-20
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-26
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-21
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-21
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-53
 Identities = 116/192 (60%), Positives = 144/192 (75%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            SYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  YTHEVV
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TLWYR PEILLG K YST VDIWS GCIF+EM+T++ LF GDSEIDQLFRIFRTLGTP E
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
            VWPGV+ +P YK  FP+W  + FS+++   D     + S+++  DP +R+SAK  L H 
Sbjct: 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284

Query: 348 YFNQVEMVKPTL 359
           +F  V    P L
Sbjct: 285 FFQDVTKPVPHL 296

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-38
 Identities = 106/161 (65%), Positives = 128/161 (79%), Gaps = 1/161 (0%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL-QTT 67
           R   + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + 
Sbjct: 36  RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
              +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P
Sbjct: 96  LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +  YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM
Sbjct: 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.2 bits (150), Expect = 3e-11
 Identities = 38/75 (50%), Positives = 51/75 (68%)

Query: 487 VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE 546
             + E +T++ LF GDSEIDQLFRIFRTLGTP E VWPGV+ +P YK  FP+W  + FS+
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK 250

Query: 547 ILNLPDPLAVDVFSR 561
           ++   D     + S+
Sbjct: 251 VVPPLDEDGRSLLSQ 265

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  177 bits (449), Expect = 5e-52
 Identities = 102/184 (55%), Positives = 134/184 (72%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            S+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE+V
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TLWYR P++L+G+K YSTT+DIWS GCIF+EM+    LF G SE DQL RIFR LGTP+ 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
             WP V++LP Y  +F  + P  +   L   D   +D+ SK++ LDP QR++AK  L+H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

Query: 348 YFNQ 351
           YF +
Sbjct: 283 YFKE 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 3e-40
 Identities = 103/219 (47%), Positives = 136/219 (62%), Gaps = 1/219 (0%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
           R   + EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L    
Sbjct: 35  RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE 94

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 128
             +    AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154

Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS-RRII 187
            +YTHE+VTLWYR P++L+G+K YSTT+DIWS GCIF+EM     L   +       RI 
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214

Query: 188 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
                P +        L   D   +    +P   +   +
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 58.0 bits (139), Expect = 6e-10
 Identities = 29/75 (38%), Positives = 40/75 (53%)

Query: 487 VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE 546
             + E +    LF G SE DQL RIFR LGTP+   WP V++LP Y  +F  + P  +  
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 547 ILNLPDPLAVDVFSR 561
            L   D   +D+ S+
Sbjct: 249 FLKGLDESGIDLLSK 263

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 7e-51
 Identities = 77/184 (41%), Positives = 114/184 (61%), Gaps = 1/184 (0%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            +Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   YTH+VV
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T WYR PE+L GA++Y   VD+W+ GCI +E++ +     GDS++DQL RIF TLGTP E
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           + WP +  LP Y T F  +       I +      +D+   +   +P  R++A   L+ +
Sbjct: 223 EQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281

Query: 348 YFNQ 351
           YF+ 
Sbjct: 282 YFSN 285

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 5e-41
 Identities = 71/154 (46%), Positives = 105/154 (68%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           +G+  TALREI +L+EL HPN+I L D       + LVF+F+  DL+  ++   + + P+
Sbjct: 41  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 100

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
             K+Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   YTH+
Sbjct: 101 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVT WYR PE+L GA++Y   VD+W+ GCI +E+
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (121), Expect = 1e-07
 Identities = 25/75 (33%), Positives = 35/75 (46%), Gaps = 1/75 (1%)

Query: 487 VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSE 546
               E + +     GDS++DQL RIF TLGTP E+ WP +  LP Y T F  +       
Sbjct: 189 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHH 247

Query: 547 ILNLPDPLAVDVFSR 561
           I +      +D+   
Sbjct: 248 IFSAAGDDLLDLIQG 262

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-48
 Identities = 94/185 (50%), Positives = 130/185 (70%), Gaps = 1/185 (0%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            S+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ EVV
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPH 286
           TLWYRPP++L GAK+YST++D+WSAGCIF+E+    + LF G+   DQL RIFR LGTP 
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
           E+ WP ++KLP YK             ++   +    D+   ++  +P QR+SA+  LQH
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

Query: 347 EYFNQ 351
            YF+ 
Sbjct: 284 PYFSD 288

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 7e-38
 Identities = 97/154 (62%), Positives = 127/154 (82%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101

Query: 75  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 134
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 1e-05
 Identities = 25/82 (30%), Positives = 36/82 (43%)

Query: 480 DAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW 539
           D  S   +    +   + LF G+   DQL RIFR LGTP E+ WP ++KLP YK      
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 540 RPKKFSEILNLPDPLAVDVFSR 561
                  ++   +    D+   
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQN 265

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-47
 Identities = 79/188 (42%), Positives = 116/188 (61%), Gaps = 7/188 (3%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP----MNRYTH 224
             +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++      NRYT+
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            VVTLWYRPPE+LLG + Y   +D+W AGCI +EM T+  +  G++E  QL  I +  G+
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 285 PHEDVWPGVSKLPIY-KTDFPEWRPKKFSEILN--LPDPLAVDVFSKIMALDPKQRVSAK 341
              +VWP V    +Y K +  + + +K  + L   + DP A+D+  K++ LDP QR+ + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 342 TILQHEYF 349
             L H++F
Sbjct: 301 DALNHDFF 308

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 4e-38
 Identities = 78/193 (40%), Positives = 108/193 (55%), Gaps = 12/193 (6%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--------PVDFKLFLVFEFLRQDL 60
               + EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL
Sbjct: 44  LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 103

Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
              L    V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163

Query: 121 SRAFTIP----MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE 176
           +RAF++      NRYT+ VVTLWYRPPE+LLG + Y   +D+W AGCI +EM     +++
Sbjct: 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223

Query: 177 ALRYCHSRRIIHR 189
                H   +I +
Sbjct: 224 GNTEQHQLALISQ 236

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (107), Expect = 8e-06
 Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 3/78 (3%)

Query: 487 VTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFS 545
               E  T+  +  G++E  QL  I +  G+   +VWP V    +Y K +  + + +K  
Sbjct: 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269

Query: 546 EILN--LPDPLAVDVFSR 561
           + L   + DP A+D+  +
Sbjct: 270 DRLKAYVRDPYALDLIDK 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-47
 Identities = 82/187 (43%), Positives = 114/187 (60%), Gaps = 4/187 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
            ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++      T  VVTL
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTL 179

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PE+LL +  Y+T VD+WS GCIF+EM  +K LF G S++DQL +I   +G P E+ 
Sbjct: 180 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEYF 349
           WP    LP  +  F     +   + +   D L  D+  K +  +P +R+SA + L H YF
Sbjct: 239 WPRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

Query: 350 NQVEMVK 356
             +E  K
Sbjct: 297 QDLERCK 303

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 84/169 (49%), Positives = 111/169 (65%), Gaps = 11/169 (6%)

Query: 9   RSRVQVEGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 60
           R +   EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL
Sbjct: 42  RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 101

Query: 61  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 119
             +L   P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFG
Sbjct: 102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161

Query: 120 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L+R ++      T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM
Sbjct: 162 LARIYS-FQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEM 208

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (113), Expect = 2e-06
 Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 3/82 (3%)

Query: 480 DAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW 539
           D  S+  +   E   +K LF G S++DQL +I   +G P E+ WP    LP  +  F   
Sbjct: 197 DLWSVGCIFA-EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP--RQAFHSK 253

Query: 540 RPKKFSEILNLPDPLAVDVFSR 561
             +   + +   D L  D+  +
Sbjct: 254 SAQPIEKFVTDIDELGKDLLLK 275

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-44
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 5/152 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + EI +L    HPN+++L D    +  L+++ EF     +   +     P+  +  +   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            Q L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 141 RPPEILLG----AKVYSTTVDIWSAGCIFSEM 168
             PE+++      + Y    D+WS G    EM
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 1e-39
 Identities = 47/201 (23%), Positives = 73/201 (36%), Gaps = 33/201 (16%)

Query: 158 IWSAGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 214
           +       +E        Q L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S  
Sbjct: 100 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159

Query: 215 FTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMITKKTLFAGDS 270
            T  + R    + T ++  PE+++      + Y    D+WS G    EM   +      +
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219

Query: 271 EIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM 330
            +  L +I ++   P        S                             D   K +
Sbjct: 220 PMRVLLKIAKS-EPPTLAQPSRWS-------------------------SNFKDFLKKCL 253

Query: 331 ALDPKQRVSAKTILQHEYFNQ 351
             +   R +   +LQH +   
Sbjct: 254 EKNVDARWTTSQLLQHPFVTV 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 8e-44
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 4/155 (2%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 74
             + +  +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  
Sbjct: 45  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104

Query: 75  LAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S       +    
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS 162

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            V T  Y  PE L G   YS   DIWS G    EM
Sbjct: 163 FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEM 196

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 19/211 (9%)

Query: 168 MSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 226
                 +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S       +     V
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV 164

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAG-DSEIDQLFRIFRTLG-- 283
            T  Y  PE L G   YS   DIWS G    EM   +      D++  +L    +  G  
Sbjct: 165 GTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 284 --TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEIL----------NLPDPLAVDVFSKIMA 331
             TP     PG           P     +  + +           +      D  +K + 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283

Query: 332 LDPKQRVSAKTILQHEYFNQVEMVKPTLAVF 362
            +P +R   K ++ H +  + +  +   A +
Sbjct: 284 KNPAERADLKQLMVHAFIKRSDAEEVDFAGW 314

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 8e-44
 Identities = 58/187 (31%), Positives = 106/187 (56%), Gaps = 4/187 (2%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTIPMNRYTHEV 226
             Y+YQL  +L Y HS  I HRD+KPQN+L++   A+ KL DFG ++            +
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYI 183

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            + +YR PE++ GA  Y++++D+WSAGC+ +E++  + +F GDS +DQL  I + LGTP 
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP-DPLAVDVFSKIMALDPKQRVSAKTILQ 345
            +    ++     +  FP+ +   ++++      P A+ + S+++   P  R++      
Sbjct: 244 REQIREMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

Query: 346 HEYFNQV 352
           H +F+++
Sbjct: 303 HSFFDEL 309

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 9e-32
 Identities = 50/156 (32%), Positives = 86/156 (55%), Gaps = 11/156 (7%)

Query: 23  REISVLKELKHPNVIRLHDVI------PVDFKLFLVFEFLRQDLKDFLQ---TTPVPVPP 73
           RE+ ++++L H N++RL            +  L LV +++ + +    +        +P 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYT 132
              K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++          
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNV 180

Query: 133 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             + + +YR PE++ GA  Y++++D+WSAGC+ +E+
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (110), Expect = 4e-06
 Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 3/83 (3%)

Query: 480 DAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEW 539
           D  S   V   E +  + +F GDS +DQL  I + LGTP  +    ++     +  FP+ 
Sbjct: 205 DVWSAGCVLA-ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP-NYTEFKFPQI 262

Query: 540 RPKKFSEILNLP-DPLAVDVFSR 561
           +   ++++      P A+ + SR
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSR 285

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-43
 Identities = 66/187 (35%), Positives = 102/187 (54%), Gaps = 5/187 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT---IPMNRYTHEV 226
           +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R            T  V
Sbjct: 114 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T WYR PEI+L +K Y+ ++DIWS GCI +EM++ + +F G   +DQL  I   LG+P 
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 287 EDVWPGVSKLPIYKTDF--PEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
           ++    +  L         P      ++ +    D  A+D+  K++  +P +R+  +  L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

Query: 345 QHEYFNQ 351
            H Y  Q
Sbjct: 294 AHPYLEQ 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 62/167 (37%), Positives = 91/167 (54%), Gaps = 10/167 (5%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFL 64
           S  + +      LREI +L   +H N+I ++D+I          ++LV   +  DL   L
Sbjct: 42  SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL 101

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
           +T  +         +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R  
Sbjct: 102 KTQHLS--NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159

Query: 125 T---IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                     T  V T WYR PEI+L +K Y+ ++DIWS GCI +EM
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-42
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 2/158 (1%)

Query: 13  QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 72
           +    P    +EI + K L H NV++ +         +L  E+             + +P
Sbjct: 42  RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 101

Query: 73  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-- 130
              A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F        
Sbjct: 102 EPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 TL Y  PE+L   + ++  VD+WS G + + M
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 40/184 (21%), Positives = 80/184 (43%), Gaps = 28/184 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVV 227
           + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F              
Sbjct: 108 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TL Y  PE+L   + ++  VD+WS G + + M+  +  +   S+  Q +  ++     + 
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYL 226

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           + W  +                             + +  KI+  +P  R++   I +  
Sbjct: 227 NPWKKID-------------------------SAPLALLHKILVENPSARITIPDIKKDR 261

Query: 348 YFNQ 351
           ++N+
Sbjct: 262 WYNK 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 5e-42
 Identities = 53/161 (32%), Positives = 88/161 (54%), Gaps = 3/161 (1%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT 67
            +++++  GV     RE+ +   L+HPN++RL+       +++L+ E+            
Sbjct: 40  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 99

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                     +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P
Sbjct: 100 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--AP 157

Query: 128 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +R T    TL Y PPE++ G +++   VD+WS G +  E 
Sbjct: 158 SSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 197

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 32/182 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +R T    
Sbjct: 109 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCG 166

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           TL Y PPE++ G +++   VD+WS G +  E +  K  F  ++  +   RI R       
Sbjct: 167 TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------ 219

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
                       +  FP++               A D+ S+++  +P QR   + +L+H 
Sbjct: 220 ------------EFTFPDFVT-----------EGARDLISRLLKHNPSQRPMLREVLEHP 256

Query: 348 YF 349
           + 
Sbjct: 257 WI 258

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 82/186 (44%), Positives = 109/186 (58%), Gaps = 5/186 (2%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
             +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R      +  T  VVT
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVT 181

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            WYR PE++L    Y+ TVDIWS GCI +EMIT KTLF G   +DQL  I +  GTP  +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 289 VWPGVS--KLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
               +   +   Y    PE   K F+ IL    PLAV++  K++ LD +QRV+A   L H
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301

Query: 347 EYFNQV 352
            YF  +
Sbjct: 302 PYFESL 307

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-29
 Identities = 66/166 (39%), Positives = 90/166 (54%), Gaps = 11/166 (6%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKD 62
               Q E     A RE+ +LK ++H NVI L DV   D         +LV  F+  DL  
Sbjct: 52  YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 111

Query: 63  FLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
            ++   +       +  +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R
Sbjct: 112 LMKHEKLG--EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169

Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 +  T  VVT WYR PE++L    Y+ TVDIWS GCI +EM
Sbjct: 170 ---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 1e-05
 Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 3/90 (3%)

Query: 474 PPSLSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS--KLPI 531
             + + D  S+  +     IT KTLF G   +DQL  I +  GTP  +    +   +   
Sbjct: 195 RYTQTVDIWSVGCIMAE-MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 532 YKTDFPEWRPKKFSEILNLPDPLAVDVFSR 561
           Y    PE   K F+ IL    PLAV++  +
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEK 283

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 6e-40
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 2/147 (1%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           + EI V++E K+PN++   D   V  +L++V E+L       + T    +      +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCR 123

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE++   K Y   VDIWS G +  EM
Sbjct: 184 APEVVTR-KAYGPKVDIWSLGIMAIEM 209

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-39
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 27/185 (14%)

Query: 169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           +   + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHED 288
            ++  PE++   K Y   VDIWS G +  EMI  +  +  ++ +  L+ I    GTP   
Sbjct: 180 PYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQ 237

Query: 289 VWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHEY 348
               +S                          +  D  ++ + +D ++R SAK +LQH++
Sbjct: 238 NPEKLS-------------------------AIFRDFLNRCLDMDVEKRGSAKELLQHQF 272

Query: 349 FNQVE 353
               +
Sbjct: 273 LKIAK 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  143 bits (362), Expect = 1e-39
 Identities = 47/189 (24%), Positives = 71/189 (37%), Gaps = 31/189 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
              +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P  +      
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCG 171

Query: 228 TLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
           T  Y  PEI+  +       Y   VD+WS G I   ++     F    ++  L  I    
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
                  W   S                             D+ S+ + + P++R +A+ 
Sbjct: 232 YQFGSPEWDDYS-------------------------DTVKDLVSRFLVVQPQKRYTAEE 266

Query: 343 ILQHEYFNQ 351
            L H +F Q
Sbjct: 267 ALAHPFFQQ 275

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  138 bits (348), Expect = 1e-37
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 9/172 (5%)

Query: 4   DESRPRSRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLK 61
                 S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L 
Sbjct: 39  TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 98

Query: 62  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 121
           D+L    V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S
Sbjct: 99  DYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157

Query: 122 RAFTIPMNRYTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEM 168
                P  +      T  Y  PEI+  +       Y   VD+WS G I   +
Sbjct: 158 CQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-39
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 17/227 (7%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQ 65
                 E      + E+++L+ELKHPN++R +D I    +  L++V E+    DL   + 
Sbjct: 38  DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 97

Query: 66  ---TTPVPVPPALAKSYLYQLLEALRYCHSR-----RIIHRDLKPQNILINKSGALKLAD 117
                   +        + QL  AL+ CH R      ++HRDLKP N+ ++    +KL D
Sbjct: 98  KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157

Query: 118 FGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA 177
           FGL+R      +     V T +Y  PE +     Y+   DIWS GC+  E+  L     A
Sbjct: 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTA 216

Query: 178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYT 223
                 + +  +  + +   I    + +L +  ++R   +   +R +
Sbjct: 217 F---SQKELAGKIREGKFRRIPYRYSDELNEI-ITRMLNLKDYHRPS 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-35
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 34/186 (18%)

Query: 168 MSYLYQLLEALRYCHSR-----RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 222
           +  + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +  
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 171

Query: 223 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
              V T +Y  PE +     Y+   DIWS GC+  E+      F   S+ +   +I    
Sbjct: 172 KAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--- 227

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
                            +  F    P ++S           ++ ++++ L    R S + 
Sbjct: 228 -----------------EGKFRRI-PYRYS-------DELNEIITRMLNLKDYHRPSVEE 262

Query: 343 ILQHEY 348
           IL++  
Sbjct: 263 ILENPL 268

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-39
 Identities = 77/184 (41%), Positives = 105/184 (57%), Gaps = 5/184 (2%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
            +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y     T 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA---TR 182

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           WYR PEI+L    Y+ TVDIWS GCI +E++T +TLF G   IDQL  I R +GTP  ++
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242

Query: 290 WPGVSKLP--IYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
              +S      Y     +     F+ +    +PLAVD+  K++ LD  +R++A   L H 
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302

Query: 348 YFNQ 351
           YF Q
Sbjct: 303 YFAQ 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-24
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 9/209 (4%)

Query: 21  ALREISVLKELKHPNVIRLHDVI-----PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPAL 75
             RE+ +LK +KH NVI L DV        +F    +   L     + +      +    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDH 122

Query: 76  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 135
            +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y    
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 180

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQN 195
            T WYR PEI+L    Y+ TVDIWS GCI +E+     L     +    ++I R +    
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 196 ILINKSGALKLADFGLSRAFTIPMNRYTH 224
             + K  + + A   +     +P   + +
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFAN 268

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (113), Expect = 2e-06
 Identities = 32/148 (21%), Positives = 51/148 (34%), Gaps = 10/148 (6%)

Query: 423 LTRLRIGHTRLTHKYLFTREPQPVCQCGETLSIQHILVCPTHAHIRSSLPSPPSLSD--- 479
           +    I H  L    L   E   +      L+         +   R        L+    
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 196

Query: 480 ----DAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLP--IYK 533
               D  S+  +     +T +TLF G   IDQL  I R +GTP  ++   +S      Y 
Sbjct: 197 NQTVDIWSVGCIMAE-LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 534 TDFPEWRPKKFSEILNLPDPLAVDVFSR 561
               +     F+ +    +PLAVD+  +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEK 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 3e-39
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 6/163 (3%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT 67
             S  Q        ++E+  L++L+HPN I+       +   +LV E+      D L+  
Sbjct: 49  SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH 108

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
             P+      +  +  L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG +      
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----I 164

Query: 128 MNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEM 168
           M      V T ++  PE++L      Y   VD+WS G    E+
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (332), Expect = 4e-35
 Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 33/186 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
            +  +  L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG +      M      V 
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANSFVG 173

Query: 228 TLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
           T ++  PE++L      Y   VD+WS G    E+  +K      + +  L+ I       
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------ 227

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                         + + P  +   +SE          +     +   P+ R +++ +L+
Sbjct: 228 --------------QNESPALQSGHWSE-------YFRNFVDSCLQKIPQDRPTSEVLLK 266

Query: 346 HEYFNQ 351
           H +  +
Sbjct: 267 HRFVLR 272

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  143 bits (361), Expect = 9e-39
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 5/152 (3%)

Query: 20  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 78
           T   EIS++ +L HP +I LHD     +++ L+ EFL   +L D +      +  A   +
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVV 136
           Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTA 190

Query: 137 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           T  +  PEI+   +      D+W+ G +   +
Sbjct: 191 TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVL 221

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  137 bits (347), Expect = 9e-37
 Identities = 42/182 (23%), Positives = 79/182 (43%), Gaps = 29/182 (15%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTA 190

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  +  PEI+   +      D+W+ G +   +++  + FAG+ +++ L  + R      E
Sbjct: 191 TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQHE 347
           D +  VS                         P A D    ++  +P++R++    L+H 
Sbjct: 250 DAFSSVS-------------------------PEAKDFIKNLLQKEPRKRLTVHDALEHP 284

Query: 348 YF 349
           + 
Sbjct: 285 WL 286

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 5/154 (3%)

Query: 18  PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 76
             T  +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +    A
Sbjct: 67  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 126

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHE 134
             Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+     P       
Sbjct: 127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVT 185

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             T  +  PE+  G K      D+WS G +   +
Sbjct: 186 TGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYIL 218

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  141 bits (357), Expect = 4e-38
 Identities = 43/200 (21%), Positives = 76/200 (38%), Gaps = 32/200 (16%)

Query: 158 IWSAGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLS 212
           +       SE   + Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+
Sbjct: 114 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173

Query: 213 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEI 272
                P         T  +  PE+  G K      D+WS G +   +++  + F G+++ 
Sbjct: 174 AHLD-PKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231

Query: 273 DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL 332
           + L  +        +  + G+S                             D   K++  
Sbjct: 232 ETLRNVKSCDWNMDDSAFSGIS-------------------------EDGKDFIRKLLLA 266

Query: 333 DPKQRVSAKTILQHEYFNQV 352
           DP  R++    L+H +    
Sbjct: 267 DPNTRMTIHQALEHPWLTPG 286

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  142 bits (358), Expect = 1e-38
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 11/193 (5%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILI-NKSGALKLADFGLSRAFTIPMNRYTHEVVT 228
           Y+Y++L+AL YCHS  I+HRD+KP N++I ++   L+L D+GL+  +  P   Y   V +
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVAS 192

Query: 229 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKT-LFAGDSEIDQLFRIFRTLGTPHE 287
            +++ PE+L+  ++Y  ++D+WS GC+ + MI +K   F G    DQL RI + LGT   
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 288 DVWPGVSKLPIY--------KTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS 339
             +     + +         +     W     SE  +L  P A+D   K++  D + R++
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 340 AKTILQHEYFNQV 352
           A+  ++H YF  V
Sbjct: 313 AREAMEHPYFYTV 325

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (290), Expect = 3e-29
 Identities = 54/155 (34%), Positives = 91/155 (58%), Gaps = 10/155 (6%)

Query: 21  ALREISVLKELK-HPNVIRLHDVI--PVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALA 76
             REI +L+ L+  PN+I L D++  PV     LVFE +   D K   Q     +     
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDI 131

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI-NKSGALKLADFGLSRAFTIPMNRYTHEV 135
           + Y+Y++L+AL YCHS  I+HRD+KP N++I ++   L+L D+GL+  +  P   Y   V
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRV 190

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            + +++ PE+L+  ++Y  ++D+WS GC+ + M +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-37
 Identities = 34/152 (22%), Positives = 67/152 (44%), Gaps = 6/152 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 80
             E+ VL++ +H N++          +L +V ++     L   L                
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TL 138
            Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E +  ++
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

Query: 139 WYRPPEILLGAK--VYSTTVDIWSAGCIFSEM 168
            +  PE++       YS   D+++ G +  E+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 7e-32
 Identities = 32/183 (17%), Positives = 72/183 (39%), Gaps = 27/183 (14%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E +
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166

Query: 228 --TLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
             ++ +  PE++       YS   D+++ G +  E++T +  ++  +  DQ+  +     
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-- 224

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                                 +     S++ +        + ++ +     +R     I
Sbjct: 225 ---------------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263

Query: 344 LQH 346
           L  
Sbjct: 264 LAS 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-36
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 3/163 (1%)

Query: 8   PRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT 67
            +  +  E       RE  V+  L HP  ++L+     D KL+    + +          
Sbjct: 42  EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 101

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                    + Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +  
Sbjct: 102 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

Query: 128 --MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               R    V T  Y  PE+L   K    + D+W+ GCI  ++
Sbjct: 162 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQL 203

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-32
 Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 38/191 (19%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVV 227
           Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V 
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L   K    + D+W+ GCI  +++     F   +E     +I +      E
Sbjct: 173 TAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK------ 341
             +P                              A D+  K++ LD  +R+  +      
Sbjct: 232 KFFPK-----------------------------ARDLVEKLLVLDATKRLGCEEMEGYG 262

Query: 342 TILQHEYFNQV 352
            +  H +F  V
Sbjct: 263 PLKAHPFFESV 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-36
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 5/151 (3%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 79
             +EIS+L   +H N++ LH+      +L ++FEF+   D+ + + T+   +      SY
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVT 137
           ++Q+ EAL++ HS  I H D++P+NI+    +S  +K+ +FG +R      N        
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +Y P        V ST  D+WS G +   +
Sbjct: 168 EYYAPEV--HQHDVVSTATDMWSLGTLVYVL 196

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 29/186 (15%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHE 225
           +SY++Q+ EAL++ HS  I H D++P+NI+    +S  +K+ +FG +R      N     
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
               +Y P        V ST  D+WS G +   +++    F  ++    +  I     T 
Sbjct: 165 TAPEYYAPEV--HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
            E+ +  +S                           A+D   +++  + K R++A   LQ
Sbjct: 223 DEEAFKEIS-------------------------IEAMDFVDRLLVKERKSRMTASEALQ 257

Query: 346 HEYFNQ 351
           H +  Q
Sbjct: 258 HPWLKQ 263

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 9/219 (4%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP 68
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 43  AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 102

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFT 125
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L    ++   + ++DFGLS+   
Sbjct: 103 -FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 160

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRR 185
            P +  +    T  Y  PE+L   K YS  VD WS G I   +   Y             
Sbjct: 161 DPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 219

Query: 186 IIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYT 223
            I +     +       +    DF +       P  R+T
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDF-IRHLMEKDPEKRFT 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (310), Expect = 4e-32
 Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 30/187 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 224
              ++Q+L+A++Y H   I+HRDLKP+N+L    ++   + ++DFGLS+    P +  + 
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLST 168

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
              T  Y  PE+L   K YS  VD WS G I   ++     F  +++     +I +    
Sbjct: 169 ACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                W  +S                           A D    +M  DP++R + +  L
Sbjct: 228 FDSPYWDDIS-------------------------DSAKDFIRHLMEKDPEKRFTCEQAL 262

Query: 345 QHEYFNQ 351
           QH +   
Sbjct: 263 QHPWIAG 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 16/211 (7%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPALAK 77
             E  +LK L+HPN++R +D      K    + LV E +              +   + +
Sbjct: 56  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR 115

Query: 78  SYLYQLLEALRYCHSR--RIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHE 134
           S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+       +     
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAV 173

Query: 135 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS-RRIIHRDLKP 193
           + T  +  PE+      Y  +VD+++ G    EM+         +      R +   +KP
Sbjct: 174 IGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231

Query: 194 QNILINKSGALKLADFGLSRAFTI-PMNRYT 223
            +        +K  +  +          RY+
Sbjct: 232 ASFDKVAIPEVK--EI-IEGCIRQNKDERYS 259

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-33
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 33/185 (17%)

Query: 168 MSYLYQLLEALRYCHSR--RIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTH 224
            S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+       +    
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA 172

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
            + T  +  PE+      Y  +VD+++ G    EM T +  ++      Q++R       
Sbjct: 173 VIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------ 224

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                        +     P    K          P   ++    +  +  +R S K +L
Sbjct: 225 -------------VTSGVKPASFDKVAI-------PEVKEIIEGCIRQNKDERYSIKDLL 264

Query: 345 QHEYF 349
            H +F
Sbjct: 265 NHAFF 269

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-34
 Identities = 74/195 (37%), Positives = 100/195 (51%), Gaps = 15/195 (7%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
            LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  VVT 
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTR 182

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
           +YR PE++LG   Y   VDIWS GCI  EM+  K LF G   IDQ  ++   LGTP  + 
Sbjct: 183 YYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 290 WPGV-SKLPIYKTDFPEWRPKKF------------SEILNLPDPLAVDVFSKIMALDPKQ 336
              +   +  Y  + P++    F            SE   L    A D+ SK++ +DP +
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301

Query: 337 RVSAKTILQHEYFNQ 351
           R+S    LQH Y N 
Sbjct: 302 RISVDDALQHPYINV 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 9e-24
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 11/211 (5%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDV------IPVDFKLFLVFEFLRQDLKD 62
               Q +     A RE+ ++K + H N+I L +V      +     ++LV E +  +L  
Sbjct: 51  SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 110

Query: 63  FLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
            +Q     +        LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R
Sbjct: 111 VIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 123 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCH 182
                    T  VVT +YR PE++LG   Y   VDIWS GCI  EM     L     Y  
Sbjct: 168 TAG-TSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

Query: 183 SRRIIHRDLKPQNILINKSGALKLADFGLSR 213
               +   L        K     + ++  +R
Sbjct: 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  129 bits (326), Expect = 8e-34
 Identities = 38/168 (22%), Positives = 79/168 (47%), Gaps = 3/168 (1%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDL 60
           K  D+ R + + Q E +       +S++     P ++ +        KL  + + +    
Sbjct: 35  KCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 93

Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
             +  +       A  + Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL
Sbjct: 94  LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 153

Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +  F+    +    V T  Y  PE+L     Y ++ D +S GC+  ++
Sbjct: 154 ACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  119 bits (299), Expect = 4e-30
 Identities = 39/191 (20%), Positives = 80/191 (41%), Gaps = 33/191 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
             Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +    V 
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVG 167

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PE+L     Y ++ D +S GC+  +++   + F      D+   I R   T   
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAV 226

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS-----AKT 342
           ++    S                         P    +   ++  D  +R+      A+ 
Sbjct: 227 ELPDSFS-------------------------PELRSLLEGLLQRDVNRRLGCLGRGAQE 261

Query: 343 ILQHEYFNQVE 353
           + +  +F  ++
Sbjct: 262 VKESPFFRSLD 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 7/150 (4%)

Query: 22  LREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKS 78
           L E SV+ +L+H N+++L  V +     L++V E++ +  L D+L++     +       
Sbjct: 48  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107

Query: 79  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 138
           +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +      + +
Sbjct: 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPV 164

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  PE L   K +ST  D+WS G +  E+
Sbjct: 165 KWTAPEALRE-KKFSTKSDVWSFGILLWEI 193

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 9e-26
 Identities = 37/180 (20%), Positives = 71/180 (39%), Gaps = 33/180 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +      +
Sbjct: 106 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKL 162

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPH 286
            + +  PE L   K +ST  D+WS G +  E+ +  +  +      D + R+ +      
Sbjct: 163 PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----- 216

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                       YK D P+  P    E++                LD   R S   + + 
Sbjct: 217 ------------YKMDAPDGCPPAVYEVM-----------KNCWHLDAAMRPSFLQLREQ 253

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 6/151 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           +RE  ++ +L +P ++RL  V      L LV E      L  FL      +P +     L
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---T 137
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT        
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           L +  PE +   + +S+  D+WS G    E 
Sbjct: 176 LKWYAPECINF-RKFSSRSDVWSYGVTMWEA 205

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 7e-24
 Identities = 34/190 (17%), Positives = 71/190 (37%), Gaps = 36/190 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
              L+Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT    
Sbjct: 112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 228 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLG 283
               L +  PE +   + +S+  D+WS G    E ++  +  +      + +  I +   
Sbjct: 172 GKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--- 227

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                           + + P   P +   ++           S       + R    T+
Sbjct: 228 --------------GKRMECPPECPPELYALM-----------SDCWIYKWEDRPDFLTV 262

Query: 344 ---LQHEYFN 350
              ++  Y++
Sbjct: 263 EQRMRACYYS 272

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 6e-33
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 3/163 (1%)

Query: 7   RPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ 65
           +    +  + V  T + +  +    +HP +  +         LF V E+L   DL   +Q
Sbjct: 36  KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ 95

Query: 66  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
           +       + A  Y  +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   
Sbjct: 96  SCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154

Query: 126 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +   +      T  Y  PEILLG + Y+ +VD WS G +  EM
Sbjct: 155 LGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEM 196

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 31/186 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
             Y  +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +   +      
Sbjct: 106 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG 165

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
           T  Y  PEILLG + Y+ +VD WS G +  EM+  ++ F G  E +    I         
Sbjct: 166 TPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------ 218

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT-ILQH 346
                          +P W               A D+  K+   +P++R+  +  I QH
Sbjct: 219 ------------NPFYPRWLE-----------KEAKDLLVKLFVREPEKRLGVRGDIRQH 255

Query: 347 EYFNQV 352
             F ++
Sbjct: 256 PLFREI 261

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 3/149 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 139
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R         +      + 
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +  PE+   ++ YS+  D+WS G +  E+
Sbjct: 168 WASPEVFSFSR-YSSKSDVWSFGVLMWEV 195

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 9e-25
 Identities = 29/180 (16%), Positives = 67/180 (37%), Gaps = 29/180 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +     + E + Y     +IHRDL  +N L+ ++  +K++DFG++R         +    
Sbjct: 104 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163

Query: 228 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
             + +  PE+   ++ YS+  D+WS G +  E+ ++  +   +    ++     T     
Sbjct: 164 FPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---- 218

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                       ++   P        +I+           +      P+ R +   +L+ 
Sbjct: 219 ------------FRLYKPRLASTHVYQIM-----------NHCWKERPEDRPAFSRLLRQ 255

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-32
 Identities = 45/192 (23%), Positives = 78/192 (40%), Gaps = 26/192 (13%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEV 226
            +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T   
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC 174

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T +Y  PE+L   K Y  + D+WS G I   ++     F  +  +     +        
Sbjct: 175 YTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------ 227

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                   ++ + + +FP     + S            +   ++  +P QR++    + H
Sbjct: 228 --------RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNH 272

Query: 347 EYFNQVEMVKPT 358
            +  Q   V  T
Sbjct: 273 PWIMQSTKVPQT 284

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 1e-31
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 12/160 (7%)

Query: 21  ALREISVL-KELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQT-TPVPVPP 73
           A RE+ +  +  + P+++R+ DV    +     L +V E L   +L   +Q         
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNR 130
             A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N 
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNS 169

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY 170
            T    T +Y  PE+L   K Y  + D+WS G I   +  
Sbjct: 170 LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLC 208

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 5e-32
 Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 8/207 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
            RE+S+LKE++HPNVI LH+V      + L+ E +              +    A  +L 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 137
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGT 179

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNIL 197
             +  PEI+   +      D+WS G I   +              +   +          
Sbjct: 180 PEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238

Query: 198 INKSGALKLADFGLSRAFTI-PMNRYT 223
              + +    DF + R     P  R T
Sbjct: 239 YFSNTSALAKDF-IRRLLVKDPKKRMT 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 31/190 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYT 223
             +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + 
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFK 174

Query: 224 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLG 283
           +   T  +  PEI+   +      D+WS G I   +++  + F GD++ + L  +     
Sbjct: 175 NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
              ++ +   S                          LA D   +++  DPK+R++ +  
Sbjct: 234 EFEDEYFSNTS-------------------------ALAKDFIRRLLVKDPKKRMTIQDS 268

Query: 344 LQHEYFNQVE 353
           LQH +    +
Sbjct: 269 LQHPWIKPKD 278

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 7e-32
 Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 6/151 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 80
           +RE++ +  L H N+IRL+ V+ +   + +V E      L D L+             Y 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVT 137
            Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  V 
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +  PE L   + +S   D W  G    EM
Sbjct: 178 FAWCAPESLKT-RTFSHASDTWMFGVTLWEM 207

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 5e-24
 Identities = 42/183 (22%), Positives = 67/183 (36%), Gaps = 32/183 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
             Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLG 283
             V   +  PE L   + +S   D W  G    EM T  +  + G +    L +I +   
Sbjct: 174 RKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--- 229

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                           +   PE  P+    ++            +  A  P+ R +   +
Sbjct: 230 -------------EGERLPRPEDCPQDIYNVM-----------VQCWAHKPEDRPTFVAL 265

Query: 344 LQH 346
              
Sbjct: 266 RDF 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 5/163 (3%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP 68
           ++      +    L E +V+++L +P ++R+  +   +    LV E       +      
Sbjct: 43  KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN 101

Query: 69  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 128
             V        ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     
Sbjct: 102 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161

Query: 129 NRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           N Y   TH    + +  PE +   K +S+  D+WS G +  E 
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEA 203

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 4e-24
 Identities = 36/192 (18%), Positives = 75/192 (39%), Gaps = 36/192 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
           +  ++Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y   TH
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLG 283
               + +  PE +   K +S+  D+WS G +  E  +  +  + G    +    + +   
Sbjct: 170 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-- 226

Query: 284 TPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTI 343
                           +   P   P++  +++           +     D + R     +
Sbjct: 227 ---------------ERMGCPAGCPREMYDLM-----------NLCWTYDVENRPGFAAV 260

Query: 344 ---LQHEYFNQV 352
              L++ Y++ V
Sbjct: 261 ELRLRNYYYDVV 272

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 1e-31
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 3/149 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTLW 139
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR                + 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + PPE+L+ +K +S+  DIW+ G +  E+
Sbjct: 167 WSPPEVLMYSK-FSSKSDIWAFGVLMWEI 194

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 1e-23
 Identities = 38/181 (20%), Positives = 71/181 (39%), Gaps = 31/181 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEV 226
           +     + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR              
Sbjct: 103 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLGTP 285
             + + PPE+L+ +K +S+  DIW+ G +  E+ +  K  +   +  +    I +     
Sbjct: 163 FPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---- 217

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                         +   P    +K   I+                    +R + K +L 
Sbjct: 218 -------------LRLYRPHLASEKVYTIM-----------YSCWHEKADERPTFKILLS 253

Query: 346 H 346
           +
Sbjct: 254 N 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 4/147 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
             E  +L  + HP +IR+        ++F++ +++       L       P  +AK Y  
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 111

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 141
           ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++                 Y 
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP---DYI 168

Query: 142 PPEILLGAKVYSTTVDIWSAGCIFSEM 168
            PE++   K Y+ ++D WS G +  EM
Sbjct: 169 APEVVST-KPYNKSIDWWSFGILIYEM 194

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 1e-28
 Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 38/188 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++                
Sbjct: 109 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP--- 165

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
            Y  PE++   K Y+ ++D WS G +  EM+   T F   + +    +I           
Sbjct: 166 DYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------- 216

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTIL 344
                     +  FP +  +   ++L           S+++  D  QR+       + + 
Sbjct: 217 ----------ELRFPPFFNEDVKDLL-----------SRLITRDLSQRLGNLQNGTEDVK 255

Query: 345 QHEYFNQV 352
            H +F +V
Sbjct: 256 NHPWFKEV 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 2e-31
 Identities = 51/153 (33%), Positives = 78/153 (50%), Gaps = 8/153 (5%)

Query: 21  ALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFL--RQDLKDFLQTTPVPVPPALA 76
              E+ +LK++      VIRL D         L+ E     QDL DF+      +   LA
Sbjct: 54  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELA 112

Query: 77  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEV 135
           +S+ +Q+LEA+R+CH+  ++HRD+K +NILI+ + G LKL DFG           YT   
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD 170

Query: 136 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            T  Y PPE +   + +  +  +WS G +  +M
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-30
 Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 38/192 (19%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEV 226
            S+ +Q+LEA+R+CH+  ++HRD+K +NILI+ + G LKL DFG           YT   
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD 170

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y PPE +   + +  +  +WS G +  +M+     F  D EI +    F       
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF------- 223

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                                 ++ S            +    +AL P  R + + I  H
Sbjct: 224 ---------------------RQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNH 255

Query: 347 EYFNQVEMVKPT 358
            +   V + + T
Sbjct: 256 PWMQDVLLPQET 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 5/150 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQT-TPVPVPPALAKSY 79
           L E +++K+L+H  ++RL+ V+     ++++ E++    L DFL+T + + +        
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 138
             Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R                +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  PE +     ++   D+WS G + +E+
Sbjct: 175 KWTAPEAINYGT-FTIKSDVWSFGILLTEI 203

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 36/190 (18%), Positives = 70/190 (36%), Gaps = 33/190 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEV 226
           +    Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R              
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTP 285
             + +  PE +     ++   D+WS G + +E++T  +  + G +  + +  + R     
Sbjct: 172 FPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----- 225

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                            +   RP    E L         +        P+ R +   +  
Sbjct: 226 ----------------GYRMVRPDNCPEEL-------YQLMRLCWKERPEDRPTFDYLRS 262

Query: 346 --HEYFNQVE 353
              ++F   E
Sbjct: 263 VLEDFFTATE 272

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 5/152 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 80
           L E S++ +  HPNVI L  V+     + ++ EF+    L  FL+              L
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+       
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 141 RPPEIL----LGAKVYSTTVDIWSAGCIFSEM 168
            P        +  + +++  D+WS G +  E+
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEV 226

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 95.2 bits (236), Expect = 3e-22
 Identities = 32/184 (17%), Positives = 62/184 (33%), Gaps = 33/184 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +  L  +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+   
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190

Query: 228 TLWYRPPEIL----LGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTL 282
                P        +  + +++  D+WS G +  E+++  +  +   +  D +  I    
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---- 246

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
                            + D+    P      L         +       D   R     
Sbjct: 247 -----------------EQDYRLPPPMDCPSAL-------HQLMLDCWQKDRNHRPKFGQ 282

Query: 343 ILQH 346
           I+  
Sbjct: 283 IVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-30
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 2/155 (1%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP 73
           + V    L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  
Sbjct: 49  DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL 107

Query: 74  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 133
           A    Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR           
Sbjct: 108 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167

Query: 134 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +            +  + +++  D+W  G    E+
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 5e-22
 Identities = 38/180 (21%), Positives = 64/180 (35%), Gaps = 29/180 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR           +  
Sbjct: 111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPH 286
                     +  + +++  D+W  G    E++      F G    D + RI        
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----- 225

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                        +   P   P     ++           +K  A DP +R     +   
Sbjct: 226 ------------ERLPMPPNCPPTLYSLM-----------TKCWAYDPSRRPRFTELKAQ 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-30
 Identities = 34/173 (19%), Positives = 73/173 (42%), Gaps = 27/173 (15%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT------------- 66
           + E+ ++ +L  H N++ L     +   ++L+FE+    DL ++L++             
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147

Query: 67  ---------TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 117
                        +       + YQ+ + + +   +  +HRDL  +N+L+     +K+ D
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 207

Query: 118 FGLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           FGL+R            +  + + +  PE L    +Y+   D+WS G +  E+
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEI 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-28
 Identities = 32/182 (17%), Positives = 69/182 (37%), Gaps = 31/182 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHE 225
           + + YQ+ + + +   +  +HRDL  +N+L+     +K+ DFGL+R            + 
Sbjct: 167 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 226

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGT 284
            + + +  PE L    +Y+   D+WS G +  E+ +     + G       +++ +    
Sbjct: 227 RLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ---- 281

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                         +K D P +  ++   I+               A D ++R S   + 
Sbjct: 282 ------------NGFKMDQPFYATEEIYIIM-----------QSCWAFDSRKRPSFPNLT 318

Query: 345 QH 346
             
Sbjct: 319 SF 320

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (293), Expect = 4e-30
 Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 8/167 (4%)

Query: 9   RSRVQVEGVPSTALREISVLKELKHPNVIRLHDVI----PVDFKLFLVFEFLRQDLKDFL 64
               +         RE      L HP ++ ++D      P     ++V E++       +
Sbjct: 42  ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI 101

Query: 65  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
             T  P+ P  A   +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA 
Sbjct: 102 VHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161

Query: 125 TIPMNRYTHE---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
               N  T     + T  Y  PE   G        D++S GC+  E+
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEV 207

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  107 bits (268), Expect = 9e-27
 Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 29/181 (16%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---V 226
            +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     +
Sbjct: 116 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPH 286
            T  Y  PE   G        D++S GC+  E++T +  F GDS +   ++  R    P 
Sbjct: 176 GTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234

Query: 287 EDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                G+S                              V  K +A +P+ R      ++ 
Sbjct: 235 SARHEGLS-------------------------ADLDAVVLKALAKNPENRYQTAAEMRA 269

Query: 347 E 347
           +
Sbjct: 270 D 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 5e-30
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 1/148 (0%)

Query: 21  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
            + E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG 111

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 140
            +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171

Query: 141 RPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             PE+L     Y   VD W  G +  EM
Sbjct: 172 LAPEVLED-NDYGRAVDWWGLGVVMYEM 198

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 4e-28
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 38/204 (18%)

Query: 157 DIWSAGCIFSE---MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 213
              S   +F+E     Y  +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +
Sbjct: 94  FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

Query: 214 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEID 273
                         T  Y  PE+L     Y   VD W  G +  EM+  +  F       
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

Query: 274 QLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD 333
               I                     +  FP               P A  + + ++  D
Sbjct: 213 LFELILME------------------EIRFPRTLS-----------PEAKSLLAGLLKKD 243

Query: 334 PKQRVS-----AKTILQHEYFNQV 352
           PKQR+      AK +++H +F  +
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSI 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 7e-30
 Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 27/180 (15%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT------ 67
             + +   RE +++ E  +PN+++L  V  V   + L+FE++   DL +FL++       
Sbjct: 57  ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116

Query: 68  -----------------PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS 110
                            P P+  A       Q+   + Y   R+ +HRDL  +N L+ ++
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176

Query: 111 GALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
             +K+ADFGLSR            ++ + + + PPE +   + Y+T  D+W+ G +  E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 235

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 34/181 (18%), Positives = 70/181 (38%), Gaps = 32/181 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +    Q+   + Y   R+ +HRDL  +N L+ ++  +K+ADFGLSR            ++
Sbjct: 143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 202

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGT 284
            + + + PPE +   + Y+T  D+W+ G +  E+ +     + G +  + ++ +      
Sbjct: 203 AIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG--- 258

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                              PE  P +   ++               +  P  R S  +I 
Sbjct: 259 --------------NILACPENCPLELYNLM-----------RLCWSKLPADRPSFCSIH 293

Query: 345 Q 345
           +
Sbjct: 294 R 294

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-29
 Identities = 35/150 (23%), Positives = 70/150 (46%), Gaps = 5/150 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ--TTPVPVPPALAKSY 79
           L+E  V+K+L+H  +++L+ V+  +  +++V E++ +          T   +        
Sbjct: 60  LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL 138
             Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R                +
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178

Query: 139 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +  PE  L  + ++   D+WS G + +E+
Sbjct: 179 KWTAPEAALYGR-FTIKSDVWSFGILLTEL 207

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 8e-26
 Identities = 36/190 (18%), Positives = 72/190 (37%), Gaps = 33/190 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEV 226
           +    Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R              
Sbjct: 116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 175

Query: 227 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTP 285
             + +  PE  L  + ++   D+WS G + +E+ T  +  + G    + L ++ R    P
Sbjct: 176 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                             P   P+   +++            +    +P++R + + +  
Sbjct: 235 -----------------CPPECPESLHDLM-----------CQCWRKEPEERPTFEYLQA 266

Query: 346 --HEYFNQVE 353
              +YF   E
Sbjct: 267 FLEDYFTSTE 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  115 bits (288), Expect = 2e-29
 Identities = 34/181 (18%), Positives = 64/181 (35%), Gaps = 14/181 (7%)

Query: 22  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
             E    K L     +  ++          LV + L   L+D L                
Sbjct: 48  RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 107

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINK-----SGALKLADFGLSRAF-------TIPM 128
            Q+L  ++  H + +++RD+KP N LI +     +  + + DFG+ + +        IP 
Sbjct: 108 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167

Query: 129 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIH 188
               +   T  Y      LG +  S   D+ + G +F          + L+   +++   
Sbjct: 168 REKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226

Query: 189 R 189
           R
Sbjct: 227 R 227

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 29/188 (15%), Positives = 59/188 (31%), Gaps = 34/188 (18%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINK-----SGALKLADFGLSRAF-------TI 217
              Q+L  ++  H + +++RD+KP N LI +     +  + + DFG+ + +        I
Sbjct: 106 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
           P     +   T  Y      LG +  S   D+ + G +F   +     + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
             R              K      +     P++F + ++               L     
Sbjct: 225 YERIGEK----------KQSTPLRELCAGFPEEFYKYMH-----------YARNLAFDAT 263

Query: 338 VSAKTILQ 345
                +  
Sbjct: 264 PDYDYLQG 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 7e-29
 Identities = 35/149 (23%), Positives = 67/149 (44%), Gaps = 3/149 (2%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 81
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118

Query: 82  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTLW 139
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V + 
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +   E +L  ++Y+   D+WS G    E+
Sbjct: 179 WMALESILH-RIYTHQSDVWSYGVTVWEL 206

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 3e-23
 Identities = 33/181 (18%), Positives = 66/181 (36%), Gaps = 30/181 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           +++  Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E  
Sbjct: 114 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
            V + +   E +L  ++Y+   D+WS G    E++T  +         ++  I       
Sbjct: 174 KVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----- 227

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                         +   P         I+            K   +D   R   + ++ 
Sbjct: 228 -----------KGERLPQPPICTIDVYMIM-----------VKCWMIDADSRPKFRELII 265

Query: 346 H 346
            
Sbjct: 266 E 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 32/192 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HE 225
             Y+ +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F            
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
               +  P  +  G   +   VD WS G +  E++T  + F  D E +    I R +   
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS-----A 340
                  +S                          LA D+  +++  DPK+R+      A
Sbjct: 252 EPPYPQEMS-------------------------ALAKDLIQRLLMKDPKKRLGCGPRDA 286

Query: 341 KTILQHEYFNQV 352
             I +H +F ++
Sbjct: 287 DEIKEHLFFQKI 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 4e-26
 Identities = 46/226 (20%), Positives = 84/226 (37%), Gaps = 5/226 (2%)

Query: 7   RPRSRVQVEGVPSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ 65
           +  + VQ          E  VL+ ++  P ++ LH     + KL L+ +++         
Sbjct: 61  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120

Query: 66  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
           +          + Y+ +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F 
Sbjct: 121 SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180

Query: 126 IPMNRYT--HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHS 183
                          +  P  +  G   +   VD WS G +  E+             +S
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240

Query: 184 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVT 228
           +  I R +        +  +    D  + R     P  R       
Sbjct: 241 QAEISRRILKSEPPYPQEMSALAKDL-IQRLLMKDPKKRLGCGPRD 285

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 3/176 (1%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL--QTTPVPVPPALAKSY 79
           L+E +V+KE+KHPN+++L  V   +   +++ EF+          +     V   +    
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 80  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 139
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T              
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 140 YRPPEILLGAKVYSTTVDIWSAGCIFSEM-SYLYQLLEALRYCHSRRIIHRDLKPQ 194
                  L    +S   D+W+ G +  E+ +Y       +       ++ +D + +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.9 bits (243), Expect = 3e-23
 Identities = 38/178 (21%), Positives = 64/178 (35%), Gaps = 27/178 (15%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           +    Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T           
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
                     L    +S   D+W+ G +  E+ T         ++ Q++ +         
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------- 230

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                      Y+ + PE  P+K  E++                 +P  R S   I Q
Sbjct: 231 ---------KDYRMERPEGCPEKVYELM-----------RACWQWNPSDRPSFAEIHQ 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 7e-28
 Identities = 43/166 (25%), Positives = 67/166 (40%), Gaps = 20/166 (12%)

Query: 23  REISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPAL-- 75
            EI     L+H N++        D     +L+LV ++     L D+L    V V   +  
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL 105

Query: 76  ----AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 131
               A    +  +E +       I HRDLK +NIL+ K+G   +AD GL+       +  
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165

Query: 132 ----THEVVTLWYRPPEILLGAKV-----YSTTVDIWSAGCIFSEM 168
                H V T  Y  PE+L  +            DI++ G +F E+
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 18/184 (9%)

Query: 172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----THEVV 227
           +  +E +       I HRDLK +NIL+ K+G   +AD GL+       +       H V 
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 228 TLWYRPPEILLGAKV-----YSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTL 282
           T  Y  PE+L  +            DI++ G +F E+  + ++  G  E  QL       
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 283 GTPHEDVWPGVSKLPIYKTDFPE-WRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAK 341
             P  +    V      + + P  W+  +   ++         +  +    +   R++A 
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-------AKIMRECWYANGAARLTAL 286

Query: 342 TILQ 345
            I +
Sbjct: 287 RIKK 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 37/184 (20%), Positives = 64/184 (34%), Gaps = 12/184 (6%)

Query: 22  LREISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 80
             E  + K ++    I  +           +V E L   L+D                  
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFT-------IPMNR 130
            Q++  + Y HS+  IHRD+KP N L+        + + DFGL++ +        IP   
Sbjct: 110 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 131 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRD 190
             +   T  Y      LG +  S   D+ S G +    +      + L+    R+   R 
Sbjct: 170 NKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228

Query: 191 LKPQ 194
            + +
Sbjct: 229 SEKK 232

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.6 bits (242), Expect = 4e-23
 Identities = 35/197 (17%), Positives = 64/197 (32%), Gaps = 35/197 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFT-------I 217
           +    Q++  + Y HS+  IHRD+KP N L+        + + DFGL++ +        I
Sbjct: 106 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

Query: 218 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFR 277
           P     +   T  Y      LG +  S   D+ S G +          + G     +  +
Sbjct: 166 PYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224

Query: 278 IFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQR 337
             R              K+        +  P +F+  LN              +L    +
Sbjct: 225 YER----------ISEKKMSTPIEVLCKGYPSEFATYLN-----------FCRSLRFDDK 263

Query: 338 VSAKTI---LQHEYFNQ 351
                +    ++ +  Q
Sbjct: 264 PDYSYLRQLFRNLFHRQ 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 8/168 (4%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDL 60
           K+ D+ +     Q+E      L E  +L+ +  P +++L      +  L++V E++    
Sbjct: 72  KILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
                          A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 121 SRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           ++                    PEI+L  K Y+  VD W+ G +  EM
Sbjct: 188 AKRVKGRTWTLCGTP---EALAPEIILS-KGYNKAVDWWALGVLIYEM 231

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (272), Expect = 1e-26
 Identities = 40/188 (21%), Positives = 65/188 (34%), Gaps = 38/188 (20%)

Query: 170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 229
           Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++                
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP--- 202

Query: 230 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDV 289
               PEI+L  K Y+  VD W+ G +  EM      F  D  I    +I           
Sbjct: 203 EALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261

Query: 290 WPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRV-----SAKTIL 344
                                             D+   ++ +D  +R          I 
Sbjct: 262 SSD-----------------------------LKDLLRNLLQVDLTKRFGNLKNGVNDIK 292

Query: 345 QHEYFNQV 352
            H++F   
Sbjct: 293 NHKWFATT 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 61/237 (25%), Positives = 92/237 (38%), Gaps = 33/237 (13%)

Query: 168 MSYLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGA------LKLADFGLSRAFTIPMN 220
                QLL  L Y H R  IIH D+KP+N+L+    +      +K+AD G +  +     
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DE 184

Query: 221 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQ 274
            YT+ + T  YR PE+LLGA  +    DIWS  C+  E+IT   LF  D       + D 
Sbjct: 185 HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

Query: 275 LFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD-------------PL 321
           + +I   LG     +         +       R     +   L D               
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

Query: 322 AVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMVKPTLAVFPELGYGGNGCKDFKPW 378
             D  S ++ LDP++R  A  ++ H +      ++       EL   G+   D   W
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGS---DIPGW 357

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.8 bits (198), Expect = 3e-17
 Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 27/177 (15%)

Query: 15  EGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQD-------------- 59
           +     A  EI +L+ +   +  +   +      KL   F     +              
Sbjct: 50  KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN 109

Query: 60  -LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGA----- 112
            L    +     +P    K    QLL  L Y H R  IIH D+KP+N+L+    +     
Sbjct: 110 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169

Query: 113 -LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
            +K+AD G +  +      YT+ + T  YR PE+LLGA  +    DIWS  C+  E+
Sbjct: 170 QIKIADLGNACWY---DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFEL 222

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-27
 Identities = 39/165 (23%), Positives = 81/165 (49%), Gaps = 7/165 (4%)

Query: 10  SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLR-QDLKDFLQTT 67
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123

Query: 68  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 127
                      +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R     
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183

Query: 128 MNRYTHE----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                H      + + +   E L   K ++T  D+WS G +  E+
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWEL 227

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 1e-20
 Identities = 33/184 (17%), Positives = 71/184 (38%), Gaps = 34/184 (18%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 225
           + +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R          H   
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192

Query: 226 --VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTL 282
              + + +   E L   K ++T  D+WS G +  E++T     +   +  D    + +  
Sbjct: 193 GAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG- 250

Query: 283 GTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKT 342
                            +   PE+ P    E++            K      + R S   
Sbjct: 251 ----------------RRLLQPEYCPDPLYEVM-----------LKCWHPKAEMRPSFSE 283

Query: 343 ILQH 346
           ++  
Sbjct: 284 LVSR 287

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 8e-27
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 19/170 (11%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQ-------------- 65
             E+ VL +L  HPN+I L         L+L  E+    +L DFL+              
Sbjct: 58  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117

Query: 66  -TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
            +T   +       +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR  
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177

Query: 125 TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL 174
            + + +     + + +   E L    VY+T  D+WS G +  E+  L   
Sbjct: 178 EVYVKKTMG-RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGT 225

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 2e-22
 Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 29/179 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 227
           + +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   + + +     +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-RL 188

Query: 228 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHE 287
            + +   E L    VY+T  D+WS G +  E+++            +L+           
Sbjct: 189 PVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 241

Query: 288 DVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH 346
                      Y+ + P     +  +++            +     P +R S   IL  
Sbjct: 242 ----------GYRLEKPLNCDDEVYDLM-----------RQCWREKPYERPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 5/151 (3%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYL 80
           L E  ++ +  H N+IRL  VI     + ++ E++       FL+              L
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116

Query: 81  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVT 137
             +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR            +   + 
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 138 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           + +  PE +   + +++  D+WS G +  E+
Sbjct: 177 IRWTAPEAISY-RKFTSASDVWSFGIVMWEV 206

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 1e-20
 Identities = 33/199 (16%), Positives = 72/199 (36%), Gaps = 32/199 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---TH 224
           +  L  +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR            + 
Sbjct: 113 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 225 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGT 284
             + + +  PE +   + +++  D+WS G +  E++T       +    ++ +       
Sbjct: 173 GKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---- 227

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                         ++   P   P    +++            +    +  +R     I+
Sbjct: 228 ------------DGFRLPTPMDCPSAIYQLM-----------MQCWQQERARRPKFADIV 264

Query: 345 QH-EYFNQVEMVKPTLAVF 362
              +   +      TLA F
Sbjct: 265 SILDKLIRAPDSLKTLADF 283

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 22/168 (13%)

Query: 22  LREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------------- 65
           + E+ VL  L  H N++ L     +     ++ E+    DL +FL+              
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 66  ---TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 122
                 + +      S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 123 AFTIPMNRY--THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                 N     +  + + +  PE +    VY+   D+WS G    E+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWEL 240

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 2e-21
 Identities = 39/181 (21%), Positives = 74/181 (40%), Gaps = 31/181 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--THE 225
           +S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R      N     + 
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGT 284
            + + +  PE +    VY+   D+WS G    E+ +   + + G     + +++ +    
Sbjct: 208 RLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK---- 262

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                         ++   PE  P +  +I+                 DP +R + K I+
Sbjct: 263 ------------EGFRMLSPEHAPAEMYDIM-----------KTCWDADPLKRPTFKQIV 299

Query: 345 Q 345
           Q
Sbjct: 300 Q 300

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 2e-23
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 20/166 (12%)

Query: 22  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP--------- 70
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ    P         
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 71  ------VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 124
                 +      S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R  
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 125 --TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
                  + T+  + + +  PE L   ++Y+   D+WS G +  E+
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 230

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 1e-21
 Identities = 38/181 (20%), Positives = 76/181 (41%), Gaps = 30/181 (16%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 225
           +S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R         + T+ 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTP 285
            + + +  PE L   ++Y+   D+WS G +  E+ T          +++LF++ +     
Sbjct: 198 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE---- 252

Query: 286 HEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ 345
                        ++ D P     +   ++                  P QR + K +++
Sbjct: 253 ------------GHRMDKPSNCTNELYMMM-----------RDCWHAVPSQRPTFKQLVE 289

Query: 346 H 346
            
Sbjct: 290 D 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 4e-23
 Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 13/159 (8%)

Query: 22  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQ---------TTPVPV 71
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L+             P 
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 72  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MN 129
             +       ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R         
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 130 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 191 KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEI 228

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 2e-18
 Identities = 34/182 (18%), Positives = 69/182 (37%), Gaps = 32/182 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHE 225
           +    ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R         +    
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGT 284
           ++ + +  PE L    V++T  D+WS G +  E+ T  +  + G S    L  +      
Sbjct: 196 LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG--- 251

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                            D P+  P    E++                 +PK R S   I+
Sbjct: 252 --------------GLLDKPDNCPDMLFELM-----------RMCWQYNPKMRPSFLEII 286

Query: 345 QH 346
             
Sbjct: 287 SS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 3e-22
 Identities = 36/182 (19%), Positives = 76/182 (41%), Gaps = 31/182 (17%)

Query: 168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHE 225
           + Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R    
Sbjct: 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 226 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGT 284
            + L +  PE +   +VY+   D+WS G +  E+ +   + + G    ++  R  +    
Sbjct: 197 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--- 252

Query: 285 PHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVSAKTIL 344
                          +   P++   +  + +                 +P QR +   ++
Sbjct: 253 -------------GTRMRAPDYTTPEMYQTM-----------LDCWHGEPSQRPTFSELV 288

Query: 345 QH 346
           +H
Sbjct: 289 EH 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 7e-20
 Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 20/165 (12%)

Query: 23  REISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLR-QDLKDFLQT-------------- 66
               ++    H NV+ L          L ++ EF +  +L  +L++              
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 67  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 125
                +       Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R   
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185

Query: 126 IPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 168
              +  R     + L +  PE +   +VY+   D+WS G +  E+
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 229

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 1e-18
 Identities = 29/166 (17%), Positives = 57/166 (34%), Gaps = 24/166 (14%)

Query: 1   KVSDESRPRSRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDL 60
           KV ++              +A  E   L++L+   V +++          ++ E +    
Sbjct: 41  KVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKE 96

Query: 61  KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 120
              ++              L  +LE +   + R I+H DL   N+L+++ G + + DF  
Sbjct: 97  LYRVRVENP-------DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148

Query: 121 SRAFTIPMNRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAG 162
           S        R         +  ++         + Y T  DI SA 
Sbjct: 149 SVEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSAI 186

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.3 bits (179), Expect = 1e-15
 Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 13/101 (12%)

Query: 157 DIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 216
                  + +    L  +LE +   + R I+H DL   N+L+++ G + + DF  S    
Sbjct: 95  KELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153

Query: 217 IPMNRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAG 253
               R         +  ++         + Y T  DI SA 
Sbjct: 154 EEGWREILERDVRNIITYFS--------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	562
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.88
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.84
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.83
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.81
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.81
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.79
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.79
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.79
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.76
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.76
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.75
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.74
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.74
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.71
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.69
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.69
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.68
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.65
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.64
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.63
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.62
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.59
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.59
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.59
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.57
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.57
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.56
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.56
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.55
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.54
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.52
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.52
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.52
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.5
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.5
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.49
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.46
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.45
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.45
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.45
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.42
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.42
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.41
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.4
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.37
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.37
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.36
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.36
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.36
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.33
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.33
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.29
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.27
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.2
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.19
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.17
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.16
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.13
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.1
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.08
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.07
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.07
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.02
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	98.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.5
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.17
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.57
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.35
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	90.69
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	86.74
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	86.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	85.91

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=411.57  Aligned_cols=251  Identities=40%  Similarity=0.787  Sum_probs=212.3

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .....+.+|+++|++++|||||+++++|..++++|||||||.+++...+......+++..++.+++||+.||+|||++||
T Consensus        42 ~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~i  121 (299)
T d1ua2a_          42 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI  121 (299)
T ss_dssp             --CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccce
Confidence            34567899999999999999999999999999999999999987777776666679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+|+.....                                                
T Consensus       122 iHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------------------------------------------------  153 (299)
T d1ua2a_         122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------------------------------------------------  153 (299)
T ss_dssp             CCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------------------------------------------------
T ss_pred             ecccCCcceEEecCCCccccccCccccccCCC------------------------------------------------
Confidence            99999999999999999999999987644211                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .....+.+||+.|||||++.+...|+.++||||+||+
T Consensus       154 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  190 (299)
T d1ua2a_         154 -------------------------------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI  190 (299)
T ss_dssp             -------------------------------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHH
T ss_pred             -------------------------------------------cccccceecChhhccHHHHccCCCCChhhhhhhcchH
Confidence                                                       0011234789999999999887789999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|.+||.+.++.+++.+|.+.+|++..+.|+......... .+.......+...++..++.+.|||.+||++||+
T Consensus       191 l~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~  269 (299)
T d1ua2a_         191 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC  269 (299)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT
T ss_pred             HHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh-hhccCCCCChHHhcccCCHHHHHHHHHHccCChh
Confidence            999999999999999999999999999999998887665543322 2223333445556677789999999999999999


Q ss_pred             CCCCHHHHHcCccccCCcccCCc
Q psy10954        336 QRVSAKTILQHEYFNQVEMVKPT  358 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~~~~~~  358 (562)
                      +||||+|+|+||||++.....+.
T Consensus       270 ~R~sa~e~L~Hp~f~~~p~p~~~  292 (299)
T d1ua2a_         270 ARITATQALKMKYFSNRPGPTPG  292 (299)
T ss_dssp             TSCCHHHHHTSGGGTSSSCCCCS
T ss_pred             hCcCHHHHhCCHhhCCCCCCCCC
Confidence            99999999999999987654443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=397.79  Aligned_cols=248  Identities=60%  Similarity=1.078  Sum_probs=217.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~-~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+++|++++|||||+++++|.+++.+|+|||||.+++.+++.. ....+++..++.++.|++.||+|||++||
T Consensus        44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~I  123 (298)
T d1gz8a_          44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV  123 (298)
T ss_dssp             CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            45678899999999999999999999999999999999999877776644 34569999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+|+.....                                                
T Consensus       124 iHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~------------------------------------------------  155 (298)
T d1gz8a_         124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVP------------------------------------------------  155 (298)
T ss_dssp             CCSCCCGGGEEECTTSCEEECSTTHHHHHCCC------------------------------------------------
T ss_pred             EccccCchheeecccCcceeccCCcceeccCC------------------------------------------------
Confidence            99999999999999999999999987643211                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                 .......+||+.|+|||++.....++.++||||+||+
T Consensus       156 -------------------------------------------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvi  192 (298)
T d1gz8a_         156 -------------------------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI  192 (298)
T ss_dssp             -------------------------------------------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             -------------------------------------------cccceeecccceeeehhhhccccCCCccccccccchh
Confidence                                                       0111234789999999999888878999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|+.||.+.+..+++.++....|.+....|+.....+.+...++.+....+.......++.++|||++||++||+
T Consensus       193 ly~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~  272 (298)
T d1gz8a_         193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN  272 (298)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTT
T ss_pred             hhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChh
Confidence            99999999999999999999999999999999998887777777777777766666667777789999999999999999


Q ss_pred             CCCCHHHHHcCccccCCccc
Q psy10954        336 QRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      +|||++|+|+||||+++..+
T Consensus       273 ~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         273 KRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TSCCHHHHHTSGGGTTCCCC
T ss_pred             HCcCHHHHhCCHhhccCCCC
Confidence            99999999999999988644

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=394.92  Aligned_cols=218  Identities=25%  Similarity=0.432  Sum_probs=178.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+.+|+++|+.++|||||++++++.+++.+|||||||++ +|.+++... ..+++..++.++.|++.||+|||++|||
T Consensus        47 ~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~Ii  125 (271)
T d1nvra_          47 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGIT  125 (271)
T ss_dssp             --CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence            45688999999999999999999999999999999999985 999988654 4699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.......                                               
T Consensus       126 HrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~-----------------------------------------------  158 (271)
T d1nvra_         126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNR-----------------------------------------------  158 (271)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCTTCEECEETTE-----------------------------------------------
T ss_pred             cCcccHHHEEECCCCCEEEccchhheeeccCCc-----------------------------------------------
Confidence            999999999999999999999999875431100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                .....+.+||+.|||||++.+...++.++||||+||++
T Consensus       159 ------------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvil  196 (271)
T d1nvra_         159 ------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL  196 (271)
T ss_dssp             ------------------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHH
T ss_pred             ------------------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHH
Confidence                                                      00112457999999999998877678899999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        257 SEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       257 ~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      |||++|++||.+.+................                 +         .....++.+.|||.+||+.||++
T Consensus       197 yeml~G~~pf~~~~~~~~~~~~~~~~~~~~-----------------~---------~~~~~s~~~~~li~~~L~~dP~~  250 (271)
T d1nvra_         197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYL-----------------N---------PWKKIDSAPLALLHKILVENPSA  250 (271)
T ss_dssp             HHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-----------------T---------TGGGSCHHHHHHHHHHSCSSTTT
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------------C---------ccccCCHHHHHHHHHHcCCChhH
Confidence            999999999987765444333332111000                 0         01123578999999999999999


Q ss_pred             CCCHHHHHcCccccC
Q psy10954        337 RVSAKTILQHEYFNQ  351 (562)
Q Consensus       337 R~Ta~elL~Hp~f~~  351 (562)
                      |||++|+|+||||++
T Consensus       251 R~t~~eil~hpwf~~  265 (271)
T d1nvra_         251 RITIPDIKKDRWYNK  265 (271)
T ss_dssp             SCCHHHHTTCTTTTC
T ss_pred             CcCHHHHhcCHhhCc
Confidence            999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=391.36  Aligned_cols=213  Identities=33%  Similarity=0.561  Sum_probs=181.7

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ......+.+|+++|+.++|||||++++++.+++.+|||||||++ +|.+++.... .+++..++.++.||+.||+|||++
T Consensus        47 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~  125 (263)
T d2j4za1          47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK  125 (263)
T ss_dssp             TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34556788999999999999999999999999999999999984 9999987643 699999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |||||||||+|||++.++.+||+|||+|+.....                                              
T Consensus       126 ~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----------------------------------------------  159 (263)
T d2j4za1         126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----------------------------------------------  159 (263)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----------------------------------------------
T ss_pred             CeeeeeeccccceecCCCCEeecccceeeecCCC----------------------------------------------
Confidence            9999999999999999999999999987533210                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                     .....+||+.|||||++.+.. |+.++||||+|
T Consensus       160 -----------------------------------------------~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlG  191 (263)
T d2j4za1         160 -----------------------------------------------RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLG  191 (263)
T ss_dssp             -----------------------------------------------CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHH
T ss_pred             -----------------------------------------------cccccCCCCcccCHHHHcCCC-CCchhhhhhHh
Confidence                                                           011246899999999998754 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|++||.+.+..+.+..+.+.-..                  +|           ...++.+++||.+||+.|
T Consensus       192 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~~L~~d  242 (263)
T d2j4za1         192 VLCYEFLVGKPPFEANTYQETYKRISRVEFT------------------FP-----------DFVTEGARDLISRLLKHN  242 (263)
T ss_dssp             HHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------------------CC-----------TTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------CC-----------ccCCHHHHHHHHHHccCC
Confidence            9999999999999999887777766542100                  01           123578999999999999


Q ss_pred             CCCCCCHHHHHcCccccC
Q psy10954        334 PKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~  351 (562)
                      |++|||++|+|+||||+.
T Consensus       243 p~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         243 PSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             GGGSCCHHHHHTCHHHHH
T ss_pred             HhHCcCHHHHHcCcCcCC
Confidence            999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-47  Score=386.72  Aligned_cols=246  Identities=55%  Similarity=0.998  Sum_probs=211.9

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      +....++.+|+.+|++++|||||+++++|..++..|+||||+.+++...+......+++..++.++.||+.||+|||++|
T Consensus        41 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  120 (286)
T d1ob3a_          41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR  120 (286)
T ss_dssp             GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc
Confidence            34457889999999999999999999999999999999999998777777666678999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.++.+||+|||+|.....+.                                              
T Consensus       121 IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~----------------------------------------------  154 (286)
T d1ob3a_         121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPV----------------------------------------------  154 (286)
T ss_dssp             CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------------------------------------------
T ss_pred             EEecCCCCceeeEcCCCCEEecccccceecccCc----------------------------------------------
Confidence            9999999999999999999999999876432110                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ......+||+.|+|||++.+...++.++||||+||
T Consensus       155 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv  189 (286)
T d1ob3a_         155 ---------------------------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC  189 (286)
T ss_dssp             ----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             ---------------------------------------------cccceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence                                                         00123367899999999988888999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.++.+++.++...+|.+....|+.......+........+..........++.+.|||++||++||
T Consensus       190 ~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP  269 (286)
T d1ob3a_         190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP  269 (286)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCCh
Confidence            99999999999999999999999999999999998887776666555555555555556666778899999999999999


Q ss_pred             CCCCCHHHHHcCccccC
Q psy10954        335 KQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~  351 (562)
                      ++|+||+|+|+||||++
T Consensus       270 ~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         270 NQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTSCCHHHHHTSGGGGC
T ss_pred             hHCcCHHHHhcCcccCc
Confidence            99999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=389.71  Aligned_cols=222  Identities=27%  Similarity=0.466  Sum_probs=185.5

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+.+|+++|++++|||||+++++|.+++.+|||||||++ +|.+++...+ .+++..++.++.|++.||+|||++|
T Consensus        50 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~  128 (288)
T d1uu3a_          50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG  128 (288)
T ss_dssp             TCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcccc
Confidence            3456688999999999999999999999999999999999985 9999887653 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.++.+||+|||+|+.+.....                                             
T Consensus       129 iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~---------------------------------------------  163 (288)
T d1uu3a_         129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---------------------------------------------  163 (288)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECC-------------------------------------------------
T ss_pred             EEcCcCCccccccCCCceEEecccccceecccCCc---------------------------------------------
Confidence            99999999999999999999999999875431100                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .....+.+||+.|||||++.+.. |+.++||||+||
T Consensus       164 --------------------------------------------~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGv  198 (288)
T d1uu3a_         164 --------------------------------------------QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGC  198 (288)
T ss_dssp             --------------------------------------------------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccccCCccccCceeeccCC-CCcccceehhhH
Confidence                                                        00112357999999999998765 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+.+|.+.-.                  .++           ...++.++|||.+||+.||
T Consensus       199 ilyell~g~~Pf~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~~li~~~L~~dP  249 (288)
T d1uu3a_         199 IIYQLVAGLPPFRAGNEYLIFQKIIKLEY------------------DFP-----------EKFFPKARDLVEKLLVLDA  249 (288)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHTTCC------------------CCC-----------TTCCHHHHHHHHTTSCSSG
T ss_pred             HHHHHhhCCCCCCCcCHHHHHHHHHcCCC------------------CCC-----------ccCCHHHHHHHHHHccCCH
Confidence            99999999999999988887777754210                  011           1235789999999999999


Q ss_pred             CCCCCHHH------HHcCccccCCcccCC
Q psy10954        335 KQRVSAKT------ILQHEYFNQVEMVKP  357 (562)
Q Consensus       335 ~~R~Ta~e------lL~Hp~f~~~~~~~~  357 (562)
                      ++|+|++|      +++||||+++++.+.
T Consensus       250 ~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         250 TKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             GGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             hHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            99999987      689999999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=388.15  Aligned_cols=215  Identities=29%  Similarity=0.474  Sum_probs=182.5

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+.+|+++|+.++|||||+++++|..++.+|||||||++ +|.+++...  .+++..++.+++||+.||+|||++||
T Consensus        60 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~i  137 (293)
T d1yhwa1          60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQV  137 (293)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            345688999999999999999999999999999999999985 999888654  59999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.+|.+||+|||+|+.+....                                               
T Consensus       138 iHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-----------------------------------------------  170 (293)
T d1yhwa1         138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----------------------------------------------  170 (293)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----------------------------------------------
T ss_pred             cccCCcHHHeEECCCCcEeeccchhheeecccc-----------------------------------------------
Confidence            999999999999999999999999986542110                                               


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       171 --------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvi  205 (293)
T d1yhwa1         171 --------------------------------------------SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  205 (293)
T ss_dssp             --------------------------------------------CCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccccCCCccChhhhcCCC-CCchhceehHhHH
Confidence                                                        0112347899999999998754 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|++||.+.+..+.+..+..... +...                         .....++.+++||.+||+.||+
T Consensus       206 lyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~  259 (293)
T d1yhwa1         206 AIEMIEGEPPYLNENPLRALYLIATNGT-PELQ-------------------------NPEKLSAIFRDFLNRCLDMDVE  259 (293)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCS-------------------------SGGGSCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCC-------------------------CcccCCHHHHHHHHHHccCChh
Confidence            9999999999999998888777765321 1100                         0012356899999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy10954        336 QRVSAKTILQHEYFNQ  351 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~  351 (562)
                      +|||++|+|+||||+.
T Consensus       260 ~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         260 KRGSAKELLQHQFLKI  275 (293)
T ss_dssp             TSCCHHHHTTCGGGGG
T ss_pred             HCcCHHHHhcCHhhCC
Confidence            9999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=399.70  Aligned_cols=243  Identities=25%  Similarity=0.380  Sum_probs=176.5

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-R   93 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~-~   93 (562)
                      .....+.+|+.+|++++|||||+++++|.+.+++|||||||.+ +|.+++.+.+ .+++..++.++.|++.||+|||+ +
T Consensus        46 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~  124 (322)
T d1s9ja_          46 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH  124 (322)
T ss_dssp             THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4456788999999999999999999999999999999999985 9999987643 69999999999999999999997 4


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |||||||||+|||++.+|.+||+|||+|+.....                                              
T Consensus       125 ~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----------------------------------------------  158 (322)
T d1s9ja_         125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----------------------------------------------  158 (322)
T ss_dssp             CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----------------------------------------------
T ss_pred             CEEccccCHHHeeECCCCCEEEeeCCCccccCCC----------------------------------------------
Confidence            9999999999999999999999999987643100                                              


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                     ...+.+||++|||||++.+.+ |+.++||||+|
T Consensus       159 -----------------------------------------------~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlG  190 (322)
T d1s9ja_         159 -----------------------------------------------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMG  190 (322)
T ss_dssp             -----------------------------------------------TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHH
T ss_pred             -----------------------------------------------ccccccCCccccCchHHcCCC-CCcHHHHHHHH
Confidence                                                           012357999999999999865 99999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCCCCC----CCCCCCCCccCCCCCCCc-cchhhh-------c--CCC
Q psy10954        254 CIFSEMITKKTLFAGDSEID-QLFRIFRTLGTPHEDVW----PGVSKLPIYKTDFPEWRP-KKFSEI-------L--NLP  318 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~-------l--~~~  318 (562)
                      |++|||++|+.||.+.+..+ ++..+....|.+.....    .............+.... ......       +  ...
T Consensus       191 vil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (322)
T d1s9ja_         191 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF  270 (322)
T ss_dssp             HHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTB
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccC
Confidence            99999999999998766432 22223333332221110    000000000000000000 000000       0  123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      +..+.|||.+||++||++||||+|+|+||||++.+
T Consensus       271 s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         271 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            57899999999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=389.81  Aligned_cols=217  Identities=26%  Similarity=0.401  Sum_probs=181.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+.+|+++|++++|||||+++++|.+++.+|||||||++ +|.+++.+....+++..++.++.||+.||+|||++|||
T Consensus        53 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~iv  132 (288)
T d2jfla1          53 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII  132 (288)
T ss_dssp             GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            45688999999999999999999999999999999999985 89998876666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.......                                               
T Consensus       133 HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-----------------------------------------------  165 (288)
T d2jfla1         133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-----------------------------------------------  165 (288)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-----------------------------------------------
T ss_pred             EeecChhheeECCCCCEEEEechhhhccCCCcc-----------------------------------------------
Confidence            999999999999999999999999864321100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC----CCCCCchhhHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSA  252 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~----~~~y~~~~DIWSl  252 (562)
                                                                  ...+.+||+.|||||++.+    ...|+.++||||+
T Consensus       166 --------------------------------------------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl  201 (288)
T d2jfla1         166 --------------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  201 (288)
T ss_dssp             --------------------------------------------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred             --------------------------------------------cccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence                                                        0123468899999998853    3458999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|||++|++||.+.+..+.+.++...-...                    ..      .....++.+.|||.+||+.
T Consensus       202 Gvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~--------------------~~------~~~~~s~~~~~li~~~L~~  255 (288)
T d2jfla1         202 GITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT--------------------LA------QPSRWSSNFKDFLKKCLEK  255 (288)
T ss_dssp             HHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC--------------------CS------SGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------------------CC------ccccCCHHHHHHHHHHccC
Confidence            999999999999999988888777776531100                    00      0012357899999999999


Q ss_pred             CCCCCCCHHHHHcCccccC
Q psy10954        333 DPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~  351 (562)
                      ||++|||++|+|+||||+.
T Consensus       256 dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         256 NVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             STTTSCCHHHHTTSGGGCC
T ss_pred             ChhHCcCHHHHhcCcccCC
Confidence            9999999999999999973

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.5e-47  Score=393.99  Aligned_cols=220  Identities=23%  Similarity=0.388  Sum_probs=185.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+.+|+++|++++|||||+++++|.+++.+|||||||++ +|.+++.+..+.+++..++.+++||+.||+|||++|||
T Consensus        67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii  146 (350)
T d1koaa2          67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV  146 (350)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence            35678999999999999999999999999999999999975 99999977666799999999999999999999999999


Q ss_pred             eccCCCCcEEEcc--CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILINK--SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||+|||++.  ++.+||+|||+|+.....                                               
T Consensus       147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-----------------------------------------------  179 (350)
T d1koaa2         147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-----------------------------------------------  179 (350)
T ss_dssp             CCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-----------------------------------------------
T ss_pred             eeeechhHeeeccCCCCeEEEeecchheecccc-----------------------------------------------
Confidence            9999999999964  467899999987644210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ....+.+||+.|||||++.+.. |+.++||||+||
T Consensus       180 ---------------------------------------------~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGv  213 (350)
T d1koaa2         180 ---------------------------------------------QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGV  213 (350)
T ss_dssp             ---------------------------------------------SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHH
T ss_pred             ---------------------------------------------cccceecCcccccCHHHHcCCC-CChhHhhhhhhH
Confidence                                                         0112347899999999998765 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..|......++..                         .....++.++|||.+||+.||
T Consensus       214 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP  268 (350)
T d1koaa2         214 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------------------------AFSGISEDGKDFIRKLLLADP  268 (350)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-------------------------GGGGCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHccCCh
Confidence            9999999999999999888888887643222111                         112345789999999999999


Q ss_pred             CCCCCHHHHHcCccccCCccc
Q psy10954        335 KQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ++|||++|+|+||||++....
T Consensus       269 ~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         269 NTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             GGSCCHHHHHHSTTTSCTTCC
T ss_pred             hHCcCHHHHhcCcccCCCCCC
Confidence            999999999999999986543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=382.21  Aligned_cols=244  Identities=45%  Similarity=0.815  Sum_probs=198.2

Q ss_pred             CchhhHHHHHHHHHcc---CCCCcceEEEEEEe-----CCEEEEEeecCcCCHHHHH-hhCCCCCCHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKEL---KHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFL-QTTPVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l---~HpnIv~L~~~~~~-----~~~i~lV~Ey~~~~L~~~i-~~~~~~l~e~~i~~i~~qll~a   86 (562)
                      .....+.+|+++|+.|   +|||||+++++|..     ...+|+|||||.+++..+. ......+++..++.+++|++.|
T Consensus        49 ~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  128 (305)
T d1blxa_          49 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG  128 (305)
T ss_dssp             SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHH
Confidence            3455678999998877   79999999999863     2478999999998655544 4444569999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |+|||++|||||||||+|||++.++.+||+|||+++.....                                       
T Consensus       129 L~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---------------------------------------  169 (305)
T d1blxa_         129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---------------------------------------  169 (305)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---------------------------------------
T ss_pred             HHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc---------------------------------------
Confidence            99999999999999999999999999999999987533210                                       


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           ......+||+.|||||++.+.+ |+.+
T Consensus       170 -----------------------------------------------------~~~~~~~gT~~Y~APE~~~~~~-y~~~  195 (305)
T d1blxa_         170 -----------------------------------------------------MALTSVVVTLWYRAPEVLLQSS-YATP  195 (305)
T ss_dssp             -----------------------------------------------------GGGCCCCCCCTTCCHHHHTTCC-CCTH
T ss_pred             -----------------------------------------------------ccCCCcccChhhcCcchhcCCC-CChh
Confidence                                                                 0012347899999999998765 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|||++|++||.+.+..+++.++.+.+|.+....|+.....+...  +...............++.++|||
T Consensus       196 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~dli  273 (305)
T d1blxa_         196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA--FHSKSAQPIEKFVTDIDELGKDLL  273 (305)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG--SCCCCCCCGGGTCCSCCHHHHHHH
T ss_pred             ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhh--hccccccchhhccccCCHHHHHHH
Confidence            999999999999999999999999999999999999998887776554432221  111122223334455678999999


Q ss_pred             HHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      ++||++||++||||+|+|+||||++++.
T Consensus       274 ~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         274 LKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            9999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-47  Score=387.46  Aligned_cols=214  Identities=27%  Similarity=0.430  Sum_probs=169.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++|||||+++++|.+++.+|||||||+ ++|.+++... +.+++..++.++.||+.||+|||++||||
T Consensus        52 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiH  130 (307)
T d1a06a_          52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVH  130 (307)
T ss_dssp             ---CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeee
Confidence            456799999999999999999999999999999999998 5999999764 46999999999999999999999999999


Q ss_pred             ccCCCCcEEEc---cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         98 RDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        98 RDLKP~NILl~---~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      |||||+|||+.   .++.+||+|||+|+....                                                
T Consensus       131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~------------------------------------------------  162 (307)
T d1a06a_         131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDP------------------------------------------------  162 (307)
T ss_dssp             SCCCGGGEEESSSSTTCCEEECCC--------------------------------------------------------
T ss_pred             EEecccceeecccCCCceEEEeccceeEEccC------------------------------------------------
Confidence            99999999995   357788888887653211                                                


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                  .....+.+||+.|||||++.+.. |+.++||||+||
T Consensus       163 --------------------------------------------~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGv  197 (307)
T d1a06a_         163 --------------------------------------------GSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGV  197 (307)
T ss_dssp             ------------------------------------------------------CTTSCHHHHTTCC-CCTHHHHHHHHH
T ss_pred             --------------------------------------------CCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhH
Confidence                                                        00112357999999999998764 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+....+.+.-..++..                         .....++.+.|||.+||+.||
T Consensus       198 ilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP  252 (307)
T d1a06a_         198 IAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------------------------YWDDISDSAKDFIRHLMEKDP  252 (307)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSSG
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc-------------------------cccCCCHHHHHHHHHHccCCH
Confidence            9999999999999998887777776532111110                         112345789999999999999


Q ss_pred             CCCCCHHHHHcCccccC
Q psy10954        335 KQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~  351 (562)
                      ++|||++|+|+||||++
T Consensus       253 ~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         253 EKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             GGSCCHHHHHHSTTTTS
T ss_pred             hHCcCHHHHhcCHhhCC
Confidence            99999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-46  Score=393.37  Aligned_cols=217  Identities=26%  Similarity=0.464  Sum_probs=184.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||+++++|.+++.+|||||||++ +|.+.+......+++..++.+++||+.||+|||++|||
T Consensus        70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii  149 (352)
T d1koba_          70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV  149 (352)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34678999999999999999999999999999999999984 99998877766799999999999999999999999999


Q ss_pred             eccCCCCcEEEc--cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         97 HRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        97 HRDLKP~NILl~--~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||+|||++  .++.+||+|||+|+.....                                               
T Consensus       150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-----------------------------------------------  182 (352)
T d1koba_         150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPD-----------------------------------------------  182 (352)
T ss_dssp             CCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-----------------------------------------------
T ss_pred             ecccccccccccccCCCeEEEeecccceecCCC-----------------------------------------------
Confidence            999999999997  5678899999987644210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ....+.+||+.|+|||++.+.. |+.++||||+||
T Consensus       183 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGv  216 (352)
T d1koba_         183 ---------------------------------------------EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGV  216 (352)
T ss_dssp             ---------------------------------------------SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHH
T ss_pred             ---------------------------------------------CceeeccCcccccCHHHHcCCC-CCCccchHHHHH
Confidence                                                         0112346799999999997755 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..+......++...                         ....++.+.|||.+||+.||
T Consensus       217 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp  271 (352)
T d1koba_         217 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA-------------------------FSSVSPEAKDFIKNLLQKEP  271 (352)
T ss_dssp             HHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST-------------------------TTTSCHHHHHHHHTTSCSSG
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-------------------------ccCCCHHHHHHHHHHccCCh
Confidence            99999999999999999888888876433322211                         12345789999999999999


Q ss_pred             CCCCCHHHHHcCccccCC
Q psy10954        335 KQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       335 ~~R~Ta~elL~Hp~f~~~  352 (562)
                      .+|||++|+|+||||++.
T Consensus       272 ~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         272 RKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             GGSCCHHHHHTSTTTSSC
T ss_pred             hHCcCHHHHhcCHhhCCC
Confidence            999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-46  Score=385.79  Aligned_cols=210  Identities=23%  Similarity=0.394  Sum_probs=176.3

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      +.+.+|+++|++++|||||+++++|.+++.+|||||||.+ +|..++.. ...+++..++.+++||+.||.|||++||||
T Consensus        60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH  138 (309)
T d1u5ra_          60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIH  138 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            4578999999999999999999999999999999999986 45444443 457999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+|||++.++.+||+|||+|+....                                                   
T Consensus       139 rDiKp~NILl~~~~~~Kl~DFG~a~~~~~---------------------------------------------------  167 (309)
T d1u5ra_         139 RDVKAGNILLSEPGLVKLGDFGSASIMAP---------------------------------------------------  167 (309)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCBSSSS---------------------------------------------------
T ss_pred             cCCCcceEEECCCCCEEEeecccccccCC---------------------------------------------------
Confidence            99999999999999999999998753210                                                   


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCI  255 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIWSlG~i  255 (562)
                                                                  ....+||+.|||||++.+.  ..|+.++||||+||+
T Consensus       168 --------------------------------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvi  203 (309)
T d1u5ra_         168 --------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (309)
T ss_dssp             --------------------------------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHH
T ss_pred             --------------------------------------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHH
Confidence                                                        0123689999999998653  358999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+..+.+..+......+                    ..       ....++.+.+||.+||+.||+
T Consensus       204 lyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------~~-------~~~~s~~~~~li~~~L~~dP~  256 (309)
T d1u5ra_         204 CIELAERKPPLFNMNAMSALYHIAQNESPA--------------------LQ-------SGHWSEYFRNFVDSCLQKIPQ  256 (309)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------------CS-------CTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------------------CC-------CCCCCHHHHHHHHHHCcCChh
Confidence            999999999999998888877776531110                    00       012357899999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy10954        336 QRVSAKTILQHEYFNQ  351 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~  351 (562)
                      +|||++|+|+||||..
T Consensus       257 ~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         257 DRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             GSCCHHHHTTCHHHHS
T ss_pred             HCcCHHHHHhCHHhcC
Confidence            9999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=377.06  Aligned_cols=211  Identities=27%  Similarity=0.431  Sum_probs=171.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      .+.+.+|+++|++++|||||+++++|+.    +..+|||||||++ +|.+++.+.. .+++..++.++.||+.||+|||+
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~  130 (270)
T d1t4ha_          52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT  130 (270)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999975    3568999999975 9999987643 69999999999999999999999


Q ss_pred             CC--ceeccCCCCcEEEc-cCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhh
Q psy10954         93 RR--IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMS  169 (562)
Q Consensus        93 ~g--IiHRDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~  169 (562)
                      +|  ||||||||+|||++ .++.+||+|||+|+....                                           
T Consensus       131 ~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-------------------------------------------  167 (270)
T d1t4ha_         131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------------------------------------------  167 (270)
T ss_dssp             SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-------------------------------------------
T ss_pred             CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-------------------------------------------
Confidence            98  99999999999996 478899999998753210                                           


Q ss_pred             hHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhH
Q psy10954        170 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  249 (562)
Q Consensus       170 ~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DI  249 (562)
                                                                        ....+.+||+.|||||++.+  .|+.++||
T Consensus       168 --------------------------------------------------~~~~~~~GT~~Y~aPE~~~~--~~~~~~DI  195 (270)
T d1t4ha_         168 --------------------------------------------------SFAKAVIGTPEFMAPEMYEE--KYDESVDV  195 (270)
T ss_dssp             --------------------------------------------------TSBEESCSSCCCCCGGGGGT--CCCTHHHH
T ss_pred             --------------------------------------------------CccCCcccCccccCHHHhCC--CCCCcCch
Confidence                                                              00123478999999999865  39999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        250 WSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       250 WSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      ||+||++|||++|+.||.+......+.+.+.. +..+.                      .   .....++.+.+||.+|
T Consensus       196 wSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~----------------------~---~~~~~~~~~~~li~~~  249 (270)
T d1t4ha_         196 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA----------------------S---FDKVAIPEVKEIIEGC  249 (270)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG----------------------G---GGGCCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc----------------------c---cCccCCHHHHHHHHHH
Confidence            99999999999999999877665555444321 11100                      0   1123457899999999


Q ss_pred             cccCCCCCCCHHHHHcCcccc
Q psy10954        330 MALDPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~  350 (562)
                      |+.||++|||++|+|+||||+
T Consensus       250 l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         250 IRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGC
T ss_pred             ccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999995

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=386.99  Aligned_cols=217  Identities=26%  Similarity=0.419  Sum_probs=184.7

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+.+|+.+|+.++|||||+++++|++++.+|+|||||++ +|.+++.+.. .++|..++.++.||+.||+|||++|
T Consensus        47 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~  125 (337)
T d1o6la_          47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD  125 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC
Confidence            3456688999999999999999999999999999999999985 9999887654 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.+|.+||+|||+|+......                                              
T Consensus       126 iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~----------------------------------------------  159 (337)
T d1o6la_         126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----------------------------------------------  159 (337)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT----------------------------------------------
T ss_pred             ccccccCHHHeEecCCCCEEEeecccccccccCC----------------------------------------------
Confidence            9999999999999999999999999986442110                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   ....+.+||+.|+|||++.+.+ |+.++||||+||
T Consensus       160 ---------------------------------------------~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGv  193 (337)
T d1o6la_         160 ---------------------------------------------ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGV  193 (337)
T ss_dssp             ---------------------------------------------CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHH
T ss_pred             ---------------------------------------------cccccceeCHHHhhhhhccCCC-CChhhcccchhh
Confidence                                                         0112357899999999998765 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+..+.+..+...--                  .+|           ...++.++|||++||++||
T Consensus       194 ilyeml~G~~pf~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~dli~~~L~~dP  244 (337)
T d1o6la_         194 VMYEMMCGRLPFYNQDHERLFELILMEEI------------------RFP-----------RTLSPEAKSLLAGLLKKDP  244 (337)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------CCC-----------TTSCHHHHHHHHHHTCSST
T ss_pred             HHHHHHHCCCCCCCcCHHHHHHHHhcCCC------------------CCC-----------ccCCHHHHHHHHhhccCCc
Confidence            99999999999999998777766654210                  011           1235789999999999999


Q ss_pred             CCCCC-----HHHHHcCccccCCcc
Q psy10954        335 KQRVS-----AKTILQHEYFNQVEM  354 (562)
Q Consensus       335 ~~R~T-----a~elL~Hp~f~~~~~  354 (562)
                      ++|++     ++|+++||||+++++
T Consensus       245 ~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         245 KQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             TTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             hhhcccccccHHHHHcCcccccCCH
Confidence            99994     999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=378.68  Aligned_cols=219  Identities=30%  Similarity=0.486  Sum_probs=180.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||+++++|.+++.+|||||||++ +|.+++...+ .+++..++.+++|++.||+|||++|||
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~iv  135 (293)
T d1jksa_          57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIA  135 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhccee
Confidence            45688999999999999999999999999999999999984 9999987654 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCC----CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         97 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        97 HRDLKP~NILl~~~~----~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ||||||+|||++.++    .+||+|||+|+....                                              
T Consensus       136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~----------------------------------------------  169 (293)
T d1jksa_         136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----------------------------------------------  169 (293)
T ss_dssp             CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT----------------------------------------------
T ss_pred             ecccccceEEEecCCCcccceEecchhhhhhcCC----------------------------------------------
Confidence            999999999998765    367777776543321                                              


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                   . ....+.+||+.|+|||++.+. .|+.++||||+
T Consensus       170 ---------------------------------------------~-~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSl  202 (293)
T d1jksa_         170 ---------------------------------------------G-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSI  202 (293)
T ss_dssp             ---------------------------------------------S-CBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHH
T ss_pred             ---------------------------------------------C-ccccccCCCCcccCHHHHcCC-CCCCcccchhh
Confidence                                                         0 112345789999999999865 48999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|||++|+.||.+.+..+.+..+.......+                         .......++.++|||++||+.
T Consensus       203 Gvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~  257 (293)
T d1jksa_         203 GVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------------------DEYFSNTSALAKDFIRRLLVK  257 (293)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTSCHHHHHHHHTTSCS
T ss_pred             hHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-------------------------chhcCCCCHHHHHHHHHHccC
Confidence            9999999999999999998888877754311110                         012233467899999999999


Q ss_pred             CCCCCCCHHHHHcCccccCCccc
Q psy10954        333 DPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ||++|||++|+|+||||+..++.
T Consensus       258 dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         258 DPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             SGGGSCCHHHHHHSTTTCC----
T ss_pred             ChhHCcCHHHHhcCcccCCCChh
Confidence            99999999999999999876643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-45  Score=378.99  Aligned_cols=214  Identities=27%  Similarity=0.461  Sum_probs=183.1

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+.+|+.+|+.++|||||++++++.+++.+|+|||||.+ +|..++.... .+++..++.++.||+.||+|||++||
T Consensus        47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~i  125 (316)
T d1fota_          47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDI  125 (316)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcE
Confidence            345688999999999999999999999999999999999985 7888776644 68999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.+|.+||+|||+|+....                                                 
T Consensus       126 iHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-------------------------------------------------  156 (316)
T d1fota_         126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD-------------------------------------------------  156 (316)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCSSCEECSS-------------------------------------------------
T ss_pred             EccccCchheeEcCCCCEEEecCccceEecc-------------------------------------------------
Confidence            9999999999999999999999998754310                                                 


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                   ...+.+||+.|||||++.+.. |+.++||||+||+
T Consensus       157 ---------------------------------------------~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvi  190 (316)
T d1fota_         157 ---------------------------------------------VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGIL  190 (316)
T ss_dssp             ---------------------------------------------CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHH
T ss_pred             ---------------------------------------------ccccccCcccccCHHHHcCCC-CCchhhccccchh
Confidence                                                         011347899999999997654 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|+.||.+.+..+.+.++.+.-..                  ++           ...++.+.|++.+||+.||.
T Consensus       191 lyemltG~~Pf~~~~~~~~~~~i~~~~~~------------------~p-----------~~~s~~~~~li~~~L~~dp~  241 (316)
T d1fota_         191 IYEMLAGYTPFYDSNTMKTYEKILNAELR------------------FP-----------PFFNEDVKDLLSRLITRDLS  241 (316)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------------CC-----------TTSCHHHHHHHHHHTCSCTT
T ss_pred             HHHHHhCCCCCCCcCHHHHHHHHHcCCCC------------------CC-----------CCCCHHHHHHHHHHhhhCHH
Confidence            99999999999999988888777653110                  00           12356899999999999999


Q ss_pred             CCC-----CHHHHHcCccccCCccc
Q psy10954        336 QRV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       336 ~R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      +|+     |++|+|+||||+++.+.
T Consensus       242 ~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         242 QRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             TCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             hccccchhhHHHHHcCcccccCCHH
Confidence            997     89999999999998654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=381.90  Aligned_cols=241  Identities=29%  Similarity=0.602  Sum_probs=192.0

Q ss_pred             HHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         21 ALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        21 ~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~---~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+|+++|++++|||||+++++|...      .++|||||||++++.+.+.   .....+++..++.+++||+.||+|||
T Consensus        60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH  139 (350)
T d1q5ka_          60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH  139 (350)
T ss_dssp             CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            35899999999999999999998643      4689999999987665553   24456999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhh
Q psy10954         92 SRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSY  170 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~  170 (562)
                      ++|||||||||+|||++.++ .+||+|||+|+.....                                           
T Consensus       140 ~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-------------------------------------------  176 (350)
T d1q5ka_         140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-------------------------------------------  176 (350)
T ss_dssp             TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-------------------------------------------
T ss_pred             hcCCcccCCCcceEEEecCCCceeEecccchhhccCC-------------------------------------------
Confidence            99999999999999999775 7899999987543210                                           


Q ss_pred             HHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHH
Q psy10954        171 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  250 (562)
Q Consensus       171 l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIW  250 (562)
                                                                       ....+.+||+.|+|||++.+...|+.++|||
T Consensus       177 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIw  207 (350)
T d1q5ka_         177 -------------------------------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVW  207 (350)
T ss_dssp             -------------------------------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHH
T ss_pred             -------------------------------------------------cccccccccccccChHHhhcccCCCcceeec
Confidence                                                             0112347899999999998877899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhh-cCCCCHHHHHHHHHc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEI-LNLPDPLAVDVFSKI  329 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~dLi~~m  329 (562)
                      |+||++|||++|++||.+.+..+++..+++.+|.+..+.+...... .....++......+.+. ....++.+.|||.+|
T Consensus       208 SlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m  286 (350)
T d1q5ka_         208 SAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL  286 (350)
T ss_dssp             HHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHH
T ss_pred             ccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc-hhhccccccccCchhhhcccCCCHHHHHHHHHH
Confidence            9999999999999999999999999999999998876544322110 01112222222222222 233578899999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++||++|+||+|+|+||||+++..
T Consensus       287 L~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         287 LEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccCChhHCcCHHHHhcCHhhccccC
Confidence            9999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-45  Score=382.16  Aligned_cols=215  Identities=23%  Similarity=0.372  Sum_probs=184.0

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+.+|+++|+.++|||||+++++|.....+|+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++|
T Consensus        83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~  161 (350)
T d1rdqe_          83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD  161 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3345688999999999999999999999999999999999975 8988887654 6999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.+|.+||+|||+|+.....                                               
T Consensus       162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----------------------------------------------  194 (350)
T d1rdqe_         162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------------------------------------------  194 (350)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----------------------------------------------
T ss_pred             EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----------------------------------------------
Confidence            999999999999999999999999987643210                                               


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                     ..+.+||+.|||||++.+.. |+.++||||+||
T Consensus       195 -----------------------------------------------~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGv  226 (350)
T d1rdqe_         195 -----------------------------------------------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGV  226 (350)
T ss_dssp             -----------------------------------------------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             -----------------------------------------------cccccCccccCCHHHHcCCC-CCccccccchhH
Confidence                                                           11346899999999998755 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|++||.+.+....+.+|.......                             ....++.+.+||++||+.||
T Consensus       227 ilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------p~~~s~~~~~li~~~L~~dP  277 (350)
T d1rdqe_         227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----------------------------PSHFSSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------------------CTTCCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-----------------------------CccCCHHHHHHHHHHhhhCH
Confidence            9999999999999998888877776532111                             01235789999999999999


Q ss_pred             CCCC-----CHHHHHcCccccCCccc
Q psy10954        335 KQRV-----SAKTILQHEYFNQVEMV  355 (562)
Q Consensus       335 ~~R~-----Ta~elL~Hp~f~~~~~~  355 (562)
                      .+|+     |++|+|+||||+++++.
T Consensus       278 ~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         278 TKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HhccccccccHHHHHcCccccCCCHH
Confidence            9995     89999999999988753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-46  Score=384.41  Aligned_cols=241  Identities=41%  Similarity=0.699  Sum_probs=200.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC------EEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~------~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      .+.+.+|+++|++++|||||+++++|...+      .+|+|||||+.+|..+++..  .+++..++.+++||+.||+|||
T Consensus        61 ~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH  138 (346)
T d1cm8a_          61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH  138 (346)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH
Confidence            457889999999999999999999997654      57999999988888887654  5999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++|||||||||+|||++.++.+|++|||+|+....                                             
T Consensus       139 ~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~---------------------------------------------  173 (346)
T d1cm8a_         139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------------------------------------------  173 (346)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---------------------------------------------
T ss_pred             hCCCcccccCcchhhcccccccccccccceeccCC---------------------------------------------
Confidence            99999999999999999999999999998753321                                             


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                       ..+..+||+.|+|||++.+...++.++||||
T Consensus       174 -------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  204 (346)
T d1cm8a_         174 -------------------------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWS  204 (346)
T ss_dssp             -------------------------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred             -------------------------------------------------ccccccccccccCHHHHcCCCCCCccchhhc
Confidence                                                             0123468999999999988777899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|||++|++||.+.+..+.+..+....+.++.+.+......  ..+....+......+...+...++.++|||.+|
T Consensus       205 lGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m  284 (346)
T d1cm8a_         205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM  284 (346)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred             chHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHH
Confidence            999999999999999999999999999999888776544332210  011112333334445556666788999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++||++||||+|+|+||||+++..
T Consensus       285 L~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         285 LVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             SCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             CcCChhHCcCHHHHhcChhhCcCCC
Confidence            9999999999999999999998753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=371.70  Aligned_cols=251  Identities=41%  Similarity=0.768  Sum_probs=199.1

Q ss_pred             CCchhhHHHHHHHHHccCCCCcceEEEEEEe--------CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q psy10954         15 EGVPSTALREISVLKELKHPNVIRLHDVIPV--------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA   86 (562)
Q Consensus        15 ~~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~--------~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~a   86 (562)
                      +....++.+|+++|+.++||||+++++++..        ++.+|+|||||++++..........+++..++.+++|++.|
T Consensus        50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~  129 (318)
T d3blha1          50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG  129 (318)
T ss_dssp             TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHH
Confidence            4456678999999999999999999999855        34689999999987777776666679999999999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         87 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        87 L~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      |.|||++|||||||||+|||++.++.+||+|||+|+........                                    
T Consensus       130 l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~------------------------------------  173 (318)
T d3blha1         130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS------------------------------------  173 (318)
T ss_dssp             HHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC----------------------------------------
T ss_pred             HHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccc------------------------------------
Confidence            99999999999999999999999999999999998654311000                                    


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                         ......+.+||++|+|||++.+...|+++
T Consensus       174 ---------------------------------------------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k  202 (318)
T d3blha1         174 ---------------------------------------------------QPNRYTNRVVTLWYRPPELLLGERDYGPP  202 (318)
T ss_dssp             ----------------------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred             ---------------------------------------------------ccccccceecCHHHhhHHHHcCCCCCCcH
Confidence                                                               00111235799999999999988789999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccC-CCCCCCccchhhhcC--CCCHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKT-DFPEWRPKKFSEILN--LPDPLAV  323 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~--~~~~~~~  323 (562)
                      +||||+||++|||++|++||.+.++.+.+..+.+..|.+..+.+........+.. .............+.  ..++.++
T Consensus       203 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (318)
T d3blha1         203 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL  282 (318)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHH
T ss_pred             HHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHH
Confidence            9999999999999999999999999999999999999988877765544322211 111111111211111  2367889


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCC
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      |||.+||++||++|+||+|+|+||||++-
T Consensus       283 dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         283 DLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             HHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            99999999999999999999999999863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.1e-45  Score=367.49  Aligned_cols=216  Identities=28%  Similarity=0.480  Sum_probs=179.0

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|++++ |||||+++++|.+++.+|||||||++ +|.++++.. +.+++..++.++.||+.||+|||++||
T Consensus        53 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (277)
T d1phka_          53 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNI  131 (277)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            346889999999997 99999999999999999999999975 999999764 479999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+|+..... ...                                            
T Consensus       132 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~--------------------------------------------  166 (277)
T d1phka_         132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKL--------------------------------------------  166 (277)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCB--------------------------------------------
T ss_pred             cccccccceEEEcCCCCeEEccchheeEccCC-Cce--------------------------------------------
Confidence            99999999999999999999999998755321 111                                            


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC-----CCCCCchhhHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-----AKVYSTTVDIW  250 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~-----~~~y~~~~DIW  250 (562)
                                                                     ...+||+.|+|||++.+     ...|+.++|||
T Consensus       167 -----------------------------------------------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw  199 (277)
T d1phka_         167 -----------------------------------------------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW  199 (277)
T ss_dssp             -----------------------------------------------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred             -----------------------------------------------eeeeccCCCCCHHHhhccccccCCCCCchheEc
Confidence                                                           12345666666666642     33478999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        251 SAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       251 SlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      |+||++|||++|+.||.+.+..+.+..+.+.--.++..                         .....++.++||+.+||
T Consensus       200 slGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L  254 (277)
T d1phka_         200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP-------------------------EWDDYSDTVKDLVSRFL  254 (277)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-------------------------TGGGSCHHHHHHHHHHC
T ss_pred             ccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-------------------------ccccCCHHHHHHHHHHc
Confidence            99999999999999999999888777776531111000                         11234578999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccC
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQ  351 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~  351 (562)
                      +.||++|||++|+|+||||++
T Consensus       255 ~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         255 VVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CSSGGGSCCHHHHTTSGGGCT
T ss_pred             cCChhHCcCHHHHHcCHHHHH
Confidence            999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.1e-45  Score=382.36  Aligned_cols=213  Identities=22%  Similarity=0.352  Sum_probs=173.6

Q ss_pred             HHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q psy10954         23 REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLK  101 (562)
Q Consensus        23 rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRDLK  101 (562)
                      +|+++++.++|||||+++++|.+.+.+|||||||+ ++|.+++.+. ..+++..++.++.||+.||+|||++||||||||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK  134 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  134 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeec
Confidence            34777788899999999999999999999999998 5999999765 368999999999999999999999999999999


Q ss_pred             CCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHHHHhh
Q psy10954        102 PQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEALRYC  181 (562)
Q Consensus       102 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~gL~yL  181 (562)
                      |+|||++.+|.+||+|||+|+.....                                                      
T Consensus       135 P~NILl~~~g~iKl~DFGla~~~~~~------------------------------------------------------  160 (364)
T d1omwa3         135 PANILLDEHGHVRISDLGLACDFSKK------------------------------------------------------  160 (364)
T ss_dssp             GGGEEECSSSCEEECCCTTCEECSSS------------------------------------------------------
T ss_pred             cceeEEcCCCcEEEeeeceeeecCCC------------------------------------------------------
Confidence            99999999999999999987643210                                                      


Q ss_pred             hcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHHHHHh
Q psy10954        182 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIT  261 (562)
Q Consensus       182 Hs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~eLlt  261 (562)
                                                             .....+||+.|+|||++.+...|+.++||||+||++|||++
T Consensus       161 ---------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt  201 (364)
T d1omwa3         161 ---------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR  201 (364)
T ss_dssp             ---------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ---------------------------------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh
Confidence                                                   01234689999999999876679999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCCCCC--
Q psy10954        262 KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQRVS--  339 (562)
Q Consensus       262 G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~R~T--  339 (562)
                      |+.||.+.+..+... +..........                         .....++.+.|||.+||+.||++|+|  
T Consensus       202 G~~Pf~~~~~~~~~~-~~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~  255 (364)
T d1omwa3         202 GHSPFRQHKTKDKHE-IDRMTLTMAVE-------------------------LPDSFSPELRSLLEGLLQRDVNRRLGCL  255 (364)
T ss_dssp             SSCSSCSSCSSCHHH-HHHHSSSCCCC-------------------------CCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred             CCCCCCCCCHHHHHH-HHHhcccCCCC-------------------------CCCCCCHHHHHHHHHHcccCHHHhCCCc
Confidence            999998765432221 22211111100                         01123578999999999999999999  


Q ss_pred             ---HHHHHcCccccCCccc
Q psy10954        340 ---AKTILQHEYFNQVEMV  355 (562)
Q Consensus       340 ---a~elL~Hp~f~~~~~~  355 (562)
                         |+|+++||||+++++.
T Consensus       256 ~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         256 GRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             SSTHHHHHTSGGGTTCCHH
T ss_pred             ccCHHHHHcCccccCCCHH
Confidence               8999999999998753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=370.87  Aligned_cols=212  Identities=28%  Similarity=0.446  Sum_probs=167.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe--CCEEEEEeecCcC-CHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~--~~~i~lV~Ey~~~-~L~~~i~~---~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      .+.+.+|+++|++++|||||++++++.+  +..+|||||||++ +|.+++.+   ....+++..++.++.|++.||+|||
T Consensus        47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH  126 (269)
T d2java1          47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH  126 (269)
T ss_dssp             HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999864  4569999999985 99998864   2346999999999999999999999


Q ss_pred             HCC-----ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccch
Q psy10954         92 SRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  166 (562)
Q Consensus        92 ~~g-----IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~  166 (562)
                      ++|     ||||||||+|||++.++.+||+|||+|+......                                      
T Consensus       127 ~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--------------------------------------  168 (269)
T d2java1         127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--------------------------------------  168 (269)
T ss_dssp             HHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------------------------------------
T ss_pred             HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--------------------------------------
Confidence            976     9999999999999999999999999986543110                                      


Q ss_pred             hhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCch
Q psy10954        167 EMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT  246 (562)
Q Consensus       167 Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~  246 (562)
                                                                           ....+.+||+.|||||++.+.. |+.+
T Consensus       169 -----------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~-~~~~  194 (269)
T d2java1         169 -----------------------------------------------------SFAKAFVGTPYYMSPEQMNRMS-YNEK  194 (269)
T ss_dssp             ------------------------------------------------------------CCCSCCCHHHHTTCC-CCHH
T ss_pred             -----------------------------------------------------CccccCCCCcccCCHHHHcCCC-CChH
Confidence                                                                 0012347899999999997654 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHH
Q psy10954        247 VDIWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVF  326 (562)
Q Consensus       247 ~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi  326 (562)
                      +||||+||++|||++|++||.+.+..+....+.+.-  ..                  .        +....++.+.+||
T Consensus       195 ~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--~~------------------~--------~~~~~s~~l~~li  246 (269)
T d2java1         195 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR------------------R--------IPYRYSDELNEII  246 (269)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CC------------------C--------CCTTSCHHHHHHH
T ss_pred             HHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC------------------C--------CCcccCHHHHHHH
Confidence            999999999999999999999988877777665421  00                  0        0012356799999


Q ss_pred             HHccccCCCCCCCHHHHHcCccc
Q psy10954        327 SKIMALDPKQRVSAKTILQHEYF  349 (562)
Q Consensus       327 ~~mL~~DP~~R~Ta~elL~Hp~f  349 (562)
                      .+||+.||++|||++|+|+|||+
T Consensus       247 ~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         247 TRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=377.87  Aligned_cols=215  Identities=26%  Similarity=0.418  Sum_probs=181.5

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|+.++|||||+++++|++++.+|||||||++ +|.+++...+..+++.+++.++.||+.||+|||++||+|
T Consensus        46 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiH  125 (321)
T d1tkia_          46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH  125 (321)
T ss_dssp             HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCc
Confidence            3567999999999999999999999999999999999985 999999877667999999999999999999999999999


Q ss_pred             ccCCCCcEEEccC--CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         98 RDLKPQNILINKS--GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        98 RDLKP~NILl~~~--~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||+|||++.+  +.+||+|||+++.....                                                
T Consensus       126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~------------------------------------------------  157 (321)
T d1tkia_         126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------------------------------------------------  157 (321)
T ss_dssp             CCCCGGGEEESSSSCCCEEECCCTTCEECCTT------------------------------------------------
T ss_pred             ccccccceeecCCCceEEEEcccchhhccccC------------------------------------------------
Confidence            9999999999854  46888899887543210                                                


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       158 --------------------------------------------~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvi  192 (321)
T d1tkia_         158 --------------------------------------------DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTL  192 (321)
T ss_dssp             --------------------------------------------CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHH
T ss_pred             --------------------------------------------CcccccccccccccchhccCCC-CCchhhcccHHHH
Confidence                                                        0012346789999999987655 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|+|++|.+||.+.+..+.+.+|.+....++.                         ......++.++|||.+||+.||+
T Consensus       193 ly~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~  247 (321)
T d1tkia_         193 VYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------------------------EAFKEISIEAMDFVDRLLVKERK  247 (321)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHHHHTTSCSSGG
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh-------------------------hhccCCCHHHHHHHHHHccCChh
Confidence            99999999999999988888888763221111                         12233467899999999999999


Q ss_pred             CCCCHHHHHcCccccC
Q psy10954        336 QRVSAKTILQHEYFNQ  351 (562)
Q Consensus       336 ~R~Ta~elL~Hp~f~~  351 (562)
                      +|+|++|+|+||||++
T Consensus       248 ~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         248 SRMTASEALQHPWLKQ  263 (321)
T ss_dssp             GSCCHHHHHHSHHHHS
T ss_pred             HCcCHHHHhcCHhhcc
Confidence            9999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-44  Score=358.74  Aligned_cols=245  Identities=52%  Similarity=0.892  Sum_probs=198.5

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....++.+|+.+|+.++|||||+++++|......++|||++.+ +|..++ ...+.+++..++.++.|++.||+|||++|
T Consensus        43 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~  121 (292)
T d1unla_          43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence            3456788999999999999999999999999999999999987 555544 44557999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.++.+||+|||.|+......                                              
T Consensus       122 IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----------------------------------------------  155 (292)
T d1unla_         122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----------------------------------------------  155 (292)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----------------------------------------------
T ss_pred             EeeecccCcccccccCCceeeeecchhhcccCCC----------------------------------------------
Confidence            9999999999999999999999999876543110                                              


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  254 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~  254 (562)
                                                                   .......++++|+|||++.+...++.++||||+||
T Consensus       156 ---------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~  190 (292)
T d1unla_         156 ---------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC  190 (292)
T ss_dssp             ---------------------------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             ---------------------------------------------ccceeeccccchhhhhHhccCCCCCchhhccccch
Confidence                                                         00112356788999999988887899999999999


Q ss_pred             HHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        255 IFSEMITKKTL-FAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       255 il~eLltG~~p-F~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      ++|||++|+.| |.+.+..+++.++....+.+....|+.......+...................++.+.|||++||++|
T Consensus       191 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d  270 (292)
T d1unla_         191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN  270 (292)
T ss_dssp             HHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSS
T ss_pred             HHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCC
Confidence            99999999887 56667778888899999998888777665544332211111112223334455788999999999999


Q ss_pred             CCCCCCHHHHHcCccccCC
Q psy10954        334 PKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~  352 (562)
                      |++||||+|+|+||||++.
T Consensus       271 P~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         271 PVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GGGSCCHHHHTTSGGGSSC
T ss_pred             hhHCcCHHHHhcChhhcCC
Confidence            9999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-44  Score=371.11  Aligned_cols=247  Identities=34%  Similarity=0.638  Sum_probs=197.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC-----CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~-----~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+++|+++|+.++||||+++++++...     ..+|+||++++++|.+++...  .+++..++.++.|++.||+|||+
T Consensus        50 ~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~  127 (345)
T d1pmea_          50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS  127 (345)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999998754     357888887778999999764  59999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|||||||||+|||++.++.+||+|||+|+........                                          
T Consensus       128 ~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~------------------------------------------  165 (345)
T d1pmea_         128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH------------------------------------------  165 (345)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB------------------------------------------
T ss_pred             CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc------------------------------------------
Confidence            99999999999999999999999999998654311000                                          


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                    .......+||+.|+|||++.....|+.++||||+
T Consensus       166 ----------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl  199 (345)
T d1pmea_         166 ----------------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV  199 (345)
T ss_dssp             ----------------------------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred             ----------------------------------------------ceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence                                                          0011235789999999999777779999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHcc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIM  330 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL  330 (562)
                      ||++|||++|++||.+.+..++...+...++.+...........  ..+....+...+..+...++..++.++||+.+||
T Consensus       200 G~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  279 (345)
T d1pmea_         200 GCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML  279 (345)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHS
T ss_pred             CceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHc
Confidence            99999999999999999998888888887776654322111110  0111122333334455566667889999999999


Q ss_pred             ccCCCCCCCHHHHHcCccccCCcc
Q psy10954        331 ALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       331 ~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      ++||++||||+|+|+||||++...
T Consensus       280 ~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         280 TFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             CSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             cCChhHCcCHHHHhcCHhhccCCC
Confidence            999999999999999999997653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=373.02  Aligned_cols=220  Identities=25%  Similarity=0.388  Sum_probs=168.3

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEe----CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~----~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..+.+|++++.++ +|||||+++++|++    +..+|||||||++ +|.+++.+.+ ..+++.+++.++.||+.||+|||
T Consensus        49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH  128 (335)
T d2ozaa1          49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  128 (335)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            4578999997654 89999999999976    3679999999975 9999998754 46999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         92 SRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      ++||+||||||+|||++.   ++.+||+|||+|+.....                                         
T Consensus       129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-----------------------------------------  167 (335)
T d2ozaa1         129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----------------------------------------  167 (335)
T ss_dssp             HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-----------------------------------------
T ss_pred             HcCCccccccccccccccccccccccccccceeeeccCC-----------------------------------------
Confidence            999999999999999975   356888888877543210                                         


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         ......+||+.|||||++.+.. |+.++|
T Consensus       168 ---------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-y~~~~D  195 (335)
T d2ozaa1         168 ---------------------------------------------------NSLTTPCYTPYYVAPEVLGPEK-YDKSCD  195 (335)
T ss_dssp             ---------------------------------------------------CCCCCCSCCCSSCCCCCCCGGG-GSHHHH
T ss_pred             ---------------------------------------------------CccccccCCcccCCcHHHcCCC-CCHHHH
Confidence                                                               0112347899999999887654 899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       249 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      |||+||++|+|++|++||.+.+.......+.......              ...++..       .....++.+.|||++
T Consensus       196 iwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~--------------~~~~~~~-------~~~~~s~~~~~li~~  254 (335)
T d2ozaa1         196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--------------QYEFPNP-------EWSEVSEEVKMLIRN  254 (335)
T ss_dssp             HHHHHHHHHHHTTSSCSCEETTCC--------CCCSC--------------SSSCCTT-------HHHHSCHHHHHHHHH
T ss_pred             HHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC--------------CCCCCCc-------ccccCCHHHHHHHHH
Confidence            9999999999999999998876544333332211000              0011110       111235789999999


Q ss_pred             ccccCCCCCCCHHHHHcCccccCC
Q psy10954        329 IMALDPKQRVSAKTILQHEYFNQV  352 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~Hp~f~~~  352 (562)
                      ||+.||++|||+.|+|+||||.+.
T Consensus       255 ~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         255 LLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HccCChhHCcCHHHHHcCHHhhCC
Confidence            999999999999999999999753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=365.96  Aligned_cols=217  Identities=30%  Similarity=0.499  Sum_probs=182.0

Q ss_pred             CchhhHHHHHHHHH-ccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         16 GVPSTALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        16 ~~~~~~~rEi~iL~-~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      .....+.+|+.++. .++|||||++++++.+++.+|||||||++ +|.+++.... .+++..++.++.||+.||+|||++
T Consensus        44 ~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~  122 (320)
T d1xjda_          44 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK  122 (320)
T ss_dssp             TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            33456778888775 68999999999999999999999999985 9999997644 699999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      |||||||||+|||++.++.+||+|||+|+......                                             
T Consensus       123 ~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---------------------------------------------  157 (320)
T d1xjda_         123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---------------------------------------------  157 (320)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---------------------------------------------
T ss_pred             CeeeccCcccceeecCCCceeccccchhhhccccc---------------------------------------------
Confidence            99999999999999999999999999986432110                                             


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ......+||+.|+|||++.+.. |+.++||||+|
T Consensus       158 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG  190 (320)
T d1xjda_         158 ----------------------------------------------AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFG  190 (320)
T ss_dssp             ----------------------------------------------CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCCCCCcCCHHHHcCCC-CCchhhhhhhh
Confidence                                                          0012347899999999998765 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.+..+.+..+...  .+.                +|           ...++.+.|||++||+.|
T Consensus       191 vilyemltG~~PF~~~~~~~~~~~i~~~--~~~----------------~p-----------~~~s~~~~dli~~~L~~d  241 (320)
T d1xjda_         191 VLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF----------------YP-----------RWLEKEAKDLLVKLFVRE  241 (320)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC----------------CC-----------TTSCHHHHHHHHHHSCSS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC----------------CC-----------ccCCHHHHHHHHHhcccC
Confidence            9999999999999999888777766532  110                00           123578999999999999


Q ss_pred             CCCCCCHH-HHHcCccccCCcc
Q psy10954        334 PKQRVSAK-TILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~Ta~-elL~Hp~f~~~~~  354 (562)
                      |++|||+. |+++||||+++++
T Consensus       242 P~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         242 PEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             GGGSBTTBSCGGGSGGGTTCCH
T ss_pred             CCCCcCHHHHHHhCchhccCCH
Confidence            99999995 8999999998764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-44  Score=360.68  Aligned_cols=206  Identities=31%  Similarity=0.464  Sum_probs=170.0

Q ss_pred             hhHHHHHHHHHccC--CCCcceEEEEEEeCCEEEEEeecCcC--CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         19 STALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        19 ~~~~rEi~iL~~l~--HpnIv~L~~~~~~~~~i~lV~Ey~~~--~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .++.+|+.+|++++  |||||+++++|.+++.+|+||||+.+  ++.+++... ..+++..++.++.|++.||+|||++|
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~  130 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG  130 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34679999999996  89999999999999999999999963  777877654 36999999999999999999999999


Q ss_pred             ceeccCCCCcEEEccC-CCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         95 IIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        95 IiHRDLKP~NILl~~~-~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||||+|||++.+ +.+||+|||+|+....                                               
T Consensus       131 iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~-----------------------------------------------  163 (273)
T d1xwsa_         131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----------------------------------------------  163 (273)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECCS-----------------------------------------------
T ss_pred             CccccCcccceEEecCCCeEEECccccceeccc-----------------------------------------------
Confidence            9999999999999855 6899999998753210                                               


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                    ...++.+||+.|+|||++.+.+.++.++||||+|
T Consensus       164 ----------------------------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlG  197 (273)
T d1xwsa_         164 ----------------------------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG  197 (273)
T ss_dssp             ----------------------------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH
T ss_pred             ----------------------------------------------ccccccccCCCcCCHHHHcCCCCCCcccccccce
Confidence                                                          0112357899999999998877778899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.++      +.+.  ..                .+           -...++.+.|||++||+.|
T Consensus       198 vilyell~g~~Pf~~~~~------i~~~--~~----------------~~-----------~~~~s~~~~~li~~~L~~d  242 (273)
T d1xwsa_         198 ILLYDMVCGDIPFEHDEE------IIRG--QV----------------FF-----------RQRVSSECQHLIRWCLALR  242 (273)
T ss_dssp             HHHHHHHHSSCSCCSHHH------HHHC--CC----------------CC-----------SSCCCHHHHHHHHHHTCSS
T ss_pred             eeehhHhhCCCCCCCchH------Hhhc--cc----------------CC-----------CCCCCHHHHHHHHHHccCC
Confidence            999999999999986432      2211  00                00           0123578999999999999


Q ss_pred             CCCCCCHHHHHcCccccCCc
Q psy10954        334 PKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       334 P~~R~Ta~elL~Hp~f~~~~  353 (562)
                      |++|||++|+|+||||+++.
T Consensus       243 p~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         243 PSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             GGGSCCHHHHHTSGGGSSCC
T ss_pred             HhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999998753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-43  Score=352.90  Aligned_cols=216  Identities=19%  Similarity=0.270  Sum_probs=172.7

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+.+|+++|++++|||||++++++. ...+|||||||+ ++|.+++...+..+++..+..++.|++.||+|||++|||
T Consensus        48 ~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iv  126 (276)
T d1uwha_          48 LQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII  126 (276)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEe
Confidence            456789999999999999999999864 457899999998 599999987777899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.......                                               
T Consensus       127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~-----------------------------------------------  159 (276)
T d1uwha_         127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-----------------------------------------------  159 (276)
T ss_dssp             CSCCCGGGEEEETTSSEEECCCCCSCC-----------------------------------------------------
T ss_pred             ccccCHHHEEEcCCCCEEEccccceeeccccCC-----------------------------------------------
Confidence            999999999999999999999999865431100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC--CCCCchhhHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGC  254 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~--~~y~~~~DIWSlG~  254 (562)
                                                                .....+.+||+.|||||++.+.  ..|+.++||||+||
T Consensus       160 ------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv  197 (276)
T d1uwha_         160 ------------------------------------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI  197 (276)
T ss_dssp             ------------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHH
T ss_pred             ------------------------------------------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHH
Confidence                                                      0011234689999999999753  34899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        255 IFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       255 il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      ++|||++|+.||.+.+....+..+......++.                       ........++.+.+|+.+||..||
T Consensus       198 ~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li~~cl~~dp  254 (276)
T d1uwha_         198 VLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-----------------------LSKVRSNCPKAMKRLMAECLKKKR  254 (276)
T ss_dssp             HHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----------------------GGGSCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----------------------chhccccchHHHHHHHHHHcCCCH
Confidence            999999999999988776666555443211110                       011112345688999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||++|++++
T Consensus       255 ~~RPt~~~il~~  266 (276)
T d1uwha_         255 DERPLFPQILAS  266 (276)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.2e-43  Score=360.58  Aligned_cols=241  Identities=31%  Similarity=0.582  Sum_probs=180.7

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeC--CEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   93 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~--~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~   93 (562)
                      ...+.+|+++|+.++ ||||++++++|...  ..+|+|||||.+ +|..+.    ..+++..++.+++||+.||+|||++
T Consensus        73 ~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~  148 (328)
T d3bqca1          73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM  148 (328)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            467889999999995 99999999999854  569999999985 765542    3599999999999999999999999


Q ss_pred             CceeccCCCCcEEEccCC-CeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         94 RIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~-~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      |||||||||+|||++.++ .+||+|||+|+.....                                             
T Consensus       149 gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~---------------------------------------------  183 (328)
T d3bqca1         149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---------------------------------------------  183 (328)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT---------------------------------------------
T ss_pred             ccccccccccceEEcCCCCeeeecccccceeccCC---------------------------------------------
Confidence            999999999999998765 5899999987643210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                     ......+||+.|+|||++.+...|+.++||||+
T Consensus       184 -----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  216 (328)
T d3bqca1         184 -----------------------------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  216 (328)
T ss_dssp             -----------------------------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             -----------------------------------------------CcccccccCccccCcccccCCCCCCcccchhhh
Confidence                                                           011234679999999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCCCCCCCC---CCCCCccCCCCCCCccchhh-----hcCCCCHHHH
Q psy10954        253 GCIFSEMITKKTLFAGD-SEIDQLFRIFRTLGTPHEDVWPGV---SKLPIYKTDFPEWRPKKFSE-----ILNLPDPLAV  323 (562)
Q Consensus       253 G~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-----~l~~~~~~~~  323 (562)
                      ||++|||++|+.||... +..++...+...+|.+....+...   ...+.+..............     .....++++.
T Consensus       217 G~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  296 (328)
T d3bqca1         217 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL  296 (328)
T ss_dssp             HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHH
T ss_pred             hhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHH
Confidence            99999999999998654 456677777776664322111000   00000000000000011111     1123467899


Q ss_pred             HHHHHccccCCCCCCCHHHHHcCccccCCcc
Q psy10954        324 DVFSKIMALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       324 dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |||++||++||++|+||+|+|+||||+++.+
T Consensus       297 dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         297 DFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            9999999999999999999999999998753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=363.42  Aligned_cols=241  Identities=39%  Similarity=0.661  Sum_probs=191.3

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeC------CEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~------~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..++.+|+++|++++|||||+++++|...      ...|+++++++++|.+++...  .+++..++.+++||+.||+|||
T Consensus        61 ~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH  138 (348)
T d2gfsa1          61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH  138 (348)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999643      345666666667999998653  5999999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++|||||||||+|||++.+|.+|++|||+|.....                                             
T Consensus       139 ~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---------------------------------------------  173 (348)
T d2gfsa1         139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---------------------------------------------  173 (348)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---------------------------------------------
T ss_pred             hCCCcccccCCccccccccccccccccchhcccCc---------------------------------------------
Confidence            99999999999999999999999999998643210                                             


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                       ...+.+||+.|+|||++.+...++.++||||
T Consensus       174 -------------------------------------------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwS  204 (348)
T d2gfsa1         174 -------------------------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWS  204 (348)
T ss_dssp             -------------------------------------------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHH
T ss_pred             -------------------------------------------------ccccccccccccCchhhcCCccCCcccchhh
Confidence                                                             0113467889999999988887899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC--CCccCCCCCCCccchhhhcCCCCHHHHHHHHHc
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKI  329 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~m  329 (562)
                      +||++|+|++|++||.+.+.......+.+..+.+..+.+......  ..+....+......+.......++.++|||.+|
T Consensus       205 lGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m  284 (348)
T d2gfsa1         205 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM  284 (348)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHH
Confidence            999999999999999999999999999988887765443322211  011112223333344555566788999999999


Q ss_pred             cccCCCCCCCHHHHHcCccccCCcc
Q psy10954        330 MALDPKQRVSAKTILQHEYFNQVEM  354 (562)
Q Consensus       330 L~~DP~~R~Ta~elL~Hp~f~~~~~  354 (562)
                      |++||++|+||+|+|+||||++...
T Consensus       285 L~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         285 LVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CcCChhhCcCHHHHhcCHhhCCCCC
Confidence            9999999999999999999998754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-43  Score=360.14  Aligned_cols=213  Identities=19%  Similarity=0.359  Sum_probs=174.2

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC----------------------CCCC
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP----------------------VPVP   72 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~----------------------~~l~   72 (562)
                      ....+.+|+.+|+++ +|||||++++++.+.+.+|||||||+ ++|.++++...                      ..++
T Consensus        83 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  162 (325)
T d1rjba_          83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT  162 (325)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CC
T ss_pred             HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCC
Confidence            345688999999998 89999999999999999999999997 59999997643                      2488


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccc
Q psy10954         73 PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  152 (562)
Q Consensus        73 e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~  152 (562)
                      +..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+........                      
T Consensus       163 ~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~----------------------  220 (325)
T d1rjba_         163 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY----------------------  220 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCce----------------------
Confidence            9999999999999999999999999999999999999999999999998754311000                      


Q ss_pred             ccccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCcc
Q psy10954        153 STTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR  232 (562)
Q Consensus       153 s~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~  232 (562)
                                                                                         ....+.+||+.||
T Consensus       221 -------------------------------------------------------------------~~~~~~~gt~~y~  233 (325)
T d1rjba_         221 -------------------------------------------------------------------VVRGNARLPVKWM  233 (325)
T ss_dssp             -------------------------------------------------------------------EEETTEEECGGGC
T ss_pred             -------------------------------------------------------------------eeeccccCCCccC
Confidence                                                                               0012346799999


Q ss_pred             chhhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccch
Q psy10954        233 PPEILLGAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKF  311 (562)
Q Consensus       233 APEvl~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (562)
                      |||++.+.. |+.++||||+||++|||++ |++||.+.+..+.+.+++.....++                .|       
T Consensus       234 aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------~p-------  289 (325)
T d1rjba_         234 APESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD----------------QP-------  289 (325)
T ss_dssp             CHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC----------------CC-------
T ss_pred             ChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----------------CC-------
Confidence            999998655 8999999999999999997 8999998877666766655311110                00       


Q ss_pred             hhhcCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        312 SEILNLPDPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       312 ~~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                          ...++.+.+|+.+||+.||++|||++|+++|
T Consensus       290 ----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         290 ----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                1235679999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-42  Score=352.52  Aligned_cols=214  Identities=22%  Similarity=0.332  Sum_probs=168.2

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      .+.+.+|+++|++++|||||++++++..++.+|+|||||++ +|.+++....+.+++..+..++.|++.||+|||++|||
T Consensus        71 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii  150 (299)
T d1jpaa_          71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV  150 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCc
Confidence            34688999999999999999999999999999999999985 89998887777799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.........+                                            
T Consensus       151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~--------------------------------------------  186 (299)
T d1jpaa_         151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--------------------------------------------  186 (299)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC----------------------------------------------------------
T ss_pred             cCccccceEEECCCCcEEECCcccceEccCCCCcce--------------------------------------------
Confidence            999999999999999999999999875532100000                                            


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                ........||+.|||||++.+.. |+.++||||+||++
T Consensus       187 ------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl  223 (299)
T d1jpaa_         187 ------------------------------------------YTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVM  223 (299)
T ss_dssp             ---------------------------------------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHH
T ss_pred             ------------------------------------------eeecccccCCccccCHHHHhcCC-CCcccccccchHHH
Confidence                                                      00011235789999999998754 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |++||.+.+..+.+..+.+....+.                            -...++.+.+|+.+||+.||+
T Consensus       224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~~P~  275 (299)
T d1jpaa_         224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPP----------------------------PMDCPSALHQLMLDCWQKDRN  275 (299)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------------------------CccchHHHHHHHHHHcCCCHh
Confidence            99998 8999999888777666643211110                            012346789999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||+.|++++
T Consensus       276 ~RPs~~ei~~~  286 (299)
T d1jpaa_         276 HRPKFGQIVNT  286 (299)
T ss_dssp             TSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999998864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=362.63  Aligned_cols=240  Identities=36%  Similarity=0.601  Sum_probs=185.0

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe------CCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~------~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ..++.+|+.+|++++|||||+++++|..      ..++|+|||||.+++.+.+..   .+++..++.+++||+.||+|||
T Consensus        60 ~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH  136 (355)
T d2b1pa1          60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  136 (355)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhh
Confidence            3467899999999999999999999964      368999999999888877643   5899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ++||+||||||+|||++.++.+|++|||+++.....                                            
T Consensus       137 ~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--------------------------------------------  172 (355)
T d2b1pa1         137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------------------------------------  172 (355)
T ss_dssp             HTTCCCSCCCGGGEEECTTCCEEECCCCC---------------------------------------------------
T ss_pred             hcccccccCCccccccccccceeeechhhhhccccc--------------------------------------------
Confidence            999999999999999999999999999986533210                                            


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                      ......+||+.|+|||++.+. .|+.++||||
T Consensus       173 ------------------------------------------------~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwS  203 (355)
T d2b1pa1         173 ------------------------------------------------FMMTPYVVTRYYRAPEVILGM-GYKENVDIWS  203 (355)
T ss_dssp             --------------------------------------------------------CCTTCCHHHHTTC-CCCTTHHHHH
T ss_pred             ------------------------------------------------cccccccccccccChhhhcCC-CCCCCccccc
Confidence                                                            001234689999999999875 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCC-CCccCCCCCCCccchhhhc------------CCC
Q psy10954        252 AGCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL-PIYKTDFPEWRPKKFSEIL------------NLP  318 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l------------~~~  318 (562)
                      +||++|||++|++||.+.+...++.++.+.++.+..+.|...... ..+....+..........+            ...
T Consensus       204 lG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (355)
T d2b1pa1         204 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK  283 (355)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred             ccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccC
Confidence            999999999999999999999999999998888776655443221 0001111111111111110            112


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcCccccCCc
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVE  353 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~  353 (562)
                      ++.+.|||++||++||++||||+|+|+||||+...
T Consensus       284 s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         284 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            45789999999999999999999999999998743

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=348.53  Aligned_cols=215  Identities=23%  Similarity=0.335  Sum_probs=175.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||++++++.. +.+|||||||++ +|.+++...+..+++..+..++.|++.||+|||++|||
T Consensus        53 ~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~ii  131 (285)
T d1u59a_          53 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV  131 (285)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3568899999999999999999999875 468999999985 99999887767899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.........                                             
T Consensus       132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~---------------------------------------------  166 (285)
T d1u59a_         132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---------------------------------------------  166 (285)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE---------------------------------------------
T ss_pred             cCcCchhheeeccCCceeeccchhhhccccccccc---------------------------------------------
Confidence            99999999999999999999999987653210000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||+.|+|||++.+.. |+.++||||+||++
T Consensus       167 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l  202 (285)
T d1u59a_         167 -------------------------------------------TARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTM  202 (285)
T ss_dssp             -------------------------------------------CCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccccccCccccChHHHhCCC-CCccchhhcchHHH
Confidence                                                       0012246799999999997654 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |+.||.+.+..+.+..+.+....                    +        .....++.+.+|+.+||+.||+
T Consensus       203 ~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~--------------------~--------~p~~~~~~l~~li~~cl~~~p~  254 (285)
T d1u59a_         203 WEALSYGQKPYKKMKGPEVMAFIEQGKRM--------------------E--------CPPECPPELYALMSDCWIYKWE  254 (285)
T ss_dssp             HHHHTTSCCTTTTCCTHHHHHHHHTTCCC--------------------C--------CCTTCCHHHHHHHHHTTCSSGG
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------C--------CCCcCCHHHHHHHHHHcCCCHh
Confidence            99998 99999988877666655432100                    0        0012346789999999999999


Q ss_pred             CCCCHHHH---HcCcccc
Q psy10954        336 QRVSAKTI---LQHEYFN  350 (562)
Q Consensus       336 ~R~Ta~el---L~Hp~f~  350 (562)
                      +|||+.++   |+|+|++
T Consensus       255 ~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         255 DRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             GSCCHHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHHHH
Confidence            99999876   6788874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=347.53  Aligned_cols=215  Identities=22%  Similarity=0.333  Sum_probs=172.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||++++++.. +..|||||||++ +|.++++... .+++..+..++.||+.||+|||++|||
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~ii  129 (277)
T d1xbba_          52 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV  129 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcc
Confidence            4568899999999999999999999965 467999999985 9999987654 699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.........                                             
T Consensus       130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~---------------------------------------------  164 (277)
T d1xbba_         130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---------------------------------------------  164 (277)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE---------------------------------------------
T ss_pred             cCCCcchhhcccccCcccccchhhhhhcccccccc---------------------------------------------
Confidence            99999999999999999999999987543210000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||+.|+|||++.+.. |+.++||||+||++
T Consensus       165 -------------------------------------------~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l  200 (277)
T d1xbba_         165 -------------------------------------------KAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLM  200 (277)
T ss_dssp             -------------------------------------------EC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             -------------------------------------------ccccccCCCceecCchhhcCCC-CCchhhhccchhhh
Confidence                                                       0001236799999999998755 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |++||.+.+..+....+.+.  ..+                  .        .-...++.+.+|+.+||+.||+
T Consensus       201 ~ellt~g~~Pf~~~~~~~~~~~i~~~--~~~------------------~--------~p~~~~~~~~~li~~cl~~dp~  252 (277)
T d1xbba_         201 WEAFSYGQKPYRGMKGSEVTAMLEKG--ERM------------------G--------CPAGCPREMYDLMNLCWTYDVE  252 (277)
T ss_dssp             HHHHTTTCCSSTTCCHHHHHHHHHTT--CCC------------------C--------CCTTCCHHHHHHHHHHTCSSTT
T ss_pred             hHHhhCCCCCCCCCCHHHHHHHHHcC--CCC------------------C--------CCcccCHHHHHHHHHHcCCCHh
Confidence            99997 89999998876655555331  100                  0        0012346789999999999999


Q ss_pred             CCCCHHHH---HcCccccC
Q psy10954        336 QRVSAKTI---LQHEYFNQ  351 (562)
Q Consensus       336 ~R~Ta~el---L~Hp~f~~  351 (562)
                      +|||++++   |+|+|++-
T Consensus       253 ~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         253 NRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             TSCCHHHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHhhCHHhhc
Confidence            99999987   56766643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-42  Score=341.67  Aligned_cols=210  Identities=23%  Similarity=0.376  Sum_probs=167.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||++++++..++.+|+|||||+ ++|.+++......+++..+..++.|++.||+|||+++|+
T Consensus        44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~ii  123 (263)
T d1sm2a_          44 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  123 (263)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcccee
Confidence            4568899999999999999999999999999999999997 599999987777799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.......                                               
T Consensus       124 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-----------------------------------------------  156 (263)
T d1sm2a_         124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----------------------------------------------  156 (263)
T ss_dssp             CTTCSGGGEEECGGGCEEECSCC---------------------------------------------------------
T ss_pred             ecccchhheeecCCCCeEecccchheeccCCCc-----------------------------------------------
Confidence            999999999999999999999999865421100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||+.|+|||++.+.. |+.++||||+||++
T Consensus       157 -------------------------------------------~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil  192 (263)
T d1sm2a_         157 -------------------------------------------TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLM  192 (263)
T ss_dssp             ---------------------------------------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred             -------------------------------------------eeecceecCcccCChHHhcCCC-CCchhhhcchHHHH
Confidence                                                       0011236899999999998765 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |.+||.+.+..+.+..+......+                 .|           ...++.+.+|+.+||+.||+
T Consensus       193 ~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-----------------~p-----------~~~~~~l~~li~~cl~~~p~  244 (263)
T d1sm2a_         193 WEVFSEGKIPYENRSNSEVVEDISTGFRLY-----------------KP-----------RLASTHVYQIMNHCWKERPE  244 (263)
T ss_dssp             HHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-----------------CC-----------TTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-----------------Cc-----------cccCHHHHHHHHHHccCCHh
Confidence            99999 577777777666666554421110                 00           12346789999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||++|+++|
T Consensus       245 ~Rps~~~il~~  255 (263)
T d1sm2a_         245 DRPAFSRLLRQ  255 (263)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-42  Score=345.58  Aligned_cols=218  Identities=26%  Similarity=0.415  Sum_probs=169.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCC----EEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+|+++|+.++|||||++++++...+    .+|||||||++ +|.+++...+ .+++..++.++.||+.||+|||+
T Consensus        51 ~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~  129 (277)
T d1o6ya_          51 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ  129 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            346789999999999999999999998653    48999999985 8998886653 69999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      +|||||||||+|||++.++.++++|||.+........                                           
T Consensus       130 ~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~-------------------------------------------  166 (277)
T d1o6ya_         130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-------------------------------------------  166 (277)
T ss_dssp             TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----------------------------------------------
T ss_pred             CCccCccccCcccccCccccceeehhhhhhhhccccc-------------------------------------------
Confidence            9999999999999999999999999998754321100                                           


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                   ........+||+.|+|||++.+.. |+.++||||+
T Consensus       167 ---------------------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSl  200 (277)
T d1o6ya_         167 ---------------------------------------------SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSL  200 (277)
T ss_dssp             ---------------------------------------------------------TTCCHHHHTTCC-CCHHHHHHHH
T ss_pred             ---------------------------------------------cccccccccCcccccCHHHHcCCC-CCcceecccc
Confidence                                                         000113457999999999997754 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHcccc
Q psy10954        253 GCIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMAL  332 (562)
Q Consensus       253 G~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~  332 (562)
                      ||++|||++|++||.+.+..+.+.++......++..                         .....++.+.+||.+||+.
T Consensus       201 GvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s~~l~~li~~~L~~  255 (277)
T d1o6ya_         201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-------------------------RHEGLSADLDAVVLKALAK  255 (277)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG-------------------------TSSSCCHHHHHHHHHHTCS
T ss_pred             hHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch-------------------------hccCCCHHHHHHHHHHccC
Confidence            999999999999999999888877776532221111                         1123457899999999999


Q ss_pred             CCCCCCCHHHHHcCcccc
Q psy10954        333 DPKQRVSAKTILQHEYFN  350 (562)
Q Consensus       333 DP~~R~Ta~elL~Hp~f~  350 (562)
                      ||++||+..+.+.|+|.+
T Consensus       256 dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         256 NPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SGGGSCSSHHHHHHHHHH
T ss_pred             CHhHCHhHHHHHHHHHHH
Confidence            999999555555566653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-41  Score=343.10  Aligned_cols=210  Identities=25%  Similarity=0.368  Sum_probs=168.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .+.+.+|+++|++++|||||++++++.+++.+|||||||+ ++|.+++... ...+++..+..++.|++.||+|||++||
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i  136 (287)
T d1opja_          57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF  136 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4568899999999999999999999999999999999998 5999998754 3469999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+|+.......                                              
T Consensus       137 iHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~----------------------------------------------  170 (287)
T d1opja_         137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----------------------------------------------  170 (287)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS----------------------------------------------
T ss_pred             ccCccccCeEEECCCCcEEEccccceeecCCCCc----------------------------------------------
Confidence            9999999999999999999999999875431100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. |+.++||||+||+
T Consensus       171 --------------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~  205 (287)
T d1opja_         171 --------------------------------------------TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVL  205 (287)
T ss_dssp             --------------------------------------------EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHH
T ss_pred             --------------------------------------------eeeccccccccccChHHHcCCC-CCchhhhhhHHHH
Confidence                                                        0011235788999999998765 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        256 FSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      +|||++|..||........+.+++..-..+                .           .....++.+.+|+.+||+.||+
T Consensus       206 l~ell~~~~p~~~~~~~~~~~~~i~~~~~~----------------~-----------~~~~~~~~l~~li~~cl~~dP~  258 (287)
T d1opja_         206 LWEIATYGMSPYPGIDLSQVYELLEKDYRM----------------E-----------RPEGCPEKVYELMRACWQWNPS  258 (287)
T ss_dssp             HHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----------------C-----------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHhCCCCCCCcchHHHHHHHHhcCCCC----------------C-----------CCccchHHHHHHHHHHcCCCHh
Confidence            999999766655544444444444321000                0           0112356799999999999999


Q ss_pred             CCCCHHHHHc
Q psy10954        336 QRVSAKTILQ  345 (562)
Q Consensus       336 ~R~Ta~elL~  345 (562)
                      +|||++|+++
T Consensus       259 ~Rps~~ei~~  268 (287)
T d1opja_         259 DRPSFAEIHQ  268 (287)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-41  Score=339.43  Aligned_cols=209  Identities=25%  Similarity=0.430  Sum_probs=165.6

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++|++++|||||++++++. .+.+|+|||||.+ +|.+++......+++..++.++.|++.||+|||++|||
T Consensus        52 ~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ii  130 (273)
T d1mp8a_          52 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV  130 (273)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCee
Confidence            356789999999999999999999985 5679999999985 89998887777899999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+|+.......                                               
T Consensus       131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-----------------------------------------------  163 (273)
T d1mp8a_         131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----------------------------------------------  163 (273)
T ss_dssp             CSCCSGGGEEEEETTEEEECC-----------------------------------------------------------
T ss_pred             ccccchhheeecCCCcEEEccchhheeccCCcc-----------------------------------------------
Confidence            999999999999999999999999865431100                                               


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||+.|+|||++.+.. |+.++||||+||++
T Consensus       164 -------------------------------------------~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil  199 (273)
T d1mp8a_         164 -------------------------------------------YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCM  199 (273)
T ss_dssp             --------------------------------------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHH
T ss_pred             -------------------------------------------eeccceecCcccchhhHhccCC-CCCccccccchHHH
Confidence                                                       0011235789999999998655 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |.+||.+.+..+.+..+.+....+                            .....++.+.+||.+||..||+
T Consensus       200 ~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~cl~~dp~  251 (273)
T d1mp8a_         200 WEILMHGVKPFQGVKNNDVIGRIENGERLP----------------------------MPPNCPPTLYSLMTKCWAYDPS  251 (273)
T ss_dssp             HHHHTTSCCTTTTCCGGGHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCHh
Confidence            99997 899999988877766664321100                            0112356899999999999999


Q ss_pred             CCCCHHHHHcC
Q psy10954        336 QRVSAKTILQH  346 (562)
Q Consensus       336 ~R~Ta~elL~H  346 (562)
                      +|||++|+++|
T Consensus       252 ~Rps~~ei~~~  262 (273)
T d1mp8a_         252 RRPRFTELKAQ  262 (273)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-42  Score=352.00  Aligned_cols=222  Identities=27%  Similarity=0.438  Sum_probs=178.9

Q ss_pred             chhhHHHHHHHHHccCC-CCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         17 VPSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~H-pnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      ....+.+|+++|++++| |||+++++++.....+|+|||||.+ +|.+++.... .+++..++.++.||+.||+|||++|
T Consensus        71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~  149 (322)
T d1vzoa_          71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG  149 (322)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC
Confidence            35567899999999976 8999999999999999999999984 9999987654 5889999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHH
Q psy10954         95 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQL  174 (562)
Q Consensus        95 IiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QI  174 (562)
                      ||||||||+|||++.+|.+||+|||+|+.+.....                                             
T Consensus       150 ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~---------------------------------------------  184 (322)
T d1vzoa_         150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET---------------------------------------------  184 (322)
T ss_dssp             CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG---------------------------------------------
T ss_pred             EEeccCCccceeecCCCCEEEeeccchhhhccccc---------------------------------------------
Confidence            99999999999999999999999999865431100                                             


Q ss_pred             HHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC-CCCchhhHHHHH
Q psy10954        175 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAG  253 (562)
Q Consensus       175 l~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~-~y~~~~DIWSlG  253 (562)
                                                                   ....+..||+.|+|||++.+.. .|+.++||||+|
T Consensus       185 ---------------------------------------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG  219 (322)
T d1vzoa_         185 ---------------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG  219 (322)
T ss_dssp             ---------------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred             ---------------------------------------------ccccccccccccchhHHhhcCCcCCCchhhhHHHH
Confidence                                                         0012346899999999997654 478899999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+.+..+....+.+........                         .....++.+.+||.+||++|
T Consensus       220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~l~~d  274 (322)
T d1vzoa_         220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-------------------------YPQEMSALAKDLIQRLLMKD  274 (322)
T ss_dssp             HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-------------------------CcccCCHHHHHHHHHHcccC
Confidence            99999999999998876544444443321110000                         11224678999999999999


Q ss_pred             CCCCC-----CHHHHHcCccccCCcc
Q psy10954        334 PKQRV-----SAKTILQHEYFNQVEM  354 (562)
Q Consensus       334 P~~R~-----Ta~elL~Hp~f~~~~~  354 (562)
                      |++|+     ||+|+|+||||+++++
T Consensus       275 P~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         275 PKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             GGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            99999     5899999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-41  Score=333.96  Aligned_cols=211  Identities=23%  Similarity=0.375  Sum_probs=177.0

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ....+.+|+++|++++|||||++++++.+++.+|+|||||. ++|.+++......+++..+..++.|++.||+|||++||
T Consensus        42 ~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  121 (258)
T d1k2pa_          42 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF  121 (258)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCc
Confidence            34678999999999999999999999999999999999997 58999887766679999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+|+.......                                              
T Consensus       122 iH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~----------------------------------------------  155 (258)
T d1k2pa_         122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----------------------------------------------  155 (258)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC----------------------------------------------
T ss_pred             ccccccceeEEEcCCCcEEECcchhheeccCCCc----------------------------------------------
Confidence            9999999999999999999999999865431100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. |+.++||||+||+
T Consensus       156 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~  190 (258)
T d1k2pa_         156 --------------------------------------------TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVL  190 (258)
T ss_dssp             --------------------------------------------CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------eeecccCCCCCcCCcHHhcCCC-CCcceeecccchh
Confidence                                                        0011246799999999998765 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |+.||.+.+..+....+.+....+.                 |           ...++.+.+|+++||+.||
T Consensus       191 l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------------p-----------~~~~~~l~~li~~cl~~dP  242 (258)
T d1k2pa_         191 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----------------P-----------HLASEKVYTIMYSCWHEKA  242 (258)
T ss_dssp             HHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-----------------C-----------TTCCHHHHHHHHHTTCSSG
T ss_pred             hHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC-----------------c-----------ccccHHHHHHHHHHccCCH
Confidence            999998 8999999988777766654211110                 0           1234678999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||++|+++|
T Consensus       243 ~~RPt~~eil~~  254 (258)
T d1k2pa_         243 DERPTFKILLSN  254 (258)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=340.46  Aligned_cols=214  Identities=22%  Similarity=0.402  Sum_probs=170.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      .+.+.+|+++|++++|||||++++++. ++.+|+|||||+ ++|.+++.... ..+++..+..++.||+.||+|||++||
T Consensus        52 ~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i  130 (272)
T d1qpca_          52 PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY  130 (272)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            456899999999999999999999875 457899999997 58988775433 258999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||||+.++.+||+|||+|+.......                                              
T Consensus       131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~----------------------------------------------  164 (272)
T d1qpca_         131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----------------------------------------------  164 (272)
T ss_dssp             ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE----------------------------------------------
T ss_pred             ccCccchhheeeecccceeeccccceEEccCCcc----------------------------------------------
Confidence            9999999999999999999999999875431100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. |+.++||||+||+
T Consensus       165 --------------------------------------------~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvv  199 (272)
T d1qpca_         165 --------------------------------------------TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGIL  199 (272)
T ss_dssp             --------------------------------------------ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccCCcccccChHHHhCCC-CCchhhhhhhHHH
Confidence                                                        0011246789999999997654 8999999999999


Q ss_pred             HHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG-~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++| .+||.+.+..+.+..+......+                 .+           ...++.+.+|+.+||+.||
T Consensus       200 l~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-----------------~p-----------~~~~~~l~~li~~cl~~~P  251 (272)
T d1qpca_         200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-----------------RP-----------DNCPEELYQLMRLCWKERP  251 (272)
T ss_dssp             HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------CC-----------TTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------Cc-----------ccChHHHHHHHHHHcCCCH
Confidence            9999995 55666666665555554321100                 00           1234678999999999999


Q ss_pred             CCCCCHHHHHc--CccccC
Q psy10954        335 KQRVSAKTILQ--HEYFNQ  351 (562)
Q Consensus       335 ~~R~Ta~elL~--Hp~f~~  351 (562)
                      ++|||++|+++  |+||..
T Consensus       252 ~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         252 EDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             GGSCCHHHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHhhhhhhc
Confidence            99999999998  888864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-40  Score=331.62  Aligned_cols=210  Identities=21%  Similarity=0.310  Sum_probs=163.6

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   97 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiH   97 (562)
                      ..+.+|+++|++++|||||++++++.....+|+|||||.+ ++.+++......+++..+..++.|++.||+|||+++|||
T Consensus        54 ~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH  133 (283)
T d1mqba_          54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH  133 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccccccc
Confidence            4578999999999999999999999999999999999986 788888777778999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHHH
Q psy10954         98 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLEA  177 (562)
Q Consensus        98 RDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~g  177 (562)
                      |||||+||||+.++.+||+|||+|+........                                               
T Consensus       134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~-----------------------------------------------  166 (283)
T d1mqba_         134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-----------------------------------------------  166 (283)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC---------------------------------------------------------
T ss_pred             CccccceEEECCCCeEEEcccchhhcccCCCcc-----------------------------------------------
Confidence            999999999999999999999998754311000                                               


Q ss_pred             HHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHHH
Q psy10954        178 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  257 (562)
Q Consensus       178 L~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il~  257 (562)
                                                               ........||+.|+|||++.+.. |+.++||||+||++|
T Consensus       167 -----------------------------------------~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~  204 (283)
T d1mqba_         167 -----------------------------------------TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMW  204 (283)
T ss_dssp             ------------------------------------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHH
T ss_pred             -----------------------------------------ceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHH
Confidence                                                     00011235799999999998764 899999999999999


Q ss_pred             HHHhCCCC-CCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCCC
Q psy10954        258 EMITKKTL-FAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPKQ  336 (562)
Q Consensus       258 eLltG~~p-F~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~~  336 (562)
                      ||++|..| |.+.+..+.+..+......+                 .           ....+..+.+|+.+||+.||++
T Consensus       205 el~t~~~~~~~~~~~~~~~~~i~~~~~~~-----------------~-----------~~~~~~~l~~li~~cl~~~p~~  256 (283)
T d1mqba_         205 EVMTYGERPYWELSNHEVMKAINDGFRLP-----------------T-----------PMDCPSAIYQLMMQCWQQERAR  256 (283)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------------C-----------CTTCBHHHHHHHHHHTCSSTTT
T ss_pred             HHHhCCCCccccCCHHHHHHHHhccCCCC-----------------C-----------chhhHHHHHHHHHHHCcCCHhH
Confidence            99996554 55555544444443211100                 0           0112457899999999999999


Q ss_pred             CCCHHHHHc
Q psy10954        337 RVSAKTILQ  345 (562)
Q Consensus       337 R~Ta~elL~  345 (562)
                      |||+.|+++
T Consensus       257 RPt~~eil~  265 (283)
T d1mqba_         257 RPKFADIVS  265 (283)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-40  Score=336.08  Aligned_cols=211  Identities=19%  Similarity=0.306  Sum_probs=169.1

Q ss_pred             chhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         17 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..+.+.+|+++|++++|||||++++++.++ ..++||||+. ++|.+.+......+++..+..++.||+.||+|||++||
T Consensus        54 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~i  132 (317)
T d1xkka_          54 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL  132 (317)
T ss_dssp             THHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence            355789999999999999999999999875 4666777775 69999988877789999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      |||||||+|||++.++.+||+|||+|+........                                             
T Consensus       133 iHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~---------------------------------------------  167 (317)
T d1xkka_         133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE---------------------------------------------  167 (317)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC----------------------------------------------
T ss_pred             ccCcchhhcceeCCCCCeEeeccccceeccccccc---------------------------------------------
Confidence            99999999999999999999999998754311000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       168 --------------------------------------------~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvi  202 (317)
T d1xkka_         168 --------------------------------------------YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  202 (317)
T ss_dssp             ---------------------------------------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccccccCccccChHHHhcCC-CChhhhhhhHHHH
Confidence                                                        0011235799999999998765 8999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++ |.+||.+.+..+....+......+                 .           -...++.+.+|+.+||+.||
T Consensus       203 l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-----------------~-----------p~~~~~~~~~li~~cl~~dP  254 (317)
T d1xkka_         203 VWELMTFGSKPYDGIPASEISSILEKGERLP-----------------Q-----------PPICTIDVYMIMVKCWMIDA  254 (317)
T ss_dssp             HHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC-----------------C-----------CTTBCHHHHHHHHHHTCSSG
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------------C-----------CcccCHHHHHHHHHhCCCCh
Confidence            999998 789998877655444443321100                 0           01234678999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||+.|+++|
T Consensus       255 ~~RPs~~eil~~  266 (317)
T d1xkka_         255 DSRPKFRELIIE  266 (317)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-40  Score=330.04  Aligned_cols=210  Identities=26%  Similarity=0.330  Sum_probs=170.9

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+.+|++++|||||++++++.+ ..+|+|||||. +++.+.+....+.+++..+..++.|++.||.|||++||+
T Consensus        55 ~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ii  133 (273)
T d1u46a_          55 MDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI  133 (273)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEe
Confidence            3567899999999999999999999965 47899999997 588888877666799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHHH
Q psy10954         97 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLLE  176 (562)
Q Consensus        97 HRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl~  176 (562)
                      ||||||+|||++.++.+||+|||+++.........                                             
T Consensus       134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~---------------------------------------------  168 (273)
T d1u46a_         134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY---------------------------------------------  168 (273)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE---------------------------------------------
T ss_pred             eeeecHHHhccccccceeeccchhhhhcccCCCcc---------------------------------------------
Confidence            99999999999999999999999987553211000                                             


Q ss_pred             HHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHHH
Q psy10954        177 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  256 (562)
Q Consensus       177 gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~il  256 (562)
                                                                 .......||..|+|||++.+.. |+.++||||+||++
T Consensus       169 -------------------------------------------~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil  204 (273)
T d1u46a_         169 -------------------------------------------VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTL  204 (273)
T ss_dssp             -------------------------------------------EC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             -------------------------------------------eecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHH
Confidence                                                       0011235688999999998754 89999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCCC
Q psy10954        257 SEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDPK  335 (562)
Q Consensus       257 ~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP~  335 (562)
                      |||++ |++||.+.+..+.+..+.+..-.++                           .....++.+.+|+.+||..||+
T Consensus       205 ~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~  257 (273)
T d1u46a_         205 WEMFTYGQEPWIGLNGSQILHKIDKEGERLP---------------------------RPEDCPQDIYNVMVQCWAHKPE  257 (273)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---------------------------CcccccHHHHHHHHHHcCCChh
Confidence            99998 8999999998888777754211100                           0112346789999999999999


Q ss_pred             CCCCHHHHH
Q psy10954        336 QRVSAKTIL  344 (562)
Q Consensus       336 ~R~Ta~elL  344 (562)
                      +|||++|++
T Consensus       258 ~RPt~~ei~  266 (273)
T d1u46a_         258 DRPTFVALR  266 (273)
T ss_dssp             GSCCHHHHH
T ss_pred             HCcCHHHHH
Confidence            999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=329.43  Aligned_cols=216  Identities=24%  Similarity=0.405  Sum_probs=169.5

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~-~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ...+.+|+.+|++++|||||++++++. .+.+|+|||||.+ +|..++... ...+++..+..++.||+.||+|||++||
T Consensus        56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i  134 (285)
T d1fmka3          56 PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  134 (285)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe
Confidence            456889999999999999999999985 4568999999985 788877543 2459999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+||||+.++.+||+|||+|+.......                                              
T Consensus       135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~----------------------------------------------  168 (285)
T d1fmka3         135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY----------------------------------------------  168 (285)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCCTTC-----------------------------------------------------
T ss_pred             ecccccceEEEECCCCcEEEcccchhhhccCCCc----------------------------------------------
Confidence            9999999999999999999999999865421100                                              


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                  .......||+.|+|||++.+.. ++.++||||+||+
T Consensus       169 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Gii  203 (285)
T d1fmka3         169 --------------------------------------------TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGIL  203 (285)
T ss_dssp             ---------------------------------------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             --------------------------------------------eeeccccccccccChHHHhCCC-CCcHHhhhcchHH
Confidence                                                        0011236799999999998655 8999999999999


Q ss_pred             HHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG-~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++| .++|.+....+.+..+.+....+                            .....++.+.+|+.+||+.||
T Consensus       204 l~el~t~~~p~~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP  255 (285)
T d1fmka3         204 LTELTTKGRVPYPGMVNREVLDQVERGYRMP----------------------------CPPECPESLHDLMCQCWRKEP  255 (285)
T ss_dssp             HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------CCcccCHHHHHHHHHHcccCH
Confidence            9999995 55566666666665554321111                            011235678999999999999


Q ss_pred             CCCCCHHHHHc--CccccCCc
Q psy10954        335 KQRVSAKTILQ--HEYFNQVE  353 (562)
Q Consensus       335 ~~R~Ta~elL~--Hp~f~~~~  353 (562)
                      ++|||++++++  ++||....
T Consensus       256 ~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         256 EERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             GGSCCHHHHHHHHHTTTSCSC
T ss_pred             hHCcCHHHHHHHHhhhhcCCC
Confidence            99999999987  88987653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-39  Score=328.84  Aligned_cols=211  Identities=22%  Similarity=0.389  Sum_probs=162.6

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeC-CEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVD-FKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYL   80 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~-~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~   80 (562)
                      ..+.+|..++.++ +|+|||.+++++... ..+|+|||||+ ++|.++++...               ..+++..++.++
T Consensus        61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  140 (299)
T d1ywna1          61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  140 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence            4567888888777 689999999987654 56899999998 59999997532               248999999999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         81 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        81 ~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      .|++.||+|||++|||||||||+|||++.++.+||+|||+|+.......                               
T Consensus       141 ~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~-------------------------------  189 (299)
T d1ywna1         141 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-------------------------------  189 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTT-------------------------------
T ss_pred             HHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcccccc-------------------------------
Confidence            9999999999999999999999999999999999999999875431100                               


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                                                .......+||+.|+|||++.+.
T Consensus       190 ----------------------------------------------------------~~~~~~~~gt~~y~APE~l~~~  211 (299)
T d1ywna1         190 ----------------------------------------------------------YVRKGDARLPLKWMAPETIFDR  211 (299)
T ss_dssp             ----------------------------------------------------------SCCTTSCCCGGGGCCHHHHHHC
T ss_pred             ----------------------------------------------------------ccccCceeeCccccchhHhhcC
Confidence                                                                      0011234789999999999875


Q ss_pred             CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCC
Q psy10954        241 KVYSTTVDIWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPD  319 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (562)
                      . |+.++||||+||++|||++| .+||.+.+..+.+..++.....+.                           .....+
T Consensus       212 ~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  263 (299)
T d1ywna1         212 V-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTT  263 (299)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCC
T ss_pred             C-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCC
Confidence            4 89999999999999999986 578887766555555544311110                           011235


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        320 PLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       320 ~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      +.+.+|+.+||+.||++|||++|+++|
T Consensus       264 ~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         264 PEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            678999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=325.58  Aligned_cols=209  Identities=25%  Similarity=0.350  Sum_probs=169.7

Q ss_pred             chhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhC---------------CCCCCHHHHHHH
Q psy10954         17 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---------------PVPVPPALAKSY   79 (562)
Q Consensus        17 ~~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~---------------~~~l~e~~i~~i   79 (562)
                      ..+.+.+|+++|+++ +|||||++++++..++.+|+|||||+ ++|.++++..               ...+++..+..+
T Consensus        53 ~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  132 (309)
T d1fvra_          53 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF  132 (309)
T ss_dssp             --CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHH
Confidence            345689999999999 79999999999999999999999998 5999998754               246999999999


Q ss_pred             HHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccc
Q psy10954         80 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  159 (562)
Q Consensus        80 ~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~Dvw  159 (562)
                      +.|++.||.|||++|||||||||+|||++.++.+||+|||+|+......                               
T Consensus       133 ~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-------------------------------  181 (309)
T d1fvra_         133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------------------------------  181 (309)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-------------------------------
T ss_pred             HHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc-------------------------------
Confidence            9999999999999999999999999999999999999999986432100                               


Q ss_pred             cccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcC
Q psy10954        160 SAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG  239 (562)
Q Consensus       160 SlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~  239 (562)
                                                                                   ......||..|+|||.+.+
T Consensus       182 -------------------------------------------------------------~~~~~~gt~~y~aPE~l~~  200 (309)
T d1fvra_         182 -------------------------------------------------------------KKTMGRLPVRWMAIESLNY  200 (309)
T ss_dssp             -------------------------------------------------------------CC----CCTTTCCHHHHHH
T ss_pred             -------------------------------------------------------------cccceecCCcccchHHhcc
Confidence                                                                         0012357899999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCC
Q psy10954        240 AKVYSTTVDIWSAGCIFSEMITKK-TLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLP  318 (562)
Q Consensus       240 ~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  318 (562)
                      .. |+.++||||+||++|||++|. +||.+.+..+.+..+.+....                    +        .....
T Consensus       201 ~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~--------------------~--------~~~~~  251 (309)
T d1fvra_         201 SV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--------------------E--------KPLNC  251 (309)
T ss_dssp             CE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC--------------------C--------CCTTB
T ss_pred             CC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC--------------------C--------CCccC
Confidence            65 899999999999999999964 678888777666555331100                    0        00123


Q ss_pred             CHHHHHHHHHccccCCCCCCCHHHHHcC
Q psy10954        319 DPLAVDVFSKIMALDPKQRVSAKTILQH  346 (562)
Q Consensus       319 ~~~~~dLi~~mL~~DP~~R~Ta~elL~H  346 (562)
                      ++.+.+||.+||+.||++|||++|+++|
T Consensus       252 ~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         252 DDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4689999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-39  Score=321.17  Aligned_cols=208  Identities=24%  Similarity=0.384  Sum_probs=163.3

Q ss_pred             CchhhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCcC-CHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~~-~L~~~i~~~~-~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      ...+.+.+|+++|++++|||||++++++.. .+.+|+|||||++ +|.+++.... ..+++..+..++.||+.||.|||+
T Consensus        42 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~  121 (262)
T d1byga_          42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG  121 (262)
T ss_dssp             C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc
Confidence            445678999999999999999999999854 4668999999975 9999986543 248999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHH
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLY  172 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~  172 (562)
                      ++||||||||+|||++.++.+||+|||+++.....                                             
T Consensus       122 ~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---------------------------------------------  156 (262)
T d1byga_         122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------------------------------------------  156 (262)
T ss_dssp             TTCCCSCCSGGGEEECTTSCEEECCCCC----------------------------------------------------
T ss_pred             CceeccccchHhheecCCCCEeecccccceecCCC---------------------------------------------
Confidence            99999999999999999999999999987533210                                             


Q ss_pred             HHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHH
Q psy10954        173 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  252 (562)
Q Consensus       173 QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSl  252 (562)
                                                                       .....+|+.|+|||++.+.. |+.++||||+
T Consensus       157 -------------------------------------------------~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSf  186 (262)
T d1byga_         157 -------------------------------------------------QDTGKLPVKWTAPEALREKK-FSTKSDVWSF  186 (262)
T ss_dssp             ------------------------------------------------------CCTTTSCHHHHHHCC-CCHHHHHHHH
T ss_pred             -------------------------------------------------CccccccccCCChHHHhCCC-CChHHHHHhH
Confidence                                                             01224678899999998754 8999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccc
Q psy10954        253 GCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMA  331 (562)
Q Consensus       253 G~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~  331 (562)
                      ||++|||++ |++||.+.+..+....+.+..-                    ++        .....++.+.+|+++||.
T Consensus       187 G~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------------------~~--------~~~~~~~~~~~li~~cl~  238 (262)
T d1byga_         187 GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------------MD--------APDGCPPAVYEVMKNCWH  238 (262)
T ss_dssp             HHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------------------CC--------CCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------------CC--------CCccCCHHHHHHHHHHcc
Confidence            999999998 7999988776665555532100                    00        112235788999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q psy10954        332 LDPKQRVSAKTILQH  346 (562)
Q Consensus       332 ~DP~~R~Ta~elL~H  346 (562)
                      .||++|||+.|++++
T Consensus       239 ~dP~~Rps~~~l~~~  253 (262)
T d1byga_         239 LDAAMRPSFLQLREQ  253 (262)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             cCHhHCcCHHHHHHH
Confidence            999999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-38  Score=322.51  Aligned_cols=210  Identities=23%  Similarity=0.385  Sum_probs=171.4

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC-----------------------CCCCH
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-----------------------VPVPP   73 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~-----------------------~~l~e   73 (562)
                      ...+.+|+++|++++||||+++++++......++|||||+ ++|.+++....                       ..+++
T Consensus        60 ~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  139 (301)
T d1lufa_          60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC  139 (301)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred             HHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCH
Confidence            4568999999999999999999999999999999999997 59999986532                       13889


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccc
Q psy10954         74 ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYS  153 (562)
Q Consensus        74 ~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s  153 (562)
                      ..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.......                        
T Consensus       140 ~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~------------------------  195 (301)
T d1lufa_         140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY------------------------  195 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------------------------
T ss_pred             HHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCcc------------------------
Confidence            99999999999999999999999999999999999999999999999865431100                        


Q ss_pred             cccccccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccc
Q psy10954        154 TTVDIWSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP  233 (562)
Q Consensus       154 ~~~DvwSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~A  233 (562)
                                                                                       .....+..||+.|+|
T Consensus       196 -----------------------------------------------------------------~~~~~~~~~~~~y~a  210 (301)
T d1lufa_         196 -----------------------------------------------------------------YKADGNDAIPIRWMP  210 (301)
T ss_dssp             -----------------------------------------------------------------BC----CCBCGGGCC
T ss_pred             -----------------------------------------------------------------ccccCCCCcCcCcCC
Confidence                                                                             001123467899999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchh
Q psy10954        234 PEILLGAKVYSTTVDIWSAGCIFSEMITKK-TLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFS  312 (562)
Q Consensus       234 PEvl~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (562)
                      ||++.+.. |+.++||||+||++|||++|. +||.+.+..+.+..+.+....                    .       
T Consensus       211 PE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~--------------------~-------  262 (301)
T d1lufa_         211 PESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--------------------A-------  262 (301)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------------------C-------
T ss_pred             HHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------------C-------
Confidence            99998755 899999999999999999985 789888888777666432100                    0       


Q ss_pred             hhcCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        313 EILNLPDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       313 ~~l~~~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                       .....++.+.+|+.+||+.||++|||+.|+++
T Consensus       263 -~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         263 -CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             00123467899999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-38  Score=319.66  Aligned_cols=209  Identities=24%  Similarity=0.403  Sum_probs=169.4

Q ss_pred             hhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------------CCCCHHHHHHHHH
Q psy10954         19 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYLY   81 (562)
Q Consensus        19 ~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------------~~l~e~~i~~i~~   81 (562)
                      ..+.+|...+.++ +|||||++++++..+..+|+|||||. ++|.+++....               ..+++..++.++.
T Consensus        63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  142 (299)
T d1fgka_          63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY  142 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence            4567899999888 89999999999999999999999997 59999997543               3489999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccc
Q psy10954         82 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  161 (562)
Q Consensus        82 qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSl  161 (562)
                      |++.||+|||++|||||||||+|||++.++.+||+|||+++.......                                
T Consensus       143 qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~--------------------------------  190 (299)
T d1fgka_         143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY--------------------------------  190 (299)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCT--------------------------------
T ss_pred             HHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhcccccccc--------------------------------
Confidence            999999999999999999999999999999999999999865432100                                


Q ss_pred             cccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCC
Q psy10954        162 GCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK  241 (562)
Q Consensus       162 G~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~  241 (562)
                                                                               .......+||+.|+|||++.+. 
T Consensus       191 ---------------------------------------------------------~~~~~~~~~~~~y~aPE~l~~~-  212 (299)
T d1fgka_         191 ---------------------------------------------------------YKKTTNGRLPVKWMAPEALFDR-  212 (299)
T ss_dssp             ---------------------------------------------------------TCCCTTSCCGGGGSCHHHHHHC-
T ss_pred             ---------------------------------------------------------ccccccCCCChhhhhhhHhcCC-
Confidence                                                                     0011234678999999999875 


Q ss_pred             CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCH
Q psy10954        242 VYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDP  320 (562)
Q Consensus       242 ~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  320 (562)
                      .|+.++||||+||++|||++ |.+||.+.+..+....+.+.  ..+.               .+           ...++
T Consensus       213 ~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~--~~~~---------------~p-----------~~~~~  264 (299)
T d1fgka_         213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG--HRMD---------------KP-----------SNCTN  264 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--CCCC---------------CC-----------SSCCH
T ss_pred             CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC--CCCC---------------CC-----------ccchH
Confidence            49999999999999999998 78899887766544443321  1100               00           12346


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        321 LAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       321 ~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .+.+|+.+||+.||++|||+.|+++
T Consensus       265 ~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         265 ELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHH
Confidence            7899999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-38  Score=320.14  Aligned_cols=211  Identities=23%  Similarity=0.366  Sum_probs=171.4

Q ss_pred             hhhHHHHHHHHHcc-CCCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCC-----------------CCCCHHHHHH
Q psy10954         18 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-----------------VPVPPALAKS   78 (562)
Q Consensus        18 ~~~~~rEi~iL~~l-~HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~-----------------~~l~e~~i~~   78 (562)
                      ...+.+|+.+++.+ +|||||++++++..+..+|||||||++ +|.++++...                 ..+++..+..
T Consensus        70 ~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  149 (311)
T d1t46a_          70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS  149 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHH
Confidence            34578999999999 799999999999999999999999985 9999987542                 2489999999


Q ss_pred             HHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccc
Q psy10954         79 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  158 (562)
Q Consensus        79 i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~Dv  158 (562)
                      ++.||+.||+|||++|||||||||+|||++.++.+|++|||+++........                            
T Consensus       150 ~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~----------------------------  201 (311)
T d1t46a_         150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----------------------------  201 (311)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS----------------------------
T ss_pred             HHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcc----------------------------
Confidence            9999999999999999999999999999999999999999998754311000                            


Q ss_pred             ccccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhc
Q psy10954        159 WSAGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL  238 (562)
Q Consensus       159 wSlG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~  238 (562)
                                                                                   ......+||+.|+|||++.
T Consensus       202 -------------------------------------------------------------~~~~~~~gt~~y~aPE~~~  220 (311)
T d1t46a_         202 -------------------------------------------------------------VVKGNARLPVKWMAPESIF  220 (311)
T ss_dssp             -------------------------------------------------------------EECSSSEECGGGCCHHHHH
T ss_pred             -------------------------------------------------------------eEeeecccChHHcCHHHhc
Confidence                                                                         0011246899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCC
Q psy10954        239 GAKVYSTTVDIWSAGCIFSEMIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNL  317 (562)
Q Consensus       239 ~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  317 (562)
                      +. .|+.++||||+||++|||++ |.+||.+.+..+.+.++++.--.+.                           ....
T Consensus       221 ~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~---------------------------~~~~  272 (311)
T d1t46a_         221 NC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEH  272 (311)
T ss_dssp             HC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTT
T ss_pred             CC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------Cccc
Confidence            65 48999999999999999998 6777877777666666654311110                           0012


Q ss_pred             CCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        318 PDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       318 ~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      .++.+.+||.+||+.||++|||++|+++
T Consensus       273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         273 APAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3567899999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-37  Score=316.20  Aligned_cols=213  Identities=22%  Similarity=0.337  Sum_probs=166.8

Q ss_pred             hhhHHHHHHHHHccCCCCcceEEEEEEe-CCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy10954         18 PSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   95 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~HpnIv~L~~~~~~-~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gI   95 (562)
                      ..++.+|+++|++++|||||++++++.. ++..|+|||||++ +|.+++......+++..+..++.|++.||.|||+++|
T Consensus        72 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~i  151 (311)
T d1r0pa_          72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF  151 (311)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCc
Confidence            3568899999999999999999999765 5689999999985 8999988777778899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHHHH
Q psy10954         96 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQLL  175 (562)
Q Consensus        96 iHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~QIl  175 (562)
                      +||||||+|||++.++.+||+|||+++........                                             
T Consensus       152 iHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~---------------------------------------------  186 (311)
T d1r0pa_         152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---------------------------------------------  186 (311)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC---------------------------------------------
T ss_pred             ccCCccHHhEeECCCCCEEEecccchhhccccccc---------------------------------------------
Confidence            99999999999999999999999998755321000                                             


Q ss_pred             HHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHHHH
Q psy10954        176 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  255 (562)
Q Consensus       176 ~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG~i  255 (562)
                                                                .........||+.|+|||++.+.. |+.++||||+||+
T Consensus       187 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGiv  223 (311)
T d1r0pa_         187 ------------------------------------------SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVL  223 (311)
T ss_dssp             ------------------------------------------CTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             ------------------------------------------cceecccccccccccChHHHhcCC-CCChhHhhhhHHH
Confidence                                                      000012346899999999998655 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccCC
Q psy10954        256 FSEMITKKTLFAGDSEI-DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALDP  334 (562)
Q Consensus       256 l~eLltG~~pF~~~~~~-~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~DP  334 (562)
                      +|||++|..||...... +....+.+  |..+.               .|           ...++.+.+|+.+||+.||
T Consensus       224 l~El~t~~~p~~~~~~~~~~~~~i~~--g~~~~---------------~p-----------~~~~~~l~~li~~cl~~dP  275 (311)
T d1r0pa_         224 LWELMTRGAPPYPDVNTFDITVYLLQ--GRRLL---------------QP-----------EYCPDPLYEVMLKCWHPKA  275 (311)
T ss_dssp             HHHHHTTSCCSCC------CHHHHHT--TCCCC---------------CC-----------TTCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHc--CCCCC---------------Cc-----------ccCcHHHHHHHHHHcCCCH
Confidence            99999987777654433 22223322  11000               00           1234678999999999999


Q ss_pred             CCCCCHHHHHcC
Q psy10954        335 KQRVSAKTILQH  346 (562)
Q Consensus       335 ~~R~Ta~elL~H  346 (562)
                      ++|||+.|+++|
T Consensus       276 ~~RPs~~ei~~~  287 (311)
T d1r0pa_         276 EMRPSFSELVSR  287 (311)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=317.43  Aligned_cols=216  Identities=22%  Similarity=0.340  Sum_probs=175.2

Q ss_pred             hhHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCc-CCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   88 (562)
Q Consensus        19 ~~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~-~~L~~~i~~~~---------~~l~e~~i~~i~~qll~aL~   88 (562)
                      ..+.+|+++|++++|||||++++++..+...++|||||. ++|.+++....         ..+++..+..++.|++.||.
T Consensus        68 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~  147 (308)
T d1p4oa_          68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA  147 (308)
T ss_dssp             HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence            357899999999999999999999999999999999997 59999875421         24788999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhh
Q psy10954         89 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus        89 yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em  168 (562)
                      |||+++|+||||||+|||++.++.+||+|||+|+........                                      
T Consensus       148 ~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~--------------------------------------  189 (308)
T d1p4oa_         148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------------------------------------  189 (308)
T ss_dssp             HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE--------------------------------------
T ss_pred             HHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcce--------------------------------------
Confidence            999999999999999999999999999999998754321000                                      


Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhh
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  248 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~D  248 (562)
                                                                         ......+||+.|+|||.+.+.. |+.++|
T Consensus       190 ---------------------------------------------------~~~~~~~~t~~y~aPe~l~~~~-~~~~~D  217 (308)
T d1p4oa_         190 ---------------------------------------------------RKGGKGLLPVRWMSPESLKDGV-FTTYSD  217 (308)
T ss_dssp             ---------------------------------------------------EGGGSSEECGGGCCHHHHHHCC-CCHHHH
T ss_pred             ---------------------------------------------------eeccceecccccCCHHHHccCC-CCcccc
Confidence                                                               0012246799999999998765 899999


Q ss_pred             HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHH
Q psy10954        249 IWSAGCIFSEMITK-KTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFS  327 (562)
Q Consensus       249 IWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~  327 (562)
                      |||+||++|||++| .+||.+.+..+.+..+.+....+                            .....++.+.+++.
T Consensus       218 v~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~  269 (308)
T d1p4oa_         218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD----------------------------KPDNCPDMLFELMR  269 (308)
T ss_dssp             HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHH
T ss_pred             cccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC----------------------------CcccchHHHHHHHH
Confidence            99999999999998 58898888877776665321100                            00123467999999


Q ss_pred             HccccCCCCCCCHHHHHc------CccccCC
Q psy10954        328 KIMALDPKQRVSAKTILQ------HEYFNQV  352 (562)
Q Consensus       328 ~mL~~DP~~R~Ta~elL~------Hp~f~~~  352 (562)
                      +||+.||++|||++|+++      +|+|+++
T Consensus       270 ~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         270 MCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            999999999999999987      6666543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-37  Score=311.90  Aligned_cols=227  Identities=16%  Similarity=0.166  Sum_probs=168.6

Q ss_pred             hhhHHHHHHHHHccCCCC-cceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKHPN-VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~Hpn-Iv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++|+| |+.+++++..+...++|||||+++|...+......+++..+..++.|++.||+|||++|||
T Consensus        46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii  125 (299)
T d1ckia_          46 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI  125 (299)
T ss_dssp             SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCee
Confidence            346789999999998766 5566677788899999999999999888877777899999999999999999999999999


Q ss_pred             eccCCCCcEEEcc---CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhHHH
Q psy10954         97 HRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYLYQ  173 (562)
Q Consensus        97 HRDLKP~NILl~~---~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l~Q  173 (562)
                      ||||||+|||++.   +..+||+|||+|+.+.......                                          
T Consensus       126 HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~------------------------------------------  163 (299)
T d1ckia_         126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ------------------------------------------  163 (299)
T ss_dssp             CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC------------------------------------------
T ss_pred             eccCCHhhccccccCCCceeeeeccCcceecccccccc------------------------------------------
Confidence            9999999999864   4469999999987653211000                                          


Q ss_pred             HHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHHHH
Q psy10954        174 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  253 (562)
Q Consensus       174 Il~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWSlG  253 (562)
                                                                ........+.+||+.|||||++.+.. |+.++||||+|
T Consensus       164 ------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG  200 (299)
T d1ckia_         164 ------------------------------------------HIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLG  200 (299)
T ss_dssp             ------------------------------------------BCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHH
T ss_pred             ------------------------------------------ceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecC
Confidence                                                      00001123457999999999998765 89999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHHccccC
Q psy10954        254 CIFSEMITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSKIMALD  333 (562)
Q Consensus       254 ~il~eLltG~~pF~~~~~~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~mL~~D  333 (562)
                      |++|||++|+.||.+....+....+.......                     ............++.+.+|+.+||+.|
T Consensus       201 ~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~p~~~~~li~~cl~~~  259 (299)
T d1ckia_         201 YVLMYFNLGSLPWQGLKAATKRQKYERISEKK---------------------MSTPIEVLCKGYPSEFATYLNFCRSLR  259 (299)
T ss_dssp             HHHHHHHHSSCTTCCCC-------HHHHHHHH---------------------HHSCHHHHTTTSCHHHHHHHHHHHHSC
T ss_pred             HHHHHHHhCCCcccccchHHHHHHHHHhhccc---------------------CCCChhHhccCCCHHHHHHHHHHccCC
Confidence            99999999999998766544333222110000                     000011122334678999999999999


Q ss_pred             CCCCCCHH---HHHcCcccc
Q psy10954        334 PKQRVSAK---TILQHEYFN  350 (562)
Q Consensus       334 P~~R~Ta~---elL~Hp~f~  350 (562)
                      |++||+++   ++|+|+|.+
T Consensus       260 p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         260 FDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TTCCCCHHHHHHHHHHHHHH
T ss_pred             hhHCcCHHHHHHHHHHHHHH
Confidence            99999987   557777764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-37  Score=313.06  Aligned_cols=220  Identities=21%  Similarity=0.271  Sum_probs=160.5

Q ss_pred             hhHHHHHHHH--HccCCCCcceEEEEEEeCC----EEEEEeecCc-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10954         19 STALREISVL--KELKHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   91 (562)
Q Consensus        19 ~~~~rEi~iL--~~l~HpnIv~L~~~~~~~~----~i~lV~Ey~~-~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH   91 (562)
                      ....+|.+++  +.++|||||++++++...+    .+|+|||||. ++|.+++++.  .+++..+..++.|++.||.|+|
T Consensus        40 ~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH  117 (303)
T d1vjya_          40 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH  117 (303)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence            3455555554  5789999999999997653    6899999997 5999999875  5899999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         92 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        92 ~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      +..                                                                             
T Consensus       118 ~~~-----------------------------------------------------------------------------  120 (303)
T d1vjya_         118 MEI-----------------------------------------------------------------------------  120 (303)
T ss_dssp             CCB-----------------------------------------------------------------------------
T ss_pred             Hhh-----------------------------------------------------------------------------
Confidence            531                                                                             


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCC----cccccccCCCccchhhhcCCC-----C
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAK-----V  242 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~----~~~~~vgT~~Y~APEvl~~~~-----~  242 (562)
                            +.|+|++|||||||||+||||+.+|.+||+|||+++.......    .....+||+.|+|||++.+..     .
T Consensus       121 ------~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  194 (303)
T d1vjya_         121 ------VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE  194 (303)
T ss_dssp             ------CSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHH
T ss_pred             ------hhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCC
Confidence                  2367889999999999999999999999999999887654332    234568999999999997643     2


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCc
Q psy10954        243 YSTTVDIWSAGCIFSEMITKKTLFAGDSEI--------------DQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRP  308 (562)
Q Consensus       243 y~~~~DIWSlG~il~eLltG~~pF~~~~~~--------------~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~  308 (562)
                      ++.++||||+||++|||++|.+||......              +.+......-+                  ..|.. +
T Consensus       195 ~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~p~~-~  255 (303)
T d1vjya_         195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK------------------LRPNI-P  255 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC------------------CCCCC-C
T ss_pred             cCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc------------------cCCCC-C
Confidence            577899999999999999998887543211              11111100000                  00000 0


Q ss_pred             cchhhhcCC-CCHHHHHHHHHccccCCCCCCCHHHHHc
Q psy10954        309 KKFSEILNL-PDPLAVDVFSKIMALDPKQRVSAKTILQ  345 (562)
Q Consensus       309 ~~~~~~l~~-~~~~~~dLi~~mL~~DP~~R~Ta~elL~  345 (562)
                      ..   .... ....+.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         256 NR---WQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             GG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            00   0000 1134789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-36  Score=315.03  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=169.3

Q ss_pred             hhhHHHHHHHHHccC-----------CCCcceEEEEEEe--CCEEEEEeecCc--CCHHHHH-hhCCCCCCHHHHHHHHH
Q psy10954         18 PSTALREISVLKELK-----------HPNVIRLHDVIPV--DFKLFLVFEFLR--QDLKDFL-QTTPVPVPPALAKSYLY   81 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-----------HpnIv~L~~~~~~--~~~i~lV~Ey~~--~~L~~~i-~~~~~~l~e~~i~~i~~   81 (562)
                      .+...+|+.+|++++           |+||+++++++..  ....++||+++.  ++..... ......+++..++.++.
T Consensus        53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~  132 (362)
T d1q8ya_          53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK  132 (362)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence            356789999998885           4789999998864  356677777664  3433333 33445699999999999


Q ss_pred             HHHHHHHHHHH-CCceeccCCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCccceecccccccccccccc
Q psy10954         82 QLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  160 (562)
Q Consensus        82 qll~aL~yLH~-~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwS  160 (562)
                      |++.||+|||+ +||+||||||+|||++.++.-      .                                        
T Consensus       133 qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~------~----------------------------------------  166 (362)
T d1q8ya_         133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP------E----------------------------------------  166 (362)
T ss_dssp             HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT------T----------------------------------------
T ss_pred             HHHHHHHHHhhhcCcccccCChhHeeeeccCcc------c----------------------------------------
Confidence            99999999998 899999999999999755420      0                                        


Q ss_pred             ccccchhhhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCC
Q psy10954        161 AGCIFSEMSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA  240 (562)
Q Consensus       161 lG~il~Em~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~  240 (562)
                                                             ....+|++|||.|.....   .....+||+.|+|||++.+.
T Consensus       167 ---------------------------------------~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~  204 (362)
T d1q8ya_         167 ---------------------------------------NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGA  204 (362)
T ss_dssp             ---------------------------------------TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTC
T ss_pred             ---------------------------------------ccceeeEeeccccccccc---ccccccccccccChhhcccc
Confidence                                                   001234444444433221   12345789999999999876


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCCCCCCCCCCCCCc------cCCCCCCCc
Q psy10954        241 KVYSTTVDIWSAGCIFSEMITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVWPGVSKLPIY------KTDFPEWRP  308 (562)
Q Consensus       241 ~~y~~~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~~~~~~~~~~~~~~~~------~~~~~~~~~  308 (562)
                      + |+.++||||+||++++|++|+.||.+.+      ..+.+..++..+|.++.+.+........+      .........
T Consensus       205 ~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (362)
T d1q8ya_         205 P-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF  283 (362)
T ss_dssp             C-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred             C-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC
Confidence            5 8999999999999999999999997553      34567777888887655433211110000      001111111


Q ss_pred             cchh----hhcC---CCCHHHHHHHHHccccCCCCCCCHHHHHcCccccCCccc
Q psy10954        309 KKFS----EILN---LPDPLAVDVFSKIMALDPKQRVSAKTILQHEYFNQVEMV  355 (562)
Q Consensus       309 ~~~~----~~l~---~~~~~~~dLi~~mL~~DP~~R~Ta~elL~Hp~f~~~~~~  355 (562)
                      ....    ....   ..++.+.|||.+||++||.+||||+|+|+||||+++...
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM  337 (362)
T ss_dssp             CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred             CchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCc
Confidence            1111    1111   124678999999999999999999999999999976543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-35  Score=301.57  Aligned_cols=219  Identities=17%  Similarity=0.188  Sum_probs=170.6

Q ss_pred             hhhHHHHHHHHHccCC-CCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy10954         18 PSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   96 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~H-pnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIi   96 (562)
                      ...+.+|+++++.++| +||+.+++++..+...|+|||||+++|.+++......+++..+..++.|++.||+|||++|||
T Consensus        44 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~gii  123 (293)
T d1csna_          44 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV  123 (293)
T ss_dssp             SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCce
Confidence            3457889999999976 899999999999999999999999999999988777899999999999999999999999999


Q ss_pred             eccCCCCcEEEcc-----CCCeeEeeccccccccccCcccceeeeeccCCccceeccccccccccccccccccchhhhhH
Q psy10954         97 HRDLKPQNILINK-----SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMSYL  171 (562)
Q Consensus        97 HRDLKP~NILl~~-----~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~s~~~DvwSlG~il~Em~~l  171 (562)
                      ||||||+|||++.     ++.+||+|||+|+.+........                                       
T Consensus       124 HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~---------------------------------------  164 (293)
T d1csna_         124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH---------------------------------------  164 (293)
T ss_dssp             CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB---------------------------------------
T ss_pred             eccCCccceeecCcccccCCceEEcccceeEEcccCccccc---------------------------------------
Confidence            9999999999974     46789999998876542211000                                       


Q ss_pred             HHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhhcCCCCCCchhhHHH
Q psy10954        172 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  251 (562)
Q Consensus       172 ~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl~~~~~y~~~~DIWS  251 (562)
                                                                   .+.....+.+||+.|||||++.+.. |+.++||||
T Consensus       165 ---------------------------------------------~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwS  198 (293)
T d1csna_         165 ---------------------------------------------IPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEA  198 (293)
T ss_dssp             ---------------------------------------------CCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHH
T ss_pred             ---------------------------------------------eeecccCceEEchhhcCHHHhcCCC-CChHHHHHH
Confidence                                                         0011123458999999999998765 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCCCCCCCCCCCCCccCCCCCCCccchhhhcCCCCHHHHHHHHH
Q psy10954        252 AGCIFSEMITKKTLFAGDSE---IDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVDVFSK  328 (562)
Q Consensus       252 lG~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~dLi~~  328 (562)
                      +||++|||++|+.||.+...   .+...++....-.                        ....++....++.+.+++..
T Consensus       199 lG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~------------------------~~~~~l~~~~p~~l~~ii~~  254 (293)
T d1csna_         199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------------------------TPLRELCAGFPEEFYKYMHY  254 (293)
T ss_dssp             HHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH------------------------SCHHHHTTTSCHHHHHHHHH
T ss_pred             hhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC------------------------CChHHhcCCCCHHHHHHHHH
Confidence            99999999999999986542   3333333221000                        00112233345788999999


Q ss_pred             ccccCCCCCCCHHHHHc
Q psy10954        329 IMALDPKQRVSAKTILQ  345 (562)
Q Consensus       329 mL~~DP~~R~Ta~elL~  345 (562)
                      |+..+|++||+.+.+.+
T Consensus       255 ~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         255 ARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHCCTTCCCCHHHHHH
T ss_pred             HhcCCcccCcCHHHHHH
Confidence            99999999999876643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.7e-23  Score=211.37  Aligned_cols=84  Identities=31%  Similarity=0.578  Sum_probs=75.2

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ...|.||+||+ +.|++++++.|+|.++.||+.+|++.+|+|+++.||...+++.+.. +..+.+..+.++++..++.+.
T Consensus       180 ~~~DiwSlGvi-l~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~  257 (299)
T d1ua2a_         180 VGVDMWAVGCI-LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLL  257 (299)
T ss_dssp             HHHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC-CCCCCCCCHHHHCTTCCHHHH
T ss_pred             hhhhhhhcchH-HHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh-hccCCCCChHHhcccCCHHHH
Confidence            35699999998 7799999999999999999999999999999999999999998764 667777778888889999999


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++++|
T Consensus       258 dll~~~  263 (299)
T d1ua2a_         258 DLIQGL  263 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=5.1e-22  Score=200.51  Aligned_cols=85  Identities=47%  Similarity=0.876  Sum_probs=80.0

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHH
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAV  556 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (562)
                      ...|.||+|++ +-|++++++.|+|.++.+++++|++.+|+|.+..|+..+.+|.+...+|.|..+.+....+..++.+.
T Consensus       182 ~~~DiwSlGvi-ly~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  260 (298)
T d1gz8a_         182 TAVDIWSLGCI-FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR  260 (298)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHH
T ss_pred             ccccccccchh-hhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHH
Confidence            34699999999 78999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcC
Q psy10954        557 DVFSRV  562 (562)
Q Consensus       557 ~~~~~~  562 (562)
                      |++++|
T Consensus       261 dll~~m  266 (298)
T d1gz8a_         261 SLLSQM  266 (298)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.83  E-value=1.9e-21  Score=194.78  Aligned_cols=84  Identities=37%  Similarity=0.701  Sum_probs=79.7

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ ..|++++++.|.|.++.+|+.+|++.+|+|....||..+.++.+...+..+.+....+.+...++.+.|
T Consensus       181 ~~DiwslGv~-l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  259 (286)
T d1ob3a_         181 TIDIWSVGCI-FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID  259 (286)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred             ceeehhcCcH-HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHH
Confidence            4699999999 999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++.+|
T Consensus       260 li~~~  264 (286)
T d1ob3a_         260 LLSKM  264 (286)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=5.2e-21  Score=193.21  Aligned_cols=47  Identities=40%  Similarity=0.731  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       119 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~  165 (293)
T d1yhwa1         119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (293)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence            36899999999999999999999999999999999999999999753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=1.2e-20  Score=190.25  Aligned_cols=82  Identities=28%  Similarity=0.498  Sum_probs=71.8

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCcccCccccccCCCCChhHHH
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWRPKKFSEILNLPDPLAVD  557 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  557 (562)
                      ..|.||+||+ +-|++++++.|+|.++.+++.+|++.+|+|.++.||....+|.  ..+....+.....+....++.+.|
T Consensus       195 ~~DiwSlG~i-l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~d  271 (305)
T d1blxa_         195 PVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKD  271 (305)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG--GGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred             hehhhchHHH-HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh--hhhccccccchhhccccCCHHHHH
Confidence            4699999998 7899999999999999999999999999999999999988884  445666666777788888999999


Q ss_pred             HHhcC
Q psy10954        558 VFSRV  562 (562)
Q Consensus       558 ~~~~~  562 (562)
                      ++++|
T Consensus       272 li~~m  276 (305)
T d1blxa_         272 LLLKC  276 (305)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.3e-20  Score=189.63  Aligned_cols=47  Identities=51%  Similarity=0.748  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       113 ~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1         113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence            46899999999999999999999999999999999999999999753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.3e-20  Score=192.11  Aligned_cols=45  Identities=40%  Similarity=0.798  Sum_probs=43.3

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       109 ~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_         109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             HHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccc
Confidence            588999999999999999999999999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.8e-20  Score=191.92  Aligned_cols=83  Identities=30%  Similarity=0.521  Sum_probs=66.0

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCC-CCCCCcccCccccccC-CCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIY-KTDFPEWRPKKFSEIL-NLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~  554 (562)
                      ...|.||+||+ +.|+++++++|++.++.+|+.+|++.+|+|.++.|+...  +.+ ...+|...+..+.++. +..++.
T Consensus       202 ~~~DIwSlG~i-l~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~  278 (350)
T d1q5ka_         202 SSIDVWSAGCV-LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPE  278 (350)
T ss_dssp             THHHHHHHHHH-HHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC--C---CCCCCCCCCCCGGGTSCTTSCHH
T ss_pred             cceeecccceE-EEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc--cchhhccccccccCchhhhcccCCCHH
Confidence            45799999998 999999999999999999999999999999999887542  332 3356776666655544 457888


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       279 ~~dLl~~m  286 (350)
T d1q5ka_         279 AIALCSRL  286 (350)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99988764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=7e-19  Score=175.56  Aligned_cols=83  Identities=34%  Similarity=0.613  Sum_probs=69.1

Q ss_pred             CCCccccchhhhhhccc-CCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCCCCccc-CccccccCCCCChhH
Q psy10954        478 SDDAVSIDVVTYHESIT-KKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTDFPEWR-PKKFSEILNLPDPLA  555 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  555 (562)
                      ..|.||+||+ +.|+++ +.|.|+|....+++.+|....|+|++..||...+++.++. ++... .....+..+..++.+
T Consensus       182 ~~DiwSlG~i-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~  259 (292)
T d1unla_         182 SIDMWSAGCI-FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP-YPMYPATTSLVNVVPKLNATG  259 (292)
T ss_dssp             HHHHHHHHHH-HHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC-CCCCCTTCCCTTTSTTCCHHH
T ss_pred             hhhccccchH-HHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc-cccccccchhhhccccCCHHH
Confidence            4699999999 778887 5688999999999999999999999999999999998865 33332 334666777888999


Q ss_pred             HHHHhcC
Q psy10954        556 VDVFSRV  562 (562)
Q Consensus       556 ~~~~~~~  562 (562)
                      .|++.+|
T Consensus       260 ~dll~~m  266 (292)
T d1unla_         260 RDLLQNL  266 (292)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.2e-19  Score=180.85  Aligned_cols=47  Identities=45%  Similarity=0.833  Sum_probs=38.4

Q ss_pred             hhhHHHHHHHHHhhhcCc-----eeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~-----IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||+++     ||||||||+|||++.+|.+||+|||+|+.
T Consensus       112 ~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1         112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            367899999999999876     99999999999999999999999998764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=4.5e-19  Score=179.77  Aligned_cols=85  Identities=24%  Similarity=0.417  Sum_probs=60.8

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCCCCCC-CCcccCccccccCC--CCCh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPIYKTD-FPEWRPKKFSEILN--LPDP  553 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~  553 (562)
                      -..|.||+||+ +-|+++++++|.|..+.+++..|.+.+|+|..+.|+.......+... ...-.+..+.+.++  ..++
T Consensus       201 ~k~DiwSlGvi-l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (318)
T d3blha1         201 PPIDLWGAGCI-MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDP  279 (318)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCH
T ss_pred             cHHHcccCCce-eeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCH
Confidence            34799999999 88999999999999999999999999999999999998777665432 11112222333322  2467


Q ss_pred             hHHHHHhcC
Q psy10954        554 LAVDVFSRV  562 (562)
Q Consensus       554 ~~~~~~~~~  562 (562)
                      .+.|++.+|
T Consensus       280 ~~~dLl~~m  288 (318)
T d3blha1         280 YALDLIDKL  288 (318)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            778887754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=8.2e-19  Score=179.00  Aligned_cols=47  Identities=40%  Similarity=0.755  Sum_probs=44.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.
T Consensus       106 ~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_         106 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             HHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence            46889999999999999999999999999999999999999999753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=2.4e-19  Score=184.23  Aligned_cols=85  Identities=33%  Similarity=0.512  Sum_probs=69.9

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccC--CCCCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKL--PIYKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      -..|.||+||+ +.|+++++++|+|..+.+++.++.+..|+|+.+.|+....-  ..+...+|+...+.+..+++..++.
T Consensus       198 ~~~DiwSlGvi-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  276 (346)
T d1cm8a_         198 QTVDIWSVGCI-MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL  276 (346)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred             ccchhhcchHH-HHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHH
Confidence            45799999999 78999999999999999999999999999999887655321  1223346677777888888999999


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      ++|++++|
T Consensus       277 ~~dli~~m  284 (346)
T d1cm8a_         277 AVNLLEKM  284 (346)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=7.6e-19  Score=180.67  Aligned_cols=85  Identities=22%  Similarity=0.406  Sum_probs=64.9

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCC--CCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|+|.+..++..++.++++.|..+..........  +...+|.-.+..+..+++..++.
T Consensus       192 ~~~DiwSlG~i-l~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  270 (345)
T d1pmea_         192 KSIDIWSVGCI-LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK  270 (345)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHH
T ss_pred             chhhhhccCce-ehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHH
Confidence            45799999999 8889999999999999999999999999998876554433221  11234444455566777888888


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++++|
T Consensus       271 ~~~li~~~  278 (345)
T d1pmea_         271 ALDLLDKM  278 (345)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88888753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=3.6e-19  Score=180.10  Aligned_cols=96  Identities=30%  Similarity=0.386  Sum_probs=76.2

Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCeeEeeccccccccccCc----ccceeeeeccCCccceecc
Q psy10954         73 PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLG  148 (562)
Q Consensus        73 e~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~vKL~DFGla~~~~~~~~----~~~~~~~t~~y~aPE~l~~  148 (562)
                      ...+..+.+....++.|+|++|||||||||+||||+.++.+||+|||+++.......    .....+||+.|+|||++.+
T Consensus       107 ~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  186 (303)
T d1vjya_         107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             HHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence            344555666666778899999999999999999999999999999999987643321    2234578999999999875


Q ss_pred             cc-----ccccccccccccccchhh
Q psy10954        149 AK-----VYSTTVDIWSAGCIFSEM  168 (562)
Q Consensus       149 ~~-----~~s~~~DvwSlG~il~Em  168 (562)
                      ..     .++.++|||||||++|||
T Consensus       187 ~~~~~~~~~~~k~Di~S~Gvvl~el  211 (303)
T d1vjya_         187 SINMKHFESFKRADIYAMGLVFWEI  211 (303)
T ss_dssp             CSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccCCCcCcchhhhhhHHHHHHH
Confidence            42     367899999999999997

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=2e-18  Score=176.92  Aligned_cols=85  Identities=29%  Similarity=0.483  Sum_probs=69.3

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcccCCC--CCCCCCcccCccccccCCCCChh
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVSKLPI--YKTDFPEWRPKKFSEILNLPDPL  554 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  554 (562)
                      ...|.||+||+ +.|++++++.|+|.++.++...|++..|.|..+.++.......  +...+++.....++......++.
T Consensus       198 ~~~DiwSlGv~-l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  276 (348)
T d2gfsa1         198 QTVDIWSVGCI-MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL  276 (348)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHH
T ss_pred             cccchhhhhHH-HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHH
Confidence            45799999999 7899999999999999999999999999999988876644321  22345566666678888889999


Q ss_pred             HHHHHhcC
Q psy10954        555 AVDVFSRV  562 (562)
Q Consensus       555 ~~~~~~~~  562 (562)
                      +.|++.+|
T Consensus       277 ~~dli~~m  284 (348)
T d2gfsa1         277 AVDLLEKM  284 (348)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.68  E-value=4.8e-18  Score=159.84  Aligned_cols=121  Identities=22%  Similarity=0.191  Sum_probs=90.8

Q ss_pred             hHHHHHHHHHccCCCCcceEEEEEEeCCEEEEEeecCcCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy10954         20 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   99 (562)
Q Consensus        20 ~~~rEi~iL~~l~HpnIv~L~~~~~~~~~i~lV~Ey~~~~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~gIiHRD   99 (562)
                      .+.+|...|.++.|++++..+++.  .  -++||||+++....       .+++..+..++.|++.||.|||++||+|||
T Consensus        60 ~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrD  128 (191)
T d1zara2          60 SARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGD  128 (191)
T ss_dssp             HHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEcc
Confidence            456799999999999999988763  2  27999999863211       255666788999999999999999999999


Q ss_pred             CCCCcEEEccCCCeeEeeccccccccccCcccceeeeeccCCc------cceecccccccccccccccc
Q psy10954        100 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP------PEILLGAKVYSTTVDIWSAG  162 (562)
Q Consensus       100 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~t~~y~a------PE~l~~~~~~s~~~DvwSlG  162 (562)
                      |||+|||++.+ .++|+|||+|.....+....        |..      .+.+  .+.|+.++|+||..
T Consensus       129 iKP~NILv~~~-~~~liDFG~a~~~~~~~~~~--------~l~rd~~~~~~~f--~r~y~~~~d~~s~~  186 (191)
T d1zara2         129 LSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE--------ILERDVRNIITYF--SRTYRTEKDINSAI  186 (191)
T ss_dssp             CSTTSEEEETT-EEEECCCTTCEETTSTTHHH--------HHHHHHHHHHHHH--HHHHCCCCCHHHHH
T ss_pred             CChhheeeeCC-CEEEEECCCcccCCCCCcHH--------HHHHHHHHHHHHH--cCCCCCcccHHHHH
Confidence            99999999854 58999999987664332110        100      0111  24578899999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=2.7e-17  Score=163.72  Aligned_cols=47  Identities=38%  Similarity=0.764  Sum_probs=44.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.
T Consensus       106 ~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~  152 (271)
T d1nvra_         106 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV  152 (271)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence            36899999999999999999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=2.3e-17  Score=168.07  Aligned_cols=45  Identities=42%  Similarity=0.801  Sum_probs=42.3

Q ss_pred             hhHHHHHHHHHhhhc-CceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs-~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.|++.||+|||+ +||+||||||+|||++++|.+||+|||+|+
T Consensus       108 ~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_         108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            588999999999997 599999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.63  E-value=9.3e-17  Score=165.74  Aligned_cols=49  Identities=24%  Similarity=0.274  Sum_probs=44.1

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcc
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS  527 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (562)
                      ..|.||+||+ +-|++++++.|+|.++.+++.+|.+.-.+++++.|++++
T Consensus       208 ~~DiwSlGvi-lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  256 (352)
T d1koba_         208 YTDMWAIGVL-GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  256 (352)
T ss_dssp             HHHHHHHHHH-HHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             ccchHHHHHH-HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence            3699999998 779999999999999999999999988888888888763

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.62  E-value=4.8e-17  Score=165.43  Aligned_cols=45  Identities=49%  Similarity=1.015  Sum_probs=41.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCC-CEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g-~vKL~DFGla~  213 (562)
                      .+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus       133 ~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         133 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             HHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence            5899999999999999999999999999999765 59999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.59  E-value=1.8e-16  Score=163.35  Aligned_cols=49  Identities=16%  Similarity=0.211  Sum_probs=43.4

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcc
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS  527 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (562)
                      ..|.||+||+ +-|++++++.|.|.+..+++.+|.+.-.++....|++++
T Consensus       205 ~~DiwSlGvi-lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  253 (350)
T d1koaa2         205 YTDMWSVGVL-SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS  253 (350)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred             hHhhhhhhHH-HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence            4699999998 889999999999999999999999988888887777764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.59  E-value=4.5e-16  Score=161.20  Aligned_cols=46  Identities=35%  Similarity=0.658  Sum_probs=43.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       110 ~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3         110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceee
Confidence            3588999999999999999999999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.59  E-value=4.1e-16  Score=160.72  Aligned_cols=45  Identities=40%  Similarity=0.780  Sum_probs=43.4

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       145 ~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence            589999999999999999999999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.2e-16  Score=164.69  Aligned_cols=49  Identities=29%  Similarity=0.428  Sum_probs=44.7

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCc
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGV  526 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (562)
                      -..|.||+||+ ..|+++++++|+|+++.+++.+|++.+++|..+.|...
T Consensus       197 ~~~DiwSlG~~-l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         197 ENVDIWSVGCI-MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             TTHHHHHHHHH-HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             CCcccccccch-HHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            34699999998 88999999999999999999999999999999888644

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.57  E-value=1.2e-15  Score=152.08  Aligned_cols=47  Identities=43%  Similarity=0.674  Sum_probs=44.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       113 ~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_         113 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            36899999999999999999999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=3.7e-16  Score=156.80  Aligned_cols=47  Identities=43%  Similarity=0.793  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.|++.||+|||++|||||||||+|||++++|.+||+|||+|+.
T Consensus       111 ~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_         111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence            35889999999999999999999999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=9.4e-16  Score=151.73  Aligned_cols=46  Identities=54%  Similarity=1.054  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus       109 ~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1         109 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             HHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence            3589999999999999999999999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=1e-15  Score=155.04  Aligned_cols=46  Identities=41%  Similarity=0.681  Sum_probs=43.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..+++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       118 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_         118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             HHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccc
Confidence            3689999999999999999999999999999999999999999863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.54  E-value=1.3e-15  Score=154.63  Aligned_cols=45  Identities=49%  Similarity=0.862  Sum_probs=43.0

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       108 ~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_         108 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             HHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccce
Confidence            578999999999999999999999999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=2.9e-15  Score=149.09  Aligned_cols=47  Identities=36%  Similarity=0.675  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus       107 ~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_         107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             HHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence            46899999999999999999999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.52  E-value=2.1e-15  Score=149.66  Aligned_cols=47  Identities=43%  Similarity=0.781  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++.++.++|+|||.++.
T Consensus       114 ~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_         114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence            46899999999999999999999999999999999999999998654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=2.9e-15  Score=151.40  Aligned_cols=45  Identities=42%  Similarity=0.867  Sum_probs=38.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeec---CCCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~---~~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||+.   .+|.+||+|||+|+
T Consensus       111 ~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_         111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             HHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            5899999999999999999999999999995   47899999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=4.7e-15  Score=150.81  Aligned_cols=47  Identities=30%  Similarity=0.709  Sum_probs=44.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++||||||||+|||++.+|.+||+|||+|+.
T Consensus       167 ~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~  213 (325)
T d1rjba_         167 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD  213 (325)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSC
T ss_pred             HHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeecccccc
Confidence            46899999999999999999999999999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.50  E-value=5e-15  Score=149.02  Aligned_cols=48  Identities=35%  Similarity=0.607  Sum_probs=40.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++||||||||+|||++++|.+||+|||+|+..
T Consensus       131 ~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             HHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            468999999999999999999999999999999999999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=7e-15  Score=145.93  Aligned_cols=46  Identities=46%  Similarity=0.807  Sum_probs=42.3

Q ss_pred             hhhHHHHHHHHHhhhcCc--eeecCCCCcceeec-CCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRR--IIHRDLKPQNILIN-KSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~--IIHRDLKPeNILl~-~~g~vKL~DFGla~  213 (562)
                      ..++.||+.||+|||+++  |+||||||+|||++ .+|.+||+|||+|+
T Consensus       115 ~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_         115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             HHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            368999999999999999  99999999999997 47999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=6.4e-15  Score=149.78  Aligned_cols=49  Identities=14%  Similarity=0.150  Sum_probs=43.7

Q ss_pred             CCCccccchhhhhhcccCCcccCCCCchhhHHHHHHhcCCCCCCCCCCcc
Q psy10954        478 SDDAVSIDVVTYHESITKKTLFAGDSEIDQLFRIFRTLGTPHEDVWPGVS  527 (562)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (562)
                      ..|.||+||+ +.|++++++.|+|....+.+.+|.+.--+++++.||.++
T Consensus       183 ~~DiWSlGvi-ly~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  231 (321)
T d1tkia_         183 ATDMWSLGTL-VYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS  231 (321)
T ss_dssp             HHHHHHHHHH-HHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             hhhcccHHHH-HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCC
Confidence            3699999999 679999999999999999999999988888888888764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=6.9e-15  Score=145.88  Aligned_cols=45  Identities=51%  Similarity=0.921  Sum_probs=41.7

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecC-CCCEEEeeccccc
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSR  213 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~-~g~vKL~DFGla~  213 (562)
                      .++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus       114 ~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_         114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence            58999999999999999999999999999985 5799999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=1.7e-14  Score=144.43  Aligned_cols=46  Identities=41%  Similarity=0.732  Sum_probs=42.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCC----CEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g----~vKL~DFGla~  213 (562)
                      ..+++|++.||+|||+++|+||||||+|||++.+|    .+||+|||+|+
T Consensus       116 ~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_         116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            36899999999999999999999999999998776    59999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2.9e-14  Score=141.27  Aligned_cols=47  Identities=38%  Similarity=0.665  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+.
T Consensus       112 ~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_         112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence            46899999999999999999999999999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=3e-14  Score=144.74  Aligned_cols=47  Identities=40%  Similarity=0.627  Sum_probs=44.2

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       132 ~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             HHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            35789999999999999999999999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=2.1e-14  Score=146.86  Aligned_cols=46  Identities=41%  Similarity=0.725  Sum_probs=42.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla~  213 (562)
                      ..+++||+.||+|||++||+||||||+|||++.   .+.+||+|||+|+
T Consensus       114 ~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1         114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence            368999999999999999999999999999985   5679999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=6.1e-14  Score=140.11  Aligned_cols=48  Identities=33%  Similarity=0.615  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus       112 ~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_         112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            468999999999999999999999999999999999999999998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=3.9e-14  Score=143.38  Aligned_cols=47  Identities=32%  Similarity=0.740  Sum_probs=44.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus       114 ~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_         114 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             HHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence            46889999999999999999999999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=1.2e-13  Score=137.04  Aligned_cols=48  Identities=42%  Similarity=0.732  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus       114 ~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_         114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            468999999999999999999999999999999999999999998764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.37  E-value=1.6e-13  Score=137.14  Aligned_cols=49  Identities=27%  Similarity=0.563  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC-----CCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-----SGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~-----~g~vKL~DFGla~~~~  216 (562)
                      ..++.|++.||+|||++|||||||||+|||++.     ++.+||+|||+|+...
T Consensus       104 ~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_         104 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             HHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            468999999999999999999999999999974     5789999999998654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.36  E-value=5.4e-14  Score=143.87  Aligned_cols=47  Identities=26%  Similarity=0.266  Sum_probs=37.0

Q ss_pred             CCCCccccchhhhhhcccCCcccCCCC------chhhHHHHHHhcCCCCCCCCC
Q psy10954        477 LSDDAVSIDVVTYHESITKKTLFAGDS------EIDQLFRIFRTLGTPHEDVWP  524 (562)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  524 (562)
                      ...|.||+||+ +.|++++++.|.++.      +.+++.++++.+|+++.+.|.
T Consensus       208 ~~~DiwSlG~i-l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~  260 (362)
T d1q8ya_         208 CGADIWSTACL-IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR  260 (362)
T ss_dssp             THHHHHHHHHH-HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccccccchHHH-HHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhh
Confidence            35799999999 899999999998654      468899999999998776653

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.36  E-value=7.1e-14  Score=139.79  Aligned_cols=49  Identities=33%  Similarity=0.688  Sum_probs=43.4

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecC---CCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~---~g~vKL~DFGla~~~~  216 (562)
                      +.++.|++.||+|||++|||||||||+|||++.   ++.+||+|||+|+...
T Consensus       106 ~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_         106 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             HHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            467899999999999999999999999998764   4579999999988654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=1.3e-13  Score=137.67  Aligned_cols=47  Identities=34%  Similarity=0.588  Sum_probs=43.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus       116 ~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3         116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             HHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence            46899999999999999999999999999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.33  E-value=1.3e-13  Score=129.01  Aligned_cols=77  Identities=29%  Similarity=0.286  Sum_probs=55.9

Q ss_pred             hhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccc----hhhhcCCCCCC
Q psy10954        169 SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP----PEILLGAKVYS  244 (562)
Q Consensus       169 ~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~A----PEvl~~~~~y~  244 (562)
                      .++.|++.||+|||++||+||||||+|||++++| ++|+|||+|.....+...  ..    ..+.    .|.+  .+.|+
T Consensus       107 ~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~--~~----l~rd~~~~~~~f--~r~y~  177 (191)
T d1zara2         107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR--EI----LERDVRNIITYF--SRTYR  177 (191)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH--HH----HHHHHHHHHHHH--HHHHC
T ss_pred             HHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH--HH----HHHHHHHHHHHH--cCCCC
Confidence            4789999999999999999999999999998655 899999998765432211  00    0000    1112  23488


Q ss_pred             chhhHHHHHH
Q psy10954        245 TTVDIWSAGC  254 (562)
Q Consensus       245 ~~~DIWSlG~  254 (562)
                      .++|+||+.-
T Consensus       178 ~~~d~~s~~~  187 (191)
T d1zara2         178 TEKDINSAID  187 (191)
T ss_dssp             CCCCHHHHHH
T ss_pred             CcccHHHHHH
Confidence            9999999854

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=2e-13  Score=136.48  Aligned_cols=48  Identities=38%  Similarity=0.778  Sum_probs=40.0

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      ..++.||+.||+|||+++||||||||+|||++++|.+||+|||+|+..
T Consensus       137 ~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~  184 (299)
T d1ywna1         137 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI  184 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------C
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhc
Confidence            468999999999999999999999999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.29  E-value=3.7e-13  Score=134.31  Aligned_cols=48  Identities=38%  Similarity=0.632  Sum_probs=44.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus       118 ~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_         118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             HHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            467899999999999999999999999999999999999999998753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=7.3e-13  Score=131.69  Aligned_cols=49  Identities=35%  Similarity=0.613  Sum_probs=42.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus       113 ~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_         113 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             HHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            4689999999999999999999999999999999999999999998654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=2.7e-12  Score=127.25  Aligned_cols=49  Identities=31%  Similarity=0.586  Sum_probs=46.1

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  216 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~  216 (562)
                      +.++.||+.||+|||+++||||||||+|||++++|.+||+|||+|+...
T Consensus       110 ~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~  158 (277)
T d1xbba_         110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  158 (277)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence            4689999999999999999999999999999999999999999998654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=2.4e-12  Score=126.49  Aligned_cols=47  Identities=30%  Similarity=0.612  Sum_probs=41.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+.
T Consensus       104 ~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  150 (263)
T d1sm2a_         104 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  150 (263)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred             HHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhee
Confidence            46899999999999999999999999999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.17  E-value=3.4e-12  Score=127.80  Aligned_cols=47  Identities=36%  Similarity=0.650  Sum_probs=44.7

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.|++.||+|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus       143 ~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~  189 (301)
T d1lufa_         143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN  189 (301)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred             HHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhhee
Confidence            46899999999999999999999999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=3.8e-12  Score=125.57  Aligned_cols=48  Identities=46%  Similarity=0.831  Sum_probs=39.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++||||||||+||++++++.+||+|||+|+..
T Consensus       111 ~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_         111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             HHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence            468899999999999999999999999999999999999999998653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=1.2e-11  Score=124.39  Aligned_cols=67  Identities=18%  Similarity=0.328  Sum_probs=54.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccccccCCCcccccccCCCccchhhh
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL  237 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~~~~~~~~~vgT~~Y~APEvl  237 (562)
                      ..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+....   ......++..+.+|+.+
T Consensus       136 ~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~---~~~~~~~~~~~~t~~y~  202 (308)
T d1p4oa_         136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE---TDYYRKGGKGLLPVRWM  202 (308)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGG---GGCEEGGGSSEECGGGC
T ss_pred             HHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccC---CcceeeccceecccccC
Confidence            45899999999999999999999999999999999999999999876531   22334456666677644

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=1.9e-11  Score=122.26  Aligned_cols=48  Identities=40%  Similarity=0.769  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++||||||||+|||++.+|.+||+|||+++..
T Consensus       138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~  185 (299)
T d1fgka_         138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI  185 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCG
T ss_pred             HHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccc
Confidence            478999999999999999999999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=2.3e-11  Score=119.26  Aligned_cols=48  Identities=40%  Similarity=0.717  Sum_probs=44.9

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.|+++||+|||++||+||||||+|||+++++.+||+|||+|+..
T Consensus       103 ~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_         103 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             HHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             HHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            468899999999999999999999999999999999999999998653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=3e-11  Score=121.44  Aligned_cols=48  Identities=38%  Similarity=0.715  Sum_probs=45.3

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  215 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~  215 (562)
                      +.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus       148 ~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~  195 (311)
T d1t46a_         148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI  195 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCT
T ss_pred             HHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheec
Confidence            368999999999999999999999999999999999999999998754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=3.8e-11  Score=120.84  Aligned_cols=50  Identities=28%  Similarity=0.597  Sum_probs=46.8

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI  217 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~~~~  217 (562)
                      +.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus       133 ~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             HHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            46899999999999999999999999999999999999999999987653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.02  E-value=4.5e-11  Score=119.94  Aligned_cols=47  Identities=36%  Similarity=0.680  Sum_probs=44.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeecccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA  214 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~~  214 (562)
                      +.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus       130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~  176 (309)
T d1fvra_         130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG  176 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEES
T ss_pred             HHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccc
Confidence            46899999999999999999999999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.94  E-value=1.7e-10  Score=113.14  Aligned_cols=46  Identities=30%  Similarity=0.706  Sum_probs=42.6

Q ss_pred             hhhHHHHHHHHHhhhcCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        168 MSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       168 m~~l~QIl~gL~yLHs~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      +.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++
T Consensus       106 ~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_         106 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             HHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence            4689999999999999999999999999999999999999999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.50  E-value=0.00012  Score=69.28  Aligned_cols=71  Identities=14%  Similarity=0.002  Sum_probs=51.5

Q ss_pred             hhhHHHHHHHHHccC-CCCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy10954         18 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   94 (562)
Q Consensus        18 ~~~~~rEi~iL~~l~-HpnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~~g   94 (562)
                      .....+|...|+.+. +--+.+++.+...++..|+||+++++ .+.+....      ......+..++...+..||+..
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~  125 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSC
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccC
Confidence            445789999998874 43467888888888999999999987 66554321      1223456778888899999753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.17  E-value=0.00018  Score=67.65  Aligned_cols=69  Identities=20%  Similarity=0.202  Sum_probs=47.8

Q ss_pred             CchhhHHHHHHHHHccCC--CCcceEEEEEEeCCEEEEEeecCcC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy10954         16 GVPSTALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   92 (562)
Q Consensus        16 ~~~~~~~rEi~iL~~l~H--pnIv~L~~~~~~~~~i~lV~Ey~~~-~L~~~i~~~~~~l~e~~i~~i~~qll~aL~yLH~   92 (562)
                      +....+.+|...|+.+..  -.+.+++.+...++..++||+++++ ++.+      ......   ..+.++...|.-||+
T Consensus        46 ~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~------~~~~~~---~~~~~l~~~la~LH~  116 (255)
T d1nd4a_          46 GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS------SHLAPA---EKVSIMADAMRRLHT  116 (255)
T ss_dssp             CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT------SCCCHH---HHHHHHHHHHHHHTT
T ss_pred             cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc------ccccHH---HHHHHHHHHHHHHcc
Confidence            334457789999988843  3467888888888889999999987 4422      112322   335677888888997


Q ss_pred             C
Q psy10954         93 R   93 (562)
Q Consensus        93 ~   93 (562)
                      .
T Consensus       117 ~  117 (255)
T d1nd4a_         117 L  117 (255)
T ss_dssp             S
T ss_pred             C
Confidence            4

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.57  E-value=0.0099  Score=59.82  Aligned_cols=28  Identities=25%  Similarity=0.360  Sum_probs=24.0

Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccc
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSR  122 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~  122 (562)
                      .++|+|+.|.|||++.++ ++|+||-.|.
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            589999999999998664 8999997753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.35  E-value=0.028  Score=53.98  Aligned_cols=31  Identities=26%  Similarity=0.327  Sum_probs=27.4

Q ss_pred             cCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        183 SRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       183 s~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ..|+||.|+.++||+++.++..-++||+.|.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3589999999999999988877899999864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=90.69  E-value=0.11  Score=51.47  Aligned_cols=36  Identities=14%  Similarity=0.105  Sum_probs=25.0

Q ss_pred             hhHHHHHHHHHccCCCC-cceEEEEEEeCCEEEEEeecCcC
Q psy10954         19 STALREISVLKELKHPN-VIRLHDVIPVDFKLFLVFEFLRQ   58 (562)
Q Consensus        19 ~~~~rEi~iL~~l~Hpn-Iv~L~~~~~~~~~i~lV~Ey~~~   58 (562)
                      ....+|..+++.+.--+ ..+++.++..    .+||||+++
T Consensus        89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g  125 (395)
T d1nw1a_          89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS  125 (395)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecc
Confidence            34568999999885334 4578887642    578899864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.32  E-value=0.038  Score=53.01  Aligned_cols=30  Identities=27%  Similarity=0.334  Sum_probs=26.4

Q ss_pred             CCceeccCCCCcEEEccCCCeeEeeccccc
Q psy10954         93 RRIIHRDLKPQNILINKSGALKLADFGLSR  122 (562)
Q Consensus        93 ~gIiHRDLKP~NILl~~~~~vKL~DFGla~  122 (562)
                      .|+||.|+.++||+++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=86.74  E-value=0.21  Score=49.59  Aligned_cols=30  Identities=23%  Similarity=0.352  Sum_probs=25.5

Q ss_pred             cCceeecCCCCcceeecCCCCEEEeeccccc
Q psy10954        183 SRRIIHRDLKPQNILINKSGALKLADFGLSR  213 (562)
Q Consensus       183 s~~IIHRDLKPeNILl~~~g~vKL~DFGla~  213 (562)
                      ...++|+|+.|.|||++.++ ++|+||-.|.
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            34799999999999998765 8999998764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=86.29  E-value=0.13  Score=47.22  Aligned_cols=29  Identities=28%  Similarity=0.383  Sum_probs=24.9

Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccc
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSR  122 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~  122 (562)
                      .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            48999999999999876666799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=85.91  E-value=0.12  Score=47.20  Aligned_cols=29  Identities=21%  Similarity=0.225  Sum_probs=25.0

Q ss_pred             CceeccCCCCcEEEccCCCeeEeeccccc
Q psy10954         94 RIIHRDLKPQNILINKSGALKLADFGLSR  122 (562)
Q Consensus        94 gIiHRDLKP~NILl~~~~~vKL~DFGla~  122 (562)
                      .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            48999999999999977667799999764